Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
MET	"DFNB97, HGFR, RCCP2"	ENSG00000105976	"MET proto-oncogene, receptor tyrosine kinase"	P08581	7	116672390-116798386	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 78.1;Club cells: 116.0;Urothelial cells: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 45.3;CAPAN-2: 49.5"	"Group enriched"	"Detected in many"	5	"amygdala: 3.5;basal ganglia: 9.9;cerebral cortex: 7.6;hippocampal formation: 8.0;olfactory region: 9.1"	"Low region specificity"	"Detected in many"			"CAB005282, CAB018577, HPA055607"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	179000000	70000000	"Plasma membrane, Cytosol"		"CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: AB_2682860"	"unprognostic (1.60e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (1.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.20e-1)"	16.2	1.1	1.8	4.5	2.3	4.3	11.2	0.9	15.2	9.9	6.5	2.4	2.4	4.4	7.5	5.2	5.1	4.6	12.3	5.4	5.7	1.8	20.1	30.2	15.6	1.4	3.6	2.1	2.0	9.3	0.7	8.1	24.4	2.6	8.0	6.6	34.1	12.2	8.4	12.8	7.2	8.6	4.0	2.3	5.7	10.6	2.7	2.4	0.5	21.4	7.0	2.1	10.1	15.0	0.2	0.3	1.2	0.2	0.3	0.4	0.0	45.3	26.1	0.0	0.1	2.0	2.0	1.8	25.9	10.5	14.0	11.8	5.4	49.5	2.0	43.2	16.2	37.7	12.0	4.4	24.7	28.6	0.1	5.6	0.0	27.1	4.7	0.3	0.0	0.0	2.6	9.8	9.1	30.0	25.3	9.6	0.0	0.9	0.2	25.9	1.0	0.0	0.0	3.9	7.2	26.6	0.0	22.0	0.0	24.5	5.2	3.8	0.0	10.6	3.4	10.1	4.7	0.0	0.2	17.6	20.9	7.4	11.0	20.0	0.5	4.0	0.2	22.9	0.0	2.9	1.1	0.2	0.4	0.4	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	1.2	0.3	0.1	0.3	0.1	0.0	1.8	2.3	0.9	15.2	5.7	1.8	3.6	2.1	2.6	2.4	26.8	78.1	2.4	56.1	34.7	0.9	10.0	15.3	22.7	116.0	29.6	0.0	57.9	0.0	28.0	0.0	11.7	11.2	0.0	39.8	5.0	4.0	55.8	0.0	26.0	6.1	0.0	6.9	1.3	1.0	0.0	0.6	2.0	3.3	1.8	19.7	7.4	69.4	7.0	0.0	13.5	0.3	0.0	2.3	0.0	0.6	15.6	18.2	0.0	12.7	88.5
MYEOV	OCIM	ENSG00000172927	"Myeloma overexpressed"	Q96EZ4	11	69294138-69367726	"Predicted membrane proteins"			Proto-oncogene	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 29.4;breast: 16.9;esophagus: 17.3"	"Cell type enriched"	"Detected in some"	8	"Pancreatic endocrine cells: 116.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 59.2;A549: 28.4;CAPAN-2: 8.7;U-2 OS: 13.1"									HPA012949	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA012949: AB_1854241"	"unprognostic (1.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.36e-1)"	"unprognostic (5.60e-2)"	"unprognostic (7.28e-3)"	"unprognostic (7.58e-3)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (3.49e-1)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (1.54e-7)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.69e-2)"	29.4	0.2	0.0	2.4	0.0	0.2	16.9	0.1	0.0	2.6	1.1	0.0	0.4	0.4	0.5	8.1	17.3	0.0	1.3	0.1	0.0	0.2	0.2	8.6	0.1	0.2	0.0	0.1	0.1	2.1	0.0	0.1	0.0	0.0	0.1	0.6	0.9	2.0	0.0	0.6	4.9	0.8	0.1	0.0	0.3	10.7	0.4	0.0	0.1	0.1	5.3	13.6	0.2	4.7	0.5	0.0	0.0	0.1	1.0	0.3	2.1	59.2	28.4	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.2	8.7	0.2	2.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	1.0	2.3	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.0	0.1	0.8	0.0	13.1	0.0	0.6	0.1	0.6	0.1	0.0	0.2	1.1	0.0	0.1	0.0	0.2	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.3	0.0	0.0	0.0	3.5	0.0	0.0	0.0	15.5	10.5	0.0	0.4	0.0	8.4	0.2	0.2	1.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	4.7	0.3	0.0	0.0	0.0	1.0	0.0	116.0	12.5	0.0	0.0	0.0	0.0	1.4	0.0	0.4	1.1	0.1	0.0	0.5	6.8
EPS8		ENSG00000151491	"Epidermal growth factor receptor pathway substrate 8"	Q12929	12	15620158-15882329	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Sertoli cells: 394.5;Smooth muscle cells: 265.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 16.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 56.9;HHSteC: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003897	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA003897: AB_1848224"	"unprognostic (6.16e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavorable (3.33e-7)"	"unprognostic (2.68e-1)"	"prognostic favorable (1.45e-7)"	"unprognostic (7.47e-3)"	"unprognostic (7.20e-2)"	"prognostic favorable (5.11e-4)"	"unprognostic (1.79e-2)"	52.6	5.9	7.9	7.4	10.7	0.1	37.3	7.9	7.6	28.7	24.9	9.5	13.5	16.6	39.1	28.5	12.2	16.9	25.4	16.3	8.4	6.8	25.4	16.3	12.7	7.0	12.6	6.6	23.4	6.6	6.4	4.4	23.4	10.9	24.4	24.2	23.3	12.0	19.0	12.7	9.8	26.2	36.0	13.5	11.1	14.2	12.1	11.8	0.1	15.9	9.5	2.8	33.5	40.1	1.0	4.4	3.6	16.7	0.7	0.9	1.2	13.6	8.3	8.3	0.3	56.9	40.5	11.7	15.9	13.0	7.6	10.2	7.1	21.0	0.0	0.5	29.9	25.3	3.5	2.4	2.0	11.5	0.0	2.7	1.2	2.6	7.3	49.2	0.9	0.0	35.7	9.2	20.1	25.7	9.9	3.8	0.0	0.0	0.0	36.6	3.7	0.0	0.6	1.1	10.6	6.7	0.0	24.1	0.1	21.7	19.7	0.6	1.0	4.6	2.6	19.6	1.4	7.5	0.9	6.1	12.2	3.2	7.0	6.5	0.7	0.0	0.0	7.1	2.2	34.7	0.0	2.2	0.2	0.2	8.7	0.1	1.0	0.8	0.3	4.4	0.3	0.9	0.4	3.6	0.7	16.7	0.3	0.1	1.2	7.9	10.7	7.9	7.6	8.4	6.8	12.6	6.6	10.9	11.8	11.9	128.1	6.4	32.5	15.0	9.0	26.6	45.9	123.1	67.1	22.7	62.8	28.6	51.4	61.2	44.8	38.3	132.6	0.0	60.3	5.2	39.1	23.0	5.8	29.8	50.7	6.4	36.8	43.0	42.7	39.2	124.8	32.7	33.7	10.0	53.1	11.3	68.7	76.3	41.1	88.2	140.5	394.5	265.9	10.8	3.1	11.4	17.6	5.7	61.9	92.1
ZNF488	FLJ32104	ENSG00000265763	"Zinc finger protein 488"	Q96MN9	10	47365496-47384273	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"brain: 29.7;intestine: 25.8"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 30.2"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 23.7;HDLM-2: 34.3;RT4: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035957, HPA035958"			Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"HPA035957: AB_10672234, HPA035958: AB_2674887"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.49e-4)"	"unprognostic (1.16e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (4.02e-7)"	"unprognostic (3.60e-1)"	"unprognostic (6.62e-5)"	"unprognostic (2.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.18e-2)"	0.4	0.4	5.7	0.4	18.5	0.3	1.2	2.9	14.2	0.5	3.2	17.0	0.0	25.8	0.5	2.3	0.9	0.5	0.6	0.4	15.1		1.1	0.3	0.5	0.3	19.8	6.0	0.7	0.3	0.3	0.0	4.1	21.4	0.6	1.1	0.0	0.6	0.4	0.3	2.2	12.5	0.4	29.7	0.3	0.6	1.2	12.8	0.0	0.3	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	6.8	1.2	0.3	0.0	0.0	0.1	0.2	0.3	0.4	0.4	2.7	6.4	0.1	0.4	0.0	2.7	23.7	0.6	2.6	0.3	34.3	0.7	0.1	0.7	0.2	0.0	0.0	0.3	0.0	6.2	0.2	0.6	0.1	0.0	1.3	0.0	0.0	0.0	0.1	0.2	0.1	1.8	5.1	0.6	0.0	3.0	0.0	0.1	19.1	5.7	1.0	1.6	0.2	0.0	2.7	0.5	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.8	0.6	0.8	0.3	0.0	0.0	0.0	0.0	0.0	5.6	5.0	0.3	0.0	0.0	1.0	0.0	0.2	0.3	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.1	30.2	0.0	0.8	0.3
KPNA4	"IPOA3, MGC12217, MGC26703, QIP1, SRP3"	ENSG00000186432	"Karyopherin subunit alpha 4"	O00629	3	160494995-160565588	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 66.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034336, HPA043154, HPA045500"	Enhanced		Enhanced	Nucleoplasm		NA	NA		250000	Nucleoplasm		"CAB034336: AB_2281054, HPA043154: AB_2678343, HPA045500: AB_2679351"	"unprognostic (1.58e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (8.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.24e-7)"	"unprognostic (7.71e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.48e-1)"	18.0	9.4	12.6	12.9	12.7	15.2	25.1	13.1	14.1	14.8	14.4	8.6	11.1	7.3	13.1	10.8	22.1	8.9	13.9	45.0	12.0	12.1	11.0	12.6	11.4	12.4	11.6	10.8	15.0	10.7	12.5	6.9	17.5	11.1	11.0	9.7	7.1	10.9	13.1	66.1	10.6	9.5	20.4	10.4	12.1	10.8	13.5	6.3	13.8	11.4	22.2	10.2	21.8	25.2	2.9	2.9	6.8	11.5	8.3	5.6	3.2	33.8	12.0	12.4	16.7	14.3	13.2	16.3	21.1	15.1	15.5	13.2	15.3	17.8	18.0	25.3	21.6	23.2	15.8	13.9	13.6	23.4	22.3	7.8	15.2	10.7	9.1	18.6	21.2	13.7	13.5	14.4	15.0	30.6	12.5	20.4	8.9	11.4	14.6	22.0	9.5	19.1	8.8	25.2	15.3	11.2	12.8	18.5	18.2	12.5	13.0	10.1	9.8	20.4	20.5	29.3	14.4	17.8	11.6	22.7	17.8	15.3	17.7	33.9	26.8	17.7	41.3	16.2	22.2	15.7	6.8	3.6	6.0	3.1	6.7	5.6	2.9	4.5	4.5	2.7	2.5	3.6	4.7	5.4	8.3	11.5	2.9	4.2	3.2	12.6	12.7	13.1	13.3	12.0	12.1	11.6	10.8	11.1	6.3	35.7	24.3	27.5	63.0	109.9	56.4	153.2	20.4	40.2	43.3	10.4	74.6	22.7	29.9	33.3	19.9	45.0	51.2	0.0	32.4	20.6	50.3	69.0	30.1	26.1	35.0	50.9	27.5	29.4	41.9	14.3	31.4	45.8	42.2	26.2	29.9	52.1	57.1	33.4	32.5	31.4	60.8	32.3	42.2	40.3	21.8	110.2	34.0	29.9	30.5	94.6
FZD6	Hfz6	ENSG00000164930	"Frizzled class receptor 6"	O60353	8	103298433-103332866	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 41.7;Suprabasal keratinocytes: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 7.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 41.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017991	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA017991: AB_1849138"	"unprognostic (8.22e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (1.20e-6)"	"unprognostic (3.62e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	"unprognostic (7.54e-2)"	13.1	9.2	3.4	5.2	3.8	0.5	13.3	4.3	5.9	12.1	10.7	3.5	8.6	4.0	12.0	16.4	17.9	17.8	12.3	9.6	3.7	3.8	17.4	5.8	17.1	4.7	4.2	2.9	11.6	14.4	21.3	27.2	14.1	10.0	12.4	4.9	11.6	15.3	8.8	4.3	16.9	7.7	12.7	4.2	6.1	8.0	7.2	1.5	10.9	21.2	18.7	14.7	15.9	11.3	1.7	1.0	0.2	0.0	7.9	2.2	0.5	19.6	4.0	9.5	0.0	2.2	7.0	5.9	10.5	11.5	9.3	6.1	2.1	15.1	0.0	17.9	9.2	2.9	29.1	5.3	21.7	16.6	4.4	6.5	10.4	4.6	2.6	31.3	0.0	0.0	7.9	41.8	9.9	30.6	22.2	19.1	2.2	1.0	8.6	10.0	8.1	9.2	0.8	2.2	1.4	6.9	0.7	4.5	0.0	19.0	12.4	3.3	2.7	14.6	7.7	19.0	5.3	0.0	3.5	1.5	2.2	11.0	8.4	10.6	2.2	1.1	4.2	6.1	0.0	13.5	0.0	0.0	0.2	0.6	0.0	0.0	0.9	2.1	0.9	1.0	1.7	2.2	1.0	0.0	7.9	0.0	0.2	0.6	0.5	3.4	3.8	4.3	5.9	3.7	3.8	4.2	2.9	10.0	1.5	23.8	16.1	0.8	13.5	41.7	3.7	4.7	7.6	26.8	25.0	12.2	2.0	17.8	0.0	10.9	7.8	28.9	3.2	0.0	7.2	6.6	6.9	11.0	0.0	3.2	2.1	6.4	5.1	11.1	0.6	2.1	1.1	1.7	13.5	1.0	6.9	15.5	8.1	3.5	1.4	8.2	4.4	0.0	4.1	7.2	0.7	39.0	12.2	2.5	5.2	19.2
LY6D	E48	ENSG00000167656	"Lymphocyte antigen 6 family member D"	Q14210	8	142784880-142786592	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 236.9;skin 1: 111.6;tongue: 316.2"	"Group enriched"	"Detected in some"	14	"Basal keratinocytes: 1040.7;Suprabasal keratinocytes: 3379.4"	"Group enriched"	"Detected in many"	7	"cervical cancer: 409.8;head and neck cancer: 444.6;urothelial cancer: 242.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	20	"A-431: 57.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA024755, HPA064317"	Enhanced					NA	NA		92000			"HPA024755: AB_1853410, HPA064317: AB_2685244"	"unprognostic (2.13e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.08e-2)"		"unprognostic (8.97e-2)"		"unprognostic (1.51e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (2.50e-1)"	"unprognostic (3.97e-1)"	"unprognostic (5.40e-4)"	"unprognostic (1.06e-1)"	0.2	3.7	0.2	0.2	0.2	0.1	3.7	0.2	0.2	23.0	0.2	0.2	0.2	0.1	2.1	0.2	236.9	0.1	0.5	0.2	0.2	0.0	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	1.3	0.2	1.2	0.1	0.2	18.1	0.2	0.4	111.6	0.2	0.9	0.2	0.2	2.0	0.2	0.2	0.9	0.2	316.2	61.8	6.3	36.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	1.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	3.0	0.0	0.0	6.9	1040.7	0.0	0.0	0.0	1.4	39.8	1.8	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	4.6	0.5	2.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	155.3	0.0	0.0	0.0	4.1	0.0	0.0	0.6	0.0	0.0	2.0	0.0	0.0	3379.4	6.9	0.0	0.0	148.4
ANLN	"ANILLIN, scra, Scraps"	ENSG00000011426	"Anillin actin binding protein"	Q9NQW6	7	36389806-36453791	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.4;lymphoid tissue: 32.7"	"Cell type enhanced"	"Detected in many"	21	"Early spermatids: 106.8;Late spermatids: 41.2;Spermatocytes: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 100.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005680, CAB033902, HPA050556, CAB062547, CAB068175"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			Nucleoplasm	Midbody	"CAB033902: AB_2058302, CAB062547: AB_2665622, CAB068175: AB_2665623, HPA005680: AB_2667388, HPA050556: AB_2681175"	"unprognostic (4.23e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (5.97e-7)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (2.69e-2)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (2.00e-6)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.04e-3)"	1.7	0.6	13.9	7.2	10.5	20.9	1.3	1.8	36.7	1.9	3.9	1.6	0.0	2.9	1.3	2.4	12.8	0.6	1.4	0.6	24.0	12.1	0.7	0.8	3.3	4.2	30.5	2.5	0.9	0.4	0.3	0.3	12.9	9.7	0.7	5.5	0.0	0.9	0.3	0.4	8.9	3.4	9.4	63.4	1.6	3.3	9.2	12.5	32.7	0.6	17.7	6.7	2.6	1.3	0.0	0.3	0.6	0.9	0.0	1.7	2.0	68.4	14.4	12.0	9.1	1.6	4.2	12.9	43.2	25.3	52.2	39.2	9.8	21.2	3.4	12.5	21.8	27.8	35.3	9.4	25.2	100.3	2.3	6.8	4.7	16.2	8.1	0.2	6.7	5.5	0.9	1.1	34.0	22.4	6.2	16.2	4.6	9.8	7.3	42.5	10.3	5.7	7.8	13.3	10.5	15.2	4.2	36.0	2.3	11.5	11.2	5.1	6.0	22.7	26.4	3.9	17.4	17.8	7.7	15.3	32.7	36.8	19.2	50.4	3.0	4.8	6.4	11.1	10.9	68.6	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.9	0.5	0.3	0.0	0.6	0.0	0.6	0.0	0.3	0.2	1.7	2.0	13.9	10.5	1.8	7.7	24.0	12.1	30.5	2.5	9.7	12.5	0.0	0.6	0.0	1.0	12.6	0.0	0.6	0.0	2.7	1.2	0.0	0.0	2.5	0.0	0.5	106.8	0.1	0.9	0.0	0.2	20.2	3.5	1.3	0.0	0.0	8.0	0.0	0.0	1.8	1.5	41.2	1.1	2.6	0.0	0.0	2.2	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.4	20.9	14.9	8.2	2.4	1.5	1.6	1.4
INSIG2		ENSG00000125629	"Insulin induced gene 2"	Q9Y5U4	2	118088452-118110997	"Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							CAB033861	Uncertain					NA	NA					"CAB033861: AB_2249149"	"unprognostic (3.84e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.84e-1)"	"unprognostic (7.00e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (1.80e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.41e-2)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (2.19e-6)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (4.11e-6)"	"unprognostic (1.40e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.75e-2)"	12.3	8.2	14.3	7.1	16.5	3.2	13.5	24.4	22.5	10.0	9.6	8.9	7.8	11.6	12.1	16.8	8.1	8.3	9.4	11.0	12.2	10.6	16.0	38.6	12.9	10.2	12.0	13.1	11.8	14.5	16.9	15.8	11.0	17.5	11.8	8.3	8.9	9.4	10.1	8.8	12.1	14.7	10.1	13.9	14.1	13.5	7.3	11.6	18.5	13.2	1.8	9.6	10.0	9.8	11.8	11.4	17.5	17.6	15.4	15.4	9.2	23.6	4.2	6.4	2.7	16.4	8.1	7.0	6.7	7.3	5.4	9.5	3.9	22.8	4.6	22.6	8.5	8.4	8.8	4.8	11.2	10.1	8.7	5.8	4.4	5.5	26.9	6.3	5.5	7.2	12.8	10.2	4.9	11.5	18.0	12.5	7.0	2.4	8.7	8.8	2.5	7.0	7.4	3.1	6.7	5.9	4.6	5.5	5.0	12.3	7.4	5.1	6.8	3.9	6.9	3.8	7.4	3.5	5.4	13.3	6.8	4.9	6.1	3.4	16.1	8.6	4.2	13.8	4.4	4.4	10.2	10.3	17.5	11.9	15.2	13.9	11.8	13.0	11.4	11.4	10.8	14.2	15.4	10.8	15.4	17.6	10.6	11.6	9.2	14.3	16.5	24.4	22.5	12.2	10.6	12.0	13.1	17.5	11.6	32.8	21.6	20.4	11.6	36.4	15.1	17.3	48.4	10.7	15.9	41.8	11.8	16.4	16.6	75.4	3.4	16.9	14.9	23.3	54.3	27.8	15.5	20.7	20.7	37.6	24.9	23.8	20.1	42.4	24.1	2.5	11.8	21.4	30.4	24.4	13.2	17.1	69.7	11.0	13.4	23.7	11.5	0.0	31.1	33.8	14.3	35.0	16.6	21.4	12.3	13.3
ARMC10	"MGC3195, SVH"	ENSG00000170632	"Armadillo repeat containing 10"	Q8N2F6	7	103074881-103099764	"Predicted intracellular proteins, Predicted membrane proteins"	"Growth regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011036, HPA011057"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA011036: AB_1080139, HPA011057: AB_1080137"	"unprognostic (7.03e-3)"	"unprognostic (2.44e-1)"	"unprognostic (8.18e-2)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (8.90e-6)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (5.57e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.90e-2)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (1.02e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.67e-2)"	21.6	21.7	28.0	12.6	25.0	9.1	24.5	11.4	28.0	24.4	18.6	24.7	20.8	14.0	20.4	24.2	22.2	23.2	20.0	16.7	26.2	26.2	27.4	30.2	15.0	15.7	26.3	24.2	26.5	28.7	26.0	12.0	15.4	19.7	22.2	18.8	17.6	15.7	23.4	15.8	21.6	12.8	20.3	25.5	14.4	19.8	14.1	19.6	21.5	30.7	15.6	15.7	22.3	20.5	5.1	6.8	6.6	5.4	3.9	4.7	2.2	12.6	10.8	6.4	12.4	13.4	12.8	6.4	8.9	9.7	6.4	7.8	5.8	15.0	22.8	19.3	7.8	18.4	11.4	9.0	9.9	9.2	8.5	10.3	8.0	4.6	2.8	13.5	22.0	9.6	8.3	17.5	8.1	13.3	19.6	14.6	12.9	19.6	14.1	11.4	23.4	16.1	17.1	14.3	21.7	11.7	9.8	6.7	29.6	16.3	8.9	7.2	9.9	12.1	18.3	13.4	11.6	7.4	11.0	9.7	10.0	9.5	23.4	13.3	21.7	33.9	18.3	11.3	20.5	12.4	0.0	4.4	6.6	2.6	5.4	4.5	4.0	4.1	4.4	6.8	5.1	4.6	4.7	0.9	3.9	2.8	5.3	4.2	2.2	28.0	25.0	11.4	28.0	26.2	26.2	26.3	24.2	19.7	19.6	23.8	17.0	26.1	49.5	69.9	22.6	15.4	22.9	6.7	15.9	26.2	13.7	38.2	56.3	15.6	10.1	27.0	15.3	0.0	13.3	39.5	28.9	60.5	17.3	34.7	41.8	7.9	14.5	25.2	32.4	6.3	31.4	31.1	43.9	2.8	33.1	24.5	20.4	10.5	32.2	71.6	26.5	32.3	47.6	11.6	30.8	91.1	37.6	30.5	39.3	65.2
WNT7A		ENSG00000154764	"Wnt family member 7A"	O00755	3	13816258-13880121	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.5;gallbladder: 8.7;placenta: 19.4"	"Group enriched"	"Detected in some"	7	"Cytotrophoblasts: 48.0;Extravillous trophoblasts: 129.2;Pancreatic endocrine cells: 57.6;Syncytiotrophoblasts: 155.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory CD4 T-cell: 4.4;naive CD4 T-cell: 4.2"	"Lineage enriched"	"Detected in single"	45	"T-cells: 4.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 25.3;EFO-21: 23.8;PC-3: 8.3;RPTEC TERT1: 42.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015719, CAB025894"	Approved				"Secreted to extracellular matrix"	NA	NA					"CAB025894: , HPA015719: AB_1858856"	"unprognostic (1.26e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (2.96e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.32e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (7.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.49e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.88e-3)"	0.4	0.4	7.8	0.6	6.1	0.7	0.4	1.2	11.5	1.1	0.4	2.1	0.0	0.4	3.4	1.0	1.6	0.7	8.7	0.4	3.3	2.8	0.7	0.5	5.7	1.4	3.1	3.2	0.4	0.8	0.4	0.2	19.4	3.9	0.5	0.4	0.0	0.5	1.4	0.4	2.8	0.4	0.5	4.4	3.1	0.4	2.3	2.3	0.0	0.4	0.0	0.7	0.9	0.5	0.0	0.0	0.0	0.0	0.0	4.4	0.5	3.4	0.0	0.3	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.0	3.1	0.0	23.8	0.0	0.0	4.6	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.6	42.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.6	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.5	7.8	6.1	1.2	7.2	3.3	2.8	3.1	3.2	3.9	2.3	11.9	0.0	0.0	2.3	5.3	0.0	0.6	0.0	0.0	1.2	0.0	0.0	48.0	0.0	13.3	14.3	0.0	0.0	0.0	8.2	129.2	0.5	0.2	0.0	0.0	6.6	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	57.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.4	1.1	155.3	0.5	0.0	4.7
CHEK1	CHK1	ENSG00000149554	"Checkpoint kinase 1"	O14757	11	125625136-125676255	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 80.0;seminal vesicle: 66.8"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 33.1;Extravillous trophoblasts: 31.3;Spermatogonia: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 11.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 11.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							HPA044364			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA044364: AB_2678913"	"unprognostic (6.74e-2)"	"unprognostic (3.63e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (5.54e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.70e-6)"	"unprognostic (3.95e-3)"	"unprognostic (1.26e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.10e-6)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (1.04e-8)"	"unprognostic (2.89e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.33e-1)"	3.0	2.5	2.5	9.0	2.8	14.9	2.1	1.1	2.2	2.5	5.2	1.3	80.0	5.0	1.9	10.2	6.5	1.7	3.6	1.5	2.4	2.4	3.7	2.0	1.8	9.6	3.0	1.2	3.8	4.0	25.5	3.5	3.8	1.5	2.9	6.3	1.6	2.6	66.8	1.2	2.9	5.2	2.3	3.0	3.6	2.8	7.2	1.5	22.4	1.8	4.5	8.8	3.8	3.3	1.9	1.8	1.9	0.7	1.2	11.7	1.0	13.0	10.6	23.9	14.5	4.9	10.5	10.4	18.3	8.8	11.7	12.6	25.9	28.8	34.0	18.8	7.2	15.6	15.7	14.6	9.6	14.5	21.3	6.7	63.1	8.9	13.2	1.5	32.2	12.0	5.4	2.0	14.8	10.5	7.0	13.9	23.2	32.0	30.0	15.4	6.7	47.8	15.8	24.2	21.3	9.6	29.1	22.3	17.9	10.8	17.4	15.1	16.0	15.0	10.4	4.4	16.9	28.0	10.5	9.3	16.9	14.4	8.1	16.8	6.7	12.0	48.5	6.2	24.3	19.8	1.9	0.5	0.3	1.3	0.7	1.2	1.9	3.5	1.6	1.1	1.5	3.3	2.0	0.4	1.2	0.4	1.8	11.7	1.0	2.5	2.8	1.1	2.2	2.4	2.4	3.0	1.2	1.5	1.5	3.0	0.3	6.0	4.4	5.6	1.4	3.7	33.1	2.7	5.7	7.0	0.0	9.6	3.3	3.7	3.3	1.9	3.3	23.3	1.0	31.3	5.6	2.0	0.0	0.8	9.4	0.0	1.7	4.9	0.0	2.2	1.4	2.4	0.0	4.6	5.6	2.7	2.4	3.7	1.1	6.8	1.5	0.0	4.1	23.3	60.3	4.3	6.5	4.4	12.0	1.4
MRPL3	"MRL3, RPML3"	ENSG00000114686	"Mitochondrial ribosomal protein L3"	P09001	3	131462212-131502983	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043665, HPA060132"	Approved					NA	NA					"HPA043665: AB_2678606, HPA060132: AB_2684209"	"unprognostic (1.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.61e-3)"	"unprognostic (7.83e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (4.33e-7)"	"unprognostic (1.54e-1)"	"unprognostic (8.23e-2)"	"prognostic favorable (1.36e-4)"	"prognostic unfavorable (3.51e-6)"	"unprognostic (2.05e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.29e-1)"	30.8	32.6	23.3	23.4	25.9	13.8	34.7	20.4	29.6	27.1	31.1	17.8	32.8	25.1	26.8	39.7	36.0	31.7	22.9	46.3	23.6	26.3	48.9	53.5	20.2	36.5	23.0	20.1	38.7	44.8	33.7	31.7	23.5	27.0	32.1	35.7	19.9	29.4	27.2	51.6	21.5	30.7	26.6	21.4	28.7	26.9	34.9	17.2	42.3	47.5	37.5	30.3	35.5	23.8	23.8	46.1	5.8	32.3	28.3	30.3	33.7	54.7	23.2	26.1	29.3	24.7	32.1	47.4	30.0	26.4	38.8	34.7	51.2	32.0	44.7	40.7	29.9	30.5	36.1	44.3	43.0	59.7	29.0	34.6	41.4	25.7	42.9	29.0	82.8	26.7	25.2	35.8	29.8	53.3	21.2	25.0	34.4	37.8	24.5	32.0	41.8	41.4	41.6	55.5	58.7	41.9	16.6	33.6	68.5	38.2	38.7	42.6	28.7	26.8	30.7	42.0	22.9	35.9	44.6	22.6	28.1	29.2	39.6	41.3	23.5	23.6	80.1	30.0	40.0	38.5	3.4	24.7	5.8	19.5	32.3	30.3	23.8	24.2	23.2	46.1	22.0	28.1	25.0	1.4	28.3	23.3	16.1	23.4	33.7	23.3	25.9	20.4	29.6	23.6	26.3	23.0	20.1	27.0	17.2	23.8	21.1	52.2	74.7	40.8	27.8	31.9	38.2	34.8	38.7	29.6	7.9	83.1	129.3	84.1	64.2	20.3	35.7	0.0	88.7	110.1	51.3	58.9	28.8	45.2	60.4	28.6	28.9	35.6	49.5	14.8	51.5	54.1	40.5	45.9	68.9	30.1	77.5	21.0	48.4	133.1	17.3	32.3	35.4	148.5	76.8	41.5	53.4	32.4	73.7	68.6
LAMA3	"BM600-150kDa, epiligrin, kalinin-165kDa, LAMNA, nicein-150kDa"	ENSG00000053747	"Laminin subunit alpha 3"	Q16787	18	23689443-23955066	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 70.8"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 107.2;Pancreatic endocrine cells: 340.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"HBEC3-KT: 154.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA009309, CAB010757"	Uncertain		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		810000	"Endoplasmic reticulum"		"CAB010757: AB_477162, HPA009309: AB_1079224"	"unprognostic (1.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.82e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavorable (3.58e-6)"	"unprognostic (1.98e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.15e-1)"	"unprognostic (9.91e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.13e-1)"	8.2	0.9	2.9	8.2	1.9	0.0	16.7	0.6	2.3	18.2	13.3	2.4	5.4	11.2	19.1	9.5	12.4	7.8	8.1	2.7	1.8	1.5	3.1	1.3	26.2	7.0	2.4	0.9	5.8	3.1	10.3	2.3	70.8	1.6	8.7	5.2	5.7	14.9	9.1	2.2	20.7	27.8	10.2	1.3	0.8	19.7	3.8	0.5	3.3	1.8	9.7	8.0	11.5	15.2	0.0	0.0	0.8	0.0	0.0	1.3	0.2	17.3	2.2	0.0	0.0	0.9	0.2	0.0	0.3	0.2	0.1	0.2	0.7	20.1	0.0	2.3	0.2	0.0	31.7	0.0	154.2	0.1	0.0	1.2	0.0	0.6	0.3	0.1	0.0	0.0	0.2	17.3	0.1	18.3	0.1	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	5.4	2.0	0.3	0.0	0.0	6.8	2.0	0.0	0.3	0.7	0.3	0.0	0.0	0.6	0.2	1.6	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	2.9	1.9	0.6	2.3	1.8	1.5	2.4	0.9	1.6	0.5	107.2	23.7	0.5	53.6	27.8	3.8	2.0	5.1	13.4	23.9	1.8	0.0	0.1	0.0	30.0	3.7	2.8	50.4	0.0	30.6	0.2	2.0	16.7	5.7	0.8	0.2	0.0	7.9	1.8	0.0	2.8	5.5	1.1	1.7	1.0	11.0	0.0	340.7	31.6	3.2	0.0	1.9	6.5	19.6	3.1	1.9	8.7	0.1	0.7	6.6	15.4
COMMD2	HSPC042	ENSG00000114744	"COMM domain containing 2"	Q86X83	3	149738470-149752499	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cone photoreceptor cells: 176.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044190	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA044190: AB_10966289"	"unprognostic (2.17e-1)"	"unprognostic (8.34e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.53e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (3.69e-6)"	"unprognostic (1.31e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.25e-2)"	"unprognostic (4.86e-2)"	14.1	11.2	13.3	9.6	16.1	10.3	20.9	22.0	18.3	17.2	10.9	21.1	4.8	10.6	18.8	10.5	14.6	13.2	10.6	11.2	13.4	12.3	21.9	17.2	17.0	13.2	16.0	12.5	18.1	11.3	14.4	14.2	22.3	18.7	14.0	11.7	14.1	14.6	12.2	9.4	13.3	15.8	17.0	19.6	15.2	10.4	9.6	14.4	20.5	19.3	9.6	14.6	12.4	12.8	8.7	10.0	16.4	14.2	11.7	11.4	9.4	17.0	5.0	16.3	9.4	14.3	16.5	10.8	10.7	11.2	16.6	16.8	8.7	10.6	13.7	12.3	10.4	10.5	10.9	15.5	13.0	19.4	10.1	14.8	12.3	6.9	5.8	15.3	17.6	5.6	12.4	14.4	8.2	14.7	11.2	11.6	8.7	6.0	7.8	11.8	5.3	12.2	8.7	18.0	10.4	6.7	11.3	16.5	18.3	15.7	4.5	7.5	11.5	12.4	10.1	22.9	13.5	18.6	11.7	10.1	9.8	3.9	9.7	12.6	14.1	5.5	22.6	9.5	15.9	4.0	16.4	8.2	13.9	8.0	12.0	11.4	8.7	9.8	9.5	10.0	8.0	10.4	10.9	6.4	11.7	14.2	6.2	7.8	9.4	13.3	16.1	22.0	18.3	13.4	12.3	16.0	12.5	18.7	14.4	59.6	21.7	26.8	30.7	18.5	54.4	14.9	30.6	28.1	51.2	21.0	176.7	44.6	36.5	47.3	2.3	33.1	18.8	23.3	34.6	49.7	36.6	22.9	45.1	14.4	39.4	27.0	23.6	31.9	20.9	3.2	33.6	37.2	32.1	121.8	16.3	33.3	44.0	20.1	33.9	23.3	98.2	51.8	29.9	48.9	49.0	18.9	26.7	32.4	20.0	20.5
ZFP91	"PZF, ZNF757"	ENSG00000186660	"ZFP91 zinc finger protein"	Q96JP5	11	58579111-58621042	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 181.7;Late spermatids: 146.8;Spermatocytes: 142.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024037, CAB025417, HPA065325"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"CAB025417: , HPA024037: AB_1859051, HPA065325: AB_2685468"	"unprognostic (6.10e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.33e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.00e-3)"	17.1	14.7	20.1	13.6	25.6	32.0	14.9	24.4	21.7	15.3	18.1	23.2	15.8	16.2	16.3	11.8	16.3	13.6	13.8	26.5	20.3	15.4	16.3	19.4	15.0	14.4	20.8	18.1	14.9	14.3	26.7	17.0	14.2	19.7	13.1	21.9	11.2	14.5	15.5	33.8	17.5	19.6	16.9	21.6	15.0	13.9	71.0	19.4	15.7	16.8	14.6	15.9	17.8	21.4	4.6	7.0	5.4	5.0	3.7	5.4	2.8	24.8	14.3	16.8	17.0	16.1	19.5	9.2	20.6	38.7	23.8	20.4	7.8	26.3	29.8	20.4	25.9	23.8	22.2	17.0	21.8	31.4	15.8	9.6	19.6	14.5	8.4	18.3	24.7	32.4	17.0	21.5	33.5	39.3	19.8	23.6	20.2	19.4	28.3	30.6	8.3	21.3	13.7	8.8	14.4	13.9	16.6	28.4	19.7	17.5	24.0	18.0	14.4	26.2	24.1	33.5	9.5	26.9	18.6	26.4	30.2	20.8	45.3	22.8	16.4	12.1	24.7	26.6	13.9	30.7	3.9	5.0	3.5	5.4	4.5	3.0	4.5	3.3	3.3	4.9	4.6	3.6	4.6	5.4	3.7	4.2	7.0	2.6	2.8	20.1	25.6	24.4	21.7	20.3	15.4	20.8	18.1	19.7	19.4	23.8	34.8	33.2	21.5	53.3	28.8	39.5	48.4	25.4	21.6	17.4	15.7	10.3	11.6	19.8	181.7	27.0	27.7	46.7	27.1	10.5	32.9	25.9	48.6	41.4	14.5	33.4	24.2	25.8	36.8	146.8	28.4	27.0	21.9	20.8	30.4	19.8	24.5	11.5	25.5	19.1	19.0	19.4	20.6	142.7	40.2	58.2	11.6	21.8	37.2	34.3
CA12	HsT18816	ENSG00000074410	"Carbonic anhydrase 12"	O43570	15	63321378-63382161	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"		Lyase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 103.5"	"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 155.1;Enterocytes: 240.0;Paneth cells: 157.9;Suprabasal keratinocytes: 220.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 109.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 39.0;ASC TERT1: 41.1;RT4: 41.3;SK-BR-3: 33.1;T-47d: 53.4;U-138 MG: 57.0;U-87 MG: 68.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA008773, CAB025181, CAB062549, CAB068179"	Enhanced					NA	NA		29000			"CAB025181: , CAB062549: AB_2665617, CAB068179: AB_2665616, HPA008773: AB_1078394"	"unprognostic (2.01e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.47e-1)"	"unprognostic (3.25e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (3.80e-6)"	"unprognostic (2.59e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.56e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.21e-1)"	3.7	0.3	4.7	15.0	27.4	0.3	14.5	3.7	2.3	15.7	32.0	2.6	5.0	0.4	9.8	12.3	42.8	8.5	2.6	1.6	4.9	1.4	103.5	0.3	1.2	0.3	1.8	0.2	2.1	43.8	0.3	3.9	5.9	16.9	3.8	30.3	8.5	8.2	17.9	0.5	44.1	2.4	18.1	0.1	0.4	2.2	1.3	6.7	0.0	1.7	18.4	25.9	10.6	14.5	0.3	0.2	0.6	0.7	0.3	0.2	0.0	0.0	39.0	0.6	0.1	5.2	41.1	2.1	2.8	2.5	0.4	0.7	0.2	0.1	0.0	9.6	2.3	15.4	0.2	0.0	1.9	1.1	0.0	1.4	0.0	2.6	0.0	0.1	0.0	0.0	15.5	2.1	11.9	3.8	0.0	0.5	0.0	0.0	0.0	0.5	22.4	0.0	0.0	0.6	0.0	6.1	0.0	0.0	0.0	0.0	41.3	0.3	0.0	0.1	33.1	0.0	0.4	53.4	0.0	0.0	57.0	3.0	1.8	0.0	0.0	0.0	0.0	68.4	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.2	0.6	0.3	0.7	0.2	0.1	0.0	4.7	27.4	3.7	1.3	4.9	1.4	1.8	0.2	16.9	6.7	0.0	5.8	1.5	18.6	155.1	0.0	0.6	0.0	2.7	3.4	38.4	0.0	0.4	46.4	14.9	12.0	0.0	240.0	0.0	48.3	1.7	5.1	14.8	1.1	0.0	0.6	0.0	8.1	0.0	0.0	3.0	0.0	2.2	21.9	0.0	92.2	2.5	15.0	157.9	0.0	59.0	0.2	0.0	3.9	0.0	0.0	220.4	1.5	0.0	95.7	16.3
CDK6	PLSTIRE	ENSG00000105810	"Cyclin dependent kinase 6"	Q00534	7	92604921-92836594	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 74.6"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 219.8;Late spermatids: 186.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 93.5;REH: 45.7"					"Low region specificity"	"Detected in all"			"HPA002637, CAB004363"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004363: AB_627242, HPA002637: AB_1846432"	"unprognostic (1.29e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.19e-2)"	"unprognostic (7.78e-3)"	"prognostic unfavorable (3.86e-6)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (2.33e-5)"	6.6	11.3	6.0	9.1	7.5	22.5	5.9	2.4	6.0	7.8	10.0	9.6	5.7	7.5	6.0	5.9	8.5	4.6	7.8	6.6	6.9	4.2	6.5	7.5	7.3	7.4	7.0	5.2	5.0	10.0	25.7	4.2	20.5	7.5	6.1	9.2	4.4	10.9	6.1	2.0	11.6	9.4	9.8	7.5	6.3	10.8	5.4	8.0	74.6	4.3	9.2	10.3	6.7	9.0	3.6	5.6	6.5	4.8	3.9	7.1	2.3	6.2	2.9	8.0	5.1	2.3	2.6	1.7	6.4	4.0	3.2	3.0	7.8	4.8	4.8	3.7	4.3	2.0	3.8	4.4	9.2	7.6	10.5	3.1	12.0	5.5	7.5	1.4	7.4	0.6	2.6	5.0	4.3	20.4	3.0	1.2	19.6	11.5	13.3	5.7	1.2	93.5	0.8	2.5	7.9	2.6	45.7	28.1	8.1	4.4	0.1	4.2	27.3	0.7	2.2	3.7	6.1	0.1	12.3	4.7	10.5	16.5	4.1	12.9	7.1	0.1	6.4	1.5	25.5	13.9	4.9	1.9	6.5	5.2	3.9	5.9	2.0	5.5	5.6	4.0	3.6	7.1	4.0	1.1	3.9	4.8	5.6	2.8	2.3	6.0	7.5	2.4	6.0	6.9	4.2	7.0	5.2	7.5	8.0	23.8	3.0	11.9	19.5	53.5	0.2	14.8	25.5	4.0	27.3	21.0	0.0	42.7	8.3	31.7	219.8	24.1	11.0	0.0	20.1	3.4	21.6	18.1	24.3	18.4	15.0	0.0	16.1	7.4	23.4	186.0	4.6	21.9	18.6	20.8	46.7	0.5	63.1	14.0	3.2	5.1	0.0	6.5	22.1	2.6	46.4	44.2	14.8	20.3	68.3	23.3
AHNAK2	C14orf78	ENSG00000185567	"AHNAK nucleoprotein 2"	Q8IVF2	14	104937244-104978357	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 131.1"	"Cell type enhanced"	"Detected in many"	13	"Basal keratinocytes: 101.5;Horizontal cells: 57.2;Suprabasal keratinocytes: 143.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 1.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 28.6;ASC TERT1: 32.5;HBEC3-KT: 28.6;hTCEpi: 72.0;hTERT-HME1: 30.7;TIME: 32.3"									"HPA000878, HPA002940, HPA004145, HPA020111"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No			Cytosol	"Plasma membrane"	"HPA000878: AB_2666127, HPA002940: AB_1859547, HPA004145: AB_1859546, HPA020111: AB_2670371"	"unprognostic (3.56e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.31e-3)"	"unprognostic (9.55e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (2.79e-5)"	"unprognostic (3.43e-1)"	"unprognostic (3.06e-3)"	"prognostic unfavorable (4.05e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.23e-5)"	6.9	1.8	2.9	2.0	5.6	1.0	8.5	3.0	13.7	17.2	23.0	2.9	5.7	1.7	16.3	2.9	25.8	7.1	3.2	1.5	2.4	3.1	1.1	10.8	2.3	1.0	2.7	11.6	1.8	1.2	1.2	0.7	1.8	23.3	5.7	5.1	10.1	6.0	14.6	1.6	131.1	4.8	19.9	4.8	1.1	7.1	3.2	0.8	0.0	1.2	14.4	3.0	10.0	19.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.6	20.0	0.0	1.4	28.6	32.5	0.0	2.4	5.1	0.9	0.4	0.0	8.9	0.0	3.4	18.8	20.0	14.5	0.0	28.6	0.4	0.0	0.1	0.0	13.3	0.1	2.6	0.0	0.9	4.1	72.0	2.8	30.7	12.3	12.5	0.0	0.0	0.0	14.4	1.6	0.0	0.0	0.0	2.1	9.9	0.0	1.3	0.0	19.6	0.0	0.1	0.1	10.6	0.0	0.5	0.6	1.3	0.0	32.3	6.9	4.3	7.9	2.2	0.0	0.0	0.0	21.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.9	5.6	3.0	13.7	2.4	3.1	2.7	11.6	23.3	0.8	11.9	1.4	0.0	4.0	101.5	4.7	1.0	0.0	25.4	18.2	1.8	2.0	0.0	0.0	10.2	20.6	16.7	0.0	0.0	7.7	0.2	11.4	1.9	16.2	0.5	1.0	57.2	0.0	1.8	0.3	1.6	0.6	0.7	30.4	0.0	0.0	3.0	41.0	0.0	0.4	0.3	10.5	0.0	7.2	0.4	3.8	143.9	0.1	0.7	0.0	4.9
JAG1	"AGS, AHD, AWS, CD339, HJ1, JAGL1"	ENSG00000101384	"Jagged 1"	P78504	20	10637684-10673999	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Notch signaling pathway"	"Developmental protein"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Smooth muscle cells: 154.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 56.7;hTERT-HME1: 35.0;U-251 MG: 47.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010343, HPA021555"	Supported		Approved	"Golgi apparatus,Plasma membrane"		NA	NA		14000000	"Golgi apparatus, Plasma membrane"		"CAB010343: AB_649685, HPA021555: AB_1851969"	"unprognostic (2.23e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.21e-2)"	"unprognostic (8.94e-3)"	"unprognostic (6.07e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (4.10e-6)"	"unprognostic (5.48e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.41e-3)"	27.7	5.6	6.8	14.5	5.4	9.7	56.5	2.9	6.7	34.2	20.1	4.3	17.4	7.2	26.1	22.8	33.9	16.7	23.1	18.8	5.4	5.1	12.9	3.8	22.0	12.4	5.4	4.0	14.7	22.2	21.7	6.0	36.3	6.0	19.2	12.7	21.4	11.2	23.4	16.8	34.8	11.7	21.4	13.0	14.2	13.4	9.1	3.8	1.5	14.5	24.6	16.1	18.7	31.4	0.0	0.9	2.4	2.0	0.4	0.1	0.4	1.0	5.3	16.6	20.4	3.2	3.1	0.6	0.6	3.1	0.9	0.4	4.7	2.9	0.1	15.7	0.6	4.7	22.2	2.4	56.7	0.7	0.0	1.1	1.7	0.5	22.2	1.5	7.1	0.1	1.2	16.8	2.8	35.0	3.3	5.5	0.0	0.0	2.3	1.5	0.0	0.0	5.1	4.8	17.5	5.3	1.3	1.0	3.3	8.0	6.5	0.7	0.5	1.6	1.1	6.7	13.8	0.1	0.8	20.7	3.8	2.6	3.1	47.7	0.9	0.1	0.2	2.4	2.6	2.9	0.0	2.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	1.6	0.4	0.3	0.9	0.0	0.4	6.8	5.4	2.9	6.7	5.4	5.1	5.4	4.0	6.0	3.8	38.7	12.5	0.0	46.4	93.0	10.0	12.5	35.7	20.1	22.7	15.7	41.2	12.0	1.7	26.8	3.9	70.8	26.0	0.0	27.0	0.9	33.7	18.4	6.9	1.5	3.7	20.6	5.1	38.1	3.7	6.3	19.8	7.7	13.5	1.8	10.2	9.3	60.7	22.4	31.8	2.1	72.6	84.1	154.6	0.7	2.8	93.3	1.8	0.0	22.9	32.5
RACGAP1	MgcRacGAP	ENSG00000161800	"Rac GTPase activating protein 1"	Q9H0H5	12	49976923-50033136	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.9"	"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 46.7;Extravillous trophoblasts: 40.9;Spermatocytes: 65.3;Spermatogonia: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB025859, HPA039427, HPA043912"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		"CAB025859: , HPA039427: AB_2676503, HPA043912: AB_2678728"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (1.86e-6)"	"unprognostic (1.15e-3)"	"unprognostic (3.07e-3)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.12e-6)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (3.98e-8)"	"unprognostic (3.13e-2)"	"unprognostic (4.94e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.15e-1)"	3.7	2.6	4.9	10.0	11.3	21.0	4.2	6.3	7.8	4.2	10.1	4.7	1.5	6.5	3.3	1.9	17.7	2.7	4.0	2.7	4.8	4.5	5.9	2.8	5.6	13.7	7.8	5.0	2.5	2.0	3.3	1.4	8.4	5.4	2.4	11.9	2.0	4.7	2.1	3.8	8.7	7.5	7.6	5.9	5.9	6.8	29.4	6.6	40.9	2.4	8.7	17.8	6.0	6.5	6.3	2.2	16.5	3.5	8.8	14.8	4.8	44.6	40.8	32.5	20.8	6.0	7.2	27.8	47.4	22.8	49.7	34.0	40.7	34.2	24.8	21.2	25.1	24.3	30.3	32.4	22.0	53.0	47.5	20.4	31.9	40.4	13.3	2.2	33.6	26.4	3.9	4.1	33.7	26.9	14.6	16.8	22.7	23.0	38.1	46.4	31.3	27.7	16.8	23.2	25.3	27.0	26.4	39.8	18.2	13.2	22.3	27.4	23.7	38.7	24.6	13.1	17.3	47.8	15.2	15.3	32.9	29.7	21.0	34.1	20.2	49.9	29.4	16.6	23.0	19.2	16.5	2.6	3.9	5.7	3.5	4.9	6.3	6.9	7.8	2.2	3.9	4.2	5.5	0.5	8.8	1.9	1.5	14.8	4.8	4.9	11.3	6.3	7.8	4.8	4.5	7.8	5.0	5.4	6.6	6.0	5.4	8.5	2.4	11.4	1.6	1.2	2.5	2.7	3.4	5.2	3.9	6.2	16.6	1.5	9.3	1.7	1.5	46.7	1.8	40.9	4.1	2.1	2.3	1.8	11.4	1.6	0.0	6.2	11.7	11.4	1.4	8.0	1.7	3.6	2.6	1.7	1.6	0.0	3.5	1.9	0.7	12.9	2.8	65.3	40.1	11.3	7.2	4.4	4.1	1.1
CDK1	"CDC2, CDC28A"	ENSG00000170312	"Cyclin dependent kinase 1"	P06493	10	60778331-60794852	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 88.4"	"Cell type enhanced"	"Detected in many"	18	"Erythroid cells: 280.4;Extravillous trophoblasts: 116.8;Spermatocytes: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 6.1;T-reg: 5.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;NK-cells: 6.1;T-cells: 5.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"HPA003387, CAB003799"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			Cytosol	Nucleoplasm	"CAB003799: AB_344898, HPA003387: AB_1846356"	"unprognostic (6.34e-2)"	"prognostic favorable (8.81e-4)"	"unprognostic (1.90e-1)"	"unprognostic (6.82e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (1.10e-6)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.15e-6)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	4.1	2.2	0.8	17.8	2.4	17.8	4.4	0.7	1.6	4.2	6.5	1.1	3.4	6.1	2.9	4.8	19.0	1.5	2.4	2.3	0.9	0.7	3.1	1.7	5.7	15.1	1.7	0.6	2.2	1.0	0.5	4.4	13.3	1.2	1.5	8.3	1.0	3.8	2.9	1.0	4.9	8.3	2.7	2.5	8.3	5.0	13.8	1.2	88.4	1.8	16.7	20.1	3.2	6.9	0.9	1.7	0.0	0.2	6.1	5.7	1.8	48.9	18.6	49.6	19.6	3.2	5.0	20.4	37.0	27.0	45.2	43.6	43.6	43.3	44.9	14.4	10.1	16.6	30.5	33.7	21.5	47.1	31.9	24.6	23.5	18.4	25.3	0.6	36.0	24.3	0.9	2.1	29.2	28.5	10.3	27.1	29.6	35.9	55.3	50.2	13.0	45.3	25.9	21.8	29.6	39.3	39.4	46.2	22.0	17.2	16.3	23.3	20.4	24.9	37.8	19.2	28.1	40.8	22.1	11.1	19.3	41.2	20.3	50.6	21.7	34.8	40.5	16.6	40.4	23.9	0.0	0.0	0.0	0.5	0.2	0.5	0.9	1.5	2.7	0.5	0.5	0.5	1.5	0.0	6.1	0.2	1.7	5.7	1.8	0.8	2.4	0.7	1.6	0.9	0.7	1.7	0.6	1.2	1.2	0.0	2.7	2.2	3.6	35.3	1.0	0.5	0.0	14.7	7.9	17.4	0.0	11.0	3.3	0.7	8.8	4.5	1.7	280.4	0.0	116.8	5.1	1.0	0.0	0.8	46.3	0.0	2.9	9.8	15.3	6.3	2.0	8.8	1.7	1.8	4.0	1.0	0.3	0.0	0.7	2.1	0.5	0.0	1.4	104.2	29.6	16.3	18.4	7.0	5.6	6.0
CCNA2	"CCN1, CCNA"	ENSG00000145386	"Cyclin A2"	P20248	4	121816444-121823933	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 122.3"	"Cell type enhanced"	"Detected in many"	13	"Erythroid cells: 70.0;Extravillous trophoblasts: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 6.8"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.7;T-cells: 6.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"CAB000114, HPA020626"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Nucleoplasm, Cytosol"		"CAB000114: AB_563675, HPA020626: AB_1847376"	"unprognostic (4.02e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.67e-2)"	"prognostic unfavorable (9.17e-5)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (3.92e-3)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (4.43e-6)"	"unprognostic (8.38e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.59e-1)"	3.2	1.5	1.3	18.6	1.7	21.6	1.8	5.1	1.2	2.5	6.3	1.0	0.8	6.6	2.2	2.1	11.7	1.7	2.4	3.2	1.8	1.8	1.7	1.6	3.4	15.6	1.6	0.8	4.5	0.9	0.5	3.2	12.0	1.3	2.2	7.8	1.0	2.1	0.8	1.1	4.2	7.4	2.4	1.8	8.9	2.9	8.4	0.8	122.3	1.4	18.8	18.4	2.5	5.1	0.3	0.9	0.6	0.3	1.7	6.8	1.9	38.7	10.1	27.7	11.8	1.5	3.8	22.7	27.1	11.9	36.0	26.8	22.0	24.1	35.7	7.3	14.2	12.7	13.1	34.8	15.9	29.7	17.1	16.1	28.6	13.4	21.3	0.3	43.1	20.3	1.0	1.2	14.9	8.9	5.7	21.5	19.0	40.7	35.9	28.5	13.9	54.9	25.0	21.8	24.3	11.3	25.2	53.7	17.4	10.2	7.7	11.8	12.5	14.2	17.4	7.5	21.7	14.5	18.3	12.7	16.9	25.7	17.8	25.8	22.8	24.1	40.9	9.7	43.9	18.7	0.0	0.3	0.6	0.2	0.1	0.1	0.3	2.0	1.4	0.9	0.1	0.0	0.5	0.3	1.7	0.3	0.1	6.8	1.9	1.3	1.7	5.1	1.2	1.8	1.8	1.6	0.8	1.3	0.8	0.0	0.6	0.0	0.7	2.5	1.1	0.7	0.0	2.7	1.2	0.0	11.8	5.7	0.0	0.3	4.8	0.7	1.5	70.0	0.2	72.3	3.3	1.1	0.0	1.5	21.0	0.0	1.2	2.5	7.5	1.5	0.9	2.9	1.7	0.0	3.1	1.3	0.4	1.5	1.1	0.0	14.2	0.0	0.9	6.1	7.9	1.1	7.1	3.2	6.4	1.3
GPR87	GPR95	ENSG00000138271	"G protein-coupled receptor 87"	Q9BY21	3	151294086-151316952	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 24.8;skin 1: 19.7;tongue: 21.9"	"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 127.1;Suprabasal keratinocytes: 59.6;Syncytiotrophoblasts: 171.4;Urothelial cells: 178.7"	"Group enriched"	"Detected in many"	6	"cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3"	"Region enriched"	"Detected in single"	12	"pons and medulla: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 31.5;HaCaT: 25.2;HBEC3-KT: 33.5;hTCEpi: 44.8;hTERT-HME1: 18.8;RT4: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066313			Approved	"Nucleoplasm,Lipid droplets,Mitochondria"		No	No			"Lipid droplets, Mitochondria"	Nucleoplasm	"HPA066313: AB_2685656"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"		"unprognostic (4.07e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.28e-2)"		"unprognostic (4.61e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (4.62e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.66e-4)"	"unprognostic (8.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.17e-1)"	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.4	6.5	0.0	0.0	2.8	0.0	0.4	2.1	24.8	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.6	11.1	5.1	4.5	0.0	0.0	9.5	4.0	0.0	19.7	0.0	0.4	0.0	0.0	0.2	0.7	0.0	2.0	0.0	21.9	13.5	6.2	13.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	31.5	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.2	0.0	0.0	11.5	0.0	0.0	0.0	0.1	25.2	0.0	33.5	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	44.8	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	1.1	13.2	0.0	0.0	5.6	0.1	0.0	0.9	0.1	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.6	0.0	127.1	52.7	0.0	0.0	0.0	4.0	20.5	3.5	0.0	46.3	0.0	1.3	0.1	0.2	0.0	0.0	0.6	10.3	2.1	36.4	1.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.1	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	59.6	171.4	0.0	0.0	178.7
GPRC5A	"PEIG-1, RAI3, RAIG1, TIG1"	ENSG00000013588	"G protein-coupled receptor class C group 5 member A"	Q8NFJ5	12	12890782-12917937	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 155.0"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 872.5;Glandular cells: 325.5;Pancreatic endocrine cells: 368.5;Urothelial cells: 1048.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 3.1"	"Cell type enhanced"	"Detected in some"		"basophil: 3.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.1"	"Cell line enhanced"	"Detected in many"		"A-431: 42.7;CAPAN-2: 164.8;HaCaT: 43.2;SiHa: 60.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA007928, HPA046526"	Enhanced		Enhanced	"Vesicles,Plasma membrane"		NA	Yes			"Vesicles, Plasma membrane"		"HPA007928: AB_1849318, HPA046526: AB_2679685"	"unprognostic (4.79e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.65e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (4.63e-6)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (9.02e-5)"	"unprognostic (9.30e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.49e-1)"	9.8	1.4	0.2	6.0	0.6	0.4	5.4	0.1	0.3	12.1	19.8	0.5	2.0	6.2	4.3	1.9	9.1	3.0	15.5	7.1	0.1	0.2	5.1	0.6	155.0	0.1	0.5	0.1	18.5	1.1	0.0	0.9	20.1	3.1	10.4	16.9	4.8	9.6	1.5	1.1	2.0	36.9	14.2	1.1	0.1	11.4	4.8	0.3	0.1	54.2	14.9	11.5	32.1	14.0	0.6	0.6	3.1	0.3	0.5	0.4	0.0	42.7	34.2	0.0	0.1	0.4	0.2	2.2	12.9	4.9	8.4	6.4	6.0	164.8	0.0	1.1	10.3	8.9	43.2	0.1	6.2	12.9	0.0	0.5	0.0	14.1	0.2	3.1	0.0	0.0	0.2	8.4	3.5	0.8	10.4	5.1	0.0	0.0	0.0	0.3	30.0	0.0	0.0	0.1	15.6	5.4	0.0	0.9	0.0	16.6	8.5	0.0	0.0	60.6	4.6	1.9	6.9	1.3	0.1	0.5	0.3	10.9	19.6	0.5	0.0	0.0	0.0	4.4	0.0	0.2	3.1	0.3	0.4	0.3	0.2	0.3	0.3	0.2	0.3	0.1	0.6	0.4	0.4	1.3	0.5	0.2	0.6	0.3	0.0	0.2	0.6	0.1	0.3	0.1	0.2	0.5	0.1	3.1	0.3	872.5	165.8	0.0	282.3	11.1	0.0	1.0	5.1	69.6	257.0	43.6	0.0	0.7	0.0	49.3	0.0	7.5	159.2	0.0	63.3	8.9	57.8	325.5	9.3	0.0	1.5	0.0	7.9	4.9	0.0	0.0	12.4	10.7	49.0	1.0	28.8	1.3	368.5	52.7	9.6	0.0	0.2	0.0	24.7	0.0	0.2	8.0	0.9	1.3	79.7	1048.5
FAM83A	"BJ-TSA-9, MGC14128"	ENSG00000147689	"Family with sequence similarity 83 member A"	Q86UY5	8	123178960-123210079	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.8;lymphoid tissue: 28.6"	"Cell type enhanced"	"Detected in some"	14	"Pancreatic endocrine cells: 16.6;Suprabasal keratinocytes: 13.2;Urothelial cells: 19.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 52.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A-431: 24.3;HBEC3-KT: 37.9;hTCEpi: 20.3;K-562: 59.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA052615			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052615: AB_2797244"	"unprognostic (4.48e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (3.85e-4)"	"unprognostic (2.49e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (2.98e-9)"	"unprognostic (2.62e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (4.99e-6)"	"unprognostic (2.04e-1)"	"unprognostic (2.22e-16)"	"unprognostic (2.76e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (6.07e-2)"	0.1	0.3	0.0	0.1	0.0	0.1	0.3	0.0	0.1	15.6	0.4	0.0	8.3	0.6	0.8	2.0	44.8	2.8	1.2	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.7	0.1	0.0	0.1	2.7	0.0	1.3	0.0	0.0	3.1	13.6	0.1	4.4	2.5	0.2	0.0	0.1	0.1	0.3	0.0	0.1	0.3	13.4	28.6	3.1	18.4	0.4	0.3	0.7	0.2	0.3	0.4	0.0	24.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	3.2	0.0	0.0	7.8	0.0	37.9	0.0	0.0	0.0	0.2	2.9	0.0	0.0	0.0	0.0	0.0	20.3	0.0	5.2	0.0	0.0	0.0	59.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	4.3	2.9	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.2	0.4	0.1	0.3	0.1	0.2	0.1	0.0	0.4	0.1	0.2	0.7	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.4	0.0	0.6	0.0	4.0	4.5	1.8	0.0	0.0	0.0	0.3	0.6	0.0	0.5	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	1.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	13.2	0.0	0.0	0.4	19.7
RIPK2	"CARD3, CARDIAK, RICK, RIP2"	ENSG00000104312	"Receptor interacting serine/threonine kinase 2"	O43353	8	89757747-89791063	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015273, HPA016499"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA015273: AB_1856299, HPA016499: AB_1856300"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (6.33e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.84e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.05e-2)"	"prognostic favorable (8.05e-4)"	12.0	5.5	9.3	11.2	7.9	13.6	10.0	3.0	9.3	9.7	7.9	10.6	5.2	3.5	10.9	7.8	8.3	7.0	17.3	11.6	9.2	8.6	7.7	10.4	18.7	10.9	11.8	5.8	8.9	13.2	14.7	7.3	20.8	9.1	10.7	5.6	4.6	10.2	5.8	3.1	10.4	6.9	10.4	16.5	14.2	8.3	5.6	11.5	5.1	8.5	4.9	11.8	15.0	7.6	7.5	6.9	19.4	11.2	3.8	5.5	4.3	10.3	3.6	1.8	2.6	4.5	6.3	3.4	11.5	19.6	6.1	7.9	3.1	5.4	8.0	17.9	6.4	4.9	2.5	4.9	3.8	11.3	5.7	4.9	6.7	1.7	3.1	12.7	2.4	3.3	5.0	3.1	8.7	28.1	6.5	6.4	0.0	3.2	2.6	5.6	2.1	0.0	5.1	1.0	4.7	8.5	1.7	2.6	3.9	14.3	4.6	0.3	2.0	2.7	7.2	5.4	2.5	7.0	3.0	5.7	3.7	3.5	6.3	5.3	5.3	2.4	4.8	9.1	0.2	2.4	8.8	5.7	19.4	3.6	10.6	4.1	7.5	5.5	4.7	6.9	4.3	5.2	5.5	4.5	3.8	11.2	2.3	1.2	4.3	9.3	7.9	3.0	7.4	9.2	8.6	11.8	5.8	9.1	11.5	32.8	17.8	13.4	31.1	51.2	2.4	2.8	5.1	10.7	22.7	3.5	0.0	10.6	5.0	66.4	5.0	9.5	2.3	0.0	53.1	35.2	38.5	46.3	42.7	2.6	39.0	3.2	0.0	5.5	25.3	1.6	7.2	48.6	18.6	50.5	5.2	10.0	41.2	0.0	5.6	6.7	0.1	12.9	22.7	8.1	10.9	42.2	70.0	12.7	6.6	40.4
ITGB6		ENSG00000115221	"Integrin subunit beta 6"	P18564	2	160099666-160200313	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Amelogenesis imperfecta, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 62.1"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 142.9;Alveolar cells type 2: 159.2;Pancreatic endocrine cells: 133.9;Spermatocytes: 219.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 37.5;RPTEC TERT1: 74.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023626, CAB073536"	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA			"Nucleoplasm, Cell Junctions"	Centrosome	"CAB073536: , HPA023626: AB_2671267"	"unprognostic (1.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (6.90e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.61e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavorable (5.03e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.00e-1)"	0.3	0.3	0.3	3.1	0.3	0.0	8.7	0.3	0.3	4.1	8.3	0.1	4.5	3.5	2.1	2.5	18.7	1.2	12.0	0.7	0.3	0.3	62.1	0.3	28.8	0.1	0.3	0.1	1.5	3.8	7.0	2.2	18.7	0.2	7.5	3.0	0.1	3.8	4.8	31.5	1.9	11.7	2.0	0.3	0.3	7.9	0.6	0.1	0.1	4.9	6.8	5.9	12.8	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	37.5	0.0	0.2	0.0	0.0	7.7	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	8.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	2.4	0.0	0.0	2.9	0.0	74.9	12.4	0.0	0.0	0.0	11.8	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.2	0.1	142.9	159.2	0.0	106.9	9.3	0.0	37.4	10.2	8.1	77.3	68.0	0.0	6.6	0.0	51.3	71.2	2.2	10.3	0.0	92.6	5.2	3.3	42.3	3.5	0.8	2.0	0.0	0.0	1.8	0.8	24.4	2.6	2.5	1.7	3.6	14.1	0.8	133.9	21.0	1.1	0.2	0.0	0.0	2.7	219.5	2.4	7.4	3.9	0.0	11.2	104.4
ARNTL2	"bHLHe6, BMAL2, CLIF, MOP9, PASD9"	ENSG00000029153	"Aryl hydrocarbon receptor nuclear translocator like 2"	Q8WYA1	12	27332854-27425289	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 30.0"	"Cell type enhanced"	"Detected in many"	15	"Glandular cells: 33.6;Pancreatic endocrine cells: 57.8;Urothelial cells: 126.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.3;U-2197: 48.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059074	Uncertain		Supported	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA059074: AB_2683897"	"unprognostic (6.86e-2)"	"unprognostic (6.16e-2)"	"unprognostic (5.88e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.84e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (5.29e-6)"	"unprognostic (5.26e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (7.81e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-1)"	3.5	1.3	5.7	9.8	5.9	2.2	3.3	3.6	10.6	6.8	3.1	1.1	0.0	2.9	1.5	0.5	30.0	1.5	3.9	1.9	9.1	2.8	1.6	10.3	2.7	5.0	2.1	6.8	0.9	2.3	2.4	1.5	14.7	2.6	1.9	3.5	0.0	9.2	0.9	1.0	7.7	2.8	4.7	2.0	1.2	10.9	2.8	1.3	3.8	1.2	15.4	21.1	5.9	12.5	0.6	1.4	4.5	0.5	0.5	1.5	0.2	21.9	5.6	1.2	0.4	1.1	3.4	17.7	7.8	10.3	5.1	8.0	5.3	17.1	0.2	4.4	3.7	15.8	9.1	3.6	27.4	13.1	35.3	4.7	4.2	3.7	4.4	1.5	8.5	1.8	1.2	2.4	17.8	14.0	8.8	23.9	5.3	2.1	9.0	5.8	2.6	4.6	4.6	9.7	7.5	19.7	8.6	20.7	1.3	4.3	12.6	4.1	0.7	4.0	0.6	0.1	3.1	0.8	2.8	16.2	16.6	9.6	48.3	32.2	1.3	2.4	0.0	14.3	6.9	3.2	4.5	0.5	0.5	0.2	0.3	0.2	0.5	0.2	0.2	1.4	0.6	0.2	0.3	2.4	0.5	0.2	0.3	1.5	0.2	5.7	5.9	3.6	10.6	9.1	2.8	2.1	6.8	2.6	1.3	3.0	2.2	0.0	32.7	0.7	1.1	0.8	17.8	0.0	7.9	8.7	0.0	1.3	0.0	22.0	3.3	4.2	0.7	0.0	23.8	3.5	2.3	33.6	0.0	4.2	1.3	0.0	1.2	3.1	2.8	3.0	0.0	5.0	1.7	26.2	2.7	0.0	57.8	0.0	0.0	0.6	0.0	0.0	2.1	3.4	4.9	1.9	3.5	0.0	0.6	126.8
PLA2G16	"AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-3, MGC118754."	ENSG00000176485	"Phospholipase A2 group XVI"	P53816	11	63573195-63616883	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 113.6"	"Cell type enhanced"	"Detected in many"	9	"monocytes: 759.2;Proximal tubular cells: 471.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 52.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 52.4;T-cells: 16.0"	"Cell line enhanced"	"Detected in many"		"A549: 32.7;ASC diff: 37.1;CAPAN-2: 59.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011749, HPA058997"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA011749: , HPA058997: AB_2683874"	"unprognostic (5.18e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (5.58e-6)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.54e-5)"	"unprognostic (2.35e-1)"	113.6	15.2	32.0	4.4	39.4	1.6	33.9	4.8	30.2	6.1	7.2	46.6	6.1	4.0	5.0	11.5	5.9	13.9	12.9	39.0	37.6	25.2	24.7	28.9	13.5	4.5	58.4	22.2	30.9	13.2	15.1	8.1	16.2	30.5	5.9	3.7	8.8	10.1	13.2	37.8	2.4	7.5	8.0	70.4	6.4	10.2	17.8	48.9	0.1	17.1	11.1	2.3	8.0	4.7	2.1	52.4	0.4	6.2	5.3	16.0	6.4	20.6	32.7	0.9	0.0	37.1	6.4	6.0	0.7	6.6	5.5	2.7	7.4	59.7	0.0	13.8	1.6	18.0	1.0	30.9	1.6	4.2	25.5	1.2	0.3	7.8	1.2	22.1	0.0	0.3	3.8	0.1	13.6	0.5	22.0	8.6	0.0	0.3	2.3	5.8	3.6	0.0	0.1	2.6	13.0	10.6	0.0	0.0	2.0	17.3	2.9	0.4	2.4	4.4	12.5	6.8	14.0	27.1	1.0	12.6	2.4	0.1	8.3	1.8	9.8	6.4	0.0	9.9	0.0	0.2	0.0	6.2	0.0	16.0	2.4	8.8	2.1	3.7	11.6	1.7	0.3	1.2	9.4	0.4	5.3	0.1	52.4	2.4	6.4	32.0	39.4	4.8	21.9	37.6	25.2	58.4	22.2	30.5	48.9	95.3	77.4	17.6	17.3	10.3	10.6	128.7	96.8	113.8	45.5	109.9	3.9	112.1	96.2	54.1	56.9	116.5	22.2	0.0	99.5	300.4	35.3	29.0	56.6	210.7	56.9	38.1	3.4	165.7	48.0	16.0	28.7	51.4	25.3	759.2	4.5	120.3	123.3	14.4	20.5	471.4	17.2	12.9	42.8	135.2	4.9	8.2	243.0	69.8	1.7	59.6
TUBA1C	"bcm948, MGC10851, MGC14580, TUBA6"	ENSG00000167553	"Tubulin alpha 1c"	Q9BQE3	12	49188736-49274603	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Extravillous trophoblasts: 900.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 35.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 279.1"					"Low region specificity"	"Detected in all"			"HPA039247, HPA043684, HPA063394"	Supported		Supported	Microtubules		NA	Yes			Microtubules		"HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.15e-2)"	"prognostic favorable (7.37e-5)"	"unprognostic (3.25e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (8.48e-8)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (5.64e-6)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (6.26e-7)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.45e-3)"	40.4	17.0	4.6	22.2	6.7	25.4	22.5	3.5	5.2	39.1	40.8	7.3	20.0	22.2	21.9	27.9	125.5	15.0	40.3	17.6	5.4	4.4	73.2	74.8	24.9	38.9	8.4	1.2	25.2	19.4	5.1	9.4	62.1	22.8	15.1	34.2	28.6	40.9	26.3	18.6	37.5	77.1	27.1	9.3	24.6	25.7	16.7	5.2	52.6	32.7	129.7	82.9	26.7	41.9	4.6	12.1	35.4	7.7	5.4	8.8	7.9	86.6	67.8	14.8	25.4	15.9	26.8	57.6	69.7	78.5	123.1	66.1	65.9	65.7	39.2	74.6	81.8	73.9	40.1	86.5	97.5	82.1	37.9	31.0	47.6	29.5	63.4	11.9	36.7	35.2	19.4	46.7	104.6	44.1	39.1	79.1	22.0	68.1	21.4	105.9	54.6	20.1	35.9	44.7	279.1	134.7	23.1	29.1	21.7	54.1	41.3	11.8	0.6	60.5	40.1	26.2	61.3	39.1	28.9	57.5	58.4	64.7	57.7	115.8	7.1	19.9	38.0	30.7	36.3	50.4	35.4	6.1	13.2	5.8	7.7	8.8	4.6	6.1	5.3	12.1	3.2	3.0	3.4	5.6	5.4	5.7	9.4	7.6	7.9	4.6	6.7	3.5	5.2	5.4	4.4	8.4	1.2	22.8	5.2	110.2	146.6	47.0	283.9	172.8	0.6	0.6	30.6	41.5	103.5	55.8	0.0	214.4	59.7	229.8	7.4	44.2	249.9	163.5	483.8	900.6	110.0	150.7	65.8	47.8	250.7	0.0	74.3	47.3	60.7	6.3	63.0	86.0	43.9	432.8	111.1	2.9	339.7	108.7	38.2	109.4	0.4	38.8	152.7	6.9	57.4	160.1	135.1	67.5	106.5	297.1
SERPINB5	"maspin, PI5"	ENSG00000206075	"Serpin family B member 5"	P36952	18	63476761-63505085	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 99.3;skin 1: 60.7;tongue: 118.8"	"Cell type enhanced"	"Detected in many"	18	"Basal keratinocytes: 856.4;Suprabasal keratinocytes: 1062.2;Urothelial cells: 663.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 124.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 147.0;HBEC3-KT: 48.5;hTCEpi: 102.0;hTERT-HME1: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009570, HPA019025, HPA019132, HPA020136"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		660000	Vesicles		"CAB009570: AB_2186315, HPA019025: AB_1856726, HPA019132: AB_1856727, HPA020136: AB_1856728"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.04e-3)"		"unprognostic (2.09e-2)"		"prognostic unfavorable (1.54e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.47e-3)"	"prognostic unfavorable (5.71e-6)"	"unprognostic (1.28e-1)"	"unprognostic (1.84e-6)"	"unprognostic (2.57e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.38e-2)"	0.2	0.1	0.1	0.9	0.1	0.0	9.7	0.1	0.1	23.6	2.7	0.1	0.7	3.9	2.1	0.5	99.3	0.1	4.3	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	4.1	1.0	0.1	11.1	0.3	0.1	60.7	6.8	0.9	0.1	0.1	2.2	0.4	0.1	5.1	0.1	118.8	41.2	7.1	19.7	0.6	0.5	1.2	0.4	1.0	0.5	0.1	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.4	0.0	0.0	147.0	0.0	48.5	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	102.0	0.0	25.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.2	10.7	0.0	0.0	0.0	0.0	10.7	0.1	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.4	0.3	0.4	0.2	0.1	0.2	0.2	0.4	0.2	0.6	0.5	0.3	1.2	1.0	0.2	0.5	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	229.2	856.4	0.0	0.2	0.0	16.0	20.5	3.5	0.0	0.2	0.0	0.1	7.6	0.0	5.4	0.0	0.0	0.2	8.7	51.7	0.0	0.0	0.0	0.0	3.4	0.0	0.0	15.2	0.6	0.2	59.1	0.0	3.2	0.0	9.5	46.0	0.0	0.0	0.0	0.0	14.4	2.6	0.6	1062.2	0.1	0.0	7.0	663.3
SLC35F2	FLJ13018	ENSG00000110660	"Solute carrier family 35 member F2"	Q8IXU6	11	107790991-107928293	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 43.2"	"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 40.9;Suprabasal keratinocytes: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 54.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048185, HPA050695, HPA060150"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA048185: AB_2680304, HPA050695: AB_2681217, HPA060150: "	"unprognostic (7.73e-2)"	"unprognostic (3.28e-3)"	"unprognostic (8.37e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.07e-2)"	"unprognostic (7.26e-2)"	"prognostic unfavorable (4.03e-4)"	"unprognostic (6.22e-2)"	"unprognostic (8.20e-2)"	"prognostic unfavorable (5.92e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	3.0	2.5	2.4	7.4	2.2	1.3	2.7	2.1	2.4	7.4	8.1	1.8	3.8	8.4	2.6	4.8	5.0	6.2	5.9	2.4	3.7	2.6	5.6	2.0	4.0	7.7	2.4	2.2	3.4	3.4	0.3	2.6	9.7	1.9	10.6	9.8	5.2	43.2	2.7	2.3	8.5	7.4	1.8	4.2	2.7	2.8	3.7	2.3	1.8	3.2	6.7	6.9	3.4	3.7	9.3	5.9	0.5	0.2	2.9	11.2	1.6	8.5	5.6	0.6	7.9	4.7	7.0	8.1	2.0	1.1	5.3	6.8	24.2	9.0	14.2	20.3	5.9	28.6	17.9	11.3	18.1	10.5	11.8	10.4	7.9	5.5	10.0	7.7	18.5	4.0	4.8	10.5	17.5	37.9	15.9	27.6	11.3	20.7	5.9	3.7	5.1	7.6	17.8	6.0	18.9	54.7	15.5	7.2	18.6	28.3	7.8	13.8	5.8	6.4	14.9	3.9	7.9	11.0	3.9	20.5	9.7	16.1	0.2	20.4	15.4	17.4	15.6	6.2	5.9	6.3	0.1	0.2	0.0	2.8	0.1	7.3	9.3	4.8	4.9	5.9	6.1	1.8	2.5	0.5	2.9	0.0	0.3	11.2	1.6	2.4	2.2	2.1	2.4	3.7	2.6	2.4	2.2	1.9	2.3	8.9	1.0	11.1	30.1	40.9	1.1	0.5	0.0	0.0	15.9	3.5	11.8	0.7	3.3	10.1	0.3	5.8	14.0	0.0	7.2	13.5	5.1	19.0	2.3	0.0	5.0	0.0	5.8	0.0	0.8	0.9	0.9	3.9	21.9	6.4	10.2	1.3	17.0	10.5	2.5	5.5	7.5	6.5	4.1	0.3	4.9	44.0	3.8	2.5	22.6	15.2
RARRES3	"HRASLS4, TIG3"	ENSG00000133321	"Retinoic acid receptor responder 3"	Q9UL19	11	63536809-63546462	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 86.6"	"Cell type enhanced"	"Detected in many"	9	"Proximal tubular cells: 687.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 60.2;HHSteC: 22.0;HSkMC: 22.0;RPTEC TERT1: 30.5;SK-BR-3: 46.1;U-266/70: 23.0"															NA	NA						"prognostic favorable (1.35e-5)"	"prognostic favorable (4.00e-4)"	"unprognostic (4.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (6.26e-6)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.36e-3)"	"unprognostic (2.64e-1)"	13.3	5.9	15.0	16.4	14.6	4.6	30.9	3.1	10.6	13.7	32.7	12.9	12.5	25.1	16.0	18.6	12.1	29.7	21.0	7.3	11.7	10.2	86.6	31.8	36.5	23.5	12.1	10.8	23.1	8.2	0.2	7.9	5.8	8.7	25.0	16.8	9.8	25.4	23.5	7.1	2.6	50.0	12.6	15.0	21.6	18.0	5.4	11.4	24.0	66.4	8.5	17.0	14.3	7.5	10.9	6.6	30.8	15.4	33.3	66.1	63.1	5.8	3.6	0.0	0.1	5.5	19.1	1.3	0.5	10.1	7.7	7.0	0.1	60.2	0.9	5.1	1.0	6.1	1.6	1.3	1.0	1.6	9.9	0.0	0.3	0.4	0.0	22.0	0.1	0.2	22.0	0.1	2.9	0.0	16.2	0.9	2.0	0.0	7.7	1.1	0.0	14.1	1.1	0.0	0.9	0.5	6.4	0.0	0.4	30.5	1.2	0.0	0.0	1.2	46.1	2.4	0.3	5.4	0.4	1.7	0.5	0.0	1.1	0.2	23.0	0.3	0.2	2.3	3.6	0.4	30.8	11.3	7.1	63.6	15.4	47.3	10.9	47.6	66.1	6.6	7.2	41.5	53.7	8.4	33.3	12.5	0.8	35.7	63.1	15.0	14.6	3.1	10.6	11.7	10.2	12.1	10.8	8.7	11.4	291.8	62.1	57.5	128.0	17.3	0.2	5.0	76.5	232.9	87.6	82.0	0.0	11.3	252.0	40.6	0.1	30.9	264.6	0.0	98.0	19.1	35.1	48.0	63.4	78.1	25.0	0.0	20.1	56.4	44.3	1.1	68.7	43.5	13.5	14.4	46.4	43.6	91.5	259.6	19.1	687.8	1.1	6.5	15.5	0.4	0.0	11.2	25.2	276.7	11.5	252.0
MMP28	"EPILYSIN, MM28, MMP-25, MMP-28"	ENSG00000271447	"Matrix metallopeptidase 28"	Q9H239	17	35756249-35795707	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 34.2;Enterocytes: 39.1;Mucus-secreting cells: 31.9;Paneth cells: 47.6;Urothelial cells: 34.5"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.2;naive CD8 T-cell: 5.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 7.2"	"Cell line enriched"	"Detected in some"	7	"HaCaT: 28.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057288, HPA057890"			Approved	"Nucleoplasm,Focal adhesion sites"	"Secreted to extracellular matrix"	NA	NA			Nucleoplasm	"Focal adhesion sites"	"HPA057288: , HPA057890: "	"unprognostic (7.99e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (6.28e-6)"	"unprognostic (9.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.27e-3)"	8.0	1.6	1.8	2.7	3.7	0.5	4.3	0.0	5.1	1.7	7.3	1.6	1.4	3.0	3.2	4.8	4.3	1.5	12.3	0.5	2.8		0.8	0.2	10.3	0.4	0.0	2.9	0.1	1.3	0.5	0.0	0.7	1.3	2.9	4.1	2.7	0.1	2.1	0.6	4.5	9.3	4.3	0.2	0.6	7.2	13.4	0.2	0.0	4.2	4.4	2.5	5.5	2.2	1.1	1.5	0.1	0.2	1.3	7.2	0.9	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.7	0.0	0.1	28.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.1	0.2	0.0	3.9	0.2	0.6	0.0	0.0	0.0	1.6	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	2.0	1.1	0.4	1.7	0.1	0.9	7.2	5.9	0.1	1.3	0.2	1.5	0.0	0.9											26.8	20.8	0.0	5.1	34.2	0.4	1.0	2.5	5.3	5.7	7.0	0.0	0.0	0.0	0.1	5.0	8.1	39.1	0.0	0.3	0.0	1.6	1.8	0.0	0.0	0.1	1.6	3.5	6.2	0.0	7.1	1.1	0.9	3.3	0.0	31.9	9.1	9.7	47.6	2.8	0.7	0.5	6.5	2.0	0.5	2.5	29.0	0.0	0.7	18.5	34.5
EIF2A	EIF-2A	ENSG00000144895	"Eukaryotic translation initiation factor 2A"	Q9BY44	3	150546678-150584242	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036256	Approved		Approved	Mitochondria,Cytosol		No	No			"Mitochondria, Cytosol"		"HPA036256: AB_10611961"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.96e-3)"	"unprognostic (7.05e-3)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (2.11e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (6.30e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.39e-1)"	33.5	23.7	12.6	21.4	22.8	27.2	34.3	38.3	23.8	35.1	29.4	12.6	17.3	23.1	31.5	19.9	37.2	20.6	19.0	24.9	11.3	11.9	27.0	44.5	24.7	32.8	16.5	11.7	35.6	39.4	22.6	36.4	26.2	22.7	32.9	23.8	15.4	29.8	23.9	53.3	26.8	33.1	25.0	16.9	28.9	26.5	16.3	17.9	38.5	41.8	33.8	25.8	44.0	26.1	17.0	27.7	7.9	24.6	20.5	26.9	19.0	38.5	14.0	19.7	20.7	25.3	50.4	27.2	23.8	33.0	30.5	33.0	38.8	42.6	50.9	36.5	28.3	39.0	31.3	32.6	33.0	43.5	19.2	21.9	29.8	16.9	30.0	24.3	37.2	28.5	33.6	37.6	22.4	50.1	44.5	37.8	26.3	24.5	30.3	24.6	27.1	27.0	19.7	27.9	38.8	22.2	23.8	25.8	59.0	31.9	24.0	25.0	26.8	14.3	22.9	37.2	23.2	33.6	34.6	22.1	19.3	18.4	27.3	45.7	52.6	27.6	46.8	24.5	32.6	9.6	7.9	22.6	4.7	14.9	23.5	23.3	17.0	21.2	18.2	27.7	14.9	26.9	21.0	1.8	20.5	24.6	13.1	17.3	19.0	12.6	22.8	38.3	23.8	11.3	11.9	16.5	11.7	22.7	17.9	32.8	55.5	71.7	137.7	124.4	27.0	97.7	48.4	41.5	48.9	33.2	25.5	72.1	116.0	60.9	13.8	61.2	56.4	0.0	94.1	85.0	60.9	65.4	74.9	27.6	57.0	22.3	54.5	46.1	95.5	5.0	57.0	72.0	65.8	64.9	76.1	26.1	62.8	40.3	53.0	90.1	30.8	77.6	69.4	29.9	39.0	107.4	100.6	76.1	82.2	109.1
RPE		ENSG00000197713	Ribulose-5-phosphate-3-epimerase	Q96AT9	2	210002565-210022259	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA036498, HPA036499"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA036498: AB_2675157, HPA036499: AB_10670109"	"unprognostic (5.07e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (1.59e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.00e-6)"	"unprognostic (2.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.84e-2)"	19.4	26.9	20.6	16.7	28.0	14.6	22.6	26.4	27.7	18.7	19.7	23.3	20.7	17.4	27.8	21.5	24.0	17.6	17.3	17.2	21.1	21.0	26.7	23.3	19.4	21.6	21.7	21.7	22.9	14.1	14.8	41.9	24.4	18.6	20.5	26.6	18.9	18.3	27.9	12.3	17.2	16.0	27.1	25.8	15.6	19.8	11.9	19.7	23.5	25.2	14.5	23.2	24.1	20.2	8.6	28.9	8.0	20.5	30.5	10.7	11.3	20.6	26.8	17.4	17.5	28.3	27.4	29.9	27.2	21.8	25.9	34.8	38.5	31.7	13.9	17.9	21.0	35.1	20.3	25.6	29.0	39.6	16.7	18.1	25.8	39.3	35.9	38.6	27.3	19.9	19.2	28.9	29.7	38.7	23.6	33.7	13.9	25.9	19.4	21.2	32.9	14.8	23.8	25.5	41.7	19.6	18.7	20.8	19.9	29.9	30.9	20.9	12.0	23.0	22.5	18.2	32.8	19.4	31.4	27.6	34.8	23.2	16.9	25.1	11.7	14.8	29.9	25.2	27.0	22.5	6.9	17.3	8.0	10.2	20.5	8.9	8.6	8.0	9.6	28.9	8.4	10.7	9.6	1.7	30.5	13.7	10.6	10.7	11.3	20.6	28.0	26.4	27.7	21.1	21.0	21.7	21.7	18.6	19.7	6.0	6.9	14.7	13.5	14.7	12.5	5.3	7.6	13.4	19.4	17.4	19.6	32.4	26.6	20.5	8.8	11.9	12.3	23.3	15.1	36.8	15.5	12.1	5.8	15.5	33.1	9.5	9.8	17.2	17.6	9.3	10.3	20.4	13.5	16.2	14.2	8.2	17.4	14.0	13.8	37.0	12.9	6.5	14.1	16.4	16.1	17.8	21.4	11.4	18.9	12.0
ERGIC2	"Erv41, PTX1"	ENSG00000087502	"ERGIC and golgi 2"	Q96RQ1	12	29337352-29381189	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 351.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049695	Approved		Supported	"Nucleoli rim,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	"Nucleoli rim"	"HPA049695: AB_2680855"	"unprognostic (1.62e-2)"	"unprognostic (3.50e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.19e-3)"	"prognostic unfavorable (8.06e-6)"	"unprognostic (3.70e-2)"	"unprognostic (2.32e-2)"	"prognostic favorable (8.18e-4)"	"prognostic unfavorable (7.02e-6)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (3.76e-6)"	"unprognostic (6.02e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.64e-1)"	26.6	21.0	24.4	21.9	32.8	5.5	29.9	28.1	36.1	25.4	22.7	14.6	25.8	21.2	23.1	33.1	32.5	16.6	21.2	33.7	25.3	22.6	27.7	36.2	18.6	18.9	29.8	24.2	24.9	32.6	27.3	40.1	40.9	31.2	29.5	21.4	12.1	28.8	23.8	29.2	15.6	24.3	31.4	31.0	25.6	21.1	32.8	30.7	25.7	28.6	21.6	25.8	33.4	20.6	27.0	39.0	59.2	30.1	22.1	40.8	27.5	24.5	22.5	18.5	12.4	26.8	31.5	45.1	40.0	33.7	25.1	27.1	29.7	41.4	13.5	39.8	31.7	45.3	25.7	17.6	26.4	40.1	28.9	18.9	22.0	32.3	17.2	15.7	30.5	18.6	22.2	21.3	31.6	32.0	46.6	19.4	18.5	17.9	38.5	33.3	13.2	15.2	33.1	26.1	26.1	63.8	14.1	51.0	27.4	21.2	35.9	7.1	11.6	20.3	23.1	23.6	41.1	44.7	25.1	21.4	34.1	29.1	45.1	43.0	28.3	35.8	27.0	28.5	22.9	27.6	24.2	17.0	22.1	29.7	25.3	35.8	27.0	38.1	34.8	17.8	22.3	38.4	32.3	59.2	22.1	30.1	39.0	40.8	27.5	24.4	32.8	28.1	36.1	25.3	22.6	29.8	24.2	31.2	30.7	26.8	22.9	45.6	61.3	51.4	54.1	50.9	35.7	38.8	36.4	50.6	51.1	98.6	41.4	61.1	351.1	42.1	17.7	46.7	54.6	97.9	61.2	75.0	54.3	44.3	50.6	46.1	40.1	33.7	17.2	29.1	48.6	35.9	59.1	46.9	30.8	66.0	56.1	21.0	56.3	38.6	50.8	32.3	70.7	51.7	35.3	58.1	130.7	44.8	32.4	68.7
B3GNT5	"B3GN-T5, beta3Gn-T5"	ENSG00000176597	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5"	Q9BYG0	3	183253244-183298504	"Enzymes, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 80.2"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 101.7;Syncytiotrophoblasts: 132.0;Urothelial cells: 125.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 9.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"GAMG: 30.4;HBEC3-KT: 25.2;hTCEpi: 30.7"	"Region enriched"	"Detected in single"	12	"cerebellum: 16.5"	"Low region specificity"	"Detected in all"			HPA017292	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA017292: AB_1845237"	"unprognostic (2.17e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (7.10e-3)"	"unprognostic (7.78e-2)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.23e-6)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.18e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.10e-3)"	8.6	1.4	2.2	6.1	2.3	31.6	4.3	1.2	2.5	6.4	29.8	5.4	2.1	17.5	3.2	5.4	23.5	5.4	10.1	3.3	3.0	2.9	3.5	3.0	11.2	5.1	4.0	0.7	4.2	3.5	1.8	5.1	19.8	4.5	3.9	9.2	3.2	8.7	2.5	6.6	8.0	80.2	2.9	6.3	2.3	5.1	2.9	2.3	1.0	4.6	18.9	8.9	5.0	10.6	0.1	1.1	9.0	1.5	0.0	0.3	0.4	16.1	1.5	8.7	5.3	7.3	21.6	7.9	0.2	0.4	1.7	1.4	3.2	8.5	0.0	1.0	0.0	30.4	7.4	8.9	25.2	1.4	0.0	5.5	0.8	0.7	0.0	9.3	8.1	4.0	10.1	30.7	1.3	23.0	2.3	15.7	0.0	9.2	0.0	13.8	0.0	0.0	2.6	3.6	9.5	14.0	2.5	4.4	0.0	5.3	4.5	0.4	8.3	4.5	0.0	1.9	4.1	0.0	9.9	23.1	0.4	3.4	0.5	3.9	0.0	0.0	0.0	3.3	19.2	8.6	0.0	1.5	1.5	0.0	0.3	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.3	0.4	2.2	2.3	1.2	2.5	3.0	2.9	4.0	0.7	4.5	2.3	6.0	17.4	0.0	55.5	57.9	7.1	2.0	12.7	101.7	27.3	5.2	21.6	24.4	1.7	15.7	9.9	10.0	77.7	0.0	10.5	9.4	7.4	42.6	13.9	0.4	25.3	3.2	36.7	3.1	9.7	19.2	1.4	50.1	11.8	11.8	73.1	3.2	25.3	42.1	0.4	4.3	12.7	0.0	3.4	0.9	0.4	74.2	132.0	0.7	26.9	125.2
LDHA		ENSG00000134333	"Lactate dehydrogenase A"	P00338	11	18394388-18408425	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease mutation, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 249.1"	"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 1952.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB015336, CAB069404"	Uncertain		Supported	Vesicles,Cytosol		NA	NA		300000000	Cytosol	Vesicles	"CAB015336: AB_2134947, CAB069404: "	"unprognostic (8.83e-2)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (3.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.66e-3)"	"prognostic unfavorable (3.26e-8)"	"prognostic unfavorable (2.27e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (8.09e-6)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (9.69e-9)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-2)"	84.2	56.4	24.5	52.6	32.5	64.0	56.0	22.3	40.2	38.1	53.5	13.5	9.1	60.5	24.9	36.2	77.7	29.0	31.6	59.4	24.4	33.0	100.1	249.1	37.1	59.4	29.7	25.7	49.7	34.1	10.5	16.4	49.7	44.3	33.3	51.2	45.9	46.3	37.0	199.6	70.2	128.3	50.7	35.5	45.0	31.2	25.9	23.9	45.0	56.4	90.6	60.1	81.9	44.8	27.6	76.5	29.1	61.2	32.8	52.2	72.1	131.7	82.0	3.1	46.2	72.2	49.3	44.0	127.5	135.5	112.0	166.7	36.6	21.7	99.7	41.9	128.8	80.8	106.6	82.0	195.4	242.9	34.0	48.5	34.5	74.9	62.8	17.8	85.1	25.9	49.2	90.1	44.0	44.1	189.0	66.1	31.6	48.6	48.0	131.1	34.9	70.0	53.9	19.8	43.8	102.6	45.4	32.7	83.5	178.0	30.6	24.6	30.4	69.1	57.0	23.6	50.2	26.8	20.3	59.5	140.3	50.9	122.1	1.5	38.2	55.9	95.9	200.8	44.1	47.2	28.9	53.1	29.1	38.1	61.2	42.6	27.6	50.2	40.1	76.5	19.2	32.8	33.3	18.1	32.8	59.5	25.8	52.2	72.1	24.5	32.5	22.3	40.2	24.4	33.0	29.7	25.7	44.3	23.9	68.5	191.6	171.4	331.5	1952.6	415.5	222.7	142.7	85.6	187.7	293.1	137.4	475.1	368.1	1059.9	147.3	475.2	671.1	0.0	1350.8	1780.5	725.6	281.3	256.4	438.3	607.6	486.3	43.8	182.3	215.4	106.3	266.3	427.9	1116.8	1462.6	176.8	316.6	1380.9	487.5	192.7	408.8	354.8	187.5	1239.9	102.9	38.5	1506.3	419.6	213.6	251.8	384.9
IPO7	"Imp7, RANBP7"	ENSG00000205339	"Importin 7"	O95373	11	9384622-9448126	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019002, HPA056590"	Approved	Approved	Supported	Nucleoplasm,Cytosol		NA	NA		26000	"Nucleoplasm, Cytosol"		"HPA019002: AB_1856059, HPA056590: AB_2683180"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (9.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.19e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.38e-6)"	"unprognostic (3.06e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.90e-3)"	23.9	20.6	21.8	18.6	24.4	12.3	36.0	24.1	30.6	24.3	27.4	14.4	19.3	17.0	25.7	19.3	29.0	20.3	20.3	37.7	22.8	23.4	26.5	24.7	22.0	23.2	23.3	17.4	23.4	25.9	33.1	19.1	26.5	24.8	24.4	22.1	12.0	21.4	22.4	88.2	17.1	16.1	53.4	25.7	16.6	21.5	9.7	16.8	20.8	34.3	28.5	20.9	43.7	33.9	3.8	5.8	1.3	6.3	6.9	5.4	1.6	37.7	29.5	34.8	27.6	35.3	45.6	27.9	46.0	29.6	34.0	36.8	25.5	34.8	35.4	16.8	35.3	30.9	29.7	49.3	35.7	56.9	16.8	40.7	29.3	33.5	25.6	22.1	44.7	22.3	29.1	38.7	22.4	52.7	34.8	40.1	12.2	43.9	21.3	44.3	15.3	26.9	21.9	34.2	35.0	34.3	28.4	54.8	16.0	28.1	35.7	13.8	27.2	20.5	40.7	33.1	28.9	18.7	22.5	31.5	41.9	28.9	43.1	49.1	6.2	23.6	24.5	27.5	24.2	22.7	0.1	2.5	0.6	2.7	4.8	5.4	3.8	3.1	3.9	5.8	3.1	3.9	3.2	1.3	6.9	6.3	2.7	2.8	1.6	21.8	24.4	24.1	30.6	22.8	23.4	23.3	17.4	24.8	16.8	62.5	53.8	24.3	76.2	128.0	37.1	127.5	30.6	49.5	67.1	33.2	55.0	44.9	28.2	32.5	3.3	40.5	18.6	0.0	35.7	54.7	55.8	105.1	35.9	39.4	31.6	33.4	29.9	25.2	47.7	3.6	25.9	41.8	37.1	26.2	36.8	30.1	37.3	28.8	33.6	35.8	38.8	12.9	55.6	15.4	22.6	129.4	30.7	22.3	45.0	129.0
ANXA2	"ANX2, ANX2L4, CAL1H, LIP2, LPC2D"	ENSG00000182718	"Annexin A2"	P07355	15	60347134-60402883	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004311, HPA046964, HPA061798"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		16000000	"Plasma membrane"	Cytosol	"CAB004311: AB_626677, HPA046964: AB_2732537, HPA061798: AB_2732671"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (6.88e-5)"	"unprognostic (4.06e-3)"	"unprognostic (5.42e-3)"	"prognostic unfavorable (2.54e-5)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (2.94e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (8.47e-6)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (7.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (6.59e-5)"	91.7	29.8	4.9	23.5	7.1	6.6	50.1	4.5	5.6	65.1	39.1	8.6	38.2	26.4	38.3	40.3	158.8	26.2	54.9	29.9	4.7	5.5	36.7	28.5	62.0	46.6	10.8	5.7	23.3	94.3	29.7	12.8	84.1	25.7	29.5	35.2	31.7	74.7	27.9	22.7	77.3	71.9	37.1	15.1	32.6	25.6	18.7	7.1	14.6	31.0	122.7	81.4	34.0	87.4	35.5	209.6	183.3	138.0	15.2	83.9	150.8	144.7	161.6	8.5	3.8	116.8	187.4	37.1	173.0	111.6	109.9	96.5	76.6	69.9	0.3	142.5	223.8	82.7	154.9	38.0	324.9	120.6	30.8	4.0	2.9	77.8	29.7	70.4	0.1	2.1	91.5	88.7	78.1	168.4	132.2	204.9	2.1	11.5	16.9	234.8	16.8	0.6	8.5	18.5	123.9	125.9	1.7	46.9	8.1	194.9	88.2	11.2	6.3	68.4	15.6	67.9	92.0	33.4	6.0	233.6	93.8	127.8	314.4	169.8	6.3	20.7	2.8	88.3	1.6	186.5	183.3	138.0	17.7	33.4	122.6	36.5	35.5	38.5	38.5	209.6	16.9	4.5	18.1	3.9	15.2	129.1	32.0	83.9	150.8	4.9	7.1	4.5	5.6	4.7	5.5	10.8	5.7	25.7	7.1	1989.1	372.8	135.8	2699.6	2231.6	2.1	19.9	922.3	1675.6	1452.5	532.1	0.0	1604.6	11.6	3597.2	77.7	904.5	724.0	23.3	2130.9	2200.2	1229.1	3363.5	101.8	70.0	1517.4	0.0	99.2	465.3	432.0	90.7	714.0	1131.8	1344.5	1757.5	521.7	18.0	3399.7	582.2	600.4	22.4	6.8	181.1	774.1	7.0	17.7	2032.4	961.8	162.4	580.5	3656.9
CDCA5		ENSG00000146670	"Cell division cycle associated 5"	Q96FF9	11	65066300-65084164	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 27.4;lymphoid tissue: 39.9;testis: 27.9"	"Group enriched"	"Detected in many"	5	"Early spermatids: 41.6;Extravillous trophoblasts: 30.6;Late spermatids: 84.2;Spermatocytes: 40.4;Spermatogonia: 22.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"NK-cell: 5.8;T-reg: 4.2"	"Group enriched"	"Detected in many"	4	"NK-cells: 5.8;T-cells: 4.2"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023691, HPA076007"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		"HPA023691: AB_1846392, HPA076007: "	"unprognostic (3.14e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (8.21e-6)"	"unprognostic (1.41e-3)"	"unprognostic (7.55e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (8.72e-6)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.55e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.97e-2)"	1.3	1.3	1.1	12.3	1.1	27.4	4.3	1.0	2.8	1.6	3.8	0.6	0.0	3.3	0.9	1.4	7.9	0.7	1.4	1.3	1.1	0.9	1.3	1.3	1.9	9.5	1.1	0.5	0.8	0.7	0.2	0.7	5.5	1.3	0.9	4.7	0.1	1.5	0.1	0.7	2.4	3.6	1.7	0.7	5.7	2.1	27.9	0.2	39.9	0.7	6.6	9.9	1.5	2.3	1.2	0.8	0.3	0.5	5.8	4.2	1.4	30.7	17.6	16.9	14.3	1.1	1.8	14.1	22.0	9.2	25.8	20.6	18.0	18.7	28.0	12.7	7.1	30.4	21.3	27.3	12.1	25.2	28.0	11.9	25.2	12.8	15.1	0.1	26.8	20.4	0.6	1.1	24.1	11.2	2.7	7.8	33.6	28.5	51.8	15.7	25.5	37.8	27.7	26.6	15.2	21.4	33.2	18.7	26.7	5.3	11.8	22.0	16.5	14.1	20.2	14.9	11.0	26.0	13.2	4.9	23.4	24.2	24.6	24.4	26.2	41.5	45.6	9.4	16.6	24.1	0.0	0.2	0.3	0.8	0.0	0.1	0.7	1.1	0.6	0.8	1.2	0.1	0.8	0.1	5.8	0.5	0.7	4.2	1.4	1.1	1.1	1.0	2.8	1.1	0.9	1.1	0.5	1.3	0.2	0.0	0.3	0.8	0.8	3.4	0.8	0.8	0.0	0.0	1.2	0.0	2.0	3.7	1.7	0.9	41.6	0.9	0.9	0.0	0.7	30.6	1.8	0.4	3.5	0.0	9.5	1.6	0.0	1.3	2.8	84.2	2.6	1.9	0.0	3.6	2.3	0.8	0.5	0.0	1.4	0.3	0.2	0.0	0.3	40.4	22.0	0.9	3.1	1.9	2.8	1.0
VPS26A	"Hbeta58, PEP8A, VPS26"	ENSG00000122958	"VPS26, retromer complex component A"	O75436	10	69123512-69172861	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011602, HPA057498, CAB075733"	Supported		Enhanced	Endosomes,Lysosomes		NA	NA		19000	"Endosomes, Lysosomes"		"CAB011602: AB_2215043, CAB075733: AB_2665739, HPA057498: AB_2683448"	"unprognostic (1.17e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.35e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (1.72e-4)"	"prognostic unfavorable (1.70e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.88e-2)"	"prognostic unfavorable (9.18e-6)"	"unprognostic (4.63e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.14e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.72e-1)"	30.7	25.8	31.8	18.8	37.1	25.2	29.6	42.6	37.2	23.3	27.5	14.5	15.1	21.4	24.5	20.7	37.1	20.7	20.9	40.7	33.3	21.1	34.3	26.5	23.9	17.7	26.5	25.4	24.1	19.3	31.4	24.5	36.4	29.9	23.9	28.8	15.3	25.7	20.3	29.3	33.8	28.0	22.9	35.4	24.7	22.7	34.2	29.1	21.8	27.8	23.6	22.8	30.8	27.3	16.9	28.1	28.2	29.4	34.7	28.1	25.3	33.4	12.8	15.8	28.3	27.9	25.4	14.0	20.5	33.4	25.1	28.7	30.1	32.9	10.5	16.7	22.4	23.9	23.3	23.7	20.5	35.0	9.4	12.9	15.6	11.9	16.8	36.1	23.6	12.6	23.0	32.2	25.1	55.9	34.0	26.3	12.5	30.0	14.8	40.0	10.7	10.6	26.8	10.6	17.1	32.6	13.2	26.2	12.5	29.3	19.9	9.7	14.5	27.9	38.6	37.3	14.9	15.2	20.3	30.3	17.1	21.9	27.7	26.7	8.9	21.5	17.1	23.4	38.6	8.9	28.2	25.4	22.9	27.9	29.4	25.3	16.9	21.6	28.1	28.1	13.7	19.2	26.6	23.0	34.7	24.2	11.5	24.1	25.3	31.8	37.1	42.6	37.2	33.3	21.1	26.5	25.4	29.9	29.1	68.5	47.5	29.0	70.8	107.3	21.8	36.4	35.7	50.9	63.7	38.4	13.7	103.0	68.0	58.4	46.4	48.6	35.8	23.3	46.6	75.5	56.3	52.1	42.9	27.6	75.3	19.1	15.5	31.9	46.6	23.9	39.1	86.2	59.1	73.1	33.8	53.3	51.3	41.0	42.1	58.0	26.2	12.9	72.1	78.0	63.2	93.5	203.8	67.5	35.4	66.3
HIST1H3H	"H3/k, H3F1K, H3FK"	ENSG00000278828	"Histone cluster 1 H3 family member h"	P68431	6	27810064-27811300	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"blood: 55.3;lymphoid tissue: 204.8"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 9.9;Intestinal endocrine cells: 5.8"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in many"	6	"basophil: 15.9;neutrophil: 10.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 15.9"	"Cell line enhanced"	"Detected in many"		"K-562: 17.8;SiHa: 15.5;U-266/70: 13.2;U-266/84: 32.1"									HPA042570	Approved					NA	Yes					"HPA042570: AB_2678056"	"unprognostic (1.61e-1)"	"prognostic favorable (4.35e-4)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.93e-1)"	"prognostic unfavorable (9.25e-6)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (5.73e-5)"	"unprognostic (4.09e-1)"	"unprognostic (4.94e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.82e-2)"	1.2	2.6	0.0	25.2	0.0	7.5	1.7	0.2	0.3	1.7	4.7	0.0	2.5	2.3	1.6	2.5	9.0	0.6	3.0	1.3	0.0		0.4	3.1	4.4	8.1	0.0	0.0	2.2	1.5	1.4	0.0	3.4	0.1	2.7	5.3	0.5	0.9	2.8	0.8	0.3	3.9	1.0	0.2	11.0	3.1	3.4	0.0	204.8	1.3	10.6	22.6	1.7	0.9	1.1	1.8	15.9	1.1	0.3	2.0	55.3	1.0	3.9	1.7	1.4	2.4	0.3	0.2	0.6	0.4	1.9	0.7	1.2	1.1	0.7	3.7	0.4	1.1	2.1	0.6	0.9	1.2	4.9	2.4	0.9	3.5	5.0	0.6	0.8	1.5	3.2	0.3	0.4	0.4	0.8	0.8	0.9	17.8	8.6	0.3	7.8	1.6	1.9	0.8	7.2	1.5	0.8	0.0	8.9	2.0	0.4	5.2	1.0	15.5	3.2	0.6	0.9	7.5	0.2	0.8	0.8	2.5	0.5	0.2	13.2	32.1	2.7	0.0	4.2	0.2	15.9	1.1	2.1	0.3	0.3	0.4	0.3	0.6	0.5	0.8	1.1	0.4	0.3	10.3	0.3	0.3	1.8	2.0	55.3											0.0	1.0	2.7	3.6	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	9.9	0.0	0.2	2.9	0.8	4.6	0.0	1.5	1.8	0.0	5.8	0.0	1.8	0.0	0.6	0.0	1.7	1.0	2.9	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.3	0.0	1.0	0.1	4.3	4.3	1.7	1.4
KIF4A	"FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100"	ENSG00000090889	"Kinesin family member 4A"	O95239	X	70290090-70420832	"Predicted intracellular proteins"		"DNA-binding, Motor protein"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.1;lymphoid tissue: 19.3"	"Cell type enriched"	"Detected in some"	5	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.2"	"Low cell line specificity"	"Detected in many"											"HPA034745, HPA034746, HPA061583"	Approved		Supported	Nucleoplasm,Midbody		Yes	Yes			"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564"	"unprognostic (8.17e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (7.37e-6)"	"unprognostic (2.18e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (9.44e-6)"	"unprognostic (3.79e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	0.9	0.6	0.8	3.3	1.0	11.1	0.5	0.4	3.4	1.2	4.1	0.4	0.4	3.4	0.8	0.4	7.4	1.5	2.5	2.0	0.8	1.3	0.7	0.7	1.5	5.8	0.5	0.9	0.4	0.4	0.0	1.3	2.4	0.8	0.7	5.2	0.4	1.2	0.4	0.8	2.3	3.6	1.2	0.5	4.9	2.1	7.5	1.1	19.3	0.4	0.4	7.2	1.1	2.0	0.7	0.0	0.0	0.2	0.2	3.2	0.3	22.5	15.8	23.9	11.7	1.1	2.0	9.4	17.2	9.2	23.5	20.5	17.7	13.3	13.9	10.8	8.4	18.2	13.6	25.8	9.3	26.6	15.9	13.0	15.7	19.3	12.5	0.2	17.4	10.9	0.7	0.5	19.5	11.2	2.8	14.3	10.7	19.9	30.9	22.1	14.5	15.9	8.6	24.1	24.1	16.8	17.7	32.3	13.0	5.6	8.9	15.8	13.2	28.0	11.9	7.3	12.6	9.5	6.8	9.9	15.6	20.3	16.7	20.4	8.9	15.3	20.1	8.2	19.1	23.4	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	3.2	0.3	0.8	1.0	0.4	3.4	0.8	1.3	0.5	0.9	0.8	1.1	0.0	0.3	0.0	0.2	1.5	0.0	0.4	2.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.1	0.1	46.7	0.0	10.3	1.0	0.1	0.0	0.0	4.3	0.0	1.2	1.8	0.6	0.5	0.0	0.9	0.0	0.0	1.2	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	7.2	5.8	0.3	1.5	0.5	2.1	0.3
DLGAP5	"DLG1, DLG7, HURP, KIAA0008"	ENSG00000126787	"DLG associated protein 5"	Q15398	14	55148112-55191678	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 65.1"	"Cell type enhanced"	"Detected in many"	22	"Erythroid cells: 140.2;Spermatocytes: 61.2;Spermatogonia: 32.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 8.3"	"Lineage enriched"	"Detected in many"	6	"T-cells: 8.3"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA005546	Enhanced		Supported	"Centriolar satellite,Cytosol"		Yes	Yes			"Centriolar satellite, Cytosol"		"HPA005546: AB_1078677"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.19e-3)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.52e-6)"	"prognostic unfavorable (7.85e-4)"	"unprognostic (6.15e-3)"	"unprognostic (3.55e-1)"	"prognostic unfavorable (9.94e-6)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-2)"	1.4	0.9	0.3	11.4	0.4	16.2	0.5	0.3	0.5	1.3	3.3	0.2	0.2	2.9	0.9	1.0	8.7	0.3	1.3	0.7	0.2	0.3	1.1	0.8	2.1	10.6	0.3	0.2	0.7	0.4	0.0	0.3	3.3	0.3	0.5	4.1	0.3	1.5	0.2	0.5	1.9	4.1	1.3	0.3	6.6	2.2	13.0	0.2	65.1	0.4	6.4	11.4	1.7	2.4	1.1	0.4	0.4	0.0	1.3	8.3	1.2	37.6	15.0	39.4	17.7	0.9	3.9	12.2	21.9	14.5	32.4	30.9	12.2	20.8	21.9	12.1	12.7	13.0	23.4	25.2	17.5	42.6	26.4	12.4	22.5	14.1	10.5	0.1	22.0	13.8	0.8	0.6	15.2	7.3	5.2	35.6	22.5	18.2	22.0	30.1	18.1	27.7	11.2	20.3	16.8	15.6	21.7	38.1	10.1	10.6	12.2	20.1	11.3	23.3	8.8	8.6	17.5	19.6	8.2	13.8	14.5	38.0	14.0	25.1	5.4	11.7	29.1	10.1	15.7	23.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.1	2.3	0.4	0.1	0.5	0.2	0.4	1.3	0.0	0.0	8.3	1.2	0.3	0.4	0.3	0.5	0.2	0.3	0.3	0.2	0.3	0.2	0.0	0.3	8.5	0.2	1.0	0.0	0.3	0.0	1.4	1.2	0.0	0.0	1.3	0.0	0.4	10.7	0.0	0.2	140.2	0.0	19.8	1.0	0.2	0.0	0.8	8.6	0.0	0.0	1.8	4.5	4.6	0.9	2.2	0.0	0.0	1.3	0.0	0.1	0.0	1.1	0.0	0.0	6.5	0.0	61.2	32.3	0.4	1.6	1.5	2.5	1.1
ITGA2	CD49b	ENSG00000164171	"Integrin subunit alpha 2"	P17301	5	52989326-53094779	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 300.3;Glandular cells: 266.4;Pancreatic endocrine cells: 350.7;Urothelial cells: 321.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 29.9;HaCaT: 30.2;hTERT-RPE1: 28.1;HUVEC TERT2: 27.8;TIME: 23.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017690, HPA060991, HPA063556"	Enhanced		Approved	Nucleoplasm,Cytosol		Yes	No		46000000	Nucleoplasm	Cytosol	"CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040"	"unprognostic (8.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (4.27e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.11e-1)"	1.9	14.0	2.9	4.7	13.4	0.4	7.9	1.8	6.8	7.1	6.5	22.5	12.1	7.6	5.1	10.4	16.7	2.8	9.3	2.5	5.4	3.6	15.1	1.8	17.2	1.4	18.3	4.5	1.8	2.7	16.1	2.5	4.8	10.7	8.5	6.0	0.8	15.8	16.8	1.2	16.9	17.0	2.5	8.4	9.1	7.4	1.3	13.0	1.5	2.5	7.4	10.0	7.5	11.1	0.5	1.5	1.7	0.6	0.2	0.6	0.3	19.4	5.0	0.4	0.2	1.3	2.4	1.5	19.6	29.9	0.7	1.2	9.3	13.7	0.0	3.4	8.3	11.5	30.2	1.6	22.1	2.8	0.0	1.5	1.4	1.2	5.5	4.5	0.2	0.4	0.9	3.8	19.7	3.5	28.1	27.8	1.0	0.0	0.0	0.5	3.6	0.2	0.0	1.2	5.0	10.0	0.0	0.1	0.0	6.3	10.3	0.2	1.1	1.0	1.3	2.0	0.8	3.2	0.0	23.8	3.6	2.1	0.5	3.9	0.0	0.0	0.0	21.6	0.0	15.8	1.7	0.6	0.2	0.6	0.2	0.4	0.4	0.5	0.5	0.1	0.5	0.5	0.6	0.8	0.2	0.1	1.5	0.4	0.3	2.9	13.4	1.8	6.8	5.4	3.6	18.3	4.5	10.7	13.0	53.6	13.6	0.0	300.3	134.2	2.3	1.2	20.4	88.3	161.5	50.6	3.9	0.2	8.3	157.1	0.0	15.8	20.6	0.0	144.3	1.6	1.9	266.4	1.1	0.0	0.3	0.0	13.3	5.5	0.0	0.0	1.1	3.8	11.8	1.8	32.4	18.0	350.7	15.2	0.0	2.9	5.0	0.0	4.2	0.0	0.9	32.5	0.3	1.9	28.1	321.7
SERP1	"FLJ43424, RAMP4"	ENSG00000120742	"Stress associated endoplasmic reticulum protein 1"	Q9Y6X1	3	150541994-150603228	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 122.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038970	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA038970: AB_2676296"	"unprognostic (8.81e-3)"	"unprognostic (2.35e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.29e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.35e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.55e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.78e-1)"	24.5	34.2	23.1	22.4	22.6	25.4	38.0	12.5	18.4	38.6	26.7	15.6	59.9	21.4	20.2	56.7	29.6	28.1	25.1	15.1	17.4	16.5	27.7	93.6	38.1	47.8	17.5	15.6	31.5	137.6	21.1	33.0	33.2	14.7	32.9	23.8	15.6	103.1	58.9	9.7	18.1	33.5	15.6	18.9	42.9	38.4	17.8	16.0	38.4	51.3	17.3	33.6	31.2	29.8	49.6	67.9	76.4	89.1	36.8	68.2	90.5	33.1	7.1	10.9	8.2	16.0	18.8	25.0	23.7	15.3	13.0	15.3	18.5	14.6	26.8	45.8	17.1	10.8	16.2	17.6	12.2	17.3	16.5	15.2	28.4	6.2	18.7	31.3	25.6	19.1	11.2	22.0	7.5	37.7	14.2	15.1	18.3	13.8	37.9	11.0	14.3	21.6	22.3	20.4	21.0	18.5	28.2	8.3	83.3	15.7	10.7	18.8	16.0	9.1	20.1	35.9	13.7	17.7	25.1	14.6	6.2	11.4	13.3	18.2	122.2	34.9	36.0	11.3	25.2	5.7	62.2	88.3	76.4	52.9	81.8	68.2	49.6	56.9	53.3	67.5	47.9	56.7	52.1	64.4	36.8	89.1	67.9	54.3	90.5	23.1	22.6	12.5	18.4	17.4	16.5	17.5	15.6	14.7	16.0	62.5	139.6	390.1	556.3	477.8	73.3	37.8	160.5	156.6	144.5	164.0	55.0	242.2	310.0	207.9	287.5	159.5	300.1	0.0	263.4	394.7	208.5	631.9	219.9	431.3	345.7	39.7	243.7	217.3	540.1	505.4	203.4	389.3	330.7	232.6	361.6	114.7	332.1	414.1	178.9	241.5	64.5	109.9	173.1	132.7	83.4	518.0	790.1	279.9	304.6	899.5
PERP	"dJ496H19.1, KCP1, KRTCAP1, PIGPC1, THW"	ENSG00000112378	"PERP, TP53 apoptosis effector"	Q96FX8	6	138088505-138107511	"Predicted membrane proteins"	"Apoptosis, Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 250.2;skin 1: 157.9;tongue: 230.6"	"Cell type enhanced"	"Detected in many"	14	"Basal keratinocytes: 2942.7;Suprabasal keratinocytes: 5094.7;Urothelial cells: 1450.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 21.3"	"Group enriched"	"Detected in many"	9	"granulocytes: 21.3;T-cells: 5.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 37.9;hTCEpi: 142.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA022269	Enhanced					NA	NA					"HPA022269: AB_1855219"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-3)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (4.02e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.51e-2)"	4.2	1.6	1.0	2.7	1.2	0.0	25.5	1.3	0.9	51.9	12.5	0.5	7.1	6.3	6.4	11.7	250.2	7.7	15.6	14.7	1.2	1.5	4.4	28.0	8.4	1.7	1.3	0.3	3.3	11.5	5.0	3.3	31.5	1.6	17.5	5.0	2.4	46.6	7.9	1.4	157.9	23.4	7.1	1.3	0.6	8.4	1.9	0.6	6.7	8.7	230.6	113.6	14.0	57.8	1.4	0.0	21.3	0.0	0.0	5.6	0.8	10.2	11.5	0.0	1.1	8.1	8.6	24.0	16.7	18.9	2.4	1.7	9.4	21.2	0.0	6.0	4.2	19.9	37.9	2.0	30.2	0.5	16.1	9.4	0.0	11.5	8.8	5.8	0.0	0.0	6.4	142.2	0.2	15.5	13.8	9.4	0.6	0.1	4.5	0.2	7.1	0.0	0.5	4.9	24.5	6.2	0.0	3.8	0.0	16.1	12.0	4.0	0.0	17.7	9.5	8.1	11.6	5.3	2.1	11.2	4.2	1.6	4.5	0.0	1.4	1.8	0.0	3.3	0.0	8.8	21.3	0.0	0.0	3.0	0.0	5.2	1.4	3.8	2.6	0.0	0.4	0.4	1.7	0.2	0.0	0.0	0.0	5.6	0.8	1.0	1.2	1.3	0.9	1.2	1.5	1.3	0.3	1.6	0.6	196.5	66.8	11.7	1261.9	2942.7	3.4	114.6	234.4	397.5	227.5	146.5	15.7	849.6	53.0	494.4	1.4	53.7	255.2	0.0	273.4	823.5	67.6	524.2	10.4	153.4	71.8	3.2	141.3	9.8	2.2	2.0	9.8	5.1	332.3	18.0	159.9	23.8	453.2	273.5	2.5	10.1	25.6	6.5	122.7	1.8	0.9	5094.7	689.2	31.2	162.2	1450.6
KRT16	NEPPK	ENSG00000186832	"Keratin 16"	P08779	17	41609778-41615899	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"tongue: 503.5"	"Group enriched"	"Detected in some"	8	"Basal glandular cells: 391.0;Basal keratinocytes: 804.9;Suprabasal keratinocytes: 1178.6;Urothelial cells: 555.3"	"Group enriched"	"Detected in many"	7	"cervical cancer: 713.1;head and neck cancer: 2720.5;melanoma: 712.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"hTCEpi: 137.6"	"Not detected"	"Not detected"							"CAB000136, HPA000539"	Approved		Approved	"Intermediate filaments"		NA	NA		2200000000	"Intermediate filaments"		"CAB000136: , HPA000539: "	"unprognostic (3.95e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.14e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (8.23e-2)"	"unprognostic (6.53e-8)"	"unprognostic (3.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.61e-2)"	1.6	0.2	0.2	0.2	0.2	0.0	2.1	0.2	0.2	32.4	0.2	0.2	0.2	0.0	1.1	0.2	112.4	0.1	0.6	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.6	0.2	0.7	0.0	0.3	15.5	9.9	0.4	41.4	0.2	0.2	0.2	0.2	0.1	0.6	0.2	3.0	0.2	503.5	26.4	0.6	50.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	4.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	137.6	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.1	0.0	0.0	15.6	0.1	1.0	0.0	0.0	9.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	391.0	804.9	0.0	0.0	0.0	0.0	1.2	1.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.2	2.5	20.6	95.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	60.8	0.0	0.0	0.0	48.1	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	1178.6	0.1	0.0	0.0	555.3
AP3S1	CLAPS3	ENSG00000177879	"Adaptor related protein complex 3 sigma 1 subunit"	Q92572	5	115841481-115914081	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049270	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA049270: AB_2680696"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.54e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (2.60e-2)"	"unprognostic (3.83e-3)"	"unprognostic (4.42e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (9.57e-8)"	"unprognostic (2.73e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.64e-1)"	22.0	13.8	28.6	15.0	28.6	33.0	26.1	21.7	30.8	30.8	22.5	10.4	60.4	17.6	20.6	27.6	23.4	16.7	17.0	17.0	30.7	21.1	11.7	23.8	12.7	18.3	23.7	19.4	23.3	34.8	9.1	20.9	20.9	19.8	15.3	20.8	9.7	26.8	64.1	8.5	15.7	28.9	28.7	20.6	11.5	12.8	26.9	13.2	12.1	19.0	12.7	20.1	21.6	19.7	20.1	23.8	39.8	21.9	11.8	17.1	15.4	19.9	5.1	16.8	8.4	43.4	71.3	11.0	23.4	32.6	20.7	36.7	9.8	18.7	15.2	13.2	29.1	18.4	5.8	9.2	38.9	31.0	45.1	15.9	6.7	6.8	14.7	24.8	9.5	13.2	31.5	31.1	16.4	15.6	21.7	20.9	23.5	7.1	11.7	26.9	4.1	11.5	12.0	10.3	9.6	9.7	14.2	24.0	26.6	19.8	5.8	5.9	8.2	33.4	6.4	19.2	15.1	11.2	10.8	14.4	28.0	17.1	20.9	15.5	8.7	9.3	18.0	23.0	22.0	10.3	17.6	18.5	39.8	10.9	21.9	17.0	20.1	13.8	14.8	15.4	13.0	12.3	12.4	26.7	11.8	19.0	23.8	17.1	15.4	28.6	28.6	21.7	30.8	30.7	21.1	23.7	19.4	19.8	13.2	20.8	21.6	70.7	83.1	180.3	35.7	21.5	43.3	18.7	17.0	43.6	23.6	67.6	59.7	84.5	93.7	65.3	174.5	23.3	74.6	264.6	188.4	82.3	80.9	77.3	136.0	25.4	73.1	62.0	99.6	164.9	160.2	110.4	109.6	87.4	103.7	14.1	98.1	98.2	104.7	120.7	71.2	32.3	148.2	104.4	86.7	199.2	107.7	106.5	61.3	84.5
PPP2R3A	"PPP2R3, PR130, PR72"	ENSG00000073711	"Protein phosphatase 2 regulatory subunit B''alpha"	Q06190	3	135965673-136147891	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 85.6"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 102.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 19.2;BJ hTERT+: 18.8;RPTEC TERT1: 25.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035829, HPA035830, HPA065338"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA035829: AB_10696513, HPA035830: AB_10670121, HPA065338: AB_2685475"	"unprognostic (3.35e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.71e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.44e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (8.92e-2)"	"prognostic favorable (1.15e-5)"	"unprognostic (4.55e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.91e-4)"	6.3	3.3	3.4	1.9	6.4	0.7	4.3	1.5	4.9	5.5	6.7	5.2	5.8	1.7	6.8	5.1	5.0	3.0	3.3	27.4	3.9	2.8	31.7	1.2	2.6	0.9	7.0	4.4	3.7	3.8	7.5	3.7	9.0	5.3	3.8	3.5	1.6	7.7	7.8	85.6	10.4	2.5	11.4	6.1	1.2	5.2	4.2	6.5	0.0	2.3	31.6	1.2	6.5	3.9	1.5	1.8	1.7	1.4	1.8	1.5	0.6	19.2	1.1	5.5	2.6	4.5	5.7	6.4	15.1	18.8	7.1	8.9	1.2	1.2	0.0	5.8	15.4	5.1	2.5	2.3	5.3	15.5	0.0	0.7	0.8	0.6	0.0	3.2	0.0	0.8	5.1	4.6	9.1	4.3	7.2	6.8	0.5	0.5	0.0	10.2	3.2	0.1	0.1	3.8	0.2	3.7	0.0	8.1	0.0	25.0	0.7	0.4	3.1	2.4	3.0	5.8	5.2	4.8	0.2	4.4	7.5	4.1	10.1	6.6	0.2	0.5	0.0	5.5	0.4	2.6	1.1	1.2	1.5	0.9	1.4	0.5	0.7	1.0	0.8	1.1	1.5	1.5	1.2	1.7	1.8	1.2	1.8	0.7	0.6	3.4	6.4	1.5	4.9	3.9	2.8	7.0	4.4	5.3	6.5	26.8	22.2	2.7	15.3	23.5	4.1	102.3	0.0	9.4	11.4	52.4	0.0	7.6	18.3	18.1	6.1	8.7	15.8	0.0	8.5	13.2	12.8	12.5	3.5	2.4	2.2	3.2	12.5	5.5	2.1	9.5	22.7	4.6	27.0	14.4	7.9	9.5	12.6	9.9	17.3	37.2	2.2	6.5	11.9	6.6	19.6	29.1	8.7	3.8	7.3	15.3
TRIM59	"Mrf1, RNF104, TRIM57, TSBF1"	ENSG00000213186	"Tripartite motif containing 59"	Q8IWR1	3	160432445-160485773	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.6;lymphoid tissue: 24.6"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 23.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017750	Uncertain		Approved	"Rods & Rings"		NA	Yes			"Rods & Rings"		"HPA017750: AB_1858312"	"unprognostic (3.74e-1)"	"prognostic favorable (4.36e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.02e-1)"	"unprognostic (8.00e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (1.02e-3)"	"unprognostic (2.44e-11)"	"unprognostic (7.92e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.03e-2)"	"unprognostic (5.91e-3)"	1.3	1.4	8.0	6.0	19.3	18.6	2.7	2.1	14.5	1.8	3.5	30.6	0.3	3.6	4.1	1.3	6.6	2.8	3.6	1.2	13.4	6.4	2.0	1.6	2.6	13.8	28.3	6.3	2.1	2.4	2.7	2.5	2.6	14.3	2.9	3.5	0.1	2.6	1.6	1.6	6.8	4.0	3.8	14.5	6.3	3.3	10.4	28.4	24.6	2.8	0.3	14.5	6.1	3.1	7.8	4.7	16.1	2.2	8.8	15.2	2.6	8.9	7.1	9.1	0.6	3.6	5.0	12.0	14.2	12.3	17.8	17.1	0.7	15.6	23.9	10.6	10.6	5.6	15.3	0.0	5.8	23.5	21.7	8.6	0.8	2.1	1.0	5.1	10.5	1.4	4.2	1.7	8.6	6.1	10.8	12.4	3.6	11.2	10.2	16.6	9.4	6.4	0.7	23.9	5.8	11.9	9.0	7.9	10.7	6.2	2.9	5.9	1.3	4.0	11.9	0.3	12.8	14.1	9.8	9.4	1.3	4.2	2.1	1.3	17.0	6.1	6.0	1.5	13.8	1.4	16.1	2.2	3.7	8.3	2.2	9.4	7.8	13.6	11.2	3.2	6.9	9.4	11.1	2.7	8.8	1.0	4.7	15.2	2.6	8.0	19.3	2.1	11.8	13.4	6.4	28.3	6.3	14.3	28.4	0.0	6.2	12.3	4.2	4.2	0.4	0.7	2.5	1.4	1.2	1.8	5.9	4.1	0.0	1.7	23.4	1.8	1.1	0.0	1.7	9.8	1.8	1.8	1.1	0.0	2.5	0.0	10.4	2.5	3.0	10.7	0.3	2.1	3.3	1.0	2.2	0.5	1.4	3.5	0.7	1.4	1.3	0.0	0.5	12.5	13.9	3.9	2.1	12.8	4.4	2.7
FAM111B	CANP	ENSG00000189057	"Family with sequence similarity 111 member B"	Q6SJ93	11	59107185-59127410	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 43.9"	"Cell type enhanced"	"Detected in some"	9	"B-cells: 4.8;Basal keratinocytes: 3.8;Hofbauer cells: 3.4;Undifferentiated cells: 6.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.7;naive B-cell: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA038637	Uncertain		Approved	Nucleoplasm,Cytosol		No	Yes			Nucleoplasm	Cytosol	"HPA038637: AB_10672522"	"unprognostic (2.31e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.96e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (1.49e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.24e-5)"	"unprognostic (2.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.24e-1)"	1.3	1.3	0.4	8.9	0.8	3.5	1.9	0.3	1.1	1.8	4.7	0.4	0.3	2.5	0.8	2.0	9.3	0.7	1.8	1.0	0.4	0.4	1.8	2.6	2.1	9.9	0.5	0.3	1.0	0.8	1.4	0.9	2.8	0.8	1.2	5.0	0.3	2.6	0.3	0.5	3.5	4.1	1.3	0.6	5.4	2.8	1.0	0.6	43.9	0.7	9.2	11.1	1.5	2.6	5.7	0.3	3.1	0.2	0.1	1.4	0.3	24.4	6.3	9.4	0.1	1.0	1.8	0.1	18.6	9.3	11.1	16.5	13.3	9.7	30.5	12.6	5.4	9.3	19.0	13.7	12.6	19.8	15.8	3.3	3.3	12.0	5.8	0.0	0.1	3.9	0.4	0.4	10.7	0.8	2.1	5.9	8.3	0.9	28.8	13.0	9.2	19.2	0.2	0.1	14.8	7.4	20.3	14.0	11.9	5.9	21.1	1.8	6.0	15.4	17.8	3.0	3.6	19.7	1.7	3.2	8.6	18.8	26.0	16.9	22.2	16.0	0.2	12.5	0.1	12.3	0.5	0.2	0.2	0.3	0.1	0.2	5.7	0.4	0.7	0.3	5.7	0.2	0.2	3.1	0.1	0.2	0.3	1.4	0.3	0.4	0.8	0.3	1.1	0.4	0.4	0.5	0.3	0.8	0.6	0.0	0.0	4.8	2.0	3.8	0.0	0.3	0.0	2.7	1.2	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.3	0.3	0.8	0.0	0.0	3.4	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.3	2.4	0.1	0.5	6.3	0.9
SPDL1	"CCDC99, FLJ20364, hSpindly"	ENSG00000040275	"Spindle apparatus coiled-coil protein 1"	Q96EA4	5	169583634-169604778	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.7"	"Cell type enhanced"	"Detected in many"	11	"Spermatocytes: 97.4;Spermatogonia: 70.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA044700, HPA048146"	Enhanced		Approved	Cytosol		NA	Yes			Cytosol		"HPA044700: AB_2679052, HPA048146: AB_2680284"	"unprognostic (2.61e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.59e-3)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (4.24e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.48e-6)"	"unprognostic (2.63e-3)"	"unprognostic (5.70e-3)"	"unprognostic (8.27e-3)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (2.13e-6)"	"unprognostic (2.81e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.93e-1)"	5.5	4.7	6.5	9.0	11.5	9.9	8.0	14.5	11.0	5.5	5.6	6.6	3.4	5.9	6.4	4.4	9.7	4.9	4.9	4.0	7.8	5.8	5.1	3.6	4.7	13.9	8.3	7.1	7.2	4.1	5.6	8.0	8.4	11.6	4.1	6.0	2.0	5.1	3.6	5.0	5.3	5.9	7.7	16.7	8.2	5.3	33.7	10.4	23.9	4.5	8.5	13.6	5.4	5.8	10.7	16.5	3.2	4.6	6.4	9.3	3.0	14.6	17.6	18.0	12.6	4.8	4.5	15.9	46.6	6.2	34.9	31.7	23.1	9.9	13.8	30.9	38.1	24.0	10.3	14.6	20.0	38.3	14.2	16.3	16.1	31.7	9.0	2.2	16.9	13.9	2.1	1.7	14.6	9.2	7.4	15.8	14.3	10.1	10.2	37.1	14.2	13.8	7.2	13.1	7.3	17.1	16.2	17.7	10.2	22.8	5.2	11.6	8.5	21.7	6.2	9.1	13.3	7.0	11.3	11.2	39.8	12.6	11.3	36.1	8.1	17.0	18.6	9.6	15.6	13.3	3.2	2.2	2.9	7.3	3.0	7.7	8.8	6.6	7.7	2.2	10.7	9.3	7.4	0.4	6.4	4.6	16.5	6.4	3.0	6.5	11.5	14.5	11.0	7.8	5.8	8.3	7.1	11.6	10.4	3.0	7.5	6.7	1.7	3.5	7.1	7.2	0.0	4.0	7.9	1.8	0.0	7.9	5.0	4.9	7.6	3.9	0.5	23.3	4.2	21.7	7.5	1.1	8.1	2.9	10.0	3.2	1.7	11.6	4.0	8.7	4.0	6.1	3.3	6.4	1.9	6.1	5.4	1.7	6.0	5.1	3.9	6.5	9.2	97.4	70.9	3.9	4.1	4.4	5.1	2.1
TGFA		ENSG00000163235	"Transforming growth factor alpha"	P01135	2	70447280-70554193	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 36.6;Pancreatic endocrine cells: 47.6;Urothelial cells: 56.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 6.3;eosinophil: 14.0;neutrophil: 14.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.7"	"Cell line enhanced"	"Detected in many"		"A-431: 24.0;CAPAN-2: 29.7;HBEC3-KT: 25.9;OE19: 19.0;RPTEC TERT1: 26.1;U-87 MG: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042297	Approved		Approved	Vesicles	"Secreted to blood"	No	No	57900		Vesicles		"HPA042297: AB_10793878"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.57e-3)"	"unprognostic (6.39e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.00e-3)"	"unprognostic (6.69e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (7.74e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.21e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (9.19e-2)"	2.0	0.5	8.4	4.3	10.7	1.2	6.2	3.5	7.9	5.7	9.4	21.4	0.3	7.4	1.2	2.8	23.8	5.7	14.6	0.8	10.7	6.9	12.4	4.0	3.5	4.2	10.9	5.2	0.5	12.0	1.0	0.8	1.7	9.4	2.2	7.3	9.7	6.3	1.2	0.4	10.8	13.7	1.3	22.5	5.1	7.6	2.3	12.8	0.2	7.4	17.4	12.1	5.4	10.8	0.0	0.6	14.7	0.4	0.2	2.7	0.4	24.0	3.8	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	29.7	0.0	15.3	0.1	4.1	12.9	0.2	25.9	0.0	0.0	0.6	0.0	0.6	2.0	0.0	0.3	0.0	0.0	10.4	0.0	10.2	1.2	0.0	1.9	0.0	0.1	0.0	0.9	0.0	0.5	0.4	19.0	7.3	0.0	0.1	6.3	26.1	9.3	0.2	0.0	2.0	0.0	0.0	0.0	3.3	0.2	0.2	0.1	1.8	0.0	5.3	0.1	0.1	0.0	24.6	0.8	8.9	6.3	0.4	14.0	1.0	0.1	2.7	0.0	0.6	0.6	0.6	0.0	0.3	0.2	14.7	0.2	0.0	0.0	0.0	0.4	8.4	10.7	3.5	7.9	10.7	6.9	10.9	5.2	9.4	12.8	6.0	2.4	0.0	6.5	14.3	1.4	1.4	28.1	12.0	6.8	24.4	0.0	0.0	1.7	36.6	14.8	1.2	14.9	0.0	8.8	0.0	0.5	11.0	5.7	1.5	3.0	0.0	1.2	0.0	2.2	1.4	0.3	3.1	0.0	30.7	5.8	8.6	47.6	8.5	0.0	6.1	0.7	0.0	0.9	0.0	0.2	21.8	0.0	2.2	4.7	56.3
YWHAZ	"14-3-3-zeta, KCIP-1, YWHAD"	ENSG00000164924	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta"	P63104	8	100916525-100953388	"Plasma proteins, Predicted intracellular proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 1590.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB005065, HPA061603"	Approved		Approved	"Nucleoplasm,Nucleoli rim,Cytosol"		NA	NA		760000000	Cytosol	"Nucleoplasm, Nucleoli rim"	"CAB005065: AB_2218378, HPA061603: "	"unprognostic (4.70e-3)"	"unprognostic (7.38e-3)"	"unprognostic (8.09e-2)"	"prognostic unfavorable (3.91e-4)"	"unprognostic (1.83e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (2.28e-5)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.72e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.03e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	54.6	40.9	89.9	51.8	104.6	70.8	39.6	55.8	117.7	52.4	69.6	38.7	25.3	47.4	43.5	37.6	141.8	38.3	51.9	29.1	81.7	67.0	44.1	32.9	40.7	60.0	50.1	66.7	46.4	27.5	37.8	25.2	69.0	78.2	42.5	70.3	31.7	55.2	47.2	19.7	63.0	71.4	53.5	43.8	56.3	51.5	34.1	31.5	89.4	46.0	74.9	83.2	53.6	70.2	58.6	57.2	129.4	77.9	57.0	78.4	104.9	135.5	66.0	125.8	36.1	31.3	39.8	62.4	63.7	82.9	86.3	84.1	45.9	89.0	60.9	69.1	101.2	71.9	59.0	79.1	90.8	131.5	53.9	31.2	57.5	49.9	29.7	41.2	24.0	66.0	36.9	123.8	71.3	113.7	73.1	77.5	43.6	65.4	59.8	73.7	49.2	99.1	42.6	42.5	171.2	69.1	42.2	36.6	41.9	83.0	76.6	70.5	50.3	48.4	48.1	100.9	93.7	69.7	28.4	63.0	43.8	64.3	52.7	57.1	38.1	45.2	74.8	72.4	45.4	179.2	129.4	45.0	81.2	69.1	66.5	70.3	58.6	59.0	66.5	57.2	48.0	44.8	56.4	74.6	57.0	77.9	35.4	78.4	104.9	89.9	104.6	55.8	117.7	81.7	67.0	50.1	66.7	78.2	31.5	232.3	218.0	255.7	330.0	894.5	96.7	77.9	206.4	306.5	335.5	249.5	84.4	219.2	102.8	385.1	1094.8	171.9	335.2	46.7	365.6	441.5	215.1	349.2	432.9	89.1	253.4	127.1	254.5	172.5	286.2	1590.1	116.2	345.3	371.2	266.9	443.9	100.4	544.8	334.6	138.3	122.2	86.4	129.4	256.3	148.6	68.6	1035.6	342.0	343.9	282.9	758.7
TES	"DKFZP586B2022, TESS-2, TESTIN"	ENSG00000135269	"Testin LIM domain protein"	Q9UGI8	7	116210493-116258783	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 226.3;Early spermatids: 327.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 51.4;hTCEpi: 58.1;SK-BR-3: 58.3"					"Low region specificity"	"Detected in single"			"HPA015269, HPA018123"	Approved		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites,Cytosol"		NA	NA			"Focal adhesion sites, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA015269: AB_1857899, HPA018123: AB_1857900"	"unprognostic (9.81e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.01e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.84e-3)"	"unprognostic (4.81e-3)"	"unprognostic (8.81e-3)"	"unprognostic (6.19e-3)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.60e-2)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.86e-1)"	12.1	2.9	1.2	36.4	1.5	8.6	22.1	0.8	1.2	42.4	53.1	1.5	43.9	9.3	47.6	21.2	22.6	19.5	15.3	7.9	1.6	1.4	14.3	4.6	16.8	20.3	1.9	0.7	17.1	12.3	3.1	4.2	21.2	3.3	26.1	16.8	5.0	19.0	50.9	5.2	9.1	27.4	84.5	3.0	19.1	25.2	18.4	0.7	17.1	26.3	11.2	18.4	71.6	33.9	26.8	21.9	56.8	39.6	49.0	40.5	34.7	24.4	5.2	5.9	0.0	2.6	6.7	13.8	12.8	6.2	2.4	2.3	12.9	27.3	0.0	51.4	8.9	0.3	25.2	3.1	18.8	5.9	12.1	10.1	2.4	12.1	6.3	15.7	11.1	0.0	14.9	58.1	8.3	21.1	16.6	6.7	0.0	2.5	8.6	0.6	5.0	0.0	0.1	3.9	28.4	14.9	0.0	0.0	9.6	24.2	9.4	2.7	25.5	18.7	58.3	14.1	17.9	0.0	4.5	11.3	0.1	0.3	18.9	0.1	20.5	9.9	0.2	1.6	5.7	19.4	56.8	20.2	53.4	40.5	32.6	39.0	26.8	31.0	36.6	21.9	23.8	31.0	35.0	10.5	49.0	39.6	5.4	31.5	34.7	1.2	1.5	0.8	1.2	1.6	1.4	1.9	0.7	3.3	0.7	226.3	36.4	52.3	147.2	177.9	2.3	14.5	38.2	84.3	97.8	34.9	11.8	16.7	18.3	104.8	327.4	24.0	101.5	0.0	97.9	69.1	27.0	83.0	17.4	9.9	14.9	1.6	48.4	15.4	52.9	82.2	1.7	62.3	27.0	36.1	57.8	23.0	142.2	58.6	0.4	10.3	12.6	6.5	20.6	18.2	9.7	107.3	24.4	57.4	44.4	125.3
RAD51AP1	PIR51	ENSG00000111247	"RAD51 associated protein 1"	Q96B01	12	4538798-4560048	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.8"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 33.7;Erythroid cells: 46.7;Extravillous trophoblasts: 30.1;Hofbauer cells: 34.3;Late spermatids: 50.0;Spermatocytes: 35.8;Spermatogonia: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051499			Approved	Nucleoplasm		Yes	Yes			Nucleoplasm		"HPA051499: AB_2681508"	"unprognostic (1.03e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (9.42e-4)"	"unprognostic (6.30e-2)"	"unprognostic (5.25e-3)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (2.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.29e-3)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (4.44e-15)"	"unprognostic (2.68e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.88e-2)"	"unprognostic (3.75e-2)"	3.0	2.0	1.7	9.2	3.6	15.4	2.7	4.5	2.6	1.8	5.4	1.4	3.8	5.4	1.5	3.2	7.6	1.1	2.2	1.9	1.5	1.2	1.7	1.7	2.6	8.8	2.1	1.7	1.5	1.2	0.5	1.2	4.2	1.8	1.7	7.1	1.5	2.8	1.0	1.2	3.2	6.2	1.9	2.9	5.8	2.9	9.2	2.5	29.8	1.4	4.7	8.2	2.1	3.1	4.5	9.7	0.9	3.1	1.9	1.5	0.9	13.0	4.6	16.5	8.2	1.0	2.1	19.3	17.2	7.6	19.2	25.4	12.5	12.7	17.1	2.5	3.7	9.0	8.3	11.4	5.1	29.5	13.4	9.7	21.5	8.0	8.6	0.2	19.5	10.9	0.4	0.5	11.5	11.2	2.7	7.7	11.8	13.4	19.7	12.1	4.7	15.9	7.1	40.1	12.7	5.2	16.0	19.8	6.7	5.8	6.5	5.5	6.1	12.8	10.0	4.1	17.4	4.0	11.4	3.4	13.1	13.4	14.1	18.3	3.0	3.4	32.7	4.9	14.1	10.5	0.0	0.8	0.9	0.2	3.1	0.8	4.2	0.6	1.5	0.6	4.5	0.2	0.4	0.0	1.9	2.7	9.7	1.4	0.9	1.7	3.6	4.5	2.6	1.5	1.2	2.1	1.7	1.8	2.5	0.0	0.3	7.5	1.7	4.6	3.0	1.2	2.5	0.0	5.7	0.0	3.9	6.8	0.0	2.0	33.7	0.7	1.3	46.7	2.3	30.1	2.9	1.1	1.1	1.0	34.3	0.0	2.4	1.8	4.7	50.0	1.1	6.6	0.0	10.8	2.8	2.6	1.1	0.0	1.4	1.2	4.9	0.0	1.9	35.8	29.9	2.3	3.9	3.8	7.7	0.9
ATR	"FRP1, MEC1, SCKL, SCKL1"	ENSG00000175054	"ATR serine/threonine kinase"	Q13535	3	142449235-142578826	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 35.3;Spermatocytes: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054320			Supported	"Nucleoplasm,Golgi apparatus"		No	No			Nucleoplasm	"Golgi apparatus"	"HPA054320: AB_2682448"	"unprognostic (1.47e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.42e-2)"	"prognostic unfavorable (8.39e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.94e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	10.5	24.3	7.7	11.4	15.9	10.1	14.8	11.3	14.6	10.1	8.5	10.0	10.4	6.0	14.7	16.8	9.4	12.1	9.3	8.8	9.8	7.1	9.6	12.0	10.3	16.0	10.0	8.1	12.3	13.6	18.0	22.5	8.8	12.5	11.0	11.2	9.5	12.5	10.8	7.7	11.2	10.9	9.8	8.8	14.2	9.0	15.3	9.7	19.0	13.8	7.7	15.1	10.9	10.6	5.8	2.8	2.2	4.0	6.7	6.0	0.8	22.7	11.2	7.5	8.5	10.7	11.8	8.9	12.6	7.1	9.4	9.7	5.2	7.3	18.6	13.0	8.9	12.3	14.8	11.0	11.6	14.2	5.9	7.2	10.2	8.5	5.1	4.7	17.1	5.7	9.2	6.4	8.9	10.6	6.4	9.7	9.7	7.1	8.4	9.6	10.0	12.9	7.1	7.2	14.9	8.0	10.7	10.9	13.5	9.5	10.6	5.3	5.4	23.2	8.4	8.2	7.1	12.2	6.9	12.5	9.6	4.8	12.4	13.5	11.0	6.5	17.3	12.5	6.7	7.6	0.7	2.7	2.2	4.4	4.0	6.0	3.1	3.2	4.2	2.8	5.8	4.1	4.0	1.7	6.7	2.5	2.5	2.4	0.8	7.7	15.9	11.3	14.6	9.8	7.1	10.0	8.1	12.5	9.7	6.0	8.8	13.4	6.5	3.5	14.7	7.1	7.6	18.7	6.8	3.5	35.3	6.6	0.0	5.3	12.0	7.1	2.1	0.0	4.3	3.3	4.8	6.7	1.1	6.0	5.7	7.9	7.5	8.6	9.1	6.9	6.1	6.9	10.1	4.6	5.4	4.8	6.2	0.0	6.7	4.1	23.4	0.0	6.4	42.3	15.8	4.0	4.2	5.1	7.0	5.2
HRH1		ENSG00000196639	"Histamine receptor H1"	P35367	3	11137093-11263557	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 41.0;Club cells: 30.7;Enterocytes: 29.3;Suprabasal keratinocytes: 36.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.2;T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 17.5;hTEC/SVTERT24-B: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029740	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA029740: AB_10601578"	"unprognostic (4.60e-3)"	"unprognostic (3.41e-2)"	"unprognostic (6.37e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.60e-3)"	"unprognostic (4.00e-3)"	"unprognostic (7.54e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (1.27e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.20e-1)"	9.1	4.4	7.3	4.6	4.4	0.2	9.6	0.5	10.6	8.0	13.5	1.3	2.4	3.8	6.2	7.2	5.7	10.6	9.9	7.0	5.1	4.0	3.3	1.1	8.2	1.8	2.2	2.1	8.7	2.1	1.7	1.2	5.5	3.2	7.2	7.2	2.0	3.4	6.1	3.0	8.0	10.5	9.2	8.6	1.4	3.3	2.4	2.0	0.1	2.5	7.2	3.1	11.2	16.2	0.1	0.3	1.2	0.2	0.1	3.5	0.1	1.5	3.5	0.0	0.0	1.6	17.5	2.4	2.6	8.8	7.8	5.3	0.6	12.6	0.0	7.8	6.1	8.0	9.9	0.0	3.6	10.7	5.5	0.0	0.8	5.7	0.0	5.3	2.4	1.4	6.1	2.2	17.7	6.2	10.9	10.9	0.1	0.0	0.0	3.5	0.0	0.0	1.1	0.0	1.5	3.2	0.2	0.9	0.3	14.0	2.0	0.1	0.0	3.7	2.7	0.0	0.1	0.0	2.0	16.2	8.8	5.5	9.0	13.1	0.0	0.9	0.0	13.5	2.2	7.6	0.4	0.2	0.0	0.1	0.2	0.0	0.0	1.3	0.5	0.3	0.1	0.1	0.1	1.2	0.1	0.0	0.1	3.5	0.1	7.3	4.4	0.5	8.4	5.1	4.0	2.2	2.1	3.2	2.0	6.0	1.4	0.0	7.7	41.0	0.0	0.4	0.0	2.7	30.7	1.8	0.0	0.2	0.0	0.4	0.3	9.3	29.3	0.0	0.6	1.0	6.7	3.9	2.3	0.0	21.0	0.0	3.4	0.6	6.9	0.0	3.4	5.7	0.0	0.0	8.0	0.0	8.3	11.4	0.0	0.3	0.1	0.0	2.3	2.3	2.8	36.3	0.5	0.0	8.8	18.2
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ito cells: 45.4;Pancreatic endocrine cells: 72.9;Rod photoreceptor cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 13.4;memory CD8 T-cell: 6.6;naive B-cell: 19.9;naive CD8 T-cell: 17.3"	"Group enriched"	"Detected in many"	47	"B-cells: 19.9;T-cells: 17.3"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 93.4;LHCN-M2: 105.7;TIME: 61.2;U-87 MG: 95.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1600000	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	12.2	3.2	9.3	7.7	11.6	0.5	16.6	1.1	6.9	58.8	13.9	3.6	8.1	18.6	33.3	14.8	7.6	12.2	15.4	6.1	5.7	5.5	8.8	26.0	3.4	6.8	6.3	6.6	25.4	1.4	1.6	9.3	42.2	5.3	16.4	15.6	15.3	4.6	17.8	5.7	4.5	14.9	35.3	6.3	7.0	6.0	12.4	4.2	1.6	26.5	7.3	7.1	16.6	20.2	19.9	0.0	0.2	0.0	0.4	17.3	3.9	5.3	2.8	4.9	0.1	11.2	35.7	0.0	34.5	37.8	17.0	32.0	0.0	53.0	0.0	12.4	30.1	43.8	2.7	0.0	34.7	40.6	0.0	0.0	0.0	0.8	0.6	5.6	0.0	0.0	9.1	0.4	34.7	22.1	93.4	14.1	0.0	0.0	0.1	105.7	0.9	0.0	0.0	0.1	0.9	3.8	0.1	1.1	0.1	36.8	2.4	0.0	0.6	0.4	2.1	11.7	0.2	0.0	0.9	61.2	13.9	0.1	17.5	56.1	2.6	1.6	0.0	95.4	0.0	43.5	0.0	0.0	0.2	2.0	0.0	3.5	13.4	2.3	6.6	0.0	19.9	2.4	17.3	0.2	0.4	0.0	0.0	0.8	3.9	9.3	11.6	1.1	6.9	5.7	5.5	6.3	6.6	5.3	4.2	0.0	4.3	15.6	1.0	4.6	4.6	0.8	20.4	6.7	6.8	1.8	9.8	0.4	3.3	3.7	0.5	13.5	10.3	0.0	3.7	1.5	16.9	0.9	0.0	29.0	1.3	0.0	0.0	45.4	5.3	0.9	12.0	2.5	6.8	0.0	33.2	5.6	72.9	31.7	24.1	20.6	77.4	0.0	8.0	0.0	0.2	4.3	12.7	2.2	13.8	5.9
DSG3	CDHF6	ENSG00000134757	"Desmoglein 3"	P32926	18	31447795-31478702	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 156.7;lymphoid tissue: 50.7;tongue: 158.9"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 175.5;Suprabasal keratinocytes: 180.4;Urothelial cells: 67.6"	"Group enriched"	"Detected in many"	5	"cervical cancer: 104.0;head and neck cancer: 183.9;lung cancer: 36.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	26	"basophil: 9.0"	"Lineage enriched"	"Detected in single"	42	"granulocytes: 9.0"	"Group enriched"	"Detected in some"	7	"HaCaT: 42.1;hTCEpi: 104.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA046864, HPA056863, CAB069880"	Enhanced					NA	NA					"CAB069880: AB_2093604, HPA046864: AB_2679846, HPA056863: AB_2683260"	"unprognostic (5.76e-3)"	"unprognostic (6.99e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.79e-2)"		"unprognostic (1.00e-2)"		"unprognostic (4.08e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (1.43e-5)"	"unprognostic (8.26e-2)"	"unprognostic (8.35e-7)"	"unprognostic (8.85e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (9.90e-4)"	0.0	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.1	35.9	1.1	0.0	0.0	1.6	2.3	0.0	156.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.0	10.6	0.0	0.0	10.2	1.8	0.1	0.0	0.0	0.0	0.1	0.0	3.2	0.0	158.9	50.7	0.4	24.8	0.2	0.1	9.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.1	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.2	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	21.0	0.0	12.2	175.5	0.0	0.3	0.0	24.1	22.7	0.0	0.0	0.3	0.0	0.3	0.4	0.1	0.9	0.0	0.3	0.3	0.8	3.0	11.6	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	2.5	6.8	1.0	0.0	0.2	0.7	2.9	0.7	0.0	0.6	6.5	2.2	3.1	2.6	180.4	0.2	0.0	0.2	67.6
CENPN	"BM039, C16orf60, FLJ13607, FLJ22660"	ENSG00000166451	"Centromere protein N"	Q96H22	16	81006498-81033114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 70.0;Extravillous trophoblasts: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052870			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052870: AB_2681978"	"unprognostic (1.23e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.69e-3)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.36e-3)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (2.34e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.41e-2)"	"unprognostic (7.99e-2)"	4.2	4.9	4.8	8.2	5.0	26.9	3.2	2.4	5.4	2.7	6.6	5.9	4.8	6.4	2.6	6.8	9.9	2.1	3.7	7.3	5.0	4.6	6.5	21.0	5.2	8.9	6.0	4.5	2.4	3.9	12.0	2.5	8.8	5.1	25.3	7.0	1.5	3.7	4.7	5.6	3.5	7.7	5.6	6.1	5.9	5.1	11.8	5.6	24.6	4.2	12.6	10.2	4.2	3.8	6.6	8.5	2.9	3.7	4.0	10.1	2.7	23.2	22.4	19.4	17.2	5.3	4.3	23.3	23.9	16.9	38.9	17.3	40.7	18.8	13.2	13.8	14.0	18.3	19.9	15.6	17.3	50.6	7.9	13.3	11.6	18.2	27.2	2.6	16.9	22.9	3.8	1.8	35.4	12.5	5.4	17.7	16.8	21.2	19.0	19.9	42.7	21.6	21.7	20.6	10.7	12.3	25.4	18.4	14.2	7.0	15.8	12.4	11.3	36.2	9.1	10.8	12.0	21.4	9.7	9.3	28.7	29.1	18.9	26.8	13.3	29.2	50.1	13.5	12.1	24.9	0.0	1.7	2.9	2.5	3.3	2.3	1.9	3.9	2.1	8.5	6.6	1.9	2.0	1.4	4.0	3.7	2.7	10.1	2.7	4.8	5.0	2.4	5.4	5.0	4.6	6.0	4.5	5.1	5.6	0.0	4.5	1.5	14.2	21.3	1.0	3.4	7.6	1.4	4.5	3.5	0.0	29.0	0.0	4.8	34.5	2.9	4.3	70.0	5.7	78.1	10.5	11.7	5.8	3.9	23.1	0.0	1.2	5.5	8.8	31.4	2.6	8.4	6.8	4.6	7.7	0.8	4.7	2.9	3.2	6.7	0.0	0.0	8.3	40.2	40.3	14.3	22.8	15.4	12.7	11.9
C16orf74	MGC17624	ENSG00000154102	"Chromosome 16 open reading frame 74"	Q96GX8	16	85690084-85751129	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.6"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 47.6;Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 69.6;Syncytiotrophoblasts: 62.1;Urothelial cells: 43.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 26.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 34.3;hTCEpi: 29.3;T-47d: 30.5"					"Low region specificity"	"Detected in all"			HPA049367	Uncertain		Approved	"Plasma membrane,Centrosome"		NA	NA			"Plasma membrane"	Centrosome	"HPA049367: AB_2680730"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.15e-3)"	"unprognostic (3.65e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (1.08e-3)"	"unprognostic (4.22e-3)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (3.40e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.07e-3)"	2.7	0.7	6.3	5.6	3.9	9.3	6.8	0.6	3.3	4.7	3.0	1.4	10.8	1.5	2.1	3.7	6.8	1.5	2.4	1.8	9.2	1.7	2.0	0.8	2.0	11.7	2.0	2.1	0.9	2.1	3.9	1.0	44.6	1.6	7.1	1.3	18.8	4.5	9.5	1.5	6.3	4.2	3.9	1.5	12.9	3.0	1.4	1.5	0.4	4.7	6.2	10.3	18.9	10.0	26.3	8.8	10.3	8.2	3.3	8.3	5.4	12.2	4.1	0.1	1.7	1.9	2.1	5.1	1.5	2.0	4.8	1.3	3.1	11.5	0.1	17.4	1.2	2.0	17.7	0.7	34.3	2.7	0.0	2.7	0.0	1.8	0.3	5.2	0.3	0.0	4.5	29.3	4.6	20.1	3.6	15.6	2.1	0.0	0.0	0.1	10.3	0.0	18.7	1.1	13.2	11.8	0.5	0.0	1.0	0.0	14.0	3.9	1.0	6.2	3.2	3.1	1.4	30.5	5.2	15.9	3.1	8.0	1.3	4.4	4.3	3.1	13.5	0.0	4.4	0.6	0.0	8.2	10.3	0.6	2.7	2.2	20.4	4.5	3.6	8.8	26.3	7.6	4.7	3.2	3.3	0.8	0.1	8.3	5.4	6.3	3.9	0.6	3.3	9.2	1.7	2.0	2.1	1.6	1.5	3.0	0.6	38.4	47.6	8.2	17.9	1.2	0.0	1.4	3.4	1.8	55.0	38.4	3.3	2.8	1.3	2.1	0.0	0.0	1.0	13.5	4.8	4.1	0.0	0.0	4.3	14.3	0.0	1.3	0.8	0.0	3.1	1.6	18.6	0.0	0.0	8.8	2.2	0.0	3.2	1.7	69.6	0.0	3.4	0.9	6.4	6.0	62.1	0.9	0.0	43.2
MRPS22	"C3orf5, GIBT, GK002, MRP-S22"	ENSG00000175110	"Mitochondrial ribosomal protein S22"	P82650	3	139005806-139357223	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006083, HPA007830"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA006083: AB_1854122, HPA007830: AB_1854123"	"unprognostic (8.38e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (5.22e-3)"	"unprognostic (5.45e-3)"	"unprognostic (4.85e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.49e-3)"	"prognostic unfavorable (1.55e-5)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (3.22e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.40e-1)"	17.6	45.3	16.9	14.5	24.9	22.1	18.3	15.5	26.7	16.3	22.7	14.6	12.2	24.0	17.0	14.7	26.7	14.5	13.8	39.2	23.4	15.0	24.9	43.3	12.9	20.2	18.2	19.7	15.7	22.4	13.6	15.2	16.9	22.6	11.6	22.0	8.8	15.3	15.8	50.8	17.2	21.1	16.8	18.1	14.0	19.0	21.9	19.9	15.3	15.1	31.0	16.0	16.5	16.9	24.9	27.9	21.7	31.6	21.1	27.8	20.9	30.7	13.3	11.3	13.7	17.0	14.4	26.1	18.1	23.4	32.5	26.7	42.3	22.2	21.2	34.1	22.0	32.1	35.0	20.4	24.7	31.3	12.0	19.0	33.9	11.5	29.3	19.0	31.7	18.5	15.4	19.4	19.5	20.4	14.5	19.8	24.5	46.8	13.4	19.6	22.7	15.8	24.9	20.2	30.3	23.4	20.1	19.3	29.7	23.5	18.3	13.5	12.1	29.3	43.2	45.9	11.7	30.2	28.7	14.1	13.0	13.8	25.8	17.0	20.8	11.4	38.0	16.1	22.6	12.6	21.7	24.0	21.2	22.9	31.6	27.6	24.9	24.7	25.7	27.9	21.6	27.3	25.3	5.4	21.1	30.3	17.8	27.8	20.9	16.9	24.9	15.5	26.7	23.4	15.0	18.2	19.7	22.6	19.9	17.9	11.2	18.2	23.5	20.3	19.9	43.4	25.5	37.5	14.8	17.4	13.7	54.0	58.0	36.5	37.3	20.4	26.9	0.0	52.8	37.9	24.4	15.6	26.5	34.2	42.5	19.1	15.0	18.4	17.7	5.6	21.6	21.0	15.1	38.7	25.1	18.5	38.5	20.1	22.3	37.0	25.3	38.8	24.2	73.7	46.5	17.9	63.0	22.4	39.6	26.5
PRPF40A	"FBP-11, FBP11, FLAF1, FLJ20585, FNBP3, HIP10, HYPA, NY-REN-6, Prp40"	ENSG00000196504	"Pre-mRNA processing factor 40 homolog A"	O75400	2	152651593-152717997	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038272, HPA038273"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA038272: AB_2675923, HPA038273: AB_10671526"	"unprognostic (1.81e-1)"	"unprognostic (2.91e-1)"	"unprognostic (4.31e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (4.62e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.05e-2)"	22.8	21.5	18.8	25.6	21.7	36.6	22.3	30.0	21.3	23.2	24.8	13.0	19.0	22.2	25.1	20.6	28.8	20.3	17.1	16.8	21.1	14.3	26.0	31.1	21.8	27.0	25.2	15.6	24.5	21.1	25.3	30.8	28.4	21.4	23.0	20.7	11.5	23.4	23.3	32.7	25.4	27.0	18.6	24.4	30.5	21.3	25.7	28.7	48.6	24.7	25.7	26.0	24.6	22.8	41.3	50.9	53.3	55.6	39.5	43.4	40.5	21.1	21.2	23.8	24.3	13.9	18.7	33.3	21.0	18.7	29.8	27.6	39.5	20.0	44.4	31.1	21.2	17.1	21.7	31.1	25.2	32.3	24.4	26.2	40.6	19.6	26.4	18.0	44.7	28.5	14.8	21.6	39.7	45.3	18.6	23.0	20.7	43.3	20.9	18.3	12.7	18.9	20.4	35.7	14.0	25.4	36.7	25.3	28.9	15.2	34.1	29.7	19.8	25.1	18.5	23.1	18.5	16.3	28.1	27.0	31.9	19.9	18.0	27.0	13.7	21.8	44.8	20.2	26.3	19.2	45.0	42.2	53.3	43.1	51.7	39.5	39.9	40.1	38.6	47.7	41.3	43.4	38.5	37.8	39.5	55.6	50.9	34.4	40.5	18.8	21.7	30.0	21.3	21.1	14.3	25.2	15.6	21.4	28.7	104.2	99.8	88.1	94.9	125.2	58.8	55.1	58.6	190.1	119.4	50.6	68.7	107.5	41.4	89.9	82.8	82.9	56.4	0.0	97.3	130.2	70.2	81.3	119.1	61.8	96.5	57.2	75.1	47.3	85.8	22.4	64.2	103.4	52.3	193.8	67.9	60.9	100.1	84.3	75.0	58.5	66.2	97.0	82.4	214.0	123.3	132.6	110.5	92.4	83.7	122.9
CCNB2	HsT17299	ENSG00000157456	"Cyclin B2"	O95067	15	59105078-59125045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 70.2;testis: 73.9"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 102.4;Erythroid cells: 163.5;Extravillous trophoblasts: 106.5;Spermatocytes: 88.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	4	"T-reg: 17.8"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008873, CAB009575"	Enhanced		Enhanced	"Golgi apparatus,Cytosol"		Yes	Yes			Cytosol	"Golgi apparatus"	"CAB009575: AB_2072392, HPA008873: AB_1078604"	"unprognostic (2.69e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (2.83e-4)"	"prognostic unfavorable (4.63e-4)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.44e-1)"	2.0	1.1	0.4	21.0	0.4	24.7	2.5	0.3	0.6	1.8	5.5	0.5	0.2	5.2	1.0	1.5	11.3	0.5	1.6	1.2	0.4	0.4	1.0	1.0	1.9	12.0	0.4	0.3	0.8	0.7	0.0	0.4	6.7	0.4	1.1	6.3	0.4	2.1	0.6	0.4	3.6	5.1	2.0	1.3	5.2	3.0	73.9	0.2	70.2	0.8	10.3	16.0	1.8	3.4	1.8	2.3	0.7	0.1	3.0	17.8	1.8	28.7	25.3	41.6	10.3	1.9	3.8	22.1	23.8	15.3	36.9	30.4	40.9	17.7	26.7	17.3	15.4	21.6	35.5	39.3	20.2	34.9	27.7	21.1	34.6	29.6	23.2	0.5	25.7	22.3	1.4	2.7	15.9	20.3	7.2	25.0	33.0	34.9	42.9	27.8	20.9	29.3	37.5	30.7	12.4	15.0	34.3	58.9	27.1	11.6	20.3	25.9	17.5	32.6	17.7	21.5	34.0	30.7	25.7	13.0	18.4	31.2	20.2	45.3	19.1	28.7	47.5	12.0	58.9	25.9	0.0	0.1	0.6	0.1	0.0	0.2	1.8	3.9	4.1	2.3	0.9	0.0	0.1	0.7	3.0	0.0	0.1	17.8	1.8	0.4	0.4	0.3	0.6	0.4	0.4	0.4	0.3	0.4	0.2	0.0	1.1	7.8	1.0	4.2	0.0	0.3	0.0	1.4	2.3	0.0	0.0	26.7	0.0	0.4	102.4	0.4	1.7	163.5	0.2	106.5	1.1	1.7	0.0	0.8	25.3	0.0	2.9	3.1	10.7	30.4	4.0	4.2	0.0	3.6	5.5	0.0	0.5	1.7	1.8	0.0	0.2	0.0	0.0	88.2	36.6	5.4	13.6	3.2	12.4	2.0
GLUD1	"GDH, GLUD"	ENSG00000148672	"Glutamate dehydrogenase 1"	P00367	10	87050486-87094866	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 182.4"	"Cell type enhanced"	"Detected in all"	6	"Hepatocytes: 357.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 108.1"									"HPA042492, HPA044839, HPA061369"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		26000000	Mitochondria		"HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494"	"unprognostic (1.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.81e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.57e-3)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.44e-6)"	"unprognostic (2.29e-1)"	"unprognostic (4.23e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.27e-2)"	15.5	21.5	57.8	9.9	54.5	5.9	23.2	13.4	37.9	12.1	14.5	19.9	5.5	18.4	10.9	7.5	17.0	11.5	12.6	16.7	44.1	35.3	56.2	182.4	13.1	11.5	40.6	30.8	17.5	15.2	8.7	6.6	13.5	31.1	26.5	14.6	8.1	10.0	13.3	9.2	15.3	19.8	14.0	22.7	10.2	12.2	6.4	33.2	12.6	16.1	8.7	13.1	14.0	9.5	9.2	15.8	9.2	14.6	13.7	11.9	5.9	24.5	19.8	15.6	26.4	29.7	36.6	17.1	19.4	33.6	18.8	20.7	45.8	24.1	27.6	15.9	28.3	10.8	38.7	20.3	19.5	20.2	19.9	16.0	13.4	11.9	108.1	66.3	31.3	19.4	25.2	36.9	20.9	62.6	28.7	22.4	21.8	13.5	25.0	20.3	17.8	28.2	28.1	17.8	26.7	16.0	21.4	19.9	18.0	54.1	20.1	8.0	15.0	17.4	13.8	24.7	15.7	19.0	22.1	22.2	9.8	8.7	19.8	19.7	15.0	15.4	33.0	23.6	35.9	5.8	5.5	13.8	9.2	8.7	11.1	10.9	9.2	11.8	10.6	15.8	8.8	10.6	8.5	1.3	13.7	14.6	5.9	11.9	5.9	57.8	54.5	13.4	37.9	44.1	35.3	40.6	30.8	31.1	33.2	20.8	19.2	40.4	53.0	94.2	20.7	49.8	53.5	17.4	45.5	57.6	35.3	77.3	132.6	27.7	11.2	45.6	54.7	46.7	29.4	52.4	55.2	96.0	43.7	357.2	63.1	14.3	37.8	50.3	67.1	18.7	81.4	68.2	99.5	30.7	44.6	133.3	37.2	42.1	85.2	119.8	60.1	64.7	76.2	9.6	6.4	107.0	39.8	55.4	40.7	75.9
UBE2E3	UbcH9	ENSG00000170035	"Ubiquitin conjugating enzyme E2 E3"	Q969T4	2	180967248-181076585	"Enzymes, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 115.4"	"Low region specificity"	"Detected in all"							"HPA003303, HPA030445"	Approved					NA	NA					"HPA003303: AB_1858521, HPA030445: AB_10669599"	"unprognostic (8.85e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.08e-5)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.00e-3)"	"unprognostic (4.99e-2)"	"unprognostic (8.46e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (8.75e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.40e-1)"	29.1	23.9	35.6	21.1	33.0	20.1	49.7	37.4	62.9	30.4	25.2	18.6	19.8	23.0	26.6	29.2	23.1	29.7	35.9	37.8	43.9	32.5	36.0	29.6	28.5	37.6	31.5	31.9	27.7	29.9	42.9	21.6	23.9	30.5	20.9	27.8	24.6	26.3	22.7	76.8	28.1	26.2	24.1	41.3	20.4	28.3	28.1	21.5	30.9	37.4	27.8	23.0	31.8	23.0	7.7	29.7	25.6	16.9	8.5	12.0	9.6	17.6	8.1	115.4	4.0	34.3	44.3	18.4	23.7	30.0	20.0	25.0	8.7	21.5	8.7	20.8	32.3	16.8	7.6	69.6	24.3	36.0	21.2	21.0	30.1	10.9	24.1	16.5	13.9	14.4	17.4	22.7	17.5	16.9	20.4	26.3	18.3	15.3	16.3	49.0	9.7	25.3	13.1	22.0	12.1	38.2	24.8	11.8	20.7	34.0	15.6	20.1	22.5	10.3	11.0	9.7	33.0	5.9	20.7	24.2	39.0	25.7	22.8	27.5	14.3	9.1	24.5	38.4	5.5	21.6	13.0	14.0	25.6	9.3	12.3	11.1	7.7	7.3	12.0	9.2	4.9	7.8	8.5	13.2	8.5	16.9	29.7	2.8	9.6	35.6	33.0	37.4	62.9	43.9	32.5	31.5	31.9	30.5	21.5	8.9	21.6	43.9	66.6	91.4	128.2	30.3	89.2	34.8	33.0	52.4	27.5	34.3	193.9	78.5	28.7	62.5	41.0	70.0	89.6	68.0	102.0	68.5	23.1	44.5	72.1	71.5	57.4	65.7	57.3	50.1	58.1	56.9	123.2	35.1	42.3	53.3	82.5	28.1	33.9	136.3	56.9	25.8	51.2	91.9	204.0	107.0	30.1	59.0	46.5	88.8
B4GALT5	beta4GalT-V	ENSG00000158470	"Beta-1,4-galactosyltransferase 5"	O43286	20	49632945-49713878	"Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Urothelial cells: 107.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.2"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 10.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (7.98e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (1.87e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.41e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.69e-2)"	20.0	37.2	16.2	13.8	15.8	53.3	15.7	22.6	19.0	15.5	16.4	8.5	10.6	16.5	17.2	7.5	27.4	14.6	21.1	32.7	12.4	12.6	16.8	17.3	20.1	7.7	10.4	9.9	19.5	11.7	7.0	14.1	17.8	17.3	12.4	16.1	15.3	15.7	15.7	46.9	6.4	15.5	24.7	13.5	22.6	16.9	16.6	9.3	3.9	9.5	8.0	13.7	19.2	16.0	0.4	1.1	10.2	1.6	1.7	2.4	0.6	15.8	18.3	24.4	10.3	25.5	17.4	21.4	7.8	14.7	36.0	17.3	23.5	19.8	4.8	33.7	13.0	34.1	25.4	15.3	11.7	21.2	14.9	4.2	12.9	10.0	14.0	8.0	16.7	25.3	26.0	11.0	15.6	7.5	33.3	21.8	8.7	20.8	3.0	10.4	7.9	1.0	15.4	12.7	15.7	11.9	8.7	21.1	7.0	17.3	11.3	29.2	14.8	28.0	35.9	15.7	18.8	8.1	23.1	16.7	21.7	17.5	11.5	16.4	3.7	3.2	11.8	11.3	16.1	13.7	1.3	1.6	3.7	2.2	1.6	2.4	0.3	1.0	2.1	1.1	0.4	0.2	1.5	10.2	1.7	1.6	0.9	1.3	0.6	16.2	15.8	22.6	19.0	12.4	12.6	10.4	9.9	17.3	9.3	14.9	45.0	3.2	24.2	16.8	6.2	15.3	30.6	24.1	35.2	34.9	9.8	19.4	1.7	27.9	4.5	43.9	21.4	23.3	17.1	21.5	24.3	41.5	84.0	20.2	21.9	11.1	33.0	47.3	27.6	5.3	18.4	28.0	20.3	9.0	23.7	5.2	29.8	28.6	30.8	31.6	4.8	25.8	26.8	7.5	17.7	15.3	4.7	15.2	16.4	107.6
MRPL19	"KIAA0104, MRP-L15, RLX1, RPML15"	ENSG00000115364	"Mitochondrial ribosomal protein L19"	P49406	2	75646783-75690851	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046805, HPA056622"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA046805: AB_2679816, HPA056622: AB_2683195"	"unprognostic (9.24e-2)"	"unprognostic (3.84e-2)"	"prognostic favorable (7.39e-4)"	"unprognostic (8.40e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.52e-3)"	"unprognostic (5.75e-2)"	"unprognostic (9.86e-2)"	"unprognostic (6.21e-3)"	"unprognostic (9.71e-3)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (2.42e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.20e-1)"	21.3	33.9	22.5	13.0	25.2	8.8	21.1	15.9	26.7	23.0	19.5	24.1	12.1	16.8	19.1	19.6	25.7	13.9	15.6	24.4	21.3	20.4	40.8	44.9	13.0	13.5	26.0	21.2	17.3	17.8	30.9	20.6	18.4	26.6	16.4	23.0	13.2	17.7	19.6	47.3	17.2	16.3	21.1	27.7	18.1	16.3	12.0	24.4	19.2	27.3	22.0	17.3	15.1	15.9	18.5	23.7	9.6	17.1	15.5	18.0	11.1	36.3	21.2	20.1	18.1	22.1	26.6	28.6	23.5	21.2	29.8	23.8	32.7	15.1	20.6	23.7	25.6	27.9	25.8	31.3	35.5	45.0	22.8	26.9	28.0	16.6	41.3	23.6	29.8	16.9	17.6	27.4	30.2	27.7	19.0	31.3	22.6	30.8	12.1	29.4	22.2	27.0	23.5	26.3	37.5	23.7	34.2	44.0	27.1	50.5	22.8	22.3	19.3	23.0	26.7	26.1	21.2	22.8	12.0	21.0	26.1	28.9	23.1	34.6	12.6	18.9	17.0	20.6	29.6	22.7	9.6	14.1	9.2	16.0	17.1	18.0	18.5	16.5	16.9	19.9	16.1	14.7	18.0	0.9	15.5	15.4	23.7	17.4	11.1	22.5	25.2	15.9	26.7	21.3	20.4	26.0	21.2	26.6	24.4	17.9	23.5	28.2	24.4	25.8	35.5	37.0	20.4	25.4	29.6	47.1	49.1	79.0	106.1	76.8	15.8	17.3	26.5	23.3	53.4	71.7	27.2	28.3	18.5	62.2	42.7	46.1	26.6	25.2	15.1	7.8	32.8	25.7	32.1	33.3	32.5	38.9	50.8	31.6	34.3	130.8	48.5	19.4	25.3	60.1	14.7	24.7	48.3	20.8	41.3	30.5
SLC5A3	"SMIT, SMIT1"	ENSG00000198743	"Solute carrier family 5 member 3"	P53794	21	34073570-34106262	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 46.0"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 130.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029791			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA029791: AB_10601892"	"unprognostic (9.70e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.54e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.60e-2)"	10.1	9.5	10.5	7.3	11.0	3.6	26.6	8.0	10.1	6.5	7.6	4.6	9.4	5.0	11.3	9.1	7.5	8.5	4.9	6.8	11.6	6.8	46.0	9.5	8.5	7.6	11.7	4.7	9.0	5.8	6.3	6.6	15.8	13.6	7.0	8.8	11.3	6.4	6.9	7.8	10.1	7.4	5.9	14.7	4.9	7.8	10.6	9.0	5.9	42.7	4.4	8.0	6.5	22.1	0.8	2.3	0.7	1.0	1.0	2.6	0.7	6.3	5.7	11.9	8.4	10.0	8.2	5.7	7.2	22.1	4.5	6.9	9.4	13.9	10.2	5.9	14.6	8.5	3.3	14.4	4.1	7.7	10.6	3.7	10.6	5.3	3.1	2.6	4.5	4.5	3.9	10.7	12.3	4.9	13.9	2.7	8.5	10.4	2.4	11.6	4.3	4.8	3.7	6.0	2.4	5.6	4.9	2.1	4.6	17.8	8.9	6.2	2.9	15.0	4.0	3.4	7.4	2.4	4.8	2.6	8.9	6.9	16.9	2.9	12.7	10.9	7.7	17.9	6.6	5.9	0.0	1.0	0.2	2.6	0.9	2.1	0.8	1.4	1.7	0.9	0.8	1.9	2.6	0.7	1.0	0.4	2.3	0.4	0.7	10.5	11.0	8.0	10.1	11.6	6.8	11.7	4.7	13.6	9.0	14.9	12.2	8.0	40.9	0.0	28.5	7.6	12.7	16.0	23.9	130.9	19.6	21.2	18.3	3.4	8.6	4.5	28.0	0.0	4.5	15.7	10.7	71.1	41.4	15.3	12.8	35.0	47.1	6.7	12.1	5.2	6.1	9.8	0.0	24.4	48.3	6.0	5.8	46.0	19.4	6.5	20.8	12.9	2.2	12.1	18.9	0.0	23.6	17.3	26.6	32.3
NMD3	CGI-07	ENSG00000169251	"NMD3 ribosome export adaptor"	Q96D46	3	161104696-161253532	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035019			Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA035019: AB_10600922"	"unprognostic (1.37e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.50e-2)"	"unprognostic (9.39e-3)"	"unprognostic (1.95e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (2.03e-5)"	"unprognostic (7.97e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.86e-3)"	26.8	15.7	16.2	10.7	16.5	34.7	20.3	26.6	21.8	23.1	14.4	13.2	10.9	10.8	23.4	17.7	22.9	14.3	14.2	24.1	15.5	13.6	25.7	46.7	19.4	12.5	16.7	18.2	27.9	29.0	13.4	27.5	20.1	21.6	21.7	13.5	14.1	19.7	13.3	31.8	15.5	16.3	22.1	16.3	17.1	25.3	12.1	13.1	19.6	21.7	21.3	15.0	32.1	16.0	12.1	13.2	15.9	11.8	22.8	18.7	13.6	21.9	12.8	12.7	12.9	15.9	21.9	17.5	25.2	19.1	18.8	22.0	21.7	18.2	28.0	32.2	17.6	13.2	14.5	20.2	18.5	29.5	29.0	12.4	28.8	11.3	13.5	17.5	34.6	17.5	18.3	13.8	13.3	44.0	20.2	20.4	9.8	21.1	15.5	22.2	50.2	15.6	13.2	15.9	26.6	20.5	19.3	18.3	28.3	17.9	49.9	20.2	12.6	14.3	35.2	20.8	14.4	26.2	15.9	17.8	15.1	10.8	17.2	30.3	25.6	17.2	28.7	18.8	22.6	20.5	15.9	10.8	5.7	11.8	11.8	18.3	12.1	13.9	14.5	13.2	10.4	18.7	14.5	2.5	22.8	7.3	7.4	17.1	13.6	16.2	16.5	26.6	21.8	15.5	13.6	16.7	18.2	21.6	13.1	17.9	13.4	25.1	43.8	57.7	23.4	39.6	20.4	16.0	17.0	10.4	13.7	29.3	29.9	22.3	12.2	23.2	13.4	0.0	33.9	37.0	34.9	39.0	25.3	38.5	21.3	28.6	13.2	20.9	32.4	4.7	23.6	22.5	23.6	25.2	17.7	12.3	30.1	10.5	25.8	26.9	18.0	25.8	91.0	30.3	26.0	65.0	47.4	25.9	18.8	62.7
AP1S3		ENSG00000152056	"Adaptor related protein complex 1 sigma 3 subunit"	Q96PC3	2	223751686-223838027	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 50.0;epididymis: 64.5;seminal vesicle: 39.6"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 60.9;Cytotrophoblasts: 43.1;Urothelial cells: 65.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 8.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 56.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA066782	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA066782: AB_2685720"	"unprognostic (9.45e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.89e-1)"	"unprognostic (1.65e-3)"	"prognostic unfavorable (3.36e-5)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.08e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.61e-2)"	1.9	1.4	1.6	5.4	3.0	1.8	1.6	2.2	1.9	1.6	1.8	0.2	50.0	3.1	0.8	64.5	5.8	1.7	7.6	1.0	2.3	1.7	7.0	1.9	5.2	3.8	1.1	1.0	0.8	5.1	3.3	6.8	4.6	0.9	2.5	2.0	1.9	4.1	39.6	0.5	1.6	4.1	0.9	1.0	3.1	6.2	1.1	0.4	0.8	10.5	3.1	5.7	8.1	2.9	8.8	5.3	4.9	0.5	0.7	1.6	0.7	9.1	8.6	1.0	3.3	0.5	0.2	4.7	3.8	0.9	1.9	1.7	56.2	7.1	3.6	3.2	0.5	2.0	15.1	2.7	10.4	2.9	5.2	4.4	0.4	13.8	5.7	0.2	1.1	0.4	0.1	11.3	3.4	12.0	4.1	1.3	2.0	0.5	0.8	1.1	3.8	0.1	0.2	1.2	10.5	6.1	1.3	0.0	1.5	17.8	18.0	2.5	0.8	2.0	3.7	1.3	2.2	1.8	1.7	0.7	0.4	2.0	1.0	3.0	3.6	3.1	9.8	1.3	0.4	2.1	4.9	0.5	0.4	1.1	0.3	0.8	8.8	0.5	0.4	2.2	3.5	0.4	0.7	1.9	0.7	0.2	5.3	1.6	0.7	1.6	3.0	2.2	1.9	2.3	1.7	1.1	1.0	0.9	0.4	32.8	7.0	9.5	25.9	3.8	3.2	1.2	0.0	5.3	10.3	10.4	60.9	43.1	8.3	15.5	0.0	1.4	3.8	0.0	16.0	1.5	2.3	25.3	3.5	0.4	4.2	6.4	2.4	0.0	1.9	0.0	0.3	3.4	3.3	11.8	3.2	1.5	29.8	2.9	0.0	2.8	6.2	0.0	1.4	0.2	2.4	3.6	11.0	5.9	3.4	65.3
CHMP2B	"CHMP2.5, DKFZP564O123, VPS2B"	ENSG00000083937	"Charged multivesicular body protein 2B"	Q9UQN3	3	87227271-87255548	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 108.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035069, HPA052754"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA035069: AB_10602798, HPA052754: AB_2681936"	"unprognostic (7.83e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.78e-2)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (2.11e-5)"	"unprognostic (5.76e-2)"	"prognostic favorable (1.74e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.41e-3)"	"unprognostic (1.21e-1)"	21.8	21.5	20.1	17.6	23.5	36.5	22.1	12.5	35.9	23.6	32.4	21.4	19.2	30.1	28.2	20.5	30.9	20.1	23.4	26.2	20.8	22.0	30.9	36.1	21.5	17.7	29.5	21.0	22.9	23.5	14.7	41.7	45.1	30.7	29.2	30.5	14.7	22.7	25.4	30.1	22.9	45.8	24.8	52.6	22.3	24.3	13.3	25.6	14.5	35.5	26.3	16.4	30.7	25.3	21.2	22.4	53.4	24.8	11.4	20.0	14.3	16.8	18.3	6.2	3.9	11.4	9.2	8.0	13.3	16.9	11.0	14.2	14.3	27.6	6.0	9.4	14.3	10.1	8.6	8.1	9.2	13.3	10.6	8.5	7.4	6.6	5.8	10.0	9.9	10.3	7.0	15.6	10.9	14.8	10.6	8.4	7.4	4.4	9.1	11.8	12.1	9.6	4.1	8.1	20.3	16.4	5.1	7.7	5.8	8.3	17.3	2.4	2.5	13.0	10.6	20.2	7.5	9.5	3.0	7.6	10.2	9.4	108.6	9.0	9.2	13.6	10.3	11.2	5.7	7.3	42.8	20.8	53.4	11.9	24.8	16.0	20.0	14.9	14.6	22.4	21.2	14.1	13.7	40.3	11.4	24.7	12.8	20.0	14.3	20.1	23.5	12.5	35.9	20.8	22.0	29.5	21.0	30.7	25.6	77.4	53.5	37.2	193.5	117.3	17.0	65.5	58.6	95.0	73.9	47.1	3.9	64.1	117.7	128.3	5.1	42.3	109.6	46.7	227.8	159.4	64.8	193.3	71.7	54.0	75.6	35.0	44.9	35.6	51.1	4.0	61.2	79.5	38.8	48.7	61.4	189.8	186.7	138.6	90.5	117.0	14.1	71.1	49.5	56.6	68.8	127.2	151.3	45.3	63.1	267.1
PAQR5	"FLJ20190, MPRG"	ENSG00000137819	"Progestin and adipoQ receptor family member 5"	Q9NXK6	15	69298947-69407780	"Predicted membrane proteins"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 41.4"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 39.7;Early spermatids: 33.3;granulocytes: 65.8;Late spermatids: 86.2;Proximal tubular cells: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.5"	"Cell line enhanced"	"Detected in many"		"A549: 17.5;CAPAN-2: 21.1;fHDF/TERT166: 14.9;HMC-1: 37.0;U-87 MG: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA076729			Approved	Vesicles		NA	NA			Vesicles		"HPA076729: AB_2686813"	"unprognostic (4.47e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.05e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (2.15e-5)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.47e-14)"	"unprognostic (5.64e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.16e-4)"	"unprognostic (4.94e-2)"	1.8	15.4	1.9	4.1	2.6	0.7	1.2	1.5	3.1	1.6	12.3	3.0	1.7	1.5	1.1	1.6	9.0	1.0	1.7	1.9	1.8	1.5	41.4	1.0	10.4	0.3	2.0	1.0	0.5	4.8	5.8	0.9	1.0	3.5	1.1	10.8	3.6	1.8	4.2	0.4	3.2	5.2	3.2	3.8	0.2	4.5	1.5	2.2	0.0	0.6	5.7	4.9	2.3	2.6	0.2	0.2	3.5	0.3	0.4	0.7	0.0	5.1	17.5	0.3	0.3	0.7	2.0	0.1	1.6	10.1	2.0	4.3	1.0	21.1	0.0	2.7	14.9	1.7	0.3	5.0	0.2	3.5	0.0	0.7	3.0	2.7	0.3	1.3	0.1	37.0	1.0	0.8	9.0	9.7	2.6	0.0	0.1	0.0	0.3	8.4	0.7	0.0	0.1	1.2	2.7	1.5	0.0	0.3	0.9	7.7	0.4	1.5	0.3	2.7	1.0	1.4	1.0	0.4	1.2	0.2	6.1	2.0	0.5	0.2	0.1	0.1	0.0	15.4	0.0	1.7	3.5	0.3	0.1	0.3	0.1	0.2	0.1	0.2	0.2	0.1	0.2	0.3	0.7	1.3	0.4	0.2	0.2	0.1	0.0	1.9	2.6	1.5	3.1	1.8	1.5	2.0	1.0	3.5	2.2	11.9	21.8	0.0	1.1	0.8	0.5	0.8	22.9	1.4	1.2	19.2	0.0	0.0	39.7	16.0	33.3	0.4	18.4	0.0	0.4	0.0	0.2	0.5	65.8	0.0	3.5	0.0	0.0	0.0	0.3	86.2	0.9	0.9	0.0	0.0	4.8	5.7	1.8	3.5	1.1	33.2	0.0	6.5	0.4	0.3	0.5	1.6	0.1	0.5	11.5	0.7
P2RY2	P2U	ENSG00000175591	"Purinergic receptor P2Y2"	P41231	11	73218298-73236352	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.1;skeletal muscle: 29.5"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 14.0;Enterocytes: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 28.1"	"Group enriched"	"Detected in many"	12	"granulocytes: 28.1;monocytes: 10.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 16.4;HL-60: 15.5;MCF7: 12.4;NB-4: 12.6;PC-3: 12.9;SK-BR-3: 14.3;THP-1: 36.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB022642	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"CAB022642: "	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.97e-3)"	"unprognostic (6.50e-4)"	"unprognostic (2.04e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.93e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (9.69e-2)"	"unprognostic (4.92e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.57e-3)"	0.4	2.3	0.9	1.4	1.2	10.8	1.3	0.3	1.1	5.5	3.1	1.1	0.3	2.2	1.3	2.3	20.0	1.2	2.8	11.7	0.6	0.3	0.9	2.6	2.9	1.5	1.2	0.6	1.7	1.7	6.1	1.1	10.3	1.0	1.7	2.4	3.3	4.0	1.6	29.5	3.4	10.8	0.4	0.4	6.6	0.6	0.7	0.6	0.6	20.2	20.6	12.8	2.1	10.9	0.0	1.6	28.1	10.4	0.0	0.0	1.2	3.6	3.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	8.4	2.8	0.0	5.6	0.2	0.0	16.4	0.4	7.7	0.0	0.0	0.3	1.2	0.2	1.5	0.0	15.5	0.0	0.0	3.6	1.2	0.2	0.0	0.7	0.0	0.7	0.0	0.0	12.4	0.0	12.6	0.2	3.3	12.9	0.0	0.0	0.5	1.2	8.8	0.0	0.0	0.2	14.3	0.0	0.1	6.6	36.3	5.3	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	2.8	0.0	0.2	3.4	28.1	0.0	10.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	1.2	0.9	1.2	0.3	1.1	0.6	0.3	1.2	0.6	1.0	0.6	3.0	0.3	0.0	6.8	3.3	0.5	5.3	7.6	0.0	4.5	0.0	0.0	14.0	1.7	5.0	5.3	0.5	12.9	0.0	5.6	0.5	0.4	1.1	0.0	4.5	2.3	0.0	0.0	0.0	2.7	6.7	0.0	0.9	0.0	0.0	2.9	5.2	11.6	10.5	0.0	0.3	0.2	0.0	0.2	0.0	0.0	6.4	9.2	0.0	2.3	11.1
ECT2	ARHGEF31	ENSG00000114346	"Epithelial cell transforming 2"	Q9H8V3	3	172750682-172821474	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport"	"Guanine-nucleotide releasing factor"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 50.8"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 60.9;Erythroid cells: 70.0;Spermatogonia: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA036363, HPA053261"			Enhanced	Nucleoplasm,Cytosol		No	Yes			Nucleoplasm	Cytosol	"HPA036363: AB_2732472, HPA053261: AB_2682094"	"unprognostic (3.83e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.22e-3)"	"unprognostic (4.49e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (6.82e-6)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (1.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.33e-1)"	6.4	6.0	5.4	9.9	7.2	16.3	7.4	11.1	7.6	9.0	11.0	2.6	2.1	9.1	4.6	2.8	14.9	3.2	6.6	4.2	5.4	5.0	10.1	4.3	8.9	9.6	6.7	5.8	3.2	4.1	4.0	6.1	11.1	10.2	4.1	16.1	2.4	9.0	2.7	2.9	7.0	7.6	7.2	8.4	8.7	9.2	14.7	6.8	50.8	5.7	9.3	10.8	8.0	6.5	2.8	2.6	10.4	3.2	1.3	3.6	1.0	46.2	33.0	26.1	13.5	2.7	5.6	13.0	20.5	16.8	30.8	30.0	18.3	49.1	11.5	31.2	12.0	29.5	20.4	21.0	13.1	42.1	16.4	11.6	7.2	18.1	9.3	1.2	11.1	8.3	1.8	2.2	18.3	18.7	8.7	13.2	17.1	7.4	16.9	24.3	16.3	11.3	8.3	21.2	38.3	18.0	8.1	25.6	14.8	23.4	10.8	17.4	11.2	25.9	29.5	10.4	13.7	49.1	8.3	11.4	15.0	14.4	20.1	42.6	8.3	11.1	21.7	13.2	9.7	19.5	6.8	3.2	1.3	1.8	2.8	1.9	2.2	2.4	1.6	2.4	2.8	1.2	1.8	10.4	1.3	1.2	2.6	3.6	1.0	5.4	7.2	11.1	7.6	5.4	5.0	6.7	5.8	10.2	6.8	6.0	2.7	9.0	4.3	17.3	3.4	3.1	7.6	10.7	4.5	3.5	60.9	4.9	0.0	9.0	2.7	6.4	3.2	70.0	7.9	13.0	7.0	8.8	0.0	1.5	6.1	0.0	4.6	5.5	3.1	2.3	0.9	5.1	6.8	1.8	10.8	2.9	14.3	3.5	1.4	1.9	13.4	0.0	3.3	33.1	37.4	11.2	3.2	1.5	6.2	7.8
MYO5B	KIAA1119	ENSG00000167306	"Myosin VB"	Q9ULV0	18	49822813-50195093	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 92.2"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 114.3;Pancreatic endocrine cells: 76.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 21.0;HaCaT: 33.2;RH-30: 51.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040593, HPA040902, HPA069773"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA040593: AB_10795525, HPA040902: AB_10796230, HPA069773: AB_2686194"	"unprognostic (2.51e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.46e-1)"	"prognostic unfavorable (2.26e-5)"	"unprognostic (4.48e-2)"	"prognostic favorable (1.45e-11)"	"unprognostic (2.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.28e-1)"	2.0	1.2	1.1	12.7	1.3	0.0	5.2	0.4	2.5	7.5	56.9	1.0	13.7	23.5	1.8	10.4	20.3	4.6	20.6	2.0	1.8	1.2	19.1	13.9	9.4	0.6	0.7	1.5	1.7	16.4	9.3	10.5	13.5	2.1	6.0	17.5	8.4	21.6	8.7	0.6	14.5	92.2	0.8	0.7	0.9	13.1	5.5	0.3	2.4	16.3	14.9	17.4	4.0	11.8	1.0	0.1	0.0	0.0	2.4	0.6	0.0	21.0	5.7	0.1	0.1	0.0	0.0	11.5	0.1	0.8	0.4	0.0	14.9	9.0	0.0	5.3	0.0	1.7	33.2	7.5	9.0	0.4	0.0	2.3	0.0	2.5	10.5	0.0	0.0	0.1	0.0	7.9	0.2	5.5	1.7	0.7	0.1	0.1	8.3	0.9	8.1	0.0	0.0	1.5	12.3	2.3	0.0	51.4	3.5	19.0	4.3	11.4	0.2	8.0	9.5	0.0	3.0	5.6	0.0	0.5	0.0	11.6	0.1	2.2	5.6	3.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	1.0	0.4	0.1	0.0	0.0	0.2	0.4	0.0	2.4	0.0	0.1	0.1	0.0	1.1	1.3	0.4	2.5	1.8	1.2	0.7	1.5	2.1	0.3	50.6	12.0	0.8	8.3	0.3	8.2	1.9	15.3	24.1	19.4	7.0	9.8	3.2	5.0	40.6	14.7	0.6	114.3	0.0	41.1	1.1	0.5	42.9	0.0	15.3	0.7	0.0	6.4	0.0	0.3	1.5	0.9	0.9	3.3	3.6	33.5	29.9	76.1	53.7	0.7	13.0	29.0	0.0	0.2	9.5	3.8	5.6	3.9	0.0	38.0	58.3
METAP1	"KIAA0094, MAP1A, MetAP1A"	ENSG00000164024	"Methionyl aminopeptidase 1"	P53582	4	98995620-99062813	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Early spermatids: 345.0;Late spermatids: 1171.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025485, HPA037997, HPA037998"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		11000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025485: , HPA037997: AB_2675777, HPA037998: AB_2675778"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"prognostic favorable (7.22e-4)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.15e-3)"	"prognostic favorable (9.31e-4)"	12.1	8.3	10.0	16.0	10.1	11.8	18.6	9.2	13.8	16.0	17.9	7.0	22.9	13.4	24.1	25.9	37.2	14.0	12.3	27.9	9.5	7.1	14.3	13.7	10.7	12.6	7.9	9.8	11.3	13.0	7.8	14.4	9.2	9.9	19.1	19.3	7.5	19.0	21.5	27.2	16.4	15.2	27.8	10.1	13.9	11.6	46.8	8.1	27.0	10.8	21.8	19.1	36.6	22.6	12.7	11.7	10.4	11.1	12.5	19.2	10.8	21.7	21.5	18.9	20.3	15.0	24.1	21.0	31.2	20.1	26.7	25.5	24.1	32.5	32.3	12.5	25.2	16.0	21.9	33.1	31.2	37.1	22.5	15.8	28.8	15.7	25.9	16.3	38.9	24.2	17.3	22.8	22.7	24.1	20.8	21.9	18.3	22.5	19.5	28.5	16.6	34.1	18.6	23.2	37.1	17.5	22.4	29.5	17.2	42.9	28.2	25.9	15.3	10.4	32.4	12.3	22.1	12.4	14.9	17.8	21.6	27.5	19.8	27.2	14.2	19.9	25.5	18.6	20.0	21.4	10.4	9.4	4.2	14.9	11.1	19.2	12.7	15.4	14.5	11.7	10.1	15.1	13.5	2.3	12.5	10.7	5.8	13.4	10.8	10.0	10.1	9.2	13.8	9.5	7.1	7.9	9.8	9.9	8.1	38.7	10.5	13.7	44.1	37.7	4.6	49.8	20.4	18.7	17.0	14.0	2.0	22.0	11.6	26.9	345.0	13.5	29.0	0.0	25.4	55.9	12.3	21.8	3.5	16.4	15.6	3.2	7.5	16.5	19.6	1171.9	17.8	14.6	15.1	6.4	25.2	8.3	22.3	34.2	21.2	22.9	3.5	25.8	22.1	15.1	46.4	33.9	6.4	15.2	32.6	39.6
UBE2H	"GID3, UBC8, UBCH"	ENSG00000186591	"Ubiquitin conjugating enzyme E2 H"	P62256	7	129830732-129952949	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003302	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA003302: AB_1858526"	"unprognostic (1.15e-1)"	"unprognostic (5.85e-2)"	"unprognostic (5.67e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (2.33e-5)"	"unprognostic (1.13e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.23e-1)"	29.0	49.9	31.1	16.6	31.0	22.5	24.5	36.1	30.2	31.1	27.3	33.2	26.6	15.2	35.5	25.3	32.1	29.4	26.6	61.0	26.4	25.4	27.6	28.1	26.3	17.5	28.1	23.4	27.6	52.3	41.8	29.5	37.9	33.3	24.1	16.8	22.9	28.5	28.8	46.3	21.3	16.5	31.5	26.2	19.1	22.7	24.7	29.5	24.7	37.7	23.6	29.5	25.5	34.3	6.1	3.7	7.8	2.2	1.3	6.5	1.9	22.1	12.0	14.3	14.5	35.4	30.5	24.7	20.5	26.5	12.6	14.1	6.4	23.8	9.2	25.7	20.2	32.6	16.9	12.2	21.8	16.5	11.3	6.5	3.2	17.7	7.7	27.9	6.3	10.1	41.0	29.0	17.0	27.3	28.0	24.5	9.8	7.5	26.7	19.4	7.9	8.4	6.9	22.4	15.1	14.3	6.6	7.3	19.6	26.3	29.1	5.4	16.5	18.8	42.1	11.0	44.9	4.4	6.2	24.8	13.7	6.9	19.3	20.4	24.4	17.5	15.2	27.3	7.6	13.3	3.5	2.2	5.1	4.7	1.7	6.4	3.8	4.7	4.2	2.0	6.1	6.0	6.4	7.8	1.3	2.1	3.7	6.5	1.9	31.1	31.0	36.1	30.2	26.4	25.4	28.1	23.4	33.3	29.5	38.7	38.0	39.2	140.7	129.5	52.7	101.3	53.5	54.9	53.4	68.0	56.9	93.6	34.9	51.9	67.1	55.4	27.8	116.8	62.1	57.4	57.8	206.4	14.9	63.8	35.3	41.3	56.6	44.8	35.5	35.6	40.9	28.3	45.5	12.6	27.9	82.0	95.7	31.7	73.9	39.7	32.0	12.9	55.1	22.7	17.7	134.4	167.6	24.9	23.0	232.4
PALB2	"FANCN, FLJ21816"	ENSG00000083093	"Partner and localizer of BRCA2"	Q86YC2	16	23603160-23641310	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB014895, HPA057000"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB014895: , HPA057000: AB_2683307"	"unprognostic (1.11e-1)"	"unprognostic (5.67e-3)"	"prognostic favorable (2.83e-5)"	"unprognostic (1.43e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.00e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (2.35e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.21e-1)"	12.4	9.9	10.7	19.6	11.9	6.8	15.2	16.5	14.1	12.4	14.0	10.8	9.1	14.8	10.9	13.5	17.6	9.6	7.8	10.5	10.0	10.6	13.7	16.1	9.2	13.4	9.7	12.5	15.3	10.6	13.7	16.1	9.1	14.9	10.9	12.7	8.6	11.0	14.7	10.3	17.0	14.1	12.8	10.8	14.1	11.0	16.9	10.5	12.9	12.1	12.0	15.3	13.6	13.3	3.7	3.9	7.2	7.7	3.9	5.5	2.0	12.0	9.3	11.3	7.9	9.4	7.4	10.1	8.7	13.4	14.4	17.5	7.9	12.6	12.7	6.4	6.1	11.1	10.8	10.0	14.7	17.2	7.5	5.8	7.8	12.9	22.4	8.7	14.3	12.7	8.4	15.0	13.6	15.5	8.0	7.6	12.3	16.0	6.9	12.6	11.9	14.7	14.9	25.1	8.8	5.5	17.1	13.8	17.4	11.0	10.8	8.3	8.3	8.9	10.2	11.4	10.3	9.4	9.8	5.5	17.3	6.6	8.5	9.3	8.1	13.1	13.0	11.3	10.5	10.3	7.2	3.3	3.0	4.4	4.2	5.3	3.7	4.9	5.3	3.9	3.1	5.5	4.3	0.2	3.9	7.7	2.8	3.1	2.0	10.7	11.9	16.5	14.1	10.0	10.6	9.7	12.5	14.9	10.5	11.9	3.4	9.4	3.5	0.8	6.2	4.2	5.1	12.0	10.3	3.5	3.9	2.3	3.3	4.3	3.0	2.3	2.6	0.0	4.4	1.7	1.4	1.5	4.7	4.7	3.2	1.6	1.2	3.1	7.0	2.9	4.4	4.0	1.7	9.0	2.6	4.7	6.9	3.4	6.0	4.6	7.1	6.5	2.1	20.2	14.4	2.4	1.0	2.5	4.3	3.7
BUB1	"BUB1A, BUB1L, hBUB1"	ENSG00000169679	"BUB1 mitotic checkpoint serine/threonine kinase"	O43683	2	110637698-110678114	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 56.5;testis: 30.9"	"Cell type enriched"	"Detected in many"	5	"Spermatocytes: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"T-reg: 6.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 68.1"	"Not detected"	"Not detected"							HPA006123			Supported	Nucleoplasm,Cytosol		NA	Yes			Nucleoplasm	Cytosol	"HPA006123: AB_1845498"	"unprognostic (7.74e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.72e-3)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (1.03e-5)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.37e-5)"	"unprognostic (1.76e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.45e-2)"	"unprognostic (3.64e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	1.1	0.9	0.5	15.8	1.0	8.9	0.6	0.3	1.0	1.2	2.8	0.4	0.0	2.4	0.7	2.3	5.8	0.5	1.0	1.1	0.5	0.5	0.9	0.8	2.1	11.6	0.6	0.2	1.0	0.7	0.0	0.4	2.4	0.5	0.7	4.3	0.4	1.4	0.0	0.5	1.8	3.1	1.4	1.3	7.9	1.8	30.9	0.1	56.5	0.6	5.7	12.1	2.5	2.0	1.8	2.4	3.0	0.2	1.4	6.1	1.1	30.3	8.9	23.4	14.7	1.0	1.7	12.4	15.8	10.4	27.5	20.8	18.7	17.5	20.6	9.8	9.1	25.8	13.3	29.9	11.5	34.2	16.3	14.6	68.1	9.5	14.9	0.2	19.6	19.3	0.4	0.7	21.2	10.5	3.9	16.1	23.1	29.8	43.0	22.5	10.0	32.8	16.4	22.6	10.8	16.9	21.8	20.0	31.4	5.6	9.6	15.7	6.8	11.2	9.6	8.5	14.9	7.5	16.6	6.6	12.5	20.5	9.4	21.9	22.5	21.1	25.3	8.5	15.2	22.0	3.0	0.0	0.7	0.6	0.2	0.9	1.8	2.5	1.0	0.8	1.4	1.6	1.5	0.0	1.4	0.1	2.4	6.1	1.1	0.5	1.0	0.3	1.0	0.5	0.5	0.6	0.2	0.5	0.1	0.0	1.0	7.8	0.2	0.5	0.0	0.8	0.0	1.4	2.3	0.0	0.0	1.3	0.0	0.2	8.3	0.0	0.0	0.0	0.0	8.1	0.3	0.2	0.0	0.2	6.6	0.0	0.0	1.3	1.3	4.7	0.3	1.7	0.0	1.0	0.9	0.0	0.1	0.0	0.4	0.0	0.0	6.5	0.0	68.0	14.1	0.4	0.6	2.5	2.0	0.9
ADAM9	"CORD9, KIAA0021, MCMP, MDC9, Mltng"	ENSG00000168615	"ADAM metallopeptidase domain 9"	Q13443	8	38996869-39105144	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Cone-rod dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Pancreatic endocrine cells: 140.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 11.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004000			Approved	"Endoplasmic reticulum,Vesicles"	"Secreted - unknown location"	NA	NA		640000	Vesicles	"Endoplasmic reticulum"	"HPA004000: AB_1844584"	"prognostic unfavorable (1.14e-4)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (7.21e-6)"	"unprognostic (5.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (5.83e-2)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (2.80e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.23e-2)"	36.7	25.0	14.7	21.7	13.6	10.4	17.1	20.9	14.4	21.8	24.4	13.2	21.8	19.4	24.9	19.8	24.1	15.5	31.7	28.5	12.5	10.1	29.4	11.6	39.2	20.3	19.2	12.9	17.6	11.1	37.5	10.4	30.1	15.8	23.8	23.8	15.4	44.5	21.4	18.3	12.8	25.4	32.8	22.0	25.7	33.2	13.7	12.7	2.4	24.0	14.9	11.7	34.8	19.2	0.6	8.1	3.4	11.4	3.1	0.8	2.8	41.2	29.9	11.8	7.2	19.2	61.9	15.4	56.1	61.4	31.5	29.5	14.2	30.0	2.1	21.2	38.6	32.2	17.7	5.0	39.6	61.1	2.0	5.1	2.2	20.8	12.2	38.8	1.6	4.8	47.5	23.5	31.0	35.3	60.1	42.9	3.6	4.3	14.1	65.5	4.0	1.6	1.0	1.7	29.5	9.7	1.4	21.4	7.2	51.2	11.8	1.6	2.4	14.9	18.0	13.6	13.3	14.5	3.0	73.6	24.1	23.2	45.5	25.6	4.5	6.9	2.3	40.0	2.7	16.4	1.4	11.4	2.2	0.6	6.1	0.3	0.1	0.3	0.8	8.1	0.6	0.1	0.6	3.4	3.1	2.6	2.7	0.4	2.8	14.7	13.6	20.9	14.4	12.5	10.1	19.2	12.9	15.8	12.7	44.7	35.4	8.2	50.9	31.9	18.5	45.6	25.5	14.7	39.8	33.2	19.6	17.9	3.3	80.4	10.3	23.6	20.8	0.0	100.4	80.2	38.5	85.4	4.7	6.7	104.9	4.8	10.3	26.4	54.2	5.1	26.4	39.7	20.3	22.6	26.3	15.2	140.3	25.9	23.3	36.6	23.8	12.9	32.5	4.3	2.0	18.7	28.7	4.1	25.8	75.5
CEP55	"C10orf3, CT111, FLJ10540"	ENSG00000138180	"Centrosomal protein 55"	Q53EZ4	10	93496632-93529092	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 52.9;testis: 19.3"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 15.9;Extravillous trophoblasts: 14.7;Hofbauer cells: 10.9;Spermatocytes: 35.6;Spermatogonia: 19.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"T-reg: 4.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 4.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023430	Approved		Supported	"Plasma membrane,Midbody,Centriolar satellite"		Yes	Yes			"Plasma membrane, Centriolar satellite"	Midbody	"HPA023430: AB_10960212"	"unprognostic (9.85e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (3.20e-9)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (0.00e+0)"	"prognostic favorable (3.15e-4)"	"unprognostic (7.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	3.2	1.4	0.5	12.1	0.4	3.1	3.6	0.3	0.6	2.0	5.2	0.3	0.2	4.6	0.8	1.5	11.6	0.6	2.5	0.7	0.4	0.5	1.5	0.7	4.4	10.1	0.6	0.2	0.8	0.6	0.0	0.7	3.8	0.5	0.8	6.5	0.4	2.3	0.2	0.7	3.0	5.2	3.5	1.1	4.8	3.2	19.3	0.3	52.9	0.7	10.8	11.0	2.7	3.3	0.1	0.1	0.0	0.0	0.0	4.4	0.0	51.9	20.8	13.8	17.6	1.5	3.2	7.7	28.6	20.3	27.2	28.2	22.1	28.0	13.9	12.7	18.5	18.3	29.7	16.7	14.0	32.7	41.8	8.7	5.2	12.9	7.5	0.1	9.0	12.2	0.7	1.0	29.0	35.4	8.1	25.0	23.1	4.7	26.4	30.7	12.0	23.7	13.7	5.4	16.2	15.2	10.3	22.7	7.6	12.3	6.5	5.7	8.0	22.0	6.8	17.3	11.0	17.9	9.2	15.6	17.3	24.2	23.6	46.9	11.8	16.0	17.0	13.5	34.0	15.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.5	0.4	0.3	0.6	0.4	0.5	0.6	0.2	0.5	0.3	0.0	2.2	0.8	0.6	3.2	0.0	0.4	5.1	0.0	0.0	0.0	0.0	0.9	0.0	0.6	15.9	0.0	0.3	0.0	0.2	14.7	0.4	0.1	0.0	0.2	10.9	0.0	0.0	2.5	4.1	3.8	0.3	5.4	0.0	0.0	1.4	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	35.6	19.5	1.1	1.3	1.9	2.3	0.9
TPX2	"C20orf1, C20orf2, DIL-2, p100"	ENSG00000088325	"TPX2, microtubule nucleation factor"	Q9ULW0	20	31739271-31801805	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 92.7"	"Group enriched"	"Detected in many"	5	"Erythroid cells: 70.0;Extravillous trophoblasts: 57.2;Spermatocytes: 121.8;Spermatogonia: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.0;NK-cells: 4.8;T-cells: 10.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005487	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"		Yes	Yes			Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"HPA005487: AB_1858223"	"unprognostic (2.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.43e-6)"	"unprognostic (2.99e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (8.07e-7)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (3.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.68e-5)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.56e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.39e-1)"	1.8	1.7	1.0	13.4	2.0	21.7	1.2	2.2	1.7	2.2	5.7	0.5	0.3	4.6	1.2	2.3	13.3	0.5	1.9	1.5	0.8	0.7	1.2	2.7	2.6	12.9	0.7	1.1	0.8	0.5	0.0	0.7	6.6	0.9	0.7	7.4	0.5	2.3	0.5	2.2	5.9	4.7	3.2	0.9	5.9	3.2	22.0	0.6	92.7	0.7	11.0	16.2	2.2	3.8	1.0	1.4	4.0	0.1	4.8	10.4	1.3	70.8	23.8	28.8	22.5	2.3	4.2	27.8	29.8	16.9	43.3	32.7	50.5	30.7	33.4	17.6	16.6	32.4	37.5	32.8	27.0	49.5	14.4	12.7	65.4	22.8	34.4	0.7	25.1	16.8	1.4	1.5	27.1	19.8	6.2	23.3	25.3	48.3	30.5	33.9	29.1	41.9	19.5	32.1	27.4	25.8	23.9	77.8	20.2	11.6	11.6	20.9	14.1	45.6	17.3	13.5	20.7	30.0	15.3	15.7	48.6	29.9	22.2	45.7	12.2	21.1	29.9	15.2	89.5	31.6	4.0	0.0	0.5	0.6	0.0	0.3	1.0	1.9	2.3	0.6	0.4	0.4	0.7	0.4	4.8	0.1	1.4	10.4	1.3	1.0	2.0	2.2	1.7	0.8	0.7	0.7	1.1	0.9	0.6	0.0	6.2	16.2	0.8	6.2	0.8	0.8	7.6	0.0	5.7	0.0	0.0	4.4	0.0	1.0	6.4	0.3	0.6	70.0	0.4	57.2	2.9	0.6	0.0	2.5	15.9	1.6	1.2	9.8	5.3	10.6	0.9	5.1	0.0	3.6	2.6	0.3	1.2	0.6	0.0	0.0	0.3	0.0	2.1	121.8	68.8	5.4	3.9	6.9	7.3	1.4
PRC1	ASE1	ENSG00000198901	"Protein regulator of cytokinesis 1"	O43663	15	90966038-90995629	"Predicted intracellular proteins"	"Cell cycle, Cell division"		Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.3;lymphoid tissue: 44.5;testis: 44.3"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 70.0;Extravillous trophoblasts: 59.0;Spermatocytes: 129.3;Spermatogonia: 60.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 18.9;T-reg: 5.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 18.9;T-cells: 5.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"HPA034521, HPA048816"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody"		Yes	Yes			"Plasma membrane, Microtubules, Cytokinetic bridge, Midbody"	Nucleoplasm	"HPA034521: AB_10670169, HPA048816: "	"unprognostic (1.14e-1)"	"unprognostic (3.98e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.24e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (2.76e-5)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.92e-2)"	3.2	2.8	3.5	13.0	3.8	43.3	3.6	12.5	5.8	3.4	9.3	1.6	0.2	6.1	3.5	4.7	15.0	2.6	2.8	3.5	5.1	4.9	2.3	1.9	5.8	9.2	3.4	4.7	3.6	3.8	1.6	1.5	10.4	5.2	2.4	9.9	2.7	3.9	1.0	2.5	9.9	6.6	5.4	3.5	5.8	5.0	44.3	0.8	44.5	1.8	15.3	16.5	3.5	4.9	0.9	2.0	18.9	0.4	2.0	5.8	0.7	32.9	40.2	33.7	22.8	3.5	6.0	18.1	47.4	28.0	52.5	40.3	26.8	32.1	12.5	18.9	30.2	32.5	44.9	38.3	20.3	49.8	23.2	42.5	26.0	52.6	24.6	0.9	12.8	22.5	1.5	2.6	29.8	30.6	11.7	29.4	20.3	21.6	26.9	48.8	28.6	13.1	19.5	13.2	43.1	17.3	13.8	42.0	16.8	23.4	25.0	30.7	24.3	45.1	25.1	16.3	24.3	30.1	25.3	17.6	34.7	30.7	28.6	68.2	8.7	23.1	15.5	15.2	31.8	53.0	18.9	0.4	2.0	0.5	0.0	0.3	0.9	1.0	1.0	1.8	0.4	0.9	0.4	0.2	2.0	0.2	2.0	5.8	0.7	3.5	3.8	12.5	5.8	5.1	4.9	3.4	4.7	5.2	0.8	0.0	1.9	12.3	5.2	14.7	6.8	2.4	0.0	4.0	10.3	3.5	0.0	9.5	0.0	2.9	17.7	3.2	2.0	70.0	2.5	59.0	7.4	5.1	9.2	1.6	17.6	3.2	5.2	9.8	8.6	12.3	3.4	7.0	3.3	9.0	4.5	4.5	1.7	2.6	1.8	0.0	3.5	6.5	10.3	129.3	60.0	12.4	12.2	6.9	7.4	5.4
SLK	"KIAA0204, se20-9, STK2"	ENSG00000065613	"STE20 like kinase"	Q9H2G2	10	103967201-104029233	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Urothelial cells: 181.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015757	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		17000	"Plasma membrane, Cytosol"		"HPA015757: AB_1857236"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.67e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (1.95e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (8.48e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.07e-1)"	15.2	11.2	13.7	11.0	36.7	14.6	16.1	16.7	13.1	16.6	19.0	9.9	10.9	9.1	17.0	12.1	40.2	12.1	13.6	17.2	10.6	7.1	14.9	12.2	17.1	10.1	11.2	13.4	17.2	12.5	22.6	13.1	17.4	12.8	19.3	13.6	11.4	19.8	12.7	19.3	16.6	15.5	29.8	13.0	12.1	15.7	10.2	12.8	12.0	15.8	21.6	12.5	24.9	23.6	1.4	2.2	6.5	1.4	1.3	3.6	0.7	21.6	12.7	15.1	10.8	16.4	22.9	6.4	13.5	18.0	10.1	9.5	8.0	23.3	11.5	8.5	13.9	8.6	23.6	8.0	17.1	14.8	9.2	11.0	11.7	10.4	6.7	12.3	13.9	10.1	11.7	22.5	13.6	39.9	14.1	18.1	7.5	14.6	8.0	13.2	7.5	9.7	7.7	3.7	14.0	8.1	9.5	18.6	6.0	13.2	25.0	3.5	6.2	11.7	11.4	11.2	8.0	5.9	10.1	27.3	7.4	7.8	13.6	15.8	9.7	11.8	7.3	11.0	18.8	4.7	1.2	1.4	3.3	3.6	1.2	3.6	1.1	2.2	2.2	1.2	1.4	1.5	2.5	6.5	1.3	1.0	2.2	1.4	0.7	13.7	36.7	16.7	13.1	10.6	7.1	11.2	13.4	12.8	12.8	166.7	108.1	23.8	57.3	50.6	27.3	89.7	28.1	66.9	138.8	41.8	23.6	27.8	3.3	28.4	6.3	53.4	45.3	23.3	46.5	11.5	39.3	60.5	32.5	21.7	17.3	23.8	17.7	41.7	24.0	11.0	43.1	31.1	8.5	37.9	31.8	23.4	61.5	54.9	59.4	11.3	24.1	6.5	34.9	42.3	39.1	59.8	43.8	21.8	29.4	181.1
ADGRG6	"FLJ14937, GPR126"	ENSG00000112414	"Adhesion G protein-coupled receptor G6"	Q86SQ4	6	142301854-142446266	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"liver: 51.9;placenta: 104.9"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 118.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"myeloid DC: 3.5"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 3.5"	"Cell line enhanced"	"Detected in many"		"A549: 25.7;Hep G2: 24.0;hTERT-HME1: 24.4;HUVEC TERT2: 47.1;MCF7: 44.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017346	Approved					NA	NA		70000000			"HPA017346: AB_1849260"	"unprognostic (1.04e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.00e-2)"	"unprognostic (8.64e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (4.46e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.59e-2)"	5.6	1.4	1.1	4.1	1.0	0.0	6.1	0.5	1.1	4.1	14.0	1.0	2.7	8.9	2.2	2.8	9.1	2.6	8.8	4.4	1.4	1.1	5.3	51.9	12.0	2.6	1.9	0.8	1.4	3.1	0.3	0.7	104.9	1.3	7.2	3.3	3.3	6.3	3.6	1.5	7.8	17.5	5.0	2.3	6.1	6.6	1.5	0.9	2.2	2.1	3.9	4.7	11.3	9.2	0.0	3.5	0.0	0.2	0.0	0.1	0.0	4.8	25.7	0.5	2.7	0.1	0.0	0.0	6.7	1.2	5.1	3.2	20.5	14.9	0.0	6.0	3.8	1.4	12.1	0.7	6.4	8.4	0.0	2.0	1.0	4.4	24.0	5.0	4.0	0.0	0.0	10.4	0.1	24.4	2.9	47.1	0.1	0.1	0.0	2.0	44.2	0.0	0.0	0.2	1.7	5.9	0.0	2.3	5.0	2.6	10.9	0.0	0.0	1.9	9.0	4.2	4.4	4.9	0.0	1.6	0.0	2.3	2.2	3.3	0.0	0.0	0.0	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	1.0	0.5	1.1	1.4	1.1	1.9	0.8	1.3	0.9	6.0	5.1	0.5	15.4	0.0	0.0	1.4	15.3	5.3	14.8	8.7	0.0	4.8	0.0	11.5	0.0	4.4	0.8	0.0	4.7	24.6	0.6	11.8	0.0	118.8	2.0	0.0	0.0	16.5	24.7	0.2	0.6	0.6	0.0	1.0	0.9	0.0	22.8	3.6	0.4	10.3	0.0	6.5	0.5	1.6	5.1	0.0	11.3	0.0	1.8	21.0
ZWILCH	"FLJ10036, KNTC1AP"	ENSG00000174442	"Zwilch kinetochore protein"	Q9H900	15	66504959-66550128	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 34.5"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 80.0;Late spermatids: 61.6;Spermatocytes: 202.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.10e-1)"	"unprognostic (9.99e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.83e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.90e-5)"	"prognostic unfavorable (7.34e-4)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (2.81e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.42e-1)"	4.1	2.6	4.8	6.8	6.3	6.0	4.5	4.8	7.3	4.6	5.7	2.4	2.2	3.5	4.3	4.4	7.7	3.3	3.9	2.5	4.5	3.3	4.6	4.2	3.5	7.1	2.4	6.2	5.4	3.8	2.4	2.8	6.5	5.4	3.2	6.8	2.3	4.0	2.6	3.5	5.2	4.0	4.2	3.6	8.1	3.6	34.5	1.5	17.8	2.9	6.6	9.2	3.7	4.5	8.0	4.2	7.4	8.9	8.5	8.7	4.4	12.1	15.6	19.4	17.0	4.6	8.2	10.3	19.0	11.7	23.1	25.6	12.6	10.5	26.3	9.0	12.4	19.3	30.2	51.1	13.7	28.1	13.3	10.3	18.8	21.6	10.0	1.6	13.0	10.6	3.3	3.5	23.6	17.4	7.1	14.6	11.2	18.1	14.3	17.9	12.0	11.4	7.9	36.7	24.1	10.1	13.2	23.7	19.0	8.2	13.8	11.4	12.4	10.4	13.6	16.2	23.1	10.9	8.7	9.6	21.3	23.0	12.4	27.8	7.2	28.3	26.9	14.3	30.1	17.6	7.4	3.8	6.3	8.4	7.8	7.3	8.0	8.7	7.9	3.8	7.0	5.8	8.0	5.1	8.5	8.9	4.2	8.4	4.4	4.8	6.3	4.8	7.3	4.5	3.3	2.4	6.2	5.4	1.5	3.0	5.8	5.2	4.7	9.8	4.8	0.9	5.1	4.0	10.3	1.8	0.0	10.2	3.3	6.4	80.0	6.2	1.8	23.3	5.7	20.9	6.5	3.9	14.0	4.3	10.9	0.0	4.6	3.7	4.9	61.6	6.9	8.8	5.0	9.0	7.6	1.3	6.8	0.0	4.9	1.6	3.8	25.8	5.2	202.6	41.9	7.4	10.8	8.4	8.1	5.0
ARHGAP11A	KIAA0013	ENSG00000198826	"Rho GTPase activating protein 11A"	Q6P4F7	15	32615144-32639949	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.4;lymphoid tissue: 35.0"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 20.0;Spermatocytes: 24.4;Spermatogonia: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA040830, HPA066481"	Enhanced		Approved	Nucleoli,Cytosol		No	Yes			Cytosol	Nucleoli	"HPA040830: AB_10805830, HPA066481: "	"unprognostic (5.00e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (2.05e-4)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (4.87e-2)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (3.43e-2)"	"unprognostic (1.07e-12)"	"unprognostic (7.37e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.64e-2)"	1.9	1.5	2.0	17.2	2.9	16.4	3.3	1.1	3.9	1.6	5.4	1.6	0.5	4.3	2.3	0.5	7.5	0.5	4.1	1.4	2.2	1.9	0.8	1.2	2.0	9.4	4.4	0.8	0.8	3.1	0.9	1.0	4.7	2.0	1.2	6.7	0.8	2.0	0.5	1.7	3.2	9.6	3.3	8.9	5.0	2.6	6.4	1.9	35.0	1.0	5.3	10.3	2.6	2.7	0.9	1.7	2.6	1.8	0.5	3.8	1.1	23.5	25.4	20.3	13.4	1.4	3.8	12.2	23.9	13.8	22.8	17.6	17.5	12.0	13.7	7.6	14.0	26.1	17.5	14.3	12.5	30.8	26.9	8.3	43.4	22.9	8.9	0.5	32.3	17.4	1.2	1.5	18.3	14.5	4.3	16.8	27.0	30.0	32.6	26.4	9.6	16.9	10.8	12.7	19.7	14.9	20.1	45.5	10.7	8.1	12.5	19.6	13.5	25.1	13.0	5.4	11.0	18.5	31.0	12.9	30.8	22.8	12.9	25.4	11.9	18.8	37.8	13.2	38.4	26.9	0.1	1.1	2.6	2.3	1.8	0.9	0.9	3.8	3.3	1.7	0.7	1.5	2.0	0.0	0.5	0.3	0.6	2.8	1.1	2.0	2.9	1.1	3.9	2.2	1.9	4.4	0.8	2.0	1.9	0.0	2.9	1.5	0.9	4.2	0.0	0.8	5.1	1.4	2.3	1.8	0.0	2.5	0.0	0.8	2.9	1.1	0.5	0.0	0.7	20.0	1.1	1.0	0.0	1.0	8.0	0.0	0.0	2.5	4.1	3.4	0.6	3.2	0.0	3.6	3.7	0.0	0.5	1.1	0.4	0.2	0.9	6.5	0.9	24.4	18.6	1.9	2.6	3.2	5.1	1.4
CD59	"16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20"	ENSG00000085063	"CD59 molecule (CD59 blood group)"	P13987	11	33703010-33736491	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 285.5"	"Cell type enhanced"	"Detected in all"	4	"Urothelial cells: 1502.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 217.5;U-2197: 180.1"									"CAB001448, HPA026494"	Supported		Uncertain	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		98000000	"Golgi apparatus, Vesicles"		"CAB001448: AB_563604, HPA026494: AB_1846321"	"unprognostic (2.07e-2)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (7.40e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (3.10e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (1.66e-2)"	"prognostic favorable (1.39e-10)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.09e-1)"	96.7	41.0	36.7	26.3	44.3	23.8	76.0	25.9	32.7	44.8	36.9	24.0	57.9	16.5	45.4	132.8	68.4	53.2	67.6	90.5	35.6	38.4	100.0	61.0	86.4	39.8	39.7	25.8	39.3	52.3	60.6	48.0	285.5	68.7	47.4	37.7	51.4	114.8	62.6	70.6	43.4	25.0	52.4	32.9	26.2	54.7	28.1	23.1	16.1	85.9	57.7	40.0	51.2	63.4	13.5	20.5	42.8	4.8	17.7	60.4	11.1	16.8	15.8	4.7	13.8	109.9	86.2	2.7	96.0	107.2	24.1	28.2	7.3	50.7	1.3	17.2	103.4	28.7	19.0	8.6	95.8	33.8	26.8	13.1	1.7	56.0	11.0	30.0	10.1	5.8	40.0	24.2	20.4	98.3	66.8	146.8	5.9	11.8	39.0	151.5	15.4	4.7	4.2	2.6	31.1	82.5	1.8	14.6	13.5	72.7	28.8	3.2	4.4	33.4	15.5	17.6	13.9	11.8	1.0	217.5	55.4	13.3	180.1	33.3	17.3	33.8	1.6	47.6	0.0	96.2	30.5	4.8	42.8	11.3	1.6	14.4	13.5	24.0	12.7	20.5	10.6	15.7	9.3	28.4	17.7	0.9	10.5	60.4	11.1	36.7	44.3	25.9	32.7	35.6	38.4	39.7	25.8	68.7	23.1	253.1	215.4	44.4	795.7	254.1	47.4	262.5	430.6	580.9	208.1	230.3	31.4	513.5	139.3	1251.4	102.0	802.4	90.2	140.2	547.4	330.2	284.0	787.9	136.2	175.7	400.2	44.5	160.2	566.0	129.7	49.4	219.8	141.1	1204.5	272.3	85.9	184.1	823.9	122.8	192.3	162.3	45.0	271.7	576.8	86.8	27.6	248.5	699.7	62.8	98.2	1502.4
SERPINB7	MEGSIN	ENSG00000166396	"Serpin family B member 7"	O75635	18	63752935-63805376	"Disease related genes, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 16.7;skin 1: 54.6;tongue: 22.6"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 70.6;Ductal cells: 49.1;Extravillous trophoblasts: 68.8;Pancreatic endocrine cells: 169.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 46.7;fHDF/TERT166: 32.9;HaCaT: 80.4;HBEC3-KT: 25.6;HBF TERT88: 44.7;hTERT-HME1: 26.0;U-138 MG: 44.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024200	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA			"Endoplasmic reticulum"	Mitochondria	"HPA024200: AB_1856730"	"unprognostic (8.66e-3)"	"unprognostic (6.31e-3)"	"unprognostic (6.55e-2)"	"unprognostic (4.03e-4)"	"unprognostic (9.11e-2)"	"unprognostic (1.30e-1)"		"unprognostic (1.20e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (2.02e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.76e-3)"	0.2	0.0	0.1	0.1	0.1	0.0	6.6	0.1	0.1	2.0	0.2	0.0	0.0	0.0	0.5	0.0	2.6	0.1	1.3	0.1	0.1	0.1	0.4	0.1	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	8.4	0.0	0.1	0.0	0.0	0.6	0.0	0.9	54.6	0.1	0.0	0.1	0.0	0.3	0.3	0.0	6.7	0.1	22.6	16.7	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.7	0.0	46.7	9.4	7.1	5.3	0.0	0.2	0.0	0.0	32.9	12.4	80.4	0.0	25.6	44.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	4.6	1.1	26.0	0.3	0.0	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	44.0	1.6	0.9	4.4	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	70.6	0.0	0.0	0.0	1.4	1.2	0.0	0.0	1.2	0.0	49.1	0.0	0.0	0.0	0.0	7.8	68.8	1.1	2.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.3	2.8	0.0	0.0	169.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	19.2	5.1	0.0	0.0	2.5
FOXM1	"FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident"	ENSG00000111206	"Forkhead box M1"	Q08050	12	2857681-2877155	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.5;testis: 40.1"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 16.5;Erythroid cells: 23.3;Extravillous trophoblasts: 15.0;Late spermatids: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			CAB017832	Uncertain		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	Yes			"Nucleoplasm, Nucleoli, Nucleoli rim"	Cytosol	"CAB017832: "	"unprognostic (3.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (1.95e-6)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (1.01e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (6.09e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.94e-1)"	1.7	1.7	1.0	9.3	0.9	13.8	2.4	0.4	1.2	2.0	6.5	0.4	1.1	6.0	1.2	2.1	13.5	0.4	4.1	1.2	0.8	0.6	1.3	1.6	2.8	6.6	0.8	0.3	0.8	0.6	0.0	0.5	3.9	0.9	0.9	8.2	0.6	2.6	1.1	0.7	3.7	7.1	4.4	1.2	5.0	3.2	40.1	0.4	47.5	0.6	11.4	11.6	2.0	3.7	0.7	0.6	1.0	0.6	0.4	1.9	0.1	28.5	29.0	22.5	20.7	3.4	4.5	28.7	18.7	18.4	37.9	34.4	36.6	25.6	18.5	4.0	26.7	43.1	22.2	33.7	17.1	37.2	34.5	18.0	20.8	27.8	15.6	0.5	16.7	17.1	2.3	1.9	35.2	24.8	9.0	26.7	21.2	11.6	41.5	29.8	26.8	22.7	7.9	49.7	29.7	21.7	16.5	34.2	9.6	8.9	18.3	12.7	20.1	23.9	20.1	10.9	44.4	19.6	18.7	10.7	30.8	46.8	35.9	64.8	5.5	9.1	26.8	14.3	16.1	32.6	0.4	0.6	0.1	0.4	0.2	0.4	0.7	0.5	0.4	0.2	0.7	0.9	0.3	1.0	0.4	0.1	0.6	1.9	0.1	1.0	0.9	0.4	1.2	0.8	0.6	0.8	0.3	0.9	0.4	0.0	2.2	0.8	0.7	2.6	1.6	0.5	2.5	0.0	1.2	1.8	3.9	1.4	1.7	0.2	16.5	0.3	1.7	23.3	0.0	15.0	1.3	0.8	0.0	0.9	7.3	4.8	0.0	3.1	1.9	20.0	0.9	1.7	0.0	1.8	3.7	0.6	0.2	0.0	0.7	0.0	4.4	0.0	0.0	7.6	5.9	1.3	1.6	2.5	3.7	1.3
DDX60L	FLJ31033	ENSG00000181381	"DExD/H-box 60 like"	Q5H9U9	4	168356735-168537786	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.5"	"Group enriched"	"Detected in all"	4	"granulocytes: 22.5;monocytes: 7.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 23.3"									"HPA043211, HPA055501"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043211: AB_10794390, HPA055501: AB_2682838"	"unprognostic (8.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.13e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.69e-1)"	12.7	5.0	2.8	13.1	3.1	33.0	9.9	1.4	3.2	7.2	8.4	3.2	2.7	6.0	9.2	7.9	3.8	6.9	6.7	6.0	2.4	2.4	4.5	6.0	25.8	17.7	3.8	1.4	7.3	5.1	4.4	5.2	32.6	3.4	5.0	6.5	6.8	7.0	5.7	3.3	4.3	14.0	5.3	4.2	11.9	9.5	2.7	3.1	25.3	5.8	3.5	8.1	4.9	6.8	1.6	2.4	22.5	7.8	1.7	3.7	1.6	6.1	3.6	1.4	0.6	3.7	10.8	7.0	6.2	13.1	23.3	16.2	0.0	14.5	0.1	0.3	6.3	12.7	2.4	0.6	3.7	6.8	3.5	0.5	13.6	4.0	0.3	4.5	5.5	3.4	3.0	1.1	8.4	0.7	4.9	16.4	3.1	0.2	0.1	14.9	0.1	4.9	3.5	0.3	0.6	3.1	2.7	3.2	0.0	2.2	3.6	0.2	1.9	11.0	1.3	6.2	0.2	1.0	7.8	17.5	1.2	8.2	2.9	2.1	5.9	0.9	0.0	4.1	16.5	1.8	1.6	4.0	3.5	2.7	6.3	3.7	0.9	2.7	2.7	2.4	1.6	2.2	2.3	22.5	1.7	7.8	0.0	3.6	1.6	2.8	3.1	1.4	3.2	2.4	2.4	3.8	1.4	3.4	3.1	8.9	7.9	0.0	2.1	0.9	1.3	8.1	5.1	12.0	3.4	3.5	21.6	4.5	0.0	6.8	10.7	13.1	11.6	0.0	8.7	29.4	7.0	2.6	8.1	5.4	22.5	0.0	0.0	9.2	23.2	3.6	3.1	29.7	0.0	26.2	13.2	3.2	17.0	14.0	3.9	3.3	16.8	6.5	3.3	0.5	1.3	2.0	5.9	8.7	3.8	1.4
ARF6		ENSG00000165527	"ADP ribosylation factor 6"	P62330	14	49893092-49897054	"Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Suprabasal keratinocytes: 588.6;Urothelial cells: 680.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002778, CAB079914"	Approved		Supported	Cytosol		NA	NA		130000	Cytosol		"CAB002778: , CAB079914: AB_2539861"	"unprognostic (1.21e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.80e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (3.10e-5)"	"unprognostic (1.61e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.37e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.49e-2)"	19.7	14.3	8.1	22.3	11.0	31.8	18.7	10.8	11.2	23.1	27.2	9.6	17.4	20.6	17.5	17.8	73.2	16.0	20.4	12.8	7.9	7.7	21.4	23.0	19.3	27.0	10.3	11.0	17.3	15.9	8.2	10.3	29.1	9.8	21.6	23.6	13.7	25.0	13.6	20.6	42.7	43.7	16.7	10.7	28.9	20.6	17.3	8.9	33.7	18.8	34.4	44.0	22.2	35.2	22.9	15.7	17.6	21.5	18.5	26.4	13.9	41.4	17.4	11.8	13.6	16.2	21.7	24.1	26.1	19.0	18.6	19.3	12.6	29.1	27.1	13.5	21.7	14.3	30.7	13.2	20.9	22.2	53.2	10.6	13.9	9.4	11.2	18.3	25.4	18.7	16.8	25.1	15.0	29.1	22.4	20.5	17.6	13.3	54.1	25.7	29.7	22.4	22.4	12.8	22.5	25.2	17.5	15.4	15.8	48.1	33.8	17.4	11.5	20.7	31.3	25.3	15.0	23.7	20.7	27.0	34.8	17.8	20.4	19.5	29.1	29.9	20.5	12.4	15.1	24.6	17.6	14.3	13.3	24.4	21.5	26.4	22.9	24.1	24.7	15.7	17.5	16.8	21.3	9.8	18.5	19.3	10.4	23.2	13.9	8.1	11.0	10.8	11.2	7.9	7.7	10.3	11.0	9.8	8.9	47.6	25.1	175.3	466.8	532.8	22.5	16.1	104.4	18.7	33.0	96.0	2.0	137.2	134.3	117.8	2.7	72.9	203.3	93.5	70.0	160.9	87.6	430.3	78.5	116.3	146.8	31.8	95.3	90.9	177.7	5.6	31.1	185.3	288.5	199.2	149.8	40.2	95.1	160.9	30.8	117.8	17.6	45.3	154.6	55.6	45.6	588.6	169.7	182.7	111.6	680.4
BACH1	"BACH-1, BTBD24"	ENSG00000156273	"BTB domain and CNC homolog 1"	O14867	21	29194071-29630751	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 165.1;Late spermatids: 300.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 46.7"	"Group enriched"	"Detected in all"	4	"granulocytes: 46.7;monocytes: 15.2"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034949	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA034949: AB_2674376"	"unprognostic (1.57e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.99e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.79e-3)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.19e-2)"	"unprognostic (8.70e-2)"	23.3	7.8	7.9	15.5	13.1	44.7	10.3	4.7	8.8	13.5	12.8	9.6	6.7	9.9	16.0	10.0	18.6	8.9	15.6	10.7	8.0	5.8	11.7	17.6	25.2	21.9	10.8	5.5	9.5	12.5	5.3	9.2	28.8	11.1	14.9	7.8	9.2	12.2	5.3	30.7	22.9	17.9	15.9	16.0	22.9	9.5	20.6	11.1	14.3	11.3	12.6	14.0	19.4	15.8	4.0	7.6	46.7	15.2	2.1	4.4	4.0	7.6	3.1	9.7	2.5	7.6	22.2	6.1	8.4	20.1	8.1	9.1	6.4	10.6	9.1	6.8	7.6	8.5	4.0	5.8	11.2	14.4	7.5	4.8	28.0	6.5	6.6	10.1	8.0	10.5	11.4	17.2	15.9	23.8	9.6	4.2	5.0	14.1	48.1	11.1	2.7	6.8	4.7	14.9	3.0	3.2	7.0	23.0	11.7	4.3	6.0	4.0	4.6	4.5	8.6	10.6	10.1	6.3	9.8	10.7	8.0	11.1	8.6	4.2	27.9	17.8	9.8	6.5	10.0	23.9	17.9	15.2	11.3	1.6	12.4	1.3	3.2	2.7	1.4	7.6	4.0	3.9	1.9	46.7	2.1	13.3	1.8	4.4	4.0	7.9	13.1	4.7	8.8	8.0	5.8	10.8	5.5	11.1	11.1	26.8	15.4	19.9	36.3	52.4	17.0	19.0	17.8	16.0	27.3	14.0	17.7	11.1	6.6	16.3	165.1	28.5	21.5	0.0	14.0	13.5	23.3	45.2	45.3	15.7	19.4	12.7	29.6	28.8	52.8	300.7	12.4	74.4	20.3	39.7	16.5	10.6	22.1	14.0	13.4	9.8	11.9	32.3	23.6	21.8	17.9	50.7	33.2	13.8	9.3	37.3
SPTBN2	SCA5	ENSG00000173898	"Spectrin beta, non-erythrocytic 2"	O15020	11	66685248-66729226	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.7;skin 1: 36.9"	"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 82.0;Cone photoreceptor cells: 98.2;Late spermatids: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 20.3;NTERA-2: 23.5;SCLC-21H: 23.9;SK-BR-3: 16.7;T-47d: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009844, HPA039293, HPA043529"	Enhanced		Approved	"Plasma membrane,Cell Junctions"		NA	NA		4800000	"Plasma membrane"	"Cell Junctions"	"CAB009844: AB_2194521, HPA039293: AB_2676430, HPA043529: AB_2678531"	"unprognostic (9.34e-2)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.41e-3)"	"unprognostic (4.91e-1)"	"unprognostic (6.05e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.67e-2)"	"prognostic unfavorable (3.14e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.00e-3)"	0.8	4.9	26.2	1.0	38.3	1.7	4.5	29.6	46.7	9.6	0.9	2.0	0.0	1.0	1.1	1.2	12.7	2.6	1.2	0.7	19.7	8.2	12.7	7.1	0.9	0.5	6.5	24.7	0.8	8.3	12.2	3.9	0.7	14.4	6.8	0.7	1.7	13.4	3.1	0.7	36.9	0.9	1.2	1.9	0.9	1.2	18.9	6.2	0.0	0.5	0.1	3.3	1.1	3.6	0.1	0.0	0.4	0.0	0.0	0.0	0.0	6.5	3.4	1.6	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.2	8.1	0.0	1.8	0.0	0.3	7.8	11.9	1.1	0.0	0.0	4.7	0.0	20.3	1.1	0.3	3.3	0.3	0.1	5.5	0.0	3.5	1.9	2.9	2.4	3.3	0.0	0.0	12.8	2.6	1.5	23.5	9.2	10.5	10.9	1.3	6.7	4.5	1.1	23.9	14.1	6.6	16.7	1.5	1.3	19.1	0.9	0.6	0.0	4.2	0.6	5.2	0.3	1.2	7.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	26.2	38.3	29.6	46.7	19.7	8.2	6.5	24.7	14.4	6.2	3.0	0.6	0.0	1.7	3.3	7.4	1.6	2.5	1.4	2.3	82.0	98.2	0.8	0.0	2.4	24.4	0.6	0.0	0.0	8.7	0.3	0.5	3.1	0.0	20.2	0.1	0.0	2.9	1.3	0.0	50.4	1.7	0.0	0.0	1.0	1.6	1.4	6.9	0.0	1.4	1.2	21.0	0.0	0.0	2.7	8.6	10.9	0.2	0.0	0.6	1.4
PRMT3	HRMT1L3	ENSG00000185238	"Protein arginine methyltransferase 3"	O60678	11	20387530-20509294	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007832, CAB022083"	Uncertain					NA	NA					"CAB022083: , HPA007832: AB_1855721"	"unprognostic (2.08e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.57e-2)"	"unprognostic (8.97e-2)"	"prognostic unfavorable (2.81e-5)"	"unprognostic (2.01e-1)"	"unprognostic (9.92e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (3.17e-5)"	"unprognostic (9.15e-2)"	"unprognostic (7.22e-2)"	"unprognostic (8.86e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.11e-2)"	10.5	14.6	11.3	15.2	13.0	10.4	11.5	7.4	14.7	10.7	9.0	14.2	6.5	12.3	12.6	8.5	13.5	12.9	9.0	15.1	9.6	7.9	8.6	10.6	7.0	12.6	15.9	11.0	12.0	12.7	16.7	9.6	9.1	13.2	8.6	8.9	7.2	10.2	9.7	21.3	10.5	9.5	10.5	13.4	9.3	10.8	10.3	13.6	14.5	28.4	15.2	11.8	12.3	10.3	8.9	13.7	6.9	9.5	14.0	11.5	5.7	12.2	13.9	8.5	7.6	3.0	7.4	18.8	8.5	5.9	11.3	7.7	11.6	3.1	25.2	6.9	5.9	10.0	16.1	10.3	9.6	11.3	12.9	13.6	13.1	12.0	6.5	9.9	21.1	5.7	7.3	10.6	6.8	23.3	3.9	8.0	9.1	28.1	5.7	3.8	10.6	17.0	4.2	12.8	18.5	13.2	12.5	21.5	18.8	7.0	7.6	8.5	11.8	15.6	12.3	10.0	8.2	12.6	4.7	5.7	8.9	8.3	14.6	14.6	4.4	4.6	26.7	7.1	14.2	17.7	5.5	8.1	6.9	7.3	9.5	11.5	8.2	8.1	7.6	13.7	8.9	10.4	8.1	2.2	14.0	7.9	3.4	5.3	5.7	11.3	13.0	7.4	13.1	9.6	7.9	15.9	11.0	13.2	13.6	8.9	3.2	6.9	6.2	5.4	4.3	11.7	2.5	5.3	4.5	0.0	2.0	9.8	8.3	4.5	1.7	5.6	2.9	0.0	4.5	9.1	6.0	3.5	5.7	3.9	5.9	6.4	7.5	1.8	3.7	0.4	6.1	6.1	3.3	5.4	7.6	4.8	4.2	0.0	6.0	5.6	6.7	0.0	6.2	11.7	9.4	5.1	6.1	2.9	8.1	4.3
GJB4	CX30.3	ENSG00000189433	"Gap junction protein beta 4"	Q9NTQ9	1	34759741-34763724	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 11.1;skin 1: 26.2"	"Cell type enriched"	"Detected in some"	4	"Urothelial cells: 91.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.7;HaCaT: 9.9;HBEC3-KT: 6.4;hTCEpi: 4.2;OE19: 3.7;RPTEC TERT1: 3.9;RT4: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055112, HPA073904"	Enhanced		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA055112: AB_2682699, HPA073904: "	"unprognostic (3.30e-2)"	"prognostic favorable (5.48e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.65e-1)"	"prognostic unfavorable (3.24e-5)"	"unprognostic (3.73e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.52e-4)"	"unprognostic (5.42e-2)"	0.1	0.1	0.1	1.2	0.1	0.0	1.5	0.1	0.1	1.7	0.3	0.0	2.9	0.0	0.1	11.1	2.9	0.1	8.3	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	3.4	0.0	2.0	0.2	0.0	0.8	2.0	0.1	26.2	0.3	1.2	0.1	0.1	0.2	0.7	0.0	0.1	0.1	1.6	2.4	3.2	6.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	6.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	1.0	0.0	0.1	9.9	0.0	6.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	3.9	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	22.7	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	6.5	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	21.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.2	0.0	0.0	91.2
ZNF185	SCELL	ENSG00000147394	"Zinc finger protein 185 with LIM domain"	O15231	X	152914442-152973480	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 93.5;esophagus: 67.6"	"Cell type enhanced"	"Detected in many"	10	"Pancreatic endocrine cells: 42.4;Suprabasal keratinocytes: 18.4;Urothelial cells: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 21.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 21.6;monocytes: 13.9"	"Cell line enhanced"	"Detected in many"		"A-431: 31.7;EFO-21: 37.7;HBEC3-KT: 26.2;PC-3: 23.2;TIME: 61.8"					"Low region specificity"	"Detected in all"			"HPA000400, HPA016438"	Enhanced		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol"		NA	NA		5400	"Plasma membrane, Cytosol"	"Actin filaments, Focal adhesion sites"	"HPA000400: AB_1080685, HPA016438: AB_1859109"	"unprognostic (1.34e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.75e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (7.94e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (3.30e-5)"	"unprognostic (5.18e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	3.9	1.7	1.8	2.0	3.2	0.8	1.8	2.7	2.0	14.3	1.8	1.4	10.7	0.0	3.8	93.5	67.6	3.1	2.0	1.9	1.7	0.8	2.0	1.1	3.3	3.1	2.1	1.1	1.2	0.9	0.1	2.3	4.0	1.7	4.2	0.3	1.3	10.1	28.1	1.5	9.9	1.2	1.4	1.2	3.7	0.8	1.9	2.0	1.2	3.9	1.4	6.6	2.1	22.8	0.4	3.8	21.6	13.9	0.2	0.6	10.2	31.7	6.7	0.6	0.4	0.8	1.1	1.5	1.5	0.1	3.9	0.5	0.2	9.6	0.4	37.7	2.3	0.4	4.5	0.9	26.2	16.3	0.3	0.6	2.0	2.7	1.0	1.9	0.1	0.1	0.8	18.8	0.4	15.4	3.9	20.2	0.4	0.1	0.3	0.1	7.5	0.1	0.1	0.5	8.1	23.2	0.1	0.1	0.2	2.0	3.0	0.2	2.2	0.0	6.0	0.9	6.5	6.2	0.7	61.8	0.2	13.7	0.8	1.1	0.3	0.2	0.2	0.4	2.3	0.4	21.6	13.9	5.7	0.5	12.9	0.3	0.4	0.4	0.6	3.8	0.3	0.6	0.3	9.5	0.2	10.2	2.5	0.5	10.2	1.8	3.2	2.7	2.0	1.7	0.8	2.1	1.1	1.7	2.0	11.9	1.6	0.5	4.9	8.1	0.5	1.0	2.5	2.7	4.5	8.7	2.0	3.2	0.0	8.6	0.2	0.5	0.0	0.0	2.6	4.3	2.8	5.1	1.1	0.0	8.6	0.0	0.0	0.6	8.8	0.0	1.1	4.6	3.3	4.6	2.1	3.0	42.4	0.0	1.1	0.9	0.0	0.0	0.5	2.3	5.3	18.4	0.6	0.0	3.3	17.6
TMOD3	UTMOD	ENSG00000138594	"Tropomodulin 3"	Q9NYL9	15	51829628-51947295	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Alveolar cells type 1: 369.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001849	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		21000000	Cytosol	"Actin filaments"	"HPA001849: AB_1080313"	"unprognostic (6.31e-2)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (3.19e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (3.38e-5)"	"unprognostic (7.06e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.58e-3)"	23.0	9.6	7.3	14.2	9.7	7.7	14.1	7.5	7.7	16.4	16.0	4.6	32.4	13.3	13.4	11.8	53.1	12.0	12.0	10.5	7.7	6.3	16.6	14.6	25.4	10.3	8.1	4.2	12.7	9.3	8.0	9.2	20.2	8.5	11.0	13.9	6.9	20.8	21.4	5.9	15.4	21.7	11.1	8.7	20.5	14.4	6.6	8.0	19.6	11.4	21.9	22.7	16.5	27.2	14.4	17.6	28.3	21.9	10.7	15.1	9.4	23.6	23.7	9.6	2.5	9.5	16.0	10.9	11.0	15.1	11.5	10.4	9.1	18.0	5.8	9.0	11.7	8.2	34.8	8.8	24.8	14.8	9.6	3.9	8.5	26.2	7.4	10.7	10.9	9.4	10.7	24.2	9.3	28.9	14.3	20.3	8.4	9.0	8.8	13.9	17.5	7.2	7.3	5.3	15.1	3.9	8.7	11.4	14.9	18.8	16.3	2.3	6.3	18.4	12.4	6.6	13.5	8.4	8.8	22.1	14.8	9.8	11.9	12.7	5.3	15.5	6.4	9.5	20.0	8.7	22.7	17.7	24.0	14.8	20.9	13.1	12.0	12.8	12.9	12.4	14.4	11.1	10.3	28.3	10.7	21.9	17.6	15.1	9.4	7.3	9.7	7.5	7.7	7.7	6.3	8.1	4.2	8.5	8.0	369.2	56.9	24.7	56.4	94.9	9.3	43.7	30.6	88.3	134.2	40.1	13.7	46.5	34.9	68.2	29.3	115.0	73.8	23.3	62.5	56.4	63.7	135.6	137.6	46.1	47.0	14.3	17.9	73.1	47.6	83.9	41.7	68.9	30.4	56.9	46.7	16.4	111.6	56.1	41.8	38.7	12.9	12.9	48.2	11.7	11.4	115.6	42.9	50.7	44.2	216.2
KNSTRN	"C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1"	ENSG00000128944	"Kinetochore localized astrin/SPAG5 binding protein"	Q9Y448	15	40382721-40394246	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 26.2;lymphoid tissue: 18.4;testis: 40.1;thyroid gland: 59.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 321.9;Late spermatids: 423.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA042027	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		Yes	Yes			"Mitotic spindle, Centriolar satellite"	"Plasma membrane"	"HPA042027: AB_10797378"	"unprognostic (2.35e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.23e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.43e-5)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (7.88e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.52e-2)"	5.5	4.4	6.7	5.5	6.3	7.3	9.0	8.1	7.0	3.3	4.5	4.0	8.0	5.3	3.9	7.8	6.2	3.4	2.5	4.1	6.0	5.3	4.2	7.0	4.1	8.0	4.6	7.1	3.4	3.5	6.0	4.2	7.4	6.8	4.4	6.3	2.5	6.4	5.0	7.5	4.2	4.1	5.9	4.3	4.8	6.2	40.1	4.5	18.4	59.8	6.0	9.1	3.8	3.7	5.9	11.0	10.0	26.2	5.5	5.5	4.0	31.2	14.7	29.4	19.2	6.5	10.1	15.3	21.7	16.9	44.9	39.7	31.5	13.8	12.1	11.1	14.6	35.8	36.2	31.3	20.1	40.7	21.5	15.3	35.9	33.0	19.8	6.1	19.2	18.8	5.2	11.6	22.6	22.7	11.0	25.1	30.5	25.8	21.0	37.7	15.8	16.6	15.5	18.5	26.8	22.4	17.1	22.1	14.0	15.6	13.0	28.7	19.9	18.1	20.0	4.8	18.6	20.9	13.8	12.9	21.7	22.2	22.1	30.0	18.0	29.1	21.8	13.4	25.8	17.7	4.8	10.3	10.0	4.8	14.5	4.4	5.9	3.6	4.4	11.0	5.4	3.5	3.6	5.9	5.5	26.2	7.5	5.5	4.0	6.7	6.3	8.1	7.0	6.0	5.3	4.6	7.1	6.8	4.5	8.9	0.6	0.8	3.1	1.9	7.8	4.7	2.5	9.4	5.7	0.0	7.9	14.3	3.3	9.5	321.9	1.7	1.6	46.7	8.1	35.4	6.2	3.8	1.1	5.7	18.4	4.8	2.4	3.1	7.5	423.6	8.3	7.6	3.3	8.2	3.6	7.0	8.7	0.0	6.7	4.4	7.4	0.0	2.7	83.7	18.1	1.3	17.6	3.2	3.0	2.8
KIF23	"KNSL5, MKLP-1, MKLP1"	ENSG00000137807	"Kinesin family member 23"	Q02241	15	69414246-69448427	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.8;testis: 20.4"	"Cell type enhanced"	"Detected in many"	12	"Extravillous trophoblasts: 31.4;Spermatocytes: 47.9;Spermatogonia: 18.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"eosinophil: 7.7"	"Group enriched"	"Detected in many"	12	"granulocytes: 7.7;monocytes: 2.2;T-cells: 2.1"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB010414, HPA045208, HPA068831"	Uncertain		Enhanced	"Nucleoplasm,Midbody ring,Mitotic spindle"		Yes	Yes			Nucleoplasm	"Midbody ring, Mitotic spindle"	"CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045"	"unprognostic (1.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.86e-1)"	"unprognostic (7.99e-3)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (1.43e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (5.85e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	1.8	2.6	1.8	12.7	1.3	16.3	3.2	0.3	0.9	2.2	3.3	0.3	1.4	3.5	3.3	1.2	8.8	1.8	2.4	2.2	0.7	0.5	4.9	0.8	2.5	6.7	0.9	0.5	1.6	0.9	0.0	0.3	10.8	1.3	1.9	4.3	0.6	2.1	0.9	0.3	3.0	3.9	3.4	1.4	4.5	3.1	20.4	0.2	41.8	0.6	6.3	8.8	1.8	3.3	0.3	0.1	7.7	2.2	0.1	2.1	0.6	25.2	22.0	16.3	15.6	1.0	1.9	9.9	27.7	15.0	40.2	31.3	13.3	19.8	14.8	8.4	14.3	21.4	29.2	33.6	10.3	40.9	13.7	15.7	13.9	20.6	8.2	0.6	14.3	12.9	0.9	1.1	19.2	16.2	5.1	13.6	12.0	9.2	18.5	25.2	11.1	8.0	7.7	20.2	9.4	8.8	9.1	36.3	8.2	10.6	13.1	8.3	6.9	32.2	14.2	12.1	21.4	13.5	6.5	8.8	24.3	32.4	16.8	40.7	7.2	19.5	13.3	8.6	19.3	21.4	0.0	2.2	7.7	0.0	1.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.1	1.0	0.1	2.1	0.6	1.8	1.3	0.3	0.9	0.7	0.5	0.9	0.5	1.3	0.2	0.0	0.3	0.0	2.6	1.6	0.2	0.8	7.6	1.4	6.8	7.0	2.0	5.9	3.3	1.8	6.3	0.1	1.1	0.0	0.0	31.4	3.1	0.5	2.3	0.0	6.8	0.0	1.7	6.2	3.2	3.2	0.9	2.9	0.0	10.0	2.2	0.1	0.4	0.0	1.8	0.5	0.0	6.5	2.3	47.9	18.3	0.9	2.1	0.8	2.3	1.0
HMMR	"CD168, RHAMM"	ENSG00000072571	"Hyaluronan mediated motility receptor"	O75330	5	163460203-163491945	"CD markers, FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 54.5;testis: 16.7"	"Cell type enhanced"	"Detected in many"	21	"Early spermatids: 60.3;Erythroid cells: 256.9;Extravillous trophoblasts: 50.4;Spermatocytes: 80.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002433, HPA040025, HPA043926, HPA061524"	Enhanced		Enhanced	Microtubules,Centrosome,Cytosol		Yes	Yes			Microtubules	"Centrosome, Cytosol"	"CAB002433: AB_564080, HPA040025: AB_2676805, HPA043926: , HPA061524: AB_2684551"	"unprognostic (3.53e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.38e-3)"	"unprognostic (8.88e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (5.52e-4)"	"prognostic unfavorable (1.93e-7)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (5.68e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (1.02e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.65e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.77e-2)"	1.6	1.4	0.6	13.4	0.6	11.4	2.4	0.4	0.9	1.7	5.0	0.6	0.6	4.5	0.6	2.3	6.4	0.5	0.9	1.6	0.8	0.7	1.4	1.8	2.5	10.9	1.0	0.4	0.6	1.1	0.6	0.5	6.9	1.1	0.7	5.6	0.4	1.6	0.2	1.4	2.3	4.8	1.4	1.9	8.6	2.6	16.7	0.3	54.5	0.7	5.6	10.8	1.8	2.1	1.2	1.8	0.6	0.7	1.5	4.8	0.8	21.1	13.3	27.2	14.5	1.4	2.7	20.3	20.1	9.8	25.2	22.9	27.0	40.9	35.2	19.2	6.2	34.4	24.5	31.4	19.1	43.1	31.9	9.7	21.0	9.5	13.2	0.4	18.6	19.4	0.7	1.1	23.7	18.6	4.2	14.3	24.2	19.9	28.8	26.2	7.7	19.6	10.6	23.4	14.2	14.6	21.4	36.4	17.6	9.8	5.7	22.7	12.6	29.9	9.4	11.4	13.5	27.7	15.0	9.3	18.1	15.4	14.5	26.9	15.5	25.9	28.4	12.0	28.9	17.4	0.5	0.7	0.0	0.5	0.3	0.9	1.2	1.0	0.6	0.9	0.9	0.4	0.7	0.6	1.5	0.0	1.8	4.8	0.8	0.6	0.6	0.4	0.9	0.8	0.7	1.0	0.4	1.1	0.3	0.0	0.6	15.5	0.8	2.3	0.6	1.7	7.6	4.0	4.5	0.0	0.0	5.1	0.0	0.6	60.3	0.1	1.3	256.9	0.2	50.4	2.4	0.8	0.0	1.7	17.7	0.0	1.2	3.1	3.5	44.1	2.0	4.3	0.0	3.6	1.6	0.0	0.1	0.0	0.7	2.4	0.7	6.5	0.0	80.6	18.5	1.3	3.8	1.0	4.2	0.9
TOP2A	TOP2	ENSG00000131747	"DNA topoisomerase II alpha"	P11388	17	40388516-40417950	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 146.3;testis: 36.8"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 280.4;Spermatocytes: 527.8;Spermatogonia: 241.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002448, HPA006458, HPA026773"	Enhanced	Approved	Supported	Nucleoplasm,Nucleoli		Yes	Yes			Nucleoplasm	Nucleoli	"CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.92e-6)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (6.21e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	2.7	2.0	0.4	20.0	0.5	14.6	4.1	0.4	0.5	3.0	6.9	0.5	0.5	7.0	2.0	3.4	18.2	0.7	2.4	2.3	0.6	0.5	1.4	1.9	5.5	15.4	0.6	0.4	1.2	1.1	0.0	0.4	10.7	0.6	1.2	8.0	0.6	3.2	0.3	0.6	5.9	9.2	2.6	1.8	7.3	4.5	36.8	0.3	146.3	0.9	11.8	16.7	3.2	5.7	1.3	0.3	0.3	0.3	3.2	5.7	1.1	34.3	45.6	58.1	26.6	2.9	5.9	12.9	47.1	25.4	43.4	38.5	21.4	26.3	55.4	24.0	15.9	26.0	54.7	44.6	18.8	58.3	29.5	29.8	36.6	29.2	35.6	0.2	51.2	39.0	1.3	1.5	30.5	31.1	9.4	22.8	36.1	39.5	38.0	46.8	11.9	59.3	34.4	24.1	24.9	18.2	50.4	90.2	23.0	10.4	22.0	34.3	24.7	38.0	47.5	15.0	35.3	39.8	23.6	14.9	28.6	40.4	33.0	45.2	21.8	24.6	48.3	16.1	35.3	47.7	0.3	0.0	0.0	0.6	0.0	0.0	1.3	0.9	0.9	0.3	0.4	0.2	0.1	0.3	3.2	0.3	0.0	5.7	1.1	0.4	0.5	0.4	0.5	0.6	0.5	0.6	0.4	0.6	0.3	0.0	1.3	28.7	1.4	10.4	0.0	1.1	2.5	0.0	6.8	0.0	0.0	8.4	0.0	0.9	12.5	0.7	2.1	280.4	0.0	81.4	9.7	1.2	0.0	3.9	64.5	0.0	0.0	27.6	30.0	15.2	4.4	13.1	1.7	2.8	5.9	0.0	0.2	3.6	1.8	0.0	0.0	71.1	1.4	527.8	241.9	5.4	7.4	7.7	24.2	2.6
PIK3CB	PIK3C1	ENSG00000051382	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"	P42338	3	138652699-138834938	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Autophagy, Cell adhesion, Endocytosis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 42.0;HMC-1: 66.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031938, HPA042288, HPA064207"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles,Midbody		Yes	No			Nucleoplasm	"Nucleoli, Vesicles, Midbody"	"CAB031938: AB_2165408, HPA042288: , HPA064207: AB_2685212"	"unprognostic (4.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.99e-5)"	"unprognostic (2.15e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.59e-2)"	12.5	9.9	10.6	9.7	20.6	17.4	11.5	29.9	25.0	12.4	14.6	11.9	11.7	13.7	9.6	6.9	15.2	10.9	8.7	12.7	12.2	14.2	22.6	9.3	9.5	9.1	11.9	15.2	8.8	20.3	20.2	10.9	18.1	24.1	13.4	15.7	12.2	14.9	15.9	33.4	19.6	16.4	8.3	12.5	9.9	11.0	6.4	10.7	14.4	37.4	7.1	11.9	13.4	11.0	4.6	9.1	11.3	7.8	1.3	6.5	2.6	23.0	10.0	4.3	3.6	3.9	5.3	29.3	5.4	5.2	5.5	5.9	10.7	8.8	9.3	14.8	5.3	10.6	9.9	5.6	8.6	9.9	11.8	6.3	42.0	6.8	6.4	4.0	10.2	66.6	4.5	6.6	3.8	7.8	9.8	8.3	4.5	16.0	6.9	6.9	10.6	5.9	7.2	6.2	17.0	9.4	4.3	4.5	6.6	8.5	12.8	3.7	2.7	15.0	6.5	19.3	13.2	16.3	24.4	8.7	3.5	4.5	7.7	7.6	11.7	7.6	8.5	8.6	9.9	4.9	7.0	7.8	11.3	4.0	4.5	2.7	4.6	5.2	3.0	9.1	4.1	6.5	4.4	10.0	1.3	4.3	1.4	2.2	2.6	10.6	20.6	29.9	25.0	12.2	14.2	11.9	15.2	24.1	10.7	8.9	14.7	4.7	12.9	16.9	15.4	30.2	12.7	14.7	21.6	17.4	23.6	29.1	5.0	9.4	0.9	8.5	21.3	0.0	16.5	46.3	6.5	23.0	13.9	15.8	13.4	20.6	15.6	11.6	28.8	1.1	3.4	19.7	6.8	14.4	14.9	8.2	15.2	21.8	6.3	18.9	17.9	6.5	6.1	10.7	14.9	20.5	40.0	6.1	12.7	15.3
SEMA3C	"SEMAE, SemE"	ENSG00000075223	"Semaphorin 3C"	Q99985	7	80742538-80922359	"Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 109.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"basophil: 25.8"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 25.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 49.5;hTERT-RPE1: 43.2;RT4: 45.2;T-47d: 51.2;U-2197: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042418			Approved	"Golgi apparatus,Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA			"Golgi apparatus, Cytosol"	"Plasma membrane"	"HPA042418: AB_10797389"	"unprognostic (1.93e-2)"	"unprognostic (2.54e-3)"	"unprognostic (4.94e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.74e-2)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (9.28e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-2)"	27.1	4.1	3.7	11.9	5.6	0.2	25.1	1.2	6.8	37.0	31.7	7.6	21.6	4.3	26.9	25.1	20.0	7.1	16.4	12.4	5.2	6.1	5.8	1.1	12.3	0.3	13.1	3.0	23.5	1.5	0.0	4.1	5.9	25.5	29.6	14.1	27.4	13.6	19.7	7.3	9.7	10.6	48.8	8.5	8.9	13.3	11.6	6.0	0.2	2.5	15.2	1.5	35.5	14.5	0.0	2.0	25.8	3.2	0.0	0.0	0.8	1.1	14.6	30.4	0.1	6.8	16.5	0.0	9.9	11.4	5.0	6.4	2.3	27.6	0.0	0.4	3.3	49.5	5.9	0.1	8.9	8.2	0.0	3.0	1.8	13.1	0.1	8.2	0.1	0.0	7.2	5.9	12.4	12.2	43.2	0.0	0.0	0.1	0.0	8.4	21.1	0.0	0.0	0.2	4.1	2.3	0.0	14.7	0.2	26.3	45.2	0.1	15.7	27.8	7.2	1.7	13.5	51.2	0.0	23.8	27.5	12.6	66.4	17.4	0.2	0.0	0.0	10.4	0.0	27.2	25.8	3.2	0.5	0.0	1.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.5	0.0	1.0	1.8	0.0	0.8	3.7	5.6	1.2	6.8	5.2	6.1	13.1	3.0	25.5	6.0	8.9	12.8	0.0	33.4	23.5	0.0	35.1	0.0	109.7	19.4	7.0	5.9	0.3	1.7	3.6	0.4	3.5	25.9	0.0	5.8	0.5	25.3	36.0	4.7	0.0	9.3	0.0	5.8	1.3	2.6	1.7	7.2	8.6	52.3	4.6	16.2	1.3	40.1	15.8	49.1	0.1	0.3	0.0	16.2	0.3	0.2	16.6	0.2	0.0	23.4	52.9
SMC4	"CAP-C, hCAP-C, SMC4L1"	ENSG00000113810	"Structural maintenance of chromosomes 4"	Q9NTJ3	3	160399274-160434962	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.2"	"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 332.4;Spermatogonia: 238.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029449, CAB055509"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	Yes			"Nuclear speckles, Cytosol"		"CAB055509: , HPA029449: AB_10603891"	"unprognostic (2.63e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (4.20e-5)"	"prognostic unfavorable (9.00e-4)"	"prognostic unfavorable (8.05e-7)"	"unprognostic (3.03e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.98e-2)"	4.8	5.5	3.0	25.4	4.4	15.1	4.0	3.1	3.2	5.3	10.1	1.7	5.3	6.5	5.2	4.9	19.3	4.6	7.0	5.7	2.4	1.7	4.4	6.3	7.9	16.5	3.1	1.3	4.7	4.2	1.7	10.8	7.4	2.6	4.4	6.9	2.7	5.7	6.9	5.9	4.6	7.0	6.2	3.1	13.1	5.7	20.7	3.2	70.2	5.1	7.6	14.3	7.8	6.3	8.8	6.1	30.5	7.6	7.8	15.8	4.8	63.3	11.7	26.7	12.3	5.1	5.2	12.3	31.6	14.9	36.6	31.7	14.8	36.5	40.1	18.5	13.0	24.3	36.6	30.3	15.3	58.8	53.1	21.1	38.8	20.1	4.7	2.8	25.7	31.8	2.6	2.2	19.3	15.8	13.3	15.5	17.1	22.3	46.7	21.8	11.4	31.5	6.4	15.7	15.7	27.6	32.0	41.9	29.1	6.8	7.9	16.1	16.7	24.1	22.3	11.0	13.1	26.8	19.2	14.6	23.4	19.6	21.3	57.6	31.2	31.8	73.2	16.8	26.4	25.9	30.5	3.2	12.1	6.7	4.7	6.5	8.8	10.5	8.0	3.5	7.2	6.7	6.0	5.7	7.8	7.6	6.1	15.8	4.8	3.0	4.4	3.1	3.2	2.4	1.7	3.1	1.3	2.6	3.2	98.3	146.6	24.2	16.6	36.2	14.2	31.9	22.9	32.1	44.3	33.2	7.9	29.7	3.3	18.2	26.7	45.6	21.1	116.8	12.6	126.9	41.4	11.7	76.3	15.6	51.1	0.0	28.9	39.3	26.0	21.5	23.3	45.4	16.9	37.9	24.6	9.8	11.3	20.1	45.3	6.2	24.1	129.4	30.3	332.4	238.9	31.1	28.5	48.4	46.6	17.6
AK4	"AK3, AK3L1"	ENSG00000162433	"Adenylate kinase 4"	P27144	1	65147549-65232145	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 89.7;liver: 50.7"	"Cell type enhanced"	"Detected in many"	15	"Hepatocytes: 223.0;Proximal tubular cells: 422.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 6.1;myeloid DC: 5.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.3;granulocytes: 1.6;monocytes: 6.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 59.4"	"Low region specificity"	"Detected in all"							"HPA042753, HPA049461"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		18000	Mitochondria		"HPA042753: AB_2678146, HPA049461: AB_2680776"	"unprognostic (3.73e-2)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (2.25e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (1.16e-3)"	"unprognostic (3.89e-2)"	"unprognostic (4.03e-1)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (4.34e-5)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (4.36e-4)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (2.69e-1)"	"unprognostic (7.07e-2)"	"unprognostic (7.57e-2)"	12.4	1.6	11.7	3.7	11.2	2.7	13.4	12.0	9.9	4.0	9.5	4.0	4.7	2.7	3.9	4.4	12.3	4.2	8.6	26.0	9.3	7.1	89.7	50.7	1.6	1.4	6.3	9.1	5.8	1.8	8.2	2.6	4.5	7.2	8.9	7.7	4.4	9.4	7.3	2.2	14.0	3.5	13.6	8.1	1.2	7.8	6.0	5.0	0.4	1.9	5.7	3.2	12.4	7.4	0.5	5.3	1.6	6.1	0.6	0.5	1.4	20.6	1.4	1.6	7.0	15.6	14.9	3.5	3.5	4.4	7.6	21.2	31.0	2.5	11.1	9.2	5.4	9.5	13.4	5.5	26.1	30.6	9.3	6.3	10.8	7.0	59.4	0.7	8.3	1.3	8.2	14.7	7.4	21.9	12.6	0.2	3.5	13.4	0.2	11.6	8.8	0.3	0.3	7.2	0.3	12.4	0.0	12.1	2.0	11.2	0.9	6.1	4.5	6.2	0.4	4.9	8.0	8.7	3.7	1.2	12.7	10.9	0.9	5.9	11.7	5.2	0.6	20.5	3.1	0.7	1.6	6.1	0.0	0.2	1.4	0.4	0.5	0.2	0.5	5.3	0.4	0.2	0.2	1.0	0.6	0.2	0.8	0.1	1.4	11.7	11.2	12.0	9.9	9.3	7.1	6.3	9.1	7.2	5.0	0.0	0.3	4.9	19.8	44.2	14.7	91.5	61.1	5.3	6.8	29.6	2.0	1.2	48.0	16.1	1.6	17.5	13.5	0.0	11.0	13.9	10.3	33.2	0.0	223.0	3.3	15.9	5.2	5.5	5.6	4.2	3.7	2.7	23.6	7.2	6.7	27.4	22.8	3.5	8.9	422.4	6.2	6.5	27.4	2.1	5.1	65.0	4.1	1.0	22.9	16.6
SLC2A1	"CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR"	ENSG00000117394	"Solute carrier family 2 member 1"	P11166	1	42925375-42959176	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Cancer-related genes, Cataract, Disease mutation, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 194.0"	"Cell type enhanced"	"Detected in many"	20	"Cytotrophoblasts: 686.5;Extravillous trophoblasts: 412.9;Syncytiotrophoblasts: 2076.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 44.8;CACO-2: 72.7;Hep G2: 49.6"	"Low region specificity"	"Detected in all"							"CAB002759, HPA031345, HPA058494"	Enhanced	Supported	Enhanced	"Plasma membrane"		No	No		36000000	"Plasma membrane"		"CAB002759: , HPA031345: AB_2673835, HPA058494: AB_2683734"	"unprognostic (3.60e-2)"	"unprognostic (5.85e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (3.65e-8)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (1.11e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.05e-4)"	4.2	3.7	12.4	3.9	16.9	45.2	4.1	6.7	15.5	15.2	4.8	15.1	4.3	2.4	7.6	3.4	28.8	8.5	8.6	5.0	15.4	13.7	7.6	2.1	2.4	5.3	18.2	5.0	3.4	3.7	7.3	2.9	194.0	15.5	5.2	3.3	44.2	8.4	7.9	1.8	42.1	2.9	2.5	17.8	3.4	5.5	2.5	12.5	1.8	4.0	11.5	12.0	22.2	24.5	8.4	14.7	1.3	0.2	3.0	7.5	2.7	10.7	15.6	12.8	3.2	1.5	0.5	44.8	7.1	15.4	8.8	12.9	72.7	30.1	4.1	21.2	2.1	6.2	10.1	2.8	16.5	3.9	2.4	2.6	6.7	9.0	49.6	4.5	3.6	1.9	1.9	12.7	5.5	5.9	26.0	1.4	3.5	15.0	0.9	3.9	19.2	1.7	2.5	8.2	5.3	3.9	1.6	4.1	5.7	8.0	5.2	6.8	4.8	8.3	26.3	3.1	19.2	1.1	4.6	3.2	8.0	5.8	1.4	16.0	0.7	1.5	2.5	15.8	2.6	6.5	0.3	0.2	1.3	7.5	0.2	6.9	8.4	4.1	5.1	2.9	7.3	3.2	4.7	1.0	3.0	0.1	14.7	4.7	2.7	12.4	16.9	6.7	15.5	15.4	13.7	18.2	5.0	15.5	12.5	0.0	2.6	23.8	35.5	254.3	8.1	23.0	25.5	28.1	9.1	26.2	62.8	686.5	5.0	47.8	4.0	9.9	16.8	303.7	10.3	412.9	42.1	25.5	5.8	1.3	74.8	4.8	17.6	0.6	1.3	0.0	7.2	3.2	20.3	61.3	13.7	394.9	72.4	18.7	13.8	1.6	31.1	0.0	20.2	0.0	1.7	208.3	2076.2	17.3	9.0	98.7
SHCBP1	"FLJ22009, PAL"	ENSG00000171241	"SHC binding and spindle associated 1"	Q8NEM2	16	46580554-46621626	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.9;lymphoid tissue: 22.9;testis: 14.1"	"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 24.1;Spermatocytes: 27.0;Spermatogonia: 30.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA048876	Uncertain		Approved	"Nuclear bodies,Microtubules,Midbody,Mitotic spindle"		Yes	Yes			"Nuclear bodies"	"Microtubules, Midbody, Mitotic spindle"	"HPA048876: AB_2680542"	"unprognostic (2.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.96e-4)"	"unprognostic (2.26e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.47e-5)"	"unprognostic (4.81e-2)"	"unprognostic (2.22e-16)"	"unprognostic (3.59e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.66e-1)"	1.5	0.8	1.0	17.3	3.0	18.9	0.9	2.4	1.3	0.8	2.2	0.6	0.3	1.3	1.5	2.0	5.7	0.4	1.1	1.5	1.0	0.7	5.0	0.3	1.7	11.2	0.7	0.7	1.2	0.3	0.2	0.8	2.8	0.7	0.9	2.5	0.3	2.6	0.3	1.4	3.8	2.3	1.9	1.1	9.9	1.4	14.1	0.9	22.9	0.6	3.0	12.9	2.0	1.6	4.6	2.0	1.8	5.4	0.3	3.4	2.1	15.3	16.4	6.2	7.5	1.3	3.2	8.6	31.4	12.4	30.7	14.3	7.8	10.1	13.5	14.2	14.3	12.4	10.2	13.6	10.2	38.0	8.6	9.1	14.8	12.4	13.2	0.0	13.0	18.9	0.6	0.6	22.5	9.2	3.0	16.0	7.1	6.1	14.3	33.3	10.2	11.6	10.8	4.8	7.2	17.5	21.2	41.6	21.6	6.3	4.8	2.6	3.4	21.7	11.5	4.9	5.6	6.3	10.7	9.2	22.5	14.6	21.7	24.9	11.3	14.9	21.6	10.3	14.0	22.6	0.3	0.8	1.8	0.5	1.3	0.1	4.6	0.8	0.4	1.2	1.9	0.1	0.3	0.8	0.3	5.4	2.0	3.4	2.1	1.0	3.0	2.4	1.3	1.0	0.7	0.7	0.7	0.7	0.9	0.0	1.4	0.0	0.5	1.4	0.2	1.4	2.5	0.0	2.3	0.0	0.0	3.1	0.0	0.3	6.4	0.3	0.4	0.0	0.0	24.1	1.0	0.4	0.0	0.0	10.7	0.0	0.0	2.5	2.9	1.5	0.6	3.9	1.7	2.8	0.2	1.0	0.1	0.0	0.4	0.0	0.3	0.0	0.5	27.0	30.1	0.5	3.1	0.7	0.6	0.9
UHRF1	"FLJ21925, ICBP90, Np95, RNF106, TDRD22"	ENSG00000276043	"Ubiquitin like with PHD and ring finger domains 1"	Q96T88	19	4903080-4962154	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 75.6"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 5.8;Hofbauer cells: 7.5;Spermatogonia: 6.9"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 8.2;T-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 63.9;REH: 145.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA049408, HPA055446"	Enhanced		Supported	Nucleoplasm		No	Yes			Nucleoplasm		"HPA049408: AB_2756317, HPA055446: AB_2732597"	"unprognostic (3.83e-2)"	"unprognostic (6.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (6.81e-4)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (4.52e-5)"	"unprognostic (2.33e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	0.7	0.0	0.7	8.2	3.7	16.5	0.7	0.3	4.2	0.3	1.5	1.6	0.0	2.1	0.3	0.2	2.0	0.0	1.0	0.9	1.2		0.1	0.1	0.3	10.0	4.3	0.7	0.3	0.6	0.0	0.0	1.0	1.4	0.0	1.4	0.0	0.0	0.0	0.3	1.9	2.2	0.8	0.7	2.2	1.9	3.1	4.0	75.6	0.0	4.0	6.6	1.1	0.0	0.4	8.2	1.5	0.4	0.9	4.2	0.9	15.9	11.6	17.5	12.4	0.5	2.0	2.8	13.0	6.2	13.6	13.2	13.8	8.1	9.1	3.2	5.7	4.9	8.0	12.0	7.0	9.6	14.7	13.7	7.8	10.8	14.7	0.2	19.3	11.9	1.0	0.5	7.3	1.9	2.1	4.0	14.4	11.2	10.5	8.1	12.5	63.9	11.8	7.8	5.8	12.5	145.0	39.1	6.6	3.7	11.7	13.0	10.3	10.2	5.6	1.8	2.9	10.1	18.4	5.0	14.4	11.7	18.6	15.7	4.5	4.6	26.8	8.3	18.8	18.3	0.6	0.4	0.2	1.1	0.1	0.1	0.3	1.5	1.9	2.2	0.4	0.4	1.5	1.5	0.9	0.3	8.2	4.2	0.9											0.0	0.0	1.5	0.6	0.0	2.6	1.6	2.5	1.4	1.2	0.0	0.0	1.7	0.0	1.7	2.5	0.0	0.9	0.0	0.3	5.8	0.5	0.5	0.0	0.6	7.5	3.2	0.0	0.0	2.1	0.9	0.6	0.7	0.0	2.8	1.5	0.5	2.6	1.9	0.4	0.0	0.8	0.0	1.5	4.2	6.9	0.0	1.1	0.0	4.7	0.7
RAC1	"p21-Rac1, Rac-1, TC-25"	ENSG00000136238	"Rac family small GTPase 1"	P63000	7	6374523-6403977	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035994, HPA047820"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		44000000	"Nucleoplasm, Cytosol"	Nucleoli	"CAB035994: , HPA047820: AB_2680167"	"unprognostic (8.66e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.88e-3)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (1.74e-5)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.72e-3)"	45.2	35.0	71.0	28.4	64.0	24.4	46.5	42.1	93.0	48.7	58.9	75.5	22.5	51.6	48.7	49.5	93.4	47.2	40.0	48.4	73.8	59.8	47.8	42.9	45.6	38.3	76.7	60.9	45.1	29.2	51.0	25.2	55.8	54.9	40.5	64.0	37.2	43.3	48.9	57.4	58.6	49.8	57.3	88.2	35.0	49.7	28.1	47.1	41.3	40.9	42.8	50.7	52.2	54.0	11.0	32.0	49.1	31.9	7.3	11.8	10.7	75.1	34.1	35.3	38.3	41.9	53.5	21.1	42.4	52.1	56.6	57.7	33.5	71.1	21.2	27.5	59.1	58.6	53.6	37.6	51.4	72.5	9.9	31.2	21.3	27.6	24.1	50.4	19.2	17.4	35.6	46.0	40.7	45.7	43.1	49.8	21.0	38.0	16.8	60.9	54.8	10.5	45.2	63.2	38.3	40.9	18.7	35.9	31.1	72.7	47.7	26.8	45.1	29.9	109.6	34.0	42.1	61.8	57.8	52.2	37.2	56.0	45.5	48.9	12.8	14.0	20.0	34.3	36.7	70.4	7.6	31.9	16.4	7.2	22.2	4.5	11.0	8.1	9.2	32.0	11.0	9.8	6.5	49.1	7.3	22.1	18.2	11.8	10.7	71.0	64.0	42.1	93.0	73.8	59.8	76.7	60.9	54.9	47.1	137.0	112.5	192.8	745.4	829.8	84.3	183.1	481.6	92.3	104.6	338.5	23.6	691.3	454.3	121.1	58.5	522.9	706.2	303.7	149.3	914.8	466.9	1152.5	132.3	288.4	738.1	138.2	323.2	535.2	736.9	43.7	441.0	745.3	435.3	408.4	531.5	280.9	231.2	471.0	444.5	611.5	54.4	472.1	495.6	210.1	328.6	1004.1	707.0	194.1	436.1	1582.5
FGD6	"FLJ11183, ZFYVE24"	ENSG00000180263	"FYVE, RhoGEF and PH domain containing 6"	Q6ZV73	12	95076749-95217482	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Pancreatic endocrine cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 5.5"	"Group enriched"	"Detected in many"	6	"B-cells: 2.0;dendritic cells: 1.9;monocytes: 5.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 15.8;hTERT-HME1: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007974	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA007974: AB_1848520"	"unprognostic (1.28e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.06e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.70e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (4.62e-5)"	"prognostic unfavorable (9.83e-4)"	"prognostic unfavorable (5.46e-6)"	"unprognostic (1.01e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.92e-1)"	4.6	8.6	7.8	31.4	9.1	2.6	6.4	5.3	8.5	7.2	10.0	3.9	14.5	2.7	6.6	2.6	9.2	5.1	9.3	8.2	7.4	3.4	6.5	6.0	9.9	9.5	3.7	5.2	9.0	10.2	4.2	3.8	13.1	4.3	7.4	8.1	6.2	4.8	17.2	4.2	14.3	8.7	9.8	6.3	5.9	5.2	5.6	5.4	5.0	9.9	5.1	17.1	7.2	11.1	2.0	1.9	0.5	5.5	0.3	0.2	0.9	14.8	13.6	12.6	1.4	1.3	1.2	6.6	2.1	3.0	0.8	1.2	5.2	10.3	15.8	3.6	1.3	0.9	6.0	2.2	12.7	1.8	1.6	1.4	0.7	2.2	2.5	1.8	1.6	0.1	5.3	5.8	1.5	15.6	5.1	8.1	2.2	3.3	0.3	0.4	0.8	1.3	0.3	5.2	1.9	4.7	3.6	2.5	1.2	9.0	4.8	2.1	3.4	6.1	3.2	0.3	6.6	1.4	0.1	11.1	0.5	1.4	0.6	1.6	1.5	3.4	4.5	0.6	1.0	1.0	0.5	3.3	0.0	0.1	5.5	0.0	1.3	0.0	0.0	1.9	2.0	0.2	0.0	0.2	0.3	3.8	0.0	0.0	0.9	7.8	9.1	5.3	8.5	7.4	3.4	3.7	5.2	4.3	5.4	14.9	13.4	0.9	19.4	43.0	4.5	20.5	5.1	9.4	12.5	8.7	3.9	3.7	0.0	20.4	1.1	15.7	13.1	0.0	19.3	7.2	3.3	17.0	1.1	5.0	9.9	1.6	12.0	15.4	13.4	1.5	11.5	7.8	1.7	5.4	9.4	2.0	51.0	10.5	9.9	4.4	8.1	0.0	3.4	1.5	16.8	21.8	36.6	0.0	4.6	26.3
FAM83D	"C20orf129, CHICA, dJ616B8.3"	ENSG00000101447	"Family with sequence similarity 83 member D"	Q9H4H8	20	38926312-38953106	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 39.0;smooth muscle: 69.8"	"Cell type enhanced"	"Detected in many"	22	"Erythroid cells: 23.3;Extravillous trophoblasts: 36.2;Syncytiotrophoblasts: 127.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 1.6;NK-cells: 2.4;T-cells: 4.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049333, HPA060854"			Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	Yes			"Mitotic spindle"	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA049333: AB_2680717, HPA060854: "	"unprognostic (7.90e-3)"	"unprognostic (4.34e-2)"	"unprognostic (6.41e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (5.44e-6)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.73e-5)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.81e-14)"	"unprognostic (2.57e-3)"	"unprognostic (5.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.87e-2)"	0.5	0.5	0.5	4.9	0.8	7.9	0.7	0.4	1.2	1.7	29.6	0.4	0.7	3.4	0.8	1.5	39.0	0.2	5.6	1.5	0.5	0.1	2.2	1.4	2.6	1.5	0.3	0.5	0.7	0.2	0.0	0.3	2.2	0.7	7.6	3.6	1.2	3.1	1.0	0.4	4.1	16.2	69.8	0.4	1.0	22.8	3.8	0.2	9.2	0.5	8.6	17.9	24.5	6.4	1.6	0.1	0.0	0.4	2.4	4.6	1.2	31.5	19.5	15.4	12.9	1.7	2.0	27.7	14.2	8.9	28.2	17.3	29.8	14.5	8.0	14.1	9.3	21.9	27.2	21.1	24.4	26.5	2.6	8.3	9.3	15.0	21.4	1.4	4.1	4.9	1.0	1.2	16.2	9.4	3.4	15.4	3.6	8.2	11.6	16.0	17.0	6.3	6.0	12.8	18.4	24.9	6.1	28.5	4.4	8.1	8.1	7.1	11.9	41.5	34.7	6.1	15.0	21.7	4.2	7.3	18.7	23.0	21.2	31.3	3.5	5.4	8.3	8.4	6.1	13.7	0.0	0.0	0.0	0.7	0.4	2.3	1.6	2.4	2.7	0.1	1.6	2.7	3.4	0.0	2.4	0.1	0.0	4.6	1.2	0.5	0.8	0.4	1.2	0.5	0.1	0.3	0.5	0.7	0.2	0.0	2.2	0.0	5.2	2.1	0.0	0.8	0.0	1.4	1.2	0.0	0.0	2.6	0.0	0.0	0.4	0.5	2.6	23.3	0.0	36.2	0.9	0.7	0.0	5.4	4.0	0.0	1.7	1.8	2.1	0.6	0.3	0.4	0.0	0.0	2.2	0.0	0.1	3.7	0.0	4.3	0.0	19.4	2.1	11.1	14.5	1.6	127.6	2.2	2.5	4.3
BFAR	"BAR, RNF47"	ENSG00000103429	"Bifunctional apoptosis regulator"	Q9NZS9	16	14632815-14669236	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (1.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.88e-3)"	"unprognostic (2.81e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (3.22e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.51e-2)"	26.5	17.4	11.8	17.0	14.2	16.3	22.4	18.2	14.0	20.5	27.9	18.1	15.8	22.8	26.9	15.9	15.4	15.2	18.7	18.1	12.4	12.7	24.0	19.7	28.2	26.2	12.9	10.3	21.1	46.5	18.4	17.6	23.4	16.8	18.8	23.0	22.7	21.9	15.1	34.2	13.2	23.6	19.5	16.0	22.0	19.6	19.1	12.5	25.8	26.2	15.2	20.9	26.4	16.7	13.5	11.4	11.1	12.1	9.5	18.0	8.9	11.4	12.9	13.3	14.1	15.4	21.2	10.5	17.5	21.6	16.6	17.9	7.8	18.5	16.8	30.0	21.3	15.5	14.6	21.1	17.6	20.4	10.5	11.3	10.9	12.0	24.2	22.2	16.5	13.7	23.5	21.0	16.1	21.2	18.3	26.9	11.7	15.9	15.0	19.4	14.3	11.6	13.4	24.9	11.2	7.6	19.7	17.1	17.5	18.5	12.1	14.7	15.7	18.2	13.7	39.4	13.8	12.8	13.3	23.1	22.8	11.0	11.9	13.7	17.5	19.4	17.7	15.0	15.4	16.8	9.3	10.3	11.1	13.9	12.1	15.9	13.5	13.8	16.7	11.4	10.9	13.8	13.8	7.3	9.5	10.9	9.4	18.0	8.9	11.8	14.2	18.2	14.0	12.4	12.7	12.9	10.3	16.8	12.5	41.7	44.7	38.6	33.1	34.9	32.5	17.3	30.6	21.4	30.7	22.7	35.3	38.5	26.6	44.7	6.9	38.7	31.6	23.3	80.9	59.4	33.9	18.1	46.2	20.2	34.7	23.8	31.7	44.8	36.5	5.7	27.9	39.4	18.6	40.5	46.4	25.4	51.8	38.4	25.1	34.7	33.7	25.8	19.6	28.1	37.5	17.2	36.8	45.0	31.2	32.3
MASTL	"FLJ14813, Gwl, THC2"	ENSG00000120539	"Microtubule associated serine/threonine kinase like"	Q96GX5	10	27154824-27186924	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027175, HPA054273"	Approved		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA027175: AB_1853591, HPA054273: AB_2682433"	"unprognostic (4.10e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (2.19e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (4.81e-5)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (1.71e-6)"	"unprognostic (1.55e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.79e-1)"	9.1	7.0	3.6	8.9	6.1	21.1	8.3	4.0	7.5	7.4	7.6	3.8	5.7	5.7	6.0	6.7	12.3	5.4	5.3	5.6	6.8	4.5	6.5	7.1	10.2	14.8	5.4	5.7	7.0	12.7	6.7	6.3	14.2	6.7	5.5	7.1	5.6	8.0	4.7	4.0	10.1	10.0	6.1	5.6	8.7	6.2	11.3	2.3	21.1	6.5	4.3	12.3	8.7	7.5	3.9	2.6	5.6	4.9	2.3	4.0	1.8	11.9	9.6	18.4	6.8	2.8	4.2	10.9	17.9	7.5	29.7	36.6	11.6	12.0	9.6	6.8	7.5	14.4	11.6	11.7	7.1	21.1	8.1	11.3	11.3	6.7	6.7	1.6	4.3	8.5	2.5	3.2	17.9	3.5	3.9	6.4	7.8	8.6	21.6	18.0	7.9	14.0	4.7	13.7	6.7	3.9	9.0	30.7	7.9	7.3	4.5	8.2	11.8	11.3	7.6	7.9	12.7	7.6	9.1	5.5	7.4	15.6	18.9	15.7	2.6	4.2	14.1	8.1	13.1	6.1	0.1	4.4	3.8	2.0	4.3	3.0	2.6	2.5	1.8	2.5	3.9	2.5	2.3	5.6	2.3	4.9	2.6	4.0	1.8	3.6	6.1	4.0	7.5	6.8	4.5	5.4	5.7	6.7	2.3	6.0	8.5	7.2	4.0	9.7	1.9	1.6	0.0	4.0	9.1	1.8	0.0	3.3	0.0	3.2	1.7	3.6	3.0	0.0	2.2	20.7	5.8	3.3	12.7	1.7	5.1	3.2	4.1	2.5	12.0	1.5	2.8	5.6	0.0	1.8	3.4	1.5	3.6	1.9	2.5	1.4	0.9	0.0	5.9	11.2	16.4	8.7	5.1	8.7	3.5	5.9
DSG2	CDHF5	ENSG00000046604	"Desmoglein 2"	Q14126	18	31498043-31549008	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 70.7"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 208.8;Mucus-secreting cells: 176.4;Pancreatic endocrine cells: 177.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	7	"pons and medulla: 6.9"	"Cell type enriched"	"Detected in single"	10	"basophil: 9.5"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 9.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 36.3;HaCaT: 56.6;HBEC3-KT: 42.0;hTERT-HME1: 45.7;OE19: 47.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA004896, CAB025122"	Enhanced		Supported	"Cell Junctions"		NA	NA		94000000	"Cell Junctions"		"CAB025122: , HPA004896: AB_1078643"	"unprognostic (1.56e-3)"	"prognostic unfavorable (8.22e-4)"	"prognostic favorable (7.81e-4)"	"unprognostic (8.77e-3)"	"unprognostic (3.53e-4)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (2.86e-3)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (4.94e-5)"	"unprognostic (3.40e-1)"	"prognostic favorable (3.14e-10)"	"unprognostic (1.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.72e-1)"	"unprognostic (8.57e-3)"	17.3	1.1	0.6	11.6	0.7	0.0	21.1	0.7	0.7	3.9	50.2	1.3	4.0	18.1	3.8	5.6	6.3	4.9	14.2	15.7	0.7	0.6	22.4	10.8	7.0	2.4	0.6	0.9	8.8	15.5	39.9	2.7	39.8	6.9	10.4	23.8	4.5	27.3	1.5	2.2	5.3	70.7	3.1	0.5	0.6	17.3	2.3	0.5	13.6	20.8	3.2	5.8	18.5	7.7	0.1	0.9	9.5	0.0	0.0	0.3	0.0	24.2	9.4	0.8	0.0	0.1	1.5	30.5	0.0	0.0	0.0	0.0	6.5	36.3	0.0	13.8	0.0	11.6	56.6	11.5	42.0	0.0	0.0	7.1	0.0	10.8	7.3	4.4	3.0	0.0	2.1	29.2	0.9	45.7	22.0	0.0	7.2	9.6	0.0	0.0	6.4	6.4	0.4	11.7	47.1	4.8	10.8	0.0	15.5	14.1	12.1	5.1	0.0	18.4	13.1	0.0	26.3	9.3	2.6	0.0	0.0	5.4	0.0	6.0	1.2	0.0	0.0	4.3	0.0	5.3	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.6	0.7	0.7	0.7	0.7	0.6	0.6	0.9	6.9	0.5	50.6	38.4	0.5	64.3	11.9	0.2	51.1	89.2	42.8	50.0	12.2	0.0	70.4	3.3	82.4	0.6	8.7	208.8	23.3	65.2	91.9	9.5	96.7	4.6	22.1	9.0	1.6	76.9	2.5	1.5	1.6	1.4	1.8	16.9	10.8	176.4	4.2	177.3	149.7	0.4	10.0	0.2	0.0	9.5	3.0	8.1	5.3	50.1	1.3	168.5	163.4
TOB1	"APRO5, TOB, TROB, TROB1"	ENSG00000141232	"Transducer of ERBB2, 1"	P50616	17	50862223-50867978	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047839	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA047839: AB_2680175"	"unprognostic (3.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (5.04e-5)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (3.92e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.13e-2)"	"unprognostic (6.97e-2)"	14.3	68.4	10.5	10.4	15.7	19.6	29.5	11.3	13.4	20.9	24.2	23.6	24.2	16.9	7.9	12.9	30.2	17.4	42.7	21.7	12.0	11.8	22.5	57.5	17.7	7.5	12.0	10.2	21.5	74.4	30.2	20.0	5.6	13.9	24.5	18.3	36.5	32.4	56.0	60.4	44.7	26.3	23.7	11.9	6.1	28.8	9.0	13.1	8.9	30.3	31.0	13.8	38.8	22.9	7.8	21.3	63.0	25.1	4.8	51.2	25.2	11.0	22.8	7.4	3.0	14.0	7.0	5.6	8.3	20.6	5.4	6.7	9.1	14.3	10.1	16.0	11.3	5.4	15.8	5.0	14.1	5.7	5.0	7.3	1.2	26.7	15.0	19.5	5.1	5.0	14.9	17.5	6.2	32.3	7.3	2.6	3.1	4.1	8.9	11.4	30.1	4.0	4.9	2.6	27.8	8.7	3.5	9.4	12.0	21.4	23.0	4.3	10.6	14.1	42.1	4.9	11.9	66.4	6.9	3.4	6.3	4.4	6.9	3.9	13.6	14.2	4.7	5.1	2.6	2.4	63.0	10.5	49.9	46.6	18.6	51.2	7.8	43.4	36.4	21.3	6.2	38.4	46.2	23.6	4.8	25.1	6.9	35.9	25.2	10.5	15.7	11.3	13.4	12.0	11.8	12.0	10.2	13.9	13.1	107.2	101.9	31.7	161.4	251.6	130.0	101.0	127.4	71.0	51.2	64.6	53.0	14.5	87.9	38.8	73.3	29.2	99.6	23.3	47.3	1.2	76.4	113.9	61.3	179.4	31.5	17.5	195.2	33.2	33.0	32.8	24.5	54.0	67.4	26.2	199.4	88.3	38.3	178.0	56.3	51.2	56.2	161.7	81.2	43.1	8.3	201.7	9.2	75.9	142.2	265.3
PKM	"OIP3, PK3, PKM2, THBP1"	ENSG00000067225	"Pyruvate kinase M1/2"	P14618	15	72199029-72231822	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Translation regulation"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 541.2"	"Cell type enhanced"	"Detected in all"	5	"monocytes: 1878.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019421, HPA029501"	Uncertain		Enhanced	Cytosol		No	No		540000000	Cytosol		"CAB019421: AB_2252325, HPA029501: AB_10602118"	"unprognostic (8.73e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (1.30e-4)"	"prognostic unfavorable (2.74e-6)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (5.17e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-2)"	23.2	76.8	53.8	49.8	70.4	57.5	41.6	56.6	85.9	65.7	31.2	32.1	31.5	26.4	24.7	41.8	76.4	37.9	32.9	94.8	50.1	57.1	60.9	6.1	33.3	39.4	62.5	63.6	26.2	15.6	33.3	28.3	27.1	80.5	34.8	31.9	54.4	47.1	47.5	541.2	51.8	25.1	44.7	34.9	30.7	26.7	29.0	29.4	23.5	23.8	114.4	60.6	53.1	40.9	25.1	79.6	14.9	90.6	11.6	37.4	114.9	81.9	210.9	42.5	50.3	51.2	57.5	35.1	88.9	207.7	142.9	144.6	59.3	101.0	62.4	90.0	166.4	106.4	119.5	134.4	181.0	112.0	109.5	63.5	38.2	106.1	49.1	35.6	49.5	82.5	52.2	84.3	110.0	45.2	185.5	84.1	32.1	9.5	50.1	225.2	50.9	18.5	21.3	52.6	125.8	80.5	55.0	136.1	118.9	189.6	105.5	44.2	48.3	116.0	71.6	90.9	74.7	50.2	36.1	65.4	162.8	89.0	159.0	161.3	64.4	90.9	55.0	200.4	82.0	159.4	12.6	90.6	14.9	23.5	52.6	22.8	25.1	31.3	23.2	79.6	16.1	27.3	20.2	11.8	11.6	40.2	16.2	37.4	114.9	53.8	70.4	56.6	85.9	50.1	57.1	62.5	63.6	80.5	29.4	110.2	78.1	134.8	464.1	502.3	450.3	279.7	94.3	129.8	157.0	786.9	347.5	523.8	679.8	1147.1	307.8	224.6	361.4	70.0	528.2	1096.0	273.6	329.6	203.1	2.0	698.2	1005.9	270.8	71.2	307.3	1333.1	145.6	439.7	337.4	1878.3	130.3	624.4	887.7	231.5	252.1	165.5	510.0	122.9	245.6	32.6	84.3	340.0	481.5	163.0	247.6	730.1
PDCD10	"CCM3, TFAR15"	ENSG00000114209	"Programmed cell death 10"	Q9BUL8	3	167683298-167734939	"Disease related genes, Predicted intracellular proteins"	"Angiogenesis, Apoptosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027095	Approved					NA	NA		680000			"HPA027095: AB_1855101"	"unprognostic (3.39e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (9.34e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.89e-4)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (4.98e-3)"	"unprognostic (2.41e-2)"	"unprognostic (9.95e-3)"	"prognostic unfavorable (5.22e-5)"	"unprognostic (3.08e-2)"	"prognostic favorable (5.88e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.14e-1)"	"unprognostic (5.58e-2)"	29.1	24.9	22.4	24.8	29.6	35.5	28.5	23.6	33.1	24.1	33.4	17.7	12.7	32.3	22.6	20.6	42.3	19.1	20.2	23.3	23.5	24.0	45.3	27.4	24.6	32.1	31.3	19.6	24.3	20.7	18.1	34.9	44.8	34.0	22.1	33.5	14.6	27.0	18.4	16.9	20.7	45.0	20.5	35.3	35.8	26.6	27.9	25.8	38.4	30.1	27.3	33.7	31.1	25.8	40.2	24.0	57.6	38.9	30.7	53.1	38.3	36.1	13.7	17.5	11.2	16.5	18.3	19.3	21.9	23.3	25.7	26.0	25.5	43.0	29.6	43.2	20.3	44.9	24.1	20.5	25.4	31.2	46.9	14.9	45.1	18.2	16.7	23.5	29.7	26.6	13.9	26.5	16.2	26.7	18.5	20.6	24.9	34.8	29.8	23.2	31.9	23.7	18.4	22.5	32.8	19.1	14.0	13.3	43.0	32.1	14.8	16.8	15.0	21.0	22.9	40.3	23.0	42.2	25.5	19.6	18.3	11.8	19.6	31.1	32.4	45.4	51.0	21.7	31.5	14.9	53.9	25.7	57.6	27.0	31.9	32.2	40.2	36.8	32.3	24.0	38.7	30.9	31.8	53.7	30.7	38.9	22.1	53.1	38.3	22.4	29.6	23.6	33.1	23.5	24.0	31.3	19.6	34.0	25.8	41.7	32.3	53.3	71.3	96.0	20.2	66.6	33.1	69.6	67.1	31.4	5.9	95.8	89.5	94.1	39.6	59.9	63.0	23.3	107.3	94.2	49.1	73.3	61.2	36.4	81.7	19.1	33.3	40.5	50.3	20.3	46.1	74.1	47.2	107.4	66.6	42.2	96.2	77.2	37.1	84.8	23.0	32.3	59.0	110.0	100.9	112.8	86.2	65.4	43.1	105.0
HRASLS2	FLJ20556	ENSG00000133328	"HRAS like suppressor 2"	Q9NWW9	11	63552770-63563383	"Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 16.1;intestine: 42.5"	"Group enriched"	"Detected in many"	6	"Basal glandular cells: 19.5;Ciliated cells: 45.5;Enterocytes: 59.0;Proximal tubular cells: 75.2;Urothelial cells: 43.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 16.1;naive B-cell: 5.3"	"Lineage enriched"	"Detected in many"	12	"B-cells: 16.1"	"Cell line enriched"	"Detected in some"	8	"U-266/70: 54.4"									HPA058997	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA058997: AB_2683874"	"unprognostic (4.76e-2)"	"prognostic favorable (6.87e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.69e-2)"	"unprognostic (3.91e-3)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.57e-2)"	0.4	0.0	0.4	1.5	0.4	0.0	4.7	0.4	0.4	0.6	20.6	0.5	0.4	33.4	0.6	1.1	0.5	2.1	0.4	1.0	0.4	0.2	5.5	1.9	3.3	1.1	0.4	0.4	0.4	0.4	0.0	0.4	1.4	0.4	0.4	6.5	0.4	0.7	0.4	0.4	0.2	42.5	0.4	0.4	0.7	8.8	0.4	0.4	0.4	0.4	0.4	0.5	0.4	0.4	16.1	0.8	0.1	0.1	1.2	0.9	3.6	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	6.4	0.0	0.4	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.1	0.0	3.5	0.8	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	54.4	6.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.9	16.1	0.2	0.9	0.0	5.3	0.2	0.6	0.1	1.2	0.0	0.8	0.0	3.6	0.4	0.4	0.4	0.4	0.4	0.2	0.4	0.4	0.4	0.4	3.0	0.6	3.0	19.5	0.1	0.0	0.3	5.1	45.5	5.7	0.0	0.0	0.1	8.3	0.4	0.3	0.0	59.0	0.0	0.4	0.3	0.0	6.2	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.7	7.0	0.0	75.2	0.0	0.0	0.0	0.7	0.1	0.0	0.7	1.0	0.9	43.6
QSER1	FLJ21924	ENSG00000060749	"Glutamine and serine rich 1"	Q2KHR3	11	32893178-32993316	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005682	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA005682: AB_1855985"	"unprognostic (2.94e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (7.94e-5)"	"unprognostic (1.14e-1)"	"unprognostic (4.75e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (1.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.96e-2)"	10.8	8.3	13.6	9.1	11.3	8.3	22.0	21.3	14.9	13.1	8.7	9.8	9.5	5.4	13.8	13.1	15.9	11.2	8.9	10.0	12.5	7.1	9.3	9.5	9.1	8.2	13.1	10.9	21.4	15.6	16.5	11.4	9.0	11.5	11.5	9.2	10.9	16.7	9.7	9.8	20.1	7.9	10.4	11.5	10.1	9.3	14.2	12.8	14.2	14.2	14.0	10.1	11.8	24.8	2.0	2.2	0.3	2.4	1.7	1.1	0.4	11.4	14.2	16.6	15.3	6.5	12.6	8.0	10.0	9.0	7.3	9.0	12.3	5.4	12.0	6.5	12.1	12.2	14.9	15.2	9.0	15.6	5.1	9.8	11.2	13.7	10.2	4.9	13.5	6.1	6.1	9.6	9.3	15.1	8.9	10.0	7.0	17.1	5.4	11.4	10.2	6.5	5.4	17.6	7.1	8.7	10.8	32.8	5.0	7.5	12.6	8.7	12.4	18.9	10.1	6.3	12.8	10.4	7.1	9.8	17.8	17.9	31.9	21.4	3.7	5.0	12.6	11.5	6.4	11.4	0.0	1.2	0.3	1.1	2.4	0.5	2.0	0.7	1.0	1.1	0.9	0.6	0.7	0.0	1.7	0.6	2.2	0.2	0.4	13.6	11.3	21.3	14.9	12.5	7.1	13.1	10.9	11.5	12.8	17.9	12.0	7.3	8.6	24.7	16.5	26.8	12.7	13.4	19.4	7.0	13.7	10.6	3.3	8.1	11.1	13.5	4.2	0.0	10.3	10.6	16.9	9.2	3.5	9.0	12.2	9.5	0.0	13.5	16.4	7.6	22.7	13.3	15.1	1.8	11.0	11.8	10.0	11.6	19.8	6.9	14.1	6.5	12.0	19.7	19.1	24.1	3.5	4.3	10.4	11.1
WASL	"N-WASP, NWASP, WASPB"	ENSG00000106299	"Wiskott-Aldrich syndrome like"	O00401	7	123681935-123749067	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 212.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 45.1;U-2197: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005399, HPA005750"	Supported		Approved	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"CAB005399: AB_2288632, HPA005750: AB_1854729"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.30e-5)"	"unprognostic (7.32e-2)"	"prognostic favorable (4.51e-8)"	"unprognostic (9.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (5.14e-1)"	17.9	19.3	25.6	11.6	29.5	3.8	20.7	21.0	39.3	23.7	31.2	17.0	8.9	27.4	21.0	14.6	22.5	14.8	21.7	15.4	35.2	22.5	33.3	34.5	15.3	5.5	18.8	23.0	27.8	21.9	36.7	16.9	25.4	28.6	19.9	28.8	18.0	16.9	19.5	21.6	14.4	30.2	18.2	16.6	12.1	22.0	17.3	15.0	10.0	26.7	12.0	9.7	23.7	21.1	4.6	4.5	4.9	6.2	6.2	4.3	1.5	10.9	8.1	8.9	7.6	14.1	14.6	11.6	7.6	12.8	5.6	7.3	6.6	13.9	1.1	6.1	11.5	12.1	8.3	16.5	8.4	8.8	1.9	6.6	0.9	6.7	7.1	15.3	1.4	0.9	11.7	15.8	8.3	14.3	12.8	9.7	1.1	4.8	2.1	13.4	6.6	1.8	1.9	16.7	11.7	7.4	1.1	7.2	2.4	11.9	45.1	11.0	16.2	10.5	31.6	20.5	14.5	6.1	1.4	11.0	15.2	4.3	42.8	7.4	2.4	0.8	2.4	13.1	1.2	12.1	4.9	4.1	1.8	4.3	4.1	3.6	4.6	2.8	2.6	3.5	3.2	3.6	3.8	1.8	6.2	6.2	4.5	1.4	1.5	25.6	29.5	21.0	39.3	35.2	22.5	18.8	23.0	28.6	15.0	80.4	46.6	7.8	37.8	53.7	27.6	63.7	61.1	45.5	51.2	50.6	19.6	36.7	44.7	43.5	16.7	34.6	105.1	0.0	46.9	46.1	45.8	67.4	3.5	49.7	11.1	25.4	65.3	56.4	14.8	6.2	44.5	13.4	28.7	14.4	96.1	57.1	59.0	118.1	60.8	80.1	28.9	19.4	43.2	15.5	19.8	59.7	68.0	7.5	56.6	212.0
PLEKHA5	"FLJ10667, KIAA1686, PEPP2"	ENSG00000052126	"Pleckstrin homology domain containing A5"	Q9HAU0	12	19129752-19376400	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 290.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 14.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.2;NTERA-2: 27.8;SuSa: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035923, HPA035924, HPA041455"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA035923: AB_10673491, HPA035924: AB_10672994, HPA041455: AB_2677490"	"unprognostic (3.16e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.85e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (5.41e-5)"	"unprognostic (3.71e-1)"	"prognostic unfavorable (7.42e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.07e-2)"	7.7	52.3	13.8	7.8	22.0	2.9	11.9	13.0	22.4	23.5	9.8	7.2	19.4	10.0	23.1	25.7	16.0	16.0	16.7	25.2	11.2	11.5	32.2	12.1	9.9	2.4	10.7	16.3	26.1	11.3	27.2	14.4	10.2	15.0	17.6	10.8	22.2	11.4	22.7	2.0	13.2	10.0	23.1	23.7	2.8	13.7	14.8	13.0	6.1	11.5	5.9	4.3	18.1	18.1	0.4	2.7	14.8	0.4	1.7	6.4	0.4	10.7	5.3	19.4	0.2	6.6	8.9	6.9	4.6	10.0	2.8	4.4	7.9	9.7	0.2	1.5	5.1	5.7	4.6	13.0	8.5	5.9	27.2	4.6	6.4	11.8	3.8	6.2	0.2	0.9	5.2	9.0	8.0	15.3	15.4	3.0	5.5	2.7	0.4	2.9	3.3	4.1	0.8	27.8	8.7	2.8	0.1	9.0	0.1	19.6	12.7	1.8	4.0	4.4	2.6	16.4	27.5	3.2	1.5	4.5	1.8	7.7	0.4	0.2	0.3	0.2	0.2	4.2	0.1	3.5	14.8	0.4	0.3	2.7	0.3	6.4	0.2	2.5	2.3	1.8	0.4	0.4	1.9	1.0	1.7	0.2	2.7	2.1	0.4	13.8	22.0	13.0	22.4	11.2	11.5	10.7	16.3	15.0	13.0	23.8	23.3	2.7	42.8	18.2	89.3	123.9	50.9	72.3	50.0	43.6	129.6	22.7	29.9	26.9	20.2	15.5	24.5	0.0	28.7	34.1	41.5	27.0	3.5	36.2	5.8	119.2	31.2	16.5	8.6	11.8	37.4	12.0	111.3	290.4	12.7	99.2	39.4	30.6	26.5	85.1	145.1	32.3	27.2	41.2	47.8	22.5	22.1	10.7	33.8	41.1
PNPT1	"DFNB70, old-35, OLD35, PNPase"	ENSG00000138035	"Polyribonucleotide nucleotidyltransferase 1"	Q8TCS8	2	55634265-55693910	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, Transport"	"Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, RNA-binding, Transferase"	"Deafness, Disease mutation, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033424, HPA034602, HPA034603"	Supported		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"CAB033424: AB_2299801, HPA034602: AB_2674243, HPA034603: AB_10603130"	"unprognostic (9.09e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (1.95e-7)"	"unprognostic (1.88e-1)"	"unprognostic (5.93e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (2.19e-2)"	"unprognostic (2.11e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	11.1	11.7	13.3	6.5	21.7	11.7	10.8	13.3	18.8	5.7	8.2	12.8	5.4	5.7	8.3	8.8	9.5	7.9	5.8	11.0	12.4	10.9	9.8	11.4	9.1	7.1	24.1	7.4	6.9	9.1	7.4	14.3	5.1	15.2	7.7	10.1	4.2	9.0	6.3	23.5	10.1	7.0	7.9	17.6	10.4	7.6	13.5	22.5	9.6	10.0	7.8	5.9	5.3	7.4	9.8	7.4	6.1	6.5	3.8	8.6	4.7	6.8	3.7	5.1	2.3	3.6	6.4	6.8	10.2	6.2	16.2	10.9	10.7	3.2	14.3	4.3	4.7	5.2	5.5	6.5	7.9	7.5	5.1	14.4	8.3	4.7	5.4	9.7	18.6	5.6	7.1	5.5	6.7	5.8	3.9	4.9	6.0	8.7	3.2	6.4	3.9	11.3	13.1	12.3	7.2	6.2	11.3	8.5	12.6	6.8	4.3	12.4	7.4	3.6	11.3	12.4	4.7	3.0	8.3	5.1	3.8	3.2	3.4	10.4	14.5	1.1	3.1	7.4	16.3	6.5	4.2	6.5	6.1	8.1	5.7	4.8	5.4	3.7	8.6	2.8	9.8	6.9	7.9	6.1	3.8	5.1	7.4	2.4	4.7	13.3	21.7	13.3	18.8	12.4	10.9	24.1	7.4	15.2	22.5	44.7	72.6	7.5	15.0	21.5	40.4	23.8	12.7	46.8	69.4	19.2	55.0	17.7	8.3	14.2	15.0	19.3	7.4	0.0	13.8	18.9	14.2	10.3	54.6	14.7	13.8	28.6	9.8	12.9	11.1	1.9	16.1	15.2	15.1	9.0	12.3	27.5	11.7	14.1	17.3	16.7	61.4	25.8	18.4	39.0	20.0	17.7	10.3	17.3	16.4	14.2
ACTL6A	"Actl6, Arp4, BAF53A, INO80K"	ENSG00000136518	"Actin like 6A"	O96019	3	179562880-179588408	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 197.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012188, HPA018671, HPA063149"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB012188: AB_304125, HPA018671: AB_2669914, HPA063149: "	"unprognostic (2.13e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.24e-3)"	"unprognostic (7.79e-3)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.89e-5)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (4.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.21e-3)"	"unprognostic (5.20e-2)"	18.8	17.9	9.9	23.4	16.8	8.7	21.3	8.7	9.6	16.8	21.3	15.3	15.6	14.5	24.8	16.4	23.2	16.3	14.9	24.2	8.7	7.4	19.6	18.6	14.6	17.4	16.7	5.4	24.8	20.9	13.7	23.4	20.1	13.7	17.7	23.5	10.4	19.0	17.4	12.8	19.4	19.8	16.1	14.8	19.3	16.7	47.5	17.0	46.1	21.9	20.4	23.8	18.7	22.7	17.5	19.8	8.0	16.1	14.5	22.4	13.8	46.2	14.0	34.9	18.4	13.4	14.7	27.4	18.7	14.6	34.9	29.6	31.6	22.8	36.2	33.6	17.5	40.6	21.4	30.5	23.0	43.5	35.8	25.4	29.6	15.5	23.9	15.3	36.7	18.6	10.2	23.6	22.5	19.0	11.0	19.8	21.9	23.0	20.7	25.1	31.6	32.1	22.7	31.0	42.0	31.4	30.2	29.2	66.9	27.6	18.7	28.7	20.5	28.8	28.8	28.8	18.2	56.2	30.3	14.9	24.9	21.5	25.5	56.3	13.5	20.1	55.5	13.8	39.1	27.4	3.3	11.3	8.0	15.1	14.3	20.0	17.5	17.5	17.4	19.8	13.7	19.2	19.4	1.5	14.5	16.1	11.2	22.4	13.8	9.9	16.8	8.7	9.6	8.7	7.4	16.7	5.4	13.7	17.0	20.8	23.9	24.3	37.3	41.9	4.8	6.0	28.1	30.8	23.9	26.2	7.9	42.0	29.9	42.1	15.5	20.7	13.0	0.0	39.2	57.0	28.9	28.3	13.9	14.0	30.6	0.0	29.2	12.3	18.6	11.4	30.0	16.7	28.7	33.3	24.6	16.3	32.2	17.5	28.3	17.9	12.3	25.8	23.6	197.2	97.8	40.1	25.6	19.2	36.2	35.1
CD2AP	CMS	ENSG00000198087	"CD2 associated protein"	Q9Y5K6	6	47477789-47627263	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 12.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003267, HPA003326, CAB004352"	Enhanced		Supported	"Plasma membrane,Centriolar satellite,Cytosol"		NA	NA		160000	"Plasma membrane"	"Centriolar satellite, Cytosol"	"CAB004352: AB_627009, HPA003267: AB_1078458, HPA003326: AB_1078457"	"unprognostic (5.98e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (7.57e-5)"	15.2	9.9	5.3	18.0	7.6	6.6	11.9	13.6	6.1	13.2	23.5	6.2	19.0	31.0	13.2	12.9	20.1	8.0	14.7	7.3	4.9	5.3	31.3	19.2	17.3	8.0	5.8	4.0	9.9	19.3	24.0	14.4	17.2	7.3	15.0	20.9	6.6	17.5	19.4	8.7	13.0	31.9	9.5	7.7	17.0	22.3	8.7	6.4	55.1	13.3	13.3	13.8	16.9	15.5	1.3	12.2	3.7	0.7	3.8	2.4	0.7	20.6	8.2	2.6	5.3	3.6	5.2	20.5	5.1	6.2	6.9	8.8	13.5	14.7	26.8	21.4	6.6	9.0	7.8	8.5	12.7	11.3	10.7	13.7	14.8	6.9	12.0	4.8	8.2	5.7	3.7	12.0	6.6	9.6	13.4	11.1	9.0	25.9	8.6	6.2	6.5	15.7	3.1	7.6	25.1	3.0	8.4	6.6	12.2	43.5	37.0	7.8	3.0	10.2	13.7	9.9	12.2	13.0	5.3	13.2	13.9	11.7	4.4	14.3	6.5	10.9	19.2	14.9	4.5	7.1	1.9	0.7	3.7	1.5	0.5	2.4	1.2	1.4	1.5	1.5	1.3	1.3	2.0	0.1	3.8	0.4	12.2	1.1	0.7	5.3	7.6	13.6	6.1	4.9	5.3	5.8	4.0	7.3	6.4	89.3	52.6	27.4	48.2	28.6	9.7	13.7	22.9	75.0	93.3	68.0	15.7	42.2	18.3	68.4	7.7	43.2	159.3	23.3	85.1	12.7	11.4	76.4	23.1	21.5	15.6	14.3	53.6	31.3	20.7	8.4	15.5	17.8	13.5	11.8	79.7	12.1	114.0	81.8	10.3	48.5	13.3	25.8	18.6	22.2	31.1	35.9	34.2	20.0	51.8	104.3
PSCA		ENSG00000167653	"Prostate stem cell antigen"	O43653	8	142670308-142682724	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 72.6;stomach 1: 230.2;urinary bladder: 112.0"	"Cell type enhanced"	"Detected in many"	19	"Cholangiocytes: 124.9;Glandular cells: 317.3;Intestinal endocrine cells: 265.2;Urothelial cells: 540.7"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 785.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.6;HeLa: 22.6;OE19: 8.9;RT4: 32.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030783, HPA056418"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA030783: AB_2673611, HPA056418: AB_2683123"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.81e-3)"	"unprognostic (8.25e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (5.60e-5)"	"unprognostic (6.82e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-3)"	0.4	0.2	0.0	0.2	0.0	0.2	0.3	0.0	0.2	7.0	2.4	0.7	0.1	0.6	0.3	0.2	72.6	1.1	21.2	0.1	0.0	0.0	2.6	0.1	3.0	0.2	0.0	0.0	0.1	0.3	0.1	0.5	17.2	0.0	30.1	0.7	0.1	11.7	0.6	0.1	0.8	1.5	18.9	0.0	0.2	230.2	0.2	0.0	0.0	0.1	9.3	35.1	112.0	54.5	0.0	0.8	0.0	0.3	0.0	0.0	0.0	5.4	0.3	0.0	0.0	1.1	3.7	5.6	2.5	0.6	1.1	0.9	0.0	11.6	0.0	0.2	0.2	4.2	1.1	0.0	0.2	0.7	0.3	0.0	0.0	22.6	0.0	0.0	0.0	0.8	3.2	4.1	2.4	0.0	0.3	0.0	0.0	0.0	0.0	0.8	3.0	0.8	0.3	0.6	8.9	0.6	0.3	0.0	0.4	0.5	32.2	0.1	0.2	2.7	8.3	1.7	0.2	0.1	0.1	0.5	0.8	0.9	1.5	0.0	1.0	0.0	0.0	1.5	0.4	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.0	0.0	16.8	0.8	0.0	1.0	124.9	115.1	19.4	1.8	0.0	2.1	6.6	0.3	0.2	0.0	0.0	0.0	1.0	1.8	0.3	317.3	0.0	0.0	0.6	0.0	265.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.9	0.0	33.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	1.1	23.8	0.0	0.6	540.7
IQGAP1	"HUMORFA01, KIAA0051, p195, SAR1"	ENSG00000140575	"IQ motif containing GTPase activating protein 1"	P46940	15	90388218-90502243	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013302, HPA014055"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		890000	"Plasma membrane, Cell Junctions"		"CAB013302: AB_2533146, HPA014055: AB_1851856"	"unprognostic (2.83e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.25e-3)"	46.2	23.2	9.9	27.8	17.1	23.7	31.7	5.9	11.2	41.8	26.7	18.1	19.7	12.3	50.8	28.8	41.3	27.4	22.0	17.6	12.0	9.1	25.9	9.8	38.3	45.3	17.5	6.6	31.3	16.4	27.6	19.1	53.7	15.5	28.9	27.1	12.0	37.8	22.0	23.1	32.7	25.8	37.6	17.4	48.0	20.3	11.4	15.4	39.5	32.7	29.6	34.9	43.0	40.8	5.9	9.9	39.3	12.4	11.5	9.9	6.3	31.5	17.5	8.7	10.3	22.7	29.6	51.2	30.2	28.0	27.8	30.0	20.0	33.0	17.6	14.8	50.4	24.8	57.0	17.5	33.7	33.8	22.4	12.4	11.8	33.8	7.3	27.5	21.5	25.3	17.4	31.2	32.7	46.8	34.5	38.1	11.6	10.1	24.9	42.4	16.4	11.6	6.5	11.4	51.0	10.0	14.3	23.6	15.4	28.7	50.2	11.1	8.3	42.0	21.6	22.4	38.3	18.8	18.6	48.3	31.8	16.5	26.6	31.1	9.7	13.8	17.9	28.9	21.2	17.0	10.5	11.6	8.1	9.9	10.9	8.9	5.6	6.2	8.5	9.9	5.9	3.8	6.6	39.3	11.5	12.4	6.0	6.7	6.3	9.9	17.1	5.9	11.2	12.0	9.1	17.5	6.6	15.5	15.4	247.1	255.8	85.7	86.1	91.5	2.3	11.8	40.8	176.7	226.3	73.3	15.7	77.6	6.6	78.9	6.5	111.9	155.2	23.3	85.6	126.0	70.8	89.0	199.2	6.8	130.4	1.6	58.3	93.3	343.0	9.3	44.3	168.0	67.4	158.7	118.3	14.0	97.0	121.4	45.3	15.9	25.3	77.6	70.3	11.5	32.6	99.1	80.0	132.1	104.7	126.4
CMTM1	"CKLFH, CKLFH1a, CKLFSF1"	ENSG00000089505	"CKLF like MARVEL transmembrane domain containing 1"	Q8IZ96	16	66566393-66579137	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 80.7"	"Group enriched"	"Detected in some"	13	"Early spermatids: 60.6;Late spermatids: 113.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"granulocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"REH: 16.8"									"HPA013801, HPA017136"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA013801: AB_1846990, HPA017136: AB_1846992"	"unprognostic (2.37e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.97e-3)"	"unprognostic (5.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (2.47e-2)"	"unprognostic (1.56e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (3.49e-1)"	0.9	0.8	0.8	1.9	1.2	0.0	0.5	2.2	1.3	0.7	0.9	0.5	0.5	1.7	1.3	1.1	0.6	0.8	1.5	0.7	0.8	1.1	0.8	0.5	0.9	1.2	0.8	0.6	1.7	0.5	0.3	1.1	0.9	0.7	0.7	0.2	0.5	0.6	0.5	0.6	0.6	1.2	0.5	0.9	2.8	0.9	80.7	0.7	0.8	0.7	0.5	0.6	0.9	0.6	0.3	1.9	8.7	2.1	1.3	1.9	1.1	4.2	6.7	1.2	5.6	2.4	2.3	1.2	5.6	2.7	4.5	4.7	1.4	2.9	2.0	3.0	1.6	1.4	3.4	1.9	0.3	2.4	7.4	1.3	0.7	3.0	1.4	1.1	3.9	4.9	1.9	0.5	4.0	0.5	6.9	2.3	4.0	3.5	2.8	1.9	1.6	7.4	3.8	1.0	0.6	2.5	16.8	14.4	4.6	4.0	2.0	3.2	4.3	7.8	0.6	2.0	0.2	2.0	2.8	5.7	8.0	12.7	4.8	2.4	2.8	6.7	7.3	3.8	5.3	9.3	8.7	2.1	7.1	1.9	0.6	1.6	0.2	0.6	0.9	1.9	0.3	0.5	0.6	8.4	1.3	1.2	0.5	0.6	1.1	0.8	1.2	2.2	1.0	0.8	1.1	0.8	0.6	0.7	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	113.2	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	6.5	0.0	4.8	0.4	0.3	0.1	0.0	0.0	0.0
GBP2		ENSG00000162645	"Guanylate binding protein 2"	P32456	1	89106132-89150456	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 23.9;HDLM-2: 26.3;RT4: 33.0"									"HPA042682, CAB045975"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB045975: AB_10584474, HPA042682: AB_2678113"	"prognostic favorable (7.57e-4)"	"unprognostic (2.92e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.75e-3)"	"prognostic unfavorable (5.73e-5)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (2.14e-10)"	"unprognostic (7.75e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.10e-5)"	40.1	39.4	4.7	24.4	14.3	8.9	31.9	2.3	11.0	38.2	35.7	3.3	9.5	11.0	29.0	20.6	39.0	17.5	18.5	12.6	4.6	4.1	21.6	17.9	42.8	21.3	14.3	2.9	35.5	4.9	39.8	5.9	17.3	12.2	48.7	13.8	12.4	14.2	15.4	20.1	19.5	39.6	48.1	26.7	27.5	20.2	13.0	6.0	7.7	22.0	18.2	15.3	63.1	40.3	3.1	8.5	78.9	44.2	20.1	61.2	22.2	6.1	0.5	0.0	0.0	17.7	15.4	4.6	1.6	15.9	2.6	6.1	0.1	9.7	0.0	23.9	10.6	12.0	1.2	0.0	0.2	1.4	26.3	0.0	0.1	4.5	1.3	4.7	0.7	1.1	16.1	0.1	3.9	0.0	8.9	18.0	0.0	0.3	1.0	7.3	0.0	0.0	5.8	0.0	5.6	0.4	0.1	6.8	0.0	5.0	33.0	0.0	0.2	7.8	2.2	0.2	0.5	0.2	1.0	12.2	2.0	0.4	2.8	1.7	19.1	0.0	0.0	6.1	0.1	0.3	12.2	20.5	6.6	24.6	31.2	32.6	3.1	26.3	27.1	8.5	2.7	18.0	18.9	78.9	20.1	44.2	0.5	61.2	22.2	4.7	14.3	2.3	11.0	4.6	4.1	14.3	2.9	12.2	6.0	23.8	30.1	5.9	100.6	41.3	0.1	2.8	28.1	24.1	17.0	17.4	0.0	26.1	0.0	75.3	22.8	54.8	48.0	23.3	62.4	50.9	30.1	66.0	44.1	22.2	33.3	0.0	9.8	22.1	68.8	22.5	4.4	82.4	8.5	45.9	9.7	0.6	67.5	28.1	8.1	7.7	0.0	19.4	69.6	0.7	2.1	54.1	48.3	77.8	8.6	78.8
INCENP	FLJ31633	ENSG00000149503	"Inner centromere protein"	Q9NQS7	11	62123973-62153163	"Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.1"	"Cell type enhanced"	"Detected in many"	4	"monocytes: 8.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 2.9;NK-cell: 4.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.9;NK-cells: 4.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013292, HPA051339, HPA070550"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Kinetochore,Midbody"		Yes	Yes			"Nuclear bodies, Kinetochore"	"Nucleoplasm, Midbody"	"CAB013292: AB_2533405, HPA051339: AB_2732566, HPA070550: AB_2686279"	"unprognostic (6.31e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.25e-4)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (4.37e-2)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (1.74e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.78e-3)"	5.1	5.0	6.9	9.2	8.2	23.8	7.7	19.3	13.6	6.9	6.5	5.7	2.8	9.5	5.7	11.7	22.2	5.3	4.7	4.1	5.9	5.0	3.9	3.8	5.0	14.1	6.9	7.9	5.3	5.4	6.0	3.1	5.7	6.9	4.2	5.3	4.9	10.6	4.6	6.7	9.8	7.5	4.9	5.1	7.5	6.4	12.3	6.4	36.1	8.5	8.5	13.2	5.9	8.6	0.2	0.0	2.9	0.3	4.0	0.5	0.0	27.0	25.9	19.7	16.8	2.6	3.2	10.5	17.0	7.4	15.9	10.2	13.6	18.4	25.1	14.1	5.8	17.6	26.6	19.5	10.3	12.5	22.3	13.5	16.4	25.5	11.1	1.0	18.8	23.4	1.6	2.3	15.3	8.9	2.6	9.5	18.3	17.3	21.0	8.7	22.0	30.3	15.4	21.2	10.5	12.7	28.4	24.8	18.9	4.5	13.6	15.0	16.3	17.1	11.1	10.5	8.2	17.4	6.8	10.6	15.7	20.1	22.4	18.1	11.2	17.2	28.2	8.7	12.4	18.8	2.9	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.5	0.2	4.0	0.1	0.0	0.0	0.0	6.9	8.2	19.3	13.6	5.9	5.0	6.9	7.9	6.9	6.4	3.0	2.9	2.2	0.8	4.9	1.9	0.9	0.0	4.0	5.7	0.0	0.0	1.6	0.0	1.7	0.8	0.8	1.3	0.0	2.1	6.0	0.8	1.0	3.5	0.9	3.5	0.0	0.0	0.0	0.8	0.2	2.6	2.5	3.3	8.2	2.0	2.3	1.7	1.5	1.4	0.3	2.2	0.0	0.4	6.9	5.8	2.9	1.8	2.5	1.7	1.0
DIRC2	"FLJ14784, RCC4"	ENSG00000138463	"Disrupted in renal carcinoma 2"	Q96SL1	3	122794795-122881139	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Syncytiotrophoblasts: 189.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072579			Supported	Vesicles		NA	NA			Vesicles		"HPA072579: AB_2686536"	"unprognostic (1.40e-1)"	"unprognostic (8.53e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (9.74e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.87e-1)"	"prognostic favorable (8.81e-11)"	"unprognostic (2.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.13e-2)"	7.6	7.8	6.5	4.0	7.7	7.9	6.8	5.2	8.8	5.0	6.2	10.0	4.4	3.0	4.2	6.1	8.8	5.0	5.9	9.9	6.4	6.3	7.5	9.2	8.0	6.9	7.5	4.5	4.9	12.9	18.4	7.6	34.8	6.7	7.8	6.9	11.9	7.7	6.0	27.0	9.7	6.1	6.7	7.8	5.8	5.9	4.2	3.8	3.1	8.0	11.2	7.4	7.4	5.4	0.6	0.3	4.2	0.8	0.0	0.5	0.1	5.6	4.7	4.7	2.6	6.1	5.0	15.7	2.4	5.3	3.9	4.0	11.1	6.4	0.8	3.1	2.7	8.8	8.3	3.4	4.4	3.8	1.2	2.5	0.9	2.6	4.7	4.5	0.5	0.6	4.1	12.0	2.8	4.8	6.1	4.4	1.6	0.5	1.0	5.0	2.5	0.7	0.6	4.2	1.9	7.8	1.5	10.6	1.2	5.6	6.6	4.9	3.8	7.1	3.3	6.3	3.1	3.8	1.2	6.2	6.1	2.3	3.7	2.0	1.1	0.9	0.3	3.1	1.0	3.3	0.0	0.7	0.1	0.5	0.8	0.0	0.1	0.0	0.0	0.3	0.6	0.5	0.3	4.2	0.0	0.7	0.0	0.1	0.1	6.5	7.7	5.2	8.8	6.4	6.3	7.5	4.5	6.7	3.8	11.9	5.9	2.7	17.9	9.4	4.8	11.8	7.6	6.7	7.9	14.0	3.9	38.7	1.7	19.4	2.9	3.9	4.4	0.0	22.2	50.7	5.1	13.3	2.3	3.9	11.3	1.6	14.3	4.3	12.7	1.0	3.1	12.2	8.5	21.6	5.6	20.3	18.6	6.8	4.2	5.7	5.4	6.5	3.8	4.7	4.1	10.2	189.5	1.8	4.7	14.5
ITGA3	"CD49c, GAP-B3, MSK18, VCA-2, VLA3a"	ENSG00000005884	"Integrin subunit alpha 3"	P26006	17	50055968-50090481	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 96.5;Exocrine glandular cells: 90.7;Pancreatic endocrine cells: 158.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.1"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 74.4;hTERT-RPE1: 68.2;RPTEC TERT1: 65.6;U-87 MG: 111.7;WM-115: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008572, CAB018594"	Enhanced		Supported	"Plasma membrane"		NA	NA		180000	"Plasma membrane"		"CAB018594: AB_668044, HPA008572: AB_2668094"	"unprognostic (3.24e-3)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (9.51e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.45e-3)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (8.28e-3)"	"unprognostic (2.76e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (5.95e-5)"	"unprognostic (7.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.35e-2)"	15.7	15.8	4.1	8.6	5.1	0.1	8.7	7.7	6.5	10.9	20.9	2.3	8.9	17.1	11.6	11.6	12.8	14.5	32.6	8.4	4.2	5.4	36.0	1.7	37.6	3.2	3.2	6.7	10.7	8.0	13.0	11.2	26.4	4.3	12.0	8.9	11.6	10.0	9.7	6.6	17.3	37.3	11.6	3.3	6.5	13.7	3.9	1.5	3.3	36.1	13.3	8.3	19.0	8.1	0.2	0.0	0.0	0.0	0.0	1.1	0.2	20.4	27.1	0.1	0.8	0.5	2.1	4.4	9.6	20.7	14.5	11.1	0.6	31.9	0.0	60.6	6.9	48.4	14.6	0.2	74.4	8.9	2.5	0.4	0.0	6.8	0.1	12.8	0.0	0.6	2.6	36.7	14.5	64.6	68.2	10.6	1.0	0.0	0.3	27.3	5.9	0.0	0.0	0.6	9.2	16.4	0.0	1.4	1.5	65.6	35.7	1.1	0.4	10.4	1.4	24.0	6.9	2.4	0.2	23.0	64.8	20.4	0.6	37.3	0.9	1.5	0.6	111.7	0.2	67.3	0.0	0.0	0.0	0.8	0.0	1.0	0.2	0.1	0.1	0.0	0.2	0.2	0.6	0.0	0.0	0.0	0.0	1.1	0.2	4.1	5.1	7.7	6.5	4.2	5.4	3.2	6.7	4.3	1.5	50.6	29.6	5.7	51.4	50.9	14.4	4.4	33.1	4.0	27.3	73.3	23.6	1.8	0.0	96.5	0.4	11.2	77.3	0.0	90.7	2.6	4.5	26.1	3.5	0.0	1.1	3.2	13.9	4.9	1.5	0.0	1.7	3.8	16.9	7.2	21.8	2.3	158.1	31.7	3.9	2.2	13.1	12.9	18.6	0.2	1.6	20.3	1.5	1.3	29.6	70.4
KCMF1	"DEBT91, DKFZP434L1021, PCMF, ZZZ1"	ENSG00000176407	"Potassium channel modulatory factor 1"	Q9P0J7	2	84971093-85059472	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030383, HPA030384"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA030383: AB_10599977, HPA030384: AB_10601230"	"unprognostic (8.01e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.95e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (2.33e-7)"	"unprognostic (5.68e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.81e-2)"	"prognostic unfavorable (6.10e-5)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (4.18e-6)"	"unprognostic (6.11e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.01e-1)"	19.2	13.3	17.9	20.2	16.0	23.6	26.1	13.4	18.6	15.0	20.2	10.7	20.3	15.4	16.3	18.8	28.5	12.8	17.9	30.4	16.5	12.0	14.8	20.7	16.4	18.8	13.7	11.1	17.2	48.6	14.7	18.7	20.5	14.4	17.5	21.4	14.0	19.4	15.7	67.2	17.6	20.6	25.7	10.3	16.7	16.8	29.0	11.5	19.7	18.7	21.8	22.5	23.9	34.0	4.0	4.2	8.1	3.4	2.8	8.8	1.5	27.6	21.7	19.4	14.9	20.5	19.9	33.1	29.6	27.5	28.4	19.0	26.5	29.9	30.1	29.8	40.1	28.4	18.4	15.1	28.6	37.6	22.5	10.5	19.2	16.4	27.0	40.2	21.1	18.3	20.5	45.3	27.8	77.2	25.4	21.4	16.3	19.0	24.0	28.4	25.5	20.3	11.7	21.2	35.2	18.3	14.7	27.3	18.8	25.7	24.3	18.7	14.0	17.2	22.0	28.7	23.3	10.2	13.5	18.2	29.1	28.3	27.1	30.7	27.4	33.8	30.5	21.9	15.6	21.7	5.0	2.6	8.1	4.5	2.2	3.6	3.5	3.2	3.4	2.2	4.0	2.8	3.1	7.5	2.8	3.4	4.2	8.8	1.5	17.9	16.0	13.4	18.6	16.5	12.0	13.7	11.1	14.4	11.5	29.8	28.2	27.9	82.6	63.0	31.1	41.6	20.4	10.7	25.0	12.2	13.7	22.2	21.6	33.1	65.6	24.8	41.1	23.3	45.9	22.3	26.3	94.5	17.3	29.8	18.4	68.3	18.5	25.8	25.1	87.4	23.9	22.8	25.3	23.4	27.6	31.3	46.8	35.9	27.3	28.6	27.5	25.8	36.8	31.0	29.4	69.1	34.1	19.1	28.1	106.5
CASK	"CAGH39, FGS4, LIN2, TNRC8"	ENSG00000147044	"Calcium/calmodulin dependent serine protein kinase"	O14936	X	41514934-41923645	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 26.3"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 26.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001949, HPA023857"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB001949: , HPA023857: AB_1846035"	"unprognostic (6.30e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (6.11e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.85e-2)"	9.1	15.9	13.9	18.8	12.7	9.8	13.2	14.2	15.7	11.1	22.1	20.0	7.1	27.1	12.2	13.7	17.2	9.9	16.0	7.0	12.1	12.8	14.6	10.8	10.3	13.6	16.3	8.5	13.9	14.2	11.1	9.8	13.4	11.9	10.7	23.8	10.4	15.9	7.7	5.8	12.8	32.9	12.1	10.1	9.6	16.2	2.9	14.3	30.9	9.3	8.1	14.0	11.8	13.1	0.6	0.3	26.3	0.8	2.4	2.3	0.3	10.9	14.0	13.4	8.0	9.1	7.4	4.3	9.6	8.0	5.6	5.2	30.1	17.9	0.1	4.9	11.9	10.2	22.0	14.7	9.8	9.4	9.7	8.2	0.0	12.6	10.6	9.4	1.7	1.5	8.4	26.9	10.7	13.7	11.3	4.6	6.4	0.8	8.5	12.2	12.8	3.1	0.7	12.3	15.8	9.1	5.1	33.0	5.2	12.7	23.8	12.3	6.5	18.0	7.2	5.5	22.6	7.7	0.3	5.3	10.5	10.7	9.0	5.3	3.3	2.1	3.7	10.3	1.2	6.7	26.3	0.8	4.8	0.5	0.7	0.5	0.4	0.6	0.8	0.2	0.6	0.7	0.7	1.1	2.4	0.4	0.3	2.3	0.3	13.9	12.7	14.2	14.2	12.1	12.8	16.3	8.5	11.9	14.3	11.9	14.8	0.9	33.3	29.0	40.5	6.5	10.2	20.1	14.8	7.0	21.6	1.6	43.1	13.2	0.8	10.8	22.7	0.0	12.7	0.7	17.5	19.6	0.0	13.0	16.2	47.7	13.3	4.9	3.5	0.2	9.2	6.8	10.1	0.0	30.6	11.9	17.9	28.1	8.9	17.0	26.0	19.4	14.4	1.6	1.9	28.4	1.4	12.5	36.5	26.9
SPRR3		ENSG00000163209	"Small proline rich protein 3"	Q9UBC9	1	153001747-153003856	"Cancer-related genes, Predicted intracellular proteins"	Keratinization		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 855.8;lymphoid tissue: 537.4;tongue: 389.6"	"Cell type enriched"	"Detected in some"	5	"Urothelial cells: 109.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 423.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.8;hTCEpi: 11.1;OE19: 4.2;RT4: 14.1;TIME: 4.0"									HPA044467	Enhanced					NA	NA		15000			"HPA044467: AB_2678952"		"unprognostic (2.78e-2)"	"unprognostic (3.54e-1)"	"unprognostic (8.77e-2)"		"unprognostic (7.50e-3)"		"unprognostic (9.67e-3)"	"unprognostic (2.36e-1)"		"prognostic unfavorable (6.27e-5)"			"unprognostic (9.70e-2)"	"unprognostic (4.66e-2)"		"unprognostic (1.58e-2)"	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	157.6	0.2	0.0	0.0	0.2	11.5	0.2	855.8	0.2	1.8	0.5	0.0	0.0	0.2	0.3	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.0	1.2	0.0	0.2	0.2	0.0	93.4	0.2	0.4	0.2	0.2	0.3	0.0	0.2	0.2	0.2	0.0	0.0	0.2	389.6	537.4	0.6	163.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	6.8	3.5	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.2	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.3	0.0	0.0	0.0	4.2	0.0	0.0	1.3	0.0	0.0	14.1	0.0	0.0	0.4	3.3	0.0	0.7	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	1.5	1.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.9	0.0	0.0	0.0	0.0	3.4	1.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	109.5
KLK10	"NES1, PRSSL1"	ENSG00000129451	"Kallikrein related peptidase 10"	O43240	19	51012739-51020175	"Cancer-related genes, Enzymes, Predicted secreted proteins"	"Cell cycle"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 78.6;lymphoid tissue: 58.6;tongue: 136.3"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 29.8;Club cells: 77.3;Glandular cells: 41.6;Pancreatic endocrine cells: 43.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 50.7;HaCaT: 76.9;OE19: 49.9"	"Region enriched"	"Detected in single"	4	"hippocampal formation: 1.7"	"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		670000				"prognostic favorable (8.32e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.26e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.46e-6)"	"unprognostic (9.34e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.52e-2)"	1.5	0.5	0.2	1.7	0.3	0.3	2.4	0.7	0.4	20.8	0.9	0.3	0.5	0.2	2.9	0.8	78.6	7.8	36.0	0.7	0.2	0.5	0.2	0.3	4.3	0.2	0.2	0.3	7.2	0.2	0.0	0.2	0.8	0.6	1.6	0.4	0.3	11.0	0.6	0.4	17.7	0.4	0.4	0.4	0.2	0.5	1.6	0.2	1.0	0.3	136.3	58.6	0.5	33.4	0.4	0.5	2.1	0.4	0.4	0.3	0.1	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	50.7	0.0	2.8	0.0	0.0	76.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	49.9	0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.3	0.2	0.3	0.2	0.3	0.2	0.1	0.4	0.3	0.3	2.1	0.4	0.4	0.5	0.3	0.1	0.2	0.3	0.7	0.4	0.2	0.5	0.2	0.3	0.6	0.2	29.8	1.6	0.0	13.6	6.6	0.6	0.4	7.6	10.7	77.3	0.0	0.0	0.0	0.0	3.4	0.2	0.3	0.0	0.0	14.1	0.0	0.5	41.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	10.6	1.1	0.0	1.0	0.0	0.2	43.5	0.0	5.6	0.0	0.4	0.0	0.9	0.9	1.2	3.8	0.0	0.0	0.0	18.7
SRPK1	SFRSK1	ENSG00000096063	"SRSF protein kinase 1"	Q96SB4	6	35832966-35921342	"Enzymes, Predicted intracellular proteins"	"Chromosome partition, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 311.7;Late spermatids: 401.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016431, HPA056486"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA016431: AB_1857478, HPA056486: AB_2683148"	"unprognostic (4.65e-3)"	"unprognostic (6.82e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.01e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (7.90e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (6.53e-5)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.55e-3)"	13.5	7.1	8.1	15.4	11.7	32.1	11.7	22.5	17.8	12.8	23.8	7.8	10.8	20.3	15.2	7.9	24.9	8.9	10.8	8.7	8.9	7.8	17.8	18.9	14.9	14.6	8.0	8.3	9.5	26.0	11.7	17.7	27.9	9.6	10.5	28.7	12.4	17.6	9.4	19.9	26.2	25.7	11.3	7.9	19.0	13.9	32.7	7.6	21.0	8.5	17.0	19.8	15.2	15.7	4.3	2.8	24.6	3.4	5.0	6.7	2.9	29.9	11.4	16.8	25.0	9.4	12.3	21.2	18.4	17.8	17.2	18.3	32.0	10.1	40.0	15.6	11.3	20.0	15.4	32.8	21.9	31.0	27.3	23.6	21.0	13.4	27.7	8.3	31.1	10.4	7.9	12.0	19.8	26.0	13.7	21.6	22.9	44.5	17.0	14.4	10.6	32.0	24.2	13.7	18.3	12.5	22.5	20.1	24.7	17.3	50.4	35.8	13.1	18.9	18.0	12.7	17.8	10.1	20.7	15.6	16.2	12.7	11.0	23.1	10.0	22.1	37.6	6.4	36.1	14.4	24.5	2.1	13.7	4.3	2.5	6.1	4.3	5.7	5.7	2.8	3.3	4.8	5.2	24.6	5.0	3.4	1.6	6.7	2.9	8.1	11.7	22.5	17.8	8.9	7.8	8.0	8.3	9.6	7.6	8.9	26.3	24.4	65.1	37.5	33.6	21.8	12.7	32.1	38.7	21.0	35.3	43.2	24.9	50.7	311.7	24.1	38.6	23.3	58.8	43.3	21.3	68.6	7.0	40.0	19.1	9.5	44.4	11.1	17.1	401.7	20.4	16.9	15.1	36.1	44.8	13.4	78.7	42.1	23.3	44.4	84.4	6.5	23.1	154.9	90.6	36.5	33.2	34.8	87.4	132.9
EREG	ER	ENSG00000124882	Epiregulin	O14944	4	74365143-74388751	"Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.1;tongue: 44.0"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 44.2;Kupffer cells: 56.9;Macrophages: 122.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 60.3;CAPAN-2: 17.1;hTEC/SVTERT24-B: 19.0;U-2197: 41.1;U-87 MG: 70.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054373			Approved	Vesicles	"Secreted to blood"	NA	NA	46000		Vesicles		"HPA054373: "	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (4.56e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (1.07e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (6.57e-5)"	"unprognostic (2.94e-1)"	"unprognostic (1.70e-6)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.59e-3)"	"unprognostic (3.16e-3)"	2.2	0.0	0.1	4.6	0.3	52.1	1.2	0.0	0.1	5.0	1.2	0.1	0.0	0.0	0.1	0.5	15.3	1.2	7.3	0.8	0.0	0.0	0.4	0.2	6.7	1.1	0.0	0.2	0.5	0.1	0.0	0.0	2.0	0.3	0.2	1.6	0.1	1.6	0.0	0.5	10.7	1.0	1.3	0.1	1.9	0.3	0.3	0.0	0.2	0.0	44.0	7.2	4.1	4.6	0.6	1.3	2.6	1.2	0.4	0.3	0.3	0.3	9.1	0.0	0.0	0.9	1.5	0.0	2.0	60.3	0.6	0.3	7.1	17.1	0.0	10.1	0.0	4.6	0.5	0.0	13.1	0.6	0.0	0.0	0.2	0.3	0.2	0.2	0.0	0.0	0.9	4.6	19.0	10.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	41.1	0.0	0.0	0.0	0.0	70.5	0.0	0.0	1.9	1.2	2.6	0.3	1.0	0.2	0.2	0.2	0.2	1.3	0.6	0.3	0.2	1.0	0.4	0.2	0.4	0.2	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	6.0	11.1	1.9	4.9	4.7	0.0	15.7	2.5	4.0	29.6	0.0	0.0	0.5	0.0	0.0	3.1	2.2	44.2	0.0	0.2	0.7	6.1	2.0	6.9	0.0	28.2	0.0	3.5	0.6	56.9	0.4	0.3	122.8	6.8	29.7	24.7	0.0	0.4	17.5	0.0	0.1	0.0	0.0	2.2	0.5	0.2	8.2	0.6	1.0	27.7	6.7
LDLR	LDLCQ2	ENSG00000130164	"Low density lipoprotein receptor"	P01130	19	11089362-11133816	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Endocytosis, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 369.2;Alveolar cells type 2: 436.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 23.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 23.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009647, HPA013159"	Approved					NA	NA		12000000			"HPA009647: AB_1079243, HPA013159: AB_1852775"	"unprognostic (4.39e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.71e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (6.60e-5)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (5.92e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.43e-4)"	24.6	50.7	6.1	13.7	5.6	11.9	20.0	4.7	9.1	15.4	10.3	17.2	4.8	12.3	14.0	6.5	33.6	12.2	27.2	11.3	7.4	5.0	5.3	33.4	28.7	5.2	4.2	4.9	42.4	26.7	9.6	4.3	9.7	18.9	11.3	6.6	7.1	11.4	4.6	3.2	12.5	15.1	15.1	14.6	8.7	19.5	6.3	9.1	2.1	4.8	17.5	13.2	13.2	13.8	0.4	1.0	23.6	1.7	1.6	3.7	1.8	27.3	12.7	15.8	7.5	21.5	41.1	5.3	5.9	22.9	10.7	23.4	13.2	26.2	9.3	23.5	11.4	35.2	21.8	8.0	47.4	5.1	6.5	1.5	4.5	8.8	11.8	31.8	4.6	25.6	50.9	17.8	36.1	7.8	7.4	11.6	7.5	9.2	53.7	8.0	10.3	5.9	5.9	16.9	13.8	17.2	4.1	11.5	11.7	26.4	22.0	3.7	3.9	5.0	11.5	0.9	11.9	4.8	10.9	12.5	9.3	6.7	5.8	10.7	6.6	5.5	5.6	10.9	11.0	21.1	23.6	1.7	0.1	3.7	1.6	0.9	0.4	1.5	1.1	1.0	0.4	1.6	1.5	0.6	1.6	0.5	0.4	1.0	1.8	6.1	5.6	4.7	9.1	7.4	5.0	4.2	4.9	18.9	9.1	369.2	436.1	9.6	159.5	127.4	3.8	21.8	101.9	97.7	208.1	14.0	5.9	17.8	1.7	47.9	1.0	47.6	71.0	0.0	77.9	25.8	39.9	168.7	71.8	120.7	12.0	1.6	59.3	25.2	10.4	0.4	18.1	19.4	54.0	1.8	66.6	2.7	63.1	19.8	6.7	0.2	6.7	6.5	32.5	3.9	1.3	172.4	40.3	20.3	29.9	183.1
NFE2L3	Nrf3	ENSG00000050344	"Nuclear factor, erythroid 2 like 3"	Q9Y4A8	7	26152240-26187125	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 54.9"	"Group enriched"	"Detected in many"	14	"Cytotrophoblasts: 226.3;Syncytiotrophoblasts: 584.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 44.0;NTERA-2: 36.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055889	Enhanced		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Vesicles"		"HPA055889: AB_2682958"	"unprognostic (4.99e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.00e-3)"	"unprognostic (7.29e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.88e-2)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (7.58e-12)"	"prognostic favorable (2.14e-4)"	"unprognostic (2.40e-1)"	"unprognostic (8.25e-2)"	"unprognostic (4.13e-3)"	3.5	2.5	0.8	7.8	1.2	1.6	4.1	6.2	1.6	1.8	6.7	4.0	2.4	6.2	1.9	1.7	3.1	2.4	7.1	3.6	1.3	1.1	4.2	2.3	5.8	6.9	2.5	0.8	1.7	7.5	0.0	2.1	54.9	2.1	3.7	4.0	2.1	7.7	0.4	3.4	8.2	7.1	0.8	3.7	10.4	5.6	2.5	1.5	11.2	1.6	1.5	8.9	3.1	2.1	1.4	2.8	0.8	1.1	1.1	2.6	0.4	12.7	1.1	0.5	1.3	0.0	0.0	44.0	2.5	5.0	4.9	9.1	8.4	22.3	0.9	16.8	0.2	18.6	2.7	1.9	4.3	11.3	8.7	2.7	1.7	1.8	6.1	3.4	1.5	17.0	0.4	0.5	2.0	0.7	7.3	11.4	3.6	2.6	22.6	1.0	1.7	1.0	2.7	36.9	3.5	4.5	1.5	0.1	6.3	6.7	12.6	4.0	4.7	0.0	1.0	0.4	12.8	0.6	0.9	23.9	0.4	0.7	0.2	10.2	13.8	21.9	1.0	0.0	5.5	17.0	0.0	1.1	0.0	0.5	1.1	1.6	1.0	2.1	1.0	2.8	1.4	1.2	0.7	0.8	1.1	0.3	0.9	2.6	0.4	0.8	1.2	6.2	1.6	1.3	1.1	2.5	0.8	2.1	1.5	6.0	3.2	0.8	2.8	1.5	1.2	1.4	17.8	1.4	5.7	10.4	0.0	226.3	0.0	9.8	0.7	3.8	3.3	0.0	4.7	28.3	2.3	3.6	27.6	0.0	21.3	0.0	1.2	3.1	12.9	0.0	0.0	11.1	1.7	5.4	6.5	0.9	11.2	4.3	0.0	0.3	1.3	0.0	1.0	0.3	5.7	1.4	584.2	4.9	8.3	5.4
NIP7	"CGI-37, FLJ10296, HSPC031, KD93"	ENSG00000132603	"NIP7, nucleolar pre-rRNA processing protein"	Q9Y221	16	69339430-69343111	"Predicted intracellular proteins"	"Ribosome biogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040856, HPA059850"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA040856: AB_2677171, HPA059850: AB_2684142"	"unprognostic (2.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.02e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.04e-3)"	"unprognostic (1.37e-3)"	"unprognostic (5.72e-2)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (6.69e-5)"	"unprognostic (6.99e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	17.8	15.5	8.1	16.4	8.7	20.4	14.0	7.0	12.4	10.2	13.7	9.5	11.1	11.8	15.6	13.1	24.0	13.0	11.3	9.1	9.0	7.8	18.0	18.0	10.7	17.6	12.6	9.6	11.6	18.4	9.6	10.2	14.3	10.9	10.1	14.2	8.8	13.1	13.2	12.1	14.7	14.2	11.7	8.3	15.4	12.3	14.8	9.5	27.1	19.2	23.8	21.0	10.6	11.8	16.6	14.2	8.4	11.7	15.3	19.0	9.5	15.1	10.8	9.2	12.2	12.1	11.0	13.7	13.7	11.1	24.1	17.7	17.4	16.4	27.7	15.4	12.7	10.1	15.2	17.3	21.8	30.7	7.3	13.9	14.4	7.7	22.8	11.9	31.6	9.5	11.8	17.4	22.1	24.5	7.5	13.2	15.0	28.5	5.0	16.6	18.6	19.0	23.2	26.8	14.0	12.6	27.6	9.5	25.3	14.8	11.3	11.7	16.7	27.5	8.8	16.9	10.9	12.0	19.4	11.5	17.6	15.5	13.1	25.3	15.3	11.6	67.8	10.2	18.9	17.5	8.4	8.1	5.7	16.8	9.2	18.1	16.6	15.6	19.0	14.2	12.1	15.1	18.3	4.0	15.3	11.7	12.5	14.8	9.5	8.1	8.7	7.0	12.4	9.0	7.8	12.6	9.6	10.9	9.5	3.0	10.1	24.6	46.2	47.7	8.2	4.8	17.8	29.4	18.2	19.2	15.7	27.5	18.3	30.3	29.3	22.4	13.8	0.0	22.6	28.1	22.2	16.9	17.3	9.6	21.6	11.1	2.9	18.4	10.8	29.4	15.8	15.5	18.6	16.2	11.7	8.8	30.2	17.5	16.3	21.4	6.9	12.9	19.8	31.2	39.4	45.9	21.4	27.7	16.6	36.0
GAREM1	"C18orf11, FAM59A, FLJ21610, GAREM"	ENSG00000141441	"GRB2 associated regulator of MAPK1 subtype 1"	Q9H706	18	32124877-32470484	"Predicted intracellular proteins"		Mitogen		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 43.5"	"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 48.3;Urothelial cells: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 12.2;hTERT-HME1: 21.2;RT4: 18.0;SH-SY5Y: 14.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040709, HPA042046"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA040709: AB_2677090, HPA042046: AB_2677818"	"unprognostic (9.52e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (6.73e-5)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.49e-6)"	"unprognostic (2.36e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	11.1	8.7	9.7	2.9	10.9	8.0	6.0	17.6	11.1	6.0	7.2	19.5	0.3	6.5	4.2	3.4	11.0	4.8	4.9	8.9	11.8	5.8	15.3	12.5	5.2	1.3	16.3	10.1	4.4	43.5	1.9	5.1	4.8	13.2	4.3	6.3	3.0	11.2	5.1	7.7	13.9	7.8	4.6	12.9	3.1	12.7	6.7	16.4	0.0	3.5	3.1	2.9	9.3	9.1	1.9	5.0	2.6	1.0	3.1	1.4	0.0	1.0	1.6	1.7	0.3	4.7	3.3	4.8	0.3	0.0	0.0	0.0	0.3	2.6	3.0	2.5	0.2	2.0	3.4	2.6	5.0	0.0	1.0	1.6	0.0	3.0	1.0	2.4	0.3	0.2	3.9	12.2	0.2	21.2	0.2	0.2	1.8	0.1	0.6	1.8	2.5	0.8	0.1	1.9	7.9	0.9	1.2	6.9	5.3	6.1	18.0	5.7	14.9	3.9	5.1	0.2	2.2	1.0	2.6	0.2	1.2	1.4	0.0	0.5	2.1	0.2	0.7	1.9	0.0	1.4	0.0	1.0	0.2	0.5	0.1	0.2	0.3	0.8	0.5	0.1	1.9	1.0	1.4	2.6	3.1	0.1	5.0	0.1	0.0	9.7	10.9	17.6	11.1	11.8	5.8	16.3	10.1	13.2	16.4	8.9	35.2	0.0	30.5	0.0	31.8	0.0	7.6	8.1	15.9	24.4	3.9	15.6	1.7	9.4	10.1	0.0	6.3	0.0	11.4	2.0	0.3	48.3	3.5	7.7	1.6	39.7	3.5	0.6	3.7	2.5	1.7	0.9	0.0	1.0	10.2	41.9	10.3	7.0	4.9	20.9	7.0	0.0	0.0	1.4	2.5	0.0	28.0	0.0	8.3	68.5
ZDHHC5	"DHHC5, KIAA1748, ZNF375"	ENSG00000156599	"Zinc finger DHHC-type containing 5"	Q9C0B5	11	57667747-57701187	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014670	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA014670: AB_2257442"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.74e-3)"	"unprognostic (4.36e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.72e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.74e-3)"	19.6	18.2	6.9	14.2	16.1	13.0	17.3	12.4	19.2	20.0	18.7	14.1	20.9	14.6	19.8	15.9	45.8	16.0	19.1	18.2	8.2	8.1	27.8	24.8	18.7	18.0	8.5	8.2	16.2	21.3	31.4	13.9	31.4	12.8	15.5	18.2	19.1	29.3	18.4	31.3	33.2	25.9	15.2	8.7	21.5	16.3	35.7	7.8	26.4	25.5	23.9	39.1	23.3	26.0	9.4	13.4	15.5	11.3	6.9	13.1	9.0	28.4	31.6	12.4	12.6	27.5	21.2	23.4	26.8	32.1	22.4	16.8	19.1	35.1	19.2	34.8	31.6	19.3	40.3	19.3	31.7	20.0	23.6	8.7	16.3	14.5	17.0	30.8	30.5	27.7	29.8	28.7	33.1	33.7	18.6	25.2	16.2	21.4	24.3	28.3	17.1	17.1	8.5	15.0	21.1	19.0	17.1	25.1	23.7	25.6	42.2	9.0	11.5	24.9	28.2	26.1	17.5	30.2	17.5	29.5	29.1	15.1	30.5	18.6	17.7	21.9	16.5	21.6	15.8	25.2	15.5	8.1	9.8	11.1	10.1	13.1	9.0	10.9	9.4	8.0	9.4	11.0	11.1	10.2	6.9	11.3	13.4	9.8	9.0	6.9	16.1	12.4	19.2	8.2	8.1	8.5	8.2	12.8	7.8	14.9	10.9	5.3	10.2	14.3	17.5	18.1	12.7	14.7	20.5	12.2	35.3	8.5	3.3	13.1	15.8	11.7	31.9	0.0	15.7	8.4	8.5	14.0	19.6	13.2	11.0	12.7	11.1	13.5	16.1	6.8	10.9	12.0	1.7	9.0	16.2	9.6	19.0	19.3	7.1	10.2	45.0	0.0	9.2	6.5	6.6	17.3	15.6	8.7	15.8	15.9
KRT19	"CK19, K19, K1CS, MGC15366"	ENSG00000171345	"Keratin 19"	P08727	17	41523617-41528308	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 205.3;intestine: 184.9;placenta: 179.4"	"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 4255.4;Enterocytes: 4014.8;Extravillous trophoblasts: 5684.1;Pancreatic endocrine cells: 4513.8;Urothelial cells: 5295.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 2.7"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 102.7;HBEC3-KT: 154.6;MCF7: 114.1;RT4: 164.2;SK-BR-3: 290.2;T-47d: 195.5"	"Not detected"	"Not detected"							"CAB000031, HPA002465"	Enhanced		Supported	"Intermediate filaments"		NA	NA		330000000	"Intermediate filaments"		"CAB000031: AB_2234418, HPA002465: AB_1079179"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavorable (6.82e-5)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (2.98e-5)"	"unprognostic (3.52e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.35e-2)"	9.8	1.6	0.7	22.8	0.9	0.0	50.1	2.9	0.8	37.4	126.7	1.0	38.0	37.8	9.9	53.0	102.1	19.5	205.3	2.3	0.8	0.2	35.0	2.1	50.6	0.7	0.8	0.8	16.7	7.5	1.2	2.6	179.4	1.3	39.2	40.1	1.8	103.0	46.3	0.7	15.8	184.9	11.7	0.6	0.6	69.1	6.4	0.7	33.3	4.9	21.2	89.2	77.0	35.4	0.0	0.0	0.0	0.0	2.7	0.6	0.2	0.1	18.0	0.0	0.3	0.0	0.1	62.8	21.6	0.0	0.6	0.1	51.6	102.7	0.0	21.2	10.3	0.0	55.0	0.0	154.6	0.1	0.0	0.5	0.0	11.6	35.3	1.6	0.0	4.4	0.0	28.1	0.4	0.0	0.0	1.3	0.0	7.4	0.1	0.0	114.1	0.2	0.1	0.9	68.3	26.1	0.1	0.0	0.3	70.9	164.2	2.1	0.0	0.1	290.2	0.0	15.0	195.5	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	0.7	0.9	2.9	0.8	0.8	0.2	0.8	0.8	1.3	0.7	625.3	180.1	0.5	3332.5	4.6	0.0	1.4	746.5	641.1	757.5	846.2	0.0	833.1	1.7	4255.4	0.1	5.4	4014.8	0.0	2348.9	5684.1	55.9	1574.4	94.4	0.0	159.5	0.0	348.1	0.6	1.8	0.7	35.1	13.4	180.5	52.3	1103.8	0.6	4513.8	2781.1	83.4	4.2	0.0	0.0	4.6	0.2	0.7	1.0	1779.2	1.0	1201.4	5295.6
NOG	"SYM1, SYNS1"	ENSG00000183691	Noggin	Q13253	17	56593699-56595590	"Disease related genes, Predicted secreted proteins"	"Chondrogenesis, Differentiation"	"Developmental protein"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.8;placenta: 37.1;retina: 18.6"	"Cell type enriched"	"Detected in single"	11	"Extravillous trophoblasts: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"naive CD4 T-cell: 32.8;naive CD8 T-cell: 15.1"	"Lineage enriched"	"Detected in single"	81	"T-cells: 32.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 51.0;LHCN-M2: 15.5;NB-4: 11.3;PC-3: 15.4;U-2 OS: 15.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061318	Approved				"Secreted to blood"	NA	NA					"HPA061318: AB_2684478"	"unprognostic (1.49e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.49e-5)"	"prognostic favorable (6.66e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.23e-3)"		"unprognostic (1.26e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (6.86e-5)"	"unprognostic (2.88e-1)"	"unprognostic (1.14e-6)"	"unprognostic (8.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.65e-1)"	0.9	0.3	4.9	2.0	7.2	0.7	0.5	0.9	8.3	5.5	0.6	1.8	0.4	0.5	0.8	6.3	0.4	0.4	0.3	0.4	3.8	3.1	0.8	0.4	1.0	3.3	1.9	2.7	0.3	0.5	0.3	0.8	37.1	1.1	1.4	0.4	18.6	0.4	2.9	3.6	0.4	0.7	0.5	0.8	1.5	0.8	1.6	1.8	1.7	0.3	0.0	1.1	0.9	3.1	0.0	0.1	0.4	0.1	0.2	32.8	1.7	2.4	0.0	0.1	0.0	0.1	0.0	0.0	1.3	1.4	0.5	0.5	0.1	0.4	0.0	51.0	0.6	2.0	0.2	0.8	0.1	1.4	0.0	0.9	0.0	1.9	0.0	0.0	0.3	0.0	0.2	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	15.5	0.0	0.4	11.3	1.0	0.0	15.4	6.7	4.7	0.0	1.2	0.0	0.1	0.0	2.6	0.0	0.0	4.3	0.0	0.2	0.3	0.9	15.8	0.1	1.1	0.0	0.0	0.1	0.0	1.2	0.0	0.3	0.0	0.1	0.2	0.1	0.1	0.0	1.9	0.2	0.0	0.0	32.8	15.1	0.4	0.2	0.1	0.1	1.3	1.7	4.9	7.2	0.9	2.5	3.8	3.1	1.9	2.7	1.1	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	8.9	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.7	0.0	0.0	0.0
C11orf86	FLJ22675	ENSG00000173237	"Chromosome 11 open reading frame 86"	A6NJI1	11	66975277-66977004	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	14	"intestine: 57.7"	"Cell type enriched"	"Detected in some"	5	"Enterocytes: 358.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HeLa: 6.9;SiHa: 23.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039348	Uncertain					NA	NA					"HPA039348: AB_10673421"		"unprognostic (1.54e-2)"	"unprognostic (7.67e-3)"		"unprognostic (3.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.90e-4)"	"prognostic unfavorable (8.97e-4)"		"unprognostic (4.17e-1)"	"prognostic unfavorable (6.97e-5)"		"prognostic unfavorable (1.02e-5)"	"unprognostic (7.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.58e-3)"	0.1	4.0	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	24.4	0.1	0.1	33.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.5	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	2.1	0.1	0.1	3.0	0.1	0.1	0.1	0.1	0.0	57.7	0.2	0.1	0.1	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	23.3	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	358.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.7	66.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.1
CHMP4C	"MGC22825, Shax3, VPS32C"	ENSG00000164695	"Charged multivesicular body protein 4C"	Q96CF2	8	81732434-81759515	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 45.3"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 63.1;Pancreatic endocrine cells: 59.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"NK-cell: 5.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 18.2;hTCEpi: 22.9;hTERT-HME1: 18.7;OE19: 31.3;RPTEC TERT1: 16.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023799	Enhanced					NA	NA					"HPA023799: AB_1846670"	"unprognostic (3.98e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.45e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (9.33e-5)"	"unprognostic (7.54e-2)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (1.99e-2)"	"prognostic favorable (1.96e-6)"	"unprognostic (3.29e-3)"	"unprognostic (4.95e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (6.45e-4)"	1.3	5.0	0.5	3.4	1.2	0.1	8.2	0.3	0.7	4.4	26.4	0.4	17.4	21.1	1.5	10.9	16.9	4.2	14.5	4.1	0.6	0.5	12.8	11.7	7.0	0.7	0.6	0.8	1.3	31.8	6.1	13.8	17.5	3.0	8.2	7.4	2.6	30.7	16.1	0.4	21.5	45.3	1.1	0.7	5.6	11.9	1.9	0.4	1.1	20.5	11.5	8.0	6.5	10.2	1.3	0.4	1.4	0.4	5.3	0.2	0.3	15.7	3.3	0.0	0.1	0.0	0.0	7.4	0.8	0.9	0.0	0.0	6.1	18.2	0.0	12.9	0.0	2.8	9.6	0.1	6.8	0.0	0.0	7.9	0.3	4.6	5.8	0.3	0.0	0.0	0.0	22.9	0.0	18.7	6.9	0.0	0.0	4.2	5.5	0.0	7.8	0.0	0.1	0.0	31.3	6.6	0.0	0.0	3.5	16.1	9.5	3.5	0.0	4.3	7.2	0.0	4.0	10.5	0.1	0.0	0.0	4.0	0.0	0.1	2.9	1.8	0.0	0.0	0.0	0.0	1.4	0.4	0.2	0.2	0.1	0.2	1.3	0.2	0.1	0.1	0.6	0.2	0.2	1.2	5.3	0.2	0.4	0.1	0.3	0.5	1.2	0.3	0.7	0.6	0.5	0.6	0.8	3.0	0.4	23.8	15.5	1.4	29.9	4.0	0.0	3.9	15.3	26.8	26.1	5.2	0.0	34.9	21.6	39.1	0.3	3.1	50.3	0.0	63.1	32.3	1.3	22.9	1.1	6.7	3.9	0.0	8.7	2.5	0.0	0.4	0.0	0.3	8.5	0.0	34.7	0.0	59.5	40.3	0.0	17.0	0.0	0.0	3.4	0.0	0.0	15.3	37.2	0.7	26.6	26.3
UACA	"FLJ10128, KIAA1561"	ENSG00000137831	"Uveal autoantigen with coiled-coil domains and ankyrin repeats"	Q9BZF9	15	70654554-70763593	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 68.0"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 148.5;Leydig cells: 115.9;Peritubular cells: 132.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 2.2;intermediate monocyte: 4.3;memory B-cell: 1.2;myeloid DC: 2.0;naive B-cell: 3.4;non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	11	"B-cells: 3.4;dendritic cells: 2.0;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"BJ: 62.0;BJ hTERT+: 37.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041412, HPA043503, HPA056006"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041412: AB_10966708, HPA043503: AB_2678517, HPA056006: "	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.14e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (1.03e-4)"	21.7	8.9	4.7	8.6	8.1	0.4	25.9	2.9	5.8	15.4	14.1	8.4	22.8	10.6	17.2	22.3	15.6	10.5	15.7	18.0	6.1	4.2	16.4	8.2	23.7	7.5	9.0	4.6	17.5	8.6	8.2	6.5	13.7	9.6	15.5	7.6	26.7	18.8	26.9	68.0	10.1	16.9	11.4	14.9	15.7	8.4	10.1	7.1	1.0	18.6	32.4	5.3	9.9	13.5	3.4	2.0	0.2	4.3	0.1	0.3	0.7	10.5	8.7	3.9	5.1	7.9	34.2	0.0	62.0	37.9	16.2	14.1	14.6	15.6	7.2	17.1	15.4	4.7	12.2	8.8	4.9	20.5	0.0	3.9	4.0	6.8	3.0	10.3	0.1	1.5	16.1	2.8	9.6	7.3	26.9	17.2	1.7	1.0	0.0	20.1	3.4	0.0	0.6	3.2	4.8	4.6	0.0	28.3	0.0	7.8	3.6	1.0	2.0	11.7	1.8	12.5	8.2	3.4	1.2	33.0	0.9	6.5	5.3	9.8	0.6	2.1	0.0	8.2	1.1	7.0	0.2	2.2	0.0	0.0	4.3	0.0	1.2	0.1	0.0	2.0	3.4	0.3	0.1	0.2	0.1	2.9	0.1	0.0	0.7	4.7	8.1	2.9	5.8	6.1	4.2	9.0	4.6	9.6	7.1	6.0	8.3	4.7	14.2	10.1	7.0	148.5	12.7	87.0	22.7	47.1	3.9	0.8	3.3	42.5	15.2	80.4	36.5	0.0	42.6	1.0	25.7	13.4	15.0	14.8	8.6	23.8	8.7	43.6	19.1	8.1	115.9	9.6	28.7	11.8	23.3	55.9	56.3	28.5	132.6	3.0	3.4	51.8	46.4	38.5	29.6	11.4	0.8	3.2	20.0	9.6
TLDC1	KIAA1609	ENSG00000140950	"TBC/LysM-associated domain containing 1"	Q6P9B6	16	84476421-84554033	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 115.8;Rod photoreceptor cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 29.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041020	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Nucleoli"	"HPA041020: AB_10794184"	"unprognostic (8.35e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-3)"	"unprognostic (5.97e-4)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (3.94e-1)"	"unprognostic (2.85e-2)"	"prognostic unfavorable (7.05e-5)"	"unprognostic (2.92e-2)"	"unprognostic (6.78e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-2)"	5.5	4.9	7.6	7.1	10.7	1.8	7.3	8.1	11.5	8.1	7.1	6.3	5.2	6.0	14.0	8.8	24.4	6.9	6.5	4.7	6.3	4.5	7.6	5.1	6.4	6.1	5.0	9.4	8.7	5.2	11.3	4.4	15.8	10.7	7.8	7.8	12.9	7.7	6.1	4.5	11.0	9.3	10.7	4.0	5.4	6.8	8.1	3.4	8.3	7.6	6.5	10.0	10.4	12.1	3.3	2.7	13.6	3.5	3.1	8.7	2.6	14.7	10.4	9.1	4.9	4.2	7.4	4.3	10.9	9.8	11.3	3.3	5.9	17.9	2.0	5.9	21.0	8.3	16.5	2.5	29.3	14.9	1.1	2.2	1.6	5.1	5.1	5.2	1.2	5.1	5.1	12.7	10.5	13.9	9.2	4.7	5.9	2.7	2.5	7.6	3.5	1.1	1.2	2.8	7.7	3.6	4.5	2.3	0.7	10.0	8.3	3.0	2.1	9.9	7.1	4.9	10.0	10.2	2.0	11.5	7.9	3.6	4.2	4.5	2.0	3.5	5.4	4.7	0.6	2.7	13.6	3.1	4.4	3.8	2.7	3.7	3.3	6.8	5.5	2.7	2.7	7.6	4.7	3.1	3.1	3.5	0.8	8.7	2.6	7.6	10.7	8.1	11.5	6.3	4.5	5.0	9.4	10.7	3.4	3.0	4.5	2.7	8.9	2.1	14.1	3.3	5.1	8.1	6.8	12.2	115.8	28.9	5.0	15.5	1.4	5.8	13.6	0.0	7.5	8.8	5.1	7.2	4.7	1.5	7.3	4.8	2.9	5.5	4.8	1.2	7.5	2.7	3.3	10.8	4.5	8.1	14.4	7.0	5.3	6.1	65.7	0.0	5.1	4.6	3.9	3.0	39.4	3.2	4.8	20.0
LAMC2	"BM600-100kDa, EBR2, EBR2A, kalinin-105kDa, LAMB2T, LAMNB2, nicein-100kDa"	ENSG00000058085	"Laminin subunit gamma 2"	Q13753	1	183186238-183244900	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Pancreatic endocrine cells: 902.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 231.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 49.4;CAPAN-2: 44.7;HBEC3-KT: 221.9;hTERT-HME1: 137.0;RPTEC TERT1: 53.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004257, HPA024638, CAB078165"	Enhanced		Approved	Cytosol	"Secreted to extracellular matrix"	No	No			Cytosol		"CAB004257: AB_627873, CAB078165: AB_2665800, HPA024638: AB_1852689"	"unprognostic (7.27e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.20e-3)"	"unprognostic (9.43e-2)"	"unprognostic (4.94e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (1.25e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (2.77e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	2.6	0.0	1.0	20.6	4.1	0.0	11.4	3.6	1.2	8.7	8.4	0.9	2.4	0.9	6.6	2.9	6.5	19.0	12.8	1.8	0.7	0.1	10.5	0.8	18.3	3.3	1.6	1.1	1.9	2.9	0.0	7.0	21.2	1.5	3.7	6.8	0.9	11.2	3.2	1.3	12.8	14.3	1.8	0.7	0.7	7.6	1.9	0.9	3.5	9.8	10.0	15.6	3.4	4.8	0.9	0.8	1.7	0.5	0.4	0.6	0.1	49.4	2.2	0.0	0.0	0.4	1.1	3.6	0.3	0.4	0.1	0.0	3.6	44.7	0.0	19.0	0.1	1.4	22.3	0.0	221.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	17.2	0.5	137.0	0.2	2.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	18.1	3.1	0.0	0.1	0.0	53.2	12.9	2.7	0.0	1.3	0.0	0.0	1.4	0.1	0.2	0.3	0.2	2.7	1.3	0.6	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.4	0.6	0.4	0.3	0.4	0.5	0.4	0.4	0.1	0.9	0.5	0.6	1.7	0.4	0.5	0.8	0.3	0.1	1.0	4.1	3.6	1.2	0.7	0.1	1.6	1.1	1.5	0.9	202.5	19.1	0.0	163.7	76.6	0.0	1.1	15.3	66.9	51.2	22.7	0.0	26.6	0.0	197.8	16.4	0.5	28.1	0.0	81.6	9.8	7.8	209.4	0.0	0.0	2.2	0.0	8.6	0.0	0.0	8.3	3.1	2.9	8.5	4.6	13.0	0.0	902.6	26.0	0.4	0.0	0.0	0.0	2.3	3.7	1.0	26.0	69.7	0.7	7.1	119.2
MAP3K13	"LZK, MEKK13"	ENSG00000073803	"Mitogen-activated protein kinase kinase kinase 13"	O43283	3	185282941-185489097	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 456.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016497, HPA036691, HPA036692"	Uncertain		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA016497: AB_10670027, HPA036691: AB_10673661, HPA036692: AB_10670845"	"unprognostic (8.95e-2)"	"unprognostic (6.72e-3)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (5.16e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (1.11e-4)"	"prognostic unfavorable (7.27e-5)"	"unprognostic (2.70e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.31e-3)"	9.8	24.8	21.7	8.7	22.2	9.5	15.1	16.4	26.1	12.9	16.9	18.4	10.5	16.8	12.9	42.1	15.2	14.6	13.1	8.1	19.2	18.6	21.9	20.7	15.2	7.4	23.2	17.1	16.5	24.9	20.9	24.5	9.1	21.8	14.5	18.9	18.6	26.2	11.4	3.3	9.8	23.4	12.1	26.4	8.7	16.4	12.9	15.8	4.4	18.6	8.3	10.3	12.5	11.5	23.7	21.5	21.1	13.2	11.5	17.4	7.8	29.1	5.8	11.3	0.3	10.3	12.7	6.7	6.7	4.6	10.9	13.2	11.2	11.0	0.2	23.0	12.2	18.2	16.7	0.3	15.5	19.4	32.5	15.0	0.1	7.9	9.2	11.2	15.3	8.4	11.5	13.6	9.3	11.7	11.3	12.1	0.3	0.3	23.7	9.7	9.1	1.8	7.2	13.0	22.5	13.7	0.2	13.5	16.0	19.2	7.6	18.6	12.4	11.3	17.1	23.2	12.9	25.8	8.6	8.0	9.0	11.7	16.2	14.5	12.1	15.6	9.6	13.2	7.8	14.7	6.4	13.2	5.1	10.3	12.2	15.8	23.7	12.4	12.8	21.5	19.0	17.4	16.8	21.1	11.5	8.6	9.4	4.8	7.8	21.7	22.2	16.4	26.1	19.2	18.6	23.2	17.1	21.8	15.8	50.6	76.2	44.7	172.9	125.7	111.5	22.1	104.4	64.3	84.2	75.0	86.4	120.9	243.7	92.5	109.7	52.6	82.0	0.0	111.2	29.4	48.3	249.1	28.9	83.1	55.4	42.9	102.2	83.4	50.4	168.4	40.0	59.4	81.0	456.3	109.9	93.7	112.0	96.2	50.9	224.8	81.3	45.3	74.0	119.3	28.8	127.2	170.1	31.2	98.7	249.0
IGF2BP2	IMP-2	ENSG00000073792	"Insulin like growth factor 2 mRNA binding protein 2"	Q9Y6M1	3	185643739-185825056	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 43.0"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 118.2;Rod photoreceptor cells: 160.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 60.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017126, HPA035145"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"CAB017126: , HPA035145: AB_2674491"	"unprognostic (7.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (2.46e-3)"	"unprognostic (8.25e-3)"	"unprognostic (4.17e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (7.37e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.94e-3)"	7.9	8.9	1.0	6.4	1.9	7.6	4.9	8.6	1.6	6.5	16.4	1.6	1.5	11.3	7.6	4.8	3.7	8.3	8.1	9.9	1.7	1.4	8.0	2.6	14.0	4.0	2.8	0.7	6.7	11.3	7.6	2.9	43.0	4.5	4.9	11.6	16.9	9.0	1.6	3.2	4.3	21.4	3.3	3.7	5.8	9.9	5.1	1.5	2.4	8.6	3.2	3.3	6.2	12.5	0.0	5.5	0.9	3.3	1.3	0.0	1.2	28.3	2.4	27.8	5.2	15.2	24.0	17.0	15.0	21.2	23.3	28.0	20.4	8.0	0.0	22.3	12.6	29.9	12.9	13.0	21.8	37.9	0.0	13.4	8.1	0.1	14.1	32.5	0.2	0.0	17.5	11.6	15.5	60.3	12.2	21.4	2.1	7.9	0.0	17.0	0.2	0.0	6.8	20.3	4.8	10.3	2.9	11.0	8.5	15.1	0.1	1.7	0.2	1.1	0.0	26.7	28.8	2.2	18.9	32.4	8.1	17.7	10.1	17.2	0.1	0.0	0.0	8.0	0.0	11.3	0.9	3.0	0.5	0.0	2.8	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.2	1.3	3.3	1.0	0.0	1.2	1.0	1.9	8.6	1.6	1.7	1.4	2.8	0.7	4.5	1.5	11.9	12.3	0.0	21.8	17.5	3.2	13.6	28.1	48.2	35.2	24.4	15.7	1.7	3.3	33.9	118.2	12.2	59.3	23.3	22.6	14.2	28.3	47.6	2.3	0.0	13.3	1.6	34.2	44.2	10.5	64.7	4.9	7.4	13.5	4.6	42.1	30.6	38.8	84.6	0.4	7.6	160.2	0.0	8.6	2.8	7.0	12.8	5.3	0.0	34.5	53.7
RAB10		ENSG00000084733	"RAB10, member RAS oncogene family"	P61026	2	26034107-26137454	"Predicted intracellular proteins"	"Protein transport, Transport"	Hydrolase	Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Suprabasal keratinocytes: 426.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045611	Approved					NA	Yes		14000000			"HPA045611: AB_10961124"	"unprognostic (7.73e-3)"	"unprognostic (2.45e-2)"	"unprognostic (8.21e-3)"	"prognostic unfavorable (7.40e-4)"	"unprognostic (8.22e-3)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (9.22e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (7.37e-5)"	"unprognostic (1.06e-2)"	"unprognostic (8.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.99e-2)"	17.8	21.8	24.1	15.9	21.0	6.0	20.4	16.0	23.2	23.0	22.2	22.6	11.9	15.6	16.9	16.4	82.0	15.8	17.4	18.6	22.8	22.3	22.2	18.4	15.9	22.7	28.7	15.6	16.4	20.9	20.2	13.5	15.6	22.0	17.1	22.9	10.6	24.6	17.4	72.8	26.9	20.2	18.7	34.7	28.0	21.9	13.2	23.9	19.7	21.3	62.6	41.8	21.4	32.7	11.1	22.0	16.8	44.5	15.2	13.7	21.8	36.1	43.2	21.0	17.4	44.4	37.0	20.1	28.4	25.0	23.1	20.6	25.2	27.2	24.7	27.4	31.0	25.4	19.9	25.1	27.3	24.8	25.3	17.3	42.5	18.9	42.1	41.4	34.9	24.3	30.1	45.1	28.1	33.5	36.3	29.0	15.4	34.9	25.2	31.1	16.0	21.2	27.4	21.3	43.9	25.3	20.6	44.0	41.5	46.6	35.3	29.6	27.5	24.0	44.4	29.3	24.4	19.5	25.4	35.1	35.8	18.6	24.7	30.4	16.4	25.6	39.7	36.0	42.2	27.3	13.9	23.7	10.5	10.7	42.4	12.9	11.1	12.7	11.4	22.0	9.8	11.0	12.1	16.8	15.2	44.5	7.6	13.7	21.8	24.1	21.0	16.0	23.2	22.8	22.3	28.7	15.6	22.0	23.9	74.5	42.5	50.8	151.1	303.7	24.2	71.1	79.0	80.3	95.5	87.2	7.9	107.8	97.8	172.1	25.9	86.3	114.1	70.0	83.7	161.5	85.0	175.1	49.7	56.7	141.2	25.4	62.6	51.0	147.7	25.4	58.1	132.5	84.4	310.2	76.0	99.5	118.1	90.2	65.7	112.3	29.8	84.1	116.4	51.6	71.4	426.6	107.3	53.2	80.4	307.2
LSM12	FLJ30656	ENSG00000161654	"LSM12 homolog"	Q3MHD2	17	44034635-44067619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 220.5;Late spermatids: 409.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051934	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA051934: AB_2681666"	"unprognostic (3.42e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.98e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.87e-3)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (7.49e-5)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.18e-7)"	"unprognostic (8.91e-3)"	"unprognostic (2.79e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.18e-2)"	26.7	26.6	26.9	19.8	22.1	30.1	35.1	22.5	30.0	19.5	23.8	23.0	20.7	20.8	22.6	31.5	32.8	18.8	23.8	42.7	24.6	28.9	24.8	44.8	20.4	26.8	25.5	21.2	24.5	36.8	27.4	23.7	30.5	20.4	20.7	30.0	21.7	21.8	26.6	40.8	19.6	19.6	29.2	23.6	23.4	23.4	37.5	18.6	27.7	24.2	17.4	29.1	30.5	19.8	25.4	36.3	16.8	40.1	22.8	29.4	27.0	20.4	22.9	16.1	25.3	21.4	23.3	29.1	23.4	23.0	29.7	30.1	26.3	22.6	34.3	17.0	26.3	23.6	16.9	33.9	30.2	45.2	25.4	35.4	23.8	17.7	31.7	19.7	41.1	25.5	20.7	24.4	27.9	40.6	19.6	25.7	22.4	34.4	25.5	20.2	20.2	39.0	22.5	23.7	20.4	32.4	24.9	31.8	33.1	27.7	30.5	22.6	14.9	18.8	20.5	24.4	35.4	42.6	27.4	22.7	38.0	22.5	20.4	37.8	20.2	20.6	37.5	32.4	29.5	28.6	16.7	32.6	13.6	26.3	40.1	29.4	25.4	29.3	27.9	36.0	23.0	26.3	25.8	16.8	22.8	36.8	36.3	28.7	27.0	26.9	22.1	22.5	30.0	24.6	28.9	25.5	21.2	20.4	18.6	14.9	13.7	22.0	33.6	44.8	40.9	15.7	28.1	14.7	14.8	15.7	82.5	42.0	36.5	47.6	220.5	35.1	29.2	0.0	88.6	80.1	36.6	58.3	7.0	41.9	39.3	33.4	38.2	25.2	29.8	409.2	32.5	34.3	32.1	43.3	44.1	22.7	71.0	35.1	29.7	46.8	61.7	25.8	33.3	54.9	61.7	42.8	70.0	21.8	38.8	70.1
GJB3	"CX31, DFNA2, EKV"	ENSG00000188910	"Gap junction protein beta 3"	O75712	1	34781189-34786369	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease mutation, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.1;lymphoid tissue: 25.0;skin 1: 49.3;tongue: 32.1"	"Group enriched"	"Detected in many"	7	"Basal glandular cells: 49.4;Basal keratinocytes: 123.0;Pancreatic endocrine cells: 70.6;Suprabasal keratinocytes: 149.2;Urothelial cells: 169.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 26.3;CAPAN-2: 37.4;HaCaT: 30.4;HBEC3-KT: 26.0;hTCEpi: 42.7;OE19: 16.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074472			Supported	"Vesicles,Cell Junctions"		NA	NA			"Vesicles, Cell Junctions"		"HPA074472: AB_2686694"	"unprognostic (1.34e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.21e-4)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (4.50e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.46e-2)"	0.1	0.1	1.0	2.4	0.4	0.0	3.4	1.4	1.2	6.3	2.2	0.0	0.6	0.0	0.7	3.0	40.1	0.5	4.1	0.1	0.2	0.1	0.5	0.8	0.6	0.4	0.1	0.1	0.2	0.2	0.0	0.1	11.3	0.0	3.7	2.8	0.0	3.7	0.9	0.2	49.3	0.6	0.2	0.1	0.1	3.2	0.5	0.0	0.7	0.2	32.1	25.0	4.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	3.6	0.0	0.0	30.4	0.0	26.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	42.7	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	16.3	6.8	0.0	0.0	0.0	12.7	10.0	0.0	0.0	4.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	1.4	1.2	0.2	0.1	0.1	0.1	0.0	0.0	3.0	0.0	0.0	49.4	123.0	0.0	0.3	2.5	1.4	2.3	5.2	0.0	0.0	0.0	15.7	0.0	0.1	3.1	0.0	6.3	0.1	3.1	16.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	13.5	0.0	1.9	0.0	70.6	7.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	149.2	0.1	0.0	16.1	169.4
SPRR1B	"GADD33, SPRR1"	ENSG00000169469	"Small proline rich protein 1B"	P22528	1	153031202-153032900	"Cancer-related genes, Predicted intracellular proteins"	Keratinization		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 264.7;lymphoid tissue: 188.6;tongue: 618.5"	"Group enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 333.0;Urothelial cells: 93.4"	"Group enriched"	"Detected in many"	6	"cervical cancer: 468.6;head and neck cancer: 1812.5;melanoma: 425.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"hTCEpi: 92.1"															NA	NA							"unprognostic (1.73e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.59e-2)"		"unprognostic (9.68e-2)"		"prognostic unfavorable (7.66e-5)"	"unprognostic (2.22e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (7.64e-5)"			"unprognostic (5.71e-2)"		"unprognostic (2.15e-1)"	"prognostic unfavorable (7.28e-4)"	0.1	0.1	0.1	0.1	0.1	0.2	1.0	0.1	0.1	94.9	0.1	0.1	0.1	0.1	9.5	0.2	264.7	0.2	2.2	0.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	48.7	0.1	0.2	33.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.9	0.1	618.5	188.6	0.2	113.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	9.7	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	92.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.0	34.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	333.0	0.2	0.0	0.0	93.4
NCAPG	"CAP-G, FLJ12450, hCAP-G, YCG1"	ENSG00000109805	"Non-SMC condensin I complex subunit G"	Q9BPX3	4	17810902-17844862	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 65.4"	"Cell type enhanced"	"Detected in many"	12	"Erythroid cells: 23.3;Extravillous trophoblasts: 22.2;Spermatocytes: 40.4;Spermatogonia: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.9"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039613	Uncertain					NA	Yes					"HPA039613: AB_10805481"	"unprognostic (5.23e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.59e-3)"	"prognostic unfavorable (8.28e-4)"	"unprognostic (4.22e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.13e-6)"	"unprognostic (1.18e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (7.65e-5)"	"unprognostic (3.44e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.94e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-1)"	1.4	1.1	0.3	18.0	0.4	12.5	2.5	0.7	0.5	1.4	2.9	0.3	0.2	3.7	0.8	1.2	7.1	0.3	0.7	1.6	0.4	0.7	0.9	1.1	1.8	8.3	2.0	0.3	0.6	0.5	0.0	0.4	3.7	0.5	0.7	2.4	0.3	1.6	0.9	0.6	3.4	3.3	0.7	1.0	6.4	1.9	11.8	0.3	65.4	0.5	6.7	8.6	1.6	2.0	0.5	0.5	0.0	0.4	0.3	2.9	1.7	16.4	10.6	24.3	15.9	1.5	3.0	8.9	21.4	8.4	21.1	21.7	13.4	10.1	24.7	4.3	5.9	18.3	7.5	20.6	8.2	29.1	11.2	10.1	19.6	14.5	10.9	0.1	13.8	7.7	0.5	0.5	15.6	7.2	3.3	10.5	10.8	19.1	28.2	20.9	4.9	15.8	13.4	12.5	9.6	10.5	15.6	22.0	10.3	6.4	5.1	19.2	11.4	19.2	4.1	6.1	10.9	9.7	7.8	8.6	20.3	9.2	11.4	29.1	8.8	8.3	21.0	8.4	14.4	13.4	0.0	0.0	0.0	0.5	0.2	0.0	0.5	1.0	0.6	0.5	0.2	0.1	0.7	0.0	0.3	0.4	0.0	2.9	1.7	0.3	0.4	0.7	0.5	0.4	0.7	2.0	0.3	0.5	0.3	0.0	1.4	1.5	0.2	2.2	0.0	0.1	0.0	0.0	1.2	0.0	0.0	2.0	0.0	0.0	12.5	0.0	0.2	23.3	0.0	22.2	0.6	0.3	1.1	0.0	7.7	0.0	1.7	3.1	2.2	8.4	0.6	2.2	1.7	1.0	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	40.4	29.7	1.0	1.8	1.5	2.3	0.1
HJURP	"DKFZp762E1312, FAKTS, hFLEG1, URLC9"	ENSG00000123485	"Holliday junction recognition protein"	Q8NCD3	2	233833416-233854566	"Predicted intracellular proteins"	"Cell cycle"	"Chaperone, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 27.4;lymphoid tissue: 51.1;testis: 20.9"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 12.4;Erythroid cells: 46.7;Extravillous trophoblasts: 13.7;Spermatocytes: 18.4;Spermatogonia: 12.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.2;monocytes: 1.3;T-cells: 4.2"	"Low cell line specificity"	"Detected in many"							"Not detected"	"Not detected"			"HPA008436, HPA027261"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitochondria"		Yes	Yes			"Nucleoplasm, Nucleoli, Nucleoli rim"	Mitochondria	"HPA008436: AB_1850757, HPA027261: AB_2672184"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.37e-5)"	"prognostic unfavorable (2.46e-4)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (7.60e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-2)"	1.4	0.9	0.1	12.2	0.4	27.4	2.2	0.1	0.7	1.1	3.7	0.3	0.1	2.6	0.6	1.8	8.0	0.3	0.7	1.1	0.1	0.2	1.0	1.2	2.0	8.1	0.2	0.1	0.6	0.4	0.0	0.2	3.1	0.2	0.7	3.6	0.3	1.5	1.0	0.2	2.6	4.8	1.1	0.4	5.8	2.4	20.9	0.1	51.1	0.4	3.0	11.6	1.0	2.8	0.5	0.3	1.2	1.3	0.5	4.2	1.7	17.0	23.1	22.6	10.6	0.8	1.8	14.1	25.6	12.3	18.3	20.0	16.2	18.7	5.3	2.9	10.1	32.6	20.0	18.0	13.3	24.4	12.5	6.8	20.6	18.6	15.7	0.1	16.9	14.2	0.6	0.5	14.9	10.3	5.2	11.4	16.5	17.4	13.3	33.6	17.2	23.7	18.7	19.3	13.4	16.0	18.4	33.9	9.5	9.4	10.3	13.0	8.1	14.8	11.2	10.5	10.8	8.4	13.1	8.3	19.8	21.6	14.5	27.7	12.7	10.0	21.4	11.9	12.5	49.3	0.6	0.2	0.2	0.3	0.2	0.2	0.4	0.7	0.6	0.3	0.5	0.3	0.5	1.2	0.5	1.3	0.2	4.2	1.7	0.1	0.4	0.1	0.7	0.1	0.2	0.2	0.1	0.2	0.1	0.0	0.3	0.8	0.4	1.1	0.0	0.8	0.0	0.0	3.4	0.0	0.0	1.1	0.0	0.0	12.4	0.1	0.9	46.7	0.0	13.7	0.3	0.4	0.0	0.0	5.7	0.0	0.0	2.5	2.4	7.4	0.6	2.1	0.0	0.0	0.7	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.3	18.4	12.9	0.6	1.3	1.3	1.2	0.6
KRT7	"CK7, K2C7, K7, SCL"	ENSG00000135480	"Keratin 7"	P08729	12	52232520-52252186	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 156.6;salivary gland: 142.6;thyroid gland: 199.7"	"Cell type enhanced"	"Detected in many"	9	"Ductal cells: 3055.9;Exocrine glandular cells: 1910.6;Extravillous trophoblasts: 3534.8;Pancreatic endocrine cells: 3941.8;Urothelial cells: 1796.1"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 560.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"intermediate monocyte: 3.8"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 120.3;HBEC3-KT: 267.7;hTERT-HME1: 108.0;RT4: 319.2;SiHa: 251.7;SK-BR-3: 147.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000028, HPA007272, HPA007315"	Enhanced		Supported	"Intermediate filaments,Cytosol"		NA	NA		350000000	"Intermediate filaments"	Cytosol	"CAB000028: AB_2134589, HPA007272: AB_1079181, HPA007315: "	"unprognostic (2.71e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (2.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.44e-3)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (9.42e-5)"	"prognostic unfavorable (7.78e-5)"	"unprognostic (4.54e-2)"	"prognostic favorable (2.77e-9)"	"unprognostic (2.82e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.98e-3)"	3.5	0.2	0.2	0.6	0.2	0.0	43.1	0.2	0.2	7.8	0.5	0.1	18.0	0.0	1.7	9.6	14.4	11.7	27.1	1.2	0.2	0.2	35.0	4.3	63.2	0.0	0.2	0.2	3.3	15.1	1.7	2.1	156.6	0.6	23.1	0.0	0.1	142.6	67.3	0.4	10.7	0.3	4.3	0.3	0.2	2.3	4.3	0.0	0.4	199.7	6.1	16.3	58.2	22.3	0.0	0.8	0.0	3.8	0.0	0.0	0.2	0.1	101.9	0.0	0.0	0.1	0.0	120.3	21.9	0.0	11.5	1.0	0.3	72.7	0.0	0.0	7.5	0.0	80.2	0.0	267.7	0.5	0.1	0.0	0.0	54.7	0.3	2.5	0.0	0.0	0.0	16.7	0.0	108.0	0.0	11.5	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.0	0.1	0.0	0.2	1.6	66.1	319.2	0.1	0.1	251.7	147.0	0.0	1.2	5.6	0.0	87.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.0	607.4	92.0	0.0	937.0	3.2	0.0	0.8	743.9	127.2	357.2	342.0	0.0	1328.4	114.4	3055.9	12.2	11.7	0.2	0.0	1910.6	3534.8	10.3	851.4	3.5	0.9	166.7	0.0	6.3	7.4	5.2	97.2	3.4	6.2	124.9	61.3	2.1	0.0	3941.8	0.0	0.4	2.8	0.0	0.0	7.2	0.7	0.5	1.9	1206.3	1.8	0.6	1796.1
PAFAH1B2		ENSG00000168092	"Platelet activating factor acetylhydrolase 1b catalytic subunit 2"	P68402	11	117144267-117176894	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051836	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		1600000	Cytosol	"Nucleoli, Plasma membrane"	"HPA051836: AB_2681630"	"unprognostic (1.08e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.21e-3)"	"prognostic unfavorable (9.44e-4)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.25e-4)"	"prognostic unfavorable (7.79e-5)"	"unprognostic (8.18e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.34e-1)"	21.5	34.1	30.6	19.2	29.7	33.5	32.3	43.5	41.3	21.6	20.2	33.3	12.7	21.1	23.4	22.8	23.3	20.8	19.3	26.2	31.9	36.8	24.6	22.5	20.5	17.7	39.3	31.6	23.6	23.0	23.1	24.2	26.9	39.6	22.2	19.6	17.3	19.3	17.4	14.1	20.8	18.0	19.9	51.6	18.3	21.4	29.9	26.3	15.1	30.9	10.8	20.4	25.9	20.3	26.8	21.6	36.8	35.7	18.9	31.4	26.9	15.0	17.2	19.9	28.7	22.2	15.6	15.5	25.3	22.1	14.1	12.9	31.4	33.2	16.2	36.3	30.3	14.1	24.1	28.9	32.7	18.6	14.5	11.1	41.8	15.7	20.1	19.9	14.4	16.0	17.2	25.9	28.1	35.5	15.4	23.0	9.1	22.1	12.4	21.5	9.6	13.9	21.2	18.2	20.9	13.6	15.6	22.5	17.8	21.5	23.5	22.2	29.4	29.2	22.1	9.6	17.6	24.6	12.4	36.8	25.8	17.1	12.6	17.9	3.9	6.0	21.8	10.4	27.7	21.6	32.1	30.8	26.7	24.2	33.3	28.2	26.8	28.0	25.3	21.6	25.4	29.3	31.4	36.8	18.9	35.7	15.8	19.5	26.9	30.6	29.7	43.5	37.8	31.9	36.8	39.3	31.6	39.6	26.3	26.8	33.3	41.0	38.7	108.6	36.9	31.1	68.8	17.4	26.1	62.8	45.2	36.3	39.7	52.6	7.3	54.4	31.6	0.0	34.5	77.2	42.9	53.9	18.5	39.2	38.5	44.5	79.3	57.7	59.6	8.9	42.0	55.7	47.2	49.5	37.2	33.5	72.8	46.7	32.2	44.8	33.5	12.9	46.4	45.1	75.6	101.4	45.7	38.5	39.1	38.8
DIAPH1	"DFNA1, hDIA1, LFHL1"	ENSG00000131504	"Diaphanous related formin 1"	O60610	5	141515016-141619055	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	Hearing	Actin-binding	"Cancer-related genes, Deafness, Disease mutation, Epilepsy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 106.8"	"Low region specificity"	"Detected in all"							"HPA004916, HPA076913"	Approved		Approved	"Plasma membrane"		NA	NA		10000000	"Plasma membrane"		"HPA004916: AB_1847668, HPA076913: "	"unprognostic (6.79e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.73e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.54e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (7.81e-5)"	"unprognostic (2.88e-3)"	"prognostic favorable (1.29e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.65e-1)"	14.5	10.0	5.2	22.3	10.4	27.9	10.6	8.8	7.8	11.6	17.1	3.9	11.4	14.2	9.9	16.8	26.5	9.1	15.7	21.3	5.1	6.3	30.1	48.7	22.4	21.7	3.8	4.3	9.7	20.2	17.6	22.1	28.2	7.2	7.8	11.0	8.8	18.0	13.8	79.8	19.1	24.1	9.6	3.4	20.2	15.5	12.1	2.9	44.2	14.9	23.8	34.1	12.3	13.3	5.9	8.6	19.2	9.3	8.2	22.7	9.3	25.7	16.7	9.7	12.8	7.8	10.5	13.4	10.6	11.3	12.4	13.0	57.1	24.7	28.8	16.3	15.6	19.7	28.8	21.6	36.1	15.7	15.5	12.0	49.8	22.1	18.6	7.4	34.6	106.8	6.7	19.2	17.8	18.0	5.7	16.2	44.1	17.5	20.3	12.2	25.2	38.4	45.2	9.6	13.6	11.1	43.2	16.0	15.9	23.8	28.5	12.9	6.9	26.3	35.0	10.5	9.1	14.6	16.8	9.4	17.5	9.3	9.6	21.5	10.2	16.2	20.0	9.5	27.8	10.8	12.7	8.6	19.2	22.7	9.2	15.2	5.9	14.4	17.6	8.6	5.0	10.5	17.3	9.4	8.2	9.3	6.6	11.9	9.3	5.2	10.4	8.8	7.8	5.1	6.3	3.8	4.3	7.2	2.9	44.7	41.4	32.0	39.1	46.8	17.7	17.9	22.9	24.1	60.3	41.8	51.1	15.3	5.0	57.1	16.9	35.0	40.0	0.0	84.2	26.5	20.2	67.6	45.1	77.8	16.2	6.4	5.2	9.2	34.1	6.8	10.9	53.5	18.6	17.2	18.0	10.9	93.8	28.1	10.3	13.0	72.6	12.9	19.6	15.4	23.7	52.1	43.6	55.8	23.9	92.4
NAA50	"FLJ13194, MAK3, NAT13, NAT5, San"	ENSG00000121579	"N(alpha)-acetyltransferase 50, NatE catalytic subunit"	Q9GZZ1	3	113716460-113746300	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 86.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074489	Approved					NA	NA					"HPA074489: "	"unprognostic (9.74e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.51e-5)"	"unprognostic (1.62e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (7.92e-5)"	"unprognostic (2.97e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.59e-2)"	"unprognostic (7.13e-3)"	"unprognostic (2.43e-1)"	23.4	23.6	15.9	18.0	19.8	19.7	25.6	17.1	16.5	14.7	16.2	9.3	12.9	12.7	18.4	13.3	32.6	14.7	13.6	17.0	14.1	10.8	17.6	31.8	17.3	20.7	13.8	13.7	17.8	20.7	18.4	14.1	14.9	15.6	14.5	14.7	10.7	21.6	13.8	86.5	17.7	14.0	16.1	15.7	17.7	16.9	19.0	12.9	22.5	18.3	37.0	23.2	19.9	19.8	32.3	24.7	28.7	22.6	17.4	27.3	26.2	90.0	39.4	21.7	25.2	29.5	24.0	45.3	48.5	27.3	30.0	34.6	56.5	32.5	62.4	30.1	25.7	23.7	37.3	37.7	33.2	55.1	13.0	19.3	67.2	29.7	34.0	27.1	70.0	21.9	20.4	26.3	33.5	48.5	19.8	26.7	26.4	42.2	25.2	30.9	42.7	46.2	15.2	48.5	35.3	58.0	47.6	33.3	49.3	22.8	68.8	33.4	19.3	35.2	26.2	35.3	19.6	36.3	23.3	24.6	41.5	41.2	17.5	36.5	28.0	46.4	115.8	32.5	39.5	25.4	8.5	22.5	11.9	27.3	22.6	24.3	32.3	20.6	25.5	24.7	20.5	18.2	24.0	28.7	17.4	19.8	14.4	21.9	26.2	15.9	19.8	17.1	16.5	14.1	10.8	13.8	13.7	15.6	12.9	44.7	29.9	65.7	72.5	149.5	21.5	41.9	22.9	25.4	42.1	34.9	7.9	37.5	66.3	50.5	52.7	36.5	37.5	0.0	47.8	76.9	38.8	84.6	46.2	63.8	57.0	38.1	19.1	26.4	50.8	39.9	28.4	52.5	59.1	42.3	31.3	30.1	51.1	34.9	29.4	56.1	16.9	19.4	85.8	52.4	57.5	155.5	52.3	62.5	39.8	140.8
PTGES	"MGST-IV, MGST1-L1, MGST1L1, PIG12, TP53I12"	ENSG00000148344	"Prostaglandin E synthase"	O14684	9	129738331-129753047	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 59.8;placenta: 51.7;seminal vesicle: 182.9"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 118.4;Extravillous trophoblasts: 226.1;Fibroblasts: 92.9;Syncytiotrophoblasts: 231.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 16.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 30.0;BEWO: 31.9;GAMG: 57.8;HaCaT: 41.7;SK-BR-3: 30.6;U-2197: 79.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA045064	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA045064: AB_10795889"	"unprognostic (2.92e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (2.22e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.20e-2)"	17.0	0.6	1.1	6.2	1.7	3.0	16.7	1.1	1.8	11.9	4.2	0.8	59.8	1.2	2.0	9.1	8.7	2.7	4.1	4.2	2.1	3.5	3.9	0.4	3.5	3.1	1.3	0.7	2.7	0.6	6.3	0.7	51.7	2.1	11.2	2.0	2.9	16.3	182.9	2.5	19.8	3.7	4.8	1.4	1.3	3.4	9.9	0.6	2.3	1.7	6.6	14.1	14.5	15.0	0.0	0.1	16.8	3.2	0.0	0.0	0.1	0.2	18.7	0.0	8.9	30.0	10.4	31.9	1.4	12.3	0.2	0.3	0.9	13.7	0.0	0.5	3.4	57.8	41.7	0.1	1.4	0.1	0.0	0.1	0.0	13.3	0.0	0.7	0.0	0.0	6.1	9.7	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	8.9	1.6	0.0	0.0	0.0	1.0	19.9	0.1	0.7	16.7	30.6	0.1	1.3	16.0	0.0	0.0	0.0	0.0	79.1	0.0	0.0	0.0	0.0	15.7	0.0	0.1	16.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	3.2	0.0	0.0	0.1	1.1	1.7	1.1	1.8	2.1	3.5	1.3	0.7	2.1	0.6	0.0	0.0	0.0	8.2	15.9	0.0	0.0	0.0	0.0	4.5	3.5	0.0	118.4	1.7	10.6	0.4	0.3	0.0	0.0	1.0	226.1	92.9	6.9	1.1	0.0	15.4	0.0	7.0	0.0	0.0	0.0	0.3	3.8	13.5	12.6	6.4	0.0	5.7	0.0	0.0	0.5	0.0	0.0	11.2	0.3	0.0	37.6	231.0	0.0	0.3	38.2
PEX13		ENSG00000162928	"Peroxisomal biogenesis factor 13"	Q92968	2	61017225-61051990	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032141, HPA032142, CAB032689"	Enhanced		Supported	Peroxisomes		NA	NA			Peroxisomes		"CAB032689: AB_2162137, HPA032141: AB_2674176, HPA032142: AB_10669676"	"unprognostic (2.44e-3)"	"unprognostic (4.10e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (5.42e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.63e-2)"	11.7	11.5	14.2	9.1	14.7	8.4	29.2	21.4	14.9	14.3	13.1	10.3	6.0	13.0	12.3	10.3	15.7	8.9	11.6	16.3	14.1	11.7	17.7	31.8	16.8	13.1	11.7	11.7	16.5	19.5	10.9	18.7	11.9	10.8	19.6	14.1	11.6	13.7	8.7	20.7	11.5	15.3	17.4	12.2	8.2	12.7	18.2	12.3	11.7	18.0	9.7	11.0	13.7	13.3	8.3	7.9	15.1	7.0	8.0	10.5	6.2	10.4	7.7	11.1	14.2	10.6	8.4	17.1	10.9	8.6	7.5	7.7	11.5	15.9	6.8	11.9	10.7	14.1	15.8	9.8	13.2	14.2	6.6	6.8	6.3	10.4	19.0	12.6	9.3	7.7	10.2	20.4	10.2	15.8	11.5	13.5	7.8	15.1	6.1	11.3	9.5	6.9	11.2	12.0	19.4	7.8	7.4	12.2	8.6	14.2	26.2	12.5	8.6	12.2	16.7	9.8	13.7	11.1	4.9	10.5	14.4	19.2	8.3	9.3	10.0	7.7	17.2	9.1	9.6	10.1	15.1	6.1	8.8	8.3	5.8	7.9	8.3	9.7	9.2	7.9	6.7	10.5	7.9	6.0	8.0	7.0	7.0	8.2	6.2	14.2	14.7	21.4	14.9	14.1	11.7	11.7	11.7	10.8	12.3	17.9	15.5	20.1	29.3	45.4	11.5	17.5	22.9	22.7	21.6	21.0	7.9	33.0	21.6	24.5	86.1	14.6	23.6	0.0	24.5	33.0	13.4	37.4	8.1	40.0	18.9	15.9	2.4	12.3	12.1	19.4	8.9	19.0	15.1	24.4	13.1	11.4	23.4	15.8	11.0	25.0	13.8	6.5	16.7	40.9	19.0	44.0	57.4	17.3	16.3	77.9
CXCL11	"b-R1, H174, I-TAC, IP-9, SCYB11, SCYB9B"	ENSG00000169248	"C-X-C motif chemokine ligand 11"	O14625	4	76033682-76041415	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 20.1"	"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 3.0;Basal glandular cells: 2.5;Cholangiocytes: 2.5;Exocrine glandular cells: 3.0;Kupffer cells: 4.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 2.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"BJ hTERT+: 5.3;BJ hTERT+ SV40 Large T+: 8.3;BJ hTERT+ SV40 Large T+ RasG12V: 8.8;GAMG: 2.3"					"Not detected"	"Not detected"			CAB009921	Uncertain				"Secreted to blood"	NA	NA	187000				"CAB009921: AB_2088137"	"unprognostic (2.00e-1)"	"unprognostic (3.62e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.87e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (4.31e-7)"	"prognostic unfavorable (8.18e-5)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (3.29e-6)"	"unprognostic (1.53e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.48e-2)"	"unprognostic (5.32e-2)"	3.6	0.3	3.8	10.5	3.1	0.0	3.4	1.3	2.0	3.3	1.4	0.6	0.1	0.6	1.3	2.0	2.3	1.4	2.0	3.3	2.2	2.8	2.5	2.1	13.7	10.0	3.1	1.5	1.3	8.9	0.0	0.7	3.5	2.8	8.5	4.5	0.3	2.9	1.1	6.4	0.6	1.0	1.4	9.8	7.0	5.6	0.6	1.5	4.3	20.1	3.6	1.4	3.2	0.7	0.0	0.9	0.0	2.1	0.0	0.1	0.6	1.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	5.3	8.3	8.8	0.0	0.2	1.0	0.0	0.0	2.3	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.6	3.8	3.1	1.3	2.0	2.2	2.8	3.1	1.5	2.8	1.5	3.0	0.0	0.0	2.5	0.1	0.0	0.0	2.5	1.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.7	0.0	3.0	0.0	0.0	1.7	0.0	0.0	1.9	0.0	0.0	0.6	4.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.5
SIAH2		ENSG00000181788	"Siah E3 ubiquitin protein ligase 2"	O43255	3	150741127-150763477	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Syncytiotrophoblasts: 325.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061293, CAB069930"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB069930: AB_1217916, HPA061293: AB_2684470"	"prognostic favorable (1.17e-4)"	"unprognostic (1.04e-3)"	"unprognostic (3.83e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.69e-2)"	9.6	48.0	7.6	11.8	10.3	22.7	23.5	10.9	17.2	30.0	10.5	8.4	20.3	7.9	23.5	13.9	28.8	14.9	11.0	10.7	7.2	7.3	8.4	35.5	11.8	19.1	9.9	7.5	19.0	14.6	6.4	8.1	31.4	7.9	18.8	9.2	8.3	11.2	21.7	8.3	19.3	9.5	17.4	9.4	16.9	12.0	8.7	8.6	23.6	11.4	10.6	25.1	22.7	25.6	3.0	3.1	10.0	2.7	1.6	3.6	1.1	16.9	4.2	3.3	6.6	11.3	8.5	13.3	7.1	8.2	8.6	10.4	8.6	7.6	9.4	10.4	7.3	7.2	10.5	8.8	6.3	8.1	7.9	6.3	18.5	5.1	28.4	16.2	10.2	5.5	7.7	14.7	5.1	11.7	6.8	6.6	18.6	4.6	37.4	5.3	20.3	18.6	5.2	10.7	15.8	8.4	13.7	7.1	33.9	5.4	5.9	12.7	6.0	5.3	5.0	12.5	7.8	33.4	15.4	4.6	5.9	5.3	12.8	9.5	44.5	16.9	13.2	5.6	14.7	3.0	9.5	2.7	10.0	2.1	1.5	3.2	2.5	3.6	3.2	2.4	3.0	1.9	1.9	5.9	1.6	1.5	3.1	2.0	1.1	7.6	10.3	10.9	17.2	7.2	7.3	9.9	7.5	7.9	8.6	6.0	3.7	47.8	71.4	130.4	40.0	14.9	15.3	17.4	7.9	21.0	35.3	144.9	11.6	5.6	2.0	9.2	26.2	46.7	5.7	18.3	47.9	44.4	10.3	47.4	28.4	33.4	36.8	16.5	64.5	1.5	40.9	27.9	42.2	16.2	31.8	33.5	8.9	10.5	29.0	13.0	2.2	12.9	39.1	0.5	6.6	124.5	325.6	52.4	29.9	65.9
KIAA1522		ENSG00000162522	KIAA1522	Q9P206	1	32741885-32774970	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 90.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 38.4;hTCEpi: 32.0;RT4: 35.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA032050, HPA032051, HPA064839"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA032050: AB_10601764, HPA032051: AB_2674126, HPA064839: AB_2685366"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (6.29e-7)"	"unprognostic (1.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (4.55e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (1.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.12e-1)"	3.7	39.4	12.1	8.6	8.7	0.7	14.1	1.6	15.8	8.7	25.9	2.7	27.8	28.1	5.4	8.7	33.8	13.5	28.8	2.3	6.4	4.5	23.1	5.9	13.4	0.8	2.4	6.6	18.0	32.8	21.7	4.8	19.3	7.3	18.5	17.4	10.0	36.9	44.6	1.8	33.4	36.0	6.8	1.6	1.1	25.5	2.9	3.0	3.1	19.2	17.9	20.3	15.0	22.3	0.0	2.1	0.0	1.0	0.0	0.4	0.2	19.4	10.2	1.6	2.8	0.7	1.5	7.6	2.4	4.7	2.8	2.7	11.1	38.4	0.0	10.1	3.5	8.2	29.0	3.1	20.6	1.4	0.0	4.1	4.0	14.5	9.0	1.2	0.0	10.4	0.5	32.0	7.3	8.8	12.5	5.7	0.8	5.8	0.1	1.3	16.1	0.1	0.1	3.4	16.8	6.4	2.6	2.1	4.9	26.5	35.5	1.4	1.4	15.0	21.6	2.9	10.9	23.0	1.3	5.3	4.6	12.6	4.2	5.1	0.2	0.1	0.1	4.7	0.7	5.3	0.0	0.6	0.0	0.0	1.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	12.1	8.7	1.6	15.8	6.4	4.5	2.4	6.6	7.3	3.0	11.9	49.9	0.5	31.7	65.7	0.5	3.3	76.5	20.1	23.9	26.2	2.0	12.1	8.3	38.3	3.6	6.7	90.1	0.0	57.6	3.7	5.6	56.0	26.6	8.6	2.5	0.0	27.9	1.3	0.3	3.6	8.1	2.5	6.8	3.6	55.5	0.8	52.7	49.1	4.6	12.5	0.0	6.5	5.0	1.8	2.5	72.6	6.6	1.9	54.5	60.9
NCEH1	"AADACL1, KIAA1363, NCEH"	ENSG00000144959	"Neutral cholesterol ester hydrolase 1"	Q6PIU2	3	172630249-172711218	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 30.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 15.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 70.8;LHCN-M2: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026888, HPA043873"	Enhanced		Approved	"Endoplasmic reticulum"		No	No			"Endoplasmic reticulum"		"HPA026888: AB_10601557, HPA043873: "	"unprognostic (3.19e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.88e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (5.29e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.28e-1)"	17.0	14.8	6.5	7.1	23.8	6.0	5.1	14.3	30.1	4.1	9.8	2.3	1.4	3.5	3.9	2.9	4.4	3.5	6.0	14.6	13.2	9.6	18.8	4.2	17.0	11.2	6.6	11.4	2.5	4.0	6.3	4.2	5.7	17.7	6.0	10.7	4.3	8.2	4.2	6.6	2.7	4.1	2.9	5.0	9.1	10.9	2.0	4.0	1.9	3.9	3.1	9.3	5.1	3.4	3.0	10.6	4.8	15.1	2.8	2.3	4.8	23.3	13.6	0.4	0.7	0.8	0.9	1.9	17.6	11.7	11.7	6.8	3.4	70.8	1.9	26.5	10.6	11.2	4.7	0.5	8.6	27.2	6.5	1.1	1.3	2.2	2.6	1.0	3.5	4.9	0.4	0.8	8.0	12.0	11.0	7.8	1.0	0.3	1.7	33.1	1.9	0.5	1.2	0.6	6.6	11.2	0.5	1.3	2.4	20.9	3.1	0.4	0.2	10.6	11.2	2.3	0.8	3.8	1.6	21.1	18.0	2.7	8.4	31.8	2.0	3.8	1.6	13.4	3.4	13.6	4.8	15.1	0.5	2.3	9.6	1.5	3.0	1.5	1.6	10.6	1.9	1.5	1.8	0.5	2.8	6.2	0.6	1.3	4.8	6.5	23.8	14.3	30.1	13.2	9.6	6.6	11.4	17.7	4.0	44.7	19.9	6.4	16.9	6.1	12.9	27.7	25.5	30.8	28.4	15.7	21.6	6.2	3.3	54.9	4.5	8.7	13.1	46.7	26.6	3.8	6.1	23.2	4.7	1.6	48.4	4.8	7.5	5.5	34.7	2.6	0.9	14.5	5.0	1.8	9.7	4.9	50.0	10.5	2.5	25.4	19.2	6.5	5.8	0.0	0.9	3.0	8.8	3.8	6.0	22.8
PLEK2		ENSG00000100558	"Pleckstrin 2"	Q9NYT0	14	67386983-67412200	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 132.3;Pancreatic endocrine cells: 114.0;Suprabasal keratinocytes: 79.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 4.0;naive CD4 T-cell: 6.5"	"Lineage enriched"	"Detected in single"	8	"T-cells: 6.5"	"Cell line enhanced"	"Detected in many"		"A-431: 26.7;CAPAN-2: 28.6;HBEC3-KT: 53.3;PC-3: 19.5;TIME: 20.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA001208	Enhanced		Uncertain	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA001208: AB_1079631"	"unprognostic (4.41e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.23e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.97e-1)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (8.26e-5)"	"unprognostic (1.06e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.59e-2)"	1.7	28.8	0.5	7.6	1.1	4.1	1.5	0.5	0.8	2.4	14.9	1.4	1.6	12.4	1.1	14.9	9.7	0.4	7.4	0.5	0.5	0.2	6.0	29.1	1.9	0.5	0.5	0.5	1.0	16.5	2.5	0.9	2.6	0.7	5.1	12.7	0.9	6.9	2.3	1.4	12.1	28.1	1.2	0.7	0.6	8.5	2.4	0.5	13.9	28.6	6.5	6.5	4.8	4.4	0.0	0.8	0.0	0.1	0.0	6.5	1.2	26.7	4.0	0.0	0.0	0.0	0.3	2.7	5.4	0.8	1.3	1.6	14.6	28.6	0.0	5.3	0.7	0.0	12.8	0.0	53.3	3.0	0.0	0.2	0.0	6.2	0.1	1.1	0.0	0.0	0.6	3.8	1.4	17.1	0.0	4.4	0.0	0.1	0.1	0.9	8.5	0.0	0.0	0.1	17.3	19.5	0.0	0.0	4.1	9.1	0.7	0.2	0.0	5.1	2.4	1.5	0.2	3.5	0.2	20.7	0.0	16.7	0.1	0.1	0.0	0.0	0.1	3.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.7	0.8	0.0	6.5	0.7	0.0	0.0	0.0	0.0	0.0	1.2	0.5	1.1	0.5	0.8	0.5	0.2	0.5	0.5	0.7	0.5	0.0	0.6	0.0	20.4	132.3	0.0	0.3	5.1	1.4	3.4	5.2	0.0	0.9	3.3	40.6	0.1	0.7	36.5	0.0	41.0	5.1	9.3	10.8	0.0	9.4	7.0	0.0	8.1	0.0	1.0	0.0	0.3	15.0	20.3	9.0	44.7	0.0	114.0	21.0	0.0	1.6	0.0	0.0	5.1	0.3	0.9	79.3	1.3	0.0	46.5	23.8
SAMD9	"C7orf5, FLJ20073, KIAA2004"	ENSG00000205413	"Sterile alpha motif domain containing 9"	Q5K651	7	93099513-93118023	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 34.6;lymphoid tissue: 35.4"	"Cell type enhanced"	"Detected in many"	5	"Paneth cells: 59.6;T-cells: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 29.4;GAMG: 28.8"					"Low region specificity"	"Detected in all"			"HPA021318, HPA021319"	Approved		Supported	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA021318: AB_2183383, HPA021319: AB_1856554"	"unprognostic (3.66e-2)"	"unprognostic (5.35e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.48e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (8.31e-5)"	"unprognostic (6.00e-2)"	"prognostic unfavorable (8.40e-7)"	"unprognostic (5.91e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.64e-1)"	9.6	4.0	2.3	9.2	2.4	5.2	2.6	1.0	1.6	9.3	6.8	0.6	0.9	4.3	2.8	3.0	34.6	2.7	4.3	2.5	1.3	1.5	6.3	3.5	7.8	10.8	2.5	1.1	6.3	2.3	0.1	6.4	11.3	3.1	5.3	7.0	0.7	5.7	1.6	2.4	1.5	12.7	2.2	2.5	21.7	6.3	2.5	1.7	35.4	3.3	9.9	9.5	4.8	9.7	5.5	3.0	15.6	9.8	7.4	7.6	2.6	11.7	1.5	0.4	0.1	5.3	6.8	0.1	4.6	19.3	22.2	29.4	0.0	13.1	4.9	7.3	11.4	28.8	13.9	0.0	4.2	7.5	16.8	0.5	7.2	7.9	0.0	2.4	8.0	10.0	3.0	6.1	7.3	2.0	1.2	3.3	5.5	0.5	12.3	4.6	0.0	11.9	6.6	0.0	0.0	3.3	3.9	3.9	5.6	0.1	1.5	1.9	0.2	3.6	1.4	3.8	0.0	0.4	3.9	14.2	5.2	1.9	15.5	2.5	7.4	1.4	4.6	5.4	4.7	5.1	15.6	3.6	12.7	7.6	7.0	7.3	5.0	5.9	6.5	3.0	5.5	6.3	5.7	15.5	7.4	9.8	2.1	7.2	2.6	2.3	2.4	1.0	1.6	1.3	1.5	2.5	1.1	3.1	1.7	8.9	3.0	23.2	7.5	2.1	1.6	0.9	2.5	20.1	9.1	14.0	0.0	1.5	0.0	20.9	0.0	24.8	12.1	0.0	10.8	4.6	8.3	6.6	41.7	1.0	10.7	6.4	2.9	8.0	24.0	0.2	14.1	26.3	3.3	13.6	20.9	2.0	32.1	59.6	11.7	2.1	0.0	12.9	9.2	0.2	0.0	1.6	0.3	50.7	3.3	25.5
AREG	"AREGB, SDGF"	ENSG00000109321	Amphiregulin	P15514	4	74445134-74455009	"Cancer-related genes, Predicted membrane proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 83.5"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 759.9;Basal keratinocytes: 994.1;Enterocytes: 632.3;granulocytes: 633.9;Urothelial cells: 1407.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"basophil: 8.2;eosinophil: 11.6;NK-cell: 3.3"	"Group enriched"	"Detected in many"	9	"granulocytes: 11.6;NK-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 42.8;HBEC3-KT: 74.1;hTCEpi: 75.5;hTERT-HME1: 161.4;MCF7: 46.5"	"Region enriched"	"Detected in single"	4	"olfactory region: 1.5"	"Low region specificity"	"Detected in all"			"HPA008720, CAB023519"	Approved		Approved	Mitochondria		NA	NA	1520000		Mitochondria		"CAB023519: AB_2060673, HPA008720: AB_1844978"	"unprognostic (1.44e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.90e-1)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (8.32e-5)"	"unprognostic (2.56e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.83e-3)"	19.5	1.1	0.4	9.2	2.1	28.9	20.3	0.3	0.4	5.7	6.7	0.2	0.2	0.7	1.7	1.6	22.3	6.0	34.8	13.6	0.5	0.4	2.5	1.7	14.4	13.3	0.4	0.0	5.8	1.0	0.0	7.8	83.5	1.3	1.9	5.0	1.4	3.9	0.9	9.9	3.4	10.0	1.5	1.0	11.3	5.3	4.6	0.0	1.6	1.2	13.4	13.6	8.7	4.6	0.4	0.8	11.6	0.0	3.3	0.4	0.1	1.7	12.2	0.0	0.0	0.1	0.1	0.0	0.3	0.5	0.0	0.3	42.8	6.8	0.0	0.9	0.0	0.0	1.9	0.0	74.1	0.7	0.0	0.0	0.0	0.3	2.0	23.0	0.2	0.0	0.7	75.5	4.4	161.4	0.1	0.0	0.0	0.1	0.0	1.6	46.5	0.0	0.0	0.0	8.8	4.9	0.0	0.0	0.0	4.2	0.3	0.0	0.0	2.5	0.1	0.0	0.0	1.3	0.0	0.1	0.0	1.7	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	8.2	0.0	11.6	0.0	0.0	0.0	0.3	0.4	0.0	0.8	0.4	0.2	0.0	0.1	3.3	0.0	0.1	0.0	0.1	0.4	2.1	0.3	0.4	0.5	0.4	0.4	0.0	1.3	0.0	184.6	339.4	82.8	759.9	994.1	0.0	30.5	71.4	92.3	310.5	48.8	0.0	1.3	0.0	52.7	45.1	3.9	632.3	0.0	8.6	1.2	28.2	73.6	633.9	2.9	31.8	0.0	39.8	10.4	189.5	5.9	0.3	134.1	32.1	1.8	188.0	0.0	301.5	221.0	1.1	0.5	0.0	19.4	4.4	52.0	45.0	299.4	0.9	149.6	119.9	1407.8
OPA1	"FLJ12460, KIAA0567, MGM1, NPG, NTG"	ENSG00000198836	"OPA1, mitochondrial dynamin like GTPase"	O60313	3	193593144-193697823	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Sensory transduction, Vision"	Hydrolase	"Cardiomyopathy, Deafness, Disease mutation, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 130.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036926, HPA036927"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA		13000	"Nucleoplasm, Mitochondria"		"HPA036926: AB_10671247, HPA036927: AB_2675388"	"unprognostic (2.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (1.62e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.44e-5)"	"unprognostic (3.48e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (2.92e-1)"	"unprognostic (4.75e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.21e-1)"	17.0	19.7	18.2	13.5	31.7	25.9	15.9	20.2	30.9	13.9	21.8	11.1	12.6	20.0	15.2	11.8	18.8	11.8	12.8	43.9	23.0	19.4	21.8	24.1	10.7	15.3	19.0	22.4	13.2	13.4	20.9	15.6	13.8	28.0	15.5	20.5	9.1	15.7	20.8	38.4	14.6	17.3	16.5	17.0	13.1	16.7	7.6	10.8	18.0	16.8	18.4	14.2	16.5	13.6	8.3	8.8	8.2	17.6	5.0	7.5	5.9	26.0	8.4	8.5	9.3	7.5	11.9	9.0	12.7	11.7	13.9	13.6	20.3	8.8	17.3	27.4	11.9	12.7	17.0	14.8	14.3	24.7	20.8	12.0	29.9	7.5	10.2	11.7	24.6	13.8	13.3	12.8	13.4	19.1	8.6	11.7	7.3	12.7	17.0	13.8	20.6	9.5	13.7	11.9	15.0	28.0	12.5	18.7	18.5	10.4	16.3	18.5	11.3	18.9	21.2	13.4	6.8	27.8	19.5	11.7	12.9	9.8	13.8	26.6	15.4	17.8	33.9	14.3	19.7	12.9	8.2	8.1	7.7	7.2	9.3	6.6	8.3	6.8	6.8	8.8	6.3	6.9	7.3	3.2	5.0	17.6	4.6	7.5	5.9	18.2	31.7	20.2	30.9	23.0	19.4	19.0	22.4	28.0	10.8	14.9	20.0	20.6	13.8	14.2	17.0	130.0	15.3	16.0	20.5	17.4	29.5	16.2	14.9	14.8	7.2	13.5	20.6	70.0	20.7	12.2	15.9	15.5	18.5	30.2	15.9	20.6	22.4	16.0	23.5	10.2	14.7	21.2	20.3	11.8	20.6	15.7	22.7	7.0	13.8	26.9	21.6	6.5	17.5	11.3	15.0	19.6	15.0	12.8	25.8	19.6
FLNB	"ABP-278, FH1, FLN1L, LRS1, TABP, TAP"	ENSG00000136068	"Filamin B"	O75369	3	58008400-58172251	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Differentiation, Myogenesis"	"Actin-binding, Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 215.6;Extravillous trophoblasts: 184.6;Pancreatic endocrine cells: 247.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 71.8;TIME: 80.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004747, HPA004886, CAB019322"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Actin filaments,Cytosol"		NA	NA		37000000	"Plasma membrane"	"Golgi apparatus, Actin filaments, Cytosol"	"CAB019322: , HPA004747: AB_1848599, HPA004886: AB_1848600"	"unprognostic (1.29e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (9.23e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (4.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.33e-1)"	24.7	17.8	7.8	25.3	10.6	2.2	30.0	12.6	7.4	21.3	33.5	17.2	49.6	19.4	36.1	47.4	18.6	17.3	16.0	7.7	10.6	8.5	20.6	29.2	14.1	9.4	16.1	5.3	22.9	22.4	25.6	7.8	36.0	13.2	35.8	28.5	20.1	25.5	44.0	7.7	28.9	50.2	39.7	24.3	12.1	21.2	11.7	13.5	49.3	28.2	12.0	13.0	32.8	34.7	3.8	15.9	7.4	1.2	5.9	4.9	1.2	20.2	34.7	3.5	5.1	2.4	4.1	61.2	7.5	6.1	16.9	17.3	34.7	34.8	3.3	2.8	26.6	27.5	33.4	6.5	48.2	16.5	18.3	3.2	2.8	29.5	16.8	17.5	2.4	10.0	6.5	20.9	23.4	71.8	20.0	57.0	14.8	4.6	1.0	10.5	4.4	7.3	5.8	5.4	22.4	30.1	3.2	0.9	2.8	22.5	34.6	3.9	3.6	38.3	21.0	4.2	26.8	17.3	6.7	80.8	4.4	13.8	52.7	26.9	0.7	0.2	2.6	16.4	4.4	4.6	7.4	0.3	4.2	0.5	0.8	2.6	3.8	1.6	0.7	1.2	1.6	4.9	3.5	0.1	5.9	1.2	15.9	1.7	1.2	7.8	10.6	12.6	7.4	10.6	8.5	16.1	5.3	13.2	13.5	47.6	33.3	5.1	35.9	45.0	2.7	10.5	58.6	54.9	44.3	45.4	37.3	23.5	0.0	81.2	15.8	61.2	215.6	0.0	57.7	184.6	26.7	99.5	24.3	46.4	13.6	1.6	47.3	130.8	11.4	17.1	15.0	10.9	5.0	17.2	70.6	10.0	247.2	108.7	26.2	6.8	10.9	0.0	12.0	1.9	5.1	45.2	41.6	7.5	60.6	62.1
GNPNAT1	"FLJ10607, Gpnat1"	ENSG00000100522	"Glucosamine-phosphate N-acetyltransferase 1"	Q96EK6	14	52775194-52791668	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.3"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044647	Approved					NA	NA		17000			"HPA044647: AB_10795986"	"unprognostic (4.55e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.18e-3)"	"unprognostic (4.23e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (8.52e-5)"	"unprognostic (5.82e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.05e-2)"	13.4	6.9	6.4	6.7	6.6	2.1	10.6	9.2	9.2	10.0	11.2	4.6	6.8	9.3	8.1	6.4	8.4	6.3	9.3	6.3	5.8	6.3	11.5	47.3	6.4	8.6	5.4	5.2	9.3	28.4	6.9	12.4	6.5	7.1	10.1	14.0	4.1	22.2	4.7	9.4	4.8	8.5	8.2	6.3	7.3	12.0	12.5	4.2	3.6	5.4	6.0	7.1	7.3	7.2	6.1	5.1	6.6	5.7	7.7	8.4	4.2	33.0	13.2	10.5	11.9	11.4	25.8	17.3	21.6	13.9	18.9	19.5	15.0	19.6	18.8	12.1	21.3	9.0	13.4	20.1	21.7	32.7	10.7	10.8	12.6	12.7	18.6	16.5	14.0	6.8	10.8	18.6	31.9	34.2	9.7	21.0	12.0	12.1	4.6	24.1	28.7	16.7	7.3	11.0	43.3	23.3	11.6	4.9	11.3	17.8	17.7	10.8	14.8	17.8	24.2	15.4	7.5	27.6	4.8	23.4	19.2	20.1	33.8	16.6	4.8	9.3	8.3	9.0	9.2	11.1	6.6	2.2	0.1	7.1	2.7	8.4	6.1	7.3	6.2	5.1	5.4	8.4	6.8	0.7	7.7	5.7	3.2	8.4	4.2	6.4	6.6	9.2	9.2	5.8	6.3	5.4	5.2	7.1	4.2	14.9	8.9	6.0	18.9	17.1	10.1	3.4	25.5	16.0	13.6	12.2	3.9	21.4	28.2	29.2	16.2	12.4	8.5	0.0	32.6	61.8	19.0	28.0	6.9	81.6	14.0	3.2	5.2	9.2	7.1	5.4	18.1	8.3	6.8	4.6	38.1	5.0	34.9	14.0	17.0	12.2	6.5	19.4	14.6	24.2	4.1	18.6	10.2	7.7	25.6	33.5
CDA	CDD	ENSG00000158825	"Cytidine deaminase"	P32320	1	20588948-20618908	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 126.5;bone marrow: 68.0"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 120.2;Hepatocytes: 94.4;Kupffer cells: 118.1;Pancreatic endocrine cells: 70.1;Paneth cells: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 126.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 126.5"	"Cell line enhanced"	"Detected in many"		"A-431: 42.9;CAPAN-2: 28.6;HeLa: 40.6;PC-3: 20.4;SiHa: 51.0;U-937: 18.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA064202	Enhanced		Approved	Nucleoplasm		NA	NA		3700000	Nucleoplasm		"HPA064202: AB_2685211"	"unprognostic (2.38e-1)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (2.86e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.02e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (8.56e-5)"	"unprognostic (2.94e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.89e-3)"	4.0	1.4	1.5	4.0	1.5	68.0	2.2	1.1	2.4	19.0	8.6	1.7	2.0	2.6	6.7	3.5	38.3	2.9	1.8	5.9	1.7	1.6	12.5	42.1	8.4	9.1	2.0	1.3	2.9	0.8	1.2	0.7	30.8	3.5	4.2	10.2	4.5	6.9	1.5	3.2	7.0	24.7	4.3	1.9	11.8	1.2	2.9	0.9	0.9	3.0	23.3	10.5	3.1	16.5	0.0	1.3	126.5	21.7	0.0	0.1	7.1	42.9	4.2	0.0	0.0	0.0	1.3	0.0	3.3	0.9	0.8	3.4	0.2	28.6	0.0	1.6	6.8	1.8	15.1	0.8	11.2	2.2	0.0	0.8	0.0	40.6	5.4	0.3	0.0	0.0	1.9	1.8	8.1	0.0	0.1	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	5.0	20.4	0.0	0.0	0.4	0.1	0.0	0.0	0.0	51.0	0.0	0.0	0.5	0.0	1.2	0.7	0.0	1.7	3.9	0.2	0.0	0.0	0.0	0.5	18.0	0.0	16.3	21.7	43.3	0.0	11.4	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	126.5	0.0	9.3	0.2	0.0	7.1	1.5	1.5	1.1	2.4	1.7	1.6	2.0	1.3	3.5	0.9	3.0	1.4	0.9	0.2	1.3	0.1	2.8	2.5	0.0	0.0	5.2	0.0	0.2	36.5	2.4	0.6	4.4	120.2	0.0	1.3	2.7	1.0	0.9	0.0	94.4	6.1	0.0	0.0	28.8	118.1	0.8	0.3	3.7	0.0	0.0	12.5	0.0	70.1	48.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	2.1	1.5	4.9	0.3
EFNB2	"EPLG5, Htk-L, HTKL, LERK5, MGC126226, MGC126227, MGC126228"	ENSG00000125266	"Ephrin B2"	P52799	13	106489731-106535662	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 134.4;Muller glia cells: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.5"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 48.7;OE19: 27.9;SH-SY5Y: 24.4;U-87 MG: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008999, CAB009368"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		760000	Nucleoplasm	Cytosol	"CAB009368: AB_2095700, HPA008999: AB_1078721"	"unprognostic (1.70e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.52e-3)"	"prognostic unfavorable (3.11e-6)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.43e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (8.70e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.27e-3)"	15.7	4.9	11.2	8.2	11.0	0.8	21.8	8.3	14.0	13.2	23.1	5.8	13.1	13.9	10.8	5.2	11.4	13.6	11.2	11.8	10.4	6.5	9.3	11.8	50.1	7.8	6.2	11.5	8.4	3.7	5.7	6.1	27.7	5.2	11.8	18.4	15.2	12.7	20.6	6.6	14.3	20.6	10.5	5.0	9.3	21.3	7.2	5.9	7.3	11.2	8.8	5.9	7.7	12.4	0.2	0.0	0.4	0.0	1.5	0.0	0.0	11.6	1.1	48.7	0.0	0.1	0.3	0.1	5.3	3.3	5.3	3.0	11.8	17.8	0.0	5.1	1.6	0.4	13.9	1.8	6.8	5.7	0.0	10.4	0.0	4.0	0.0	1.0	3.8	0.3	2.2	12.2	0.2	10.4	2.6	6.6	0.1	0.0	0.0	5.7	2.0	0.1	0.0	2.6	27.9	2.3	9.8	1.9	0.0	7.5	1.5	3.4	24.4	2.0	1.0	0.0	14.3	0.6	0.1	5.2	10.4	0.0	0.3	11.9	0.1	0.0	0.0	21.9	0.2	2.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	11.2	11.0	8.3	14.0	10.4	6.5	6.2	11.5	5.2	5.9	6.0	29.4	1.9	48.4	73.8	9.4	7.4	7.6	9.4	12.5	24.4	0.0	1.1	0.0	6.9	0.4	80.4	63.8	0.0	1.2	2.6	17.1	25.9	18.4	0.4	1.0	6.4	48.6	134.4	8.6	0.5	0.3	1.3	30.4	0.0	38.0	92.0	27.1	53.7	0.4	0.0	2.8	0.0	20.3	0.6	3.2	75.2	1.6	3.2	27.5	75.5
PGM1		ENSG00000079739	"Phosphoglucomutase 1"	P36871	1	63593276-63660245	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase	"Congenital disorder of glycosylation, Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 233.5"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 209.3;Hepatocytes: 186.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004666, HPA024190, HPA024637, HPA046329"	Enhanced		Approved	Cytosol		NA	NA		20000000	Cytosol		"CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: AB_2679625"	"unprognostic (2.50e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (8.74e-5)"	"unprognostic (7.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.74e-3)"	17.8	14.1	7.0	4.4	8.3	3.5	9.8	4.4	8.3	6.7	12.9	5.2	4.6	10.6	4.6	7.7	8.8	3.3	8.9	36.9	6.4	5.4	10.0	56.4	7.6	2.7	6.2	6.3	9.7	21.6	12.9	6.2	11.5	8.5	8.7	9.1	5.4	7.9	9.4	233.5	5.3	12.4	8.4	5.6	3.0	5.7	3.0	5.5	3.0	6.0	42.8	6.3	9.4	4.7	12.2	25.9	25.6	17.9	21.1	23.3	16.6	29.8	12.5	4.7	15.5	31.2	23.1	38.3	12.3	16.7	13.4	22.0	10.3	13.9	9.4	25.8	19.0	29.7	7.1	6.5	25.9	15.8	11.5	8.7	19.9	21.2	10.6	25.8	17.4	1.1	29.1	16.7	15.6	24.8	36.0	8.0	9.8	0.0	12.6	21.5	1.8	5.0	9.6	21.4	0.9	20.1	7.1	22.0	3.0	19.5	9.4	2.8	18.4	26.9	28.2	41.0	22.9	8.8	6.6	0.7	19.9	10.2	17.6	10.4	8.0	11.7	15.4	32.5	15.3	8.5	20.5	17.9	25.6	23.3	12.0	18.6	12.2	13.7	17.5	25.9	6.9	12.5	14.5	21.2	21.1	10.2	7.5	10.6	16.6	7.0	8.3	4.4	8.3	6.4	5.4	6.2	6.3	8.5	5.5	86.4	31.4	19.9	24.0	15.9	8.1	140.8	50.9	14.7	10.3	15.7	9.8	71.5	74.6	42.0	24.0	10.7	74.3	0.0	209.3	136.9	28.0	18.3	4.7	186.6	22.2	0.0	12.6	16.0	18.3	5.2	20.4	10.7	25.3	32.5	40.1	54.2	92.3	23.0	35.7	59.8	10.7	12.9	17.9	4.7	7.5	15.8	49.2	21.8	71.1	13.6
FNDC3B	"DKFZp762K137, FAD104, FLJ23399, PRO4979, YVTM2421"	ENSG00000075420	"Fibronectin type III domain containing 3B"	Q53EP0	3	172039628-172401665	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 22.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007859	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA007859: AB_1078900"	"unprognostic (7.18e-2)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (6.03e-2)"	"unprognostic (6.38e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (2.17e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (9.06e-5)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (5.65e-7)"	"unprognostic (4.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.00e-2)"	39.6	22.1	4.0	16.5	5.7	18.2	27.3	2.9	5.1	20.8	18.4	4.2	20.9	7.5	28.9	21.7	13.2	12.3	18.3	18.9	4.9	4.2	17.6	35.6	23.1	10.9	6.7	2.3	26.4	30.7	12.3	21.4	64.1	5.9	15.1	11.5	13.4	27.7	19.8	22.0	8.1	13.1	17.8	6.6	17.5	15.0	10.5	5.0	4.8	21.2	10.5	12.8	25.4	25.8	0.6	2.7	22.7	5.0	2.4	2.6	1.8	12.2	14.2	9.9	12.0	31.0	21.4	24.0	17.6	19.9	11.9	16.3	7.8	27.1	1.2	47.2	26.5	23.7	7.3	3.4	14.3	21.0	7.0	2.5	1.7	9.1	21.4	31.2	15.7	27.6	21.6	7.3	22.2	21.2	28.6	31.7	2.2	2.8	8.9	12.5	3.8	0.6	6.9	5.7	4.7	5.8	1.4	10.2	5.9	13.1	10.9	0.6	3.0	16.8	8.7	14.6	14.3	8.2	8.1	45.8	16.8	7.8	21.2	13.8	18.7	20.7	2.4	17.7	9.1	16.5	7.8	5.0	11.4	2.6	3.0	1.1	0.6	0.8	1.4	2.7	0.0	0.9	1.6	22.7	2.4	1.5	0.4	0.7	1.8	4.0	5.7	2.9	5.1	4.9	4.2	6.7	2.3	5.9	5.0	80.4	43.5	12.0	47.6	56.7	7.5	43.1	50.9	13.4	35.2	43.6	11.8	35.6	13.3	62.0	7.7	56.2	22.4	0.0	39.5	90.0	84.5	54.9	15.0	60.6	44.9	0.0	16.1	62.0	65.2	5.3	53.2	61.1	65.8	50.5	28.4	16.6	73.1	40.8	51.2	30.5	12.2	51.8	50.5	2.4	2.7	29.4	29.1	19.2	20.0	74.5
NCK1	"NCK, NCKalpha"	ENSG00000158092	"NCK adaptor protein 1"	P16333	3	136862208-136949823	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005063, HPA030766"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB005063: AB_562169, HPA030766: AB_2673602"	"unprognostic (7.47e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.06e-2)"	"unprognostic (8.77e-3)"	"unprognostic (4.24e-3)"	"unprognostic (8.30e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (9.14e-5)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.17e-2)"	44.5	15.7	11.5	24.5	13.4	19.3	38.9	22.6	11.6	23.7	18.3	8.4	16.5	10.2	20.8	19.2	35.9	14.6	13.9	16.8	11.8	11.1	14.0	20.9	22.4	33.0	13.9	12.1	19.6	14.3	17.9	17.7	22.7	13.5	26.3	19.5	10.8	24.0	15.8	29.0	27.3	14.3	24.0	13.5	18.7	12.8	14.7	12.7	41.1	23.8	23.5	29.0	27.3	43.3	8.5	13.3	26.8	27.1	11.2	20.2	11.9	20.0	8.9	11.8	9.7	27.4	26.6	13.2	14.9	26.8	17.3	18.1	12.9	20.0	19.7	30.9	17.4	22.4	15.5	16.6	15.1	23.1	14.2	6.8	17.1	12.6	10.1	44.6	12.3	11.8	24.1	19.9	16.8	33.5	17.7	26.5	18.7	10.2	17.6	18.1	10.9	27.9	10.0	11.2	18.1	11.3	15.3	11.0	18.9	16.1	13.8	8.4	8.1	26.8	12.0	23.9	15.0	17.3	13.6	13.1	11.3	7.3	16.0	8.4	17.7	13.8	24.4	11.9	11.1	12.0	26.8	12.4	13.2	19.7	27.1	20.2	8.1	15.6	19.8	13.3	8.5	12.6	15.0	7.2	11.2	13.4	5.2	15.0	11.9	11.5	13.4	22.6	11.6	11.8	11.1	13.9	12.1	13.5	12.7	8.9	15.7	26.5	64.7	66.4	18.9	9.4	15.3	10.7	23.9	8.7	5.9	42.1	13.3	38.5	9.2	68.0	17.2	0.0	24.2	41.6	41.4	45.8	9.2	33.7	45.3	23.8	13.3	25.2	28.8	7.3	40.9	45.6	40.5	48.7	17.1	19.3	29.4	23.0	25.1	18.7	12.7	12.9	33.0	44.9	32.9	72.8	51.0	68.2	15.6	120.8
STK3	"KRS1, MST2"	ENSG00000104375	"Serine/threonine kinase 3"	Q13188	8	98401403-98942827	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 118.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 8.3;granulocytes: 9.0;monocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"A-431: 37.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007120, CAB025316"	Uncertain		Approved	"Intermediate filaments,Rods & Rings"		NA	NA			"Intermediate filaments, Rods & Rings"		"CAB025316: , HPA007120: AB_10601664"	"unprognostic (7.88e-3)"	"unprognostic (1.96e-1)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.12e-3)"	"unprognostic (9.68e-3)"	"prognostic unfavorable (4.25e-4)"	"unprognostic (6.71e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (9.21e-5)"	"unprognostic (9.16e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.72e-2)"	16.5	16.6	6.5	8.1	12.4	2.5	20.5	2.6	10.6	17.2	13.1	10.5	14.2	4.6	22.2	13.1	9.0	16.0	12.6	10.0	7.4	4.1	14.7	12.0	16.2	10.8	12.8	3.6	22.8	10.7	15.1	18.9	53.1	9.9	15.0	6.0	8.2	10.8	16.4	11.6	10.0	10.8	23.5	12.9	8.2	9.5	10.1	11.4	3.4	10.6	7.9	5.9	16.4	24.3	1.9	8.3	9.0	8.7	1.8	1.8	2.9	37.3	7.0	7.5	9.8	24.2	12.1	7.5	13.0	11.7	12.2	10.6	5.2	15.9	0.0	11.4	12.9	6.4	15.1	5.2	11.2	19.7	9.0	6.6	10.0	3.5	3.5	8.3	3.3	8.7	8.0	19.4	6.2	17.0	8.0	5.2	5.9	4.2	5.4	8.8	4.7	8.3	4.0	2.2	25.8	2.7	7.4	6.4	3.2	13.8	4.7	1.9	4.3	8.3	9.6	8.0	10.0	7.9	5.4	3.9	8.2	5.2	12.4	7.2	4.3	6.5	2.7	7.4	4.2	13.0	2.1	8.6	4.5	1.3	8.7	1.4	1.9	0.8	1.8	8.3	1.3	1.1	0.7	9.0	1.8	5.4	3.4	0.1	2.9	6.5	12.4	2.6	10.6	7.4	4.1	12.8	3.6	9.9	11.4	35.7	32.0	4.7	38.6	38.8	6.0	15.1	22.9	33.5	42.1	27.9	13.7	36.5	19.9	17.3	118.9	30.2	17.6	0.0	16.5	49.2	41.3	37.6	16.2	18.4	16.1	9.5	8.7	22.1	14.6	63.7	84.3	20.2	23.6	7.2	7.6	15.1	19.7	9.5	69.6	20.3	14.2	38.8	39.6	17.0	11.9	35.4	54.1	8.2	9.3	31.1
IARS2	FLJ10326	ENSG00000067704	"Isoleucyl-tRNA synthetase 2, mitochondrial"	Q9NSE4	1	220094102-220148041	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cataract, Deafness, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024212, HPA024594, HPA024596"	Enhanced		Enhanced	Mitochondria		NA	NA		26000	Mitochondria		"HPA024212: AB_1851363, HPA024594: AB_1851368, HPA024596: AB_1851370"	"unprognostic (2.15e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (9.24e-5)"	"unprognostic (9.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.27e-3)"	25.9	39.3	18.0	17.9	16.9	6.7	31.9	15.1	20.8	16.9	26.2	14.8	24.3	18.9	21.5	16.8	23.8	18.8	16.5	40.0	17.5	12.6	29.5	37.3	16.8	25.9	15.6	16.0	20.5	20.5	42.5	15.3	26.2	17.4	18.5	24.9	15.0	22.4	22.3	57.8	22.2	23.4	17.7	15.7	16.1	18.5	15.7	13.7	19.5	17.8	25.9	20.1	24.9	18.7	16.8	20.0	17.2	19.0	18.5	22.6	16.8	38.3	36.0	20.7	20.3	31.3	31.6	49.9	23.4	25.2	25.9	21.0	34.6	40.1	35.5	31.7	28.9	20.1	37.3	28.7	29.2	30.0	24.5	34.6	17.6	29.4	38.8	19.5	27.9	19.1	22.8	29.8	28.0	29.0	25.1	25.2	23.1	43.4	20.6	33.9	21.3	22.0	20.2	26.9	30.0	23.9	19.5	41.3	56.8	37.3	25.8	11.2	31.5	35.4	55.0	36.4	24.8	63.6	31.7	25.7	25.6	21.4	34.3	39.1	17.7	27.1	25.8	27.1	22.0	28.3	17.2	16.7	15.1	16.8	19.0	22.6	16.8	18.4	22.0	20.0	13.6	20.8	19.0	3.3	18.5	14.5	7.3	19.7	16.8	18.0	16.9	15.1	20.8	17.5	12.6	15.6	16.0	17.4	13.7	32.8	33.1	24.4	24.3	17.9	26.7	126.1	15.3	58.9	45.5	27.9	23.6	68.4	10.0	37.8	12.3	43.0	33.8	0.0	56.4	44.9	24.9	20.4	18.5	88.4	40.3	19.1	34.8	38.6	46.6	2.0	34.5	26.7	18.6	25.2	50.3	28.6	54.2	28.8	40.0	28.3	31.0	45.3	22.6	32.5	40.2	23.2	60.0	22.7	61.0	20.5
FOSL1	fra-1	ENSG00000175592	"FOS like 1, AP-1 transcription factor subunit"	P15407	11	65892049-65900573	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 35.2;tongue: 46.8"	"Group enriched"	"Detected in many"	7	"Basal glandular cells: 279.5;Basal keratinocytes: 300.3;Glandular cells: 139.2;Suprabasal keratinocytes: 296.9;Urothelial cells: 386.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"myeloid DC: 6.9"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 6.9"	"Cell line enhanced"	"Detected in many"		"PC-3: 94.2;U-2197: 63.2;WM-115: 142.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004396, HPA030728"	Enhanced		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB004396: AB_627632, HPA030728: "	"unprognostic (2.88e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.80e-4)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (9.26e-5)"	"unprognostic (7.85e-2)"	"prognostic unfavorable (6.40e-6)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.82e-2)"	22.4	3.7	1.5	8.2	3.1	17.9	3.6	1.1	2.8	5.4	2.8	1.5	0.2	0.8	2.1	2.0	35.2	4.4	24.4	5.8	2.3	1.3	2.2	4.4	7.7	1.7	2.6	0.5	2.6	9.9	0.4	2.0	3.2	6.5	3.1	1.7	0.6	5.4	1.0	6.6	9.2	2.0	3.6	3.5	1.6	8.7	1.5	2.3	0.3	2.1	46.8	16.5	16.6	4.6	0.0	6.9	1.0	1.6	0.0	0.6	1.1	36.6	5.4	0.6	2.4	5.5	5.5	5.3	34.3	31.5	29.7	16.7	1.7	30.5	0.0	7.5	23.7	46.9	6.9	2.2	27.6	25.5	1.1	0.0	2.2	0.5	4.0	6.9	1.4	0.8	2.3	2.8	23.3	35.2	14.5	9.5	0.0	5.3	0.2	38.9	1.5	0.0	3.0	2.5	3.1	94.2	0.1	3.0	0.1	13.8	2.4	0.0	0.0	2.0	0.0	25.7	1.6	0.1	1.3	23.7	35.2	7.2	63.2	50.2	0.0	0.1	0.1	49.5	0.6	142.9	0.0	1.6	0.0	0.3	1.1	0.2	0.0	0.6	0.3	6.9	0.0	0.6	0.0	1.0	0.0	0.5	0.8	0.0	1.1	1.5	3.1	1.1	2.7	2.3	1.3	2.6	0.5	6.5	2.3	6.0	4.1	0.0	279.5	300.3	0.0	0.6	0.0	9.4	19.4	0.0	0.0	1.1	0.0	14.2	0.1	11.3	2.8	0.0	3.1	3.8	23.0	139.2	9.2	0.0	1.8	0.0	10.9	8.0	0.6	0.0	0.3	9.0	42.2	1.8	1.2	0.0	23.7	0.2	0.0	0.0	0.0	0.0	40.8	0.2	0.7	296.9	14.8	0.0	0.7	386.7
CAST		ENSG00000153113	Calpastatin	P20810	5	96525267-96779595	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 201.9"	"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 948.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009491, HPA036881, HPA036882, HPA075906"	Enhanced		Enhanced	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA		18000000	"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"CAB009491: AB_2259755, HPA036881: AB_2675359, HPA036882: AB_2675360, HPA075906: "	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.94e-2)"	"unprognostic (6.11e-3)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (4.98e-4)"	38.3	20.7	10.4	25.0	16.3	22.1	32.0	8.7	21.7	38.0	44.6	10.5	18.6	25.6	24.8	25.9	87.4	19.5	25.5	98.5	11.9	10.6	27.2	38.2	29.5	21.1	14.3	12.5	26.9	14.8	22.3	25.3	52.6	24.8	30.0	34.5	12.7	38.7	23.2	201.9	40.7	56.3	36.2	18.7	21.7	22.2	21.2	15.6	10.1	25.6	51.2	34.1	42.2	57.0	24.5	32.7	12.4	48.0	18.3	26.6	27.2	48.5	40.0	6.8	17.7	41.1	76.6	24.0	34.6	49.0	27.7	36.1	9.9	29.6	7.0	32.7	46.9	41.3	82.6	12.9	47.1	33.5	45.1	12.2	9.0	42.4	11.7	31.6	5.9	15.7	34.6	43.6	39.7	64.9	38.7	30.9	5.4	7.5	22.7	33.7	15.3	2.9	0.2	5.3	13.2	14.9	2.7	23.0	12.0	55.0	20.5	28.7	6.9	35.3	19.4	22.6	16.2	11.8	6.4	41.1	37.8	16.1	25.2	34.9	7.6	20.2	3.3	42.9	3.2	10.4	2.5	48.0	7.0	26.6	29.0	25.2	24.5	23.9	26.5	32.7	22.7	12.2	16.3	12.4	18.3	32.2	9.0	24.2	27.2	10.4	16.3	8.7	21.7	11.9	10.6	14.3	12.5	24.8	15.6	375.2	182.6	82.4	358.6	212.9	34.7	740.0	140.1	410.9	277.5	102.9	17.7	150.3	112.7	215.3	948.1	166.8	282.7	280.4	218.0	79.9	187.6	259.7	169.0	148.0	103.8	12.7	136.3	108.6	206.2	312.7	159.3	211.5	124.9	235.4	207.6	36.8	240.8	170.9	137.6	98.2	16.9	90.5	162.6	20.9	10.1	220.1	117.7	139.5	143.0	490.4
OIP5	"CT86, hMIS18beta, MIS18B"	ENSG00000104147	"Opa interacting protein 5"	O43482	15	41309268-41332621	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.7;testis: 41.7"	"Cell type enhanced"	"Detected in many"	18	"Extravillous trophoblasts: 19.9;Spermatocytes: 82.8;Spermatogonia: 66.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA052271, HPA059602"	Enhanced		Supported	"Nuclear speckles,Vesicles"		NA	Yes			"Nuclear speckles"	Vesicles	"HPA052271: AB_2681780, HPA059602: AB_2684079"	"unprognostic (5.17e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.94e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.79e-4)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (9.34e-5)"	"unprognostic (5.51e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.84e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.86e-2)"	1.3	2.1	0.5	3.8	0.8	7.5	0.7	1.5	1.1	1.1	3.4	0.7	2.3	3.0	0.6	0.6	4.6	0.6	1.3	1.9	0.9	0.4	1.1	1.1	1.0	4.3	0.6	0.4	1.2	0.6	0.0	0.3	1.6	0.5	0.5	3.1	0.2	1.2	1.3	8.3	2.5	3.1	0.6	0.8	2.7	1.4	41.7	0.7	16.7	0.5	6.3	4.0	0.7	1.5	2.5	7.7	1.1	1.3	1.9	5.9	1.7	13.3	7.1	14.1	10.3	0.7	0.9	13.4	8.3	3.8	9.9	10.7	12.7	6.6	8.0	7.3	3.0	15.6	20.9	14.3	6.4	7.9	17.2	16.5	16.9	20.8	13.1	0.1	18.4	9.5	0.3	1.3	5.6	5.9	2.1	8.4	16.8	23.1	15.4	6.6	6.4	10.8	13.7	12.8	19.9	15.5	13.3	11.8	12.0	4.4	6.2	22.4	7.5	13.7	14.0	3.8	5.9	13.9	10.5	4.1	10.2	15.8	10.2	14.7	7.4	32.4	28.3	3.0	22.5	14.7	0.0	0.8	1.1	0.6	1.3	1.5	2.1	1.8	1.6	1.4	2.5	2.6	1.7	0.0	1.9	0.8	7.7	5.9	1.7	0.5	0.8	1.5	1.1	0.9	0.4	0.6	0.4	0.5	0.7	0.0	0.3	0.0	0.6	3.7	0.0	0.2	0.0	0.0	2.3	0.0	0.0	7.1	0.0	0.5	5.5	0.1	0.9	0.0	0.3	19.9	1.5	0.3	1.1	0.8	6.5	0.0	0.0	0.0	0.6	9.2	0.9	1.6	0.0	1.0	1.7	0.6	0.1	0.0	1.1	0.2	0.2	6.5	0.9	82.8	66.8	2.0	3.2	0.7	3.0	0.1
ETV6	TEL	ENSG00000139083	"ETS variant 6"	P41212	12	11649854-11895402	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.7;NB-4: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA000264	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA000264: AB_611466"	"unprognostic (4.03e-3)"	"unprognostic (3.08e-2)"	"unprognostic (7.54e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.16e-1)"	"unprognostic (9.46e-2)"	"prognostic unfavorable (9.38e-5)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (4.66e-8)"	"unprognostic (1.33e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.92e-2)"	"prognostic favorable (1.54e-5)"	17.2	8.9	5.1	20.0	7.6	32.8	20.4	1.6	9.1	10.5	14.5	6.0	9.8	7.2	10.8	14.2	11.3	8.9	15.3	6.7	5.6	3.8	9.2	9.6	16.0	13.4	6.0	3.1	10.5	10.4	8.4	8.7	7.7	7.4	14.9	11.0	8.0	41.9	12.4	6.9	23.9	14.6	25.0	9.4	17.8	9.7	4.7	5.7	30.6	10.0	10.0	19.9	19.0	15.8	2.9	6.2	11.4	7.1	2.4	2.2	1.3	2.6	3.5	3.2	5.6	2.5	2.3	3.9	1.9	3.3	2.5	3.0	0.2	12.4	2.2	1.9	3.3	3.0	3.4	1.4	5.9	3.1	39.7	0.7	14.0	1.9	1.3	3.1	14.7	15.3	4.6	3.7	2.5	5.2	4.9	7.6	10.2	1.0	7.4	2.3	1.7	8.3	21.1	5.3	2.7	0.9	2.3	3.1	5.7	5.8	16.5	0.6	3.3	3.8	3.7	3.6	5.4	1.2	9.3	8.6	5.7	4.9	1.9	4.1	3.3	2.5	1.2	3.7	0.1	6.5	5.6	5.7	6.6	1.5	6.6	2.0	2.9	2.2	1.4	4.1	2.3	1.3	0.8	11.4	2.4	7.1	6.2	1.4	1.3	5.1	7.6	1.6	9.1	5.6	3.8	6.0	3.1	7.4	5.7	6.0	8.1	21.4	28.1	13.3	1.9	7.5	17.8	28.1	22.7	14.0	5.9	11.8	1.7	15.2	4.5	23.5	22.5	0.0	30.8	3.6	10.8	33.7	10.4	9.3	17.1	0.0	31.2	38.6	48.1	3.6	7.2	48.8	27.0	40.5	26.8	4.8	31.2	24.9	10.3	7.9	4.0	19.4	28.8	0.6	7.0	19.6	7.2	14.6	20.4	60.6
MKI67	"MIB-, PPP1R105"	ENSG00000148773	"Marker of proliferation Ki-67"	P46013	10	128096659-128126385	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.2;lymphoid tissue: 81.5"	"Cell type enhanced"	"Detected in many"	19	"Erythroid cells: 163.5;Extravillous trophoblasts: 71.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.4;T-reg: 1.3"	"Group enriched"	"Detected in many"	13	"NK-cells: 1.1;T-cells: 1.4"	"Low cell line specificity"	"Detected in many"											"CAB000058, HPA000451, HPA001164, CAB068198"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	Yes			"Nucleoplasm, Nucleoli rim"	"Mitotic chromosome"	"CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187"	"unprognostic (2.54e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (7.16e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (9.47e-5)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.61e-1)"	1.8	1.2	0.2	9.9	0.5	25.2	1.8	0.3	0.5	1.5	5.0	0.6	0.2	3.6	0.7	1.4	13.4	0.3	1.2	1.3	0.2	0.2	1.2	1.0	1.9	8.8	0.2	0.2	0.5	0.4	0.0	0.4	2.9	0.5	0.7	5.8	0.5	2.2	0.6	0.5	3.9	6.2	1.3	0.8	6.5	3.5	2.5	0.2	81.5	0.4	5.2	10.0	1.3	3.5	0.0	0.0	0.0	0.0	1.1	1.4	0.4	48.1	24.5	25.5	18.0	1.0	2.2	7.9	18.3	13.5	17.4	15.6	20.0	20.0	36.3	5.3	12.5	11.5	29.4	26.7	13.7	26.2	38.2	12.9	31.1	18.1	12.5	0.0	43.6	16.9	0.5	0.6	17.8	18.3	4.3	17.0	16.9	14.2	34.9	17.2	19.1	26.0	13.3	10.1	12.5	11.2	19.4	33.4	4.8	6.3	13.5	8.9	9.6	25.9	9.3	4.4	8.8	7.7	9.3	15.7	9.2	18.5	13.0	49.4	15.9	12.6	44.0	7.7	20.0	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.4	1.0	0.0	1.1	0.0	0.0	1.3	0.4	0.2	0.5	0.3	0.5	0.2	0.2	0.2	0.2	0.5	0.2	0.0	4.8	10.7	0.5	5.7	0.0	1.2	2.5	2.7	7.9	0.0	0.0	2.7	0.0	0.4	2.5	0.0	2.7	163.5	0.0	71.7	3.4	1.4	1.1	1.0	34.1	0.0	6.4	3.7	8.0	0.5	0.3	12.7	3.3	0.0	4.8	0.0	0.1	2.9	0.4	0.0	0.0	0.0	0.4	8.8	14.6	2.6	6.5	13.4	20.7	4.1
DHX32	"DDX32, DHLP1, FLJ10694, FLJ10889"	ENSG00000089876	"DEAH-box helicase 32 (putative)"	Q7L7V1	10	125836337-125896436	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 69.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048872	Approved					NA	NA					"HPA048872: AB_2680540"	"unprognostic (1.05e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.55e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavorable (9.49e-5)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.03e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-1)"	15.4	16.3	7.8	10.2	9.7	4.0	18.0	7.3	11.5	10.5	20.1	12.1	11.2	11.4	10.6	14.0	20.6	8.6	13.1	27.3	7.6	7.5	12.1	14.5	10.1	16.8	10.3	7.0	18.1	23.5	11.7	9.5	19.3	8.9	13.1	24.5	12.8	17.9	8.4	16.0	18.5	16.1	9.1	9.8	12.2	21.7	20.6	9.5	8.0	13.6	10.7	10.0	13.0	12.6	6.8	2.3	3.2	3.5	4.5	5.3	0.9	27.3	15.1	10.2	21.0	13.6	12.6	18.3	12.1	28.2	11.1	12.5	3.5	27.2	0.1	9.1	14.1	12.3	20.0	4.6	20.4	9.2	13.8	9.1	3.4	7.8	5.3	15.1	6.6	11.3	12.4	21.5	10.9	24.6	20.0	16.1	0.1	9.4	0.1	10.7	12.3	0.1	10.4	7.7	13.4	10.5	0.1	16.6	5.9	16.2	12.7	1.4	7.5	11.2	20.3	16.6	13.9	7.4	5.9	14.4	8.7	5.3	11.0	10.7	10.8	10.5	0.2	15.7	0.1	4.4	0.3	3.0	3.2	2.7	3.5	2.2	6.8	1.3	1.1	2.3	3.2	5.3	2.1	0.1	4.5	1.7	1.3	0.4	0.9	7.8	9.7	7.3	11.5	7.6	7.5	10.3	7.0	8.9	9.5	14.9	12.1	4.7	11.4	4.4	12.6	22.1	10.2	6.7	13.6	7.0	21.6	16.9	13.3	27.9	69.4	9.2	15.7	0.0	32.3	23.7	6.3	19.4	11.5	9.6	10.3	11.1	4.1	6.7	7.3	19.5	9.8	6.1	6.8	4.6	41.9	30.9	41.9	20.1	15.9	13.5	14.5	12.9	8.2	31.9	5.6	6.0	37.0	4.4	19.5	21.7
HACD2	PTPLB	ENSG00000206527	"3-hydroxyacyl-CoA dehydratase 2"	Q6Y1H2	3	123490820-123585185	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SiHa: 65.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB019282	Approved					NA	NA					"CAB019282: "	"unprognostic (3.04e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.65e-3)"	"unprognostic (5.36e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (9.59e-5)"	"unprognostic (6.90e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.59e-2)"	43.2	9.7	18.0	11.2	30.0	5.7	16.6	20.5	18.7	14.1	20.4	28.6	7.4	21.2	12.4	13.5	18.8	9.9	12.2	9.9	20.7	13.4	20.7	34.3	13.8	14.1	29.4	12.0	13.8	13.4	15.6	12.5	11.1	18.5	22.1	20.4	7.3	15.5	10.2	5.6	23.2	30.8	12.3	24.9	9.6	15.3	13.3	25.7	9.1	16.0	10.5	19.7	10.9	16.6	4.9	6.4	2.4	3.5	2.9	5.3	2.4	19.6	11.2	7.7	5.6	24.2	5.4	28.7	14.1	5.9	14.7	10.7	22.8	17.5	11.4	10.2	13.5	17.1	43.2	13.8	17.7	15.6	7.2	4.6	7.9	10.5	17.7	7.9	10.5	7.9	7.5	45.7	7.1	20.0	23.1	7.6	7.9	1.6	11.4	8.8	15.3	4.9	3.1	9.9	24.0	9.9	7.6	8.5	12.1	17.8	12.7	13.6	4.2	65.7	14.1	9.0	11.7	14.6	5.4	5.9	15.4	11.6	15.4	13.7	6.8	8.6	9.4	6.9	7.4	8.2	1.5	3.5	2.4	3.6	2.8	5.3	3.4	4.8	4.6	6.4	4.9	4.4	4.3	1.1	2.9	2.2	3.7	5.3	2.4	18.0	30.0	20.5	18.7	20.7	13.4	29.4	12.0	18.5	25.7	6.0	35.5	13.7	26.4	0.0	8.3	12.6	15.3	5.3	28.4	43.6	5.9	20.9	6.6	13.4	12.7	13.7	18.6	0.0	16.5	13.3	10.4	36.8	3.5	42.9	20.1	1.6	15.2	14.7	20.2	7.3	10.6	17.1	0.0	16.2	21.7	13.5	16.4	21.0	16.6	13.9	12.9	6.5	8.8	8.1	20.5	0.0	5.6	11.7	24.7	26.3
COX6B2	"COXVIB2, CT59, FLJ32865"	ENSG00000160471	"Cytochrome c oxidase subunit 6B2"	Q6YFQ2	19	55349306-55354814	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"testis: 66.5"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 23.6;Late spermatids: 19.1;Spermatocytes: 77.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 22.6;SCLC-21H: 9.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA035014			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA035014: AB_10601261"	"unprognostic (7.43e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (9.70e-5)"	"unprognostic (8.11e-2)"	"unprognostic (1.81e-6)"	"unprognostic (9.91e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.02e-1)"	0.3	0.0	0.4	0.6	0.6	0.7	0.5	0.3	0.6	0.2	3.3	0.2	0.2	0.0	0.2	0.8	0.5	0.4	0.2	0.2	0.2	0.5	0.5	0.2	0.2	0.6	0.4	0.2	0.4	0.2	0.0	0.4	0.2	0.6	0.2	3.5	0.7	0.6	0.2	0.2	1.8	0.2	0.2	0.7	0.2	0.0	66.5	0.3	0.2	0.2	0.2	1.2	0.2	0.4	1.3	1.4	5.7	1.0	1.6	0.9	0.8	2.7	0.4	0.1	0.1	0.0	0.0	0.2	0.4	0.1	0.3	0.5	0.1	22.6	0.1	0.2	0.2	0.3	1.8	0.7	0.2	0.2	0.8	0.7	0.0	1.7	0.1	0.3	0.2	1.8	0.2	2.5	0.4	0.5	1.7	0.0	0.1	0.4	0.2	0.0	0.5	0.1	0.2	0.6	2.3	0.5	0.1	0.0	0.2	0.0	0.4	9.7	0.3	0.3	0.1	0.0	0.6	0.4	0.0	0.4	0.3	0.5	0.1	0.2	1.5	1.2	0.1	0.1	0.3	0.2	1.9	1.0	1.0	0.8	0.5	0.5	0.7	0.7	0.6	0.3	1.3	0.7	0.9	5.7	1.6	0.7	1.4	0.6	0.8	0.4	0.6	0.3	0.6	0.2	0.5	0.4	0.2	0.6	0.3	0.0	0.3	0.0	0.6	0.5	2.1	0.4	0.0	0.0	0.0	0.0	3.9	0.5	0.0	0.6	23.6	0.0	3.2	0.0	0.6	0.2	0.4	0.2	0.0	0.0	0.1	3.2	1.2	0.0	0.0	19.1	0.6	0.0	0.0	0.0	1.3	0.9	5.6	3.5	0.0	0.0	4.1	0.0	0.0	77.8	1.3	0.4	0.3	0.0	4.4	2.5
TNFRSF10A	"Apo2, CD261, DR4, TRAILR-1, TRAILR1"	ENSG00000104689	"TNF receptor superfamily member 10a"	O00220	8	23190452-23225126	"Cancer-related genes, CD markers, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Suprabasal keratinocytes: 24.0;Urothelial cells: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA050958, HPA054475"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA050958: AB_2681290, HPA054475: AB_2682500"	"unprognostic (3.66e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.44e-2)"	"unprognostic (8.39e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.87e-1)"	11.9	4.0	2.1	13.0	3.4	8.4	9.7	2.0	2.8	6.0	10.9	1.4	4.5	5.9	5.3	5.6	13.6	4.1	12.7	6.3	2.2	2.0	10.9	10.6	11.0	12.4	3.0	0.7	2.7	12.9	3.6	1.8	6.9	4.0	5.1	7.2	2.1	8.2	4.3	3.8	7.1	10.2	3.8	2.9	13.2	6.1	2.6	3.0	9.5	5.8	14.9	25.4	6.7	8.7	13.2	4.5	3.8	4.3	3.9	13.9	4.2	8.0	14.5	0.7	0.0	0.5	3.0	0.0	1.6	1.0	0.8	2.4	11.2	14.2	18.6	19.0	1.0	4.1	15.3	13.1	20.8	1.4	4.6	0.1	9.8	8.8	6.3	7.5	5.2	9.4	5.0	17.2	18.5	16.0	2.5	9.8	0.6	15.1	6.7	3.9	6.3	0.2	3.3	10.1	14.3	8.9	0.1	0.0	13.4	11.1	17.4	0.4	0.5	4.1	10.3	0.0	3.2	5.5	4.0	13.8	0.0	0.1	0.8	0.0	7.9	11.1	14.4	0.1	1.7	0.2	2.0	4.3	3.8	3.8	1.9	10.3	10.4	12.3	7.7	4.5	13.2	12.1	7.0	0.5	3.9	1.7	0.0	13.9	4.2	2.1	3.4	2.0	2.8	2.2	2.0	3.0	0.7	4.0	3.0	3.0	8.3	6.4	16.2	20.9	0.1	0.8	12.7	6.7	19.4	10.4	0.0	0.1	0.0	9.2	0.0	11.8	6.2	0.0	3.5	0.4	1.3	10.0	7.0	4.0	3.0	0.0	2.4	1.3	2.1	0.0	0.0	7.1	3.3	1.8	6.0	0.0	14.3	7.4	0.0	2.4	0.0	0.0	1.1	0.0	0.2	24.0	0.0	2.9	6.3	27.1
NAB1		ENSG00000138386	"NGFI-A binding protein 1"	Q13506	2	190646746-190692766	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 90.6;Suprabasal keratinocytes: 121.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002738	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"	"Golgi apparatus"	"HPA002738: AB_1079447"	"unprognostic (1.44e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.02e-3)"	"unprognostic (4.04e-3)"	"unprognostic (9.05e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.12e-3)"	"unprognostic (6.41e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.52e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.85e-2)"	19.1	10.3	12.1	12.5	13.7	7.6	28.3	28.2	15.7	18.5	19.9	10.4	7.2	7.4	16.2	26.4	32.3	14.1	13.9	21.2	12.1	9.7	10.6	18.6	12.5	13.8	14.5	12.0	15.7	9.3	16.4	20.2	12.8	12.4	16.3	12.9	19.8	15.9	17.5	6.9	33.2	10.9	13.3	14.3	9.3	18.4	12.3	12.4	13.6	19.0	15.7	13.0	13.0	25.8	1.4	1.7	5.4	6.1	4.6	6.0	1.4	12.2	9.1	23.2	8.1	9.1	15.8	40.2	12.5	19.7	9.4	10.8	22.1	13.6	13.7	14.7	9.8	17.6	31.4	13.2	16.1	18.8	43.7	11.2	16.1	32.5	10.5	5.9	6.7	8.1	9.1	25.8	20.0	6.2	13.5	14.6	8.4	15.7	11.8	14.5	6.0	9.7	7.0	8.2	13.2	12.6	12.0	16.7	5.4	7.2	12.0	21.0	17.0	14.7	5.0	13.1	31.0	4.0	10.6	10.1	19.9	15.8	11.2	7.4	9.4	10.1	10.2	21.0	6.2	15.5	0.0	2.6	1.1	2.7	2.0	4.0	1.4	2.8	3.5	1.7	0.9	2.9	3.1	5.4	4.6	6.1	1.6	6.0	1.4	12.1	13.7	28.2	15.7	12.1	9.7	14.5	12.0	12.4	12.4	6.0	23.4	2.2	21.8	90.6	15.9	15.7	17.8	21.4	31.8	12.2	11.8	3.8	3.3	8.7	1.1	28.6	7.3	0.0	6.9	8.3	21.6	24.1	19.7	23.7	6.0	6.4	13.8	35.0	19.5	3.2	12.4	18.1	37.1	6.4	15.0	11.5	7.4	28.8	13.8	3.6	14.1	45.3	59.7	1.4	36.3	121.5	1.0	12.8	13.6	26.5
NCAPH	"BRRN1, CAP-H, hCAP-H"	ENSG00000121152	"Non-SMC condensin I complex subunit H"	Q15003	2	96335787-96373845	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 17.2;lymphoid tissue: 41.3;testis: 60.4"	"Cell type enhanced"	"Detected in many"	22	"Spermatocytes: 77.0;Spermatogonia: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"basophil: 5.6;T-reg: 8.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.6;T-cells: 8.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA002647, HPA003008"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	Yes			Cytosol	Nucleoplasm	"HPA002647: AB_1078300, HPA003008: AB_1078301"	"unprognostic (5.52e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (9.53e-6)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.16e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.30e-2)"	1.3	1.1	0.8	13.2	0.9	17.2	1.7	0.7	1.2	1.5	3.9	0.7	0.4	2.9	0.7	1.1	7.4	0.4	1.0	0.8	0.8	0.7	0.9	0.9	1.5	10.6	1.0	0.6	0.8	0.6	0.1	0.5	3.4	1.0	0.7	5.1	0.6	1.9	0.4	0.6	2.7	3.5	1.4	1.2	6.7	2.1	60.4	0.8	41.3	0.6	6.4	12.2	1.7	2.2	1.3	0.5	5.6	1.0	0.1	8.7	0.8	31.2	11.9	30.2	15.6	1.1	1.6	20.0	14.8	10.4	28.7	30.3	21.9	17.5	29.2	10.5	6.5	26.2	14.1	25.8	10.1	30.8	25.6	17.1	30.1	12.4	19.8	0.2	27.8	25.7	0.5	1.1	22.2	9.4	2.7	11.3	23.4	20.8	21.6	13.6	14.7	40.7	29.0	21.6	13.8	15.1	31.7	27.5	23.7	5.7	12.1	17.9	13.7	8.6	12.1	5.2	11.9	8.9	20.6	6.5	21.2	32.4	19.8	23.9	11.6	16.5	31.0	9.1	27.9	23.9	5.6	0.0	0.3	1.3	1.0	0.2	1.3	1.9	1.5	0.5	0.9	0.0	0.7	0.3	0.1	0.0	0.0	8.7	0.8	0.8	0.9	0.7	1.2	0.8	0.7	1.0	0.6	1.0	0.8	0.0	0.0	0.8	0.2	0.6	0.4	0.4	0.0	2.7	2.3	0.0	7.9	1.1	0.0	0.4	3.9	0.5	0.0	0.0	0.0	14.1	0.4	0.5	1.1	0.5	6.8	0.0	0.0	0.6	3.2	4.0	0.9	3.0	1.7	0.0	1.0	4.7	0.2	0.0	0.4	0.0	2.3	0.0	0.9	77.0	26.2	0.6	1.6	5.4	1.2	0.6
KRT13	"CK13, K13, MGC161462, MGC3781"	ENSG00000171401	"Keratin 13"	P13646	17	41500981-41505705	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 1075.6;lymphoid tissue: 404.8;tongue: 499.8"	"Cell type enriched"	"Detected in some"	11	"Urothelial cells: 2979.9"	"Group enriched"	"Detected in many"	5	"cervical cancer: 899.2;head and neck cancer: 758.7;urothelial cancer: 504.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Group enriched"	"Detected in some"	100	"A-431: 216.9;HaCaT: 144.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000133, HPA030877, HPA069771"	Enhanced		Enhanced	"Intermediate filaments"		NA	NA		1100000000	"Intermediate filaments"		"CAB000133: , HPA030877: AB_2673641, HPA069771: AB_2732141"	"unprognostic (1.45e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	"unprognostic (9.30e-5)"	"unprognostic (7.30e-3)"		"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.81e-3)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.45e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.33e-1)"	0.3	0.3	0.0	0.3	0.0	0.5	0.3	0.0	0.3	250.9	0.3	0.0	0.0	0.3	13.7	0.3	1075.6	0.3	0.6	0.5	0.0	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.3	0.3	0.3	0.0	0.3	0.0	2.4	0.3	0.1	134.9	0.4	0.4	0.3	0.3	1.7	0.0	0.3	0.3	0.4	0.0	0.6	0.3	499.8	404.8	14.9	222.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	216.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	144.9	0.0	0.0	0.0	0.1	0.0	0.3	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.7	0.0	0.2	0.5	0.4	0.0	0.0	0.0	0.6	0.0	0.5	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.6	1.3	250.4	2.5	0.0	0.6	0.0	1.4	14.8	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.2	66.7	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.2	51.8	0.0	0.0	0.0	0.4	0.0	0.1	2.5	269.4	0.0	0.0	0.0	0.2	0.2	0.4	1.4	0.3	0.0	0.2	2979.9
INPP4B		ENSG00000109452	"Inositol polyphosphate-4-phosphatase type II B"	O15327	4	142023160-142847432	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 163.6;Late spermatids: 196.7;Sertoli cells: 84.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 19.2"	"Group enriched"	"Detected in many"	6	"NK-cells: 9.1;T-cells: 19.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 52.6;SK-MEL-30: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037681, HPA037682"	Approved		Approved	Centrosome		NA	NA			Centrosome		"HPA037681: AB_10670389, HPA037682: AB_10671377"	"unprognostic (9.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.24e-2)"	"unprognostic (3.03e-3)"	"unprognostic (5.76e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.39e-2)"	15.4	4.7	8.4	8.5	12.5	2.2	21.2	5.1	10.3	28.1	7.1	1.8	5.6	5.0	19.7	18.4	9.1	9.2	8.7	18.4	5.9	6.1	6.1	2.0	9.9	10.8	5.5	8.9	15.4	4.0	2.3	3.8	6.2	4.6	8.3	5.8	1.7	4.9	6.8	10.8	4.7	7.3	10.2	3.1	7.0	7.0	19.6	2.4	8.2	6.5	4.9	7.4	15.8	14.6	0.0	0.0	2.2	0.1	9.1	19.2	3.7	9.3	3.9	2.6	1.2	2.0	1.2	0.5	11.3	13.3	2.9	5.5	1.0	52.6	0.2	3.2	10.1	4.5	14.3	0.0	13.2	6.9	0.0	0.4	2.2	1.5	0.0	0.6	0.4	1.8	2.1	1.8	2.0	7.0	8.8	1.6	0.0	0.0	0.5	6.3	16.7	0.3	0.0	0.1	5.7	2.8	0.1	8.7	0.4	4.0	17.4	0.2	0.2	1.3	4.0	23.4	1.6	12.0	1.6	1.0	6.7	8.2	9.9	0.1	0.1	0.0	0.0	1.5	10.3	17.4	2.2	0.1	0.0	3.3	0.0	6.5	0.0	19.2	8.5	0.0	0.0	13.2	5.7	0.2	9.1	0.0	0.0	9.8	3.7	8.4	12.5	5.1	10.3	5.9	6.1	5.5	8.9	4.6	2.4	0.0	1.1	0.0	9.8	6.0	7.3	36.2	7.6	17.4	9.1	8.7	0.0	1.4	5.0	12.2	163.6	10.8	8.4	0.0	26.9	3.9	4.1	13.4	5.8	0.0	6.2	6.4	8.5	3.7	4.4	196.7	12.7	1.9	69.2	0.0	3.4	0.8	47.4	0.0	6.0	0.8	0.6	84.1	43.7	3.1	2.0	2.3	1.6	16.6	3.4	41.0
SPRR1A		ENSG00000169474	"Small proline rich protein 1A"	P35321	1	152985231-152985500	"Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"esophagus: 495.3"	"Cell type enriched"	"Detected in some"	10	"Suprabasal keratinocytes: 126.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 1736.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HaCaT: 13.0;hTCEpi: 38.1;RT4: 14.5"									CAB011237	Enhanced					NA	NA					"CAB011237: "		"unprognostic (1.39e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.64e-2)"		"unprognostic (1.19e-2)"		"unprognostic (1.25e-2)"	"unprognostic (2.92e-1)"		"prognostic unfavorable (1.03e-4)"			"unprognostic (1.96e-1)"			"unprognostic (1.04e-1)"	0.4	0.0	0.4	0.4	0.4	0.0	0.7	0.4	0.4	72.3	0.4	0.4	0.4	0.0	0.4	0.4	495.3	0.0	3.8	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.0	0.4	52.5	0.4	0.4	11.7	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	70.7	47.3	0.5	111.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.5	0.0	0.0	0.0	13.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	38.1	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	14.5	0.2	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.1	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	126.6	0.0	0.0	0.0	13.1
GMPS	GATD7	ENSG00000163655	"Guanine monophosphate synthase"	P49915	3	155870536-155944026	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	Ligase	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 191.9;Late spermatids: 149.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046630			Approved	Cytosol		No	No			Cytosol		"HPA046630: AB_2679727"	"unprognostic (3.89e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (5.54e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (8.73e-7)"	"unprognostic (1.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.79e-2)"	15.9	18.3	10.4	19.7	14.0	24.6	22.4	22.1	24.9	16.1	13.9	9.8	15.3	10.3	17.5	15.4	19.5	14.0	10.8	15.3	9.2	7.7	11.0	14.7	15.8	19.5	9.3	12.1	15.7	23.5	19.1	14.1	13.5	14.8	13.0	15.3	9.0	21.6	18.6	16.6	21.0	12.6	16.1	8.9	14.6	15.4	60.9	10.5	28.3	13.6	12.5	18.4	15.9	18.5	11.1	17.2	10.9	18.1	19.0	20.7	10.8	56.8	22.5	30.6	25.0	12.5	19.8	29.5	24.3	22.5	32.1	32.5	41.0	38.4	41.1	29.0	18.7	24.6	28.0	26.0	25.5	44.2	23.8	20.0	43.8	16.5	22.2	14.3	44.5	17.1	14.6	15.7	24.8	38.0	17.1	19.6	22.4	30.8	15.8	23.8	38.2	36.1	23.6	29.3	31.3	16.7	35.5	36.3	49.6	16.5	25.1	18.3	17.0	27.0	38.7	24.2	22.0	40.5	29.4	13.8	21.3	17.3	30.0	48.9	22.1	13.6	70.3	21.4	33.2	18.9	10.9	10.4	7.2	17.3	13.1	20.7	11.1	16.8	15.7	17.2	8.8	16.8	15.8	1.4	19.0	18.1	9.5	17.6	10.8	10.4	14.0	22.1	24.9	9.2	7.7	9.3	12.1	14.8	10.5	17.9	19.8	20.4	39.9	35.4	21.9	14.1	15.3	13.4	22.7	7.0	2.0	33.4	21.6	24.9	191.9	28.5	8.4	23.3	25.9	43.0	27.2	23.6	28.8	11.1	26.5	20.6	6.9	14.7	18.3	149.6	21.3	24.7	21.9	29.7	17.8	17.3	20.4	10.5	23.3	22.3	7.7	19.4	31.6	80.1	54.5	33.4	25.7	24.9	24.7	34.5
ATL3	DKFZP564J0863	ENSG00000184743	"Atlastin GTPase 3"	Q6DD88	11	63624087-63671921	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 242.0;Late spermatids: 574.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065702, HPA076616"			Enhanced	"Endoplasmic reticulum"		NA	NA		1600000	"Endoplasmic reticulum"		"HPA065702: AB_2685536, HPA076616: AB_2732318"	"unprognostic (4.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.09e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (4.52e-2)"	"unprognostic (1.11e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.67e-3)"	40.3	17.7	7.9	11.8	10.4	8.2	28.3	5.6	7.4	20.9	15.0	12.4	14.0	6.7	22.5	15.7	23.4	14.5	15.1	9.7	7.0	5.0	15.0	23.6	15.9	24.7	10.9	5.4	22.3	18.4	12.9	8.8	11.8	9.8	17.9	11.7	14.0	17.5	15.4	7.6	20.3	11.0	35.6	12.8	12.0	14.1	43.3	10.7	11.0	18.9	14.2	13.0	32.2	22.3	6.2	9.6	6.6	13.7	7.4	11.8	8.1	13.3	12.9	3.6	8.9	19.3	26.3	0.0	15.9	18.9	16.0	11.0	10.3	21.0	7.8	16.5	27.4	12.3	8.6	6.8	10.7	23.1	11.6	1.8	7.9	14.5	0.0	12.7	15.6	12.0	16.7	18.0	20.5	13.4	10.7	17.2	9.1	8.8	21.9	18.5	14.5	5.7	9.8	4.6	4.4	10.2	12.3	9.1	11.7	13.3	9.6	2.0	5.5	47.6	11.4	15.3	5.0	21.0	6.0	23.7	33.7	16.1	32.9	11.1	6.2	8.5	15.8	18.1	10.5	20.4	6.6	9.1	4.0	10.8	12.4	11.8	6.2	9.0	8.7	9.6	5.2	7.5	10.1	3.9	7.4	13.7	4.8	9.9	8.1	7.9	10.4	5.6	7.4	7.0	5.0	10.9	5.4	9.8	10.7	41.7	22.7	18.0	39.1	38.8	4.3	7.8	30.6	13.4	21.6	31.4	0.0	5.8	1.7	37.0	242.0	45.4	28.8	23.3	43.5	16.5	29.6	47.3	16.2	46.1	35.2	4.8	10.3	47.9	54.0	574.9	50.3	34.8	40.5	40.5	18.4	12.4	59.3	22.9	63.3	18.2	7.0	71.1	60.4	25.8	27.3	35.5	3.3	23.5	15.9	44.8
KCTD14	MGC2376	ENSG00000151364	"Potassium channel tetramerization domain containing 14"	Q9BQ13	11	78015715-78046191	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 40.8;pancreas: 42.8;salivary gland: 43.9;seminal vesicle: 47.8"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 14.8;Mucus-secreting cells: 15.2;Pancreatic endocrine cells: 12.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 5.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 15.4;Hep G2: 16.8;RPTEC TERT1: 27.3;U-2 OS: 12.4"									"HPA041118, HPA042181"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA041118: AB_10963117, HPA042181: AB_10968059"	"unprognostic (7.37e-3)"	"unprognostic (4.27e-2)"	"unprognostic (7.03e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (3.96e-5)"	"prognostic favorable (8.01e-4)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (3.19e-1)"	"prognostic favorable (6.92e-5)"	"unprognostic (2.42e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.63e-1)"	2.6	18.9	1.2	1.5	0.8	0.0	11.6	5.5	0.8	6.5	4.8	1.2	40.8	2.5	2.3	10.8	2.1	6.8	10.3	0.7	1.0	1.3	10.7	14.4	9.6	0.3	0.9	0.5	2.4	42.8	6.2	2.5	5.1	1.3	5.3	6.9	5.8	43.9	47.8	0.7	1.5	6.1	0.9	0.8	0.7	12.1	1.9	0.8	0.7	12.4	2.9	3.6	1.4	1.1	0.4	1.4	0.6	1.1	1.1	1.8	0.4	0.0	2.1	0.3	0.3	0.8	0.5	2.1	1.1	1.0	2.1	5.1	8.0	5.2	0.0	5.7	0.6	0.2	0.6	0.3	15.4	5.4	0.2	7.8	0.0	1.8	16.8	3.1	0.1	0.1	2.4	0.4	8.4	6.6	1.5	0.5	0.1	0.1	0.0	0.8	0.1	0.2	0.4	3.9	0.2	0.3	0.2	0.0	0.0	27.3	2.0	1.4	0.1	0.0	0.1	2.5	0.5	0.8	0.6	0.4	0.1	12.4	0.4	0.2	0.1	0.1	0.1	0.1	0.1	2.2	0.0	0.7	0.6	0.7	0.9	0.5	0.0	0.7	1.8	1.4	0.4	0.8	1.8	0.2	1.1	1.1	1.3	0.0	0.4	1.2	0.8	5.5	0.8	1.0	1.3	0.9	0.5	1.3	0.8	3.0	9.6	0.0	9.5	0.3	0.0	0.0	2.5	0.0	5.7	5.2	0.0	0.6	3.3	2.0	0.1	0.0	2.5	0.0	14.8	1.2	0.8	10.5	1.1	4.0	0.2	0.0	4.6	0.0	0.0	0.0	3.1	0.0	1.7	0.0	15.2	1.7	12.8	7.0	4.9	11.3	0.0	0.0	1.9	0.2	0.2	0.1	0.6	0.0	8.5	5.8
TAX1BP1	"CALCOCO3, TXBP151"	ENSG00000106052	"Tax1 binding protein 1"	Q86VP1	7	27739331-27844564	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024432	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA024432: AB_1857783"	"unprognostic (1.38e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.59e-2)"	"unprognostic (6.72e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (3.69e-1)"	"prognostic favorable (2.80e-6)"	"unprognostic (1.76e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.03e-1)"	28.5	63.0	31.1	19.5	49.8	34.9	30.7	33.5	48.4	33.8	33.4	16.1	26.7	23.7	27.4	35.5	46.6	30.7	28.2	47.4	30.8	31.9	51.0	35.3	28.7	23.0	41.0	34.8	32.0	29.7	46.3	69.4	65.8	54.1	36.4	31.1	18.7	32.3	32.6	50.3	23.5	41.0	48.8	41.7	34.5	30.3	30.3	35.2	34.2	44.5	27.0	24.6	51.3	29.0	21.1	17.5	59.7	31.3	17.3	33.0	22.5	39.8	22.1	22.6	21.4	35.9	26.2	15.4	29.8	36.7	22.4	28.1	17.9	32.5	8.5	28.2	43.5	38.7	28.4	21.2	19.5	35.1	15.9	11.0	23.0	23.7	35.5	34.0	33.5	27.4	22.1	40.6	26.0	29.9	27.0	24.1	14.8	25.5	26.2	45.2	14.7	14.7	33.1	25.5	52.3	20.8	12.3	24.3	17.4	31.7	45.2	15.0	24.5	41.8	54.7	62.2	45.5	25.5	50.6	25.9	21.2	33.2	26.3	19.6	48.2	33.4	15.9	24.8	63.7	48.4	37.4	24.2	59.7	21.8	29.3	26.3	21.1	25.9	25.3	17.5	17.9	24.0	24.0	48.9	17.3	31.3	16.2	33.0	22.5	31.1	49.8	33.5	48.4	30.8	31.9	41.0	34.8	54.1	35.2	199.5	169.7	106.1	180.8	162.8	267.0	498.7	129.9	654.5	232.0	122.1	90.3	129.6	349.8	187.1	99.7	143.3	138.9	70.0	229.8	91.8	123.1	243.4	143.4	96.2	109.6	151.0	134.4	76.7	127.2	72.2	108.1	171.8	108.0	226.4	131.6	177.5	242.3	125.6	139.7	231.8	140.4	103.5	117.9	217.7	133.4	167.7	519.6	133.7	103.0	398.4
F3	"CD142, TF"	ENSG00000117525	"Coagulation factor III, tissue factor"	P13726	1	94529225-94541800	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 636.0;Exocrine glandular cells: 410.4;Muller glia cells: 389.7;Pancreatic endocrine cells: 1078.7;Peritubular cells: 498.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 117.4;HaCaT: 55.6;HBEC3-KT: 144.4;U-2197: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009438, HPA049292, HPA069132"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	603000		Vesicles		"CAB009438: AB_668005, HPA049292: AB_2680701, HPA069132: AB_2686092"	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (4.93e-2)"	"unprognostic (8.00e-2)"	"unprognostic (5.88e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.02e-8)"	"unprognostic (4.84e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.08e-1)"	45.5	9.8	27.0	14.1	42.9	2.1	55.1	3.4	27.9	14.8	18.7	20.9	18.7	18.3	30.5	23.7	21.3	25.4	30.9	18.8	26.9	14.5	6.6	2.8	31.4	5.8	14.1	20.3	41.6	35.0	6.1	28.8	65.4	39.2	29.7	22.2	49.9	29.2	33.0	2.4	17.7	19.2	5.9	46.3	2.9	18.2	16.4	16.0	0.0	21.8	17.3	11.9	24.7	22.3	0.5	0.9	2.8	0.8	0.7	0.4	0.2	117.4	0.2	0.2	0.0	12.8	6.3	6.6	16.7	10.0	18.1	19.7	2.1	25.2	0.0	8.6	20.7	3.9	55.6	1.5	144.4	29.9	0.1	0.1	0.0	3.6	0.3	4.2	0.0	0.0	10.9	3.2	8.5	41.9	34.4	0.1	0.1	0.1	0.1	12.6	0.2	0.1	2.4	1.1	0.7	0.2	0.1	1.2	0.0	2.2	0.3	0.1	0.3	13.3	5.5	0.4	3.6	0.1	1.6	0.0	11.0	0.3	54.8	5.0	0.1	0.1	0.1	8.4	0.6	0.4	1.7	0.8	0.1	0.3	0.3	0.4	0.2	0.3	0.2	0.2	0.5	0.3	0.3	2.8	0.7	0.2	0.9	0.2	0.2	27.0	42.9	3.4	27.1	26.9	14.5	14.1	20.3	39.2	16.0	122.1	188.9	0.5	636.0	14.4	1.5	21.1	7.6	72.3	238.8	14.0	0.0	13.6	0.0	120.9	5.6	10.5	10.3	0.0	410.4	4.8	48.3	85.3	2.3	0.6	5.4	3.2	12.6	12.3	4.0	9.8	260.4	4.9	3.3	3.6	40.9	389.7	1078.7	11.0	498.9	0.3	13.3	6.5	7.2	1.1	3.4	6.6	6.4	0.8	9.5	358.5
ATP11B	"ATPIF, ATPIR, KIAA0956"	ENSG00000058063	"ATPase phospholipid transporting 11B (putative)"	Q9Y2G3	3	182793500-182921635	"Enzymes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036237, HPA036238"	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"HPA036237: AB_10673123, HPA036238: AB_10670792"	"unprognostic (4.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.03e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.35e-1)"	16.8	7.9	7.7	19.7	9.8	35.4	17.0	18.4	9.4	20.5	21.6	8.9	14.3	13.6	15.0	11.7	37.3	11.8	12.7	21.1	6.9	5.9	13.7	14.3	19.4	20.3	10.3	5.7	15.2	14.6	21.0	26.0	8.0	8.3	16.8	16.9	9.8	19.7	13.8	13.1	21.8	22.8	16.5	11.3	23.4	27.6	22.8	8.9	49.0	10.8	20.4	21.9	22.7	25.5	3.6	4.2	7.5	1.8	3.0	3.4	1.3	22.7	3.3	7.2	10.0	15.3	16.8	6.6	10.5	14.5	8.2	9.6	8.1	11.8	10.6	18.0	15.1	17.1	13.8	8.5	10.8	14.3	23.4	6.8	25.4	4.4	1.7	8.9	20.0	16.3	11.3	12.3	9.2	13.3	12.1	12.8	16.9	9.0	32.9	13.2	7.7	16.6	6.4	5.1	12.9	6.4	6.9	21.0	12.7	9.9	19.1	4.3	7.7	29.3	3.7	12.8	6.8	4.1	14.9	12.6	12.5	13.5	10.7	18.2	45.0	40.2	19.8	8.6	8.6	7.3	7.5	1.7	7.2	3.1	1.8	3.0	3.6	2.7	3.1	1.9	2.4	2.3	3.4	6.8	3.0	1.7	4.2	2.0	1.3	7.7	9.8	18.4	9.4	6.9	5.9	10.3	5.7	8.3	8.9	14.9	10.4	9.7	20.0	30.5	11.4	15.9	17.8	6.7	11.4	19.2	13.7	9.6	0.0	10.9	27.7	14.5	26.1	46.7	14.4	3.2	14.9	34.3	10.5	13.6	9.2	36.5	6.4	14.1	17.8	19.9	17.8	17.7	13.5	5.4	27.5	8.1	20.8	27.1	19.8	6.2	28.3	19.4	16.5	15.4	10.7	39.0	8.0	24.9	20.4	44.2
KLK8	"HNP, neuropsin, ovasin, PRSS19, TADG14"	ENSG00000129455	"Kallikrein related peptidase 8"	O60259	19	50996007-51002711	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 43.6;skin 1: 40.4;tongue: 46.9"	"Group enriched"	"Detected in some"	13	"Basal keratinocytes: 58.6;Suprabasal keratinocytes: 157.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 29.9;ovarian cancer: 30.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"A-431: 32.2;CAPAN-2: 42.3;HaCaT: 31.2"	"Region enriched"	"Detected in many"	5	"hippocampal formation: 39.6"					"CAB019393, HPA035761"	Enhanced		Approved	Vesicles	"Secreted in other tissues"	NA	NA		950000	Vesicles		"CAB019393: , HPA035761: AB_2674769"	"unprognostic (4.27e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (2.31e-4)"		"unprognostic (5.46e-2)"		"prognostic unfavorable (5.72e-4)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.10e-4)"			"unprognostic (4.29e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (6.17e-4)"	1.6	0.0	0.1	0.4	0.1	0.0	4.5	1.0	0.3	8.1	0.7	0.1	0.1	0.0	1.1	0.7	43.6	6.7	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.0	0.1	0.4	0.6	0.3	0.0	0.3	6.0	0.1	0.3	40.4	0.1	0.1	0.6	0.3	0.0	0.7	0.1	0.5	0.3	46.9	11.1	0.3	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	0.2	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.6	42.3	0.0	0.8	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.3	0.1	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	58.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	1.7	0.0	8.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.4	157.5	0.0	0.0	0.0	0.1
HIST1H1C	"H1.2, H1c, H1F2, H1s-1"	ENSG00000187837	"Histone cluster 1 H1 family member c"	P16403	6	26055787-26056428	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 353.5"	"Cell type enhanced"	"Detected in all"	6	"Glandular cells: 442.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 79.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 79.7"	"Cell line enhanced"	"Detected in many"		"K-562: 50.0;SiHa: 47.6;U-2 OS: 93.7;U-266/70: 103.9;U-266/84: 98.7"	"Low region specificity"	"Detected in all"							"CAB011507, HPA055907"	Supported		Supported	"Nucleoplasm,Nucleoli rim"		NA	NA		1800000	"Nucleoplasm, Nucleoli rim"		"CAB011507: AB_2117984, HPA055907: AB_2682966"	"unprognostic (4.43e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.06e-5)"	25.1	17.4	10.1	32.1	10.2	94.7	36.0	23.8	12.8	29.8	23.3	8.1	14.3	15.0	24.7	21.0	48.6	16.6	27.4	37.6	9.3	7.3	23.8	43.1	31.4	37.2	8.2	8.7	34.4	46.6	2.3	5.8	29.1	6.9	44.3	21.2	26.5	22.0	9.5	69.1	21.0	21.1	22.9	12.5	28.4	25.6	33.7	5.4	353.5	21.7	28.5	39.7	38.8	28.0	14.9	5.9	79.7	3.2	3.3	8.6	4.2	5.9	4.2	3.1	3.4	8.1	1.6	0.1	2.9	4.9	14.1	15.0	2.3	4.3	0.4	17.2	3.9	5.1	2.6	1.0	2.3	3.9	5.7	3.7	2.4	4.7	2.6	2.4	1.1	5.9	11.5	3.1	1.8	3.1	4.3	2.2	2.7	50.0	37.6	7.0	2.6	3.0	2.6	1.7	14.5	6.5	1.6	1.4	19.1	8.3	4.3	8.2	2.8	47.6	8.2	3.3	3.1	10.1	1.7	1.0	6.4	93.7	1.9	1.3	103.9	98.7	4.5	4.7	38.9	2.2	35.8	2.6	79.7	3.8	2.6	4.8	9.8	6.3	4.1	5.6	14.9	5.8	4.4	43.0	3.3	3.2	5.9	8.6	4.2	10.1	10.2	23.8	12.8	9.3	7.3	8.2	8.7	6.9	5.4	65.5	28.8	111.5	307.6	7.2	72.6	41.5	30.6	100.4	35.2	66.3	47.1	37.6	44.7	79.4	2.2	29.5	161.7	256.9	100.4	59.2	37.4	442.5	18.6	102.4	61.4	49.3	37.3	33.7	27.5	4.2	24.2	37.4	3.3	16.2	65.1	147.0	86.1	92.5	10.3	161.0	135.9	25.8	23.3	14.2	90.3	6.9	249.6	48.4	36.8	295.6
RNF141	"ZFP26, ZNF230"	ENSG00000110315	"Ring finger protein 141"	Q8WVD5	11	10511678-10541230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 903.9;Late spermatids: 383.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 63.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018133	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			Microtubules	Nucleoplasm	"HPA018133: AB_1859142"	"unprognostic (7.41e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.88e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.50e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (6.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.61e-2)"	14.0	17.6	27.9	14.8	39.0	10.0	15.8	10.2	28.8	10.9	10.0	44.4	6.0	12.5	8.2	11.8	33.7	9.7	8.4	12.8	30.1	23.6	14.2	12.4	12.3	9.4	44.7	18.7	6.5	8.2	19.4	9.5	8.5	33.7	13.6	9.9	7.3	20.6	8.8	23.9	24.2	17.5	7.8	56.2	15.1	12.3	42.2	39.3	7.7	13.3	12.8	15.4	10.6	12.9	19.1	8.2	43.5	29.2	2.4	4.2	8.6	17.7	9.3	12.9	7.8	19.7	19.2	9.5	12.1	9.5	4.6	5.6	13.9	63.6	7.3	11.2	9.3	8.3	12.8	5.5	13.9	7.1	8.0	7.4	5.0	5.9	7.2	7.6	7.9	6.0	12.6	16.2	2.5	15.3	17.0	12.4	9.4	13.5	6.9	11.5	7.4	7.8	2.9	6.5	11.4	5.2	10.0	5.8	8.0	7.4	19.2	4.0	8.5	11.7	13.7	7.5	11.3	8.8	4.2	13.1	11.6	7.2	9.5	3.7	3.1	5.9	8.2	14.2	11.2	13.9	8.5	15.0	25.2	2.5	29.2	4.2	19.1	2.9	2.4	8.2	18.4	3.3	2.2	43.5	2.4	27.0	7.6	3.4	8.6	27.9	39.0	10.2	28.4	30.1	23.6	44.7	18.7	33.7	39.3	17.9	42.2	20.1	35.2	36.2	18.2	41.6	17.8	22.7	11.4	19.2	11.8	11.7	34.9	17.4	903.9	18.9	19.7	0.0	21.5	12.7	11.6	45.2	12.7	24.5	34.2	35.0	20.2	22.1	101.8	383.0	18.1	24.1	18.6	27.9	29.7	19.0	35.2	5.8	18.4	25.6	11.0	6.5	13.7	68.5	25.8	35.0	15.0	10.4	22.5	62.0
MPZL2	"EVA, EVA1"	ENSG00000149573	"Myelin protein zero like 2"	O60487	11	118253403-118264536	"Predicted membrane proteins"	"Cell adhesion"		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.8"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 405.2;Basal keratinocytes: 295.4;Suprabasal keratinocytes: 408.6;Urothelial cells: 416.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 9.3;intermediate monocyte: 7.2;myeloid DC: 13.4;neutrophil: 10.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 13.4;granulocytes: 10.9;monocytes: 9.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 25.3;EFO-21: 27.9;HaCaT: 34.9;RT4: 66.3;TIME: 72.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA060740	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA060740: AB_2684352"	"unprognostic (1.74e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.28e-3)"	"unprognostic (9.95e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (2.08e-2)"	11.7	1.7	1.5	2.8	1.5	0.0	17.1	1.5	1.6	31.0	8.5	1.0	26.3	4.4	6.8	17.8	103.8	13.4	12.3	4.7	2.4	1.5	11.7	7.9	21.7	1.8	2.4	0.6	7.4	4.6	10.2	9.2	1.5	4.0	17.8	8.7	6.2	21.6	32.8	7.8	11.4	4.4	5.6	4.3	1.3	10.0	3.7	1.3	5.7	21.7	52.3	41.1	29.4	37.4	0.0	13.4	10.9	9.3	0.3	1.0	2.8	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	25.3	0.0	27.9	0.0	0.1	34.9	0.0	8.0	0.0	0.0	2.0	0.0	0.3	7.3	0.0	0.0	0.0	0.0	19.2	0.0	0.6	0.0	18.2	0.1	0.0	0.0	0.0	10.5	0.0	0.0	0.3	7.0	0.0	0.0	0.0	1.3	3.1	66.3	0.0	0.0	1.2	12.9	0.0	0.1	5.5	0.1	72.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	9.3	2.3	0.1	7.2	1.0	0.0	0.5	0.4	13.4	0.0	0.6	0.7	10.9	0.3	1.0	0.2	0.2	2.8	1.5	1.5	1.5	1.6	2.4	1.5	2.4	0.6	4.0	1.3	77.4	91.1	0.0	405.2	295.4	0.0	3.4	28.1	46.8	146.7	122.1	0.0	1.0	0.0	32.1	0.0	28.8	29.1	0.0	45.6	0.1	7.2	133.5	6.9	13.6	0.8	0.0	5.1	23.4	4.0	0.0	0.0	11.0	20.3	0.0	3.3	0.0	45.3	14.8	0.0	5.6	0.0	0.0	7.1	0.0	0.6	408.6	14.9	2.6	32.4	416.5
KLK7	"PRSS6, SCCE"	ENSG00000169035	"Kallikrein related peptidase 7"	P49862	19	50976482-50984099	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 29.1;skin 1: 77.5;tongue: 90.2"	"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 1: 6.0;Basal keratinocytes: 4.4;Suprabasal keratinocytes: 9.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 139.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 6.7;HaCaT: 26.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018994, CAB026342, HPA062126"	Enhanced		Supported	"Nuclear membrane,Plasma membrane"	"Secreted in other tissues"	NA	NA		960000	"Plasma membrane"	"Nuclear membrane"	"CAB026342: , HPA018994: AB_1852607, HPA062126: AB_2684691"	"unprognostic (1.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (8.06e-5)"	"unprognostic (4.33e-3)"	"unprognostic (2.28e-1)"		"unprognostic (4.44e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.60e-3)"	2.1	0.3	5.4	0.3	4.3	0.4	5.6	0.5	11.3	5.4	0.3	0.0	0.0	0.5	0.7	0.3	29.1	7.8	3.3	0.2	4.8	0.5	2.6	0.2	1.6	0.3	0.3	3.5	1.0	0.2	0.2	0.1	0.5	4.2	0.3	0.2	0.0	7.4	0.3	0.6	77.5	0.3	0.4	0.3	0.5	0.4	0.3	0.0	0.0	0.4	90.2	15.3	0.2	9.0	1.1	0.4	1.3	0.8	2.1	1.0	0.6	2.7	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.5	6.7	0.0	1.0	0.0	0.1	26.6	0.0	0.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.1	1.3	0.8	0.4	0.4	0.4	0.7	0.6	0.6	0.4	0.4	1.1	1.0	0.9	0.9	2.1	0.4	0.4	0.7	0.6	5.4	4.3	0.5	11.3	4.8	0.5	0.3	3.5	4.2	0.0	6.0	0.6	0.0	0.1	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.4	0.0	0.0	0.0	1.8
HMGXB4	"HMG2L1, THC211630"	ENSG00000100281	"HMG-box containing 4"	Q9UGU5	22	35257452-35295807	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Wnt signaling pathway"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000725, HPA076681"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000725: AB_1079073, HPA076681: "	"unprognostic (2.22e-1)"	"unprognostic (1.12e-1)"	"prognostic favorable (3.24e-5)"	"unprognostic (4.81e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (2.85e-2)"	"unprognostic (8.25e-3)"	"unprognostic (6.67e-3)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.62e-1)"	"unprognostic (8.71e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.54e-2)"	13.6	11.6	11.4	11.4	17.6	28.6	13.6	17.4	15.1	14.4	10.9	17.2	9.5	10.6	17.4	8.4	14.4	14.5	10.8	9.8	10.0	8.6	8.6	8.0	10.2	10.5	14.4	13.8	21.7	10.9	9.4	7.6	20.2	12.4	12.4	12.2	8.7	11.9	12.7	17.2	14.4	13.1	15.0	12.6	10.0	10.3	12.1	16.9	20.0	10.6	10.2	11.6	14.8	13.5	11.8	9.4	22.6	12.5	7.4	13.1	4.7	13.1	2.9	20.6	10.3	5.0	9.9	5.9	13.7	18.0	13.4	12.5	2.2	4.9	15.8	6.1	13.5	8.5	8.1	8.9	9.6	15.6	13.8	10.0	14.5	3.9	2.9	6.8	30.4	14.8	9.0	8.4	11.2	8.6	8.1	9.2	12.1	11.3	13.1	9.9	6.0	18.3	7.3	9.5	9.1	8.8	14.7	19.4	5.5	7.5	9.7	13.0	12.8	12.2	8.9	9.8	6.8	6.1	9.5	8.5	12.2	27.0	14.1	11.2	14.1	13.7	19.7	10.3	9.3	17.3	22.6	11.1	13.8	12.6	12.5	10.8	8.9	12.1	13.1	8.8	11.8	8.1	9.2	16.8	7.4	11.5	9.4	10.1	4.7	11.4	17.6	17.4	15.1	10.0	8.6	14.4	13.8	12.4	16.9	11.9	14.4	20.9	45.0	18.5	60.2	11.2	38.2	10.7	25.0	26.2	33.4	42.1	24.9	34.2	7.5	26.4	25.5	23.3	25.8	44.6	29.1	49.7	52.9	21.9	26.9	63.5	16.3	35.6	29.7	7.7	49.8	31.0	8.5	24.4	24.8	21.2	29.9	24.5	53.4	18.1	66.1	38.8	27.8	50.4	77.1	19.7	54.1	24.1	26.6	46.9
RBM7		ENSG00000076053	"RNA binding motif protein 7"	Q9Y580	11	114400030-114414203	"Predicted intracellular proteins"	Meiosis	RNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 146.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA013993, HPA048003"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA013993: AB_1856137, HPA048003: AB_2680231"	"unprognostic (2.90e-3)"	"unprognostic (8.21e-3)"	"prognostic favorable (6.14e-4)"	"unprognostic (1.03e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.38e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.49e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.30e-2)"	21.6	13.0	11.4	12.9	14.9	39.9	20.2	15.1	13.0	19.9	17.2	11.9	8.4	11.0	20.2	13.9	19.2	18.2	15.4	13.9	12.1	7.3	14.7	28.6	18.2	18.7	15.5	8.7	26.3	14.9	14.4	17.7	23.8	11.9	20.9	16.8	8.4	18.1	12.1	17.2	13.9	17.7	18.7	15.8	20.0	16.6	16.7	16.1	22.0	21.5	12.5	15.8	24.3	20.5	13.4	15.4	36.2	16.5	17.5	18.6	12.7	12.8	8.6	11.3	10.7	14.8	20.1	12.4	21.1	28.6	24.8	28.7	18.7	29.1	15.5	29.5	19.6	22.8	11.7	13.7	15.4	32.6	14.3	7.5	18.5	9.8	15.4	25.1	12.1	12.9	19.9	20.6	20.7	29.2	22.3	22.0	12.9	18.0	2.9	19.1	3.7	14.1	12.4	14.1	12.1	14.3	11.1	20.6	14.8	20.7	14.3	9.2	8.8	18.3	8.6	9.6	22.4	8.4	8.3	19.7	7.5	17.7	9.5	22.1	7.6	7.8	13.7	5.3	21.5	12.7	36.2	16.2	18.2	13.0	16.5	18.6	13.4	14.0	12.3	15.4	11.9	17.5	15.0	15.6	17.5	16.0	14.8	14.9	12.7	11.4	14.9	15.1	13.0	12.1	7.3	15.5	8.7	11.9	16.1	14.9	18.8	43.6	71.5	59.9	11.2	12.8	10.2	24.1	19.4	27.9	11.8	43.4	56.3	42.2	146.5	38.3	29.0	0.0	30.7	67.9	54.3	61.6	39.3	23.2	27.3	7.9	45.5	34.4	25.7	16.1	29.1	22.4	40.5	31.5	26.8	21.6	37.8	33.2	15.9	28.4	11.6	0.0	60.8	29.2	15.2	60.0	77.2	40.5	34.3	73.7
LRRC1	"dJ523E19.1, FLJ10775, FLJ11834, LANO"	ENSG00000137269	"Leucine rich repeat containing 1"	Q9BTT6	6	53794497-53924121	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 81.7;Syncytiotrophoblasts: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031603, HPA031604"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA031603: AB_10601753, HPA031604: AB_10601224"	"unprognostic (2.90e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.46e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.19e-3)"	"unprognostic (6.37e-2)"	"unprognostic (7.02e-2)"	"unprognostic (7.12e-3)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.97e-1)"	"prognostic favorable (2.21e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.84e-3)"	13.1	2.3	8.6	7.6	17.0	2.5	12.4	4.0	13.4	12.1	22.6	17.5	7.3	15.3	5.3	8.9	17.2	7.9	12.0	3.8	9.4	6.1	7.3	1.1	7.0	2.4	21.8	6.1	5.7	8.3	24.8	8.0	26.1	11.2	8.3	23.2	7.8	14.9	7.0	1.9	20.2	20.7	6.1	11.9	1.8	13.2	12.3	20.6	8.3	16.3	8.4	9.3	12.3	16.1	1.8	1.4	0.4	0.2	3.3	1.1	0.1	20.1	2.6	2.8	5.0	0.7	0.4	20.1	2.8	5.7	2.4	3.3	22.4	10.0	2.9	2.3	1.7	4.5	10.0	22.1	8.9	3.1	3.5	6.4	1.7	2.0	15.0	7.3	2.2	1.3	0.7	7.4	0.2	5.4	3.8	4.3	10.6	0.4	2.7	1.3	8.8	14.7	0.3	2.2	15.1	2.0	3.0	4.7	1.5	6.5	26.1	7.4	0.7	3.3	14.7	4.3	7.4	9.6	2.2	2.0	1.8	6.0	0.1	2.5	2.7	2.1	2.0	2.1	3.0	2.2	0.0	0.2	0.4	1.0	0.0	0.4	0.3	0.9	1.1	1.4	1.8	0.8	0.6	0.0	3.3	0.0	1.2	0.1	0.1	8.6	17.0	4.0	13.4	9.4	6.1	21.8	6.1	11.2	20.6	38.7	3.8	2.7	22.4	46.8	33.1	3.3	5.1	9.4	20.5	15.7	3.9	42.9	6.6	17.3	75.0	17.5	33.2	0.0	13.8	43.0	5.2	14.6	5.7	0.0	4.5	7.9	17.2	7.4	0.3	81.7	8.6	1.5	10.1	3.6	22.1	38.2	21.5	36.6	9.6	10.1	2.7	6.5	2.5	6.1	6.9	46.0	89.7	3.8	18.4	26.7
ERAP2	"L-RAP, LRAP"	ENSG00000164308	"Endoplasmic reticulum aminopeptidase 2"	Q6P179	5	96875939-96919716	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 63.4;T-cells: 53.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 49.1;GAMG: 30.0;hTEC/SVTERT24-B: 23.7;MOLT-4: 26.2;TIME: 51.5"					"Low region specificity"	"Detected in all"			"CAB025618, HPA034498, HPA064360"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		7400000	"Golgi apparatus"		"CAB025618: , HPA034498: AB_2674191, HPA064360: "	"unprognostic (4.62e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.01e-1)"	"unprognostic (9.54e-3)"	"unprognostic (6.59e-2)"	"unprognostic (8.48e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.05e-1)"	9.0	6.0	3.1	21.6	3.8	3.5	7.4	2.2	3.5	9.6	37.0	3.1	6.2	17.0	8.3	10.3	12.4	5.7	5.6	5.8	3.3	2.6	8.6	10.8	16.8	30.8	4.2	0.5	18.2	5.9	1.4	11.1	13.6	3.6	9.4	3.1	7.0	9.3	3.5	4.1	4.9	22.4	5.1	8.7	37.6	9.2	2.6	3.1	32.5	11.3	9.6	24.4	11.8	8.7	16.4	10.7	10.9	15.3	24.0	22.4	14.1	0.5	0.6	0.4	0.2	0.5	1.0	0.1	2.1	3.7	2.0	3.3	2.1	49.1	2.9	9.7	3.1	30.0	0.7	0.2	17.8	1.6	1.0	2.1	0.1	0.7	2.0	0.7	10.8	5.2	7.3	3.3	23.7	0.1	0.3	1.3	7.3	0.0	7.3	5.6	0.3	26.2	5.4	0.0	0.0	1.0	11.7	4.2	7.7	14.2	4.1	0.9	0.0	0.3	0.2	4.1	0.1	1.7	0.4	51.5	1.0	0.3	2.7	6.3	7.1	6.1	1.0	14.3	1.4	0.2	10.9	6.5	7.8	14.2	15.3	18.1	16.4	20.2	17.6	10.7	9.6	22.4	17.0	2.2	24.0	14.4	3.5	18.2	14.1	3.1	3.8	2.2	3.5	3.3	2.6	4.2	0.5	3.6	3.1	29.8	18.3	63.4	8.3	5.0	1.4	3.5	7.6	9.4	15.9	41.8	0.0	10.0	0.0	5.0	0.2	29.2	40.8	0.0	21.9	14.9	15.1	3.1	6.9	14.3	12.0	0.0	1.7	20.3	17.4	0.0	9.8	22.3	6.8	7.2	21.5	7.5	14.1	24.6	7.4	5.7	2.0	0.0	8.2	0.9	0.7	2.6	5.6	53.6	20.6	8.1
CAV2	CAV	ENSG00000105971	"Caveolin 2"	P51636	7	116287380-116508541	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 824.8;Basal keratinocytes: 429.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	82	"basophil: 31.8"	"Lineage enriched"	"Detected in single"	318	"granulocytes: 31.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 48.8;HBEC3-KT: 55.8;LHCN-M2: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013488, HPA044810"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"CAB013488: AB_2533493, HPA044810: AB_2679098"	"unprognostic (4.76e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.56e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.09e-3)"	"prognostic unfavorable (5.80e-5)"	"unprognostic (3.66e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.81e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (6.32e-2)"	"unprognostic (3.44e-3)"	"unprognostic (7.84e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.34e-3)"	61.9	4.5	3.0	9.5	6.6	0.2	39.9	1.0	3.7	26.3	15.7	3.1	10.3	3.3	23.4	19.6	25.2	10.8	31.3	54.6	4.4	3.1	9.5	17.4	59.4	6.0	7.5	3.8	17.7	16.0	1.4	2.8	35.2	4.6	20.6	5.0	12.1	10.7	10.5	15.3	13.3	8.3	34.0	8.6	25.3	8.9	12.1	5.3	1.7	61.2	23.2	4.9	29.5	15.4	0.0	0.0	31.8	0.0	0.0	0.0	0.2	39.3	10.7	0.5	0.0	18.2	19.6	0.8	27.5	32.8	9.1	8.2	2.0	48.8	0.0	33.0	28.2	29.4	38.2	0.5	55.8	13.2	0.0	2.6	0.3	8.2	0.0	11.2	0.0	0.1	11.5	32.2	12.3	25.5	14.6	29.4	0.0	1.9	1.6	60.2	2.1	0.0	0.0	0.5	1.3	6.9	0.4	13.4	0.5	33.5	1.2	0.0	0.0	21.0	0.7	5.1	5.9	0.0	0.2	41.9	0.0	5.8	18.2	9.0	1.7	0.0	0.1	3.7	0.0	19.7	31.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	3.0	6.6	1.0	3.7	4.4	3.1	7.5	3.8	4.6	5.3	824.8	93.2	3.0	234.5	429.9	3.3	197.7	119.8	33.5	164.9	38.4	3.9	12.5	29.9	203.4	19.4	231.9	2.4	0.0	87.5	115.4	81.9	72.8	2.3	42.7	4.3	0.0	1.7	104.3	4.7	13.0	87.5	7.4	138.3	3.6	4.7	140.5	278.7	0.0	182.5	2.2	6.0	187.5	172.0	2.3	1.3	246.5	10.4	2.5	5.1	133.6
KIF20B	"CT90, KRMP1, MPHOSPH1, MPP1"	ENSG00000138182	"Kinesin family member 20B"	Q96Q89	10	89701610-89774939	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 26.2"	"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 70.0;Spermatocytes: 149.9;Spermatogonia: 96.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA050214	Supported		Supported	"Nucleoplasm,Cytokinetic bridge,Midbody,Cytosol"		Yes	Yes			"Nucleoplasm, Cytokinetic bridge"	"Midbody, Cytosol"	"HPA050214: AB_2681053"	"unprognostic (2.13e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.39e-2)"	"unprognostic (8.95e-5)"	"unprognostic (3.32e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.14e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (3.06e-6)"	"unprognostic (4.22e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.43e-2)"	3.9	2.3	1.3	5.9	6.6	11.1	3.2	12.8	3.0	4.1	3.8	0.7	1.1	4.3	3.4	2.2	7.0	3.3	1.5	2.2	2.1	1.3	2.4	3.2	2.8	9.5	1.6	2.6	4.3	2.0	2.1	3.2	4.0	3.6	2.3	5.1	1.5	3.4	2.0	2.1	4.9	5.5	3.0	3.0	8.0	3.0	10.2	2.6	26.2	2.8	3.9	9.1	2.8	3.8	13.3	4.8	8.3	3.9	2.4	8.6	1.9	36.0	7.4	10.8	9.6	2.1	3.7	9.0	14.8	13.6	15.6	16.4	9.7	16.7	14.0	4.7	7.5	5.8	18.4	12.0	8.3	21.0	16.8	8.2	14.2	12.9	8.4	0.6	24.1	11.8	1.5	1.2	15.0	15.4	5.5	10.0	7.4	13.5	16.2	13.8	6.2	14.1	4.6	11.1	5.9	7.1	9.8	21.3	6.1	4.8	4.8	3.4	6.2	10.6	4.8	5.6	8.1	12.6	7.0	7.8	10.0	10.1	13.0	23.8	4.5	12.2	18.8	9.5	21.5	7.4	8.3	2.3	3.7	5.5	3.9	6.7	11.5	7.4	5.9	1.2	13.3	8.6	8.0	0.1	2.4	3.8	4.8	8.6	1.9	1.3	6.6	12.8	3.0	2.1	1.3	1.6	2.6	3.6	2.6	3.0	15.7	46.6	7.4	15.8	11.8	7.1	2.5	6.7	7.9	0.0	9.8	9.8	3.3	5.1	8.6	7.8	5.9	70.0	4.0	30.5	12.7	3.4	43.8	3.8	17.2	12.7	1.2	8.6	11.6	9.6	7.5	16.4	5.0	9.0	5.4	6.4	2.9	5.7	8.1	2.4	9.1	6.5	15.5	149.9	96.9	12.3	4.3	26.1	13.0	2.2
PRKCI	"DXS1179E, PKCI"	ENSG00000163558	"Protein kinase C iota"	P41743	3	170222365-170305981	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026574, HPA038635"	Approved		Supported	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			Cytosol	"Microtubules, Cytokinetic bridge"	"HPA026574: AB_1855428, HPA038635: AB_2676124"	"unprognostic (2.26e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.57e-2)"	"prognostic unfavorable (3.93e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.52e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (5.32e-3)"	"prognostic favorable (3.10e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.73e-2)"	10.3	7.5	11.4	5.9	15.5	2.1	9.5	14.8	16.6	12.5	11.1	7.0	6.0	10.4	13.1	8.4	20.6	15.1	10.5	10.1	9.5	7.7	13.0	6.7	14.8	3.9	5.6	9.4	15.2	7.7	12.4	14.7	9.8	11.0	16.3	12.2	7.3	25.8	12.6	12.7	11.0	11.6	12.5	6.8	6.1	30.2	15.0	5.3	12.6	23.1	8.4	9.9	16.3	13.0	1.9	1.8	1.0	1.3	5.8	4.8	1.4	34.3	8.7	8.8	9.4	7.8	10.9	14.2	8.8	13.0	11.7	12.7	12.7	16.8	10.5	29.1	12.3	16.1	16.1	16.5	17.3	20.1	7.6	10.2	9.7	11.0	7.0	12.4	8.7	4.4	9.8	12.1	10.0	15.7	19.0	9.1	5.8	10.7	8.7	11.7	11.8	12.6	3.4	18.4	36.7	9.7	9.2	13.5	17.3	18.4	10.5	14.0	11.4	19.0	25.0	8.6	13.6	27.5	6.0	9.6	12.2	9.4	11.4	14.5	15.0	14.4	15.0	8.8	6.9	4.7	0.1	1.3	1.0	2.6	1.2	4.0	1.8	3.6	4.8	1.8	1.9	3.9	2.2	0.7	5.8	1.1	1.8	2.3	1.4	11.4	15.5	14.8	16.6	9.5	7.7	5.6	9.4	11.0	5.3	68.5	56.0	2.2	46.0	50.7	15.9	14.9	25.5	22.7	46.6	47.1	13.7	23.8	21.6	13.9	5.5	18.0	21.2	0.0	19.5	22.1	25.6	78.7	8.1	17.8	8.9	14.3	28.2	16.5	20.8	3.6	21.6	10.0	16.9	6.4	28.1	8.1	36.5	17.5	26.9	15.1	9.3	19.4	11.4	12.9	15.1	55.7	17.3	5.7	27.7	69.1
PTBP3	"DKFZp781I1117, ROD1"	ENSG00000119314	"Polypyrimidine tract binding protein 3"	O95758	9	112217716-112333667	"Predicted intracellular proteins"	"Differentiation, Erythrocyte maturation, mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048374			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA048374: AB_2680376"	"unprognostic (6.12e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.38e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.39e-2)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (1.17e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.72e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.04e-2)"	"unprognostic (5.10e-2)"	22.4	9.4	7.2	24.5	9.2	22.9	26.3	9.5	6.8	17.2	21.7	5.6	18.9	17.7	14.3	18.9	38.4	10.0	17.2	11.6	6.1	8.7	26.8	12.7	25.1	37.2	6.2	4.5	13.0	17.9	9.0	17.8	25.8	6.6	13.8	22.1	9.0	20.2	22.6	8.0	25.0	32.4	12.8	11.4	23.9	20.9	22.6	6.6	41.7	12.6	30.7	38.4	22.1	21.5	7.0	11.8	23.9	9.5	4.3	8.7	4.5	20.0	21.3	8.1	7.0	7.2	7.9	41.5	8.2	6.7	10.1	10.5	24.2	30.1	23.0	9.2	10.6	8.0	28.5	11.2	23.4	13.5	25.6	3.9	23.3	8.8	17.0	9.1	30.5	28.4	8.9	15.9	13.5	18.7	6.4	17.1	17.9	31.1	21.6	11.5	18.7	30.1	8.3	12.8	31.0	7.3	19.6	27.7	11.6	14.9	26.6	10.2	6.5	16.3	21.4	7.9	18.2	25.3	13.8	13.2	8.9	12.2	12.8	10.1	11.1	27.4	20.9	7.7	15.6	8.7	14.2	6.3	11.8	8.4	7.7	8.7	5.5	6.3	6.8	7.2	7.0	5.0	6.0	23.9	4.3	9.5	11.8	6.5	4.5	7.2	9.2	9.5	6.8	6.1	8.7	6.2	4.5	6.6	6.6	26.8	59.3	29.8	34.2	71.2	7.7	6.7	63.7	69.6	70.5	108.2	17.7	29.6	24.9	37.2	53.1	41.4	73.5	46.7	61.6	89.7	27.7	65.8	62.5	27.0	49.5	7.9	86.8	43.6	100.8	105.3	20.1	76.6	27.0	63.1	73.2	3.5	88.0	63.3	17.7	25.4	15.7	19.4	25.9	17.2	19.8	90.8	29.3	57.3	69.2	200.8
PRRG1	PRGP1	ENSG00000130962	"Proline rich and Gla domain 1"	O14668	X	37349275-37457295	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.4"	"Cell type enhanced"	"Detected in many"	5	"Collecting duct cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 39.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078129			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"	Nucleoplasm	"HPA078129: AB_2686878"	"unprognostic (8.82e-2)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (8.34e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.24e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (8.21e-2)"	"prognostic favorable (2.05e-7)"	"unprognostic (1.43e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.48e-1)"	11.6	5.5	12.0	3.1	22.0	0.7	5.8	2.6	18.7	6.7	5.7	35.9	4.6	4.1	6.2	2.5	5.9	4.0	12.4	8.5	17.9	10.7	14.9	10.7	6.3	2.5	31.0	9.9	6.2	2.6	1.2	2.3	10.6	21.3	5.1	6.0	3.0	3.9	11.6	19.3	3.1	4.3	7.5	43.4	4.0	3.4	2.4	23.7	0.0	11.6	2.9	1.6	5.9	4.5	0.6	0.2	2.6	1.7	0.2	0.4	0.1	15.0	3.4	2.8	2.8	9.4	7.6	1.2	6.4	8.6	2.3	4.0	8.2	9.7	0.0	11.1	5.0	4.3	4.9	7.6	4.8	4.0	0.0	2.4	2.7	3.6	2.8	11.5	0.0	3.5	11.8	4.0	4.5	3.8	4.6	11.9	0.0	1.2	0.0	8.0	1.1	0.0	0.0	3.3	2.4	7.2	0.0	6.2	0.0	39.4	0.7	0.0	0.0	4.7	7.5	2.8	7.7	0.0	1.6	8.5	3.6	2.2	7.0	1.9	0.0	0.0	0.0	3.6	0.0	3.3	2.6	1.7	0.1	0.2	0.5	0.2	0.6	0.1	0.3	0.1	0.4	0.2	0.4	0.8	0.2	0.2	0.2	0.2	0.1	12.0	22.0	2.6	13.9	17.9	10.7	31.0	9.9	21.3	23.7	6.0	3.4	0.0	4.2	10.1	1.8	7.6	12.7	0.0	0.0	31.4	0.0	5.5	6.6	5.9	0.6	16.5	5.6	0.0	2.7	11.7	8.7	5.9	1.1	15.3	3.8	17.5	2.9	14.7	5.1	0.0	4.4	1.4	3.3	1.0	4.8	1.9	12.9	8.0	2.5	7.3	0.2	6.5	5.6	0.9	3.6	5.5	8.7	0.0	4.1	7.4
SPC24	"FLJ90806, SPBC24"	ENSG00000161888	"SPC24, NDC80 kinetochore complex component"	Q8NBT2	19	11131520-11155808	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.0"	"Cell type enriched"	"Detected in many"	5	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA051234	Approved		Supported	Nucleoplasm,Nucleoli		NA	Yes			Nucleoplasm	Nucleoli	"HPA051234: AB_2681397"	"unprognostic (1.57e-1)"	"prognostic favorable (3.59e-4)"	"unprognostic (6.79e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.04e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (6.12e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.62e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.82e-2)"	2.8	3.2	1.1	9.0	1.0	19.4	3.8	0.4	1.9	2.8	4.0	0.8	0.9	3.5	2.2	2.8	8.4	1.4	2.4	8.2	1.0	0.4	1.8	2.6	4.2	4.9	0.6	1.0	1.1	1.0	0.1	1.0	5.9	0.6	1.4	3.5	0.8	2.4	1.5	2.7	3.2	4.4	6.7	0.7	5.5	4.0	13.3	0.7	58.0	0.9	12.8	12.2	2.3	3.2	1.9	1.3	7.2	1.4	4.2	3.7	0.7	26.2	9.9	13.7	11.1	1.9	3.6	6.2	15.4	5.7	14.6	16.6	10.4	9.0	20.8	17.6	6.8	8.5	14.3	10.6	11.0	10.8	11.0	9.1	28.0	23.0	15.4	0.4	19.6	12.5	0.7	0.4	10.4	4.8	3.8	12.8	23.0	14.9	43.9	10.1	17.3	26.7	11.9	9.6	7.3	16.0	21.4	21.0	6.7	4.3	8.7	14.3	10.3	13.5	8.4	3.6	6.8	8.3	7.1	12.1	13.8	14.7	18.5	18.4	26.8	13.8	20.0	10.2	19.4	11.2	4.1	1.4	1.5	1.4	1.2	1.2	1.9	2.3	3.4	0.5	1.9	2.7	1.7	7.2	4.2	1.3	1.3	3.7	0.7	1.1	1.0	0.4	1.9	1.0	0.4	0.6	1.0	0.6	0.7	0.0	0.3	0.0	0.8	1.0	0.0	7.0	2.5	0.0	1.2	5.2	5.9	3.0	0.0	0.2	0.1	0.1	0.7	70.0	0.0	13.5	4.0	0.3	5.7	0.0	11.2	0.0	2.4	2.5	2.8	1.7	0.6	1.3	0.0	0.0	1.1	0.9	0.2	0.0	0.4	0.4	0.3	0.0	0.3	6.5	10.1	0.3	1.7	2.2	2.9	0.4
MALL	BENE	ENSG00000144063	"Mal, T cell differentiation protein like"	Q13021	2	110083870-110116566	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 107.7;intestine: 142.1;lung: 72.9"	"Cell type enhanced"	"Detected in many"	14	"Ductal cells: 224.3;Enterocytes: 724.1;Pancreatic endocrine cells: 223.5;Urothelial cells: 444.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 9.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 9.3"	"Cell line enhanced"	"Detected in some"		"A-431: 40.7;A549: 39.9;CAPAN-2: 55.2;fHDF/TERT166: 60.6;HaCaT: 43.0;PC-3: 24.4"	"Low region specificity"	"Detected in single"							HPA051410	Uncertain					NA	NA					"HPA051410: AB_2681474"	"unprognostic (5.17e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.50e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (2.37e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.50e-3)"	5.5	1.0	0.9	11.1	2.1	0.1	7.7	0.4	1.1	22.5	46.4	0.2	1.3	41.2	6.0	2.7	107.7	2.8	6.7	10.8	1.7	1.0	1.9	1.1	72.9	3.7	1.1	0.2	1.6	2.9	49.8	1.0	3.7	3.6	5.5	19.0	1.6	11.2	1.5	2.1	11.1	142.1	5.1	4.2	2.0	1.8	2.2	0.4	0.6	5.6	45.8	63.8	7.8	35.4	0.9	0.7	9.3	0.7	2.1	1.0	0.5	40.7	39.9	0.0	0.1	0.0	0.0	0.1	7.9	0.4	0.0	0.0	6.6	55.2	0.1	20.1	60.6	0.0	43.0	0.0	2.3	0.0	0.1	0.0	0.3	1.1	0.0	0.3	0.0	0.1	0.9	2.2	0.1	0.0	0.0	19.8	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	19.1	24.4	0.0	0.0	0.1	5.2	2.3	0.1	0.0	0.0	1.4	0.1	0.0	0.0	0.2	20.3	0.0	0.1	0.1	0.1	0.0	0.0	4.7	0.0	0.0	0.0	9.3	0.7	1.0	0.4	0.4	0.4	0.7	0.8	0.7	0.3	0.9	0.5	1.0	4.4	2.1	0.2	0.7	0.6	0.5	0.9	2.1	0.4	1.1	1.7	1.0	1.1	0.2	3.6	0.4	38.7	157.7	0.0	55.9	14.5	0.0	2.8	5.1	10.7	42.1	1.8	0.0	0.1	0.0	224.3	19.6	50.2	724.1	0.0	57.6	0.1	7.4	142.5	6.9	0.6	6.2	0.0	16.8	27.6	1.2	5.6	2.3	1.8	13.5	1.8	39.1	0.0	223.5	112.2	1.1	11.3	0.0	0.0	5.0	7.7	0.9	11.5	0.5	1.3	52.5	444.9
SCEL	"FLJ21667, MGC22531"	ENSG00000136155	Sciellin	O95171	13	77535674-77645263	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 145.6;skin 1: 70.8;tongue: 62.2"	"Cell type enriched"	"Detected in many"	13	"Alveolar cells type 1: 631.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.4;HaCaT: 23.3;HBEC3-KT: 11.1;OE19: 31.1;RPTEC TERT1: 45.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039737, HPA040154"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA039737: AB_10805485, HPA040154: AB_10795359"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.54e-2)"		"unprognostic (6.62e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (6.87e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavorable (1.73e-5)"	0.4	0.0	0.1	0.2	0.4	0.0	4.9	0.1	0.2	15.2	0.2	0.2	0.1	0.0	0.8	0.2	145.6	0.0	0.3	0.1	0.1	0.0	0.4	0.1	27.8	0.1	0.1	0.1	0.2	0.1	0.0	0.1	3.7	0.2	0.1	0.4	0.1	11.8	0.1	0.3	70.8	0.2	0.1	0.2	0.1	0.0	0.5	0.1	0.4	0.5	62.2	35.1	0.4	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.7	0.0	0.0	23.3	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.1	6.3	0.0	0.0	0.0	45.3	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1	631.3	30.6	0.0	0.0	9.5	0.0	0.2	0.0	6.7	42.1	0.0	0.0	0.3	0.0	4.1	5.8	0.0	0.0	0.0	0.2	0.0	0.3	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.6	1.7	0.0	4.3	1.5	26.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.7	48.8	0.1	0.0	0.0	2.6
SFTA2	SFTPG	ENSG00000196260	"Surfactant associated 2"	Q6UW10	6	30931353-30955636	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	8	"lung: 104.5"	"Group enriched"	"Detected in many"	7	"Alveolar cells type 1: 497.3;Alveolar cells type 2: 624.9;Cholangiocytes: 170.7;Club cells: 204.8"	"Cancer enhanced"	"Detected in many"		"lung cancer: 121.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	11	"B-cells: 1.7;T-cells: 1.7"	"Group enriched"	"Detected in some"	5	"CACO-2: 13.8;CAPAN-2: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA						"unprognostic (5.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.20e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.34e-1)"		"unprognostic (6.37e-2)"		"unprognostic (2.27e-1)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.96e-4)"	"unprognostic (8.84e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.39e-3)"	"unprognostic (7.95e-2)"	0.1	0.2	0.1	0.1	0.1	0.0	0.2	0.1	0.1	1.2	0.1	0.1	0.5	0.0	0.2	0.1	13.6	1.4	6.3	0.2	0.1	0.0	1.6	0.1	104.5	0.1	0.1	0.1	0.3	1.1	0.4	0.1	0.6	0.2	0.2	0.0	0.1	1.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	2.0	1.3	0.1	0.1	1.0	0.4	0.3	0.1	5.4	1.7	0.1	0.1	0.0	0.0	1.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	7.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	1.5	0.5	0.1	1.7	1.3	1.7	0.1	0.0	0.0	0.0	0.4	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	497.3	624.9	0.0	0.1	0.1	0.4	0.0	170.7	14.7	204.8	50.6	0.0	0.0	3.3	18.0	2.9	0.7	0.0	0.0	32.4	0.0	0.2	0.3	11.6	0.0	0.1	0.0	0.0	0.0	0.0	7.4	0.3	0.2	0.0	0.0	0.0	1.1	57.0	0.0	0.4	0.3	0.0	0.0	0.0	6.2	0.9	0.0	0.0	0.0	0.0	1.3
DKK1	"DKK-1, SK"	ENSG00000107984	"Dickkopf WNT signaling pathway inhibitor 1"	O94907	10	52314296-52318042	"Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"placenta: 153.6"	"Cell type enhanced"	"Detected in many"	19	"Basal glandular cells: 400.3;Glandular cells: 95.5;Pancreatic endocrine cells: 113.3;Urothelial cells: 308.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	9	"pons and medulla: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 113.4;BJ hTERT+: 62.2;CACO-2: 99.0;fHDF/TERT166: 156.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted in female reproductive system"	NA	NA						"unprognostic (5.65e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.09e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (4.35e-8)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (7.80e-6)"	"unprognostic (1.54e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (1.27e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.47e-3)"	"unprognostic (4.05e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.06e-2)"	15.6	0.1	0.5	0.3	0.4	0.0	4.0	0.4	0.6	26.2	0.3	0.6	1.8	0.1	2.1	0.5	5.3	0.1	2.8	0.6	0.8	1.7	0.5	0.2	0.6	0.3	0.7	0.3	0.9	0.1	0.1	0.2	153.6	15.2	4.2	0.1	0.7	1.6	1.3	0.6	11.7	0.2	1.2	0.2	0.4	0.8	1.6	0.4	0.1	0.2	0.1	0.5	10.6	7.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	30.3	21.3	0.0	3.2	15.5	3.1	0.0	113.4	62.2	39.0	20.8	99.0	6.4	0.0	0.1	156.8	9.5	24.3	0.0	12.9	37.1	0.0	0.0	0.0	0.4	2.5	3.3	0.0	0.0	3.1	1.6	8.4	50.0	2.0	3.5	0.0	0.0	0.0	25.6	13.1	0.0	0.0	0.0	1.3	54.5	0.0	3.5	0.0	14.9	2.5	0.0	34.8	10.2	0.1	1.6	0.0	0.1	0.0	7.8	0.0	0.0	34.2	20.6	0.0	0.0	0.0	0.4	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.6	0.8	1.7	0.7	0.3	15.2	0.4	23.8	0.0	0.0	400.3	4.7	0.1	0.4	0.0	1.4	1.2	0.0	0.0	3.4	0.0	3.5	1.1	0.3	0.4	0.0	3.6	4.7	77.0	95.5	4.6	0.0	8.5	0.0	0.0	1.8	0.0	0.4	0.0	0.8	0.0	0.0	0.3	5.8	113.3	0.0	0.0	0.0	0.3	0.0	1.4	0.2	0.9	2.8	7.0	0.0	0.4	308.8
ANXA3	ANX3	ENSG00000138772	"Annexin A3"	P12429	4	78551519-78610451	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Phospholipase A2 inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 83.0"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 547.9;Ductal cells: 468.5;Exocrine glandular cells: 274.5;Pancreatic endocrine cells: 473.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	319	"neutrophil: 51.3"	"Lineage enriched"	"Detected in single"	319	"granulocytes: 51.3"	"Cell line enhanced"	"Detected in many"		"A-431: 51.5;CACO-2: 52.8;CAPAN-2: 71.5;EFO-21: 43.8;hTERT-HME1: 72.9;OE19: 61.8;RPTEC TERT1: 61.4"	"Low region specificity"	"Detected in all"							"HPA013398, HPA013431"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		7400000	"Plasma membrane"		"HPA013398: AB_1844861, HPA013431: AB_1844862"	"unprognostic (2.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (4.92e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (4.82e-2)"	"prognostic favorable (8.48e-6)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.30e-2)"	20.3	1.1	4.0	7.1	7.4	83.0	16.2	2.4	6.8	7.0	8.5	2.3	0.9	4.2	3.4	4.2	25.0	4.6	11.7	20.5	5.2	5.2	19.8	1.6	46.0	5.7	6.6	5.6	2.8	14.7	6.5	5.8	33.7	10.4	18.8	7.4	2.6	50.8	3.6	14.2	4.1	9.3	5.3	4.0	11.0	23.4	1.8	5.0	2.0	45.3	13.6	7.4	2.8	5.9	0.1	0.0	51.3	0.1	0.0	0.0	0.5	51.5	9.8	0.1	0.1	0.1	0.2	0.0	0.6	0.0	1.5	1.4	52.8	71.5	0.0	43.8	1.8	0.0	20.4	0.0	37.7	2.3	0.2	0.4	4.6	21.1	3.1	6.1	0.6	0.0	0.3	33.4	0.5	72.9	7.6	14.9	1.2	0.1	0.0	0.2	2.0	0.2	0.0	1.6	61.8	7.2	0.0	0.1	0.0	61.4	5.9	0.0	0.0	30.4	7.5	2.1	25.3	1.3	0.6	18.9	0.1	6.8	0.0	11.6	0.4	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	51.3	0.0	0.1	0.0	0.0	0.5	4.0	7.4	2.4	6.8	5.2	5.2	6.6	5.6	10.4	5.0	547.9	38.9	0.0	51.1	22.0	0.0	6.4	58.6	36.1	144.5	36.6	0.0	172.1	14.9	468.5	0.9	32.1	19.7	0.0	274.5	87.0	24.3	117.9	4.7	0.4	16.1	0.0	5.2	20.3	0.0	0.0	2.8	1.7	5.0	36.1	30.9	0.8	473.1	58.5	0.4	1.1	0.3	0.0	9.5	1.2	0.7	5.8	52.5	0.5	28.7	32.0
GTSE1	"B99, GTSE-1"	ENSG00000075218	"G2 and S-phase expressed 1"	Q9NYZ3	22	46296741-46330810	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.0;testis: 22.3"	"Cell type enhanced"	"Detected in many"	18	"Erythroid cells: 93.5;Extravillous trophoblasts: 27.0;Spermatocytes: 47.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029457			Approved	"Plasma membrane,Centrosome"		Yes	Yes			Centrosome	"Plasma membrane"	"HPA029457: "	"unprognostic (1.97e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (1.90e-10)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (1.09e-1)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (3.49e-3)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.85e-2)"	1.1	1.3	0.3	10.4	0.8	10.2	1.3	1.0	1.1	1.2	2.5	0.7	0.1	4.1	1.1	1.3	6.6	0.4	0.4	0.8	1.0	0.3	0.9	0.9	1.3	9.0	0.6	0.4	0.9	0.5	0.0	0.9	2.8	1.8	0.6	2.6	0.7	1.5	0.1	0.3	2.4	3.3	1.0	0.6	4.6	2.4	22.3	0.3	20.0	0.5	5.8	8.8	1.1	2.1	1.4	1.9	3.0	0.2	1.8	1.6	0.9	21.8	10.4	20.5	16.2	0.4	1.2	9.8	19.0	9.0	27.7	22.9	10.8	8.3	20.7	5.0	7.3	12.7	11.5	18.3	4.8	17.8	12.4	19.7	13.8	14.6	8.4	0.0	24.7	16.9	0.2	0.3	11.9	6.1	2.9	11.9	15.0	10.5	26.0	16.5	12.2	22.1	12.1	14.3	9.0	11.7	22.0	23.0	13.5	4.5	4.0	10.6	14.5	18.1	11.8	8.4	9.6	10.0	9.6	9.4	15.8	30.0	12.9	19.9	14.9	7.1	21.0	10.0	11.9	23.0	0.1	0.2	1.5	1.3	0.1	0.4	1.4	0.6	0.6	0.3	0.6	0.4	0.3	3.0	1.8	0.1	1.9	1.6	0.9	0.3	0.8	1.0	1.1	1.0	0.3	0.6	0.4	1.8	0.3	0.0	0.0	0.8	0.6	2.5	0.6	1.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	3.9	0.4	0.5	93.5	0.2	27.0	1.1	0.6	0.0	0.5	16.0	0.0	1.2	5.5	6.2	3.8	0.3	3.5	0.0	0.0	2.0	0.2	0.4	0.0	0.7	0.4	0.1	6.5	0.9	47.7	20.4	2.3	1.3	2.9	3.7	1.4
MOCOS	"FLJ20733, HMCS, MOS"	ENSG00000075643	"Molybdenum cofactor sulfurase"	Q96EN8	18	36187519-36272157	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.0;liver: 36.6"	"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 30.1;monocytes: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 20.8;hTERT-HME1: 25.6;SiHa: 27.4;SK-MEL-30: 19.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039412, HPA047958"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA039412: AB_2676496, HPA047958: AB_2680225"	"unprognostic (3.07e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.84e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.91e-2)"	"prognostic unfavorable (3.03e-12)"	"unprognostic (8.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.35e-2)"	3.7	12.7	0.6	1.6	0.5	0.2	6.4	0.4	0.4	1.4	10.4	0.7	8.0	6.7	1.3	4.6	4.8	1.9	5.8	1.3	0.4	0.5	1.7	36.6	1.8	0.2	0.4	0.1	17.2	3.2	1.1	9.4	11.2	2.2	2.8	1.8	2.1	2.5	7.2	1.3	2.6	33.0	1.0	0.4	0.7	1.7	1.3	0.2	0.0	1.2	2.9	3.5	2.6	1.7	0.4	0.3	1.9	0.3	1.1	0.3	0.1	6.9	2.4	0.1	0.0	2.2	2.9	1.5	4.1	2.3	2.0	5.1	1.5	2.2	0.0	1.3	6.6	0.5	4.3	1.5	6.5	2.8	1.2	1.2	0.1	6.9	5.7	7.6	0.0	2.0	4.5	20.8	7.7	25.6	0.2	0.3	0.0	2.3	0.0	3.2	1.8	0.0	0.0	0.4	1.6	2.0	0.0	0.0	0.0	2.8	9.1	0.0	0.6	27.4	1.7	19.1	0.4	1.3	0.1	1.3	1.6	1.9	3.4	0.7	0.0	0.0	0.0	4.0	0.0	0.7	1.7	0.3	0.3	0.3	0.2	0.2	0.3	0.2	0.3	0.1	0.4	0.2	0.3	1.9	1.1	0.2	0.3	0.1	0.1	0.6	0.5	0.4	0.4	0.4	0.5	0.4	0.1	2.2	0.2	11.9	5.3	3.4	1.2	0.6	0.2	0.4	0.0	2.7	6.8	0.0	2.0	0.4	0.0	2.7	5.7	0.9	2.6	0.0	10.9	3.3	1.5	1.2	0.0	30.1	0.5	0.0	2.9	0.0	0.6	1.7	1.7	1.4	3.3	20.8	2.3	7.6	4.3	2.8	8.5	0.0	0.3	0.0	0.5	0.1	0.2	1.1	1.9	0.0	2.8	2.2
CENPA	"CenH3, CENP-A"	ENSG00000115163	"Centromere protein A"	P49450	2	26764289-26801067	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 53.7"	"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 27.3;Hofbauer cells: 12.7;Spermatogonia: 18.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.6"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB008371, HPA073086"	Enhanced		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB008371: AB_591074, HPA073086: AB_2686569"	"unprognostic (3.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (2.88e-8)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.69e-3)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (4.21e-3)"	"unprognostic (0.00e+0)"	"unprognostic (5.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.07e-1)"	1.2	0.9	0.2	12.1	0.2	3.5	3.0	0.2	0.2	1.3	3.5	0.4	0.3	5.3	0.9	1.5	8.5	0.1	1.2	1.5	0.2	0.3	0.8	0.7	1.4	8.2	0.3	0.0	0.5	0.7	0.0	0.3	3.1	0.3	0.5	3.2	0.1	1.7	0.0	0.3	4.5	3.6	0.8	0.3	4.9	1.8	7.8	0.0	53.7	0.4	9.2	10.0	1.3	2.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	31.2	7.2	11.2	6.2	0.9	1.8	9.3	9.7	7.4	13.1	11.3	5.2	10.2	9.4	6.3	3.5	15.4	9.2	10.0	5.1	13.0	27.9	9.8	15.9	3.3	8.7	0.3	9.2	17.8	0.1	0.6	5.2	7.2	2.0	6.7	11.6	12.8	19.5	10.3	10.5	13.3	14.2	10.0	10.4	13.3	15.9	20.0	10.4	5.7	1.4	9.6	9.7	9.3	10.4	7.6	4.0	6.2	9.9	4.8	8.1	20.6	9.6	16.0	19.4	19.2	38.4	3.9	19.0	15.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.2	0.2	0.2	0.2	0.3	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.5	5.6	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.4	0.0	0.4	0.0	0.2	27.3	1.0	0.9	0.0	0.0	12.7	0.0	4.1	2.5	1.6	0.0	0.9	1.8	1.7	0.0	3.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	7.1	18.1	4.5	2.9	1.7	3.7	2.1
PPP1R3B	"FLJ14005, GL, PPP1R4"	ENSG00000173281	"Protein phosphatase 1 regulatory subunit 3B"	Q86XI6	8	9136255-9151574	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 66.2;Hepatocytes: 135.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"basophil: 18.0;eosinophil: 7.4;neutrophil: 25.3"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 25.3"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 26.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA028731	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA028731: AB_10602120"	"unprognostic (4.97e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (4.08e-7)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (3.33e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.21e-1)"	26.6	4.3	1.2	3.2	3.4	4.4	21.4	0.8	1.7	19.7	8.3	1.5	10.3	1.9	22.8	11.0	12.8	6.5	4.3	17.3	1.5	1.4	4.7	58.5	7.8	6.9	3.3	1.0	16.2	4.1	40.7	2.4	18.7	4.7	25.3	4.0	3.3	12.9	15.5	34.8	6.7	4.5	33.7	5.1	5.4	6.3	8.6	2.8	1.6	11.5	6.8	4.5	37.0	21.7	0.8	0.8	25.3	0.7	0.9	1.5	0.6	3.6	1.4	4.1	1.4	10.3	8.8	14.9	1.3	4.4	1.6	2.0	5.5	1.7	1.3	2.2	2.7	9.1	0.6	0.7	1.0	1.7	3.9	0.6	2.2	0.6	0.0	4.6	1.1	9.7	7.2	3.3	1.4	8.3	12.5	26.3	6.5	1.6	3.1	0.6	2.2	5.9	2.0	5.9	8.2	1.2	2.4	5.2	2.2	16.0	14.8	0.0	7.7	2.4	0.1	10.3	6.9	1.9	2.2	18.2	4.8	1.6	0.9	1.7	1.7	3.9	0.0	8.4	3.4	1.4	18.0	0.7	7.4	1.1	0.6	0.9	0.8	1.0	0.6	0.4	0.7	1.5	0.7	25.3	0.9	0.3	0.8	0.7	0.6	1.2	3.4	0.8	1.7	1.5	1.4	3.3	1.0	4.7	2.8	11.9	34.6	3.0	17.9	9.5	3.4	66.2	35.7	48.2	30.7	8.7	5.9	10.1	3.3	8.3	10.4	20.6	8.4	0.0	11.2	25.5	12.1	10.8	32.4	135.4	6.1	6.4	0.0	32.5	10.8	2.7	8.9	13.6	5.0	1.0	8.9	3.5	13.2	3.5	17.0	5.3	13.5	12.9	15.5	1.9	4.7	10.7	15.3	6.4	4.7	1.6
IL1RAP	"C3orf13, IL-1RAcP, IL1R3"	ENSG00000196083	"Interleukin 1 receptor accessory protein"	Q9NPH3	3	190514051-190659750	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 36.5;liver: 91.8;placenta: 35.9"	"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 100.2;Hepatocytes: 172.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 36.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 36.5"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 72.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035293	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		260000000	"Vesicles, Cytosol"		"HPA035293: AB_10671511"	"unprognostic (6.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.35e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.16e-7)"	"unprognostic (4.02e-3)"	"unprognostic (9.06e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (6.29e-4)"	3.4	1.7	3.7	5.2	4.5	7.8	2.8	0.8	6.0	2.9	1.8	3.4	0.7	1.1	2.6	1.7	9.1	3.2	5.7	3.3	7.4	2.9	1.9	91.8	6.3	12.6	3.5	2.5	2.2	2.0	1.0	1.4	35.9	5.5	2.1	1.4	1.6	4.7	2.0	1.2	5.8	1.5	3.1	6.3	7.1	2.3	1.0	2.9	2.3	2.2	3.8	3.4	3.3	4.4	0.9	1.4	36.5	2.2	0.1	1.3	0.5	3.9	1.0	1.6	0.2	2.9	2.4	3.1	1.7	3.5	4.1	4.0	1.7	8.8	0.7	18.3	4.8	9.5	10.2	0.9	17.1	5.7	0.7	1.0	0.8	1.7	4.2	6.1	5.8	2.8	3.2	7.0	5.9	18.9	8.6	1.8	1.8	0.1	0.0	1.9	1.8	0.5	2.6	2.6	1.7	1.8	2.8	2.5	1.4	1.5	4.2	0.3	0.0	8.0	4.4	72.7	1.6	2.9	4.2	2.4	3.2	3.2	9.7	7.9	1.5	0.0	0.1	5.4	5.3	18.6	3.5	1.5	8.5	0.7	1.7	1.3	0.9	0.8	0.9	1.4	0.9	0.8	0.5	36.5	0.1	2.2	0.2	0.8	0.5	3.7	4.5	0.8	6.0	7.4	2.9	3.5	2.5	5.5	2.9	0.0	14.3	1.4	14.3	39.8	5.4	4.0	43.3	2.7	20.5	3.5	7.9	3.1	0.0	6.5	2.3	7.1	1.3	0.0	6.4	100.2	7.0	5.6	7.0	172.7	6.9	0.0	5.2	8.0	33.0	0.0	4.0	18.3	8.5	1.0	1.3	0.9	14.8	0.0	2.5	0.8	0.6	0.0	3.1	0.0	0.6	32.5	20.3	2.5	1.2	12.8
PLAU	"UPA, URK"	ENSG00000122861	"Plasminogen activator, urokinase"	P00749	10	73909177-73917497	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 48.4"	"Cell type enhanced"	"Detected in many"	17	"Basal glandular cells: 550.8;Pancreatic endocrine cells: 366.2;Urothelial cells: 779.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 2.4;neutrophil: 4.5;plasmacytoid DC: 4.5"	"Group enriched"	"Detected in many"	11	"dendritic cells: 4.5;granulocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 70.3;LHCN-M2: 67.8;RPTEC TERT1: 257.8;U-251 MG: 69.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA070796	Supported				"Secreted to blood"	NA	NA	647000	58000			"HPA070796: "	"unprognostic (1.96e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (2.26e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (2.83e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.77e-2)"	26.7	2.4	1.0	15.5	2.1	11.3	9.7	1.6	1.5	6.9	5.8	2.9	4.9	3.8	10.7	21.2	9.1	6.5	10.7	14.3	1.3	1.0	23.3	2.3	23.4	5.5	1.6	1.5	6.8	3.7	3.6	1.8	48.4	3.1	7.5	6.7	4.5	10.6	5.0	12.2	9.0	8.1	8.4	2.5	23.8	7.8	5.8	1.3	4.8	10.9	11.6	8.2	16.3	9.3	0.1	4.5	4.5	0.4	0.0	0.0	0.3	13.3	7.1	3.0	0.1	0.2	5.1	0.1	8.1	37.9	3.3	5.2	0.1	70.3	0.0	15.0	1.1	35.0	9.2	0.0	13.5	3.8	0.7	0.0	0.0	0.3	0.1	6.2	1.2	2.6	13.5	1.6	22.6	8.7	37.6	9.4	0.0	0.0	0.0	67.8	0.0	0.0	1.7	0.8	0.0	18.7	0.0	9.2	0.0	257.8	10.5	0.0	0.0	0.0	0.3	0.2	2.2	0.0	1.8	23.8	0.2	1.7	1.7	69.2	0.0	0.1	0.1	18.2	2.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	4.5	0.0	0.0	4.5	0.0	0.3	1.0	2.1	1.6	1.5	1.3	1.0	1.6	1.5	3.1	1.3	3.0	5.8	0.5	550.8	33.2	0.0	2.4	0.0	1.4	10.3	27.9	0.0	17.1	58.0	65.4	0.5	11.7	0.0	0.0	18.1	16.5	18.1	169.7	31.1	0.0	38.5	0.0	3.4	6.2	3.9	0.0	2.3	31.5	6.8	41.5	0.0	0.0	366.2	0.0	0.0	0.7	0.0	6.5	25.9	0.0	0.1	25.7	14.6	0.5	0.9	779.6
DERA	"CGI-26, DEOC"	ENSG00000023697	"Deoxyribose-phosphate aldolase"	Q9Y315	12	15911172-16037282	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055897			Supported	Nucleoplasm		NA	NA		180000	Nucleoplasm		"HPA055897: AB_2682963"	"unprognostic (3.05e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.26e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (3.64e-5)"	"unprognostic (3.66e-2)"	20.3	12.0	10.5	10.8	10.8	7.5	11.5	5.2	7.7	11.3	30.3	11.4	12.7	20.2	21.5	14.7	20.0	8.2	11.1	11.7	10.1	9.1	40.9	51.5	13.6	14.1	12.5	6.5	5.8	16.9	6.6	27.5	12.3	11.3	9.2	21.2	11.0	11.4	11.3	15.3	12.4	46.7	10.4	14.6	14.6	10.5	5.5	11.0	13.8	26.6	16.7	14.3	10.1	13.1	12.4	30.2	14.1	28.2	17.1	14.9	15.7	19.0	15.8	12.4	10.9	8.4	19.2	25.4	11.1	10.5	15.2	19.5	19.0	35.4	13.0	9.9	14.2	13.7	13.5	13.4	14.3	27.0	21.7	7.8	11.5	7.9	17.9	12.1	12.1	7.8	12.8	16.6	12.4	25.5	12.9	21.9	11.1	1.6	4.0	27.6	7.0	9.0	10.1	27.0	10.7	7.8	13.8	27.2	8.1	38.1	6.9	9.0	15.3	21.0	7.0	21.9	51.1	37.9	15.2	21.6	16.2	10.7	7.4	11.9	4.3	6.3	22.4	20.8	12.2	11.9	5.4	24.4	14.1	7.2	27.1	7.9	12.4	7.8	7.7	30.2	11.4	8.6	6.9	6.5	17.1	28.2	16.5	14.9	15.7	10.5	10.8	5.2	7.7	10.1	9.1	12.5	6.5	11.3	11.0	41.7	25.0	18.6	24.3	26.1	5.0	11.4	22.9	21.4	22.7	12.2	13.7	54.5	92.9	55.2	33.8	25.2	49.7	0.0	52.2	57.8	21.3	17.5	8.1	44.5	53.2	3.2	25.4	30.7	32.6	3.0	22.7	32.0	69.2	55.9	43.0	20.9	60.6	45.0	28.7	104.3	25.2	6.5	18.6	5.0	14.7	22.6	59.6	10.0	39.9	24.7
REEP3	"C10orf74, Yip2b"	ENSG00000165476	"Receptor accessory protein 3"	Q6NUK4	10	63521363-63625123	"Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 295.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.85e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.89e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.50e-3)"	"prognostic unfavorable (7.83e-4)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (1.13e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.06e-2)"	17.2	14.3	12.0	6.7	17.2	1.1	13.0	27.9	11.4	18.0	19.0	31.2	18.1	19.6	16.5	12.0	12.4	7.8	11.1	9.7	14.4	8.1	12.0	18.0	14.4	5.6	26.1	6.6	8.4	9.4	26.5	11.7	17.2	16.2	15.9	12.3	10.4	13.3	17.5	5.7	10.7	31.7	18.3	24.8	7.4	15.2	15.0	20.0	4.3	15.0	4.2	6.0	16.3	10.4	3.3	5.2	3.3	7.4	2.8	8.4	2.4	18.6	8.4	7.8	7.5	29.0	28.9	8.8	14.3	23.7	10.9	15.5	11.8	29.0	1.7	5.4	20.7	3.6	22.1	3.1	20.0	19.4	5.6	6.4	3.9	3.8	7.5	18.8	4.3	0.1	24.2	15.7	15.3	23.3	27.2	18.9	2.3	1.9	8.5	19.8	5.6	3.1	6.7	2.7	3.5	18.0	5.6	5.3	3.5	15.6	11.0	2.3	7.9	13.2	13.0	12.0	11.6	12.8	10.0	14.2	10.5	3.2	9.4	10.9	7.3	11.1	2.6	9.5	0.0	10.9	0.1	5.3	3.3	2.8	7.4	5.9	3.3	6.1	4.2	4.8	2.7	2.4	3.3	2.4	2.8	4.8	5.2	8.4	2.4	12.0	17.2	27.9	11.4	14.4	8.1	26.1	6.6	16.2	20.0	26.8	25.4	21.6	75.2	57.4	13.1	24.3	38.2	26.8	22.7	78.5	25.5	56.1	24.9	62.3	295.1	61.0	120.2	0.0	63.3	84.1	59.4	160.7	9.2	60.6	40.7	19.1	41.2	58.3	33.4	54.7	98.1	44.9	37.1	19.8	36.2	16.3	116.5	52.6	117.4	39.3	22.1	97.0	84.8	33.0	8.9	64.0	98.2	21.0	23.2	157.9
CDC20	"CDC20A, p55CDC"	ENSG00000117399	"Cell division cycle 20"	Q12834	1	43358955-43363203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.0;testis: 73.2"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 97.6;Erythroid cells: 70.0;Extravillous trophoblasts: 127.9;Spermatocytes: 74.9;Spermatogonia: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 4.5;memory CD4 T-cell: 3.3;memory CD8 T-cell: 3.6;NK-cell: 9.8;T-reg: 11.2"	"Group enriched"	"Detected in many"	9	"B-cells: 4.5;NK-cells: 9.8;T-cells: 11.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB004525, HPA045842, HPA055288"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Nucleoplasm, Cytosol"		"CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773"	"unprognostic (1.66e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.00e-8)"	"unprognostic (9.06e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.29e-2)"	1.3	1.2	0.6	16.6	1.1	20.2	1.8	0.8	1.3	2.1	6.2	2.8	0.4	5.8	1.1	1.6	17.8	0.4	1.9	1.2	0.9	0.5	2.2	1.2	1.8	13.4	1.1	0.7	0.9	0.5	0.0	0.4	3.9	1.2	0.8	7.0	0.4	2.9	0.4	0.6	4.6	6.4	2.8	1.2	7.8	4.4	73.2	0.7	42.0	1.2	11.7	21.7	1.9	4.2	4.5	0.9	0.8	0.1	9.8	11.2	2.7	52.6	25.7	35.9	23.4	1.2	3.2	34.4	24.4	21.9	71.2	38.0	40.3	43.8	30.5	14.3	22.4	25.1	37.1	39.2	46.6	59.5	23.9	29.0	44.6	25.4	24.9	0.3	31.1	16.3	1.0	2.2	49.4	44.8	6.2	30.1	29.3	20.1	21.0	32.2	20.4	29.9	19.1	45.4	25.1	34.6	43.5	49.3	19.3	17.3	14.0	21.2	10.4	43.1	29.2	13.5	28.8	20.5	39.4	15.6	21.3	50.0	23.6	75.6	16.1	14.3	31.6	15.3	38.8	31.7	0.0	0.1	0.0	0.4	0.0	0.0	4.5	3.3	3.6	0.9	0.9	0.1	0.3	0.8	9.8	0.0	0.2	11.2	2.7	0.6	1.1	0.8	1.3	0.9	0.5	1.1	0.7	1.2	0.7	0.0	0.6	16.2	2.0	9.3	0.0	0.7	0.0	2.7	1.2	0.0	0.0	13.4	0.0	2.1	97.6	0.7	3.2	70.0	0.3	127.9	4.1	2.0	0.0	1.0	30.9	0.0	0.0	8.0	5.0	7.0	2.6	5.2	0.0	2.8	2.9	0.2	0.7	0.0	1.8	2.1	2.6	0.0	1.4	74.9	48.1	7.3	8.9	1.3	15.5	2.6
STIL	"MCPH7, SIL"	ENSG00000123473	"STIL, centriolar assembly protein"	Q15468	1	47250139-47314147	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 36.0;testis: 23.8"	"Cell type enhanced"	"Detected in many"	9	"Spermatocytes: 18.6;Spermatogonia: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA046543			Approved	"Plasma membrane,Cytosol"		NA	Yes			"Plasma membrane, Cytosol"		"HPA046543: AB_2679692"	"unprognostic (2.07e-1)"	"unprognostic (6.29e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.90e-5)"	"unprognostic (7.35e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (5.81e-2)"	"unprognostic (3.36e-14)"	"unprognostic (5.76e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.28e-1)"	1.2	1.4	1.3	10.8	2.4	11.0	2.9	1.4	2.2	1.2	4.1	0.9	2.5	3.6	1.5	2.2	5.8	0.9	1.7	2.0	1.4	1.2	1.5	1.6	1.7	5.0	1.3	1.5	1.2	1.5	0.9	0.9	5.5	1.1	1.7	6.4	0.8	3.6	0.5	0.8	4.2	4.0	1.3	1.2	3.4	2.2	23.8	1.0	36.0	1.1	3.5	7.1	1.3	2.1	1.9	1.6	5.4	0.7	3.3	1.2	0.5	16.9	9.1	13.1	11.7	0.9	2.3	8.4	15.0	7.2	16.8	17.7	9.8	8.4	20.0	7.1	7.5	17.3	11.3	15.3	7.9	18.1	14.9	6.9	22.5	11.3	8.6	0.5	18.2	11.5	0.8	1.3	14.4	9.4	2.1	11.1	15.3	15.9	19.1	12.6	7.7	17.6	5.7	15.9	9.4	7.5	11.5	21.4	9.6	4.7	10.2	11.7	7.0	16.1	11.9	7.8	16.3	7.7	10.4	6.5	15.9	16.1	11.4	20.3	6.3	13.1	19.7	7.4	13.9	14.7	4.3	0.7	1.1	1.1	0.4	0.5	1.7	1.2	1.0	0.5	1.9	0.8	0.8	5.4	3.3	0.3	1.6	1.1	0.5	1.3	2.4	1.4	2.2	1.4	1.2	1.3	1.5	1.1	1.0	3.0	0.3	2.2	0.5	0.8	1.2	0.5	0.0	6.7	2.3	0.0	3.9	1.2	0.0	1.2	0.7	0.9	1.8	0.0	0.4	3.8	0.8	1.2	2.3	0.5	2.3	0.0	1.7	1.8	1.9	1.3	0.3	1.2	0.0	4.6	4.3	0.8	1.8	1.5	0.7	0.3	0.7	0.0	0.0	18.6	17.8	2.0	0.7	0.8	3.4	1.4
ANTXR2	"CMG-2, CMG2, FLJ31074"	ENSG00000163297	"Anthrax toxin receptor 2"	P58335	4	79901149-80125454	"Disease related genes, Plasma proteins, Predicted membrane proteins"		Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 43.4;HHSteC: 37.2;LHCN-M2: 43.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		6600000				"unprognostic (3.01e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.95e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (3.34e-6)"	"unprognostic (1.03e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.78e-1)"	18.6	8.8	1.7	14.4	2.0	4.3	16.8	1.0	1.8	30.7	24.6	2.4	10.2	4.1	36.3	11.1	20.1	14.6	22.9	10.0	2.9	1.5	4.1	10.4	9.8	10.1	1.9	2.0	23.5	3.1	16.7	2.5	23.1	2.8	40.2	11.1	6.2	4.6	22.2	8.9	4.8	17.3	56.5	3.9	9.1	19.5	11.1	2.1	4.3	4.3	5.0	8.2	38.0	20.3	9.2	12.4	22.1	6.8	1.5	14.1	5.0	2.6	0.2	6.4	1.1	43.4	25.6	0.6	8.7	25.9	3.8	4.5	0.1	2.1	0.0	0.1	16.0	2.3	0.8	0.9	10.3	14.9	0.3	0.8	2.1	0.1	0.8	37.2	9.0	5.6	30.4	3.0	27.2	14.4	29.0	11.2	0.3	4.9	6.5	43.9	0.0	0.1	4.9	0.8	4.0	12.4	0.4	3.8	1.6	2.1	2.7	6.1	8.4	0.9	0.1	1.1	3.3	0.1	1.8	12.5	28.2	1.5	31.2	15.9	0.3	0.0	0.0	15.8	6.8	8.6	22.1	6.8	21.1	5.1	3.6	5.6	9.2	8.1	5.0	12.4	3.8	4.6	2.0	20.2	1.5	6.8	10.3	14.1	5.0	1.7	2.0	1.0	1.8	2.9	1.5	1.9	2.0	2.8	2.1	11.9	11.4	18.5	14.4	6.3	2.8	20.6	2.5	4.0	14.8	0.0	27.5	10.0	3.3	3.4	1.8	10.5	20.2	0.0	5.8	24.2	36.7	10.6	57.8	18.8	15.6	0.0	17.9	17.8	15.2	4.4	36.2	15.5	1.7	60.5	14.5	8.1	28.0	32.8	60.1	2.9	11.6	38.8	16.4	0.5	1.5	3.8	5.5	17.3	8.1	1.4
NRAS	N-ras	ENSG00000213281	"NRAS proto-oncogene, GTPase"	P01111	1	114704469-114716894	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB010157, HPA049830, CAB079912"	Uncertain		Supported	"Plasma membrane"		NA	NA		4800000	"Plasma membrane"		"CAB010157: AB_632073, CAB079912: AB_2784586, HPA049830: AB_2680903"	"unprognostic (4.75e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.11e-2)"	"unprognostic (8.59e-3)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.03e-7)"	"unprognostic (7.76e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (6.60e-3)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.33e-2)"	18.0	9.7	13.1	16.5	14.4	33.5	12.4	9.7	16.6	10.0	18.4	15.8	3.8	14.4	9.8	6.2	19.7	8.7	11.8	7.1	11.7	13.8	24.0	23.9	13.4	18.7	15.3	9.6	10.3	14.2	8.3	7.6	27.4	19.0	9.2	18.5	8.4	12.4	5.2	7.9	16.1	23.4	9.6	20.9	19.5	14.4	9.8	9.7	45.0	11.1	14.0	19.6	13.2	10.5	11.0	9.9	23.7	15.0	12.1	11.1	10.1	24.7	6.7	18.1	6.8	7.5	16.1	12.9	11.8	13.2	22.2	25.0	13.5	9.3	18.8	15.7	15.9	15.5	7.1	24.1	19.2	31.9	25.6	9.4	12.7	10.2	16.0	14.9	31.6	19.8	14.5	15.6	25.4	18.6	7.0	28.2	14.9	20.2	21.7	19.5	66.1	21.8	12.3	30.7	8.1	4.9	16.7	32.2	11.7	19.6	13.4	11.0	16.5	12.1	10.0	28.4	22.0	8.8	25.7	21.5	12.1	23.2	22.6	24.2	38.4	26.4	22.1	24.2	17.3	43.6	23.7	10.0	9.6	9.8	15.0	8.9	11.0	8.0	9.7	9.9	8.8	8.7	11.1	2.7	12.1	12.7	7.7	10.4	10.1	13.1	14.4	9.7	16.6	11.7	13.8	15.3	9.6	19.0	9.7	14.9	13.9	22.5	24.9	27.2	4.4	4.0	25.5	18.7	12.5	21.0	7.9	18.9	11.6	31.0	2.9	23.3	32.2	0.0	27.3	39.9	16.8	25.2	31.1	24.5	43.1	4.8	23.6	40.5	41.2	4.4	7.5	27.8	21.9	41.5	29.5	7.1	39.8	29.4	6.0	27.8	2.2	6.5	10.8	6.5	14.1	31.7	26.1	20.3	24.7	34.0
CENPF	hcp-1	ENSG00000117724	"Centromere protein F"	P49454	1	214603195-214664588	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, DNA synthesis, Mitosis, Myogenesis"	"Developmental protein"	"Cancer-related genes, Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 19.5;lymphoid tissue: 67.5"	"Cell type enhanced"	"Detected in many"	20	"Erythroid cells: 303.7;Extravillous trophoblasts: 74.0;Spermatogonia: 88.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052382, HPA064308, CAB070134"	Enhanced		Supported	Nucleoplasm		Yes	Yes			Nucleoplasm		"CAB070134: AB_2229328, HPA052382: AB_2681808, HPA064308: AB_2732711"	"unprognostic (2.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (1.13e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.12e-1)"	1.6	1.5	1.0	10.7	1.3	19.5	1.1	0.4	0.9	2.1	5.6	0.3	0.0	4.6	1.2	1.7	9.4	0.8	0.4	1.7	0.6	0.6	1.0	0.8	3.2	6.2	0.6	0.5	1.4	0.6	0.0	0.4	6.4	0.8	0.7	4.5	0.4	1.9	0.0	0.5	4.7	6.4	1.6	1.5	3.8	2.3	9.4	0.6	67.5	0.6	7.6	7.6	1.4	2.9	0.3	0.3	0.0	0.0	0.7	1.9	0.2	32.6	18.5	39.9	20.8	1.5	2.0	15.6	20.2	8.3	12.2	12.0	14.7	20.2	31.1	12.0	11.2	11.0	20.3	24.6	13.2	20.7	27.1	15.4	25.5	28.4	20.9	0.2	36.1	14.0	0.7	1.0	17.5	20.2	3.5	12.7	14.3	23.0	18.6	21.7	12.4	21.3	14.4	35.3	9.8	8.2	22.7	56.4	10.2	11.9	8.1	18.7	25.5	27.3	18.2	10.5	22.2	21.7	13.8	16.7	22.1	26.0	18.3	41.7	14.3	15.4	29.9	9.6	26.1	19.5	0.0	0.0	0.0	0.4	0.0	0.1	0.2	1.4	0.4	0.3	0.3	1.9	0.8	0.0	0.7	0.0	0.3	1.7	0.2	1.0	1.3	0.4	0.9	0.6	0.6	0.6	0.5	0.8	0.6	0.0	1.9	40.2	1.2	8.2	3.2	1.9	2.5	26.8	14.8	0.0	0.0	9.1	0.0	1.8	32.4	2.8	1.3	303.7	0.4	74.0	7.7	1.0	1.1	1.9	26.4	1.6	0.0	9.8	11.2	9.4	1.1	9.9	1.7	0.0	5.3	1.1	0.5	0.0	2.8	0.0	2.8	0.0	0.3	20.9	88.3	4.8	4.2	10.9	15.5	0.9
SSRP1	FACT80	ENSG00000149136	"Structure specific recognition protein 1"	Q08945	11	57325985-57335877	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002697	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		8300	Cytosol	Nucleoplasm	"HPA002697: AB_1857509"	"unprognostic (1.67e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (4.03e-7)"	"unprognostic (3.22e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (5.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.52e-2)"	25.3	23.2	23.5	37.7	25.1	32.0	38.4	28.5	27.6	27.2	30.5	19.4	28.8	23.0	34.9	28.2	34.6	34.4	33.1	28.4	22.7	20.3	22.6	27.8	26.5	33.7	21.6	20.7	41.8	39.3	39.7	31.2	34.8	22.0	26.6	33.0	17.2	32.8	27.5	47.7	32.9	26.2	28.9	17.1	28.3	29.3	28.3	25.2	44.0	45.9	37.0	42.5	28.7	51.7	10.2	10.3	4.5	5.2	6.9	12.0	4.7	57.5	55.7	52.8	38.6	16.7	18.6	25.9	31.7	30.7	55.5	39.8	38.2	43.1	70.0	33.9	27.8	35.3	44.6	83.7	49.4	70.1	48.8	47.0	44.7	41.0	41.0	26.3	74.0	33.6	18.7	30.2	57.0	79.4	25.8	36.2	54.2	60.7	35.5	37.7	39.0	74.9	65.5	69.4	30.7	34.3	63.3	89.3	68.0	25.9	41.6	55.3	46.9	44.9	38.6	46.8	28.3	46.8	29.2	27.2	37.9	50.1	51.0	54.2	41.4	41.0	72.4	32.1	41.8	49.9	0.8	4.3	4.5	9.4	5.2	9.1	8.7	8.1	10.2	6.1	10.2	8.9	12.0	1.2	6.9	5.0	10.3	9.6	4.7	23.5	25.1	28.5	27.6	22.7	20.3	21.6	20.7	22.0	25.2	71.5	73.4	41.0	69.0	66.5	23.9	23.5	33.1	148.5	102.4	27.9	23.6	89.5	11.6	62.9	64.9	43.6	26.8	0.0	86.1	90.2	43.5	42.4	38.3	31.8	50.8	23.8	27.6	32.5	32.2	93.2	39.4	40.0	27.0	44.1	40.8	23.8	58.2	35.1	41.8	20.2	16.4	19.4	46.2	55.9	93.5	66.7	56.5	36.3	68.4	62.2
ITGB5		ENSG00000082781	"Integrin subunit beta 5"	P18084	3	124761948-124901418	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 71.2;hTERT-RPE1: 81.6;WM-115: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001820, CAB022050"	Approved		Approved	"Plasma membrane,Mitochondria"		NA	NA		95000	"Plasma membrane, Mitochondria"		"CAB022050: , HPA001820: AB_1079142"	"unprognostic (2.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.16e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-3)"	72.5	13.8	9.7	9.7	10.0	0.8	50.1	5.7	8.2	34.2	18.8	14.8	28.0	12.9	31.7	17.2	25.6	13.9	29.1	32.9	9.4	5.1	19.6	22.1	20.4	3.5	12.0	6.2	17.4	12.1	8.9	8.4	36.4	13.0	23.0	10.1	27.1	18.6	23.1	15.9	33.3	16.1	25.1	9.0	18.7	12.4	17.0	8.7	2.8	18.8	16.2	10.9	24.4	27.1	0.1	1.1	0.4	0.6	0.9	2.1	5.8	28.5	71.2	5.1	12.9	48.3	14.1	26.4	30.6	19.0	5.7	9.2	14.2	37.3	0.1	14.9	51.9	28.1	22.9	4.6	15.9	5.0	0.3	3.1	10.1	11.0	14.9	8.4	0.0	18.5	8.4	3.7	14.3	7.5	81.6	19.1	0.0	9.0	15.3	19.5	29.0	0.1	0.1	22.9	16.0	7.9	0.0	8.2	10.7	16.1	6.3	0.1	10.7	22.7	33.8	25.8	9.4	19.1	0.6	49.1	21.5	32.5	18.6	15.8	2.6	2.7	0.1	22.5	0.1	74.2	0.4	0.6	0.2	2.1	0.2	0.0	0.0	0.2	0.0	1.1	0.1	0.3	0.4	0.4	0.9	0.4	0.1	0.0	5.8	9.7	10.0	5.7	8.2	9.4	5.1	12.0	6.2	13.0	8.7	6.0	7.9	2.2	18.8	15.2	6.2	26.4	43.3	5.3	10.3	27.9	3.9	56.6	10.0	34.5	7.5	22.6	19.6	0.0	16.3	4.7	30.7	22.0	0.0	32.1	60.3	33.4	3.4	41.1	27.6	2.3	18.7	16.7	10.1	0.0	13.3	47.4	43.9	27.4	15.6	10.2	15.2	38.8	35.3	1.4	6.4	19.4	46.1	0.0	15.0	12.0
MYOF	"FER1L3, KIAA1207"	ENSG00000138119	Myoferlin	Q9NZM1	10	93306429-93482317	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Pancreatic endocrine cells: 95.7;Urothelial cells: 93.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 15.9;non-classical monocyte: 18.0"	"Group enriched"	"Detected in many"	65	"dendritic cells: 6.2;monocytes: 18.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 76.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014245	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		14000	Vesicles	"Plasma membrane"	"HPA014245: AB_1848495"	"unprognostic (3.41e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.57e-3)"	"unprognostic (3.48e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.74e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.17e-2)"	"unprognostic (9.18e-2)"	27.5	7.3	2.1	8.9	4.1	0.2	21.7	1.3	2.7	27.0	12.3	5.1	16.0	2.0	27.2	17.7	27.2	16.2	11.4	7.2	3.5	2.1	12.2	1.7	18.7	7.5	5.8	2.5	12.7	3.3	16.1	4.2	31.9	15.0	20.7	12.8	10.1	14.9	17.4	5.7	22.4	6.8	49.0	9.4	10.0	8.8	5.7	4.4	1.5	15.7	14.2	9.4	35.0	20.0	0.0	6.2	0.1	18.0	0.0	0.1	1.1	36.1	34.2	3.7	2.3	25.6	57.0	10.4	31.8	76.2	19.4	19.2	8.2	28.4	0.0	12.7	58.2	19.9	55.3	0.3	32.6	14.3	0.2	0.1	0.0	13.4	0.3	8.9	0.0	0.0	29.9	11.3	13.1	53.6	48.5	50.3	0.0	0.0	0.0	45.7	5.7	0.0	0.1	0.2	10.9	30.5	0.0	2.6	0.0	50.3	45.2	0.0	0.0	21.8	4.6	8.0	14.3	22.6	0.7	62.8	28.6	1.9	18.9	18.5	0.0	0.0	0.0	21.2	0.4	33.7	0.0	4.3	0.0	0.0	15.9	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.1	0.0	18.0	2.1	0.1	1.1	2.1	4.1	1.3	2.7	3.5	2.1	5.8	2.5	15.0	4.4	56.6	42.0	2.7	42.9	21.1	0.0	7.6	10.2	32.1	66.0	21.0	0.0	48.8	1.7	48.5	0.5	20.4	36.0	0.0	28.8	20.4	33.3	62.3	1.1	0.0	21.2	0.0	1.7	27.0	31.3	0.6	5.5	20.9	8.5	3.6	24.4	0.0	95.7	18.2	8.5	0.5	0.9	6.5	31.9	0.1	0.1	26.8	42.8	0.0	13.3	93.6
CCL28	"CCK1, MEC, SCYA28"	ENSG00000151882	"C-C motif chemokine ligand 28"	Q9NRJ3	5	43376645-43412391	"Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"salivary gland: 207.1"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 56.0;Ductal cells: 64.1;Enterocytes: 76.4;Exocrine glandular cells: 59.4;Paneth cells: 62.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.0;EFO-21: 8.6;SiHa: 19.4;SK-MEL-30: 10.6;T-47d: 26.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA077434	Supported				"Secreted to blood"	NA	NA	700000000				"HPA077434: AB_2732346"	"unprognostic (1.04e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.85e-4)"	"unprognostic (4.93e-3)"	"unprognostic (1.20e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.91e-3)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (4.43e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.53e-2)"	1.2	0.6	0.8	5.3	0.6	0.6	15.7	0.4	0.8	4.0	8.2	0.2	0.2	6.2	1.4	1.0	2.0	1.1	5.2	0.9	0.6	0.7	1.9	1.0	1.5	2.5	0.6	0.6	0.9	29.8	1.2	1.5	3.1	0.7	1.3	7.6	4.1	207.1	1.1	0.4	2.7	4.9	0.3	1.1	3.0	3.9	1.1	0.5	1.1	9.0	8.4	5.4	1.1	1.4	6.7	1.3	3.8	0.4	4.3	7.7	1.9	0.5	0.0	0.1	0.1	0.6	0.1	3.2	0.4	0.3	0.0	0.0	1.3	7.0	0.0	8.6	0.2	0.0	1.1	0.0	0.1	0.0	0.1	0.2	0.5	0.8	0.0	0.5	0.1	0.1	0.7	1.8	0.1	0.3	0.3	0.0	0.1	0.0	0.2	0.8	0.2	1.1	0.1	0.1	0.0	1.1	0.0	0.0	0.3	0.1	0.9	0.2	0.1	19.4	0.7	10.6	0.2	26.3	5.1	0.1	0.1	0.8	0.1	0.1	0.5	0.0	0.1	0.0	0.1	5.8	3.8	0.4	0.4	4.8	0.3	3.7	5.5	5.3	3.9	0.8	6.7	6.4	4.6	1.2	4.3	0.2	1.3	7.7	1.9	0.8	0.6	0.4	0.8	0.6	0.7	0.6	0.6	0.7	0.5	0.0	4.8	11.5	4.7	2.4	0.0	0.3	56.0	28.1	12.5	5.2	0.0	4.7	5.0	64.1	2.2	3.3	76.4	0.0	59.4	2.7	2.8	13.2	11.5	1.6	2.2	0.0	3.5	5.5	1.2	0.4	11.5	0.2	16.9	1.0	43.5	8.5	28.2	62.6	4.6	0.0	0.6	0.0	2.2	5.1	2.3	1.1	2.3	10.1	28.3	10.1
SP1		ENSG00000185591	"Sp1 transcription factor"	P08047	12	53380176-53416446	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000330, HPA001853, HPA012292"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000330: AB_2171049, HPA001853: AB_1080069, HPA012292: AB_1857394"	"unprognostic (1.12e-1)"	"unprognostic (8.52e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.38e-2)"	"unprognostic (5.14e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.12e-2)"	20.7	18.1	8.8	13.9	14.2	17.0	20.1	30.0	14.7	20.9	21.9	17.5	19.3	19.6	25.4	21.2	35.0	20.4	18.7	12.1	14.1	6.8	31.3	14.1	17.6	14.2	18.3	9.7	22.5	17.9	19.0	11.3	19.5	14.4	16.2	20.1	21.5	25.8	19.5	22.0	25.8	30.0	18.4	21.0	19.0	18.8	22.4	15.2	25.8	16.6	17.3	26.6	25.1	21.6	2.7	3.0	11.2	4.2	1.7	2.8	1.4	17.7	19.5	22.4	16.3	18.0	20.8	17.8	12.9	16.6	15.8	14.6	16.2	35.6	24.1	17.1	14.7	10.2	25.8	25.7	17.4	17.7	18.4	14.9	21.2	24.7	8.8	12.6	19.3	18.0	22.0	18.2	16.2	31.6	28.7	16.2	19.3	20.3	35.0	11.6	25.4	28.8	14.8	12.4	13.7	14.7	20.5	21.6	14.3	12.5	32.2	11.8	15.8	26.1	21.9	13.2	18.4	27.5	20.8	15.7	18.6	17.4	13.9	13.7	12.1	13.8	24.1	14.3	16.1	14.9	4.5	4.2	2.5	2.2	2.7	2.8	2.3	2.2	2.1	2.4	2.7	2.4	2.6	11.2	1.7	3.1	3.0	1.6	1.4	8.8	14.2	30.0	14.7	14.1	6.8	18.3	9.7	14.4	15.2	20.8	12.9	13.5	18.3	21.2	11.0	6.7	35.7	12.0	21.6	29.6	7.9	13.5	5.0	15.2	44.6	19.7	33.8	23.3	11.9	13.5	16.5	21.7	5.8	25.9	16.0	15.9	12.1	28.8	37.1	35.5	25.3	17.2	8.5	9.0	29.3	20.6	15.6	17.3	24.4	18.4	9.7	12.9	17.0	27.9	22.6	27.4	17.8	13.1	23.4	40.6
IL20RB	"DIRS1, FNDC6, IL-20R2, MGC34923"	ENSG00000174564	"Interleukin 20 receptor subunit beta"	Q6UXL0	3	136946230-137011085	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 64.5;skin 1: 61.2"	"Group enriched"	"Detected in some"	7	"Basal keratinocytes: 32.6;Early spermatids: 38.8;Late spermatids: 24.0;Suprabasal keratinocytes: 33.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 54.5;head and neck cancer: 50.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"hTCEpi: 106.6"	"Region enriched"	"Detected in single"	9	"cerebellum: 0.6"	"Not detected"	"Not detected"			HPA063914			Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA063914: AB_2732709"	"unprognostic (1.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.43e-4)"	"unprognostic (2.48e-4)"	"unprognostic (2.74e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.43e-4)"	"unprognostic (4.08e-3)"	"unprognostic (7.64e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.55e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.57e-2)"	1.6	0.0	0.0	0.1	0.0	0.1	4.6	0.0	0.1	13.2	0.2	0.0	0.0	0.0	1.3	0.3	64.5	0.1	0.1	0.3	0.0	0.0	0.1	2.1	0.2	0.1	0.0	0.0	0.3	0.0	0.1	0.2	2.8	0.0	1.6	0.3	0.4	4.1	0.2	0.4	61.2	0.1	0.1	0.3	0.0	0.1	0.9	0.0	0.5	0.2	22.6	17.1	0.9	19.2	0.1	0.4	0.0	0.3	0.0	0.6	0.0	4.9	0.0	0.0	0.0	3.0	12.9	0.5	0.1	0.3	0.0	0.2	0.4	0.6	0.0	2.8	1.8	0.1	16.0	0.0	26.4	0.1	0.0	0.0	0.0	3.3	0.0	17.8	0.0	0.0	2.2	106.6	0.8	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.5	0.8	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	32.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.7	38.8	1.0	0.6	0.0	0.2	1.1	0.8	1.1	0.0	0.8	0.3	0.0	0.0	0.0	0.0	24.0	0.3	0.8	3.3	2.8	0.7	0.0	0.8	0.0	0.7	0.1	0.0	0.0	2.3	0.6	1.5	33.2	1.4	0.0	0.5	4.8
COPB2	"beta'-COP, betaprime-COP"	ENSG00000184432	"Coatomer protein complex subunit beta 2"	P35606	3	139355600-139389732	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036867, HPA058180"	Approved		Approved	Cytosol		NA	NA		1000000	Cytosol		"HPA036867: AB_10672271, HPA058180: AB_2683630"	"unprognostic (3.37e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.38e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (2.41e-7)"	"unprognostic (5.59e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.95e-2)"	28.7	40.8	21.9	22.3	26.2	12.1	28.7	31.7	29.0	39.5	32.4	22.6	40.3	26.1	33.0	44.7	35.9	28.9	26.2	31.4	21.6	18.9	42.1	67.5	29.1	20.1	26.0	16.6	36.0	65.5	41.2	72.2	51.7	28.7	35.5	33.8	20.5	46.5	28.6	20.6	23.5	37.1	30.0	21.1	31.3	29.9	21.1	25.7	33.1	40.4	27.4	31.2	30.0	26.5	22.6	36.4	35.9	34.4	27.4	23.5	22.6	53.5	21.5	31.6	28.5	63.6	58.6	27.7	64.2	61.0	41.5	51.3	40.2	20.4	21.7	59.4	68.0	37.6	28.5	35.9	34.3	52.1	37.4	24.6	32.6	34.1	38.4	38.1	29.0	37.4	41.0	31.2	32.6	33.8	48.2	40.0	19.6	21.3	26.3	49.1	32.4	14.5	17.8	28.7	53.3	23.7	19.6	25.6	37.3	38.1	38.8	22.4	20.6	63.1	57.2	35.4	44.7	45.6	31.3	46.6	23.3	18.8	34.4	22.5	41.1	24.5	38.3	39.0	16.5	36.0	35.9	28.4	30.1	22.9	34.4	23.2	22.6	20.4	23.5	36.4	16.3	15.9	20.0	26.9	27.4	32.3	17.0	21.9	22.6	21.9	26.2	31.7	29.0	21.6	18.9	26.0	16.6	28.7	25.7	53.6	34.0	32.0	34.0	17.4	34.8	47.2	33.1	93.7	52.4	19.2	29.5	71.4	34.9	71.2	24.9	41.9	41.4	0.0	72.1	64.7	71.0	57.8	43.9	43.3	46.9	39.7	61.3	37.4	38.0	5.8	50.6	31.5	20.3	57.7	71.8	55.4	68.4	28.8	47.0	37.2	44.9	19.4	46.7	47.7	43.0	13.0	111.3	34.9	36.6	37.8
CDCP1	"CD318, SIMA135"	ENSG00000163814	"CUB domain containing protein 1"	Q9H5V8	3	45082278-45146422	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 107.6;Ductal cells: 84.9;Pancreatic endocrine cells: 100.0;Urothelial cells: 90.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	5	"pons and medulla: 5.5"	"Group enriched"	"Detected in some"	5	"myeloid DC: 4.0;neutrophil: 1.8;NK-cell: 7.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.0;granulocytes: 1.8;NK-cells: 7.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 23.8;HBEC3-KT: 27.2;hTEC/SVTERT24-B: 67.5;hTERT-HME1: 45.8;PC-3: 21.1;RPTEC TERT1: 20.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010978, HPA010979, CAB025637"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB025637: , HPA010978: AB_1846403, HPA010979: AB_1846401"	"unprognostic (9.31e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (2.15e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.14e-2)"	"unprognostic (9.98e-3)"	"unprognostic (3.59e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.34e-1)"	2.3	0.7	0.5	5.6	1.0	0.2	4.4	0.3	0.7	6.9	17.4	1.1	10.1	11.4	3.2	11.1	28.6	2.4	9.8	0.8	1.0	0.5	4.4	0.8	7.1	1.4	0.6	0.3	1.6	13.9	0.0	2.3	4.0	5.5	5.2	11.3	0.5	11.4	13.0	0.6	15.2	29.8	1.8	1.3	0.8	10.8	1.3	0.5	1.0	21.8	19.2	19.1	7.3	11.7	0.2	4.0	1.8	0.9	7.1	0.3	0.3	12.3	3.7	0.0	0.0	0.0	0.6	3.0	2.2	0.4	1.1	1.0	5.2	23.8	0.0	2.8	0.7	0.6	10.0	0.0	27.2	2.3	0.0	0.0	0.0	4.2	0.0	2.0	0.0	0.9	0.9	14.3	67.5	45.8	4.1	0.2	0.0	7.2	0.0	3.4	0.0	0.0	0.2	1.8	6.0	21.1	0.0	0.0	2.1	20.8	10.0	0.8	0.0	4.6	1.2	0.0	1.2	5.8	0.1	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.4	0.9	0.1	0.1	0.1	0.0	0.1	0.3	0.1	4.0	0.2	0.2	0.1	1.8	7.1	0.0	0.1	0.0	0.3	0.5	1.0	0.3	0.7	1.0	0.5	0.6	0.3	5.5	0.5	3.0	13.3	0.0	52.1	107.6	0.0	0.4	12.7	26.8	18.2	8.7	0.0	4.5	0.0	84.9	0.0	0.6	30.4	0.0	61.1	6.7	5.8	52.2	8.1	0.0	10.2	0.0	36.0	0.0	4.8	0.0	2.8	26.8	3.3	18.0	34.1	0.0	100.0	28.8	0.0	0.0	0.0	0.0	3.3	0.0	0.4	65.6	2.7	0.0	22.5	90.5
TFG	"FLJ36137, SPG57, TF6"	ENSG00000114354	"TRK-fused gene"	Q92734	3	100709331-100748966	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019473, HPA052206"	Approved		Supported	Vesicles,Cytosol		No	No			Vesicles	Cytosol	"HPA019473: AB_1857936, HPA052206: AB_2681760"	"unprognostic (1.14e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (3.31e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (8.45e-2)"	36.4	40.3	27.2	21.9	33.8	29.7	31.0	28.1	40.5	31.2	34.7	33.3	44.2	52.5	31.2	45.8	46.7	29.0	40.8	46.2	28.1	30.7	44.6	68.6	29.9	25.4	28.2	21.5	33.5	49.2	52.3	45.1	63.3	33.7	27.5	40.7	31.9	39.6	45.8	38.6	31.0	67.1	37.5	31.7	28.3	28.9	33.5	23.0	27.6	43.6	42.9	41.2	29.5	30.1	25.8	27.8	43.2	28.4	27.7	26.8	21.8	48.7	26.6	33.1	21.0	41.8	47.4	40.9	35.3	47.5	46.2	55.1	33.5	24.4	6.5	26.0	43.8	35.8	36.6	35.6	40.3	55.0	30.0	20.9	24.5	20.5	31.1	46.8	18.1	14.7	38.8	54.4	27.6	48.8	42.9	40.8	11.5	17.6	18.1	47.6	34.1	15.9	14.3	31.5	45.4	40.0	14.0	19.4	21.2	56.0	32.9	26.2	24.0	23.2	30.2	41.1	28.7	35.6	24.6	27.3	27.9	33.8	12.8	25.5	15.5	15.6	23.4	44.6	19.8	32.7	43.2	28.3	27.0	21.8	28.4	26.4	25.8	22.6	24.4	27.8	22.9	21.6	21.6	18.7	27.7	26.4	19.4	26.8	21.8	27.2	33.8	28.1	40.5	28.1	30.7	28.2	21.5	33.7	23.0	56.6	28.8	33.5	90.7	121.3	43.5	83.1	53.5	36.1	40.9	34.9	23.6	186.8	116.0	161.1	64.7	63.1	162.1	23.3	94.6	171.9	101.9	94.0	76.1	59.6	75.5	54.0	50.5	51.0	25.1	36.9	65.6	40.7	60.8	142.5	99.4	86.6	108.9	83.4	69.6	72.7	59.0	38.8	84.4	49.9	48.5	104.0	237.9	28.8	82.9	98.7
NAMPT	"PBEF, PBEF1"	ENSG00000105835	"Nicotinamide phosphoribosyltransferase"	P43490	7	106248285-106286326	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Biological rhythms, Pyridine nucleotide biosynthesis"	"Cytokine, Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 597.4;Macrophages: 479.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	18	"neutrophil: 143.5"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 143.5"	"Cell line enhanced"	"Detected in all"		"U-87 MG: 110.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034349, HPA047776, HPA057722"	Approved		Approved	"Nuclear speckles,Cell Junctions"	"Secreted to blood"	NA	NA	2140000	410000	"Nuclear speckles"	"Cell Junctions"	"CAB034349: AB_2251220, HPA047776: AB_2680151, HPA057722: "	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (8.81e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (6.83e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.44e-3)"	67.3	22.2	8.1	113.6	18.1	110.4	52.6	7.8	12.9	11.6	18.2	2.9	9.5	9.3	9.9	13.5	53.4	27.8	28.1	84.4	13.4	6.3	13.5	92.9	48.9	117.5	10.3	5.2	27.3	18.3	5.5	10.0	23.9	29.2	17.4	10.5	8.2	32.9	14.3	41.0	12.9	14.1	44.9	59.1	41.1	26.4	11.9	7.1	6.2	13.5	40.7	13.2	48.8	26.4	0.8	2.0	143.5	7.3	1.0	1.5	1.3	19.2	12.9	4.6	7.8	19.7	23.0	7.6	6.1	34.6	12.4	21.9	7.6	11.7	16.1	14.7	6.8	37.2	15.2	8.6	18.4	27.2	9.5	9.2	6.5	5.5	5.9	73.7	12.6	12.1	21.9	21.1	22.2	26.0	18.6	39.5	8.0	13.6	62.0	14.8	10.1	12.6	5.3	9.0	12.2	10.4	6.0	6.6	35.5	11.8	18.2	9.5	5.2	8.6	18.8	21.8	13.4	6.0	3.6	33.6	18.5	14.3	26.5	11.2	42.7	24.2	23.3	110.0	14.3	27.4	8.1	2.3	3.5	0.4	5.6	0.7	0.8	0.5	0.6	2.0	0.7	0.8	0.4	143.5	1.0	7.3	0.8	1.5	1.3	8.1	18.1	7.8	12.9	13.4	6.3	10.3	5.2	29.2	7.1	122.1	246.8	48.1	258.1	184.4	22.1	87.9	163.1	104.4	177.5	40.1	11.8	23.8	39.7	250.8	6.3	173.0	92.2	0.0	120.5	44.2	117.9	276.9	178.5	597.4	98.8	38.1	24.1	141.8	340.8	4.5	37.4	479.6	153.5	65.9	46.4	19.5	161.8	35.1	29.4	36.0	28.4	25.8	234.9	14.9	57.9	181.7	21.2	41.5	63.9	273.8
TAP2	"ABCB3, D6S217E, PSF2, RING11"	ENSG00000204267	"Transporter 2, ATP binding cassette subfamily B member"	Q03519	6	32821833-32838780	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"monocytes: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 28.6;U-251 MG: 28.3"									HPA001312	Approved		Supported	"Nuclear speckles,Endoplasmic reticulum"		NA	NA		14000	"Endoplasmic reticulum"	"Nuclear speckles"	"HPA001312: AB_1080206"	"unprognostic (2.95e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (5.22e-8)"	"unprognostic (5.32e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.71e-2)"	12.8	8.4	6.5	22.5	6.9	14.7	9.5	6.3	7.3	8.8	15.0	7.6	3.3	15.3	9.6	5.9	17.4	7.9	11.5	7.7	5.2	6.0	10.8	19.0	18.0	14.0	7.1	6.3	9.7	6.1	2.6	5.8	5.7	7.9	8.2	11.9	7.9	12.1	5.2	5.8	9.6	28.0	7.0	6.1	24.9	7.7	3.3	6.9	25.9	14.7	7.1	20.1	23.6	10.7	0.9	2.8	4.9	5.4	2.9	4.1	1.9	7.9	0.0	0.0	2.3	2.2	3.1	0.0	0.5	1.6	6.2	8.5	2.1	16.3	15.5	3.1	4.0	11.2	8.3	7.1	28.6	2.5	10.5	0.9	1.8	6.1	0.7	1.0	0.0	12.3	0.3	0.4	8.4	13.1	0.0	4.0	0.0	8.6	5.2	0.0	0.6	2.0	1.0	0.3	0.6	4.0	8.4	0.0	5.9	5.2	0.1	0.1	0.0	7.7	16.4	1.6	0.3	0.8	0.0	2.3	8.8	2.0	2.3	28.3	8.1	13.4	14.5	8.1	10.9	1.6	1.7	2.0	1.8	4.1	5.4	2.0	0.9	1.2	2.7	2.0	0.6	1.0	0.6	4.9	2.9	4.1	2.8	1.9	1.9	6.5	6.9	6.3	7.3	5.2	6.0	7.1	6.3	7.9	6.9	0.0	6.9	28.3	12.0	0.0	4.5	2.4	2.5	2.7	6.8	14.0	2.0	1.2	1.7	33.7	0.0	28.7	19.3	0.0	28.6	35.6	4.1	11.3	4.7	5.8	22.4	17.5	3.5	16.0	12.3	0.0	5.2	14.5	0.0	92.8	18.4	18.9	27.4	13.9	5.6	4.7	4.8	0.0	7.5	0.4	1.2	0.0	1.4	24.5	10.3	14.8
KRT8	"CARD2, CK8, CYK8, K2C8, K8, KO"	ENSG00000170421	"Keratin 8"	P05787	12	52897187-52949954	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 102.9"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 5778.2;Enterocytes: 4471.9;Exocrine glandular cells: 4777.1;Extravillous trophoblasts: 4560.4;Pancreatic endocrine cells: 3911.0;Syncytiotrophoblasts: 4406.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"pons and medulla: 13.7"	"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.9;granulocytes: 3.2;NK-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"A549: 228.5;BEWO: 153.1;CACO-2: 284.3;CAPAN-2: 179.6;MCF7: 383.7;SK-BR-3: 195.0;T-47d: 164.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000131, CAB001696, HPA049866"	Enhanced		Supported	"Intermediate filaments"		NA	NA		920000000	"Intermediate filaments"		"CAB000131: AB_2281144, CAB001696: , HPA049866: AB_2680923"	"unprognostic (5.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.86e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.58e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (8.99e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.19e-2)"	13.4	4.8	2.0	11.0	1.5	0.0	13.9	2.7	1.3	15.1	90.2	2.1	29.8	87.2	11.1	18.3	19.3	10.4	20.3	17.6	1.1	0.2	28.8	55.8	20.1	18.4	1.4	1.2	10.6	75.9	4.0	31.8	28.9	13.7	25.2	45.0	12.1	36.9	46.0	3.7	5.0	102.9	5.2	3.3	14.3	61.8	5.1	1.2	2.9	27.6	9.2	11.6	27.1	10.5	0.7	4.9	3.2	0.7	1.6	0.6	0.5	101.4	228.5	0.0	0.3	0.0	0.1	153.1	0.4	1.8	0.2	0.2	284.3	179.6	0.0	43.4	0.5	0.2	35.5	0.6	28.1	0.2	0.1	4.9	0.1	47.6	81.3	8.3	0.0	0.0	0.3	0.4	0.5	1.9	16.2	0.6	0.0	17.4	0.0	0.0	383.7	0.2	0.3	15.9	100.9	5.0	0.1	0.0	0.5	45.2	50.4	4.9	0.1	39.7	195.0	0.3	50.7	164.0	0.3	0.7	0.2	17.2	0.3	0.3	0.0	0.2	0.2	0.1	0.0	0.5	3.2	0.5	0.6	0.6	0.7	0.4	0.3	0.4	0.3	2.1	0.7	0.4	0.5	1.4	1.6	0.3	4.9	0.5	0.5	2.0	1.5	2.7	1.3	1.1	0.2	1.4	1.2	13.7	1.2	372.2	157.7	26.9	1665.1	5.4	2.4	26.3	1065.0	434.9	350.3	465.9	0.0	1661.4	252.0	5778.2	13.8	28.9	4471.9	0.0	4777.1	4560.4	56.5	694.5	77.0	253.1	223.9	1.6	905.1	28.3	8.4	52.9	7.5	27.5	124.9	94.6	2325.6	3.9	3911.0	3583.7	1.8	388.7	3.8	0.0	11.3	1.1	4.1	1.5	4406.3	7.5	1775.0	1380.2
ATP2C1	"ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1"	ENSG00000017260	"ATPase secretory pathway Ca2+ transporting 1"	P98194	3	130850595-131016712	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010207, HPA035116, HPA069684"	Supported		Supported	"Golgi apparatus"		NA	NA		28000	"Golgi apparatus"		"CAB010207: AB_2061744, HPA035116: AB_10673106, HPA069684: AB_2686169"	"unprognostic (1.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (5.06e-6)"	"unprognostic (7.66e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (8.44e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.06e-1)"	18.6	22.9	29.6	14.5	29.4	20.4	36.8	24.5	34.6	22.2	21.6	23.0	14.3	14.4	19.3	18.0	16.9	23.4	16.8	19.2	31.6	32.3	28.0	17.1	30.7	16.0	31.8	25.4	18.5	14.6	47.6	31.0	19.6	26.7	54.0	22.4	18.1	20.3	16.6	16.1	21.3	16.0	19.2	44.6	11.1	18.7	16.0	25.6	20.5	21.7	15.5	15.4	19.3	29.6	4.7	7.6	21.6	7.0	8.7	7.2	4.9	36.6	14.4	14.5	13.9	40.6	32.9	15.6	40.1	53.5	20.2	25.5	23.4	30.3	13.3	27.9	37.9	28.1	43.7	27.2	22.1	29.6	28.7	9.8	35.4	15.3	10.8	25.9	14.1	43.2	25.8	22.3	21.2	24.1	36.9	21.3	16.9	10.2	24.3	24.8	16.3	13.8	11.3	16.4	20.0	15.7	10.0	14.4	20.9	37.2	24.7	22.4	13.4	34.5	10.8	20.2	21.6	16.0	11.6	29.1	21.5	12.0	27.6	18.4	15.7	19.0	19.7	22.2	10.6	17.9	21.6	7.0	12.1	6.3	6.0	5.9	4.7	6.2	5.6	7.6	2.9	4.3	4.3	3.5	8.7	7.0	6.6	7.2	4.9	29.6	29.4	24.5	34.6	31.6	32.3	31.8	25.4	26.7	25.6	35.7	45.2	11.3	32.9	34.9	26.4	27.0	40.8	24.1	23.9	43.6	19.6	13.5	5.0	32.7	12.6	25.1	15.9	0.0	33.1	24.1	29.4	68.4	27.7	24.6	26.6	77.9	34.2	22.7	18.3	14.0	15.0	28.6	20.3	19.8	31.3	22.6	44.4	25.9	13.8	18.6	33.2	6.5	24.2	15.2	14.9	46.2	14.8	13.8	29.3	33.5
DCBLD2	"CLCP1, ESDN"	ENSG00000057019	"Discoidin, CUB and LCCL domain containing 2"	Q96PD2	3	98795941-98901689	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 66.0;Cone photoreceptor cells: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 59.8;hTERT-RPE1: 84.9;LHCN-M2: 99.6;RPTEC TERT1: 62.4;U-87 MG: 76.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016909	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		1800000	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA016909: AB_1847510"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-1)"	"unprognostic (5.97e-3)"	"unprognostic (9.29e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (3.32e-5)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (7.76e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.59e-3)"	13.1	14.6	4.5	6.4	7.2	1.1	19.3	9.7	9.6	12.0	13.1	5.1	8.1	2.7	16.8	9.2	8.8	13.9	11.7	24.2	4.5	6.2	11.3	9.2	13.1	3.2	6.7	3.5	19.0	6.4	17.6	12.7	9.9	6.5	11.2	6.8	19.3	11.1	14.7	6.6	7.7	5.2	16.7	7.1	2.1	8.6	33.8	7.3	8.1	18.7	6.3	3.6	15.1	6.8	0.6	1.2	1.7	0.5	0.1	1.1	0.2	6.8	50.2	6.7	5.3	9.0	21.4	2.9	15.5	7.4	10.6	12.0	4.2	21.9	0.0	48.8	26.6	32.5	6.4	3.0	25.2	24.4	0.1	1.0	2.4	1.6	6.4	5.5	1.1	1.1	8.4	3.9	30.4	59.8	84.9	6.9	0.9	0.4	0.6	99.6	1.8	0.9	0.6	4.7	0.0	17.4	1.0	12.7	0.6	62.4	1.8	1.8	3.1	4.2	0.8	18.1	4.8	3.4	0.9	11.4	27.3	21.9	6.9	54.2	0.8	1.1	0.9	76.2	0.4	11.8	1.2	0.5	1.7	0.0	0.1	0.0	0.6	0.1	0.1	0.5	0.2	1.1	0.1	0.9	0.1	0.3	1.2	0.0	0.2	4.5	7.2	9.7	9.6	4.5	6.2	6.7	3.5	6.5	7.3	29.8	44.4	4.5	12.4	20.3	11.2	66.0	12.7	18.7	20.5	17.4	72.6	9.6	0.0	20.3	2.5	7.1	0.9	0.0	7.0	8.2	18.1	10.1	36.9	18.7	3.5	12.7	3.5	4.9	1.6	3.6	20.4	2.6	8.5	1.8	7.3	44.0	17.8	3.5	47.4	6.9	49.1	0.0	19.1	15.8	23.3	13.7	3.3	0.0	10.7	5.9
FLRT3		ENSG00000125848	"Fibronectin leucine rich transmembrane protein 3"	Q9NZU0	20	14322988-14337616	"Disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 43.1"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 202.5;Alveolar cells type 2: 116.8;Basal glandular cells: 129.3;Club cells: 126.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.6;hTCEpi: 29.4;RPTEC TERT1: 9.9;WM-115: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056033	Enhanced		Supported	"Plasma membrane,Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA		240000	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA056033: AB_2683016"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.85e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.49e-7)"	"unprognostic (1.54e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.65e-1)"	7.3	4.3	3.4	2.2	7.4	0.1	2.7	27.5	18.9	3.8	5.0	0.7	3.2	12.4	2.6	5.5	2.5	2.7	5.6	1.6	9.3	4.1	43.1	28.9	26.2	0.2	2.3	5.3	11.9	2.3	4.6	2.1	2.0	2.9	12.7	1.0	1.9	1.5	16.4	2.1	6.9	6.0	3.9	2.3	0.8	9.7	1.7	0.7	4.8	8.5	1.8	0.4	12.0	3.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	15.6	0.0	0.0	0.0	0.0	1.5	0.4	0.1	0.0	8.5	3.1	0.0	0.5	0.3	0.0	4.4	0.0	4.6	0.1	0.0	1.0	0.0	0.2	0.1	1.3	0.0	0.0	2.7	29.4	0.0	5.5	0.0	0.0	0.1	0.0	0.1	3.0	0.2	1.9	0.0	5.1	3.4	0.0	0.0	0.1	0.0	9.9	1.9	0.3	3.2	0.0	0.0	4.9	9.2	0.2	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	35.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	7.4	27.5	18.9	9.3	4.1	2.3	5.3	2.9	0.7	202.5	116.8	0.0	129.3	7.7	13.3	0.9	17.8	22.7	126.3	21.0	5.9	0.3	11.6	18.8	0.0	1.6	2.0	0.0	13.0	0.0	5.4	11.3	4.7	7.8	0.2	6.4	10.9	1.8	0.0	0.2	3.4	0.9	5.0	2.8	1.0	0.5	9.4	2.9	0.4	41.7	2.9	0.0	0.1	0.0	0.0	14.4	0.0	0.5	1.5	9.0
GKN1	"AMP18, BRICD1, CA11"	ENSG00000169605	"Gastrokine 1"	Q9NS71	2	68974573-68980974	"Plasma proteins, Predicted secreted proteins"		Mitogen		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"stomach 1: 918.9"	"Cell type enriched"	"Detected in some"	61	"Pancreatic endocrine cells: 201.5"	"Cancer enriched"	"Detected in some"	116	"stomach cancer: 255.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 5.2;HMC-1: 14.2;MOLT-4: 9.9;NTERA-2: 13.5;REH: 5.8;U-2 OS: 8.8;U-266/70: 8.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA047684	Enhanced				"Secreted to digestive system"	NA	NA		26000000			"HPA047684: AB_2680120"						"unprognostic (5.40e-2)"					"prognostic unfavorable (1.54e-4)"			"unprognostic (4.54e-1)"			"prognostic favorable (4.53e-4)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.4	0.0	2.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	918.9	0.0	0.0	1.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.2	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.9	0.0	13.5	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	8.8	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	201.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
GJB5	CX31.1	ENSG00000189280	"Gap junction protein beta 5"	O95377	1	34755047-34758512	"Cancer-related genes, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 39.0;lymphoid tissue: 26.1;skin 1: 37.7;tongue: 28.0"	"Group enriched"	"Detected in some"	16	"Basal glandular cells: 21.6;Basal keratinocytes: 43.0;Suprabasal keratinocytes: 73.0;Urothelial cells: 70.5"	"Group enriched"	"Detected in many"	5	"cervical cancer: 36.7;head and neck cancer: 57.5;lung cancer: 13.7;urothelial cancer: 21.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 9.9;HaCaT: 31.8;HBEC3-KT: 14.2;hTCEpi: 52.7;hTERT-HME1: 8.4;RT4: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038146	Uncertain					NA	NA					"HPA038146: AB_10697242"	"unprognostic (2.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.71e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.67e-3)"	0.0	0.1	0.7	0.0	0.5	0.1	2.6	0.6	2.3	7.5	0.1	0.0	0.5	0.0	0.1	2.1	39.0	0.4	3.3	0.1	0.8	0.1	0.1	0.1	0.3	0.0	0.2	0.5	0.1	0.6	0.0	0.4	7.0	0.2	3.0	0.1	0.0	5.6	2.1	0.2	37.7	0.1	0.3	0.1	0.0	0.1	0.8	0.0	0.6	0.6	28.0	26.1	3.4	11.7	0.0	0.0	0.0	0.8	0.0	0.1	0.8	9.9	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.1	31.8	0.0	14.2	0.0	0.0	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.0	52.7	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	17.7	0.0	0.0	1.2	0.5	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.8	0.7	0.5	0.6	2.3	0.8	0.1	0.2	0.5	0.2	0.0	0.0	0.6	0.0	21.6	43.0	0.0	0.4	0.0	1.4	2.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	73.0	0.3	0.0	0.0	70.5
CD9	"BA2, MIC3, MRP-1, P24, TSPAN29"	ENSG00000010278	"CD9 molecule"	P21926	12	6199715-6238271	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Fertilization"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Urothelial cells: 2399.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	21	"basophil: 137.8;eosinophil: 98.3"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 137.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 129.4;RT4: 95.9;TIME: 191.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002490	Supported		Supported	"Plasma membrane"		NA	NA		68000000	"Plasma membrane"		"CAB002490: AB_563643"	"unprognostic (1.38e-1)"	"unprognostic (6.36e-3)"	"unprognostic (8.27e-3)"	"unprognostic (6.98e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.30e-1)"	"prognostic favorable (6.49e-5)"	"unprognostic (6.10e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (8.93e-5)"	"unprognostic (9.26e-2)"	38.1	44.5	20.0	24.1	36.2	3.1	48.2	6.8	29.6	55.0	68.3	63.1	151.6	19.5	36.2	43.4	139.8	38.4	23.2	39.2	30.3	15.6	39.9	12.2	61.1	8.2	43.3	23.3	14.1	23.3	89.5	15.2	13.0	28.7	77.9	73.5	25.5	91.6	180.4	11.3	60.1	29.6	62.2	48.9	12.2	27.7	10.4	47.7	6.0	63.6	112.3	85.8	54.5	76.0	1.9	0.9	137.8	5.6	0.2	1.1	5.6	34.3	15.1	0.3	9.3	14.8	15.3	13.1	20.4	40.7	7.0	10.7	11.1	129.4	0.1	5.1	4.3	20.8	75.4	7.9	40.7	5.4	1.7	5.5	0.1	11.5	2.4	6.4	0.1	43.3	0.0	30.3	12.8	11.0	19.7	83.6	2.5	1.6	0.1	4.4	49.2	0.1	3.7	11.7	41.8	15.2	0.3	24.9	43.8	68.4	95.9	0.0	2.9	20.3	16.8	17.5	71.5	7.8	3.5	191.3	0.7	19.1	0.7	2.4	0.1	0.1	5.2	11.9	0.0	18.8	137.8	5.6	98.3	0.1	1.8	0.2	0.5	0.1	0.1	0.9	1.9	0.4	1.1	2.6	0.2	0.0	0.3	0.0	5.6	20.0	36.2	6.8	29.6	30.3	15.6	43.3	23.3	28.7	47.7	738.4	321.6	28.1	1345.7	921.9	3.7	14.2	76.5	519.3	651.7	1020.6	0.0	8.4	116.0	478.4	2.3	477.7	411.2	0.0	155.9	225.1	473.0	1465.7	638.5	36.4	653.0	0.0	166.1	406.4	33.8	7.3	29.7	438.3	892.5	256.1	636.4	386.7	257.1	669.9	66.4	14.0	13.1	653.2	455.3	7.0	76.5	1118.7	45.2	23.0	620.5	2399.6
TMEM159	promethin	ENSG00000011638	"Transmembrane protein 159"	Q96B96	16	21158377-21180616	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 107.6;Suprabasal keratinocytes: 131.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 14.6;cerebellum: 13.7"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018033, HPA063509"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA018033: AB_2204762, HPA063509: AB_2685026"	"unprognostic (7.62e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.68e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.93e-3)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (8.11e-5)"	"unprognostic (8.28e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.57e-2)"	35.6	12.7	2.2	6.0	14.6	1.8	27.4	13.7	2.8	25.3	13.5	1.0	10.1	2.7	28.3	9.8	37.1	8.4	23.9	32.4	1.4	1.6	11.3	1.2	10.7	7.6	1.2	1.6	22.0	6.1	5.6	1.2	5.3	1.7	29.7	6.4	10.9	35.2	7.9	57.5	32.5	7.3	45.5	1.5	3.6	7.9	10.9	1.4	6.1	17.4	35.5	21.9	43.7	21.1	11.4	11.3	12.2	8.6	7.5	13.1	7.3	5.9	2.8	3.1	11.3	29.4	18.9	1.6	2.7	12.0	1.2	2.3	2.1	8.2	7.8	3.2	9.0	5.5	9.0	5.1	4.6	1.3	3.5	1.8	3.6	1.0	4.0	6.8	2.8	9.6	7.0	24.0	6.6	21.3	4.8	6.7	4.4	2.5	2.4	2.1	10.5	2.1	2.1	2.7	5.0	1.7	11.2	1.6	2.9	14.8	17.9	0.4	0.4	7.6	10.4	3.5	6.1	17.2	2.1	4.7	1.7	2.2	9.5	0.7	0.2	0.6	2.5	8.5	2.5	1.9	12.2	8.6	8.0	10.1	5.9	8.7	11.4	13.1	8.6	5.0	9.2	9.6	8.8	3.9	7.5	7.1	11.3	13.0	7.3	2.2	14.6	13.7	2.8	1.4	1.6	1.2	1.6	1.7	1.4	8.9	18.1	0.5	34.8	107.6	0.5	54.1	12.7	4.0	22.7	21.0	0.0	3.4	6.6	16.7	0.5	15.3	21.3	0.0	18.5	1.9	18.8	41.3	15.1	0.0	9.7	1.6	13.9	9.2	11.9	0.0	62.5	15.3	28.7	26.2	28.8	23.3	18.9	40.7	35.0	16.3	1.8	32.3	32.3	2.2	6.1	131.2	1.6	10.1	27.2	56.7
ATP13A3	AFURS1	ENSG00000133657	"ATPase 13A3"	Q9H7F0	3	194402672-194498364	"Predicted membrane proteins"		Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029471	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			Nucleoli	"Plasma membrane, Cytosol"	"HPA029471: AB_10600784"	"unprognostic (5.07e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.77e-1)"	27.1	14.4	9.0	20.8	12.7	17.5	22.8	15.3	13.8	12.1	13.4	10.8	17.2	11.4	16.2	13.2	12.4	11.3	17.1	37.8	9.6	8.1	29.7	56.9	22.1	11.6	10.1	8.3	13.2	11.4	37.6	10.6	28.9	10.6	11.8	12.6	12.9	16.7	15.9	11.8	7.7	15.0	12.1	9.0	17.1	16.3	8.8	8.4	18.9	37.1	12.0	12.7	17.8	16.1	1.9	2.4	2.3	2.3	2.2	4.7	1.0	49.1	5.6	10.0	9.5	11.4	17.8	24.4	16.9	18.4	18.4	33.5	30.8	12.0	19.4	50.3	24.3	61.0	16.7	9.6	16.8	42.8	64.7	8.3	10.7	7.4	6.5	19.8	34.8	28.1	8.1	7.5	38.2	24.9	30.2	9.5	12.0	12.3	39.3	22.3	8.4	14.0	6.9	9.5	16.1	9.7	12.8	21.6	11.6	15.6	15.7	15.4	8.1	17.9	18.6	12.5	8.8	35.7	24.4	12.4	22.5	18.7	44.6	31.5	25.9	46.7	34.5	44.6	20.7	15.5	1.8	1.7	2.3	1.8	2.3	2.2	1.9	1.7	2.8	2.4	1.1	2.5	2.5	0.3	2.2	0.9	1.6	4.7	1.0	9.0	12.7	15.3	13.8	9.6	8.1	10.1	8.3	10.6	8.4	47.6	35.1	27.9	35.7	73.3	24.1	34.6	96.8	24.1	37.5	47.1	19.6	25.7	3.3	56.7	1.9	46.6	20.8	0.0	60.7	16.3	46.0	62.6	8.1	112.9	37.1	14.3	29.4	49.1	35.1	1.1	9.5	48.5	59.1	8.2	21.5	10.3	76.7	20.4	12.4	39.8	13.3	12.9	36.0	14.0	7.0	62.2	54.0	20.1	19.9	58.3
RSF1	"HBXAP, p325, RSF-1, XAP8"	ENSG00000048649	"Remodeling and spacing factor 1"	Q96T23	11	77659996-77821017	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022626, HPA046129, HPA057547, HPA064567"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"CAB022626: , HPA046129: AB_2679550, HPA057547: AB_2683462, HPA064567: AB_2685289"	"unprognostic (2.67e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.00e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (6.19e-2)"	"prognostic favorable (5.94e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	15.9	20.1	20.4	19.5	23.5	21.1	14.4	32.3	20.0	19.0	14.2	11.0	15.2	8.7	19.3	14.6	13.4	14.1	15.7	13.1	18.7	17.2	14.0	10.9	15.6	13.2	16.2	15.3	26.0	15.6	25.3	27.3	16.9	18.7	16.3	12.0	8.1	13.4	21.3	15.7	13.5	12.7	16.7	15.8	16.2	12.5	21.1	21.8	22.4	21.1	8.4	12.3	21.3	25.8	21.7	18.5	27.7	15.7	13.6	17.1	4.0	10.5	7.1	24.8	13.2	8.4	10.7	9.3	12.5	12.3	10.3	12.7	18.7	14.8	18.0	13.4	8.7	15.9	11.1	14.5	9.3	19.3	12.8	6.5	16.9	10.1	5.0	8.1	16.0	12.1	8.9	7.1	14.0	22.6	12.0	12.9	6.0	27.5	17.1	11.8	7.2	11.2	9.0	14.4	12.7	9.8	18.8	43.1	11.7	5.4	13.8	15.0	15.2	19.2	7.6	7.5	13.5	13.6	8.0	16.1	18.2	15.8	28.4	8.9	10.3	13.2	41.5	4.8	10.9	13.6	21.3	10.7	17.8	17.1	9.9	11.7	18.2	10.3	10.7	8.1	21.7	14.3	14.2	27.7	13.6	15.7	18.5	9.6	4.0	20.4	23.5	32.3	20.0	18.7	17.2	16.2	15.3	18.7	21.8	110.2	97.4	50.0	60.3	80.4	120.3	86.5	48.4	78.9	81.9	69.8	70.7	51.8	39.7	63.9	69.5	87.9	40.1	70.0	48.5	44.1	80.8	77.0	91.4	37.7	39.8	138.2	82.1	72.4	47.5	29.1	117.3	58.4	54.0	85.6	57.6	115.2	62.7	57.7	111.0	31.1	94.9	103.5	72.1	96.0	109.4	73.4	56.4	77.8	54.2	72.5
RRM2		ENSG00000171848	"Ribonucleotide reductase regulatory subunit M2"	P31350	2	10120698-10131419	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"DNA replication"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 120.9"	"Cell type enhanced"	"Detected in many"	19	"Erythroid cells: 93.5;Extravillous trophoblasts: 192.1;Spermatogonia: 44.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 10.4"	"Low cell line specificity"	"Detected in many"											HPA056994	Enhanced		Supported	Cytosol		Yes	Yes			Cytosol		"HPA056994: AB_2683304"	"unprognostic (2.10e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.40e-3)"	"unprognostic (4.42e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (1.04e-3)"	"unprognostic (6.67e-3)"	"unprognostic (4.53e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (5.11e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-2)"	4.7	2.2	0.4	32.6	0.4	29.0	4.2	0.4	0.9	3.5	9.3	0.4	0.4	5.2	2.1	1.7	21.6	0.7	5.0	3.3	0.4	0.5	2.0	3.9	5.7	16.4	0.6	0.1	0.9	2.9	0.0	0.7	5.4	0.3	1.0	10.6	0.1	2.9	0.0	0.5	2.8	11.3	3.2	0.8	19.8	5.4	8.0	0.0	120.9	0.8	22.3	33.1	3.8	5.2	1.4	0.3	0.6	0.2	1.8	10.4	2.6	29.5	17.9	25.4	17.4	2.2	4.1	25.1	48.3	24.0	34.5	37.6	29.9	14.1	27.1	6.7	15.1	35.0	14.5	41.0	24.9	42.3	60.8	15.8	52.3	17.2	26.3	0.1	38.7	25.1	1.5	0.5	42.2	3.6	5.7	27.9	21.0	21.9	80.5	42.9	22.3	42.7	20.8	20.5	30.4	21.0	32.2	55.4	18.6	17.0	22.5	25.1	20.7	39.7	28.2	4.9	11.0	15.2	6.9	9.7	26.5	38.5	19.8	67.7	52.3	41.0	55.4	18.8	32.9	38.0	0.3	0.1	0.1	3.7	0.0	0.0	1.4	2.6	2.9	0.2	0.4	0.2	1.2	0.6	1.8	0.2	0.3	10.4	2.6	0.4	0.4	0.4	0.9	0.4	0.5	0.6	0.1	0.3	0.0	3.0	1.0	2.2	1.0	9.3	0.0	1.2	2.5	5.3	1.2	0.0	0.0	5.4	1.7	0.5	3.0	0.3	2.6	93.5	0.0	192.1	3.6	1.1	5.7	1.7	40.1	0.0	0.0	5.5	5.9	5.7	0.3	3.5	0.0	0.0	7.9	0.0	0.5	0.0	0.4	1.6	0.0	0.0	0.3	5.2	44.5	1.4	40.7	7.2	13.0	2.0
B3GNT2	"B3GN-T1, B3GN-T2, B3GNT-2, B3GNT1, BETA3GNT"	ENSG00000170340	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2"	Q9NY97	2	62196113-62224731	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005997	Approved		Approved	Vesicles		NA	NA		43000000	Vesicles		"HPA005997: AB_1845234"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.63e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.25e-1)"	18.9	14.3	8.6	10.8	23.0	41.6	17.5	3.1	14.1	18.4	17.9	7.4	5.6	17.9	19.8	8.0	24.5	8.7	18.1	20.9	7.6	11.5	24.4	14.2	23.9	13.9	9.7	7.1	9.0	43.2	5.4	25.9	22.8	9.5	7.5	16.3	14.4	17.2	6.0	5.2	13.0	21.7	16.3	7.6	14.6	12.0	7.0	10.6	27.0	15.6	8.5	18.5	11.8	14.7	8.4	6.8	28.3	5.6	20.3	19.3	8.2	7.8	5.4	8.2	3.6	9.0	4.1	23.7	7.6	8.5	6.1	8.2	11.1	12.6	8.5	7.0	7.1	8.6	7.5	5.2	6.4	10.6	17.6	4.2	20.8	2.6	6.5	6.8	12.4	9.4	4.9	12.1	11.7	4.2	4.3	9.1	5.9	11.3	5.3	7.3	5.9	23.6	18.6	7.8	14.2	2.2	43.4	5.7	4.6	11.6	7.7	8.0	5.9	5.4	11.7	8.7	13.8	3.3	14.7	10.3	7.4	6.5	12.5	7.5	15.1	5.3	36.5	5.8	21.6	7.1	7.2	4.5	28.3	11.0	4.4	15.6	7.6	8.2	19.3	5.5	8.4	9.9	14.4	11.3	20.3	5.6	6.8	13.2	8.2	8.6	23.0	3.1	14.1	7.6	11.5	9.7	7.1	9.5	10.6	59.6	9.8	25.1	27.0	63.4	16.0	8.7	17.8	5.3	3.4	17.4	0.0	31.1	19.9	20.8	0.1	21.0	17.3	46.7	50.7	30.1	35.3	23.6	3.5	15.5	51.9	0.0	9.1	37.4	22.7	0.2	2.3	20.4	33.7	24.4	19.1	8.1	37.8	21.8	2.1	18.9	2.4	64.7	52.3	0.2	1.5	56.7	54.6	17.5	11.9	34.6
PLBD1	FLJ22662	ENSG00000121316	"Phospholipase B domain containing 1"	Q6P4A8	12	14503661-14568349	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 76.8;bone marrow: 54.7;pancreas: 51.9"	"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 142.5;Hofbauer cells: 102.1;Kupffer cells: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"classical monocyte: 76.8;intermediate monocyte: 24.0;myeloid DC: 43.0;neutrophil: 53.2"	"Group enriched"	"Detected in many"	148	"dendritic cells: 43.0;granulocytes: 53.2;monocytes: 76.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 11.8;BEWO: 25.8;CAPAN-2: 66.8;MCF7: 11.1"	"Not detected"	"Not detected"							HPA040303	Enhanced				"Intracellular and membrane"	NA	NA					"HPA040303: AB_2676922"	"unprognostic (9.13e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (2.81e-5)"	"unprognostic (4.80e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.99e-2)"	"unprognostic (5.44e-2)"	9.6	1.2	2.0	6.3	2.5	54.7	12.4	1.2	1.8	8.4	10.7	2.2	5.7	5.4	5.5	3.4	22.0	5.0	7.6	11.8	1.0	0.5	8.8	6.0	11.9	7.2	2.4	1.6	4.7	51.9	0.4	1.7	10.9	4.7	4.8	14.5	4.8	6.1	3.5	6.6	10.8	9.1	4.7	2.4	13.5	6.7	11.3	2.0	1.9	3.2	5.0	5.1	15.5	14.2	0.3	43.0	53.2	76.8	0.2	0.1	38.5	1.7	1.1	0.1	11.8	0.0	0.0	25.8	0.0	0.0	0.7	0.6	3.4	66.8	0.0	0.4	0.3	0.1	2.4	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	1.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.3	11.1	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.1	0.1	7.0	0.0	0.1	8.8	3.7	0.6	6.8	2.4	2.3	0.0	0.1	0.1	0.0	0.1	2.2	6.6	0.0	0.0	0.0	0.1	0.0	76.8	0.6	0.1	24.0	0.0	0.3	0.0	0.0	43.0	0.1	0.0	0.0	53.2	0.2	8.0	0.5	0.1	38.5	2.0	2.5	1.2	1.8	1.0	0.5	2.4	1.6	4.7	2.0	8.9	11.3	3.7	6.3	6.1	0.0	14.2	22.9	13.4	7.9	31.4	0.0	80.6	10.0	11.6	23.8	7.1	36.4	0.0	41.7	142.5	27.8	2.6	4.7	1.7	102.1	0.0	8.7	4.9	116.3	3.1	24.2	96.9	5.0	28.9	29.4	1.3	26.8	70.2	26.2	13.5	0.1	0.0	4.1	3.8	10.0	17.3	58.8	0.7	65.0	23.0
TMEM139	FLJ90586	ENSG00000178826	"Transmembrane protein 139"	Q8IV31	7	143279957-143288048	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.1;kidney: 22.6;placenta: 28.0"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 48.8;Ductal cells: 42.9;Enterocytes: 54.0;Proximal tubular cells: 67.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 9.7;CAPAN-2: 18.3;EFO-21: 12.9;RPTEC TERT1: 32.2;SK-BR-3: 11.3;T-47d: 31.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036982, HPA036983"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane"	"Focal adhesion sites"	"HPA036982: AB_2675413, HPA036983: AB_10672275"	"unprognostic (2.58e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (2.89e-1)"	"prognostic favorable (3.05e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.08e-3)"	1.5	2.2	0.9	2.8	1.9	0.0	2.1	0.6	1.6	6.3	14.7	6.0	1.5	22.7	1.6	3.5	0.4	4.6	4.8	2.3	1.6	1.1	22.6	7.8	5.5	0.1	4.2	0.7	0.9	9.6	6.4	2.0	28.0	4.8	1.6	2.9	1.4	6.1	2.2	0.1	1.1	25.1	0.4	13.4	0.8	2.0	3.0	2.1	0.1	8.8	0.4	0.7	2.1	2.4	0.5	0.3	0.9	3.2	0.0	2.0	0.4	9.7	0.7	0.1	0.0	0.0	0.0	6.5	0.1	0.0	0.0	0.0	2.3	18.3	0.1	12.9	0.0	0.8	8.3	0.0	4.2	0.0	0.1	0.0	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.2	0.0	0.6	0.7	0.4	0.0	0.2	0.7	0.1	0.1	0.0	32.2	2.5	0.1	0.0	0.5	11.3	0.0	0.2	31.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.9	0.0	3.2	0.0	0.5	1.3	0.8	0.0	0.0	1.1	0.6	0.0	0.0	2.4	0.3	2.0	0.4	0.9	1.9	0.6	1.6	1.6	1.1	4.2	0.7	4.8	2.1	14.9	5.1	0.0	2.4	0.1	0.0	2.0	35.7	2.7	5.7	48.8	0.0	26.6	29.9	42.9	12.0	0.3	54.0	0.0	4.0	4.7	0.3	0.3	0.0	13.4	1.7	0.0	3.5	1.3	0.6	8.8	0.0	0.1	5.0	1.8	4.3	8.3	23.3	23.0	0.0	67.4	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	7.4	1.2
SOWAHC	"ANKRD57, C2orf26, FLJ21870"	ENSG00000198142	"Sosondowah ankyrin repeat domain family member C"	Q53LP3	2	109614334-109618990	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 131.1;Suprabasal keratinocytes: 174.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 55.9;hTCEpi: 18.6;RT4: 23.6"	"Low region specificity"	"Detected in all"							HPA056131	Enhanced		Approved	Cytosol		No	No			Cytosol		"HPA056131: AB_2683047"	"unprognostic (6.76e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.61e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.87e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (5.11e-3)"	"prognostic favorable (3.56e-5)"	"unprognostic (2.30e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.54e-2)"	4.9	2.7	2.7	3.7	2.7	0.1	6.5	0.8	2.3	8.9	11.8	3.5	5.3	3.3	3.7	6.4	30.4	3.6	7.2	2.2	2.5	3.2	11.5	35.4	5.1	3.7	5.7	0.8	9.2	4.1	4.1	2.2	20.7	3.6	9.8	5.9	3.9	8.1	6.3	1.1	14.4	17.9	7.8	5.7	3.6	4.4	7.8	2.8	3.2	5.3	30.4	15.9	11.5	10.5	0.8	0.5	1.3	2.3	0.5	1.1	0.5	6.7	1.3	3.9	2.1	2.0	3.3	12.8	14.8	8.7	2.6	2.7	6.0	2.1	0.0	6.1	2.2	4.9	6.4	0.9	9.7	2.8	55.9	6.5	0.0	3.0	8.5	1.8	0.0	1.7	1.7	18.6	5.6	4.0	2.2	0.6	0.0	0.1	0.0	1.9	2.2	0.0	0.6	2.8	6.2	5.9	0.0	0.8	0.1	3.9	23.6	4.9	2.1	5.0	0.9	3.9	4.0	1.9	0.1	0.9	2.1	7.9	1.2	1.0	1.9	1.8	0.0	2.4	0.2	4.7	1.3	2.3	0.3	0.3	0.9	0.4	0.8	0.7	0.3	0.2	0.6	0.5	0.7	1.2	0.5	0.8	0.5	1.1	0.5	2.7	2.7	0.8	2.3	2.5	3.2	5.7	0.8	3.6	2.8	14.9	9.8	3.0	32.5	131.1	10.3	4.2	20.4	2.7	12.5	12.2	9.8	3.1	3.3	14.2	38.3	6.8	30.2	0.0	6.2	25.3	12.3	14.5	0.0	44.5	6.9	0.0	15.0	7.4	7.2	8.5	10.9	6.1	18.6	1.8	27.8	8.0	11.7	40.3	14.2	17.4	18.6	12.9	15.3	10.4	6.9	174.3	8.4	1.5	31.7	73.5
EPSTI1	"BRESI1, MGC29634"	ENSG00000133106	"Epithelial stromal interaction 1"	Q96J88	13	42886388-42992271	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 42.2"	"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 146.8;monocytes: 201.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 36.9;BJ hTERT+ SV40 Large T+ RasG12V: 38.7;HDLM-2: 27.2;RPMI-8226: 13.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017362	Approved					NA	NA					"HPA017362: AB_1848226"	"unprognostic (2.06e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.55e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (7.90e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.05e-3)"	"unprognostic (8.13e-2)"	22.4	11.9	3.9	42.2	5.5	18.2	7.1	1.4	3.7	6.5	14.1	5.1	5.9	20.3	7.0	9.7	6.8	5.4	11.2	7.5	3.8	3.9	14.8	7.9	14.6	18.7	5.4	3.9	5.4	2.9	5.1	4.7	18.1	6.4	6.5	6.8	6.6	10.5	16.8	3.0	2.7	22.2	5.8	7.4	28.3	9.2	5.8	4.0	28.5	7.6	4.3	18.0	10.1	5.4	12.7	14.4	19.3	26.8	10.2	26.4	9.7	1.0	0.0	0.0	0.0	0.0	2.0	1.1	0.9	9.8	36.9	38.7	8.6	2.1	1.3	0.3	1.2	3.9	4.3	0.0	1.4	4.7	27.2	0.0	4.3	0.0	0.0	9.0	0.0	0.7	6.8	2.0	2.9	0.2	0.5	0.5	2.1	0.0	6.8	0.9	0.0	6.8	1.0	0.2	0.7	0.0	0.0	0.0	13.0	6.1	0.2	0.7	0.0	0.1	0.0	0.7	0.1	0.2	0.7	1.4	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.7	0.0	0.4	19.3	16.2	13.0	5.5	26.8	5.7	12.7	11.1	6.0	14.4	10.9	5.3	4.0	7.8	10.2	16.6	1.7	26.4	9.7	3.9	5.5	1.4	3.7	3.8	3.9	5.4	3.9	6.4	4.0	17.9	10.4	22.5	1.3	3.8	0.0	2.4	12.7	4.0	9.1	5.2	0.0	8.1	1.7	29.5	48.9	12.4	65.2	0.0	34.8	146.8	15.4	3.9	10.4	5.9	77.7	0.0	23.6	15.4	21.0	17.6	13.8	49.5	10.1	201.0	13.5	0.2	43.1	16.5	4.6	28.0	0.0	0.0	4.2	2.1	1.9	3.3	12.1	22.4	16.6	3.1
RALB		ENSG00000144118	"RAS like proto-oncogene B"	P11234	2	120240064-120294713	"Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Cell division"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 155.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 69.6"	"Group enriched"	"Detected in all"	4	"granulocytes: 69.6;monocytes: 28.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026010, HPA065232"	Enhanced					NA	NA		10000000			"CAB026010: , HPA065232: AB_2685440"	"unprognostic (5.16e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.77e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (2.29e-2)"	"unprognostic (8.30e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.72e-2)"	21.1	16.1	21.5	19.6	18.9	16.9	17.6	9.1	32.7	17.1	20.0	11.2	7.0	18.0	16.5	9.4	28.0	16.4	16.3	19.6	20.3	16.4	23.2	11.7	18.3	19.7	23.7	18.9	14.8	11.0	155.9	9.8	21.0	15.0	18.1	16.7	9.8	16.7	11.9	12.3	11.1	20.0	15.6	16.1	23.7	13.6	13.4	11.6	7.5	15.3	12.6	12.6	17.2	24.5	9.8	12.2	69.6	28.6	4.3	4.2	9.1	38.7	11.1	10.5	6.7	16.7	25.8	15.2	27.9	24.0	21.4	16.2	22.4	26.5	1.6	14.9	29.4	20.1	14.3	5.1	20.5	17.6	64.8	5.8	18.5	8.6	15.7	10.8	9.6	33.0	14.2	22.1	22.2	16.6	17.9	60.3	1.3	14.4	5.9	22.8	20.4	1.2	19.0	6.8	15.2	23.3	0.2	13.3	8.1	20.0	10.4	2.9	7.1	11.4	30.9	17.6	9.3	9.7	13.9	38.5	21.1	16.0	21.6	10.6	3.7	2.0	2.8	16.6	12.3	21.3	15.7	14.7	41.4	3.7	20.6	3.7	8.5	3.5	3.6	12.2	9.8	2.3	2.7	69.6	4.3	28.6	1.2	4.2	9.1	21.5	18.9	9.1	32.7	20.3	16.4	23.7	18.9	15.0	11.6	8.9	24.8	18.2	25.1	17.2	3.6	48.4	12.7	58.9	23.9	10.4	11.8	4.4	56.3	65.6	12.1	80.8	40.7	0.0	48.5	94.9	28.7	36.1	99.7	9.3	46.6	12.7	17.9	69.3	46.2	17.7	18.4	56.0	33.7	42.3	19.6	12.4	88.9	42.5	29.4	84.1	6.1	19.4	33.0	8.6	17.7	16.6	30.7	21.9	27.4	29.1
LEMD1	"CT50, LEMP-1"	ENSG00000186007	"LEM domain containing 1"	Q68G75	1	205381378-205457091	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 13.1;testis: 34.8"	"Group enriched"	"Detected in some"	129	"Early spermatids: 869.0;Late spermatids: 3077.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.6"	"Group enriched"	"Detected in some"	13	"cerebellum: 2.6;pons and medulla: 5.3"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 29.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045425			Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA045425: AB_10960538"	"unprognostic (1.78e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.20e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.48e-1)"		"unprognostic (2.72e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.26e-4)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.31e-1)"	"unprognostic (5.66e-6)"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-2)"	0.2	0.2	0.2	0.0	0.3	0.0	0.3	2.6	0.2	0.4	1.4	0.0	3.8	0.6	1.0	13.1	1.0	1.5	0.7	0.2	0.2	0.3	0.9	0.2	0.4	0.0	0.3	0.0	0.6	0.6	0.0	0.6	4.7	5.3	0.3	0.0	0.3	3.2	0.4	0.2	0.3	1.4	0.1	0.2	0.2	0.3	34.8	0.0	0.0	4.8	2.2	2.6	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.7	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	29.9	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.9	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.2	0.3	2.6	0.2	0.2	0.3	0.3	0.0	5.3	0.0	0.0	1.6	0.0	1.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	1.4	869.0	0.0	0.0	0.0	0.6	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3077.5	11.8	0.0	0.0	0.0	0.0	0.9	4.0	0.0	13.1	1.5	0.7	6.5	0.0	15.3	7.2	0.0	0.3	0.0	0.0	2.2
ANO1	"DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A"	ENSG00000131620	"Anoctamin 1"	Q5XXA6	11	70078302-70189528	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Developmental protein, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"ductus deferens: 142.4;epididymis: 38.5;salivary gland: 122.9;seminal vesicle: 93.6"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 56.2;Hepatocytes: 117.3;Late spermatids: 50.1;Sertoli cells: 45.3;Smooth muscle cells: 42.3;Suprabasal keratinocytes: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 32.9;CAPAN-2: 50.5;HaCaT: 61.6;OE19: 43.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA032148, HPA057356"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA032148: AB_2674180, HPA057356: AB_2732610"	"unprognostic (2.73e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.66e-2)"	"prognostic favorable (4.58e-6)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (7.28e-5)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (2.13e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.81e-1)"	6.9	0.4	1.1	2.1	1.1	0.0	17.2	1.6	1.4	9.7	5.3	1.1	142.4	0.2	14.2	38.5	3.6	11.7	10.6	6.9	1.1	0.2	2.6	24.4	4.4	1.5	1.0	1.0	3.9	4.5	0.5	2.0	6.2	1.5	7.2	1.7	1.7	122.9	93.6	3.4	19.1	1.8	5.7	1.0	1.1	9.5	7.6	0.9	1.1	8.9	8.1	3.8	4.5	5.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	32.9	1.3	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	50.5	0.0	0.6	0.0	0.0	61.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	43.3	4.8	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	10.5	0.2	0.3	3.9	0.1	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.1	1.6	1.4	1.1	0.2	1.0	1.0	1.5	0.9	0.0	0.0	0.0	18.1	15.8	0.0	2.8	25.5	0.0	1.2	0.0	0.0	1.1	0.0	2.9	56.2	2.2	0.0	0.0	0.0	0.6	3.5	9.1	4.6	117.3	0.2	0.0	0.0	4.9	1.6	50.1	1.7	0.9	5.0	0.0	11.4	1.0	0.6	0.0	1.4	0.4	0.3	45.3	42.3	1.4	1.5	40.8	3.4	0.0	0.2	17.8
EZR	VIL2	ENSG00000092820	Ezrin	P15311	6	158765741-158819412	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 1685.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004035, HPA021616, CAB047324, CAB075739"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		75000000	"Plasma membrane"		"CAB004035: AB_2100309, CAB047324: , CAB075739: AB_2665745, HPA021616: AB_1848342"	"unprognostic (4.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (5.59e-2)"	"prognostic favorable (9.56e-8)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-2)"	"unprognostic (9.00e-2)"	22.8	56.4	30.9	31.2	31.4	24.7	13.3	4.0	21.5	18.0	45.5	28.2	35.2	33.8	9.8	25.8	71.8	25.1	30.2	34.3	37.6	13.9	53.5	16.2	44.3	36.7	14.8	19.0	20.7	33.0	77.1	14.6	125.1	23.5	21.7	22.8	37.0	27.4	32.0	13.6	47.5	87.9	22.8	12.8	26.0	55.4	21.4	22.2	41.6	37.1	34.4	75.6	38.2	25.3	81.7	30.0	24.3	31.2	20.7	61.7	41.1	88.1	48.2	11.9	17.1	1.3	1.4	69.7	27.7	9.1	31.3	26.4	56.4	48.9	88.8	27.5	31.6	15.0	67.6	23.5	30.9	36.4	31.0	15.2	1.8	29.2	24.9	31.8	21.9	13.7	2.3	24.0	29.4	28.6	26.8	20.5	12.3	17.5	43.5	18.1	23.2	31.1	26.5	19.9	24.1	16.1	23.4	5.6	20.2	64.3	26.8	21.7	17.7	48.5	69.9	5.2	57.0	17.0	29.0	26.4	10.1	32.5	13.9	42.6	30.0	27.3	76.1	6.3	11.3	12.0	24.3	14.0	16.4	34.8	31.2	41.0	81.7	36.7	42.9	30.0	67.5	19.9	26.5	6.1	20.7	30.6	14.0	61.7	41.1	30.9	31.4	4.0	21.5	37.6	13.9	14.8	19.0	23.5	22.2	884.4	543.1	187.4	615.4	546.1	5.3	247.6	119.8	1685.0	977.1	148.3	0.0	366.9	82.9	222.1	7.9	84.3	679.2	46.7	221.5	488.7	135.0	354.7	114.5	30.6	98.9	0.0	153.2	31.3	77.1	21.1	125.4	213.0	305.4	115.4	206.3	31.3	408.3	238.4	276.5	168.7	4.0	245.8	120.5	46.2	56.6	635.1	1039.8	112.2	143.1	1039.6
UNC93B1	UNC93	ENSG00000110057	"Unc-93 homolog B1, TLR signaling regulator"	Q9H1C4	11	67991104-68004982	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.6"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 87.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 13.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 31.3;RPMI-8226: 87.0;SK-BR-3: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038716, HPA038717, HPA042803"	Approved		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA038716: AB_2676169, HPA038717: AB_10674836, HPA042803: AB_2678176"	"unprognostic (3.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.36e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (4.76e-2)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.05e-3)"	"unprognostic (5.23e-3)"	8.0	2.7	5.7	9.7	7.4	9.2	5.0	6.2	7.0	4.7	11.9	5.3	6.9	11.8	2.3	5.7	5.5	4.1	13.9	4.6	8.7	6.0	5.9	7.1	13.4	20.8	3.6	0.4	3.0	5.2	0.8	3.3	6.7	2.7	5.3	1.2	5.0	12.3	9.0	6.1	3.7	16.9	2.7	3.5	28.6	10.7	4.1	2.2	2.6	5.3	2.4	13.3	5.9	2.8	2.5	13.6	5.7	6.6	1.8	0.2	0.9	4.5	8.2	0.6	3.3	1.8	0.6	7.1	2.0	1.8	3.2	2.9	0.6	31.3	10.0	7.8	0.9	2.7	10.9	0.2	1.7	0.1	3.5	2.3	1.0	2.6	1.5	2.8	7.1	5.7	1.5	1.8	0.9	0.3	1.2	0.6	1.5	0.7	4.7	0.5	4.3	0.0	5.6	1.5	11.0	4.4	5.9	0.0	87.0	2.8	2.5	0.9	1.4	3.4	23.4	4.5	0.2	8.7	9.3	2.2	2.1	3.1	3.1	0.2	3.3	4.4	1.6	4.0	7.3	2.5	0.1	3.6	5.7	0.1	6.6	0.2	2.4	0.2	0.2	4.7	2.5	0.0	0.0	3.1	1.8	6.6	13.6	0.0	0.9	5.7	7.4	6.2	7.0	8.7	6.0	3.6	0.4	2.7	2.2	8.9	7.8	29.4	21.8	3.5	0.0	1.6	35.7	36.1	6.8	15.7	0.0	9.0	1.7	33.6	0.6	5.8	24.2	0.0	20.5	41.1	8.3	14.1	6.9	4.0	87.3	4.8	4.1	5.5	53.9	0.0	4.0	51.3	21.9	53.3	14.2	4.8	34.0	21.0	3.9	5.7	0.3	0.0	4.2	0.0	0.9	5.6	6.1	9.6	18.7	30.4
UBAC2	"FLJ30548, PHGDHL1, RP11-178C10.1"	ENSG00000134882	"UBA domain containing 2"	Q8NBM4	13	99200774-99386434	"Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013448	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA013448: AB_1855301"	"unprognostic (7.04e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.43e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.79e-3)"	"unprognostic (9.48e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.58e-1)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (6.44e-2)"	"unprognostic (6.13e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.08e-2)"	"unprognostic (3.26e-2)"	16.7	15.6	9.1	15.6	10.4	11.0	24.2	8.2	13.9	14.6	14.6	10.0	18.3	16.7	17.2	17.1	29.6	18.1	15.4	15.5	11.0	7.6	15.1	20.0	20.6	36.5	8.2	10.1	15.1	25.5	11.8	9.5	22.1	9.8	11.1	14.6	11.9	19.5	13.7	26.9	26.3	17.6	13.8	11.7	13.4	14.9	24.8	8.1	21.6	20.6	17.3	24.5	17.2	15.8	25.3	23.9	24.7	23.1	31.3	37.5	31.8	13.1	8.3	6.3	9.1	16.0	17.4	15.2	6.9	24.7	12.6	9.8	8.0	28.6	5.5	12.3	10.5	7.8	12.1	9.1	11.8	7.3	9.3	9.0	9.1	4.4	4.9	13.6	11.4	7.0	13.5	14.9	7.2	22.8	16.7	11.0	10.5	8.0	2.8	10.2	3.5	8.7	2.9	7.9	27.4	6.5	7.0	5.5	4.0	8.6	6.7	6.8	10.1	5.7	17.2	10.0	10.5	11.5	36.8	7.8	4.9	4.9	5.1	7.5	3.9	3.3	1.9	10.7	17.7	9.6	20.8	23.1	17.3	27.3	22.1	37.5	19.6	23.4	27.3	18.6	25.3	32.7	32.2	24.7	31.3	21.2	23.9	15.1	31.8	9.1	10.4	8.2	13.9	11.0	7.6	8.2	10.1	9.8	8.1	6.0	18.4	15.9	23.5	24.2	26.2	19.7	17.8	25.4	14.8	22.7	25.5	99.9	19.9	38.6	19.2	23.6	34.4	0.0	30.4	70.7	31.5	23.0	21.9	25.0	43.6	30.2	8.1	12.9	33.8	16.7	32.5	40.2	28.7	16.2	26.9	44.7	25.3	35.1	47.7	18.3	21.9	32.3	24.0	59.0	37.8	29.0	110.8	50.4	33.9	23.3
ASPH	"BAH, CASQ2BP1, HAAH, JCTN"	ENSG00000198363	"Aspartate beta-hydroxylase"	Q12797	8	61500556-61714640	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 462.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 102.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055161, HPA059303"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA		900000	"Endoplasmic reticulum"		"HPA055161: AB_2682721, HPA059303: AB_2683973"	"unprognostic (8.07e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (6.39e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (8.96e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (2.74e-2)"	104.6	60.4	27.3	15.0	29.5	4.8	84.3	35.2	31.3	22.3	23.8	10.6	18.3	14.0	16.8	17.8	22.4	16.5	19.1	33.9	26.1	22.4	19.0	23.0	22.5	10.9	21.1	22.2	20.5	13.8	12.5	15.7	14.7	20.5	17.3	26.8	23.6	28.8	23.4	103.1	12.0	13.9	26.1	16.7	12.8	30.5	6.4	19.6	2.9	31.7	36.0	13.7	30.0	25.4	3.3	21.0	15.9	5.2	4.9	3.4	2.3	49.9	72.6	10.2	6.2	45.7	43.5	3.5	89.7	83.3	38.4	40.3	12.4	66.6	3.8	6.2	52.5	30.9	18.7	6.3	31.3	65.7	1.4	6.4	8.9	44.1	33.9	29.3	1.3	1.4	35.7	7.0	21.3	27.3	75.4	16.2	2.0	2.4	3.6	33.8	10.6	0.3	1.8	5.8	48.4	42.8	2.4	11.0	0.8	23.4	41.4	10.6	3.6	27.8	13.1	11.1	5.8	5.3	2.4	50.8	38.9	20.0	35.5	31.6	2.3	2.9	0.1	102.4	0.8	26.0	1.1	5.2	0.1	1.6	1.9	3.1	3.3	2.3	1.6	6.1	3.3	3.4	1.6	15.9	4.9	1.0	21.0	2.3	2.3	27.3	29.5	35.2	31.3	26.1	22.4	21.1	22.2	20.5	19.6	181.7	183.4	8.3	108.3	41.8	126.7	192.2	22.9	57.6	137.6	82.0	276.9	97.4	13.3	97.2	1.6	71.6	39.8	0.0	158.3	85.9	64.5	113.1	8.1	51.6	62.4	120.8	111.8	38.6	25.4	0.5	65.6	43.4	40.5	13.6	178.8	462.0	186.9	24.6	54.1	31.9	150.0	45.3	73.9	2.6	16.8	44.0	40.2	10.0	58.7	212.3
POC1A	"DKFZP434C245, WDR51A"	ENSG00000164087	"POC1 centriolar protein A"	Q8NBT0	3	52075253-52154690	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Dwarfism, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 19.7;testis: 34.3"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 39.9;Extravillous trophoblasts: 27.7;Late spermatids: 45.8;Spermatocytes: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040600	Approved					NA	NA					"HPA040600: AB_10672837"	"unprognostic (2.68e-1)"	"unprognostic (7.17e-2)"	"prognostic favorable (1.78e-4)"	"unprognostic (5.08e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (1.76e-4)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (9.43e-7)"	"unprognostic (9.90e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.32e-2)"	2.2	4.6	1.3	5.5	1.6	9.2	1.8	1.0	2.2	1.3	5.5	1.5	1.5	4.4	1.0	2.8	5.0	1.4	2.8	1.7	1.8	1.4	1.8	5.2	2.2	4.6	1.5	0.6	1.1	0.9	0.5	0.7	5.9	1.3	1.4	5.9	0.9	1.5	1.5	1.5	2.2	3.5	2.5	1.4	3.1	2.7	34.3	1.1	19.7	1.1	5.5	6.9	1.8	1.8	2.2	3.9	1.1	4.5	2.8	5.5	2.2	13.4	11.5	11.7	15.6	2.4	3.1	15.9	13.8	13.3	29.7	23.2	10.1	14.4	14.2	4.1	10.9	22.9	8.5	17.6	15.6	21.7	11.6	7.4	9.6	12.3	10.8	0.6	10.9	6.1	1.7	3.4	23.4	12.3	4.1	13.5	21.4	8.3	15.4	17.5	10.7	20.2	19.9	8.9	15.3	19.1	8.8	9.3	13.5	6.6	9.6	5.4	7.9	11.0	11.0	8.4	12.8	13.6	20.7	4.4	13.5	13.3	21.7	22.2	13.1	21.4	11.9	9.1	19.2	13.5	0.0	3.4	0.0	2.8	4.5	0.3	2.2	2.0	0.9	3.9	1.1	1.6	1.1	1.1	2.8	3.2	3.9	5.5	2.2	1.3	1.6	1.0	2.2	1.8	1.4	1.5	0.6	1.3	1.1	0.0	2.2	7.8	1.0	1.4	0.7	0.6	0.0	2.7	0.0	1.8	0.0	9.2	0.0	1.8	39.9	1.1	1.7	0.0	2.7	27.7	1.0	0.8	0.0	3.9	11.1	1.6	1.7	1.3	1.6	45.8	1.1	2.9	1.7	4.6	2.1	0.8	1.5	0.0	0.4	2.2	0.0	0.0	1.4	27.7	18.5	1.6	6.3	1.3	4.1	1.1
ACOT4	"FLJ31235, PTE-Ib, PTE2B"	ENSG00000177465	"Acyl-CoA thioesterase 4"	Q8N9L9	14	73591706-73596496	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 15.6"	"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 22.2;Proximal tubular cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.3;MCF7: 5.6;SK-BR-3: 11.7;T-47d: 29.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000779	Enhanced					NA	NA					"HPA000779: AB_1078093"	"unprognostic (2.29e-3)"	"unprognostic (2.53e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.77e-4)"	"unprognostic (3.95e-1)"	"prognostic favorable (8.43e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.73e-1)"	6.3	2.2	2.9	1.4	3.6	0.6	4.4	1.6	5.7	3.6	2.6	1.0	1.5	3.9	1.0	2.4	2.0	0.9	3.3	2.9	2.1	2.0	13.0	15.6	3.9	1.1	1.6	2.8	0.9	2.2	1.1	0.7	4.9	2.7	1.4	3.1	1.8	3.1	3.4	0.7	0.9	7.4	2.5	0.8	1.4	1.9	2.8	0.9	0.3	1.2	0.8	1.2	1.1	1.3	1.7	0.6	5.0	0.4	4.6	10.6	3.2	4.3	1.2	0.1	0.0	0.5	0.2	0.0	0.3	0.0	0.3	0.5	0.1	7.3	0.0	0.2	0.4	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	1.6	0.0	0.8	0.0	4.1	0.3	0.5	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	5.6	0.1	0.8	0.4	1.5	1.2	0.0	0.0	0.0	0.1	2.1	0.6	0.2	2.8	11.7	0.8	0.0	29.2	4.4	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	1.0	10.6	0.4	5.5	1.6	5.2	6.0	0.2	1.7	3.2	6.5	0.3	4.6	0.2	0.6	4.8	3.2	2.9	3.6	1.6	5.7	2.1	2.0	1.6	2.8	2.7	0.9	0.0	2.4	2.2	1.0	0.2	0.2	1.2	2.5	2.7	1.2	10.4	0.0	11.8	13.3	3.6	1.6	0.3	10.3	0.0	8.3	11.5	1.1	0.5	5.7	22.2	10.2	1.6	0.0	0.0	2.7	3.8	0.3	1.7	0.0	1.8	2.7	0.5	4.8	2.9	0.4	51.8	0.5	0.0	0.9	2.7	14.3	0.3	3.8	4.4	2.8	1.1
KRT18		ENSG00000111057	"Keratin 18"	P05783	12	52948871-52952901	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 268.7"	"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 6515.6;Exocrine glandular cells: 4232.0;Extravillous trophoblasts: 4401.0;Pancreatic endocrine cells: 4358.9;Syncytiotrophoblasts: 6392.2"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 10.0"	"Cell type enriched"	"Detected in many"	5	"basophil: 28.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 28.6"	"Cell line enhanced"	"Detected in many"		"A549: 228.6;BEWO: 144.3;CACO-2: 251.4;CAPAN-2: 182.6;MCF7: 334.7;SK-BR-3: 185.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000008, CAB000030, HPA001605"	Enhanced		Supported	Cytosol		NA	NA		140000000	Cytosol		"CAB000008: , CAB000030: , HPA001605: AB_2666381"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.26e-3)"	"unprognostic (4.09e-3)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (8.81e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-2)"	23.3	4.8	1.0	31.0	1.1	0.0	24.1	2.9	1.2	28.6	45.4	1.3	66.3	35.0	6.6	55.3	22.4	21.7	147.4	6.8	1.1	2.5	61.9	181.0	39.6	2.8	1.2	1.0	13.7	162.9	8.2	39.8	268.7	10.0	29.3	57.0	14.1	121.1	49.9	1.3	6.5	83.6	3.9	1.4	4.4	36.0	9.5	0.8	4.2	83.4	10.8	20.9	21.5	10.8	4.1	1.0	28.6	0.1	1.0	5.9	1.6	76.6	228.6	0.0	0.3	0.0	0.0	144.3	11.6	14.2	15.1	4.3	251.4	182.6	0.0	32.5	12.6	7.9	18.8	3.2	88.6	9.1	0.0	5.4	0.7	37.4	69.1	39.1	0.0	0.0	0.5	8.3	13.2	18.2	43.2	16.1	0.1	18.5	0.0	0.0	334.7	0.1	1.4	18.6	107.6	17.3	0.1	0.0	8.7	73.6	46.3	2.6	0.1	18.9	185.1	0.7	116.4	97.7	0.2	5.1	0.2	17.6	0.2	2.6	0.0	0.2	0.1	0.0	0.0	1.4	28.6	0.1	1.1	0.2	0.1	1.1	2.1	2.3	0.6	1.0	4.1	5.9	2.1	1.5	1.0	0.0	0.0	0.2	1.6	1.0	1.1	2.9	1.2	1.1	2.5	1.2	1.0	10.0	0.8	801.0	239.7	47.5	1382.6	13.2	0.0	4.9	1332.4	459.0	466.3	591.5	0.0	2872.9	233.8	6515.6	0.9	56.4	1517.2	0.0	4232.0	4401.0	68.2	910.9	48.4	492.5	270.7	1.6	616.3	87.8	9.9	2.3	9.8	37.0	197.4	71.3	2268.9	5.8	4358.9	1644.8	0.0	407.9	0.5	0.0	45.3	1.6	5.9	5.8	6392.2	10.7	1202.1	1262.3
BUB1B	"Bub1A, BUBR1, MAD3L, SSK1"	ENSG00000156970	"BUB1 mitotic checkpoint serine/threonine kinase B"	O60566	15	40161023-40221136	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 49.5;testis: 25.6"	"Group enriched"	"Detected in many"	7	"Spermatocytes: 66.9;Spermatogonia: 28.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.8;plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA008419			Supported	Cytosol		Yes	Yes			Cytosol		"HPA008419: AB_1078308"	"unprognostic (4.40e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.44e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (7.43e-6)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (3.69e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.94e-2)"	1.0	0.9	0.3	18.4	0.6	11.4	1.5	0.4	0.5	1.3	4.0	0.4	0.1	3.3	1.1	0.8	6.5	0.5	1.1	0.6	0.4	0.4	0.8	0.7	1.8	8.7	0.4	0.3	0.6	0.5	0.0	0.4	3.4	0.5	0.6	4.4	0.3	1.6	0.1	0.7	2.3	2.9	1.2	0.6	5.4	1.7	25.6	0.1	49.5	0.5	3.1	10.6	1.1	2.0	2.8	2.8	0.0	0.2	0.7	0.7	0.5	21.8	11.1	35.5	14.1	0.9	2.5	11.5	20.8	11.7	22.3	19.4	16.2	8.4	19.8	11.7	7.5	20.5	24.7	33.5	11.3	24.3	17.0	18.0	28.9	28.7	15.0	0.0	26.1	15.9	0.5	0.6	13.6	12.8	4.4	16.1	22.9	24.9	21.1	22.2	7.4	20.4	15.9	24.0	18.4	12.7	21.9	29.2	15.0	6.8	11.1	23.2	14.3	12.8	12.3	4.5	16.2	14.3	13.5	9.3	17.1	18.1	17.0	18.4	11.1	18.8	32.4	9.1	29.3	22.2	0.0	0.0	0.0	0.2	0.2	0.3	2.4	0.7	0.6	0.7	2.8	0.1	0.4	0.0	0.7	0.1	2.8	0.0	0.5	0.3	0.6	0.4	0.5	0.4	0.4	0.4	0.3	0.5	0.1	3.0	1.4	0.8	0.3	0.7	0.4	0.4	0.0	0.0	3.4	0.0	0.0	1.3	0.0	0.3	2.5	0.0	0.3	0.0	0.0	5.1	0.4	0.2	0.0	0.2	4.3	0.0	0.0	1.3	0.6	2.4	1.4	1.5	0.0	0.0	1.4	0.0	0.8	0.8	0.4	0.0	0.1	6.5	0.0	66.9	28.8	0.3	0.7	0.8	1.7	0.4
AMIGO2	"ALI1, DEGA"	ENSG00000139211	"Adhesion molecule with Ig like domain 2"	Q86SJ2	12	47075707-47079951	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 43.4"	"Cell type enhanced"	"Detected in many"	8	"Intestinal endocrine cells: 58.0;Ito cells: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 40.9;fHDF/TERT166: 39.3;hTERT-RPE1: 69.7;LHCN-M2: 39.3;RT4: 53.8;U-2 OS: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054004, HPA059601"	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	Yes		160000	"Golgi apparatus, Plasma membrane"	Cytosol	"HPA054004: AB_2682339, HPA059601: AB_2684078"	"unprognostic (2.63e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (2.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.29e-3)"	5.6	11.9	5.4	4.0	8.8	1.4	14.5	1.6	6.5	18.3	20.3	3.5	1.9	1.6	19.7	12.4	3.1	21.2	12.4	3.4	2.7	7.5	4.3	2.9	11.9	6.7	2.9	5.1	43.4	2.3	2.0	9.5	7.6	16.2	12.8	5.6	6.7	3.1	7.1	1.5	2.3	7.1	21.0	3.0	9.8	3.5	13.1	3.6	1.6	2.5	4.1	4.5	16.6	15.1	2.8	7.4	0.1	0.2	6.6	14.2	4.3	9.0	22.5	1.4	0.0	0.5	0.0	3.7	3.1	8.5	1.0	0.8	0.0	40.9	0.0	10.3	39.3	25.8	13.6	0.0	25.1	1.2	1.7	0.1	0.0	2.2	0.0	0.8	0.2	0.3	0.2	4.4	26.9	13.3	69.7	3.2	0.2	1.7	0.0	39.3	0.4	0.7	0.0	0.9	4.5	5.7	0.0	10.1	0.0	11.6	53.8	4.1	0.0	16.2	1.9	0.1	0.8	2.4	0.2	0.8	0.5	32.6	0.3	25.1	0.3	0.0	0.0	2.1	0.7	0.6	0.0	0.1	0.0	4.0	0.2	5.4	2.8	6.2	6.2	0.6	1.3	14.2	11.1	0.1	6.6	0.0	7.4	3.6	4.3	5.4	8.8	1.6	6.5	2.7	7.5	2.9	5.1	16.2	3.6	8.9	1.9	5.9	10.4	2.2	21.1	0.8	0.0	2.7	6.8	1.8	0.0	0.7	1.7	4.3	1.2	4.5	0.0	0.0	17.0	23.1	6.7	5.2	6.9	0.8	4.4	0.0	58.0	30.7	3.8	0.9	2.3	2.3	1.7	8.2	2.5	14.9	26.7	0.8	0.7	0.0	4.1	0.0	25.5	0.3	0.7	0.4	7.1	4.4	0.2	13.4
EPYC	"DSPG3, Pg-Lb, SLRR3B"	ENSG00000083782	Epiphycan	Q99645	12	90963679-91005026	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"placenta: 67.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"ovarian cancer: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"hTERT-RPE1: 8.2;U-266/70: 2.0"	"Region enhanced"	"Detected in single"		"midbrain: 1.6"	"Group enriched"	"Detected in many"	5	"amygdala: 3.8;basal ganglia: 3.8;cerebral cortex: 6.2;hippocampal formation: 4.4"	"HPA038212, HPA045455"	Approved				"Secreted to extracellular matrix"	NA	NA					"HPA038212: AB_10672739, HPA045455: AB_2679330"	"unprognostic (2.25e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.28e-2)"		"unprognostic (1.81e-2)"		"unprognostic (4.07e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (2.77e-2)"	"unprognostic (6.44e-9)"	"unprognostic (2.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.20e-1)"	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.4	0.1	0.2	0.4	0.5	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	2.5	0.0	0.0	0.0	67.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
COL17A1	"BP180, BPAG2"	ENSG00000065618	"Collagen type XVII alpha 1 chain"	Q9UMD9	10	104031286-104086002	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 85.8;skin 1: 123.2;tongue: 64.0"	"Cell type enriched"	"Detected in many"	4	"Basal keratinocytes: 520.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 227.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 1.2"	"Cell type enriched"	"Detected in single"	15	"neutrophil: 3.7"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 24.8;HaCaT: 56.6;HBEC3-KT: 90.6;hTCEpi: 117.8;hTERT-HME1: 100.3"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.1"	"Not detected"	"Not detected"			"HPA043673, HPA052963"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane"	"Golgi apparatus"	"HPA043673: AB_10960893, HPA052963: AB_2681999"	"prognostic favorable (1.38e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.35e-2)"	0.2	0.0	0.2	4.4	1.2	7.5	8.1	0.2	0.2	15.2	9.3	0.2	0.9	2.0	0.6	2.6	31.5	0.1	1.2	0.2	0.2	0.1	0.4	0.2	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.6	85.8	0.2	5.0	5.4	0.2	15.5	7.3	0.5	123.2	23.2	0.8	0.2	0.3	3.9	4.0	0.2	18.1	2.0	64.0	24.7	3.0	17.3	0.0	0.0	3.7	0.2	0.0	0.0	0.8	3.1	0.0	0.1	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	24.8	0.0	0.7	0.0	0.5	56.6	0.1	90.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.8	0.0	100.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.0	5.1	3.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.8	0.2	1.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.6	0.0	12.4	520.3	0.6	0.8	0.0	2.7	20.5	0.0	0.0	3.5	0.0	0.7	8.5	1.0	105.8	0.0	0.8	8.3	2.1	0.6	0.0	0.0	1.2	0.0	2.4	0.0	0.0	2.6	0.3	1.0	32.1	0.0	5.9	0.4	45.8	16.1	0.7	0.0	0.4	0.0	1.7	8.3	1.1	121.8	4.7	0.0	14.5	8.0
SPCS3	"FLJ22649, PRO3567, SPC22/23, SPC3, YLR066W"	ENSG00000129128	"Signal peptidase complex subunit 3"	P61009	4	176319964-176332245	"Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 88.1"					"Low region specificity"	"Detected in all"			HPA053180	Approved					NA	NA					"HPA053180: AB_2682071"	"unprognostic (4.30e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.20e-3)"	"prognostic favorable (8.89e-6)"	"unprognostic (1.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.79e-2)"	"unprognostic (4.78e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.44e-1)"	20.3	14.2	15.5	24.5	15.8	29.3	30.0	18.3	24.9	26.2	25.3	12.6	40.9	17.3	23.5	27.4	18.2	19.2	20.0	24.4	14.1	14.5	18.1	41.3	25.4	38.2	18.9	17.5	15.8	85.0	21.2	24.9	26.3	14.6	17.6	19.8	11.0	52.4	37.4	17.4	16.2	18.6	26.4	21.2	29.5	24.5	8.3	12.9	19.1	32.5	16.1	23.8	22.4	19.5	8.0	17.1	26.2	14.6	13.0	16.3	12.8	14.6	4.9	13.7	11.2	19.6	34.8	14.5	29.0	27.9	17.0	14.7	5.3	32.4	28.3	6.0	16.7	8.9	10.2	12.9	21.4	25.9	19.0	5.7	24.4	8.0	12.1	20.0	36.5	21.6	21.0	23.6	15.0	14.6	19.1	25.0	13.8	15.7	88.1	23.3	8.9	22.2	13.9	9.3	10.4	4.9	11.0	21.3	24.6	20.9	10.7	10.9	10.0	30.3	22.7	13.3	12.4	7.3	17.1	23.2	12.6	12.6	11.2	13.2	40.9	12.1	35.6	26.8	18.5	17.3	26.2	12.2	10.3	12.3	14.6	16.3	8.0	11.5	11.1	9.2	5.3	9.7	12.0	12.2	13.0	11.6	17.1	8.9	12.8	15.5	15.8	18.3	24.9	14.1	14.5	18.9	17.5	14.6	12.9	50.6	81.3	47.6	49.0	50.8	32.2	67.8	40.8	42.8	54.6	27.9	25.5	58.7	18.3	68.9	48.1	87.5	44.5	116.8	117.4	151.8	62.7	93.0	89.0	104.2	140.2	22.3	43.0	92.1	105.2	14.2	20.8	125.0	104.6	64.9	66.2	31.5	141.6	34.5	15.9	52.2	28.5	12.9	51.2	75.3	39.6	57.0	154.2	63.7	42.2	96.6
TMCC1	KIAA0779	ENSG00000172765	"Transmembrane and coiled-coil domain family 1"	O94876	3	129647792-129893576	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 12.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 12.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053894	Uncertain					NA	NA					"HPA053894: AB_2682295"	"unprognostic (4.26e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (7.75e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (2.50e-2)"	"prognostic unfavorable (1.77e-6)"	"unprognostic (6.82e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.32e-1)"	7.8	8.1	10.0	7.1	10.9	3.5	8.4	28.9	11.5	11.6	6.7	14.1	2.6	4.7	8.9	7.9	8.6	8.0	9.7	8.8	9.8	8.8	6.7	37.2	7.5	5.2	16.1	9.2	9.4	7.2	8.7	19.8	10.7	11.3	8.8	6.0	6.2	6.0	7.5	28.2	7.7	4.8	7.9	13.5	7.2	4.7	14.0	13.1	10.3	7.8	5.6	5.9	8.3	7.3	1.3	1.8	12.2	2.4	1.0	2.2	0.9	8.6	9.6	7.5	6.1	11.3	8.0	7.6	3.4	4.5	3.0	3.2	6.0	4.8	5.3	9.8	6.6	3.6	8.0	4.2	6.8	2.3	7.0	1.4	3.5	2.8	22.0	3.8	2.6	2.2	4.6	12.9	2.4	5.7	6.7	9.3	3.2	1.7	3.9	7.0	9.3	4.6	1.6	5.7	6.3	3.0	4.2	6.3	4.4	7.1	10.7	6.9	4.9	11.7	4.0	3.4	7.6	7.8	2.9	8.0	4.9	8.0	4.4	7.0	5.9	3.9	4.1	3.6	3.1	2.5	0.8	1.2	2.6	1.6	1.1	1.7	0.9	1.3	1.3	0.6	1.3	1.6	2.0	12.2	1.0	2.4	1.8	2.2	0.9	10.0	10.9	28.9	11.3	9.8	8.8	16.1	9.2	11.3	13.1	50.6	6.1	7.5	11.5	6.0	33.3	19.3	7.6	21.4	15.9	21.0	29.5	8.1	6.6	15.6	8.8	9.4	4.9	0.0	7.2	17.9	7.6	20.7	3.5	28.0	8.7	33.4	12.1	9.8	18.3	8.8	12.0	7.4	1.7	2.8	10.4	28.6	19.7	14.8	8.1	11.8	24.9	6.5	10.3	31.0	15.1	6.0	20.0	4.5	6.8	18.6
TOPBP1	"KIAA0259, TOP2BP1"	ENSG00000163781	"DNA topoisomerase II binding protein 1"	Q92547	3	133598175-133662380	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 79.9;Spermatocytes: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022451, HPA036738, HPA036739"	Approved		Supported	Nucleoplasm		No	No			Nucleoplasm		"CAB022451: , HPA036738: AB_2675280, HPA036739: AB_2675281"	"unprognostic (7.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (2.05e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (8.03e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (2.74e-3)"	"unprognostic (8.65e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.60e-1)"	13.0	8.2	9.7	16.1	11.7	32.9	17.2	14.4	13.8	9.6	10.8	5.4	8.2	9.7	11.5	10.3	15.0	9.7	8.8	12.1	9.2	7.8	7.4	8.6	10.2	21.3	8.8	9.2	11.0	12.6	10.0	9.8	14.0	10.7	9.5	14.0	5.1	12.0	7.2	10.8	13.6	13.0	11.0	13.1	18.9	10.9	24.6	8.8	38.0	10.3	11.5	20.9	11.0	11.1	2.8	3.1	6.1	2.7	3.0	4.4	1.2	16.0	10.0	16.3	13.2	3.1	4.1	12.2	12.5	10.0	15.5	20.1	13.9	10.2	29.1	11.1	9.1	18.8	18.7	23.4	8.3	24.0	17.6	10.4	27.3	14.5	8.5	3.0	29.1	21.6	4.8	5.2	15.2	9.1	5.8	10.6	17.3	16.9	20.9	12.2	11.0	28.5	15.5	13.4	18.4	8.5	19.3	20.3	21.2	5.5	11.1	15.5	17.2	15.4	8.5	12.9	16.6	14.2	27.2	7.3	16.4	14.9	16.6	13.7	12.6	18.9	56.1	9.7	15.6	14.4	4.6	2.0	6.1	2.2	2.7	3.3	2.8	2.3	2.2	2.0	1.9	2.2	2.3	2.4	3.0	1.5	3.1	4.4	1.2	9.7	11.7	14.4	13.8	9.2	7.8	8.8	9.2	10.7	8.8	20.8	24.5	14.2	6.9	11.0	14.7	7.9	15.3	12.0	30.7	10.4	2.0	15.8	8.3	9.3	56.8	13.2	6.5	23.3	11.5	18.3	8.0	7.5	7.0	8.6	9.8	3.2	6.9	7.4	11.9	79.9	9.5	14.0	8.5	20.8	10.1	10.4	11.7	10.5	9.2	5.0	8.5	12.9	5.2	68.9	51.3	10.0	11.7	13.8	12.4	8.8
ABCE1	"OABP, RLI, RLI1, RNASEL1, RNASELI, RNS4I"	ENSG00000164163	"ATP binding cassette subfamily E member 1"	P61221	4	145097932-145129179	"Predicted intracellular proteins"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012476, HPA036846"	Approved		Enhanced	Cytosol		No	No			Cytosol		"CAB012476: , HPA036846: AB_2675346"	"unprognostic (2.22e-3)"	"unprognostic (8.11e-3)"	"prognostic favorable (8.69e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.51e-3)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (5.68e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-1)"	27.5	19.4	17.5	23.3	23.7	17.5	25.3	21.0	23.2	20.8	16.5	17.7	14.7	14.4	19.5	15.8	28.5	19.4	16.4	19.5	19.5	18.0	23.1	40.1	17.3	27.3	22.1	15.5	28.2	34.2	23.0	31.7	21.2	26.0	18.4	21.1	11.0	19.0	15.1	33.1	19.9	14.1	20.7	22.1	29.0	16.7	21.2	20.7	36.5	20.1	29.7	29.5	26.0	19.0	9.9	13.2	1.0	8.8	10.4	18.2	9.9	26.7	14.0	21.7	15.0	18.9	27.4	21.2	29.3	21.1	35.7	25.3	21.1	25.4	43.9	9.5	26.1	18.8	18.0	32.3	38.2	48.4	24.4	19.0	24.7	10.5	18.6	24.9	56.9	20.0	20.2	26.7	37.8	53.4	18.4	38.3	33.5	49.6	32.9	38.1	16.1	54.5	19.0	17.9	41.4	32.5	29.0	26.1	31.3	26.8	17.8	27.1	13.3	17.8	30.3	20.9	17.2	18.1	22.3	25.2	35.4	21.8	24.6	35.3	29.5	47.0	47.0	21.7	49.7	39.1	1.0	6.7	0.7	9.2	8.8	18.2	9.9	11.1	11.1	13.2	9.2	15.6	12.9	0.6	10.4	8.1	7.4	12.4	9.9	17.5	23.7	21.0	23.2	19.5	18.0	22.1	15.5	26.0	20.7	23.8	16.0	38.8	65.1	53.1	33.8	21.0	15.3	32.1	52.4	24.4	19.6	32.6	33.2	31.5	22.0	37.2	6.4	23.3	24.2	35.3	34.5	51.8	31.3	28.0	37.4	39.7	19.7	22.1	22.2	9.3	43.4	34.8	18.6	27.9	22.3	17.5	33.7	3.5	32.5	29.3	34.2	32.3	31.6	76.0	70.9	51.9	22.2	27.7	30.4	68.4
KIF20A	RAB6KIFL	ENSG00000112984	"Kinesin family member 20A"	O95235	5	138178719-138187715	"Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.7;testis: 18.2"	"Cell type enhanced"	"Detected in some"	23	"Erythroid cells: 46.7;Extravillous trophoblasts: 10.5;Spermatocytes: 17.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"NK-cell: 10.0;T-reg: 3.2"	"Group enriched"	"Detected in many"	64	"NK-cells: 10.0;T-cells: 3.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA036909, HPA036910"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge,Cleavage furrow"		Yes	Yes			"Nucleoplasm, Cleavage furrow"	"Cytokinetic bridge"	"HPA036909: AB_10670245, HPA036910: AB_10671716"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (2.14e-12)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (9.05e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	2.3	1.7	0.3	3.6	0.4	10.4	0.7	0.3	0.7	1.7	2.7	0.4	0.3	2.7	1.6	2.2	10.7	0.3	0.3	0.8	0.3	0.3	1.2	1.2	2.3	6.7	0.6	0.4	0.8	0.5	0.0	0.3	6.6	0.5	1.0	4.2	0.4	2.0	0.3	0.5	3.5	2.7	4.4	0.5	3.8	2.1	18.2	0.3	47.7	0.5	6.1	11.7	1.8	3.0	0.1	0.0	0.0	0.0	10.0	3.2	0.4	22.2	15.0	33.2	22.0	1.7	3.3	14.3	19.3	17.7	42.1	31.8	28.2	20.8	9.6	10.4	24.3	15.8	22.1	31.1	36.1	42.2	14.0	14.7	14.2	26.8	17.9	0.1	6.9	6.6	1.2	0.6	22.4	12.9	7.1	27.2	13.7	5.9	18.4	29.1	20.4	11.6	6.8	21.0	13.1	16.4	12.8	33.3	9.9	11.5	11.0	9.9	9.8	36.5	12.4	8.5	44.5	15.8	7.2	12.9	11.0	16.4	9.9	32.2	9.5	9.1	10.7	7.1	20.5	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.5	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	3.2	0.4	0.3	0.4	0.3	0.7	0.3	0.3	0.6	0.4	0.5	0.3	0.0	1.7	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.6	0.0	0.4	46.7	0.0	10.5	0.4	0.1	4.6	0.0	4.9	0.0	0.0	3.7	1.0	1.0	0.3	0.6	0.0	0.0	0.1	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	17.9	4.6	0.4	0.8	0.0	1.6	0.0
ADAM10	"CD156c, HsT18717, kuz, MADM"	ENSG00000137845	"ADAM metallopeptidase domain 10"	O14672	15	58588807-58749978	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 77.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001709, HPA050670"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		8200000	"Plasma membrane"	"Nucleoplasm, Vesicles"	"CAB001709: , HPA050670: "	"unprognostic (1.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-3)"	"unprognostic (7.48e-2)"	"prognostic unfavorable (8.46e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (6.69e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.60e-2)"	25.9	11.1	15.5	17.1	17.7	15.6	20.0	25.2	17.6	18.6	20.1	15.7	12.7	13.9	19.9	11.8	17.1	13.8	18.0	18.8	17.6	13.7	20.8	14.8	25.0	26.1	23.1	12.4	13.9	13.1	10.9	11.6	36.1	14.5	23.6	16.7	14.6	12.4	19.1	8.9	15.4	15.6	12.8	30.4	40.4	18.4	8.5	18.9	38.5	27.3	9.2	14.9	30.0	19.1	6.2	12.7	26.9	23.7	9.8	12.2	12.8	12.1	27.4	7.5	8.1	9.6	13.9	18.9	10.4	31.0	7.7	10.7	12.6	16.1	5.6	32.2	9.3	13.5	24.8	4.5	11.0	10.2	8.4	5.8	9.6	10.0	11.7	10.7	6.8	27.7	12.1	8.1	5.4	7.9	11.2	14.9	12.2	6.0	15.3	13.5	4.5	22.4	7.7	10.2	4.0	3.9	9.3	24.5	14.4	17.9	32.7	8.1	5.3	11.3	13.2	18.0	17.1	7.8	13.6	10.5	10.1	11.3	77.5	10.0	8.6	18.5	6.1	14.1	13.1	17.6	12.9	18.8	10.4	8.1	21.5	12.2	5.3	8.0	7.1	12.7	6.2	8.4	7.0	26.9	9.8	23.7	5.8	10.3	12.8	15.5	17.7	25.2	16.9	17.6	13.7	23.1	12.4	14.5	18.9	77.4	49.8	30.6	25.8	23.7	20.2	29.7	30.6	30.8	35.2	76.8	25.5	27.4	1.7	45.7	21.6	61.6	39.3	0.0	27.7	46.7	28.8	75.5	27.9	30.4	56.9	42.9	34.7	76.1	87.0	16.2	16.7	64.0	43.9	13.6	45.8	27.0	37.3	43.2	15.9	20.3	32.7	12.9	28.3	13.6	16.2	19.4	22.2	43.6	33.7	59.6
COLGALT1	"FLJ22329, GLT25D1"	ENSG00000130309	"Collagen beta(1-O)galactosyltransferase 1"	Q8NBJ5	19	17555594-17583162	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 66.0;Hofbauer cells: 81.3;Kupffer cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047821	Approved		Approved	Vesicles	"Intracellular and membrane"	No	No			Vesicles		"HPA047821: AB_2680168"	"unprognostic (2.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (2.92e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (3.83e-4)"	29.8	11.4	12.1	26.9	16.5	21.3	36.2	15.6	13.1	18.2	18.5	10.8	9.6	12.0	21.9	20.2	17.6	19.2	18.1	21.7	10.8	7.1	11.1	17.8	25.1	46.1	19.4	7.3	19.0	15.2	7.9	8.1	29.6	11.8	12.6	11.6	9.5	12.0	13.0	10.7	16.7	17.3	25.7	11.3	30.9	13.9	11.2	17.9	10.3	11.3	12.7	11.9	19.6	19.1	2.5	11.5	7.6	17.4	1.4	3.6	7.1	23.2	27.5	13.4	18.4	53.2	33.0	21.4	21.8	12.8	28.8	29.9	20.8	36.7	11.9	39.1	38.2	24.6	20.8	13.6	25.3	17.5	6.7	21.8	11.4	35.8	19.7	29.2	27.2	34.9	27.3	22.7	32.2	13.5	11.7	32.3	7.6	23.3	6.0	10.4	10.2	13.7	17.6	9.9	16.9	26.9	14.7	17.1	18.2	6.1	15.5	9.7	7.0	23.4	18.7	22.1	9.1	9.7	39.7	22.5	57.2	16.2	50.7	35.4	10.8	27.3	13.1	33.8	51.9	25.9	1.1	15.0	7.6	3.4	17.4	2.0	2.3	3.2	3.2	11.5	2.5	2.3	3.6	2.4	1.4	12.6	4.4	1.9	7.1	12.1	16.5	15.6	13.1	10.8	7.1	19.4	7.3	11.8	17.9	17.9	30.0	6.0	4.6	17.3	3.6	8.9	5.1	5.3	18.2	10.4	5.9	5.4	0.0	11.4	2.7	14.6	9.7	0.0	6.9	66.0	26.7	5.5	8.1	12.3	81.3	12.7	5.2	9.2	58.8	2.3	17.5	43.3	16.9	8.2	13.7	1.7	10.2	5.8	20.5	4.1	2.9	12.9	17.3	3.1	13.9	18.2	7.0	10.2	15.3	7.5
CCND1	"BCL1, D11S287E, PRAD1, U21B31"	ENSG00000110092	"Cyclin D1"	P24385	11	69641087-69654474	"Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, Transcription, Transcription regulation"	"Cyclin, Repressor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 534.1;Pancreatic endocrine cells: 367.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.0;myeloid DC: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 96.3;WM-115: 134.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000024, HPA027802"	Uncertain		Supported	Nucleoplasm		Yes	No			Nucleoplasm		"CAB000024: AB_563678, HPA027802: AB_2672390"	"unprognostic (4.90e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (5.51e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.53e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.84e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (4.39e-2)"	"unprognostic (2.61e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.40e-3)"	"unprognostic (2.57e-1)"	52.0	11.6	9.7	6.0	9.7	0.7	22.8	3.4	7.7	15.4	8.9	15.4	19.9	8.4	18.8	23.1	37.7	11.8	31.0	23.9	10.8	8.8	14.5	68.1	22.2	3.7	12.4	5.6	6.5	31.5	83.2	16.6	38.1	10.0	30.7	6.8	24.8	25.6	21.7	2.0	43.6	10.4	16.5	12.6	12.9	19.2	4.0	7.5	9.0	17.1	23.1	23.6	21.4	22.1	3.0	3.4	0.8	0.0	0.0	0.9	0.3	48.7	19.5	6.5	0.2	20.0	21.1	14.0	77.2	28.8	9.0	5.3	21.9	37.8	0.0	35.1	40.1	15.1	35.7	0.7	21.0	16.2	0.1	3.9	0.0	4.8	22.2	4.8	0.3	0.7	11.9	4.1	12.7	4.9	21.3	15.4	0.0	0.0	0.1	71.0	20.6	0.0	2.8	11.9	20.2	21.5	0.1	20.6	1.1	41.9	30.1	1.1	25.5	0.9	18.3	48.0	16.5	11.1	1.0	64.4	44.3	12.3	19.2	52.4	96.3	57.5	0.1	37.9	0.6	134.1	0.8	0.0	0.0	0.9	0.0	0.1	3.0	0.4	0.2	3.4	2.5	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.3	9.7	9.7	3.4	7.7	10.8	8.8	12.4	5.6	10.0	7.5	169.7	99.5	5.9	202.5	179.8	2.2	68.0	124.9	78.9	155.8	118.7	2.0	6.4	26.6	534.1	0.2	134.5	22.2	0.0	128.5	1.1	63.9	195.1	27.8	148.1	60.6	0.0	54.3	108.1	18.0	0.9	3.7	17.9	49.0	3.6	40.4	66.7	367.2	54.7	54.1	42.3	2.0	129.4	220.1	0.2	19.0	306.9	2.1	7.0	62.1	326.2
PTK6	BRK	ENSG00000101213	"Protein tyrosine kinase 6"	Q13882	20	63528001-63537370	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.0;intestine: 24.2;skin 1: 24.2"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 34.1;Enterocytes: 90.1;Mucus-secreting cells: 39.1;Paneth cells: 65.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 10.6;CAPAN-2: 20.4;HaCaT: 16.6;hTCEpi: 22.5;OE19: 27.4;RT4: 13.0;T-47d: 12.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB032952, HPA036070, HPA036071"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Plasma membrane, Cytosol"	"CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982"	"unprognostic (2.32e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.26e-9)"	"unprognostic (4.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.24e-2)"	0.7	0.0	0.4	5.3	0.4	0.0	1.7	0.4	0.4	7.6	18.1	0.5	0.8	13.6	0.6	0.5	44.0	0.0	11.7	0.4	0.4	0.0	0.8	1.7	1.1	0.4	0.4	0.4	0.4	1.4	0.0	0.4	0.6	0.4	2.2	7.4	0.4	7.6	0.4	0.4	24.2	24.2	0.9	0.4	0.4	12.5	0.4	0.4	0.4	0.4	18.9	17.2	6.5	15.0	1.3	4.5	1.2	2.4	0.3	1.9	0.9	10.6	1.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	20.4	0.0	3.6	0.0	0.0	16.6	0.0	0.0	0.0	2.6	0.2	0.0	4.3	0.0	0.0	0.0	3.4	0.0	22.5	0.0	0.1	0.1	0.0	0.0	0.1	1.2	0.1	5.9	0.0	0.1	0.1	27.4	7.7	0.0	0.6	0.2	0.0	13.0	0.1	1.1	1.2	4.0	0.0	0.0	12.5	0.8	0.1	0.1	0.2	0.4	0.1	0.2	0.0	0.0	0.2	0.2	0.5	1.2	2.4	0.4	0.5	1.7	1.9	1.2	0.4	0.1	4.5	1.3	0.4	0.6	1.2	0.3	1.3	0.3	0.5	0.9	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	11.9	34.1	0.0	2.8	5.3	2.0	0.4	12.7	9.4	17.0	0.0	2.0	0.2	0.0	1.4	0.0	0.3	90.1	0.0	1.4	0.1	0.4	1.3	9.2	1.5	0.7	0.0	5.2	0.6	4.1	0.0	0.3	2.8	0.0	0.0	39.1	2.4	10.3	65.1	0.0	0.1	3.9	0.0	0.4	0.2	0.2	13.6	0.1	0.0	18.8	13.8
ASF1B	FLJ10604	ENSG00000105011	"Anti-silencing function 1B histone chaperone"	Q9NVP2	19	14119509-14136956	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 39.2;lymphoid tissue: 45.1;testis: 45.2"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 35.5;Extravillous trophoblasts: 30.7;Spermatocytes: 54.1;Spermatogonia: 88.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 39.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 39.2"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA054036, HPA069385"	Enhanced		Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA054036: AB_2682350, HPA069385: "	"unprognostic (3.14e-1)"	"prognostic favorable (4.45e-5)"	"unprognostic (2.41e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (8.48e-3)"	"prognostic unfavorable (2.22e-16)"	"prognostic favorable (2.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.31e-2)"	1.3	1.6	0.7	15.1	1.3	10.0	0.9	0.3	0.8	2.0	7.2	0.8	1.1	4.9	0.9	1.9	9.3	0.7	3.0	1.2	0.6	0.4	1.5	1.4	3.1	11.5	0.9	0.3	1.0	0.8	0.0	0.9	3.8	0.9	0.9	7.6	0.7	2.0	0.3	0.7	2.9	5.2	1.5	1.0	6.4	3.1	45.2	0.6	45.1	0.7	6.4	14.0	1.9	2.9	0.8	0.8	39.2	5.2	1.0	3.3	2.0	28.6	11.1	17.5	13.3	1.7	1.6	7.6	15.2	12.5	28.6	36.2	11.5	14.1	27.4	14.0	7.7	12.1	17.6	18.6	10.6	22.5	24.3	13.4	25.9	23.5	8.0	0.1	17.4	16.2	0.3	0.7	16.0	5.5	3.2	11.1	20.0	22.3	38.4	14.0	32.6	35.3	14.8	8.0	30.2	27.1	34.1	25.9	22.6	8.9	12.4	21.4	7.8	18.0	13.3	7.6	4.9	10.0	18.0	5.4	16.6	10.3	41.9	25.1	20.6	20.8	35.0	13.2	32.0	16.1	0.4	4.0	1.0	1.4	5.2	0.8	0.8	1.2	1.5	0.8	0.8	0.7	1.3	39.2	1.0	5.1	0.3	3.3	2.0	0.7	1.3	0.3	0.8	0.6	0.4	0.9	0.3	0.9	0.6	0.0	1.1	4.5	2.3	2.3	0.0	0.4	2.5	0.0	1.2	0.0	0.0	9.2	0.0	1.3	35.5	0.1	2.9	23.3	1.1	30.7	0.4	0.8	4.6	0.0	17.8	0.0	1.2	0.6	7.1	22.9	0.0	4.2	1.7	1.8	3.4	0.4	0.8	2.9	0.7	0.0	0.7	0.0	0.2	54.1	88.8	1.0	8.7	4.4	7.1	0.9
PTPRK	R-PTP-kappa	ENSG00000152894	"Protein tyrosine phosphatase, receptor type K"	Q15262	6	127968779-128520674	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.3;naive B-cell: 4.8;naive CD8 T-cell: 1.6"	"Group enriched"	"Detected in many"	7	"B-cells: 4.8;T-cells: 1.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054056, HPA054822"	Uncertain		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		13000000	"Cell Junctions"	"Vesicles, Plasma membrane"	"HPA054056: AB_2682359, HPA054822: AB_2682614"	"unprognostic (3.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.79e-3)"	"unprognostic (4.95e-3)"	"unprognostic (1.89e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.33e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.32e-2)"	12.0	5.2	18.6	10.7	20.3	1.2	20.9	4.7	24.4	12.2	21.9	25.6	11.2	25.7	12.1	10.3	9.1	13.2	29.6	11.4	17.2	12.6	13.3	23.6	17.4	5.7	20.5	19.3	15.6	25.7	11.4	12.2	17.4	14.9	16.3	23.4	3.9	18.3	17.5	9.1	13.5	27.4	14.6	17.1	6.4	24.6	2.7	23.7	15.3	10.1	6.5	7.6	18.4	15.1	4.8	0.0	0.0	0.0	0.4	1.6	0.2	4.5	4.9	2.9	0.2	6.2	8.3	3.0	12.3	23.8	5.1	4.6	8.1	3.8	0.0	3.7	11.3	14.8	12.9	3.1	9.7	7.2	13.6	4.9	0.1	7.5	11.2	7.6	0.0	0.4	6.1	9.0	10.6	14.5	13.3	13.8	4.4	0.0	0.2	12.4	9.1	6.9	0.0	3.1	8.3	6.3	24.8	6.3	0.8	12.6	9.3	15.5	0.0	12.7	14.2	0.7	3.5	3.9	0.3	23.4	8.0	5.6	15.5	11.1	0.1	1.6	0.0	10.2	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	4.8	0.4	1.6	0.0	0.4	0.0	0.0	0.1	0.2	18.6	20.3	4.7	24.4	17.2	12.6	20.5	19.3	14.9	23.7	23.8	27.4	9.7	78.6	56.3	3.1	19.3	76.5	18.7	33.0	17.4	3.9	21.8	0.0	51.8	3.4	46.7	63.1	0.0	53.2	4.5	30.5	99.0	1.1	36.5	5.1	9.5	42.2	8.0	1.0	2.1	15.8	1.8	16.9	2.8	41.3	7.0	84.8	57.5	17.0	11.2	0.6	58.2	35.8	3.6	5.8	33.2	22.4	1.0	48.9	100.5
MBNL2	"MBLL, MBLL39"	ENSG00000139793	"Muscleblind like splicing regulator 2"	Q5VZF2	13	97221434-97394120	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062685			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062685: AB_2684834"	"unprognostic (8.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (6.37e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (1.00e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.17e-2)"	38.4	43.3	26.5	12.9	38.6	5.0	23.2	31.2	41.0	27.8	21.6	45.9	9.5	13.8	23.9	11.2	25.6	14.8	29.7	23.4	31.0	22.6	24.6	59.6	19.3	12.3	46.5	22.4	40.8	28.9	16.9	35.9	33.5	49.8	21.8	16.4	16.6	24.6	27.0	28.9	13.3	12.2	27.4	52.3	12.4	19.0	9.7	46.9	11.1	24.2	17.2	15.3	25.6	28.0	9.2	6.5	13.3	8.4	5.5	12.9	7.1	11.0	3.9	4.3	4.5	23.9	12.7	0.3	25.4	12.8	11.8	12.0	4.5	16.5	3.7	10.6	35.0	13.2	15.7	2.0	11.2	15.4	9.9	1.9	4.6	8.9	11.2	35.2	0.5	4.1	13.0	19.2	9.6	18.6	13.5	22.3	5.1	5.6	2.0	5.9	2.8	2.6	1.6	0.1	1.3	6.7	1.2	9.3	3.1	15.7	12.5	5.5	9.4	14.5	15.0	25.1	10.6	6.1	0.6	7.0	1.7	5.5	3.3	5.3	5.4	1.3	1.0	11.3	1.3	31.1	13.3	6.2	8.9	10.1	8.4	12.9	9.2	9.2	9.0	6.5	7.6	8.1	10.8	1.0	5.5	5.8	5.5	9.6	7.1	26.5	38.6	31.2	41.0	31.0	22.6	46.5	22.4	49.8	46.9	77.4	33.1	17.2	23.5	62.4	22.9	62.9	28.1	78.9	59.1	27.9	45.2	19.3	16.6	21.2	2.1	46.8	13.1	0.0	36.5	66.4	35.8	27.2	17.3	61.0	12.9	44.5	46.7	42.4	25.3	6.4	65.3	18.4	54.0	7.2	27.1	73.1	48.9	10.5	42.1	24.9	104.0	45.3	43.8	0.5	0.7	42.4	20.9	22.7	16.6	26.3
EPHX4	"ABHD7, EPHXRP, FLJ90341"	ENSG00000172031	"Epoxide hydrolase 4"	Q8IUS5	1	92029982-92063536	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 13.3;brain: 20.7"	"Cell type enhanced"	"Detected in some"	11	"Endothelial cells: 2.9;Melanocytes: 3.3;Muller glia cells: 8.1;Pancreatic endocrine cells: 3.0;Spermatocytes: 3.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 13.3"	"Lineage enriched"	"Detected in single"	24	"T-cells: 13.3"	"Cell line enhanced"	"Detected in some"		"A-431: 10.0;CAPAN-2: 8.8;EFO-21: 17.9;RPTEC TERT1: 24.8;U-251 MG: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035067	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA035067: AB_10601465"	"unprognostic (1.27e-1)"	"unprognostic (4.17e-2)"	"unprognostic (6.76e-3)"	"unprognostic (6.10e-8)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (5.36e-3)"	"unprognostic (2.72e-4)"	"unprognostic (4.85e-2)"	"unprognostic (9.44e-3)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.36e-6)"	"unprognostic (6.93e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.25e-1)"	1.0	1.3	5.8	1.3	14.1	0.3	3.2	1.7	20.7	2.4	1.0	0.3	0.1	1.6	1.7	1.3	2.1	1.3	1.2	1.2	3.3	2.4	0.9	0.4	1.5	0.7	3.1	9.8	0.6	0.3	0.5	1.3	1.9	4.4	2.2	1.4	1.5	0.4	4.1	0.4	0.6	0.9	2.5	1.1	0.4	0.5	2.6	2.1	0.0	3.9	0.0	0.7	1.9	0.4	0.1	0.0	0.0	0.0	0.5	13.3	1.4	10.0	0.3	2.0	0.0	0.0	0.0	0.5	0.2	3.7	0.3	0.2	0.0	8.8	0.0	17.9	0.0	2.7	0.1	0.3	0.8	0.3	0.0	5.4	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.4	0.0	0.0	6.5	3.1	0.0	0.0	0.0	0.3	0.6	1.4	0.3	1.9	0.0	3.5	0.3	0.2	0.0	24.8	2.0	1.2	1.5	6.1	0.0	1.8	0.1	0.0	1.4	0.1	0.0	0.0	0.0	7.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.3	0.0	2.3	0.1	1.7	3.3	0.0	0.0	0.4	3.4	0.0	0.5	0.0	0.0	0.0	1.4	5.8	14.1	1.7	20.7	3.3	2.4	3.1	9.8	4.4	2.1	0.0	0.0	0.0	0.1	0.1	0.8	1.2	0.0	0.0	1.2	0.0	2.0	0.4	0.0	0.3	1.3	2.9	0.0	0.0	0.7	0.6	0.5	0.2	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	8.1	3.0	0.0	0.0	0.0	1.8	0.0	0.8	3.8	0.7	0.4	0.0	0.0	0.0	0.3
ASCC1	"ASC1p50, CGI-18, Em:AC022392.3"	ENSG00000138303	"Activating signal cointegrator 1 complex subunit 1"	Q8N9N2	10	72096032-72217134	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"		Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038038, HPA057567"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038038: AB_10674544, HPA057567: "	"unprognostic (1.96e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.34e-2)"	"prognostic unfavorable (3.52e-4)"	"unprognostic (1.22e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.64e-2)"	17.2	23.3	23.2	13.3	25.9	10.9	20.9	27.4	23.8	21.2	12.4	25.7	19.6	9.5	16.9	21.3	16.4	17.2	16.0	26.4	24.7	21.6	18.6	24.3	12.7	19.8	35.2	14.9	21.9	24.8	19.3	22.0	14.5	28.2	15.4	12.9	13.1	11.9	19.5	25.7	14.8	12.5	18.0	35.4	16.9	13.7	20.9	34.5	20.8	17.8	9.4	20.9	18.0	15.7	24.9	22.9	25.4	14.9	19.7	24.2	14.6	13.4	17.7	13.5	25.5	18.7	19.6	10.3	8.2	17.6	14.0	17.3	19.2	48.6	18.2	16.9	11.9	10.2	17.5	10.8	16.5	15.2	12.8	9.6	11.4	14.6	17.7	16.9	12.5	12.1	18.4	36.2	15.0	21.1	19.4	17.1	20.1	15.8	22.7	14.9	12.8	16.4	17.3	7.1	9.8	4.3	9.3	10.9	13.3	24.1	9.1	12.8	9.2	11.4	29.4	22.2	12.0	10.1	8.5	16.2	7.1	13.5	5.6	8.6	14.1	18.2	22.0	11.4	28.6	5.5	16.5	14.9	25.4	14.5	14.7	14.4	24.3	17.2	15.2	15.1	24.9	24.2	21.9	9.4	19.7	11.5	22.9	21.6	14.6	23.2	25.9	27.4	23.8	24.7	21.6	35.2	14.9	28.2	34.5	8.9	4.3	18.4	13.0	5.6	11.5	19.7	5.1	5.3	7.9	12.2	13.7	14.9	19.9	17.7	22.1	10.8	4.5	23.3	17.8	16.4	12.8	6.0	12.7	17.7	15.8	23.8	3.5	7.4	28.5	10.0	19.0	7.9	18.6	27.9	4.9	17.7	13.3	4.5	19.4	9.2	13.9	12.9	17.9	28.9	20.6	6.0	12.7	16.6	4.7	8.2
S100P		ENSG00000163993	"S100 calcium binding protein P"	P25815	4	6693069-6697170	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 89.9;bone marrow: 42.8;stomach 1: 70.0;urinary bladder: 47.6"	"Group enriched"	"Detected in many"	5	"Syncytiotrophoblasts: 2319.4;Urothelial cells: 3591.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 564.7"					"Group enriched"	"Detected in some"	41	"basophil: 47.8;eosinophil: 24.8;neutrophil: 89.9"	"Lineage enriched"	"Detected in many"	68	"granulocytes: 89.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 28.5;Hep G2: 30.0;hTCEpi: 33.4;OE19: 130.4;RT4: 61.3;SK-BR-3: 34.3"									"HPA019502, HPA075251"	Enhanced		Supported	Nucleoplasm		NA	NA		1200000	Nucleoplasm		"HPA019502: AB_1856530, HPA075251: "	"unprognostic (1.46e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (3.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.12e-2)"	0.1	0.0	0.0	1.1	0.0	42.8	0.0	0.0	0.0	0.3	5.2			0.1	0.0	0.0	23.3	0.3	1.0	0.0	0.0	0.0	0.0	1.9	2.4	0.0	0.0		0.0	0.0	0.0	0.0	16.4		4.8	5.4		1.1	0.0	0.0	3.9	0.5	0.1	0.0	4.4	70.0	0.0			0.0		2.5	47.6	5.1	0.0	0.0	89.9	1.3	0.0	0.0	0.4	3.8	2.4	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.4	0.0	0.0	4.7	0.0	0.0	0.0	1.8	0.0	0.0	2.7	30.0	0.0	1.7	0.1	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.4	0.0	3.5	0.0	130.4	4.3	0.0	0.0	0.0	0.0	61.3	0.0	0.0	5.6	34.3	0.0	1.2	0.9	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	47.8	1.3	24.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.9	0.0	0.1	0.0	0.0	0.4											8.9	66.8	2.9	152.0	1.0	0.0	0.8	43.3	224.9	151.2	1.8	0.0	512.0	0.0	0.2	11.8	0.5	133.5	0.0	27.6	604.2	12.6	292.8	30.1	1.1	61.5	0.0	16.0	1.8	14.1	5.6	0.0	3.6	8.5	2.8	160.2	0.0	481.5	254.0	0.0	0.1	0.0	0.0	2.1	0.0	0.2	5.5	2319.4	2.2	48.0	3591.7
PTPN12	"PTP-PEST, PTPG1"	ENSG00000127947	"Protein tyrosine phosphatase, non-receptor type 12"	Q05209	7	77537275-77640071	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007097	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		1100000	"Plasma membrane, Cytosol"		"HPA007097: AB_1079689"	"unprognostic (2.28e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.48e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.27e-6)"	"unprognostic (4.99e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.21e-1)"	29.6	15.1	14.3	20.5	19.6	29.7	25.1	15.7	22.7	20.0	28.9	8.1	13.8	8.8	20.7	9.6	22.0	18.1	19.8	45.6	17.3	12.6	16.9	14.8	34.7	17.4	15.3	13.4	19.0	10.7	12.4	19.8	36.0	18.6	14.1	13.8	9.9	12.8	17.1	17.6	17.6	14.6	23.0	24.0	25.0	14.4	13.9	17.7	9.7	16.7	11.9	12.9	23.2	61.2	2.5	3.9	9.9	4.9	12.8	3.8	2.8	17.2	10.6	25.2	12.8	17.7	18.5	13.5	18.0	23.0	14.2	20.3	5.2	27.0	2.0	5.8	21.0	31.1	12.3	8.4	18.0	28.7	5.0	4.7	10.8	10.7	21.2	17.4	6.1	7.2	15.1	20.1	30.9	39.9	25.5	30.0	0.5	12.9	3.0	45.2	11.8	0.8	17.1	20.3	23.5	12.2	3.6	20.2	1.0	24.4	9.3	3.1	16.7	22.1	20.3	17.5	45.3	9.8	22.5	21.8	30.8	18.6	11.2	33.9	3.1	1.7	5.3	18.1	15.9	53.3	3.7	4.2	6.6	3.6	2.9	1.4	2.5	1.2	2.7	3.9	1.1	0.6	3.8	9.9	12.8	4.9	0.3	1.5	2.8	14.3	19.6	15.7	22.7	17.3	12.6	15.3	13.4	18.6	17.7	65.5	54.6	13.7	41.5	61.1	15.5	35.1	22.9	16.0	46.6	19.2	7.9	34.1	3.3	38.7	2.6	99.1	17.1	0.0	34.2	48.2	53.7	44.4	13.9	19.2	45.4	33.4	11.6	98.8	74.4	5.4	43.1	86.9	33.7	25.2	19.9	63.0	55.1	20.1	44.2	15.8	14.3	64.7	55.6	14.7	57.8	88.7	60.3	26.2	18.0	78.6
YAP1	YAP65	ENSG00000137693	"Yes associated protein 1"	P46937	11	102110461-102233423	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009370, HPA038885, CAB069915, HPA070359"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"CAB009370: AB_2273277, CAB069915: AB_922796, HPA038885: AB_2676255, HPA070359: AB_2732154"	"unprognostic (9.56e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (9.26e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-2)"	27.1	15.8	11.6	12.1	10.0	0.0	34.9	7.0	9.5	37.5	21.3	7.0	40.1	9.8	51.7	33.3	36.9	25.5	34.6	18.8	12.5	6.0	17.3	32.1	26.2	7.6	9.3	6.1	41.1	8.9	18.9	6.4	34.0	15.0	34.8	11.4	21.7	22.2	35.2	27.8	23.4	15.1	58.2	17.2	7.6	18.2	15.6	9.7	2.6	34.0	25.7	12.6	42.3	41.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	11.7	11.0	30.7	15.0	33.6	32.1	25.7	27.7	31.7	27.0	22.3	27.4	28.6	0.0	22.9	36.2	20.1	20.8	15.2	39.5	28.7	3.4	5.4	0.0	15.0	18.6	25.7	0.0	0.5	25.6	26.0	29.6	48.3	30.2	8.4	1.4	0.0	0.0	30.5	5.6	0.5	0.0	14.5	28.3	10.5	0.0	17.3	0.0	19.9	21.0	0.1	1.0	32.6	12.3	9.2	29.4	22.2	0.1	9.2	38.5	15.1	19.3	11.6	0.0	0.0	0.1	11.2	0.0	27.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	11.6	10.0	7.0	9.5	12.5	6.0	9.3	6.1	15.0	9.7	32.8	51.8	1.7	40.6	101.0	0.3	34.4	76.5	24.1	35.2	87.2	0.0	79.0	10.0	28.8	3.9	26.3	16.2	0.0	15.8	14.7	61.4	50.8	0.0	36.0	9.2	0.0	7.0	24.5	1.3	2.7	35.1	2.3	42.2	1.8	13.7	26.2	23.1	20.9	38.2	20.0	1.0	38.8	48.4	2.7	0.9	107.6	51.5	0.0	24.7	55.2
IGSF3	"EWI-3, MGC117164, V8"	ENSG00000143061	"Immunoglobulin superfamily member 3"	O75054	1	116574399-116667755	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 62.5;WM-115: 60.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036305, HPA036306"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036305: AB_2675050, HPA036306: AB_10671245"	"unprognostic (9.87e-2)"	"unprognostic (3.64e-1)"	"unprognostic (9.51e-2)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (4.03e-6)"	"unprognostic (9.40e-2)"	"unprognostic (4.41e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (4.18e-1)"	"prognostic favorable (2.87e-6)"	"unprognostic (5.29e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	1.4	1.5	1.9	1.2	5.1	0.1	7.7	2.5	8.3	5.8	5.7	1.5	3.0	6.7	2.5	6.5	22.0	1.7	3.5	7.9	1.8	2.8	10.7	0.8	7.4	0.3	1.8	2.8	0.7	4.5	1.4	2.7	42.9	4.1	5.1	5.1	7.8	9.3	5.5	1.1	16.1	12.9	2.4	1.7	0.5	7.3	3.6	0.9	6.2	8.1	9.0	9.3	8.2	9.8	0.0	0.2	0.3	0.6	0.0	0.7	0.2	5.4	9.3	7.2	1.8	1.6	3.5	19.3	0.0	0.2	0.7	0.2	5.3	3.1	0.0	2.9	0.0	4.0	15.2	3.2	7.5	0.3	62.5	2.3	2.9	3.6	0.1	0.0	0.2	5.7	0.4	5.9	0.0	1.3	1.3	0.0	1.0	0.9	0.0	0.1	19.1	0.2	0.1	4.5	3.3	0.2	2.2	8.8	0.0	5.5	6.8	4.2	12.8	2.2	21.5	13.7	14.4	7.2	0.3	0.0	1.2	4.3	0.0	5.6	0.0	0.3	0.0	0.5	0.1	60.3	0.0	0.6	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.2	1.9	5.1	2.5	8.3	1.8	2.8	1.8	2.8	4.1	0.9	14.9	25.2	0.0	7.0	17.4	1.9	14.4	12.7	8.1	5.7	14.0	0.0	10.1	3.3	13.2	1.8	2.1	14.7	0.0	1.7	24.6	6.6	7.2	1.1	0.0	1.9	6.4	2.9	1.8	1.6	2.1	1.1	0.9	8.5	5.4	5.5	12.8	11.2	8.6	0.0	11.3	0.5	0.0	2.1	0.5	4.3	24.2	11.1	0.0	7.1	9.6
S100A16	"DT1P1A7, MGC17528, S100F"	ENSG00000188643	"S100 calcium binding protein A16"	Q96FQ6	1	153606886-153613145	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 223.9;tongue: 102.1"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 744.7;Glandular cells: 697.0;Pancreatic endocrine cells: 790.1;Suprabasal keratinocytes: 794.3;Urothelial cells: 1359.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 2.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 117.9;SK-BR-3: 142.9"	"Low region specificity"	"Detected in all"							HPA045841	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		92000	Cytosol	"Plasma membrane"	"HPA045841: AB_10966282"	"unprognostic (9.86e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (3.18e-4)"	"prognostic unfavorable (3.14e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.59e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.91e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.29e-3)"	20.1	5.5	9.3	8.0	7.2	0.0	11.9	3.4	8.3	37.2	21.1	8.3	3.2	16.2	8.7	7.2	223.9	7.6	18.2	9.5	6.7	5.4	14.3	27.0	18.3	7.5	7.1	5.7	15.3	4.1	6.5	3.3	14.9	7.2	9.3	14.5	5.1	35.5	5.4	9.8	43.1	31.2	10.6	5.9	13.4	10.6	12.3	4.6	3.2	11.3	102.1	87.5	11.3	51.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	56.4	27.2	1.4	3.2	9.4	35.7	3.7	32.3	29.7	26.6	23.6	25.5	31.6	0.0	51.9	48.3	6.0	41.5	0.0	72.5	15.6	0.1	0.0	0.0	23.7	7.5	10.8	0.0	0.0	16.9	69.7	64.4	50.7	34.8	117.9	0.0	0.6	0.0	58.5	75.0	0.0	0.1	6.0	100.1	73.6	0.0	16.4	0.1	100.2	20.3	0.0	0.1	23.8	142.9	4.7	12.9	44.4	0.3	63.2	16.0	25.6	15.4	73.0	0.0	0.2	0.1	47.6	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	9.3	7.2	3.4	8.3	6.7	5.4	7.1	5.7	7.2	4.6	35.7	18.0	15.1	744.7	563.0	0.4	29.7	119.8	26.8	103.5	102.9	2.0	12.3	61.3	584.7	3.2	283.5	336.2	0.0	172.2	7.2	105.8	697.0	19.5	109.5	4.7	0.0	133.3	333.3	22.5	10.0	62.2	11.1	106.3	12.6	178.6	38.3	790.1	294.7	57.7	126.7	1.8	6.5	41.5	1.7	1.2	794.3	6.9	12.8	201.3	1359.9
PATL1	"FLJ36874, Pat1b"	ENSG00000166889	"PAT1 homolog 1, processing body mRNA decay factor"	Q86TB9	11	59636716-59668980	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039030, HPA074680"	Approved		Supported	"Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"		"HPA039030: AB_10673232, HPA074680: "	"unprognostic (3.00e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (4.56e-4)"	"unprognostic (3.93e-3)"	"unprognostic (3.03e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.37e-3)"	"unprognostic (6.74e-3)"	"unprognostic (2.16e-1)"	"unprognostic (7.34e-3)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (3.86e-2)"	"unprognostic (4.54e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.04e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.18e-1)"	17.8	17.7	12.8	23.2	17.3	41.3	17.5	18.3	16.2	16.2	19.6	15.1	10.8	18.5	17.6	15.3	18.8	12.7	14.7	16.3	11.8	8.9	17.7	27.6	20.5	15.7	16.9	9.1	20.2	11.4	14.1	14.7	27.1	14.1	12.2	17.9	14.0	16.5	17.2	37.3	18.2	19.3	15.8	15.4	17.8	13.9	11.1	16.5	19.2	15.0	17.2	19.7	18.9	27.5	4.8	5.3	8.2	6.7	3.8	6.8	3.1	22.9	18.0	13.3	13.0	13.1	14.8	11.5	15.3	26.4	27.8	28.0	11.6	20.3	22.7	15.0	16.4	26.9	17.3	19.3	18.4	29.9	19.7	8.8	13.0	8.8	11.5	47.3	17.1	29.1	16.7	14.2	23.8	32.8	13.4	13.2	14.1	16.0	18.5	15.7	10.7	16.4	15.6	13.5	16.9	11.9	13.4	22.3	9.7	17.2	21.6	9.6	9.2	21.6	16.3	26.4	11.7	23.1	12.7	12.8	18.2	16.7	31.5	13.5	19.1	21.0	19.6	21.9	14.4	14.9	3.9	5.5	7.6	6.8	6.7	5.7	4.8	5.3	6.0	5.3	4.0	5.4	5.1	8.2	3.8	6.5	3.5	4.3	3.1	12.8	17.3	18.3	16.2	11.8	8.9	16.9	9.1	14.1	16.5	3.0	15.7	10.7	16.9	24.0	9.0	12.5	20.4	13.4	18.2	10.4	0.0	9.5	11.6	12.5	3.5	16.5	16.8	0.0	16.0	11.3	11.6	17.1	22.0	29.7	20.2	6.4	13.1	12.9	25.1	3.3	10.0	21.1	10.1	19.8	15.5	7.8	17.6	11.5	8.9	6.8	10.4	6.5	11.7	11.8	8.3	29.7	10.6	17.3	14.5	16.6
S100A2	"CAN19, S100L"	ENSG00000196754	"S100 calcium binding protein A2"	P29034	1	153561108-153567890	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 224.8;tongue: 246.5"	"Cell type enhanced"	"Detected in many"	20	"Basal glandular cells: 2667.8;Basal keratinocytes: 10183.7;Suprabasal keratinocytes: 3170.0;Urothelial cells: 4604.3"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 1229.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 11.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.9"	"Group enriched"	"Detected in some"	5	"HBEC3-KT: 671.5;RT4: 262.5"					"Not detected"	"Not detected"			"CAB002600, CAB047340, HPA062451"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		NA	NA		130000	"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"CAB002600: , CAB047340: , HPA062451: AB_2684767"	"unprognostic (8.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.21e-4)"	"unprognostic (9.00e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (3.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	0.4	0.0	0.4	0.5	0.4	0.0	2.1	0.4	0.5	16.9	0.4	0.4	0.9	0.0	1.8	1.9	224.8	0.5	0.4	0.4	0.4	0.0	16.6	0.4	1.6	0.4	0.4	0.4	0.4	0.4	0.0	0.5	0.6	0.6	3.3	0.0	0.4	23.3	2.1	0.7	27.5	0.4	1.5	0.5	0.4	0.0	0.5	0.4	0.7	1.0	246.5	48.4	36.2	43.8	0.5	2.6	11.9	0.6	0.0	2.9	0.7	25.4	0.2	0.0	0.0	0.3	0.1	0.0	0.3	0.3	0.2	0.2	0.0	0.8	0.0	13.5	0.5	0.5	63.2	0.0	671.5	0.3	0.1	0.1	0.1	1.7	0.1	0.1	0.0	0.0	0.2	89.4	0.7	102.0	0.7	0.4	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.6	4.9	0.0	16.0	0.0	15.9	262.5	0.5	0.0	1.1	0.1	0.2	0.2	0.1	0.1	0.1	0.4	22.2	2.9	8.6	0.0	0.0	0.1	0.8	0.0	0.7	11.9	0.5	0.0	2.9	0.0	1.8	0.5	2.0	1.6	0.4	0.0	0.6	0.5	5.0	0.0	0.6	2.6	1.8	0.7	0.4	0.4	0.4	0.5	0.4	0.0	0.4	0.4	0.6	0.4	8.9	15.9	2.2	2667.8	10183.7	0.0	2.0	2.5	307.9	1714.1	207.6	0.0	0.1	1039.5	26.2	3.0	3.6	1.3	0.0	24.2	0.9	117.2	609.3	16.2	0.0	1.8	0.0	1.7	0.6	1.5	3.8	0.6	38.5	720.4	9.0	1.7	1.0	390.7	2.9	0.7	9.8	0.0	0.0	213.2	0.2	2.3	3170.0	0.2	1.3	1.5	4604.3
ESRP1	"FLJ20171, RBM35A"	ENSG00000104413	"Epithelial splicing regulatory protein 1"	Q6NXG1	8	94641074-94707466	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 65.1"	"Cell type enhanced"	"Detected in many"	6	"Mucus-secreting cells: 101.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"MAIT T-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"A-431: 33.3;BEWO: 25.6;CAPAN-2: 35.1;HaCaT: 20.4;hTCEpi: 57.4;OE19: 34.8;RT4: 24.4;T-47d: 27.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA023719, HPA023720, HPA067104"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA023719: AB_1856124, HPA023720: AB_1856125, HPA067104: AB_2685779"	"prognostic unfavorable (9.28e-4)"	"unprognostic (7.12e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.12e-1)"	"unprognostic (6.99e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.61e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (4.48e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.29e-1)"	0.6	0.5	0.5	15.1	0.5	0.0	7.6	0.5	0.6	9.7	18.1	0.2	18.7	7.7	3.3	21.3	43.1	6.6	14.5	0.6	0.5	0.5	6.4	0.7	15.5	0.8	0.5	0.2	1.8	65.1	11.8	10.1	18.5	0.3	8.9	20.8	0.2	38.2	15.1	0.5	24.8	12.7	1.9	0.5	0.5	12.1	1.0	0.2	1.4	20.2	30.4	28.9	9.0	16.8	0.0	0.0	0.0	0.0	0.0	1.9	0.0	33.3	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	10.9	35.1	0.0	0.9	0.0	0.0	20.4	0.9	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.4	0.0	0.3	0.0	0.0	2.6	0.0	0.0	0.0	16.2	0.4	0.1	3.1	34.8	0.8	0.0	0.0	4.4	4.4	24.4	8.9	0.0	0.0	5.2	3.3	5.6	27.1	0.2	0.0	0.0	0.0	0.0	0.0	3.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.6	0.5	0.5	0.5	0.2	0.3	0.2	35.7	23.4	0.5	19.5	39.6	0.0	0.7	20.4	30.8	22.7	26.2	0.0	45.8	11.6	18.7	5.9	0.0	53.4	0.0	24.0	54.1	2.0	25.5	1.1	0.0	5.1	0.0	31.9	0.0	0.0	6.8	0.0	0.6	23.6	1.0	101.9	0.0	21.5	42.1	0.7	0.3	0.0	0.0	0.9	0.2	0.7	69.3	51.9	0.0	68.9	33.0
EIF2AK2	"EIF2AK1, PKR, PPP1R83, PRKR"	ENSG00000055332	"Eukaryotic translation initiation factor 2 alpha kinase 2"	P19525	2	37099210-37157065	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003845, HPA019795, HPA063893"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"CAB003845: AB_562332, HPA019795: AB_1848060, HPA063893: AB_2685144"	"unprognostic (1.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.77e-3)"	"unprognostic (8.42e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.65e-2)"	"unprognostic (5.32e-2)"	25.5	14.2	15.9	16.3	15.5	36.4	13.9	16.4	19.0	14.7	13.7	9.9	9.3	14.5	17.2	21.5	12.1	12.8	15.4	10.7	13.7	19.2	12.2	11.5	13.7	10.7	14.3	15.0	18.7	11.7	19.2	21.1	18.2	17.3	15.0	12.8	10.2	23.0	17.8	7.1	6.7	15.2	16.2	14.0	15.5	14.3	5.1	12.8	14.1	13.6	8.1	10.6	14.8	15.5	8.8	6.9	27.6	10.8	8.6	9.9	3.3	23.3	12.0	7.4	9.3	8.1	11.2	14.6	12.3	17.7	39.0	37.6	13.7	13.9	12.5	16.1	13.5	46.4	13.9	12.7	12.5	17.5	27.4	6.7	13.7	9.1	8.9	8.0	13.0	0.1	9.1	4.9	15.6	11.3	6.8	9.7	5.5	9.5	12.6	8.8	10.4	16.7	6.7	7.7	3.9	8.6	16.9	18.1	6.2	7.3	9.0	8.3	8.8	15.1	11.0	23.7	6.5	5.6	3.7	12.5	15.8	16.8	6.8	19.8	9.3	15.3	0.2	7.6	8.9	13.8	17.1	8.2	11.1	8.9	10.6	9.0	8.8	7.5	8.1	6.9	7.0	6.1	7.5	27.6	8.6	10.8	4.7	9.9	3.3	15.9	15.5	16.4	19.0	13.7	19.2	14.3	15.0	17.3	12.8	62.5	27.7	15.7	36.6	17.3	37.2	25.3	33.1	53.5	58.0	21.0	13.7	40.9	18.3	31.1	1.7	56.2	26.2	0.0	42.4	72.4	35.3	31.0	39.4	15.8	34.3	44.5	14.5	29.4	21.6	2.1	52.9	24.7	20.3	23.4	22.2	48.9	41.0	24.6	79.2	28.5	24.1	38.8	34.2	2.6	3.4	8.8	34.1	30.2	26.2	36.3
CENPU	"CENP-50, CENP-U, KLIP1, MLF1IP, PBIP1"	ENSG00000151725	"Centromere protein U"	Q71F23	4	184694618-184734133	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.7;lymphoid tissue: 30.0;testis: 50.2"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 353.4;Late spermatids: 668.4;Spermatocytes: 448.9;Spermatogonia: 166.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 14.1;eosinophil: 14.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 58.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA022048			Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Nucleoplasm, Centriolar satellite"		"HPA022048: AB_1853985"	"unprognostic (1.47e-1)"	"unprognostic (9.88e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.97e-2)"	"unprognostic (4.39e-3)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.67e-3)"	"unprognostic (3.34e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (7.27e-2)"	"prognostic unfavorable (1.11e-9)"	"unprognostic (2.19e-2)"	"unprognostic (7.40e-3)"	"unprognostic (4.46e-2)"	"unprognostic (2.74e-1)"	2.7	1.7	1.4	7.8	1.0	30.7	3.1	1.2	1.3	2.8	4.4	1.2	2.9	2.8	1.4	3.2	11.2	0.9	1.7	1.0	1.2	0.6	1.4	2.3	2.0	9.5	1.3	0.2	1.1	1.3	0.7	0.6	7.0	1.0	2.0	5.1	0.9	3.5	0.5	1.2	7.1	5.2	1.5	1.0	5.8	2.3	50.2	0.6	30.0	0.9	7.3	9.1	1.6	4.5	0.8	1.7	14.3	2.8	3.0	2.5	0.7	23.3	6.6	28.4	14.3	1.5	2.5	15.1	14.1	6.3	11.6	8.0	7.9	13.5	19.5	1.3	6.6	8.9	9.4	23.4	14.4	11.8	9.4	9.3	16.8	6.0	4.0	0.2	29.6	11.7	1.2	0.7	14.2	2.7	3.9	12.0	20.2	18.4	58.6	21.6	15.5	38.0	18.9	15.0	5.6	8.9	30.1	9.2	5.7	6.4	9.0	20.1	21.4	10.2	13.1	10.7	12.1	18.0	16.2	7.2	10.4	13.5	10.6	16.2	8.7	8.7	16.0	14.5	23.0	33.9	14.1	0.7	14.3	0.6	1.9	0.4	0.8	1.0	1.0	0.5	0.8	0.6	0.8	0.1	3.0	2.8	1.7	2.5	0.7	1.4	1.0	1.2	1.3	1.2	0.6	1.3	0.2	1.0	0.6	8.9	2.7	6.0	3.6	12.4	0.9	2.4	2.5	6.7	10.3	1.8	0.0	13.0	3.3	4.4	353.4	0.7	1.1	23.3	2.2	45.0	5.2	2.9	9.2	0.8	18.2	0.0	0.0	1.3	5.4	668.4	8.3	9.9	0.0	7.2	5.6	0.3	2.7	0.0	6.3	0.6	1.3	19.4	1.0	448.9	166.7	18.7	6.3	4.4	8.5	5.4
SLC16A1	"MCT, MCT1"	ENSG00000155380	"Solute carrier family 16 member 1"	P53985	1	112911847-112957013	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 149.2;Muller glia cells: 221.8;Rod photoreceptor cells: 246.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003324, CAB017489, HPA071055, CAB079035"	Enhanced	Supported	Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: AB_2686337"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (1.53e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavorable (4.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-3)"	11.6	7.2	17.4	8.7	19.5	3.1	4.4	10.0	24.0	4.6	23.4	12.7	3.3	18.4	19.3	15.1	10.4	8.7	8.3	39.0	19.5	12.3	6.5	26.9	3.2	5.8	19.2	6.5	6.0	1.9	5.6	3.7	18.8	16.6	8.3	18.1	22.8	2.5	6.5	31.4	7.5	9.5	20.0	16.1	4.8	14.5	17.9	22.5	4.9	5.4	17.7	6.2	9.6	6.2	3.0	5.9	0.6	3.2	2.0	11.4	2.4	20.2	4.7	14.6	12.4	10.1	8.6	48.0	10.9	8.3	8.6	13.9	16.0	11.8	22.2	15.3	9.9	6.4	19.4	20.4	20.3	16.3	13.9	20.7	18.2	12.9	18.6	17.9	23.2	1.9	12.0	24.9	12.7	25.0	13.9	20.8	11.6	23.0	14.8	9.6	3.9	13.6	11.7	47.2	5.6	15.2	12.2	23.0	15.3	10.6	0.4	16.2	8.5	21.2	0.6	16.2	21.9	0.9	8.8	14.0	8.3	14.6	16.3	16.1	7.8	6.8	22.4	24.1	14.7	10.2	0.6	3.2	0.0	4.1	2.6	6.3	3.0	4.1	4.4	5.9	2.1	4.4	3.8	0.3	2.0	0.7	1.0	11.4	2.4	17.4	19.5	10.0	24.0	19.5	12.3	19.2	6.5	16.6	22.5	0.0	1.6	15.2	6.7	79.3	17.1	109.7	5.1	0.0	1.2	0.0	149.2	57.9	0.0	2.0	102.1	20.4	27.6	0.0	2.9	62.5	30.5	13.5	9.2	34.7	13.7	19.1	3.4	8.0	9.1	75.6	10.9	4.8	37.1	1.8	14.9	221.8	5.1	5.7	7.1	10.2	246.9	0.0	20.6	35.1	10.2	34.5	38.4	6.9	13.6	0.9
DIAPH2	"DIA, DIA2, POF, POF2"	ENSG00000147202	"Diaphanous related formin 2"	O60879	X	96684663-97604997	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Oogenesis"	"Developmental protein"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 117.7;Syncytiotrophoblasts: 99.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005647, CAB015461, CAB068183, CAB068184"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum, Vesicles"	Nucleoli	"CAB015461: AB_831223, CAB068183: AB_2665693, CAB068184: AB_2665694, HPA005647: AB_1078657"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (2.16e-5)"	"unprognostic (1.58e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (6.44e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.99e-3)"	"unprognostic (6.08e-3)"	25.3	5.7	8.2	16.5	13.6	19.9	12.0	1.6	4.6	17.8	18.5	2.9	15.1	5.5	10.7	9.1	16.3	10.4	12.6	13.0	6.6	3.0	6.1	15.7	16.8	6.9	4.1	4.4	14.2	6.6	8.7	5.5	37.2	7.1	16.0	11.4	4.7	9.4	17.2	19.9	9.3	12.0	18.5	7.3	9.8	9.9	12.3	5.1	9.4	7.5	12.0	4.9	19.8	26.9	2.7	4.3	5.7	5.8	1.4	2.8	1.0	0.0	4.0	1.9	3.9	11.1	18.5	0.0	7.0	7.4	3.8	8.0	3.3	7.6	11.3	5.6	6.0	7.2	0.0	10.4	1.1	4.9	0.3	5.9	0.0	4.9	3.6	9.3	14.6	5.2	9.3	3.7	5.0	15.8	5.1	7.3	8.5	0.0	9.4	7.0	3.2	5.5	6.0	15.4	0.0	5.9	0.0	10.5	0.0	2.1	6.0	0.0	4.0	0.0	2.0	5.6	12.5	1.7	8.0	9.1	8.1	3.7	6.7	4.5	0.1	0.0	9.5	6.8	14.9	4.7	0.0	5.8	5.7	2.3	5.4	1.8	2.7	2.4	2.8	4.3	2.4	1.6	1.5	0.6	1.4	4.5	4.1	1.3	1.0	8.2	13.6	1.6	4.6	6.6	3.0	4.1	4.4	7.1	5.1	29.8	42.7	10.6	4.8	9.6	5.7	19.0	7.6	42.8	18.2	19.2	0.0	41.5	6.6	16.9	60.0	25.2	23.6	0.0	20.1	14.6	25.5	6.7	7.0	23.1	17.8	0.0	23.6	8.0	30.6	117.7	41.7	21.4	8.5	6.4	27.6	12.5	26.4	35.1	19.1	6.1	14.0	25.8	18.6	4.9	12.2	15.9	99.0	12.5	28.1	4.8
BATF2	MGC20410	ENSG00000168062	"Basic leucine zipper ATF-like transcription factor 2"	Q8N1L9	11	64987943-64997045	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 8.4;Mucus-secreting cells: 8.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 6.6;neutrophil: 9.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 9.6;monocytes: 6.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 11.4;BJ hTERT+ SV40 Large T+ RasG12V: 17.5;GAMG: 15.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062496	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA062496: AB_2684783"	"unprognostic (5.29e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.08e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (9.39e-5)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (1.28e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.34e-3)"	"unprognostic (3.17e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.12e-2)"	2.8	5.3	2.4	8.3	3.3	0.4	3.2	1.0	3.4	2.0	8.9	1.9	7.2	8.8	2.1	2.8	2.3	2.9	9.3	2.2	1.9	1.7	10.0	5.4	7.8	2.7	2.2	2.4	3.2	17.3	0.7	3.1	3.0	5.9	7.9	6.7	4.2	14.0	5.1	4.8	0.5	14.0	2.7	2.1	18.7	5.1	0.9	1.7	0.9	16.5	1.0	3.4	3.9	1.2	1.3	0.3	9.6	6.6	0.1	0.1	0.9	1.2	0.8	0.1	0.0	0.1	0.5	0.0	0.4	5.4	11.4	17.5	1.5	4.7	0.0	2.2	0.7	15.6	0.1	0.0	1.3	0.8	0.1	0.3	1.6	0.0	3.9	4.3	0.0	1.0	0.3	0.4	1.5	1.9	0.4	2.7	0.1	3.4	0.1	0.2	0.3	0.0	0.1	0.3	0.0	0.5	0.0	1.1	0.4	1.4	0.1	0.1	0.0	0.4	0.3	5.4	0.1	0.5	0.8	2.0	0.6	0.6	1.0	0.0	0.0	0.1	0.4	0.9	0.5	0.5	0.0	2.6	1.1	0.0	6.6	0.0	1.3	0.0	0.1	0.3	0.4	0.0	0.0	9.6	0.1	3.1	0.0	0.0	0.9	2.4	3.3	1.0	3.4	1.9	1.7	2.2	2.4	5.9	1.7	3.0	1.3	3.7	0.6	0.0	0.0	0.5	5.1	4.0	2.3	1.8	0.0	0.0	1.7	4.6	0.9	1.5	8.4	0.0	5.8	0.2	0.9	0.2	0.0	0.8	3.8	0.0	2.4	5.5	2.7	1.7	0.0	1.0	0.0	1.0	8.0	0.8	4.6	7.0	0.7	3.3	0.1	0.0	1.5	0.1	0.6	0.0	0.0	0.0	6.3	1.1
RAB27B		ENSG00000041353	"RAB27B, member RAS oncogene family"	O00194	18	54717860-54895516	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0;stomach 1: 36.6"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 200.3;granulocytes: 234.0;Late spermatids: 149.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 4.6;NK-cell: 5.0"	"Group enriched"	"Detected in many"	4	"NK-cells: 5.0;T-cells: 4.6"	"Cell line enhanced"	"Detected in many"		"HEL: 20.9;hTCEpi: 16.0;hTERT-HME1: 19.4;U-87 MG: 56.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017712, HPA019849"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		37000000	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB017712: , HPA019849: AB_1856000"	"unprognostic (1.59e-1)"	"unprognostic (5.20e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.51e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.75e-1)"	"unprognostic (1.29e-1)"	1.1	2.4	13.8	2.3	11.3	1.0	10.8	0.8	30.0	4.5	4.4	0.3	0.0	4.5	1.1	0.7	17.0	1.3	9.8	0.9	12.0	7.9	0.8	1.4	6.2	0.7	4.6	18.4	0.7	5.3	1.3	3.6	2.4	8.6	18.0	4.8	0.0	12.8	3.3	0.6	13.2	4.3	1.1	2.1	1.8	36.6	4.8	0.4	0.1	0.7	13.9	5.9	6.8	7.1	0.0	0.0	1.1	0.0	5.0	4.6	3.4	2.5	7.4	0.2	0.0	0.5	6.8	0.0	0.5	4.5	0.6	0.4	0.0	2.9	0.4	0.0	1.3	5.8	4.9	0.0	3.0	0.1	0.0	0.2	20.9	1.8	0.0	0.9	1.1	2.3	5.4	16.0	8.8	19.4	7.3	0.2	0.1	0.0	1.3	5.5	2.5	0.0	2.4	0.1	4.6	5.0	0.0	0.0	0.1	1.4	9.6	0.0	3.6	0.7	4.5	0.0	0.0	2.8	0.1	0.1	6.5	0.2	3.3	0.6	0.1	0.0	0.0	56.8	11.9	0.3	1.1	0.0	0.2	4.6	0.0	1.1	0.0	1.5	2.3	0.0	0.0	0.6	2.3	0.5	5.0	0.0	0.0	0.0	3.4	13.8	11.3	0.8	30.0	12.0	7.9	4.6	18.4	8.6	0.4	44.7	32.8	0.0	6.7	22.8	1.7	0.4	15.3	6.7	21.6	5.2	2.0	5.4	1.7	5.2	200.3	0.7	3.1	0.0	35.6	4.0	2.5	73.1	234.0	0.8	0.6	6.4	4.1	3.1	0.8	149.0	2.0	2.4	6.8	1.8	17.2	1.3	24.0	17.5	0.4	0.0	0.4	6.5	1.3	2.2	1.2	43.0	2.4	20.1	8.1	27.8
SLC38A5	"JM24, SN2"	ENSG00000017483	"Solute carrier family 38 member 5"	Q8WUX1	X	48458537-48470256	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pancreas: 87.7"	"Cell type enhanced"	"Detected in many"	14	"Exocrine glandular cells: 67.4;Pancreatic endocrine cells: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 35.6;HBEC3-KT: 54.3;HeLa: 53.5;hTCEpi: 40.4;Karpas-707: 47.8;RPMI-8226: 87.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047411	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	Cytosol	"HPA047411: AB_10964355"	"unprognostic (2.81e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.75e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.27e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.20e-1)"	1.5	0.9	5.3	4.7	7.1	17.3	0.9	3.5	11.6	4.0	4.9	7.7	0.1	5.1	1.8	1.3	3.7	2.0	1.5	2.4	6.9	5.7	0.7	0.4	9.4	3.3	7.0	2.7	3.7	87.7	0.4	0.4	2.8	14.6	5.1	6.4	1.5	4.4	3.7	0.4	8.0	3.5	2.8	7.3	4.8	4.5	0.5	4.6	2.4	7.9	3.6	3.4	4.8	3.1	7.4	8.3	0.3	0.4	5.4	16.2	5.7	23.0	0.0	0.0	0.2	0.4	2.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	24.2	0.0	10.2	0.0	35.6	27.6	54.3	0.0	7.7	0.0	13.1	53.5	16.6	4.0	26.8	0.0	3.8	40.4	0.5	0.1	0.0	0.4	5.9	24.1	47.8	5.4	0.0	5.8	9.3	12.5	0.0	0.1	21.3	0.1	87.9	0.0	0.0	2.2	0.1	0.0	0.1	0.0	0.1	0.0	1.1	0.7	0.1	0.0	0.0	0.0	0.0	0.1	8.7	0.2	0.1	0.1	0.0	0.2	0.2	11.5	0.4	16.2	7.4	12.6	10.8	1.5	4.7	6.0	7.7	0.3	5.4	0.0	8.3	13.0	5.7	5.3	7.1	3.5	11.6	6.9	5.7	7.0	2.7	14.6	4.6	0.0	1.1	0.8	1.6	23.7	0.6	0.4	0.0	1.4	0.0	5.2	17.7	0.1	0.0	4.9	0.4	3.1	2.3	23.3	67.4	0.4	5.6	0.9	4.6	0.4	2.5	0.0	0.0	0.0	0.0	0.7	2.3	1.1	8.5	2.8	12.3	0.0	93.7	3.5	1.1	0.0	0.2	0.0	1.0	0.0	0.0	7.4	0.0	8.5	19.1	0.9
KIF18B		ENSG00000186185	"Kinesin family member 18B"	Q86Y91	17	44924709-44947711	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 12.3;lymphoid tissue: 34.7"	"Cell type enhanced"	"Detected in some"	10	"Cardiomyocytes: 1.6;Extravillous trophoblasts: 3.6;Hofbauer cells: 1.9;Kupffer cells: 1.8;Spermatogonia: 2.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA024205	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends,Cytosol"		Yes	Yes			"Nucleoplasm, Microtubule ends"	"Nuclear bodies, Cytosol"	"HPA024205: AB_1852472"	"unprognostic (1.88e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.17e-1)"	"unprognostic (7.27e-3)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (3.34e-3)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (8.18e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.69e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.68e-2)"	0.7	0.6	0.5	8.2	0.4	12.3	0.4	0.4	0.5	0.9	1.6	0.3	0.7	2.9	0.5	0.6	3.2	0.3	1.3	1.5	0.5	0.5	0.5	0.7	0.8	5.9	0.6	0.1	0.6	0.4	0.0	0.4	1.9	0.2	0.5	1.5	0.1	0.7	0.1	0.4	2.9	2.5	0.8	0.4	1.7	1.5	3.8	0.1	34.7	0.4	2.7	7.6	0.7	1.1	1.1	0.8	2.0	0.6	1.0	1.4	0.4	14.4	18.8	16.2	15.1	0.4	1.4	13.6	12.4	4.6	15.6	12.3	15.6	12.5	12.8	5.3	4.7	10.0	15.9	11.1	5.0	7.9	26.3	16.6	16.5	21.2	9.6	0.0	13.6	14.5	0.3	0.2	13.5	5.4	2.1	7.9	13.3	12.4	21.8	8.0	11.2	25.3	13.4	11.9	13.1	13.0	19.4	24.7	8.5	2.5	7.9	12.2	11.8	8.3	7.5	4.6	7.8	14.1	9.7	5.2	23.3	23.1	13.7	26.0	7.0	6.9	15.7	7.5	10.4	15.0	1.8	0.6	0.4	0.5	0.3	0.4	0.8	0.7	0.5	0.3	1.1	0.4	0.5	2.0	1.0	0.3	0.8	1.4	0.4	0.5	0.4	0.4	0.4	0.5	0.5	0.6	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.4	0.1	0.0	0.0	1.9	0.0	0.0	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.6	2.5	0.4	0.7	0.5	0.6	0.1
B3GNT3	"B3GN-T3, B3GNT-3, beta3Gn-T3, HP10328, TMEM3"	ENSG00000179913	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3"	Q9Y2A9	19	17794828-17813082	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 69.9;intestine: 61.6;placenta: 56.0"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 53.5;Cytotrophoblasts: 51.9;Enterocytes: 58.5;Mucus-secreting cells: 40.2;Paneth cells: 42.5;Syncytiotrophoblasts: 57.1;Urothelial cells: 43.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"memory CD4 T-cell: 2.7;memory CD8 T-cell: 1.1;naive CD4 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	32	"T-cells: 3.2"	"Cell line enhanced"	"Detected in some"		"A-431: 16.5;BEWO: 16.3;CAPAN-2: 44.2;OE19: 40.5;RT4: 15.8;SK-BR-3: 15.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA024298	Enhanced				"Intracellular and membrane"	NA	NA					"HPA024298: AB_1845236"	"unprognostic (1.10e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.84e-3)"		"unprognostic (1.10e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (3.26e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.57e-2)"	0.4	0.2	0.2	8.7	0.3	0.0	1.8	0.2	0.3	3.5	25.3	0.0	12.0	16.6	0.4	1.2	15.1	0.6	69.9	0.5	0.2	0.3	11.4	2.5	1.0	1.2	0.2	0.0	0.3	9.1	0.0	0.3	56.0	0.0	4.4	22.4	0.3	24.4	12.8	0.3	2.0	61.6	1.9	0.2	0.3	21.8	0.3	0.0	0.3	0.4	2.6	18.3	10.2	5.4	0.0	0.0	0.0	0.0	0.0	3.2	0.6	16.5	4.4	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.2	44.2	0.0	11.3	0.0	0.0	1.6	0.0	5.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.1	40.5	7.1	0.0	0.0	0.4	9.8	15.8	0.0	0.0	0.0	15.0	0.0	0.0	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.1	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.2	0.3	0.2	0.3	0.2	0.0	0.0	0.0	0.0	2.9	0.5	1.3	0.1	0.0	0.4	53.5	0.0	6.8	15.7	0.0	51.9	1.7	15.2	0.0	0.5	58.5	0.0	24.8	5.9	0.7	7.2	5.7	0.0	5.1	0.0	15.6	0.6	0.0	0.0	0.0	0.0	0.0	1.0	40.2	0.0	23.5	42.5	0.0	1.8	0.0	0.0	0.0	0.0	0.4	0.0	57.1	0.0	20.6	43.1
MBD4	MED1	ENSG00000129071	"Methyl-CpG binding domain 4, DNA glycosylase"	O95243	3	129430944-129440179	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002031	Supported		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA002031: AB_1079319"	"unprognostic (2.70e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.18e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (2.18e-4)"	"prognostic unfavorable (4.75e-4)"	"prognostic unfavorable (2.73e-6)"	"unprognostic (9.27e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.35e-2)"	18.1	14.5	14.9	41.9	19.0	26.2	22.8	22.1	16.3	24.0	17.2	14.2	11.2	16.0	16.6	17.8	14.1	15.3	17.4	22.0	15.3	12.8	24.1	30.1	19.0	41.6	17.6	13.7	26.5	18.9	14.8	23.8	17.4	13.6	14.7	16.2	8.4	16.2	16.2	18.2	16.0	21.9	14.7	15.9	34.2	18.7	11.3	15.4	30.4	16.0	14.7	47.8	18.3	18.0	40.3	8.7	19.6	9.5	9.3	15.1	8.7	19.8	12.0	14.7	16.4	16.9	15.2	17.0	17.2	16.3	16.5	19.7	14.7	13.4	28.0	14.1	10.7	15.3	18.0	11.2	10.6	20.2	15.8	7.4	16.7	13.8	10.6	27.0	30.5	22.3	18.0	15.3	14.1	12.5	16.6	15.6	16.4	18.6	21.2	12.2	18.4	17.6	21.5	12.9	16.8	10.4	16.6	8.6	19.2	18.4	9.9	16.5	9.2	21.7	11.4	18.1	13.3	14.4	27.1	10.3	15.7	12.1	16.8	11.3	14.5	8.7	49.1	13.4	17.4	12.9	19.6	8.7	11.6	11.5	7.8	8.7	40.3	12.3	11.3	7.3	36.0	15.1	12.6	15.4	9.3	9.5	8.7	10.5	8.7	14.9	19.0	22.1	16.3	15.3	12.8	17.6	13.7	13.6	15.4	17.9	51.1	69.0	27.1	15.3	31.5	31.3	12.7	30.8	33.0	41.8	17.7	40.7	38.1	28.3	15.4	28.5	22.2	0.0	61.2	41.7	32.4	24.5	56.7	29.7	66.1	20.6	32.3	25.8	40.5	5.3	30.5	34.9	20.3	36.9	23.5	18.6	35.8	24.3	34.3	52.3	41.2	38.8	29.2	38.6	68.7	17.1	31.0	39.9	24.4	28.8
GART	"GARS-AIRS-GART, PGFT, PRGS"	ENSG00000159131	"Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"	P22102	21	33503931-33543491	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Ligase, Multifunctional enzyme, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002119, HPA005779"	Approved		Approved	Mitochondria,Cytosol		NA	NA		1300000	Cytosol	Mitochondria	"HPA002119: AB_1849482, HPA005779: AB_1849484"	"unprognostic (3.77e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (5.05e-5)"	"prognostic unfavorable (9.82e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (1.98e-3)"	"prognostic unfavorable (3.95e-6)"	"unprognostic (1.36e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	24.9	24.7	16.0	20.0	22.3	14.2	22.2	14.5	20.3	16.2	20.1	20.5	13.3	18.9	21.7	15.9	28.1	19.9	14.3	19.3	16.4	14.9	19.2	33.6	18.3	24.4	21.9	14.6	21.0	30.6	21.6	22.9	23.1	21.0	16.4	26.9	19.5	18.6	16.1	33.2	17.6	19.1	23.5	17.9	21.4	21.9	47.0	21.7	40.8	20.0	19.4	32.8	21.6	17.6	18.7	19.5	9.7	20.9	27.1	21.1	13.3	30.2	14.4	21.3	23.6	15.7	16.2	24.0	19.6	16.7	23.0	24.4	27.3	25.7	40.3	11.7	13.1	30.1	16.0	44.7	30.8	33.6	21.1	26.6	60.8	17.2	17.8	21.5	33.7	16.0	14.3	21.6	27.1	39.9	11.7	21.7	32.6	70.6	25.9	20.7	14.5	35.6	22.6	46.6	44.2	17.0	29.7	39.8	57.0	18.4	16.2	22.7	20.5	27.2	21.4	25.4	20.6	27.2	21.7	15.9	15.6	18.7	13.5	21.0	25.8	35.6	44.0	16.4	39.7	23.1	5.3	15.2	9.7	17.3	20.9	21.1	18.7	16.9	17.9	19.5	14.4	17.7	17.4	7.0	27.1	17.7	14.7	20.6	13.3	16.0	22.3	14.5	20.3	16.4	14.9	21.9	14.6	21.0	21.7	17.9	17.5	28.9	32.0	40.9	17.7	16.9	2.5	14.7	26.1	14.0	33.4	35.3	19.9	22.6	9.1	20.1	11.8	0.0	20.8	29.3	16.6	18.9	7.0	17.1	21.0	4.8	12.6	16.5	18.7	2.2	16.1	16.9	11.8	17.2	15.1	12.9	24.5	10.5	17.0	11.3	25.4	12.9	25.0	50.8	27.2	40.1	21.4	17.5	20.8	38.9
MCMBP	"C10orf119, FLJ13081, MCM-BP"	ENSG00000197771	"Minichromosome maintenance complex binding protein"	Q9BTE3	10	119829404-119892556	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013792, HPA038481"	Uncertain		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			Nucleoplasm	"Cell Junctions, Cytosol"	"CAB013792: , HPA038481: AB_10794620"	"unprognostic (1.26e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.31e-3)"	"unprognostic (5.61e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (2.23e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.87e-2)"	33.6	15.3	11.7	23.2	13.8	14.6	35.5	17.2	13.8	27.0	26.3	16.9	11.4	15.5	28.0	14.9	26.4	23.0	18.7	26.3	12.0	10.2	18.7	23.7	28.5	38.6	17.4	8.5	29.2	18.2	23.2	17.6	35.4	14.2	22.5	21.4	15.7	21.0	17.4	30.1	23.8	20.7	26.0	16.8	26.0	20.7	15.4	15.5	38.0	24.5	28.2	24.7	32.5	28.6	4.5	6.9	12.1	9.7	4.1	5.1	2.4	31.0	22.1	31.0	21.4	15.7	19.3	18.2	28.8	31.6	36.7	38.0	28.8	25.5	36.2	13.3	23.0	16.7	29.0	37.0	29.0	43.0	26.5	27.3	18.6	17.6	22.0	24.4	34.3	45.0	15.8	16.4	33.2	43.8	20.2	25.1	23.7	17.1	27.3	24.0	23.0	43.0	20.7	15.6	23.1	16.0	27.2	60.0	18.4	15.7	21.4	13.4	17.2	21.0	17.5	24.0	24.3	11.9	24.5	19.4	18.1	17.8	18.3	34.3	19.7	21.9	40.1	21.6	23.1	11.1	12.1	5.3	3.6	4.2	9.7	5.1	4.5	3.9	4.4	6.9	1.8	4.2	3.8	6.4	4.1	6.1	3.5	3.9	2.4	11.7	13.8	17.2	13.8	12.0	10.2	17.4	8.5	14.2	15.5	14.9	13.9	20.1	27.2	38.0	10.0	16.2	12.7	10.7	18.2	19.2	3.9	30.7	11.6	9.6	3.3	32.4	15.1	0.0	11.5	42.5	26.3	18.7	17.4	23.1	33.4	30.2	10.4	30.1	35.7	4.9	27.9	31.3	21.9	8.2	18.5	16.9	12.8	7.0	21.2	17.5	17.1	19.4	29.9	27.6	61.5	37.4	33.2	27.4	26.9	24.5
CXCL5	"ENA-78, SCYB5"	ENSG00000163735	"C-X-C motif chemokine ligand 5"	P42830	4	73995642-73998779	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 20.0;lymphoid tissue: 28.0;salivary gland: 31.2"	"Group enriched"	"Detected in some"	8	"Ductal cells: 71.4;Pancreatic endocrine cells: 163.7"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 74.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"A549: 34.5;EFO-21: 29.1;HSkMC: 20.9;hTEC/SVTERT24-B: 15.0;RPTEC TERT1: 111.3"									HPA065474	Approved				"Secreted to blood"	NA	NA	1110000				"HPA065474: AB_2685494"	"unprognostic (5.56e-3)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (3.72e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.30e-2)"	1.7	0.3	1.6	28.0	6.0	0.7	2.4	0.4	1.4	10.5	0.7	1.5	0.2	0.6	0.3	0.0	0.6	0.4	3.9	1.4	4.3	2.8	0.4	2.1	20.0	13.6	1.2	0.1	0.3	0.8	0.0	0.3	1.5	7.4	1.5	0.2	0.0	31.2	0.5	0.3	0.3	1.8	0.1	2.6	5.2	6.4	5.4	0.2	1.0	0.3	10.8	0.8	10.9	0.3	0.0	0.0	1.1	0.1	0.0	0.2	5.5	0.0	34.5	0.1	0.0	0.0	1.3	0.0	0.6	0.5	0.2	0.5	0.1	0.3	0.0	29.1	0.0	6.3	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	20.9	0.0	15.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	5.5	1.6	6.0	0.4	1.0	4.3	2.8	1.2	0.1	7.4	0.2	3.0	0.0	0.0	0.8	0.8	0.0	1.3	15.3	1.4	3.4	0.0	0.0	0.0	0.0	71.4	0.2	0.7	0.0	0.0	1.2	0.0	0.5	2.8	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	9.3	0.0	2.8	0.0	0.0	163.7	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.3	0.0	0.0	0.0	0.3
RAB6A	RAB6	ENSG00000175582	"RAB6A, member RAS oncogene family"	P20340	11	73675638-73761137	"Predicted intracellular proteins"	"ER-Golgi transport, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB009936, HPA059131"	Approved		Approved	"Golgi apparatus"		NA	NA		7200000	"Golgi apparatus"		"CAB009936: AB_2175466, HPA059131: AB_2683916"	"unprognostic (2.84e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (8.18e-5)"	"unprognostic (1.79e-1)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (8.67e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (9.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.36e-1)"	25.7	27.3	50.7	18.5	52.6	12.1	21.7	46.1	64.7	25.8	24.1	30.7	16.1	26.5	25.5	20.4	37.4	20.7	21.1	35.7	50.2	50.5	29.0	36.5	25.0	15.1	46.0	30.7	25.3	18.0	27.3	16.0	33.2	76.4	24.7	26.6	19.1	19.2	25.7	35.0	20.8	31.6	29.6	40.8	19.9	20.1	12.7	27.4	15.0	37.4	16.7	21.4	29.0	23.8	17.6	19.8	62.0	27.1	23.9	28.5	29.5	20.7	16.0	26.3	17.0	34.8	39.5	35.8	32.4	31.0	28.1	25.5	31.0	36.7	17.7	35.5	42.0	23.7	23.6	16.6	33.1	35.5	20.3	6.5	28.9	17.8	26.1	29.7	18.7	28.9	29.1	62.4	28.1	41.6	31.0	33.0	18.5	16.8	28.1	32.9	23.3	19.9	13.0	10.6	46.4	15.5	15.4	48.6	32.3	34.3	34.9	20.6	18.1	33.4	34.9	72.3	27.0	27.0	17.3	40.7	29.0	15.1	49.4	13.8	18.7	21.4	37.0	12.0	15.6	26.2	62.0	25.7	40.5	28.5	27.1	25.6	17.6	24.0	25.1	19.8	15.3	18.1	21.3	20.2	23.9	26.3	10.5	26.1	29.5	50.7	52.6	46.1	64.7	50.2	50.5	46.0	30.7	76.4	27.4	29.8	44.8	43.1	42.2	74.1	46.8	58.5	30.6	30.8	25.0	64.6	82.5	84.3	36.5	59.0	6.8	82.4	79.7	23.3	43.5	131.1	64.6	49.3	47.4	60.1	56.8	38.1	49.8	67.5	53.7	5.9	48.9	55.5	69.2	76.7	55.6	49.5	60.9	48.7	58.0	43.7	44.5	25.8	63.8	31.4	33.5	98.5	145.2	58.6	44.1	59.1
IRAK2		ENSG00000134070	"Interleukin 1 receptor associated kinase 2"	O43187	3	10164865-10243743	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 28.7"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 18.1;Glandular cells: 20.2;Urothelial cells: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.2;BJ hTERT+: 16.9;CAPAN-2: 17.1;GAMG: 30.8;RT4: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013483, HPA050520"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"CAB013483: , HPA050520: AB_2681154"	"unprognostic (1.31e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.61e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (1.89e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.24e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.22e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.91e-2)"	"prognostic favorable (6.60e-5)"	12.1	5.8	3.6	8.6	5.9	28.7	5.4	4.5	7.0	3.3	4.0	12.2	2.3	3.3	3.5	2.6	8.4	2.4	6.8	2.7	3.6	5.2	4.3	15.4	12.7	5.3	10.4	3.7	1.9	3.2	2.4	1.8	3.5	7.8	6.4	3.1	2.1	4.8	3.4	19.6	6.2	6.7	3.4	6.1	5.9	5.2	1.7	8.6	3.9	4.1	2.7	16.7	14.3	7.2	5.0	1.3	2.5	1.2	8.4	7.9	2.5	1.2	3.7	0.1	0.5	4.0	3.4	16.2	1.3	16.9	2.3	2.2	1.7	17.1	0.0	0.4	2.0	30.8	0.4	0.4	4.3	3.1	1.0	1.2	0.3	0.8	4.7	2.0	0.0	0.5	2.1	0.7	8.5	11.0	6.1	4.7	0.1	0.8	5.2	2.7	0.0	0.0	0.8	0.1	2.0	3.6	0.8	0.0	0.2	5.1	23.4	0.2	0.1	1.6	0.0	0.1	0.4	0.4	0.8	4.8	5.3	0.4	3.2	3.3	1.7	5.1	1.0	11.3	2.2	0.9	0.2	1.2	0.1	7.5	0.7	7.9	5.0	2.2	4.1	1.3	4.5	1.6	3.9	2.5	8.4	0.2	0.1	0.9	2.5	3.6	5.9	4.5	7.0	3.6	5.2	10.4	3.7	7.8	8.6	0.0	5.5	0.9	18.1	7.1	0.6	1.6	0.0	0.0	2.3	0.0	0.0	0.1	0.0	8.5	3.3	2.1	1.1	0.0	3.5	0.4	1.0	20.2	0.0	4.7	2.9	0.0	0.0	1.3	2.5	1.1	0.9	4.3	5.0	2.8	0.1	1.7	10.4	0.0	0.0	1.0	0.0	0.0	3.1	0.4	0.4	6.5	0.8	1.5	0.4	22.1
ERO1A	"ERO1-alpha, Ero1alpha, ERO1L"	ENSG00000197930	"Endoplasmic reticulum oxidoreductase 1 alpha"	Q96HE7	14	52639916-52695900	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 98.4"	"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 166.6;Pancreatic endocrine cells: 235.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026653, HPA030053, CAB034294"	Enhanced				"Intracellular and membrane"	NA	NA		75000			"CAB034294: AB_2098744, HPA026653: AB_1848254, HPA030053: AB_10601467"	"unprognostic (8.64e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.86e-2)"	"unprognostic (5.89e-2)"	"unprognostic (5.69e-3)"	"unprognostic (4.23e-2)"	"prognostic unfavorable (7.59e-4)"	"prognostic unfavorable (1.10e-5)"	"unprognostic (4.98e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (6.54e-9)"	"unprognostic (9.19e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.58e-1)"	"unprognostic (5.03e-2)"	12.4	3.9	4.7	8.2	5.7	18.1	6.8	6.3	7.4	27.8	8.1	3.6	8.2	7.6	5.3	6.9	98.4	4.4	8.3	6.9	4.3	5.8	6.6	16.2	8.3	8.9	4.0	5.5	7.0	9.0	6.1	5.8	20.0	5.8	7.1	7.9	7.0	20.3	7.3	4.1	7.1	10.0	5.9	5.4	8.2	12.2	3.3	3.7	4.4	6.7	31.0	28.2	27.5	28.3	4.5	4.2	14.9	7.5	6.1	10.5	2.1	32.5	7.6	6.5	7.1	18.1	21.0	12.0	14.2	16.9	11.2	18.8	10.6	51.0	8.6	17.5	9.0	13.8	20.3	8.6	26.9	28.2	7.2	4.3	1.1	7.7	13.2	15.7	19.2	23.6	18.2	18.0	14.3	14.7	26.3	15.4	10.5	5.3	16.6	14.8	4.9	11.4	11.7	3.7	14.6	5.3	7.0	20.4	11.5	17.2	31.2	5.8	15.6	9.5	5.8	12.7	8.8	8.0	7.1	13.3	20.3	10.1	16.5	12.3	8.5	9.1	7.3	29.5	9.9	9.3	14.9	5.5	9.6	4.8	6.1	10.4	4.5	9.2	6.1	4.2	3.1	5.5	5.4	13.4	6.1	7.5	3.3	10.5	2.1	4.7	5.7	6.3	7.4	4.3	5.8	4.0	5.5	5.8	3.7	14.9	31.8	9.3	59.0	0.0	22.2	0.0	35.7	24.1	28.4	36.6	15.7	17.2	3.3	166.6	0.4	13.1	15.8	0.0	112.4	116.8	9.3	107.5	5.8	47.8	39.8	39.7	10.5	22.7	38.1	1.4	5.8	33.6	0.0	36.9	16.0	11.6	235.4	24.6	12.0	13.0	24.5	19.4	0.0	0.5	1.0	0.0	76.4	24.9	24.7	102.5
PTTG1IP	"C21orf1, C21orf3, PBF"	ENSG00000183255	"PTTG1 interacting protein"	P53801	21	44849585-44873903	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034146, HPA061827"	Uncertain		Supported	Nucleoplasm		NA	NA		380000	Nucleoplasm		"CAB034146: AB_1568894, HPA061827: AB_2684620"	"unprognostic (1.78e-2)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (5.24e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (9.30e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (5.40e-4)"	"unprognostic (1.38e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.90e-1)"	47.1	52.1	46.7	33.6	48.7	29.6	53.3	20.9	38.7	50.1	47.2	57.0	29.3	43.6	53.2	47.6	36.2	40.4	50.9	59.9	51.8	31.0	75.6	71.9	58.2	38.8	59.6	30.2	49.6	39.8	23.4	27.3	111.6	43.0	40.5	41.4	50.0	46.0	57.7	30.8	32.1	72.8	51.8	45.8	38.8	58.9	35.2	52.6	19.8	62.4	25.1	25.3	48.2	60.0	5.3	40.5	58.1	35.6	12.5	16.8	37.2	31.0	17.5	20.8	19.7	40.8	23.8	16.9	28.5	40.6	23.1	22.3	37.7	42.7	4.2	108.8	44.3	55.5	14.4	9.5	18.2	22.3	7.3	10.5	33.1	11.0	33.0	39.8	12.6	11.3	36.6	30.0	25.1	17.5	46.3	49.6	11.6	16.6	11.2	71.3	13.4	9.1	12.9	22.0	45.1	22.1	9.1	21.3	20.5	99.6	10.9	15.7	24.3	31.6	34.8	61.6	26.4	26.9	21.2	68.0	29.3	17.1	22.7	43.6	10.7	10.0	5.4	19.7	28.4	26.2	58.1	35.6	20.8	10.3	28.9	16.8	5.3	13.4	10.8	40.5	5.0	13.0	8.9	49.4	12.5	30.4	18.4	16.8	37.2	46.7	48.7	20.9	35.7	51.8	31.0	59.6	30.2	43.0	52.6	366.3	135.9	29.8	68.7	45.1	14.1	137.7	73.9	242.2	240.0	137.9	5.9	181.6	41.4	311.5	36.3	156.9	223.5	0.0	105.1	61.5	84.2	101.0	76.5	97.8	96.5	11.1	76.1	106.2	71.4	76.2	66.7	89.8	82.7	81.2	82.0	66.8	225.0	140.3	93.0	67.3	14.0	64.7	78.7	66.8	49.6	37.5	306.6	30.5	75.0	159.3
PTPN14	PEZ	ENSG00000152104	"Protein tyrosine phosphatase, non-receptor type 14"	Q15678	1	214348696-214552449	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011469, HPA053864, CAB069441"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB011469: AB_299202, CAB069441: , HPA053864: AB_2682281"	"unprognostic (1.54e-1)"	"unprognostic (8.19e-2)"	"unprognostic (5.42e-5)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (7.43e-2)"	"unprognostic (8.34e-3)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-3)"	13.6	10.0	3.0	6.5	2.4	0.2	15.0	0.8	3.7	13.6	8.5	2.6	11.0	1.0	15.4	8.0	8.6	9.2	9.7	7.0	3.5	1.9	11.2	2.0	12.2	6.6	2.4	1.3	11.8	5.0	6.3	4.0	13.2	4.9	10.6	2.9	7.2	9.2	23.4	21.6	18.8	3.5	9.4	4.3	5.3	5.7	8.3	2.4	1.4	8.1	6.9	3.7	12.4	17.7	1.0	0.5	1.9	0.4	1.0	0.6	0.1	8.8	3.9	3.2	4.7	5.6	9.6	9.5	10.1	9.4	7.7	6.5	7.9	4.6	0.0	11.2	23.4	4.4	7.9	4.4	11.2	13.2	0.1	3.3	0.8	11.3	1.5	10.2	0.1	0.4	7.1	11.8	13.4	21.6	12.7	14.9	0.3	0.0	0.1	18.6	0.9	0.1	0.1	7.0	1.6	4.3	0.1	16.2	0.0	13.9	4.5	0.0	0.7	12.5	8.2	5.1	11.9	8.1	0.3	26.5	18.1	7.1	6.4	14.2	0.5	0.0	0.0	9.7	0.1	15.0	1.3	0.4	0.3	0.5	0.3	0.6	0.5	0.5	0.4	0.1	1.0	0.5	0.6	1.9	1.0	0.4	0.5	0.6	0.1	3.0	2.4	0.8	3.7	3.5	1.9	2.4	1.3	4.9	2.4	68.5	15.9	0.5	27.7	50.3	0.4	17.5	2.5	21.4	44.3	27.9	0.0	30.2	6.6	12.0	8.1	42.7	0.4	0.0	9.4	11.6	27.8	19.5	1.1	0.8	4.0	0.0	3.4	36.8	1.2	4.0	24.2	2.5	10.1	0.0	5.0	3.3	20.7	0.0	27.6	12.5	1.3	19.4	20.6	0.7	7.2	31.6	20.3	1.8	2.9	24.0
SCNN1A	"ENaCalpha, SCNN1"	ENSG00000111319	"Sodium channel epithelial 1 alpha subunit"	P37088	12	6346843-6377730	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 100.4"	"Cell type enhanced"	"Detected in many"	9	"Collecting duct cells: 108.2;Mucus-secreting cells: 167.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	8	"pons and medulla: 9.4"	"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 1.7;neutrophil: 4.4;plasmacytoid DC: 3.0;T-reg: 1.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.0;granulocytes: 4.4;T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 71.8;HBEC3-KT: 48.2;hTCEpi: 20.7;RPTEC TERT1: 25.2;RT4: 27.0;SK-BR-3: 23.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA012743	Enhanced					NA	NA					"HPA012743: AB_1856627"	"unprognostic (1.68e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.62e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (8.86e-4)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (5.56e-2)"	"prognostic favorable (9.21e-8)"	"unprognostic (2.38e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-2)"	0.9	3.7	0.4	7.5	0.4	0.0	10.1	0.4	0.9	22.0	20.6	2.2	60.9	5.6	8.1	15.7	47.3	19.3	7.0	0.4	1.1	0.1	100.4	2.2	53.6	0.4	0.5	0.4	5.9	14.2	0.0	10.2	1.6	9.4	15.0	21.5	6.2	53.1	55.5	0.6	14.4	11.8	1.0	0.4	0.4	20.3	2.8	0.4	0.9	74.7	21.1	41.3	10.3	13.8	0.0	3.0	4.4	0.5	0.0	1.7	0.3	5.0	0.9	0.0	0.4	0.0	0.1	4.3	0.0	0.0	0.0	0.0	1.4	71.8	0.0	0.1	0.0	0.0	3.3	0.0	48.2	0.0	0.0	0.0	0.0	4.0	0.7	5.2	0.0	0.0	1.2	20.7	0.0	15.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	4.2	9.1	0.1	0.0	0.0	0.1	25.2	27.0	0.3	0.0	0.5	23.3	0.0	4.3	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.0	0.0	0.2	0.6	0.5	0.0	1.7	0.3	4.4	0.0	0.1	3.0	1.3	0.3	0.4	0.4	0.4	0.9	1.1	0.1	0.5	0.4	9.4	0.4	68.5	63.0	0.0	21.9	1.6	0.8	0.8	68.8	26.8	47.8	108.2	3.9	1.2	5.0	41.1	0.4	1.4	57.4	0.0	30.8	0.2	2.4	31.3	2.3	2.4	0.3	1.6	26.0	0.6	1.9	0.2	1.7	2.1	0.0	1.8	167.5	0.3	24.0	47.5	1.4	4.2	1.6	0.0	1.0	1.4	2.1	7.8	1.4	1.9	31.6	33.3
KIF11	"Eg5, HKSP, KNSL1, TRIP5"	ENSG00000138160	"Kinesin family member 11"	P52732	10	92593286-92655395	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 74.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 9.6;Erythroid cells: 23.3;Extravillous trophoblasts: 11.2;Hofbauer cells: 6.7;Spermatocytes: 24.7;Spermatogonia: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA006916, HPA010093, HPA010568, CAB017617"	Enhanced		Supported	"Mitotic spindle,Cytosol"		Yes	Yes			Cytosol	"Mitotic spindle"	"CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: AB_2668281, HPA010568: AB_1848034"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (8.19e-7)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (6.59e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.35e-3)"	"unprognostic (7.23e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.01e-1)"	2.3	1.6	1.0	20.2	2.6	14.3	1.6	0.7	1.5	2.4	4.6	0.7	0.5	3.7	1.4	1.9	11.5	0.8	2.6	2.0	1.1	1.2	1.1	1.1	2.8	12.1	1.0	1.0	1.1	1.1	0.5	0.7	3.1	1.4	1.0	5.4	0.5	2.7	0.2	0.6	4.2	4.4	1.6	1.8	5.2	2.7	10.5	1.1	74.2	1.2	7.5	13.4	2.2	3.8	2.4	0.9	2.5	1.2	3.5	3.9	1.0	31.0	13.9	31.4	29.2	2.3	3.5	7.8	22.4	19.6	24.9	24.8	12.1	20.6	34.4	11.5	10.4	10.6	22.5	22.4	11.4	29.3	20.5	12.9	21.5	13.3	12.7	0.4	34.6	20.1	1.1	1.0	19.2	18.0	5.8	15.4	14.4	15.2	40.2	18.8	12.4	29.4	19.5	12.5	12.6	9.6	31.7	31.1	12.1	6.5	9.1	9.6	13.8	17.5	7.9	9.1	11.2	21.5	11.1	8.7	11.4	16.4	11.6	29.4	11.2	17.3	35.4	9.2	25.0	15.4	2.5	0.5	0.5	0.4	1.2	1.1	2.4	1.4	1.9	0.9	1.0	0.5	0.7	1.4	3.5	0.4	0.4	3.9	1.0	1.0	2.6	0.7	1.5	1.1	1.2	1.0	1.0	1.4	1.1	0.0	1.3	0.8	0.8	2.6	1.3	1.4	0.0	4.0	3.4	1.8	0.0	1.5	1.7	0.4	9.6	0.3	0.4	23.3	0.6	11.2	1.6	0.8	0.0	0.0	6.7	0.0	0.0	2.5	2.5	3.9	0.9	2.6	0.0	1.0	1.9	0.8	0.3	0.0	0.7	0.5	0.4	0.0	1.2	24.7	25.8	2.9	1.3	3.8	2.9	0.9
GOLT1B	"CGI-141, GOT1, YMR292W"	ENSG00000111711	"Golgi transport 1B"	Q9Y3E0	12	21501781-21518408	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055909, HPA066383"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA055909: AB_2682967, HPA066383: AB_2685667"	"unprognostic (1.22e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.37e-3)"	"prognostic unfavorable (1.99e-8)"	"unprognostic (2.24e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.83e-10)"	"unprognostic (3.13e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.04e-1)"	21.1	26.0	18.3	18.2	24.4	23.4	20.4	31.9	30.4	22.3	14.7	18.9	13.8	12.0	16.9	18.9	15.3	14.6	16.4	17.0	19.1	22.4	23.2	40.1	19.9	16.0	20.1	16.2	14.1	30.9	11.3	34.9	31.1	23.8	19.0	16.8	16.1	17.4	15.3	15.9	14.5	13.0	19.6	22.2	17.8	15.3	11.6	17.5	13.5	19.1	11.6	15.6	22.5	14.2	17.7	22.2	26.7	22.9	14.8	21.1	19.4	11.4	12.1	10.0	12.9	20.2	31.5	17.0	45.1	17.2	14.3	23.4	15.8	17.0	6.9	11.6	23.4	26.6	11.1	8.3	9.3	25.1	10.1	7.9	10.1	7.9	11.0	22.5	13.0	13.0	15.9	18.2	17.1	31.5	24.6	12.9	8.6	6.3	7.7	21.9	10.7	5.8	21.6	27.6	9.9	8.7	5.0	24.4	14.5	11.8	7.0	2.7	8.4	18.4	7.2	24.6	33.8	10.0	14.7	14.4	16.9	18.4	20.8	24.5	7.5	16.3	18.3	23.1	12.5	22.7	26.7	20.6	14.8	17.9	22.9	21.1	17.7	21.1	19.5	20.2	16.5	19.3	19.2	5.6	14.8	20.9	22.2	20.4	19.4	18.3	24.4	31.9	30.4	19.1	22.4	20.1	16.2	23.8	17.5	8.9	14.1	38.8	20.4	41.4	28.9	15.5	15.3	8.1	25.0	15.7	9.8	25.0	23.2	28.8	2.7	27.1	10.5	0.0	29.2	54.0	45.6	35.7	20.8	21.7	37.8	17.5	12.6	17.8	21.3	3.6	16.1	35.7	50.6	22.6	22.7	17.8	30.7	14.4	18.7	17.4	6.7	12.9	30.7	22.9	31.0	55.8	53.5	33.1	13.2	20.5
LYPLA1	LPL1	ENSG00000120992	"Lysophospholipase I"	O75608	8	54046367-54102017	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 729.6;Late spermatids: 528.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA050941, HPA063151"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		1700000	"Nucleoplasm, Cytosol"		"HPA050941: AB_2681284, HPA063151: "	"unprognostic (2.62e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.42e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.56e-3)"	14.1	17.7	7.2	12.2	8.9	13.4	16.4	10.8	15.2	10.7	14.6	6.9	4.7	15.4	8.0	11.1	30.4	8.0	11.9	27.1	6.8	6.8	31.1	37.3	13.6	23.4	7.3	4.9	12.3	24.3	9.0	7.4	51.1	12.0	15.3	15.2	17.0	23.3	7.1	26.4	22.1	17.6	10.4	6.3	14.0	14.9	64.8	4.1	21.3	13.3	19.3	19.7	24.6	17.3	29.1	37.1	42.7	40.4	27.1	29.2	35.1	30.2	17.1	22.3	20.0	8.1	13.2	28.1	18.1	10.4	16.8	15.8	12.3	29.4	53.0	21.2	11.7	18.5	20.3	31.3	30.1	23.4	19.2	17.1	36.9	10.9	19.8	13.3	22.5	50.1	11.6	26.6	13.0	29.4	14.4	43.3	23.1	37.4	16.1	23.2	8.0	34.3	17.2	33.1	50.7	7.9	20.8	11.8	24.2	25.8	41.0	11.7	20.0	12.7	23.8	27.8	22.1	34.7	20.2	20.8	10.1	14.8	17.5	16.7	22.5	33.8	47.8	13.7	24.0	19.8	31.4	33.1	42.7	19.1	31.1	19.0	29.1	18.2	18.4	37.1	23.9	18.4	17.8	19.5	27.1	40.4	23.8	29.2	35.1	7.2	8.9	10.8	15.2	6.8	6.8	7.3	4.9	12.0	4.1	26.8	44.0	77.0	68.7	54.8	33.9	58.1	45.9	38.8	33.0	59.3	49.1	180.5	257.0	74.6	729.6	72.2	62.9	0.0	77.4	255.5	43.3	142.6	49.5	102.9	105.0	17.5	55.2	78.0	108.6	528.5	26.2	78.4	70.9	59.5	73.4	26.2	94.9	67.1	21.5	145.1	62.5	45.3	42.2	70.4	176.9	70.9	279.5	61.2	78.8	160.0
MCM4	"CDC21, CDC54, hCdc21, MGC33310, P1-Cdc21"	ENSG00000104738	"Minichromosome maintenance complex component 4"	P33991	8	47960185-47978160	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 56.6"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 117.9;Late spermatids: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004497, HPA004873, HPA031052"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB004497: AB_627916, HPA004873: AB_1079337, HPA031052: AB_2673712"	"unprognostic (4.55e-2)"	"unprognostic (3.16e-3)"	"prognostic favorable (2.19e-4)"	"prognostic unfavorable (2.84e-5)"	"unprognostic (7.71e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.12e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.40e-1)"	4.9	8.7	6.7	18.4	12.6	33.1	9.3	13.9	14.8	6.7	11.9	6.9	3.6	8.3	4.7	7.8	21.6	5.9	6.8	8.3	6.6	7.1	8.0	6.6	4.4	20.3	5.9	7.7	5.3	5.5	4.3	4.1	29.2	7.7	4.2	13.2	5.3	9.0	3.1	8.7	16.2	10.3	5.9	6.4	10.1	6.3	39.0	4.1	56.6	4.0	21.8	23.7	8.0	9.5	5.1	4.9	3.4	4.3	4.9	12.9	4.5	34.5	21.5	39.9	14.6	3.9	6.9	17.6	26.4	17.3	33.3	37.7	22.8	31.5	37.5	14.8	13.1	25.0	25.5	50.3	21.4	37.6	11.8	33.2	64.3	25.8	25.3	1.1	34.3	14.1	4.1	4.3	26.5	9.5	5.1	11.7	25.3	35.4	31.2	22.9	21.4	75.8	25.0	43.3	41.1	9.3	48.2	31.3	24.4	12.0	31.0	38.4	18.4	53.4	22.3	7.9	23.8	26.6	18.1	7.8	25.4	24.7	28.5	24.2	10.3	24.6	76.5	20.4	31.9	22.7	3.4	2.1	1.5	5.5	3.7	2.7	5.1	5.0	6.8	4.9	2.1	4.6	3.4	0.1	4.9	4.3	1.7	12.9	4.5	6.7	12.6	13.9	14.8	6.6	7.1	5.9	7.7	7.7	4.1	0.0	4.6	3.0	9.5	19.3	11.6	22.4	0.0	17.4	10.3	5.2	9.8	26.7	3.3	6.0	117.9	5.2	5.0	46.7	5.2	33.9	7.4	4.3	1.1	3.4	10.4	15.9	6.4	1.3	3.5	57.7	4.9	9.9	3.3	2.8	9.6	6.5	4.1	3.5	2.8	2.2	15.3	0.0	8.0	45.2	31.3	16.7	24.9	3.8	20.2	8.2
ASPM	"ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5"	ENSG00000066279	"Abnormal spindle microtubule assembly"	Q8IZT6	1	197084128-197146694	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Calmodulin-binding	"Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 62.8"	"Cell type enhanced"	"Detected in many"	16	"Erythroid cells: 70.0;Spermatocytes: 32.6;Spermatogonia: 30.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"plasmacytoid DC: 1.5;T-reg: 2.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;T-cells: 2.4"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB017816			Approved	"Plasma membrane,Cytosol"		NA	Yes			"Plasma membrane, Cytosol"		"CAB017816: "	"unprognostic (3.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.67e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (1.25e-4)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (4.67e-3)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.03e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.66e-2)"	0.7	0.7	0.2	12.4	0.4	13.8	1.5	0.2	0.4	1.2	2.8	0.2	0.2	2.8	0.3	1.5	8.7	0.2	0.4	0.6	0.2	0.2	0.5	1.3	1.9	7.0	0.3	0.2	0.5	0.3	0.0	0.2	1.8	0.5	0.4	2.8	0.3	1.5	0.2	0.5	4.6	3.1	0.8	0.5	4.3	1.7	6.3	0.2	62.8	0.3	5.0	6.9	1.2	2.3	0.0	1.5	0.0	0.0	0.3	2.4	0.0	20.1	11.3	18.3	11.2	1.1	2.5	6.9	16.1	11.3	16.0	12.7	7.8	15.7	20.5	5.7	12.6	7.0	20.3	15.7	6.4	20.0	18.5	11.9	14.4	26.5	7.5	0.2	21.5	10.3	0.2	0.6	12.8	9.0	4.1	16.8	16.6	18.0	24.4	16.4	7.9	17.2	10.0	8.3	16.2	3.1	13.2	25.2	15.1	5.8	5.5	9.6	13.7	22.9	11.8	5.1	11.8	13.2	8.9	12.8	9.9	9.7	17.0	29.2	7.0	9.5	11.9	7.8	5.9	20.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	2.4	0.0	0.2	0.4	0.2	0.4	0.2	0.2	0.3	0.2	0.5	0.2	0.0	0.6	3.7	0.6	5.5	0.0	1.0	0.0	0.0	1.2	1.8	0.0	6.4	0.0	0.3	2.9	0.3	0.3	70.0	0.0	13.2	1.3	0.7	1.1	1.0	9.3	0.0	0.0	1.8	4.0	3.3	0.6	3.1	0.0	1.0	1.5	0.5	0.4	0.0	1.4	0.0	0.3	0.0	0.0	32.6	30.2	3.0	3.1	4.9	4.9	1.7
AHNAK	MGC5395	ENSG00000124942	"AHNAK nucleoprotein"	Q09666	11	62433542-62556235	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 86.5;fHDF/TERT166: 80.4;TIME: 84.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019010, HPA019070, HPA026643"	Uncertain		Enhanced	"Plasma membrane,Cytosol"		NA	NA		950000	"Plasma membrane, Cytosol"		"HPA019010: AB_1844657, HPA019070: AB_1844656, HPA026643: AB_10670426"	"unprognostic (1.39e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.98e-3)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (4.30e-1)"	"unprognostic (4.49e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (3.47e-6)"	85.2	8.2	15.3	35.3	9.3	10.0	91.1	9.3	10.8	69.7	66.3	16.8	36.4	13.0	52.2	47.4	96.9	39.4	59.2	55.8	20.9	6.0	18.4	16.0	54.9	16.6	16.2	13.4	40.2	8.9	8.0	5.3	39.8	15.9	42.6	26.8	29.6	35.5	36.8	64.8	88.4	38.2	101.5	16.1	16.9	38.3	16.9	16.2	5.8	18.4	72.9	44.0	54.3	86.1	8.2	28.9	15.3	30.1	11.1	16.7	12.2	26.5	15.7	1.4	6.5	64.4	86.5	10.4	24.1	29.6	15.4	8.6	13.5	9.5	0.0	9.2	80.4	11.9	35.4	6.0	29.7	19.7	21.5	1.0	3.2	23.3	4.0	12.3	4.4	21.2	31.2	34.9	30.2	27.7	19.7	31.7	0.4	3.0	20.5	31.2	10.3	0.0	8.6	0.4	8.5	23.8	0.0	6.6	15.9	34.2	17.4	0.0	1.3	24.3	10.3	10.3	31.1	19.7	4.1	84.1	27.5	17.9	34.1	10.6	3.6	0.7	0.0	20.9	1.4	8.9	15.3	30.1	0.1	16.7	17.5	11.0	8.2	10.7	13.1	28.9	5.2	1.4	7.6	0.4	11.1	14.0	7.9	7.9	12.2	15.3	9.3	9.3	10.8	20.9	6.0	16.2	13.4	15.9	16.2	408.0	109.1	70.5	114.1	425.8	1.3	166.6	206.4	97.7	178.6	183.2	0.0	83.1	11.6	83.1	9.2	245.0	291.2	0.0	57.2	123.8	177.9	136.3	226.0	73.3	79.4	1.6	45.8	165.7	304.6	18.1	418.0	252.7	301.9	91.0	140.5	27.9	164.5	142.7	438.1	5.4	1.0	174.6	271.5	1.7	7.6	533.5	85.5	86.3	79.4	166.3
RRAS2	TC21	ENSG00000133818	"RAS related 2"	P62070	11	14277926-14364506	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 12.3"	"Group enriched"	"Detected in many"	5	"B-cells: 12.3;NK-cells: 3.5;T-cells: 6.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB010420, HPA050942"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB010420: AB_2253855, HPA050942: AB_2681285"	"unprognostic (6.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (7.80e-4)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (4.50e-2)"	"unprognostic (4.15e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.63e-1)"	22.3	11.8	8.3	27.5	7.8	2.3	22.6	9.5	7.0	14.1	16.9	6.4	7.8	11.9	16.2	9.8	13.5	11.1	12.9	29.8	8.7	8.1	25.6	33.0	18.1	15.2	6.5	7.6	16.6	18.5	13.5	7.4	50.8	8.4	16.7	11.0	14.5	15.1	12.9	31.4	9.2	37.7	31.4	7.6	17.6	13.7	21.0	5.2	11.3	26.2	14.4	20.8	27.3	15.0	12.3	0.4	1.5	0.0	3.5	6.2	0.9	15.3	6.7	6.4	5.6	22.9	22.4	9.5	54.3	28.4	46.9	59.6	13.5	19.2	17.7	9.1	36.4	15.2	17.7	10.8	19.4	47.3	15.7	10.5	1.1	4.0	10.7	24.5	0.0	0.1	23.7	36.8	18.7	60.1	19.3	23.3	4.3	7.7	0.0	40.7	7.4	3.7	0.9	18.2	3.1	6.3	3.7	21.2	0.3	24.0	8.5	1.7	3.3	13.1	8.4	7.4	22.6	5.4	1.1	53.1	25.4	14.1	48.7	14.7	0.0	0.0	8.3	10.2	0.0	5.1	1.5	0.0	0.0	6.2	0.0	2.6	12.3	1.1	3.2	0.0	6.9	0.6	2.5	0.4	3.5	0.0	0.4	0.0	0.9	8.3	7.8	9.5	7.0	8.7	8.1	6.5	7.6	8.4	5.2	17.9	17.6	46.8	50.4	61.6	5.2	23.2	43.3	10.7	18.2	17.4	0.0	32.7	19.9	40.3	48.4	18.0	39.6	0.0	16.1	49.9	26.8	69.2	9.2	27.6	6.9	12.7	18.3	12.9	1.6	34.5	15.3	2.5	25.3	2.8	16.6	18.6	42.0	25.9	10.6	70.4	10.3	19.4	21.2	34.6	41.4	43.5	24.3	26.6	19.6	64.4
YES1	"c-yes, HsT441, Yes"	ENSG00000176105	"YES proto-oncogene 1, Src family tyrosine kinase"	P07947	18	721588-812546	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 14.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 14.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004370, HPA026480"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		4300000	"Plasma membrane, Cytosol"		"CAB004370: AB_627370, HPA026480: AB_1858921"	"unprognostic (3.28e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.24e-2)"	"unprognostic (4.24e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.14e-1)"	"unprognostic (8.12e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.11e-1)"	26.2	13.1	17.0	9.4	15.6	2.6	47.2	6.7	12.8	15.8	23.8	8.9	13.7	18.2	13.1	17.4	22.0	10.7	14.9	17.9	14.8	12.4	22.6	43.2	23.6	13.7	15.8	6.6	13.2	21.4	16.7	10.7	31.3	16.8	12.2	17.3	6.5	23.7	21.0	10.6	12.3	24.8	18.8	16.8	34.5	15.5	13.6	12.0	8.1	16.8	15.6	7.1	21.9	17.5	0.1	0.1	14.7	0.0	1.0	2.5	0.6	14.4	7.2	22.8	17.8	13.7	17.0	26.8	9.6	19.7	11.4	15.7	17.1	10.7	0.0	10.3	16.3	14.6	8.5	21.3	17.1	22.4	0.0	7.2	4.3	7.1	11.9	11.1	3.3	7.7	13.0	18.4	17.2	19.2	14.2	38.4	2.4	18.7	6.4	16.2	9.9	2.0	4.3	14.4	8.8	9.2	2.5	17.9	1.2	16.6	17.2	4.6	5.4	19.9	15.1	12.6	15.7	10.4	6.9	33.0	28.1	31.2	21.2	25.9	5.6	2.7	0.8	10.6	4.7	16.6	14.7	0.0	0.9	2.5	0.0	1.6	0.1	0.5	1.4	0.0	0.0	1.2	1.9	0.0	1.0	0.0	0.1	0.1	0.6	17.0	15.6	6.7	12.8	14.8	12.4	15.8	6.6	16.8	12.0	23.8	30.8	1.5	33.5	53.3	6.2	16.5	20.4	26.8	34.2	27.9	5.9	28.2	3.3	25.6	20.2	77.6	27.4	0.0	34.0	20.3	31.2	52.1	12.8	33.4	4.3	3.2	21.9	41.1	5.6	7.9	17.0	5.3	23.6	1.0	35.7	16.3	40.3	21.0	12.0	38.5	8.0	19.4	20.6	12.8	11.7	43.4	38.1	15.2	31.0	58.7
SMAD3	"HsT17436, JV15-2, MADH3"	ENSG00000166949	"SMAD family member 3"	P84022	15	67063763-67195195	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Aortic aneurysm, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Glandular cells: 111.1;Urothelial cells: 247.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008094, HPA046386, HPA067203, CAB069409"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB008094: AB_2302271, CAB069409: AB_1622941, HPA046386: AB_2679647, HPA067203: AB_2685803"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.80e-2)"	"unprognostic (7.62e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (2.93e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.97e-2)"	25.3	4.6	12.2	18.5	12.4	12.4	21.6	5.0	12.7	20.9	17.9	7.6	9.5	12.7	19.9	16.6	35.3	14.3	27.7	19.7	7.5	4.8	15.6	13.6	13.9	14.0	6.0	7.5	23.0	12.6	7.0	10.8	11.5	8.2	20.5	9.2	30.8	12.5	10.8	37.3	19.6	19.0	23.2	5.5	11.2	15.8	7.0	7.7	10.5	21.8	23.4	29.7	31.4	24.6	4.8	2.5	3.2	1.9	0.4	6.3	1.8	12.2	41.2	7.7	3.7	13.6	31.4	6.1	7.1	29.3	9.9	8.0	8.5	32.9	4.1	9.6	20.2	44.6	29.1	8.0	30.0	9.9	3.2	3.0	0.4	11.6	6.4	10.2	1.6	0.7	28.4	7.0	8.7	7.4	22.0	33.3	1.3	9.9	11.5	12.3	6.3	0.3	6.2	4.5	6.5	12.9	0.4	2.3	1.5	6.6	39.5	0.2	2.6	9.4	5.2	8.1	15.7	1.4	7.6	28.0	13.4	12.6	9.6	8.0	4.4	1.2	5.1	12.1	1.7	12.0	0.0	1.9	3.2	5.5	1.5	5.7	2.1	6.2	6.3	1.8	4.8	2.8	2.4	0.1	0.4	1.5	2.5	3.1	1.8	12.2	12.4	5.0	12.7	7.5	4.8	6.0	7.5	8.2	7.7	44.7	14.5	13.6	67.6	79.0	8.3	9.5	15.3	24.1	30.7	34.9	5.9	0.8	3.3	53.0	0.9	20.1	34.4	0.0	44.0	4.0	34.3	111.1	24.2	11.3	8.4	0.0	3.4	9.8	4.8	3.7	24.7	13.8	20.3	3.6	11.9	9.7	71.0	21.0	19.4	12.2	0.4	25.8	14.6	0.3	0.7	42.8	1.4	12.5	15.7	247.9
CAPN2	"CANPL2, CANPml, mCANP"	ENSG00000162909	"Calpain 2"	P17655	1	223701593-223776018	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 366.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024470	Approved	Approved	Supported	Cytosol		NA	NA		1500000	Cytosol		"HPA024470: AB_1845925"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.21e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.61e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (6.21e-4)"	56.2	41.0	23.8	20.7	22.2	11.1	61.1	26.1	20.9	40.3	44.8	18.3	23.3	14.5	29.1	44.5	56.3	40.1	58.9	33.0	26.5	13.1	41.6	13.3	58.6	18.2	27.4	18.2	32.4	26.8	53.7	12.7	26.4	23.8	27.2	44.4	16.5	62.5	31.9	48.1	16.5	22.7	35.7	32.3	15.9	48.2	17.2	24.7	5.0	29.9	39.7	35.9	28.3	38.8	9.0	41.6	1.7	29.1	6.0	28.7	28.2	46.1	29.6	9.5	6.3	31.7	44.0	9.1	43.7	63.5	31.8	18.1	23.4	37.2	0.0	14.4	48.5	25.0	28.9	10.2	69.1	29.6	11.8	10.6	0.8	15.1	2.9	28.5	2.4	1.5	23.5	22.4	49.5	26.5	57.1	63.0	0.0	13.3	12.4	93.6	0.9	0.1	2.1	5.2	5.7	38.7	3.9	31.0	0.7	54.8	2.7	2.0	11.0	22.5	61.5	13.6	24.0	9.3	11.1	96.9	29.8	24.7	25.6	56.0	3.7	6.9	0.1	74.6	5.2	32.7	1.7	29.1	1.7	28.7	19.5	24.5	9.0	20.0	27.7	41.6	3.6	6.4	17.4	1.5	6.0	17.5	1.9	19.9	28.2	23.8	22.2	26.1	20.9	26.5	13.1	27.4	18.2	23.8	24.7	366.3	110.0	19.7	85.8	42.0	12.0	35.9	96.8	180.7	191.1	50.6	31.4	18.1	154.2	234.2	86.1	110.2	114.4	0.0	171.9	77.1	101.6	155.1	26.6	6.0	36.6	12.7	23.6	33.2	58.4	173.5	71.7	66.7	106.3	13.6	104.2	15.8	261.3	139.7	64.7	17.0	17.0	38.8	112.7	3.0	3.2	24.1	6.9	57.7	90.7	256.2
SH3GLB1	"Bif-1, CGI-61, KIAA0491, PPP1R70"	ENSG00000097033	"SH3 domain containing GRB2 like, endophilin B1"	Q9Y371	1	86704570-86748184	"Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 468.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 69.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 69.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004650, HPA015608, HPA019900"	Enhanced		Supported	Cytosol		NA	NA		18000	Cytosol		"CAB004650: AB_425966, HPA015608: AB_1845355, HPA019900: AB_1845356"	"unprognostic (1.72e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (8.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.29e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (1.56e-1)"	"unprognostic (4.04e-3)"	"unprognostic (7.70e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.69e-1)"	42.3	19.9	15.0	22.1	18.8	23.7	50.5	13.7	16.9	20.1	24.1	17.8	25.7	20.0	19.9	25.6	42.4	15.2	20.0	48.1	15.4	12.6	22.4	24.0	27.6	40.2	18.2	14.8	18.0	28.5	18.2	18.4	23.7	20.3	19.7	24.8	11.7	30.2	24.5	89.7	19.4	24.4	26.6	24.5	33.6	16.1	45.4	16.2	19.0	20.0	29.7	20.8	28.5	35.6	8.9	10.4	69.7	16.3	13.9	14.5	10.0	19.3	7.1	11.4	10.4	47.9	41.6	18.8	29.3	29.4	27.9	29.6	20.5	16.2	9.9	18.9	36.3	34.8	11.3	10.1	19.1	26.6	21.4	7.2	23.6	10.9	21.7	29.0	12.7	24.1	29.7	22.2	30.7	33.8	30.0	43.9	10.6	8.8	28.0	37.3	5.7	11.4	8.1	11.1	14.2	12.2	13.2	48.0	7.3	24.0	33.4	12.5	9.1	16.5	21.3	34.9	17.8	8.4	13.0	38.4	26.9	16.3	33.5	24.1	14.8	13.6	14.6	13.3	13.1	16.2	29.4	13.7	14.7	10.6	14.5	10.4	8.9	9.9	10.6	10.4	8.1	4.8	8.5	69.7	13.9	16.3	10.2	14.5	10.0	15.0	18.8	13.7	16.9	15.4	12.6	18.2	14.8	20.3	16.2	77.4	64.0	67.1	96.1	79.6	31.2	138.8	43.3	80.3	58.0	52.4	49.1	72.5	72.9	127.2	468.5	101.4	103.4	46.7	149.1	181.7	92.1	83.8	111.9	70.0	131.7	15.9	83.1	143.6	150.6	144.3	65.0	116.4	77.6	140.7	120.2	67.6	162.6	110.1	79.9	93.5	53.0	77.6	110.4	217.9	73.1	103.3	85.2	73.9	68.5	158.5
TNNT1	"ANM, FLJ98147, MGC104241, NEM5, STNT, TNT, TNTS"	ENSG00000105048	"Troponin T1, slow skeletal type"	P13805	19	55132794-55149354	"Disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 1047.7"	"Cell type enhanced"	"Detected in many"	11	"Basal keratinocytes: 54.4;Cardiomyocytes: 49.6;Spermatogonia: 26.7;Suprabasal keratinocytes: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"eosinophil: 53.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 53.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 121.8;RH-30: 91.7"	"Region enriched"	"Detected in many"	5	"thalamus: 136.6"	"Low region specificity"	"Detected in some"			"CAB015168, HPA058448"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus, Cytosol"		"CAB015168: AB_2206426, HPA058448: AB_2683720"	"unprognostic (1.88e-1)"	"unprognostic (7.23e-2)"	"prognostic unfavorable (4.66e-4)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (3.47e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.91e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-2)"	3.2	0.0	1.6	0.0	1.0	0.1	0.1	0.1	1.0	0.0	0.1	0.0	0.0	0.1	0.0	24.4	22.3	0.4	0.1	6.1	0.9	0.4	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	7.2	0.0	0.0	11.5	0.0	1047.7	1.8	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0	9.2	124.4	17.8	0.3	0.1	0.1	9.9	53.3	11.6	0.1	0.1	2.6	24.8	14.6	0.1	3.2	0.0	0.2	4.8	1.1	4.3	1.6	4.8	5.3	16.6	0.3	9.7	0.4	13.0	12.7	3.4	10.8	1.3	1.6	27.6	4.7	1.5	0.9	0.5	0.3	121.8	5.4	17.6	0.5	18.7	18.5	0.0	5.0	23.6	23.1	1.5	23.7	0.4	0.0	3.1	6.3	29.0	15.9	91.7	2.9	3.8	0.8	0.9	7.2	1.5	0.2	8.0	1.3	15.1	14.5	0.5	24.1	35.9	0.9	1.8	0.1	0.9	1.2	25.4	3.7	7.3	0.5	11.6	53.3	0.0	5.9	0.1	0.0	0.1	0.0	9.9	0.1	0.1	0.1	0.5	0.1	2.6	0.2	0.0	2.6	1.6	1.0	0.1	1.0	0.9	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.4	1.5	49.6	0.0	6.7	0.0	0.0	0.0	1.3	0.0	1.8	1.3	0.0	0.0	0.0	0.0	14.0	8.0	0.0	0.0	0.0	13.2	0.0	2.4	1.8	12.0	6.0	0.3	4.2	3.3	0.0	0.2	0.8	0.4	0.0	0.0	0.0	0.6	0.0	0.9	2.8	26.7	26.6	3.0	0.0	0.3	0.1
TATDN1	CDA11	ENSG00000147687	"TatD DNase domain containing 1"	Q6P1N9	8	124488485-124539458	"Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023634, HPA053045"	Uncertain		Supported	Nucleoplasm		NA	NA		2000000	Nucleoplasm		"HPA023634: AB_1857779, HPA053045: AB_2682024"	"unprognostic (2.19e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.12e-2)"	16.6	14.1	16.1	13.0	18.6	9.9	27.4	22.7	18.8	14.9	14.4	11.7	9.9	12.3	16.7	15.3	15.5	16.8	10.1	16.4	14.9	14.4	19.4	17.1	16.3	14.7	22.7	17.0	28.9	34.7	13.2	18.4	10.5	19.4	13.8	16.0	8.1	18.6	11.1	40.4	14.0	11.9	16.9	21.2	8.2	16.3	8.3	18.3	15.1	26.2	14.5	13.3	15.2	13.3	10.5	10.0	13.7	7.2	11.1	18.1	8.9	20.0	14.2	13.6	9.5	12.3	23.3	10.3	11.0	12.2	14.1	13.1	13.9	22.0	15.3	25.0	12.1	10.9	16.6	16.4	16.4	23.4	19.5	10.9	14.1	11.8	12.0	23.4	10.7	5.3	17.4	26.2	20.5	43.4	15.7	11.2	15.0	11.5	10.0	18.7	61.0	16.0	6.7	13.6	41.2	18.4	10.7	10.1	17.1	19.8	14.2	11.4	16.0	12.3	25.1	25.9	13.3	16.8	11.6	8.7	10.0	26.6	18.3	30.0	12.9	19.6	19.2	18.8	19.1	8.6	13.7	7.2	2.8	8.2	6.0	12.7	10.5	12.5	10.1	10.0	10.4	18.1	16.6	1.5	11.1	4.5	7.5	12.9	8.9	16.1	18.6	22.7	18.8	14.9	14.4	22.7	17.0	19.4	18.3	14.9	21.9	35.0	84.7	57.6	17.6	15.3	28.1	22.7	30.7	26.2	13.7	55.3	91.2	43.0	5.1	28.0	20.7	23.3	53.6	54.4	44.2	63.1	19.7	35.5	48.7	15.9	15.5	22.1	39.4	4.7	46.1	38.8	45.5	49.5	34.9	18.4	41.4	24.6	32.5	91.6	17.1	19.4	47.2	30.9	37.3	50.8	49.9	35.5	57.5	61.6
TTK	"CT96, MPH1, MPS1, MPS1L1"	ENSG00000112742	"TTK protein kinase"	P33981	6	80003887-80042527	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.3;testis: 31.7"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 19.9;Erythroid cells: 23.3;Spermatocytes: 63.4;Spermatogonia: 28.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010166, CAB013229"	Enhanced		Approved	Nucleoli,Cytosol		NA	Yes			"Nucleoli, Cytosol"		"CAB010166: AB_632567, CAB013229: AB_2533230"	"unprognostic (4.27e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (7.97e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (3.84e-10)"	"unprognostic (1.56e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (1.54e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	1.1	1.4	0.3	3.2	0.4	13.9	1.0	0.3	0.4	1.0	2.7	0.2	0.2	2.2	0.5	1.0	6.5	0.3	0.4	1.5	0.4	0.3	0.9	0.6	1.2	4.6	0.4	0.2	0.4	0.5	0.0	0.3	3.0	0.6	0.6	3.6	0.3	1.2	0.6	0.3	2.0	2.8	0.7	0.8	2.1	1.8	31.7	0.2	58.3	0.5	2.6	5.4	0.8	1.8	1.7	0.0	1.1	0.0	1.1	4.0	0.8	13.3	8.0	24.0	19.6	1.1	3.5	13.6	15.5	9.5	22.7	27.8	10.9	10.2	19.8	12.1	6.6	23.8	17.3	21.1	9.5	31.6	18.0	17.0	18.3	10.6	8.9	0.0	21.5	11.9	0.4	1.0	15.8	10.1	3.3	12.8	27.9	19.9	20.4	19.2	9.9	12.2	15.5	14.1	12.0	9.7	11.0	43.8	8.2	5.7	8.6	16.5	9.7	9.1	9.9	5.6	13.5	9.3	16.3	5.3	10.2	10.2	6.6	24.7	4.6	15.5	11.0	3.6	20.0	8.7	0.0	0.0	1.1	0.6	0.0	0.6	0.9	1.0	1.6	0.0	1.7	0.3	0.5	0.3	1.1	0.0	0.0	4.0	0.8	0.3	0.4	0.3	0.4	0.4	0.3	0.4	0.2	0.6	0.2	3.0	0.6	0.0	0.5	1.1	0.0	0.7	0.0	4.0	3.4	0.0	2.0	4.1	3.3	0.4	19.9	0.1	0.2	23.3	0.2	13.1	0.8	0.2	1.1	0.0	5.2	0.0	1.7	0.0	2.4	12.8	0.9	1.2	0.0	9.0	1.0	0.3	0.4	0.0	0.7	0.0	1.2	6.5	0.2	63.4	28.5	0.3	3.1	0.0	1.2	0.7
ARHGAP18	"bA307O14.2, MacGAP"	ENSG00000146376	"Rho GTPase activating protein 18"	Q8N392	6	129576132-129710225	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 362.7;granulocytes: 240.9;Syncytiotrophoblasts: 177.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 92.9;LHCN-M2: 26.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031595	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA		840000	"Plasma membrane, Cytosol"	"Nuclear speckles"	"HPA031595: AB_10959905"	"unprognostic (6.39e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (4.08e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.05e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.08e-1)"	23.8	32.2	4.1	14.1	4.0	1.7	19.7	2.5	2.4	9.6	19.5	2.9	12.0	13.3	7.8	25.8	5.8	15.7	11.8	16.9	4.4	6.8	33.2	4.5	38.8	15.5	4.1	1.4	8.0	38.2	10.6	22.0	16.7	12.2	9.6	8.2	10.4	16.7	24.2	12.1	5.4	40.6	6.5	9.0	15.8	15.1	10.9	3.8	5.1	12.7	12.1	6.4	10.3	5.8	2.9	11.8	13.0	5.9	2.5	5.8	6.0	1.9	4.3	0.4	0.6	4.2	6.0	3.5	14.6	11.2	6.5	4.3	2.2	3.2	1.6	7.2	9.8	2.0	2.5	3.1	4.8	12.1	1.5	1.3	10.4	3.4	12.8	6.0	1.5	92.9	3.8	0.7	11.7	10.5	13.6	18.4	0.0	5.5	4.0	26.1	0.5	0.0	1.5	0.4	3.6	1.0	0.0	2.0	3.0	19.8	1.1	0.0	0.0	1.2	2.0	7.2	2.2	2.2	1.8	14.0	6.8	0.9	0.5	11.7	1.8	1.3	1.0	2.3	2.8	9.4	8.9	5.2	13.0	5.3	5.9	3.3	2.9	2.8	5.8	4.8	1.7	0.5	2.9	4.0	2.5	3.1	11.8	2.7	6.0	4.1	4.0	2.5	2.4	4.4	6.8	4.1	1.4	12.2	3.8	53.6	36.1	12.9	16.2	11.6	0.0	3.1	15.3	362.7	50.0	36.6	2.0	73.2	127.6	38.7	17.9	35.4	23.6	0.0	105.3	16.5	19.2	20.3	240.9	4.4	101.2	0.0	12.6	11.6	45.7	13.8	3.4	131.1	6.8	18.0	19.9	14.3	82.5	24.6	1.1	20.3	0.6	25.8	11.9	3.4	1.2	11.3	177.5	25.4	28.3	15.9
KLF5	"BTEB2, CKLF, IKLF"	ENSG00000102554	"Kruppel like factor 5"	Q13887	13	73054976-73077542	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.4;intestine: 88.1"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 1017.1;Suprabasal keratinocytes: 599.6;Urothelial cells: 1225.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"basal ganglia: 22.2"	"Cell type enriched"	"Detected in single"	18	"basophil: 16.3"	"Lineage enriched"	"Detected in single"	106	"granulocytes: 16.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 27.5;HaCaT: 31.5;HBEC3-KT: 27.5;hTCEpi: 39.3;OE19: 59.4;RT4: 33.2;SiHa: 28.0"	"Group enriched"	"Detected in many"	4	"amygdala: 5.6;basal ganglia: 9.3;cerebral cortex: 6.9;hippocampal formation: 8.8;hypothalamus: 4.3"	"Low region specificity"	"Detected in some"			HPA040398	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA040398: AB_10673267"	"unprognostic (7.90e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.82e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (2.55e-4)"	"unprognostic (4.43e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.98e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.54e-2)"	2.3	1.5	4.1	24.3	22.2	12.9	8.1	0.7	1.2	19.6	74.4	0.4	4.3	28.7	4.8	3.7	88.4	8.3	48.4	1.3	1.4	1.2	3.9	1.2	12.8	0.1	0.9	1.1	5.0	3.5	0.0	7.3	22.8	4.3	17.6	32.9	1.8	26.4	5.4	10.0	59.4	88.1	4.1	2.4	0.8	17.9	12.2	1.4	3.0	20.7	64.4	61.8	23.4	34.1	0.0	0.0	16.3	0.0	0.0	0.1	0.0	5.3	7.4	0.0	0.1	0.2	0.4	8.5	3.1	7.3	1.4	1.7	6.9	27.5	0.1	16.7	2.7	0.5	31.5	9.6	27.5	2.2	0.2	2.5	0.1	15.7	0.6	2.0	2.5	0.4	2.0	39.3	0.4	15.4	1.4	0.0	0.9	0.3	0.5	6.3	1.8	0.5	0.1	0.3	59.4	10.6	0.4	7.0	0.6	21.8	33.2	0.7	0.3	28.0	4.5	1.9	3.6	0.6	0.6	0.0	1.9	5.7	0.0	1.3	0.9	0.4	0.9	2.7	0.5	2.3	16.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	4.1	22.2	0.7	1.2	1.4	1.2	0.9	1.1	4.3	1.4	151.8	97.6	0.5	1017.1	460.9	0.4	5.6	79.0	128.5	151.2	34.9	2.0	57.7	18.3	30.8	305.6	1.1	308.2	0.0	40.2	87.3	46.1	522.9	3.5	2.9	5.4	9.5	195.2	0.6	0.0	162.5	6.1	6.1	55.6	5.4	327.8	0.0	63.9	284.0	1.4	2.6	0.0	0.0	28.8	7.2	25.9	599.6	48.5	0.7	397.9	1225.4
LAMB3	"BM600-125kDa, kalinin-140kDa, LAMNB1, nicein-125kDa"	ENSG00000196878	"Laminin subunit beta 3"	Q13751	1	209614870-209652466	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Amelogenesis imperfecta, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 205.4;Basal glandular cells: 278.5;Pancreatic endocrine cells: 523.1;Urothelial cells: 285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"myeloid DC: 1.9;neutrophil: 3.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.9;granulocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.5;HaCaT: 66.0;HBEC3-KT: 161.1;hTCEpi: 51.6;hTERT-HME1: 32.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA007584, HPA008069, CAB078183"	Enhanced		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		15000	Vesicles		"CAB078183: AB_2665825, HPA007584: , HPA008069: AB_1079228"	"prognostic favorable (8.43e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.62e-5)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (2.55e-4)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.43e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.01e-2)"	"unprognostic (4.92e-3)"	24.5	8.4	1.2	5.5	1.7	3.3	11.7	0.8	4.1	10.2	9.9	0.9	3.2	12.1	7.0	3.1	22.1	6.3	8.4	8.9	1.1	0.8	4.7	4.7	11.0	1.6	1.2	2.2	1.4	2.1	0.0	1.1	16.1	1.1	11.9	6.3	0.8	19.1	10.3	1.9	17.9	22.8	2.7	1.4	2.1	28.7	1.7	0.8	4.9	1.1	35.8	30.2	16.2	13.3	0.1	1.9	3.4	0.5	0.4	0.4	0.1	21.1	3.1	0.0	0.0	2.3	1.5	0.1	0.6	1.9	0.7	1.1	8.3	43.5	0.0	1.8	0.4	1.1	66.0	0.0	161.1	1.1	1.5	0.1	0.1	11.2	0.1	0.3	0.1	0.1	0.3	51.6	2.4	32.1	1.4	0.7	0.0	0.3	0.8	0.2	0.0	0.0	0.1	0.0	9.7	9.1	0.0	2.1	19.3	8.9	13.2	0.0	0.0	9.0	1.0	1.8	0.1	0.2	1.1	16.8	3.6	7.8	0.1	12.6	0.2	0.4	0.0	5.3	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.4	0.0	1.9	0.1	0.4	0.0	3.4	0.4	0.0	0.0	0.0	0.1	1.2	1.7	0.8	4.1	1.1	0.8	1.2	2.2	1.1	0.8	205.4	75.6	2.2	278.5	97.4	0.2	6.9	2.5	44.2	151.2	45.4	0.0	0.1	0.0	174.0	4.1	1.1	142.2	0.0	132.9	1.1	4.3	108.8	18.4	3.9	2.1	3.2	7.5	0.0	0.0	7.4	1.7	10.1	8.5	3.6	43.8	0.8	523.1	80.7	0.7	1.9	0.3	0.0	4.2	0.3	0.7	22.7	0.5	0.0	20.5	285.9
PPFIBP1	"hSGT2, hSgt2p, L2, SGT2"	ENSG00000110841	"PPFIA binding protein 1"	Q86W92	12	27523431-27695564	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 154.9;Endothelial cells: 139.6;Ito cells: 144.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 7.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SuSa: 53.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001924	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA001924: AB_1079665"	"unprognostic (5.27e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (4.73e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.11e-4)"	"unprognostic (7.33e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.92e-2)"	"prognostic favorable (5.11e-7)"	"unprognostic (8.54e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.09e-2)"	21.3	17.1	15.5	8.0	16.8	2.2	22.6	4.9	25.0	18.3	15.4	13.3	13.0	7.1	28.1	9.3	17.1	16.5	12.2	43.3	17.1	9.0	23.8	15.7	25.0	7.8	13.1	16.4	53.1	13.7	12.7	22.2	34.5	15.3	15.3	11.1	8.1	14.2	18.4	13.7	17.8	10.0	20.5	11.2	16.6	15.1	7.1	13.3	6.2	23.9	14.9	6.2	17.2	18.4	7.0	2.0	1.5	0.6	0.3	1.8	0.6	4.4	8.9	7.3	6.2	12.1	33.8	13.0	16.1	18.1	9.5	13.7	23.4	13.5	3.3	18.8	32.6	12.7	11.1	3.9	14.7	17.1	7.6	2.2	7.4	6.8	3.4	5.3	2.2	4.1	26.2	10.3	27.6	28.4	18.6	32.4	4.5	3.8	3.4	33.7	3.4	2.1	0.6	13.0	6.3	6.9	3.4	18.1	1.2	14.1	9.8	0.6	3.0	8.0	4.3	22.4	53.2	5.5	3.4	31.5	26.8	9.0	14.6	16.4	0.0	0.0	0.2	29.8	3.2	42.2	1.5	0.6	0.3	0.7	0.2	1.4	0.7	1.3	0.7	0.6	7.0	1.3	1.3	1.5	0.3	0.2	2.0	1.8	0.6	15.5	16.8	4.9	25.0	17.1	9.0	13.1	16.4	15.3	13.3	92.3	20.3	24.3	55.3	36.5	2.3	154.9	2.5	9.4	14.8	76.8	3.9	28.5	10.0	37.2	2.6	139.6	7.0	0.0	21.6	18.9	41.3	34.7	3.5	12.7	8.3	42.9	17.9	144.9	21.5	3.1	19.5	6.4	59.1	3.6	14.6	7.5	26.9	14.4	39.6	16.6	1.7	19.4	44.8	1.7	9.1	24.1	76.9	5.9	11.5	75.3
SPTY2D1	"DKFZp686I068, FLJ39441, Spt2"	ENSG00000179119	"SPT2 chromatin protein domain containing 1"	Q68D10	11	18606401-18634791	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039372, HPA040177, HPA047957"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA039372: AB_2676472, HPA040177: , HPA047957: AB_2680224"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.07e-4)"	"unprognostic (1.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-1)"	14.0	12.7	6.2	9.7	9.2	33.6	11.9	10.9	10.9	13.7	10.9	6.9	9.9	8.3	11.9	8.6	15.5	12.5	12.2	9.9	5.8	6.5	14.9	25.1	9.7	8.7	6.0	6.8	16.7	16.9	13.6	14.0	15.3	8.5	12.5	9.7	7.9	13.3	13.9	16.3	12.5	13.7	9.3	7.6	15.0	11.0	7.1	5.5	17.7	12.8	8.0	13.3	12.5	11.8	2.7	3.4	7.8	5.7	7.3	8.7	3.3	8.2	8.1	6.5	9.1	10.9	11.4	10.0	12.2	13.4	10.2	12.3	7.2	3.6	18.5	6.9	11.5	8.0	8.6	10.8	9.6	14.7	9.7	10.1	7.4	4.9	6.6	10.5	15.6	14.8	9.4	10.0	6.5	13.3	7.4	11.2	11.1	10.3	29.5	11.3	8.9	10.4	6.2	5.9	16.2	9.1	9.6	18.1	7.9	10.7	11.9	6.3	8.9	10.9	12.7	8.5	8.9	7.9	6.7	9.8	10.0	8.5	19.4	7.4	10.3	12.7	14.5	11.9	8.7	8.4	7.8	4.1	5.8	5.7	5.7	8.7	2.6	5.6	5.7	3.4	2.7	5.2	5.6	6.0	7.3	5.4	2.9	6.0	3.3	6.2	9.2	10.9	10.9	5.8	6.5	6.0	6.8	8.5	5.5	23.8	45.0	23.8	18.6	49.6	12.8	23.6	12.7	61.6	34.2	26.2	9.8	12.3	14.9	21.5	1.6	21.9	22.7	0.0	21.7	19.7	31.0	20.1	56.6	25.6	14.3	11.1	42.5	21.5	27.0	1.7	17.5	31.7	15.1	13.6	24.2	13.8	21.6	22.1	13.1	12.6	11.2	32.3	23.0	10.7	14.2	58.1	23.0	35.5	18.6	29.3
MECOM	"EVI1, KMT8E, MDS1, MDS1-EVI1, PRDM3"	ENSG00000085276	"MDS1 and EVI1 complex locus"	Q03112	3	169083499-169663618	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 169.5;Club cells: 93.3;Collecting duct cells: 118.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 15.6;HUVEC TERT2: 22.0;RPTEC TERT1: 28.2;RT4: 44.4;TIME: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA046537	Supported		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA046537: AB_2679689"	"unprognostic (4.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.27e-3)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.37e-3)"	25.9	0.7	3.3	5.7	5.6	0.3	9.1	3.4	5.3	13.5	13.9	1.6	22.1	11.2	15.4	5.7	10.4	14.3	8.1	8.2	3.3	2.9	32.2	2.6	30.0	1.5	4.6	1.4	6.2	27.8	1.1	5.3	10.0	4.7	9.3	17.5	4.2	5.9	25.3	16.0	2.3	5.9	5.6	5.8	6.4	39.4	2.7	3.5	0.2	4.7	3.3	3.5	18.1	18.5	0.3	0.0	0.6	1.5	1.8	1.0	0.0	9.8	0.1	0.2	0.0	1.3	1.0	0.1	1.3	1.6	0.5	0.9	3.9	10.1	0.0	15.6	0.2	2.2	5.2	4.1	6.1	1.1	0.5	6.4	6.2	1.7	0.1	0.1	0.0	1.9	2.1	0.8	0.3	4.6	4.8	22.0	0.5	4.7	0.7	3.9	1.0	0.0	0.0	0.2	5.1	2.5	3.7	5.1	0.2	28.2	44.4	0.3	1.2	0.4	2.6	0.1	0.3	3.0	0.0	20.9	3.9	2.5	1.0	6.5	0.5	0.1	0.3	1.9	0.0	0.6	0.3	0.0	0.6	0.4	0.2	1.0	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.3	1.8	1.5	0.0	0.1	0.0	3.3	5.6	3.4	5.3	3.3	2.9	4.6	1.4	4.7	3.5	56.6	169.5	0.0	27.4	1.9	0.0	6.7	5.1	64.3	93.3	118.7	0.0	0.9	44.7	0.8	4.6	40.2	10.5	0.0	65.4	0.1	1.5	9.9	9.2	0.0	0.0	0.0	19.1	34.4	0.6	1.7	0.3	1.0	1.7	1.8	23.3	0.0	42.3	3.5	0.0	0.3	0.0	0.0	0.7	2.1	0.4	1.3	0.3	0.5	49.4	38.8
PRMT5	"HRMT1L5, SKB1, SKB1Hs"	ENSG00000100462	"Protein arginine methyltransferase 5"	O14744	14	22920511-22929585	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005525, CAB012459, HPA064708"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB012459: , HPA005525: AB_1079679, HPA064708: AB_2685330"	"unprognostic (8.34e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.19e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.56e-3)"	"prognostic unfavorable (1.82e-4)"	"prognostic unfavorable (4.77e-5)"	"unprognostic (3.64e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.04e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavorable (1.04e-4)"	17.0	21.6	18.3	17.8	22.8	12.0	21.2	18.4	24.9	20.3	25.0	18.1	24.9	16.1	24.9	19.6	33.1	28.0	16.6	22.3	15.3	13.2	25.7	22.2	15.8	15.6	17.2	15.2	30.2	30.9	30.8	17.4	24.3	15.9	21.1	22.6	16.9	19.0	21.7	42.0	21.7	14.5	22.2	13.4	17.9	19.5	22.1	17.3	22.7	30.9	19.6	22.1	20.8	22.0	17.6	23.8	4.3	17.6	9.8	15.6	15.5	40.7	39.4	28.5	28.2	13.6	15.5	31.1	28.1	20.9	43.6	37.0	36.0	37.9	39.8	23.0	20.7	25.9	32.6	56.4	47.2	50.5	25.5	27.2	24.7	26.6	55.3	26.1	51.8	21.6	15.2	25.2	33.7	61.6	17.8	20.6	31.8	35.0	21.8	22.5	36.8	37.1	23.2	25.5	35.5	49.8	43.8	34.5	28.9	21.2	28.0	30.7	20.1	30.7	32.9	14.3	25.5	22.2	19.6	19.3	18.5	26.4	26.3	35.8	29.9	63.7	52.9	11.7	25.2	28.9	1.7	16.8	0.2	8.2	17.6	13.4	17.6	11.3	13.5	23.8	15.5	15.6	12.5	4.3	9.8	13.2	14.1	9.4	15.5	18.3	22.8	18.4	24.9	15.3	13.2	17.2	15.2	15.9	17.3	17.9	10.8	4.5	23.8	23.6	9.5	0.8	28.1	26.8	11.4	7.0	7.9	33.6	19.9	25.6	1.9	11.2	6.3	0.0	23.3	26.7	18.6	11.3	6.9	15.5	17.4	15.9	5.8	11.1	4.9	2.7	15.3	10.4	25.3	11.8	15.7	19.1	60.5	8.6	19.8	18.4	7.5	6.5	27.8	34.9	54.7	24.3	27.9	10.1	19.0	16.8
PYGL		ENSG00000100504	"Glycogen phosphorylase L"	P06737	14	50857891-50944736	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 117.8;Hofbauer cells: 137.9;Muller glia cells: 253.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 36.0;neutrophil: 41.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 57.0;HMC-1: 63.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000962, HPA004119"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		17000000	"Plasma membrane, Cytosol"		"HPA000962: AB_1079722, HPA004119: AB_1079723"	"unprognostic (2.70e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.55e-2)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (4.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.12e-3)"	47.6	9.9	4.9	9.7	6.8	40.0	28.1	1.3	3.9	17.2	10.1	3.0	23.7	1.7	10.9	7.3	24.8	7.8	5.5	15.0	3.9	3.4	6.8	58.8	19.6	25.6	6.5	1.6	15.4	4.1	12.5	3.7	23.3	5.3	11.4	10.3	17.8	11.8	55.2	7.1	15.3	3.5	11.2	8.7	38.8	4.5	6.8	5.4	2.4	7.1	9.1	7.3	18.4	24.3	0.0	7.3	41.4	13.8	0.1	0.0	5.5	28.7	8.1	2.1	13.4	10.0	12.0	23.4	5.8	4.9	16.0	24.4	21.4	3.7	0.0	11.3	34.4	19.0	57.0	21.7	29.2	27.8	0.1	9.2	5.5	13.0	16.6	17.9	20.9	63.0	25.5	11.9	21.6	9.1	15.9	14.1	0.1	2.2	0.1	11.3	28.7	0.0	28.9	8.1	2.6	30.2	0.5	7.5	1.1	22.1	19.3	0.9	0.9	26.3	9.1	0.3	8.5	4.3	41.1	0.6	6.2	10.4	11.5	18.6	0.2	0.0	0.0	5.7	21.7	3.3	11.3	13.8	36.0	0.0	6.3	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	41.4	0.1	3.9	0.3	0.0	5.5	4.9	6.8	1.3	3.9	3.9	3.4	6.5	1.6	5.3	5.4	20.8	7.5	2.7	8.9	27.2	4.1	2.0	7.6	10.7	15.9	7.0	0.0	29.4	3.3	9.4	0.4	6.0	3.4	0.0	1.8	117.8	14.4	8.6	5.8	53.3	137.9	1.6	1.2	6.7	43.8	0.7	13.3	29.1	18.6	15.4	6.9	253.1	7.2	0.0	20.5	3.4	9.1	6.5	7.1	0.7	0.6	19.4	17.6	2.9	11.5	7.4
TMEM123	"KCT3, PORIMIN"	ENSG00000152558	"Transmembrane protein 123"	Q8N131	11	102396332-102470384	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 142.0"					"Low region specificity"	"Detected in all"			"CAB026001, HPA062862"			Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus"	"Vesicles, Cytosol"	"CAB026001: , HPA062862: AB_2732691"	"unprognostic (2.64e-1)"	"unprognostic (8.39e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.40e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.65e-2)"	21.3	23.1	18.8	30.1	23.3	39.8	38.6	7.4	18.8	35.2	38.2	19.1	15.1	12.4	65.3	20.8	31.9	21.6	20.8	36.8	20.7	14.0	27.0	95.4	39.5	55.5	22.6	13.7	27.8	24.7	14.5	8.5	23.9	21.1	34.9	19.9	13.9	53.3	22.2	13.2	29.7	17.6	29.7	22.4	39.9	23.7	22.9	24.6	71.9	66.0	20.1	27.1	43.7	39.8	23.3	30.3	48.3	29.2	52.4	55.5	51.3	29.2	26.2	27.2	25.2	34.8	28.5	18.5	22.8	49.4	46.7	52.0	33.2	142.0	49.3	58.8	52.8	33.5	31.8	29.5	37.6	51.7	29.7	10.8	25.7	10.3	49.4	30.7	54.4	19.2	31.8	42.9	33.3	50.0	65.2	52.2	26.6	17.2	0.1	38.5	9.4	47.2	17.1	16.2	48.6	24.1	29.0	75.1	47.3	44.4	29.0	12.9	15.2	27.7	37.9	15.0	30.5	23.4	21.3	61.1	31.4	35.2	27.2	17.1	19.1	10.6	50.1	9.1	60.7	20.7	30.1	26.8	48.3	26.3	29.2	40.0	16.7	41.3	31.8	30.3	23.3	55.5	46.9	17.6	52.4	24.2	8.1	42.9	51.3	18.8	23.3	7.4	18.8	20.7	14.0	22.6	13.7	21.1	24.6	116.1	70.4	106.9	216.5	142.4	0.7	46.0	145.2	156.6	139.9	155.3	0.0	39.5	68.0	142.3	41.1	161.1	25.3	46.7	102.9	31.6	66.8	247.8	57.7	245.2	98.2	1.6	86.9	279.3	203.3	16.8	87.2	149.4	153.5	211.0	157.1	3.3	143.2	24.6	87.7	40.5	1.0	64.7	91.8	25.6	58.6	154.8	25.4	130.8	142.2	235.1
FRMD6	"C14orf31, EX1, MGC17921, willin"	ENSG00000139926	"FERM domain containing 6"	Q96NE9	14	51489100-51730727	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 119.7;Early spermatids: 184.0;Late spermatids: 333.9;Suprabasal keratinocytes: 120.2;Urothelial cells: 134.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.3;naive CD4 T-cell: 2.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.3;T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"BJ: 58.1;fHDF/TERT166: 121.7;U-138 MG: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001297	Uncertain	Supported	Approved	Mitochondria		NA	NA			Mitochondria		"HPA001297: AB_1078913"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.64e-2)"	"unprognostic (8.05e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (1.28e-4)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.20e-2)"	7.8	6.4	2.7	7.6	5.3	0.2	12.9	14.3	4.6	44.6	9.8	4.8	14.1	2.2	52.3	11.6	32.8	8.8	16.0	9.0	4.3	2.1	2.7	4.7	5.4	4.1	3.8	2.8	12.0	2.8	1.0	2.7	10.7	4.4	21.5	5.0	13.2	10.7	23.0	3.8	20.4	4.8	27.5	3.6	8.3	5.4	14.0	2.1	5.2	4.8	20.9	23.3	20.3	18.5	0.1	0.0	3.3	0.6	0.3	2.5	0.7	12.2	2.1	3.5	6.7	7.3	11.2	1.4	58.1	30.2	32.4	29.2	7.6	2.8	0.2	1.8	121.7	10.1	12.7	1.0	18.6	39.0	0.1	1.3	0.1	1.1	0.3	9.3	0.0	0.6	9.6	7.5	26.9	33.4	14.2	9.8	0.6	0.1	3.9	33.7	1.8	1.0	0.0	0.8	0.0	4.2	0.1	13.6	0.1	6.0	18.4	0.6	7.8	4.1	0.8	5.7	7.3	0.5	0.1	36.4	49.8	19.0	12.5	12.4	3.0	2.4	0.0	3.2	0.0	19.7	3.3	0.3	0.0	0.1	0.2	0.0	0.1	0.7	0.0	0.0	0.0	2.5	1.9	0.2	0.3	0.6	0.0	0.0	0.7	2.7	5.3	14.3	4.6	4.3	2.1	3.8	2.8	4.4	2.1	3.0	1.0	0.0	119.7	99.0	0.4	2.2	10.2	0.0	5.7	0.0	0.0	32.7	0.0	13.0	184.0	10.3	0.0	0.0	2.5	3.7	47.2	36.8	1.1	3.4	3.3	0.0	0.0	9.8	0.3	333.9	16.4	3.3	30.4	1.0	0.0	10.1	37.9	0.0	20.8	0.3	0.2	6.5	24.7	4.4	6.4	120.2	32.6	0.0	0.0	134.9
ANXA8	ANX8	ENSG00000265190	"Annexin A8"	P13928	10	47460162-47484158	"Predicted intracellular proteins"	"Blood coagulation, Hemostasis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"esophagus: 41.6;skin 1: 60.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 92.3;Ciliated cells: 25.4;Club cells: 73.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 16.1"					"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 73.7;HBEC3-KT: 107.5;hTCEpi: 60.8;hTERT-HME1: 23.2;RT4: 27.0"									"HPA045246, HPA047451"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045246: AB_2679271, HPA047451: AB_2680052"	"unprognostic (8.32e-4)"	"unprognostic (2.52e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (5.94e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (2.68e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.55e-15)"	"unprognostic (1.04e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.39e-1)"	0.1	0.0	0.1	3.7	0.1	0.0	2.3	0.1	0.1	2.9	0.4	0.1	0.1	0.0	0.1	1.3	41.6	0.2	0.1	0.1	0.1		0.1	0.1	2.4	0.1	0.1	0.1	0.4	0.1	0.0	0.1	7.7	0.1	1.2	0.0	0.3	0.1	1.8	0.1	60.7	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	2.5	9.5	10.2	0.1	0.0	5.5	1.1	2.1	0.7	0.0	0.5	20.5	2.6	0.0	0.0	0.0	0.0	6.1	0.4	0.0	0.0	0.0	1.3	5.9	0.0	0.4	0.1	0.3	73.7	0.0	107.5	0.0	4.7	0.0	0.0	6.7	0.0	4.4	0.0	0.2	0.0	60.8	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	10.7	3.1	0.0	1.6	0.0	0.5	0.0	0.0	6.4	0.1	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5											92.3	8.2	0.0	9.1	1.0	0.0	1.6	5.1	25.4	73.9	3.5	0.0	5.7	0.0	3.2	0.4	0.4	0.7	0.0	0.4	7.2	0.5	1.1	1.1	0.0	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	1.8	5.1	0.0	0.0	15.7
SQLE		ENSG00000104549	"Squalene epoxidase"	Q14534	8	124998497-125022283	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018038, HPA020762"	Enhanced		Uncertain	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA018038: AB_2669753, HPA020762: AB_2670512"	"unprognostic (1.37e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.12e-2)"	"unprognostic (9.51e-3)"	"unprognostic (4.63e-1)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (4.76e-3)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (3.45e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (9.71e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-3)"	"unprognostic (7.74e-3)"	4.6	15.7	11.1	9.9	13.9	10.4	12.1	8.9	19.9	15.1	11.5	28.8	4.4	15.8	8.9	5.1	40.3	10.0	6.3	4.2	15.4	14.5	7.8	38.1	16.0	8.6	10.8	9.7	17.5	6.3	16.5	9.5	24.7	28.5	13.8	10.1	9.3	10.4	4.7	1.3	23.8	8.7	6.6	36.0	5.6	11.5	29.3	18.7	9.8	5.7	24.2	15.0	5.3	21.6	15.1	12.4	1.2	9.7	9.5	9.0	6.1	25.8	10.0	60.2	17.3	18.7	31.8	6.1	6.8	21.0	9.3	17.1	13.6	37.9	17.8	9.9	8.4	37.4	19.8	25.1	37.7	10.8	14.7	53.0	50.9	6.8	34.7	27.6	5.9	15.0	21.7	40.4	27.7	22.9	6.0	10.1	12.6	29.0	34.7	7.5	42.7	20.6	7.5	24.9	17.8	6.9	9.1	11.0	24.3	65.6	29.8	18.8	9.5	14.0	45.0	14.0	20.2	12.0	15.6	9.9	3.8	13.6	4.5	6.0	6.3	12.8	24.4	6.4	18.2	6.6	1.2	5.1	0.5	9.0	8.5	4.4	13.6	5.4	8.3	12.4	15.1	7.5	7.8	0.1	9.5	9.7	8.8	5.6	6.1	11.1	13.9	8.9	16.4	15.4	14.5	10.8	9.7	28.5	18.7	56.6	84.1	38.7	41.4	20.4	26.3	6.1	28.1	108.4	52.4	50.6	47.1	81.6	6.6	50.5	18.8	11.2	44.6	46.7	73.0	111.6	54.5	79.8	41.4	15.7	48.5	139.8	30.4	12.3	13.0	9.6	22.2	16.0	20.3	154.1	29.4	23.5	64.9	21.0	10.3	2.9	47.5	25.8	29.0	131.6	152.1	77.9	181.6	17.5	20.4	100.4
DHRS9	"3alpha-HSD, RDH15, RDHL, RETSDR8, SDR9C4"	ENSG00000073737	"Dehydrogenase/reductase 9"	Q9BPW9	2	169064789-169096167	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.0;blood: 53.1;heart muscle: 32.2;intestine: 30.9"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 118.1;granulocytes: 85.8;Syncytiotrophoblasts: 223.7;Urothelial cells: 225.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 16.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 53.1;eosinophil: 23.9;neutrophil: 19.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 53.1"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 10.1;HUVEC TERT2: 8.9;NB-4: 14.7;THP-1: 42.9;TIME: 19.1;U-2197: 14.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA036491, HPA036667"	Approved				"Intracellular and membrane"	NA	NA					"HPA036491: AB_10673498, HPA036667: AB_10670237"	"unprognostic (1.15e-1)"	"unprognostic (3.82e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.62e-4)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (2.72e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.41e-1)"	40.0	0.1	1.3	14.9	1.0	3.3	2.2	0.3	1.9	4.0	30.9	1.1	0.8	0.6	1.3	0.9	12.8	0.6	2.3	32.2	1.2	0.8	0.4	1.0	9.6	8.0	2.5	1.1	1.2	1.4	0.0	0.3	4.9	1.1	3.5	20.9	0.6	2.9	0.3	1.0	1.5	2.7	3.5	2.4	4.0	4.6	12.3	0.6	0.9	0.5	23.2	12.0	3.7	4.6	1.7	5.4	53.1	6.1	0.0	0.1	1.3	0.0	0.3	0.0	0.0	1.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.7	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.4	0.2	0.2	0.6	2.7	10.1	8.9	0.0	0.4	0.0	0.0	0.0	0.0	14.7	0.0	0.1	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.9	19.1	0.0	0.1	14.1	0.1	0.0	0.0	0.0	0.3	7.7	0.0	53.1	5.4	23.9	0.0	6.1	0.1	1.7	0.0	0.0	5.4	1.0	0.0	0.0	19.5	0.0	1.2	0.4	0.0	1.3	1.3	1.0	0.3	0.7	1.2	0.8	2.5	1.1	1.1	0.6	0.0	2.2	0.9	6.8	1.4	0.0	26.4	0.0	57.6	10.3	0.0	0.0	1.7	0.0	0.3	118.1	0.6	34.9	0.0	21.0	1.1	1.1	5.5	85.8	0.5	25.7	0.0	1.7	0.0	5.7	33.8	1.1	6.4	0.0	0.0	38.5	3.5	40.1	9.5	0.4	0.0	0.0	6.5	0.1	0.7	0.6	1.3	223.7	0.0	1.3	225.8
MMADHC	"C2orf25, cblD, CL25022"	ENSG00000168288	"Methylmalonic aciduria and homocystinuria, cblD type"	Q9H3L0	2	149569634-149587816	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037531, HPA037532"	Supported					NA	NA					"HPA037531: AB_10671628, HPA037532: AB_2675526"	"unprognostic (5.67e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.07e-3)"	"unprognostic (8.17e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (3.14e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.16e-1)"	34.2	28.8	14.6	15.3	20.5	37.2	29.1	20.5	23.3	27.9	23.4	12.3	25.9	19.3	26.2	19.2	40.2	21.1	17.1	32.7	14.0	14.6	37.6	80.1	20.4	24.7	17.6	11.6	23.9	38.8	22.9	34.9	34.6	20.4	32.6	27.2	17.2	37.1	22.0	78.6	30.3	35.5	27.4	15.1	29.8	28.4	30.3	15.1	40.2	35.5	39.2	28.7	38.2	27.9	40.6	44.3	58.8	38.3	43.0	46.6	40.9	28.7	21.5	27.5	67.9	33.2	55.6	42.2	47.2	62.5	49.7	42.9	40.9	32.3	46.4	26.7	50.3	29.5	37.3	38.4	48.1	63.0	31.2	31.1	37.1	29.0	44.8	54.1	55.3	35.5	44.5	49.5	64.3	66.8	46.5	55.8	31.1	49.2	49.4	58.5	31.1	24.2	35.1	39.4	39.3	43.7	30.0	31.6	39.5	52.8	49.3	35.0	19.6	35.2	32.6	44.8	31.2	33.6	31.2	37.8	39.8	37.7	29.2	36.2	31.7	39.9	50.4	39.0	33.6	52.7	58.2	30.3	48.8	31.5	33.7	36.5	40.6	39.6	34.4	44.3	32.6	42.2	34.5	58.8	43.0	38.3	37.5	46.6	40.9	14.6	20.5	20.5	23.3	14.0	14.6	17.6	11.6	20.4	15.1	44.7	50.2	67.7	153.7	117.0	23.8	164.3	73.9	100.4	50.0	47.1	11.8	130.7	170.8	133.2	113.6	65.5	69.1	70.0	161.8	149.0	78.0	155.6	65.7	125.0	113.7	19.1	93.4	71.8	84.5	27.8	61.5	71.8	74.2	87.4	107.6	43.3	137.4	82.3	73.6	167.8	14.0	97.0	128.2	194.9	45.6	123.7	204.9	76.2	74.8	193.6
CCL20	"CKb4, exodus-1, LARC, MIP-3a, SCYA20, ST38"	ENSG00000115009	"C-C motif chemokine ligand 20"	P78556	2	227805739-227817564	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	"Antibiotic, Antimicrobial, Cytokine"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 48.5;lung: 36.8;lymphoid tissue: 50.9"	"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 266.2;Glandular cells: 185.4;Paneth cells: 292.5;Urothelial cells: 548.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 6.6"	"Lineage enriched"	"Detected in single"	10	"T-cells: 6.6"	"Cell line enhanced"	"Detected in many"		"GAMG: 36.0;Hep G2: 19.3;NB-4: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	28000					"unprognostic (2.40e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.87e-2)"	"unprognostic (7.06e-2)"	"unprognostic (7.08e-3)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (1.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.21e-1)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.19e-8)"	"unprognostic (1.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.82e-1)"	5.6	0.1	0.4	23.3	0.9	1.5	0.4	0.3	0.4	7.1	5.5	0.3	0.3	4.4	3.9	1.5	11.8	2.0	48.5	1.5	0.4	0.2	7.1	17.2	36.8	16.3	0.4	0.3	1.5	1.9	0.0	0.3	0.9	1.3	2.0	7.8	0.4	4.0	0.3	0.5	4.3	18.2	1.0	1.3	0.5	2.8	1.6	0.4	1.8	0.5	18.3	50.9	19.6	2.5	0.3	0.6	0.0	0.3	0.0	6.6	0.3	0.2	0.8	0.4	0.4	1.8	3.7	0.5	0.2	1.1	0.1	0.4	2.1	0.3	0.7	2.5	0.0	36.0	0.4	0.1	4.8	0.8	0.5	0.8	0.1	1.6	19.3	1.4	2.7	0.2	5.8	1.0	1.1	1.3	0.5	0.0	0.6	0.1	3.0	0.3	0.2	0.2	14.0	0.9	2.8	0.4	0.3	5.0	0.5	0.1	8.5	0.3	0.2	0.2	0.8	0.5	0.4	0.7	2.8	1.4	1.8	2.4	4.1	0.4	0.5	1.6	1.1	2.9	1.9	3.8	0.0	0.3	0.0	0.1	0.1	6.6	0.2	2.7	1.4	0.3	0.3	0.4	0.3	0.0	0.0	0.2	0.6	1.0	0.3	0.4	0.9	0.3	0.4	0.4	0.2	0.4	0.3	1.3	0.4	44.7	86.3	5.0	266.2	105.6	0.2	0.8	30.6	20.1	105.8	17.4	0.0	0.1	0.0	133.7	2.4	0.2	119.7	0.0	2.5	0.3	3.3	185.4	5.7	1.0	30.6	1.6	55.7	0.0	2.2	0.0	0.0	33.0	1.7	16.2	60.3	0.0	31.3	292.5	0.0	2.4	0.1	0.0	3.8	0.0	0.9	56.7	0.7	16.0	52.5	548.3
VCL		ENSG00000035403	Vinculin	P18206	10	73995193-74121363	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Actin-binding	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 304.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 90.2;hTERT-RPE1: 88.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002131, CAB002453, HPA063777"	Enhanced		Enhanced	"Focal adhesion sites"		NA	NA		1800000000	"Focal adhesion sites"		"CAB002453: AB_564057, HPA002131: AB_1080570, HPA063777: AB_2685121"	"unprognostic (8.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.14e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.37e-3)"	31.9	7.3	4.3	19.0	6.0	8.6	24.4	5.4	5.3	37.9	41.2	6.7	24.4	8.0	72.1	29.2	36.1	27.6	44.8	35.0	4.7	3.9	20.8	6.9	25.9	9.3	3.8	5.5	29.2	12.8	18.1	7.6	22.6	9.6	43.3	18.0	20.2	14.9	38.8	59.1	14.4	20.2	113.1	3.8	23.6	23.6	29.5	3.3	3.0	15.3	20.5	11.7	73.9	26.1	3.7	12.9	21.6	11.3	2.8	9.9	15.6	22.4	15.4	27.9	19.7	35.0	40.8	15.4	29.7	90.2	20.3	23.1	13.8	19.6	1.0	24.8	51.8	13.9	28.9	18.3	14.9	21.5	1.9	7.8	10.7	15.0	5.7	19.2	2.1	16.4	33.7	4.0	27.5	25.1	88.6	27.1	1.8	7.7	2.2	33.8	3.8	0.3	2.5	13.2	10.8	54.5	3.7	14.6	2.8	29.1	29.1	1.0	4.1	16.5	18.7	8.5	25.7	8.6	3.2	36.2	22.2	9.3	10.7	27.7	0.4	0.9	4.4	25.9	6.0	6.2	8.5	7.6	21.6	9.9	10.8	7.0	3.7	4.7	5.1	12.9	1.6	1.8	3.6	7.0	2.8	11.3	5.0	1.2	15.6	4.3	6.0	5.4	5.3	4.7	3.9	3.8	5.5	9.6	3.3	92.3	37.8	11.5	94.3	102.0	13.5	304.7	50.9	28.1	77.3	40.1	80.5	44.5	3.3	59.0	2.3	54.3	61.0	0.0	53.1	67.5	69.7	88.5	33.6	30.6	21.4	15.9	36.8	73.1	36.2	4.7	46.3	28.0	25.3	9.0	29.5	12.2	85.6	31.9	72.2	12.4	35.2	103.5	102.7	14.2	10.9	81.3	33.2	19.8	37.5	76.0
DDIT4	"Dig2, FLJ20500, REDD-1, REDD1, RTP801"	ENSG00000168209	"DNA damage inducible transcript 4"	Q9NX09	10	72273920-72276036	"Predicted intracellular proteins"	"Antiviral defense, Apoptosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 159.3"	"Cell type enhanced"	"Detected in all"	5	"Muller glia cells: 589.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 66.5;hTCEpi: 225.6;hTERT-HME1: 82.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034507, HPA034508"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA034507: AB_2674199, HPA034508: AB_10601206"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.91e-3)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (7.65e-2)"	"unprognostic (1.62e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.96e-3)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (9.72e-2)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (8.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.66e-1)"	29.0	43.9	27.3	28.0	28.0	35.5	88.2	23.1	27.1	38.7	18.7	6.4	14.4	7.5	16.3	13.5	37.0	14.5	21.7	23.0	28.2	8.4	13.6	27.5	33.7	26.5	45.5	11.6	73.4	159.3	5.4	16.4	16.2	34.4	15.8	5.1	10.2	41.2	29.2	29.5	21.0	13.0	11.7	22.8	17.5	19.6	8.1	34.9	30.8	13.4	11.1	34.5	37.8	47.7	25.9	40.5	9.7	2.5	70.6	57.1	40.9	12.8	9.3	1.9	17.3	12.5	7.2	5.6	3.9	4.3	1.4	5.8	1.0	27.8	1.4	11.8	0.6	1.8	15.1	2.6	66.5	3.2	20.8	3.4	1.5	21.0	6.9	49.5	4.3	6.3	30.4	225.6	6.0	82.9	13.2	5.5	3.3	12.4	34.6	5.0	5.3	2.6	6.0	0.4	6.2	2.1	1.5	2.1	24.6	11.9	3.0	3.4	4.8	9.2	14.6	52.1	4.5	2.0	9.7	11.4	0.4	3.7	0.8	2.1	24.6	13.6	3.8	24.8	9.8	2.9	9.2	1.6	9.7	50.4	2.5	48.6	17.9	32.8	27.8	7.2	25.9	57.1	42.9	5.3	70.6	2.0	40.5	24.0	40.9	27.3	28.0	23.1	27.1	28.2	8.4	45.5	11.6	34.4	34.9	11.9	40.9	153.5	238.2	203.1	78.2	12.9	58.6	36.1	63.7	57.6	74.6	7.9	51.4	226.4	2.3	154.0	50.8	23.3	146.9	35.2	109.4	154.5	397.0	55.0	80.1	28.6	71.9	166.3	61.3	4.7	81.7	238.1	376.2	53.3	48.9	589.5	133.5	28.1	120.6	9.0	131.0	71.1	402.1	1.9	4.3	219.8	15.9	277.0	34.0	244.9
P4HA1	"C-P4Halpha(I), P4HA"	ENSG00000122884	"Prolyl 4-hydroxylase subunit alpha 1"	P13674	10	73007217-73096974	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 105.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 94.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007599, HPA026593"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles,Mitochondria"	"Intracellular and membrane"	Yes	No			"Endoplasmic reticulum"	"Vesicles, Mitochondria"	"HPA007599: AB_1854891, HPA026593: AB_1854892"	"prognostic unfavorable (9.01e-4)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (2.76e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.15e-2)"	"prognostic unfavorable (9.40e-9)"	"unprognostic (3.14e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.75e-2)"	16.8	14.4	16.5	10.4	20.2	7.0	47.6	9.9	18.2	18.5	10.9	11.3	7.4	5.6	14.8	12.2	11.6	22.4	14.1	23.9	17.0	10.9	19.0	39.9	18.1	7.5	33.5	4.9	22.3	13.1	11.1	8.6	33.5	25.4	17.9	9.4	8.6	8.5	10.4	63.5	10.3	7.8	15.1	45.8	9.7	11.1	9.7	30.9	4.1	19.4	7.5	7.3	34.4	105.7	6.9	14.8	10.2	17.3	3.4	7.3	6.1	15.2	3.9	11.4	22.1	35.2	27.1	9.5	44.7	40.5	17.3	41.6	6.5	11.9	5.2	17.1	44.2	10.5	17.3	7.1	16.3	37.9	6.6	2.7	4.4	3.7	7.7	14.7	8.1	3.1	16.4	9.5	14.7	19.5	94.8	8.1	4.4	6.8	2.7	14.9	4.0	3.2	7.8	4.1	7.1	17.3	2.9	7.6	9.3	9.7	6.6	1.0	6.4	9.1	27.0	10.6	26.9	4.1	7.6	7.7	21.2	8.7	5.9	10.4	15.6	5.6	2.5	38.0	11.8	10.3	0.8	13.5	10.2	5.2	16.4	6.7	6.0	6.2	6.0	14.8	6.9	4.6	4.7	7.4	3.4	17.3	11.8	7.3	6.1	16.5	20.2	9.9	18.2	17.0	10.9	33.5	4.9	25.4	30.9	6.0	27.9	18.6	25.1	32.3	12.9	37.9	2.5	56.2	31.8	22.7	25.5	25.0	0.0	26.6	10.0	23.3	10.7	0.0	17.0	76.6	76.1	22.0	39.3	25.1	39.6	11.1	9.9	19.0	44.8	4.7	48.1	41.1	42.2	36.1	7.6	33.4	37.2	18.2	44.2	22.8	17.6	38.8	31.1	35.7	35.8	20.8	27.8	13.8	6.5	17.3
TXNRD3	"TGR, TR2, TRXR3"	ENSG00000197763	"Thioredoxin reductase 3"	Q86VQ6	3	126607052-126655155	"Enzymes, Predicted intracellular proteins"	"Differentiation, Electron transport, Spermatogenesis, Transport"	"Developmental protein, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.8"	"Cell type enhanced"	"Detected in many"	13	"Spermatocytes: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.0"	"Lineage enriched"	"Detected in single"	4	"T-cells: 4.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020802, HPA036109"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB020802: , HPA036109: AB_2674945"	"unprognostic (1.41e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (3.90e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.72e-4)"	"unprognostic (5.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	5.4	5.9	4.9	2.4	4.7	0.9	7.2	5.5	5.7	7.3	4.2	4.6	5.5	1.6	8.3	7.1	6.4	4.7	5.2	4.9	4.0	2.9	6.7	10.0	7.0	5.2	4.6	3.5	8.8	7.1	12.3	8.5	3.3	7.0	5.2	3.6	6.4	5.7	5.1	7.3	4.8	2.6	8.1	5.1	3.3	4.9	27.8	5.8	5.0	7.4	3.6	2.1	6.6	5.3	0.3	0.7	0.5	0.9	0.9	4.0	0.3	14.0	3.6	4.6	7.2	8.5	13.0	2.3	6.2	5.6	5.1	7.2	6.4	7.9	0.0	7.9	8.5	3.1	5.6	5.7	6.4	6.5	0.0	4.2	1.6	3.3	4.9	7.4	5.7	0.5	11.9	5.6	1.7	11.8	7.0	3.7	4.6	3.4	0.0	8.2	10.1	1.2	3.1	6.5	3.8	2.7	0.4	4.0	2.3	5.4	7.0	8.0	4.9	17.8	5.2	9.0	3.7	7.2	2.2	6.1	6.3	1.5	8.5	2.9	3.7	1.6	0.0	3.4	2.0	5.3	0.0	0.9	0.5	0.5	0.8	0.1	0.0	0.2	0.6	0.7	0.3	4.0	1.3	0.0	0.9	0.2	0.0	0.0	0.3	4.9	4.7	5.5	5.7	4.0	2.9	4.6	3.5	7.0	5.8	3.0	7.4	0.0	4.8	0.9	1.9	3.6	5.1	2.7	3.4	3.5	2.0	7.5	3.3	4.3	15.1	1.5	0.0	0.0	3.4	4.6	3.7	2.1	5.7	7.3	2.6	0.0	4.1	1.3	0.3	2.9	4.4	0.3	0.0	0.0	2.3	2.3	3.9	0.0	8.1	2.8	0.5	0.0	2.7	54.7	15.3	0.5	6.1	0.0	1.5	2.5
CTSV	"CTSL2, CTSU"	ENSG00000136943	"Cathepsin V"	O60911	9	97029679-97039643	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 154.7"	"Cell type enhanced"	"Detected in many"	12	"Cytotrophoblasts: 114.1;Extravillous trophoblasts: 136.0;Syncytiotrophoblasts: 56.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"NK-cell: 4.2;plasmacytoid DC: 15.7"	"Group enriched"	"Detected in many"	42	"dendritic cells: 15.7;NK-cells: 4.2"	"Group enriched"	"Detected in many"	9	"BEWO: 92.0;SuSa: 118.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017112	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		260000	"Nucleoli fibrillar center, Cytosol"	"Nucleoplasm, Plasma membrane"	"CAB017112: "	"unprognostic (2.40e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (7.29e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (7.04e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.04e-3)"	"prognostic unfavorable (2.39e-4)"	0.7	0.0	0.4	0.6	0.7	0.0	3.5	0.4	1.0	23.0	1.4	2.0	0.4	0.5	1.5	1.5	9.8	0.6	0.5	0.2	0.8	0.6	9.7	0.4	0.6	0.2	1.5	0.7	0.4	1.1	1.1	0.9	8.7	1.6	0.5	1.6	4.3	5.0	0.6	0.5	25.0	0.6	0.2	3.0	0.2	1.1	32.4	1.0	154.7	0.7	6.3	2.7	0.2	9.9	0.2	15.7	0.2	0.0	4.2	0.0	0.1	5.9	1.8	2.0	5.3	0.1	0.0	92.0	0.0	0.0	1.3	1.0	12.1	5.9	0.0	0.5	0.0	8.8	11.4	9.8	7.2	1.9	0.0	1.3	0.2	0.6	1.8	0.0	0.0	0.8	0.0	2.4	0.3	0.3	0.1	0.4	1.7	0.2	0.0	2.3	2.2	0.1	0.0	12.2	12.0	1.7	0.0	4.4	0.1	1.8	0.7	0.5	0.9	6.0	2.1	2.1	118.9	3.8	0.7	0.0	0.3	6.0	0.0	0.6	1.2	3.2	0.1	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.2	4.2	0.0	15.7	0.0	0.1	0.4	0.7	0.4	1.0	0.8	0.6	1.5	0.7	1.6	1.0	0.0	0.6	1.5	13.2	27.0	4.4	0.8	0.0	0.0	3.4	1.8	9.8	114.1	1.7	1.2	1.5	1.5	1.2	0.0	0.7	136.0	2.6	7.1	0.0	0.0	11.8	0.0	1.7	0.6	0.0	9.6	3.7	1.6	0.0	0.0	0.9	4.5	0.6	1.7	1.1	11.1	26.0	6.5	0.8	34.6	32.6	10.5	56.3	0.0	3.7	6.4
TSKU	"E2IG4, LRRC54, TSK"	ENSG00000182704	"Tsukushi, small leucine rich proteoglycan"	Q8WUA8	11	76782251-76798154	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 86.8"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 427.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 41.4;ASC diff: 70.9;OE19: 44.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA008164	Approved		Approved	"Nucleoplasm,Nuclear bodies"	"Secreted - unknown location"	NA	NA		2100000	Nucleoplasm	"Nuclear bodies"	"HPA008164: AB_1853327"	"unprognostic (1.07e-2)"	"unprognostic (2.29e-3)"	"unprognostic (6.15e-2)"	"prognostic favorable (3.66e-4)"	"unprognostic (7.05e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.81e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (2.87e-4)"	"prognostic favorable (1.66e-4)"	"prognostic unfavorable (2.80e-8)"	"unprognostic (1.47e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.88e-2)"	33.1	2.8	1.0	3.6	1.4	0.6	26.9	1.5	2.0	38.8	16.1	1.8	6.4	11.5	13.2	25.5	17.8	15.3	8.6	9.3	1.2	0.3	31.8	86.8	5.1	3.7	1.7	1.3	27.8	12.2	2.6	4.3	43.0	3.4	15.7	4.5	48.5	9.3	10.8	7.0	15.0	21.4	13.0	0.8	3.0	8.7	9.0	0.8	1.5	12.2	16.0	12.4	18.2	27.9	1.8	0.7	2.1	0.4	0.7	1.3	0.2	0.8	41.4	4.6	4.5	70.9	9.1	8.5	1.4	7.8	3.1	3.0	5.3	11.4	0.1	8.1	5.1	13.2	16.6	2.6	10.2	0.9	8.5	1.4	2.0	10.7	14.8	13.4	0.7	3.1	9.3	11.2	5.5	4.5	5.9	3.8	1.5	4.5	0.3	2.8	19.1	0.1	1.5	6.1	44.7	1.8	1.3	4.4	6.5	7.3	7.2	4.2	6.9	7.9	6.2	3.8	4.1	8.3	0.6	1.1	8.7	6.9	21.1	3.3	0.3	0.1	0.3	4.1	2.1	1.5	1.8	0.4	0.5	0.9	0.2	0.4	1.8	0.8	0.7	0.4	1.8	0.9	1.3	2.1	0.7	0.4	0.7	0.8	0.2	1.0	1.4	1.5	2.0	1.2	0.3	1.7	1.3	3.4	0.8	0.0	0.3	0.0	13.0	15.3	3.2	3.9	15.3	2.7	5.7	1.8	0.0	42.8	0.0	5.8	0.2	3.6	20.6	23.3	19.6	58.8	39.7	6.5	1.1	427.8	8.4	0.0	7.5	8.6	9.5	1.2	34.5	1.6	5.0	2.8	14.2	10.4	17.7	20.1	42.5	21.9	0.5	0.0	13.4	0.4	2.3	19.7	36.6	4.4	11.3	17.0
ZNF148	"BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148"	ENSG00000163848	"Zinc finger protein 148"	Q9UQR1	3	125225561-125375354	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001656, CAB017486"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"CAB017486: AB_794260, HPA001656: AB_1079995"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.94e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (6.36e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.72e-1)"	10.5	9.2	12.5	13.4	17.4	5.3	9.4	18.4	17.7	10.7	8.9	4.1	3.3	5.7	11.2	8.3	8.9	10.2	8.6	11.7	11.2	7.2	10.6	9.0	8.8	8.8	11.9	11.8	14.5	7.7	15.7	18.2	7.6	10.5	9.1	9.2	6.7	10.3	12.2	12.2	7.6	8.0	11.0	7.6	8.6	7.4	9.5	10.9	25.4	24.4	3.2	10.8	10.7	9.8	13.9	7.3	29.7	12.1	18.8	17.3	10.2	18.4	12.2	13.3	11.8	11.9	12.9	10.1	16.8	19.7	18.9	18.1	11.5	10.3	14.9	11.8	24.8	15.3	15.1	14.5	12.7	27.0	6.6	5.5	18.3	14.7	5.9	8.8	12.5	18.5	10.4	13.3	17.7	18.8	12.5	12.9	10.9	8.9	12.7	13.9	14.4	15.5	4.6	8.5	12.5	10.5	11.2	14.6	8.3	10.8	20.6	11.5	9.7	22.4	11.4	18.7	7.7	14.2	12.6	16.6	14.4	15.5	18.0	10.7	11.1	12.6	22.6	10.8	8.0	13.2	2.5	8.7	17.4	13.4	8.4	13.8	13.8	11.8	12.5	7.3	13.9	17.3	13.5	29.7	18.8	12.1	6.5	10.8	10.2	12.5	17.4	18.4	17.7	11.2	7.2	11.9	11.8	10.5	10.9	86.4	32.9	27.3	25.1	31.6	67.0	66.1	28.1	24.1	43.3	31.4	37.3	23.6	21.6	32.2	73.6	43.1	22.7	46.7	32.7	20.8	30.5	30.4	48.6	37.5	26.6	71.5	46.0	36.8	37.3	83.4	44.5	32.2	16.9	28.9	37.1	41.2	29.0	17.5	55.5	36.0	37.8	32.3	38.1	18.2	18.1	33.5	26.4	45.9	33.3	32.5
SSH3	"FLJ10928, FLJ20515"	ENSG00000172830	"Slingshot protein phosphatase 3"	Q8TE77	11	67303448-67312607	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.8;eosinophil: 10.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 23.8;RT4: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA019949, HPA019957"	Approved		Approved	"Nuclear speckles,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Nuclear speckles, Cytosol"	"Plasma membrane, Actin filaments"	"HPA019949: AB_1857498, HPA019957: AB_1857499"	"unprognostic (4.38e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.50e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.61e-3)"	"unprognostic (9.30e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (6.78e-3)"	8.6	5.5	5.6	6.8	9.7	8.1	13.5	17.8	9.4	14.6	15.9	15.4	19.5	12.4	10.1	10.6	27.0	15.2	20.5	7.7	6.0	6.1	10.3	7.5	9.0	3.5	13.6	5.4	17.1	12.0	11.3	7.4	20.0	8.5	19.8	9.2	11.9	19.1	30.5	5.2	18.2	13.6	13.1	9.3	6.9	13.9	4.2	9.7	0.8	12.8	14.0	13.2	33.3	18.6	0.3	1.6	10.8	2.3	1.5	2.2	1.0	6.2	6.7	0.1	0.2	4.8	4.9	7.4	4.1	5.4	2.1	2.0	7.3	16.5	0.3	12.6	3.7	4.5	23.8	2.2	17.2	1.2	1.3	2.5	1.6	10.9	2.9	3.3	0.3	6.1	4.3	15.9	3.1	3.3	5.0	2.4	0.1	0.0	0.6	2.5	21.0	0.2	3.0	1.5	17.0	5.4	7.7	0.2	1.1	7.0	36.0	1.4	2.2	9.5	14.1	4.4	2.6	19.8	5.2	3.9	1.7	3.7	4.8	1.1	0.7	0.3	0.2	4.9	2.7	1.6	10.8	1.4	10.5	2.2	2.3	1.7	0.3	2.1	1.8	1.6	0.2	0.8	0.9	4.5	1.5	1.1	1.1	1.8	1.0	5.6	9.7	17.8	9.4	6.0	6.1	13.6	5.4	8.5	9.7	3.0	5.4	0.0	20.7	6.3	1.1	3.4	15.3	8.1	10.3	15.7	0.0	12.6	3.3	16.4	0.0	3.9	17.2	0.0	19.0	20.2	6.2	13.1	3.5	4.3	6.8	1.6	3.5	4.3	8.6	0.0	12.0	2.9	8.5	12.6	14.7	4.6	16.4	17.5	11.3	6.3	0.4	0.0	8.3	0.3	0.0	9.2	13.2	4.3	18.5	22.9
PROM2		ENSG00000155066	"Prominin 2"	Q8N271	2	95274453-95291308	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 45.9;Collecting duct cells: 31.4;Urothelial cells: 37.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 23.8;CAPAN-2: 42.0;HaCaT: 22.6;hTCEpi: 24.6;MCF7: 18.6;RT4: 25.6;SK-BR-3: 36.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB046005, HPA063728"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB046005: AB_2284371, HPA063728: AB_2685104"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (1.46e-2)"	"unprognostic (4.59e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-2)"	0.3	0.2	0.5	2.9	0.6	0.0	9.3	1.1	0.5	11.4	5.2	0.3	22.2	4.4	1.4	22.5	42.6	2.2	37.2	0.5	0.6	0.5	18.8	0.4	1.3	0.3	0.6	0.3	1.5	8.6	8.1	1.5	12.5	0.3	11.6	4.2	0.3	35.6	20.0	1.3	26.7	2.6	2.7	0.7	0.4	11.5	1.8	0.3	1.7	5.7	21.6	22.2	20.0	14.8	0.0	0.2	0.6	0.0	0.0	0.3	0.0	23.8	0.0	0.0	0.2	0.1	0.0	12.1	0.0	0.0	0.1	0.1	0.2	42.0	0.0	0.0	0.0	0.0	22.6	0.0	13.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	24.6	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	18.6	0.1	0.1	0.0	1.1	0.1	0.0	0.0	0.0	0.0	25.6	0.2	0.0	0.0	36.7	0.0	0.3	11.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.2	0.0	0.5	0.6	1.1	0.5	0.6	0.5	0.6	0.3	0.3	0.3	3.0	3.4	0.0	20.8	6.0	0.2	1.4	45.9	6.7	11.4	31.4	3.9	15.3	10.0	12.0	0.4	0.0	2.6	0.0	9.6	2.3	0.8	11.1	0.0	0.0	2.0	0.0	3.5	0.0	0.0	1.1	0.3	0.0	6.8	1.0	10.5	0.0	12.7	7.0	0.7	0.0	0.9	0.0	1.0	0.7	0.0	11.2	9.4	0.0	12.4	37.6
CDC6	CDC18L	ENSG00000094804	"Cell division cycle 6"	Q99741	17	40287633-40304657	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.0"	"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 23.3;Extravillous trophoblasts: 27.7;Spermatogonia: 23.0;Syncytiotrophoblasts: 14.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 6.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.2;NK-cells: 2.2;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 86.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA050114, HPA065070"	Approved		Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	Yes			"Nucleoplasm, Cytosol"	"Cytokinetic bridge, Mitotic spindle"	"HPA050114: AB_2681021, HPA065070: AB_2732729"	"unprognostic (1.29e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.97e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (5.96e-8)"	"unprognostic (2.31e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (5.47e-2)"	"unprognostic (3.00e-15)"	"unprognostic (1.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (3.88e-2)"	1.8	2.9	3.1	10.8	2.6	16.8	1.5	2.3	6.0	2.7	5.8	0.8	2.7	5.3	1.9	1.6	9.0	1.3	5.4	1.6	1.9	1.4	1.8	5.1	2.8	10.6	1.0	1.5	1.5	3.6	1.1	1.2	9.4	0.8	1.4	5.6	0.2	3.2	4.1	0.9	2.3	7.9	2.4	1.6	7.7	2.7	14.8	1.2	30.0	1.3	5.0	10.1	4.1	3.0	0.7	6.2	0.2	0.3	2.2	3.4	1.2	25.4	17.6	21.3	15.1	1.1	2.3	19.5	27.8	8.3	24.4	29.5	20.0	11.4	20.6	17.4	5.9	14.1	37.1	18.4	12.6	24.3	10.9	14.5	16.7	21.0	17.9	0.7	22.8	10.3	0.6	0.9	28.2	16.9	2.6	7.3	14.2	30.5	19.3	11.8	13.3	33.1	5.5	17.5	15.1	6.5	24.4	51.9	19.4	4.0	28.7	14.6	13.1	25.3	86.7	8.6	17.4	17.6	19.8	6.1	17.6	25.2	28.8	32.9	8.1	17.5	39.7	15.2	15.1	19.2	0.1	0.3	0.0	1.3	0.0	0.9	0.7	1.2	2.1	1.4	0.7	0.9	2.1	0.2	2.2	0.0	6.2	3.4	1.2	3.1	2.6	2.3	6.0	1.9	1.4	1.0	1.5	0.8	1.2	0.0	1.3	2.2	1.1	3.8	0.0	0.6	0.0	0.0	1.2	0.0	0.0	12.0	0.0	1.2	1.4	0.5	1.1	23.3	0.6	27.7	2.4	1.1	0.0	0.9	6.8	0.0	0.0	1.8	1.3	0.2	2.6	1.3	0.0	0.0	1.7	0.3	1.2	2.9	0.7	0.2	0.3	12.9	1.0	11.4	23.0	1.4	14.0	2.5	4.6	2.0
MACROD1	LRP16	ENSG00000133315	"MACRO domain containing 1"	Q9BQ69	11	63998558-64166106	"Disease related genes, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 142.5"	"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 116.0;Proximal tubular cells: 164.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 27.0;RPMI-8226: 51.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041031, HPA071075"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041031: AB_10794435, HPA071075: AB_2686341"	"unprognostic (1.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.15e-1)"	"prognostic favorable (4.68e-6)"	"unprognostic (2.45e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.86e-2)"	4.9	3.0	2.9	2.8	3.3	2.5	3.9	6.2	4.6	3.6	6.9	2.8	7.0	4.3	3.4	6.5	7.8	3.2	3.9	29.0	2.2	3.4	10.6	10.4	3.0	1.8	3.0	3.1	5.2	16.6	2.5	2.7	2.1	3.1	6.1	1.9	4.6	16.4	8.1	142.5	5.5	3.9	6.2	2.4	2.7	5.6	1.9	2.7	0.8	12.7	25.0	3.3	4.6	4.5	0.6	0.7	0.0	1.2	0.0	2.0	0.4	4.0	2.1	0.6	3.8	0.6	0.4	3.7	2.3	1.1	1.9	1.8	2.0	11.0	15.4	8.5	0.2	0.6	10.4	0.5	0.0	0.1	1.1	7.2	5.5	8.8	10.9	2.3	4.6	0.6	0.9	1.2	0.2	0.5	1.3	0.7	4.8	5.0	3.1	0.3	27.0	6.4	15.9	1.8	1.4	8.2	5.7	4.3	51.0	0.6	0.2	5.3	11.0	2.1	15.9	14.5	0.0	11.4	0.1	1.0	1.7	2.6	2.6	0.2	6.2	0.9	2.5	1.2	4.7	1.6	0.0	0.2	0.0	2.0	1.2	1.9	0.6	1.8	1.1	0.4	0.4	0.9	0.8	0.0	0.0	0.0	0.7	0.0	0.4	2.9	3.3	6.2	4.6	2.2	3.4	3.0	3.1	3.1	2.7	0.0	5.8	10.9	30.6	24.8	13.1	30.8	30.6	0.0	4.5	40.1	0.0	25.1	116.0	16.5	5.8	9.0	17.2	0.0	34.7	10.9	13.7	23.2	0.0	42.3	9.7	11.1	22.0	7.4	2.5	15.9	23.0	1.8	37.1	2.8	52.9	14.3	17.6	28.8	13.4	164.4	15.8	19.4	18.4	2.9	28.5	32.4	20.0	6.1	65.5	30.1
GJB2	"CX26, DFNA3, DFNB1, NSRD1"	ENSG00000165474	"Gap junction protein beta 2"	P29033	13	20187463-20193010	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Disease mutation, Ectodermal dysplasia, Ichthyosis, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix, uterine: 52.8;esophagus: 128.1;lymphoid tissue: 71.1;tongue: 129.0;vagina: 64.9"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 62.0;Hepatocytes: 24.2;Suprabasal keratinocytes: 25.1"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 447.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 43.7;hTCEpi: 32.6;OE19: 22.7;RT4: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013093, HPA014362"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"CAB013093: AB_2533903, HPA014362: "	"unprognostic (2.21e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (4.45e-4)"	"unprognostic (9.77e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.69e-3)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (2.53e-6)"	"unprognostic (5.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.93e-3)"	0.2	0.0	0.2	1.5	0.3	0.5	0.7	1.0	0.5	52.8	3.9	0.4	0.4	2.4	4.2	0.6	128.1	0.1	2.7	0.1	0.5	0.1	3.5	9.1	0.1	0.0	1.3	0.7	0.1	0.1	0.0	0.5	0.2	4.5	0.3	3.4	0.3	19.7	0.2	0.2	10.3	1.9	0.4	3.7	0.0	1.5	0.2	0.2	3.2	0.2	129.0	71.1	2.3	64.9	0.0	0.0	0.4	0.6	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.4	43.7	0.0	0.2	0.0	0.3	8.7	1.6	4.3	0.0	3.6	0.5	0.0	0.0	0.1	0.0	0.0	1.5	0.7	32.6	0.5	6.0	0.0	0.0	0.6	0.0	3.2	0.0	0.4	0.3	0.0	0.1	22.7	4.3	0.0	0.0	2.4	0.0	50.8	0.0	0.0	0.0	0.0	0.1	0.6	0.6	0.1	0.0	0.0	0.0	0.7	6.5	2.6	2.7	0.0	5.3	0.0	0.6	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.5	0.5	0.1	1.3	0.7	4.5	0.2	3.0	0.0	0.8	8.0	62.0	0.0	0.4	5.1	0.0	3.4	1.8	0.0	0.0	0.0	3.5	0.7	0.2	19.0	0.0	8.8	0.2	1.6	7.8	0.0	24.2	0.7	0.0	4.1	0.0	0.8	0.9	0.0	1.2	1.7	8.2	3.9	0.0	8.1	15.0	0.0	14.7	0.0	0.0	2.0	0.2	0.4	25.1	0.1	0.0	19.7	15.6
NLRP2	"CLR19.9, FLJ20510, NALP2, NBS1, PAN1, PYPAF2"	ENSG00000022556	"NLR family pyrin domain containing 2"	Q9NX02	19	54953130-55001142	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 14.3"	"Group enriched"	"Detected in many"	5	"Extravillous trophoblasts: 180.1;Syncytiotrophoblasts: 81.4"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 78.1"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 25.0;K-562: 10.4;SuSa: 11.1;U-266/84: 11.3"									HPA021183			Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus, Vesicles, Cytosol"		"HPA021183: AB_2670615"	"unprognostic (1.66e-2)"	"unprognostic (9.28e-2)"	"unprognostic (6.60e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (3.63e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.86e-2)"	"unprognostic (7.57e-2)"	0.6	0.9	1.1	5.0	3.8	1.7	1.4	0.6	2.7	2.6	2.6	0.9	0.2	2.5	2.1	3.7	10.8	1.0	3.7	0.7	2.0	1.8	4.7	0.9	2.2	5.0	0.8	0.8	1.0	6.1	0.3	1.7	8.1	2.9	2.1	1.2	2.4	4.1	1.6	1.4	3.5	2.9	1.1	1.0	3.0	3.1	14.3	0.9	4.2	3.1	0.2	3.5	4.7	5.6	3.8	1.8	0.6	0.9	3.4	2.6	0.8	2.3	3.9	1.9	0.4	0.1	0.1	25.0	0.1	0.0	0.2	0.1	5.0	0.5	2.6	0.2	0.1	0.1	4.1	0.0	4.2	0.2	2.5	0.2	2.5	0.3	0.0	0.3	0.1	0.3	0.1	0.2	0.0	0.1	0.1	0.0	0.0	10.4	0.3	0.0	0.3	0.2	1.0	3.0	4.4	0.0	2.8	0.0	1.4	2.3	0.9	2.4	0.6	0.1	1.1	0.0	11.1	3.4	0.8	0.0	0.2	0.5	0.3	0.3	2.7	11.3	0.9	0.3	0.7	0.1	0.6	0.7	0.3	2.6	0.9	1.5	3.8	1.1	1.0	0.6	2.6	0.8	1.5	0.5	3.4	0.5	1.8	1.2	0.8	1.1	3.8	0.6	2.7	2.0	1.8	0.8	0.8	2.9	0.9	8.9	5.3	0.5	1.3	0.5	2.1	0.6	2.5	6.7	7.9	1.8	3.9	28.7	0.0	4.2	18.8	0.2	1.3	0.0	1.8	180.1	0.4	2.2	4.6	0.0	10.4	0.0	2.4	0.0	0.0	4.9	0.9	0.5	0.0	4.6	2.8	1.1	4.4	0.0	0.0	0.3	2.2	0.0	0.3	13.5	11.4	1.1	81.4	0.5	2.3	3.1
TGM2	TGC	ENSG00000198959	"Transglutaminase 2"	P21980	20	38127387-38166578	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 187.6;placenta: 212.7"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 276.1;Ito cells: 326.6;Pancreatic endocrine cells: 240.4;Syncytiotrophoblasts: 312.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 2.5;memory B-cell: 1.9;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	23	"B-cells: 1.9;dendritic cells: 2.4;monocytes: 2.5"	"Group enriched"	"Detected in many"	4	"CAPAN-2: 155.5;EFO-21: 52.3;hTERT-RPE1: 102.6;HUVEC TERT2: 70.7;TIME: 92.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002598, HPA021019, HPA029518"	Enhanced		Approved	"Plasma membrane,Cytosol"		Yes	No		1700000	Cytosol	"Plasma membrane"	"CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133"	"unprognostic (7.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.29e-2)"	"unprognostic (9.78e-3)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (6.99e-2)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.70e-2)"	"unprognostic (6.40e-2)"	33.3	9.5	6.0	18.3	8.1	1.0	7.7	4.3	7.5	94.3	12.6	4.0	4.7	8.4	54.6	21.7	15.8	58.7	62.8	77.1	7.5	3.4	25.3	187.6	61.2	16.4	6.9	3.0	18.7	5.0	5.2	25.6	212.7	8.5	33.6	6.3	57.4	1.9	17.1	19.3	0.7	12.8	43.9	5.7	20.4	13.6	7.4	6.4	0.8	17.0	3.4	3.1	38.2	21.6	1.9	2.4	0.0	2.5	0.0	0.0	0.2	6.3	4.7	0.0	0.1	4.9	0.5	2.4	9.6	4.6	0.0	0.1	7.8	155.5	0.0	52.3	0.1	11.1	0.1	0.0	22.5	0.3	0.0	0.0	1.0	0.2	3.4	20.3	0.0	0.0	0.5	0.0	4.1	0.0	102.6	70.7	0.0	2.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.9	0.0	0.0	0.1	22.6	0.0	0.8	3.3	0.2	0.0	92.1	0.1	5.9	0.7	4.5	0.0	0.0	0.0	6.3	0.0	1.8	0.0	0.2	0.0	0.0	2.5	0.0	1.9	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.0	8.1	4.3	7.5	7.5	3.4	6.9	3.0	8.5	6.4	8.9	28.9	15.2	9.8	0.5	0.0	156.9	48.4	16.0	27.3	14.0	2.0	276.1	3.3	184.1	2.3	166.8	4.2	93.5	124.7	21.8	45.8	45.4	2.3	137.1	49.2	0.0	0.0	326.6	22.9	3.5	1.1	11.4	0.0	10.8	0.0	0.4	240.4	0.0	5.6	19.0	0.5	0.0	65.7	0.5	4.9	0.0	312.9	1.3	0.4	12.3
ZBTB7A	"DKFZp547O146, FBI-1, LRF, pokemon, ZBTB7, ZNF857A"	ENSG00000178951	"Zinc finger and BTB domain containing 7A"	O95365	19	4044364-4066945	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037214, CAB037285, HPA046387"	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB037214: AB_609875, CAB037285: AB_609874, HPA046387: AB_2679648"	"unprognostic (8.88e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.02e-1)"	"prognostic favorable (6.50e-6)"	"unprognostic (7.54e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (3.75e-1)"	"prognostic favorable (1.34e-6)"	"prognostic favorable (1.79e-4)"	"unprognostic (2.01e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.36e-2)"	19.6	13.6	18.1	14.3	19.5	17.5	13.6	26.3	26.6	15.2	23.3	14.3	16.0	27.1	16.7	10.6	29.8	12.6	21.1	11.1	20.6	10.4	11.6	12.2	13.7	14.2	13.2	11.6	12.0	12.1	16.2	11.4	12.9	16.8	14.2	11.6	12.4	16.3	14.0	32.0	21.9	22.7	14.2	10.2	19.5	29.2	5.6	13.2	12.4	10.6	15.8	20.5	17.7	16.0	2.9	2.2	4.9	3.7	2.8	2.2	0.5	17.5	8.7	1.5	5.5	12.4	12.8	6.1	12.7	8.0	3.7	3.9	3.1	7.8	8.2	8.5	9.7	5.1	15.6	2.0	6.4	3.3	15.1	8.6	4.9	6.2	4.2	8.4	7.1	17.4	7.0	10.7	5.2	5.2	7.8	4.2	3.9	9.3	7.7	4.2	12.3	8.4	4.9	3.8	8.3	11.0	6.3	4.6	8.2	5.9	7.7	6.7	5.1	7.9	18.0	7.7	1.4	10.1	12.2	12.6	14.0	6.5	18.7	16.4	15.5	6.6	4.7	17.6	7.3	8.9	1.6	2.8	0.8	2.2	3.7	1.8	2.9	1.3	1.7	0.8	1.9	1.0	2.0	4.9	2.8	2.9	2.2	0.9	0.5	18.1	19.5	26.3	26.6	20.6	10.4	13.2	11.6	16.8	13.2	38.7	38.6	34.0	57.5	78.6	100.0	23.6	79.0	18.7	21.6	40.1	51.1	18.0	23.2	18.6	4.0	41.1	124.6	23.3	17.5	8.9	23.5	73.0	25.5	59.6	21.6	151.0	46.0	63.8	54.1	4.4	40.9	49.9	35.4	16.2	105.5	27.3	24.2	77.7	46.3	15.9	69.0	32.3	43.4	3.8	1.7	99.5	45.0	54.2	87.3	93.1
DPY19L1	KIAA0877	ENSG00000173852	"Dpy-19 like C-mannosyltransferase 1"	Q2PZI1	7	34928876-35038271	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 183.8;Late spermatids: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059139	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA059139: AB_2683921"	"unprognostic (4.66e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.53e-3)"	"unprognostic (2.47e-3)"	"unprognostic (2.50e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.02e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (3.21e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.12e-2)"	9.7	12.2	11.0	10.2	13.0	9.0	13.7	16.9	27.0	15.6	9.3	13.5	4.5	4.8	17.7	4.3	7.1	10.3	13.8	18.1	11.8	13.4	7.2	25.2	13.0	9.9	16.3	12.0	8.6	6.7	5.0	11.2	19.0	23.6	8.6	11.3	10.3	6.4	8.4	4.0	4.5	6.8	17.5	38.1	14.1	9.0	31.7	5.8	2.3	10.4	3.6	8.4	11.5	11.3	1.6	1.6	2.8	2.3	1.6	4.1	1.0	5.3	21.0	12.0	15.2	23.7	18.9	2.5	11.9	10.8	7.4	10.6	5.0	14.0	7.7	17.5	12.3	30.8	9.5	9.1	6.5	16.8	4.0	7.3	11.3	13.3	8.2	8.6	10.5	10.5	9.7	5.4	10.1	6.7	21.3	30.6	3.8	8.4	31.6	26.0	3.0	0.1	10.5	7.7	12.5	9.5	7.8	15.8	11.0	28.2	18.5	5.5	14.5	10.6	1.5	6.1	19.7	10.7	12.7	35.3	14.9	18.0	10.2	16.0	14.3	30.8	8.7	18.4	9.8	41.3	2.8	1.7	0.1	3.9	2.3	4.1	1.3	1.7	3.1	1.5	1.6	0.6	1.8	0.3	1.6	0.8	1.6	1.0	1.0	11.0	13.0	16.9	27.0	11.8	13.4	16.3	12.0	23.6	5.8	26.8	16.0	1.9	5.0	6.4	7.2	12.0	5.1	10.7	14.8	7.0	17.7	10.8	0.0	6.4	183.8	10.5	4.5	0.0	14.0	3.5	8.7	7.7	26.5	13.9	7.4	11.1	14.3	21.5	8.2	52.5	8.6	4.0	5.0	0.0	5.0	7.2	16.9	5.8	9.6	1.5	13.3	0.0	6.6	8.3	3.4	4.3	17.7	5.3	6.3	9.5
SPAG5	"DEEPEST, hMAP126, MAP126"	ENSG00000076382	"Sperm associated antigen 5"	Q96R06	17	28577565-28599279	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.3;testis: 94.2"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 101.5;Spermatocytes: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 10.1;T-reg: 6.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 10.1;T-cells: 6.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA022008, HPA022479, HPA024418"	Approved		Supported	"Nuclear bodies,Mitotic spindle,Cytosol"		NA	Yes			"Nuclear bodies, Mitotic spindle"	Cytosol	"HPA022008: AB_1853519, HPA022479: AB_1853521, HPA024418: "	"unprognostic (4.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.32e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (5.43e-5)"	"unprognostic (3.37e-3)"	"unprognostic (4.84e-3)"	"unprognostic (5.97e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (3.49e-2)"	"prognostic unfavorable (5.43e-13)"	"unprognostic (2.64e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.01e-1)"	2.1	1.1	2.3	7.6	3.8	16.5	1.7	2.7	3.4	1.7	5.1	0.8	0.5	3.9	2.0	1.9	3.8	0.5	1.8	1.7	1.8	3.7	12.7	9.5	2.6	6.5	1.5	0.7	1.4	1.9	0.4	1.9	3.3	1.3	1.3	5.3	1.3	1.4	0.9	0.8	2.5	7.1	1.5	1.9	5.8	1.7	94.2	1.0	27.3	3.9	5.5	11.2	1.8	1.3	1.2	0.4	10.1	0.7	1.0	6.2	1.2	23.8	25.3	30.3	23.5	1.5	2.5	12.4	19.3	12.2	28.7	23.2	19.7	7.3	16.8	10.5	13.4	27.0	20.8	32.9	12.2	30.7	30.2	21.1	17.8	25.2	23.9	0.2	23.1	22.5	0.8	1.1	23.1	12.0	4.2	15.0	26.2	19.2	29.7	23.3	15.7	30.4	27.5	16.3	19.2	12.8	20.3	42.2	20.0	8.6	12.7	23.0	13.5	27.7	33.4	9.6	26.1	23.8	21.2	7.4	16.6	27.9	13.7	32.9	13.8	21.1	25.9	11.2	17.7	26.4	10.1	0.0	0.3	0.6	0.7	1.1	0.9	1.8	1.3	0.1	1.2	1.5	1.4	0.6	1.0	0.4	0.4	6.2	1.2	2.3	3.8	2.7	3.4	1.8	3.7	1.5	0.7	1.3	1.0	3.0	1.7	2.2	1.1	1.8	4.7	0.4	0.0	10.7	2.3	0.0	0.0	1.7	1.7	0.5	101.5	1.0	6.2	23.3	0.3	10.6	1.1	0.6	1.1	3.9	5.3	3.2	12.5	4.3	1.8	14.4	0.9	3.6	0.0	1.0	2.3	0.6	0.3	0.8	0.0	10.9	3.3	6.5	1.7	43.6	23.0	0.9	3.2	2.5	2.7	0.5
OAS1	"IFI-4, OIAS, OIASI"	ENSG00000089127	"2'-5'-oligoadenylate synthetase 1"	P00973	12	112906777-112933222	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 83.9"	"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 91.2;Urothelial cells: 142.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 83.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 50.8;BJ hTERT+ SV40 Large T+ RasG12V: 73.0;OE19: 48.0;U-266/70: 71.6;U-266/84: 54.4"									"HPA003657, CAB021104"	Uncertain		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Cytosol"		"CAB021104: AB_10057722, HPA003657: AB_1854747"	"unprognostic (1.03e-1)"	"unprognostic (6.59e-2)"	"unprognostic (8.56e-3)"	"unprognostic (2.20e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.67e-2)"	"prognostic favorable (6.12e-6)"	31.2	7.3	6.1	16.6	7.1	5.7	8.4	2.1	6.0	16.4	25.4	11.0	2.6	23.6	5.8	21.0	39.1	5.1	10.7	5.1	4.2	5.7	18.3	23.3	20.7	17.3	5.9	5.3	7.4	3.2	4.3	6.1	18.8	8.6	11.5	20.5	11.7	31.8	4.2	2.9	6.3	27.2	7.6	9.4	30.1	22.7	4.2	6.2	21.6	9.4	13.5	27.3	20.9	13.0	18.2	24.4	4.1	83.9	4.5	16.8	29.0	1.0	5.8	0.0	0.0	2.0	1.5	0.4	0.0	7.5	50.8	73.0	3.3	6.2	7.9	2.2	0.0	27.5	2.6	0.0	0.7	0.7	5.8	0.0	0.2	10.4	1.2	0.6	0.1	0.4	0.1	2.2	1.9	0.0	0.8	2.7	0.2	0.0	3.5	0.0	0.1	0.2	3.6	0.3	48.0	5.0	1.6	0.0	3.3	2.5	16.4	0.1	0.3	0.8	1.0	19.4	0.0	0.2	1.3	10.0	0.0	0.1	0.7	0.1	71.6	54.4	5.5	0.6	2.3	0.4	1.0	40.9	0.5	4.9	63.6	4.6	18.2	6.5	6.1	24.4	13.6	2.5	3.3	4.1	4.5	83.9	22.1	16.8	29.0	6.1	7.1	2.1	6.0	4.2	5.7	5.9	5.3	8.6	6.2	3.0	2.1	16.4	10.9	3.1	0.2	1.2	15.3	12.0	7.9	5.2	0.0	11.1	5.0	15.7	0.2	16.3	40.3	23.3	10.7	32.3	5.9	6.4	4.7	9.4	91.2	0.0	4.1	12.3	28.2	0.9	6.6	27.7	5.0	10.0	56.5	14.1	14.1	45.6	9.9	19.4	0.4	6.5	1.4	0.0	0.2	1.9	4.8	7.5	10.4	142.9
CTNND1	"CTNND, KIAA0384, p120, p120cas, p120ctn"	ENSG00000198561	"Catenin delta 1"	O60716	11	57753243-57819546	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway"		"Cancer-related genes, Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 12.5;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	8	"dendritic cells: 10.2;monocytes: 12.5"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB003837, HPA015954, HPA015955"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		15000	"Plasma membrane"		"CAB003837: AB_562066, HPA015954: AB_2669326, HPA015955: AB_1846068"	"unprognostic (1.06e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.87e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.52e-3)"	"unprognostic (4.17e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.75e-1)"	"prognostic favorable (3.54e-4)"	"unprognostic (7.17e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.33e-2)"	39.7	19.9	15.1	20.4	17.0	3.2	31.4	15.0	20.5	28.8	41.9	25.7	49.2	37.5	32.7	32.7	76.3	22.9	28.8	18.2	15.6	10.3	30.6	31.2	34.0	11.6	14.4	12.8	23.3	50.4	41.9	34.5	49.8	16.4	29.7	39.8	34.4	46.4	39.1	11.8	48.7	82.0	22.8	17.2	25.9	39.4	27.8	14.7	7.1	38.4	34.9	45.6	32.3	38.9	1.4	10.2	0.4	12.5	0.4	0.5	2.3	37.3	28.1	25.1	16.7	13.5	18.6	35.6	17.1	19.4	15.5	14.9	21.7	41.5	0.7	30.3	21.3	14.8	49.1	20.2	26.0	20.0	0.4	6.6	9.3	11.0	24.6	14.1	1.9	14.7	20.4	31.5	19.7	20.2	25.3	47.3	0.6	13.9	0.4	17.2	12.1	0.7	3.5	17.8	25.4	15.1	0.7	21.1	0.8	23.3	39.9	2.3	11.2	24.3	33.3	25.3	43.9	34.9	2.5	40.0	15.0	12.9	14.7	9.7	1.3	0.8	1.1	14.0	1.2	26.4	0.0	6.9	0.2	0.2	12.5	0.5	1.0	0.1	0.4	10.2	1.4	0.2	0.3	0.4	0.4	11.9	3.1	0.2	2.3	15.1	17.0	15.0	20.5	15.6	10.3	14.4	12.8	16.4	14.7	137.0	81.3	9.5	80.1	104.1	22.4	14.9	145.2	44.2	68.2	134.3	37.3	80.9	11.6	90.0	11.2	89.8	213.8	0.0	84.6	65.9	33.0	98.5	32.3	112.4	38.4	14.3	82.8	94.5	50.5	7.8	26.2	39.5	45.5	20.8	134.3	40.4	110.3	157.3	36.0	43.0	26.8	25.8	28.8	32.2	19.2	175.3	76.0	8.7	98.8	174.5
BIRC3	"API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49"	ENSG00000023445	"Baculoviral IAP repeat containing 3"	Q13489	11	102317450-102339403	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 46.0;lymphoid tissue: 46.3"	"Cell type enhanced"	"Detected in many"	16	"granulocytes: 530.1;monocytes: 1925.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 32.9;naive B-cell: 32.9"	"Group enriched"	"Detected in many"	10	"B-cells: 32.9;T-cells: 17.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 38.4;Daudi: 33.7;HDLM-2: 31.9;hTERT-HME1: 33.6;U-266/70: 22.5;U-266/84: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002317	Enhanced	Approved	Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA002317: AB_1846748"	"prognostic favorable (3.60e-4)"	"unprognostic (2.89e-1)"	"prognostic favorable (9.35e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (5.83e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.88e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.03e-4)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (6.66e-6)"	"unprognostic (6.42e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.85e-2)"	6.9	3.3	1.4	43.9	2.3	5.1	5.4	0.5	2.0	5.3	13.1	0.5	2.8	6.8	2.9	3.7	8.4	3.9	13.9	6.0	2.2	1.3	10.8	12.5	21.8	46.3	2.8	1.2	3.4	7.0	1.1	14.5	0.9	2.2	8.7	6.2	1.1	9.2	4.7	2.2	5.5	46.0	7.3	3.0	34.9	15.9	3.2	2.7	34.2	3.0	4.1	34.0	12.6	6.2	32.9	0.8	2.0	2.6	2.5	17.1	2.8	6.5	5.3	0.0	0.1	0.1	0.7	0.6	0.5	4.4	0.6	0.7	0.9	38.4	33.7	17.4	0.3	5.5	3.6	0.0	0.9	2.1	31.9	0.1	0.1	1.6	0.2	6.6	0.5	0.7	0.7	4.7	2.1	33.6	1.2	0.1	2.7	0.1	0.0	0.8	0.0	2.3	0.3	0.1	3.1	0.2	0.0	0.3	1.7	8.7	3.4	0.0	0.1	0.5	0.6	0.3	0.2	1.7	0.3	1.7	7.3	0.8	0.4	6.7	22.5	19.2	11.9	1.3	1.9	0.9	2.0	0.9	0.4	1.4	2.2	2.5	32.9	10.7	3.5	0.8	32.9	7.5	2.2	0.5	2.5	2.6	0.3	17.1	2.8	1.4	2.3	0.5	2.0	2.2	1.3	2.8	1.2	2.2	2.7	134.0	68.1	285.1	318.0	89.9	0.3	12.0	76.5	30.8	73.9	38.4	0.0	1.7	6.6	193.4	1.3	50.1	284.0	46.7	153.8	0.5	71.9	371.3	530.1	3.4	11.1	0.0	14.5	7.4	18.1	1.3	4.6	71.9	182.2	1925.2	27.1	0.1	190.8	361.2	2.1	8.8	0.0	0.0	133.5	0.5	0.4	73.9	0.5	89.3	29.9	164.7
MTPN	"GCDP, MYOTROPHIN, V-1"	ENSG00000105887	Myotrophin	P58546	7	135926761-135977353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019735	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		48000000	"Plasma membrane, Cytosol"		"HPA019735: AB_1858710"	"unprognostic (5.97e-2)"	"unprognostic (2.53e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (2.06e-3)"	"unprognostic (3.30e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.00e-3)"	"unprognostic (4.86e-3)"	31.0	22.1	40.2	28.5	53.2	55.1	39.6	34.4	50.0	30.9	21.4	20.4	16.0	17.2	29.5	21.9	62.1	27.0	23.7	31.6	38.0	31.6	25.1	20.5	31.6	49.3	24.2	32.4	22.0	10.7	29.2	22.5	26.3	22.9	23.4	23.6	21.5	22.2	24.0	27.4	19.1	23.1	27.9	23.3	42.4	17.6	23.4	19.9	36.4	36.9	24.9	42.8	26.1	30.5	37.9	24.6	50.6	43.5	12.8	16.7	17.0	27.7	22.0	24.3	36.3	34.9	41.5	12.7	44.0	44.7	28.2	30.9	25.0	30.0	49.0	32.6	54.0	43.2	17.7	22.7	34.5	52.4	36.2	22.4	33.4	23.8	16.3	28.7	44.8	48.2	30.3	34.2	33.5	31.5	39.1	43.9	39.3	39.6	29.6	53.1	21.2	45.1	33.2	34.4	25.6	31.3	26.3	18.6	39.8	30.6	23.0	31.3	57.2	35.8	22.3	33.8	23.0	16.4	27.4	47.0	42.7	19.6	42.4	41.4	24.7	36.3	72.3	68.3	39.4	90.8	25.4	21.4	22.6	16.7	28.9	14.3	30.9	10.4	12.5	24.6	37.9	6.9	9.9	50.6	12.8	43.5	24.2	9.0	17.0	40.2	53.2	34.4	50.0	38.0	31.6	24.2	32.4	22.9	19.9	44.7	37.6	120.5	45.1	105.9	0.0	68.2	66.2	34.8	50.0	66.3	0.0	53.8	76.3	60.3	68.1	93.1	49.6	70.0	44.7	56.8	87.2	72.5	93.8	50.8	91.4	0.0	31.8	97.0	229.9	24.5	80.0	156.1	96.2	119.0	41.0	0.0	73.4	59.1	116.3	67.4	0.0	90.5	53.6	60.7	100.9	130.2	57.6	66.6	47.3	89.4
RTF1	KIAA0252	ENSG00000137815	"RTF1 homolog, Paf1/RNA polymerase II complex component"	Q92541	15	41408408-41483563	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006714	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA006714: AB_1079855"	"unprognostic (1.10e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.87e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.50e-2)"	20.4	27.8	27.6	21.6	33.8	34.3	20.4	40.5	34.5	23.7	22.5	14.3	17.6	16.9	25.7	18.4	22.4	18.5	18.4	24.8	26.5	21.4	17.6	19.6	17.2	23.0	17.0	35.1	27.7	15.2	37.0	20.3	36.9	27.2	22.0	20.6	15.4	19.5	23.2	55.2	24.8	20.7	24.7	14.9	23.5	19.0	25.4	13.5	25.3	26.7	15.6	21.6	27.8	20.2	8.0	7.4	11.6	4.3	8.6	5.7	1.4	15.3	10.1	33.4	27.1	19.0	22.6	15.8	20.6	23.2	28.3	23.7	19.7	9.8	14.6	16.7	21.5	12.6	27.4	19.3	17.1	24.3	22.2	18.0	30.7	22.9	14.7	13.3	27.3	18.0	16.2	17.4	15.1	15.3	21.1	22.7	26.8	23.3	17.0	23.1	11.7	26.1	16.9	18.0	19.2	13.9	28.4	26.1	13.9	18.4	33.1	17.2	22.8	18.5	23.7	9.3	19.0	19.4	26.5	18.6	27.8	17.7	27.6	22.5	19.7	30.3	24.3	20.0	26.1	16.9	5.9	4.3	8.4	4.8	2.8	4.4	8.0	4.7	4.1	3.0	6.5	5.7	4.7	11.6	8.6	3.3	7.4	5.4	1.4	27.6	33.8	40.5	34.5	26.5	21.4	17.0	35.1	27.2	13.5	119.1	70.9	118.3	89.5	128.8	209.3	81.2	112.1	69.6	75.1	116.9	88.4	138.6	139.3	89.0	242.0	101.3	97.3	116.8	95.9	97.3	120.4	91.4	89.0	170.3	83.7	139.8	84.2	119.7	72.1	267.8	134.3	89.8	102.9	103.6	107.1	106.0	103.7	94.8	150.3	100.0	188.1	84.1	92.0	109.4	66.6	142.4	183.4	97.8	106.5	90.9
TPM4		ENSG00000167460	"Tropomyosin 4"	P67936	19	16067021-16103005	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 230.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004685, HPA047089, HPA053624"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		950000000	"Actin filaments"	Cytosol	"CAB004685: AB_425723, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.27e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.62e-3)"	"unprognostic (7.38e-3)"	"unprognostic (3.80e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.61e-1)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.26e-10)"	"unprognostic (3.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.78e-1)"	66.2	17.9	13.3	60.0	13.7	10.8	47.4	46.2	11.5	90.2	40.5	14.6	56.4	17.4	87.1	63.3	149.3	49.4	108.4	39.2	14.5	12.4	32.4	12.2	69.7	27.1	16.0	10.5	102.4	15.4	8.4	16.2	65.0	19.7	84.1	31.8	18.6	47.6	64.6	29.9	39.0	25.2	127.2	22.5	99.7	37.5	30.6	11.7	11.5	20.0	92.2	60.1	177.3	70.5	22.2	35.0	40.7	32.7	24.7	52.5	48.6	59.8	23.7	46.0	28.0	106.9	159.3	57.6	83.9	101.8	71.1	73.4	24.6	62.6	2.7	65.6	104.6	52.4	32.3	19.2	48.1	93.0	39.4	11.0	30.2	34.1	19.7	58.8	5.4	72.2	98.6	15.6	58.1	66.8	82.3	81.3	14.1	3.4	38.0	98.1	20.3	16.2	19.0	24.0	54.9	28.9	22.2	39.5	13.0	16.4	51.3	8.3	26.3	56.4	25.3	29.7	46.3	0.5	8.3	95.2	123.9	15.7	230.2	77.5	6.6	15.6	13.3	85.9	15.9	41.9	40.7	30.1	2.2	34.8	32.7	26.3	22.2	26.9	31.2	35.0	18.8	7.8	18.3	35.2	24.7	16.2	27.4	52.5	48.6	13.3	13.7	46.2	11.5	14.5	12.4	16.0	10.5	19.7	11.7	372.2	149.0	112.7	891.9	382.9	46.3	46.3	96.8	158.0	326.4	230.3	9.8	212.0	11.6	660.1	53.8	384.6	203.3	0.0	501.5	677.9	318.1	567.0	235.4	1.9	313.9	4.8	90.0	275.0	103.4	37.2	160.2	324.4	135.0	331.0	106.2	5.7	698.7	90.9	514.4	15.6	10.7	329.8	423.9	12.0	11.3	300.5	475.8	117.4	88.9	901.5
SDCBP2	"SITAC18, ST-2"	ENSG00000125775	"Syndecan binding protein 2"	Q9H190	20	1309909-1329239	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 104.7"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 454.6;Pancreatic endocrine cells: 472.7;Paneth cells: 448.9;Urothelial cells: 654.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 11.2;OE19: 33.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005804, HPA064490"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA005804: , HPA064490: AB_2732713"	"unprognostic (1.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.78e-3)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.37e-4)"	1.7	0.4	5.2	10.6	6.7	0.2	1.5	1.5	4.9	6.6	59.4	1.2	0.9	46.1	1.5	9.1	32.4	0.9	35.1	1.3	3.5	3.6	2.5	3.8	3.7	0.9	2.8	1.0	1.2	4.4	0.2	1.4	1.9	1.4	3.7	19.0	1.0	6.4	1.9	1.1	13.4	104.7	2.5	1.1	1.1	34.0	1.5	1.6	1.0	4.0	12.5	24.3	17.0	9.8	1.2	2.6	4.4	2.0	2.1	5.3	1.8	6.3	0.3	0.9	0.3	3.7	3.3	0.6	1.9	3.9	1.8	1.7	1.3	11.2	0.7	1.3	0.7	1.2	5.0	0.3	9.3	0.9	0.2	0.6	0.5	0.4	0.9	3.7	0.6	0.7	1.1	6.6	1.4	1.4	3.8	6.1	1.2	0.9	0.5	0.7	1.5	1.0	1.8	0.9	33.8	0.4	1.0	0.4	1.2	0.7	8.7	1.5	1.2	1.0	5.7	2.1	0.4	0.3	0.5	4.1	0.9	0.4	1.8	0.7	1.7	1.6	0.6	0.4	2.5	0.5	0.4	2.0	4.4	2.4	0.7	1.8	0.6	3.2	2.5	2.6	1.2	2.7	4.7	2.2	2.1	1.3	1.7	5.3	1.8	5.2	6.7	1.5	4.9	3.5	3.6	2.8	1.0	1.4	1.6	14.9	6.2	5.0	56.0	49.5	0.7	0.7	81.5	4.0	6.8	15.7	0.0	1.3	23.2	94.6	12.4	13.0	454.6	0.0	187.2	0.8	4.4	102.5	9.2	4.9	0.9	1.6	34.4	4.9	1.6	1.1	1.4	2.2	8.5	3.6	127.5	1.0	472.7	448.9	0.0	1.3	1.0	0.0	4.2	1.7	6.6	83.6	1.4	2.5	60.5	654.3
TLR3	CD283	ENSG00000164342	"Toll like receptor 3"	O15455	4	186069152-186088069	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Receptor, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 48.1"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 46.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 7.6;memory CD8 T-cell: 8.0"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.5;T-cells: 8.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 11.6;ASC TERT1: 12.1;BJ hTERT+ SV40 Large T+ RasG12V: 18.0;CAPAN-2: 28.0;HSkMC: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025658	Enhanced				"Intracellular and membrane"	NA	NA					"CAB025658: "	"unprognostic (2.13e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.56e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (1.17e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.52e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.83e-1)"	11.9	10.7	3.1	6.8	5.0	0.0	11.1	1.7	3.5	9.9	20.1	3.0	6.8	13.4	5.6	7.3	12.9	7.8	8.6	7.7	3.5	2.6	12.4	11.2	12.2	1.0	3.3	1.9	8.9	8.2	4.8	2.7	48.1	3.0	11.3	9.5	5.0	8.5	10.2	2.3	3.8	34.9	6.5	8.0	7.0	8.2	5.8	4.2	1.2	11.8	7.6	3.0	10.3	14.6	0.0	2.5	0.5	0.0	0.7	8.0	1.1	1.9	0.5	0.3	0.0	11.6	12.1	0.9	0.1	8.4	5.1	18.0	0.0	28.0	0.0	1.1	1.2	10.2	2.9	0.0	5.8	0.9	10.7	0.1	1.7	0.5	0.0	5.1	1.8	0.7	11.9	2.2	6.8	0.3	3.1	2.4	1.8	0.0	0.0	2.9	0.0	2.0	0.0	0.9	0.0	1.0	2.6	0.0	0.1	4.9	2.7	0.0	0.1	1.5	1.2	2.3	0.1	0.3	0.0	1.7	0.9	0.6	0.0	1.2	0.0	0.0	0.0	2.4	1.2	2.0	0.5	0.0	0.0	7.6	0.0	4.3	0.0	1.8	8.0	2.5	0.0	1.2	3.9	0.3	0.7	0.0	0.0	0.2	1.1	3.1	5.0	1.7	3.5	3.5	2.6	3.3	1.9	3.0	4.2	17.9	5.6	1.3	3.2	3.4	0.0	0.8	17.8	2.7	11.4	14.0	0.0	16.9	0.0	6.4	46.2	3.2	14.4	0.0	8.7	4.6	4.0	2.6	2.3	6.4	2.3	0.0	1.2	6.7	0.3	3.8	7.8	2.5	0.0	0.0	6.7	3.8	6.2	8.6	3.5	5.4	0.4	0.0	1.4	0.0	0.4	0.9	16.4	0.0	4.5	5.0
CDK7	"CAK, CAK1, CDKN7, MO15, STK1"	ENSG00000134058	"Cyclin dependent kinase 7"	P50613	5	69234795-69277430	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 97.9;Extravillous trophoblasts: 285.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004364, HPA007932, HPA008453"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center, Plasma membrane, Cytosol"	"CAB004364: AB_627243, HPA007932: AB_1078492, HPA008453: "	"unprognostic (3.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.64e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (3.09e-4)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (9.42e-7)"	"unprognostic (2.61e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.55e-2)"	7.9	12.9	10.9	6.2	15.2	44.1	14.0	10.8	14.7	9.4	12.7	6.0	6.3	15.8	9.4	8.6	23.4	18.5	16.5	8.1	11.5	9.3	13.8	10.6	10.1	8.8	7.6	9.7	7.7	9.1	3.3	16.2	22.9	11.2	11.2	14.8	6.6	13.2	6.5	15.9	15.4	9.8	12.1	9.2	7.9	13.9	29.0	7.8	12.1	20.0	15.6	15.5	10.7	11.7	15.6	15.0	22.4	11.3	12.4	15.3	7.8	3.6	7.7	1.8	0.5	2.4	11.6	14.7	6.4	7.7	10.7	17.4	16.6	1.9	2.8	10.1	1.7	12.4	2.5	1.4	2.8	5.8	1.3	7.0	0.4	8.1	7.9	0.4	6.7	3.2	14.3	13.8	9.0	2.8	9.4	13.5	15.6	10.3	4.5	4.9	0.7	4.0	14.7	1.7	3.7	7.4	6.6	0.4	1.1	1.6	1.0	0.6	6.5	1.5	5.8	3.4	6.4	11.6	0.6	2.6	0.0	3.2	0.9	5.1	4.8	8.4	3.7	0.8	4.0	0.8	7.3	10.9	22.4	8.6	11.3	14.8	12.4	12.9	15.3	15.0	15.6	11.1	13.2	10.0	12.4	8.0	11.2	12.8	7.8	10.9	15.2	10.8	12.7	11.5	9.3	7.6	9.7	11.2	7.8	14.9	10.4	2.4	16.5	51.3	6.3	8.9	5.1	48.2	10.3	5.2	11.8	97.9	13.3	21.5	6.2	11.3	9.2	0.0	19.0	285.4	10.2	19.9	15.1	6.6	21.2	1.6	2.9	6.7	8.2	3.6	6.9	10.2	6.8	9.0	11.4	9.0	22.5	14.0	6.7	20.7	8.2	25.8	12.2	25.4	15.8	36.6	54.0	9.6	11.8	28.6
DDX21	"GURDB, RH-II/GU"	ENSG00000165732	"DExD-box helicase 21"	Q9NR30	10	68956128-68985073	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Suprabasal keratinocytes: 515.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036592, HPA036593"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No		14000	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA036592: AB_10673625, HPA036593: AB_2675208"	"unprognostic (3.04e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.74e-3)"	37.5	16.0	10.0	26.6	13.3	46.8	24.4	8.0	11.8	18.5	20.1	7.2	16.2	13.3	18.7	13.7	28.3	20.1	17.6	19.1	11.4	8.0	25.1	48.0	25.9	24.4	14.9	7.2	30.2	27.9	15.6	20.7	22.8	18.3	14.0	17.6	5.9	18.0	17.8	61.2	22.5	18.5	19.0	20.4	43.5	19.0	12.9	13.3	27.1	18.1	24.1	25.8	33.2	22.4	12.6	11.5	17.1	17.3	7.7	15.0	6.2	33.1	19.7	11.5	35.6	10.4	13.8	24.4	22.8	18.4	29.5	25.1	63.7	22.8	50.0	14.1	18.9	13.9	29.6	44.3	28.4	39.6	15.5	31.2	35.0	14.0	26.4	22.3	83.2	33.3	14.1	37.0	35.2	59.0	13.7	21.4	18.8	66.6	25.0	20.7	15.1	32.6	18.1	31.5	15.8	42.1	29.2	18.9	24.6	19.6	17.9	23.9	25.6	20.5	45.5	26.6	14.5	25.8	17.5	22.0	17.3	24.6	23.2	40.0	28.9	38.2	73.9	14.4	63.2	11.7	5.0	9.7	17.1	8.4	15.0	15.0	12.6	10.9	11.0	11.5	10.4	10.3	11.3	4.5	7.7	17.3	10.8	7.9	6.2	10.0	13.3	8.0	11.8	11.4	8.0	14.9	7.2	18.3	13.3	95.3	139.8	208.1	223.1	488.7	27.0	59.4	112.1	83.0	195.7	68.0	39.3	72.5	61.3	111.8	41.5	139.6	52.0	23.3	160.6	118.9	142.8	222.8	164.0	182.5	102.7	23.8	83.2	113.5	149.3	13.6	82.8	170.5	118.1	66.7	97.0	22.8	171.9	92.1	72.5	73.0	27.4	25.8	155.6	101.9	142.2	515.4	115.0	93.8	113.1	301.9
OSBPL10		ENSG00000144645	"Oxysterol binding protein like 10"	Q9BXB5	3	31657890-32077580	"Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 39.6"	"Group enriched"	"Detected in many"	13	"Early spermatids: 436.6;Late spermatids: 951.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"memory B-cell: 11.5;naive B-cell: 6.6"	"Lineage enriched"	"Detected in single"	22	"B-cells: 11.5"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 31.5;RPTEC TERT1: 33.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003636			Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Plasma membrane, Cytosol"		"HPA003636: AB_1079529"	"unprognostic (5.28e-3)"	"unprognostic (2.06e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (2.15e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (5.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (4.85e-4)"	11.7	3.5	3.8	8.7	4.3	1.0	6.7	1.4	7.6	8.6	5.6	0.4	5.9	2.5	11.8	6.7	10.0	5.5	16.7	2.9	2.6	2.6	14.5	1.6	4.6	8.2	3.1	3.6	4.1	2.5	1.3	12.0	16.5	2.5	12.8	6.0	8.5	7.3	16.6	2.0	5.5	7.3	39.6	1.2	9.5	4.4	24.0	1.2	0.4	4.3	4.3	15.1	25.2	11.8	11.5	0.1	0.5	0.0	0.0	0.0	0.2	6.2	3.5	0.6	12.5	1.1	2.3	20.9	1.7	1.9	1.6	2.3	8.7	4.5	14.7	16.8	0.4	5.7	3.7	2.7	14.7	1.9	0.1	2.7	0.0	8.7	5.5	0.9	0.0	0.1	2.4	12.4	2.5	31.5	6.1	7.2	0.0	0.0	0.0	6.8	5.1	0.0	0.0	7.9	20.0	9.0	0.1	0.2	0.2	33.2	2.5	0.9	0.1	3.1	5.4	1.7	12.3	3.6	0.0	5.1	2.0	21.5	0.2	8.2	1.4	1.0	14.0	2.9	0.0	12.7	0.2	0.0	0.1	0.0	0.0	0.0	11.5	0.0	0.0	0.0	6.6	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.2	3.8	4.3	1.4	7.6	2.6	2.6	3.1	3.6	2.5	1.2	8.9	3.8	36.5	6.8	9.6	4.8	2.0	5.1	6.7	4.5	7.0	0.0	12.6	8.3	1.9	436.6	17.1	5.7	0.0	4.4	21.8	5.4	16.4	0.0	0.0	2.2	0.0	14.5	20.9	1.2	951.1	10.3	0.9	8.5	1.8	3.5	52.0	10.6	4.5	3.9	20.7	1.7	19.4	9.4	6.5	4.1	10.8	25.3	2.9	7.4	8.6
TMPRSS4	"MT-SP2, TMPRSS3"	ENSG00000137648	"Transmembrane serine protease 4"	Q9NRS4	11	118077012-118121890	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 60.9;gallbladder: 45.4;lymphoid tissue: 41.0;urinary bladder: 43.9"	"Cell type enhanced"	"Detected in many"	18	"Enterocytes: 108.9;Paneth cells: 61.7;Undifferentiated cells: 54.6;Urothelial cells: 226.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"basophil: 4.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.5"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 37.9;HaCaT: 16.2;OE19: 64.5;RPTEC TERT1: 26.6;RT4: 33.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA006238	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006238: AB_1080316"	"unprognostic (1.48e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (5.50e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (2.87e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.96e-3)"	0.3	0.3	0.2	14.2	0.3	0.0	0.3	0.3	0.2	11.4	23.5	0.1	0.0	16.1	3.1	2.8	60.9	0.6	45.4	0.3	0.3	0.3	17.7	0.3	3.2	0.0	0.2	0.0	0.3	0.4	0.0	0.3	0.8	0.1	9.9	26.2	0.2	4.0	0.0	0.3	2.4	27.4	4.2	0.2	0.3	13.7	0.7	0.0	0.6	0.3	13.7	41.0	43.9	22.3	0.5	0.1	4.5	0.7	0.2	0.1	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	37.9	0.0	1.4	0.0	0.0	16.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	1.1	0.0	64.5	0.0	0.0	0.0	0.0	26.6	33.2	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.5	0.1	0.1	0.9	0.2	0.7	0.1	0.1	0.0	0.2	0.3	0.3	0.2	0.3	0.3	0.2	0.0	0.1	0.0	0.0	1.7	0.0	21.5	1.0	0.0	0.6	0.0	17.4	36.4	10.4	0.0	0.1	0.0	0.1	2.6	0.0	108.9	0.0	6.6	1.6	0.2	6.8	5.7	0.0	0.2	0.0	4.1	0.0	0.0	1.3	0.0	1.0	0.0	0.0	49.1	0.0	30.7	61.7	0.0	1.4	0.0	0.0	0.7	0.0	0.1	5.5	0.2	0.0	54.6	226.3
TRPS1	"GC79, LGCR"	ENSG00000104447	"Transcriptional repressor GATA binding 1"	Q9UHF7	8	115408496-115809673	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 65.9"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 77.5;Late spermatids: 117.5"	"Cancer enriched"	"Detected in many"	8	"breast cancer: 49.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 8.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 13.7;SK-BR-3: 23.4;T-47d: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060380, HPA071767"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060380: AB_2684270, HPA071767: AB_2732185"	"unprognostic (4.34e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.87e-1)"	"prognostic favorable (9.42e-4)"	"unprognostic (2.23e-3)"	"unprognostic (2.08e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (3.16e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.07e-3)"	6.7	4.5	11.4	6.8	12.0	8.2	65.9	7.0	8.9	16.8	7.7	7.5	9.2	2.0	11.7	6.8	16.3	7.2	11.7	5.9	14.0	4.3	9.8	3.3	6.5	5.9	8.7	8.1	6.8	2.4	9.1	9.7	4.0	10.8	11.7	4.1	4.1	16.0	10.6	4.1	13.5	3.6	12.6	20.6	5.2	4.7	13.2	8.6	1.8	7.2	14.8	9.2	9.6	17.6	1.8	3.1	1.6	8.5	1.8	2.1	1.3	0.8	0.1	1.7	0.0	1.6	6.2	0.1	1.4	3.3	0.9	1.6	0.1	1.4	0.7	0.0	3.7	0.8	0.0	6.8	1.2	1.1	0.0	2.0	0.0	2.8	0.0	2.2	0.0	0.0	2.9	1.3	2.6	4.8	2.7	0.8	0.1	0.3	11.3	1.8	13.7	0.0	0.0	0.3	0.3	1.4	0.0	0.0	8.6	1.5	0.0	1.5	1.2	0.7	23.4	0.9	0.9	73.3	0.6	0.0	4.1	2.1	1.2	2.8	3.0	0.0	1.3	4.4	0.0	2.7	0.0	8.5	0.0	1.7	3.5	2.0	1.0	2.1	2.0	3.1	1.8	1.9	1.8	1.6	1.8	2.5	1.1	0.8	1.3	11.4	12.0	7.0	8.9	14.0	4.3	8.7	8.1	10.8	8.6	6.0	4.0	11.5	20.1	8.4	6.6	3.5	5.1	0.0	3.4	17.4	41.2	0.1	10.0	2.3	77.5	4.5	0.0	0.0	2.5	0.1	11.8	17.3	12.7	0.9	14.3	0.0	0.0	3.1	46.8	117.5	23.3	45.2	20.3	2.8	0.0	10.0	1.9	0.0	26.5	20.3	36.6	6.5	24.5	1.7	9.4	10.9	0.2	11.5	0.0	8.9
SERPINB3	"HsT1196, SCC, SCCA1, T4-A"	ENSG00000057149	"Serpin family B member 3"	P29508	18	63655197-63661963	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 50.7;esophagus: 140.0;vagina: 80.0"	"Group enriched"	"Detected in some"	8	"Ciliated cells: 141.8;Club cells: 465.2;Urothelial cells: 238.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 186.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.6;HaCaT: 9.1;HBEC3-KT: 2.2;SiHa: 5.6;U-2197: 11.6"									"CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		11000000	Cytosol	"Plasma membrane"	"CAB018772: AB_2285759, CAB036006: , CAB036007: , HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998"		"unprognostic (2.95e-3)"		"unprognostic (1.66e-1)"		"unprognostic (2.03e-1)"		"unprognostic (2.91e-2)"	"unprognostic (2.11e-1)"		"prognostic unfavorable (3.19e-4)"	"unprognostic (6.68e-2)"		"unprognostic (2.58e-1)"			"unprognostic (4.19e-3)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	50.7	0.2	0.2	0.2	0.0	3.8	0.2	140.0	0.0	0.2	0.2	0.2	0.0	0.2	0.2	5.4	0.2	0.2	0.2	0.2	0.2	0.0	2.4	0.2	0.2	1.1	0.0	0.2	13.0	0.2	0.2	7.1	0.2	0.2	0.2	0.2	0.0	0.2	0.2	1.4	0.2	21.3	3.1	13.1	80.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.1	0.2	9.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	10.3	0.0	15.8	0.0	0.0	0.0	0.0	141.8	465.2	0.0	0.0	0.0	0.0	3.7	24.6	0.0	0.0	0.0	7.4	0.0	0.0	36.6	2.3	0.0	0.1	0.0	0.0	0.0	0.0	33.0	1.1	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	238.3
CCDC43	FLJ31795	ENSG00000180329	"Coiled-coil domain containing 43"	Q96MW1	17	44673069-44689779	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 50.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023078, HPA023391"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"HPA023078: , HPA023391: AB_1846146"	"unprognostic (6.05e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (3.42e-5)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.14e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.11e-1)"	10.4	10.4	14.3	8.5	15.6	13.8	10.0	14.9	14.7	7.9	9.3	9.8	7.2	9.1	8.2	9.0	10.7	7.6	6.1	16.3	13.8	10.4	11.2	7.5	7.5	9.6	11.9	9.2	7.3	9.4	12.3	5.8	14.2	14.4	9.8	12.0	6.9	8.9	7.6	50.6	8.8	8.8	8.6	14.4	9.8	8.5	7.3	9.6	10.9	10.8	17.1	10.9	9.1	7.8	11.5	17.5	10.7	17.9	15.8	14.7	10.0	12.3	14.8	14.1	12.4	9.6	14.3	25.9	18.9	11.2	18.6	18.3	20.0	13.3	21.6	14.7	15.3	13.3	9.7	23.2	21.8	27.1	26.3	27.0	19.3	24.4	29.4	17.3	27.0	14.6	12.8	22.2	19.3	26.4	12.8	18.0	17.8	20.3	15.1	18.8	15.3	26.3	19.2	14.5	11.7	19.1	17.1	35.5	18.6	19.0	8.1	14.2	14.0	13.8	11.1	19.1	22.2	28.4	18.4	15.5	23.1	17.0	13.7	25.0	15.4	19.4	25.0	16.9	15.8	16.4	10.5	16.0	10.7	12.9	17.9	11.9	9.3	12.2	14.3	17.5	11.5	12.0	13.0	3.3	15.8	11.7	12.4	14.7	10.0	14.3	15.6	14.9	14.7	13.8	10.4	11.9	9.2	14.4	9.6	11.9	16.0	19.3	8.6	11.7	21.9	35.1	12.7	21.4	21.6	8.7	9.8	36.1	33.2	19.2	0.6	20.0	10.5	23.3	21.3	38.6	13.5	9.4	32.3	12.4	26.9	20.6	17.2	16.5	17.8	2.7	13.0	21.6	20.3	18.0	14.4	17.4	18.5	10.5	12.0	25.8	19.2	6.5	17.6	3.5	10.4	9.8	21.2	12.1	19.9	7.1
SLC39A10	"DKFZp564L2123, FLJ90515, KIAA1265"	ENSG00000196950	"Solute carrier family 39 member 10"	Q9ULF5	2	195575977-195737702	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 41.0;thyroid gland: 39.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036512, HPA036513, HPA066087"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		49000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA036512: AB_2675165, HPA036513: AB_10670801, HPA066087: AB_2685613"	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.33e-3)"	"prognostic favorable (1.46e-5)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (2.10e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (8.46e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.47e-2)"	"unprognostic (6.89e-2)"	6.6	10.9	16.0	6.0	24.8	3.7	6.2	10.8	41.0	9.8	3.8	4.2	4.9	3.6	9.4	3.3	3.5	8.5	7.6	4.7	15.0	11.2	7.8	2.1	6.3	6.5	8.5	24.4	7.4	5.7	5.8	5.7	10.7	15.7	16.7	4.0	1.4	4.8	6.5	3.3	5.7	5.7	6.7	10.2	14.4	4.3	7.9	6.2	10.6	39.9	1.7	6.4	6.1	4.9	9.4	18.4	19.3	2.7	11.0	4.6	1.5	2.9	9.9	18.9	5.2	3.7	8.8	9.8	13.7	6.7	6.6	3.3	14.8	10.6	4.1	20.9	7.8	5.1	4.2	11.5	12.6	8.4	2.1	8.6	4.6	15.4	12.1	4.1	16.8	1.9	5.2	1.8	7.3	8.4	23.4	14.8	4.2	13.3	5.8	10.6	2.8	4.8	5.2	22.0	17.2	7.8	11.3	6.6	10.2	28.8	4.9	7.3	10.0	13.7	28.0	7.2	34.5	4.5	10.5	14.5	12.1	14.0	7.9	7.1	2.0	1.2	2.4	9.7	7.9	12.2	19.3	2.7	1.9	4.5	2.5	3.5	6.8	4.0	3.7	3.3	9.4	3.5	4.6	0.5	11.0	1.8	18.4	3.9	1.5	16.0	24.8	10.8	39.7	15.0	11.2	8.5	24.4	15.7	6.2	3.0	10.9	18.2	9.3	22.8	21.9	7.3	7.6	6.7	29.6	34.9	7.9	41.3	1.7	17.6	23.2	27.0	2.9	23.3	9.5	54.8	20.3	18.5	12.7	2.5	21.6	7.9	15.0	24.5	18.1	11.5	17.5	29.7	6.8	8.2	5.1	15.6	17.5	2.9	17.7	14.9	19.9	12.9	13.8	47.8	27.0	17.9	19.6	21.5	4.5	6.4
REPS2	POB1	ENSG00000169891	"RALBP1 associated Eps domain containing 2"	Q8NFH8	X	16946691-17153280	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 29.8;Horizontal cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"basophil: 4.6;eosinophil: 4.2;neutrophil: 14.2"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 14.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 24.0;Karpas-707: 9.7;RH-30: 7.0;RPMI-8226: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000565, HPA026073"	Uncertain				"Intracellular and membrane"	NA	NA					"HPA000565: AB_1079800, HPA026073: AB_1856176"	"unprognostic (6.58e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.35e-2)"	"unprognostic (7.83e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.70e-3)"	"prognostic favorable (5.36e-4)"	"unprognostic (4.85e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (4.56e-4)"	2.5	12.3	10.6	1.4	24.1	2.9	3.7	13.2	24.7	17.7	4.6	11.6	8.1	2.4	4.7	14.0	1.6	2.4	2.3	1.8	10.2	10.0	11.6	8.0	5.0	0.6	11.3	16.0	4.7	10.9	10.1	5.8	2.9	9.8	9.1	5.1	4.7	5.1	9.0	1.1	1.1	2.2	4.6	9.6	1.3	6.7	2.3	9.4	0.0	2.3	0.0	0.8	2.5	1.3	0.2	0.4	14.2	0.3	0.0	0.0	0.1	1.1	0.5	0.0	0.1	0.7	0.5	0.1	0.0	0.0	0.1	0.2	0.1	4.3	0.0	0.5	0.0	3.2	0.2	0.9	2.3	0.4	24.0	0.5	0.0	0.6	0.0	0.6	0.0	0.1	4.5	0.8	0.0	3.9	4.1	1.3	0.0	0.0	9.7	0.2	1.1	0.0	0.3	0.1	3.5	0.7	0.0	7.0	7.4	0.3	2.3	3.5	0.2	1.8	1.7	1.4	1.5	3.2	0.2	0.2	0.0	0.2	0.1	0.3	0.4	0.0	0.3	0.0	0.3	0.2	4.6	0.3	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	14.2	0.0	0.2	0.3	0.0	0.1	10.6	24.1	13.2	24.7	10.2	10.0	11.3	16.0	9.8	9.4	29.8	9.1	0.8	7.8	0.6	14.4	4.5	5.1	1.4	11.4	14.0	0.0	0.2	1.7	2.1	0.0	1.4	5.1	0.0	12.5	8.6	1.7	12.7	0.0	11.9	4.0	36.5	9.1	3.7	3.5	0.4	8.6	5.5	1.7	2.8	8.5	1.1	7.1	5.8	12.0	6.3	2.4	0.0	1.2	0.7	0.7	1.1	0.6	0.0	9.2	5.4
ARHGAP23	KIAA1501	ENSG00000275832	"Rho GTPase activating protein 23"	Q9P227	17	38419280-38512392	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.4"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 56.6;Ito cells: 51.5"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 77.1;RT4: 30.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019818, HPA047291"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	Cytosol	"HPA019818: AB_1844993, HPA047291: AB_2680012"	"unprognostic (3.35e-1)"	"unprognostic (5.11e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (9.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.50e-3)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (5.38e-5)"	"unprognostic (8.36e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.25e-1)"	4.3	2.7	11.7	3.5	32.1	4.2	1.7	3.6	20.1	4.4	1.4	52.4	0.0	1.0	5.1	1.5	13.3	4.0	3.6	7.8	12.6		1.6	0.5	5.7	1.3	42.3	12.6	6.1	0.8	1.5	0.0	9.5	20.2	3.7	0.9	0.9	0.7	6.6	2.1	16.3	1.1	5.5	16.3	10.5	0.5	5.2	39.0	1.4	0.9	0.5	5.0	11.6	2.3	0.0	0.8	0.0	0.1	0.0	0.1	0.1	8.2	4.4	4.0	1.3	2.5	8.5	5.0	11.3	12.8	10.0	5.8	14.7	14.5	0.1	9.4	26.3	5.0	77.1	0.4	16.0	7.1	0.9	0.8	0.0	14.1	0.1	12.8	0.8	0.0	4.9	3.1	7.2	4.6	8.2	10.2	1.5	0.1	2.2	5.6	0.0	2.4	1.5	2.4	0.3	1.7	4.3	8.7	2.7	4.2	30.0	0.9	2.3	6.8	0.0	0.1	5.9	1.7	1.9	14.8	16.9	5.9	3.4	3.0	1.7	1.7	0.4	4.2	2.0	14.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1											11.9	1.0	0.0	14.3	8.9	56.6	16.3	2.5	1.4	15.9	3.5	0.0	20.8	0.0	2.6	6.7	24.5	0.0	23.3	1.2	2.1	14.3	5.3	0.0	0.2	4.2	25.4	0.0	51.5	3.7	15.8	8.3	0.9	1.7	0.0	0.2	7.5	4.4	0.0	6.7	0.0	3.3	0.0	7.2	17.6	1.9	22.6	13.8	0.0	0.0	35.6
ANKRD50	KIAA1223	ENSG00000151458	"Ankyrin repeat domain 50"	Q9ULJ7	4	124664052-124712732	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.4;monocytes: 3.8"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 22.2;HUVEC TERT2: 22.1;TIME: 55.6"					"Low region specificity"	"Detected in all"			HPA044008	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA044008: AB_10961996"	"unprognostic (7.82e-2)"	"unprognostic (1.68e-2)"	"unprognostic (6.85e-3)"	"unprognostic (5.90e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (1.67e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (8.16e-3)"	10.1	4.8	6.6	8.2	6.8	4.7	7.6	4.0	8.3	17.1	10.0	4.3	8.7	3.7	17.5	7.4	11.4	5.9	10.2	7.3	6.2	6.5	9.8	6.9	13.4	5.4	5.5	6.5	9.0	5.2	12.5	3.9	17.1	6.2	19.1	6.9	6.7	7.7	7.9	3.2	12.9	7.9	14.2	4.8	7.1	8.2	16.8	4.8	15.4	9.2	5.8	4.4	16.5	10.9	0.1	2.4	0.5	3.8	0.4	0.1	0.4	2.3	4.3	12.3	5.7	9.8	6.3	1.2	6.0	5.1	3.1	2.0	1.9	3.0	0.0	1.9	8.5	2.8	2.1	8.1	4.6	5.5	0.0	1.7	1.9	5.6	1.8	7.0	3.2	2.5	6.3	6.3	4.9	22.2	5.9	22.1	2.2	3.5	4.2	5.9	5.3	4.0	1.1	2.5	3.4	6.4	3.3	3.8	0.5	3.9	9.6	3.5	4.4	4.1	2.6	4.8	5.3	2.8	2.7	55.6	6.7	5.2	3.2	5.1	3.1	0.0	0.8	3.0	1.4	7.6	0.0	1.5	0.5	0.0	3.8	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.1	0.0	0.4	2.3	0.9	0.0	0.4	6.6	6.8	4.0	8.3	6.2	6.5	5.5	6.5	6.2	4.8	29.8	18.2	0.5	15.0	35.8	2.8	8.4	15.3	8.1	6.8	5.2	0.0	1.9	0.0	8.8	35.0	14.5	3.8	0.0	17.2	23.7	15.5	12.9	4.7	6.8	4.8	20.6	8.1	31.9	10.0	45.7	6.4	8.7	10.1	2.8	3.1	2.9	13.7	2.9	11.3	3.3	1.0	0.0	18.6	16.8	9.7	26.8	3.4	0.0	4.5	15.8
PML	"MYL, RNF71, TRIM19"	ENSG00000140464	"Promyelocytic leukemia"	P29590	15	73994673-74047812	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Biological rhythms, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008312, CAB010194, CAB016304"	Supported		Enhanced	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"CAB010194: AB_2166848, CAB016304: AB_628162, HPA008312: AB_1079643"	"prognostic favorable (3.24e-4)"	"unprognostic (4.83e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.53e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.35e-2)"	"unprognostic (5.30e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (3.29e-4)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (6.27e-8)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.99e-2)"	46.2	15.4	13.5	29.9	13.0	30.0	50.0	11.4	17.2	24.7	21.9	8.3	22.1	16.9	29.4	22.1	19.3	23.0	25.6	17.6	10.7	7.5	20.5	12.9	37.2	27.3	11.9	12.4	21.2	11.0	9.6	15.0	22.4	16.1	21.2	8.7	14.6	38.0	27.7	18.7	24.2	19.6	20.1	14.3	25.9	21.4	8.7	13.1	25.3	25.9	23.3	23.0	20.7	35.6	11.8	12.9	19.1	18.2	12.7	13.2	7.8	13.8	5.3	4.6	4.5	13.3	18.8	16.0	7.2	12.9	22.4	26.0	5.5	25.2	6.2	25.5	12.9	21.5	25.7	6.3	14.5	3.2	21.8	9.7	13.5	8.3	6.0	15.4	12.8	12.4	35.3	10.5	15.1	7.9	16.6	15.6	10.3	11.3	11.2	13.2	6.5	10.4	20.0	5.0	2.9	9.6	8.1	5.6	11.6	25.1	23.2	4.0	4.4	11.5	6.4	17.2	4.3	5.0	10.7	25.9	22.7	6.2	11.3	14.4	11.7	7.3	3.0	15.7	16.3	7.3	5.4	12.7	19.1	12.4	18.0	9.6	11.8	9.9	13.2	12.9	9.8	8.1	8.2	11.0	12.7	18.2	8.3	12.9	7.8	13.5	13.0	11.4	17.2	10.7	7.5	11.9	12.4	16.1	13.1	14.9	13.5	14.1	13.0	20.4	7.6	8.9	7.6	8.1	5.7	5.2	2.0	7.9	6.6	21.2	3.3	33.9	11.5	0.0	16.4	12.5	16.8	16.3	11.5	8.9	25.8	7.9	13.7	28.3	18.0	3.6	25.6	16.2	6.8	25.2	12.1	10.3	42.2	9.3	22.6	11.4	5.2	38.8	18.4	1.1	3.6	17.1	4.1	15.7	10.8	22.2
DDX60	FLJ20035	ENSG00000137628	"DExD/H-box helicase 60"	Q8IY21	4	168216293-168318807	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 22.8;BJ hTERT+ SV40 Large T+ RasG12V: 22.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA046952	Approved		Supported	"Intermediate filaments,Cytosol"		No	No			Cytosol	"Intermediate filaments"	"HPA046952: AB_10963572"	"unprognostic (4.05e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.22e-3)"	"unprognostic (7.71e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (1.65e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.44e-1)"	18.0	8.3	4.1	18.5	5.0	4.4	9.0	1.3	3.8	11.4	14.8	4.3	5.1	8.8	10.8	15.2	10.7	8.1	11.5	8.5	3.7	3.5	10.0	8.8	21.6	18.7	4.2	3.2	20.3	5.5	8.8	6.7	25.5	5.6	11.6	14.3	9.0	15.6	6.2	5.6	7.9	16.7	11.2	6.1	18.9	29.2	5.7	3.9	23.2	14.5	6.0	9.3	8.2	7.2	4.1	2.5	3.2	6.3	7.6	10.0	3.5	5.6	1.2	2.8	1.1	2.1	7.8	3.2	1.9	13.7	22.8	22.1	0.0	12.4	0.0	1.1	3.0	10.5	4.7	0.3	4.5	6.6	4.3	0.6	8.8	4.8	0.0	10.3	3.3	2.2	7.0	2.0	5.8	1.3	5.5	8.5	4.2	0.0	1.7	2.8	0.3	5.0	2.4	0.5	0.8	1.6	3.4	1.5	0.1	6.7	3.4	0.6	0.6	3.6	1.0	13.7	0.2	0.9	4.2	5.6	1.4	1.5	0.5	1.4	1.0	0.2	0.0	4.3	3.8	4.0	3.2	2.8	2.6	8.5	5.1	10.0	4.1	6.7	8.0	2.5	3.3	6.8	8.5	2.8	7.6	6.3	0.2	5.5	3.5	4.1	5.0	1.3	3.8	3.7	3.5	4.2	3.2	5.6	3.9	32.8	6.2	5.0	4.0	3.8	0.7	7.1	10.2	14.7	12.5	12.2	0.0	6.4	5.0	7.0	1.7	10.3	10.7	0.0	5.9	8.5	5.0	3.8	26.5	3.8	5.8	0.0	2.9	15.4	4.1	1.4	7.5	8.8	3.3	0.0	13.6	8.0	8.7	7.2	8.9	3.3	3.0	6.5	3.8	0.9	0.7	2.4	2.4	10.1	5.8	3.1
PAK2	"PAK65, PAKgamma"	ENSG00000180370	"P21 (RAC1) activated kinase 2"	Q13177	3	196739857-196832647	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Growth regulation, Host-virus interaction"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB007794	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		590000	"Nucleoplasm, Vesicles"		"CAB007794: AB_562363"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.85e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.36e-4)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (1.30e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.39e-1)"	28.7	18.9	22.4	27.6	23.5	21.4	56.5	17.4	20.7	19.5	23.0	27.8	17.4	19.0	22.6	19.2	23.4	17.9	20.7	29.0	22.6	22.0	19.5	34.3	35.7	50.2	26.8	13.5	19.9	16.6	30.5	13.0	27.6	22.8	17.7	23.0	12.9	19.6	21.2	34.2	16.3	25.2	23.0	32.1	34.6	18.4	15.9	24.8	44.9	16.9	19.1	31.9	24.1	32.7	6.6	13.7	25.9	12.6	6.6	10.8	7.0	36.0	12.9	18.1	13.3	12.9	17.1	27.0	18.3	15.1	19.9	18.1	30.6	18.5	23.1	52.3	18.4	20.3	18.5	19.2	17.4	30.8	10.4	9.3	34.2	14.9	24.0	26.2	33.2	32.9	13.6	14.3	17.8	37.9	21.1	19.6	25.7	16.4	28.8	19.3	38.0	31.6	17.2	10.8	19.4	19.5	28.9	10.3	20.9	17.4	25.3	10.6	12.1	24.5	17.3	13.8	14.6	60.5	24.1	20.2	16.5	9.2	17.3	26.9	19.6	34.6	56.9	13.7	33.3	15.7	16.5	10.3	24.5	6.3	12.6	8.5	6.4	7.3	7.1	13.7	6.6	5.4	6.3	25.9	6.6	10.8	5.1	10.8	7.0	22.4	23.5	17.4	20.7	22.6	22.0	26.8	13.5	22.8	24.8	74.5	44.7	76.2	49.3	86.5	39.1	56.5	63.7	88.3	47.8	78.5	49.1	41.1	28.2	62.3	49.4	78.8	52.5	0.0	51.3	82.8	47.0	116.6	143.4	125.4	90.3	52.4	43.1	63.3	144.6	51.0	56.4	118.7	32.1	120.0	42.8	58.0	77.2	48.4	42.8	60.3	40.6	38.8	52.3	24.2	41.4	75.4	29.2	71.3	38.3	112.3
HNMT		ENSG00000150540	"Histamine N-methyltransferase"	P50135	2	137964020-138016364	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 259.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	19	"classical monocyte: 34.6;intermediate monocyte: 26.7;myeloid DC: 20.9;non-classical monocyte: 14.6"	"Group enriched"	"Detected in many"	22	"dendritic cells: 20.9;monocytes: 34.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 60.9;HSkMC: 24.9;RT4: 31.6;SuSa: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035480, HPA035481, HPA073754"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA		64000	"Nucleoplasm, Cytosol"	Centrosome	"HPA035480: AB_2674645, HPA035481: AB_10672094, HPA073754: "	"unprognostic (1.32e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.02e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (5.24e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (4.68e-4)"	41.4	5.8	12.2	12.3	11.1	3.3	28.8	10.7	11.3	27.6	16.3	8.6	13.9	8.7	22.2	21.4	11.6	14.6	21.6	14.7	12.7	7.8	33.4	74.2	21.9	17.0	13.7	9.2	33.1	14.1	24.5	5.5	14.3	11.2	22.3	17.7	8.7	14.1	20.1	4.9	8.1	11.1	13.2	14.8	18.5	11.5	11.7	14.6	1.0	7.3	8.5	6.5	21.3	12.0	0.5	20.9	1.2	34.6	0.1	0.2	9.2	0.2	0.3	1.5	4.1	17.5	18.8	0.1	1.1	1.7	0.1	0.7	7.8	4.4	0.2	13.8	4.5	0.3	0.4	3.2	0.0	0.0	0.2	1.6	0.1	13.0	60.9	7.9	0.0	0.2	24.9	0.0	6.2	0.0	1.4	4.4	0.1	0.2	0.3	13.1	0.9	0.0	0.2	7.8	10.4	1.6	0.1	0.5	0.0	18.8	31.6	0.1	0.4	5.9	7.7	0.0	31.3	0.2	14.3	1.2	1.3	3.4	1.8	4.4	0.1	0.0	0.2	5.9	7.5	0.9	0.8	34.6	0.2	0.2	26.7	0.1	0.5	0.1	0.1	20.9	0.3	0.1	0.2	1.2	0.1	14.6	0.6	0.2	9.2	12.2	11.1	10.7	11.3	12.7	7.8	13.7	9.2	11.2	14.6	26.8	39.0	13.7	77.1	31.6	0.5	1.6	140.1	52.2	86.4	57.6	0.0	45.4	104.5	84.7	1.2	4.9	45.2	0.0	42.0	69.7	45.8	47.7	0.0	146.0	259.0	0.0	15.7	23.4	235.2	1.6	121.7	155.2	54.0	68.5	65.8	22.3	57.9	100.1	99.0	189.5	0.5	77.6	52.5	0.5	0.6	22.6	31.5	5.0	76.2	102.7
PDZK1IP1	"DD96, MAP17, SPAP"	ENSG00000162366	"PDZK1 interacting protein 1"	Q13113	1	47183593-47191044	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"kidney: 281.3"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 4006.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 340.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"EFO-21: 31.5;RPTEC TERT1: 104.5"	"Not detected"	"Not detected"							HPA014907	Enhanced		Approved	"Nuclear speckles,Cytosol"		NA	NA			Cytosol	"Nuclear speckles"	"HPA014907: AB_1855166"	"unprognostic (2.97e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (8.14e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.89e-1)"	2.7	1.2	0.6	2.4	0.6	3.9	4.1	0.6	0.6	9.2	9.1	0.6	0.6	2.2	1.3	4.8	30.4	2.9	23.9	0.7	0.5	0.0	281.3	1.6	7.2	0.5	0.6	0.5	2.3	16.8	0.0	0.6	3.2	0.6	2.1	3.4	0.8	33.9	12.4	0.7	19.9	9.5	0.5	0.5	0.7	9.0	1.4	0.6	1.1	1.0	18.3	18.5	4.1	8.3	0.1	0.5	2.1	1.1	0.2	0.3	42.4	11.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.6	0.0	31.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	104.5	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	2.1	0.2	0.0	0.5	0.3	42.4	0.6	0.6	0.6	0.6	0.5	0.0	0.6	0.5	0.6	0.6	71.5	39.6	6.7	11.1	12.6	0.0	0.0	359.2	6.7	34.2	221.6	0.0	0.0	351.5	818.0	0.0	1.6	60.9	140.2	656.9	0.0	0.9	37.3	10.4	1.0	0.2	0.0	38.1	2.5	0.3	0.0	3.1	1.5	8.5	21.6	123.8	0.5	959.8	81.8	0.0	4006.8	0.0	0.0	2.3	0.0	0.1	47.2	0.7	1.5	119.5	16.8
STS	"ARSC, ARSC1"	ENSG00000101846	"Steroid sulfatase"	P08842	X	7219456-7354810	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Pregnancy, Steroid metabolism"	Hydrolase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"placenta: 258.8"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 34.3;Syncytiotrophoblasts: 78.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 20.3;RPMI-8226: 25.9;U-266/70: 43.0;U-698: 18.0"									HPA002904	Enhanced					NA	NA					"HPA002904: AB_1080116"	"unprognostic (1.09e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.23e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (4.05e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.34e-1)"	10.3	2.2	3.0	2.2	3.9	0.0	4.1	2.3	9.0	3.4	3.5	2.3	2.2	0.8	2.4	2.2	2.2	2.6	4.1	3.6	3.9	4.0	2.5	4.7	5.0	2.2	3.8	2.4	2.4	2.2	1.6	2.2	258.8	2.4	2.9	3.0	2.3	2.2	3.3	4.0	2.3	2.4	3.8	2.4	2.2	6.7	2.2	2.3	2.2	2.4	2.2	2.2	4.9	2.7	0.9	1.9	1.9	4.7	1.0	0.7	1.0	4.1	1.3	2.8	0.9	20.3	10.5	15.0	8.4	3.0	2.3	2.1	7.4	3.9	7.7	1.6	6.1	1.8	1.0	1.6	1.4	2.3	0.6	3.2	0.4	4.7	2.1	1.1	1.1	4.4	3.4	0.2	1.4	0.8	1.5	3.4	0.6	0.4	8.1	6.0	0.9	0.6	1.0	1.0	0.0	1.9	1.1	1.6	25.9	5.7	6.0	2.0	1.7	1.7	3.0	0.9	4.8	1.3	0.4	6.0	9.1	0.5	11.6	1.3	43.0	0.0	18.0	2.1	0.9	2.4	0.0	3.2	0.6	0.5	4.7	0.2	0.6	0.2	0.3	1.9	0.9	0.1	0.5	1.9	1.0	2.5	0.3	0.7	1.0	3.0	3.9	2.3	9.0	3.9	4.0	3.8	2.4	2.4	2.3	11.9	2.1	1.5	1.7	0.8	3.1	5.0	2.5	0.0	1.2	1.8	0.0	34.3	0.0	6.9	0.1	4.3	4.1	0.0	17.1	18.7	4.1	7.6	6.9	7.4	6.6	1.6	3.5	2.5	5.9	0.0	2.6	2.7	1.7	2.8	2.3	3.1	8.7	7.4	6.3	1.4	0.8	0.0	4.7	0.0	1.4	0.9	78.6	0.0	2.2	7.4
RIPK4	"ANKK2, ANKRD3, DIK, PKK, RIP4"	ENSG00000183421	"Receptor interacting serine/threonine kinase 4"	P57078	21	41739369-41767106	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	9	"naive CD4 T-cell: 1.5;neutrophil: 2.2"	"Group enriched"	"Detected in many"	17	"granulocytes: 2.2;T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 15.9;GAMG: 20.8;HaCaT: 23.5;hTCEpi: 15.8;RPTEC TERT1: 14.2;RT4: 15.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030942	Enhanced					NA	NA					"HPA030942: AB_2732462"	"unprognostic (8.93e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.32e-3)"	"unprognostic (7.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (6.22e-5)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (9.98e-2)"	"prognostic favorable (6.52e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.78e-2)"	1.0	0.2	0.2	0.8	0.2	0.1	3.3	0.2	0.2	6.7	9.4	0.3	12.0	6.8	1.7	6.5	42.1	4.2	17.1	1.1	0.4	0.2	10.8	17.3	5.4	0.4	0.2	0.1	1.8	14.4	4.7	6.8	2.8	1.1	10.6	1.3	4.8	10.2	14.8	0.2	11.7	11.6	2.0	0.3	0.2	11.2	2.7	0.0	8.1	13.6	12.3	26.6	5.2	11.0	0.0	0.0	2.2	0.1	0.0	1.5	0.2	6.8	4.4	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.1	0.1	11.4	15.9	0.0	6.7	1.4	20.8	23.5	0.3	9.5	0.0	0.0	4.7	0.0	3.3	4.2	0.0	0.0	0.0	0.0	15.8	0.1	2.1	0.0	0.0	7.1	0.0	0.0	0.0	5.0	0.9	0.0	0.4	4.5	13.1	0.0	0.0	1.1	14.2	15.1	2.3	0.1	7.7	7.8	7.1	0.7	4.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.1	2.2	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.1	1.1	0.0	26.8	10.8	0.0	26.1	14.1	0.0	1.0	12.7	17.4	14.8	3.5	0.0	7.0	8.3	10.8	0.4	0.0	17.3	0.0	9.0	4.7	0.7	20.1	2.3	16.1	0.9	0.0	21.8	0.0	1.6	1.1	0.0	0.6	6.8	0.0	13.4	0.0	14.2	8.7	0.0	10.0	0.9	0.0	0.3	1.1	0.6	13.2	2.1	0.0	9.8	19.5
PIK3C2G		ENSG00000139144	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma"	O75747	12	18247614-18648416	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Chemotaxis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 54.2;epididymis: 30.7;seminal vesicle: 46.0"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 15.5;Cholangiocytes: 33.1;Collecting duct cells: 38.4;Hepatocytes: 21.5;Suprabasal keratinocytes: 18.7"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 2.9;HaCaT: 4.7;hTERT-HME1: 8.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.29e-1)"	"unprognostic (1.61e-1)"		"unprognostic (6.21e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.46e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.81e-3)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.98e-1)"		"unprognostic (2.37e-2)"	0.3	0.6	0.2	0.1	0.2	0.0	6.7	0.2	0.3	0.6	0.3	0.1	54.2	0.0	0.3	30.7	4.2	0.6	6.0	0.2	0.3	0.2	9.6	8.8	0.3	0.1	0.3	0.1	0.3	1.2	8.1	0.4	1.2	0.1	2.4	0.0	0.1	13.1	46.0	0.2	7.0	2.2	0.2	0.3	0.2	15.1	2.1	0.1	0.1	0.5	1.6	0.5	0.9	0.9	0.1	0.1	0.4	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.3	4.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.1	8.7	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.3	0.3	0.2	0.3	0.1	0.1	0.1	0.0	0.0	0.0	6.7	15.5	0.0	0.3	33.1	0.0	1.2	38.4	0.0	1.0	1.7	1.3	3.5	0.1	0.7	0.0	0.0	4.1	0.2	0.5	0.0	21.5	0.2	0.0	0.0	0.0	1.0	1.8	0.0	0.0	1.7	0.0	0.1	0.0	0.6	0.3	0.0	1.1	0.0	0.0	0.0	2.4	2.1	18.7	0.7	0.0	0.2	0.7
CNBP	"CNBP1, DM2, RNF163, ZCCHC22, ZNF9"	ENSG00000169714	"CCHC-type zinc finger nucleic acid binding protein"	P62633	3	129169484-129183922	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063097			Approved	Nucleoplasm,Cytosol		NA	NA		43000	Nucleoplasm	Cytosol	"HPA063097: AB_2684939"	"unprognostic (1.74e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.84e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.28e-2)"	"unprognostic (7.38e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-3)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (4.72e-3)"	"unprognostic (4.62e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.58e-1)"	54.2	52.8	36.4	33.6	33.7	35.9	46.6	43.5	35.6	58.1	47.1	34.5	40.5	32.4	54.5	49.4	55.6	40.9	48.5	78.2	33.0	32.0	38.0	71.6	47.5	40.6	39.7	30.3	67.4	65.4	39.3	33.5	41.5	33.3	62.3	37.1	41.3	48.9	50.9	182.1	46.7	40.6	71.9	38.0	43.2	43.1	32.1	33.1	39.0	67.3	81.1	41.2	76.1	63.5	74.3	60.3	120.1	84.1	61.7	83.4	172.9	61.7	36.6	53.4	42.3	53.4	45.8	42.2	48.6	77.1	53.0	60.9	53.6	43.5	82.2	41.7	45.2	38.9	46.5	69.8	56.3	71.9	55.1	50.8	79.4	37.8	57.7	53.2	85.1	45.7	44.3	66.2	37.1	134.1	36.1	46.7	46.4	59.4	56.6	55.5	73.9	78.8	62.6	65.1	55.1	61.9	69.3	49.6	97.9	54.9	59.5	72.8	58.3	38.3	37.9	103.0	32.6	43.6	58.6	49.2	39.3	38.7	53.9	49.1	53.2	48.4	129.3	40.5	58.4	51.8	93.4	84.1	96.8	64.1	63.8	80.6	74.3	77.4	68.9	60.3	62.7	83.4	72.0	120.1	61.7	48.9	35.1	73.9	172.9	36.4	33.7	43.5	35.6	33.0	32.0	39.7	30.3	33.3	33.1	241.2	236.8	168.8	346.4	466.2	151.2	559.4	112.1	211.5	257.0	75.0	31.4	228.5	316.7	172.7	25.7	265.4	148.7	46.7	254.5	331.1	308.6	248.1	302.0	134.8	219.0	87.4	164.4	125.8	185.1	30.7	292.6	305.9	301.9	415.6	158.2	306.6	196.4	147.3	300.5	191.8	122.5	258.7	447.2	255.1	271.9	512.9	243.9	251.4	182.3	305.2
LMO7	"FBX20, FBXO20, KIAA0858"	ENSG00000136153	"LIM domain 7"	Q8WWI1	13	75620434-75859870	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 65.6"	"Cell type enhanced"	"Detected in many"	17	"Alveolar cells type 1: 1563.3;Club cells: 396.9;Urothelial cells: 377.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 14.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.1"	"Cell line enhanced"	"Detected in many"		"BJ: 55.4;fHDF/TERT166: 91.4;LHCN-M2: 86.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 32.9;basal ganglia: 46.3;cerebral cortex: 39.4;hippocampal formation: 54.2"	"HPA020923, HPA050184"	Enhanced		Supported	"Actin filaments,Cytosol"		NA	NA			"Actin filaments"	Cytosol	"HPA020923: AB_1852963, HPA050184: AB_2681045"	"unprognostic (2.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.75e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (2.14e-1)"	"prognostic favorable (7.75e-12)"	"unprognostic (2.49e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.33e-2)"	2.2	2.2	10.1	6.3	32.6	0.9	2.5	2.7	13.2	6.7	24.3	0.5	2.4	17.5	2.3	7.8	42.5	4.0	16.3	65.6	9.8	2.5	21.7	19.9	57.0	2.6	2.3	8.8	5.5	6.8	6.2	3.1	10.9	1.1	7.6	8.9	2.7	14.3	7.0	44.4	8.6	55.0	2.1	2.0	1.5	16.7	4.7	4.1	16.2	25.7	36.3	23.7	4.6	15.4	2.4	1.1	3.0	0.5	0.5	14.1	2.6	12.2	7.0	0.2	0.2	14.6	10.4	2.4	55.4	27.4	14.1	15.3	17.1	15.9	1.0	4.2	91.4	3.5	11.9	3.0	2.6	16.3	16.5	0.7	7.5	37.2	16.0	4.2	2.4	3.9	7.1	5.2	6.1	7.0	34.6	5.9	2.4	0.2	0.1	86.0	4.8	1.8	1.0	0.3	19.0	10.6	1.1	25.9	0.2	6.0	2.8	0.9	1.9	10.1	1.7	2.2	1.5	2.3	1.8	9.0	34.9	6.5	4.1	13.5	3.7	2.7	4.4	10.2	2.7	15.8	3.0	0.2	2.4	0.7	0.5	0.9	1.1	3.2	1.0	0.4	2.4	14.1	8.5	0.1	0.5	0.3	1.1	1.2	2.6	10.1	32.6	2.7	13.2	9.8	2.5	2.3	8.8	1.1	4.1	1563.3	242.1	2.7	51.2	21.3	5.2	309.1	48.4	234.2	396.9	59.3	2.0	38.6	13.3	56.6	4.7	11.3	219.0	0.0	32.9	6.2	66.8	251.0	19.7	61.7	5.1	6.4	68.3	6.7	3.7	5.6	38.9	4.9	15.1	1.8	69.4	1.7	146.0	64.9	40.0	13.6	10.9	12.9	19.1	8.1	3.2	39.5	14.2	7.0	44.1	377.1
CRYBG2	"AIM1L, FLJ38020"	ENSG00000176092	"Crystallin beta-gamma domain containing 2"	Q8N1P7	1	26321698-26360080	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 43.9;placenta: 55.0"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 40.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 7.1;BEWO: 15.5;CACO-2: 25.1;CAPAN-2: 16.9;HaCaT: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029629			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029629: AB_10601331"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (5.11e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.39e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (2.94e-2)"	"unprognostic (4.83e-9)"	"unprognostic (9.12e-3)"	"unprognostic (3.40e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.63e-2)"	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	8.0	4.4	0.0	0.0	4.9	0.9	0.6	43.9	0.2	2.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	55.0	0.0	0.8	1.4	0.1	5.1	0.0	0.0	13.8	10.4	0.0	0.0	0.0	0.9	1.2	0.0	0.1	0.0	22.0	19.8	4.9	16.1	0.7	0.0	2.4	0.1	0.2	1.7	0.3	7.1	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.1	25.1	16.9	0.1	5.1	0.0	0.1	6.3	0.0	4.5	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	1.2	4.0	0.0	0.0	0.0	0.1	0.3	1.6	0.3	0.0	0.0	3.0	0.0	1.2	4.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.5	1.0	0.1	0.5	0.7	1.7	0.7	0.0	0.6	0.5	0.5	2.4	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	4.9	1.7	1.8	0.0	0.0	0.0	0.0	1.2	4.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	40.6	0.0	0.0	0.0
RNF139	"HRCA1, RCA1, TRC8"	ENSG00000170881	"Ring finger protein 139"	Q8WU17	8	124474738-124487914	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Ubl conjugation pathway"	"Receptor, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"Early spermatids: 763.4;Late spermatids: 690.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001202	Approved					NA	NA					"HPA001202: AB_1079824"	"unprognostic (3.28e-3)"	"unprognostic (2.92e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.71e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.45e-1)"	15.1	17.3	10.4	9.5	12.2	54.5	13.4	12.0	17.1	14.2	10.9	14.0	9.4	6.2	15.3	10.0	12.2	14.2	11.0	11.4	10.4	10.8	11.4	17.7	11.3	14.2	12.4	11.5	17.1	10.3	7.6	10.6	18.4	9.9	12.8	10.4	10.2	10.3	10.5	15.2	12.6	11.3	14.2	12.2	11.8	11.2	60.3	13.3	16.8	11.2	9.6	10.4	14.8	10.7	9.2	9.4	11.8	11.7	8.6	13.9	8.0	13.2	8.9	10.7	10.5	23.6	18.8	8.8	11.9	22.7	10.0	13.0	5.7	11.1	13.7	14.0	15.4	7.2	9.8	9.1	14.6	15.0	19.0	11.5	20.4	5.9	11.8	18.0	9.6	11.8	16.1	21.2	10.6	28.8	13.7	13.4	12.7	14.3	21.1	11.8	35.9	16.2	6.9	7.5	26.6	12.6	6.5	7.9	13.7	18.8	17.0	4.5	11.7	15.5	39.0	16.8	8.4	18.7	10.5	10.5	6.7	15.5	11.3	13.3	17.1	18.2	12.4	10.5	16.3	6.7	3.3	7.4	11.8	11.6	4.7	13.9	9.2	10.8	13.2	9.4	8.5	10.8	11.3	10.8	8.6	11.7	5.1	13.2	8.0	10.4	12.2	12.0	17.1	10.4	10.8	12.4	11.5	9.9	13.3	3.0	6.7	27.4	55.8	58.7	13.6	14.1	33.1	5.3	5.7	21.0	5.9	34.4	10.0	17.2	763.4	21.8	13.6	0.0	15.7	43.0	28.5	26.2	20.7	28.2	22.9	15.9	20.8	16.0	27.6	690.0	27.3	26.6	33.7	19.0	17.2	19.8	18.3	7.0	25.5	12.9	22.3	19.4	53.6	37.9	24.2	61.6	63.2	26.2	16.8	48.5
FCF1	"Bka, C14orf111, CGI-35, UTP24"	ENSG00000119616	"FCF1, rRNA-processing protein"	Q9Y324	14	74713144-74738620	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 87.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046681	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046681: AB_10960541"	"unprognostic (1.39e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.94e-3)"	"prognostic unfavorable (5.54e-6)"	"unprognostic (3.17e-1)"	"unprognostic (3.43e-2)"	"unprognostic (7.36e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (7.79e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (3.30e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.47e-1)"	23.9	26.0	19.5	18.4	23.0	18.3	27.1	15.7	21.6	25.6	21.6	24.6	25.9	14.4	29.5	18.5	30.4	30.6	17.8	21.9	17.7	18.2	24.6	25.1	21.1	24.2	25.2	17.5	32.7	18.3	23.1	34.5	24.4	23.8	22.8	23.2	20.8	22.7	25.4	26.3	20.3	19.3	23.8	34.9	21.4	19.8	19.4	21.6	28.3	37.8	23.3	30.5	26.6	24.0	19.0	25.2	15.8	14.5	12.1	18.1	6.8	36.1	26.7	19.3	21.8	30.8	27.3	25.5	31.8	24.5	31.8	28.5	29.6	29.9	32.4	20.8	27.7	15.4	26.7	32.2	30.0	56.4	30.0	14.0	22.4	16.8	19.3	22.3	27.3	20.7	21.3	26.6	33.7	35.5	25.3	29.6	28.2	26.8	19.6	28.5	25.8	31.7	9.8	25.9	21.1	31.1	24.2	38.0	15.4	16.2	29.7	13.6	19.8	40.8	21.7	18.1	22.4	27.7	19.1	26.9	25.5	27.3	24.0	36.3	17.3	45.3	50.4	24.2	26.1	28.2	10.0	14.5	15.8	16.6	12.3	18.1	19.0	16.0	14.2	11.2	18.7	17.4	17.8	12.1	12.1	14.2	25.2	15.4	6.8	19.5	23.0	15.7	21.6	17.7	18.2	25.2	17.5	23.8	21.6	6.0	19.4	22.2	6.5	2.7	6.9	18.9	43.3	62.9	18.2	12.2	5.9	10.3	13.3	15.2	17.6	13.6	14.2	46.7	16.3	12.5	7.3	6.1	25.4	87.3	11.2	11.1	9.8	34.4	35.1	8.8	14.4	12.0	0.0	8.2	14.0	14.5	15.2	8.6	15.9	10.7	6.3	12.9	5.2	10.6	11.9	4.3	7.3	13.8	14.2	5.5
NMI		ENSG00000123609	"N-myc and STAT interactor"	Q13287	2	151270465-151290057	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 75.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 75.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA008588	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA008588: AB_1079493"	"unprognostic (5.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.51e-3)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.57e-7)"	"unprognostic (1.91e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.57e-2)"	12.0	14.2	5.0	18.6	7.1	26.4	14.0	1.3	5.8	8.9	15.0	3.4	11.1	13.2	8.6	10.4	16.1	9.8	14.7	8.7	5.9	3.8	13.0	20.4	18.5	26.9	5.1	2.7	14.8	8.4	2.9	6.5	24.6	6.9	13.6	10.5	5.0	9.8	7.9	5.1	7.3	26.0	13.1	7.7	30.2	10.2	5.3	6.4	36.7	14.9	10.2	14.2	10.4	10.3	10.8	17.0	75.1	26.9	14.3	12.5	14.9	10.9	5.4	0.3	0.0	3.1	8.5	10.7	3.2	7.5	15.4	23.5	1.1	25.0	10.7	11.9	4.8	5.1	6.3	1.1	2.8	3.9	22.7	0.6	30.1	5.6	0.6	13.2	28.5	8.7	5.5	3.8	9.2	2.1	6.8	19.0	11.9	14.9	2.6	2.9	8.4	23.9	42.6	6.3	2.2	8.1	25.8	0.6	9.2	12.7	9.5	1.5	0.0	6.7	7.3	4.1	1.1	1.2	32.5	10.3	2.2	5.0	7.2	4.6	0.4	0.4	0.6	5.3	34.3	2.4	31.6	19.7	21.6	10.8	26.9	12.5	10.8	11.3	10.7	17.0	9.1	9.2	9.4	75.1	14.3	24.4	6.9	9.7	14.9	5.0	7.1	1.3	5.8	5.9	3.8	5.1	2.7	6.9	6.4	23.8	19.8	16.0	18.1	14.8	0.2	3.1	15.3	38.8	27.3	12.2	0.0	62.5	13.3	54.5	2.6	35.8	24.2	0.0	36.0	53.3	19.2	13.1	34.7	16.0	71.3	0.0	17.3	17.2	39.1	0.0	18.1	53.0	1.7	45.9	20.9	5.8	34.1	23.0	13.1	20.9	0.0	6.5	14.7	3.3	1.7	15.6	45.5	40.7	19.5	19.2
MAGT1	"DKFZp564K142, IAP, MRX95, OST3B"	ENSG00000102158	"Magnesium transporter 1"	Q9H0U3	X	77826364-77895593	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049851	Approved				"Intracellular and membrane"	NA	NA		14000			"HPA049851: AB_2680913"	"prognostic unfavorable (1.30e-4)"	"unprognostic (3.32e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.81e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (8.98e-4)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.66e-1)"	17.3	17.1	11.3	11.7	15.4	9.2	18.3	4.7	10.1	21.4	15.5	25.9	17.5	12.7	17.5	28.1	18.4	14.2	13.1	22.3	11.5	9.5	29.0	69.5	20.4	20.3	19.3	8.2	19.8	49.8	20.0	21.3	28.6	14.0	17.3	13.8	13.6	28.9	17.6	13.7	14.1	22.4	13.4	22.6	21.0	14.5	11.1	18.2	19.8	45.3	11.0	17.6	18.2	15.4	14.3	23.6	13.2	21.3	18.5	20.8	17.3	23.1	13.6	16.4	18.4	28.1	19.5	25.2	25.1	25.0	19.7	21.6	17.0	38.5	16.6	34.5	27.1	20.7	21.7	34.3	18.4	31.2	12.3	20.8	11.2	20.3	15.1	25.0	23.2	12.5	17.0	15.9	26.1	21.8	20.3	27.9	11.8	13.4	48.7	23.4	14.8	13.6	8.3	21.1	22.8	15.3	16.7	27.3	31.1	22.7	17.1	5.4	9.9	34.5	23.6	20.7	16.9	16.9	12.5	28.4	18.0	20.5	27.8	12.5	17.1	38.0	21.7	19.8	21.7	23.3	12.8	14.2	13.2	20.6	21.1	20.8	14.3	17.9	18.9	12.4	12.3	17.8	20.7	11.9	18.5	21.3	23.6	13.0	17.3	11.3	15.4	4.7	10.1	11.5	9.5	19.3	8.2	14.0	18.2	38.7	53.0	20.1	43.3	29.3	5.4	40.3	58.6	13.4	38.7	38.4	3.9	29.0	3.3	29.8	1.6	35.9	32.9	46.7	30.6	45.3	37.3	74.8	29.0	127.0	37.8	1.6	21.8	43.6	35.8	1.1	28.4	35.6	32.1	21.6	34.3	15.8	34.2	30.0	25.5	25.2	4.6	19.4	26.7	3.2	16.9	39.9	68.0	29.9	24.1	56.7
ECM1		ENSG00000143369	"Extracellular matrix protein 1"	Q16610	1	150508062-150513789	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Biomineralization, Mineral balance, Osteogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.2;esophagus: 257.1;lymphoid tissue: 107.2"	"Cell type enhanced"	"Detected in many"	9	"Fibroblasts: 80.6;Ito cells: 56.4;Melanocytes: 70.9;Pancreatic endocrine cells: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.2;myeloid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 77.4;BJ hTERT+: 53.9;fHDF/TERT166: 50.8;hTEC/SVTERT24-B: 36.5;LHCN-M2: 39.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA027241, HPA076029"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		12000000000	Cytosol	Nucleoplasm	"HPA027241: AB_1847976, HPA076029: "	"unprognostic (2.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (1.51e-9)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.20e-5)"	16.1	2.5	0.9	1.8	1.3	0.1	11.0	0.9	4.2	37.9	2.8	0.1	7.4	1.5	10.5	133.2	257.1	3.3	30.7	11.6	0.9	1.0	2.5	16.7	3.8	0.2	1.0	1.7	3.0	0.8	0.3	2.0	20.2	4.2	2.6	3.1	1.6	28.7	2.9	3.5	11.5	2.0	5.3	0.8	3.6	2.1	5.9	0.0	0.0	1.8	45.5	107.2	6.0	46.6	0.0	1.8	0.0	1.2	0.0	0.4	1.3	6.2	0.6	2.3	0.0	14.0	77.4	2.1	22.7	53.9	14.2	18.6	0.3	3.5	0.1	0.2	50.8	1.6	13.1	0.0	2.7	14.9	0.1	0.1	0.9	0.8	0.1	3.9	0.0	23.5	6.8	0.1	36.5	1.3	20.9	3.9	0.1	4.8	0.1	39.5	0.0	0.0	0.7	0.2	26.5	0.7	0.3	17.0	0.1	0.5	0.0	0.1	0.0	5.2	0.1	19.4	1.1	0.0	6.0	1.0	30.1	4.5	3.4	4.9	0.1	0.2	0.2	15.8	2.1	4.0	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	1.3	0.9	4.2	0.9	1.0	1.0	1.7	4.2	0.0	0.0	0.6	1.4	1.8	13.1	0.7	1.1	12.7	0.0	2.3	3.5	0.0	1.3	0.0	4.8	0.2	4.4	0.2	0.0	3.7	26.0	80.6	1.0	10.3	0.6	16.0	1.6	0.0	56.4	2.1	0.0	9.2	4.8	70.9	0.0	0.3	0.8	42.0	0.0	20.8	0.0	1.1	12.9	16.1	0.5	0.4	16.7	9.2	0.0	0.2	5.8
NDC1	"FLJ10407, NET3, TMEM48"	ENSG00000058804	"NDC1 transmembrane nucleoporin"	Q9BTX1	1	53765460-53838860	"Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069751, HPA070882"	Approved		Supported	"Nuclear membrane,Plasma membrane,Actin filaments"		NA	NA			"Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA069751: AB_2686189, HPA070882: AB_2686320"	"unprognostic (2.51e-1)"	"unprognostic (1.93e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (6.96e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.36e-3)"	"prognostic unfavorable (7.52e-7)"	"unprognostic (3.46e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (9.27e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.00e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.24e-2)"	"unprognostic (6.07e-2)"	8.8	6.7	3.3	8.6	5.7	4.9	12.9	10.9	7.7	4.8	8.4	5.1	1.9	6.2	6.0	5.4	11.0	5.3	2.9	5.5	4.3	2.8	4.9	11.7	4.4	10.6	8.0	1.5	4.6	6.0	7.6	5.5	5.5	6.6	4.0	10.7	5.5	6.4	3.7	7.1	6.8	6.5	5.0	7.5	7.1	5.8	17.4	7.5	9.1	5.8	6.7	13.0	6.4	5.8	5.5	3.8	2.0	7.2	4.0	8.2	3.4	20.0	10.6	14.4	14.7	5.3	5.4	17.0	13.8	10.3	21.6	17.5	15.6	13.5	39.6	9.0	6.1	17.5	24.2	24.3	14.3	30.6	9.8	17.5	19.3	15.5	13.2	5.0	30.9	11.0	3.2	5.7	21.3	12.7	6.3	13.0	14.8	22.0	5.7	11.8	7.2	15.1	12.3	34.3	17.0	16.9	17.1	23.3	21.6	10.1	13.8	8.7	11.1	12.3	24.0	11.8	16.0	18.6	16.4	7.6	11.3	11.3	15.5	24.7	6.3	15.6	28.2	9.4	23.5	14.1	0.0	3.2	2.0	4.5	7.2	6.9	5.5	4.3	4.0	3.8	4.1	8.2	6.3	0.2	4.0	4.5	3.3	4.7	3.4	3.3	5.7	10.9	7.7	4.3	2.8	8.0	1.5	6.6	7.5	6.0	4.6	3.7	6.1	9.0	4.1	7.6	2.5	2.7	2.3	5.2	2.0	8.2	0.0	5.9	1.7	4.8	3.3	0.0	7.7	16.4	5.9	5.0	7.0	5.9	10.3	3.2	0.0	4.3	9.1	1.7	2.6	6.7	6.8	2.8	8.4	4.1	6.1	2.9	3.2	4.5	3.2	6.5	4.7	9.3	13.1	7.4	5.7	4.1	15.1	5.4
KRAS	"KRAS1, KRAS2"	ENSG00000133703	"KRAS proto-oncogene, GTPase"	P01116	12	25204789-25250936	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Cardiomyopathy, Deafness, Disease mutation, Ectodermal dysplasia, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049830	Approved					NA	NA		5800000			"HPA049830: AB_2680903"	"unprognostic (2.24e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.08e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (6.42e-2)"	"prognostic favorable (2.75e-5)"	"unprognostic (1.95e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.81e-2)"	"unprognostic (9.97e-2)"	11.7	9.9	14.4	15.5	19.5	24.1	10.6	21.1	25.6	10.3	26.2	7.3	7.9	16.1	11.3	7.7	25.1	10.1	13.9	9.3	13.6	16.6	14.0	17.9	14.9	15.1	11.6	15.8	13.1	13.6	12.7	9.8	15.7	21.1	12.1	28.1	9.8	16.2	9.8	10.0	14.0	23.7	17.2	11.3	15.7	23.6	7.8	9.5	18.5	11.1	10.6	16.3	16.8	14.3	10.0	7.1	20.8	18.9	9.4	13.8	5.0	6.8	6.9	15.5	8.7	5.8	7.9	31.2	7.0	8.8	7.3	8.7	24.0	15.7	15.7	4.2	12.1	9.8	7.5	18.1	7.6	13.8	10.7	6.3	14.8	7.4	5.9	6.1	13.8	11.3	7.3	10.4	8.8	7.9	13.4	10.6	11.5	10.5	7.5	10.7	5.8	19.0	21.1	34.1	11.2	2.8	16.5	16.4	22.6	10.8	12.1	4.7	13.3	8.3	11.0	8.3	42.6	12.2	10.0	12.2	8.2	10.9	15.4	8.6	6.6	11.0	17.0	6.3	8.1	5.9	20.8	7.8	12.4	11.9	14.4	7.5	10.0	10.4	13.0	7.1	8.6	13.8	12.1	19.0	9.4	18.9	7.1	6.7	5.0	14.4	19.5	21.1	25.6	13.6	16.6	11.6	15.8	21.1	9.5	44.7	28.0	47.9	74.6	89.6	61.8	13.7	71.4	22.7	23.9	36.6	68.7	77.0	49.7	64.2	2.8	58.3	123.1	46.7	79.4	16.4	50.1	116.8	23.1	52.1	45.9	87.4	75.6	73.6	60.9	2.5	37.7	60.3	59.1	92.0	88.6	31.5	107.1	78.0	48.4	38.6	62.1	25.8	43.4	57.5	37.0	136.1	116.4	56.8	58.1	134.2
FANCI	"FLJ10719, KIAA1794"	ENSG00000140525	"Fanconi anemia complementation group I"	Q9NVI1	15	89243949-89317261	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 44.4;testis: 28.3"	"Cell type enhanced"	"Detected in many"	11	"Erythroid cells: 46.7;Spermatocytes: 45.0;Spermatogonia: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039972, HPA040379"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039972: AB_10673265, HPA040379: AB_2676951"	"unprognostic (6.88e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (6.82e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.59e-3)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (2.71e-13)"	"unprognostic (2.40e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-1)"	3.7	3.2	1.7	11.1	3.3	16.5	3.3	1.8	5.6	3.8	5.9	3.0	2.7	3.3	3.3	3.3	10.7	2.1	1.8	2.8	2.5	1.5	2.4	2.0	3.5	13.4	5.0	2.6	3.1	2.3	1.8	1.5	7.1	2.9	2.8	7.6	2.3	4.0	1.7	1.3	5.4	4.9	3.8	2.8	6.7	4.6	28.3	3.2	44.4	1.7	9.2	15.4	3.9	4.6	3.8	3.9	17.7	3.8	4.6	10.6	3.0	24.5	28.2	30.2	20.3	2.7	3.9	18.7	23.6	13.6	29.6	36.2	22.3	22.4	45.5	12.8	7.8	18.9	33.7	46.1	16.0	27.9	29.0	28.8	45.1	41.5	10.4	0.4	32.5	23.0	2.1	1.6	20.8	10.6	4.3	12.0	28.1	31.1	33.6	19.7	14.0	33.9	11.2	23.7	16.1	10.4	29.5	44.0	19.5	6.8	45.4	22.5	19.3	24.4	17.3	11.0	21.3	19.1	14.8	8.2	24.6	25.1	22.5	35.8	22.3	46.3	35.1	9.2	29.0	24.6	17.7	2.4	2.8	5.2	3.0	2.9	3.5	5.0	6.8	2.1	3.8	4.1	6.0	3.7	4.6	3.8	3.9	10.6	3.0	1.7	3.3	1.8	5.6	2.5	1.5	5.0	2.6	2.9	3.2	3.0	1.0	3.7	1.8	3.8	2.1	2.7	0.0	8.1	4.5	1.8	0.0	8.3	0.0	1.7	5.9	1.6	1.3	46.7	2.5	15.5	2.7	1.4	2.3	0.8	6.8	1.6	1.2	9.2	3.1	5.3	3.1	4.3	1.7	3.6	4.5	9.5	2.2	0.0	1.4	1.0	1.7	6.5	1.9	45.0	68.0	2.0	10.4	5.2	4.4	1.7
MTMR2	"CMT4B, KIAA1073"	ENSG00000087053	"Myotubularin related protein 2"	Q13614	11	95832882-95925315	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 87.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049831	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA049831: AB_2680904"	"unprognostic (1.71e-2)"	"unprognostic (2.55e-3)"	"unprognostic (7.81e-3)"	"unprognostic (4.16e-1)"	"unprognostic (4.18e-3)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (1.61e-8)"	"unprognostic (3.23e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.03e-3)"	16.4	10.4	14.2	12.1	19.9	5.3	15.4	14.9	23.3	14.1	13.5	22.6	4.9	8.0	14.1	7.5	15.5	13.3	15.4	13.8	18.1	13.9	16.9	4.5	14.3	13.6	27.5	13.6	14.5	11.0	15.9	8.2	25.1	21.3	17.6	14.5	19.6	18.8	12.3	6.8	9.7	9.5	18.2	30.0	10.5	13.6	29.0	21.8	12.2	11.3	7.7	11.7	13.4	14.3	5.4	6.6	9.7	4.9	11.8	14.2	6.6	9.4	10.1	23.3	16.9	8.2	12.7	19.5	17.7	15.8	17.6	15.9	23.9	19.2	6.8	21.2	18.6	14.9	13.1	19.0	19.3	15.9	12.4	9.2	14.1	25.3	13.4	18.8	23.9	11.7	10.6	12.9	23.1	23.2	18.0	26.5	15.3	17.4	6.5	16.5	7.0	11.9	11.1	18.9	22.8	14.3	10.0	13.6	6.4	18.1	50.8	14.9	17.4	17.5	14.8	7.9	15.3	11.7	10.2	27.1	20.6	18.9	15.0	16.3	6.1	16.8	6.2	8.6	6.6	20.8	9.7	3.3	1.4	11.4	3.9	12.3	5.4	7.7	14.2	6.6	4.8	4.1	11.0	0.9	11.8	4.9	3.4	6.9	6.6	14.2	19.9	14.9	23.3	18.1	13.9	27.5	13.6	21.3	21.8	3.0	7.5	5.1	13.3	9.2	0.0	14.0	0.0	9.4	12.5	8.7	0.0	8.0	8.3	15.9	48.9	19.5	7.3	0.0	14.6	26.0	14.0	13.2	18.5	0.9	11.0	0.0	15.5	10.4	9.1	87.8	10.3	7.5	3.3	9.0	9.1	0.0	14.2	2.9	11.3	20.7	0.0	32.3	20.0	34.6	16.4	5.3	7.6	7.9	8.4	13.2
PCDH1	pc42	ENSG00000156453	"Protocadherin 1"	Q08174	5	141853111-141879246	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 37.9;Exocrine glandular cells: 40.1;Pancreatic endocrine cells: 44.8;Urothelial cells: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2;naive CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 29.5;HaCaT: 36.8;HUVEC TERT2: 19.3;OE19: 26.1;RT4: 25.2;TIME: 25.1;WM-115: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047720, HPA050538"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA		270000	"Nucleoplasm, Cell Junctions"	Nucleoli	"HPA047720: AB_2680130, HPA050538: AB_2681162"	"unprognostic (4.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (4.96e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (2.43e-1)"	"prognostic favorable (7.55e-5)"	"unprognostic (2.05e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.91e-1)"	22.4	4.5	14.8	7.4	17.6	1.4	19.0	16.1	25.6	8.3	22.2	7.3	11.4	20.6	7.0	7.0	26.9	9.7	6.8	8.9	11.6	7.4	14.9	13.0	18.9	3.4	8.8	16.9	2.5	11.0	1.3	5.2	32.5	9.2	11.1	14.4	6.0	23.7	12.3	7.4	17.3	15.8	7.5	7.5	1.6	22.8	1.5	9.8	0.0	9.1	3.9	8.8	8.6	11.7	0.0	0.0	0.3	0.0	0.0	2.2	0.5	6.2	0.3	2.6	2.9	0.1	0.0	1.9	0.0	0.0	0.0	0.0	1.5	29.5	0.0	15.2	0.2	0.3	36.8	3.4	2.7	0.0	0.0	0.1	0.0	0.1	0.0	2.4	0.0	0.1	0.0	6.2	0.0	0.4	6.3	19.3	0.0	0.0	3.1	0.0	5.0	0.1	0.0	11.2	26.1	5.0	0.1	0.0	4.2	2.1	25.2	0.3	0.6	0.1	8.1	6.5	7.9	6.5	0.1	25.1	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.2	0.0	17.8	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.5	14.8	17.6	16.1	25.6	11.6	7.4	8.8	16.9	9.2	9.8	0.0	4.0	0.0	10.2	0.9	9.1	2.2	22.9	4.0	2.3	12.2	0.0	0.6	3.3	13.6	0.3	21.8	37.9	0.0	40.1	0.2	1.6	22.4	0.0	26.0	0.2	25.4	7.5	6.2	1.9	0.8	0.6	0.5	0.0	0.0	17.6	4.0	44.8	19.3	0.4	5.1	0.4	12.9	15.1	0.2	0.2	2.3	16.8	0.0	14.7	43.0
TPM3	"NEM1, TRK"	ENSG00000143549	"Tropomyosin 3"	P06753	1	154155304-154194648	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Disease mutation, Nemaline myopathy, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 738.4;tongue: 203.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, HPA047089, HPA053624"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA		410000000	"Actin filaments"	Cytosol	"HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.64e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.69e-3)"	"prognostic unfavorable (6.73e-6)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (2.80e-1)"	"prognostic favorable (2.39e-5)"	"prognostic unfavorable (3.65e-4)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.52e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.00e-2)"	10.1	7.3	10.8	10.8	10.5	26.5	6.2	6.4	11.2	4.6	9.6	3.9	3.2	7.9	4.1	27.9	18.3	4.4	6.7	29.7	7.7	8.1	7.2	6.8	9.6	12.9	8.9	5.8	4.8	23.2	3.6	3.2	6.7	5.0	5.7	10.7	4.4	20.5	2.5	738.4	5.9	8.2	5.2	7.7	11.7	6.9	5.4	4.4	6.7	9.3	203.6	28.6	6.8	4.9	38.9	72.6	154.8	95.9	35.4	54.4	146.1	66.5	33.2	42.5	27.9	36.0	47.1	42.9	57.2	52.9	75.9	57.3	61.8	62.4	50.1	46.6	64.5	30.5	61.7	42.1	60.2	81.0	34.7	22.9	61.7	32.4	41.6	28.6	90.2	82.0	35.5	33.0	66.9	51.5	34.2	116.7	36.9	46.3	53.9	93.7	39.9	70.2	93.1	95.7	113.6	72.2	60.2	29.5	71.0	54.8	50.8	29.9	56.1	43.5	57.9	56.7	59.2	80.8	107.9	87.2	66.5	48.1	63.7	89.6	45.9	75.4	67.0	60.1	68.0	105.0	70.8	64.7	154.8	54.4	87.8	48.6	38.9	48.5	51.1	72.6	30.1	36.6	47.3	74.9	35.4	95.9	36.0	52.1	146.1	10.8	10.5	6.4	11.2	7.7	8.1	8.9	5.8	5.0	4.4	577.7	334.3	245.8	179.3	132.8	84.5	62.7	104.4	335.9	395.8	92.5	29.5	101.3	89.5	278.9	51.0	357.1	327.9	0.0	302.5	278.2	125.9	137.0	499.8	99.0	485.9	287.6	135.3	175.6	320.5	131.0	43.1	444.6	145.1	764.7	164.6	45.8	384.6	230.6	28.0	130.8	59.1	19.4	73.4	34.9	54.6	125.3	85.2	233.3	208.9	254.0
FA2H	"FAAH, FAXDC1, FLJ25287, SPG35"	ENSG00000103089	"Fatty acid 2-hydroxylase"	Q7L5A8	16	74712955-74774831	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Oxidoreductase	"Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.2;stomach 1: 45.5"	"Cell type enhanced"	"Detected in many"	20	"Mucus-secreting cells: 34.0;Paneth cells: 56.1;Urothelial cells: 163.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	24	"memory B-cell: 3.0"	"Lineage enriched"	"Detected in single"	24	"B-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"A549: 16.0;HAP1: 20.7;JURKAT: 38.1;OE19: 25.5;SK-BR-3: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056614, HPA077840"	Approved		Uncertain	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA056614: AB_2683191, HPA077840: AB_2686858"	"unprognostic (1.33e-1)"	"unprognostic (4.97e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (6.01e-2)"	"prognostic favorable (5.01e-6)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.11e-3)"	0.7	0.7	11.8	3.4	27.7	0.7	2.6	2.8	25.3	2.0	16.2	62.4	0.0	8.1	0.7	2.2	3.7	1.8	14.3	0.7	22.3	11.0	3.7	0.7	1.5	0.9	40.5	16.5	0.6	6.8	7.1	0.8	1.0	28.5	1.9	15.4	0.0	8.4	1.0	0.6	3.5	11.3	1.4	78.2	0.8	45.5	2.4	44.6	2.6	2.0	0.0	4.7	3.8	1.2	3.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	16.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	8.7	8.9	0.0	0.0	0.0	0.9	1.5	20.7	0.2	0.0	0.0	0.6	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	38.1	0.0	0.0	0.0	6.3	0.3	0.0	0.4	25.5	1.0	0.0	0.0	0.7	10.1	6.5	2.8	0.0	0.0	12.3	0.0	0.5	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.8	27.7	2.8	16.1	22.3	11.0	40.5	16.5	28.5	44.6	0.0	2.2	0.0	4.2	0.5	0.0	0.3	10.2	4.0	2.3	0.0	0.0	0.2	6.6	11.5	6.3	0.0	25.4	0.0	12.9	0.1	0.0	20.7	0.0	0.0	0.1	0.0	6.4	0.0	0.0	2.7	0.0	0.0	3.3	0.0	34.0	0.0	26.4	56.1	0.4	0.0	0.0	0.0	0.1	0.5	2.1	0.6	0.1	0.0	16.8	163.9
AFAP1L2	"Em:AC005383.4, FLJ14564, KIAA1914, XB130"	ENSG00000169129	"Actin filament associated protein 1 like 2"	Q8N4X5	10	114294824-114404756	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 47.9"	"Cell type enhanced"	"Detected in many"	10	"Collecting duct cells: 38.4;Sertoli cells: 19.4;Smooth muscle cells: 17.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 39.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 4.0;T-cells: 4.0"	"Cell line enhanced"	"Detected in some"		"A-431: 26.4;CAPAN-2: 28.5;EFO-21: 21.2;HaCaT: 36.3;RPMI-8226: 18.6;RPTEC TERT1: 22.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"cerebellum: 169.5;olfactory region: 48.1"	HPA037843	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA037843: AB_10669990"	"unprognostic (2.31e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.06e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.86e-1)"	4.5	1.7	9.0	5.9	6.3	0.3	7.1	24.7	8.8	12.9	7.1	5.3	30.5	2.4	22.3	9.7	5.9	13.8	3.6	2.9	7.8	7.1	9.1	1.2	3.2	2.4	8.0	6.7	9.3	8.2	35.1	1.8	10.6	5.5	7.9	3.2	8.1	4.2	28.4	1.8	5.7	4.0	11.1	5.7	39.9	4.1	1.5	6.5	3.4	47.9	7.5	4.3	3.7	14.0	4.0	0.3	0.4	0.0	0.8	4.0	1.4	26.4	3.9	3.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	28.5	0.0	21.2	0.2	0.4	36.3	0.1	9.9	0.0	0.5	0.0	0.0	0.2	0.0	1.1	0.0	1.0	0.0	10.8	3.0	2.7	0.1	0.1	1.0	0.0	0.0	0.0	1.1	0.6	0.0	0.2	0.7	0.2	0.3	0.3	18.6	22.4	0.2	0.1	0.1	0.8	0.6	1.0	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	2.6	3.8	2.7	2.8	0.0	4.0	0.9	2.2	0.4	0.8	0.0	0.3	4.0	1.4	9.0	6.3	24.7	8.5	7.8	7.1	8.0	6.7	5.5	6.5	0.0	0.0	0.5	8.2	11.0	0.8	1.2	0.0	0.0	2.3	38.4	0.0	0.6	0.0	0.6	1.0	9.5	2.5	0.0	12.8	0.9	5.8	3.2	0.0	0.0	0.4	1.6	0.0	4.9	0.0	2.1	2.8	0.0	5.0	1.0	1.3	2.8	14.6	1.7	1.8	0.3	0.5	19.4	17.6	0.0	0.8	5.9	0.2	3.2	1.7	3.0
SKA3	"C13orf3, MGC4832, RAMA1"	ENSG00000165480	"Spindle and kinetochore associated complex subunit 3"	Q8IX90	13	21153595-21176602	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 41.6;testis: 12.6"	"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 19.6;Spermatocytes: 18.7;Spermatogonia: 13.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.9;T-cells: 2.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039272, HPA039356, HPA061534"	Approved		Supported	"Mitotic spindle,Centrosome,Cytosol"		Yes	Yes			"Mitotic spindle, Centrosome"	Cytosol	"HPA039272: AB_10805359, HPA039356: AB_10805475, HPA061534: "	"unprognostic (3.46e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (9.73e-6)"	"unprognostic (2.03e-3)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.39e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.24e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	0.8	0.6	0.6	6.4	0.6	6.2	0.9	0.4	1.6	0.8	2.8	0.3	0.0	1.1	1.0	0.8	5.1	0.2	0.3	0.4	0.8	0.5	0.8	0.5	1.0	6.1	0.6	0.3	0.5	0.4	0.0	0.6	2.6	0.8	0.4	4.0	0.2	0.9	0.0	0.5	2.4	3.1	1.1	0.5	2.6	1.4	12.6	0.3	41.6	0.3	5.7	6.4	0.5	1.4	0.4	0.2	0.3	0.3	1.9	2.3	0.6	11.3	6.0	10.8	9.1	0.0	2.3	8.5	15.3	6.5	19.4	13.2	9.8	12.2	15.5	4.6	8.4	8.3	10.7	14.4	6.2	21.2	13.3	7.4	20.6	3.9	5.6	0.0	16.0	8.0	0.4	0.4	15.5	5.2	1.8	9.4	13.2	10.7	6.6	12.8	8.8	24.3	14.4	12.5	17.2	11.2	16.0	23.2	7.2	4.3	4.4	13.8	5.1	5.1	8.0	3.2	7.5	7.1	12.3	3.8	7.7	11.1	7.1	18.4	4.0	8.5	15.6	1.9	12.5	22.0	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.8	1.4	0.2	0.0	0.8	0.3	0.0	1.9	0.3	0.0	2.3	0.6	0.6	0.6	0.4	1.6	0.8	0.5	0.6	0.3	0.8	0.3	0.0	0.0	2.2	0.5	1.8	0.0	0.6	0.0	2.7	2.3	0.0	0.0	1.3	0.0	0.9	5.1	0.8	0.2	0.0	1.2	19.6	0.8	0.4	0.0	0.2	4.6	0.0	0.0	2.5	1.9	6.0	1.4	2.2	0.0	1.0	0.3	0.2	0.6	0.9	1.1	0.3	0.0	0.0	0.9	18.7	13.5	2.5	1.8	1.0	2.7	0.1
PRELID2	"FLJ38376, MGC21644"	ENSG00000186314	"PRELI domain containing 2"	Q8N945	5	145471799-145835369	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 31.2"	"Cell type enriched"	"Detected in many"	4	"Cone photoreceptor cells: 377.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 15.8;myeloid DC: 5.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 5.2;granulocytes: 15.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042486	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042486: AB_10797498"	"unprognostic (9.45e-3)"	"unprognostic (1.95e-1)"	"unprognostic (7.58e-3)"	"unprognostic (2.71e-5)"	"unprognostic (1.96e-3)"	"unprognostic (6.53e-4)"	"unprognostic (6.62e-5)"	"unprognostic (2.27e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (9.65e-6)"	"unprognostic (2.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.83e-4)"	"unprognostic (6.42e-3)"	6.6	2.4	1.6	5.3	2.0	3.9	4.4	0.7	2.9	4.9	16.4	2.3	2.8	10.6	5.2	2.9	2.4	3.0	14.5	6.4	1.4	1.4	2.6	2.7	2.4	2.7	2.3	1.1	5.2	15.9	1.3	2.8	0.9	2.0	4.2	16.2	9.2	4.3	2.7	1.3	3.0	31.2	6.2	2.5	2.1	7.8	2.5	1.5	0.8	4.1	2.4	1.9	4.3	11.6	1.8	5.2	15.8	1.9	1.8	2.0	0.9	10.8	3.6	3.4	5.4	0.8	1.9	0.0	3.6	6.3	6.8	9.6	11.6	17.9	0.0	6.2	4.3	15.6	3.3	2.6	8.2	10.1	3.1	4.2	12.5	4.0	6.0	2.1	1.6	13.3	1.1	3.5	7.8	6.9	9.5	7.6	0.0	6.8	5.0	3.3	1.8	0.0	1.9	1.7	12.6	2.4	0.0	0.0	1.7	3.2	1.7	1.5	3.0	4.6	0.6	7.2	1.6	5.5	2.4	7.0	5.9	3.2	10.4	8.1	0.2	0.0	0.0	10.6	0.0	2.4	15.8	1.3	0.4	0.8	1.9	0.4	1.7	1.6	1.2	5.2	1.8	0.2	1.2	0.5	1.8	1.3	0.6	2.0	0.9	1.6	2.0	0.7	2.9	1.4	1.4	2.3	1.1	2.0	1.5	0.0	2.4	1.9	11.1	3.7	19.4	7.7	5.1	2.7	6.8	0.0	377.0	0.1	0.0	11.6	3.4	5.8	91.5	0.0	11.4	2.4	5.3	2.7	17.3	2.1	2.4	4.8	9.2	3.1	2.1	1.0	3.1	4.3	0.0	3.6	27.5	7.5	15.0	48.0	4.2	2.4	47.8	0.0	4.7	0.9	1.0	2.9	0.2	3.2	32.3	8.0
NCKAP1	"HEM2, Nap1, NAP125"	ENSG00000061676	"NCK associated protein 1"	Q9Y2A7	2	182909115-183038858	"Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020449	Enhanced		Approved	Cytosol		NA	NA		210000	Cytosol		"HPA020449: AB_1854327"	"unprognostic (7.92e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.35e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.12e-3)"	"prognostic unfavorable (9.71e-4)"	"unprognostic (5.06e-2)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (3.48e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.61e-2)"	25.2	23.7	35.8	12.6	49.7	0.6	25.5	32.9	47.2	30.8	29.1	12.9	17.8	28.2	27.9	28.6	42.6	22.6	22.0	46.1	34.0	26.8	37.0	20.8	20.5	4.9	25.8	36.4	24.5	21.9	47.9	26.2	29.4	25.5	30.0	25.6	16.9	24.2	35.9	45.4	26.2	28.5	38.2	20.0	10.2	28.4	16.0	20.4	4.3	44.3	21.0	12.2	33.3	40.9	0.2	0.2	2.8	0.2	0.5	0.9	0.3	23.3	14.7	22.6	14.4	32.0	31.2	25.2	30.6	27.8	20.8	26.3	22.7	20.1	0.1	20.6	36.3	31.3	22.3	19.1	28.8	34.8	5.6	14.9	5.2	16.6	18.8	33.0	0.0	4.5	23.3	35.7	30.1	49.5	28.5	33.0	1.4	12.6	0.0	39.2	15.0	0.4	0.1	23.2	18.9	25.5	1.5	24.7	0.1	29.3	31.6	16.7	15.9	27.7	22.1	28.6	37.5	11.8	0.1	35.7	35.5	20.0	19.9	18.7	3.0	5.6	0.1	27.4	0.0	17.9	2.1	0.2	2.8	0.8	0.1	0.7	0.1	0.6	0.6	0.2	0.2	0.2	0.8	0.9	0.5	0.2	0.2	0.9	0.3	35.8	49.7	32.9	42.3	34.0	26.8	25.8	36.4	25.5	20.4	44.7	40.1	0.9	54.6	77.4	82.1	92.1	56.0	17.4	39.8	76.8	66.8	26.6	23.2	49.3	3.9	76.4	44.4	0.0	53.6	42.5	61.5	90.7	13.9	36.6	4.6	116.0	48.5	68.7	7.0	6.0	72.8	6.1	52.3	1.0	58.2	92.2	72.3	65.1	99.0	50.0	60.1	58.2	79.6	45.9	29.8	98.2	43.6	7.5	47.8	94.9
PPP3CA	"CALN, CALNA, CNA1, PPP2B"	ENSG00000138814	"Protein phosphatase 3 catalytic subunit alpha"	Q08209	4	101023409-101348278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"	"Craniosynostosis, Disease mutation, Dwarfism, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.8"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	7	"prostate cancer: 98.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA012778, CAB018581"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		35000	Nucleoplasm	Cytosol	"CAB018581: AB_2168324, HPA012778: AB_1855660"	"unprognostic (6.66e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.74e-2)"	12.2	9.2	22.7	7.4	71.8	7.7	10.6	42.1	52.4	9.4	9.5	4.8	9.8	5.8	6.2	6.9	7.4	7.2	6.8	4.3	36.0	13.5	5.8	8.4	10.0	6.7	10.1	22.1	9.6	4.7	7.0	4.2	6.6	11.9	34.6	8.4	2.6	10.4	21.1	23.7	11.4	6.4	7.9	7.5	6.9	11.0	5.3	13.0	3.8	6.8	6.8	8.9	8.4	6.8	27.7	18.3	44.3	14.9	22.3	15.5	6.6	19.4	13.8	3.8	7.5	21.6	16.4	7.4	21.5	19.8	8.7	9.2	8.0	24.4	9.3	9.0	19.4	10.8	9.8	13.9	28.6	14.8	22.7	6.4	14.7	19.8	10.2	15.9	23.6	7.5	17.0	15.0	19.0	21.8	16.6	16.3	6.0	5.7	25.6	13.9	23.4	4.9	17.7	6.4	22.5	9.0	9.0	35.0	10.7	8.4	15.4	30.4	11.5	17.7	15.2	10.3	5.5	13.6	13.5	19.0	20.6	23.5	18.8	14.2	12.0	12.2	16.4	11.4	13.4	5.5	24.6	11.8	24.8	13.6	11.4	15.5	27.7	12.9	13.1	9.9	23.4	6.2	12.3	44.3	22.3	14.9	18.3	8.6	6.6	22.7	71.8	42.1	51.5	36.0	13.5	10.1	22.1	11.9	13.0	71.5	48.8	59.1	33.3	149.9	74.7	24.1	33.1	32.1	20.5	29.6	37.3	28.9	28.2	18.2	1.8	105.6	33.9	0.0	27.3	76.5	53.9	157.6	33.6	37.0	32.1	17.5	122.2	43.6	52.2	4.7	60.1	49.5	87.7	44.1	39.6	19.3	41.1	107.8	57.3	31.7	81.9	12.9	39.4	7.2	22.1	150.4	23.0	55.4	39.9	32.0
LRRC8A	"FLJ10337, KIAA1437, LRRC8, SWELL1"	ENSG00000136802	"Leucine rich repeat containing 8 VRAC subunit A"	Q8IWT6	9	128882112-128918039	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 147.0;Glandular cells: 170.8;Urothelial cells: 292.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 50.6"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.33e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.38e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.80e-2)"	"prognostic unfavorable (3.83e-4)"	"unprognostic (3.53e-1)"	"prognostic favorable (5.27e-5)"	"unprognostic (3.69e-1)"	"unprognostic (8.77e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.02e-2)"	25.8	10.6	24.3	14.2	26.8	13.4	17.8	28.5	50.4	13.8	14.0	18.5	10.9	9.0	18.8	7.4	37.9	12.4	21.1	14.5	22.6	21.0	11.6	16.4	20.3	7.7	27.2	19.5	11.4	19.0	21.3	7.4	21.8	21.1	18.4	8.2	12.1	16.2	24.8	8.0	16.0	9.5	25.8	13.0	10.5	16.7	9.2	22.6	8.4	13.5	12.0	14.3	20.9	18.7	2.5	2.8	3.2	1.9	6.1	7.4	1.7	10.5	16.6	10.1	8.6	23.7	9.2	12.7	12.2	8.1	7.6	5.4	7.3	22.7	3.8	13.8	13.2	9.5	50.6	6.2	27.0	3.6	3.9	5.0	3.4	10.7	8.8	16.1	4.1	6.4	7.1	19.2	13.4	16.1	15.4	26.2	5.4	7.6	3.9	9.9	9.1	4.6	3.9	30.0	17.7	18.1	6.4	11.6	6.2	11.9	5.3	6.0	12.6	13.6	8.5	4.8	7.9	6.2	3.1	45.8	22.3	9.6	9.4	17.7	4.5	10.6	4.7	12.3	3.1	12.8	1.2	1.4	3.2	7.4	1.9	3.4	2.5	3.7	4.7	1.8	2.0	3.7	3.6	2.6	6.1	0.5	2.8	6.1	1.7	24.3	26.8	28.5	32.6	22.6	21.0	27.2	19.5	21.1	22.6	14.9	14.1	6.0	147.0	93.9	11.9	28.4	15.3	9.4	34.2	7.0	5.9	10.4	0.0	22.5	5.2	46.3	20.4	46.7	18.3	15.3	18.4	170.8	5.8	12.4	5.3	23.8	15.4	51.0	7.6	2.2	21.3	7.4	25.3	2.8	15.4	42.9	51.7	13.9	41.8	7.3	9.7	64.7	30.8	3.3	5.1	126.8	17.4	10.9	8.8	292.5
UBN1		ENSG00000118900	"Ubinuclein 1"	Q9NPG3	16	4846665-4882360	"Predicted intracellular proteins"	"Host-virus interaction"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 111.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"neutrophil: 15.1"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 15.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061029, HPA069036, HPA069045"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA061029: AB_2684420, HPA069036: , HPA069045: AB_2686072"	"unprognostic (8.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.53e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.89e-2)"	14.1	12.4	10.5	16.6	11.5	38.2	19.8	20.2	15.4	12.6	12.4	11.0	18.1	13.4	13.1	11.8	24.5	11.7	16.6	15.5	11.2	6.5	10.4	15.3	19.1	16.5	9.4	10.8	14.4	12.9	17.6	12.3	10.4	9.1	11.7	13.4	15.9	15.9	14.5	20.9	15.1	15.2	12.8	6.6	21.2	12.5	36.7	10.1	27.1	12.0	13.8	13.7	11.6	15.8	1.2	1.7	15.1	1.2	0.9	1.6	0.9	9.2	11.5	13.3	13.2	11.9	11.0	11.0	11.7	10.9	13.4	13.0	9.5	11.1	17.3	10.9	11.1	14.6	12.5	17.1	10.4	11.4	17.0	9.0	14.1	15.3	7.5	11.4	17.0	15.6	7.5	14.0	15.6	16.8	10.2	17.5	17.1	23.3	14.7	9.9	13.3	18.6	7.9	11.5	9.6	9.0	30.0	16.7	16.3	7.1	10.6	18.3	10.1	20.0	16.4	10.1	10.4	16.1	15.3	17.8	14.4	13.9	46.5	14.3	14.3	14.9	34.5	8.5	10.9	24.2	1.4	1.2	0.9	1.6	1.2	1.1	0.9	1.2	1.4	0.8	1.2	1.3	0.8	15.1	0.9	0.9	1.7	0.8	0.9	10.5	11.5	20.2	15.4	11.2	6.5	9.4	10.8	9.1	10.1	8.9	15.7	27.8	19.9	16.0	51.1	22.6	22.9	8.1	9.1	8.7	104.1	20.7	6.6	15.5	36.6	25.1	29.2	0.0	15.6	20.6	17.1	24.2	7.0	24.6	19.9	47.7	29.6	25.2	29.7	42.8	27.0	21.1	25.3	14.4	24.1	26.6	21.6	28.8	21.2	11.3	98.8	12.9	17.8	91.9	111.7	19.4	24.4	26.7	23.3	22.9
C3orf52	"FLJ23186, TTMP"	ENSG00000114529	"Chromosome 3 open reading frame 52"	Q5BVD1	3	112086335-112131004	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 41.2"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 112.5;Glandular cells: 75.6;Syncytiotrophoblasts: 62.7;Urothelial cells: 119.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 14.9;U-698: 20.8"									"HPA007678, HPA008119, HPA011968"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA007678: , HPA008119: AB_1848824, HPA011968: AB_1848826"	"unprognostic (8.86e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.58e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.49e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (3.85e-4)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-6)"	"unprognostic (3.14e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.59e-2)"	1.1	1.0	0.3	5.3	0.7	0.4	1.9	0.3	0.4	1.0	9.1	0.0	6.9	2.8	1.7	1.5	2.7	1.0	12.4	3.0	0.4	0.4	7.1	0.5	6.3	0.8	0.3	0.0	0.6	41.2	0.0	8.7	6.1	0.5	5.4	9.0	0.6	3.9	9.6	1.5	22.3	12.7	4.2	0.3	0.8	10.6	1.0	0.0	20.8	10.7	4.3	3.6	6.1	6.1	0.8	0.8	0.0	0.0	0.0	2.7	1.0	8.7	1.4	2.4	0.0	0.3	0.0	3.2	6.9	2.9	4.0	4.6	14.9	4.7	0.3	1.3	2.0	4.6	6.2	2.8	1.7	7.6	0.0	2.3	6.0	2.0	0.7	1.8	0.0	0.0	0.5	3.5	3.6	6.1	2.8	0.9	0.0	1.5	1.5	3.0	0.6	0.2	0.0	5.2	5.6	1.9	0.2	7.9	0.0	7.1	7.7	0.3	0.6	2.6	2.7	2.5	2.9	4.0	0.0	2.2	1.4	2.4	0.0	0.0	5.5	0.0	20.8	1.2	0.0	1.4	0.0	0.0	0.0	1.3	0.0	0.4	0.8	2.7	1.3	0.5	0.3	1.5	0.6	0.0	0.0	0.0	0.8	0.0	1.0	0.3	0.7	0.3	0.4	0.4	0.4	0.3	0.0	0.5	0.0	14.9	7.7	0.5	112.5	28.8	0.0	1.4	5.1	13.4	22.7	17.4	0.0	15.2	0.0	29.6	24.4	0.3	14.6	0.0	31.2	16.0	1.7	75.6	0.0	0.0	1.6	0.0	11.3	0.6	0.3	18.2	0.3	0.3	1.7	4.6	32.5	0.0	53.5	5.9	0.4	1.7	0.0	0.0	3.3	1.8	5.5	29.4	62.7	0.8	5.4	119.7
OXR1	TLDC3	ENSG00000164830	"Oxidation resistance 1"	Q8N573	8	106359476-106752694	"Predicted intracellular proteins"	"Stress response"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 193.0;Late spermatids: 328.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027375, HPA027380, HPA027395"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA027375: AB_10600087, HPA027380: AB_10601569, HPA027395: AB_10601554"	"unprognostic (8.16e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.85e-4)"	"unprognostic (6.59e-2)"	"prognostic favorable (5.82e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.86e-1)"	18.3	34.2	20.5	14.1	14.6	9.3	16.8	31.2	50.2	19.0	13.9	7.3	34.8	7.9	16.2	33.4	22.0	13.0	12.6	21.4	23.6	23.0	17.9	21.4	15.0	11.4	22.6	18.8	15.9	10.0	15.0	45.7	9.9	25.9	17.5	12.6	7.2	25.3	30.3	26.4	16.1	10.4	12.7	22.8	15.3	15.2	29.1	14.6	15.5	15.2	17.3	10.5	24.1	21.2	8.7	8.1	20.8	13.3	7.8	12.6	5.5	12.3	4.7	14.0	2.8	20.6	24.9	6.5	10.2	12.0	9.5	12.3	4.1	14.9	12.2	11.8	10.8	5.8	8.8	7.7	8.8	16.1	10.5	8.8	16.8	6.8	7.6	11.1	5.1	9.8	13.8	13.6	10.2	15.3	13.3	10.3	10.4	8.4	46.1	10.6	11.0	15.2	7.2	1.8	17.7	8.4	4.2	11.3	22.8	10.7	15.6	8.4	2.6	4.5	3.1	10.6	6.3	14.8	8.8	7.9	10.7	7.6	9.6	6.4	8.7	5.5	5.2	12.7	1.6	13.0	20.8	6.5	12.4	3.0	12.4	5.0	8.7	5.2	4.7	8.1	5.8	12.6	5.5	3.4	7.8	13.3	5.8	3.7	5.5	20.5	14.6	31.2	50.2	23.6	23.0	22.6	18.8	25.9	14.6	62.5	21.0	29.0	51.7	60.0	77.0	51.5	17.8	56.2	31.8	33.2	55.0	25.1	28.2	13.9	193.0	42.2	23.1	0.0	14.9	16.8	31.9	52.5	30.0	30.4	16.9	25.4	26.4	41.7	33.5	328.3	31.7	33.5	23.6	13.6	28.7	52.4	19.1	31.7	46.0	9.1	123.6	19.4	39.2	143.6	50.3	66.0	59.5	20.8	23.6	78.5
COL7A1	"EBD1, EBDCT, EBR1"	ENSG00000114270	"Collagen type VII alpha 1 chain"	Q02388	3	48564073-48595267	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"	"Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 59.2"	"Cell type enhanced"	"Detected in many"	13	"Basal glandular cells: 22.7;Basal keratinocytes: 64.5;Suprabasal keratinocytes: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	19	"basophil: 1.9"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ: 20.8;HaCaT: 20.0;HBEC3-KT: 31.9;HDLM-2: 30.1;HeLa: 39.2;SiHa: 26.2"	"Region enhanced"	"Detected in single"		"cerebellum: 0.7"	"Not detected"	"Not detected"			"CAB016357, HPA018877, HPA042420"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA			"Endoplasmic reticulum"	Vesicles	"CAB016357: AB_2229746, HPA018877: , HPA042420: AB_2677990"	"unprognostic (2.69e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.93e-2)"	"prognostic favorable (6.31e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.74e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.86e-2)"	1.3	1.0	0.6	2.6	3.3	0.4	2.5	8.2	3.6	11.7	1.3	0.8	5.2	1.4	8.0	11.9	11.3	2.5	4.5	1.6	2.3	4.4	3.4	1.2	0.9	1.0	1.5	1.0	1.8	0.5	0.4	1.1	2.2	4.8	17.1	0.9	2.6	7.3	10.8	2.3	59.2	1.8	2.9	3.2	4.3	1.2	1.6	0.7	0.5	0.4	13.5	4.8	3.3	14.2	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	8.0	0.3	0.1	3.0	4.1	10.0	20.8	13.1	5.5	3.3	0.1	0.1	0.0	0.6	4.7	5.0	20.0	0.0	31.9	1.0	30.1	0.1	0.0	39.2	1.3	8.4	0.0	0.1	6.6	19.1	11.1	8.7	7.5	0.0	0.2	0.1	0.2	0.6	0.1	0.0	0.2	1.0	0.4	0.4	0.1	0.7	0.0	3.0	0.0	0.0	0.0	26.2	0.0	0.2	1.2	0.4	0.1	0.0	1.8	1.0	1.0	15.5	0.6	0.5	0.0	16.0	0.1	0.9	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.3	8.2	3.6	2.3	4.4	1.5	1.0	4.8	0.7	0.0	0.0	0.5	22.7	64.5	15.5	5.3	0.0	0.0	13.6	10.4	9.8	1.0	0.0	0.6	11.6	0.8	0.2	0.0	0.6	0.8	2.6	2.0	0.0	0.4	1.5	7.9	1.7	0.0	0.3	3.8	4.6	0.7	8.5	0.0	0.2	2.3	9.3	0.0	5.3	0.0	11.7	0.0	8.5	2.8	0.9	21.1	1.0	0.0	0.0	4.6
S100A10	"42C, ANX2LG, CAL1L, CLP11, P11"	ENSG00000197747	"S100 calcium binding protein A10"	P60903	1	151982915-151994390	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 148.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 148.1;monocytes: 89.2;T-cells: 85.4"	"Cell line enhanced"	"Detected in many"		"OE19: 273.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003340, CAB025484"	Enhanced		Approved	Mitochondria		Yes	No		230000	Mitochondria		"CAB025484: , HPA003340: AB_1856531"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.20e-2)"	"prognostic unfavorable (3.33e-4)"	"prognostic unfavorable (1.00e-4)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (1.09e-2)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.80e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (3.84e-4)"	36.7	19.9	7.3	12.1	9.4	4.5	30.7	7.3	10.7	19.0	42.3	8.4	7.3	23.4	7.3	10.1	87.1	8.5	10.7	16.7	7.3	4.4	19.1	10.2	33.5	7.3	7.3	7.3	11.5	7.3	1.6	7.3	18.7	11.1	8.5	49.8	9.5	21.1	7.3	7.3	21.8	21.7	14.0	9.6	7.3	8.6	61.4	7.3	7.3	7.3	22.1	13.6	8.1	37.7	17.8	148.1	21.4	89.2	25.9	85.4	74.8	63.5	65.2	0.2	13.5	73.8	98.4	48.6	36.0	48.7	32.3	32.8	117.1	88.5	0.0	35.0	62.8	38.3	111.1	18.5	140.1	30.1	11.4	5.3	7.7	29.7	27.4	26.4	2.9	6.7	25.5	118.1	35.2	40.5	29.0	71.4	4.2	0.1	0.1	42.9	55.1	0.5	18.6	8.8	273.2	72.5	0.0	12.6	1.2	136.1	18.9	0.5	0.5	58.8	21.1	27.4	77.4	46.6	7.4	75.8	15.5	38.8	73.4	25.1	1.7	0.3	10.9	91.1	2.6	54.2	21.4	89.2	21.0	33.3	54.4	35.2	17.8	52.6	42.3	148.1	8.6	19.6	29.5	3.2	25.9	46.5	24.2	85.4	74.8	7.3	9.4	7.3	10.7	7.3	4.4	7.3	7.3	11.1	7.3	2373.2	509.0	165.5	824.9	1416.6	10.1	91.6	634.4	507.3	913.4	902.0	3.9	1028.8	1291.5	1817.5	320.0	1052.4	1898.6	46.7	1882.2	473.9	2108.7	1493.1	280.8	168.1	1060.4	15.9	1037.0	742.7	952.8	225.8	599.2	1623.9	1548.8	1432.9	1679.7	14.1	2865.9	3115.1	60.8	287.0	25.8	142.3	345.1	12.6	80.7	1085.7	314.3	441.6	1750.5	1802.8
MAML2	"KIAA1819, MAM3"	ENSG00000184384	"Mastermind like transcriptional coactivator 2"	Q8IZL2	11	95976598-96343180	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Notch signaling pathway, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 86.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.9"					"Low region specificity"	"Detected in all"			HPA035223	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA035223: AB_10671101"	"unprognostic (8.11e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.08e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.57e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.99e-2)"	"unprognostic (8.05e-2)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (9.11e-2)"	"prognostic favorable (1.90e-4)"	"unprognostic (9.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.19e-2)"	26.3	5.5	10.2	16.1	8.1	4.2	19.7	27.8	13.4	15.8	9.2	10.4	8.4	4.3	11.2	8.5	9.3	11.7	10.8	8.9	10.5	6.9	13.8	3.5	15.0	10.9	6.9	3.4	11.7	8.2	13.3	15.2	18.8	9.3	12.3	8.9	10.8	16.6	12.3	4.4	14.2	8.9	10.2	14.4	16.8	6.5	4.3	10.6	21.2	11.8	4.8	13.6	16.0	15.3	2.1	1.2	4.7	1.1	4.2	6.4	2.0	5.6	1.1	9.8	2.6	10.2	11.8	2.1	6.5	9.8	4.3	4.5	0.7	12.0	1.2	15.5	15.1	2.3	5.2	2.0	6.3	6.0	27.9	0.7	0.7	2.0	2.1	6.0	0.0	0.0	17.2	0.6	7.7	4.5	8.0	2.4	0.1	3.1	1.8	7.6	0.4	0.1	1.5	1.0	2.9	1.8	1.9	1.8	6.5	6.4	8.0	0.1	0.9	2.4	1.0	2.7	3.3	0.9	0.3	10.6	7.6	1.8	2.6	4.1	1.2	0.2	1.8	3.6	1.1	13.9	0.1	1.1	0.0	1.5	0.6	2.6	1.9	3.2	4.1	1.2	2.1	6.4	4.3	4.7	4.2	0.7	0.9	1.2	2.0	10.2	8.1	27.8	7.0	10.5	6.9	6.9	3.4	9.3	10.6	14.9	7.5	12.1	17.3	17.3	40.8	4.1	12.7	18.7	19.4	12.2	86.4	10.3	10.0	14.8	1.1	20.5	18.4	0.0	0.4	20.6	19.5	17.4	1.1	0.2	16.3	0.0	6.4	6.7	12.6	1.4	8.1	15.7	11.8	16.2	6.2	24.7	9.5	14.4	8.1	11.8	21.9	32.3	17.3	0.5	0.6	11.8	10.9	16.0	11.8	13.1
BLVRB	"FLR, SDR43U1"	ENSG00000090013	"Biliverdin reductase B"	P30043	19	40447765-40465840	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 137.6"	"Cell type enhanced"	"Detected in all"	13	"Erythroid cells: 2523.0;Hofbauer cells: 895.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"classical monocyte: 73.4"	"Group enriched"	"Detected in all"	7	"dendritic cells: 54.8;monocytes: 73.4"	"Cell line enhanced"	"Detected in many"		"A549: 81.2;K-562: 73.7;OE19: 64.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041698, HPA041937"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No		440000000	Cytosol	"Nucleoplasm, Vesicles, Plasma membrane"	"HPA041698: AB_10796781, HPA041937: AB_10794308"	"unprognostic (1.86e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.92e-2)"	36.9	17.9	10.9	12.8	12.2	137.6	28.9	3.5	10.9	17.0	26.7	7.7	18.5	20.9	14.1	19.6	45.3	14.6	19.0	31.0	8.2	8.6	31.8	72.4	37.3	30.0	11.7	9.6	21.3	19.4	5.7	5.6	32.2	13.8	22.9	7.7	17.5	27.1	22.1	43.4	16.7	26.4	22.1	9.7	47.1	31.1	7.6	7.9	6.6	24.3	42.9	24.4	29.9	22.1	8.6	54.8	9.1	73.4	4.0	5.3	34.4	34.2	81.2	1.1	12.1	11.3	10.9	9.6	4.3	12.7	5.9	11.5	15.9	31.1	11.5	33.5	7.7	19.2	11.0	4.1	9.4	1.2	19.5	3.5	17.5	12.2	9.6	26.1	0.2	5.1	10.6	17.9	7.9	4.4	6.0	6.2	4.3	73.7	20.9	6.9	53.2	0.9	1.0	0.3	64.3	22.7	8.1	3.8	18.6	7.4	23.1	0.0	1.8	13.1	34.7	13.2	1.6	33.7	2.6	6.7	15.8	16.9	24.2	2.3	11.4	13.4	4.3	41.1	6.9	6.1	5.0	73.4	2.6	4.6	33.7	4.4	8.6	4.0	4.0	54.8	5.4	4.2	3.3	9.1	4.0	16.9	11.5	5.3	34.4	10.9	12.2	3.5	10.9	8.2	8.6	11.7	9.6	13.8	7.9	205.4	126.9	50.2	283.1	114.9	10.9	116.8	180.9	95.0	73.9	92.5	5.9	76.7	225.5	197.9	7.2	54.2	483.6	2523.0	231.2	82.2	103.0	212.9	41.6	520.7	895.0	9.5	43.0	55.9	549.4	16.6	115.1	152.9	136.7	94.6	130.3	62.8	228.4	480.5	88.4	302.1	11.3	32.3	73.1	2.1	3.6	114.0	62.5	43.7	144.8	253.2
PKP3		ENSG00000184363	"Plakophilin 3"	Q9Y446	11	392614-404908	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.0;skin 1: 48.4;tongue: 59.0"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 206.5;Extravillous trophoblasts: 144.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.6;NK-cell: 2.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.3;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"A-431: 37.6;CAPAN-2: 26.4;HaCaT: 50.7;hTCEpi: 33.2;MCF7: 23.7;SK-BR-3: 38.5"	"Region enriched"	"Detected in single"	37	"cerebellum: 10.0"	"Low region specificity"	"Detected in many"			"CAB012993, HPA062937"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"CAB012993: AB_2533221, HPA062937: AB_2684908"	"unprognostic (4.74e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-3)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (6.73e-3)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (3.55e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.15e-2)"	0.6	0.0	0.2	3.7	0.3	0.0	3.3	0.2	0.3	14.5	14.6	0.3	5.0	11.2	1.9	6.2	69.0	2.6	8.9	0.5	0.3	0.1	0.6	0.2	4.3	0.2	0.2	0.2	1.1	10.2	3.9	3.8	23.2	0.2	4.5	3.6	0.2	12.5	2.5	0.6	48.4	25.4	1.0	0.2	0.3	10.4	0.5	0.2	2.2	5.8	59.0	29.9	2.8	21.5	0.3	0.0	0.0	0.0	2.3	1.6	0.1	37.6	7.3	0.0	0.1	0.0	0.0	15.8	0.3	0.2	0.8	0.4	15.0	26.4	0.0	1.5	0.3	1.7	50.7	0.0	19.2	0.1	0.0	9.5	0.0	4.3	10.4	0.1	0.0	0.0	0.1	33.2	0.1	8.1	0.1	0.1	0.0	11.2	0.2	0.1	23.7	0.1	0.0	0.0	19.0	12.7	0.2	0.0	0.1	0.4	7.6	10.8	0.1	10.9	38.5	0.0	0.5	13.9	0.1	1.3	0.2	1.4	0.7	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.8	0.0	0.3	0.0	0.7	0.0	2.3	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.3	0.3	0.1	0.2	0.2	0.2	0.2	14.9	15.4	0.0	43.7	64.1	0.0	1.1	7.6	9.4	12.5	12.2	0.0	112.3	0.0	83.2	0.0	0.4	206.5	0.0	54.5	144.7	3.5	34.6	13.8	0.0	11.6	0.0	20.8	0.0	0.0	0.0	0.9	1.8	1.7	3.6	76.4	0.5	96.8	93.0	0.0	0.7	0.1	0.0	1.6	0.0	0.4	77.5	91.8	0.0	83.6	52.6
EPPK1	EPIPL1	ENSG00000261150	"Epiplakin 1"		8	143857324-143878464	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"salivary gland: 14.8;skin 1: 14.1;smooth muscle: 15.7"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 121.8;Suprabasal keratinocytes: 239.8"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.1;EFO-21: 10.4;HaCaT: 10.3;HeLa: 17.3;MCF7: 14.9;SK-BR-3: 7.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA066808, HPA067357, HPA069333"	Approved		Enhanced	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA066808: AB_2685726, HPA067357: AB_2685826, HPA069333: AB_2686123"	"unprognostic (1.42e-1)"	"unprognostic (9.30e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (5.52e-5)"	"unprognostic (2.85e-2)"	"unprognostic (5.86e-3)"	"unprognostic (4.90e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.97e-3)"	"unprognostic (5.94e-3)"	"unprognostic (4.35e-1)"	"unprognostic (3.68e-3)"	"unprognostic (5.08e-3)"	0.0	0.0	0.0	3.0	0.0	0.0	1.1	0.7	0.0	0.4	7.8	0.0	7.2	3.1	3.4	2.4	6.0	1.4	2.3	0.0	0.0		0.8	0.0	4.2	0.9	0.0	0.0	1.0	1.9	0.6	0.0	2.8	0.5	2.9	0.8	0.0	14.8	4.9	0.1	14.1	12.1	15.7	0.1	1.5	1.2	2.3	0.0	0.0	0.0	7.2	4.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	5.8	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	5.6	0.4	0.0	10.4	0.0	0.0	10.3	1.1	0.1	0.0	0.0	2.6	0.0	17.3	3.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	14.9	0.0	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	3.7	1.8	0.0	1.6	7.1	0.0	0.9	5.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	1.0	0.2	0.0	0.0	2.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0											17.9	8.6	0.0	14.7	121.8	0.8	15.4	17.8	9.4	2.3	14.0	0.0	1.6	0.0	10.2	0.3	1.1	29.4	0.0	12.8	0.1	1.9	5.7	0.0	3.0	0.3	0.0	5.8	0.6	0.0	0.0	0.0	0.6	15.1	0.0	11.2	0.5	21.7	23.0	0.0	3.5	0.1	0.0	4.1	1.6	0.4	239.8	5.1	0.0	21.5	36.3
CCDC6	"D10S170, H4, PTC, TPC, TST1"	ENSG00000108091	"Coiled-coil domain containing 6"	Q16204	10	59788763-59906656	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019049, HPA019051"	Enhanced		Supported	Cytosol		No	No			Cytosol		"HPA019049: AB_1846163, HPA019051: AB_1846164"	"unprognostic (1.88e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.98e-3)"	"prognostic favorable (5.48e-4)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.39e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (4.08e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.19e-2)"	13.7	13.3	22.8	11.7	41.8	12.8	20.7	13.8	27.1	23.0	23.9	11.3	10.7	20.4	28.4	16.6	33.2	23.6	16.2	11.2	17.0	18.1	19.4	10.9	15.5	18.7	13.8	17.6	19.8	22.5	16.8	13.7	13.3	14.5	18.7	18.4	9.6	25.5	14.0	18.2	26.0	20.4	28.1	11.8	14.5	16.6	12.6	12.3	10.6	19.1	14.8	20.7	21.7	23.8	7.1	7.3	0.2	3.4	1.2	2.3	1.4	16.0	14.5	7.3	16.3	11.1	16.8	14.9	7.9	10.5	7.9	9.4	28.2	31.6	13.8	12.0	13.2	4.6	23.9	14.6	14.4	11.9	20.7	7.3	11.2	11.8	17.1	13.5	12.8	10.6	12.1	19.1	13.2	32.5	11.2	11.7	7.9	8.4	8.9	10.3	21.6	5.3	7.4	11.7	15.2	9.9	7.2	12.0	8.7	13.3	13.8	7.5	6.5	10.0	42.1	8.8	9.9	26.7	6.9	11.9	7.4	13.6	11.4	13.2	4.7	5.4	6.3	11.7	24.5	4.6	0.0	2.9	0.0	1.5	3.4	1.8	6.7	2.3	2.1	7.3	7.1	2.2	1.6	0.2	1.2	1.9	1.9	2.1	1.4	22.8	41.8	13.8	27.1	17.0	18.1	13.8	17.6	14.5	12.3	92.3	20.4	12.6	42.6	84.3	14.0	14.2	28.1	20.1	47.8	24.4	39.3	32.1	24.9	42.8	25.1	15.7	40.4	0.0	56.0	14.6	20.6	38.1	27.8	19.1	20.3	15.9	25.9	19.6	29.9	60.3	22.7	22.5	15.1	11.8	37.1	11.8	47.6	17.5	18.4	30.5	42.9	19.4	21.8	2.6	20.8	70.0	22.5	13.4	39.3	38.3
MAL2		ENSG00000147676	"Mal, T cell differentiation protein 2 (gene/pseudogene)"	Q969L2	8	119165034-119245673	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 70.4"	"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 369.9;Suprabasal keratinocytes: 398.5;Urothelial cells: 421.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 104.3;HaCaT: 46.6;OE19: 114.7;RPTEC TERT1: 40.4;SK-BR-3: 150.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043831	Uncertain					NA	NA					"HPA043831: "	"prognostic unfavorable (4.57e-6)"	"unprognostic (3.12e-1)"	"unprognostic (4.04e-1)"	"prognostic unfavorable (8.44e-5)"	"unprognostic (2.10e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.20e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.00e-3)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.39e-5)"	"unprognostic (5.48e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.33e-1)"	"unprognostic (9.27e-3)"	3.3	1.3	7.8	5.5	21.1	0.0	17.4	17.4	26.4	13.1	25.5	1.6	19.2	16.0	1.5	5.4	70.4	13.9	16.2	1.9	8.6	4.0	22.8	11.5	20.4	0.0	2.2	11.8	1.3	19.0	9.3	22.7	6.6	1.2	6.8	24.3	0.6	21.1	16.9	1.1	31.0	18.3	0.5	1.8	1.2	33.8	3.3	1.6	0.5	43.8	30.4	31.5	13.3	28.5	0.0	0.0	0.0	0.0	0.0	0.6	0.1	104.3	0.0	0.1	0.0	0.0	0.0	9.7	0.0	0.2	0.1	0.1	8.9	34.0	0.0	5.9	0.0	0.0	46.6	0.0	3.3	0.0	0.0	0.2	0.0	1.5	8.6	0.0	0.0	0.0	0.0	23.7	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.0	0.8	114.7	32.1	0.0	0.0	0.0	40.4	26.2	5.9	0.0	1.8	150.4	0.3	0.7	19.9	0.3	0.0	0.0	0.3	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.8	21.1	17.4	26.4	8.6	4.0	2.2	11.8	1.2	1.6	104.2	103.7	5.7	58.8	102.0	1.8	1.4	79.0	52.2	76.2	369.9	0.0	18.2	92.9	208.4	0.4	0.6	183.7	0.0	156.8	18.1	7.3	197.7	14.9	43.1	2.4	4.8	40.2	0.6	0.3	1.1	0.6	4.4	15.1	6.4	101.9	0.3	231.3	126.8	0.0	14.7	1.0	0.0	2.8	1.1	5.5	398.5	7.8	2.5	89.8	421.4
CBX3	HP1Hs-gamma	ENSG00000122565	"Chromobox 3"	Q13185	7	26201162-26213356	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB001973, HPA004902"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes		40000	Nucleoplasm	"Nuclear bodies"	"CAB001973: , HPA004902: AB_1850635"	"prognostic unfavorable (7.92e-4)"	"unprognostic (1.43e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"prognostic unfavorable (2.20e-8)"	"unprognostic (2.13e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.71e-3)"	"prognostic unfavorable (4.00e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.56e-7)"	"unprognostic (7.79e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.78e-2)"	40.7	49.4	41.2	54.3	38.8	65.8	69.4	37.4	45.9	33.9	38.4	20.3	39.0	49.8	39.5	42.1	36.4	33.9	28.6	43.3	39.0	40.8	51.1	45.8	37.0	68.6	44.9	37.2	45.3	31.8	22.4	27.5	45.4	51.1	30.7	43.7	23.7	35.0	45.6	60.4	27.1	56.4	46.7	66.9	54.0	29.3	45.1	33.7	92.3	32.1	38.2	65.0	39.8	38.1	38.8	37.4	55.2	48.4	39.5	60.7	35.1	50.3	22.3	47.7	47.1	17.2	31.3	37.6	39.6	30.2	30.2	30.7	26.3	42.6	76.6	32.0	26.1	64.7	40.3	39.8	33.0	49.4	21.1	29.7	43.7	29.4	29.3	18.9	69.0	42.5	22.9	29.0	23.8	34.2	37.5	40.7	48.9	69.9	37.9	51.1	28.8	66.5	83.3	60.7	43.8	32.3	43.6	44.3	63.2	44.0	28.3	58.4	64.8	32.8	69.8	36.3	52.9	59.3	62.7	30.2	27.5	49.9	32.0	52.5	56.3	81.1	130.3	23.9	59.5	123.9	47.8	38.4	55.2	34.6	47.6	42.8	38.8	51.7	42.7	37.4	35.8	55.0	54.0	39.3	39.5	48.4	30.5	60.7	35.1	41.2	38.8	37.4	45.9	39.0	40.8	44.9	37.2	51.1	33.7	101.3	77.8	131.1	75.5	127.6	104.6	114.5	129.9	139.2	130.8	61.1	72.6	154.4	119.3	152.3	115.5	136.8	88.3	303.7	123.2	293.9	107.2	64.5	211.9	239.9	127.2	47.7	105.7	149.1	266.0	31.0	126.2	175.5	99.5	110.0	127.3	132.2	139.2	87.7	92.3	112.3	126.4	77.6	91.0	234.4	415.8	94.4	226.4	163.9	186.9	86.2
TM4SF1	"L6, M3S1"	ENSG00000169908	"Transmembrane 4 L six family member 1"	P30408	3	149369022-149377865	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 4692.6;Glandular cells: 2223.6;Pancreatic endocrine cells: 1835.5;Urothelial cells: 5293.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 71.8;hTERT-RPE1: 98.5;HUVEC TERT2: 64.8;LHCN-M2: 69.8;OE19: 70.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002760, HPA002823"	Uncertain					NA	NA					"CAB002760: , HPA002823: AB_1079221"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.47e-3)"	"unprognostic (3.85e-3)"	"unprognostic (2.74e-2)"	"unprognostic (5.09e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (4.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (3.43e-6)"	72.7	16.9	10.2	11.8	15.5	0.3	44.3	6.4	11.6	33.6	16.3	8.2	4.0	8.6	32.0	35.5	89.2	18.2	54.2	37.5	10.2	10.0	26.9	22.8	111.0	10.9	13.2	2.9	26.0	54.3	3.9	5.2	50.8	17.6	26.0	14.0	20.4	45.4	7.8	29.6	14.8	15.9	21.5	13.1	35.8	25.9	14.4	11.8	1.7	17.0	76.0	48.4	32.4	26.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	36.5	39.0	0.0	0.1	12.1	46.4	0.0	11.6	46.6	2.5	0.9	15.6	71.8	0.0	37.4	2.3	57.6	44.2	0.2	8.2	2.4	0.1	0.0	0.6	42.4	51.7	4.4	0.0	0.0	4.5	2.1	17.8	8.8	98.5	64.8	0.0	0.0	0.0	69.8	0.0	0.0	0.0	0.1	70.9	17.7	0.0	0.0	0.0	46.3	5.5	0.0	0.0	4.9	2.6	0.4	0.6	0.0	0.1	40.9	24.2	4.2	0.4	24.5	0.0	0.0	0.0	35.2	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	10.2	15.5	6.4	11.6	10.2	10.0	13.2	2.9	17.6	11.8	536.0	334.5	11.8	4692.6	246.9	0.0	21.3	221.7	149.9	565.3	54.1	0.0	0.4	0.0	1034.2	4.3	1040.2	30.7	23.3	1399.4	0.7	167.3	2223.6	29.1	22.1	1.6	0.0	37.5	904.2	35.1	4.7	236.8	42.2	285.1	45.9	2.1	0.0	1835.5	0.9	165.5	0.2	0.0	316.9	211.2	1.4	1.2	221.8	1.1	4.8	7.1	5293.1
MMP3	"STMY, STMY1"	ENSG00000149968	"Matrix metallopeptidase 3"	P08254	11	102835801-102843803	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 177.5;salivary gland: 73.4"	"Cell type enhanced"	"Detected in some"	10	"Basal glandular cells: 11.5;Basal keratinocytes: 7.4;Club cells: 11.4;Early spermatids: 14.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 59.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"BJ: 101.3;BJ hTERT+: 275.6;fHDF/TERT166: 119.3"					"Low region specificity"	"Detected in many"			HPA007875	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA	2540000	170000	Vesicles		"HPA007875: AB_1079396"	"unprognostic (2.27e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (1.63e-3)"	"unprognostic (5.11e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.11e-2)"	"unprognostic (5.26e-6)"	"unprognostic (3.46e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.09e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-15)"	"unprognostic (3.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.34e-1)"	19.1	0.0	0.2	14.4	0.3	0.0	6.9	0.2	0.5	0.2	1.5	0.3	0.2	1.8	28.3	177.5	0.2	0.0	1.4	0.2	0.2	0.0	0.3	0.5	0.4	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.2	1.2	1.7	0.2	73.4	1.5	7.3	12.6	0.7	5.9	0.2	0.2	2.8	1.4	0.2	0.2	0.6	1.5	0.9	7.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.3	275.6	1.8	0.5	0.0	0.0	0.0	0.0	119.3	6.8	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.8	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.5	0.2	0.0	0.2	0.2	0.2	0.2	3.0	0.0	0.0	11.5	7.4	0.0	0.2	5.1	0.0	11.4	0.0	0.0	0.1	0.0	0.7	14.6	0.0	0.0	0.0	1.2	2.2	1.3	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	2.3	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.9	3.0	0.2	0.0	0.1	5.2
RIOK3	SUDD	ENSG00000101782	"RIO kinase 3"	O14730	18	23452823-23486603	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Ribosome biogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001620, HPA024184"	Approved		Approved	"Golgi apparatus,Plasma membrane,Centriolar satellite,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Golgi apparatus, Centriolar satellite"	"HPA001620: AB_1079815, HPA024184: AB_1856289"	"unprognostic (7.99e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (4.10e-4)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (3.90e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.71e-2)"	10.1	8.7	6.9	11.7	7.7	52.4	10.9	8.9	10.1	14.7	21.4	8.5	5.9	15.6	8.8	9.3	41.0	7.8	10.7	11.5	6.1	5.5	10.5	19.9	10.1	10.7	9.1	6.2	7.6	10.7	7.5	11.6	21.4	11.6	6.8	14.7	6.0	14.9	7.0	40.0	13.3	36.5	15.2	10.5	8.9	12.9	22.7	7.6	11.1	7.3	16.0	16.5	13.7	21.5	11.7	11.0	21.7	21.5	8.3	11.2	10.0	14.8	5.8	6.1	7.9	11.1	12.4	11.0	14.9	11.0	10.6	10.2	6.7	16.1	10.3	19.6	16.6	10.8	19.5	10.3	17.0	16.4	10.2	4.3	9.6	10.9	8.4	27.8	27.0	8.4	14.8	32.4	18.8	26.0	12.1	14.7	6.5	13.9	13.0	15.9	7.9	9.3	4.4	5.6	21.7	11.7	10.5	12.7	12.5	12.1	19.5	14.2	10.2	19.1	8.7	10.9	15.9	7.7	14.6	23.1	17.5	4.4	7.7	9.6	23.5	19.7	15.3	10.3	12.5	13.1	21.7	13.5	8.0	9.1	19.6	6.9	8.2	7.6	7.9	11.0	11.7	6.1	6.9	9.3	8.3	21.5	5.1	11.2	10.0	6.9	7.7	8.9	10.1	6.1	5.5	9.1	6.2	11.6	7.6	74.5	51.9	21.7	78.2	107.0	43.0	61.7	43.3	56.2	67.1	24.4	53.0	38.5	21.6	40.3	191.3	39.6	193.3	116.8	45.8	56.7	46.6	92.4	61.2	72.5	37.1	27.0	60.3	33.7	55.0	227.3	20.8	49.5	40.5	47.7	85.9	17.1	98.8	75.8	28.3	40.3	43.8	6.5	38.7	23.6	9.5	125.6	73.9	34.1	42.3	194.9
PLK1	PLK	ENSG00000166851	"Polo like kinase 1"	P53350	16	23677656-23690367	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 83.9;testis: 32.4"	"Cell type enhanced"	"Detected in many"	18	"Early spermatids: 86.9;Erythroid cells: 23.3;Extravillous trophoblasts: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"T-reg: 9.0"	"Lineage enriched"	"Detected in many"	5	"T-cells: 9.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA051638, HPA053229"	Approved					NA	Yes					"HPA051638: AB_2681561, HPA053229: AB_2682084"	"unprognostic (7.21e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.98e-3)"	"unprognostic (4.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (2.70e-7)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.55e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (4.12e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.33e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.26e-2)"	2.9	1.1	1.1	14.2	1.5	15.9	1.7	2.1	1.1	1.5	7.1	0.7	0.5	6.0	1.1	0.9	10.4	0.7	1.5	1.0	1.0	0.8	1.3	1.2	2.6	15.2	0.8	0.6	1.2	0.7	0.0	0.8	6.8	0.7	0.9	5.9	0.5	1.7	0.8	0.8	2.9	5.9	2.0	0.7	8.3	3.6	32.4	0.5	83.9	0.6	6.6	20.4	2.1	2.6	1.9	0.5	0.7	0.1	1.3	9.0	2.3	43.5	45.5	37.6	20.4	1.1	2.6	21.1	24.9	16.5	39.1	29.1	39.7	28.8	21.8	13.0	16.8	20.6	25.1	51.2	20.5	47.1	31.0	28.9	27.7	35.9	54.2	0.3	31.9	30.4	1.0	1.1	27.7	28.6	4.9	28.5	28.6	43.0	30.1	30.1	39.8	30.1	31.9	42.9	17.9	23.2	46.9	25.5	34.6	11.1	9.5	21.2	14.7	28.5	20.0	12.9	22.4	25.4	19.7	14.4	18.6	23.8	18.2	42.5	21.5	33.3	37.8	15.8	27.8	30.4	0.0	0.1	0.0	0.0	0.0	0.0	1.9	1.4	0.5	0.5	0.0	0.0	0.0	0.7	1.3	0.0	0.0	9.0	2.3	1.1	1.5	2.1	1.1	1.0	0.8	0.8	0.6	0.7	0.5	3.0	0.0	0.8	1.0	1.1	1.3	0.6	0.0	0.0	0.0	0.0	3.9	4.5	0.0	0.6	86.9	0.5	1.5	23.3	0.7	48.0	0.7	1.0	1.1	0.9	17.0	0.0	0.0	3.1	3.7	4.8	1.1	2.6	0.0	0.0	2.9	1.1	0.8	0.0	0.7	0.0	1.1	0.0	0.3	3.2	5.0	1.6	3.2	1.3	3.9	1.8
SYT12	SRG1	ENSG00000173227	"Synaptotagmin 12"	Q8IV01	11	67006778-67050863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 29.9;parathyroid gland: 59.4"	"Cell type enhanced"	"Detected in some"	7	"Basal glandular cells: 3.4;Cholangiocytes: 2.5;Hepatocytes: 4.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 26.3;MCF7: 18.1;SiHa: 23.3;SK-BR-3: 11.4;T-47d: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011006, HPA074255"	Enhanced					NA	NA					"HPA011006: AB_2286996, HPA074255: "	"unprognostic (2.72e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.47e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (2.75e-1)"	"unprognostic (9.86e-4)"	"unprognostic (4.21e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.42e-2)"	"unprognostic (9.85e-2)"	1.1	2.2	4.3	0.8	7.9	0.6	4.2	29.9	16.2	0.7	0.6	0.8	3.5	1.2	0.7	6.2	0.9	3.7	1.1	0.8	5.4	4.7	0.7	10.2	0.6	0.7	2.6	5.4	0.7	0.7	59.4	3.4	4.1	6.8	0.9	0.6	0.1	1.8	2.5	0.8	1.2	0.8	0.6	1.3	0.6	0.7	1.3	0.5	0.0	0.6	0.0	0.7	1.4	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.1	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.9	0.8	1.9	0.7	0.1	0.8	0.1	2.7	0.0	0.0	0.2	0.0	26.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	18.1	0.0	0.0	0.5	0.1	0.9	0.0	0.0	0.0	0.3	0.0	0.2	0.0	23.3	11.4	0.0	0.0	11.4	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.3	7.9	29.9	16.2	5.4	4.7	2.6	5.4	6.8	0.5	0.0	0.0	0.0	3.4	1.1	0.6	1.1	2.5	0.0	2.3	1.8	0.0	0.2	0.0	2.2	0.2	0.0	0.0	0.0	0.0	1.2	0.4	1.2	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.7	0.0	0.4	0.7	0.4	1.0	1.6	0.0	0.0	1.2
KLK11	"PRSS20, TLSP"	ENSG00000167757	"Kallikrein related peptidase 11"	Q9UBX7	19	51022216-51028039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.4;lymphoid tissue: 88.5;salivary gland: 96.5"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 141.1;Glandular cells: 237.5;Late spermatids: 257.5;Suprabasal keratinocytes: 189.7;Urothelial cells: 143.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"pons and medulla: 10.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 9.6;HaCaT: 29.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB026340	Approved				"Secreted in other tissues"	NA	NA		320000			"CAB026340: "	"unprognostic (4.23e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.78e-4)"		"unprognostic (2.08e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (2.92e-2)"	"unprognostic (4.16e-6)"	"unprognostic (3.90e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.53e-1)"	5.5	0.0	0.2	1.1	0.2	0.0	4.9	0.2	0.6	24.5	1.7	2.0	0.4	0.0	5.1	2.7	103.4	9.7	61.8	0.4	0.9	0.0	0.2	0.6	12.3	0.2	0.2	0.2	2.3	25.0	0.0	2.1	0.4	10.7	18.8	0.0	5.1	96.5	1.6	0.3	49.8	0.6	0.3	0.2	0.2	18.7	7.7	0.2	0.9	0.2	65.2	88.5	0.7	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.6	0.0	9.6	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.9	0.0	0.2	0.2	10.7	0.2	80.4	7.2	0.0	141.1	94.9	0.0	0.4	63.7	26.8	108.1	0.0	0.0	0.0	0.0	2.9	105.3	2.2	0.0	0.0	118.6	0.0	8.9	237.5	1.1	0.0	0.3	0.0	19.4	0.0	0.0	257.5	2.6	2.6	8.5	0.0	2.8	0.0	49.0	0.0	0.4	0.0	1.4	0.0	0.3	2.1	2.5	189.7	0.0	0.0	0.3	143.9
E2F1	"RBBP3, RBP3"	ENSG00000101412	"E2F transcription factor 1"	Q01094	20	33675683-33686404	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5;lymphoid tissue: 21.9"	"Cell type enriched"	"Detected in many"	5	"Spermatogonia: 37.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 3.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000329, HPA008003, CAB019308, HPA029735"	Enhanced		Supported	Nucleoplasm,Centrosome		NA	Yes			"Nucleoplasm, Centrosome"		"CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: AB_2673176"	"unprognostic (7.46e-2)"	"prognostic favorable (9.22e-6)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (4.33e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (8.99e-5)"	"unprognostic (1.05e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.91e-1)"	2.4	5.3	6.8	12.7	9.7	32.5	2.1	1.1	6.4	1.2	4.4	5.1	0.7	3.9	1.4	0.8	5.1	1.5	4.1	2.0	7.1	3.6	0.9	1.7	8.1	9.3	6.2	2.9	3.4	1.2	2.3	0.3	3.3	5.9	1.7	4.8	0.3	1.6	1.4	1.4	5.4	4.9	3.3	6.2	4.8	3.4	12.1	6.0	21.9	1.0	4.9	7.7	1.9	3.1	2.2	0.6	0.7	3.7	1.4	1.2	0.6	16.0	15.6	18.1	14.1	1.8	1.3	13.8	15.4	7.5	19.7	16.6	27.6	16.6	29.6	15.6	6.9	23.9	12.1	8.8	8.2	8.8	8.9	12.6	24.2	23.2	16.0	0.1	11.3	15.3	1.0	0.5	10.8	1.9	2.0	5.0	18.6	6.4	20.9	12.1	14.2	24.0	24.0	5.4	16.2	22.5	23.9	49.4	12.2	3.3	9.8	27.1	19.1	18.8	13.1	7.6	5.4	16.4	14.3	2.7	23.0	13.5	15.9	21.8	20.5	13.8	24.4	19.2	6.7	13.6	0.0	0.0	0.7	0.1	0.9	0.0	2.2	0.6	0.4	0.2	0.2	0.2	1.2	0.3	1.4	3.7	0.6	0.8	0.6	6.8	9.7	1.1	6.4	7.1	3.6	6.2	2.9	5.9	6.0	0.0	0.6	2.9	0.7	2.6	2.2	0.4	0.0	0.0	2.3	0.0	0.0	2.6	0.0	0.9	0.7	0.1	0.5	0.0	0.2	7.9	1.1	0.6	0.0	0.8	3.8	0.0	0.0	0.6	0.0	2.3	2.0	0.9	1.7	0.0	2.9	1.2	0.5	0.0	1.1	0.0	2.0	0.0	0.9	3.8	37.5	1.5	1.5	0.7	4.6	0.9
RHOV	"ARHV, Chp, WRCH2"	ENSG00000104140	"Ras homolog family member V"	Q96L33	15	40872214-40874289	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 74.8;skin 1: 31.5;tongue: 29.2"	"Cell type enhanced"	"Detected in many"	10	"Paneth cells: 151.1;Suprabasal keratinocytes: 247.3;Urothelial cells: 237.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 91.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SK-BR-3: 84.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA053343	Enhanced					NA	NA					"HPA053343: AB_2682122"	"unprognostic (1.42e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.29e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (3.29e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.63e-3)"	0.2	0.0	0.4	0.4	0.4	0.0	7.8	0.8	0.9	8.8	0.9	0.2	0.5	0.1	0.6	4.8	74.8	1.2	0.6	0.2	0.4	0.3	1.9	0.2	1.9	0.2	0.2	0.5	0.2	7.4	0.4	0.7	7.3	1.2	4.2	1.1	0.2	12.6	1.1	0.2	31.5	0.5	0.7	0.3	0.3	0.3	0.8	0.3	2.0	0.2	29.2	27.9	5.2	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.4	0.0	0.7	0.0	0.0	1.3	0.0	0.2	0.1	0.0	1.0	1.1	0.0	0.6	0.0	0.0	19.7	1.1	0.1	0.0	2.6	3.2	0.1	2.8	0.1	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.5	0.5	0.1	0.0	6.7	0.1	0.5	0.4	4.8	0.9	0.9	0.1	0.4	1.3	8.6	1.0	0.2	2.0	84.5	0.0	0.1	10.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.8	0.9	0.4	0.3	0.2	0.5	1.2	0.3	0.0	2.7	0.0	28.5	74.8	0.0	0.8	5.1	2.7	13.6	27.9	0.0	47.9	11.6	77.6	0.0	0.1	5.4	0.0	50.4	4.7	2.4	75.1	1.1	0.0	4.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	30.4	6.4	9.1	0.0	17.2	151.1	0.7	0.8	0.0	0.0	3.1	0.0	0.9	247.3	35.5	0.0	15.6	237.2
SDC4	"amphiglycan, ryudocan, SYND4"	ENSG00000124145	"Syndecan 4"	P31431	20	45325288-45348424	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 141.1"	"Cell type enhanced"	"Detected in many"	4	"Exocrine glandular cells: 450.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 75.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005716, CAB013240"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA			"Golgi apparatus"	"Plasma membrane"	"CAB013240: AB_2533250, HPA005716: AB_1080160"	"unprognostic (1.34e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.97e-1)"	"prognostic favorable (2.44e-7)"	"unprognostic (3.00e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.67e-4)"	"unprognostic (7.42e-2)"	15.9	26.2	19.9	15.7	24.3	3.5	40.5	6.9	20.1	20.4	24.8	19.2	9.0	13.3	17.6	14.7	42.4	27.4	26.2	19.5	19.8	12.1	56.6	141.1	56.7	4.8	23.5	20.5	14.7	36.6	6.2	12.5	23.0	30.9	19.5	22.3	21.8	47.6	17.5	25.5	45.5	13.8	38.7	23.0	9.0	46.9	33.7	15.7	2.0	26.5	25.2	23.5	34.4	16.4	0.7	2.8	2.0	3.1	1.4	8.1	1.2	23.0	3.0	1.6	0.1	41.2	25.4	71.1	29.5	40.3	33.5	24.0	35.1	58.9	0.0	13.2	37.1	33.8	30.0	1.2	75.0	40.8	6.6	1.1	0.7	2.4	13.7	44.9	0.1	1.2	34.1	50.4	13.8	33.8	18.6	4.4	0.5	1.1	0.0	19.2	22.9	0.0	2.0	3.0	20.1	9.3	0.0	14.9	0.0	55.0	30.8	0.6	2.3	40.6	25.2	7.2	19.6	18.2	1.4	8.2	25.6	21.3	2.5	19.0	1.2	0.9	0.1	40.2	2.3	15.2	2.0	3.1	0.7	1.3	1.1	4.1	0.6	4.1	1.6	2.8	0.7	0.9	1.1	1.6	1.4	1.1	2.5	8.1	1.2	19.9	24.3	6.9	20.1	19.8	12.1	23.5	20.5	30.9	15.7	271.0	364.7	7.8	299.2	332.0	10.3	49.5	201.2	113.8	195.7	179.7	11.8	27.4	54.7	239.6	0.5	9.0	87.8	0.0	450.4	202.4	50.9	254.2	12.8	232.3	18.5	0.0	52.9	14.7	15.1	2.9	3.7	36.5	72.6	56.9	103.4	8.5	443.3	93.4	4.9	128.2	23.3	0.0	42.6	0.9	2.8	413.3	56.3	18.8	79.5	364.0
NBN	"AT-V1, AT-V2, ATV, NBS, NBS1"	ENSG00000104320	Nibrin	O60934	8	89933336-90003228	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 78.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001429, CAB003836"	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"CAB003836: AB_562172, HPA001429: AB_1854460"	"unprognostic (1.52e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.46e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (5.05e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.15e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.03e-1)"	19.2	16.1	17.9	23.6	29.5	41.3	23.0	17.4	21.0	19.3	22.6	12.2	16.9	13.3	33.2	16.6	19.7	17.5	20.2	14.2	19.4	16.7	25.9	19.3	17.9	26.7	16.9	18.1	19.3	17.1	21.0	29.4	13.2	18.4	17.6	20.9	7.1	18.4	17.6	15.7	11.2	18.0	22.2	18.1	26.5	14.7	13.9	18.9	23.4	20.8	14.7	22.8	17.5	16.0	10.1	12.0	21.8	18.5	9.7	8.6	7.6	15.4	8.7	8.8	4.6	4.8	12.0	5.6	11.0	14.6	14.0	15.3	5.0	11.8	23.4	12.9	10.0	5.7	5.2	10.6	10.3	18.0	10.9	6.1	19.8	5.4	7.0	9.4	11.8	10.5	9.0	5.5	7.9	17.5	6.9	11.3	9.5	14.5	13.6	15.9	13.7	18.0	7.5	2.5	11.5	9.5	12.1	7.6	13.8	18.1	21.3	2.5	8.1	6.9	78.3	6.5	5.1	14.7	8.8	8.4	12.2	8.7	7.4	10.8	6.3	7.2	13.0	12.3	11.2	11.3	14.1	11.1	20.3	8.1	12.5	8.6	10.1	5.9	5.9	12.0	6.1	5.7	6.2	21.8	9.7	18.5	6.6	3.7	7.6	17.9	29.5	17.4	21.0	19.4	16.7	16.9	18.1	18.4	18.9	44.7	13.9	32.5	12.1	10.5	23.3	25.0	17.8	42.8	42.1	26.2	2.0	18.9	36.5	30.4	10.9	17.9	8.9	0.0	27.9	17.4	18.4	8.7	76.4	27.6	22.9	12.7	11.6	17.2	22.4	5.9	17.5	30.7	11.8	52.3	15.1	27.1	19.1	5.8	24.8	31.1	10.3	6.5	20.6	11.2	43.3	11.8	9.0	23.2	17.4	8.6
KIFC1	"HSET, KNSL2"	ENSG00000237649	"Kinesin family member C1"	Q9BW19	6	33391536-33409924	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 60.9"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 21.5;Erythroid cells: 70.0;Extravillous trophoblasts: 32.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA055997, HPA062674"	Enhanced		Approved	Centrosome		NA	Yes			Centrosome		"HPA055997: AB_2683001, HPA062674: AB_2684829"	"unprognostic (7.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (7.07e-8)"	"unprognostic (6.34e-3)"	"unprognostic (9.36e-3)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.17e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.52e-1)"	0.9	0.8	0.0	18.0	0.3	9.6	1.5	0.0	0.5	1.7	5.7	0.1	0.3	3.0	0.9	1.6	10.1	0.5	2.2	0.8	0.0	0.0	0.7	0.7	2.2	6.3	0.1	0.2	1.5	0.3	0.2	0.2	3.6	0.4	0.6	2.5	0.6	1.7	0.1	0.4	3.3	4.2	0.7	0.4	4.7	2.5	9.7	0.2	60.9	0.4	7.4	14.6	0.6	2.8	0.8	0.3	0.0	0.1	0.2	1.4	0.7	10.7	1.8	10.3	10.9	0.2	0.4	6.3	7.8	2.0	6.2	5.2	3.8	4.8	7.1	3.0	1.6	8.2	5.8	2.6	3.6	6.8	4.2	5.9	5.7	8.7	5.5	0.0	4.7	6.4	0.0	0.9	5.1	1.5	0.7	0.6	5.2	1.7	17.6	4.6	2.7	2.8	9.4	4.7	3.0	2.2	7.1	5.8	2.4	0.9	2.4	9.4	4.2	2.8	6.0	1.5	4.1	6.3	4.9	1.4	3.3	10.1	5.4	11.6	5.8	11.0	6.9	0.0	7.0	5.8	0.0	0.1	0.0	0.4	0.0	0.6	0.8	0.3	1.4	0.3	0.8	0.3	0.3	0.0	0.2	0.0	0.1	0.6	0.7	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.2	0.4	0.2	0.0	4.5	5.2	0.7	4.9	0.4	0.4	0.0	0.0	2.3	0.0	0.0	6.7	0.0	0.6	21.5	1.4	2.9	70.0	0.0	32.5	2.9	0.8	1.1	0.0	11.9	0.0	0.0	2.5	2.5	9.8	0.3	4.9	3.3	5.4	3.4	0.2	0.2	2.8	0.7	0.0	0.5	0.0	1.0	11.2	6.9	3.1	5.6	4.3	4.6	2.4
TMBIM1	"LFG3, PP1201, RECS1"	ENSG00000135926	"Transmembrane BAX inhibitor motif containing 1"	Q969X1	2	218274192-218292586	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012093, HPA070824"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA012093: AB_1858056, HPA070824: AB_2686317"	"unprognostic (4.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.34e-3)"	"unprognostic (3.81e-3)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	"unprognostic (9.85e-2)"	"unprognostic (3.76e-3)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (1.69e-1)"	"prognostic favorable (3.38e-4)"	"unprognostic (1.22e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.50e-1)"	64.3	34.6	26.5	22.1	45.0	23.0	84.3	11.0	38.3	35.7	42.2	43.1	33.7	41.8	35.0	30.0	86.8	25.1	50.3	34.6	21.0	17.2	50.7	69.3	46.7	34.3	37.5	13.7	27.9	87.6	31.3	15.0	92.7	40.9	31.6	40.1	23.9	40.1	43.7	53.2	49.5	70.6	41.2	50.3	22.7	57.8	13.2	32.5	9.4	66.4	42.1	36.3	57.7	54.5	17.0	19.6	60.3	43.5	13.0	24.0	33.6	26.9	9.7	0.5	7.2	63.1	26.6	29.0	26.5	32.7	15.7	18.1	24.8	66.9	6.2	19.3	38.9	29.9	46.1	9.0	59.4	15.5	22.2	3.7	39.0	6.7	29.8	28.6	0.5	38.5	25.2	55.8	32.1	41.0	16.8	16.6	1.0	24.3	11.6	27.3	1.1	0.4	6.7	0.4	55.7	8.8	0.9	4.3	4.8	21.1	85.0	0.5	0.5	8.7	32.5	18.4	6.0	8.7	5.9	25.1	28.2	7.8	13.0	9.6	5.6	6.5	2.7	27.8	6.2	15.9	60.3	27.7	59.9	24.0	36.2	20.5	17.0	22.0	19.5	19.6	14.0	14.7	15.8	35.5	13.0	43.5	5.3	23.5	33.6	26.5	45.0	11.0	38.3	21.0	17.2	37.5	13.7	40.9	32.5	68.5	24.6	28.7	69.9	72.6	1.9	23.1	86.6	8.1	29.6	66.3	0.0	126.2	11.6	144.8	0.6	46.0	183.5	23.3	245.6	121.5	63.2	108.4	48.5	40.1	94.3	0.0	21.8	25.2	35.2	1.9	50.0	57.9	43.9	14.4	54.8	22.4	239.0	105.2	55.9	32.3	1.7	12.9	47.2	0.7	12.3	88.3	235.9	34.8	41.2	229.1
STAT1	"ISGF-3, STAT91"	ENSG00000115415	"Signal transducer and activator of transcription 1"	P42224	2	190964358-191020960	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 90.5;BJ hTERT+ SV40 Large T+ RasG12V: 101.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000931, HPA000982, CAB004049"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		22000	"Nucleoplasm, Cytosol"		"CAB004049: AB_2197984, HPA000931: AB_1080100, HPA000982: AB_1080099"	"unprognostic (6.90e-2)"	"unprognostic (6.47e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (1.75e-4)"	"prognostic unfavorable (4.23e-4)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (2.43e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.35e-3)"	"unprognostic (3.93e-2)"	27.9	27.2	17.4	47.8	17.8	19.5	20.4	15.0	21.7	21.0	19.8	14.9	17.5	22.7	17.1	27.4	23.3	14.5	29.0	25.5	15.6	22.2	34.9	35.7	29.4	57.9	16.9	18.8	24.3	18.7	20.0	24.0	24.3	23.6	23.6	20.3	17.9	47.5	18.0	20.1	17.4	24.6	24.8	21.8	49.0	24.2	13.5	10.4	58.7	36.2	18.5	30.2	29.3	16.5	10.8	16.2	55.0	47.1	22.7	54.1	44.6	8.9	9.6	4.5	7.5	19.9	26.9	14.6	13.7	41.9	90.5	101.9	15.2	10.4	3.7	8.7	29.3	30.1	7.6	5.1	10.9	18.0	30.7	4.2	16.6	7.6	8.9	13.8	8.5	10.4	17.8	7.0	16.7	5.9	9.9	10.8	6.5	9.0	22.0	16.6	7.3	6.4	10.8	6.3	5.8	15.8	5.4	12.4	4.5	11.9	11.2	6.3	6.1	16.1	6.2	41.9	6.7	6.4	10.6	9.5	18.0	10.6	15.5	8.8	37.4	54.8	3.5	13.7	7.3	8.3	13.0	36.9	27.0	14.7	47.1	19.9	10.8	35.1	21.0	16.2	8.6	35.8	26.0	55.0	22.7	27.6	7.4	54.1	44.6	17.4	17.8	15.0	21.7	15.6	22.2	16.9	18.8	23.6	10.4	68.5	26.4	26.1	13.6	19.7	12.8	39.2	48.4	49.5	50.0	50.6	23.6	11.6	6.6	40.3	8.8	23.9	22.2	0.0	32.6	47.9	29.1	25.0	50.7	45.1	91.4	3.2	20.2	25.8	63.7	2.6	20.1	70.4	16.9	25.2	23.9	14.3	30.0	22.8	28.0	36.2	16.5	38.8	21.7	18.5	24.5	27.4	7.0	25.4	27.4	24.1
EFNB1	"CFNS, Elk-L, EPLG2, LERK2"	ENSG00000090776	"Ephrin B1"	P98172	X	68828997-68842147	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 104.2;Ito cells: 108.6;Suprabasal keratinocytes: 105.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 7.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 35.3;hTCEpi: 27.6;PC-3: 26.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB031489, HPA067188"	Uncertain		Supported	"Plasma membrane"		NA	NA		790000	"Plasma membrane"		"CAB031489: AB_631414, HPA067188: AB_2685799"	"unprognostic (2.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (3.32e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (4.29e-4)"	"unprognostic (1.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.86e-2)"	36.5	13.2	5.0	11.5	4.5	1.3	26.5	2.3	4.7	19.5	21.1	4.7	13.1	14.0	15.2	14.9	17.4	15.2	33.7	16.0	3.6	2.7	25.5	15.3	23.0	5.2	4.7	3.5	21.6	4.5	15.0	6.4	34.3	3.9	15.9	10.1	14.9	7.0	13.2	9.1	26.4	24.0	12.3	2.6	15.3	13.3	7.4	4.2	4.8	11.9	22.0	11.2	16.7	14.8	0.5	7.1	0.6	3.4	1.3	1.0	1.0	3.6	1.9	15.5	5.7	8.3	5.1	8.2	3.2	3.5	1.4	1.0	1.7	6.9	0.9	21.2	1.2	1.8	19.8	14.7	35.3	0.8	1.5	3.7	0.9	0.8	3.0	7.6	0.7	7.9	9.5	27.6	3.5	15.9	1.3	10.8	1.9	1.0	0.0	1.2	3.0	1.5	0.7	10.7	22.8	26.1	6.6	1.6	5.9	5.9	13.1	5.8	2.8	2.4	0.7	0.9	12.4	0.6	1.3	18.1	2.7	3.3	7.2	1.2	0.0	0.8	0.9	1.3	4.0	1.7	0.0	1.3	0.6	1.0	3.4	0.6	0.5	0.9	0.9	7.1	0.4	0.8	0.4	0.3	1.3	2.1	1.0	0.4	1.0	5.0	4.5	2.3	4.7	3.6	2.7	4.7	3.5	3.9	4.2	3.0	1.4	5.2	58.4	104.2	2.1	8.1	22.9	0.0	7.9	21.0	0.0	9.2	0.0	17.1	0.3	33.4	38.3	0.0	13.8	68.8	20.1	10.6	4.6	3.8	10.6	1.6	8.1	108.6	9.1	0.9	25.3	7.5	20.3	3.6	26.2	14.6	28.9	46.1	7.8	6.3	1.3	12.9	11.8	1.0	3.0	105.3	9.4	4.9	22.1	71.6
CAPN1	"CANP, CANPL1, muCANP, muCL"	ENSG00000014216	"Calpain 1"	P07384	11	65180566-65212006	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 90.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005992	Enhanced		Supported	Cytosol		NA	NA		28000000	Cytosol		"HPA005992: AB_1845924"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.33e-1)"	"prognostic favorable (7.06e-8)"	"unprognostic (5.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-1)"	22.0	15.6	9.6	23.8	11.6	18.2	18.8	17.7	20.1	25.8	33.3	8.4	23.0	25.4	19.3	30.2	86.9	28.1	39.1	21.4	8.8	11.2	27.8	21.3	19.4	19.5	10.8	9.7	21.4	24.9	13.3	14.1	38.1	16.8	27.3	17.0	15.8	39.7	24.3	24.2	38.9	49.9	16.5	7.7	21.3	20.7	8.3	6.7	32.1	37.5	50.2	53.7	33.7	35.2	16.7	22.8	34.5	24.8	15.7	19.6	28.5	48.4	25.8	7.4	16.4	13.4	17.1	22.5	14.4	22.9	17.0	13.0	16.4	43.6	12.1	24.1	27.3	19.8	71.6	9.6	60.8	5.5	12.9	7.6	28.9	14.9	16.0	13.4	6.8	40.6	18.8	32.7	14.4	7.0	16.0	29.0	8.8	17.2	9.8	13.8	31.1	13.3	21.5	21.3	24.8	23.4	13.2	7.6	7.3	23.0	90.0	13.3	9.8	15.2	58.9	13.9	8.3	25.3	13.4	25.2	13.2	9.0	28.2	6.5	6.0	4.4	14.4	23.1	8.3	14.3	34.3	24.8	34.5	19.6	23.7	15.7	15.6	15.5	17.7	22.8	16.7	9.1	12.5	15.8	15.7	14.0	17.9	16.6	28.5	9.6	11.6	17.7	20.1	8.8	11.2	10.8	9.7	16.8	6.7	23.8	24.7	31.9	110.9	53.1	6.6	17.9	68.8	30.8	33.0	73.3	19.6	201.3	33.2	164.8	0.5	23.3	141.6	0.0	101.4	88.1	42.3	51.8	46.1	31.0	78.5	20.6	42.6	26.4	45.7	0.4	40.3	38.8	45.5	146.9	72.1	33.2	133.6	105.2	47.7	26.9	15.0	38.8	36.4	0.5	2.0	60.2	164.4	49.8	101.5	141.7
LONRF3	"FLJ22612, RNF127"	ENSG00000175556	"LON peptidase N-terminal domain and ring finger 3"	Q496Y0	X	118974614-119018355	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 14.9;Basal glandular cells: 13.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 7.4"	"Lineage enriched"	"Detected in single"	8	"T-cells: 7.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 9.9;K-562: 10.6;OE19: 12.0;PC-3: 12.1;SiHa: 11.0;SK-MEL-30: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050422, HPA061162"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA050422: AB_2681122, HPA061162: AB_2732658"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.01e-2)"	"prognostic unfavorable (4.32e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.31e-3)"	"unprognostic (6.34e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.27e-3)"	3.8	3.9	4.2	2.1	3.4	4.6	10.8	15.8	6.1	1.9	4.1	2.0	1.6	2.9	2.4	3.1	1.7	2.5	3.9	3.9	5.0	1.9	3.6	15.4	11.8	0.8	1.7	3.7	2.0	8.1	0.4	3.5	0.9	4.4	3.0	5.5	4.1	8.1	3.0	13.8	1.4	2.3	10.8	2.7	1.1	4.5	2.7	2.5	0.0	9.9	1.9	1.1	4.7	6.6	0.0	0.1	0.8	0.8	0.0	7.4	0.7	3.7	5.5	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	4.6	0.0	2.7	0.0	9.9	0.0	1.1	0.0	0.0	0.1	3.1	4.7	9.0	5.3	3.1	4.0	0.6	0.0	0.0	0.0	0.0	1.7	1.4	0.4	10.6	0.0	0.8	4.5	0.0	1.8	0.0	12.0	12.1	0.0	2.5	0.0	3.3	1.5	0.2	0.0	11.0	0.3	9.6	0.1	0.0	3.5	0.2	0.1	0.2	0.0	5.8	1.2	4.7	0.0	2.6	4.1	2.4	0.0	0.8	0.0	4.5	0.0	7.4	0.0	2.0	1.5	0.1	0.0	1.1	1.6	0.8	0.0	0.0	0.0	0.7	0.7	4.2	3.4	15.8	6.1	5.0	1.9	1.7	3.7	4.4	2.5	6.0	14.9	0.0	13.8	1.3	3.6	3.2	0.0	0.0	10.3	1.8	0.0	0.5	1.7	2.4	1.3	1.9	5.8	0.0	3.8	0.0	2.8	4.7	5.8	4.0	2.9	1.6	1.2	3.1	3.7	0.4	0.9	3.8	3.3	0.0	2.3	6.1	4.6	3.1	1.4	0.7	0.2	0.0	3.1	1.7	4.1	0.1	0.3	1.3	2.5	9.8
ALPP		ENSG00000163283	"Alkaline phosphatase, placental"	P05187	2	232378534-232382889	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"placenta: 240.2"	"Group enriched"	"Detected in some"	19	"Alveolar cells type 1: 11.9;Club cells: 3.4;Syncytiotrophoblasts: 5.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HaCaT: 88.1;SiHa: 24.3"									"CAB026327, HPA038764, HPA038765, HPA051699"	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB026327: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"		"unprognostic (4.86e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.67e-3)"		"unprognostic (2.60e-1)"		"unprognostic (2.44e-3)"		"unprognostic (1.26e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (1.44e-1)"		"unprognostic (4.09e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.27e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	240.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.5	1.6	0.5	1.1	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	9.9	0.0	0.0	0.0	0.0	88.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	24.3	8.6	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.7	0.5	0.2	0.5	0.3	0.3	0.3	0.1	1.0	0.4	0.4	1.6	1.1	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	5.6	0.0	0.0	0.0
LAPTM4A	"HUMORF13, KIAA0108, LAPTM4, MBNT, Mtrp"	ENSG00000068697	"Lysosomal protein transmembrane 4 alpha"	Q15012	2	20032650-20052028	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 133.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031402, HPA031404, HPA068554"	Approved		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Golgi apparatus, Vesicles"	"Plasma membrane"	"HPA031402: AB_10669882, HPA031404: AB_10670293, HPA068554: AB_2686003"	"unprognostic (2.01e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.73e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.53e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.65e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (8.70e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.18e-2)"	"unprognostic (7.98e-3)"	"unprognostic (2.36e-1)"	59.2	63.8	23.4	20.1	22.8	19.8	53.6	15.9	23.4	85.7	44.0	25.9	181.0	26.0	80.3	57.4	50.4	53.0	49.9	50.1	22.3	19.0	95.9	83.0	48.7	24.3	22.0	17.3	72.7	63.6	28.9	46.5	137.6	24.9	64.9	28.4	56.8	49.9	175.6	33.6	41.2	44.9	56.4	21.6	34.8	40.7	83.3	18.6	13.7	75.3	37.9	37.7	65.3	57.8	27.2	37.4	82.4	53.4	16.5	19.4	48.0	37.5	20.8	12.8	26.5	133.1	99.0	47.9	47.7	59.9	32.7	37.2	16.3	37.0	6.6	11.0	57.9	34.0	37.4	10.6	22.9	29.9	16.2	16.9	10.1	24.6	46.3	51.4	7.8	28.1	66.1	46.6	31.7	36.5	45.7	33.7	5.7	7.6	12.7	48.4	21.6	4.6	10.2	28.2	32.2	19.1	8.1	37.5	12.5	80.0	31.5	20.3	19.6	44.3	36.7	30.0	48.7	15.8	6.4	42.9	55.0	19.7	47.2	30.6	21.2	30.4	10.7	43.5	15.6	21.8	82.4	53.4	38.5	14.2	44.2	17.1	27.2	17.0	15.7	37.4	26.2	19.4	17.3	28.1	16.5	50.3	31.3	15.9	48.0	23.4	22.8	15.9	23.4	22.3	19.0	22.0	17.3	24.9	18.6	181.7	179.3	127.9	498.3	585.3	19.7	191.2	331.2	204.8	200.2	525.1	11.8	156.0	137.6	412.4	1117.0	311.4	159.7	46.7	306.5	887.8	890.1	264.1	506.1	427.2	285.9	19.1	132.5	307.6	307.4	952.2	773.5	352.6	558.5	334.6	176.2	293.0	282.2	210.1	564.6	774.3	23.0	523.9	560.6	321.9	146.0	620.4	253.3	94.8	178.7	415.2
RAB11A	YL8	ENSG00000103769	"RAB11A, member RAS oncogene family"	P62491	15	65726054-65891991	"Predicted intracellular proteins"	"Cell cycle, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 810.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013097, HPA051697, HPA060686"	Approved		Enhanced	"Vesicles,Centriolar satellite"		No	No			"Vesicles, Centriolar satellite"		"CAB013097: AB_2533987, HPA051697: AB_2732569, HPA060686: AB_2684342"	"unprognostic (4.15e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.74e-3)"	"unprognostic (6.85e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.60e-2)"	"unprognostic (4.83e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (4.29e-2)"	"prognostic favorable (1.46e-5)"	"unprognostic (9.93e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.23e-3)"	"unprognostic (1.21e-1)"	43.3	64.1	32.4	27.0	49.6	25.1	35.4	34.9	57.3	41.3	49.9	27.7	30.5	31.4	36.4	31.7	131.6	34.2	42.8	34.5	35.0	40.5	52.4	28.7	38.1	32.8	34.3	36.6	35.6	24.5	32.3	36.6	60.5	60.5	35.8	52.2	33.7	58.3	31.2	27.3	79.8	35.2	34.3	33.1	55.3	47.9	47.4	25.1	32.4	46.2	60.7	62.1	51.7	60.6	18.1	31.5	54.0	33.3	15.1	24.5	59.5	38.1	45.3	46.3	33.5	42.4	39.9	60.5	40.9	41.7	37.3	44.6	41.6	68.8	50.2	41.8	46.8	37.0	59.2	72.8	54.1	35.3	32.7	43.5	60.1	32.8	36.8	32.3	28.1	35.8	40.6	61.7	36.6	30.5	39.9	82.5	27.3	48.2	29.9	52.5	37.9	27.8	22.3	38.5	143.2	25.8	23.7	35.2	46.5	100.1	100.4	33.4	35.5	29.4	46.8	37.9	57.3	61.9	32.9	62.3	29.6	42.2	28.4	36.1	15.8	37.5	39.0	27.4	47.8	31.6	32.4	32.1	51.8	14.0	29.8	14.3	18.1	21.0	16.6	31.5	14.1	19.8	15.5	54.0	15.1	33.3	20.3	24.5	59.5	32.4	49.6	34.9	57.3	35.0	40.5	34.3	36.6	60.5	25.1	53.6	56.3	73.5	139.3	170.7	40.9	79.0	109.5	121.8	60.3	177.9	31.4	272.5	293.4	292.8	266.5	253.3	195.7	23.3	299.7	258.8	118.0	163.7	74.9	76.3	202.8	54.0	197.9	219.8	109.3	44.8	90.0	141.5	177.2	290.4	192.9	96.3	318.8	179.9	81.3	212.8	30.7	45.3	81.1	257.1	103.5	248.5	810.7	71.0	152.8	293.1
TMEM43	"ARVD5, DKFZp586G1919, LUMA, MGC3222"	ENSG00000170876	"Transmembrane protein 43"	Q9BTV4	3	14124940-14143679	"Disease related genes, Predicted membrane proteins"			"Cardiomyopathy, Disease mutation, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 128.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019198	Approved					NA	NA		94000			"HPA019198: AB_1858118"	"unprognostic (3.65e-3)"	"unprognostic (2.52e-1)"	"unprognostic (4.03e-2)"	"unprognostic (4.66e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (5.77e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.19e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.18e-1)"	32.3	15.3	14.7	15.0	15.1	7.7	41.5	16.6	15.6	32.3	22.4	13.3	14.9	9.9	45.8	22.2	32.0	27.7	21.4	28.7	12.1	8.6	17.4	13.9	24.8	20.1	14.0	11.2	37.7	20.2	11.1	14.4	50.6	10.9	21.9	13.0	17.2	17.2	29.8	32.7	45.8	16.4	38.4	10.8	14.2	16.6	13.7	12.1	8.8	31.7	27.6	14.9	29.4	28.8	13.3	23.3	54.1	18.0	25.9	25.3	21.3	10.1	11.6	11.3	14.7	45.2	47.5	26.9	20.2	41.4	33.3	24.1	9.5	13.5	4.8	14.5	49.9	16.6	22.1	11.8	17.8	23.9	12.1	9.6	8.6	11.5	13.2	28.6	12.5	10.4	35.5	44.4	27.6	34.2	26.7	23.9	9.2	13.6	12.1	19.3	13.2	5.6	10.5	12.3	15.4	19.1	7.8	11.9	18.9	15.1	17.7	3.3	9.1	25.2	15.0	16.2	10.0	9.4	18.2	21.6	30.5	16.6	30.6	18.6	8.3	13.1	6.2	22.9	16.9	27.3	21.1	18.0	33.4	25.3	15.7	23.3	13.3	24.9	22.9	23.3	10.8	16.9	18.5	54.1	25.9	15.6	14.8	21.8	21.3	14.7	15.1	16.6	15.6	12.1	8.6	14.0	11.2	10.9	12.1	128.1	41.4	8.3	28.0	38.8	5.2	11.8	10.2	18.7	80.8	17.4	13.7	22.4	0.0	27.3	0.7	36.0	8.1	0.0	8.7	56.4	65.8	20.5	26.7	7.8	16.6	6.4	4.7	20.3	15.2	2.8	40.0	27.3	28.7	19.8	6.7	8.9	20.1	11.0	66.4	9.6	8.0	32.3	34.4	4.9	10.9	39.6	31.4	23.5	11.1	25.3
SMAGP	"hSMAGP, MGC149453, MGC149454"	ENSG00000170545	"Small cell adhesion glycoprotein"	Q0VAQ4	12	51244558-51270890	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.4"	"Group enriched"	"Detected in many"	9	"Cytotrophoblasts: 1087.3;Syncytiotrophoblasts: 704.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 39.4;OE19: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039711	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA039711: AB_10674985"	"unprognostic (2.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (3.01e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.52e-1)"	7.5	6.9	0.9	11.3	1.7	0.9	26.3	1.1	1.3	13.1	22.6	0.9	5.3	6.9	8.0	13.6	53.4	3.2	21.8	6.0	1.0	1.0	10.9	4.3	17.6	14.2	1.5	0.4	5.2	14.9	4.6	1.9	50.0	3.0	4.8	24.3	2.6	10.2	6.9	3.6	12.6	8.5	3.4	4.3	11.5	14.1	4.8	0.7	1.2	4.2	28.7	33.1	7.9	24.6	22.5	2.6	8.6	3.7	12.3	9.5	3.5	23.3	7.2	0.8	0.8	3.2	12.7	39.4	18.0	18.1	9.2	5.7	14.2	24.6	0.2	3.2	11.1	3.4	8.3	5.1	6.9	12.9	1.1	4.1	3.1	0.9	4.7	8.9	0.7	3.0	8.2	5.3	19.9	18.0	21.1	22.1	6.0	2.4	1.3	14.8	20.6	3.8	2.8	3.6	47.5	27.9	0.2	0.3	0.8	13.3	5.4	0.9	1.1	3.9	15.8	2.8	9.9	13.6	1.2	7.7	10.3	9.8	0.5	10.9	0.4	0.6	0.4	15.1	7.7	5.5	1.9	3.7	6.4	9.5	2.4	6.1	22.5	4.2	6.9	2.6	17.6	3.9	7.0	8.6	12.3	2.6	1.5	2.7	3.5	0.9	1.7	1.1	1.3	1.0	1.0	1.5	0.4	3.0	0.7	0.0	18.8	28.2	46.4	19.3	1.2	1.1	53.5	8.1	12.5	15.7	0.0	1087.3	41.4	27.1	6.5	53.4	61.6	0.0	95.9	65.5	13.8	46.6	12.7	5.8	83.3	1.6	19.7	38.1	5.4	2.1	12.0	6.7	13.5	5.4	100.2	2.5	97.3	73.7	9.2	15.3	1.2	25.8	8.1	5.2	28.8	26.0	704.6	15.2	97.4	72.3
BCAR3	"AND-34, NSP2, SH2D3B"	ENSG00000137936	"BCAR3, NSP family adaptor protein"	O75815	1	93561786-93847150	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 59.5"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 102.8;Extravillous trophoblasts: 70.7;Sertoli cells: 71.1;Urothelial cells: 114.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.4;memory B-cell: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014858	Approved		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Centrosome	"HPA014858: AB_1845302"	"unprognostic (9.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.60e-3)"	"prognostic unfavorable (8.41e-4)"	"prognostic unfavorable (5.42e-4)"	"prognostic unfavorable (8.92e-7)"	"unprognostic (2.44e-1)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.51e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (2.13e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.87e-1)"	26.0	10.4	10.1	11.6	14.2	0.9	23.1	8.6	8.1	10.2	14.1	10.0	6.2	12.4	5.7	5.9	8.9	9.4	15.5	10.6	10.6	8.0	15.5	11.0	12.8	11.8	11.7	5.6	11.2	4.1	4.5	4.6	59.5	10.6	11.2	15.7	10.1	20.5	14.5	19.5	13.3	14.8	10.6	9.7	5.4	15.2	7.3	8.0	2.6	10.0	6.6	11.7	12.7	17.7	4.5	1.7	4.4	1.1	0.0	0.3	0.1	15.3	6.6	12.4	0.9	5.4	4.2	10.7	15.9	27.8	13.1	8.1	1.1	11.5	2.5	5.5	24.5	17.1	9.6	0.3	20.6	11.5	1.1	0.3	0.0	4.8	2.8	9.7	0.1	0.0	5.0	22.8	13.6	46.2	12.7	14.4	0.3	0.4	0.1	35.5	2.3	0.3	0.0	3.9	6.7	22.9	1.0	17.9	0.3	34.4	19.5	0.4	1.0	7.7	8.3	9.9	5.0	9.3	0.6	16.9	19.6	5.0	8.3	21.0	1.3	0.5	0.3	2.9	0.0	7.1	4.4	0.0	0.1	0.0	1.1	0.0	4.5	0.1	0.0	0.8	2.5	0.0	0.3	0.0	0.0	0.0	1.7	0.3	0.1	10.1	14.2	8.6	8.1	10.6	8.0	11.7	5.6	10.6	8.0	3.0	7.4	7.4	102.8	8.8	1.0	6.7	7.6	10.7	9.1	14.0	0.0	23.0	23.2	11.1	8.4	17.3	20.2	0.0	5.6	70.7	9.3	24.4	3.5	9.4	10.3	20.6	14.3	5.5	4.3	11.2	9.5	8.1	18.6	16.2	20.7	4.3	17.7	20.7	1.1	15.6	0.4	71.1	19.3	3.2	2.9	8.9	15.8	0.0	10.0	114.7
RPL35A	L35A	ENSG00000182899	"Ribosomal protein L35a"	P18077	3	197949980-197956610	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, tRNA-binding"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (9.48e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.89e-3)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (2.51e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (1.37e-6)"	"unprognostic (1.03e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.72e-2)"	67.4	61.5	50.0	69.8	62.5	97.2	142.7	55.7	73.5	79.5	58.7	24.0	62.6	48.6	144.5	79.4	70.5	74.4	60.6	108.6	66.7	33.7	52.4	49.8	89.4	255.9	41.6	53.5	172.0	304.9	21.5	49.1	36.4	90.1	61.0	54.8	35.0	180.2	48.5	108.0	81.3	51.8	97.8	38.8	63.0	65.1	73.9	28.5	64.4	76.9	109.8	84.2	62.7	108.4	160.0	100.9	38.8	82.2	83.4	213.5	234.3	169.4	47.9	80.9	68.3	82.7	170.7	100.2	85.4	91.9	105.7	80.5	155.8	64.2	174.3	300.9	69.2	59.2	82.3	86.7	102.7	112.1	34.9	163.5	96.2	80.1	103.3	131.6	153.3	64.7	154.1	119.9	58.7	180.2	139.1	109.6	74.9	84.6	153.5	104.5	221.7	86.8	172.9	121.6	144.8	162.9	81.7	56.3	226.3	115.4	98.6	78.4	82.0	57.4	156.6	217.2	57.2	272.1	239.4	79.8	45.4	63.3	72.3	150.2	127.3	180.0	222.1	66.9	277.0	70.2	38.8	82.2	25.9	88.3	60.9	139.0	160.0	160.9	121.4	97.2	150.9	213.5	163.2	12.8	83.4	52.5	100.9	105.9	234.3	50.0	62.5	55.7	73.5	66.7	33.7	41.6	53.5	90.1	28.5	985.6	1438.1	4533.0	3885.1	4741.1	298.3	448.9	1949.0	1452.1	2174.7	893.3	94.2	2354.2	2941.1	1752.5	1481.3	2286.5	1323.4	1168.1	3956.2	3881.0	3187.2	2899.3	1931.2	1482.5	2119.8	147.8	1576.2	2366.9	3134.8	1160.7	4192.2	3135.6	2815.7	2745.8	2752.9	433.9	3137.0	2556.6	2176.3	2591.2	311.2	1584.5	2269.1	617.6	658.1	5264.8	2251.4	2946.2	3554.4	3382.6
TRIM29	"ATDC, FLJ36085"	ENSG00000137699	"Tripartite motif containing 29"	Q14134	11	120111275-120185529	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 176.3;lymphoid tissue: 93.6;skin 1: 90.1;tongue: 113.6"	"Cell type enhanced"	"Detected in many"	17	"Basal glandular cells: 97.6;Basal keratinocytes: 241.7;Suprabasal keratinocytes: 402.6;Urothelial cells: 144.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 93.4"	"Region enriched"	"Detected in single"	8	"pons and medulla: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 54.2;hTCEpi: 72.1;RT4: 28.5;SiHa: 40.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020053, HPA074841"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Intermediate filaments"	"Nucleoplasm, Cytosol"	"HPA020053: AB_1858280, HPA074841: "	"unprognostic (1.10e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (9.79e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (9.37e-2)"	"unprognostic (4.29e-3)"	"prognostic favorable (4.93e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.15e-2)"	0.3	0.2	0.1	0.0	0.1	0.1	7.3	0.0	0.1	30.4	0.6	0.2	1.6	0.3	3.1	2.9	176.3	3.7	0.8	0.1	0.1	0.1	0.5	0.4	1.4	0.0	0.0	0.0	0.4	0.2	0.0	2.2	24.4	1.1	11.1	0.5	0.0	25.5	4.8	0.9	90.1	0.2	1.6	0.3	0.0	0.2	0.7	0.0	7.5	0.1	113.6	93.6	9.6	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	3.4	0.0	0.8	0.0	0.1	54.2	0.0	12.4	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.1	0.0	72.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	28.5	0.2	0.9	40.5	5.7	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.0	1.0	0.0	97.6	241.7	0.0	1.1	2.5	33.5	13.6	0.0	0.0	37.9	0.0	1.3	21.4	0.4	2.1	0.0	3.9	5.0	5.4	34.5	1.1	0.0	4.4	0.0	2.4	0.0	0.0	78.0	0.6	1.7	21.9	0.0	2.3	0.0	33.2	0.8	0.0	0.2	0.0	0.0	7.2	0.6	1.4	402.6	20.7	0.0	1.4	144.0
UGT1A10	UGT1J	ENSG00000242515	"UDP glucuronosyltransferase family 1 member A10"	Q9HAW8	2	233636454-233773305	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 9.4;gallbladder: 8.4;intestine: 31.1;stomach 1: 12.4"	"Cell type enhanced"	"Detected in some"	22	"Club cells: 1.2;Enterocytes: 2.1"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	142	"RT4: 109.0"														"Intracellular and membrane"	NA	NA								"unprognostic (9.33e-2)"			"unprognostic (7.64e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.73e-1)"			"prognostic unfavorable (4.55e-4)"		"unprognostic (1.49e-10)"	"unprognostic (2.90e-1)"	"unprognostic (1.50e-1)"		"unprognostic (3.59e-3)"	0.3	0.0	0.3	2.6	0.3	0.0	0.3	0.3	0.3	0.3	19.2	0.3	0.3	31.1	0.3	0.3	9.4	0.1	8.4	0.3	0.3	0.0	0.3	1.4	0.6	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	14.3	0.3	0.9	0.3	0.3	0.3	20.2	0.5	0.3	0.3	12.4	1.0	0.3	0.3	0.3	0.3	1.4	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	109.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1
KCNN4	"hIKCa1, hKCa4, hSK4, IK, KCa3.1"	ENSG00000104783	"Potassium calcium-activated channel subfamily N member 4"	O15554	19	43766533-43781257	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 45.7;salivary gland: 82.3"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 196.8;Syncytiotrophoblasts: 638.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 27.8;hTERT-RPE1: 24.5;SK-BR-3: 27.5;WM-115: 70.6"	"Region enhanced"	"Detected in single"		"olfactory region: 2.3"	"Not detected"	"Not detected"			"HPA053841, HPA059622"	Approved					NA	NA					"HPA053841: AB_2682278, HPA059622: AB_2684085"	"unprognostic (1.23e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.29e-1)"	"unprognostic (3.74e-3)"	"prognostic unfavorable (2.68e-4)"	"unprognostic (1.98e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (9.96e-3)"	"prognostic unfavorable (1.05e-14)"	"unprognostic (3.70e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (1.75e-4)"	3.0	0.1	0.5	12.2	2.5	6.5	5.6	0.4	0.5	8.0	5.7	0.7	6.4	2.0	0.9	2.9	2.6	2.6	8.8	0.6	1.4	0.5	0.8	0.3	2.6	5.7	1.7	0.6	1.3	0.3	0.0	0.3	45.7	1.5	11.0	3.8	0.8	82.3	6.8	0.7	10.8	10.0	2.0	1.1	8.4	13.6	0.9	1.0	9.1	0.7	3.6	17.3	10.3	2.4	18.7	14.4	1.9	15.8	0.0	6.9	5.2	5.1	9.6	0.0	0.0	0.0	0.8	13.5	0.2	0.7	0.5	0.1	0.1	27.8	1.5	2.2	0.2	3.2	4.1	0.0	9.8	1.4	9.3	0.0	6.8	12.5	0.2	0.0	0.0	0.1	0.0	1.2	0.6	4.4	24.5	0.0	0.0	1.5	0.8	0.1	5.0	1.5	5.2	0.0	21.9	10.3	4.6	0.1	5.1	8.5	14.4	0.0	0.0	13.8	27.5	8.1	0.6	0.0	5.5	0.3	3.8	19.7	0.1	11.1	0.0	0.3	0.6	13.1	1.2	70.6	1.9	10.2	0.0	0.3	15.8	0.4	18.7	5.1	2.6	14.4	9.4	3.4	3.2	0.5	0.0	8.6	0.4	6.9	5.2	0.5	2.5	0.4	0.5	1.4	0.5	1.7	0.6	1.5	1.0	0.0	3.4	27.2	43.3	2.5	0.1	0.4	7.6	0.0	6.8	1.8	3.9	196.8	0.0	3.0	0.7	2.8	4.2	23.3	3.5	6.8	2.8	66.7	0.0	0.0	43.0	0.0	0.0	0.0	7.5	0.0	0.0	28.3	20.3	0.0	5.9	0.0	37.2	16.9	0.0	0.0	0.3	0.0	1.0	0.0	1.3	1.9	638.3	6.5	43.7	53.5
MELK	KIAA0175	ENSG00000165304	"Maternal embryonic leucine zipper kinase"	Q14680	9	36572862-36677683	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.4"	"Cell type enhanced"	"Detected in many"	15	"Extravillous trophoblasts: 36.8;Spermatocytes: 10.2;Spermatogonia: 19.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"T-reg: 4.8"	"Lineage enriched"	"Detected in many"	5	"T-cells: 4.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA017214	Uncertain					NA	Yes					"HPA017214: AB_1853798"	"unprognostic (5.03e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.42e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.91e-7)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (8.86e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.35e-1)"	1.5	1.1	0.3	11.4	0.6	7.7	2.6	0.2	0.8	2.1	5.9	0.3	0.1	4.5	1.2	1.5	12.2	0.4	1.6	1.3	0.5	0.4	1.2	1.3	2.0	8.3	0.4	0.1	0.7	0.8	0.0	0.3	6.3	0.5	0.7	7.8	0.4	2.3	0.1	0.9	2.8	4.6	1.9	1.0	5.2	2.9	11.3	0.4	42.4	0.5	7.2	12.6	1.5	3.3	0.1	0.6	1.0	0.1	0.4	4.8	0.5	35.6	18.4	24.8	14.6	3.4	5.9	14.4	26.5	18.7	37.2	45.9	14.0	14.1	11.9	8.5	13.0	32.5	12.3	21.6	16.6	41.1	32.5	8.6	9.4	21.8	14.0	1.3	14.5	11.9	2.1	3.0	28.6	16.3	4.8	18.7	18.6	11.9	19.1	30.4	11.9	18.0	6.8	19.8	16.1	14.4	16.7	16.7	7.6	11.4	12.0	16.8	12.5	14.1	13.6	8.6	14.4	11.4	6.9	9.2	20.1	25.4	16.9	24.1	3.8	13.6	17.9	12.7	10.8	27.2	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.8	1.0	0.0	0.0	0.0	0.6	0.0	0.4	0.1	0.6	4.8	0.5	0.3	0.6	0.2	0.8	0.5	0.4	0.4	0.1	0.5	0.4	0.0	0.0	0.0	0.4	4.0	0.0	0.3	0.0	1.4	2.3	0.0	0.0	4.2	0.0	0.8	1.8	0.0	1.2	0.0	1.0	36.8	2.1	0.2	0.0	0.2	8.4	0.0	0.0	1.3	0.6	1.8	1.1	2.3	0.0	5.4	1.3	0.0	1.1	2.9	0.0	0.0	0.0	0.0	0.9	10.2	19.0	1.5	7.4	0.0	3.7	1.4
PLS3	T-plastin	ENSG00000102024	"Plastin 3"	P13797	X	115561174-115650861	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 196.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"NK-cell: 4.2;plasmacytoid DC: 13.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 13.1;NK-cells: 4.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020433, HPA076083"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		110000000	"Plasma membrane, Cytosol"		"HPA020433: AB_2670440, HPA076083: AB_2686773"	"unprognostic (1.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavorable (6.07e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.72e-4)"	"prognostic unfavorable (7.04e-4)"	41.9	11.0	11.8	9.8	12.5	0.2	24.6	3.6	16.7	43.8	14.3	13.9	24.1	6.0	37.4	27.6	54.4	21.5	23.6	18.8	12.2	8.2	40.7	100.5	64.7	6.0	14.7	13.7	44.4	8.9	2.7	4.6	21.9	22.7	21.6	9.2	10.6	16.6	31.4	17.7	38.4	8.2	34.6	14.5	31.6	13.3	14.9	13.0	5.1	64.8	34.7	12.5	38.7	29.0	0.0	13.1	0.4	0.1	4.2	1.5	0.2	28.1	29.0	25.4	7.3	25.7	24.0	38.8	29.4	33.2	28.2	34.2	31.4	23.5	0.1	85.2	24.2	20.9	36.3	26.9	47.9	45.9	0.4	33.7	2.7	36.0	13.1	23.3	0.0	1.4	15.2	23.0	43.6	30.8	45.6	61.1	2.3	0.0	0.0	26.9	8.2	0.0	0.3	33.7	12.2	34.8	0.0	17.0	0.6	33.7	15.3	0.0	5.3	61.8	15.4	12.4	38.4	8.5	0.4	66.8	45.8	7.8	46.6	58.8	1.1	4.1	0.5	20.0	0.1	18.9	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	0.1	4.2	0.0	13.1	1.5	0.2	11.8	12.5	3.6	16.7	12.2	8.2	14.7	13.7	22.7	13.0	196.5	74.7	2.9	91.8	110.9	0.2	12.5	20.4	13.4	73.9	94.2	0.0	2.1	11.6	57.0	8.6	106.8	2.5	0.0	46.9	97.6	65.4	15.9	0.0	74.6	3.6	0.0	12.7	79.2	6.3	6.5	48.1	4.7	54.0	1.0	5.7	24.0	49.2	4.3	77.8	17.5	1.2	51.8	106.6	1.2	20.9	117.2	3.8	4.3	11.8	92.1
LIPH	"LPDLR, mPA-PLA1, mPA-PLA1alpha, PLA1B"	ENSG00000163898	"Lipase H"	Q8WWY8	3	185506262-185552613	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 28.8;lung: 28.5;stomach 1: 27.0"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 134.0;Enterocytes: 247.9;Mucus-secreting cells: 115.8;Urothelial cells: 130.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 37.9;OE19: 8.6;RPTEC TERT1: 19.2;T-47d: 9.1;U-266/84: 9.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA049079	Approved				"Secreted to blood"	NA	NA					"HPA049079: AB_2680623"	"unprognostic (4.50e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (3.38e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (7.88e-2)"	"prognostic favorable (9.20e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (4.21e-4)"	"unprognostic (1.15e-1)"	0.3	0.5	0.5	5.1	1.2	0.0	2.1	0.3	1.4	2.5	20.4	0.6	3.1	6.2	0.2	5.1	12.9	0.5	16.5	0.6	0.4	0.7	8.5	0.5	28.5	0.0	0.3	0.0	0.7	13.6	0.0	2.1	0.9	1.8	10.7	21.9	2.1	15.7	3.0	0.3	6.1	28.8	1.6	0.3	0.5	27.0	6.2	0.0	0.2	0.4	4.1	14.9	8.8	5.0	0.9	0.4	2.4	0.9	0.6	0.7	1.7	5.1	6.8	0.0	0.0	0.0	0.1	1.5	0.1	0.0	0.1	0.1	0.6	37.9	0.0	3.9	0.1	1.5	1.8	2.8	0.0	0.2	0.0	0.8	0.9	0.9	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.6	0.2	0.0	0.3	8.6	0.5	0.0	0.0	0.5	19.2	4.6	0.0	0.0	0.5	6.3	0.1	0.3	9.1	0.1	0.0	0.0	0.5	0.0	0.1	0.6	9.0	0.0	0.0	0.0	0.0	2.2	0.9	0.4	0.5	0.2	0.3	0.4	0.5	0.4	0.2	0.9	0.7	0.6	2.4	0.6	0.4	0.4	0.3	1.7	0.5	1.2	0.3	1.4	0.4	0.7	0.3	0.0	1.8	0.0	134.0	29.7	0.0	12.6	0.7	0.4	0.4	68.8	45.5	54.6	64.6	0.0	0.2	1.7	42.3	0.0	0.2	247.9	0.0	22.4	0.1	0.4	71.5	6.9	0.0	0.0	0.0	21.4	1.3	0.0	0.0	0.0	0.1	15.1	1.0	115.8	0.3	39.8	89.6	0.0	1.6	0.7	0.0	0.2	0.5	0.0	1.8	0.2	0.0	61.8	130.6
MUC1	"ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM"	ENSG00000185499	"Mucin 1, cell surface associated"	P15941	1	155185824-155192916	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 168.1;kidney: 158.5;lung: 143.5"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 1308.2;Collecting duct cells: 465.9;Exocrine glandular cells: 994.6;Pancreatic endocrine cells: 807.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.0"	"Group enriched"	"Detected in many"	10	"granulocytes: 1.3;T-cells: 4.0"	"Group enriched"	"Detected in many"	6	"CAPAN-2: 139.4;OE19: 65.3;RPTEC TERT1: 107.0;T-47d: 47.0"									"CAB000036, CAB001986, HPA004179, HPA007235, HPA008855"	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	NA	NA		4900000	"Plasma membrane"		"CAB000036: AB_2148557, CAB001986: , HPA004179: AB_1846282, HPA007235: AB_1846281, HPA008855: AB_1846283"	"unprognostic (4.74e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.61e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (4.75e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.21e-1)"	1.5	0.7	0.8	12.6	1.2	0.9	12.6	0.4	0.7	31.6	15.9	1.2	2.4	2.9	10.5	9.8	51.8	18.7	168.1	0.8	0.5	0.3	158.5	2.0	143.5	0.3	0.5	0.3	14.9	74.2	0.0	4.7	15.5	2.1	6.1	16.1	0.8	17.0	5.9	0.8	1.8	3.6	2.8	0.7	0.6	105.0	4.3	0.5	0.7	15.7	10.5	47.8	12.3	5.2	0.0	0.2	1.3	0.1	0.0	4.0	0.2	1.8	0.9	0.6	0.5	0.4	0.5	0.2	0.6	1.4	0.7	1.9	0.0	139.4	0.0	10.1	1.1	0.3	2.8	0.1	0.0	0.2	1.2	0.1	0.2	11.8	0.0	0.3	0.0	4.4	1.2	0.2	0.3	0.2	1.5	0.2	0.2	1.0	1.9	0.5	14.2	0.1	0.1	0.4	65.3	0.2	0.2	0.0	3.4	107.0	0.1	0.6	0.2	3.3	5.9	0.1	0.5	47.0	0.6	0.2	0.4	0.8	1.3	0.1	2.1	1.1	0.0	0.7	0.1	0.1	1.3	0.1	0.0	0.0	0.0	0.8	0.0	2.3	0.4	0.2	0.0	0.3	0.7	0.0	0.0	0.0	0.0	4.0	0.2	0.8	1.2	0.4	0.7	0.5	0.3	0.5	0.3	2.1	0.5	402.0	1308.2	0.9	16.1	0.6	1.0	0.4	384.7	92.3	252.5	465.9	3.9	0.1	29.9	144.7	27.3	3.5	49.2	0.0	994.6	1.2	3.1	11.6	45.2	0.5	0.2	1.6	29.4	1.3	3.4	68.9	2.3	2.6	5.0	42.3	249.7	1.1	807.2	66.2	1.4	0.9	0.2	0.0	1.9	6.2	0.8	1.0	0.2	0.0	132.5	164.3
CNIH4	HSPC163	ENSG00000143771	"Cornichon family AMPA receptor auxiliary protein 4"	Q9P003	1	224356850-224379459	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044268	Approved					NA	NA					"HPA044268: AB_10965330"	"unprognostic (2.01e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (4.47e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.96e-3)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (4.27e-6)"	"unprognostic (3.15e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.63e-2)"	19.8	21.1	13.6	12.9	16.3	26.7	42.3	13.9	21.1	15.6	21.2	13.6	12.7	18.5	19.8	14.6	23.9	16.0	13.7	35.4	12.8	13.5	22.4	20.2	29.3	36.3	17.1	11.3	17.2	19.1	12.9	16.2	20.6	19.3	14.5	17.9	18.6	15.2	18.7	22.9	19.2	22.4	27.6	15.3	16.8	17.2	15.7	13.0	8.6	17.7	18.5	12.7	18.0	20.1	8.1	17.3	23.1	47.0	9.7	17.4	18.5	24.9	34.7	17.2	15.3	31.2	20.2	14.0	17.3	16.5	18.3	17.0	35.5	30.8	7.7	28.7	17.6	19.9	31.0	30.8	19.5	19.6	9.1	32.7	6.5	23.1	18.1	26.8	12.6	13.0	20.4	26.4	22.7	30.3	18.6	24.3	13.7	15.1	10.2	21.6	19.3	5.5	11.8	22.7	33.8	20.5	6.0	31.4	8.4	30.5	29.1	4.3	14.7	26.5	29.8	20.9	22.6	22.5	30.0	23.3	17.2	14.9	21.3	35.0	4.5	5.7	7.8	21.1	17.7	18.0	15.2	21.1	23.1	13.2	34.2	12.5	8.1	17.4	14.9	17.3	7.5	14.0	15.4	16.2	9.7	47.0	5.8	11.5	18.5	13.6	16.3	13.9	21.1	12.8	13.5	17.1	11.3	19.3	13.0	116.1	62.1	29.8	106.2	59.1	18.3	111.8	56.0	61.6	76.2	50.6	27.5	126.7	24.9	126.4	12.2	66.8	112.0	93.5	108.9	152.0	90.0	85.1	31.2	66.4	98.6	19.1	15.0	63.3	131.7	9.4	60.9	75.2	55.6	36.9	30.0	44.6	118.2	84.2	61.2	82.7	24.4	84.1	70.7	140.1	52.1	75.9	134.8	42.6	64.1	124.0
CXCL10	"C7, crg-2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10"	ENSG00000169245	"C-X-C motif chemokine ligand 10"	P02778	4	76021117-76023497	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 36.2;lymphoid tissue: 34.8;prostate: 34.6"	"Cell type enhanced"	"Detected in some"	12	"Basal glandular cells: 9.7;Glandular cells: 10.1;Hofbauer cells: 18.2;Macrophages: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 10.6;intermediate monocyte: 25.5;non-classical monocyte: 15.9"	"Lineage enriched"	"Detected in many"	15	"monocytes: 25.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.2;BJ hTERT+ SV40 Large T+: 3.4;BJ hTERT+ SV40 Large T+ RasG12V: 3.4;GAMG: 7.9;RPMI-8226: 6.3;RT4: 3.6;THP-1: 4.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	253000					"unprognostic (1.94e-1)"	"unprognostic (5.32e-2)"	"unprognostic (9.98e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.59e-2)"	"prognostic favorable (1.12e-5)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (1.03e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-2)"	4.3	2.1	2.7	34.8	2.5	0.0	7.3	1.8	4.8	8.1	3.5	0.9	0.2	3.8	2.3	6.7	4.7	1.2	3.8	7.6	1.2	1.2	7.5	10.6	36.2	21.7	3.2	1.6	3.9	1.2	0.0	2.3	5.6	3.0	34.6	6.0	2.6	9.1	2.1	7.3	2.1	4.1	5.5	11.3	15.8	6.4	1.3	0.9	15.0	25.7	5.4	9.2	9.2	2.2	0.5	1.6	0.6	25.5	0.0	0.1	3.7	0.7	0.0	0.0	0.3	0.0	0.2	0.0	0.0	9.2	3.4	3.4	0.3	0.1	3.0	0.3	0.0	7.9	0.0	0.0	0.2	0.2	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	6.3	0.1	3.6	0.0	0.0	0.0	0.7	2.0	0.0	0.2	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.8	0.0	0.0	10.6	0.0	0.0	25.5	0.0	0.5	0.1	0.0	1.6	0.0	0.0	0.0	0.6	0.0	15.9	0.0	0.0	3.7	2.7	2.5	1.8	4.8	1.2	1.2	3.2	1.6	3.0	0.9	0.0	2.1	0.5	9.7	0.8	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	1.1	0.0	0.0	0.0	0.8	10.1	1.1	0.0	18.2	0.0	0.0	0.0	5.6	3.5	0.3	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4
RAB7A	RAB7	ENSG00000075785	"RAB7A, member RAS oncogene family"	P51149	3	128726122-128814796	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Host-virus interaction, Lipid degradation, Lipid metabolism, Protein transport, Transport"		"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006964, CAB037131"	Supported		Supported	Lysosomes		NA	NA		9000000	Lysosomes		"CAB037131: AB_477460, HPA006964: AB_1856015"	"unprognostic (1.99e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (9.89e-6)"	"unprognostic (2.15e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (4.69e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.64e-3)"	61.5	57.0	64.6	43.8	59.9	41.7	49.5	44.8	67.1	43.5	55.4	69.5	29.4	45.1	49.8	60.7	63.2	44.2	43.1	73.5	62.9	60.2	58.4	69.6	51.7	42.7	66.9	53.6	51.3	34.1	44.0	52.7	64.2	66.2	39.2	50.8	60.9	47.0	41.6	146.3	54.2	45.9	48.9	69.0	52.3	40.7	26.3	61.9	37.7	52.0	51.0	50.7	42.8	47.7	27.7	60.7	102.8	58.7	31.7	33.8	52.9	73.3	24.9	32.4	18.7	73.5	41.5	35.0	70.9	51.6	39.8	42.0	43.8	42.3	33.8	46.5	46.6	64.5	38.6	35.9	48.4	45.1	43.6	25.4	74.1	24.3	43.0	60.7	73.2	46.7	48.9	51.8	37.0	43.5	43.5	35.4	25.1	33.8	32.9	52.0	54.1	45.5	55.3	31.4	55.5	34.2	33.6	37.0	35.9	44.4	71.1	24.4	33.9	45.3	41.4	74.5	37.7	42.4	49.7	62.7	44.5	27.5	83.5	32.7	46.9	51.4	57.1	66.7	49.6	56.2	38.2	54.1	59.1	27.5	58.7	26.1	27.7	28.5	27.3	60.7	25.1	27.2	26.5	102.8	31.7	54.6	23.6	33.8	52.9	64.6	59.9	44.8	60.8	62.9	60.2	66.9	53.6	66.2	61.9	83.4	69.7	117.9	285.8	263.5	65.1	109.4	73.9	99.0	59.1	125.6	17.7	198.6	203.9	226.9	9.1	153.7	157.4	46.7	173.6	224.2	194.3	231.2	141.1	117.7	351.9	69.9	93.0	134.4	189.9	11.4	123.7	256.5	322.2	245.3	103.4	146.4	226.3	108.4	147.8	239.3	30.0	135.8	163.7	86.8	95.4	269.2	416.4	112.2	85.4	273.2
CXCL17	"Dcip1, DMC, UNQ473, VCC1"	ENSG00000189377	"C-X-C motif chemokine ligand 17"	Q6UXB2	19	42428288-42443048	"Predicted secreted proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 68.0;lung: 83.0;stomach 1: 79.9"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 2: 380.6;Ciliated cells: 365.4;Club cells: 424.2;Pancreatic endocrine cells: 272.5;Urothelial cells: 1358.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.4"	"Group enriched"	"Detected in some"	7	"OE19: 13.0;RT4: 3.9"	"Not detected"	"Not detected"												"Secreted to blood"	NA	NA						"unprognostic (2.74e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.03e-2)"		"unprognostic (4.46e-3)"	"unprognostic (3.77e-1)"	"prognostic favorable (4.92e-5)"	"unprognostic (6.68e-2)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.70e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.13e-3)"	"unprognostic (2.29e-1)"	0.1	0.0	0.1	0.2	0.2	0.0	0.7	0.1	0.1	17.4	0.1	0.4	0.1	0.0	1.0	5.1	68.0	6.3	1.3	0.1	0.1	0.0	0.7	0.4	83.0	0.1	0.1	0.1	2.8	11.4	0.0	2.3	0.1	0.3	6.8	0.0	0.3	39.2	0.5	0.1	0.0	0.1	0.3	0.1	0.1	79.9	0.3	0.1	0.5	1.2	8.8	40.1	5.5	10.0	0.0	0.0	1.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.1	0.3	13.0	0.0	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	32.8	380.6	0.0	160.7	0.0	0.2	0.0	2.5	365.4	424.2	5.2	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0	159.6	0.0	0.0	167.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	4.6	0.0	0.0	272.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1358.9
MSH2	"COCA1, HNPCC, HNPCC1"	ENSG00000095002	"MutS homolog 2"	P43246	2	47402969-47663146	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009572, HPA066845, CAB070867"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes			Nucleoplasm	Vesicles	"CAB009572: AB_2144828, CAB070867: , HPA066845: AB_2732752"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.89e-3)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (1.72e-9)"	"unprognostic (1.77e-1)"	"unprognostic (7.09e-3)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (5.38e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.74e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.48e-1)"	7.3	9.8	14.2	12.2	25.5	11.4	14.1	22.6	18.1	9.4	11.6	7.6	5.6	6.5	10.5	13.3	10.8	11.1	4.9	8.4	13.0	14.0	7.3	5.5	7.1	19.7	12.5	17.0	7.9	8.4	15.3	9.1	9.9	18.5	7.9	13.8	12.3	9.4	7.3	6.7	10.3	8.0	7.8	13.8	9.4	6.7	13.4	13.5	37.0	13.9	6.6	21.4	8.5	7.6	7.4	2.9	3.9	4.2	12.2	12.6	6.2	28.3	9.7	26.5	14.3	2.0	5.6	16.1	16.9	8.4	21.0	20.3	18.2	12.3	34.9	22.8	5.9	14.8	12.1	19.8	9.6	31.7	18.0	14.8	25.1	11.2	16.5	2.0	24.5	8.8	3.1	2.8	17.8	4.8	4.7	11.5	0.8	41.8	8.1	16.0	11.3	28.4	18.5	49.9	17.2	11.5	38.1	47.4	20.4	9.1	15.0	22.0	23.9	14.9	11.6	11.9	22.3	11.6	9.6	4.6	13.9	18.3	14.4	18.8	5.2	18.5	48.9	8.5	18.1	8.6	2.8	1.0	3.9	7.9	4.2	8.6	6.3	7.4	9.5	2.3	7.4	12.6	11.9	0.7	12.2	3.2	2.9	10.1	6.2	14.2	25.5	22.6	18.1	13.0	14.0	12.5	17.0	18.5	13.5	8.9	11.5	13.7	5.7	7.3	16.8	13.8	5.1	25.4	13.6	8.7	43.2	14.2	3.3	9.6	13.1	11.7	4.6	23.3	7.3	16.3	8.7	3.4	11.5	1.0	9.6	11.1	3.4	3.7	4.0	17.6	4.9	4.0	8.5	6.4	9.1	20.0	6.0	5.8	6.0	3.5	38.3	0.0	5.5	34.2	59.5	5.6	4.2	8.7	9.8	2.7
OAS2		ENSG00000111335	"2'-5'-oligoadenylate synthetase 2"	P29728	12	112978395-113011723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 14.9;Endothelial cells: 14.3;Hofbauer cells: 15.1;Kupffer cells: 16.2;Macrophages: 15.1;T-cells: 13.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 72.2;BJ hTERT+ SV40 Large T+ RasG12V: 58.9;SK-MEL-30: 28.2;U-266/70: 26.3;U-266/84: 22.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA003320, CAB024984"	Approved		Approved	Centrosome		NA	NA			Centrosome		"CAB024984: , HPA003320: "	"unprognostic (2.39e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.64e-3)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (4.31e-6)"	"unprognostic (1.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.94e-2)"	37.9	3.8	4.0	13.9	5.1	9.0	7.2	1.8	4.9	8.5	4.3	7.5	1.2	4.6	9.0	6.9	13.2	3.9	9.6	6.9	3.8	4.4	8.8	9.9	15.6	24.1	5.0	3.7	3.9	1.9	1.2	2.9	22.2	7.3	6.6	4.7	6.9	32.9	1.8	2.2	2.9	8.8	6.4	7.1	36.6	9.7	2.2	3.0	32.4	9.8	8.2	27.4	13.7	5.4	12.0	12.7	2.0	26.8	15.1	17.4	13.2	0.7	0.1	0.0	0.0	0.4	2.6	0.0	0.1	8.2	72.2	58.9	0.1	1.2	18.2	1.8	1.5	16.2	0.8	0.1	0.2	2.5	4.5	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	1.3	4.1	0.0	0.0	1.1	0.9	0.0	9.5	0.0	0.3	0.5	1.0	0.0	0.1	2.6	3.9	0.0	2.7	0.0	6.5	0.0	0.0	0.7	0.2	28.2	0.0	0.6	1.1	1.8	0.1	0.0	0.3	0.0	26.3	22.6	2.8	0.6	0.9	0.7	2.0	15.9	1.2	13.4	26.8	16.8	12.0	15.4	15.2	12.7	8.9	15.2	11.2	1.8	15.1	26.0	5.3	17.4	13.2	4.0	5.1	1.8	4.9	3.8	4.4	5.0	3.7	7.3	3.0	3.0	8.9	14.9	1.5	1.8	0.0	1.4	0.0	8.1	3.4	1.8	0.0	0.1	0.0	1.0	0.6	14.3	0.3	0.0	1.0	2.1	2.1	2.4	1.1	1.8	15.1	0.0	0.0	11.1	16.2	0.7	0.6	15.1	5.0	3.6	3.1	0.5	2.3	0.2	3.2	0.0	0.1	0.0	1.0	0.0	0.1	1.0	0.1	13.8	0.1	7.7
VRK2		ENSG00000028116	"Vaccinia related kinase 2"	Q86Y07	2	57907651-58159920	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046459, HPA047503"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB046459: AB_1858773, HPA047503: AB_2680071"	"unprognostic (1.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (3.90e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (3.48e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.56e-1)"	18.7	17.7	10.9	21.9	28.3	14.9	16.1	2.4	15.1	15.6	13.5	27.3	16.3	9.9	18.4	16.7	26.8	13.2	10.9	21.6	14.4	8.9	12.4	15.2	15.6	19.5	29.2	13.5	14.2	20.0	16.1	18.7	16.1	18.7	15.7	15.6	9.3	20.5	17.6	21.5	12.8	12.9	20.1	19.0	20.1	13.5	12.5	31.2	13.6	17.4	16.7	23.0	18.1	19.4	19.7	17.0	21.6	21.3	11.3	12.2	9.2	14.2	9.5	1.1	6.3	7.1	13.1	19.7	13.2	13.2	9.1	9.3	19.4	15.1	17.4	17.4	11.6	15.0	10.9	13.8	14.4	13.7	31.2	9.3	19.6	7.7	13.8	11.3	16.6	11.7	7.2	17.2	14.6	21.1	10.9	26.2	2.4	19.2	11.2	15.2	8.2	0.1	12.7	12.0	22.6	4.8	19.0	4.8	11.8	15.1	11.7	3.8	0.1	20.9	12.5	10.5	10.9	8.8	10.2	14.6	0.2	30.3	8.2	0.2	16.5	13.0	9.3	7.4	20.6	15.0	13.7	16.8	21.6	10.1	21.3	12.2	19.7	9.8	11.8	16.6	19.0	7.4	9.5	6.0	11.3	20.6	17.0	11.5	9.2	10.9	28.3	2.4	15.1	14.4	8.9	29.2	13.5	18.7	31.2	20.8	9.1	14.1	11.3	8.8	1.0	17.1	10.2	30.8	15.9	17.4	0.0	19.7	13.3	22.0	16.8	15.0	2.9	46.7	22.8	18.5	8.5	8.1	16.3	6.8	17.1	0.0	6.3	4.9	17.7	6.5	5.5	21.4	10.1	49.5	4.3	4.6	21.8	7.8	5.6	7.1	3.6	6.5	13.7	8.3	12.6	7.3	16.2	12.7	7.1	12.2
ARPC3	"ARC21, p21-Arc"	ENSG00000111229	"Actin related protein 2/3 complex subunit 3"	O15145	12	110434825-110450422	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006550	Approved		Uncertain	Nucleoplasm		NA	NA		38000000	Nucleoplasm		"HPA006550: AB_1854869"	"unprognostic (1.83e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.15e-1)"	"unprognostic (4.26e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.10e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (9.96e-2)"	"prognostic unfavorable (2.22e-11)"	"unprognostic (3.00e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.79e-3)"	47.9	50.5	47.4	65.2	50.0	123.1	65.3	21.3	61.0	40.2	58.9	29.4	31.4	47.2	35.9	56.9	88.1	32.4	49.4	39.7	44.6	39.1	64.3	54.0	86.0	143.3	41.1	38.0	27.6	51.5	23.8	41.9	58.4	34.4	34.4	63.9	23.1	51.2	37.6	23.9	35.5	52.2	40.1	49.6	93.9	47.8	29.3	35.0	65.7	38.6	49.8	99.3	61.6	47.2	59.7	83.9	136.8	111.0	33.9	50.9	102.9	48.8	39.2	35.1	21.9	36.5	69.6	46.4	55.6	60.8	66.7	65.6	42.1	39.1	70.9	41.6	61.1	41.2	38.3	37.8	57.0	72.8	40.9	46.1	61.3	17.4	40.7	59.9	60.5	96.3	48.8	61.9	42.2	39.2	83.7	82.9	49.1	38.8	19.4	82.2	38.6	72.2	149.3	34.1	57.1	47.3	56.4	20.3	60.1	115.7	62.7	39.1	39.0	37.4	52.7	46.2	53.7	85.2	102.4	69.8	40.2	22.6	35.4	38.0	38.5	55.4	99.6	52.7	61.4	47.3	89.4	83.8	134.8	32.1	97.9	29.0	59.7	32.9	35.7	83.9	52.2	24.8	32.1	136.8	33.9	111.0	53.8	50.9	102.9	47.4	50.0	21.3	61.0	44.6	39.1	41.1	38.0	34.4	35.0	175.7	264.9	449.7	241.0	141.6	37.6	43.7	229.3	270.4	177.5	254.7	11.8	446.1	490.7	567.2	84.2	191.2	402.9	140.2	470.4	667.1	173.4	288.5	473.1	161.8	1260.7	50.9	263.3	228.9	810.9	28.3	159.6	1039.3	227.7	769.2	436.5	125.5	569.7	627.8	148.2	609.1	28.3	245.8	164.8	185.1	179.4	150.3	603.5	401.3	343.1	512.2
SNX6		ENSG00000129515	"Sorting nexin 6"	Q9UNH7	14	34561094-34630183	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049374	Approved		Supported	Endosomes,Lysosomes		NA	NA			"Endosomes, Lysosomes"		"HPA049374: AB_2680734"	"unprognostic (1.89e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.36e-3)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.23e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.10e-2)"	35.7	27.0	26.7	23.0	23.2	16.3	29.4	19.0	21.5	20.8	28.1	30.7	17.7	37.0	37.9	18.0	24.9	16.3	21.6	19.0	28.3	22.0	30.4	18.6	17.6	33.5	33.7	18.1	20.7	15.5	61.1	19.1	46.2	26.7	22.3	24.3	14.7	20.1	18.6	20.3	18.3	38.4	23.2	50.9	33.6	20.8	23.1	23.3	28.5	21.5	19.6	21.9	28.5	22.5	30.5	29.4	56.0	43.1	29.8	43.9	45.2	32.2	18.3	21.3	13.8	33.2	68.4	29.9	31.9	35.3	32.9	28.8	17.5	40.3	20.9	26.7	41.8	13.1	22.9	22.5	23.5	57.5	25.6	9.1	12.5	11.1	32.1	28.5	22.1	15.7	43.9	26.0	22.4	32.7	29.2	44.7	14.8	13.5	17.4	43.9	18.6	19.9	10.9	11.6	27.5	21.9	21.3	24.6	21.1	41.9	24.7	16.8	18.0	25.7	22.4	26.7	19.2	28.8	14.4	43.9	23.7	16.9	22.8	20.4	16.1	26.0	23.7	12.9	12.2	26.2	26.7	32.8	39.5	32.3	43.1	41.7	30.5	43.9	37.4	29.4	27.0	33.6	36.0	56.0	29.8	39.7	19.3	42.7	45.2	26.7	23.2	19.0	21.5	28.3	22.0	33.7	18.1	26.7	23.3	80.4	42.5	54.7	53.4	45.6	42.0	62.7	22.9	76.3	52.4	76.8	21.6	143.5	106.1	79.9	5.2	73.9	55.1	23.3	56.6	106.4	65.5	52.4	82.1	29.4	206.3	20.6	50.0	136.9	172.3	6.3	59.5	107.7	59.1	141.5	59.5	62.7	62.3	77.0	89.1	91.4	35.1	58.2	70.0	160.0	174.3	57.5	212.9	78.8	72.5	71.9
ASAP2	"CENTB3, DDEF2, KIAA0400, PAP, SHAG1"	ENSG00000151693	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 2"	O43150	2	9206765-9405683	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"basophil: 6.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018615	Approved		Supported	Cytosol		NA	NA		66000	Cytosol		"CAB018615: AB_2242947"	"unprognostic (1.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (8.33e-2)"	"unprognostic (1.58e-3)"	"unprognostic (3.14e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.24e-2)"	13.7	3.4	7.3	8.2	14.5	0.9	11.7	16.3	13.9	13.8	15.3	8.1	6.8	12.1	19.3	10.5	8.1	10.1	16.5	10.5	8.1	5.6	21.7	3.7	9.0	2.6	10.7	7.3	7.9	7.0	12.4	44.1	9.2	10.8	6.6	14.4	10.7	7.1	8.9	3.3	12.3	13.5	12.6	8.7	1.6	21.6	38.5	7.8	0.1	17.5	6.1	3.3	8.5	11.4	0.0	0.9	6.2	0.0	0.0	0.0	0.3	11.7	6.8	12.6	7.4	9.3	13.0	2.1	11.8	9.6	8.7	8.8	4.7	17.6	0.0	10.5	13.3	19.3	11.3	6.9	20.8	10.9	8.4	2.9	2.7	5.2	9.0	22.7	0.0	0.8	4.8	8.6	10.5	34.4	26.6	18.0	2.2	1.2	1.2	33.9	7.3	3.3	0.7	6.0	17.3	8.1	6.5	18.8	2.2	17.2	9.1	5.6	21.5	9.9	6.6	11.0	7.1	4.5	1.9	28.0	14.8	0.7	11.4	10.8	0.0	0.0	0.0	10.8	0.0	18.8	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	7.3	14.5	16.3	11.6	8.1	5.6	10.7	7.3	10.8	7.8	17.9	8.8	0.0	15.4	33.1	28.4	1.2	7.6	6.7	7.9	33.2	0.0	0.8	43.1	14.8	51.2	28.1	27.6	0.0	12.3	0.3	8.0	16.4	1.1	3.6	9.9	6.4	8.7	38.1	4.9	36.9	2.6	5.8	32.1	11.8	37.5	19.5	38.5	35.1	3.5	23.5	4.6	25.8	24.2	49.4	7.0	28.1	0.3	0.0	18.8	38.4
KCTD3	NY-REN-45	ENSG00000136636	"Potassium channel tetramerization domain containing 3"	Q9Y597	1	215567392-215621807	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 70.8"	"Low region specificity"	"Detected in all"							HPA015142	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA015142: AB_1852174"	"unprognostic (1.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.46e-3)"	"unprognostic (3.91e-2)"	"unprognostic (3.67e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.60e-3)"	"unprognostic (9.27e-2)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (8.94e-6)"	"unprognostic (2.30e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.27e-1)"	"unprognostic (3.31e-3)"	18.4	47.6	17.3	7.3	16.6	7.7	37.5	23.6	16.9	19.8	35.1	24.1	20.3	25.1	22.6	18.4	25.8	12.1	15.7	10.3	17.4	14.4	16.3	39.6	10.9	4.4	18.7	13.1	13.8	18.2	24.5	12.4	18.1	19.5	22.7	16.4	13.9	24.5	17.9	10.0	10.6	35.1	17.1	26.6	7.5	16.6	13.3	15.0	5.3	15.8	11.0	9.2	18.1	21.9	2.6	2.6	3.3	2.1	2.5	1.3	0.6	15.7	11.4	12.9	7.5	11.0	18.6	17.9	13.0	12.2	11.6	12.2	10.0	26.4	4.4	7.3	13.5	3.5	15.5	13.5	13.3	13.4	2.4	14.1	7.9	22.0	14.0	9.1	8.0	1.5	17.1	9.3	14.8	11.3	14.7	10.5	5.9	15.3	4.3	12.7	13.7	3.4	4.2	21.7	22.9	14.6	5.3	18.3	17.1	13.6	10.7	15.3	17.1	20.2	29.6	11.0	17.0	70.8	10.4	9.4	11.7	11.6	14.3	14.8	3.9	5.3	1.5	9.1	4.2	8.8	1.8	2.1	1.0	1.0	1.1	0.8	1.6	1.1	1.0	2.0	2.6	1.2	1.3	3.3	2.5	1.0	2.6	0.6	0.6	17.3	16.6	23.6	16.2	17.4	14.4	18.7	13.1	19.5	15.0	8.9	12.3	5.1	20.2	16.0	27.6	12.2	20.4	16.0	21.6	10.4	17.7	22.5	19.9	19.6	1.1	12.1	16.9	0.0	18.1	13.1	21.6	24.9	4.7	56.2	6.9	17.5	38.1	19.0	10.5	2.0	25.6	5.8	15.1	4.6	38.5	19.2	13.9	22.0	21.2	23.7	22.3	25.8	16.5	6.7	16.1	15.4	14.6	1.7	24.8	37.9
TMEM41A	MGC15397	ENSG00000163900	"Transmembrane protein 41A"	Q96HV5	3	185476496-185499057	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 54.4"	"Cell type enhanced"	"Detected in many"	4	"monocytes: 100.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA059101, HPA059790"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059101: AB_2683905, HPA059790: AB_2684125"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (6.70e-6)"	"unprognostic (2.67e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.84e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (3.63e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.02e-2)"	8.1	23.9	7.8	4.8	10.2	9.3	10.1	4.9	11.5	10.6	26.8	11.7	6.3	24.5	9.1	11.1	20.6	9.0	8.6	8.3	7.5	8.4	15.8	26.1	11.3	9.0	8.1	5.4	14.2	10.7	6.7	5.7	9.0	8.6	10.1	8.6	11.9	11.2	9.4	8.3	16.6	54.4	8.0	8.7	12.4	8.7	11.2	7.4	11.3	9.0	18.1	16.7	8.8	12.5	12.8	16.4	7.8	8.4	8.5	16.7	6.5	20.9	7.6	5.1	6.2	8.1	8.7	15.0	8.1	7.1	10.2	7.5	19.8	8.3	6.5	15.5	7.5	14.5	14.6	14.0	8.6	10.4	10.9	12.9	11.3	4.6	19.9	9.0	12.1	6.4	8.1	12.9	9.2	10.6	6.5	7.8	8.3	20.0	16.3	6.5	8.1	7.4	7.0	8.4	16.6	12.1	7.5	7.8	11.9	8.8	15.4	5.1	6.6	7.0	18.0	12.3	7.6	21.5	9.5	5.6	6.1	7.6	12.6	16.8	24.0	36.6	13.1	9.3	7.3	7.3	7.8	6.3	5.1	13.2	6.6	16.7	12.8	13.6	14.3	7.0	12.4	15.0	16.1	2.4	8.5	8.4	16.4	11.1	6.5	7.8	10.2	4.9	11.5	7.5	8.4	8.1	5.4	8.6	7.4	8.9	26.2	17.6	29.0	47.2	17.7	11.3	22.9	4.0	14.8	19.2	17.7	23.4	6.6	28.6	0.4	17.9	38.7	0.0	48.5	20.2	16.7	43.7	8.1	34.2	16.5	15.9	17.9	14.1	11.1	1.8	13.3	14.3	8.5	100.0	26.4	14.6	45.8	15.9	12.7	22.4	29.5	19.4	17.2	23.7	14.2	74.0	38.4	15.2	30.8	81.8
NCBP2	"Cbc2, CBP20, NIP1"	ENSG00000114503	"Nuclear cap binding protein subunit 2"	P52298	3	196935402-196942597	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044850, HPA062483"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044850: AB_10961012, HPA062483: AB_2684779"	"unprognostic (1.82e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.12e-3)"	"unprognostic (3.17e-1)"	"unprognostic (5.13e-3)"	"prognostic unfavorable (2.37e-7)"	"unprognostic (2.86e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (4.75e-4)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (3.28e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.30e-2)"	"unprognostic (5.04e-3)"	27.6	34.5	39.4	26.8	42.1	11.4	35.6	33.4	37.8	28.0	25.4	17.9	25.2	21.8	26.6	32.1	23.1	24.9	22.5	22.6	37.5	33.3	31.9	21.6	20.3	37.6	33.5	28.9	30.8	27.8	28.3	30.4	25.4	31.4	28.3	26.1	18.7	19.8	27.8	41.8	20.1	19.9	33.7	39.0	24.3	21.3	20.4	31.3	24.9	29.8	19.3	30.5	27.5	23.7	26.1	19.1	9.7	20.8	19.6	28.9	17.6	35.7	11.6	26.9	34.0	30.8	27.0	19.3	27.0	20.1	17.1	17.8	25.4	13.0	23.9	60.4	18.8	22.1	21.8	34.5	29.3	26.7	12.6	22.7	31.2	13.5	21.1	27.3	36.4	21.8	21.6	25.3	12.4	35.0	25.6	26.2	26.3	17.6	25.5	28.6	41.6	27.0	22.4	34.3	33.9	37.6	21.3	20.6	22.6	24.8	25.0	15.2	40.3	16.9	32.5	47.1	22.4	72.1	29.0	24.8	17.7	18.8	21.8	48.5	39.3	36.3	41.1	24.1	41.2	26.9	3.8	18.1	9.7	19.2	20.8	28.9	26.1	23.5	22.5	19.1	20.5	27.3	24.4	2.3	19.6	20.1	15.5	20.8	17.6	39.4	42.1	33.4	35.7	37.5	33.3	33.5	28.9	31.4	31.3	23.8	35.0	86.4	59.4	46.6	55.7	35.2	20.4	37.5	50.0	40.1	55.0	50.6	82.9	57.9	91.7	48.0	33.3	0.0	43.2	65.3	43.0	45.0	51.9	29.2	58.3	42.9	43.3	31.9	50.5	46.4	34.8	49.6	30.4	71.3	40.2	72.8	56.6	43.0	48.4	59.3	55.3	25.8	53.0	32.3	58.0	39.1	44.5	49.8	42.2	83.5
KIF13B	"GAKIN, KIAA0639"	ENSG00000197892	"Kinesin family member 13B"	Q9NQT8	8	29067279-29263124	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 40.5;parathyroid gland: 107.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025023, HPA049655"	Enhanced					NA	NA					"HPA025023: AB_1852471, HPA049655: AB_2732555"	"unprognostic (1.37e-1)"	"unprognostic (4.31e-1)"	"prognostic favorable (8.92e-4)"	"unprognostic (1.35e-3)"	"unprognostic (2.27e-1)"	"prognostic favorable (6.26e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-2)"	"unprognostic (9.69e-2)"	"prognostic unfavorable (4.77e-4)"	"unprognostic (9.76e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.19e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.27e-1)"	7.4	10.5	12.3	8.2	21.5	4.8	8.7	3.2	13.8	8.6	15.1	40.5	15.4	13.6	6.1	9.1	6.9	7.1	10.5	4.6	16.5	10.4	16.3	12.5	7.6	4.3	25.9	7.1	7.2	9.7	107.1	10.2	4.4	22.0	10.0	12.2	4.9	12.9	8.9	3.9	15.2	18.0	7.3	29.3	7.7	15.6	6.1	25.1	4.2	8.4	5.1	7.9	9.4	5.9	2.9	5.4	4.1	3.8	2.0	4.1	1.0	9.0	9.9	3.5	2.9	5.8	3.4	5.1	0.5	2.2	3.0	4.9	6.1	5.2	1.9	5.3	0.6	5.5	6.2	2.8	1.6	3.8	2.9	2.7	4.8	1.4	6.1	5.7	1.3	14.9	3.9	3.0	6.7	2.8	6.4	13.0	3.7	6.1	7.3	9.7	2.8	7.0	2.2	1.7	12.9	1.7	4.0	8.1	3.6	13.0	9.9	1.0	6.9	1.8	6.1	8.6	3.8	4.5	2.7	17.1	2.1	5.9	0.6	4.0	5.3	7.8	3.2	12.7	2.5	10.0	0.3	3.8	4.1	4.1	2.9	2.0	2.9	1.6	2.4	1.2	2.0	1.3	1.7	2.0	2.0	1.4	5.4	1.5	1.0	12.3	21.5	3.2	13.8	16.5	10.4	25.9	7.1	22.0	25.1	41.7	19.0	8.9	14.4	3.9	12.5	4.1	22.9	33.5	30.7	33.2	56.9	4.9	10.0	19.8	4.0	10.0	53.6	0.0	22.0	0.7	8.9	33.6	38.3	14.8	7.8	15.9	24.2	11.6	18.3	2.1	7.5	8.3	6.8	8.2	34.7	8.4	28.2	39.3	19.1	13.9	25.5	6.5	5.6	5.8	7.2	5.9	4.2	10.0	22.4	26.4
PAIP1		ENSG00000172239	"Poly(A) binding protein interacting protein 1"	Q9H074	5	43526267-43557758	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA073653, HPA076187"	Approved		Enhanced	"Plasma membrane,Cytosol"		No	No		18000	"Plasma membrane, Cytosol"		"HPA073653: AB_2732234, HPA076187: AB_2686784"	"unprognostic (4.70e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (3.54e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.30e-1)"	30.1	26.6	26.9	15.4	26.0	20.6	35.9	22.7	32.6	30.2	27.8	25.0	19.6	18.3	28.4	26.0	26.1	22.8	23.3	45.6	26.8	24.4	34.0	38.3	21.3	20.8	28.6	21.5	24.8	23.5	30.9	24.0	29.0	23.0	32.1	24.3	21.3	23.4	31.7	62.8	16.6	24.2	38.7	33.4	21.0	23.8	44.3	27.3	29.9	38.5	20.6	18.6	31.5	36.8	14.1	35.0	23.4	12.4	12.5	16.4	10.9	22.3	19.9	39.1	37.8	41.0	32.5	32.0	19.7	44.0	37.6	32.8	18.5	27.5	14.9	34.2	27.8	56.7	14.7	60.9	23.8	38.5	12.3	23.6	11.7	39.9	29.1	36.2	17.4	18.5	34.4	46.1	25.4	48.0	38.3	35.8	11.1	27.0	20.2	37.5	24.0	19.2	24.1	19.3	21.3	25.7	15.1	29.5	20.8	46.7	27.6	22.2	33.7	63.2	24.4	43.7	37.5	34.8	25.4	19.9	34.2	28.4	17.0	24.7	15.3	25.8	22.3	19.9	27.1	29.4	17.4	12.4	23.4	10.5	10.4	14.0	14.1	13.1	14.5	12.4	13.2	16.4	13.0	4.6	12.5	11.1	35.0	11.4	10.9	26.9	26.0	22.7	32.6	26.8	24.4	28.6	21.5	23.0	27.3	29.8	43.3	27.5	65.7	65.1	49.0	115.4	68.8	36.1	22.7	41.8	19.6	65.0	134.3	105.9	128.9	65.0	26.0	0.0	80.1	76.8	67.2	70.0	23.2	46.9	51.3	33.4	43.1	41.7	35.2	40.9	70.8	42.8	79.2	64.1	51.5	68.8	98.5	49.1	62.6	115.0	51.4	25.8	65.1	136.3	84.8	58.1	57.0	27.4	45.2	69.7
PLS1	"I-plastin, Plastin-1"	ENSG00000120756	"Plastin 1"	Q14651	3	142596387-142713664	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"intestine: 193.0"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 327.0;Mucus-secreting cells: 111.2;Paneth cells: 126.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 4.9;NK-cells: 5.9;T-cells: 5.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 33.7;OE19: 48.1;RPTEC TERT1: 43.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA055744, HPA061936"	Enhanced					NA	NA		50000000			"HPA055744: AB_2682903, HPA061936: "	"unprognostic (1.29e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.15e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (3.14e-2)"	"prognostic favorable (8.76e-6)"	"unprognostic (1.99e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.82e-2)"	0.5	2.3	1.0	8.2	1.0	1.0	1.7	1.5	2.0	2.0	42.3	0.6	0.2	40.0	0.5	1.1	5.7	1.3	6.3	0.9	1.2	1.1	12.5	10.6	4.4	0.3	0.9	1.0	0.6	5.0	3.8	13.6	0.8	4.5	1.8	30.0	2.9	5.3	0.9	0.5	1.2	193.0	0.6	1.2	0.5	9.6	2.6	0.5	2.5	3.7	1.3	1.6	5.1	2.3	0.7	0.9	4.9	0.4	5.9	5.0	1.8	25.7	20.3	1.4	3.1	0.2	0.0	33.7	0.5	0.7	2.8	6.1	9.2	20.3	4.4	10.8	0.1	9.6	5.5	5.5	8.4	6.0	1.5	8.0	7.8	3.2	3.3	0.2	3.7	0.5	0.0	1.4	5.3	3.4	4.5	1.3	4.8	3.3	0.5	0.3	6.0	6.0	2.0	5.6	48.1	7.6	2.5	6.1	3.6	43.1	23.9	7.2	2.9	2.9	2.1	2.3	4.1	16.6	0.6	0.3	0.3	3.4	1.0	6.2	3.8	3.5	5.1	0.9	3.7	1.0	3.4	0.4	4.9	2.9	0.3	3.8	0.7	3.5	3.8	0.7	0.6	4.3	5.0	3.3	5.9	0.4	0.9	2.1	1.8	1.0	1.0	1.5	2.0	1.2	1.1	0.9	1.0	4.5	0.5	50.6	29.4	4.7	3.1	2.6	2.4	2.4	43.3	40.2	51.2	41.8	15.7	4.9	18.3	15.2	52.6	0.4	327.0	0.0	29.7	1.6	0.5	7.8	9.2	28.7	0.6	4.8	51.8	1.3	0.6	12.6	1.1	1.3	1.7	1.0	111.2	2.8	50.2	126.2	0.0	34.0	12.5	0.0	0.8	5.1	3.6	2.9	1.1	0.0	65.5	9.7
UBE2L6	UBCH8	ENSG00000156587	"Ubiquitin conjugating enzyme E2 L6"	O14933	11	57551656-57568284	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hofbauer cells: 148.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003328, CAB073407"	Enhanced		Approved	Cytosol		NA	NA		34000	Cytosol		"CAB073407: , HPA003328: AB_1858539"	"prognostic favorable (6.75e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.37e-3)"	"prognostic unfavorable (4.88e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.42e-2)"	31.1	31.0	32.0	34.1	28.6	30.4	40.4	18.2	25.6	23.3	19.1	17.0	17.1	19.0	21.9	30.0	19.9	28.6	27.4	18.4	23.5	27.4	28.3	55.1	50.5	45.0	28.9	20.4	27.1	21.8	17.9	18.5	21.7	25.8	26.0	18.8	18.7	42.8	22.2	10.1	15.9	23.5	28.3	23.6	47.9	21.4	7.7	23.6	44.0	33.6	15.1	34.4	33.0	49.0	49.2	53.6	113.6	83.4	61.2	66.4	112.6	8.7	4.4	15.0	4.7	31.7	39.5	1.6	5.1	30.5	45.2	58.9	1.6	22.8	28.1	18.1	15.5	39.1	7.0	6.4	16.8	9.6	25.5	0.2	27.6	0.0	6.3	58.7	6.3	9.2	42.2	3.9	21.2	5.8	16.8	14.2	29.7	1.2	19.5	8.1	11.1	42.6	15.3	3.9	0.0	5.6	37.7	9.1	19.2	12.1	9.8	0.3	7.8	10.2	0.8	22.4	2.7	11.2	3.2	5.2	9.4	3.3	7.1	1.6	26.6	26.8	0.5	26.4	16.0	2.0	56.7	71.6	62.5	51.2	83.4	56.4	49.2	53.4	53.4	53.6	39.7	46.5	48.8	113.6	61.2	68.3	34.0	66.4	112.6	32.0	28.6	18.2	25.6	23.5	27.4	28.9	20.4	25.8	23.6	26.8	17.4	54.4	23.2	20.7	10.2	5.2	28.1	24.1	27.3	12.2	3.9	3.0	54.7	68.9	3.6	46.7	22.7	23.3	57.3	31.0	37.7	34.1	53.1	27.3	148.0	12.7	23.0	41.1	54.9	9.6	44.5	69.1	8.5	44.1	29.8	31.5	45.0	31.7	31.5	19.8	3.9	25.8	41.2	1.9	6.0	24.2	2.9	74.7	21.7	24.6
C6orf132	bA7K24.2	ENSG00000188112	"Chromosome 6 open reading frame 132"	Q5T0Z8	6	42101118-42142619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 66.1;lymphoid tissue: 54.3;tongue: 49.3"	"Cell type enhanced"	"Detected in many"	7	"Exocrine glandular cells: 118.2;Glandular cells: 119.1;Pancreatic endocrine cells: 145.1;Urothelial cells: 193.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 20.6;CACO-2: 18.8;CAPAN-2: 15.6;OE19: 61.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044588	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA044588: AB_10794293"	"unprognostic (7.09e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (4.90e-4)"	"unprognostic (1.31e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	1.3	0.5	0.2	3.7	0.2	0.2	4.2	0.3	0.3	13.3	20.9	0.2	1.4	15.7	0.7	1.2	66.1	2.6	15.5	0.5	0.2	0.1	6.2	0.6	5.9	0.2	0.2	0.2	1.4	20.8	1.1	2.2	3.1	0.2	6.8	5.3	0.2	16.6	4.0	1.2	24.8	37.2	0.7	0.2	0.2	16.2	0.4	0.2	0.6	12.5	49.3	54.3	4.8	17.5	2.1	1.9	3.5	1.3	0.9	1.2	0.7	20.6	0.2	0.0	0.0	0.1	2.4	10.2	1.2	1.5	2.9	3.0	18.8	15.6	0.0	2.2	2.0	0.0	13.9	0.0	6.2	1.9	1.7	2.9	1.0	1.8	4.2	0.7	0.0	0.0	1.4	11.7	2.2	3.3	1.1	0.0	0.1	0.5	0.2	0.6	7.2	0.2	0.1	1.4	61.4	0.5	0.0	0.0	0.1	2.2	9.3	1.1	0.0	1.8	12.6	0.0	1.5	9.2	0.1	0.3	0.1	1.3	5.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.9	1.3	1.7	0.8	0.8	0.6	1.0	0.8	0.8	1.4	2.1	0.9	1.2	3.5	0.9	0.5	1.9	0.5	0.7	0.2	0.2	0.3	0.3	0.2	0.1	0.2	0.2	0.2	0.2	41.7	17.6	0.0	50.1	46.6	0.8	3.6	40.8	61.6	53.4	48.8	19.6	10.6	0.0	41.6	12.9	0.5	80.5	0.0	118.2	0.5	8.4	119.1	1.1	0.0	0.7	4.8	7.0	1.8	1.6	91.9	0.6	1.2	11.8	5.4	33.6	0.5	145.1	43.5	1.4	5.6	7.4	0.0	2.1	4.3	8.3	71.6	3.4	2.2	37.9	193.5
EIF2S1	"EIF-2alpha, EIF2, EIF2A"	ENSG00000134001	"Eukaryotic translation initiation factor 2 subunit alpha"	P05198	14	67359997-67386516	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 211.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011663, HPA064885"	Supported		Enhanced	Cytosol		NA	NA		52000	Cytosol		"CAB011663: AB_2096478, HPA064885: AB_2685382"	"unprognostic (1.86e-2)"	"unprognostic (8.33e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (4.73e-7)"	"unprognostic (4.14e-3)"	"unprognostic (4.49e-1)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (4.97e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.65e-1)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (7.11e-4)"	35.5	26.2	18.7	24.8	26.3	18.9	22.5	18.9	30.6	17.8	25.7	16.3	16.1	18.5	22.9	18.0	34.8	18.4	19.1	27.9	21.9	17.0	23.8	45.0	21.1	24.1	19.9	20.8	22.9	27.8	21.3	16.3	28.0	24.1	24.4	24.2	12.6	19.9	21.0	52.0	23.8	18.4	30.9	18.9	22.8	22.9	29.1	15.1	27.3	29.0	29.9	28.0	31.1	23.1	26.6	32.9	17.3	32.7	25.7	29.2	30.2	67.4	22.5	15.9	24.4	15.4	17.4	34.1	30.2	18.0	34.1	29.9	26.3	24.2	30.5	15.3	22.7	23.0	26.2	36.6	28.8	52.1	22.2	13.7	19.7	22.0	18.0	16.2	20.9	19.3	14.1	16.8	30.4	46.6	13.4	27.7	19.3	33.4	23.7	33.6	33.5	28.5	16.4	16.2	40.6	37.8	21.9	26.4	21.7	20.9	31.1	23.0	16.2	21.7	25.6	23.3	14.7	43.6	18.2	21.1	45.2	48.8	21.8	32.0	20.6	22.4	46.1	26.2	37.5	29.0	17.3	24.2	14.8	23.9	32.7	29.1	26.6	27.9	25.7	32.9	21.3	26.0	26.5	3.3	25.7	27.4	22.5	29.2	30.2	18.7	26.3	18.9	30.6	21.9	17.0	19.9	20.8	24.1	15.1	26.8	38.1	35.0	67.4	126.8	22.8	84.7	33.1	26.8	44.3	21.0	11.8	70.2	59.7	77.0	64.0	51.3	22.3	0.0	54.6	82.1	48.2	40.6	34.6	38.0	62.8	35.0	12.5	23.9	39.6	23.3	28.7	43.9	49.0	66.7	24.0	20.9	60.9	11.5	38.2	53.2	26.2	25.8	78.5	211.8	73.9	114.0	78.1	41.7	33.8	65.0
MPZL3		ENSG00000160588	"Myelin protein zero like 3"	Q6UWV2	11	118226690-118252350	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Suprabasal keratinocytes: 55.8;Urothelial cells: 36.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 11.4;eosinophil: 33.0;MAIT T-cell: 10.6;neutrophil: 30.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 33.0;T-cells: 10.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.7;HMC-1: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029116			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA029116: AB_10610142"	"unprognostic (2.54e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.52e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.86e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (4.86e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.90e-1)"	"prognostic favorable (3.64e-4)"	"unprognostic (1.20e-1)"	3.5	0.7	0.8	3.6	3.0	5.2	7.1	6.9	1.4	9.2	5.5	0.5	8.4	4.3	5.2	6.8	28.5	4.4	8.7	1.4	0.8	1.0	4.7	9.4	10.6	4.4	0.8	0.4	1.5	9.0	7.4	12.4	2.6	2.4	5.3	5.1	1.4	19.6	11.1	1.0	23.1	8.3	1.5	1.2	5.4	5.6	2.6	0.4	5.8	7.3	27.1	32.6	6.5	12.8	0.6	2.8	33.0	2.1	2.8	10.6	1.7	3.2	0.4	0.0	0.5	0.0	0.0	0.5	0.4	0.0	0.0	0.1	11.1	17.7	3.2	8.6	0.0	1.3	4.6	0.8	3.7	0.1	0.2	1.3	2.0	0.9	5.3	0.1	2.6	20.0	0.2	9.4	0.0	3.7	0.0	6.0	2.2	2.5	1.8	0.0	11.2	1.2	1.4	1.6	10.9	0.8	0.0	0.0	4.8	6.8	4.2	2.3	0.2	4.4	5.8	0.3	0.9	10.5	1.4	2.8	0.1	0.9	0.0	0.1	0.3	3.2	2.0	0.1	0.1	0.2	11.4	2.1	33.0	2.6	1.2	10.6	0.6	4.2	3.5	2.8	0.6	3.2	2.5	30.6	2.8	0.8	0.3	2.8	1.7	0.8	3.0	6.9	1.4	0.8	1.0	0.8	0.4	2.4	0.4	14.9	24.0	0.8	20.0	31.6	0.3	1.4	5.1	22.7	9.1	8.7	2.0	0.6	0.0	9.4	6.5	3.8	10.6	0.0	7.5	0.5	1.7	30.2	1.1	6.6	1.1	0.0	11.5	0.6	6.8	4.9	0.0	6.9	10.1	0.0	4.0	0.3	12.7	7.0	0.4	0.6	1.6	0.0	2.0	0.5	1.1	55.8	1.4	26.1	6.7	36.6
AADAC	"CES5A1, DAC"	ENSG00000114771	"Arylacetamide deacetylase"	P22760	3	151814037-151828488	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 66.2;intestine: 81.7;liver: 123.1"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 610.4"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 153.4"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 11.9;ASC diff: 4.5;EFO-21: 6.4;HBEC3-KT: 5.7"	"Not detected"	"Not detected"							HPA002911	Approved					NA	NA					"HPA002911: AB_1078074"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.41e-2)"		"unprognostic (9.23e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (5.58e-6)"	"prognostic unfavorable (5.02e-4)"			"prognostic unfavorable (2.19e-4)"	"unprognostic (1.22e-1)"		"unprognostic (1.27e-1)"	3.9	66.2	0.1	0.1	1.6	0.0	2.1	0.1	0.1	0.1	26.1	0.5	0.4	29.6	0.1	0.3	0.3	0.2	4.3	0.2	0.1	0.0	0.1	123.1	1.7	0.1	0.1	0.1	0.1	22.7	0.0	0.1	1.7	0.2	0.3	0.0	0.1	0.3	0.1	0.2	1.7	81.7	0.1	0.1	0.1	7.3	0.3	0.1	0.1	0.2	4.8	1.3	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	4.5	0.2	0.3	0.0	0.0	0.1	0.0	1.1	0.1	0.2	6.4	0.0	0.1	0.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.7	0.1	0.1	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.3	0.2	1.4	0.3	0.2	0.4	2.1	0.0	2.3	0.2	1.9	0.3	0.1	0.0	0.0	0.0	0.0	2.5	0.0	2.4	1.4	0.0	0.4	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	11.0	0.0	0.0	0.2	0.0	1.1	58.6	4.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.2	0.0	0.0	610.4	0.2	0.0	0.0	3.7	10.8	0.0	0.0	0.0	3.3	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.2	0.0	0.0	0.1
WDR76	FLJ12973	ENSG00000092470	"WD repeat domain 76"	Q9H967	15	43826963-43868419	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 37.2"	"Cell type enhanced"	"Detected in many"	10	"Spermatogonia: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039804, HPA040626"	Uncertain		Approved	"Nucleoli fibrillar center,Nuclear bodies"		NA	Yes			"Nuclear bodies"	"Nucleoli fibrillar center"	"HPA039804: AB_10795297, HPA040626: AB_10795527"	"unprognostic (2.26e-1)"	"unprognostic (7.56e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (6.98e-4)"	"prognostic unfavorable (8.02e-5)"	"unprognostic (4.24e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (1.35e-8)"	"unprognostic (7.71e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.28e-2)"	5.4	1.8	2.4	21.9	3.0	17.5	4.8	12.9	6.0	5.3	6.3	1.5	1.6	3.6	4.9	3.6	8.2	3.3	2.1	2.5	2.4	2.0	2.8	2.5	5.1	19.8	2.4	2.1	4.2	4.8	3.9	3.3	4.3	3.3	4.2	6.8	4.5	4.6	2.4	1.4	6.3	5.8	7.0	3.9	6.5	4.8	6.7	2.1	37.2	2.9	7.1	21.9	5.3	5.5	3.2	1.6	0.4	0.8	5.7	8.3	2.6	11.1	5.7	13.6	10.4	1.5	3.7	3.7	18.8	11.2	20.6	26.0	7.2	5.9	16.5	8.3	8.7	10.4	16.2	14.0	6.7	18.0	25.6	8.3	20.3	18.2	2.3	0.8	20.6	9.1	1.1	1.1	11.3	2.6	3.0	6.5	17.9	15.3	28.9	14.1	3.9	19.9	4.8	4.8	3.5	5.9	21.4	23.4	10.4	3.8	11.6	10.5	10.4	11.8	7.5	2.3	4.4	11.6	10.0	2.9	19.0	9.0	21.2	19.0	14.3	35.6	42.1	13.6	18.3	10.4	0.0	0.8	0.4	5.1	0.5	5.4	2.5	6.4	4.4	1.3	3.2	5.2	4.1	0.0	5.7	0.2	1.6	8.3	2.6	2.4	3.0	12.9	6.0	2.4	2.0	2.4	2.1	3.3	2.1	3.0	2.2	6.0	3.1	6.5	2.0	1.2	0.0	0.0	3.4	1.8	9.8	5.5	1.7	2.0	1.5	3.5	0.8	0.0	3.5	11.4	2.5	1.6	5.7	0.4	7.5	1.6	0.0	3.1	3.3	0.6	1.7	3.1	3.3	3.6	2.2	7.3	0.9	1.5	2.1	0.6	15.7	6.5	5.3	8.7	44.7	5.1	3.0	10.9	5.6	1.3
FGFBP1	"FGFBP, HBP17"	ENSG00000137440	"Fibroblast growth factor binding protein 1"	Q14512	4	15935569-15938740	"Cancer-related genes, Predicted secreted proteins"		"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 106.6;lymphoid tissue: 56.8;tongue: 133.1"	"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 927.5;Suprabasal keratinocytes: 687.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 246.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 79.0;HBEC3-KT: 136.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA004332	Enhanced				"Secreted in other tissues"	NA	NA					"HPA004332: AB_1078856"	"unprognostic (2.87e-3)"	"unprognostic (3.55e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.99e-2)"		"unprognostic (1.86e-2)"		"unprognostic (1.97e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (5.03e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.31e-3)"	0.2	0.0	0.2	0.6	0.2	0.0	4.1	0.2	0.2	27.1	5.1	0.2	0.2	0.4	1.1	0.2	106.6	0.1	0.3	0.2	0.2	0.0	0.3	0.2	1.9	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.7	0.2	0.3	4.6	0.4	14.1	0.2	0.2	14.6	1.3	0.3	0.2	0.2	0.5	0.2	0.2	0.2	0.3	133.1	56.8	1.8	31.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	20.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.0	1.5	0.0	0.0	79.0	0.0	136.8	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	20.3	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	10.7	0.0	0.0	0.0	13.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	3.0	5.9	0.0	92.0	927.5	0.0	0.0	0.0	37.5	51.2	0.0	0.0	0.1	0.0	10.2	0.0	0.0	32.6	0.0	6.6	0.0	6.1	13.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	70.9	1.0	12.3	0.0	81.1	20.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	687.3	1.9	0.0	8.4	179.5
C19orf33	"H2RSP, IMUP, IMUP-1, IMUP-2"	ENSG00000167644	"Chromosome 19 open reading frame 33"	Q9GZP8	19	38304161-38305009	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.4;intestine: 105.8;tongue: 78.5"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 1588.2;Exocrine glandular cells: 683.1;Mucus-secreting cells: 800.2;Pancreatic endocrine cells: 1532.5;Paneth cells: 1006.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	11	"myeloid DC: 15.1"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 15.1"	"Cell line enhanced"	"Detected in some"		"A-431: 70.1;A549: 108.2;CAPAN-2: 66.8;HBEC3-KT: 64.8;hTCEpi: 67.9;OE19: 57.5;PC-3: 61.8"									"HPA054406, HPA059696"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA054406: AB_2682478, HPA059696: AB_2684105"	"unprognostic (9.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.63e-2)"	"unprognostic (6.01e-2)"	6.9	0.6	0.5	16.4	0.7	0.3	5.0	0.5	0.8	14.5	58.8	0.6	3.5	34.6	3.9	4.3	88.4	18.2	45.2	9.9	0.8	0.3	5.8	1.0	34.8	0.6	0.7	1.4	4.9	0.8	0.0	2.0	10.0	1.7	10.3	18.2	1.2	21.5	6.8	2.8	53.3	105.8	2.9	3.1	1.9	28.7	1.5	0.5	1.5	4.4	78.5	39.2	16.2	35.1	0.1	15.1	1.4	0.6	0.3	0.4	14.6	70.1	108.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	66.8	0.0	40.1	0.0	0.0	26.3	0.0	64.8	0.0	0.0	0.0	0.0	22.7	1.8	0.5	0.0	0.0	0.0	67.9	0.0	43.6	0.1	1.1	0.0	0.0	0.0	0.0	18.1	0.0	0.1	0.1	57.5	61.8	0.0	0.0	0.0	41.0	20.8	0.1	0.0	41.0	29.7	0.0	0.1	9.2	0.2	14.6	0.0	20.4	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	1.1	0.6	1.4	0.3	0.0	0.3	0.1	0.2	0.1	15.1	0.1	0.4	0.3	0.9	0.3	0.0	0.9	0.0	14.6	0.5	0.7	0.5	0.8	0.8	0.3	0.7	1.4	1.7	0.5	497.3	155.5	7.0	25.1	200.2	0.0	1.4	298.1	195.4	353.8	52.4	0.0	5.2	1.7	144.5	0.4	9.8	1588.2	0.0	683.1	1.0	5.6	22.7	39.1	0.0	1.3	0.0	73.3	4.9	1.6	2.8	3.7	8.2	1.7	4.6	800.2	0.0	1532.5	1006.5	0.0	21.6	0.0	0.0	5.0	1.4	1.9	304.5	2.6	0.0	506.3	112.5
ITGAV	"CD51, MSK8, VNRA, VTNR"	ENSG00000138448	"Integrin subunit alpha V"	P06756	2	186590065-186680901	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 7.7;monocytes: 2.3"	"Cell line enhanced"	"Detected in many"		"RT4: 71.7;SuSa: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002499, HPA004856"	Supported		Approved	"Focal adhesion sites,Cytosol"		NA	NA		750000	"Focal adhesion sites, Cytosol"		"CAB002499: AB_563594, HPA004856: AB_1846316"	"unprognostic (4.03e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (5.84e-2)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (1.05e-6)"	"unprognostic (2.61e-1)"	"unprognostic (9.11e-2)"	"unprognostic (8.07e-2)"	23.2	22.1	17.9	18.3	21.8	3.1	25.8	16.7	23.1	22.9	13.6	23.4	11.6	8.4	26.0	11.4	14.2	14.5	25.2	40.7	16.8	12.3	51.5	9.5	20.6	7.6	24.2	11.6	35.4	18.7	65.0	11.0	29.6	22.1	16.5	11.9	83.4	17.9	15.9	13.1	21.5	10.1	29.6	33.0	12.1	17.3	11.2	17.0	7.8	33.1	10.9	11.1	17.6	17.9	0.3	0.9	7.7	2.3	0.4	1.1	0.5	9.3	11.1	7.4	23.7	27.3	18.5	28.3	18.3	14.8	6.5	6.5	9.7	32.2	0.0	36.1	20.6	22.7	11.7	3.8	17.2	9.4	1.8	3.4	2.2	14.6	13.3	10.8	1.5	1.4	13.4	8.2	14.4	12.3	39.0	15.4	1.1	2.1	4.7	17.2	3.7	0.9	1.3	5.6	5.6	5.6	0.0	15.2	1.2	16.8	71.7	1.5	4.6	21.1	6.5	7.7	62.1	5.1	4.3	46.8	40.2	12.6	8.2	15.4	1.1	1.9	1.0	16.2	0.6	19.8	7.7	1.1	1.6	1.0	2.3	0.7	0.3	0.5	0.8	0.9	0.1	0.5	0.5	0.5	0.4	1.2	0.4	1.1	0.5	17.9	21.8	16.7	17.3	16.8	12.3	24.2	11.6	22.1	17.0	26.8	18.5	2.4	54.8	114.0	118.2	124.7	73.9	12.0	20.5	73.3	72.6	46.9	1.7	78.4	0.5	50.4	13.2	0.0	89.0	21.8	61.3	83.9	49.5	15.8	26.1	14.3	7.0	34.4	33.9	1.6	17.8	18.2	43.9	20.8	18.9	82.5	120.4	18.2	24.4	16.5	54.8	32.3	47.2	0.7	1.4	90.7	33.2	6.9	11.4	48.6
PLK4	"Sak, STK18"	ENSG00000142731	"Polo like kinase 4"	O00444	4	127880861-127899195	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.5;lymphoid tissue: 21.7;testis: 21.7"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 48.9;Erythroid cells: 23.3;Late spermatids: 60.1;Spermatocytes: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA017327, HPA035026, HPA043198"	Approved		Supported	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA017327: AB_2669584, HPA035026: AB_10602080, HPA043198: AB_2732504"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-2)"	"prognostic favorable (7.46e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.06e-5)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.44e-3)"	"unprognostic (5.66e-2)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.22e-11)"	"unprognostic (2.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.93e-2)"	1.4	1.3	1.5	4.7	2.4	16.5	2.2	0.5	2.2	2.0	3.2	0.3	0.6	2.3	1.3	1.3	5.4	1.1	1.2	2.0	1.2	1.3	1.5	0.9	1.5	5.9	1.2	1.4	1.5	0.9	0.3	0.6	5.0	2.6	1.4	3.7	0.8	1.7	0.7	0.4	2.7	3.2	1.9	1.8	2.7	1.6	21.7	1.0	21.7	1.0	2.1	6.0	1.5	2.2	0.7	0.7	1.5	0.8	1.4	4.0	0.8	11.8	5.6	21.1	10.8	0.7	2.1	9.6	11.6	8.2	15.5	16.0	7.8	12.2	16.0	4.3	6.4	12.6	7.8	14.8	9.3	23.9	12.4	6.1	14.5	9.0	7.3	0.2	20.4	17.1	0.6	0.9	14.1	6.5	2.8	11.9	12.3	16.8	21.4	13.0	8.2	31.4	9.1	9.8	12.1	6.4	16.4	14.7	5.5	5.1	7.6	11.6	9.6	7.3	6.7	3.5	9.3	5.4	8.8	5.1	12.2	11.8	8.3	14.4	11.0	12.1	22.8	6.2	15.5	13.5	0.0	0.4	1.5	1.6	0.8	1.1	0.3	1.8	1.7	0.7	0.7	0.6	2.3	0.0	1.4	0.3	0.4	4.0	0.8	1.5	2.4	0.5	2.2	1.2	1.3	1.2	1.4	2.6	1.0	0.0	1.1	0.8	0.6	1.4	2.1	0.5	0.0	2.7	0.0	1.8	0.0	3.6	0.0	0.6	48.9	0.4	0.0	23.3	0.3	10.4	0.7	0.4	1.1	0.2	3.1	0.0	2.4	0.6	1.0	60.1	2.6	1.6	0.0	1.8	1.9	1.1	0.1	0.0	0.4	0.3	0.7	0.0	0.3	27.0	12.1	0.6	3.2	1.8	2.1	0.9
CLDN1	"ILVASC, SEMP1"	ENSG00000163347	"Claudin 1"	O95832	3	190305701-190322475	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 134.3;skin 1: 73.9"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 390.9;Suprabasal keratinocytes: 730.8;Urothelial cells: 538.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"EFO-21: 107.5;HaCaT: 37.6;hTCEpi: 46.9;RPTEC TERT1: 67.3;RT4: 42.1"	"Low region specificity"	"Detected in many"							"CAB002602, HPA048319"	Enhanced					NA	NA					"CAB002602: , HPA048319: AB_2680355"	"unprognostic (5.89e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (7.92e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.43e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.22e-1)"	11.4	14.7	1.0	4.9	0.5	0.0	5.8	0.2	0.7	10.1	7.2	1.2	11.4	0.1	46.5	18.8	13.8	18.8	9.2	3.2	0.7	0.6	7.2	134.3	5.5	0.0	1.0	0.4	13.3	18.0	0.0	1.3	30.5	2.0	13.0	0.3	0.5	10.6	18.2	0.6	73.9	0.4	31.1	1.3	1.2	0.4	7.1	0.1	6.7	8.5	12.2	19.8	9.7	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	4.7	0.0	0.0	0.0	0.0	0.0	0.4	8.4	0.1	0.3	2.7	11.0	0.0	107.5	0.0	9.5	37.6	0.2	12.3	1.0	0.1	0.2	0.0	1.6	6.4	8.2	0.0	0.0	0.0	46.9	0.9	14.2	0.4	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.3	0.8	0.0	0.1	0.0	67.3	42.1	0.0	0.0	4.9	0.9	2.8	0.6	8.6	0.0	2.0	0.1	1.6	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.2	0.7	0.7	0.6	1.0	0.4	2.0	0.1	11.9	29.6	0.0	214.2	390.9	0.0	0.4	173.3	195.4	155.8	29.6	0.0	1.3	0.0	178.6	0.0	0.8	0.0	0.0	49.1	0.2	10.7	75.9	1.1	165.2	1.0	0.0	1.7	1.8	2.7	0.9	14.4	13.7	30.4	10.0	0.2	0.0	113.1	0.0	33.2	1.9	0.0	0.0	9.2	0.2	0.3	730.8	28.3	0.5	0.0	538.7
PRIM2	PRIM2A	ENSG00000146143	"DNA primase subunit 2"	P49643	6	57314805-57646849	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 21.7;prostate: 22.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046566			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046566: AB_2679701"	"unprognostic (1.24e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (3.44e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.00e-5)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.89e-1)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (2.04e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-1)"	5.4	1.6	1.7	9.0	2.3	7.8	4.1	6.5	3.3	5.3	3.9	2.5	2.4	3.0	9.7	3.7	5.6	3.7	2.7	3.1	2.8		3.5	2.7	2.7	7.1	3.6	1.5	4.3	2.2	2.4	5.4	5.9	1.7	22.6	5.0	3.5	7.3	3.4	1.1	3.4	3.7	5.8	3.6	6.7	2.4	5.3	3.1	21.7	4.6	4.5	8.7	4.7	2.7	5.0	7.3	2.5	5.4	5.6	7.9	2.7	15.4	6.3	12.6	14.6	7.2	12.8	10.5	19.1	18.7	21.3	28.6	10.0	7.4	14.1	10.6	23.8	14.5	10.5	11.3	10.9	26.4	15.4	9.2	16.7	8.6	16.7	2.9	16.1	10.6	4.8	4.1	23.5	8.2	5.2	9.6	15.2	15.8	37.6	17.7	9.7	16.9	12.8	8.0	13.2	6.3	12.9	17.5	11.3	7.7	8.0	9.3	7.1	12.4	5.9	7.7	14.6	12.6	13.9	6.6	21.7	21.4	39.7	16.1	5.1	9.8	16.4	9.9	17.0	11.6	0.3	2.4	2.5	5.5	5.1	6.2	5.0	5.0	7.5	4.1	4.9	3.6	7.9	1.0	5.6	5.4	7.3	5.9	2.7											0.0	2.4	5.1	5.5	3.5	5.0	0.9	2.5	2.7	3.4	3.5	11.8	13.3	3.3	3.7	7.2	2.9	3.5	23.3	4.5	19.3	5.2	5.5	11.5	3.8	7.9	6.4	1.2	4.9	4.8	2.8	6.1	5.1	0.0	5.4	6.1	4.9	3.9	5.3	6.3	1.4	4.5	19.4	5.2	10.6	12.1	2.6	4.8	12.8	7.5	5.0
HTR1D	"5-HT1D, HT1DA, HTRL, RDC4"	ENSG00000179546	"5-hydroxytryptamine receptor 1D"	P28221	1	23191895-23194729	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.9;intestine: 12.2"	"Cell type enriched"	"Detected in single"	12	"Cholangiocytes: 7.6"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 8.5;hTERT-RPE1: 8.2;OE19: 11.4;TIME: 21.3;U-2 OS: 7.2"	"Region enhanced"	"Detected in some"		"basal ganglia: 7.6"	"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.73e-2)"	"unprognostic (8.69e-3)"	"unprognostic (8.86e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.65e-2)"	"unprognostic (5.97e-4)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (3.87e-3)"	"unprognostic (8.88e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavorable (5.30e-4)"	"unprognostic (3.17e-2)"	"unprognostic (3.28e-6)"	"unprognostic (9.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.02e-3)"	0.0	0.0	0.3	0.0	3.9	0.1	0.0	0.0	0.2	0.0	0.1			12.2	0.0	0.0	0.0	0.5	1.9	0.0	0.2	0.4	0.0	0.0	0.2	0.0	0.2		0.0	0.1	0.0	0.1	0.0		0.1	0.1		0.0	0.0	0.0	0.1	10.4	0.0	0.2	0.0	0.0	0.4			0.0		0.0	0.5	0.0	1.0	0.7	2.2	1.2	1.2	0.9	0.2	2.5	8.5	0.0	0.0	0.0	0.2	0.7	0.0	0.6	0.3	0.3	0.5	6.1	0.0	2.5	0.3	4.3	1.8	1.7	0.0	0.4	0.0	0.7	0.0	5.0	0.1	0.3	0.0	0.0	0.1	0.1	1.0	0.3	8.2	5.0	0.1	0.0	0.0	0.2	1.0	0.0	0.0	2.0	11.4	0.1	0.0	0.0	0.0	0.2	0.0	2.1	0.0	5.7	0.3	0.1	0.7	0.1	0.0	21.3	0.0	7.2	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	1.2	0.5	0.6	0.8	0.4	1.0	0.9	0.6	0.4	1.0	0.6	0.6	2.2	1.2	1.0	0.7	0.4	0.2											0.0	0.0	0.0	0.2	0.0	0.0	0.3	7.6	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5
SRFBP1	"BUD22, FLJ25286, p49, Rlb1, STRAP"	ENSG00000151304	"Serum response factor binding protein 1"	Q8NEF9	5	121961961-122075570	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042737	Approved		Approved	"Nucleoli rim"		NA	NA			"Nucleoli rim"		"HPA042737: AB_10796583"	"unprognostic (8.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.03e-1)"	"unprognostic (8.96e-3)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (5.31e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.45e-2)"	21.8	9.4	11.6	11.1	15.2	10.1	17.2	15.0	14.8	12.7	10.2	6.1	8.5	9.1	13.0	12.1	14.2	11.1	9.6	10.7	11.8	8.0	14.3	12.6	11.2	12.5	13.1	11.9	17.1	10.6	15.5	20.2	11.5	14.2	12.8	10.9	5.1	13.0	9.5	19.7	10.7	9.5	11.3	16.0	15.4	10.1	9.3	14.9	12.5	15.6	13.8	11.6	14.4	17.5	10.3	9.6	2.6	12.8	7.4	11.5	4.3	10.6	7.9	7.3	11.5	8.3	7.8	12.2	10.3	7.5	11.3	13.3	6.4	10.7	13.5	12.0	6.4	19.5	7.9	11.8	14.0	21.2	19.1	6.7	13.0	5.7	6.6	9.0	14.9	10.8	9.3	10.9	14.3	14.1	5.4	12.2	7.0	11.8	11.0	11.8	4.9	10.3	4.8	10.7	8.5	5.2	10.7	17.2	14.2	12.5	11.1	7.5	7.0	9.5	9.4	17.7	9.5	9.6	8.9	8.9	17.6	10.7	12.5	14.9	5.9	11.1	15.6	10.0	12.1	15.4	0.6	7.3	2.6	6.6	12.8	8.4	10.3	7.3	7.2	9.6	8.9	8.6	11.5	1.2	7.4	10.1	9.1	6.7	4.3	11.6	15.2	15.0	14.8	11.8	8.0	13.1	11.9	14.2	14.9	14.9	14.6	31.2	23.5	17.1	37.0	10.9	7.6	20.1	30.7	14.0	23.6	17.2	34.9	27.1	26.2	19.4	4.3	23.3	17.5	18.2	15.9	18.3	43.8	8.2	17.3	44.5	15.5	9.2	6.4	3.4	22.5	17.5	18.6	6.4	11.8	28.6	18.2	7.0	25.1	25.9	28.0	12.9	21.7	20.2	25.6	16.7	10.8	13.1	16.1	22.5
IL15RA	"CD215, IL-15RA"	ENSG00000134470	"Interleukin 15 receptor subunit alpha"	Q13261	10	5943639-5978187	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Exocrine glandular cells: 48.0;monocytes: 89.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 30.0;EFO-21: 18.2;HDLM-2: 32.7;HHSteC: 18.7"									CAB026215	Approved				"Secreted to blood"	NA	NA					"CAB026215: "	"unprognostic (2.86e-2)"	"unprognostic (8.41e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.49e-2)"	"prognostic unfavorable (2.67e-6)"	"unprognostic (5.09e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (6.18e-3)"	"prognostic unfavorable (1.27e-12)"	"unprognostic (4.43e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.75e-2)"	20.5	5.6	2.2	13.0	4.1	6.4	33.9	1.4	2.6	12.7	15.6	1.6	7.7	10.1	10.9	9.4	14.3	10.6	18.7	19.2	2.6	1.9	7.8	17.5	35.7	15.2	4.0	2.0	8.7	9.6	0.9	3.9	15.5	3.6	13.2	7.4	6.4	8.9	9.4	9.2	7.6	18.8	10.8	2.7	18.8	10.3	5.0	2.7	3.5	13.9	7.5	9.8	12.9	17.3	7.0	4.2	6.3	19.5	6.8	18.7	6.7	7.0	1.0	0.0	0.3	9.3	2.2	1.9	3.6	7.8	4.8	5.0	0.1	30.0	0.8	18.2	6.8	2.6	6.7	0.8	5.3	1.0	32.7	1.4	0.8	1.8	0.5	18.7	0.4	0.2	1.9	1.8	2.5	0.1	1.8	11.7	0.6	8.7	10.0	0.1	3.7	1.4	3.4	0.2	2.5	3.3	4.2	0.0	5.7	1.1	0.5	0.0	0.0	5.5	0.5	0.2	0.0	2.6	3.2	4.5	0.1	0.5	13.0	4.8	9.0	2.4	0.1	2.2	5.3	0.3	6.3	16.0	3.9	12.3	19.5	18.7	7.0	9.5	12.5	4.2	3.3	4.1	7.1	4.7	6.8	11.7	0.0	10.2	6.7	2.2	4.1	1.4	2.6	2.6	1.9	4.0	2.0	3.6	2.7	6.0	5.3	7.5	4.2	5.0	0.0	5.3	25.5	2.7	0.0	0.0	0.0	0.6	0.0	30.4	1.5	20.4	6.9	23.3	48.0	1.6	12.7	6.8	3.5	6.4	6.3	0.0	5.2	34.4	12.7	1.5	4.6	6.2	3.3	89.2	7.1	0.0	29.3	13.5	0.7	0.0	0.0	0.0	5.1	0.2	0.2	5.6	0.1	5.7	7.5	6.5
HAS3		ENSG00000103044	"Hyaluronan synthase 3"	O00219	16	69105564-69118719	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 22.6;urinary bladder: 22.9"	"Cell type enhanced"	"Detected in many"	14	"Basal keratinocytes: 144.1;Suprabasal keratinocytes: 138.5;Urothelial cells: 89.2"	"Group enriched"	"Detected in many"	8	"cervical cancer: 17.1;head and neck cancer: 44.9;lung cancer: 23.3;urothelial cancer: 31.1"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 14.4;PC-3: 76.9;RT4: 30.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031554, CAB033850"	Supported		Approved	Microtubules		NA	NA			Microtubules		"CAB033850: AB_2116418, HPA031554: AB_10670703"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.59e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.40e-3)"	0.4	0.2	0.4	0.4	1.0	0.3	5.5	1.1	1.3	3.3	3.7	0.4	0.4	1.9	0.8	1.1	22.6	0.7	3.5	2.4	0.6	0.6	1.2	0.7	18.0	0.4	0.4	0.4	0.9	2.2	0.1	1.0	3.3	1.1	3.5	2.3	0.6	7.6	2.1	0.6	5.7	2.1	1.4	0.4	0.4	9.0	2.0	0.4	0.5	4.0	11.7	11.1	22.9	13.6	1.5	1.2	2.2	1.4	0.4	2.0	1.1	0.9	4.8	0.3	0.2	0.1	0.1	1.8	0.3	0.1	0.2	0.1	1.0	2.5	0.2	0.6	0.1	1.1	14.4	0.8	8.6	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.1	2.4	0.3	0.8	1.1	0.1	0.1	0.0	0.1	0.0	0.5	0.3	0.1	4.3	5.0	76.9	0.5	0.0	0.0	7.9	30.4	5.4	0.2	0.5	0.0	0.1	0.9	0.2	0.2	0.1	0.2	0.2	8.4	0.5	0.3	0.2	0.0	0.3	0.0	0.1	0.8	1.4	2.2	1.4	0.7	1.3	0.7	1.1	0.5	1.2	1.5	2.0	0.7	0.5	0.4	1.1	1.0	1.5	1.1	0.4	1.0	1.1	1.3	0.6	0.6	0.4	0.4	1.1	0.4	0.0	25.0	0.0	35.3	144.1	1.4	1.4	0.0	0.0	4.5	0.0	2.0	0.9	0.0	3.2	10.2	2.0	2.0	0.0	3.1	0.7	0.8	9.4	0.0	0.0	0.3	0.0	0.0	1.3	0.0	17.0	1.1	0.6	3.3	0.0	0.3	0.1	2.3	0.0	0.4	0.6	0.9	0.0	2.5	0.6	0.4	138.5	0.2	0.5	1.5	89.2
MTDH	"3D3, AEG-1, LYRIC"	ENSG00000147649	Metadherin	Q86UE4	8	97644179-97728770	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010932, HPA015104, CAB068204, CAB068205"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB068204: AB_2665655, CAB068205: AB_2665654, HPA010932: AB_1079422, HPA015104: AB_1854173"	"unprognostic (1.01e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (7.76e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (3.84e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.40e-1)"	26.5	28.5	17.2	28.3	21.9	44.5	29.0	21.8	20.2	27.5	24.9	20.7	24.7	23.2	31.6	28.6	27.6	23.6	23.5	23.6	18.7	16.6	24.3	97.8	21.9	31.4	26.5	19.6	26.7	22.7	27.1	18.0	13.4	23.0	24.0	22.8	16.4	22.3	21.2	49.8	19.5	32.7	29.5	34.6	35.8	21.8	19.0	24.8	40.0	30.5	22.7	27.5	27.5	35.7	26.2	42.4	17.4	26.6	19.2	20.9	10.1	38.8	20.2	13.2	18.1	22.0	23.3	6.5	35.0	29.8	22.4	17.4	11.9	29.1	36.0	39.5	34.3	24.8	25.9	32.0	24.3	31.4	38.3	16.8	66.1	21.9	14.1	26.7	34.6	30.8	17.8	24.5	27.1	61.8	21.2	25.7	26.6	43.1	64.0	23.7	16.1	58.3	9.6	8.1	34.0	24.6	38.2	15.7	52.3	14.6	22.4	20.0	15.0	24.8	21.9	27.4	13.3	33.4	22.2	26.7	31.8	11.4	29.2	25.8	35.7	38.9	36.5	29.2	40.7	27.7	17.4	26.6	13.4	14.2	17.8	20.1	26.2	20.4	20.9	32.6	18.6	20.8	18.4	3.8	19.2	19.5	42.4	11.7	10.1	17.2	21.9	21.8	20.2	18.7	16.6	26.5	19.6	23.0	24.8	119.1	103.5	196.6	171.8	232.4	0.0	87.6	201.2	52.2	100.1	134.3	0.0	9.1	21.6	197.1	211.2	149.0	122.0	46.7	201.2	89.0	152.1	236.8	136.0	389.3	243.9	0.0	116.8	148.0	225.6	132.2	180.9	250.7	175.5	149.7	148.0	0.0	214.1	126.3	203.3	76.1	0.0	219.9	203.9	116.5	108.0	275.1	11.4	146.0	177.0	291.2
CHRAC1	"CHRAC15, YCL1"	ENSG00000104472	"Chromatin accessibility complex 1"	Q9NRG0	8	140511298-140517137	"Predicted intracellular proteins"		"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059008			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059008: AB_2683878"	"unprognostic (6.34e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.29e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (4.88e-5)"	"unprognostic (8.79e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (9.72e-4)"	"prognostic unfavorable (5.43e-4)"	"unprognostic (4.19e-1)"	"unprognostic (6.22e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.49e-1)"	24.3	14.7	12.1	15.9	16.0	23.3	18.0	10.1	14.2	17.3	20.9	23.8	11.9	15.5	20.4	12.7	24.1	16.1	19.8	18.7	13.7	10.4	21.4	24.3	16.5	21.6	19.2	7.7	18.2	17.7	15.5	13.1	21.0	13.6	17.8	16.2	17.2	17.6	20.1	28.4	19.1	24.3	21.2	20.8	22.2	18.2	26.1	21.6	36.4	27.5	19.3	24.9	19.3	15.8	19.6	19.5	21.4	23.5	16.1	16.0	12.5	22.4	10.9	10.3	9.7	10.3	17.5	7.8	9.6	14.1	14.1	17.2	14.0	16.3	23.3	14.4	11.8	11.2	14.1	12.2	9.9	19.6	17.8	12.8	33.0	15.2	15.7	9.7	10.9	17.5	8.7	14.5	10.4	20.3	7.6	13.5	14.4	24.3	22.3	12.5	26.4	38.2	11.8	7.5	19.8	18.4	23.1	10.8	18.5	14.1	9.4	14.1	11.7	13.5	9.2	17.0	5.8	17.8	12.6	12.7	16.8	29.3	20.6	20.3	10.7	13.9	28.3	20.2	26.1	13.0	8.7	17.0	20.3	16.0	22.4	15.7	17.3	14.4	15.8	18.7	19.6	15.2	12.6	21.4	16.1	23.5	19.5	12.7	12.5	12.1	16.0	10.1	14.2	13.7	10.4	19.2	7.7	13.6	21.6	14.9	25.1	31.5	36.8	34.1	6.9	11.6	20.4	16.0	29.6	14.0	2.0	19.7	36.5	19.4	15.6	29.5	21.9	0.0	31.3	42.0	24.9	26.9	32.3	18.4	21.6	6.4	20.7	30.1	29.5	26.2	27.0	33.4	18.6	31.5	20.5	25.3	27.4	18.6	23.7	24.5	10.7	71.1	38.1	72.7	63.0	42.4	20.1	29.9	19.3	30.6
SERPINB4	"LEUPIN, PI11, SCCA-2, SCCA1, SCCA2"	ENSG00000206073	"Serpin family B member 4"	P48594	18	63637259-63644298	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 32.5;esophagus: 48.4;tongue: 18.4;vagina: 41.4"	"Cell type enhanced"	"Detected in some"	16	"Ciliated cells: 26.8;Club cells: 89.9;Pancreatic endocrine cells: 31.8;Urothelial cells: 72.6"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 104.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4.1;HSkMC: 2.1;SiHa: 3.2;U-2197: 11.1"									"HPA048341, HPA049988, HPA055992"	Supported					NA	NA		5700000			"HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998"		"unprognostic (8.81e-3)"				"unprognostic (9.43e-2)"		"unprognostic (8.96e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (2.46e-1)"		"unprognostic (4.37e-2)"			"unprognostic (1.27e-2)"	0.1	0.0	0.1	1.4	0.1	0.0	0.1	0.1	0.1	32.5	0.1	0.1	0.1	0.0	1.8	0.1	48.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.1	7.0	0.1	0.3	4.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	2.0	0.1	18.4	2.3	8.7	41.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	1.0	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	26.8	89.9	0.0	0.0	0.0	0.0	14.6	1.1	0.0	0.0	0.0	18.1	0.1	0.0	17.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	72.6
ADIPOR1	"ACDCR1, PAQR1"	ENSG00000159346	"Adiponectin receptor 1"	Q96A54	1	202940823-202958572	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (1.67e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (5.27e-4)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.79e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.63e-2)"	26.8	24.8	20.4	16.4	25.9	65.7	29.6	18.1	29.0	22.2	19.3	33.2	17.1	16.2	18.0	33.7	49.1	24.8	18.5	39.6	19.8	19.5	30.5	56.8	41.5	33.6	20.7	14.3	22.6	66.2	30.4	21.6	63.1	20.2	23.1	21.6	38.3	39.7	17.9	43.5	46.1	24.4	18.2	30.2	36.9	24.8	24.9	18.3	21.9	26.6	28.6	32.1	25.0	29.3	21.6	28.8	112.6	49.9	16.0	23.4	63.8	24.9	23.8	14.6	16.0	30.5	23.5	74.4	28.0	32.7	29.1	27.0	23.7	30.3	16.7	20.8	31.7	23.3	31.0	21.7	38.4	26.4	31.5	24.7	12.8	30.2	18.8	30.1	26.5	19.5	27.8	62.6	31.6	32.3	29.1	28.6	29.5	33.0	35.5	29.3	27.2	21.9	19.5	32.0	22.5	27.3	17.5	35.4	32.3	28.2	30.0	24.0	24.8	29.6	44.2	34.4	40.8	32.1	25.7	25.5	21.5	17.0	10.5	30.8	37.5	50.8	18.9	30.8	15.3	25.1	39.6	49.9	59.9	19.7	33.5	20.4	21.6	21.0	19.3	28.8	21.4	21.0	18.4	112.6	16.0	32.3	19.9	23.4	63.8	20.4	25.9	18.1	29.0	19.8	19.5	20.7	14.3	20.2	18.3	32.8	48.6	40.6	78.1	208.7	24.6	48.9	30.6	50.9	36.4	50.6	27.5	96.5	58.0	65.0	51.8	53.4	41.2	210.2	76.0	142.7	52.5	96.6	35.9	53.5	89.9	11.1	47.2	52.8	115.1	42.9	26.4	67.3	81.0	74.9	43.5	23.3	91.5	45.6	23.0	46.9	35.3	38.8	45.3	11.6	29.6	200.0	169.6	42.7	43.1	136.7
POLR1B	"FLJ10816, FLJ21921, RPA2, Rpo1-2"	ENSG00000125630	"RNA polymerase I subunit B"	Q9H9Y6	2	112541915-112577150	"Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 133.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037528			Supported	Nucleoli,Cytosol		NA	NA			Nucleoli	Cytosol	"HPA037528: AB_10671627"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	8.8	11.0	6.4	10.6	6.8	4.9	15.7	8.0	8.2	7.6	7.0	7.7	8.6	5.8	9.3	7.4	12.8	9.2	9.2	6.1	5.7	6.1	11.3	20.5	8.0	11.3	6.8	3.7	11.3	25.2	20.7	11.5	7.2	5.2	7.7	8.5	7.3	10.0	8.3	14.7	9.2	8.0	7.9	4.8	11.4	8.1	15.7	5.0	9.6	15.7	11.5	14.6	8.9	11.8	9.4	11.0	2.5	6.3	10.2	17.1	7.3	9.5	10.0	6.3	13.1	6.9	6.6	11.9	7.2	5.5	12.2	10.6	22.4	5.7	22.9	10.7	4.7	9.5	13.5	26.7	14.6	14.1	10.3	13.5	13.2	9.9	16.9	7.3	21.1	9.2	6.3	10.6	12.6	19.5	5.1	9.4	4.8	23.9	8.3	6.3	8.4	9.5	13.7	30.9	14.1	19.8	14.3	10.5	24.3	8.4	9.1	16.1	14.9	6.6	16.6	9.0	7.1	7.7	7.5	8.5	7.5	11.0	6.8	10.5	11.2	18.4	19.8	5.7	13.6	6.2	0.2	6.0	2.5	8.3	6.3	17.1	9.4	8.4	8.9	11.0	9.3	10.3	10.4	0.4	10.2	4.8	2.6	11.3	7.3	6.4	6.8	8.0	8.2	5.7	6.1	6.8	3.7	5.2	5.0	14.9	5.1	8.2	2.2	13.4	3.4	5.7	10.2	2.7	7.9	8.7	2.0	2.9	5.0	4.0	133.9	5.6	1.2	0.0	3.9	2.3	2.8	2.2	4.7	8.5	3.3	1.6	3.5	1.8	2.5	29.4	2.8	2.9	1.7	1.8	4.4	3.8	2.9	6.0	2.8	4.1	2.9	0.0	2.8	9.5	7.5	15.1	0.5	6.4	4.5	3.4
ADGRF4	"FLJ38076, GPR115, PGR18"	ENSG00000153294	"Adhesion G protein-coupled receptor F4"	Q8IZF3	6	47685864-47722021	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 15.8;placenta: 23.9;skin 1: 30.7;tongue: 17.8"	"Cell type enhanced"	"Detected in some"	14	"Extravillous trophoblasts: 9.6;Pancreatic endocrine cells: 12.3;Syncytiotrophoblasts: 6.1;Urothelial cells: 16.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.7;HBEC3-KT: 13.8;hTCEpi: 21.5;OE19: 12.0;U-87 MG: 18.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA007131, HPA007158"	Enhanced		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA007131: AB_2667756, HPA007158: AB_1849254"	"unprognostic (1.40e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.77e-2)"		"unprognostic (2.04e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.66e-8)"	"unprognostic (1.62e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	0.0	0.5	0.0	0.1	0.1	0.0	1.9	0.3	0.0	7.0	1.0	0.1	0.0	0.0	1.0	0.0	15.8	0.9	0.5	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	23.9	0.2	1.9	1.2	0.0	1.8	0.0	0.4	30.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	17.8	14.0	2.3	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.8	0.0	0.0	0.0	0.0	0.6	0.0	3.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.5	8.7	0.0	13.8	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	21.5	0.2	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	12.0	0.8	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.2	1.2	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.3	0.0	3.3	0.2	0.0	0.0	0.0	3.0	9.6	0.1	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.1	0.0	0.0	16.0
PRSS23	"SIG13, SPUVE"	ENSG00000150687	"Serine protease 23"	O95084	11	86791059-86952910	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Ductal cells: 178.1;Endothelial cells: 254.7;Ito cells: 438.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 36.4"	"Group enriched"	"Detected in many"	30	"NK-cells: 10.2;T-cells: 36.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 114.9;hTERT-RPE1: 136.8;TIME: 116.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030591	Uncertain				"Secreted to blood"	NA	NA		290000			"HPA030591: AB_10602067"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.40e-3)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (1.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.01e-2)"	19.5	8.7	2.3	10.8	4.1	0.4	40.7	1.2	2.6	89.0	33.8	2.1	37.2	5.1	44.9	27.4	14.5	9.6	45.6	17.2	5.0	3.0	17.5	10.4	36.2	15.9	3.7	4.4	16.2	14.3	9.6	6.3	30.2	12.5	36.7	14.4	15.2	17.6	37.3	19.1	7.2	12.4	100.2	4.9	7.3	22.0	19.5	1.4	3.8	15.3	10.5	5.8	68.6	31.1	0.0	0.0	0.5	0.7	10.2	36.4	10.9	6.2	15.6	16.8	0.1	7.5	18.5	0.0	27.5	25.2	30.7	24.6	36.2	49.8	0.0	21.9	42.1	114.9	12.9	0.2	20.9	7.4	0.0	1.3	2.1	8.0	0.1	3.8	0.0	0.1	14.7	2.8	14.9	17.1	136.8	62.2	0.0	0.1	0.0	23.0	8.5	0.0	0.0	1.0	21.2	1.7	0.0	0.0	0.0	11.5	8.3	0.1	0.1	6.1	0.4	1.8	43.6	0.6	0.0	116.0	18.4	0.2	36.6	15.5	0.1	0.1	0.0	13.1	0.0	18.1	0.0	0.0	0.0	36.4	0.0	0.0	0.0	6.6	20.5	0.0	0.0	1.8	18.5	0.5	10.2	0.7	0.0	0.0	10.9	2.3	4.1	1.2	2.6	5.0	3.0	3.7	4.4	12.5	1.4	26.8	22.1	5.2	74.7	13.7	0.6	3.7	33.1	52.2	75.1	50.6	2.0	6.2	6.6	178.1	2.4	254.7	6.2	0.0	73.0	14.9	79.1	74.7	2.3	5.9	4.5	0.0	13.3	438.3	42.1	5.2	13.3	6.4	69.2	1.8	24.0	0.8	162.9	73.7	7.1	3.5	0.7	38.8	37.9	1.4	6.6	8.5	3.8	17.5	9.1	44.4
SINHCAF	"C12orf14, FAM60A, TERA"	ENSG00000139146	"SIN3-HDAC complex associated factor"	Q9NP50	12	31280584-31327058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 108.4;Club cells: 103.5;Extravillous trophoblasts: 98.9;monocytes: 269.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 83.1"	"Low region specificity"	"Detected in all"							"HPA038167, HPA057585"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038167: AB_10675629, HPA057585: AB_2732615"	"unprognostic (2.89e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (1.15e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (3.22e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.07e-1)"	"unprognostic (9.75e-2)"	13.1	6.5	1.6	21.4	5.1	7.9	11.1	4.5	1.9	25.4	15.8	3.4	15.8	6.7	28.3	16.8	19.8	14.6	8.4	5.6	2.9	1.8	16.6	3.3	17.0	22.5	3.4	0.9	18.5	19.6	7.6	19.6	18.9	5.2	18.6	8.3	6.0	16.3	20.1	3.2	12.7	17.0	11.7	3.8	18.5	7.0	13.6	3.7	39.0	14.9	12.3	27.3	19.3	13.6	22.8	28.3	7.9	8.0	19.0	15.1	10.4	3.4	5.1	17.2	3.4	1.0	2.1	31.9	1.8	1.3	3.5	4.7	13.7	9.0	11.9	14.6	0.5	3.8	6.2	14.4	6.9	6.9	12.6	6.4	8.2	3.5	8.5	4.3	13.3	8.0	1.9	10.8	3.0	14.7	6.9	8.1	14.2	11.3	4.6	1.5	2.6	23.8	9.8	83.1	10.7	2.8	20.2	8.2	10.2	7.9	10.3	24.0	16.2	4.2	7.6	9.9	39.4	3.2	7.9	8.9	0.8	5.2	0.4	5.9	5.3	7.6	24.0	2.4	5.1	4.6	7.9	4.8	7.5	8.8	5.8	10.3	22.8	12.3	10.4	10.4	17.9	15.1	11.8	1.5	19.0	8.0	28.3	5.8	10.4	1.6	5.1	4.5	1.9	2.9	1.8	3.4	0.9	5.2	3.7	71.5	30.2	0.0	0.0	0.0	0.0	0.0	0.0	108.4	103.5	43.6	0.0	63.7	69.6	61.6	0.0	0.0	0.0	0.0	37.9	98.9	0.0	0.0	10.5	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	269.7	0.0	0.0	47.6	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	50.6	0.0	0.0	0.0
CD58	LFA3	ENSG00000116815	"CD58 molecule"	P19256	1	116514535-116571039	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Macrophages: 115.4;monocytes: 225.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 46.3"															NA	NA		7100000				"unprognostic (4.48e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.32e-6)"	"unprognostic (9.84e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.72e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.17e-2)"	"unprognostic (9.66e-2)"	21.5	9.6	5.9	17.6	8.7	29.9	15.2	2.2	7.7	15.8	24.7	5.9	10.4	17.0	12.4	15.3	22.1	11.0	19.2	23.9	7.3	4.8	32.8	11.0	22.4	14.5	9.6	3.7	6.5	6.6	6.5	12.0	10.0	9.3	9.4	17.9	6.4	18.4	15.3	8.8	14.9	48.3	16.3	11.5	23.1	11.1	6.5	8.8	9.3	12.0	22.9	18.2	15.4	16.2	6.0	12.4	47.3	17.1	4.9	17.8	9.5	11.8	6.8	5.0	4.8	8.5	14.3	3.1	6.1	10.6	10.6	10.4	3.0	23.0	2.1	11.3	10.6	12.4	15.4	3.7	10.4	11.3	11.6	4.3	10.7	12.5	4.2	5.4	14.7	14.9	3.9	14.2	8.8	7.9	22.7	6.1	2.8	9.4	46.3	6.4	21.3	6.3	11.2	2.5	17.6	7.5	12.5	17.0	2.8	21.3	9.7	1.7	3.5	12.2	9.1	34.2	5.4	4.7	5.5	11.2	7.7	5.9	10.3	15.5	7.0	12.4	1.4	17.7	7.3	38.0	28.7	14.7	24.4	11.5	14.2	7.9	6.0	10.1	9.5	12.4	2.1	1.4	5.8	47.3	4.9	17.1	1.4	17.8	9.5	5.9	8.7	2.2	7.7	7.3	4.8	9.6	3.7	9.3	8.8	8.9	36.4	11.5	12.8	16.3	0.0	24.6	30.6	33.5	22.7	14.0	0.0	3.6	3.3	34.2	1.7	27.4	41.0	23.3	24.6	1.6	16.2	13.6	49.9	7.8	57.7	1.6	10.4	22.1	34.3	2.1	9.8	115.4	11.8	225.4	14.5	3.9	30.7	42.1	11.0	23.7	0.5	32.3	25.9	3.0	1.4	24.3	1.6	30.5	16.3	33.1
GINS1	"KIAA0186, PSF1"	ENSG00000101003	"GINS complex subunit 1"	Q14691	20	25407727-25452628	"Predicted intracellular proteins"	"DNA replication"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.1;testis: 21.4"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 43.6;Extravillous trophoblasts: 14.7;Late spermatids: 17.2;Spermatogonia: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA051185	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051185: AB_2681378"	"unprognostic (6.10e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.74e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (4.61e-7)"	"unprognostic (5.86e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.42e-11)"	"unprognostic (5.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.55e-1)"	1.5	1.9	4.1	11.7	4.2	4.5	2.2	7.4	4.3	2.2	4.5	1.3	0.0	4.3	2.2	1.0	8.5	1.4	2.3	1.0	2.2	2.2	2.2	2.0	1.4	7.2	1.9	2.1	1.7	1.8	1.1	0.8	5.5	2.2	1.4	5.9	1.3	2.1	0.7	0.7	5.3	4.1	2.8	1.8	3.4	2.9	21.4	0.9	20.1	1.0	6.4	10.5	2.6	3.2	2.6	2.3	1.3	1.0	1.9	3.5	0.9	18.0	16.4	20.2	13.1	1.1	1.6	20.4	8.0	3.9	15.5	16.5	14.2	18.1	22.3	9.2	3.3	11.5	21.0	17.6	14.8	18.0	5.9	6.1	15.3	6.0	17.2	0.4	20.0	7.0	0.7	0.8	14.7	3.0	2.1	8.2	12.8	14.7	14.7	9.2	19.5	30.7	15.0	13.7	12.6	8.6	22.0	23.3	15.1	5.9	12.2	8.5	8.9	8.2	19.6	6.9	11.9	18.6	10.1	3.7	12.2	13.2	7.9	14.6	5.9	16.7	17.6	3.2	19.6	13.7	0.8	0.8	0.5	1.5	1.0	0.9	2.6	1.1	0.5	2.1	1.7	0.8	1.4	1.3	1.9	1.0	2.3	3.5	0.9	4.1	4.2	7.4	4.3	2.2	2.2	1.9	2.1	2.2	0.9	0.0	1.1	0.8	0.4	2.9	1.3	0.3	0.0	2.7	2.3	1.8	0.0	5.0	0.0	1.3	43.6	0.1	0.5	0.0	0.6	14.7	1.4	0.4	1.1	0.0	4.8	0.0	1.2	1.3	1.3	17.2	0.6	1.5	0.0	0.0	1.2	1.3	0.4	0.0	1.1	1.8	0.1	0.0	0.9	8.9	20.9	1.3	2.1	0.0	2.8	0.4
ACTN4	FSGS1	ENSG00000130402	"Actinin alpha 4"	O43707	19	38647649-38731583	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 92.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001873, HPA006035"	Supported		Approved	"Nuclear bodies,Actin filaments,Cytosol"		NA	NA		230000000	"Nuclear bodies, Actin filaments"	Cytosol	"HPA001873: AB_1078096, HPA006035: AB_1078095"	"unprognostic (1.03e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (2.99e-1)"	"prognostic favorable (5.25e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.75e-3)"	"unprognostic (6.52e-2)"	38.3	39.2	19.2	30.1	24.4	28.1	34.1	16.6	26.6	45.2	47.9	31.8	23.4	51.0	70.1	22.2	61.4	37.9	41.5	25.0	19.6	16.2	48.4	34.1	39.5	17.7	27.8	18.7	33.6	34.1	17.8	21.0	65.9	21.8	33.7	22.4	29.2	41.4	35.4	16.0	40.4	69.4	54.0	32.9	40.8	34.3	13.4	24.6	11.6	29.2	30.5	42.9	40.3	41.1	2.6	8.5	12.9	5.7	17.5	9.7	5.6	45.0	92.0	13.5	6.4	7.8	9.5	26.8	20.5	27.7	30.5	24.6	33.0	35.0	10.0	49.3	45.8	20.1	21.6	8.2	32.4	9.1	24.6	8.5	14.1	42.4	28.5	17.2	10.3	17.6	15.7	10.8	26.6	17.9	27.9	18.8	3.2	16.4	10.8	23.3	23.5	3.3	6.9	9.5	32.0	21.8	10.1	12.6	5.2	33.0	47.2	10.1	5.9	37.1	29.7	13.5	11.0	12.2	12.4	32.0	34.9	17.0	16.7	68.1	4.8	10.9	8.3	30.9	11.0	62.4	4.5	5.1	10.9	9.7	5.7	7.8	2.4	4.5	9.7	4.6	2.6	0.8	3.3	12.9	17.5	4.6	8.5	7.1	5.6	19.2	24.4	16.6	26.6	19.6	16.2	27.8	18.7	21.8	24.6	166.7	126.4	42.4	207.1	208.5	22.7	6.4	155.4	60.2	92.1	144.8	13.7	98.7	16.6	365.0	2.2	134.9	407.6	46.7	359.3	199.5	77.2	206.6	71.6	102.0	64.3	22.3	155.5	128.3	61.9	2.3	38.3	59.0	43.9	214.6	286.1	119.2	403.9	205.1	67.1	64.3	30.5	187.5	173.6	27.6	11.9	177.2	140.5	81.2	173.4	281.0
AJUBA	"JUB, MGC15563"	ENSG00000129474	"Ajuba LIM protein"	Q96IF1	14	22971174-22982642	"Cancer-related genes, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, RNA-mediated gene silencing, Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 55.0"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 42.2;Sertoli cells: 32.3;Suprabasal keratinocytes: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 49.9;hTCEpi: 52.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA006171	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA006171: AB_1852044"	"unprognostic (1.15e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-3)"	"unprognostic (9.81e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.19e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.07e-1)"	2.9	2.0	1.1	2.4	1.8	0.0	4.1	1.1	1.6	11.1	2.0	1.6	4.9	0.5	8.8	4.4	12.3	4.7	7.9	3.2	2.3	0.6	15.6	55.0	8.5	2.2	1.5	1.3	8.2	5.6	5.5	1.4	12.5	2.6	9.2	1.1	7.1	5.5	11.0	1.5	31.3	1.7	4.3	0.5	2.9	2.6	4.1	1.3	7.1	15.4	5.3	6.6	3.7	10.0	1.3	1.0	2.6	1.2	2.9	2.5	0.6	10.4	12.4	16.6	6.4	1.6	2.9	13.3	10.3	13.6	24.2	21.7	26.4	10.9	0.2	10.8	21.2	16.7	34.0	12.7	49.9	29.6	1.0	1.1	0.8	20.1	29.7	19.0	1.1	0.7	9.3	52.3	10.1	39.0	17.2	9.2	1.9	0.4	0.6	22.3	8.4	1.0	1.2	1.0	19.6	17.1	2.8	13.8	0.2	24.2	16.3	0.0	1.4	31.1	9.2	2.0	14.1	12.8	1.0	8.2	10.5	21.2	1.7	9.8	0.1	0.3	0.1	1.6	0.9	4.7	2.2	1.2	0.5	1.4	0.5	0.5	0.4	1.2	2.5	0.4	1.3	1.5	0.9	2.6	2.9	0.8	1.0	0.2	0.6	1.1	1.8	1.1	1.6	2.3	0.6	1.5	1.3	2.6	1.3	17.9	5.4	0.0	12.1	42.2	0.0	4.0	15.3	4.0	9.1	7.0	0.0	8.2	5.0	13.1	4.3	5.0	0.0	0.0	12.9	9.4	5.4	3.4	0.0	14.0	1.5	0.0	0.0	1.8	0.0	3.8	3.4	0.7	3.3	0.0	0.3	7.7	24.1	0.0	0.7	17.8	0.0	32.3	12.7	6.0	2.5	43.3	3.3	0.0	0.9	4.3
ESYT2	"CHR2SYT, FAM62B, KIAA1228"	ENSG00000117868	"Extended synaptotagmin 2"	A0FGR8	7	158730995-158830253	"Plasma proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002132	Approved		Uncertain	Cytosol		NA	NA		130000	Cytosol		"HPA002132: AB_1078807"	"unprognostic (2.30e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.72e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.01e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.13e-1)"	"unprognostic (7.54e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.58e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (2.81e-5)"	33.3	25.6	15.3	16.2	23.5	19.6	27.3	21.7	26.3	26.7	27.9	17.8	21.6	15.8	31.2	31.0	32.5	28.3	31.1	28.4	16.1	17.5	20.6	16.7	26.1	18.0	15.6	16.7	41.6	23.2	29.7	22.0	35.2	20.6	21.1	22.6	23.4	26.7	31.4	34.5	24.5	22.5	37.8	14.9	13.2	19.4	13.3	12.1	29.0	30.5	24.3	23.2	30.5	27.6	1.4	3.6	2.0	2.3	6.6	8.5	2.9	29.6	17.8	5.7	6.0	19.2	22.3	19.0	14.0	14.3	11.2	12.6	9.9	39.0	9.1	16.2	25.1	23.1	14.8	8.2	14.7	10.8	9.4	8.4	7.5	14.2	10.5	19.6	26.9	17.2	16.1	18.3	12.6	16.9	22.5	13.2	24.8	16.1	30.8	18.2	24.9	27.9	19.5	9.1	20.0	17.2	23.8	11.0	11.2	19.0	12.7	16.7	9.2	44.6	36.1	20.3	13.9	13.1	29.5	20.4	12.4	6.5	54.7	17.8	21.1	5.4	8.9	30.7	28.0	36.5	2.0	1.9	1.5	8.5	2.3	4.7	1.4	7.1	6.0	3.6	1.0	6.7	7.9	1.2	6.6	1.5	2.4	5.8	2.9	15.3	23.5	21.7	26.3	16.1	17.5	15.6	16.7	20.6	12.1	35.7	32.5	9.0	10.9	41.0	15.1	25.8	22.9	36.1	33.0	45.4	15.7	24.1	3.3	13.5	11.2	41.4	27.1	23.3	17.1	22.4	41.1	18.3	11.6	17.4	18.3	12.7	20.3	25.2	23.8	3.0	32.5	22.6	49.0	10.8	29.5	15.2	24.1	5.8	51.2	8.2	10.6	32.3	52.8	10.9	10.0	45.2	34.1	25.9	22.5	21.4
DDX10	"Dbp4, HRH-J8"	ENSG00000178105	"DEAD-box helicase 10"	Q13206	11	108665025-108940930	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 58.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004691	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA004691: AB_1078629"	"unprognostic (9.49e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (2.86e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.14e-5)"	"unprognostic (5.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.64e-1)"	"unprognostic (2.43e-3)"	14.0	11.9	17.3	15.0	20.3	10.4	15.5	20.5	18.3	14.3	12.2	8.1	11.7	8.8	18.4	12.8	12.6	16.8	8.8	12.1	13.5	11.5	19.6	12.5	10.6	13.1	12.2	16.3	18.6	18.0	16.7	22.2	12.9	13.1	12.4	13.3	7.9	10.6	14.7	13.6	14.8	9.1	16.8	13.3	15.0	11.3	25.1	12.6	13.8	13.4	8.8	14.2	14.3	18.8	11.6	8.4	1.4	6.7	9.4	11.3	4.3	7.4	7.3	6.9	9.7	6.9	5.6	7.2	8.0	4.3	9.7	9.6	20.8	10.9	25.3	15.1	6.1	10.5	8.3	19.8	9.7	14.0	9.6	8.9	17.1	4.3	7.7	12.3	17.4	8.2	5.0	7.6	11.0	13.8	5.8	8.8	6.6	24.0	2.8	9.5	4.8	14.6	14.7	9.0	14.0	11.1	12.5	11.3	23.6	6.0	6.4	12.9	6.8	11.2	9.9	4.2	9.7	12.0	6.1	9.2	10.2	10.4	9.7	10.8	4.3	7.5	58.4	3.5	21.1	10.3	1.4	5.0	1.0	8.6	6.7	11.3	10.4	7.5	10.1	8.4	11.6	8.1	7.8	0.7	9.4	6.4	8.2	6.3	4.3	17.3	20.3	20.5	18.3	13.5	11.5	12.2	16.3	13.1	12.6	14.9	30.3	22.6	17.3	25.2	21.1	18.2	7.6	18.7	22.7	3.5	90.3	21.4	16.6	13.2	28.6	19.8	2.9	0.0	18.3	17.8	17.6	12.7	13.9	10.2	13.1	17.5	14.5	9.2	9.2	5.9	27.3	18.2	6.8	18.0	7.8	8.9	15.1	3.5	20.1	46.2	25.2	12.9	15.6	64.4	44.6	25.3	21.6	14.4	13.6	12.2
STAMBP	AMSH	ENSG00000124356	"STAM binding protein"	O95630	2	73828916-73873659	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"LHCN-M2: 162.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035800, HPA035801"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		11000	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA035800: AB_10670591, HPA035801: AB_2732470"	"unprognostic (1.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (6.13e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.89e-1)"	12.9	12.8	22.1	13.9	23.0	10.5	17.8	20.1	21.8	18.1	18.4	35.0	13.6	17.8	23.1	15.4	22.7	16.5	14.7	19.0	23.3	21.2	19.6	16.9	13.4	15.3	33.0	14.3	16.3	15.1	20.9	17.8	20.6	26.3	20.2	20.7	14.6	18.3	15.7	30.1	14.4	25.2	19.0	54.7	13.8	15.6	13.3	22.3	18.4	20.1	15.9	19.0	16.8	16.4	17.6	16.9	27.8	17.8	16.7	20.7	12.3	5.4	6.3	5.0	4.6	4.7	5.7	5.8	3.3	4.6	6.2	6.0	10.5	5.2	4.6	5.3	2.8	8.3	4.3	5.3	11.8	7.1	8.0	6.0	6.1	4.4	8.2	6.5	5.0	7.4	4.5	8.5	7.3	10.6	7.9	3.6	6.3	6.6	7.0	162.7	6.6	7.7	4.5	8.0	7.8	3.4	5.4	13.2	6.5	6.6	6.2	9.2	6.8	4.1	5.0	7.1	5.6	4.7	3.0	3.1	5.6	6.7	3.3	5.9	6.6	6.4	3.5	6.9	5.4	6.5	22.6	16.2	27.8	14.4	17.8	15.4	17.6	16.7	14.0	16.9	16.2	17.5	13.2	24.1	16.7	15.7	16.4	20.7	12.3	22.1	23.0	20.1	21.2	23.3	21.2	33.0	14.3	26.3	22.3	17.9	15.3	14.1	25.1	14.4	19.9	35.5	35.7	25.4	27.3	24.4	11.8	35.2	41.4	32.4	59.2	21.7	40.9	46.7	31.9	28.3	22.6	34.8	51.9	34.7	29.0	25.4	9.9	20.3	24.7	104.7	30.2	29.2	6.8	36.9	31.9	21.5	36.9	38.6	32.5	47.1	19.2	38.8	20.6	32.3	49.5	18.9	37.2	19.5	31.2	23.0
CSNK1A1	"CK1, CK1a, CK1alpha, CKIa, CKIalpha"	ENSG00000113712	"Casein kinase 1 alpha 1"	P48729	5	149492197-149551552	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Suprabasal keratinocytes: 741.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016680, HPA051334"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"CAB016680: AB_1614518, HPA051334: AB_2681446"	"unprognostic (4.27e-3)"	"unprognostic (5.85e-3)"	"prognostic favorable (1.15e-4)"	"unprognostic (7.39e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.38e-1)"	"unprognostic (8.31e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (5.47e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.28e-3)"	"unprognostic (6.92e-2)"	33.5	35.8	26.0	26.9	35.2	71.0	40.2	32.0	39.3	33.8	38.2	28.2	40.5	23.2	41.0	29.4	66.1	31.8	36.0	45.7	24.4	26.1	24.0	30.1	37.5	27.3	28.0	29.8	31.7	23.9	46.9	30.9	28.7	38.0	38.1	31.4	25.5	38.5	39.3	51.4	48.4	31.8	45.8	33.9	23.6	34.2	28.6	24.1	38.6	32.0	53.1	41.1	45.0	40.0	28.6	40.6	47.4	39.6	34.2	41.9	40.8	36.9	24.7	41.6	39.4	43.0	52.7	44.5	52.8	50.2	41.2	43.4	48.1	50.1	19.7	58.5	56.1	44.2	37.8	29.3	71.1	63.0	28.5	17.7	26.7	28.6	22.1	38.7	41.8	43.0	43.1	73.8	46.2	74.5	45.6	47.4	35.6	22.5	29.7	46.4	23.2	38.3	16.9	21.8	40.9	60.2	28.7	33.0	22.4	28.7	64.4	32.1	28.9	39.2	52.6	64.3	38.5	49.3	36.4	47.0	48.5	25.5	32.1	50.3	27.6	35.4	30.4	45.3	30.4	58.6	47.4	36.6	35.4	29.0	38.7	33.1	28.6	36.7	32.9	40.6	23.4	39.9	34.0	31.1	34.2	39.6	24.2	41.9	40.8	26.0	35.2	32.0	39.3	24.4	26.1	28.0	29.8	38.0	24.1	137.0	158.5	75.9	513.8	608.0	132.0	46.4	73.9	278.4	290.0	109.9	60.9	146.8	77.9	135.8	55.7	139.6	98.3	23.3	160.7	185.9	198.0	381.5	112.3	94.7	120.9	143.0	124.9	225.9	143.6	66.9	96.4	139.7	145.1	118.2	136.8	145.0	155.3	98.2	105.0	78.9	100.0	155.2	201.9	125.6	93.5	741.0	293.5	102.2	111.1	404.2
STK24	"MST-3, MST3, MST3B, STE20, STK3"	ENSG00000102572	"Serine/threonine kinase 24"	Q9Y6E0	13	98445185-98577940	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026435, HPA026502"	Enhanced		Supported	Nucleoli,Cytosol		No	No		2800000	"Nucleoli, Cytosol"		"HPA026435: AB_1854151, HPA026502: AB_1854152"	"unprognostic (3.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.67e-3)"	"prognostic unfavorable (6.23e-6)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (9.62e-2)"	"prognostic favorable (6.91e-5)"	"unprognostic (3.10e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-2)"	28.6	14.2	15.0	29.7	16.9	19.1	34.8	12.2	21.0	36.3	37.4	12.1	23.0	31.9	24.6	26.5	68.4	20.4	41.3	30.0	14.7	12.8	30.5	14.2	23.9	31.2	10.6	10.1	20.0	20.6	12.4	13.9	38.4	14.7	28.3	28.8	36.8	30.8	21.6	18.8	60.6	67.9	34.8	9.2	31.7	30.2	22.1	7.6	38.2	28.2	41.6	48.5	39.2	45.4	8.1	11.2	11.4	13.4	1.5	13.7	6.7	36.0	11.3	20.0	18.5	30.8	18.5	28.5	16.9	23.8	23.7	23.2	33.0	49.1	25.7	8.6	21.1	14.9	32.7	18.5	37.3	22.7	64.1	9.5	27.5	14.4	18.9	43.6	27.6	19.5	11.9	59.6	18.6	54.9	25.1	20.4	20.3	9.9	17.8	15.5	15.7	20.6	11.4	17.9	49.1	8.5	26.1	12.3	13.9	22.9	32.6	11.7	16.8	10.7	17.3	22.8	31.9	20.8	26.9	27.4	15.1	11.0	12.3	19.4	17.4	9.1	9.6	23.5	16.7	24.8	5.8	13.4	6.1	6.1	10.6	7.2	6.6	11.4	8.7	11.2	8.1	7.8	6.1	11.4	1.5	12.7	7.5	13.7	6.7	15.0	16.9	12.2	21.0	14.7	12.8	10.6	10.1	14.7	7.6	11.9	24.3	29.0	62.3	63.0	20.3	2.8	68.8	34.8	44.3	64.6	53.0	35.6	21.6	29.9	2.5	26.3	110.9	0.0	47.8	36.3	36.7	53.4	18.4	22.9	24.7	9.5	40.9	27.0	68.7	3.4	24.7	40.1	54.0	16.2	70.9	22.1	67.8	59.4	28.7	31.9	11.4	38.8	29.0	1.8	3.6	71.8	16.7	21.8	51.8	117.9
EDN2	ET2	ENSG00000127129	"Endothelin 2"	P20800	1	41478775-41484673	"Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 27.8"	"Cell type enhanced"	"Detected in many"	18	"Basal glandular cells: 145.6;Collecting duct cells: 66.3;Glandular cells: 63.5"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 24.0"	"Region enriched"	"Detected in single"	12	"pons and medulla: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.6;EFO-21: 21.7;HeLa: 7.3;SCLC-21H: 10.4;SK-BR-3: 25.8;U-2 OS: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028459	Uncertain		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"HPA028459: AB_10602490"	"unprognostic (2.71e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (5.81e-4)"	"unprognostic (5.59e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.14e-2)"	"unprognostic (3.85e-1)"	0.5	0.2	0.0	0.9	0.2	0.3	2.2	0.0	0.1	15.1	13.6	0.4	1.4	4.5	1.8	6.3	17.4	2.3	0.4	1.9	0.0	0.0	4.0	0.8	18.4	0.1	0.0	0.0	0.8	3.2	0.1	1.1	0.4	2.6	9.7	1.3	1.4	4.3	1.0	0.9	8.9	27.8	0.2	0.0	0.1	0.9	0.7	0.1	0.0	1.3	4.0	13.7	1.2	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	8.6	0.0	21.7	0.0	0.0	1.1	0.0	0.1	0.0	2.4	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.5	0.2	0.0	0.0	0.8	5.1	5.8	0.4	10.4	0.0	0.2	25.8	0.0	0.5	0.5	0.0	0.0	0.0	10.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.1	6.0	1.0	0.0	145.6	27.0	0.0	0.4	5.1	1.4	0.0	66.3	0.0	0.0	0.0	6.2	0.0	0.0	10.9	0.0	0.9	0.0	0.5	63.5	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.5	6.7	2.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	25.5	0.0	0.0	3.3	23.3
STK38L	"KIAA0965, NDR2"	ENSG00000211455	"Serine/threonine kinase 38 like"	Q9Y2H1	12	27243968-27325959	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 19.3;granulocytes: 32.2;monocytes: 13.0"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 57.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038623, HPA051324"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA038623: AB_10967059, HPA051324: AB_2681442"	"unprognostic (2.14e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.94e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (5.82e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.05e-2)"	21.2	8.4	11.0	14.6	10.9	10.9	27.2	9.6	14.6	13.0	26.3	5.7	9.7	8.4	23.9	18.2	16.8	14.8	18.2	30.2	10.9	7.8	8.9	8.5	10.8	7.8	11.1	11.8	9.6	8.9	30.2	15.2	10.6	11.9	15.3	15.0	6.8	14.0	10.9	9.1	10.8	14.6	52.3	17.0	7.6	15.6	7.5	10.1	10.0	8.8	10.5	9.8	21.9	22.7	4.5	19.3	32.2	13.0	4.0	4.0	5.3	4.2	5.8	15.1	6.7	6.9	4.7	11.2	2.7	4.0	1.7	2.5	7.3	3.2	9.9	6.5	2.4	5.2	7.9	6.8	4.7	2.7	57.8	5.6	6.1	7.0	3.6	5.8	15.0	7.1	5.7	4.9	6.4	8.2	11.2	13.9	12.8	7.4	7.8	3.5	3.0	9.8	16.3	17.9	11.2	8.8	3.7	17.6	7.6	2.5	8.1	2.4	8.1	12.2	7.5	4.7	15.4	3.7	5.1	5.4	6.0	5.3	8.6	7.4	2.8	2.8	10.4	3.0	7.0	2.4	6.0	13.0	22.9	4.0	11.1	2.8	4.5	3.1	3.9	19.3	3.4	3.8	3.1	32.2	4.0	8.1	8.2	4.0	5.3	11.0	10.9	9.6	14.6	10.9	7.8	11.1	11.8	11.9	10.1	17.9	14.4	9.8	27.4	31.5	11.3	44.5	10.2	9.4	20.5	8.7	2.0	10.0	8.3	41.2	13.6	21.5	19.7	0.0	35.8	7.9	16.0	21.3	16.3	13.0	27.6	9.5	18.5	18.4	33.1	2.3	6.1	48.1	20.3	45.1	27.7	7.5	51.1	31.7	11.3	10.5	6.4	19.4	50.7	6.5	12.1	28.0	23.2	12.5	20.5	39.1
MRPL39	"C21orf92, FLJ20451, L39mt, MGC104174, MGC3400, MRP-L5, MSTP003, PRED22, PRED66, RPML5"	ENSG00000154719	"Mitochondrial ribosomal protein L39"	Q9NYK5	21	25585656-25607517	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 164.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018331	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA018331: AB_1854111"	"unprognostic (3.81e-3)"	"unprognostic (5.34e-2)"	"unprognostic (8.55e-3)"	"unprognostic (4.61e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.32e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (7.48e-2)"	"unprognostic (7.32e-3)"	"unprognostic (9.81e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.45e-2)"	"unprognostic (6.89e-2)"	15.3	29.4	18.7	14.4	22.7	12.0	17.1	24.0	25.6	11.7	17.8	12.8	13.6	15.8	14.1	27.3	20.9	13.1	9.9	38.2	22.1	13.8	24.9	33.5	12.9	19.4	23.4	23.9	13.7	18.8	28.9	13.6	16.0	19.6	13.1	20.6	8.3	14.8	13.3	35.0	15.5	14.3	16.7	16.6	13.9	17.2	35.9	21.6	13.2	12.7	26.7	21.9	13.7	14.3	28.8	19.7	14.4	13.3	15.4	24.9	8.8	28.7	14.2	20.2	12.8	10.2	14.9	31.3	18.7	16.6	26.1	22.0	27.9	16.3	31.8	10.5	11.6	23.7	8.5	42.7	25.3	29.2	16.0	22.3	32.5	15.4	29.4	11.9	32.8	10.8	12.0	22.6	25.8	21.2	14.5	19.3	33.3	35.7	26.3	25.7	18.1	21.4	17.9	32.1	29.0	22.1	25.1	32.8	33.4	26.9	11.7	12.8	12.3	17.1	31.6	24.3	14.9	22.9	18.7	12.1	14.0	20.7	14.8	22.6	18.6	23.6	39.6	20.8	35.5	20.9	14.4	8.1	9.0	18.1	13.3	22.5	28.8	22.1	20.3	14.0	22.6	22.1	19.5	1.3	15.4	9.3	19.7	24.9	8.8	18.7	22.7	24.0	25.6	22.1	13.8	23.4	23.9	19.6	21.6	23.8	8.0	16.6	17.4	17.7	21.4	70.6	5.1	33.5	17.0	24.4	9.8	41.0	26.6	27.7	164.4	23.3	8.5	0.0	29.4	36.2	20.2	11.4	15.0	17.9	26.8	9.5	7.5	13.5	8.8	22.4	13.8	14.2	18.6	18.0	9.1	19.0	23.6	5.8	21.9	40.7	14.3	45.3	21.7	74.3	25.8	14.8	30.9	13.8	18.9	10.9
KCNK5	"K2p5.1, TASK-2"	ENSG00000164626	"Potassium two pore domain channel subfamily K member 5"	O95279	6	39188973-39229450	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 48.4;intestine: 74.2;kidney: 46.3"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 43.3;Enterocytes: 50.9;Proximal tubular cells: 29.1;Syncytiotrophoblasts: 38.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 18.8;HEL: 19.3;HMC-1: 17.8;K-562: 18.0;OE19: 14.7;T-47d: 14.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059148	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059148: AB_2683929"	"unprognostic (1.46e-1)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.09e-4)"	"unprognostic (3.97e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.57e-3)"	"unprognostic (7.14e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (2.98e-1)"	"prognostic favorable (4.98e-7)"	"unprognostic (2.34e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (4.45e-4)"	2.2	1.3	0.3	4.5	0.4	4.5	3.9	0.4	0.5	4.3	25.5	0.8	2.6	16.1	5.6	4.0	4.3	1.4	48.4	1.5	0.3	0.0	46.3	12.6	3.6	1.1	0.8	0.4	4.0	15.3	1.2	1.0	15.2	0.8	2.3	4.7	3.6	16.0	1.6	0.5	15.8	74.2	1.3	0.6	1.2	9.4	0.9	0.3	2.0	9.0	2.2	4.1	2.2	3.8	0.0	0.9	0.2	0.1	0.0	1.4	0.5	3.4	3.2	4.3	1.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	18.8	7.8	0.0	5.7	0.0	0.4	7.2	3.3	0.1	0.0	0.0	2.4	19.3	1.5	0.1	0.0	3.9	17.8	0.0	0.0	0.1	0.0	0.0	0.0	4.3	18.0	0.0	0.0	6.1	8.7	4.3	7.9	14.7	0.0	0.0	0.8	7.3	3.0	2.9	1.0	0.8	3.1	4.0	0.0	1.7	14.3	6.5	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.3	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.9	1.4	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.9	0.2	0.5	0.3	0.4	0.4	0.5	0.3	0.0	0.8	0.4	0.8	0.3	0.0	19.2	0.0	1.8	3.3	0.0	0.4	43.3	0.0	6.8	1.8	0.0	22.6	5.0	13.0	0.0	0.2	50.9	0.0	10.8	3.9	1.9	1.8	0.0	23.1	1.8	0.0	0.0	0.0	0.3	0.0	0.6	0.7	1.7	1.0	10.8	0.0	7.5	10.5	0.0	29.1	0.0	0.0	0.4	0.0	0.7	2.4	38.1	1.0	6.4	10.7
BCL2L1	"Bcl-X, bcl-xL, bcl-xS, BCL2L, BCLX, PPP1R52"	ENSG00000171552	"BCL2 like 1"	Q07817	20	31664452-31723989	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Apoptosis, Endocytosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035734, CAB072801"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"CAB072801: , HPA035734: AB_2674757"	"unprognostic (2.29e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.04e-2)"	"unprognostic (7.82e-3)"	"prognostic favorable (9.57e-4)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (5.87e-4)"	"unprognostic (1.06e-1)"	"prognostic favorable (8.89e-5)"	"unprognostic (9.67e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.32e-2)"	30.8	21.4	25.1	16.4	34.3	57.0	40.7	27.7	40.7	28.2	22.6	37.0	13.0	31.3	18.7	12.2	36.9	31.5	35.9	26.9	27.0	23.7	42.6	39.3	40.6	17.8	43.4	24.3	11.5	28.5	17.5	22.8	29.0	33.4	24.8	21.4	31.5	33.8	21.5	21.9	26.1	30.4	19.2	28.8	26.6	28.0	30.2	38.4	56.4	25.8	15.4	20.7	24.5	22.4	3.9	7.8	17.0	8.9	12.5	27.2	16.5	64.0	38.2	7.1	6.8	38.0	27.5	22.6	15.3	25.1	16.1	15.4	90.1	31.1	10.5	39.2	22.1	31.2	21.7	9.4	43.4	11.4	11.0	2.4	48.0	8.2	44.8	28.5	4.8	28.5	19.7	18.1	20.3	44.2	21.8	23.0	18.4	29.7	8.0	54.3	18.3	14.1	4.6	9.7	31.8	34.1	8.9	21.3	33.3	65.8	17.9	18.3	8.6	18.8	18.6	8.8	13.5	36.9	5.5	31.8	20.3	23.5	8.1	27.5	5.3	29.7	8.7	29.9	21.1	12.8	17.0	8.1	15.4	27.2	8.2	21.0	3.9	12.4	18.1	7.8	3.7	5.7	13.0	9.8	12.5	8.9	4.7	13.8	16.5	25.1	34.3	27.7	40.7	27.0	23.7	43.4	24.3	33.4	38.4	14.9	11.6	8.2	49.1	16.4	21.1	9.0	101.9	21.4	5.7	36.6	43.2	22.9	72.9	88.0	6.3	31.5	38.7	93.5	56.7	9.6	15.0	56.5	12.7	32.5	33.2	27.0	23.7	20.9	17.2	4.2	17.5	12.2	16.9	127.2	22.5	15.8	125.9	17.5	40.3	57.4	27.1	45.3	20.2	26.5	12.6	8.5	15.8	30.5	18.5	125.1
FRMD5	MGC14161	ENSG00000171877	"FERM domain containing 5"	Q7Z6J6	15	43870761-44195252	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 24.5;heart muscle: 48.9"	"Cell type enhanced"	"Detected in some"	9	"Cardiomyocytes: 12.9;Early spermatids: 10.3;Muller glia cells: 14.6;Pancreatic endocrine cells: 7.2"	"Cancer enhanced"	"Detected in many"		"glioma: 6.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"B-cells: 1.6;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 11.9;HUVEC TERT2: 14.8;WM-115: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.54e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.26e-7)"	"unprognostic (3.55e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.00e-3)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (7.01e-2)"	"unprognostic (2.92e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.31e-1)"	1.0	7.2	8.9	1.4	12.3	1.6	1.3	8.2	15.1	1.0	1.7	24.5	0.0	1.0	0.9	1.3	1.2	2.0	1.3	48.9	10.9	6.9	1.2	0.8	1.0	1.1	14.7	4.8	1.0	1.1	1.1	1.6	0.9	10.7	1.2	1.8	2.9	2.0	1.2	0.8	1.2	1.3	1.1	13.4	1.2	2.2	4.3	11.5	0.0	1.2	0.0	0.8	1.1	0.2	1.6	0.3	0.0	0.0	0.0	1.6	0.0	3.3	1.9	1.2	0.7	1.5	0.1	0.2	0.7	1.1	2.1	4.2	5.6	3.7	0.2	0.7	0.5	5.6	4.0	1.8	3.9	1.9	0.2	2.0	0.5	1.7	2.4	0.1	0.0	0.2	0.0	0.4	5.9	11.9	4.3	14.8	3.0	0.1	0.4	2.3	0.3	0.5	0.0	1.0	11.4	1.9	0.0	2.7	0.0	2.0	1.2	7.8	2.7	0.4	0.0	8.0	1.0	0.1	0.1	0.5	4.1	7.1	1.0	10.5	0.2	1.0	0.4	5.9	0.2	33.8	0.0	0.0	0.0	0.8	0.0	1.6	1.6	1.2	0.4	0.0	0.5	0.6	0.9	0.0	0.0	0.0	0.3	1.6	0.0	8.9	12.3	8.2	12.4	10.9	6.9	14.7	4.8	10.7	11.5	0.0	0.0	0.0	0.0	0.3	6.2	12.9	0.0	0.0	0.0	0.0	2.0	0.0	0.0	2.2	10.3	0.0	0.0	0.0	5.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.2	0.0	0.0	4.1	0.3	0.0	0.0	0.0	0.3	14.6	7.2	0.0	0.0	0.6	4.1	0.0	0.0	5.8	2.5	0.0	0.0	0.0	0.6	0.0
GPSM2	"DFNB82, LGN, Pins"	ENSG00000121957	"G protein signaling modulator 2"	P81274	1	108875350-108934545	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"		Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 35.6"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 125.7;Syncytiotrophoblasts: 74.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007327, HPA008408, CAB018962"	Uncertain		Supported	Cytosol		NA	Yes			Cytosol		"CAB018962: , HPA007327: AB_1849941, HPA008408: AB_1849939"	"unprognostic (1.97e-1)"	"unprognostic (6.80e-2)"	"prognostic favorable (7.86e-5)"	"unprognostic (1.37e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (8.57e-6)"	"unprognostic (7.12e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.92e-2)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (7.55e-3)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (6.27e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.00e-2)"	3.8	4.0	16.6	4.4	17.9	13.9	8.5	10.1	20.6	7.5	13.6	17.9	2.5	8.0	6.9	4.3	30.4	2.9	3.1	3.0	15.2	14.1	2.6	1.9	6.6	5.8	19.7	9.0	2.4	2.4	4.0	2.1	7.6	19.6	6.3	15.4	1.3	7.0	5.7	8.0	35.6	10.1	10.6	25.1	2.0	5.3	11.4	18.8	14.1	2.3	23.5	12.1	6.5	10.6	1.8	1.6	8.6	1.2	0.7	4.4	0.4	41.3	5.9	13.6	10.7	13.7	8.2	10.2	8.3	21.1	10.3	15.9	6.4	10.6	9.5	2.3	11.6	7.9	9.1	8.8	21.8	13.3	9.8	5.9	7.0	11.6	7.0	1.8	9.3	6.4	1.5	44.6	11.2	44.5	3.8	11.0	7.4	5.3	14.3	22.1	12.8	7.5	4.7	3.5	18.0	10.1	6.6	22.0	2.5	8.9	6.5	10.4	9.0	11.4	23.2	8.8	3.7	9.1	9.0	6.8	7.9	12.4	21.1	15.7	6.4	5.9	9.4	12.7	15.5	36.7	0.1	1.2	8.6	0.8	0.9	0.5	0.7	0.6	1.1	1.6	1.8	1.1	0.8	1.6	0.7	0.4	0.7	4.4	0.4	16.6	17.9	10.1	13.6	15.2	14.1	19.7	9.0	19.6	18.8	14.9	3.5	5.2	16.6	55.6	46.3	2.1	0.0	6.7	14.8	7.0	125.7	42.8	10.0	2.2	39.6	3.8	8.0	0.0	1.6	37.2	12.8	3.8	2.3	0.5	7.7	41.3	8.7	1.8	5.2	16.4	17.3	4.6	25.3	6.4	12.1	7.1	3.2	7.0	4.9	0.3	43.8	0.0	5.3	15.2	25.1	35.5	74.6	7.7	11.8	13.3
SPP1	"BNSP, BSPI, ETA-1, OPN"	ENSG00000118785	"Secreted phosphoprotein 1"	P10451	4	87975650-87983426	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Biomineralization, Cell adhesion"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 303.9;kidney: 700.7;placenta: 331.0"	"Cell type enriched"	"Detected in many"	9	"Hofbauer cells: 50179.8"	"Cancer enhanced"	"Detected in all"		"glioma: 1690.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"neutrophil: 19.2"	"Lineage enriched"	"Detected in single"	192	"granulocytes: 19.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 218.9;Hep G2: 107.8;RPTEC TERT1: 477.9"	"Region enhanced"	"Detected in all"		"pons and medulla: 331.4"	"Low region specificity"	"Detected in all"			"HPA027540, HPA027541"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	114000000	54000000	"Golgi apparatus"		"HPA027540: AB_10600222, HPA027541: AB_10601446"	"unprognostic (4.74e-2)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavorable (2.84e-6)"	"unprognostic (2.46e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.63e-2)"	20.7	4.1	25.5	8.3	42.7	1.1	8.7	4.3	61.0	4.7	2.7	27.3	0.0	2.1	17.3	2.3	1.5	4.2	303.9	2.6	37.2	26.4	700.7	3.9	3.2	2.0	97.0	9.1	3.1	23.6	1.3	1.5	331.0	52.3	2.4	1.9	3.9	7.3	3.9	2.5	1.1	2.1	5.6	147.9	2.1	2.0	2.4	58.9	0.0	1.7	0.0	1.6	5.3	0.3	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	6.2	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	218.9	0.1	17.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	107.8	0.0	0.3	0.2	0.0	0.0	1.5	0.0	5.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.9	10.1	0.0	0.0	0.1	0.0	51.4	477.9	0.0	0.0	0.0	0.0	0.0	14.4	21.2	0.0	0.2	0.0	0.5	1.1	0.0	1.1	0.0	0.3	0.4	20.0	0.0	20.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	25.5	42.7	4.3	28.8	37.2	26.4	97.0	9.1	52.3	58.9	3.0	6.6	20.0	2.2	1.3	34.3	4.3	1834.4	2.7	0.0	2071.0	25.5	256.7	850.5	3124.6	0.0	17.5	0.0	0.0	59.8	221.1	15.4	0.3	0.0	2.9	50179.8	742.1	0.0	6.7	63.8	0.4	0.9	93.6	1.7	120.8	0.0	3889.3	343.9	0.0	0.0	5328.4	135.9	0.0	4.4	0.3	0.2	0.9	558.5	1.5	0.0	12.7
MAP3K5	"ASK1, MAPKKK5, MEKK5"	ENSG00000197442	"Mitogen-activated protein kinase kinase kinase 5"	Q99683	6	136557047-136792518	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Immunity, Innate immunity, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 55.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007824, HPA063245"	Supported		Supported	Cytosol		NA	NA			Cytosol		"CAB007824: AB_598175, HPA063245: AB_2684969"	"unprognostic (1.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.19e-1)"	"prognostic favorable (6.08e-4)"	"unprognostic (8.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.91e-4)"	"unprognostic (3.97e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	7.7	55.6	13.0	7.5	17.6	7.6	5.5	12.9	12.7	4.0	5.4	6.9	3.6	4.6	7.2	5.1	6.4	6.1	4.9	7.3	11.8	6.8	6.8	5.5	7.7	8.8	8.2	6.4	32.4	28.2	1.5	9.9	3.4	7.9	11.6	6.2	5.8	4.2	4.9	3.7	5.0	4.6	4.3	7.5	9.8	8.7	7.3	8.6	2.0	10.0	3.4	9.0	10.8	18.9	2.5	2.5	8.5	3.0	4.1	7.0	1.4	2.9	1.8	0.0	0.0	4.2	11.3	1.0	4.2	22.7	2.2	2.1	0.1	3.0	1.7	6.2	5.8	1.6	4.0	7.2	2.1	5.7	2.3	5.7	15.0	4.0	0.0	20.1	6.9	0.0	14.8	2.8	3.4	9.8	8.4	7.3	2.1	3.7	16.8	15.3	5.6	0.1	5.9	0.7	5.7	2.4	3.9	4.8	6.8	8.8	18.6	5.3	3.5	3.5	3.4	0.9	0.8	0.7	6.2	6.3	3.6	1.1	0.2	3.9	13.7	9.1	0.0	2.8	9.8	3.2	5.7	3.0	3.3	2.7	2.3	4.9	2.0	4.3	3.7	2.5	2.5	0.4	1.4	8.5	4.1	2.1	2.4	7.0	1.4	13.0	17.6	12.9	9.4	11.8	6.8	8.2	6.4	7.9	8.6	6.0	22.4	10.4	17.9	4.4	17.5	21.8	2.5	16.0	34.2	10.4	5.9	0.7	3.3	2.1	4.9	3.8	7.7	0.0	19.7	0.9	5.1	22.3	5.7	9.6	7.1	0.0	33.5	9.8	22.1	2.3	21.9	18.4	0.0	1.0	12.1	42.4	18.9	5.8	13.4	6.8	2.5	12.9	8.0	1.4	15.0	8.8	2.3	6.9	10.0	19.3
DEFB1	"BD1, DEFB-1, DEFB101, HBD-1, HBD1, MGC51822"	ENSG00000164825	"Defensin beta 1"	P60022	8	6870575-6878022	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 121.1;pancreas: 219.9;salivary gland: 173.0"	"Cell type enriched"	"Detected in many"	5	"Distal tubular cells: 11270.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 522.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 1.4;intermediate monocyte: 1.6"	"Lineage enriched"	"Detected in single"	9	"monocytes: 1.6"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 27.8"					"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA						"unprognostic (2.31e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (5.94e-4)"	"unprognostic (3.24e-1)"	"prognostic favorable (1.90e-5)"	"unprognostic (9.62e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.16e-1)"	1.1	0.0	0.2	0.5	0.3	0.5	10.5	0.6	0.3	38.7	2.3	0.3	1.6	0.6	2.6	3.1	14.9	2.7	6.5	0.7	0.3	0.0	121.1	22.3	0.7	0.2	0.4	0.3	0.8	219.9	0.0	1.6	4.3	0.8	3.8	1.5	0.5	173.0	3.2	0.8	14.6	0.7	0.5	0.7	0.3	4.0	0.7	0.3	0.3	0.8	10.4	8.8	1.8	10.6	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.3	0.0	1.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.1	0.2	0.0	1.3	0.6	27.8	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.3	0.3	0.0	0.4	0.3	0.8	0.3	3.0	5.0	2.9	372.3	80.0	0.3	0.0	2435.7	5.3	4.5	931.7	0.0	6.7	11270.5	1231.2	0.0	0.6	52.3	0.0	250.8	0.3	5.0	291.3	0.0	169.8	3.4	0.0	15.1	4.9	6.0	0.0	16.1	5.3	6.8	26.2	10.3	0.5	226.2	20.7	0.0	94.9	0.6	0.0	4.1	0.0	0.0	470.0	3.1	3.8	11.3	236.2
CASP14	"MGC119078, MGC119079, MICE"	ENSG00000105141	"Caspase 14"	P31944	19	15049384-15058293	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Hydrolase, Protease, Thiol protease"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 109.4"	"Cell type enriched"	"Detected in some"	5	"Suprabasal keratinocytes: 83.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 62.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"hTCEpi: 33.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010059, HPA027062"	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA		2200000	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010059: AB_626800, HPA027062: AB_2672101"	"unprognostic (1.17e-2)"	"unprognostic (6.44e-3)"		"unprognostic (6.22e-2)"		"unprognostic (2.77e-1)"		"prognostic unfavorable (7.59e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (2.68e-1)"		"unprognostic (4.30e-2)"	"unprognostic (1.99e-1)"		"unprognostic (1.97e-1)"	0.2	0.2	0.2	0.0	0.3	0.0	1.9	0.2	0.3	17.9	0.2	0.0	0.8	0.0	1.1	0.3	1.2	0.1	0.0	0.2	0.3	0.2	0.4	0.3	0.2	0.0	0.2	0.0	0.1	0.3	0.0	0.2	0.5	0.0	7.7	0.0	0.0	0.8	2.7	0.3	109.4	0.2	0.0	0.2	0.1	0.2	1.6	0.0	2.3	0.2	0.9	0.0	0.6	4.0	0.8	0.5	2.3	0.6	0.1	0.6	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.6	0.4	0.4	0.2	0.4	0.3	0.6	0.4	0.1	0.8	0.5	0.4	2.3	0.1	0.2	0.5	0.6	0.0	0.2	0.3	0.2	0.3	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	16.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	83.9	0.6	0.0	0.0	0.1
SLC44A2	CTL2	ENSG00000129353	"Solute carrier family 44 member 2"	Q8IWA5	19	10602457-10644559	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 210.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 62.3;SK-BR-3: 60.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003228, HPA070799"	Approved		Approved	"Vesicles,Cell Junctions"		NA	NA		78000	"Vesicles, Cell Junctions"		"HPA003228: AB_1080009, HPA070799: AB_2686314"	"unprognostic (6.35e-3)"	"unprognostic (5.75e-2)"	"unprognostic (4.34e-1)"	"unprognostic (3.06e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.41e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.32e-1)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (8.63e-2)"	"prognostic favorable (1.71e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.21e-3)"	"unprognostic (3.61e-2)"	29.3	14.2	25.1	21.4	28.3	23.4	31.6	24.2	33.9	24.7	23.0	40.7	21.7	10.5	21.0	17.3	31.8	24.8	24.9	29.1	21.2	17.9	29.4	9.1	39.4	46.7	26.1	18.4	14.2	16.5	21.6	8.6	114.9	31.8	19.9	20.3	36.6	22.1	28.8	51.6	29.0	19.1	19.3	37.5	49.4	44.0	51.6	21.2	30.4	26.9	26.4	39.2	29.0	26.3	19.0	17.8	86.0	45.9	13.1	21.8	22.8	62.3	1.5	14.0	8.3	21.2	13.1	39.9	13.6	33.4	22.4	26.5	14.0	29.9	12.6	18.2	37.6	2.7	48.3	2.1	10.4	14.5	0.3	1.8	8.0	7.9	0.5	23.5	0.1	6.8	14.1	13.9	8.4	7.4	18.3	17.1	5.9	3.8	2.1	34.0	45.9	6.6	6.1	4.9	18.5	5.6	14.2	19.9	0.5	7.3	33.2	1.3	8.4	10.7	60.1	1.5	15.2	23.4	0.6	15.6	10.1	3.6	12.0	3.4	0.8	1.4	12.4	2.5	5.6	11.2	22.9	7.2	39.3	21.8	19.6	17.2	17.7	15.1	16.5	3.7	19.0	16.5	16.8	86.0	13.1	45.9	17.8	16.5	22.8	25.1	28.3	24.2	33.9	21.2	17.9	26.1	18.4	31.8	21.2	50.6	29.0	40.2	16.9	8.7	11.9	32.2	20.4	16.0	39.8	87.2	13.7	107.9	1.7	38.7	130.7	26.0	27.4	46.7	39.5	210.6	15.5	11.6	19.7	0.9	32.0	3.2	9.2	66.9	28.0	20.6	35.9	7.7	5.0	4.6	17.2	33.6	29.3	37.4	53.0	3.8	2.9	58.2	18.6	3.0	2.7	7.4	78.1	41.7	20.9	16.5
UNC13D	Munc13-4	ENSG00000092929	"Unc-13 homolog D"	Q70J99	17	75827225-75844717	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Exocytosis		"Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 67.1"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 70.2;granulocytes: 43.9;Hofbauer cells: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 56.1;HMC-1: 58.2;SK-BR-3: 39.8"	"Region enriched"	"Detected in single"	6	"cerebellum: 5.6"	"Not detected"	"Not detected"			"HPA067117, HPA073525"	Enhanced		Supported	Vesicles,Cytosol		NA	NA		14000000	Cytosol	Vesicles	"HPA067117: AB_2685784, HPA073525: AB_2686615"	"unprognostic (6.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (2.98e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (5.28e-12)"	"unprognostic (3.27e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.59e-2)"	4.5	3.3	2.9	17.1	5.2	31.3	4.5	4.1	3.1	5.2	5.2	2.8	1.4	4.5	3.8	1.8	11.5	5.2	8.7	13.0	1.8	1.6	2.6	4.9	30.1	24.9	4.5	1.6	8.7	5.5	0.3	5.3	67.1	3.2	3.1	2.6	2.6	8.0	3.9	3.2	3.0	7.6	2.8	3.7	33.8	7.2	2.2	3.3	23.6	2.4	9.3	24.7	7.0	8.2	4.0	6.9	24.8	13.6	8.2	11.5	7.9	8.4	3.2	0.1	0.0	0.1	0.2	10.7	0.0	0.0	0.0	0.0	8.2	19.1	0.7	10.2	0.0	1.4	2.9	0.0	0.5	0.0	0.1	0.1	56.1	24.9	5.2	0.9	21.4	58.2	0.1	0.4	0.1	0.5	0.5	3.8	9.8	19.4	0.2	0.0	14.4	22.6	10.7	0.2	15.0	0.4	7.2	0.2	0.3	0.3	3.4	0.0	15.6	3.6	39.8	0.2	0.1	10.7	12.1	10.6	0.1	15.1	0.1	0.0	0.3	1.3	0.9	0.1	6.8	0.0	24.8	8.0	16.4	11.5	9.4	10.4	4.0	6.7	8.1	6.9	2.2	5.3	6.9	22.4	8.2	13.6	4.0	6.0	7.9	2.9	5.2	4.1	3.1	1.8	1.6	4.5	1.6	3.2	3.3	41.7	11.7	22.2	1.7	1.0	11.3	70.2	10.2	0.0	5.7	3.5	19.6	2.8	0.0	6.2	3.9	5.7	20.0	0.0	5.3	8.4	2.3	1.1	43.9	0.8	46.9	4.8	5.8	4.3	22.7	0.0	2.6	18.4	1.7	13.6	2.3	5.8	27.8	10.5	1.4	0.6	15.5	0.0	1.4	1.4	0.9	1.3	21.6	30.5	2.2	2.0
SFN	YWHAS	ENSG00000175793	Stratifin	P31947	1	26863138-26864457	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 256.2;lymphoid tissue: 107.4;skin 1: 123.8;tongue: 256.0"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 6884.3;Suprabasal keratinocytes: 9365.4;Urothelial cells: 2426.4"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 2526.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"basophil: 7.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.1"	"Cell line enhanced"	"Detected in many"		"A-431: 70.1;HaCaT: 110.7;HBEC3-KT: 170.4;hTCEpi: 114.4"	"Low region specificity"	"Detected in some"							"CAB006268, HPA011105, CAB040552, HPA061603"	Enhanced		Supported	"Nucleoli rim,Cytosol"	"Secreted in other tissues"	NA	NA		54000000	Cytosol	"Nucleoli rim"	"CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339, HPA061603: "	"unprognostic (5.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.37e-2)"	"prognostic favorable (1.92e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (7.45e-6)"	"unprognostic (7.90e-3)"	"unprognostic (3.25e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.06e-2)"	0.4	0.0	0.5	3.1	0.5	0.0	3.8	0.4	0.7	37.5	10.7	0.5	0.5	5.9	3.3	0.7	256.2	0.0	6.0	0.3	0.6	0.1	1.2	0.5	8.2	0.3	0.4	0.3	0.3	0.3	0.0	0.3	3.4	0.8	5.9	4.0	0.3	25.5	0.4	0.4	123.8	13.2	0.5	0.7	0.3	6.6	0.4	0.4	3.1	0.4	256.0	107.4	9.1	47.7	0.0	0.0	7.1	0.0	0.0	0.6	0.0	70.1	11.8	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	4.3	37.1	0.6	3.1	0.0	0.0	110.7	0.0	170.4	0.0	16.7	0.5	0.0	11.8	12.5	0.0	0.0	0.1	0.0	114.4	0.0	29.9	0.0	0.0	0.0	0.1	0.4	0.0	15.0	0.0	0.0	0.2	12.2	19.7	0.0	0.0	3.9	26.5	16.2	0.0	0.0	16.9	3.0	0.1	0.2	7.9	0.1	0.0	0.0	32.4	0.0	0.4	0.1	0.5	0.3	0.1	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.5	0.5	0.4	0.7	0.6	0.1	0.4	0.3	0.8	0.4	166.7	216.2	0.5	1339.8	6884.3	0.0	0.3	33.1	30.8	122.8	15.7	0.0	6.7	3.3	52.1	0.0	0.6	409.5	0.0	68.0	45.3	37.0	487.4	31.2	0.0	1.6	0.0	64.7	0.6	0.3	0.0	0.0	15.6	506.2	1.8	78.2	0.0	315.2	136.8	0.0	0.0	0.0	0.0	110.7	0.0	0.2	9365.4	5.0	0.0	146.1	2426.4
SPTLC3	"C20orf38, FLJ11112, hLCB2b, LCB2B, SPTLC2L"	ENSG00000172296	"Serine palmitoyltransferase long chain base subunit 3"	Q9NUV7	20	13008979-13169103	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"placenta: 154.0"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 22.9;Syncytiotrophoblasts: 38.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"pons and medulla: 10.5"	"Group enriched"	"Detected in some"	5	"MAIT T-cell: 3.0;NK-cell: 4.1"	"Group enriched"	"Detected in many"	13	"NK-cells: 4.1;T-cells: 3.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.4;RPTEC TERT1: 21.8;U-2197: 15.2;U-87 MG: 28.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA044247, HPA048079"	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"HPA044247: AB_2678872, HPA048079: AB_2680252"	"unprognostic (6.81e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.43e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.70e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (5.08e-2)"	"prognostic favorable (4.51e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.18e-1)"	3.2	4.5	1.3	1.6	2.2	0.0	4.3	1.7	1.7	4.3	5.0	2.2	4.4	8.3	4.8	9.6	5.6	3.4	5.8	4.8	2.0	1.5	15.6	11.9	5.7	0.7	2.5	2.2	4.3	3.8	10.2	4.2	154.0	10.5	4.5	3.8	3.8	7.8	5.8	1.0	25.1	9.0	3.0	6.9	1.9	2.2	4.2	1.4	5.7	24.3	3.6	1.9	4.8	6.0	0.0	0.2	0.1	0.0	4.1	3.0	0.2	0.7	1.1	0.9	0.0	7.1	10.3	5.5	0.0	1.5	1.0	4.1	8.9	4.5	0.0	0.5	0.2	9.0	12.2	0.0	3.4	1.4	0.0	0.0	0.0	2.8	12.6	0.6	0.0	0.1	5.8	10.7	4.0	1.4	3.8	0.7	2.1	0.0	16.4	11.5	0.2	0.0	0.0	0.0	1.0	1.4	1.1	2.0	7.2	21.8	8.7	0.0	0.1	0.1	1.1	0.0	1.6	9.1	0.2	1.6	4.6	1.5	15.2	1.0	0.1	0.0	0.0	28.8	0.0	0.0	0.1	0.0	0.0	0.5	0.0	3.0	0.0	0.4	0.1	0.0	0.0	0.7	0.1	0.1	4.1	0.0	0.2	0.0	0.2	1.3	2.2	1.7	1.7	2.0	1.5	2.5	2.2	10.5	1.4	6.0	18.2	0.0	4.8	2.2	0.0	15.1	5.1	4.0	6.8	8.7	0.0	22.9	6.6	2.2	15.0	2.2	4.9	0.0	3.8	10.5	7.2	3.4	1.1	18.7	2.5	0.0	0.0	0.6	2.5	8.5	3.4	0.9	0.0	0.0	4.7	13.6	2.5	8.0	2.5	11.9	0.0	0.0	0.3	0.9	0.1	1.9	38.6	1.3	6.1	1.8
ALDH3B1	ALDH7	ENSG00000006534	"Aldehyde dehydrogenase 3 family member B1"	P43353	11	68008578-68029282	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 39.8"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 1: 107.2;Ciliated cells: 265.0;Club cells: 76.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 39.8"	"Group enriched"	"Detected in many"	10	"dendritic cells: 17.6;granulocytes: 39.8;monocytes: 32.9"	"Cell line enhanced"	"Detected in many"		"A549: 45.0;CAPAN-2: 46.3;U-87 MG: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA038525	Uncertain					NA	NA					"HPA038525: AB_2676062"	"unprognostic (3.50e-1)"	"unprognostic (4.22e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (1.56e-2)"	"unprognostic (9.66e-3)"	"unprognostic (9.73e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (8.27e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.06e-1)"	9.1	9.8	1.8	5.0	2.5	21.4	2.4	1.3	2.3	6.2	7.8	4.2	1.1	11.8	4.0	7.0	4.0	21.0	13.7	3.1	2.6	2.4	9.3	5.1	28.5	14.3	4.3	1.4	6.6	12.9	0.0	3.8	13.4	3.8	4.6	3.1	7.8	5.7	2.0	2.0	1.8	21.4	4.2	5.6	11.7	10.4	2.9	1.9	0.7	1.7	1.5	3.3	7.6	3.8	0.1	17.6	39.8	32.9	2.9	0.1	9.8	3.3	45.0	0.3	0.9	3.0	9.6	8.1	4.6	7.6	3.3	1.6	1.6	46.3	0.2	8.2	10.6	4.7	3.8	0.1	0.6	0.8	0.1	0.3	0.4	18.1	3.9	19.1	2.6	0.1	7.0	2.0	1.6	4.5	7.5	0.1	0.2	0.1	8.2	5.3	2.7	0.2	2.5	0.3	22.4	2.7	1.0	1.8	24.7	5.4	0.4	0.5	0.2	10.6	8.9	4.4	0.2	10.3	5.8	5.1	4.8	6.7	23.1	1.5	0.1	0.8	0.0	27.3	7.3	2.2	11.8	23.0	39.8	0.0	32.9	0.1	0.1	0.0	0.0	17.6	0.1	0.0	0.0	6.9	2.9	29.1	1.8	0.0	9.8	1.8	2.5	1.3	2.3	2.6	2.4	4.3	1.4	3.8	1.9	107.2	53.7	0.9	2.6	1.9	0.5	2.4	17.8	265.0	76.2	5.2	0.0	0.7	0.0	4.9	18.4	1.9	11.7	0.0	2.2	6.7	8.2	2.5	23.3	2.0	31.5	3.2	2.4	1.3	54.8	7.6	1.7	31.3	3.3	8.2	10.0	2.0	11.4	7.0	1.4	20.0	0.4	0.0	4.2	0.2	0.2	0.9	0.6	0.0	10.0	4.4
PDZD8	"bA129M16.2, FLJ34427, PDZK8"	ENSG00000165650	"PDZ domain containing 8"	Q8NEN9	10	117277274-117375467	"Predicted intracellular proteins"	"Host-virus interaction, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 61.7"	"Cell type enhanced"	"Detected in all"	11	"Early spermatids: 174.2;Late spermatids: 366.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 52.1"	"Low region specificity"	"Detected in all"							"HPA015716, HPA051610"	Uncertain		Approved	"Nucleoli fibrillar center,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Nucleoli fibrillar center"	"Plasma membrane"	"HPA015716: AB_1855162, HPA051610: AB_2681549"	"unprognostic (1.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.75e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.90e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.60e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.01e-2)"	8.1	7.8	12.2	5.1	13.3	61.7	8.2	8.7	12.9	9.1	14.8	11.4	32.8	14.0	10.7	15.1	11.4	7.7	10.3	7.0	12.0	10.4	13.5	21.1	7.4	3.7	14.7	7.4	10.1	20.1	18.9	8.6	6.0	12.9	7.3	12.0	6.3	12.4	21.3	6.7	6.6	13.7	7.6	14.8	5.0	10.6	23.2	12.4	8.9	7.5	5.4	4.2	8.0	15.3	1.0	1.7	5.7	2.0	2.5	2.5	0.5	5.2	9.0	3.3	6.3	5.7	5.1	1.8	5.0	4.4	2.3	1.8	4.5	7.0	6.2	4.6	7.6	2.6	7.9	5.7	5.4	4.5	3.9	5.1	52.1	3.7	4.4	4.2	21.7	4.9	5.0	6.4	4.1	12.3	8.5	4.0	5.1	4.7	6.5	5.6	2.1	4.2	2.8	2.6	2.7	8.1	3.4	12.7	2.6	6.7	3.8	2.6	4.2	5.4	2.3	3.9	3.1	1.6	3.2	6.4	3.8	4.2	6.8	8.6	3.5	2.9	4.5	4.7	10.0	3.3	2.7	1.4	5.7	2.2	1.1	2.5	0.9	1.8	1.8	1.7	1.0	1.5	2.0	5.6	2.5	2.0	1.3	0.8	0.5	12.2	13.3	8.7	12.9	12.0	10.4	14.7	7.4	12.9	12.4	11.9	27.8	8.8	17.7	26.4	29.3	16.7	43.3	38.8	25.0	17.4	21.6	8.3	8.3	27.0	174.2	17.8	23.8	23.3	70.7	5.7	19.5	25.1	41.7	45.8	6.8	30.2	32.4	16.5	12.3	366.0	21.9	15.2	21.9	9.0	31.7	24.9	56.7	21.0	26.9	23.1	40.1	25.8	18.9	16.9	29.3	28.2	5.6	18.7	39.0	34.2
AURKA	"AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7"	ENSG00000087586	"Aurora kinase A"	O14965	20	56369389-56392337	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 32.3;testis: 41.1"	"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 70.0;Extravillous trophoblasts: 59.5;granulocytes: 55.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"CAB001454, HPA002636"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		Yes	Yes			"Nucleoplasm, Centrosome, Cytosol"		"CAB001454: AB_563420, HPA002636: AB_1845217"	"unprognostic (7.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (9.40e-5)"	"unprognostic (1.92e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (4.69e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.47e-8)"	"unprognostic (1.67e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (5.14e-2)"	3.7	2.3	1.5	12.7	1.3	8.3	3.0	1.3	1.8	1.4	6.7	1.3	0.8	7.3	1.8	1.2	7.7	1.1	3.7	4.1	1.1	1.1	2.4	5.1	2.9	12.3	1.6	0.9	8.3	1.4	0.3	0.7	6.1	1.5	1.0	8.3	1.5	2.7	0.5	6.9	2.1	7.2	2.7	1.3	7.4	4.3	41.1	1.1	32.3	1.2	5.9	13.3	2.4	2.4	3.9	5.2	6.0	8.7	2.0	6.6	2.6	33.0	24.4	16.3	11.5	0.9	2.1	20.7	27.1	12.7	65.7	27.7	68.2	23.2	10.8	18.7	11.1	34.1	26.7	29.0	18.2	70.0	9.8	11.1	19.3	25.0	42.5	0.5	25.8	27.2	1.0	1.9	22.7	20.4	5.2	15.3	17.7	21.9	8.6	27.9	33.7	15.4	20.0	14.9	27.1	25.1	11.7	31.5	12.0	10.5	8.7	14.1	7.6	37.9	43.6	18.2	15.6	25.8	16.1	8.8	28.6	28.3	15.8	38.2	12.1	14.0	18.8	15.4	15.0	23.6	0.2	5.3	6.0	1.9	8.7	2.9	3.9	3.3	1.9	5.2	1.4	1.5	1.5	3.7	2.0	4.8	1.2	6.6	2.6	1.5	1.3	1.3	1.8	1.1	1.1	1.6	0.9	1.5	1.1	0.0	3.2	4.5	1.1	1.0	1.0	3.4	2.5	1.4	2.3	3.5	2.0	9.8	1.7	3.9	16.9	1.6	5.3	70.0	4.2	59.5	3.8	0.7	55.2	2.4	14.8	1.6	5.8	3.1	2.4	9.5	1.4	5.5	0.0	18.0	5.7	3.5	3.6	3.5	0.4	1.9	2.5	6.5	2.1	16.2	31.6	1.0	6.9	4.9	9.8	1.4
CKS1B	"CKS1, ckshs1"	ENSG00000173207	"CDC28 protein kinase regulatory subunit 1B"	P61024	1	154974653-154979249	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 303.7;Extravillous trophoblasts: 535.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	Yes			"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: AB_2666948, HPA030762: AB_10670044"	"unprognostic (1.06e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (2.01e-3)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.63e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (6.03e-7)"	"unprognostic (3.12e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.37e-1)"	25.3	14.5	13.5	13.4	19.0	36.4	24.8	4.2	14.6	15.6	17.4	12.4	19.8	14.7	14.7	13.8	28.2	15.2	14.1	16.5	15.3	8.0	16.6	29.5	12.9	23.8	29.5	8.8	14.2	12.8	8.3	9.4	35.6	15.9	11.7	18.8	7.5	12.8	13.1	5.9	22.6	22.9	12.5	19.8	18.0	14.7	22.8	21.5	30.2	15.5	19.3	25.5	11.1	23.3	23.9	30.4	2.2	32.8	9.0	12.2	8.7	59.7	82.4	61.8	33.5	8.9	9.2	49.4	27.8	21.6	60.4	48.4	79.6	88.4	56.9	47.6	18.4	33.9	55.5	61.2	39.9	56.8	51.1	39.7	38.5	36.7	55.9	2.7	46.3	35.4	5.3	17.3	51.6	71.6	12.4	30.3	39.5	62.5	77.4	45.4	59.4	43.4	35.8	78.4	57.4	74.4	43.7	50.9	72.9	21.5	21.9	25.2	63.7	42.0	39.9	46.0	74.9	53.4	64.8	16.8	39.2	40.6	32.4	66.2	47.8	92.7	80.3	24.9	39.5	54.1	0.7	4.4	2.2	7.0	26.0	8.4	23.9	9.9	9.5	7.2	22.6	12.2	11.5	0.6	9.0	32.8	30.4	10.6	8.7	13.5	19.0	4.2	14.6	15.3	8.0	29.5	8.8	15.9	21.5	11.9	26.6	58.1	85.2	193.2	2.1	8.9	68.8	40.2	40.9	27.9	0.0	103.2	68.0	71.4	12.5	39.5	35.7	303.7	98.8	535.3	106.1	48.1	20.7	75.7	110.7	1.6	19.7	30.1	33.8	18.8	70.5	54.9	108.0	55.9	35.3	15.6	87.5	41.8	43.2	64.8	2.4	19.4	106.1	117.9	120.7	178.0	110.3	47.9	49.4	87.8
ANKRD22	MGC22805	ENSG00000152766	"Ankyrin repeat domain 22"	Q5VYY1	10	88822132-88851818	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 40.2;stomach 1: 27.6;tongue: 29.0"	"Cell type enhanced"	"Detected in many"	16	"Basal keratinocytes: 33.1;Suprabasal keratinocytes: 89.8;Urothelial cells: 29.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 15.4"	"Group enriched"	"Detected in many"	13	"granulocytes: 15.4;monocytes: 6.8"	"Cell line enhanced"	"Detected in some"		"A-431: 8.5;CAPAN-2: 27.2;HL-60: 8.0;OE19: 20.7;RT4: 18.4;T-47d: 12.5;U-937: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA012922	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012922: AB_1844838"	"unprognostic (1.86e-1)"	"unprognostic (1.48e-3)"	"unprognostic (9.73e-3)"	"prognostic favorable (8.73e-6)"	"unprognostic (1.18e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.21e-3)"	"prognostic unfavorable (6.15e-4)"	"unprognostic (1.09e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.01e-3)"	0.4	0.5	2.3	8.4	3.6	5.3	2.3	0.3	3.2	6.7	6.7	0.5	0.0	2.0	0.3	0.2	21.9	0.3	4.3	1.1	4.0	0.6	6.0	1.6	1.3	6.1	3.6	0.2	0.3	40.2	0.1	1.6	0.2	2.7	2.0	7.2	0.1	3.7	0.0	0.3	18.5	2.1	1.3	7.4	8.8	27.6	0.3	1.4	7.9	0.3	29.0	14.6	4.4	8.6	0.1	0.4	15.4	6.8	0.5	0.8	1.2	8.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.2	0.1	0.1	0.0	0.0	6.7	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	8.0	0.0	0.0	0.5	0.0	0.1	0.4	0.0	0.8	0.0	0.0	0.0	0.1	0.7	6.4	0.1	20.7	0.1	0.0	0.0	0.0	0.1	18.4	0.0	0.0	0.0	1.3	0.0	0.0	12.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.3	0.1	0.1	4.8	2.5	0.1	6.8	0.0	0.0	0.4	0.1	0.4	0.1	0.8	0.2	15.4	0.5	1.2	0.4	0.0	1.2	2.3	3.6	0.3	3.2	4.0	0.6	3.6	0.2	2.7	1.4	0.0	3.0	0.0	16.2	33.1	0.0	0.1	10.2	0.0	1.2	7.0	0.0	0.0	0.0	2.6	0.0	0.0	6.4	0.0	5.2	0.0	0.7	10.4	0.0	0.0	2.4	0.0	1.7	0.0	7.2	0.0	0.3	12.3	1.7	1.0	11.8	0.0	4.5	20.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	89.8	0.0	0.7	11.2	29.8
HTATIP2	"CC3, FLJ26963, SDR44U1, TIP30"	ENSG00000109854	"HIV-1 Tat interactive protein 2"	Q9BUP3	11	20363685-20383783	"Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Differentiation, Host-virus interaction"	"Developmental protein, Oxidoreductase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 60.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA006417, HPA024321"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA006417: AB_1079091, HPA024321: AB_1851288"	"unprognostic (8.05e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.79e-3)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (1.20e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (8.01e-4)"	"unprognostic (1.20e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	16.3	28.1	8.5	11.9	16.3	6.3	26.3	3.2	10.6	9.4	50.4	16.2	10.8	52.2	6.8	13.0	23.1	5.7	17.6	9.5	10.8	9.9	21.5	41.8	19.5	16.2	24.3	8.0	6.8	11.9	17.9	27.4	22.9	12.4	13.9	32.2	3.3	16.5	9.2	19.4	14.8	74.6	12.1	15.0	19.6	29.4	10.6	14.6	6.6	23.9	17.2	12.1	17.8	26.7	16.4	17.4	69.4	30.6	13.5	30.6	23.8	23.1	38.5	0.8	0.0	11.8	9.0	8.6	10.1	10.0	7.8	9.4	22.2	20.4	5.3	20.8	12.6	30.4	32.6	0.0	6.1	7.6	60.3	4.7	6.5	38.0	0.0	28.5	2.4	31.1	12.9	43.5	6.3	9.9	0.0	22.3	0.0	16.0	7.0	14.5	21.7	0.0	1.5	12.5	40.7	19.2	4.9	0.0	19.0	10.6	12.9	10.5	0.1	32.8	13.0	15.4	4.2	27.2	12.2	27.1	5.6	12.3	11.3	0.2	7.5	9.2	0.1	0.0	16.5	24.1	43.7	30.6	37.3	15.5	27.5	17.5	14.9	18.0	16.5	17.4	16.4	15.8	15.5	69.4	13.5	28.3	5.1	30.6	23.8	8.5	16.3	3.2	10.6	10.8	9.9	24.3	8.0	12.4	14.6	23.8	8.1	24.1	49.8	32.3	0.3	9.7	117.2	8.1	10.3	45.4	0.0	50.0	26.6	84.2	36.1	22.9	185.2	0.0	63.6	102.1	14.2	53.7	23.0	69.2	75.1	3.2	23.2	28.8	55.0	45.4	18.4	40.5	42.2	143.3	93.7	9.4	88.6	161.4	8.9	60.3	1.7	12.9	29.5	27.3	17.2	36.8	51.5	35.8	83.1	52.5
PRR11	FLJ11029	ENSG00000068489	"Proline rich 11"	Q96HE9	17	59155499-59204705	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.8"	"Cell type enhanced"	"Detected in many"	14	"Erythroid cells: 46.7;Extravillous trophoblasts: 19.2;Kupffer cells: 13.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 10.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023923, HPA052376"	Uncertain		Approved	"Endoplasmic reticulum"		Yes	Yes			"Endoplasmic reticulum"		"HPA023923: AB_1855783, HPA052376: AB_2681803"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.35e-7)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.56e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.55e-3)"	3.2	1.4	2.8	13.8	4.2	14.9	2.0	0.9	2.8	3.1	4.2	2.2	0.7	6.9	2.0	2.1	10.3	1.7	2.1	1.4	3.1	2.3	1.7	1.1	3.4	9.6	3.2	1.6	1.7	1.0	0.2	0.6	4.8	2.0	1.2	5.5	1.2	2.2	0.5	1.3	2.9	4.8	3.2	5.1	7.3	2.5	2.5	2.1	40.8	1.3	7.7	11.7	2.8	3.2	1.4	3.0	2.5	10.6	0.7	2.0	0.8	27.6	13.3	21.0	6.1	0.6	4.9	8.6	17.2	10.8	17.9	14.3	16.4	18.7	17.9	17.6	12.6	14.6	10.2	16.1	17.7	39.3	24.8	10.3	19.7	14.7	11.0	0.2	20.8	8.3	1.1	1.3	19.7	26.2	4.4	20.2	15.0	10.7	19.5	19.1	21.5	20.4	3.7	8.7	13.0	22.5	16.4	31.5	11.5	4.8	7.5	9.1	12.6	14.2	5.2	7.5	10.6	14.0	8.0	13.7	36.8	43.0	18.5	30.6	12.6	24.2	18.0	8.2	11.6	35.9	1.0	2.3	2.5	0.8	5.1	0.3	1.4	0.6	1.0	3.0	0.9	0.6	0.8	2.3	0.7	10.6	1.6	2.0	0.8	2.8	4.2	0.9	2.8	3.1	2.3	3.2	1.6	2.0	2.1	0.0	1.7	7.0	1.9	1.6	2.0	0.8	0.0	0.0	2.3	0.0	0.0	1.8	0.0	0.3	0.5	1.1	0.4	46.7	0.4	19.2	1.6	1.0	2.3	0.0	6.5	1.6	4.7	3.7	13.3	0.2	0.9	5.1	1.7	6.4	2.2	0.8	0.6	0.0	2.1	0.3	2.8	0.0	2.1	3.0	5.1	1.1	1.7	2.5	4.3	1.4
EXOC4	"KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p"	ENSG00000131558	"Exocyst complex component 4"	Q96A65	7	133253073-134066589	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Rod photoreceptor cells: 229.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031443, HPA031444"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA031443: AB_10602496, HPA031444: AB_2673886"	"unprognostic (1.70e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (6.19e-4)"	"unprognostic (9.78e-3)"	"prognostic favorable (6.85e-5)"	"unprognostic (5.91e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.35e-2)"	21.2	23.7	18.5	17.7	22.3	10.5	19.4	25.7	24.4	20.8	17.0	19.7	22.2	11.2	25.8	20.6	21.5	24.2	16.8	16.5	14.7	15.4	15.6	15.2	16.5	12.6	14.2	19.3	27.7	26.5	28.5	31.2	16.4	22.0	16.9	18.8	19.3	20.5	18.8	50.7	24.4	13.7	20.8	18.7	17.9	16.3	17.2	17.3	34.7	22.9	18.3	22.1	26.3	20.6	8.3	16.3	8.1	12.7	18.4	12.4	10.4	17.8	14.7	20.4	20.1	23.9	25.0	7.1	13.1	21.9	11.9	15.7	8.5	25.2	13.4	9.5	24.6	17.5	11.4	10.9	17.9	19.8	20.4	13.1	10.8	15.5	8.9	26.3	14.2	11.8	24.3	22.4	17.0	31.5	26.4	20.3	17.8	15.5	13.4	22.1	11.7	25.8	15.7	15.3	21.5	13.8	11.5	18.1	24.1	19.2	16.0	15.9	25.1	19.7	18.2	21.1	24.0	12.0	13.4	22.0	13.3	7.0	14.0	14.3	21.3	13.0	13.0	39.3	16.7	20.2	8.1	12.0	6.9	11.8	12.7	10.5	8.3	12.3	12.4	16.3	8.0	10.1	10.4	4.0	18.4	10.5	7.3	12.4	10.4	18.5	22.3	25.7	24.4	14.7	15.4	14.2	19.3	22.0	17.3	20.8	21.1	11.9	14.2	16.8	35.3	24.9	7.6	18.7	15.9	14.0	88.4	13.6	3.3	12.9	23.1	21.5	15.8	0.0	15.7	13.8	11.9	17.0	8.1	14.4	15.6	47.7	16.7	24.5	30.4	20.6	16.1	18.0	13.5	12.6	21.4	20.6	13.9	17.5	17.7	13.3	229.7	12.9	10.8	18.1	12.6	14.9	9.4	20.8	18.4	16.9
GRHL2	"BOM, DFNA28, FLJ13782, TFCP2L3"	ENSG00000083307	"Grainyhead like transcription factor 2"	Q6ISB3	8	101492432-101669726	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Corneal dystrophy, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 47.9;seminal vesicle: 42.4"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 29.8;Ciliated cells: 40.2;Club cells: 27.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"A-431: 15.6;CACO-2: 11.4;HaCaT: 19.1;hTCEpi: 14.9;MCF7: 13.1;OE19: 15.3;RT4: 28.1;T-47d: 33.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004820, HPA062839"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004820: AB_1857928, HPA062839: AB_2684878"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.59e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.29e-4)"	"unprognostic (4.54e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-2)"	0.4	0.3	0.4	3.3	0.4	0.0	11.3	0.3	0.4	6.0	9.9	0.0	34.7	2.1	1.6	16.4	18.7	5.2	10.3	0.4	0.4	0.4	6.4	0.7	11.3	0.0	0.4	0.0	1.5	22.1	7.1	1.5	47.9	0.1	15.2	5.6	0.1	15.0	42.4	0.4	18.0	8.6	1.6	0.4	0.4	5.9	0.6	0.0	1.7	12.7	14.3	12.2	7.4	8.4	0.0	0.0	0.0	0.0	1.2	0.2	0.0	15.6	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	11.4	7.8	0.0	0.0	0.0	0.0	19.1	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	28.1	0.5	0.0	0.0	6.2	0.0	1.9	33.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.4	0.4	0.4	0.4	0.0	0.1	0.0	29.8	8.8	0.0	9.3	21.6	0.0	0.4	10.2	40.2	27.3	10.4	0.0	12.4	5.0	6.5	2.2	0.4	5.9	0.0	4.8	5.9	0.8	10.0	0.0	0.0	1.3	0.0	1.2	0.0	0.0	4.1	0.0	0.0	1.7	1.0	10.0	0.0	7.4	7.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	22.7	16.6	0.0	7.6	5.1
DPYD	DPD	ENSG00000188641	"Dihydropyrimidine dehydrogenase"	Q12882	1	97077743-97995000	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 50.8;Kupffer cells: 129.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033241, HPA045210"	Uncertain					NA	NA		1300000			"CAB033241: AB_2094323, HPA045210: AB_2679256"	"unprognostic (2.33e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.56e-1)"	"unprognostic (9.29e-2)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (6.54e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.25e-1)"	24.9	15.4	8.8	17.0	20.9	7.4	18.4	2.0	11.2	17.9	15.6	20.3	6.4	17.0	13.7	10.8	19.0	13.5	20.5	13.3	8.3	6.1	10.5	52.2	26.0	25.7	25.3	7.1	20.4	9.7	15.5	18.4	8.0	13.9	11.6	8.4	6.2	16.7	11.6	6.7	7.7	22.4	15.5	15.0	27.7	12.0	6.0	22.2	27.4	13.5	10.0	10.4	16.3	19.6	2.6	14.3	28.3	28.1	5.7	7.3	8.0	7.7	2.2	2.8	0.0	15.9	27.4	0.0	12.7	11.6	11.8	8.8	0.0	3.3	4.1	18.7	11.7	1.8	1.9	0.0	2.9	21.8	4.0	2.6	3.5	4.2	0.0	7.1	1.5	0.2	21.6	1.1	9.4	10.8	25.1	9.6	2.4	0.1	13.2	6.1	0.0	8.1	2.2	0.3	0.0	2.7	0.0	13.6	6.4	14.5	0.0	4.1	3.2	10.8	0.9	0.1	0.3	0.0	3.5	11.0	25.7	1.8	20.6	25.0	1.1	0.0	0.0	3.7	4.5	20.3	6.3	28.1	1.7	5.5	13.0	7.3	0.9	6.5	5.3	14.3	2.6	6.2	5.4	28.3	5.7	10.7	0.4	7.0	8.0	8.8	20.9	2.0	11.2	8.3	6.1	25.3	7.1	13.9	22.2	14.9	33.7	3.0	8.0	6.8	1.9	3.1	30.6	6.7	12.5	7.0	0.0	0.2	5.0	2.1	5.8	11.7	4.0	0.0	5.5	0.1	11.7	5.8	9.2	50.8	17.3	0.0	2.9	17.8	129.0	2.0	31.1	44.1	3.3	10.0	3.7	4.8	3.9	2.3	17.7	5.6	0.0	12.9	9.5	1.2	1.7	4.8	0.1	10.8	3.0	8.8
NUSAP1	"ANKT, BM037, FLJ13421, LNP, NuSAP1, PRO0310p1, Q0310, SAPL"	ENSG00000137804	"Nucleolar and spindle associated protein 1"	Q9BXS6	15	41332694-41381050	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 38.3;lymphoid tissue: 123.4"	"Cell type enhanced"	"Detected in many"	19	"Erythroid cells: 350.4;Extravillous trophoblasts: 100.9;Spermatocytes: 103.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"T-reg: 16.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042904, HPA074847"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		Yes	Yes			Nucleoplasm	"Nucleoli fibrillar center"	"HPA042904: AB_2678220, HPA074847: AB_2732269"	"unprognostic (1.19e-1)"	"unprognostic (9.53e-3)"	"unprognostic (1.65e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.14e-1)"	"prognostic unfavorable (6.27e-4)"	"unprognostic (8.49e-3)"	"prognostic unfavorable (6.82e-14)"	"unprognostic (4.76e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.22e-1)"	3.2	12.9	0.7	20.3	1.3	38.3	3.8	0.7	0.9	2.9	5.4	1.1	4.4	5.8	1.5	2.8	16.1	0.9	2.5	2.7	0.7	0.7	2.5	4.2	5.7	16.5	0.9	0.5	4.2	3.0	0.0	0.6	9.2	0.9	1.8	6.5	0.8	3.6	5.6	4.4	6.0	6.3	2.2	1.2	7.4	4.1	8.6	0.6	123.4	0.8	9.7	19.4	2.9	5.3	2.7	3.1	6.4	1.4	1.7	16.3	3.1	37.4	12.6	41.8	19.9	2.2	3.6	13.9	30.0	17.7	33.1	32.1	17.0	19.6	19.4	16.7	11.3	26.6	36.2	32.2	14.7	31.8	34.9	15.8	49.4	31.3	16.0	0.6	31.4	22.2	1.1	1.7	17.6	13.6	6.5	19.8	30.1	27.0	66.3	25.6	10.0	38.8	21.1	21.5	38.5	15.6	41.9	44.6	21.0	11.8	11.7	30.3	20.8	41.3	24.3	8.6	15.9	36.6	23.3	12.0	25.7	32.3	29.0	52.7	24.7	47.7	62.1	13.5	47.2	44.1	6.4	1.4	4.4	0.7	0.9	0.4	2.7	3.5	2.6	3.1	2.1	0.2	1.9	0.8	1.7	1.2	2.9	16.3	3.1	0.7	1.3	0.7	0.9	0.7	0.7	0.9	0.5	0.9	0.6	0.0	1.0	6.7	5.9	34.2	0.8	0.8	22.9	0.0	4.5	0.0	0.0	10.7	3.3	2.1	20.6	0.7	1.8	350.4	0.4	100.9	8.5	4.1	6.9	3.8	30.5	0.0	2.9	9.2	13.2	8.5	0.3	16.4	3.3	6.4	3.4	1.5	1.6	0.0	1.8	3.9	0.9	0.0	4.1	103.5	65.4	21.8	16.1	13.4	10.2	4.7
RALA	RAL	ENSG00000006451	"RAS like proto-oncogene A"	P11233	7	39623483-39708124	"Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle, Cell division, Exocytosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Pancreatic endocrine cells: 277.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 78.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047037, HPA065232"	Approved		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane"	"Focal adhesion sites"	"HPA047037: , HPA065232: AB_2685440"	"unprognostic (1.20e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (5.32e-5)"	"unprognostic (7.71e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (7.46e-4)"	"prognostic unfavorable (6.30e-4)"	"unprognostic (3.32e-1)"	"unprognostic (4.95e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.95e-2)"	19.2	25.2	24.7	14.3	24.6	4.8	24.4	16.1	22.0	18.4	22.3	17.2	8.0	23.5	15.7	15.5	44.9	15.0	20.0	13.8	24.7	20.2	15.9	15.4	30.3	14.8	27.6	18.9	17.4	11.6	12.8	14.2	23.7	20.3	12.9	23.6	9.1	18.5	12.7	16.8	19.5	25.5	15.7	36.0	16.0	24.4	12.2	21.9	19.9	13.8	31.0	28.9	15.2	20.8	13.3	16.3	21.5	11.2	15.7	20.4	11.5	20.1	4.6	11.4	9.9	21.8	18.2	7.9	17.7	25.6	16.1	17.9	11.5	9.9	10.4	6.7	13.7	15.1	21.0	16.1	11.5	27.9	9.9	7.6	8.1	7.6	8.4	35.4	14.0	11.5	14.3	14.1	28.7	40.9	20.2	78.1	10.2	16.2	6.9	16.3	6.5	9.8	16.7	32.1	22.1	9.2	12.3	10.3	9.0	16.4	9.4	20.5	19.9	10.9	17.5	12.0	21.5	16.4	15.4	25.0	9.5	8.5	12.0	12.6	12.3	9.5	12.7	10.7	14.6	17.3	21.5	9.8	11.0	9.7	11.2	12.0	11.5	15.7	12.4	16.3	13.3	20.4	17.9	4.5	15.7	8.6	10.6	19.7	11.5	24.7	24.6	16.1	20.8	24.7	20.2	27.6	18.9	20.3	21.9	77.4	36.8	45.3	32.8	80.0	10.9	33.0	45.9	29.4	21.6	22.7	5.9	45.4	18.3	162.0	51.6	66.4	59.6	23.3	107.3	77.4	54.6	33.5	31.1	26.2	97.6	11.1	45.8	69.3	24.5	12.3	44.3	67.7	28.7	146.1	46.5	37.7	277.8	66.0	65.4	28.4	15.8	32.3	24.7	52.6	55.6	95.7	51.8	25.5	51.1	47.7
TMEM184C	"FLJ10846, TMEM34"	ENSG00000164168	"Transmembrane protein 184C"	Q9NVA4	4	147617383-147672044	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 107.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054013	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA054013: AB_2682343"	"unprognostic (5.45e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (6.37e-4)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.31e-7)"	"unprognostic (4.68e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.31e-3)"	10.4	18.4	11.3	9.6	13.1	5.5	10.0	12.3	15.9	11.8	13.0	12.3	14.3	11.8	12.4	9.8	10.7	10.0	9.6	14.3	11.8	11.3	18.0	18.7	9.2	7.7	16.1	11.8	15.7	11.6	107.2	10.5	14.0	12.7	12.0	11.6	9.3	12.1	12.8	16.2	9.5	14.8	10.1	14.0	10.0	10.6	8.3	14.1	11.7	32.9	10.3	9.4	11.8	11.2	12.8	17.3	17.7	18.1	14.7	22.8	11.6	9.2	14.5	18.4	14.0	25.2	24.6	12.1	17.3	20.3	12.9	15.0	11.9	17.7	8.6	8.7	13.5	12.8	11.1	14.9	13.3	14.3	19.1	8.7	11.1	11.2	8.6	19.4	14.8	16.6	18.3	18.0	14.2	14.9	18.8	16.6	9.8	14.2	24.3	18.0	13.8	12.8	5.4	11.8	21.1	8.5	12.8	6.3	14.8	14.3	17.3	14.3	18.5	9.4	14.7	15.1	14.9	14.7	9.3	16.2	16.4	8.9	13.3	11.0	26.6	34.8	11.5	19.2	8.9	17.7	17.7	14.1	15.5	18.0	18.0	22.8	12.3	16.7	16.4	17.3	12.8	15.9	14.8	11.0	14.7	18.1	11.9	15.3	11.6	11.3	13.1	12.3	15.9	11.8	11.3	16.1	11.8	12.7	14.1	8.9	5.7	6.4	6.6	4.0	7.7	16.5	10.2	5.3	14.8	5.2	11.8	12.5	1.7	10.6	19.6	9.8	8.5	0.0	11.1	10.6	8.4	7.2	20.8	8.5	9.0	11.1	5.2	6.7	10.4	10.3	10.0	8.8	5.0	4.6	8.3	7.8	7.5	3.5	13.8	5.3	6.2	6.5	7.3	5.4	4.9	3.0	7.2	6.4	9.9	6.4
ITGB4	CD104	ENSG00000132470	"Integrin subunit beta 4"	P16144	17	75721328-75757818	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 84.6;Pancreatic endocrine cells: 175.0;Syncytiotrophoblasts: 92.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 120.2;HaCaT: 46.0;HBEC3-KT: 102.5;hTCEpi: 35.1;RT4: 33.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB002422, CAB005258, HPA036348, HPA036349"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		79000	"Plasma membrane, Cell Junctions"		"CAB002422: AB_563480, CAB005258: AB_2129021, HPA036348: AB_2675077, HPA036349: AB_2675078"	"unprognostic (3.17e-3)"	"unprognostic (3.52e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (6.39e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-1)"	6.3	3.4	9.7	10.9	9.7	1.4	13.7	4.7	7.7	14.3	32.1	15.6	10.0	35.3	9.7	8.8	24.0	13.7	47.8	4.3	9.4	7.9	4.8	1.5	7.4	3.7	10.1	9.1	4.7	6.7	3.1	5.7	50.0	17.2	19.7	10.4	9.8	52.3	13.2	2.4	47.0	58.5	7.4	10.7	17.0	41.0	3.9	9.8	1.8	3.2	22.1	15.9	17.2	20.5	2.4	8.2	1.3	0.7	0.0	2.2	0.8	22.3	19.7	0.0	0.2	0.0	0.1	27.2	0.1	0.0	0.0	0.1	2.1	120.2	0.0	4.3	0.0	0.1	46.0	0.1	102.5	0.0	0.1	0.0	0.1	5.0	2.2	0.1	0.0	0.2	0.1	35.1	0.0	21.9	2.4	0.7	0.0	0.0	2.1	0.0	12.5	0.2	0.2	0.1	12.1	17.2	0.3	0.6	0.2	27.5	33.8	0.0	0.2	0.6	2.0	0.3	0.7	8.6	0.2	2.2	0.6	1.1	0.0	0.2	0.7	0.2	0.0	0.2	0.1	0.3	0.0	0.4	0.0	0.7	0.7	2.2	1.4	0.3	1.0	0.1	2.4	0.9	0.6	1.3	0.0	0.0	8.2	1.4	0.8	9.7	9.7	4.7	7.7	9.4	7.9	10.1	9.1	17.2	9.8	11.9	2.1	0.5	35.9	44.0	0.2	5.9	20.4	12.0	14.8	22.7	2.0	70.7	1.7	26.1	0.3	15.7	84.6	0.0	25.5	15.4	4.9	5.9	2.3	0.0	8.2	0.0	9.2	9.8	0.0	0.0	3.4	2.5	11.8	0.0	49.0	40.4	175.0	66.4	1.4	2.0	0.4	0.0	2.5	0.1	5.9	11.4	92.9	2.2	50.4	34.6
AK2		ENSG00000004455	"Adenylate kinase 2"	P54819	1	33007940-33080996	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 362.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA018479, CAB079913"	Approved		Approved	Mitochondria		NA	NA		5500000	Mitochondria		"CAB079913: AB_2546087, HPA018479: AB_1844676"	"prognostic favorable (4.37e-4)"	"unprognostic (3.25e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (8.65e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (7.86e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (4.95e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.56e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.40e-3)"	24.9	27.1	16.0	27.6	20.3	18.3	24.2	19.1	17.6	21.4	31.3	24.6	22.4	36.6	20.6	22.8	31.6	17.6	25.0	33.9	15.1	14.5	51.2	46.5	17.9	18.2	23.1	9.9	24.3	23.2	27.2	16.2	18.6	19.7	22.4	31.8	20.4	31.4	21.5	73.8	20.6	37.1	18.7	25.9	24.7	24.0	29.3	25.0	40.2	37.4	34.4	28.7	26.7	23.3	31.7	51.9	50.9	41.2	27.4	24.4	43.1	45.7	20.3	19.2	22.3	13.3	16.7	19.5	25.8	20.0	38.9	40.9	39.0	41.5	85.2	30.7	19.1	27.9	33.2	44.6	43.9	41.9	37.2	32.6	56.4	39.1	29.7	31.2	100.3	32.0	16.5	33.2	33.3	67.3	21.7	26.5	36.0	59.9	32.1	23.1	23.0	37.9	55.5	26.8	44.1	31.2	44.3	32.7	56.1	38.3	27.6	28.3	16.6	29.5	32.8	82.3	23.8	26.6	71.4	19.4	23.6	28.5	36.3	48.3	33.5	43.8	79.4	32.0	95.0	27.2	11.0	41.2	50.9	22.0	37.4	23.0	31.7	20.6	20.6	51.9	27.7	21.2	19.8	11.3	27.4	31.5	39.1	24.4	43.1	16.0	20.3	19.1	17.6	15.1	14.5	23.1	9.9	19.7	25.0	47.6	66.5	38.7	80.7	111.2	21.1	86.7	71.4	46.8	83.0	106.4	78.5	137.4	217.2	94.6	81.6	64.2	135.8	0.0	107.9	138.4	58.1	76.3	39.3	127.8	84.9	7.9	48.5	31.9	41.6	29.1	43.4	51.1	82.7	58.7	70.5	20.1	99.6	51.8	41.4	362.4	38.8	51.8	59.5	97.9	21.1	107.3	181.1	37.4	94.5	113.8
MGLL	"HU-K5, MGL"	ENSG00000074416	"Monoglyceride lipase"	Q99685	3	127689062-127823250	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 404.8;Pancreatic endocrine cells: 322.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 11.6;intermediate monocyte: 28.5;non-classical monocyte: 18.3;plasmacytoid DC: 30.4"	"Group enriched"	"Detected in many"	13	"dendritic cells: 30.4;granulocytes: 11.6;monocytes: 28.5"	"Cell line enhanced"	"Detected in many"		"BJ: 46.5;BJ hTERT+: 53.6;LHCN-M2: 42.8;RPTEC TERT1: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011348, HPA011993, HPA011994"	Enhanced		Enhanced	Nucleoplasm		NA	NA		4300000	Nucleoplasm		"HPA011348: AB_2668490, HPA011993: AB_1853914, HPA011994: AB_1853916"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.83e-2)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (7.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-3)"	72.2	6.7	29.4	22.6	29.7	7.5	39.0	32.8	36.9	13.3	36.3	8.3	8.4	16.5	8.7	10.8	63.8	16.3	24.1	35.5	23.6	10.2	22.6	32.1	32.4	6.0	15.4	17.8	3.9	3.6	1.7	5.0	18.9	10.2	10.6	27.6	10.0	31.4	13.6	40.9	11.9	22.3	13.6	12.2	19.2	17.5	3.2	15.5	2.4	6.4	33.4	19.7	14.4	14.5	1.8	30.4	11.6	28.5	0.6	0.9	6.0	11.2	10.1	0.0	0.0	17.8	21.0	1.3	46.5	53.6	10.3	16.6	0.3	4.6	2.9	12.9	15.7	3.1	0.4	0.0	6.1	5.7	5.0	0.1	0.3	7.2	0.0	6.4	0.0	0.3	7.8	3.6	19.3	21.1	5.8	21.8	0.1	0.0	0.5	42.8	1.1	0.0	0.1	0.0	7.3	16.0	0.0	5.5	23.8	38.6	1.2	6.0	0.4	8.0	15.8	2.7	0.4	0.7	0.4	27.9	11.3	3.3	27.2	6.3	0.0	0.0	9.5	23.4	0.6	35.0	4.2	2.8	11.6	0.2	28.5	0.9	1.8	0.2	0.3	3.1	0.2	0.0	0.0	0.5	0.6	18.3	30.4	0.0	6.0	29.4	29.7	32.8	36.9	23.6	10.2	15.4	17.8	10.2	15.5	181.7	90.0	5.2	8.0	20.3	16.7	42.0	119.8	56.2	34.2	40.1	0.0	68.4	142.6	90.3	3.6	101.2	167.0	23.3	144.8	129.8	47.2	9.2	8.1	126.2	122.7	0.0	85.0	14.7	24.4	4.0	30.2	33.6	20.3	404.8	177.1	46.3	322.3	129.8	65.4	60.0	6.1	84.1	176.1	0.2	1.1	19.4	60.8	10.2	49.8	4.2
LIPM	"bA304I5.1, LIPL3"	ENSG00000173239	"Lipase family member M"	Q5VYY2	10	88802730-88820546	"Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	14	"skin 1: 30.1"	"Cell type enriched"	"Detected in single"	9	"Suprabasal keratinocytes: 1.0"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.0"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"A-431: 2.1;CAPAN-2: 6.9;HL-60: 3.9;NB-4: 3.3;OE19: 6.1;RT4: 2.9;T-47d: 3.3;U-937: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA						"unprognostic (7.72e-2)"	"unprognostic (8.49e-4)"	"unprognostic (1.42e-2)"	"unprognostic (2.23e-4)"	"unprognostic (6.70e-3)"	"unprognostic (3.01e-3)"	"unprognostic (5.75e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (1.59e-2)"	"unprognostic (5.93e-2)"	"unprognostic (7.05e-3)"	"unprognostic (4.17e-2)"	"unprognostic (9.02e-2)"	"unprognostic (9.70e-6)"	0.0	0.0	0.0	0.8	0.0	0.2	1.9	0.0	0.0	0.0	0.1			0.1	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0		0.0	0.8	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	30.1	0.0	0.0	0.0	0.1	2.2	0.0			0.0		0.0	0.1	0.5	0.0	0.0	0.2	1.0	0.0	0.1	0.1	2.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	6.1	0.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.7	0.0	0.3	3.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.1	0.0	0.0	0.8	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0
TGIF1	"HPE4, TGIF"	ENSG00000177426	"TGFB induced factor homeobox 1"	Q15583	18	3411608-3459978	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 533.4;Basal keratinocytes: 319.4;Urothelial cells: 322.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062160			Supported	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA062160: AB_2684701"	"unprognostic (1.11e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.57e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (9.60e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.60e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.48e-3)"	31.9	16.6	6.9	17.2	9.3	11.2	22.0	2.7	6.2	26.8	23.8	15.5	48.4	9.6	32.7	47.3	27.1	24.8	31.4	12.9	6.5	7.2	24.7	33.6	27.9	10.6	8.1	5.9	23.0	20.2	5.3	10.2	49.6	9.9	33.2	22.4	15.3	25.1	29.8	21.2	22.9	16.6	18.5	8.6	23.1	19.8	23.1	9.2	18.1	60.2	11.2	21.0	40.5	29.0	18.2	14.0	20.4	17.3	7.4	27.5	12.7	6.2	28.5	18.7	6.0	19.1	25.8	45.7	12.0	46.0	9.8	12.6	11.2	28.6	0.3	4.0	9.8	33.0	6.4	7.1	13.4	13.0	2.5	3.0	0.8	13.6	21.2	35.9	9.0	7.5	17.9	57.8	17.8	47.5	27.0	20.9	4.3	6.4	0.1	19.2	12.2	5.8	11.0	47.6	22.6	6.3	6.2	8.4	2.0	40.3	30.7	5.2	5.2	31.6	24.8	17.5	32.7	5.7	8.1	8.9	15.4	13.4	18.1	7.5	1.0	0.1	2.8	15.8	3.4	19.3	20.4	17.3	2.9	25.9	6.5	27.5	18.2	21.6	25.2	14.0	12.8	15.5	18.0	7.8	7.4	6.1	1.4	11.4	12.7	6.9	9.3	2.7	6.2	6.5	7.2	8.1	5.9	9.9	9.2	32.8	38.1	22.9	533.4	319.4	0.0	4.8	61.1	58.9	46.6	116.9	0.0	126.0	41.4	90.1	18.0	35.0	23.5	23.3	65.8	139.4	114.7	314.8	67.9	27.2	66.3	1.6	44.5	17.2	38.3	5.0	26.4	53.4	72.6	105.6	69.3	6.0	95.9	60.4	14.5	79.5	0.0	32.3	126.7	5.0	13.2	224.7	125.7	55.4	72.7	322.0
ST6GALNAC2	"SIAT7, SIAT7B, SIATL1, ST6GalNAII, STHM"	ENSG00000070731	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2"	Q9UJ37	17	76565379-76586956	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 78.2"	"Group enriched"	"Detected in many"	11	"Early spermatids: 447.7;Late spermatids: 1248.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"pons and medulla: 19.2"	"Cell type enriched"	"Detected in some"	9	"neutrophil: 23.5"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 23.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.6;HaCaT: 11.8;HBEC3-KT: 10.7;hTCEpi: 30.0;MCF7: 11.6;SK-MEL-30: 39.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (8.93e-3)"	"unprognostic (5.86e-3)"	"unprognostic (1.67e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.37e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.69e-2)"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.57e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	4.3	1.7	0.6	2.7	1.8	0.4	7.0	0.4	1.3	8.6	7.2	6.0	3.6	0.4	2.6	8.8	17.2	28.3	2.1	4.6	2.1	1.3	10.6	1.3	11.3	1.7	4.0	1.0	5.0	3.6	1.5	2.1	18.3	19.2	6.7	3.4	78.2	6.6	6.1	11.3	27.3	2.5	4.7	3.7	2.0	3.5	17.1	1.3	0.7	17.7	12.4	6.9	8.3	7.6	0.0	0.2	23.5	1.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.2	0.0	9.6	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.2	0.7	0.0	11.8	0.1	10.7	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	30.0	0.0	3.4	1.4	0.0	0.0	0.0	0.0	0.1	11.6	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	3.2	0.1	0.0	1.3	0.0	39.0	0.6	7.6	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	1.1	2.6	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	23.5	0.0	0.1	0.0	0.0	0.1	0.6	1.8	0.4	1.3	2.1	1.3	4.0	1.0	19.2	1.3	0.0	1.0	0.5	34.2	29.2	6.0	4.8	5.1	9.4	6.8	0.0	25.5	7.7	0.0	0.1	447.7	3.1	1.3	0.0	0.0	15.3	3.4	4.5	1.1	0.8	2.8	0.0	0.0	9.2	5.6	1248.1	6.9	2.4	62.4	1.0	3.4	71.0	0.1	0.0	6.7	0.3	74.9	19.4	3.1	8.4	4.4	26.5	8.8	2.2	1.5	31.0
RNF223		ENSG00000237330	"Ring finger protein 223"	E7ERA6	1	1070966-1074307	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.8;lymphoid tissue: 17.1;tongue: 14.8"	"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 16.4;Urothelial cells: 31.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 11.9;CAPAN-2: 8.9;HaCaT: 5.6;MCF7: 19.0;OE19: 5.5;SK-BR-3: 13.0;T-47d: 8.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (4.71e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (8.08e-5)"	"unprognostic (3.50e-1)"	"unprognostic (6.50e-2)"		"unprognostic (1.43e-3)"	"unprognostic (3.91e-1)"	"unprognostic (5.09e-2)"	"prognostic unfavorable (6.53e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.06e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.58e-1)"	"unprognostic (9.52e-3)"	0.0	0.0	0.0	1.4	0.0	0.4	0.8	0.0	0.5	8.3	1.4	0.0	0.0	0.4	1.0	0.3	28.8	0.2	1.9	0.0	0.0	0.0	0.6	0.3	0.9	0.1	0.0	0.0	0.0	1.0	0.1	0.0	6.5	0.0	4.2	0.8	0.0	3.3	0.4	0.7	3.5	0.2	2.6	0.0	0.2	7.8	0.1	0.0	0.0	0.2	14.8	17.1	4.9	9.3	0.6	0.6	1.9	0.4	0.3	0.4	0.0	11.9	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.4	8.9	0.0	0.1	0.0	0.1	5.6	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	19.0	0.0	0.1	0.0	5.5	0.2	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.1	13.0	0.2	0.1	8.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	1.9	0.4	0.2	0.3	0.1	0.1	0.3	0.2	0.4	0.0	0.6	0.2	0.4	0.9	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	6.4	0.5	0.0	0.4	0.0	2.7	0.0	1.8	0.0	0.2	0.0	6.7	0.0	0.0	5.1	0.0	2.8	16.4	0.0	4.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	4.3	0.0	9.2	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.2	0.0	2.8	31.4
DARS		ENSG00000115866	"Aspartyl-tRNA synthetase"	P14868	2	135906677-135986100	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020451, HPA029804, HPA029805"	Enhanced		Enhanced	Cytosol		NA	NA		160000	Cytosol		"HPA020451: AB_1847479, HPA029804: AB_10599178, HPA029805: AB_10601994"	"unprognostic (6.13e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.54e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (2.39e-6)"	"unprognostic (2.98e-3)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (6.00e-3)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (1.04e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.00e-1)"	30.3	29.7	35.0	27.6	35.5	19.7	34.9	18.0	28.3	27.6	25.4	25.6	26.9	14.8	30.1	26.7	44.4	26.9	19.6	29.8	29.0	28.8	34.6	35.5	19.7	32.3	32.1	25.6	34.0	27.0	26.4	24.5	31.7	23.8	31.0	20.3	20.6	26.6	28.3	45.1	30.6	21.4	42.4	33.8	29.8	23.6	12.8	25.0	42.0	33.0	33.1	36.7	45.3	30.2	48.6	30.5	11.2	18.8	36.6	42.7	30.6	47.9	19.7	16.8	17.8	18.8	23.6	38.6	24.0	26.9	26.3	25.8	42.5	20.9	56.0	37.6	19.7	19.2	27.7	25.8	31.0	47.8	25.6	23.1	34.1	19.5	44.1	24.3	45.5	22.7	22.7	25.1	29.3	26.5	33.6	14.5	26.3	36.5	17.9	21.8	22.5	34.9	39.2	19.8	19.5	18.8	42.6	36.6	39.1	31.6	18.7	12.0	22.8	18.4	16.7	18.7	18.0	18.3	32.5	10.8	23.0	23.0	16.9	23.8	49.3	26.8	60.2	36.2	34.7	14.2	6.0	18.8	11.2	27.5	18.3	41.2	48.6	41.3	36.0	30.5	43.8	42.7	37.0	7.3	36.6	14.0	29.2	36.9	30.6	35.0	35.5	18.0	23.8	29.0	28.8	32.1	25.6	23.8	25.0	56.6	49.0	70.0	90.1	67.0	59.0	74.7	38.2	48.2	51.2	43.6	31.4	98.6	77.9	93.1	1.7	54.2	20.6	23.3	71.9	123.6	68.6	66.4	31.2	58.6	82.4	50.9	37.0	53.4	79.2	4.0	64.2	52.3	59.1	111.0	39.3	83.6	78.4	23.0	72.2	75.2	23.7	51.8	71.3	25.1	45.4	63.2	114.1	63.3	53.4	76.3
ZDHHC20	"DHHC20, FLJ25952"	ENSG00000180776	"Zinc finger DHHC-type containing 20"	Q5W0Z9	13	21372573-21459370	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.4"	"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 77.2;Kupffer cells: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014483, HPA014702"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA014483: AB_1859000, HPA014702: AB_1859001"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-3)"	"unprognostic (7.31e-3)"	"unprognostic (8.89e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.76e-2)"	"unprognostic (7.65e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.13e-2)"	7.5	7.0	8.3	9.4	33.6	14.9	11.3	6.4	15.3	10.3	10.9	21.0	7.6	10.8	9.3	5.6	18.4	7.1	10.0	5.4	12.7	11.8	3.8	7.6	10.6	12.3	47.4	4.9	6.5	6.1	4.0	5.3	10.8	26.1	9.2	9.6	3.1	10.4	9.9	5.5	12.2	15.4	8.9	45.0	8.6	23.1	22.0	35.8	10.4	10.0	5.1	10.9	16.2	9.6	4.6	7.8	8.8	15.2	10.1	10.2	11.1	13.2	7.7	11.2	7.1	10.5	11.1	27.5	14.6	14.7	9.8	8.7	13.9	40.9	14.2	7.9	17.8	10.3	21.7	12.9	11.2	18.5	15.4	8.2	24.9	4.8	7.7	5.9	16.8	10.8	10.0	7.9	9.6	6.8	12.4	15.1	18.4	6.9	6.0	14.4	11.2	23.5	6.4	9.1	35.2	7.6	18.9	20.2	4.9	11.6	24.9	10.7	4.9	19.1	12.0	7.8	12.0	11.0	8.6	26.2	10.3	9.9	17.3	10.8	6.2	7.6	14.7	7.4	9.7	29.1	8.8	15.2	3.4	10.2	14.2	9.4	4.6	8.8	8.7	7.8	3.7	8.3	8.5	2.7	10.1	12.0	3.9	9.3	11.1	8.3	33.6	6.4	15.3	12.7	11.8	47.4	4.9	26.1	35.8	47.6	26.9	15.8	6.9	0.9	8.3	6.4	17.8	20.1	36.4	10.4	7.9	18.2	0.0	8.6	77.2	15.0	29.0	0.0	10.5	16.6	10.3	19.1	13.9	17.4	19.9	17.5	23.1	19.6	86.8	67.8	14.4	35.8	1.7	7.2	29.0	4.4	18.7	23.0	10.3	6.2	9.6	19.4	6.9	9.7	12.3	1.4	37.3	20.8	23.4	16.9
PBK	"CT84, FLJ14385, Nori-3, SPK, TOPK"	ENSG00000168078	"PDZ binding kinase"	Q96KB5	8	27809620-27838095	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"lymphoid tissue: 19.4;testis: 67.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 218.2;Spermatocytes: 187.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1;T-reg: 1.6"	"Group enriched"	"Detected in many"	10	"NK-cells: 2.1;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"A-431: 61.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA005753, HPA050656"	Enhanced	Supported	Approved	Cytosol		NA	Yes			Cytosol		"HPA005753: AB_1855018, HPA050656: AB_2681205"	"unprognostic (7.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (3.65e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.18e-12)"	"unprognostic (9.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.68e-2)"	0.6	0.8	0.2	7.7	0.3	3.3	1.3	0.3	0.4	1.1	3.8	0.3	0.2	3.7	0.4	0.6	6.2	0.3	0.8	3.3	0.3	0.2	0.7	0.9	1.2	5.4	0.3	0.2	0.4	0.4	0.0	0.2	2.2	0.3	0.4	4.6	0.2	1.1	0.2	0.4	1.9	3.6	0.9	0.6	1.7	1.7	67.9	0.2	19.4	0.3	4.7	5.3	0.7	1.9	0.1	0.0	0.0	0.0	2.1	1.6	0.5	61.3	20.0	19.7	12.5	1.9	3.5	8.3	28.2	13.4	29.0	24.5	6.9	11.4	32.7	10.0	10.8	32.3	16.3	18.9	9.5	31.9	8.0	10.2	7.8	14.2	10.1	0.1	5.1	11.7	0.9	7.8	13.4	7.2	5.2	14.6	16.2	11.5	22.0	34.2	6.9	19.3	6.0	3.5	16.6	17.4	12.1	27.4	8.8	10.9	9.5	7.8	12.2	10.5	12.4	15.8	5.7	13.0	7.8	8.5	19.1	46.0	24.2	29.9	3.1	8.7	15.1	11.6	9.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.0	0.1	0.0	0.1	0.0	2.1	0.0	0.0	1.6	0.5	0.2	0.3	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.2	0.0	0.0	0.0	0.9	7.9	0.0	0.3	5.1	0.0	2.3	0.0	0.0	3.1	0.0	0.5	218.2	0.0	1.3	46.7	0.0	40.6	2.9	0.7	0.0	1.0	4.2	0.0	0.0	7.4	1.9	37.5	7.8	0.6	0.0	0.0	4.3	0.0	0.2	0.0	2.8	0.0	0.0	6.5	0.5	187.0	31.0	2.0	5.6	0.0	5.3	0.7
C16orf87		ENSG00000155330	"Chromosome 16 open reading frame 87"	Q6PH81	16	46796607-46831411	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 167.5;Spermatogonia: 106.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041179	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041179: AB_10795002"	"unprognostic (2.44e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (7.95e-5)"	"unprognostic (1.74e-1)"	"unprognostic (3.13e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (9.90e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.84e-2)"	5.4	7.7	10.9	7.7	22.1	23.3	8.2	6.3	13.9	5.8	6.7	3.9	5.9	5.1	6.9	5.2	7.2	5.0	6.4	10.3	7.4	6.2	14.2	19.7	6.1	12.7	5.5	10.6	5.3	4.2	22.0	9.6	8.7	6.5	6.2	5.0	4.3	5.5	4.4	18.2	5.6	11.8	7.6	6.5	7.8	4.6	28.5	8.0	10.6	5.0	6.1	9.0	8.7	6.4	13.6	10.9	9.1	9.8	3.8	15.4	4.8	8.7	3.8	13.8	7.5	3.8	3.5	12.9	10.1	6.2	6.9	4.2	6.0	6.3	13.2	11.4	5.4	3.8	6.8	13.0	4.7	9.2	10.8	8.8	8.1	5.9	7.4	8.5	9.4	11.7	5.4	5.6	8.8	8.6	10.1	5.9	12.9	9.0	2.5	7.3	5.1	13.6	14.1	12.8	4.4	7.1	20.6	21.3	8.9	11.2	5.5	8.4	9.5	12.6	12.2	4.7	25.4	5.2	10.9	6.7	8.2	6.7	8.4	5.1	11.5	12.2	35.6	3.8	8.2	7.7	3.0	7.8	9.1	5.5	9.8	3.0	13.6	7.8	6.8	10.9	8.1	7.4	5.3	1.1	3.8	9.0	6.0	15.4	4.8	10.9	22.1	6.3	13.9	7.4	6.2	5.5	10.6	6.5	8.0	14.9	11.5	27.0	14.9	41.9	8.2	30.5	22.9	4.0	7.9	15.7	21.6	61.1	26.6	17.6	34.8	10.8	9.8	0.0	10.6	46.5	31.9	16.3	13.9	34.4	20.5	28.6	18.3	14.1	20.8	12.1	15.8	35.1	32.1	20.8	10.8	18.6	12.2	8.6	13.4	66.8	10.7	32.3	21.2	167.5	106.7	36.6	28.7	16.0	12.0	13.2
DPCR1	"bCX105N19.6, C6orf37, PBLT"	ENSG00000168631	"Diffuse panbronchiolitis critical region 1"	Q3MIW9	6	30934523-30954221	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"gallbladder: 53.4;stomach 1: 70.9"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 42.0;Cholangiocytes: 48.4"	"Group enriched"	"Detected in some"	9	"pancreatic cancer: 56.8;stomach cancer: 55.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.6;OE19: 4.7;RPTEC TERT1: 1.3"									HPA014036	Enhanced					NA	NA					"HPA014036: AB_1847841"	"unprognostic (2.81e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.13e-4)"	"unprognostic (6.74e-2)"	"unprognostic (4.29e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (1.13e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.58e-2)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	1.9	0.0	0.0	0.0	0.0	4.8	0.0	53.4	0.0	0.0	0.0	0.0	2.5	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.7	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.9	42.0	0.0	0.2	0.0	0.0	0.0	48.4	1.4	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1
FERMT1	"C20orf42, FLJ20116, KIND1, UNC112A, URP1"	ENSG00000101311	"Fermitin family member 1"	Q9BQL6	20	6074845-6123544	"Disease related genes, Predicted intracellular proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	15	"Pancreatic endocrine cells: 223.7;Undifferentiated cells: 66.9"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 59.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"A-431: 17.1;CAPAN-2: 25.8;HaCaT: 30.0;HBEC3-KT: 30.4;OE19: 22.4;RT4: 17.3"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 2.1"	"Not detected"	"Not detected"			"HPA039778, HPA041966"	Approved					NA	NA					"HPA039778: AB_10805593, HPA041966: AB_10795387"	"unprognostic (1.08e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.75e-3)"	"unprognostic (2.82e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (4.38e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.60e-2)"	"unprognostic (5.33e-2)"	1.2	18.2	4.6	8.9	5.1	0.2	2.7	1.6	8.0	5.2	16.3	7.5	1.5	9.5	2.1	4.9	17.0	2.5	9.7	1.7	3.6	2.7	2.5	1.0	1.3	0.0	3.5	2.2	4.3	2.8	13.1	1.1	6.9	6.0	8.1	23.5	0.7	4.2	7.1	0.9	10.6	12.9	3.7	2.4	0.9	9.3	1.1	3.4	2.4	2.5	17.6	11.3	7.5	6.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	17.1	5.1	0.0	0.0	0.1	1.5	5.9	0.9	0.0	0.6	0.2	7.3	25.8	0.0	5.1	1.0	1.9	30.0	10.6	30.4	0.6	0.0	0.9	2.9	3.5	8.2	0.3	0.0	0.8	1.5	13.1	3.5	7.4	0.1	0.4	0.1	0.0	0.0	0.7	0.3	0.0	0.7	3.5	22.4	13.9	0.0	3.9	9.0	3.1	17.3	2.4	0.3	2.9	0.1	0.0	0.2	2.6	0.7	0.1	1.6	1.1	0.2	12.0	0.1	0.0	0.0	1.3	2.8	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	5.1	1.6	4.7	3.6	2.7	3.5	2.2	6.0	3.4	0.0	1.1	0.0	44.3	36.9	0.0	1.0	2.5	1.4	13.6	0.0	0.0	48.6	1.7	34.5	0.0	0.0	36.5	0.0	36.4	26.6	3.1	8.6	0.0	0.2	4.2	0.0	15.0	0.6	0.0	0.9	10.0	1.5	1.7	0.0	49.2	0.0	223.7	8.6	2.8	12.4	0.0	0.0	1.4	0.2	0.8	37.6	6.1	0.0	66.9	42.1
PICALM	"CALM, CLTH"	ENSG00000073921	"Phosphatidylinositol binding clathrin assembly protein"	Q13492	11	85957684-86069882	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 25.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019053, HPA019061"	Enhanced		Enhanced	Vesicles		NA	NA		28000	Vesicles		"HPA019053: AB_1855361, HPA019061: AB_1855362"	"unprognostic (9.27e-3)"	"unprognostic (7.29e-2)"	"unprognostic (3.51e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.36e-3)"	"unprognostic (9.02e-3)"	"unprognostic (9.80e-2)"	"unprognostic (6.27e-3)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (4.31e-1)"	"prognostic favorable (2.02e-6)"	"unprognostic (1.26e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.02e-1)"	72.9	24.2	35.6	43.1	51.4	37.1	51.3	30.2	39.7	38.7	35.9	60.0	27.7	39.6	41.6	26.0	41.3	31.5	48.1	41.4	43.7	34.2	63.9	53.8	45.1	35.2	52.0	33.5	38.2	29.7	70.6	23.8	76.7	50.7	29.9	32.0	26.7	31.8	37.0	35.5	35.0	45.3	49.9	70.7	49.5	30.7	22.9	55.1	31.0	30.8	28.5	34.8	44.0	49.2	2.1	7.1	25.8	8.5	3.9	5.3	3.1	29.2	13.9	22.1	15.5	33.9	35.7	41.7	37.7	48.9	29.8	26.3	54.9	39.9	22.8	38.9	60.3	31.2	24.2	23.1	27.5	43.1	6.7	8.3	64.7	19.0	17.4	34.6	15.2	29.2	30.9	29.8	55.8	46.5	50.6	32.2	15.4	41.4	18.8	56.0	17.2	17.7	14.0	12.1	47.2	7.9	12.3	33.4	16.2	57.8	24.7	13.4	10.9	46.2	15.6	12.4	29.0	21.2	12.3	34.9	55.1	19.2	64.9	30.0	6.7	17.7	20.9	13.0	12.0	37.1	3.6	8.5	4.2	3.9	7.2	3.3	2.1	2.9	5.3	7.1	1.4	3.0	2.7	25.8	3.9	7.2	2.5	3.8	3.1	35.6	51.4	30.2	39.7	43.7	34.2	52.0	33.5	50.7	55.1	32.8	63.6	25.0	34.9	103.0	19.5	39.7	33.1	32.1	25.0	68.0	11.8	37.0	26.6	54.1	51.3	74.2	54.8	70.0	32.6	99.4	46.2	37.9	47.3	49.9	74.3	38.1	24.1	74.3	121.6	73.1	33.1	105.1	57.3	46.9	31.2	20.9	64.7	45.6	41.1	65.4	16.5	77.6	77.5	17.1	12.0	84.3	34.6	40.6	25.2	76.6
ARHGAP32	"GC-GAP, GRIT, KIAA0712, MGC1892, RICS"	ENSG00000134909	"Rho GTPase activating protein 32"	A7KAX9	11	128965060-129279324	"Cancer-related genes, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.9"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 115.8;Muller glia cells: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 21.2;SK-BR-3: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038382, HPA038389, HPA061505"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA038382: AB_2675984, HPA038389: AB_10670972, HPA061505: AB_2684544"	"unprognostic (1.17e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (1.47e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.64e-2)"	4.0	5.9	22.1	3.4	32.8	1.7	9.4	4.7	46.9	8.2	12.3	5.1	1.5	18.4	7.3	8.4	21.9	12.2	6.8	3.8	9.9	6.8	6.5	4.5	5.2	1.5	6.4	21.7	10.2	13.3	14.9	5.3	7.5	5.4	6.0	14.3	4.5	13.4	4.1	6.2	16.0	19.0	5.5	4.3	2.6	10.8	9.2	8.4	5.8	3.6	12.8	12.9	8.0	13.1	1.3	1.6	0.7	2.1	3.0	1.2	0.6	6.4	3.4	10.8	0.0	3.5	3.6	7.8	2.4	3.4	1.5	1.9	7.9	13.4	0.0	3.7	4.7	7.8	14.7	4.9	6.1	3.0	0.0	1.7	0.1	1.7	2.9	1.7	0.0	0.0	3.4	8.0	1.5	9.1	3.4	1.9	5.5	0.3	0.1	2.7	5.0	5.3	0.1	2.9	19.4	3.7	13.1	3.2	1.3	1.7	21.2	10.7	4.3	3.7	23.1	4.4	4.3	12.0	2.0	3.5	5.5	2.9	3.2	4.7	0.1	0.0	0.0	2.4	14.7	3.4	0.0	0.4	0.0	0.3	2.1	1.2	0.0	0.4	0.6	1.0	1.3	0.8	0.2	0.7	3.0	0.7	1.6	0.4	0.6	22.1	32.8	4.7	46.9	9.9	6.8	6.4	21.7	5.4	8.4	6.0	12.6	0.5	10.9	16.3	25.3	3.9	12.7	41.5	28.4	10.4	115.8	17.3	1.7	6.9	12.7	4.9	46.1	0.0	23.7	3.3	11.9	19.8	1.1	13.6	5.4	17.5	39.1	6.2	4.6	10.4	6.4	3.4	15.1	0.0	61.0	120.0	20.3	45.6	12.4	8.6	31.5	19.4	5.9	8.6	5.6	27.1	23.8	1.3	46.4	48.2
MSLN	"CAK1, MPF"	ENSG00000102854	Mesothelin	Q13421	16	760762-768865	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 85.5;lung: 88.5"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 175.7;Alveolar cells type 2: 67.0;Club cells: 66.0;Paneth cells: 190.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 343.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 9.0"	"Group enriched"	"Detected in many"	59	"dendritic cells: 9.0;monocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 104.2;EFO-21: 16.1;HeLa: 31.8;hTCEpi: 23.1;OE19: 19.3"	"Low region specificity"	"Detected in many"							"CAB002216, HPA017172"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		14000000	Vesicles	Nucleoplasm	"CAB002216: AB_563874, HPA017172: AB_1853819"	"unprognostic (1.73e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (5.91e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.35e-2)"	36.5	0.0	0.4	6.7	0.5	0.7	0.3	0.1	0.4	5.4	5.4	0.8	26.8	2.1	4.8	18.9	3.1	85.5	9.6	4.3	0.4	0.3	2.6	0.2	88.5	0.4	0.6	0.0	22.3	0.4	0.0	0.6	13.7	0.9	1.9	1.2	0.2	14.4	33.1	0.0	0.5	0.7	1.0	0.8	0.1	3.7	2.1	0.0	0.1	0.1	0.6	7.8	1.4	1.3	0.0	9.0	0.0	2.6	0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	1.5	1.8	0.4	1.5	104.2	0.0	16.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	31.8	1.2	0.9	0.0	0.0	0.0	23.1	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	19.3	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.4	0.4	0.5	0.1	0.4	0.4	0.3	0.6	0.0	0.9	0.0	175.7	67.0	0.0	1.3	0.2	1.3	1.2	50.9	25.4	66.0	24.4	0.0	0.1	0.0	1.6	1.1	0.0	1.9	0.0	0.7	0.0	0.6	1.2	0.0	0.0	2.9	0.0	2.9	0.0	0.6	4.5	4.4	2.6	1.7	7.2	1.3	0.0	19.2	190.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.1	0.1	0.0	2.5	37.2
CDCA4	"FLJ20764, Hepp"	ENSG00000170779	"Cell division cycle associated 4"	Q9BXL8	14	105009573-105021148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 38.3"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 133.3;Spermatogonia: 64.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA064971			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA064971: AB_2685395"	"unprognostic (2.22e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (4.19e-4)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (4.20e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (1.47e-6)"	"unprognostic (2.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.24e-2)"	4.5	2.6	1.7	11.5	2.6	38.3	4.1	8.3	3.2	8.7	3.7	2.6	4.5	4.1	5.6	4.0	16.6	4.1	4.2	2.4	1.5	1.3	2.8	3.0	5.1	9.1	2.7	1.4	5.0	6.2	1.6	1.9	12.4	3.3	4.6	2.7	3.3	5.3	2.2	1.3	21.8	4.4	3.1	2.3	6.7	3.6	12.8	2.3	24.9	5.1	11.2	15.0	3.7	8.8	7.4	4.2	8.3	4.3	10.6	14.7	5.5	15.2	15.9	18.4	13.9	3.1	5.2	24.1	22.8	7.0	17.9	15.7	19.4	19.5	20.0	12.5	8.0	13.7	24.5	12.8	26.3	10.5	21.9	10.1	12.7	13.6	16.2	3.9	22.4	10.7	3.7	8.2	13.8	13.0	6.0	12.1	17.5	13.9	20.8	12.4	37.4	20.8	15.1	13.6	13.3	36.4	20.2	26.8	7.4	6.0	17.7	10.8	13.3	21.8	8.8	17.5	8.5	17.2	15.1	18.7	15.9	20.2	21.7	30.2	7.7	9.5	20.5	13.3	11.4	26.2	0.9	3.6	8.3	10.9	3.9	13.3	7.4	11.4	14.7	3.9	5.2	6.8	8.0	1.3	10.6	4.3	4.2	8.9	5.5	1.7	2.6	8.3	3.2	1.5	1.3	2.7	1.4	3.3	2.3	0.0	2.1	10.4	19.9	57.1	3.0	0.6	0.0	8.1	3.4	1.8	0.0	53.6	3.3	12.9	6.4	9.0	1.1	23.3	6.2	133.3	12.5	7.7	28.8	2.1	21.5	12.7	2.9	7.4	6.2	4.3	7.8	10.6	16.9	10.8	4.4	3.4	9.1	3.5	5.6	1.4	2.7	6.5	10.3	31.0	64.2	58.6	21.6	17.5	6.0	48.5
DCLRE1B	"FLJ12810, FLJ13998, SNM1B"	ENSG00000118655	"DNA cross-link repair 1B"	Q9H816	1	113905141-113914086	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"	"Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"monocytes: 15.4;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064934			Supported	"Nucleoplasm,Nuclear bodies"		NA	Yes			"Nucleoplasm, Nuclear bodies"		"HPA064934: AB_2685387"	"unprognostic (1.21e-1)"	"unprognostic (3.38e-2)"	"unprognostic (4.47e-3)"	"unprognostic (4.92e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (4.50e-5)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-3)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (6.70e-4)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (5.03e-7)"	"unprognostic (1.24e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.08e-2)"	8.7	4.9	6.7	8.3	6.8	13.1	7.3	15.4	7.8	6.7	6.8	8.3	0.4	4.3	6.9	4.3	8.4	7.0	5.8	5.4	7.0	5.6	5.3	4.2	8.0	15.1	6.7	4.5	7.7	3.8	3.4	3.1	8.7	6.5	4.4	7.8	6.1	4.6	5.0	3.4	7.0	5.5	8.7	8.5	12.8	4.7	7.2	6.4	20.9	5.1	8.2	9.6	5.9	5.9	2.3	4.2	2.4	7.0	8.7	4.4	3.5	8.3	3.1	5.9	6.6	4.4	3.1	3.7	6.6	4.8	9.1	10.0	3.7	2.7	7.9	4.5	5.1	4.7	4.3	8.1	7.2	11.9	6.8	5.7	6.5	4.9	3.2	1.1	7.4	6.6	3.9	2.5	13.1	7.2	2.5	4.8	9.9	9.8	6.7	9.8	34.0	11.4	5.6	4.6	4.2	7.3	9.2	17.8	3.8	3.1	3.0	5.2	4.6	6.4	5.4	4.3	5.3	3.5	7.5	2.8	11.1	11.8	18.0	9.3	3.2	3.3	8.9	9.3	7.7	18.3	2.4	7.0	1.9	3.4	6.4	4.3	1.4	4.4	3.1	4.2	2.3	2.6	3.6	0.3	8.7	3.7	1.5	2.4	3.5	6.7	6.8	15.4	7.8	7.0	5.6	6.7	4.5	6.5	6.4	3.0	1.3	2.7	1.0	3.2	2.8	0.8	2.5	4.0	0.0	0.0	2.0	3.5	1.7	4.0	0.8	2.3	0.2	0.0	2.4	8.0	1.5	1.2	1.1	1.0	8.9	1.6	2.9	3.1	5.9	0.0	1.7	11.7	0.0	15.4	1.8	0.8	2.7	0.0	2.1	1.4	1.3	25.8	3.8	3.4	12.0	2.4	1.1	2.9	3.4	1.1
SLAIN2	"FLJ21611, KIAA1458"	ENSG00000109171	"SLAIN motif family member 2"	Q9P270	4	48341322-48426212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 234.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035824, HPA063599"	Approved		Enhanced	Centrosome,Cytosol		NA	NA		13000	Centrosome	Cytosol	"HPA035824: AB_10602399, HPA063599: AB_2685056"	"unprognostic (6.20e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (5.77e-4)"	"prognostic favorable (7.98e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.00e-2)"	14.8	9.3	6.8	11.7	8.6	7.0	12.6	9.2	10.7	18.4	20.7	6.1	11.7	6.9	18.1	12.2	24.0	14.3	12.3	21.3	7.3	5.6	12.8	16.1	14.0	10.6	7.6	7.2	16.4	10.4	17.2	9.4	29.7	8.0	19.0	13.1	14.1	15.2	17.3	49.2	20.1	15.5	30.6	6.2	11.4	13.2	23.6	5.8	23.8	12.1	22.2	16.9	24.9	23.7	7.7	8.5	10.9	8.6	10.7	13.5	4.2	12.5	4.9	9.0	8.8	13.9	17.2	6.3	19.4	24.8	17.4	18.1	4.9	10.6	7.6	12.0	22.2	31.3	8.3	36.7	18.2	30.7	6.2	3.7	13.3	7.3	5.6	15.0	12.1	13.6	14.6	27.0	20.1	23.5	13.1	10.2	6.8	8.4	8.5	17.4	6.4	13.9	10.0	3.8	9.9	7.1	7.9	17.5	4.8	15.2	13.9	6.0	7.6	7.9	5.9	8.3	8.6	7.4	8.7	12.9	19.1	18.1	12.0	19.7	11.6	12.0	6.5	15.0	13.8	13.7	10.9	8.0	9.6	8.8	5.8	9.9	6.1	11.0	13.5	8.5	7.7	9.1	9.8	7.5	10.7	8.6	2.9	7.1	4.2	6.8	8.6	9.2	10.7	7.3	5.6	7.6	7.2	8.0	5.8	50.6	34.2	23.6	40.6	74.9	14.4	68.6	15.3	75.0	27.3	26.2	13.7	24.2	18.3	26.4	122.5	23.3	27.7	0.0	30.2	23.9	23.6	48.5	21.8	28.9	19.9	33.4	24.2	22.1	17.5	234.7	25.3	24.3	18.6	29.7	30.2	19.7	25.2	28.8	34.6	20.7	38.1	32.3	32.3	69.6	47.8	79.9	63.2	29.8	19.0	50.2
ARL14	"ARF7, FLJ22595"	ENSG00000179674	"ADP ribosylation factor like GTPase 14"	Q8N4G2	3	160677159-160678452	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"gallbladder: 44.5;intestine: 49.1;stomach 1: 24.5"	"Cell type enhanced"	"Detected in some"	21	"Enterocytes: 271.2;Intestinal endocrine cells: 85.5;Mucus-secreting cells: 83.6;Paneth cells: 63.2"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 6.6;pancreatic cancer: 26.0;stomach cancer: 14.3;urothelial cancer: 8.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"memory B-cell: 5.1"	"Lineage enriched"	"Detected in single"	52	"B-cells: 5.1"	"Group enriched"	"Detected in some"	4	"A-431: 6.5;CAPAN-2: 25.0;HaCaT: 6.2;OE19: 17.1;RT4: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.65e-1)"	"unprognostic (7.26e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.70e-3)"		"unprognostic (6.36e-2)"	"unprognostic (2.47e-3)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (2.30e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (4.74e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-2)"	0.2	0.2	0.2	6.9	0.2	0.0	0.2	0.2	0.2	0.5	26.3	0.3	0.2	16.4	0.2	0.2	0.8	0.2	44.5	0.2	0.2	0.1	0.3	1.5	0.2	0.2	0.2	0.2	0.2	6.7	0.0	0.2	0.2	0.2	1.7	11.8	0.2	0.2	0.2	0.2	0.2	49.1	0.7	0.2	0.2	24.5	0.4	0.2	0.5	0.2	0.6	1.1	6.5	1.3	5.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	25.0	0.0	0.5	0.0	3.0	6.2	0.0	0.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	17.1	1.4	0.0	0.0	0.2	2.0	12.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	1.4	0.0	3.1	1.6	0.0	0.0	20.4	1.4	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	271.2	0.0	35.2	0.1	0.0	0.9	9.2	0.0	0.0	0.0	85.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.6	0.0	30.7	63.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	28.8	23.0
PPTC7	TA-PP2C	ENSG00000196850	"PTC7 protein phosphatase homolog"	Q8NI37	12	110533245-110583320	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 53.8"	"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039335, HPA040614"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039335: AB_10805474, HPA040614: AB_10795526"	"unprognostic (2.44e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.43e-5)"	"prognostic unfavorable (6.76e-4)"	"unprognostic (1.09e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (5.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.83e-1)"	10.4	15.3	6.5	10.3	9.6	26.2	10.3	8.3	12.9	9.7	11.8	5.7	4.9	7.5	9.3	4.6	12.6	7.8	8.8	35.3	9.0	9.0	12.6	11.9	13.1	10.9	10.4	6.8	8.9	7.5	13.0	12.7	6.9	15.3	7.7	9.8	8.0	12.9	8.2	53.8	13.4	11.7	13.1	7.4	9.4	8.4	8.2	6.5	16.1	8.0	15.5	13.1	12.4	12.4	2.1	1.4	6.1	1.7	1.7	2.4	0.6	12.2	7.0	6.0	6.3	15.0	13.2	8.6	5.6	7.5	6.2	6.2	7.9	4.8	21.5	5.9	5.5	8.9	11.9	12.0	13.1	12.6	15.6	10.0	19.0	7.5	8.5	14.3	21.0	15.7	11.4	21.6	8.8	25.9	9.3	11.7	15.0	14.1	6.1	10.0	3.1	18.5	18.0	8.5	6.6	13.1	15.5	8.1	13.1	25.7	13.7	9.7	7.6	10.7	14.8	12.4	6.1	7.0	11.3	13.4	5.7	6.1	17.3	9.5	17.8	19.7	24.0	9.6	11.6	11.2	0.1	1.7	1.3	2.3	1.5	2.4	1.3	1.9	1.8	1.3	2.1	2.2	1.9	6.1	1.7	1.1	1.4	1.3	0.6	6.5	9.6	8.3	12.9	9.0	9.0	10.4	6.8	15.3	6.5	20.8	21.2	21.7	47.9	81.6	8.5	96.6	15.3	25.4	22.7	8.7	13.7	6.3	14.9	6.8	29.6	22.2	18.4	23.3	7.1	7.0	37.6	42.4	23.1	24.9	15.0	12.7	16.1	14.7	25.1	17.5	10.6	19.9	32.1	10.0	14.2	3.9	11.1	14.4	9.2	10.5	24.1	12.9	39.1	12.5	22.5	91.1	5.6	20.8	13.8	64.3
PPP1R14B	"PHI-1, PLCB3N, PNG, SOM172"	ENSG00000173457	"Protein phosphatase 1 regulatory inhibitor subunit 14B"	Q96C90	11	64244480-64246941	"Plasma proteins, Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Extravillous trophoblasts: 508.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	74	"plasmacytoid DC: 73.9"	"Lineage enriched"	"Detected in single"	74	"dendritic cells: 73.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053882	Approved					NA	NA		75000			"HPA053882: AB_2682291"	"unprognostic (1.36e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.01e-3)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (1.14e-1)"	"unprognostic (9.87e-2)"	"unprognostic (3.04e-3)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (6.86e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.43e-1)"	15.0	17.1	9.4	18.2	8.3	16.2	28.1	3.3	8.4	14.1	19.1	5.9	14.9	19.7	9.6	14.2	38.2	8.4	12.5	24.2	7.9	6.7	18.4	23.3	10.5	16.5	9.3	5.8	12.6	81.0	6.7	6.7	36.6	8.7	11.0	9.5	5.7	26.4	12.1	60.9	27.9	22.0	11.3	8.3	19.0	11.7	9.0	8.0	26.5	14.2	39.4	21.3	13.5	16.6	0.9	73.9	0.9	0.6	0.5	0.6	0.5	61.1	36.5	23.3	37.2	11.2	15.5	35.4	32.5	20.3	34.2	15.4	21.5	54.4	31.0	58.6	30.4	28.7	40.7	17.5	33.1	12.8	26.8	28.3	21.9	39.5	33.1	20.7	34.0	21.7	14.0	35.9	26.1	45.4	30.1	30.3	23.2	29.8	17.0	37.5	73.3	36.6	52.1	65.7	31.8	81.7	35.7	74.5	81.6	30.3	29.5	34.9	50.8	25.4	35.6	45.8	12.1	24.4	21.2	27.6	49.6	46.2	96.8	48.2	16.1	10.2	30.1	42.6	28.9	56.2	0.0	0.4	0.3	0.3	0.6	0.6	0.9	0.5	0.3	0.7	0.7	0.2	0.2	0.9	0.5	0.5	73.9	0.1	0.5	9.4	8.3	3.3	8.4	7.9	6.7	9.3	5.8	8.7	8.0	8.9	13.2	40.2	70.8	203.1	18.9	32.5	40.8	5.3	10.3	75.0	7.9	52.1	64.6	114.6	4.9	45.0	68.4	23.3	199.9	508.1	40.3	108.3	27.6	89.7	81.7	19.1	79.6	37.4	19.4	5.9	8.6	36.8	57.3	105.6	77.2	21.9	224.7	43.2	11.0	48.3	17.8	25.8	42.9	6.2	12.7	226.3	111.1	20.3	87.6	173.7
LHB	"CGB4, hLHB, LSH-B"	ENSG00000104826	"Luteinizing hormone beta polypeptide"	P01229	19	49015980-49017081	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"pituitary gland: 301.4"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 2.3;Late spermatids: 3.3;Pancreatic endocrine cells: 4.8;Syncytiotrophoblasts: 8.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.8;T-reg: 1.3"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"A549: 6.6;U-266/84: 7.1"									"CAB022241, CAB022707, HPA038925"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA			Cytosol		"CAB022241: , CAB022707: , HPA038925: AB_2676272"	"unprognostic (8.12e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.41e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.90e-3)"	"unprognostic (5.69e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.46e-1)"	"unprognostic (9.52e-2)"	"unprognostic (4.86e-2)"	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.1	23.1	0.0	301.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.5	0.5	0.1	0.1	0.1	0.5	1.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	1.8	0.1	1.3	6.6	0.3	1.3	0.0	0.0	1.8	0.5	0.0	1.0	0.5	5.4	1.9	1.8	0.1	0.0	0.3	0.5	0.0	0.4	0.0	1.7	5.2	0.3	1.7	2.5	0.3	0.4	1.8	0.0	0.0	0.3	0.0	0.0	0.3	1.1	4.8	2.9	0.3	0.4	0.1	0.6	0.7	0.3	0.5	2.8	1.2	1.3	0.0	1.4	3.0	1.2	2.0	0.4	2.2	0.0	2.0	0.0	0.0	2.7	2.8	0.3	3.3	2.5	7.1	1.8	1.4	3.1	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.2	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.3	0.0	0.0	0.0	0.7	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.9	1.5	0.0	8.6	0.0	0.0	0.1
RTP4	"IFRG28, Z3CXXC4"	ENSG00000136514	"Receptor transporter protein 4"	Q96DX8	3	187368332-187372076	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 27.5;Urothelial cells: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 8.9;GAMG: 11.9;HDLM-2: 9.8;Karpas-707: 8.1;REH: 7.9;SK-MEL-30: 15.2"									"HPA064887, HPA071189"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064887: AB_2685383, HPA071189: AB_2686357"	"unprognostic (1.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavorable (6.83e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.49e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.95e-2)"	"prognostic favorable (4.35e-4)"	"prognostic favorable (1.45e-4)"	7.7	4.6	3.2	6.9	3.6	0.7	5.9	1.0	3.1	8.1	13.3	6.0	3.8	9.2	6.7	7.1	6.2	11.3	7.6	2.9	3.1	3.0	8.6	8.8	8.0	12.0	3.8	3.0	6.4	9.7	0.3	3.0	5.9	3.3	10.1	6.1	7.7	10.8	5.6	0.9	2.2	23.2	5.2	5.4	13.5	8.0	1.9	1.5	16.8	10.5	4.3	8.6	10.5	4.7	5.1	6.0	4.7	10.5	12.4	16.2	5.6	2.4	0.0	0.0	0.0	1.2	4.2	0.1	0.0	1.0	1.7	1.5	0.0	8.9	1.1	0.0	1.0	11.9	3.0	0.0	0.1	0.0	9.8	0.0	0.0	0.0	0.1	1.6	0.0	2.2	1.0	0.0	0.3	0.0	0.3	0.3	0.2	0.0	8.1	0.0	0.0	5.7	0.0	0.0	0.0	0.0	7.9	0.0	6.4	2.1	6.4	0.0	0.0	0.0	0.2	15.2	0.1	0.0	3.9	0.1	0.1	0.2	0.0	0.1	6.5	2.1	0.0	0.0	2.2	4.9	4.7	6.9	4.7	10.4	8.5	10.2	5.1	8.3	9.4	6.0	4.8	6.4	7.4	2.1	12.4	10.5	0.1	16.2	5.6	3.2	3.6	1.0	3.1	3.1	3.0	3.8	3.0	3.3	1.5	6.0	5.0	2.7	24.0	1.4	0.0	0.4	12.7	17.4	7.9	5.2	0.0	0.0	13.3	27.5	0.0	7.3	8.0	0.0	8.6	0.1	2.3	9.7	1.1	2.9	5.4	0.0	8.7	9.8	5.9	0.0	2.0	4.0	1.7	3.6	11.3	4.1	12.4	10.5	4.6	2.2	0.0	0.0	1.1	0.0	0.0	1.1	0.2	7.2	7.2	41.4
CKS2		ENSG00000123975	"CDC28 protein kinase regulatory subunit 2"	P33552	9	89311198-89316703	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 54.6;testis: 103.2"	"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 581.2;Spermatogonia: 464.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 54.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003424, HPA030762"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	Yes			"Mitochondria, Cytosol"	"Nucleoplasm, Vesicles"	"HPA003424: AB_2666948, HPA030762: AB_10670044"	"unprognostic (8.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (3.57e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.84e-1)"	4.8	22.4	4.2	22.7	6.1	38.1	10.7	4.0	7.5	3.6	10.8	3.0	16.7	10.8	4.6	4.4	20.4	2.8	4.7	3.3	6.1	3.2	11.0	10.2	9.5	24.6	5.2	4.3	3.9	2.6	7.0	2.2	12.4	5.0	4.8	10.7	3.2	4.4	7.6	3.6	6.1	9.3	4.1	5.4	12.6	6.8	103.2	3.6	41.6	4.6	13.5	20.8	8.1	16.7	18.3	54.6	12.4	7.5	11.6	17.9	6.5	84.0	72.1	44.1	29.5	13.0	11.9	32.2	50.1	27.0	55.5	44.5	29.6	41.8	63.0	29.7	18.7	98.8	59.2	52.9	38.6	63.9	49.1	42.8	31.9	52.8	78.5	5.6	65.0	36.4	4.3	8.9	39.7	35.1	21.2	51.3	51.9	38.0	55.2	71.1	63.1	51.0	114.6	64.4	99.0	66.6	44.2	48.5	37.6	43.5	19.3	37.4	22.3	41.6	40.4	40.4	43.2	48.6	37.8	29.1	24.0	45.6	58.0	72.8	44.8	90.7	50.8	35.4	37.7	34.1	10.5	5.9	12.4	7.0	7.5	7.9	18.3	9.6	6.7	6.5	13.5	5.2	6.8	4.2	11.6	4.1	54.6	17.9	6.5	4.2	6.1	4.0	7.5	6.1	3.2	5.2	4.3	5.0	3.6	35.7	93.0	97.3	70.9	248.9	4.2	55.0	5.1	12.0	17.0	14.0	0.0	149.0	19.9	15.2	25.4	26.7	39.1	350.4	9.7	329.6	72.5	59.4	147.1	19.5	152.7	0.0	117.0	28.3	40.0	59.4	23.9	84.8	133.3	33.3	56.8	24.6	23.3	46.9	15.6	148.6	6.0	45.3	99.9	581.2	464.7	261.3	166.8	40.1	104.9	59.3
IL1RN	"ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430"	ENSG00000136689	"Interleukin 1 receptor antagonist"	P18510	2	113107214-113134016	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 217.8;lymphoid tissue: 194.7;tongue: 123.7"	"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 163.8;Hofbauer cells: 319.3;Suprabasal keratinocytes: 294.2;Urothelial cells: 333.6"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 92.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 17.1;myeloid DC: 17.1;neutrophil: 65.2"	"Group enriched"	"Detected in many"	332	"dendritic cells: 17.1;granulocytes: 65.2;monocytes: 17.1"	"Cell line enhanced"	"Detected in some"		"A-431: 21.1;HaCaT: 41.7;RT4: 40.8;THP-1: 11.8"	"Not detected"	"Not detected"							"HPA001482, CAB009633"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted to blood"	NA	NA	291000		Nucleoplasm	"Centrosome, Cytosol"	"CAB009633: AB_2125576, HPA001482: AB_1078437"	"unprognostic (3.85e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.46e-2)"	"unprognostic (9.54e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (5.59e-3)"	"prognostic unfavorable (2.66e-6)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (8.23e-4)"	"unprognostic (4.25e-2)"	"unprognostic (1.03e-1)"	17.3	0.2	0.2	7.2	0.3	32.9	1.1	0.2	0.5	27.2	3.8	0.6	1.4	1.1	1.5	0.7	217.8	0.2	4.1	0.5	0.2	0.0	0.5	23.5	2.9	1.9	0.3	0.2	0.4	0.4	0.1	0.3	3.1	0.6	1.6	0.3	0.4	30.9	1.3	0.5	14.4	3.7	0.7	0.2	3.6	5.7	1.4	0.2	1.0	0.7	123.7	194.7	3.3	42.2	0.0	17.1	65.2	17.1	0.0	0.0	4.9	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.4	41.7	0.0	1.2	0.0	0.0	0.0	0.1	0.0	7.0	0.0	0.1	7.9	0.0	5.4	0.2	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.2	0.0	5.6	0.0	4.7	0.0	0.0	0.0	0.0	0.0	40.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.8	0.1	0.5	0.0	0.3	0.0	0.3	0.0	0.1	4.0	4.7	0.1	0.0	17.1	0.3	0.0	7.6	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	65.2	0.0	3.4	0.1	0.0	4.9	0.2	0.3	0.2	0.5	0.2	0.0	0.3	0.2	0.6	0.2	6.0	10.6	0.5	50.9	163.8	0.0	0.3	12.7	18.7	17.0	3.5	0.0	1.3	0.0	17.2	35.3	2.2	6.5	0.0	25.2	2.5	6.6	30.8	9.3	38.4	319.3	0.0	0.0	3.1	35.8	72.7	0.6	100.5	23.6	1.0	0.6	0.0	89.0	0.0	0.4	0.0	0.0	0.0	6.6	0.7	0.1	294.2	3.8	0.9	2.2	333.6
KIF2C	"CT139, KNSL6, MCAK"	ENSG00000142945	"Kinesin family member 2C"	Q99661	1	44739818-44767767	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.9;testis: 61.4"	"Group enriched"	"Detected in many"	18	"Early spermatids: 430.2;Late spermatids: 1559.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 5.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA006219, HPA079172"	Enhanced		Supported	Nucleoplasm,Midbody,Centrosome		Yes	Yes			"Nucleoplasm, Centrosome"	Midbody	"HPA006219: AB_2667540, HPA079172: "	"unprognostic (3.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (3.07e-7)"	"unprognostic (7.49e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.41e-1)"	1.1	0.7	0.4	8.7	0.4	12.7	0.8	0.5	0.5	1.2	2.4	0.4	0.2	2.1	1.3	1.4	4.6	0.6	0.7	0.9	0.6	0.5	0.7	0.6	1.6	6.7	0.4	0.2	0.7	0.4	0.3	0.6	2.2	0.6	0.6	3.2	0.4	1.1	0.2	0.4	2.3	2.2	1.1	0.4	3.3	1.4	61.4	0.2	39.9	0.8	4.7	12.0	0.9	1.7	1.3	1.5	0.0	0.2	3.9	5.8	1.0	29.0	11.3	25.3	20.2	1.4	2.9	17.0	21.8	15.6	44.7	39.0	19.1	21.1	33.5	10.5	10.7	30.9	13.9	25.7	14.7	40.9	21.6	11.1	39.6	20.0	15.9	0.1	29.2	18.4	0.7	1.4	31.8	15.6	4.1	14.4	23.8	31.2	28.8	28.2	11.3	30.7	17.7	24.7	14.3	14.2	24.7	38.2	21.0	7.5	10.6	17.4	12.4	29.0	20.7	18.3	19.1	11.9	22.2	8.5	16.2	32.3	17.6	38.2	15.2	15.5	48.3	10.4	28.5	31.2	0.0	0.0	0.0	1.9	0.0	0.1	1.3	3.4	2.6	0.3	0.2	0.7	0.5	0.0	3.9	0.2	1.5	5.8	1.0	0.4	0.4	0.5	0.5	0.6	0.5	0.4	0.2	0.6	0.2	0.0	0.3	0.8	0.5	1.5	1.0	0.8	0.0	0.0	2.3	1.8	2.0	1.1	1.7	0.3	430.2	0.1	0.0	23.3	0.3	20.1	0.7	0.6	0.0	0.0	7.4	0.0	0.0	4.3	1.0	1559.3	8.6	1.3	0.0	7.2	0.9	0.3	0.1	0.0	6.3	0.0	0.2	6.5	0.3	55.1	28.0	0.4	3.1	0.7	1.6	0.4
LRRC59	"FLJ21675, PRO1855"	ENSG00000108829	"Leucine rich repeat containing 59"	Q96AG4	17	50375059-50397553	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030827, HPA030829"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		5400000	"Endoplasmic reticulum"		"HPA030827: AB_10602704, HPA030829: AB_10670045"	"unprognostic (4.73e-2)"	"unprognostic (2.15e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (5.63e-3)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (1.00e-5)"	"prognostic unfavorable (3.12e-6)"	"unprognostic (1.88e-3)"	"unprognostic (9.95e-2)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (3.68e-2)"	"prognostic unfavorable (1.19e-6)"	"unprognostic (2.77e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.39e-3)"	"prognostic unfavorable (1.90e-5)"	20.7	40.5	10.6	21.8	14.5	28.4	16.3	11.5	21.6	28.2	30.0	11.4	28.8	19.6	17.2	24.9	23.5	15.8	22.8	17.4	10.2	8.8	22.1	74.7	23.0	15.9	12.7	11.5	15.8	87.9	15.4	11.6	35.3	10.8	17.7	31.5	10.0	48.6	26.2	16.0	11.2	27.3	22.0	8.9	19.0	30.7	18.2	10.4	18.0	22.8	22.4	20.8	13.7	17.0	8.6	14.9	14.4	19.6	5.9	9.1	9.0	62.1	47.4	13.6	20.5	23.2	27.4	24.5	51.0	28.5	47.8	42.3	108.3	18.0	27.2	35.0	58.0	29.4	22.7	33.9	43.5	57.1	14.4	49.4	47.6	26.9	57.9	48.7	46.7	22.6	24.1	35.4	51.1	59.6	13.9	35.2	15.8	44.0	25.9	31.3	42.3	32.9	22.2	15.4	58.8	69.5	28.2	43.9	52.0	26.0	31.7	33.5	27.8	17.6	19.8	25.9	21.2	33.4	25.4	37.5	55.5	23.0	51.1	66.3	39.0	31.9	35.2	37.6	31.8	34.8	14.4	15.7	13.4	7.4	19.6	9.1	8.6	7.5	8.9	14.9	6.4	5.0	6.3	8.0	5.9	18.6	12.1	7.5	9.0	10.6	14.5	11.5	21.6	10.2	8.8	12.7	11.5	10.8	10.4	20.8	21.3	38.0	75.9	123.9	20.8	4.0	38.2	14.7	35.2	19.2	2.0	78.1	24.9	166.2	37.0	22.6	79.6	23.3	164.5	210.3	84.3	117.1	30.0	58.2	94.9	20.6	36.8	25.8	26.9	12.2	32.8	46.2	62.4	46.9	93.0	24.6	158.0	71.6	27.3	38.3	11.1	12.9	67.0	41.7	28.5	115.9	197.4	27.7	82.6	133.9
OCIAD2	MGC45416	ENSG00000145247	"OCIA domain containing 2"	Q56VL3	4	48885019-48906937	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Pancreatic endocrine cells: 896.7;Proximal tubular cells: 1166.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 56.2;U-251 MG: 66.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040979, HPA041090"	Enhanced		Enhanced	Mitochondria		No	No			Mitochondria		"HPA040979: AB_10795497, HPA041090: AB_10796236"	"unprognostic (4.29e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.76e-2)"	"prognostic favorable (7.37e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (6.56e-4)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.67e-5)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.24e-3)"	"prognostic favorable (2.34e-4)"	4.0	10.7	24.5	15.7	18.3	4.7	8.1	3.7	14.0	7.2	23.0	1.9	14.0	41.6	8.9	19.5	12.4	7.7	22.3	7.2	19.9	11.7	51.6	43.6	6.6	10.7	9.7	9.9	3.7	13.2	9.4	18.7	2.9	8.8	8.8	17.3	6.6	18.3	12.9	1.8	9.0	37.5	5.2	4.1	5.2	27.9	4.1	5.7	24.9	14.9	5.8	13.3	9.3	8.5	29.7	22.9	32.7	0.6	27.1	60.8	26.1	34.4	18.4	0.2	0.0	0.0	0.0	0.5	9.0	4.1	4.8	4.6	0.0	42.8	6.0	40.1	5.1	43.2	11.1	5.1	56.2	5.0	14.0	3.8	0.0	13.5	0.0	4.5	16.9	0.0	2.6	25.7	0.0	11.0	14.2	20.1	24.2	0.0	3.0	5.1	13.0	28.3	11.4	17.7	39.1	24.9	6.4	0.0	9.9	49.9	22.7	39.8	12.1	12.9	4.4	0.9	0.1	4.5	4.2	33.4	0.0	37.2	0.2	66.8	8.5	9.7	19.0	28.7	0.0	0.0	32.7	0.6	12.4	20.4	0.2	27.0	29.7	38.4	29.2	3.4	27.0	50.2	33.6	2.1	27.1	0.2	22.9	60.8	26.1	24.5	18.3	3.7	14.0	19.9	11.7	9.7	9.9	8.8	5.7	26.8	63.5	79.5	119.3	96.9	7.4	32.5	201.2	73.6	62.6	167.5	27.5	30.6	184.1	416.6	0.8	82.3	395.2	46.7	497.9	9.4	14.8	156.3	35.8	172.0	35.7	1.6	294.2	16.5	3.7	1.2	4.6	15.3	62.4	17.2	244.9	20.9	896.7	160.4	20.1	1166.8	52.0	0.0	20.8	0.9	2.2	114.8	12.8	114.6	155.7	207.5
PI3	"cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14"	ENSG00000124102	"Peptidase inhibitor 3"	P19957	20	45174876-45176544	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 157.1;esophagus: 200.8;lymphoid tissue: 173.5;tongue: 468.6"	"Cell type enhanced"	"Detected in many"	21	"Enterocytes: 69.5;Exocrine glandular cells: 290.8;Pancreatic endocrine cells: 135.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2666.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	1121	"neutrophil: 157.1"	"Lineage enriched"	"Detected in single"	1571	"granulocytes: 157.1"	"Group enriched"	"Detected in some"	5	"EFO-21: 26.6;HaCaT: 32.3;OE19: 29.6;PC-3: 55.0"									"CAB009449, HPA017737"	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA		2100000	"Plasma membrane"		"CAB009449: AB_2252354, HPA017737: AB_1848107"	"prognostic favorable (6.94e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.20e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.84e-6)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (8.54e-3)"	"prognostic unfavorable (1.94e-8)"	"unprognostic (1.23e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.91e-3)"	0.4	0.0	0.2	8.8	0.2	0.0	0.7	0.2	0.2	85.3	9.3	0.2	0.4	0.1	7.7	0.2	200.8	0.3	4.8	0.6	0.2	0.0	0.3	0.6	3.1	0.8	0.2	0.2	0.3	0.4	0.0	0.2	0.6	0.3	1.0	3.7	0.3	35.6	0.4	0.2	6.4	3.2	0.6	0.2	1.4	0.7	5.1	0.2	23.4	0.2	468.6	173.5	1.6	118.7	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.9	0.6	0.4	26.6	0.0	0.3	32.3	0.0	6.6	0.0	0.3	0.0	0.1	2.0	0.2	0.0	0.2	0.0	0.0	6.3	5.2	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	29.6	55.0	0.0	0.2	0.0	6.3	0.1	0.0	0.0	4.5	0.6	0.0	0.0	0.0	0.0	0.2	0.3	3.2	0.0	0.2	0.1	0.4	0.1	4.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.2	0.0	11.3	0.5	5.2	0.1	0.0	0.0	7.6	0.0	13.6	17.4	0.0	0.0	0.0	14.9	0.1	0.1	69.5	0.0	290.8	0.0	0.3	25.8	4.6	0.0	0.1	0.0	16.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	9.4	0.0	135.9	29.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	0.0	33.5	18.7
GRB7		ENSG00000141738	"Growth factor receptor bound protein 7"	Q14451	17	39737927-39747291	"Cancer-related genes, Predicted intracellular proteins"		"Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.9"	"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 79.7;Glandular cells: 69.7;Syncytiotrophoblasts: 82.5;Urothelial cells: 65.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	4	"cerebellum: 7.4"	"Cell type enriched"	"Detected in single"	20	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Cell line enriched"	"Detected in some"	5	"OE19: 193.7"	"Region enhanced"	"Detected in some"		"cerebellum: 9.3"	"Low region specificity"	"Detected in all"			"CAB005226, HPA057084, CAB073538"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB005226: AB_2113278, CAB073538: , HPA057084: AB_2683330"	"unprognostic (8.46e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.60e-7)"	"unprognostic (7.06e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (3.10e-4)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (2.59e-2)"	"prognostic favorable (8.23e-5)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (5.49e-3)"	"unprognostic (4.01e-2)"	2.9	0.1	0.1	2.8	0.6	0.0	16.1	7.4	1.2	6.7	12.7	0.3	25.0	6.7	2.6	8.1	53.9	14.5	16.3	0.8	0.2	0.1	23.4	5.2	12.3	0.1	0.1	0.4	3.1	20.5	5.8	3.7	42.6	1.6	10.2	6.4	0.7	14.0	25.5	0.5	19.1	12.4	2.0	0.1	0.3	7.2	2.3	0.3	0.5	8.5	6.5	17.2	7.2	11.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.6	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	4.9	2.8	0.0	0.4	0.0	0.1	2.6	0.0	1.8	0.0	0.0	0.2	0.0	0.6	4.3	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.5	193.7	0.4	0.0	0.0	1.9	2.2	1.6	1.1	0.0	2.1	42.8	0.0	2.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	7.4	1.2	0.2	0.1	0.1	0.4	1.6	0.3	20.8	10.0	0.0	79.7	34.0	0.0	2.0	15.3	17.4	7.9	21.0	0.0	27.0	8.3	29.6	0.0	0.5	18.0	0.0	16.9	18.8	1.9	69.7	1.1	4.0	2.5	0.0	13.8	0.0	0.0	0.0	2.6	0.9	5.0	2.8	16.8	0.3	20.5	24.6	1.1	8.6	0.0	0.0	1.0	0.4	0.2	36.6	82.5	0.9	22.1	65.1
UBE2C	UBCH10	ENSG00000175063	"Ubiquitin conjugating enzyme E2 C"	O00762	20	45812576-45816957	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 130.8"	"Group enriched"	"Detected in many"	5	"Erythroid cells: 397.1;Extravillous trophoblasts: 368.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"CAB011464, HPA034569, CAB035990, HPA054975"	Approved		Supported	"Plasma membrane,Cytosol"		Yes	Yes			"Plasma membrane, Cytosol"		"CAB011464: AB_442965, CAB035990: , HPA034569: AB_2674226, HPA054975: AB_2682658"	"unprognostic (1.45e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.24e-6)"	"unprognostic (2.27e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.09e-1)"	"unprognostic (3.61e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.68e-1)"	3.1	2.3	0.4	24.0	0.9	25.1	4.3	0.4	0.7	3.8	9.5	0.4	0.8	7.8	2.0	2.6	25.6	0.6	3.2	2.8	0.5	0.4	2.1	2.1	4.6	15.6	0.6	0.5	1.2	1.3	0.0	0.6	12.6	0.9	1.3	11.7	0.7	3.7	0.6	1.0	8.3	10.0	3.5	1.2	11.6	7.0	15.3	0.5	130.8	0.8	17.6	26.3	2.8	7.8	1.2	0.9	2.7	0.6	2.4	10.0	4.2	39.3	28.9	52.2	25.0	1.4	3.2	30.0	31.3	15.9	51.6	37.1	94.9	45.6	41.8	30.7	14.9	64.3	38.9	0.2	33.5	52.7	17.8	27.5	12.9	22.2	24.9	0.4	18.4	32.3	1.0	3.6	34.9	34.2	7.8	25.1	26.7	0.2	35.6	42.4	64.9	30.3	5.2	31.3	44.8	69.3	32.2	47.3	0.2	17.4	13.7	30.1	25.1	49.3	36.1	19.8	27.4	36.5	27.1	9.1	46.3	40.5	31.4	60.5	11.3	0.3	46.5	28.1	13.1	43.8	0.0	0.1	0.0	0.2	0.0	0.0	1.2	1.2	2.3	0.9	0.2	0.2	0.1	2.7	2.4	0.6	0.5	10.0	4.2	0.4	0.9	0.4	0.7	0.5	0.4	0.6	0.5	0.9	0.5	0.0	5.9	29.5	3.6	15.3	0.0	0.0	2.5	0.0	7.9	0.0	0.0	15.5	0.0	0.8	5.8	0.2	5.5	397.1	0.4	368.9	5.1	2.7	5.7	3.9	75.1	0.0	1.2	22.7	19.9	5.4	0.9	9.3	0.0	1.8	12.8	0.0	1.0	6.2	0.0	0.0	0.0	0.0	1.9	6.1	18.0	10.2	26.1	10.1	15.1	8.2
NUDCD1	"CML66, FLJ14991"	ENSG00000120526	"NudC domain containing 1"	Q96RS6	8	109240919-109334385	"Predicted intracellular proteins"	Immunity	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 72.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023183	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA023183: AB_1854695"	"unprognostic (5.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.52e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.52e-2)"	"unprognostic (3.62e-3)"	"prognostic unfavorable (1.39e-5)"	"prognostic unfavorable (4.37e-5)"	"unprognostic (2.13e-1)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (8.71e-6)"	"unprognostic (1.95e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.65e-1)"	22.1	9.2	9.4	10.2	12.7	3.2	17.1	16.4	12.2	14.0	9.1	4.4	9.0	5.0	14.4	9.8	10.9	12.3	9.0	10.9	9.9	8.4	13.6	10.8	12.3	14.1	12.6	8.9	12.0	13.1	9.1	15.2	25.4	9.7	10.7	12.1	4.8	11.4	12.7	10.9	7.5	8.6	13.8	8.6	19.0	10.3	20.1	8.4	19.5	15.6	11.0	14.0	13.8	13.4	4.4	4.4	1.2	4.2	5.1	5.2	2.3	13.1	7.9	11.3	6.4	6.5	8.8	6.2	9.7	11.5	27.1	25.7	8.8	10.3	8.9	6.2	10.2	7.6	7.9	17.1	15.7	37.8	11.3	6.1	13.6	5.4	8.9	13.1	5.9	5.1	5.8	8.7	13.4	18.9	8.4	24.5	10.6	14.9	4.6	22.9	11.2	15.8	6.9	8.0	26.5	10.8	10.0	9.4	8.6	16.7	6.9	9.4	8.3	4.3	11.6	9.2	12.3	9.2	4.6	6.7	13.4	8.1	6.2	8.3	3.5	4.4	10.4	5.1	10.1	11.3	0.0	1.9	1.2	3.3	4.1	4.4	4.4	3.7	4.9	4.4	3.8	4.6	5.2	0.1	5.1	4.2	3.2	4.0	2.3	9.4	12.7	16.4	12.2	9.9	8.4	12.6	8.9	9.7	8.4	3.0	10.6	12.6	15.2	15.8	5.1	7.7	0.0	18.7	27.3	3.5	5.9	22.1	6.6	15.9	72.7	22.5	2.6	0.0	9.4	19.1	11.5	9.5	17.3	5.0	8.7	4.8	8.6	7.4	4.9	13.1	12.0	9.0	6.8	21.6	4.5	4.3	12.3	5.9	6.3	11.0	8.5	0.0	12.8	44.7	31.3	14.6	6.9	8.7	9.0	17.2
EHF	"ESE3, ESEJ"	ENSG00000135373	"ETS homologous factor"	Q9NZC4	11	34621093-34661057	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 152.4;salivary gland: 118.0;seminal vesicle: 161.8"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 340.0;Ciliated cells: 235.5;Club cells: 254.8;Urothelial cells: 370.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	10	"myeloid DC: 4.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 34.8;HaCaT: 23.9;HBEC3-KT: 26.3;OE19: 29.4;RT4: 53.2;T-47d: 53.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA050923, HPA060734"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	No	NA			Nucleoplasm	"Golgi apparatus"	"HPA050923: AB_2681275, HPA060734: AB_2684351"	"unprognostic (1.06e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.81e-4)"	"unprognostic (2.82e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.79e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (1.29e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (7.08e-2)"	0.8	1.0	0.8	9.3	0.9	0.0	32.1	0.7	0.7	19.3	16.0	0.5	152.4	6.9	4.5	21.4	69.0	23.0	22.1	0.7	0.9	0.9	11.6	1.6	9.9	0.1	1.5	0.3	4.7	10.5	0.2	0.9	0.5	1.4	20.7	22.3	0.2	118.0	161.8	0.7	12.8	10.1	1.7	3.3	0.7	10.1	1.4	0.5	0.4	1.2	50.3	59.7	13.7	30.3	0.0	4.9	0.0	0.4	0.0	0.0	0.2	11.4	6.7	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.1	34.8	0.0	4.4	0.0	0.0	23.9	0.0	26.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	29.4	0.2	0.0	0.0	0.2	4.7	53.2	0.0	0.0	0.1	3.6	0.0	0.0	53.9	0.1	0.0	0.0	0.3	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.9	0.7	0.7	0.9	0.9	1.5	0.3	1.4	0.5	44.7	66.1	0.0	340.0	97.3	0.0	0.4	43.3	235.5	254.8	52.4	0.0	0.0	13.3	55.4	8.4	0.2	36.0	0.0	76.2	0.0	1.9	138.5	1.1	0.6	0.1	0.0	22.3	0.0	0.0	0.0	0.0	5.3	11.8	9.0	45.3	3.9	68.8	28.8	0.0	0.1	0.0	0.0	2.3	0.1	0.0	148.7	1.1	0.0	33.6	370.0
MTHFD1	"MTHFC, MTHFD"	ENSG00000100714	"Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1"	P11586	14	64388031-64463457	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis"	"Hydrolase, Ligase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 121.6"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 125.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000704, HPA001290, HPA015006, HPA050052"	Approved		Enhanced	Cytosol		NA	Yes		250000	Cytosol		"HPA000704: AB_1079424, HPA001290: AB_1854177, HPA015006: AB_1854178, HPA050052: AB_2680998"	"unprognostic (3.58e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.85e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.93e-5)"	"unprognostic (2.45e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.29e-2)"	18.9	9.0	8.1	8.4	18.1	9.7	12.2	5.7	15.9	7.1	9.3	9.0	4.0	7.5	8.5	6.9	12.0	6.7	6.4	10.6	8.4	6.5	20.5	121.6	6.8	9.2	8.0	10.4	10.1	13.4	13.1	5.6	5.6	10.0	5.5	11.4	9.3	11.6	5.6	26.5	7.6	7.3	8.8	6.9	8.3	7.9	2.3	7.4	15.6	8.6	14.0	12.5	8.7	7.3	21.1	12.8	0.5	13.2	12.8	14.9	8.4	72.5	41.3	15.7	34.2	16.9	13.8	25.5	28.5	19.6	37.0	36.7	40.1	33.4	30.5	13.5	16.9	18.6	35.7	48.4	28.3	43.3	30.3	31.9	37.8	41.4	30.4	12.5	29.0	20.6	10.7	9.2	33.0	17.9	15.3	23.0	30.9	28.1	25.1	28.0	60.2	46.7	17.0	28.7	46.2	43.8	37.3	54.6	27.6	27.8	42.5	34.0	13.2	47.6	25.9	14.3	15.3	40.3	14.7	14.1	27.9	48.4	25.7	34.1	16.8	20.6	53.8	25.6	33.5	31.6	0.2	8.2	0.1	8.1	13.2	10.9	21.1	9.0	9.9	12.8	11.6	7.6	10.1	0.5	12.8	10.3	3.2	14.9	8.4	8.1	18.1	5.7	15.9	8.4	6.5	8.0	10.4	10.0	7.4	17.9	26.3	11.5	9.9	12.2	0.0	38.1	17.8	12.0	20.5	15.7	0.0	20.0	34.9	15.4	0.9	9.9	5.2	0.0	9.0	24.2	10.6	8.3	49.7	125.3	21.6	0.0	2.9	7.4	11.3	0.9	12.0	10.9	13.5	14.4	11.9	0.0	10.8	2.9	12.4	49.9	0.0	19.4	18.6	0.9	7.5	9.4	8.2	20.0	21.3	9.9
CRCT1	"C1orf42, NICE-1"	ENSG00000169509	"Cysteine rich C-terminal 1"	Q9UGL9	1	152514502-152516010	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 212.8;lymphoid tissue: 82.6;tongue: 126.1;vagina: 69.4"	"Group enriched"	"Detected in some"	5	"Pancreatic endocrine cells: 88.8;Suprabasal keratinocytes: 32.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 68.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 10.8"															NA	NA							"unprognostic (3.01e-2)"				"unprognostic (6.92e-2)"		"unprognostic (2.86e-2)"	"unprognostic (3.30e-1)"		"prognostic unfavorable (7.03e-4)"			"unprognostic (1.56e-2)"			"unprognostic (1.46e-1)"	0.1	0.1	0.1	0.1	0.1	0.1	2.7	0.1	0.1	46.9	0.1	0.1	0.1	0.2	2.3	0.1	212.8	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	0.1	22.9	0.1	0.7	38.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	126.1	82.6	0.1	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	32.4	0.0	0.0	0.0	2.1
HMGB2	HMG2	ENSG00000164104	"High mobility group box 2"	P26583	4	173331695-173335125	"Plasma proteins, Predicted intracellular proteins"	"Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 95.9;bone marrow: 325.8;lymphoid tissue: 187.1"	"Cell type enhanced"	"Detected in all"	15	"Erythroid cells: 2616.4;Extravillous trophoblasts: 751.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 166.6;MOLT-4: 171.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003506, CAB037206, HPA053314"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Intracellular and membrane"	NA	Yes		380000	Nucleoplasm	Nucleoli	"CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: AB_2682109"	"unprognostic (2.82e-1)"	"unprognostic (8.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (7.04e-4)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (7.60e-12)"	"unprognostic (1.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.21e-2)"	18.8	5.9	10.3	48.9	13.2	325.8	19.9	6.6	9.5	17.1	24.0	8.6	7.9	15.7	18.6	16.2	28.6	15.4	13.8	23.4	9.5	10.2	13.2	6.9	25.4	59.8	12.5	8.2	29.0	5.8	2.9	8.0	18.5	9.3	19.0	21.2	12.2	13.8	8.6	46.2	15.5	21.5	25.3	13.3	36.7	13.0	26.7	10.6	187.1	18.7	23.0	61.6	27.1	18.5	11.6	16.8	95.9	20.5	11.9	39.9	14.3	34.9	8.4	72.2	32.2	9.0	9.0	27.7	26.1	19.9	28.8	25.8	23.7	48.8	118.3	5.9	14.5	15.4	13.7	47.3	14.2	45.0	72.4	22.1	130.0	21.2	34.7	8.8	115.0	50.2	8.7	4.3	14.4	32.8	15.7	29.5	62.9	49.0	166.6	26.3	29.2	171.4	106.6	26.3	20.9	14.6	86.7	37.1	43.9	16.5	15.0	62.5	56.4	26.3	15.3	11.7	26.4	21.2	83.9	16.9	12.9	38.3	15.9	39.1	53.9	30.1	135.4	11.0	84.1	33.6	95.9	20.5	57.6	15.6	8.5	14.1	11.6	22.7	21.2	16.8	8.8	15.0	14.3	47.8	11.9	6.8	6.8	39.9	14.3	10.3	13.2	6.6	9.5	9.5	10.2	12.5	8.2	9.3	10.6	26.8	58.1	117.6	176.4	141.0	43.0	211.0	35.7	147.2	66.0	52.4	33.4	154.7	121.0	20.6	24.5	124.1	53.3	2616.4	14.4	751.8	109.8	81.7	104.4	22.2	176.6	42.9	71.7	149.1	275.5	29.5	97.5	149.6	64.1	109.2	104.0	79.8	10.0	83.9	54.1	36.3	129.5	77.6	96.6	461.9	435.2	117.1	107.7	264.5	185.0	64.8
HBEGF	"DTR, DTS, HEGFL"	ENSG00000113070	"Heparin binding EGF like growth factor"	Q99075	5	140332843-140346631	"Predicted membrane proteins, Predicted secreted proteins"		"Growth factor, Heparin-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 536.0;Urothelial cells: 590.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 4.9;myeloid DC: 3.5;non-classical monocyte: 3.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.5;monocytes: 4.9"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 23.2;JURKAT: 30.2;TIME: 25.2;U-698: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053243	Uncertain				"Secreted to blood"	NA	NA	118000				"HPA053243: AB_2682086"	"unprognostic (3.64e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.09e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (8.44e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (7.09e-4)"	"prognostic favorable (6.00e-4)"	"unprognostic (2.20e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.87e-2)"	31.1	7.0	5.5	18.0	7.5	17.0	22.4	6.8	5.8	8.1	11.1	13.0	5.7	2.6	12.1	13.8	25.3	6.3	32.8	24.3	7.7	6.2	6.9	5.6	36.0	2.7	10.5	4.2	6.5	4.1	4.6	7.3	8.9	8.1	7.8	9.1	6.7	7.0	6.4	14.3	9.8	8.2	20.6	14.1	3.4	13.7	6.4	8.4	1.2	8.5	27.6	13.4	18.2	10.3	0.7	3.5	0.1	4.9	0.0	0.3	0.4	8.2	0.6	1.2	3.0	0.6	0.2	1.0	8.0	3.1	15.2	12.6	4.7	9.0	0.1	6.4	1.9	5.3	2.6	1.5	13.6	23.2	0.4	1.4	0.1	1.7	0.6	0.4	0.5	0.4	0.3	17.2	16.7	6.7	4.5	7.6	30.2	0.0	1.3	3.2	0.5	0.7	3.8	1.1	3.3	2.2	1.4	4.9	0.2	9.4	1.1	0.4	0.4	2.3	0.3	2.7	9.0	0.5	2.1	25.2	8.7	7.3	2.7	17.9	0.1	0.6	33.9	11.0	4.0	11.2	0.0	0.8	0.0	0.0	4.9	0.0	0.7	0.1	0.0	3.5	0.0	0.3	0.1	0.1	0.0	3.4	0.6	0.0	0.4	5.5	7.5	6.8	5.8	7.7	6.2	10.5	4.2	8.1	8.4	205.4	73.7	0.9	536.0	190.6	1.8	73.4	12.7	17.4	61.4	10.4	0.0	2.2	0.0	42.2	0.5	52.6	189.4	0.0	9.6	1.6	18.8	102.7	20.8	1.9	65.1	4.8	84.7	16.0	33.7	0.0	0.3	85.3	30.4	1.8	54.7	6.0	53.3	73.7	0.7	0.4	0.3	0.0	21.2	1.6	5.3	109.4	2.2	0.7	56.1	590.9
SMNDC1	"SMNR, SPF30, TDRD16C"	ENSG00000119953	"Survival motor neuron domain containing 1"	O75940	10	110290730-110304951	"Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061214, HPA070666"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA061214: AB_2684451, HPA070666: "	"unprognostic (4.65e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.63e-3)"	"unprognostic (5.03e-3)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (2.68e-3)"	"unprognostic (6.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.00e-1)"	21.3	18.0	16.7	20.0	17.5	38.3	26.6	24.0	20.1	19.0	18.1	17.5	13.5	13.9	23.6	13.1	24.1	18.4	16.7	19.4	15.0	15.4	19.3	20.8	23.5	32.7	15.0	14.4	23.4	15.3	18.0	24.3	25.2	16.5	18.0	16.1	19.6	18.0	17.4	34.3	19.0	16.6	21.3	22.7	21.8	17.0	19.8	16.9	30.0	18.9	14.9	24.7	25.4	22.4	6.2	9.2	17.4	9.7	6.3	8.7	4.5	15.6	11.9	17.5	20.1	13.6	16.3	13.0	18.1	19.0	24.2	24.9	15.3	19.4	22.2	11.8	11.3	13.9	17.0	25.7	12.5	27.3	12.5	13.8	22.2	10.2	17.8	16.3	24.3	21.4	12.6	13.4	19.2	32.4	18.0	13.3	12.9	19.9	20.8	18.6	7.4	25.9	23.7	19.5	12.1	8.3	22.5	35.1	11.6	13.5	11.3	8.8	11.8	11.8	10.0	20.7	15.8	12.3	14.0	14.5	14.2	16.2	13.0	23.0	17.2	17.8	33.7	14.2	34.2	10.9	5.7	9.6	14.7	6.1	9.7	7.5	6.2	7.9	7.6	9.2	5.5	7.1	6.8	17.4	6.3	9.7	5.5	8.7	4.5	16.7	17.5	24.0	20.1	15.0	15.4	15.0	14.4	16.5	16.9	26.8	29.6	33.5	33.3	61.8	25.5	19.0	10.2	34.8	29.6	10.4	19.6	28.1	28.2	21.0	5.4	32.3	18.8	23.3	15.6	27.2	32.9	39.7	57.7	21.2	28.0	31.8	17.9	21.5	34.0	3.8	27.0	39.8	33.7	40.5	14.8	22.3	19.3	17.3	20.8	26.9	30.6	19.4	28.8	44.1	36.1	72.9	38.6	30.5	17.4	60.1
EARS2	"KIAA1970, MSE1"	ENSG00000103356	"Glutamyl-tRNA synthetase 2, mitochondrial"	Q5JPH6	16	23522014-23557731	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043289, HPA043633"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA043289: AB_10963932, HPA043633: AB_10959901"	"unprognostic (3.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.20e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (8.09e-2)"	"prognostic favorable (3.16e-6)"	"unprognostic (2.48e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.29e-2)"	8.4	19.0	11.0	8.5	19.0	2.7	13.6	13.4	16.8	11.1	10.0	10.8	12.7	6.4	11.4	10.2	10.5	13.1	7.8	14.9	10.9	11.9	14.5	18.3	7.3	8.1	9.9	14.0	12.0	18.9	32.7	10.9	12.4	10.3	11.3	11.0	8.8	16.4	11.7	17.3	11.1	6.9	8.3	9.3	7.6	9.2	12.6	10.4	6.3	14.5	9.0	11.0	8.6	16.9	3.0	6.2	0.5	5.5	10.6	7.9	3.3	8.2	16.8	7.9	12.7	5.5	7.9	9.6	9.2	7.0	11.4	9.5	12.2	8.4	11.5	9.5	8.5	7.1	9.3	29.7	16.9	10.9	4.6	14.4	6.7	10.3	20.6	8.9	7.4	8.4	8.5	10.1	10.2	14.4	8.6	5.1	11.6	20.7	6.1	8.1	17.5	7.3	5.3	20.8	11.8	5.9	13.2	9.1	22.1	14.4	7.2	14.1	10.4	7.2	13.6	7.3	13.3	18.4	8.3	4.0	9.0	8.0	9.9	11.6	11.2	10.6	9.3	9.1	10.3	13.3	0.0	2.8	0.3	4.2	3.6	7.9	3.0	4.7	4.3	6.2	3.0	4.6	4.5	0.5	10.6	5.5	4.5	3.4	3.3	11.0	19.0	13.4	16.8	10.9	11.9	9.9	14.0	10.3	10.4	8.9	5.1	3.0	3.5	1.9	3.8	9.8	2.5	6.7	2.3	3.5	2.0	12.9	5.0	6.5	2.1	3.5	1.3	23.3	3.1	9.9	3.3	3.5	5.7	10.5	6.3	7.9	5.2	4.3	1.8	1.9	2.3	3.1	5.0	6.4	5.5	2.8	4.1	0.0	1.8	6.8	3.7	0.0	1.9	4.3	10.4	2.6	9.5	2.5	5.5	2.7
XKR9		ENSG00000221947	"XK related 9"	Q5GH70	8	70669365-70790371	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 17.1"	"Cell type enriched"	"Detected in many"	11	"Spermatocytes: 89.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 5.4;hTCEpi: 11.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044430	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA044430: AB_10961283"	"unprognostic (1.79e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (2.29e-1)"	"unprognostic (6.96e-6)"	"unprognostic (3.65e-1)"	"unprognostic (3.26e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.71e-2)"	0.9	3.4	1.9	0.8	4.3	0.9	1.1	0.6	6.4	0.9	1.7	1.9	0.0	4.9	0.7	2.5	1.1	0.7	4.1	1.0	2.3	1.5	1.0	7.5	2.1	1.0	1.3	7.3	1.0	1.3	0.3	2.1	0.8	7.4	1.4	1.0	2.6	2.0	0.2	0.9	1.7	9.6	3.5	1.7	1.0	3.6	17.1	0.7	0.0	1.0	0.0	1.0	2.5	1.2	1.2	0.3	0.9	0.2	0.6	3.1	0.2	3.9	0.3	0.8	0.4	0.0	1.0	0.6	1.6	0.8	0.5	1.7	5.4	0.4	0.5	2.7	0.1	1.9	0.1	0.1	0.9	2.0	0.8	0.5	0.4	0.3	0.6	0.1	1.2	2.2	1.1	11.1	0.3	0.0	0.5	0.0	2.6	0.2	3.9	0.3	0.5	0.7	0.6	2.2	0.1	0.5	0.5	1.1	0.2	0.3	2.9	2.4	0.4	0.9	1.6	0.5	0.3	0.5	0.2	0.4	0.5	1.1	0.8	0.6	3.4	0.9	2.5	0.2	0.5	0.3	0.9	0.1	0.3	0.9	0.1	1.7	0.9	1.7	0.8	0.1	1.2	2.6	1.7	0.6	0.6	0.2	0.3	3.1	0.2	1.9	4.3	0.6	6.4	2.3	1.5	1.3	7.3	7.4	0.7	6.0	2.1	0.0	3.1	2.4	2.3	0.4	2.5	4.0	4.5	0.0	7.9	0.8	0.0	1.0	4.0	0.1	1.2	0.0	3.9	0.3	0.7	1.1	0.0	0.5	0.3	1.6	0.0	0.0	0.0	2.9	0.9	0.2	0.0	0.0	1.0	1.5	5.3	0.2	0.4	0.3	5.4	0.0	0.3	89.2	5.1	0.6	0.8	0.0	0.1	1.8
SLC10A3	"DXS253E, P3"	ENSG00000126903	"Solute carrier family 10 member 3"	P09131	X	154487306-154490690	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	9	"basophil: 51.2"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 51.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021656	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA021656: AB_1856955"	"unprognostic (1.60e-1)"	"prognostic favorable (4.53e-4)"	"prognostic unfavorable (4.15e-5)"	"unprognostic (8.00e-3)"	"prognostic unfavorable (9.97e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.28e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.22e-4)"	"unprognostic (3.42e-1)"	"unprognostic (2.52e-3)"	"unprognostic (6.23e-2)"	"unprognostic (2.99e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.99e-2)"	14.5	14.6	3.6	11.6	5.1	22.5	13.4	5.0	8.1	21.5	15.3	8.1	16.3	10.6	25.0	36.1	22.8	15.4	21.1	19.5	6.0	4.6	17.7	6.7	16.3	14.0	5.8	6.2	32.3	25.7	6.1	12.7	40.1	7.6	23.7	6.4	12.4	11.7	13.3	13.7	26.2	13.6	20.1	5.3	13.1	12.6	11.6	4.7	12.6	15.7	23.3	18.6	23.3	18.3	1.6	2.7	51.2	1.7	2.2	3.8	1.8	24.9	10.7	2.9	14.6	10.1	11.0	19.0	18.6	11.4	12.6	12.7	9.5	12.1	19.0	35.4	17.8	16.8	21.5	9.4	9.5	3.4	12.3	4.4	5.9	14.1	7.5	18.6	7.0	9.6	13.7	10.9	11.7	6.3	11.3	8.6	3.3	6.6	18.7	8.2	33.1	3.8	6.3	2.2	12.2	20.8	6.1	7.7	14.4	9.5	9.3	2.6	4.7	11.7	21.3	4.9	3.5	6.8	5.6	11.3	15.0	9.4	34.8	23.5	13.4	12.9	19.6	16.0	14.7	7.7	51.2	1.3	5.6	3.8	1.7	2.9	1.6	2.6	2.8	1.1	1.6	1.9	1.8	1.7	2.2	1.5	2.7	1.8	1.8	3.6	5.1	5.0	8.1	6.0	4.6	5.8	6.2	7.6	4.7	3.0	6.5	11.7	23.8	20.0	2.0	3.6	7.6	4.0	3.4	17.4	5.9	42.9	6.6	15.3	2.4	14.3	14.4	0.0	17.0	52.6	23.3	12.1	12.7	1.6	17.2	3.2	9.8	18.4	7.8	1.0	25.0	10.5	3.3	16.2	14.0	2.3	15.9	15.3	12.4	7.7	1.6	6.5	22.6	1.2	2.7	24.3	86.2	17.5	10.6	24.7
RBMXL1	KAT3	ENSG00000213516	"RNA binding motif protein, X-linked like 1"	Q96E39	1	88979456-88992960	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA057707	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057707: AB_2683508"	"prognostic favorable (7.60e-4)"	"unprognostic (2.22e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.04e-1)"	13.3	9.8	18.5	11.7	15.3	23.8	13.4	12.0	18.0	18.2	12.2	15.3	9.7	9.8	18.5	16.2	20.9	16.7	11.5	14.0	17.1	15.2	17.4	18.3	13.0	13.5	17.1	17.0	22.8	14.5	25.0	14.1	16.7	17.9	16.3	9.5	14.8	11.8	14.3	8.9	12.1	12.2	16.9	17.4	14.4	13.9	14.2	13.0	11.7	16.2	10.1	14.0	19.3	12.4	8.8	8.6	12.3	10.1	6.3	10.8	8.4	10.7	3.2	9.2	12.0	10.9	11.1	17.6	4.6	10.7	9.4	11.1	5.3	7.3	9.1	9.2	5.5	21.9	6.3	17.4	11.5	10.5	8.3	7.7	10.8	11.2	7.0	6.3	8.5	5.9	6.4	6.7	8.4	7.5	4.1	6.0	6.5	15.0	6.0	5.6	4.0	9.0	4.4	16.9	7.0	7.3	8.3	22.6	4.5	6.2	12.5	6.7	10.3	5.0	11.3	11.6	12.9	8.2	8.9	4.4	6.1	12.5	7.1	7.8	9.5	8.9	9.4	4.3	5.2	5.6	2.5	6.6	5.9	6.9	8.9	9.3	6.7	9.7	7.3	8.6	8.8	10.8	6.6	12.3	6.3	10.1	4.4	7.6	8.4	18.5	15.3	12.0	18.0	17.1	15.2	17.1	17.0	17.9	13.0	32.8	34.6	13.7	48.3	27.2	18.9	17.1	20.4	24.1	29.6	12.2	13.7	25.6	3.3	7.6	1.2	18.0	9.7	0.0	7.6	24.9	16.5	19.0	33.5	28.7	10.2	23.8	27.6	14.1	21.3	1.5	15.8	13.8	20.3	19.0	9.4	26.1	8.1	5.8	14.2	4.3	16.8	6.5	23.1	10.1	15.4	21.2	28.5	20.8	10.5	30.8
PUDP	"DXF68S1E, FAM16AX, GS1, HDHD1, HDHD1A"	ENSG00000130021	"Pseudouridine 5'-phosphatase"	Q08623	X	7048920-7148190	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA072672	Approved					NA	NA		14000			"HPA072672: AB_2732208"	"unprognostic (1.84e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.92e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.00e-3)"	"unprognostic (3.22e-2)"	"unprognostic (4.86e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (2.24e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (4.80e-4)"	"unprognostic (3.42e-2)"	10.8	9.3	10.2	10.3	12.5	2.6	7.5	7.8	10.5	9.1	15.0	9.7	9.1	15.2	8.6	6.3	9.9	17.0	7.1	17.1	8.1	10.6	19.8	10.1	10.3	13.1	12.5	7.1	9.6	8.9	7.3	11.2	42.4	10.0	7.4	10.5	8.3	9.8	6.9	31.8	5.0	15.1	9.8	10.6	11.2	15.8	7.7	11.4	13.3	10.4	8.9	13.1	10.2	8.9	7.0	11.1	2.1	14.9	5.1	9.6	7.5	19.5	18.4	29.1	12.1	14.9	14.7	5.0	7.0	6.7	7.7	7.9	26.1	12.1	9.0	14.5	6.9	26.5	6.0	13.2	15.6	12.0	8.0	25.5	9.5	6.9	14.3	7.1	8.3	10.8	7.7	6.1	21.0	9.8	5.4	23.1	11.5	18.2	8.2	12.2	9.1	9.3	12.3	15.4	8.1	9.1	7.0	11.3	24.3	11.2	7.4	7.0	7.3	5.5	10.4	10.4	26.4	11.6	7.8	8.9	4.8	2.9	19.9	5.9	26.2	0.1	14.6	6.8	4.8	9.3	2.1	14.4	1.6	6.4	14.9	6.4	7.0	6.8	6.0	11.1	5.2	5.2	5.8	1.5	5.1	14.0	3.6	9.6	7.5	10.2	12.5	7.8	10.5	8.1	10.6	12.5	7.1	10.0	11.4	11.9	2.9	10.4	3.2	0.0	3.6	0.0	22.9	9.4	6.8	17.4	3.9	36.7	8.3	18.0	0.4	3.6	8.4	0.0	15.2	25.6	2.0	5.5	1.1	9.0	19.6	4.8	0.0	4.3	19.2	1.0	5.8	6.8	0.0	7.2	15.3	12.6	14.7	28.1	4.6	19.5	4.3	6.5	0.0	5.1	17.0	0.0	23.6	0.0	15.5	5.5
KCNK1	"DPK, K2p1.1, TWIK-1"	ENSG00000135750	"Potassium two pore domain channel subfamily K member 1"	O00180	1	233614004-233672512	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 75.3"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 117.0;Glandular cells: 169.9;Horizontal cells: 189.1;Urothelial cells: 247.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 75.3"	"Cell type enriched"	"Detected in single"	98	"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in single"	98	"dendritic cells: 9.7"	"Cell line enhanced"	"Detected in many"		"HeLa: 21.0;SCLC-21H: 19.8;U-266/70: 45.5;U-266/84: 41.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 236.2"	"HPA016049, CAB022588"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB022588: , HPA016049: AB_1855571"	"unprognostic (7.06e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.64e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.84e-4)"	"unprognostic (4.32e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (7.29e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (8.69e-8)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-1)"	1.9	3.3	15.2	2.2	12.7	0.3	4.5	75.3	22.8	5.5	11.5	7.9	5.1	12.5	4.5	22.9	12.0	8.4	9.3	20.8	10.3	5.2	7.2	10.8	3.4	0.8	8.9	11.1	3.8	4.4	2.5	11.3	5.0	22.3	4.6	10.6	2.6	7.2	9.3	0.5	8.7	9.6	3.2	12.3	0.8	28.0	0.7	7.8	0.0	5.6	1.6	3.2	4.3	6.5	0.0	9.7	0.0	0.0	0.0	0.0	0.0	10.3	5.6	0.0	0.0	0.0	0.0	15.8	2.8	0.0	0.0	0.0	0.0	17.0	0.0	6.7	2.0	2.3	15.0	2.8	4.9	0.0	0.0	4.9	0.0	21.0	0.0	0.1	0.0	0.5	1.2	5.3	0.0	3.9	0.3	0.0	5.7	2.4	4.5	0.0	3.8	3.7	0.0	3.4	12.1	12.8	0.0	0.8	1.1	4.9	8.6	19.8	3.9	10.3	4.5	0.0	0.3	1.3	0.0	0.0	0.0	8.4	0.0	0.3	45.5	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	15.2	12.7	75.3	17.1	10.3	5.2	8.9	11.1	22.3	7.8	8.9	15.6	0.0	117.0	56.2	1.2	37.7	5.1	28.1	33.0	17.4	3.9	0.2	1.7	19.6	0.9	0.7	34.8	0.0	42.5	13.5	15.3	169.9	0.0	8.2	0.6	189.1	28.2	0.0	0.8	0.0	1.4	0.8	10.1	0.0	45.4	65.8	61.4	22.8	0.0	11.3	5.0	0.0	3.4	0.4	0.7	41.7	0.7	1.5	21.1	247.4
FXR1		ENSG00000114416	"FMR1 autosomal homolog 1"	P51114	3	180868141-180982753	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 215.4"	"Group enriched"	"Detected in all"	4	"Early spermatids: 827.9;Late spermatids: 1326.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018246, HPA055475"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA018246: AB_1849204, HPA055475: AB_2682828"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.90e-3)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (7.77e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (7.30e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.84e-2)"	12.4	13.8	13.0	7.6	16.1	13.7	11.7	14.8	15.0	11.5	14.3	10.5	11.4	7.5	14.7	10.1	13.4	11.7	8.9	36.1	13.7	14.3	10.1	11.3	8.5	9.4	19.4	9.6	16.9	11.4	11.4	17.3	12.7	18.1	13.1	7.4	6.5	10.2	11.8	215.4	7.7	7.9	12.3	23.4	9.1	10.5	39.1	19.4	17.2	16.2	22.7	10.0	15.6	28.8	13.8	14.9	11.4	14.0	11.0	21.8	9.4	36.1	16.8	36.4	28.2	28.0	32.0	16.5	28.8	29.5	32.4	32.1	24.7	18.3	18.5	47.6	19.8	51.2	17.5	29.3	17.6	45.4	24.4	19.7	18.8	22.2	28.2	29.9	11.6	15.5	33.7	20.2	16.3	39.1	48.6	32.6	18.2	15.0	22.5	40.7	13.0	22.1	19.6	41.0	22.4	18.5	15.4	46.5	19.7	24.9	11.3	15.4	19.7	24.9	29.0	37.2	53.4	40.3	22.4	25.9	24.4	27.3	15.2	56.5	21.0	26.3	22.0	25.5	16.8	31.1	8.9	12.9	10.0	12.9	14.0	13.6	13.8	13.8	11.7	14.9	9.5	17.6	14.4	11.4	11.0	10.2	10.5	21.8	9.4	13.0	16.1	14.8	15.0	13.7	14.3	19.4	9.6	18.1	19.4	59.6	64.8	54.7	82.6	69.6	69.6	196.5	38.2	131.2	89.9	33.2	53.0	80.5	49.7	73.6	827.9	71.9	29.3	93.5	65.6	84.4	66.3	54.2	121.5	58.7	58.6	82.6	51.6	52.2	63.0	1326.2	77.9	61.8	47.2	139.7	33.0	89.6	70.5	35.1	71.5	67.7	82.8	32.3	61.4	245.3	103.5	61.7	51.1	57.5	38.5	60.3
CXorf38	MGC39350	ENSG00000185753	"Chromosome X open reading frame 38"	Q8TB03	X	40626921-40647554	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050120	Approved		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA050120: AB_2681024"	"unprognostic (5.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (7.30e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.73e-2)"	"prognostic favorable (1.44e-8)"	12.5	12.5	6.5	14.2	9.6	11.7	11.7	8.2	7.2	11.6	14.3	9.7	13.9	10.1	12.5	13.9	9.4	13.0	8.8	11.2	7.7	6.1	11.1	11.2	14.4	25.3	8.5	7.2	12.4	9.6	16.5	9.4	12.5	8.8	8.5	9.7	7.8	11.0	19.3	7.1	9.1	14.6	8.9	10.9	18.3	8.2	4.8	9.0	17.3	16.5	7.5	16.4	12.2	9.9	9.0	13.7	21.3	21.9	6.7	9.8	9.4	9.5	5.0	5.1	4.0	5.7	9.8	3.0	6.6	9.1	8.2	8.6	6.7	13.5	16.7	6.2	9.8	14.1	6.5	6.2	11.0	7.6	23.2	10.3	10.6	5.7	3.5	9.8	18.9	17.0	8.3	7.2	11.6	10.8	7.3	9.9	13.5	4.7	12.0	14.9	9.4	12.4	12.0	4.7	6.5	11.7	10.4	11.1	11.9	9.5	15.2	6.1	8.2	13.0	6.2	7.2	10.5	10.6	7.9	11.4	10.2	6.4	7.7	5.4	13.7	5.0	7.2	13.2	8.9	6.9	9.5	16.1	21.3	9.6	15.0	9.6	6.8	8.8	7.0	13.7	9.0	7.9	7.4	20.4	6.7	21.9	5.9	9.8	9.4	6.5	9.6	8.2	7.2	7.7	6.1	8.5	7.2	8.8	9.0	8.9	7.8	31.3	8.0	3.2	12.9	5.3	17.8	4.0	5.7	15.7	17.7	7.6	6.6	21.5	0.7	9.9	12.4	0.0	26.3	7.9	7.4	10.5	16.2	8.5	32.3	14.3	7.0	8.6	31.7	0.4	8.9	29.9	3.3	45.9	14.1	12.3	28.2	17.5	4.9	11.2	7.7	6.5	5.6	3.7	6.5	4.6	6.9	24.2	12.1	25.2
RFC4	"A1, RFC37"	ENSG00000163918	"Replication factor C subunit 4"	P35249	3	186789880-186807058	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 48.3;Spermatocytes: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004557, HPA049123, HPA058507"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB004557: AB_2178593, HPA049123: AB_2680642, HPA058507: AB_2683736"	"unprognostic (2.45e-1)"	"prognostic favorable (7.41e-5)"	"unprognostic (2.84e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.69e-3)"	"prognostic unfavorable (6.75e-7)"	"unprognostic (5.29e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.80e-2)"	"unprognostic (4.98e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.16e-1)"	7.1	6.9	11.5	14.1	16.0	26.8	10.5	28.0	13.9	8.8	11.6	5.3	5.8	8.2	11.8	7.3	13.0	10.2	7.6	8.0	8.6	6.2	8.2	9.3	6.6	22.1	14.5	9.8	12.7	11.9	6.5	9.0	11.0	12.5	7.3	16.1	5.9	8.1	5.8	8.1	8.7	11.8	13.6	8.4	15.6	9.8	20.3	12.8	28.6	6.4	11.0	25.2	8.3	8.5	11.2	7.7	7.4	10.3	7.0	16.5	6.2	34.8	12.0	28.5	18.2	4.1	4.5	22.5	16.9	10.7	27.0	29.9	17.9	16.7	25.2	39.3	8.1	25.9	18.4	25.1	16.5	33.3	38.0	22.1	25.9	18.4	18.2	3.2	27.3	17.4	3.8	6.0	18.5	14.5	6.0	9.0	39.5	20.1	35.9	18.4	16.6	34.3	25.6	25.2	31.2	16.4	27.2	24.5	34.6	9.7	13.0	27.9	13.9	21.1	23.3	19.1	22.4	39.6	26.2	4.1	16.4	20.7	27.4	50.4	20.1	44.4	83.9	14.4	30.1	21.5	0.0	2.2	7.4	9.8	3.3	9.4	10.6	9.7	10.1	3.9	11.2	9.8	8.9	0.4	7.0	10.3	7.7	16.5	6.2	11.5	16.0	28.0	13.9	8.6	6.2	14.5	9.8	12.5	12.8	0.0	2.1	20.1	13.1	5.4	17.0	6.9	10.2	9.4	7.9	10.4	0.0	26.7	5.0	9.4	18.6	4.5	2.0	23.3	14.4	48.3	5.1	4.1	8.1	2.9	20.0	7.9	1.2	6.7	2.1	7.9	9.8	5.2	1.7	15.4	4.2	12.4	7.9	3.5	7.4	6.7	14.0	6.5	10.3	67.9	38.7	2.6	9.4	8.6	11.5	3.1
CHMP3	"CGI-149, NEDF, VPS24"	ENSG00000115561	"Charged multivesicular body protein 3"	Q9Y3E7	2	86503431-86563479	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA015673, HPA073383"	Supported					NA	NA					"HPA015673: AB_1858761, HPA073383: AB_2732224"	"unprognostic (2.49e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (3.92e-5)"	"unprognostic (2.67e-1)"	"unprognostic (6.16e-2)"	"unprognostic (8.40e-2)"	"prognostic unfavorable (7.39e-4)"	"unprognostic (1.20e-1)"	"prognostic favorable (5.32e-4)"	"unprognostic (1.34e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.64e-1)"	32.1	28.4	40.4	21.6	66.7	12.9	35.7	37.9	48.0	30.1	34.6	13.2	24.9	30.1	34.2	28.8	46.1	26.0	26.3	47.0	29.6	22.9	29.3	11.0	30.5	17.4	25.2	28.9	25.0	32.0	33.1	23.8	19.1	40.7	32.1	37.3	15.7	27.7	32.2	80.5	27.9	30.4	59.8	43.5	18.2	28.7	18.8	24.1	9.4	33.4	23.9	18.3	33.6	33.1	12.3	12.5	57.5	18.2	8.4	13.3	12.3	30.0	28.2	16.1	11.7	21.6	42.1	15.7	22.4	30.3	19.2	16.8	25.1	26.6	9.8	21.6	28.3	21.6	24.4	9.8	19.5	21.2	5.9	12.5	13.1	14.0	28.4	19.0	10.3	14.3	25.2	44.0	12.0	19.5	21.1	21.4	9.9	13.9	7.5	30.8	26.1	6.8	9.1	5.6	39.8	21.9	4.4	37.6	7.8	25.5	34.3	19.7	21.4	21.6	20.2	18.8	8.0	17.2	15.9	25.8	34.4	14.2	33.3	25.0	6.2	9.2	6.6	24.6	16.6	18.1	32.2	15.6	41.0	7.5	18.2	8.8	12.0	11.2	8.9	12.5	12.3	13.3	10.2	57.5	8.4	15.8	10.6	11.0	12.3	40.4	66.7	37.9	48.0	29.6	22.9	25.2	28.9	40.7	24.1	137.0	79.1	59.5	69.0	84.6	54.8	108.4	147.7	87.0	101.2	38.4	39.3	42.9	126.0	148.7	124.3	84.2	187.2	23.3	152.9	47.4	75.1	92.5	143.3	55.7	78.9	65.2	128.3	116.6	117.3	75.3	66.4	90.4	67.4	80.2	148.1	46.7	164.8	161.3	85.6	110.2	34.9	64.7	92.6	82.5	53.4	82.2	71.1	48.9	152.8	86.4
SPATS2L	"DNAPTP6, SGNP"	ENSG00000196141	"Spermatogenesis associated serine rich 2 like"	Q9NUQ6	2	200305881-200482263	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 76.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055427, HPA066310"	Uncertain		Enhanced	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA055427: AB_2682813, HPA066310: AB_2685655"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.39e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (7.43e-4)"	"unprognostic (3.95e-1)"	"unprognostic (7.84e-3)"	"unprognostic (3.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.99e-1)"	25.0	13.5	22.4	14.3	20.1	4.2	46.1	15.7	25.7	33.1	34.5	14.5	27.2	34.3	20.4	20.7	28.0	34.8	46.9	46.4	18.4	18.8	37.7	44.9	22.4	14.7	21.9	20.9	30.0	24.3	17.1	24.7	26.9	20.3	27.3	34.6	14.9	63.4	28.8	26.5	15.6	44.6	20.6	23.4	22.1	42.2	11.5	16.7	14.3	21.6	17.5	12.3	25.4	46.5	2.2	9.8	22.9	3.3	4.2	17.0	1.6	27.3	15.8	18.6	2.3	12.5	16.0	6.9	49.0	16.4	31.9	23.9	42.6	30.1	0.1	11.3	31.1	17.4	27.1	5.6	28.6	21.0	16.4	7.8	0.2	14.4	51.1	22.5	4.7	2.1	19.6	28.5	21.3	20.4	22.7	12.4	3.4	6.3	19.7	42.4	8.4	0.7	1.3	4.5	48.8	36.4	0.1	66.3	1.9	76.9	22.4	0.5	5.3	12.7	7.1	19.9	27.6	3.8	6.5	20.5	21.2	21.4	6.6	27.9	5.8	5.6	0.3	18.1	2.2	29.8	22.9	3.1	4.2	3.6	3.3	8.3	1.6	3.9	3.6	9.8	2.2	1.7	2.0	3.1	4.2	2.5	7.6	17.0	1.6	22.4	20.1	15.7	25.7	18.4	18.8	21.9	20.9	20.3	16.7	80.4	19.2	18.1	208.3	80.9	13.9	110.0	359.2	145.9	56.9	164.0	11.8	13.7	94.5	137.6	58.2	54.0	166.5	0.0	128.0	30.2	94.6	270.0	56.4	183.0	67.0	57.2	52.9	86.5	88.0	14.5	153.4	70.0	121.4	18.0	201.8	6.1	152.6	164.9	133.7	331.2	48.9	77.6	97.1	16.5	78.7	68.1	8.2	19.2	64.2	162.6
YWHAG	PPP1R170	ENSG00000170027	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma"	P61981	7	76326794-76359031	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 117.8;skeletal muscle: 91.8"	"Cell type enhanced"	"Detected in all"	5	"Basal keratinocytes: 363.1;Suprabasal keratinocytes: 371.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013274, CAB018389, HPA026918, HPA061603"	Approved	Approved	Supported	"Nucleoplasm,Nucleoli rim,Cytosol"		NA	NA		160000000	Cytosol	"Nucleoplasm, Nucleoli rim"	"CAB013274: , CAB018389: AB_2217962, HPA026918: AB_10610566, HPA061603: "	"unprognostic (3.71e-2)"	"prognostic unfavorable (4.53e-4)"	"unprognostic (3.88e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.40e-3)"	"unprognostic (8.98e-3)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (9.31e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.70e-1)"	52.4	31.2	46.3	17.7	54.6	7.3	17.2	36.2	117.8	13.4	14.2	13.3	4.6	14.4	15.0	7.0	18.6	9.0	17.0	33.1	50.2	56.2	15.9	22.0	12.9	12.1	45.9	49.8	13.3	18.0	14.8	7.8	16.6	74.6	14.7	14.0	8.6	10.0	13.3	91.8	11.7	12.5	20.2	22.8	12.7	11.2	8.9	13.5	6.8	8.8	13.8	14.3	14.7	13.2	3.1	5.9	3.2	5.0	1.1	3.3	1.7	37.4	47.2	41.7	53.0	42.8	24.7	18.9	43.6	21.6	27.1	29.4	29.6	40.4	52.9	15.0	38.7	45.1	35.1	52.3	48.1	38.1	35.8	22.8	50.1	32.3	32.8	39.1	61.1	49.0	27.1	46.2	31.6	65.5	28.8	42.9	28.8	68.7	59.9	40.3	35.3	43.6	45.2	46.3	30.3	33.1	51.1	42.3	58.4	42.4	25.6	22.4	62.3	48.3	62.0	30.8	56.2	43.1	37.0	45.3	52.9	30.7	46.9	58.2	19.9	37.2	81.5	47.5	57.8	56.3	3.2	5.0	1.1	2.1	4.6	3.3	3.1	2.4	2.6	5.2	1.8	1.8	2.0	1.1	1.1	3.8	5.9	2.0	1.7	46.3	54.6	36.2	88.9	50.2	56.2	45.9	49.8	74.6	13.5	29.8	23.7	44.7	105.7	363.1	100.2	200.1	43.3	22.7	45.5	36.6	11.8	29.7	31.5	43.8	87.4	64.2	34.1	46.7	32.8	61.5	84.6	106.7	66.8	81.5	75.7	117.6	81.9	48.5	90.6	18.9	42.8	83.5	89.4	41.5	31.5	23.8	60.8	28.8	40.7	41.0	26.9	32.3	122.6	10.3	16.7	371.9	56.2	18.7	33.8	146.6
EMP1	"CL-20, TMP"	ENSG00000134531	"Epithelial membrane protein 1"	P54849	12	13196716-13219939	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 240.9;lymphoid tissue: 129.3"	"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 616.6;Fibroblasts: 489.5;Melanocytes: 448.7;Suprabasal keratinocytes: 601.1;Urothelial cells: 926.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 28.6"	"Cell type enriched"	"Detected in some"	7	"myeloid DC: 7.0"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 7.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 132.0;fHDF/TERT166: 91.8;HaCaT: 82.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA051931, HPA056250"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051931: , HPA056250: "	"unprognostic (1.40e-2)"	"unprognostic (7.30e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.41e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (2.26e-8)"	"prognostic unfavorable (7.46e-4)"	"unprognostic (2.98e-1)"	"unprognostic (4.84e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (9.69e-8)"	63.3	5.0	2.7	8.0	10.4	2.1	20.8	0.8	3.9	51.3	11.6	5.5	4.0	4.6	14.0	10.4	240.9	9.9	25.2	16.1	7.3	2.8	8.9	4.4	18.1	5.9	5.3	0.9	5.7	10.2	2.9	2.8	10.6	28.6	6.3	6.9	17.8	45.4	2.8	12.0	16.8	10.7	17.6	9.7	8.5	6.0	5.2	3.0	0.6	22.5	99.1	129.3	14.1	80.6	0.0	7.0	0.0	0.5	0.1	0.1	0.0	38.9	2.0	1.0	0.2	63.1	132.0	0.1	28.8	52.9	14.9	19.0	0.2	66.0	0.2	20.6	91.8	6.5	82.1	1.1	3.8	20.2	0.7	0.0	0.1	6.9	0.0	15.2	0.2	0.2	41.4	5.6	47.3	13.9	11.8	34.0	0.0	0.2	0.6	35.0	0.1	0.0	0.8	0.7	7.3	6.7	0.1	4.0	0.3	43.5	0.4	0.0	0.0	12.9	1.9	21.5	7.7	0.3	0.2	37.2	33.5	11.8	31.4	15.5	0.1	0.4	0.2	48.8	0.2	39.3	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.1	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	2.7	10.4	0.8	3.9	7.3	2.8	5.3	0.9	28.6	3.0	190.6	90.0	2.7	198.6	616.6	0.0	9.5	2.5	87.0	247.9	17.4	0.0	0.8	13.3	17.9	0.7	293.7	59.6	0.0	3.9	1.5	489.5	352.1	46.5	2.0	41.5	0.0	45.6	127.7	32.1	0.5	64.5	93.9	448.7	7.2	4.0	2.5	37.6	27.1	102.9	0.2	0.0	6.5	173.1	0.7	0.5	601.1	0.9	5.1	5.6	926.6
CDKN3	"CDI1, KAP"	ENSG00000100526	"Cyclin dependent kinase inhibitor 3"	Q16667	14	54396849-54420218	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 80.3"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 2056.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 16.1"	"Group enriched"	"Detected in all"	5	"NK-cells: 5.8;T-cells: 16.1"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005285, HPA039311, HPA058874"			Enhanced	Cytosol		NA	Yes			Cytosol		"CAB005285: AB_2078884, HPA039311: , HPA058874: AB_2683842"	"unprognostic (3.46e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.73e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.51e-3)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (2.50e-3)"	"unprognostic (2.85e-3)"	"prognostic unfavorable (7.46e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.71e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.31e-2)"	2.4	1.0	1.6	6.5	1.7	12.8	1.5	1.5	2.5	1.0	4.5	0.2	0.2	3.8	0.9	1.1	4.4	0.7	0.9	3.0	1.4	1.9	1.0	1.1	1.1	8.8	1.7	1.9	0.9	0.7	0.0	1.0	2.3	2.8	0.9	5.8	0.9	1.7	0.1	3.9	1.8	4.0	2.2	1.0	2.3	1.8	80.3	0.3	18.3	1.1	6.4	9.5	2.1	1.8	2.0	1.6	1.1	1.4	5.8	16.1	2.9	55.2	21.2	16.3	16.3	2.7	3.3	9.4	13.2	19.5	28.2	31.2	16.0	27.6	27.2	9.7	20.6	29.7	40.7	24.7	16.0	52.7	32.6	11.9	13.8	15.3	26.4	2.0	17.2	9.8	1.2	1.0	17.6	30.7	9.9	17.9	26.4	6.9	34.8	33.8	39.3	23.8	14.0	5.7	54.1	46.0	14.8	14.4	5.9	14.9	12.1	6.7	8.5	24.2	14.3	10.5	12.8	29.6	14.7	6.5	12.5	42.9	19.7	31.2	8.4	9.7	18.7	20.9	24.9	22.8	0.0	1.3	1.1	1.2	1.4	0.6	2.0	5.2	4.3	1.6	0.9	2.7	2.2	0.9	5.8	0.9	1.2	16.1	2.9	1.6	1.7	1.5	2.5	1.4	1.9	1.7	1.9	2.8	0.3	0.0	0.0	0.8	3.1	8.2	1.4	9.3	0.0	0.0	1.2	1.8	2.0	9.8	0.0	2.8	2056.4	2.0	2.9	256.9	2.1	27.0	6.6	2.2	6.9	1.8	31.5	4.8	7.5	4.9	7.5	483.1	19.8	5.7	1.7	3.6	6.2	1.2	2.0	6.2	9.9	1.7	2.3	0.0	2.1	159.2	36.4	5.6	3.4	7.0	12.8	1.4
NSD3	"FLJ20353, KMT3F, WHISTLE, WHSC1L1"	ENSG00000147548	"Nuclear receptor binding SET domain protein 3"	Q9BZ95	8	38269697-38382272	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 85.7;Extravillous trophoblasts: 142.9;monocytes: 86.6;Syncytiotrophoblasts: 109.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005659, CAB013721, HPA018893"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB013721: , HPA005659: AB_1080596, HPA018893: AB_1858833"	"unprognostic (6.21e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.60e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.60e-2)"	19.2	11.3	31.1	15.8	31.4	36.3	20.1	51.5	37.7	18.5	15.5	16.7	14.0	16.2	16.0	12.5	17.0	16.8	17.0	12.7	24.4	16.6	14.2	11.2	17.9	22.3	25.0	26.8	26.5	16.3	21.0	24.2	22.5	21.9	16.4	18.7	12.3	18.3	17.9	12.3	16.2	17.7	16.0	15.3	17.2	19.7	9.3	25.6	16.7	19.2	6.9	20.4	19.6	23.3	26.7	5.6	26.2	5.1	8.6	18.0	2.9	24.1	13.9	23.9	16.1	16.8	19.3	17.7	20.3	22.4	17.6	20.5	7.4	13.4	28.8	18.7	13.8	17.1	14.6	18.9	16.2	25.2	11.4	11.1	36.7	11.2	8.6	17.2	16.1	13.3	10.3	16.5	15.9	32.4	16.5	20.1	31.9	26.0	19.2	16.7	8.7	47.1	13.7	16.2	18.8	6.6	21.6	26.1	9.1	12.5	18.7	13.5	18.2	16.5	14.5	14.1	16.0	18.2	12.3	19.2	18.3	19.0	27.2	11.9	17.1	20.4	27.8	15.5	16.3	13.2	13.9	5.1	9.1	8.0	2.4	5.3	16.5	12.0	7.1	4.1	26.7	15.0	6.3	26.2	8.6	1.5	5.6	18.0	2.9	31.1	31.4	51.5	37.7	24.4	16.6	25.0	26.8	21.9	25.6	62.5	52.3	0.0	0.0	0.0	0.0	0.0	0.0	62.9	55.7	48.8	0.0	85.7	19.9	60.6	0.0	0.0	0.0	0.0	53.3	142.9	0.0	0.0	8.1	0.0	39.1	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	86.6	0.0	0.0	50.3	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.0	0.0	109.4	0.0	0.0	0.0
IL11	"AGIF, IL-11"	ENSG00000095752	"Interleukin 11"	P20809	19	55364389-55370463	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.2"	"Group enriched"	"Detected in some"	8	"Ductal cells: 10.9;Pancreatic endocrine cells: 37.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebellum: 9.2;hypothalamus: 3.7;pons and medulla: 2.7"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 18.3;BJ hTERT+: 20.8;hTEC/SVTERT24-B: 17.0;U-251 MG: 65.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	34800					"unprognostic (6.60e-3)"	"unprognostic (7.23e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.18e-3)"	"unprognostic (3.32e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.84e-5)"	"unprognostic (2.47e-1)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (4.83e-2)"	"unprognostic (4.07e-8)"	"unprognostic (1.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.82e-3)"	"unprognostic (3.08e-2)"	1.1	0.1	0.6	7.7	0.9	1.5	0.6	9.2	1.0	0.6	0.6	1.8	0.6	0.3	6.1	0.6	2.3	0.0	5.9	0.6	0.6	3.7	3.4	0.6	0.9	0.6	1.2	0.6	0.6	0.6	0.0	5.3	2.3	2.7	3.7	0.2	0.6	0.6	1.1	0.6	2.5	0.6	0.6	0.6	0.6	2.8	1.4	0.6	0.6	0.6	0.6	0.6	2.3	0.6	0.7	0.3	2.8	0.3	0.8	0.4	0.0	0.7	0.4	0.1	0.3	0.0	0.0	0.1	18.3	20.8	9.7	12.8	0.3	0.4	0.2	0.8	1.6	5.0	0.9	0.1	0.4	13.0	0.7	0.5	0.0	1.1	1.2	1.0	0.0	0.1	0.1	0.4	17.0	0.1	4.1	0.0	0.0	0.1	0.5	1.1	0.5	0.0	0.1	0.3	0.6	1.5	0.0	6.1	0.0	0.1	0.1	0.9	0.6	2.3	0.3	0.4	2.3	0.2	0.1	0.2	5.8	7.0	0.0	65.9	0.3	0.7	0.1	12.5	0.1	2.9	1.4	0.3	0.5	0.3	0.2	0.2	0.7	0.3	0.1	0.1	0.7	0.3	0.4	2.8	0.8	0.1	0.3	0.2	0.0	0.6	0.9	9.2	0.8	0.6	3.7	1.2	0.6	2.7	0.6	0.0	0.3	0.0	0.3	2.9	1.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.8	0.2	0.0	0.0	2.3	0.8	1.9	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.8	0.0	0.2	37.7	0.2	1.4	0.0	0.2	0.0	0.4	0.3	0.9	0.5	0.2	0.0	0.2	0.3
MCM8	"C20orf154, dJ967N21.5, MGC119522, MGC119523, MGC12866, MGC4816, REC"	ENSG00000125885	"Minichromosome maintenance 8 homologous recombination repair factor"	Q9UJA3	20	5950652-5998977	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Spermatocytes: 43.2;Spermatogonia: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045141, HPA066433"			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045141: AB_2679230, HPA066433: "	"unprognostic (6.55e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (5.78e-2)"	"prognostic unfavorable (9.30e-8)"	"unprognostic (5.21e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.47e-1)"	4.9	5.4	7.3	11.0	7.6	11.2	9.3	17.9	12.7	5.4	6.2	3.1	12.0	5.4	5.9	3.9	6.6	4.3	2.7	11.3	4.8	2.2	4.3	3.1	6.3	9.6	10.6	5.1	5.0	5.6	5.1	4.8	5.4	7.1	5.9	6.0	3.5	5.1	7.2	11.2	6.1	6.1	7.0	8.3	6.1	5.6	21.9	7.7	8.8	4.4	7.0	9.5	6.0	6.1	1.8	1.7	3.3	0.7	1.9	3.0	0.4	19.1	15.0	12.9	13.0	3.4	4.2	11.5	15.7	6.4	12.4	14.9	16.3	12.1	19.5	4.7	5.2	22.3	20.6	21.4	12.4	22.3	5.3	8.7	21.6	7.2	15.9	0.5	22.7	3.4	1.9	2.0	20.8	8.6	3.2	5.7	12.5	22.0	19.3	12.6	5.4	11.7	11.9	17.3	11.8	8.8	14.3	21.9	7.9	3.1	7.6	9.6	10.2	16.0	17.9	9.6	14.5	11.5	8.1	3.8	21.9	18.3	11.8	22.8	8.3	20.7	33.2	4.4	14.7	18.0	3.3	0.5	1.7	1.8	0.5	3.0	1.8	1.1	2.1	0.1	1.7	1.1	1.7	2.1	1.9	0.7	1.7	2.0	0.4	7.3	7.6	17.9	12.7	4.8	2.2	10.6	5.1	7.1	7.7	0.0	4.1	10.0	2.6	2.1	6.9	8.5	7.6	4.0	2.3	12.2	15.7	5.2	0.0	1.2	6.5	3.0	3.8	0.0	2.3	4.7	2.7	4.2	1.1	1.6	3.6	6.4	4.1	1.8	2.1	2.3	3.4	3.5	1.7	0.0	2.9	4.0	2.7	3.5	2.8	2.4	10.7	6.5	2.7	43.2	32.6	2.3	3.3	3.9	5.2	1.8
GPR39		ENSG00000183840	"G protein-coupled receptor 39"	O43194	2	132416574-132646559	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 22.0"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 14.9;Club cells: 10.3;Early spermatids: 16.6;Late spermatids: 12.5;Spermatocytes: 11.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 4.3"	"Lineage enriched"	"Detected in single"	44	"dendritic cells: 4.3"	"Cell line enhanced"	"Detected in many"		"A-431: 17.5;CAPAN-2: 15.0;hTEC/SVTERT24-B: 18.0;RT4: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA022111	Approved					NA	NA					"HPA022111: AB_1849298"	"unprognostic (4.06e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.54e-3)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.72e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.58e-3)"	0.5	0.1	0.6	4.9	1.1	0.0	2.2	0.4	0.3	4.8	14.4	0.1	3.5	4.7	3.2	1.8	1.5	3.4	10.0	0.7	0.5	0.5	8.7	8.6	9.3	0.0	0.6	0.0	1.4	22.0	14.1	0.4	1.3	0.6	3.0	6.0	1.6	1.3	8.7	0.1	1.0	14.4	0.8	0.3	0.1	6.5	0.8	0.0	0.6	4.1	0.0	1.0	6.5	1.9	0.0	4.3	0.0	0.0	0.0	0.0	0.0	17.5	8.4	0.1	0.0	0.3	2.3	0.0	1.2	6.3	3.4	1.9	9.6	15.0	0.0	3.3	1.0	6.8	8.3	0.0	7.3	3.3	0.0	0.0	0.0	0.9	0.3	0.4	0.0	0.0	0.6	5.6	18.0	1.8	3.6	0.0	0.0	0.0	0.0	2.3	1.4	0.0	0.0	0.1	4.0	5.4	0.0	0.2	0.0	11.5	15.8	0.0	0.1	1.0	5.9	0.0	0.3	3.4	0.0	3.0	7.2	5.4	1.5	5.3	0.0	0.0	0.0	8.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.6	1.1	0.4	0.3	0.5	0.5	0.6	0.0	0.6	0.0	14.9	5.4	0.0	0.7	0.1	0.0	0.2	2.5	8.1	10.3	0.0	0.0	0.0	0.0	4.5	16.6	0.0	4.9	0.0	2.7	0.0	0.2	0.2	0.0	2.6	0.0	0.0	2.4	0.0	0.6	12.5	0.3	0.0	0.0	1.0	1.2	1.5	3.8	2.9	0.4	0.6	0.0	0.0	0.0	11.2	0.6	0.0	0.0	0.0	3.8	0.5
NLN	"AGTBP, KIAA1226"	ENSG00000123213	Neurolysin	Q9BYT8	5	65722196-65871725	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.7;intermediate monocyte: 5.9;myeloid DC: 4.1;non-classical monocyte: 4.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.1;monocytes: 5.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031862	Approved		Approved	Mitochondria		Yes	No		53000	Mitochondria		"HPA031862: AB_10600827"	"unprognostic (5.91e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.45e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.27e-1)"	"prognostic favorable (5.58e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.18e-3)"	4.5	2.4	7.6	4.7	10.5	2.9	7.3	2.8	11.9	4.1	6.8	5.8	1.0	2.4	5.8	5.0	5.2	3.3	2.7	5.1	7.2	7.6	7.5	18.9	3.4	5.1	8.7	8.5	4.0	11.0	3.6	2.4	4.9	9.8	5.4	6.5	2.0	4.3	2.6	15.0	5.7	5.3	5.5	10.9	5.8	7.5	2.4	6.2	1.8	5.5	7.9	4.0	4.3	3.3	0.9	4.1	0.6	5.9	0.9	0.7	1.8	9.2	8.9	5.3	8.7	6.7	11.5	10.6	9.4	4.0	5.5	6.0	5.1	5.5	13.2	11.9	11.2	11.1	7.4	6.8	14.4	9.7	3.9	4.6	3.6	6.7	12.8	5.8	8.3	2.2	8.7	7.9	7.6	9.1	4.7	15.5	5.9	7.8	2.8	11.9	7.1	5.7	7.5	16.1	4.7	2.6	6.7	11.2	20.9	9.1	4.1	16.4	8.5	7.6	7.8	7.7	14.9	9.3	9.9	8.9	3.7	4.4	5.4	7.0	2.4	4.8	5.8	5.7	16.4	5.5	0.2	4.7	0.2	0.2	5.9	0.3	0.9	0.4	0.3	4.1	0.9	0.7	0.5	0.6	0.9	4.1	0.2	0.1	1.8	7.6	10.5	2.8	11.9	7.2	7.6	8.7	8.5	9.8	6.2	6.0	3.2	1.5	5.1	5.0	0.6	13.2	10.2	2.7	11.4	12.2	3.9	5.2	5.0	15.3	0.2	5.0	20.6	0.0	12.3	12.1	5.2	8.8	15.0	26.4	24.7	4.8	1.7	5.5	23.4	0.0	4.0	8.4	1.7	2.8	7.1	13.2	23.5	10.7	2.1	17.4	3.5	0.0	3.1	1.4	4.3	4.5	2.4	0.9	7.1	5.5
FAM83B	"C6orf143, FLJ30642"	ENSG00000168143	"Family with sequence similarity 83 member B"	Q5T0W9	6	54846771-54942022	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 32.7;intestine: 24.6;tongue: 30.1"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 29.9;Basal keratinocytes: 30.0;Suprabasal keratinocytes: 35.9;Urothelial cells: 28.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 15.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 12.6;HaCaT: 14.1;HBEC3-KT: 7.7;hTCEpi: 14.2;hTERT-HME1: 18.7;RT4: 16.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA031464, HPA031465"	Enhanced					NA	NA					"HPA031464: AB_10599973, HPA031465: AB_10601566"	"unprognostic (2.29e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.03e-2)"		"unprognostic (1.71e-2)"		"prognostic unfavorable (1.48e-4)"	"unprognostic (7.27e-2)"	"unprognostic (5.77e-3)"	"prognostic unfavorable (7.60e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.35e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.86e-5)"	0.4	0.4	0.4	6.9	0.4	0.0	1.6	0.4	0.4	8.8	16.4	0.0	1.9	6.5	0.4	2.9	32.7	1.4	7.0	1.6	0.4	0.4	6.3	0.5	0.5	0.0	0.4	0.0	0.5	3.7	0.0	0.4	15.6	0.0	5.5	8.2	0.0	5.5	1.7	3.5	22.3	24.6	1.3	0.4	0.4	3.6	0.9	0.0	4.3	11.0	30.1	8.5	4.3	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.1	0.0	0.0	0.0	0.0	5.6	0.0	0.1	0.0	0.0	5.4	2.9	0.0	0.0	0.0	0.0	14.1	0.0	7.7	0.0	0.0	1.8	0.0	2.4	0.0	0.0	0.0	0.0	0.0	14.2	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.3	2.9	0.0	0.0	0.0	0.0	5.8	16.1	0.2	0.0	2.4	0.4	0.0	2.6	3.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	29.9	30.0	0.0	2.4	5.1	0.0	7.9	7.0	0.0	8.0	0.0	5.5	4.5	0.0	9.3	0.0	2.9	9.4	0.7	7.2	0.0	0.0	0.5	0.0	1.2	0.6	0.0	1.8	0.0	0.0	0.0	0.0	5.5	0.0	3.6	10.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	35.9	15.7	0.0	7.1	28.6
KIAA1217	"DKFZP761L0424, ETL4, SKT"	ENSG00000120549	KIAA1217	Q5T5P2	10	23694746-24547848	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 91.1"	"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 107.7;Club cells: 95.5;Muller glia cells: 121.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.8"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 34.0;Karpas-707: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004941	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA004941: AB_2130659"	"unprognostic (3.60e-2)"	"unprognostic (7.55e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.87e-2)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-1)"	24.9	12.7	3.3	6.6	8.7	0.0	21.6	5.5	16.2	10.2	15.1	2.7	18.0	7.5	7.2	16.5	22.6	10.4	11.9	8.6	5.1	3.7	13.5	10.4	8.6	1.4	4.3	8.1	8.4	10.1	34.1	5.5	12.2	8.8	15.1	8.9	16.9	28.8	26.6	91.1	12.0	13.7	4.1	3.8	5.7	10.1	16.8	1.8	3.3	20.5	20.4	8.8	10.1	13.0	0.0	0.0	0.0	0.0	0.9	2.8	0.0	7.6	3.9	1.5	0.0	1.0	2.8	34.0	1.5	2.4	3.5	7.6	6.6	12.3	0.4	7.7	3.0	7.2	12.8	1.9	14.5	3.9	2.8	1.4	0.1	8.9	7.7	1.7	0.0	0.1	10.7	9.4	7.8	2.1	1.6	0.0	0.7	0.0	30.9	1.8	2.7	4.2	0.2	3.5	7.5	3.5	0.3	9.1	6.3	8.3	10.1	1.0	0.5	3.8	12.9	0.0	16.6	6.2	0.0	8.1	5.4	5.9	21.7	1.9	13.8	11.6	0.0	18.1	0.2	0.2	0.0	0.0	0.0	0.5	0.0	2.8	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	3.3	8.7	5.5	16.2	5.1	3.7	4.3	8.1	8.8	1.8	35.7	24.2	0.8	63.7	107.7	12.4	33.1	17.8	32.1	95.5	31.4	7.9	43.5	3.3	26.0	24.9	10.8	21.2	0.0	23.1	16.7	14.6	36.0	1.1	21.2	4.6	0.0	23.0	25.8	10.5	7.0	16.4	2.7	1.7	0.0	21.3	121.7	20.1	22.0	31.1	4.5	2.7	12.9	19.6	0.5	0.7	44.5	54.5	0.7	16.6	47.2
PIGA	GPI3	ENSG00000165195	"Phosphatidylinositol glycan anchor biosynthesis class A"	P37287	X	15319451-15335580	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001174	Approved					NA	NA					"HPA001174: AB_2666220"	"unprognostic (1.15e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.99e-3)"	"unprognostic (2.24e-2)"	"unprognostic (7.37e-3)"	"unprognostic (3.93e-3)"	"prognostic unfavorable (7.64e-4)"	"unprognostic (1.85e-3)"	"unprognostic (5.97e-3)"	"unprognostic (2.24e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.18e-2)"	6.9	6.1	6.8	5.0	8.6	16.1	7.0	7.6	10.0	6.0	6.8	9.6	5.8	3.5	6.2	7.5	9.9	5.6	7.8	6.2	8.0	5.4	7.5	11.0	14.4	5.9	9.6	6.4	7.0	9.9	8.5	5.2	10.8	16.7	5.9	7.5	7.0	11.5	9.1	4.2	10.9	4.8	5.2	10.2	5.7	7.2	5.3	9.4	4.7	8.6	8.5	8.7	11.6	6.6	2.9	3.9	16.7	7.6	1.5	4.4	2.4	12.5	7.8	8.1	4.1	2.4	2.5	6.7	3.3	5.2	7.3	7.0	8.5	5.5	5.9	2.7	2.6	8.5	5.0	13.4	11.0	11.9	5.3	9.2	5.0	9.6	5.0	4.2	7.1	2.6	3.4	7.4	9.4	14.9	2.2	4.6	4.7	5.4	6.3	4.4	7.9	8.0	2.6	4.2	4.7	8.6	2.8	11.7	9.3	5.2	8.5	5.6	8.7	6.6	5.9	12.7	8.3	6.0	6.3	3.8	5.4	2.2	12.0	6.6	4.8	6.2	9.1	8.4	5.1	6.9	16.7	3.6	3.9	2.7	6.0	3.8	2.9	4.4	2.7	3.9	2.2	4.0	3.1	5.2	1.5	7.6	2.5	3.8	2.4	6.8	8.6	7.6	10.0	8.0	5.4	9.6	6.4	16.7	9.4	17.9	84.7	1.9	34.4	26.3	3.4	6.7	2.5	17.4	22.7	3.5	0.0	4.8	10.0	6.3	3.5	4.5	5.4	23.3	5.1	8.2	10.6	28.9	32.4	4.3	7.5	3.2	10.3	2.5	6.9	3.2	2.8	13.8	27.0	1.8	3.7	3.7	7.9	4.5	2.8	4.7	2.5	12.9	19.6	1.6	3.9	48.1	23.5	6.4	4.1	49.8
TMC7	FLJ21240	ENSG00000170537	"Transmembrane channel like 7"	Q7Z402	16	18983934-19063942	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.8;testis: 14.9"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 117.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029465	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA029465: AB_10600914"	"unprognostic (1.80e-4)"	"unprognostic (6.13e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-3)"	"unprognostic (7.60e-5)"	"prognostic unfavorable (3.20e-4)"	"unprognostic (7.60e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (7.64e-4)"	"unprognostic (3.39e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.66e-2)"	"prognostic favorable (9.20e-4)"	3.6	0.7	6.2	1.9	11.4	0.7	2.0	8.5	11.1	1.1	6.7	24.8	0.0	4.4	1.5	1.3	0.9	1.0	2.6	1.6	9.7	5.3	1.0	0.7	5.2	0.7	15.7	6.6	0.7	0.9	1.4	0.7	7.7	12.8	2.8	8.2	0.6	0.7	1.9	1.6	2.0	4.9	2.2	15.7	1.1	5.4	14.9	12.8	0.0	1.6	0.0	0.6	9.6	1.3	1.6	1.2	2.9	0.8	1.6	1.0	0.2	1.9	4.0	1.2	2.0	0.2	1.7	5.3	0.7	1.1	0.7	1.8	1.3	9.3	0.2	8.9	0.7	2.0	7.3	3.2	3.1	0.9	0.1	2.3	0.2	3.2	5.7	0.2	0.2	0.1	0.4	4.5	7.2	8.1	2.4	3.0	4.1	2.2	0.7	3.2	4.5	0.3	0.3	3.4	12.1	5.9	0.2	3.5	0.3	1.3	9.7	0.7	2.0	2.2	6.1	0.6	5.6	1.8	0.7	2.6	1.2	2.0	1.4	3.5	0.5	1.0	0.3	6.2	0.3	1.0	2.5	0.8	0.8	0.9	0.6	0.5	0.9	0.9	0.7	0.3	1.6	0.9	1.0	2.9	1.6	0.4	1.2	0.5	0.2	6.2	11.4	8.5	8.3	9.7	5.3	15.7	6.6	12.8	12.8	3.0	3.8	0.0	2.5	0.3	0.6	0.8	2.5	0.0	1.2	0.0	0.0	0.1	0.0	2.8	117.6	3.0	3.9	0.0	10.0	1.5	0.4	2.0	0.0	0.2	0.2	0.0	1.2	4.3	0.0	29.3	1.1	1.2	0.0	0.0	5.4	0.2	9.6	6.8	0.4	0.0	2.5	0.0	1.0	5.4	10.0	0.9	0.2	0.0	3.3	15.2
GALNT7	GALNAC-T7	ENSG00000109586	"Polypeptide N-acetylgalactosaminyltransferase 7"	Q86SF2	4	173168753-173323967	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.4"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 70.2;Glandular cells: 85.7;Mucus-secreting cells: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064243, HPA065317"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		5000000	"Golgi apparatus"	Nucleoplasm	"HPA064243: AB_2685223, HPA065317: AB_2685465"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-1)"	"prognostic favorable (4.53e-4)"	"unprognostic (1.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (6.86e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.66e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.34e-3)"	"unprognostic (5.97e-2)"	3.7	4.4	8.4	7.4	8.4	5.0	12.0	27.6	8.0	13.4	23.3	9.4	2.8	14.1	9.3	5.5	12.0	4.9	9.5	3.5	6.5	5.2	4.9	1.2	4.5	5.2	10.8	7.0	7.2	14.9	5.3	5.6	6.3	11.2	20.3	26.7	6.2	20.1	4.2	1.4	3.1	16.2	8.4	16.3	5.7	32.8	6.4	8.8	67.4	6.6	4.4	9.6	9.4	4.8	5.0	9.8	16.8	11.4	5.5	6.8	4.7	20.4	10.7	10.6	3.3	5.7	8.4	15.2	5.4	6.1	5.1	7.0	3.3	32.5	11.4	4.0	4.8	13.7	17.5	4.4	9.5	6.9	44.2	8.7	13.9	22.3	0.1	3.8	20.4	9.9	5.4	8.6	11.3	5.7	19.3	33.5	8.3	9.2	17.8	25.7	6.7	15.0	11.3	10.4	20.4	7.1	15.0	9.8	2.9	37.2	9.6	8.5	6.5	2.5	15.0	7.4	14.4	6.0	6.1	40.0	3.6	16.2	0.1	11.6	5.2	0.0	6.1	14.8	12.3	13.0	9.6	11.4	14.6	4.3	6.0	6.2	5.0	4.9	4.6	9.8	3.1	3.9	3.0	16.8	5.5	6.1	4.1	6.8	4.7	8.4	8.4	27.6	8.0	6.5	5.2	10.8	7.0	11.2	8.8	6.0	29.4	4.7	7.8	1.5	36.4	5.9	12.7	14.7	30.7	19.2	2.0	0.9	0.0	12.2	1.8	6.9	70.2	0.0	43.4	2.9	6.6	85.7	23.1	0.0	9.6	9.5	21.9	8.0	21.3	3.1	8.6	8.8	8.5	8.2	125.7	7.5	33.8	50.7	4.9	8.6	23.6	12.9	6.8	2.3	4.4	1.0	0.7	4.4	37.4	15.7
FAM149B1	KIAA0974	ENSG00000138286	"Family with sequence similarity 149 member B1"	Q96BN6	10	73168166-73244504	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039189, HPA039859"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039189: AB_10805355, HPA039859: AB_2676712"	"unprognostic (2.23e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (7.81e-4)"	"unprognostic (5.13e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.68e-1)"	"unprognostic (5.24e-2)"	9.3	8.9	21.3	7.3	17.0	5.4	10.1	7.7	15.1	12.2	13.4	14.9	10.3	5.4	9.1	10.6	10.5	11.4	12.8	15.7	19.2	14.2	17.5	15.2	7.9	6.3	20.8	9.8	12.6	9.3	12.9	10.8	10.3	13.6	10.5	8.0	8.1	9.0	9.1	9.4	5.8	9.5	9.3	22.8	5.9	7.2	16.6	13.2	6.2	9.8	13.4	7.3	8.3	7.3	2.7	2.7	5.0	1.8	4.6	3.4	1.3	6.9	5.3	11.9	10.9	26.1	16.3	7.7	8.0	15.7	5.4	9.6	3.3	12.2	5.2	3.1	13.9	6.2	6.7	6.9	10.0	6.5	6.3	3.5	6.6	4.1	5.6	13.6	9.1	4.4	13.9	7.4	7.0	27.3	24.0	13.6	8.3	5.9	9.7	9.8	6.3	6.0	8.6	5.1	15.0	13.9	4.0	7.5	5.3	14.6	7.0	2.6	11.3	6.2	16.7	9.6	11.1	9.6	5.8	7.2	5.3	5.4	5.3	10.0	10.7	4.8	4.6	9.1	9.1	4.2	5.0	0.7	2.5	2.2	1.8	2.8	2.7	2.2	2.1	1.5	2.2	3.4	3.1	1.5	4.6	1.0	2.7	2.5	1.3	21.3	17.0	7.7	15.1	19.2	14.2	20.8	9.8	13.6	13.2	3.0	1.9	3.7	3.0	1.8	6.6	10.2	5.1	10.7	5.7	1.8	5.9	5.8	1.7	3.8	17.7	5.8	4.7	0.0	3.1	4.8	4.3	4.0	2.3	3.4	4.8	3.2	7.5	5.5	4.5	19.6	7.8	2.5	1.7	1.8	5.8	4.2	4.0	0.0	4.2	6.8	12.1	12.9	5.2	10.9	3.8	3.1	6.9	2.1	5.2	3.7
KLK6	"Bssp, Klk7, neurosin, PRSS18, PRSS9"	ENSG00000167755	"Kallikrein related peptidase 6"	Q92876	19	50958631-50969673	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.6;esophagus: 48.9"	"Cell type enhanced"	"Detected in some"	22	"Collecting duct cells: 10.4;Early spermatids: 2.0;Late spermatids: 2.1;Pancreatic endocrine cells: 4.6;Urothelial cells: 2.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 131.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 70.0;CAPAN-2: 167.5"	"Region enhanced"	"Detected in many"		"pons and medulla: 175.6"	"Group enriched"	"Detected in many"	8	"midbrain: 106.3;pons and medulla: 164.1;thalamus: 62.4"	HPA051837			Supported	"Nucleoplasm,Nuclear membrane,Cytokinetic bridge"	"Secreted in other tissues"	Yes	No		6800000	Nucleoplasm	"Nuclear membrane, Cytokinetic bridge"	"HPA051837: "	"unprognostic (7.30e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.10e-1)"	"unprognostic (2.31e-1)"		"prognostic unfavorable (8.85e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (4.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (1.27e-4)"	0.9	0.9	9.7	0.9	23.5	0.9	6.5	3.3	42.2	10.0	1.0	82.0	0.0	1.1	2.0	1.2	48.9	24.6	3.8	0.9	20.1	11.8	9.0	0.9	0.9	0.9	46.1	14.9	0.9	0.9	0.9	0.2	0.9	44.3	1.0	0.9	0.0	5.9	2.8	0.9	2.9	0.9	1.0	97.6	5.1	1.0	1.5	32.6	0.0	0.9	15.7	28.1	0.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.3	167.5	0.0	1.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	15.4	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.6	2.3	0.1	0.2	0.0	0.1	6.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	23.5	3.3	23.1	20.1	11.8	46.1	14.9	44.3	32.6	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	2.7
SNAI2	"SLUG, SLUGH, SLUGH1, SNAIL2"	ENSG00000019549	"Snail family transcriptional repressor 2"	O43623	8	48917604-48921740	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Deafness, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Basal glandular cells: 113.7;Basal keratinocytes: 144.6;Fibroblasts: 122.9;Ito cells: 49.1;Leydig cells: 68.1;Melanocytes: 82.7;Peritubular cells: 63.3;Sertoli cells: 51.8;Smooth muscle cells: 149.4;Suprabasal keratinocytes: 129.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	11	"basophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 55.8;ASC TERT1: 57.5;HSkMC: 42.4;hTERT-HME1: 39.6;LHCN-M2: 52.5;U-138 MG: 48.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			CAB011671	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB011671: AB_777968"	"unprognostic (3.52e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (7.83e-4)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (4.69e-8)"	"unprognostic (1.65e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (7.16e-4)"	13.9	6.1	1.0	13.7	1.4	0.0	60.3	4.8	1.8	52.9	7.8	2.0	14.4	2.2	31.3	17.3	15.6	20.7	12.8	12.5	1.0	0.8	17.8	4.8	6.7	14.2	1.9	1.6	27.6	5.8	1.2	2.5	11.5	3.4	34.4	4.6	20.5	11.0	18.8	6.1	21.7	6.3	21.7	3.9	10.6	5.5	9.0	0.9	4.7	6.0	11.6	8.2	22.4	37.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	3.7	0.1	9.4	0.0	55.8	57.5	0.0	8.7	14.9	8.7	11.9	0.0	3.8	0.0	0.0	10.9	13.0	6.5	0.0	25.6	9.6	0.0	0.1	0.0	2.0	0.0	19.7	0.0	0.0	42.4	26.9	7.3	39.6	1.2	0.2	0.0	0.0	4.0	52.5	0.0	0.0	0.0	0.4	0.0	7.4	0.0	26.6	0.0	0.0	1.5	1.1	0.8	0.7	0.0	13.6	4.4	0.0	0.0	2.3	48.1	1.6	8.0	4.4	0.0	0.0	0.8	16.8	0.0	16.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.4	4.8	1.8	1.0	0.8	1.9	1.6	3.4	0.9	0.0	0.0	0.0	113.7	144.6	1.1	0.8	0.0	0.0	9.1	0.0	0.0	1.5	0.0	3.4	0.5	9.0	0.0	0.0	2.1	0.4	122.9	18.4	0.0	5.5	1.4	0.0	0.0	49.1	1.0	0.6	68.1	0.8	82.7	0.0	0.0	0.0	5.1	0.0	63.3	0.0	0.1	51.8	149.4	0.2	0.2	129.4	1.8	0.0	0.0	11.1
OSBPL3	"KIAA0704, ORP-3, ORP3, OSBP3"	ENSG00000070882	"Oxysterol binding protein like 3"	Q9H4L5	7	24796539-24981634	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 75.0;Club cells: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000691, HPA048401"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA000691: AB_1854814, HPA048401: AB_2680386"	"unprognostic (3.57e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.11e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (2.34e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-2)"	3.7	2.2	3.9	18.2	9.5	3.8	6.6	1.2	16.0	12.1	6.1	6.2	0.7	9.8	3.8	3.7	10.2	6.2	10.4	5.3	4.3	4.3	14.4	1.9	9.0	10.9	4.2	7.4	8.4	3.9	23.1	4.2	6.3	3.1	4.3	6.7	3.7	6.9	2.9	6.7	12.8	10.4	4.0	6.7	10.2	8.7	3.5	4.1	13.9	16.8	7.2	14.7	12.4	9.6	3.7	3.5	6.3	2.1	8.1	9.8	2.4	14.7	4.0	3.0	5.5	6.8	13.7	6.7	16.7	18.7	7.9	12.5	10.0	19.7	8.2	2.4	17.9	10.4	13.0	9.0	12.6	12.2	4.9	3.7	1.9	5.9	7.5	9.7	5.6	44.0	6.7	10.5	10.2	12.4	10.1	11.7	7.2	10.3	11.5	13.3	0.0	3.4	6.8	5.8	14.1	5.2	2.7	8.3	3.3	7.9	10.5	0.6	6.2	11.4	8.2	2.5	9.3	4.2	0.5	13.9	3.5	7.0	18.9	12.5	8.0	11.5	20.7	7.6	9.2	38.7	6.3	2.1	1.5	9.8	1.8	8.4	3.7	6.2	6.3	3.5	1.7	2.1	4.2	0.4	8.1	1.2	2.5	9.8	2.4	3.9	9.5	1.2	16.0	4.3	4.3	4.2	7.4	3.1	4.1	0.0	25.0	4.5	6.6	10.8	0.0	4.7	0.0	75.0	30.7	24.4	0.0	7.1	3.3	3.3	0.3	2.9	2.9	0.0	3.4	1.3	2.6	2.1	0.0	0.2	9.4	0.0	1.7	4.3	12.0	0.0	0.6	9.2	15.1	7.2	0.5	5.8	14.9	3.5	0.0	0.5	0.1	0.0	2.2	0.5	4.1	6.9	3.3	13.1	3.4	12.9
VANGL1	STB2	ENSG00000173218	"VANGL planar cell polarity protein 1"	Q8TAA9	1	115641953-115698224	"Disease related genes, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 37.3;Ito cells: 31.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.5;NK-cells: 8.9;T-cells: 4.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA025235, CAB076375"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB076375: AB_2665604, HPA025235: AB_1858718"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (7.53e-4)"	"unprognostic (9.94e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.18e-3)"	"unprognostic (5.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-3)"	"unprognostic (9.06e-3)"	7.0	8.6	2.2	5.8	3.1	2.0	16.4	1.2	2.5	14.0	9.3	5.3	8.3	4.0	13.2	8.8	14.4	13.7	5.3	12.7	3.2	2.3	11.8	7.1	12.1	7.4	2.1	1.9	8.9	11.5	5.5	2.2	5.3	2.4	9.4	7.1	6.6	9.5	11.0	2.1	9.8	6.6	15.9	2.0	4.7	6.6	7.9	2.6	18.0	11.8	10.0	10.0	10.2	9.4	0.3	3.5	0.0	0.8	8.9	4.3	1.4	21.5	9.2	3.0	4.0	11.2	10.1	6.0	8.4	6.1	11.0	8.8	5.3	10.8	0.0	14.5	9.7	10.4	27.3	5.0	14.9	7.3	25.2	6.1	12.0	8.5	4.3	4.1	3.5	5.2	5.3	10.5	7.8	8.4	5.8	10.9	20.6	7.2	6.7	11.0	28.8	17.6	1.4	7.5	12.6	8.8	0.0	8.7	6.2	5.1	14.5	2.7	3.6	15.1	10.0	7.2	5.9	5.1	3.9	11.6	7.6	12.0	16.5	15.2	0.9	1.0	0.0	10.2	6.3	18.5	0.0	0.8	0.0	3.0	0.5	0.8	0.3	1.9	2.9	3.5	0.0	0.7	3.3	0.0	8.9	0.8	3.0	4.3	1.4	2.2	3.1	1.2	2.5	3.2	2.3	2.1	1.9	2.4	2.6	3.0	2.7	1.9	6.3	6.5	4.0	6.3	2.5	6.7	1.2	8.7	37.3	3.7	0.0	14.9	4.6	7.7	7.7	0.0	12.1	5.8	6.4	7.0	0.0	2.4	3.8	0.0	6.4	31.9	1.5	1.9	5.5	1.8	0.0	19.0	7.9	4.2	16.1	5.8	7.8	5.7	0.7	6.5	5.7	1.0	9.4	5.6	0.3	1.8	8.3	6.5
MYO1E	"HuncM-IC, MGC104638, MYO1C"	ENSG00000157483	"Myosin IE"	Q12965	15	59132434-59372900	"Disease related genes, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 16.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 51.5;HaCaT: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003003, HPA023886"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	Cytosol	"HPA003003: , HPA023886: AB_1854253"	"unprognostic (7.90e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (4.19e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.57e-6)"	"unprognostic (1.89e-1)"	"unprognostic (5.38e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.92e-2)"	"unprognostic (7.31e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.62e-2)"	25.9	4.6	7.9	18.4	19.0	0.7	13.3	2.3	12.6	13.6	28.5	40.6	26.5	13.6	18.1	17.0	22.1	10.0	21.5	6.8	12.6	7.6	22.4	33.4	11.6	18.9	27.2	7.6	6.8	8.8	23.7	6.6	18.7	17.2	15.6	19.4	13.0	12.4	43.5	7.2	28.8	25.9	12.3	25.5	11.4	17.1	4.7	22.4	2.6	9.9	10.6	21.7	15.6	16.2	7.0	16.9	0.4	3.4	2.5	0.4	1.6	29.6	51.5	2.8	1.9	22.1	18.1	14.6	12.1	5.9	6.7	7.9	12.7	11.6	11.8	8.7	9.4	27.7	47.8	4.3	18.7	9.0	5.4	2.4	0.1	43.0	11.2	20.5	0.0	1.6	24.7	11.5	8.6	25.4	21.4	11.0	0.2	0.0	0.1	11.4	2.7	0.1	0.2	6.8	4.8	11.5	0.0	12.5	7.2	36.4	14.0	1.5	5.1	26.9	5.6	10.4	8.9	3.7	1.3	13.3	13.6	3.9	41.3	11.8	0.0	0.7	0.2	24.9	0.1	12.2	0.0	3.1	0.0	0.1	3.4	0.0	6.6	0.0	0.0	11.0	7.0	0.0	0.0	0.4	2.5	1.2	16.9	0.4	1.6	7.9	19.0	2.3	12.6	12.6	7.6	27.2	7.6	17.2	22.4	6.0	7.7	0.0	21.2	22.0	0.0	3.2	20.4	34.8	6.8	24.4	0.0	3.3	3.3	39.7	3.4	16.1	46.1	0.0	15.8	17.7	9.9	27.4	4.6	9.4	29.8	0.0	18.9	4.3	3.3	5.2	8.6	16.2	18.6	7.2	21.7	11.7	42.3	31.6	11.3	3.0	0.9	12.9	23.0	1.0	3.8	21.0	10.8	1.0	19.6	34.4
CTNNA1	CAP102	ENSG00000044115	"Catenin alpha 1"	P35221	5	138610967-138935034	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021089, HPA046119, HPA063535"	Approved		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		5400	"Plasma membrane, Cell Junctions"		"CAB021089: AB_10123543, HPA046119: AB_2679547, HPA063535: AB_2685033"	"unprognostic (2.25e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.80e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.66e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (6.18e-2)"	"prognostic favorable (7.34e-7)"	"unprognostic (1.54e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.04e-1)"	55.9	54.0	39.6	24.4	50.2	10.9	55.1	16.5	39.5	43.4	58.9	68.5	33.9	44.2	53.0	47.5	76.9	45.8	41.1	68.6	38.8	32.3	62.2	37.7	49.8	27.0	57.3	29.3	42.7	38.1	55.5	25.6	54.0	45.5	39.4	49.0	35.6	48.8	43.5	30.5	49.8	53.9	59.6	49.7	30.9	48.2	18.7	56.6	8.1	51.2	46.4	44.1	48.4	45.1	3.8	15.2	9.8	21.8	0.3	5.0	7.1	32.2	23.5	35.7	52.8	31.1	34.2	54.4	32.7	41.2	31.3	39.7	49.0	43.9	0.1	27.7	48.8	34.4	24.7	24.5	53.8	36.5	18.5	21.3	13.6	38.8	29.7	37.5	0.2	13.3	21.5	43.1	37.4	41.1	34.9	59.0	9.8	7.4	14.0	33.7	28.5	0.3	4.1	14.3	34.4	0.5	12.7	20.8	19.4	66.1	43.2	14.3	18.8	60.4	84.9	49.4	79.5	30.0	9.3	50.0	33.0	17.9	20.4	22.6	5.1	9.5	1.9	31.4	5.9	42.5	2.2	17.1	1.5	2.9	21.8	1.9	3.8	2.1	2.1	15.2	3.2	0.1	1.1	9.8	0.3	20.2	3.7	5.0	7.1	39.6	50.2	16.5	39.5	38.8	32.3	57.3	29.3	45.5	56.6	241.2	121.7	23.1	99.7	69.7	8.7	202.9	84.1	172.6	201.3	115.1	19.6	101.5	58.0	167.3	13.9	111.5	204.4	23.3	152.7	117.7	74.1	118.0	39.3	51.3	79.8	3.2	49.0	92.7	73.9	18.8	72.2	73.0	74.2	212.8	129.6	45.5	232.1	131.5	79.5	116.5	23.0	97.0	108.1	17.0	21.1	67.5	158.8	17.0	92.7	143.6
COPB1	COPB	ENSG00000129083	"Coatomer protein complex subunit beta 1"	P53618	11	14443440-14500027	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012338, HPA043954, HPA064403"	Supported		Enhanced	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		400000	"Golgi apparatus, Vesicles, Cytosol"		"CAB012338: AB_726922, HPA043954: AB_2678746, HPA064403: AB_2685258"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (6.91e-4)"	"prognostic unfavorable (5.63e-7)"	"unprognostic (4.69e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (8.94e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-2)"	30.9	33.0	18.4	23.5	20.8	31.2	55.4	23.7	23.6	32.5	26.6	15.5	42.0	25.9	32.2	33.0	32.2	28.3	25.1	34.8	18.9	16.8	37.6	56.6	38.4	53.9	22.6	15.5	31.3	52.2	40.1	43.5	52.3	22.2	31.9	31.3	17.2	43.4	41.7	21.9	24.7	33.1	39.7	26.1	29.8	30.2	21.7	20.6	46.0	37.7	26.7	28.0	28.2	27.3	26.7	33.9	27.9	30.4	28.0	39.6	24.8	31.6	27.2	29.1	21.8	48.6	56.4	23.5	48.0	50.4	42.8	50.4	21.0	49.3	30.8	21.6	60.6	40.7	34.9	32.7	32.2	53.0	28.8	27.2	32.7	19.5	31.9	43.2	30.0	33.3	39.3	42.5	28.6	54.3	39.4	44.7	17.3	24.2	25.3	53.9	23.8	27.2	18.5	15.1	38.7	29.5	22.3	40.1	20.9	38.6	29.3	18.7	20.0	37.2	30.1	24.6	35.1	27.3	26.2	45.4	41.2	21.3	44.4	26.1	13.6	22.9	33.9	31.1	18.8	38.4	27.3	24.9	27.9	32.2	30.4	39.6	26.7	27.5	32.9	33.9	22.6	27.6	28.6	20.5	28.0	30.3	20.4	29.3	24.8	18.4	20.8	23.7	23.6	18.9	16.8	22.6	15.5	22.2	20.6	101.3	47.9	37.9	48.3	34.6	27.2	25.8	35.7	141.8	100.1	41.8	25.5	57.0	34.9	66.2	10.9	46.0	51.5	46.7	71.3	60.9	51.3	55.0	62.5	55.0	54.4	17.5	42.1	54.6	45.5	9.5	47.2	47.5	20.3	64.9	78.6	33.3	79.8	38.6	51.9	43.9	26.9	51.8	41.8	89.3	61.5	31.2	97.8	51.7	43.2	51.2
RNF169	KIAA1991	ENSG00000166439	"Ring finger protein 169"	Q8NCN4	11	74748868-74842413	"Enzymes, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038505, HPA046138, HPA047952"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Nucleoli, Nucleoli rim, Cytosol"	"HPA038505: , HPA046138: AB_2679553, HPA047952: "	"unprognostic (1.71e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.21e-1)"	12.3	7.0	12.0	11.6	14.0	23.1	12.0	22.6	15.6	13.1	11.2	12.2	6.3	7.4	14.2	8.2	20.6	10.7	10.8	9.2	12.6	5.9	8.9	9.3	16.9	11.3	15.4	9.1	14.6	10.7	17.5	10.4	8.6	13.9	10.5	10.0	8.4	12.4	8.8	15.0	14.1	10.3	14.2	10.1	12.6	10.3	7.2	14.9	12.6	11.5	7.4	12.5	13.1	15.8	0.6	0.8	5.0	1.9	1.2	1.6	0.6	8.3	6.4	7.8	7.6	5.0	6.8	3.1	6.5	6.2	7.3	6.4	10.7	6.3	14.9	6.7	7.8	5.0	8.1	10.4	7.8	9.6	7.4	6.7	10.3	11.8	4.2	5.8	5.4	8.6	6.2	6.2	8.3	19.0	8.2	11.8	10.2	9.1	12.0	7.3	7.0	9.3	9.8	3.0	10.6	4.2	8.7	18.5	8.1	4.7	8.7	3.5	6.3	8.8	6.7	14.2	6.5	8.4	7.0	7.8	12.2	10.3	7.6	5.8	8.7	4.5	17.7	2.4	6.0	7.0	2.8	1.9	1.5	1.6	1.1	1.2	0.3	1.5	0.9	0.8	0.6	1.1	0.9	5.0	1.2	1.0	0.8	1.2	0.6	12.0	14.0	22.6	15.6	12.6	5.9	15.4	9.1	13.9	14.9	8.9	10.7	13.0	26.3	17.6	51.9	2.8	2.5	5.3	7.9	3.5	49.1	5.0	5.0	8.8	2.2	11.7	6.7	0.0	9.5	5.0	9.3	37.6	6.9	11.0	7.6	35.0	11.5	8.6	10.7	2.2	6.9	9.2	10.1	1.8	7.8	33.2	9.1	5.8	9.9	9.1	32.5	25.8	15.1	10.4	10.9	16.3	6.8	16.6	9.7	39.6
CEBPZ	"CBF2, CTF2"	ENSG00000115816	"CCAAT/enhancer binding protein zeta"	Q03701	2	37201612-37231713	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052065	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA052065: AB_2681715"	"unprognostic (1.64e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.88e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (8.84e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (8.13e-4)"	"unprognostic (2.65e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.19e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.01e-2)"	21.3	23.0	13.1	23.7	14.4	20.0	21.7	17.0	16.4	22.4	17.8	8.4	17.2	12.8	17.2	16.6	18.6	17.4	12.6	19.4	12.0	12.9	30.5	22.6	15.4	16.7	13.2	12.9	24.2	17.2	18.8	27.3	18.2	16.5	20.4	15.5	8.2	15.5	17.9	88.0	14.0	19.1	19.5	15.4	23.1	15.5	27.3	14.1	19.5	22.5	18.7	17.5	30.1	41.0	20.8	17.4	17.2	14.7	17.0	23.1	9.2	19.8	15.5	16.0	8.8	15.8	17.1	13.6	19.0	13.2	16.1	17.5	24.5	15.1	36.6	17.0	11.2	22.1	17.1	41.3	19.5	20.8	23.3	18.2	34.0	16.0	19.9	12.5	34.1	15.4	13.0	19.3	21.4	21.9	10.7	14.5	9.3	37.0	16.9	16.4	10.3	19.8	26.8	52.1	26.6	14.6	15.9	26.0	27.6	15.5	18.8	17.1	27.7	15.8	19.5	21.4	24.2	14.1	15.0	11.8	15.8	18.0	14.0	26.0	19.0	19.9	29.7	14.1	31.6	17.3	17.2	11.7	10.6	17.2	14.7	21.7	20.3	18.2	16.6	11.8	20.8	23.1	19.1	4.2	17.0	14.3	17.4	14.0	9.2	13.1	14.4	17.0	16.4	12.0	12.9	13.2	12.9	16.5	14.1	80.4	74.1	56.7	60.0	95.1	42.9	29.1	56.0	68.3	106.9	47.1	41.2	45.8	91.2	46.1	195.9	50.1	23.4	46.7	53.9	30.2	41.0	51.4	70.6	63.1	30.5	41.3	42.4	44.8	35.3	23.2	56.4	35.5	20.3	47.7	48.2	52.7	48.9	24.6	47.7	55.4	87.8	51.8	44.3	132.2	95.3	88.3	37.6	59.7	48.5	54.3
SSFA2	"CS-1, KIAA1927, KRAP, SPAG13"	ENSG00000138434	"Sperm specific antigen 2"	P28290	2	181891833-181930738	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 85.5"	"Cell type enhanced"	"Detected in many"	4	"Suprabasal keratinocytes: 167.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 3.8;granulocytes: 8.1;monocytes: 6.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034665, HPA039989"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA034665: AB_2674271, HPA039989: AB_2676788"	"unprognostic (1.68e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.95e-2)"	"prognostic favorable (2.91e-5)"	"unprognostic (3.39e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (5.79e-5)"	14.2	10.1	23.3	11.8	27.0	16.1	21.6	25.8	22.5	17.7	24.4	26.2	9.4	17.5	13.0	8.9	12.0	10.7	18.7	13.6	23.7	19.1	22.8	36.0	23.0	11.2	31.3	17.7	7.2	85.5	10.5	10.2	40.9	24.8	18.1	24.1	22.3	29.2	10.0	16.6	50.6	19.5	14.2	27.8	14.7	26.0	16.7	23.8	9.3	19.6	12.2	7.9	14.3	23.5	1.2	3.8	8.1	6.4	1.0	1.4	1.8	16.4	8.2	24.0	4.0	21.0	17.4	6.8	29.2	28.4	10.3	13.7	8.5	19.1	0.4	9.5	20.5	12.7	14.3	5.8	14.0	19.9	7.5	6.6	16.6	35.3	6.8	15.5	8.5	15.6	10.3	20.7	17.7	24.1	24.4	53.7	8.0	7.4	9.2	28.6	8.3	7.5	11.9	1.6	15.3	19.4	5.6	9.7	5.7	29.0	5.0	4.2	3.7	17.1	6.1	26.1	9.5	4.4	18.6	21.3	24.4	11.8	8.7	15.1	6.3	2.7	6.6	11.4	5.1	18.2	8.1	3.9	5.7	1.4	3.9	0.9	0.6	1.0	0.9	3.8	1.2	1.3	1.1	6.6	1.0	6.4	3.1	0.6	1.8	23.3	27.0	25.8	22.5	23.7	19.1	31.3	17.7	24.8	23.8	134.0	40.6	11.2	36.2	97.1	18.5	23.0	35.7	33.5	35.2	31.4	35.3	19.9	14.9	15.8	9.0	52.6	132.6	0.0	62.2	21.0	25.9	46.7	22.0	89.3	18.4	25.4	105.7	36.8	47.5	13.4	17.5	29.8	55.6	15.4	57.0	17.2	54.1	41.9	16.3	36.3	33.6	38.8	24.5	22.3	25.4	167.2	27.9	12.9	39.3	84.6
PPFIA1	"LIP.1, LIPRIN"	ENSG00000131626	"PTPRF interacting protein alpha 1"	Q13136	11	70270700-70385312	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 163.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 80.2;SK-MEL-30: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017032, HPA042271"	Uncertain		Supported	"Focal adhesion sites,Cytosol"		NA	NA			Cytosol	"Focal adhesion sites"	"CAB017032: , HPA042271: AB_2677923"	"unprognostic (1.89e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.27e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.58e-4)"	"unprognostic (7.20e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavorable (8.26e-4)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.76e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.14e-2)"	28.9	18.6	20.9	17.5	20.8	20.8	40.5	22.8	24.1	15.9	18.3	27.7	18.5	15.5	26.2	20.4	19.4	16.9	23.9	19.3	19.7	12.0	18.1	15.5	25.4	15.9	18.9	17.8	21.0	17.7	21.2	34.1	24.9	20.7	13.8	16.3	21.9	19.0	18.5	38.7	24.2	17.8	18.4	30.0	14.7	15.6	29.8	22.5	17.0	25.2	10.0	13.6	18.7	18.6	2.6	2.8	10.0	4.8	1.1	2.2	1.0	80.2	10.8	10.0	6.7	9.3	5.8	10.6	9.4	7.7	11.7	7.8	20.5	7.2	7.5	12.3	7.5	12.0	11.6	8.4	8.1	10.1	5.0	5.9	6.0	11.3	6.5	9.5	7.9	7.4	7.4	13.0	15.1	12.4	9.4	7.5	6.4	10.1	6.1	10.2	10.9	5.4	4.7	5.9	17.1	9.3	6.3	25.1	6.5	5.7	11.0	9.7	6.6	14.0	17.7	46.1	10.8	11.9	8.4	10.3	11.8	9.2	16.3	10.0	7.5	4.7	10.5	9.8	5.5	13.7	0.0	3.6	1.7	1.3	1.9	2.2	2.6	2.2	1.9	2.8	2.3	1.7	1.0	10.0	1.1	4.8	2.8	2.1	1.0	20.9	20.8	22.8	21.4	19.7	12.0	18.9	17.8	20.7	22.5	23.8	49.3	8.8	18.7	24.4	31.5	23.0	22.9	26.8	25.0	17.4	29.5	30.5	10.0	19.2	163.8	25.1	26.3	0.0	17.6	12.0	18.6	32.7	8.1	19.8	21.9	31.8	25.8	20.3	35.7	71.1	25.6	27.2	20.3	20.8	17.6	75.0	27.2	20.3	24.1	18.0	43.9	19.4	21.9	47.9	72.2	29.0	62.1	17.3	16.9	36.9
NET1	"ARHGEF8, NET1A"	ENSG00000173848	"Neuroepithelial cell transforming 1"	Q7Z628	10	5412551-5458463	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 186.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 63.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020068	Uncertain		Approved	Nucleoplasm,Vesicles		Yes	No			Nucleoplasm	Vesicles	"HPA020068: AB_2670348"	"unprognostic (1.77e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.87e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (8.27e-4)"	"unprognostic (2.26e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.46e-1)"	19.4	4.8	14.2	25.8	16.7	15.0	39.8	11.8	15.2	30.2	39.3	21.0	32.1	24.1	19.4	25.7	38.2	20.7	25.9	8.4	16.5	12.7	21.3	19.0	9.5	10.5	19.0	9.4	15.2	19.4	2.9	6.6	51.8	20.8	23.0	38.9	20.3	43.0	23.2	16.7	21.8	54.7	33.4	19.9	3.9	33.5	11.8	10.9	14.8	18.1	26.8	20.2	28.0	31.8	1.8	5.9	2.7	1.2	1.0	11.5	2.4	27.9	16.7	11.6	12.9	6.8	3.1	63.7	17.0	9.3	13.7	13.1	9.1	53.3	10.3	7.1	10.3	3.0	45.8	14.0	25.6	16.5	9.6	10.1	18.6	5.6	20.3	1.8	5.3	8.1	4.6	15.3	13.5	3.2	12.0	7.9	10.8	32.8	16.3	7.5	13.3	17.9	7.4	15.6	38.6	12.7	11.3	21.4	8.0	8.4	14.1	10.0	5.5	14.9	27.7	5.0	20.2	9.2	15.9	7.2	5.2	8.2	8.0	13.7	10.0	5.4	13.5	4.7	8.1	10.8	2.7	0.8	1.8	0.9	1.2	0.0	1.8	1.6	0.5	5.9	0.9	11.5	2.1	0.1	1.0	0.6	2.5	5.1	2.4	14.2	16.7	11.8	15.2	16.5	12.7	19.0	9.4	20.8	10.9	29.8	38.9	8.2	74.8	35.7	7.7	10.1	45.9	77.6	83.0	12.2	3.9	84.2	5.0	11.3	2.0	33.2	153.4	0.0	21.4	96.0	33.1	71.1	15.0	45.0	12.6	3.2	77.6	14.1	12.4	1.7	20.1	13.0	33.7	83.0	146.5	3.4	41.8	114.6	82.4	21.2	3.1	109.9	58.2	24.9	18.6	28.2	98.2	7.0	102.0	186.5
RNF168	FLJ35794	ENSG00000163961	"Ring finger protein 168"	Q8IYW5	3	196468783-196503768	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 199.9;Late spermatids: 360.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046109			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA046109: AB_2679540"	"unprognostic (6.15e-3)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.11e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (6.81e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (4.83e-3)"	"unprognostic (2.80e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.65e-2)"	20.8	9.3	8.9	10.7	11.1	31.6	18.7	21.1	13.0	13.6	11.2	10.7	12.3	11.1	13.9	8.5	14.3	10.1	10.9	12.0	10.2	10.2	7.5	18.8	14.3	12.0	13.8	11.0	14.6	9.2	12.0	8.1	9.9	15.3	10.1	10.8	9.1	11.0	13.6	20.8	20.1	10.1	12.9	10.5	11.7	10.7	18.4	13.4	17.6	9.6	13.9	15.2	14.7	17.1	6.2	5.8	21.8	10.0	7.7	11.6	5.7	12.5	5.0	9.0	11.8	8.4	6.1	12.9	7.7	4.9	5.2	8.2	9.8	6.2	13.3	17.8	6.4	7.3	12.8	12.6	9.2	8.0	6.3	6.2	25.2	12.7	12.1	4.4	7.7	6.3	6.1	3.5	8.1	7.2	3.7	7.5	11.0	7.5	14.0	5.2	21.2	25.5	4.6	10.7	6.8	6.5	11.5	10.5	10.8	4.4	17.4	7.5	7.6	8.7	10.7	6.6	7.0	16.2	6.9	7.4	9.0	7.1	9.5	10.1	12.0	11.2	20.2	8.8	9.4	7.1	21.8	6.6	7.5	11.6	7.1	10.4	5.7	9.8	8.3	5.8	6.2	8.7	9.1	7.3	7.7	10.0	5.5	6.2	5.7	8.9	11.1	21.1	13.0	10.2	10.2	13.8	11.0	15.3	13.4	14.9	29.1	17.1	44.2	89.0	35.1	19.7	12.7	18.7	19.4	14.0	56.9	11.4	14.9	11.9	199.9	29.2	13.6	0.0	7.9	20.7	33.6	23.5	49.6	25.8	15.9	14.3	13.8	17.2	29.0	360.7	18.7	39.0	25.3	37.9	16.0	13.4	8.6	14.4	19.4	8.4	39.6	12.9	35.0	11.1	67.5	110.7	8.9	46.0	18.6	50.5
CDCA8	"BOR, DasraB, FLJ12042, MESRGP"	ENSG00000134690	"Cell division cycle associated 8"	Q53HL2	1	37692418-37709719	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 19.0;lymphoid tissue: 51.6;testis: 44.7"	"Cell type enhanced"	"Detected in many"	16	"Extravillous trophoblasts: 20.9;Spermatocytes: 82.1;Spermatogonia: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA028120, HPA028258, HPA028783, CAB040294"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Cytokinetic bridge"		Yes	Yes			Nucleoli	"Nucleoplasm, Cytokinetic bridge"	"CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092"	"unprognostic (8.36e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (4.93e-10)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (6.39e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.67e-1)"	1.2	1.4	0.9	12.9	1.7	19.0	1.7	0.8	1.6	1.8	6.0	1.1	0.7	5.3	1.4	1.3	9.6	0.7	2.4	0.8	0.9	0.9	1.3	1.5	2.0	12.2	1.8	1.3	0.9	1.0	0.1	0.8	3.7	1.3	1.0	7.7	0.7	2.1	1.0	0.9	4.0	5.4	1.6	1.2	5.4	3.5	44.7	1.7	51.6	0.9	6.5	14.6	1.6	2.9	2.8	1.8	4.5	5.0	6.3	8.9	2.5	28.4	12.4	23.5	17.0	1.0	2.0	15.8	21.5	10.8	38.0	27.0	19.4	21.3	34.6	8.7	13.7	15.3	16.2	27.0	14.2	40.4	23.0	12.1	31.1	13.3	15.3	0.2	29.9	16.1	0.8	1.0	21.4	19.0	4.3	16.8	24.9	26.2	37.2	27.4	12.7	27.5	18.4	27.2	16.6	17.2	26.9	32.1	19.8	8.6	11.9	20.9	9.2	23.6	11.1	14.5	21.1	16.3	11.4	10.1	18.7	19.9	10.7	33.5	25.3	32.9	47.2	8.8	27.8	21.4	0.0	1.1	1.8	2.5	2.2	4.5	2.8	5.7	3.3	1.0	2.5	1.9	3.8	4.5	6.3	5.0	1.8	8.9	2.5	0.9	1.7	0.8	1.6	0.9	0.9	1.8	1.3	1.3	1.7	0.0	0.3	9.3	0.8	3.0	1.1	0.4	5.1	8.1	0.0	0.0	0.0	2.2	0.0	1.1	0.8	0.2	4.2	0.0	0.6	20.9	0.9	0.6	0.0	1.0	9.5	1.6	3.5	1.8	3.1	2.2	1.4	4.6	1.7	2.8	5.1	0.0	1.6	4.9	1.1	0.5	0.8	19.4	0.0	82.1	41.4	2.4	2.4	3.2	6.3	0.9
CAB39	"CGI-66, MO25"	ENSG00000135932	"Calcium binding protein 39"	Q9Y376	2	230712845-230821075	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037112, HPA076632"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA		130000	"Nucleoli fibrillar center"	Cytosol	"CAB037112: AB_1078367, HPA076632: "	"unprognostic (4.36e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.84e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (1.04e-1)"	"prognostic favorable (9.05e-6)"	"unprognostic (1.59e-1)"	"unprognostic (2.92e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.36e-1)"	28.8	16.7	24.5	25.8	24.0	22.1	22.2	22.4	35.0	16.5	26.1	16.8	14.0	23.4	19.3	18.3	28.3	15.5	20.8	34.2	25.4	26.0	27.4	18.9	20.9	25.8	28.4	27.6	17.0	16.3	22.3	15.2	21.0	32.8	20.9	28.4	13.9	22.4	16.7	82.2	21.8	28.8	26.3	28.0	21.5	22.6	19.6	17.8	20.9	22.0	26.6	28.1	22.9	30.8	3.6	3.6	12.4	5.1	11.6	8.4	2.6	38.1	8.9	12.1	10.3	15.0	18.9	13.8	22.0	27.6	13.9	14.6	10.8	42.1	9.9	17.4	19.1	23.5	17.7	13.5	41.4	28.4	41.4	10.6	26.5	11.5	11.5	12.8	36.6	30.9	13.3	24.2	17.8	39.6	15.9	17.2	13.8	44.2	9.2	13.2	13.3	17.0	22.7	12.1	15.7	15.7	19.8	18.1	9.7	25.9	31.1	13.2	8.1	16.5	20.7	17.5	14.3	5.1	21.3	21.7	19.7	7.5	20.7	17.9	11.9	9.0	16.1	14.0	21.4	16.1	4.5	4.5	6.9	6.0	5.1	6.2	3.6	7.5	7.7	3.6	3.1	6.0	8.4	12.4	11.6	4.7	2.7	7.1	2.6	24.5	24.0	22.4	35.0	25.4	26.0	28.4	27.6	32.8	17.8	59.6	38.6	17.5	38.6	86.8	14.7	64.8	17.8	32.1	27.3	48.8	31.4	17.2	24.9	23.5	9.2	26.8	67.3	46.7	27.9	15.6	25.8	65.5	19.7	24.9	49.6	27.0	19.5	29.4	89.4	9.5	16.1	63.1	28.7	19.0	42.5	38.5	52.1	44.6	30.1	33.9	35.6	12.9	24.5	24.6	27.0	74.4	19.3	38.8	27.6	68.0
PGK1		ENSG00000102144	"Phosphoglycerate kinase 1"	P00558	X	77910739-78129296	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010065, HPA045385, HPA073644, HPA073656"	Approved					NA	NA		290000000			"CAB010065: AB_628116, HPA045385: AB_2679306, HPA073644: AB_2732231, HPA073656: AB_2732235"	"prognostic unfavorable (7.05e-8)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.21e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.65e-6)"	"prognostic unfavorable (2.74e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.66e-2)"	"prognostic unfavorable (8.34e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.99e-1)"	"unprognostic (8.99e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.90e-2)"	"unprognostic (6.57e-2)"	45.0	50.9	29.2	41.3	38.4	62.2	29.9	43.8	67.9	31.9	36.6	24.2	27.5	35.5	25.7	23.3	62.1	25.6	32.4	69.4	28.6	35.0	71.8	58.5	37.5	47.6	32.1	32.7	26.8	21.2	45.7	29.0	43.7	49.9	28.3	42.8	40.0	38.2	32.0	115.5	38.7	41.9	33.9	30.1	43.7	29.7	11.3	24.9	51.8	39.1	61.1	52.4	42.2	38.0	20.9	53.7	49.2	79.0	21.0	26.3	77.0	100.7	46.7	15.6	31.6	27.1	22.0	37.3	51.6	35.9	45.4	76.2	42.3	31.8	40.4	53.5	35.6	54.1	43.9	69.2	80.2	91.1	24.6	27.3	31.3	77.1	36.7	29.7	71.5	34.9	27.4	33.9	41.2	21.9	73.2	46.4	39.9	32.6	61.8	61.9	39.8	62.5	54.1	48.4	68.0	89.0	45.3	42.0	123.7	47.3	42.1	23.4	32.3	53.4	45.6	44.8	41.6	23.9	37.6	37.3	48.6	33.6	48.5	35.5	68.7	128.4	42.4	137.0	81.5	31.7	22.7	54.6	49.2	20.8	59.9	23.2	20.9	25.0	22.6	53.7	15.8	23.0	24.4	45.7	21.0	79.0	20.9	26.3	77.0	29.2	38.4	43.8	67.9	28.6	35.0	32.1	32.7	49.9	24.9	140.0	160.9	145.9	244.9	128.1	204.1	404.2	163.1	85.6	114.9	165.7	72.6	242.5	399.6	557.2	11.8	143.5	182.6	46.7	207.9	529.0	138.1	108.8	187.4	169.3	452.6	292.4	98.3	141.2	307.1	7.6	87.8	291.4	158.6	539.2	123.3	226.5	430.4	133.6	119.5	437.4	139.8	122.9	131.3	8.4	51.9	104.1	292.3	207.0	146.6	230.5
AGPS	"ADAP-S, ADAS, ADHAPS, ADPS, ALDHPSY"	ENSG00000018510	"Alkylglycerone phosphate synthase"	O00116	2	177392644-177559299	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cataract, Disease mutation, Dwarfism, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	10	"Early spermatids: 201.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030209, HPA030210, HPA030211"	Supported		Supported	Peroxisomes	"Intracellular and membrane"	NA	NA		9300	Peroxisomes		"HPA030209: AB_10600634, HPA030210: AB_10600202, HPA030211: AB_10602195"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (8.62e-6)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.41e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (7.74e-2)"	"prognostic favorable (9.45e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.92e-2)"	22.9	17.7	13.5	21.2	14.9	28.3	17.1	14.9	13.4	16.0	23.5	17.2	14.1	14.1	22.4	10.5	18.4	12.5	16.0	23.9	14.2	13.5	20.8	21.2	15.2	14.7	17.4	11.8	16.4	21.2	37.0	11.7	14.7	15.0	14.7	24.0	8.0	18.2	10.8	23.2	9.6	17.6	21.3	31.8	17.1	14.5	19.1	13.7	29.5	14.2	14.4	14.5	16.9	20.7	3.4	7.6	11.2	6.8	5.6	6.4	3.0	18.1	11.6	8.2	8.5	10.6	11.6	19.7	14.2	7.1	12.2	12.1	21.7	12.6	20.4	31.0	14.7	19.8	19.8	22.2	14.4	15.9	26.9	7.5	28.3	20.2	25.4	10.8	30.7	30.2	10.1	9.1	19.5	15.6	11.2	24.3	15.5	19.4	12.8	14.6	0.0	24.8	10.4	14.0	13.4	19.3	19.9	24.7	12.3	20.7	21.7	10.2	12.3	26.9	2.3	16.7	20.4	0.1	12.8	24.9	10.9	37.4	11.2	24.8	16.5	28.6	10.2	10.0	13.8	4.2	3.8	6.1	11.2	4.3	6.7	6.4	3.4	5.5	5.3	7.6	2.1	5.3	3.1	1.3	5.6	6.8	0.7	6.2	3.0	13.5	14.9	14.9	13.4	14.2	13.5	17.4	11.8	15.0	13.7	14.9	16.2	8.2	5.5	9.6	11.1	17.3	12.7	17.4	7.9	14.0	2.0	12.4	11.6	18.7	201.7	9.3	16.8	23.3	20.1	17.2	15.1	3.1	63.4	25.2	28.4	14.3	19.0	13.5	27.2	24.3	13.6	24.2	13.5	31.5	25.9	11.6	19.9	10.5	13.1	41.6	6.9	6.5	16.2	38.6	25.3	8.5	5.8	17.0	19.4	5.5
DNAJC13	"KIAA0678, RME8"	ENSG00000138246	"DnaJ heat shock protein family (Hsp40) member C13"	O75165	3	132417526-132539032	"Predicted membrane proteins"	"Protein transport, Transport"	Chaperone	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036923, HPA036924"	Approved		Supported	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA036923: AB_10672480, HPA036924: AB_2675386"	"unprognostic (3.35e-3)"	"unprognostic (7.47e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (3.68e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (8.36e-4)"	"unprognostic (1.92e-1)"	"unprognostic (4.81e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.22e-1)"	23.3	17.8	20.4	15.1	14.4	20.5	16.2	18.0	19.9	20.8	23.1	8.1	23.3	14.5	25.0	18.7	22.3	16.8	13.1	20.5	19.9	11.0	23.6	12.1	17.7	14.9	11.5	17.8	20.1	12.2	21.1	12.3	22.9	17.3	17.8	18.8	10.2	16.1	24.6	20.0	13.7	20.1	26.3	12.5	19.4	16.0	10.3	16.4	13.0	20.6	13.8	13.6	24.5	32.4	2.2	5.7	3.4	7.0	1.7	2.1	1.6	14.8	8.5	11.7	5.9	27.2	24.2	7.1	16.2	30.3	15.7	17.4	9.5	9.5	7.8	10.3	21.9	21.1	12.2	10.8	11.7	22.0	8.9	3.0	9.6	8.6	6.3	14.4	9.6	9.5	17.6	8.6	14.2	17.7	12.0	22.0	12.8	5.4	13.0	22.2	11.4	7.9	4.6	6.8	12.9	7.7	7.7	8.3	6.2	14.2	15.7	4.2	6.9	15.4	8.1	17.5	10.4	12.7	9.1	20.4	17.8	9.2	17.3	6.9	7.4	7.2	10.6	18.6	6.8	13.0	3.4	5.2	0.7	1.9	4.3	1.8	2.2	2.0	1.7	5.7	1.4	1.5	2.1	1.2	1.7	7.0	2.7	1.1	1.6	20.4	14.4	18.0	19.9	19.9	11.0	11.5	17.8	17.3	16.4	11.9	18.7	7.5	6.2	6.0	10.4	41.1	10.2	14.7	11.4	12.2	31.4	6.7	1.7	7.9	1.3	15.5	16.5	0.0	7.9	6.5	10.3	11.3	11.5	7.8	17.4	63.5	13.8	16.5	39.6	1.9	14.1	18.3	27.0	9.0	13.3	13.4	10.9	11.5	20.1	15.8	11.0	6.5	10.3	3.4	12.3	6.6	4.2	6.1	12.1	10.5
PARD6B	PAR-6B	ENSG00000124171	"Par-6 family cell polarity regulator beta"	Q9BYG5	20	50731544-50756795	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 40.0"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 175.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 15.8;MCF7: 27.8;T-47d: 27.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA013376	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA013376: AB_1854972"	"unprognostic (1.13e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (8.38e-4)"	"unprognostic (2.27e-1)"	"prognostic favorable (6.38e-5)"	"unprognostic (1.84e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.07e-2)"	3.7	2.3	1.6	3.1	2.3	2.6	7.9	3.5	2.0	2.7	13.9	1.4	11.3	4.5	2.2	12.1	5.8	5.7	6.6	2.1	2.0	1.9	40.0	8.0	15.4	1.9	1.5	1.3	3.4	9.9	7.3	3.7	24.1	2.7	4.0	3.0	12.2	3.6	17.2	4.3	3.8	17.5	1.0	1.6	2.4	8.3	6.4	0.5	2.9	14.4	1.0	5.8	3.5	5.5	3.6	3.1	3.4	1.5	3.8	6.1	1.1	2.9	3.4	1.0	2.1	0.6	0.2	4.5	0.2	0.3	0.5	0.4	15.8	7.0	1.3	3.0	0.0	2.2	2.4	1.4	2.1	0.8	0.6	0.8	0.7	1.1	6.2	0.6	0.5	0.7	0.0	1.0	0.3	0.9	1.0	0.0	1.2	1.6	0.9	0.0	27.8	1.3	1.2	1.7	4.9	1.3	0.7	0.9	1.1	7.1	3.2	0.6	0.9	2.2	5.3	1.5	4.2	27.2	0.7	0.1	0.3	1.8	0.3	0.5	1.1	0.7	1.1	0.7	0.5	0.6	2.9	0.7	3.4	3.6	0.9	4.0	2.9	3.7	3.6	0.8	3.6	6.1	3.8	2.8	3.8	1.5	3.1	2.3	1.1	1.6	2.3	3.5	2.0	2.0	1.9	1.5	1.3	2.7	0.5	175.7	50.3	4.5	51.0	55.9	12.3	3.3	28.1	25.4	33.0	85.5	51.1	28.8	34.9	22.0	3.2	1.1	39.4	0.0	21.2	12.5	2.6	39.6	1.1	17.8	3.1	4.8	14.3	2.5	0.3	2.2	1.7	2.5	15.1	1.0	18.0	10.0	40.3	18.2	0.7	63.2	52.4	6.5	2.3	11.2	9.8	59.7	40.5	4.6	12.1	85.3
CDH3	"CDHP, PCAD"	ENSG00000062038	"Cadherin 3"	P22223	16	68636189-68722616	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease mutation, Ectodermal dysplasia, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.0;retina: 40.5"	"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 49.5;Basal keratinocytes: 54.0;Melanocytes: 57.3;Pancreatic endocrine cells: 60.0;Urothelial cells: 48.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	10	"pons and medulla: 16.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 24.9;HaCaT: 69.1;HBEC3-KT: 33.3;hTCEpi: 26.6;hTERT-HME1: 20.3;RPTEC TERT1: 29.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA001767, CAB002487"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"CAB002487: AB_563446, HPA001767: AB_1078376"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (8.43e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-3)"	"unprognostic (8.56e-2)"	2.2	0.1	1.0	2.5	1.2	0.0	8.7	1.5	1.1	10.5	1.0	2.2	3.0	0.3	9.4	10.3	23.5	8.9	1.4	0.4	1.1	0.8	8.3	0.2	3.6	2.1	0.6	0.4	32.6	0.4	0.5	3.6	6.4	16.0	11.7	0.5	40.5	9.3	4.4	0.1	21.2	0.4	4.1	1.5	10.0	0.7	2.2	0.1	44.0	2.0	26.1	20.1	2.5	6.7	0.9	0.6	1.4	0.5	0.6	0.8	0.2	24.9	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	14.9	9.3	0.0	0.1	0.0	0.0	69.1	0.6	33.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	26.6	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	1.3	0.2	2.1	0.0	0.0	0.0	29.9	11.3	0.1	0.0	0.2	0.0	11.8	12.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.5	0.2	0.4	0.2	0.3	0.6	0.5	0.4	0.1	0.9	0.6	0.8	1.4	0.6	0.2	0.6	0.2	0.2	1.0	1.2	1.5	1.1	1.1	0.8	0.6	0.4	16.0	0.1	14.9	2.9	0.0	49.5	54.0	0.8	1.2	0.0	4.0	13.6	14.0	2.0	21.3	0.0	31.6	0.2	0.5	0.0	0.0	28.5	1.2	3.3	13.1	1.1	0.0	2.5	0.0	1.2	0.0	0.0	0.0	0.6	1.2	57.3	1.8	1.4	0.2	60.0	0.0	8.9	0.0	0.4	0.0	1.9	0.2	0.7	26.8	5.3	0.0	0.4	48.9
TMEM144	FLJ11155	ENSG00000164124	"Transmembrane protein 144"	Q7Z5S9	4	158201604-158255411	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	6	"brain: 88.7"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 195.0;Late spermatids: 77.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.3;intermediate monocyte: 1.4;myeloid DC: 3.7;plasmacytoid DC: 4.3"	"Group enriched"	"Detected in many"	10	"dendritic cells: 4.3;monocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.7;hTCEpi: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063554			Approved	Mitochondria		NA	NA			Mitochondria		"HPA063554: AB_2685039"	"unprognostic (1.26e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (2.89e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.71e-5)"	"unprognostic (8.27e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (8.48e-4)"	"unprognostic (9.34e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.05e-2)"	4.7	6.7	20.7	2.0	60.9	1.5	9.2	4.7	37.7	4.7	7.4	88.7	0.2	14.3	3.7	8.3	3.1	3.9	6.8	8.2	31.5	18.3	1.9	1.7	3.5	0.9	80.4	26.6	8.6	3.8	3.0	1.4	3.5	48.9	5.4	8.6	0.0	3.1	7.2	1.4	1.9	9.6	4.2	79.2	2.2	5.4	15.8	67.4	0.0	9.2	0.0	0.8	5.1	1.9	0.0	4.3	0.1	3.3	0.4	0.1	0.7	2.6	7.1	0.1	1.4	5.2	7.8	23.7	1.2	1.9	1.1	1.7	8.9	9.8	0.0	1.4	0.3	5.1	1.2	3.3	11.0	1.5	0.0	3.2	4.4	2.2	7.9	1.8	5.5	1.4	5.6	13.6	4.6	1.6	0.3	5.9	1.1	2.9	0.1	8.2	3.0	0.0	0.0	1.8	7.3	1.7	0.0	0.0	0.3	2.0	7.5	1.1	0.0	0.2	9.6	2.7	4.3	6.8	1.5	1.2	2.2	1.8	0.4	1.3	0.0	0.6	0.6	3.0	0.8	1.5	0.0	3.3	0.0	0.0	1.4	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.4	0.7	4.3	0.0	0.7	20.7	60.9	4.7	35.1	31.5	18.3	80.4	26.6	48.9	67.4	8.9	7.8	0.0	6.7	2.7	0.0	10.6	17.8	5.3	4.5	0.0	0.0	11.5	0.0	9.5	195.0	3.6	34.8	0.0	11.4	5.8	2.0	5.7	4.6	1.0	24.1	0.0	4.7	3.1	19.9	77.6	9.8	10.7	3.3	3.6	17.2	1.3	10.6	14.7	8.5	5.6	0.0	0.0	2.2	1.2	1.7	4.4	7.3	0.0	14.5	4.2
NCAPG2	"CAP-G2, FLJ20311, hCAP-G2, LUZP5, MTB"	ENSG00000146918	"Non-SMC condensin II complex subunit G2"	Q86XI2	7	158631311-158704829	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 39.1"	"Cell type enhanced"	"Detected in many"	10	"Spermatocytes: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026631, HPA049637"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA026631: AB_1845983, HPA049637: "	"unprognostic (2.73e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (7.94e-4)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.91e-4)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (5.33e-3)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (4.06e-5)"	"unprognostic (2.58e-3)"	"unprognostic (1.28e-1)"	"unprognostic (8.21e-2)"	"unprognostic (7.37e-2)"	5.9	4.0	4.4	8.6	4.2	20.1	5.4	9.0	5.1	4.4	6.6	5.8	3.5	4.2	5.1	5.1	9.9	3.7	3.1	4.0	4.3	3.5	3.3	3.9	4.4	11.4	6.2	4.2	4.4	4.4	6.0	5.8	6.9	4.9	4.5	7.7	3.9	5.3	4.2	4.5	6.5	5.5	4.6	6.2	6.1	5.3	14.6	5.1	39.1	3.6	7.6	13.0	4.8	5.5	1.8	2.8	6.9	5.4	6.1	9.3	2.5	30.0	16.0	19.5	12.5	2.9	4.8	7.7	22.0	14.2	27.3	30.6	14.1	15.8	18.6	13.8	9.0	29.0	15.5	16.2	10.1	36.5	19.8	12.0	16.8	19.9	11.1	1.3	20.7	19.0	2.0	1.1	22.2	6.4	5.0	15.1	21.8	20.6	28.0	25.0	32.0	34.4	14.0	19.2	17.1	13.0	20.2	20.5	17.7	6.7	13.5	21.3	16.5	27.2	10.6	6.0	13.0	9.6	13.5	7.9	18.7	14.3	50.4	35.3	18.5	13.6	22.6	19.8	26.5	35.4	6.9	1.0	1.2	6.5	1.4	9.3	1.8	6.6	4.5	2.8	1.2	2.2	2.4	0.6	6.1	5.4	1.4	8.3	2.5	4.4	4.2	9.0	5.1	4.3	3.5	6.2	4.2	4.9	5.1	6.0	1.0	1.5	1.1	3.5	3.8	3.4	2.5	8.1	6.8	1.8	0.0	2.6	0.0	2.3	9.3	2.2	0.4	0.0	2.9	8.4	2.7	0.9	1.1	2.1	6.1	7.9	0.0	4.3	2.7	4.0	2.6	4.7	1.7	2.8	1.7	1.9	1.6	0.0	3.9	1.1	2.8	6.5	4.1	40.1	15.6	1.8	2.2	5.1	1.8	2.3
MXD1	"bHLHc58, MAD, MAD1"	ENSG00000059728	"MAX dimerization protein 1"	Q05195	2	69897688-69942945	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.1;bone marrow: 72.8;esophagus: 64.8"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 212.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 81.1"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 81.1"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001599	Enhanced		Uncertain	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria"	Cytosol	"HPA001599: AB_1079434"	"unprognostic (1.59e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (8.14e-6)"	"unprognostic (1.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (8.72e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.77e-2)"	6.9	2.2	2.7	18.7	3.8	72.8	3.7	5.7	4.1	15.8	19.6	4.7	0.9	13.6	2.9	2.6	64.8	3.8	4.9	10.8	3.0	2.9	3.0	5.5	17.0	14.3	5.9	2.4	3.3	2.5	3.6	4.0	15.8	3.1	3.3	14.0	5.1	8.8	1.4	3.1	5.9	50.2	4.6	4.3	15.8	8.2	3.6	3.7	9.4	4.0	20.8	34.0	6.3	21.6	0.2	0.8	81.1	1.6	0.4	0.4	0.6	3.5	1.5	2.2	1.6	5.0	2.5	8.4	3.9	2.2	1.9	1.3	4.9	2.8	2.0	2.0	1.5	1.9	12.6	4.2	7.8	2.0	1.1	5.1	4.2	4.5	4.9	16.8	5.0	4.2	2.8	13.3	4.4	20.4	2.4	2.4	2.1	7.3	8.1	1.2	2.8	2.4	10.1	0.6	5.2	2.5	1.1	2.3	5.0	2.5	4.2	7.3	3.1	5.2	7.0	2.7	2.7	1.0	3.0	9.6	2.8	0.8	3.0	3.7	5.5	9.3	0.8	2.9	8.9	1.0	17.0	1.6	16.8	0.3	1.0	0.4	0.1	0.2	0.2	0.8	0.2	0.2	0.3	81.1	0.4	0.8	0.2	0.2	0.6	2.7	3.8	5.7	4.1	3.0	2.9	5.9	2.4	3.1	3.7	35.7	30.8	18.2	23.9	22.9	27.8	4.8	7.6	10.7	11.4	1.8	51.1	7.9	6.6	10.8	12.4	9.0	212.1	0.0	14.8	5.1	13.6	61.3	26.5	6.7	26.9	9.5	93.4	6.2	48.3	15.3	4.4	71.5	15.1	20.8	115.5	40.4	44.4	91.2	2.5	5.1	17.8	0.0	28.7	8.1	2.0	49.3	88.6	20.8	26.6	110.0
ELOVL1	Ssc1	ENSG00000066322	"ELOVL fatty acid elongase 1"	Q9BW60	1	43363397-43368074	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 101.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033426, HPA056557"	Enhanced		Supported	"Endoplasmic reticulum"		NA	Yes			"Endoplasmic reticulum"		"CAB033426: AB_2099896, HPA056557: AB_2683173"	"unprognostic (5.23e-2)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (8.00e-2)"	"unprognostic (8.45e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (2.79e-7)"	"unprognostic (4.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-1)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.00e-2)"	21.2	15.6	16.2	15.3	25.3	18.3	24.1	6.8	32.5	16.1	23.6	101.5	11.7	20.7	14.1	13.0	46.6	15.1	17.3	11.5	30.3	18.3	26.6	23.8	22.9	22.7	51.4	14.1	9.3	18.3	16.7	8.4	20.9	45.6	21.6	20.1	8.6	20.6	21.6	6.8	54.0	21.7	20.7	99.5	17.2	22.8	8.4	37.2	7.2	23.9	15.6	21.7	20.4	22.6	30.9	61.1	46.9	54.8	30.5	32.3	48.8	23.8	26.9	5.2	10.3	35.6	33.5	16.3	28.3	35.7	36.1	29.1	23.8	41.9	16.5	22.0	44.3	31.2	27.5	18.4	34.8	22.2	21.2	12.4	21.4	18.6	17.2	30.9	18.4	22.9	25.6	39.6	42.6	47.1	27.1	36.1	6.5	14.8	12.6	41.3	17.6	4.3	15.5	7.6	31.1	27.9	9.7	13.9	20.1	45.5	29.1	6.4	6.7	16.7	59.7	23.8	16.2	28.1	18.4	29.8	30.6	19.4	37.0	35.8	6.3	6.8	7.9	29.8	18.9	27.5	29.0	54.8	46.9	32.3	50.6	28.6	30.9	30.7	31.4	61.1	25.5	20.1	28.1	38.2	30.5	48.1	42.9	31.4	48.8	16.2	25.3	6.8	32.5	30.3	18.3	51.4	14.1	45.6	37.2	17.9	8.4	18.1	20.4	13.9	5.4	3.6	45.9	5.3	7.9	38.4	9.8	79.2	6.6	86.7	2.5	28.7	74.3	70.0	86.6	103.3	20.2	33.0	20.7	13.7	66.2	3.2	18.4	23.4	47.0	3.4	18.7	37.1	11.8	129.8	30.5	12.4	99.9	40.7	24.1	21.3	8.4	19.4	15.3	6.7	8.6	27.0	80.2	24.6	36.9	43.7
CCNG2		ENSG00000138764	"Cyclin G2"	Q16589	4	77157151-77433388	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 16.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034684	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA034684: AB_10669894"	"unprognostic (2.58e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.73e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (2.04e-1)"	"prognostic favorable (2.47e-5)"	"unprognostic (7.98e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.05e-3)"	18.4	8.1	11.3	13.5	15.1	25.9	26.7	53.0	17.2	15.1	12.3	8.9	9.6	8.6	16.4	10.7	45.2	8.0	10.4	6.3	9.6	5.4	23.0	3.4	12.8	21.4	7.3	10.6	12.5	7.2	8.8	7.7	20.0	7.3	26.1	11.0	12.2	18.4	10.5	7.5	12.8	9.8	13.5	7.4	14.2	7.7	8.0	7.8	25.3	17.3	7.2	22.6	20.3	18.6	4.8	2.2	16.0	2.3	1.6	4.6	0.6	10.3	1.3	23.4	12.4	15.5	19.9	15.8	8.7	25.2	6.8	12.8	1.5	15.1	20.9	14.1	8.1	6.5	7.5	6.1	28.9	13.2	14.5	4.1	1.7	6.0	3.0	8.1	3.1	21.9	16.8	14.4	3.2	7.1	22.9	10.2	12.4	1.0	12.8	12.5	4.0	14.2	6.6	2.3	5.0	1.4	8.2	22.8	1.3	43.0	28.8	6.2	19.9	10.3	16.4	6.1	14.6	12.2	4.7	9.5	9.3	9.5	6.7	1.4	9.5	7.2	14.8	6.5	4.9	4.6	11.4	1.5	16.0	0.8	2.0	1.9	2.7	1.2	0.8	1.5	4.8	0.9	0.5	6.5	1.6	2.3	2.2	4.6	0.6	11.3	15.1	53.0	17.2	9.6	5.4	7.3	10.6	7.3	7.8	11.9	10.5	50.6	33.0	33.0	67.4	4.0	5.1	4.0	4.5	52.4	21.6	23.6	72.9	23.7	0.6	35.4	27.6	0.0	17.2	86.4	68.4	86.4	38.1	1.6	26.8	23.8	16.0	31.9	38.3	0.9	25.6	27.7	54.0	67.7	29.5	17.3	37.9	17.5	25.8	40.8	46.6	64.7	34.8	5.2	10.0	23.3	13.2	22.4	13.5	38.8
UBE2K	"HIP2, HYPG, UBC1"	ENSG00000078140	"Ubiquitin conjugating enzyme E2 K"	P61086	4	39698044-39782792	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028869, CAB033212, CAB033515"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		150000	Cytosol	"Plasma membrane"	"CAB033212: AB_2272506, CAB033515: AB_2304024, HPA028869: AB_10602487"	"unprognostic (1.14e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (8.60e-4)"	"unprognostic (1.08e-1)"	"unprognostic (3.67e-1)"	"unprognostic (4.83e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.10e-3)"	27.2	21.8	27.0	21.2	27.6	17.3	21.6	38.6	40.7	17.0	33.2	11.8	14.1	29.1	19.9	18.5	29.9	14.9	18.5	28.1	27.7	26.8	26.6	44.5	17.1	17.9	24.1	26.4	16.9	15.8	18.9	26.9	29.8	25.2	19.7	24.0	13.4	18.4	17.3	31.8	22.0	24.6	18.8	19.2	16.9	29.3	16.0	15.9	21.3	23.6	19.7	18.8	22.8	20.4	17.6	23.7	20.6	19.9	10.9	14.1	8.9	24.2	24.9	13.4	12.7	8.4	7.9	22.8	33.4	7.1	9.0	9.4	37.6	25.0	30.3	29.4	9.4	22.1	10.2	25.8	14.6	14.4	20.3	18.5	39.2	25.2	32.5	10.6	42.1	22.2	7.4	16.5	12.6	13.6	9.4	11.7	13.3	39.8	10.9	9.2	23.5	29.3	23.4	17.8	14.0	19.0	17.3	40.3	11.3	12.5	33.8	27.9	12.3	25.0	9.5	14.9	15.5	12.2	14.1	32.0	14.0	29.7	16.6	30.7	15.4	45.0	33.3	7.3	27.0	16.4	13.9	16.6	20.6	13.5	14.3	12.7	17.6	14.1	12.6	16.6	12.5	10.7	12.0	13.3	10.9	19.9	23.7	13.7	8.9	27.0	27.6	38.6	37.7	27.7	26.8	24.1	26.4	25.2	15.9	53.6	50.8	35.6	49.5	109.2	60.1	57.3	45.9	71.0	67.1	47.1	27.5	74.8	56.3	76.3	97.5	58.3	92.6	70.0	77.7	144.5	61.6	76.6	33.5	101.0	71.4	98.5	57.3	61.4	71.5	150.7	60.4	73.4	54.0	103.6	63.5	70.2	109.4	73.0	53.0	81.7	38.2	38.8	67.9	71.4	46.9	120.6	123.3	48.4	65.5	98.3
HMGA1	HMGIY	ENSG00000137309	"High mobility group AT-hook 1"	P17096	6	34236873-34246231	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 107.3"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 784.6;Pancreatic endocrine cells: 1097.2;Urothelial cells: 1250.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB032200, HPA065612, HPA068442"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA		18000	Nucleoplasm	Nucleoli	"CAB032200: AB_2117771, HPA065612: , HPA068442: "	"unprognostic (1.81e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.29e-6)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (8.54e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.65e-2)"	15.8	3.5	14.8	35.7	13.5	55.4	13.0	13.8	19.0	26.1	22.0	5.9	7.7	42.3	8.6	7.2	79.4	15.1	17.8	13.0	11.7	12.6	14.6	6.9	16.0	46.1	10.7	8.7	3.9	13.0	4.1	5.1	31.8	12.5	8.7	21.2	9.9	22.0	6.9	33.7	38.3	36.0	3.8	8.4	31.6	24.2	32.6	7.2	107.3	12.5	39.6	72.7	13.0	29.6	26.6	33.4	12.8	10.1	7.3	22.4	11.0	121.6	48.2	24.7	17.2	11.5	85.4	108.0	49.2	56.3	38.2	21.3	31.5	85.4	57.4	24.8	20.1	24.0	26.1	29.1	87.7	30.4	12.5	19.5	17.6	16.2	42.1	24.4	62.8	20.3	36.6	9.8	69.1	36.1	98.7	115.2	32.8	70.8	2.9	53.1	12.3	54.4	77.4	120.4	60.7	81.6	80.9	0.5	63.3	25.8	11.2	43.2	18.3	5.2	25.0	45.4	40.8	10.0	67.4	99.8	19.9	62.8	28.9	46.0	23.6	36.5	74.1	42.1	26.2	99.3	6.2	10.1	12.8	10.2	10.1	13.3	26.6	18.7	16.0	30.7	16.4	22.4	17.7	2.6	7.3	9.4	33.4	21.0	11.0	14.8	13.5	13.8	19.0	11.7	12.6	10.7	8.7	12.5	7.2	26.8	23.7	124.5	686.8	384.1	27.4	24.5	38.2	10.7	36.4	38.4	3.9	784.6	39.7	243.5	6.1	27.0	148.7	46.7	242.2	663.0	71.9	750.7	66.8	10.6	337.7	11.1	112.2	16.0	59.4	17.5	5.2	107.5	86.0	66.7	165.5	27.9	1097.2	162.4	2.5	9.0	27.8	0.0	34.9	38.5	398.0	315.9	688.1	51.7	282.8	1250.0
BHLHE40	"BHLHB2, bHLHe40, Clast5, DEC1, SHARP2, STRA13"	ENSG00000134107	"Basic helix-loop-helix family member e40"	O14503	3	4979116-4985323	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 415.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 32.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 87.7;Karpas-707: 42.3;U-87 MG: 41.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028922	Uncertain		Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA028922: AB_2672828"	"unprognostic (8.64e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.58e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (5.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.95e-2)"	"unprognostic (7.03e-3)"	41.2	32.0	15.7	19.1	17.0	55.5	52.7	6.5	28.7	33.3	22.4	13.7	10.5	10.8	23.7	34.3	84.2	14.8	35.3	40.4	11.9	9.0	34.6	63.1	30.2	17.1	11.2	16.1	45.1	27.5	26.9	25.6	24.2	17.4	33.7	17.4	50.9	28.8	26.7	79.5	49.6	12.6	22.8	21.8	12.4	13.9	13.5	12.9	5.1	21.2	47.3	39.5	57.1	62.4	3.0	7.2	32.1	3.4	18.9	9.7	3.6	7.2	9.8	0.0	2.7	5.9	4.6	14.7	1.3	3.6	1.4	5.7	0.6	7.3	0.0	3.7	2.6	22.4	5.7	1.2	19.9	2.5	87.7	0.8	1.7	7.1	2.1	5.7	4.5	36.4	10.6	11.9	16.7	4.8	10.1	5.5	0.3	9.5	42.3	3.8	5.1	0.7	1.9	0.5	8.3	16.1	0.1	3.3	4.0	13.9	1.4	0.1	0.3	24.4	6.4	7.1	9.1	14.6	7.1	7.3	5.8	5.6	5.3	9.0	33.0	14.4	0.2	41.5	3.6	2.8	32.1	3.4	18.7	9.4	1.7	9.7	3.0	5.2	6.3	5.5	1.5	1.2	4.0	5.1	18.9	0.2	7.2	0.3	3.6	15.7	17.0	6.5	28.7	11.9	9.0	11.2	16.1	17.4	12.9	62.5	197.6	15.4	70.4	147.0	13.4	39.2	38.2	78.9	143.3	43.6	0.0	21.4	10.0	66.6	0.3	112.9	24.4	0.0	63.5	35.2	80.1	49.5	415.0	56.3	37.4	9.5	10.3	71.2	50.9	1.3	6.6	141.0	102.9	57.7	26.0	55.8	101.6	34.0	3.5	20.3	7.7	6.5	95.9	0.2	0.0	229.0	132.5	56.7	16.8	83.6
WDR3	"DIP2, FLJ12796, UTP12"	ENSG00000065183	"WD repeat domain 3"	Q9UNX4	1	117929720-117966542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027509, HPA054354, HPA072915"			Enhanced	Nucleoplasm,Nucleoli		No	No			Nucleoli	Nucleoplasm	"HPA027509: AB_10601808, HPA054354: AB_2682459, HPA072915: "	"unprognostic (6.77e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (8.90e-3)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.65e-2)"	12.5	13.5	7.7	10.6	10.7	3.3	12.2	8.4	9.7	10.5	7.7	6.8	9.7	7.3	12.6	6.5	13.3	10.5	4.6	8.7	7.1	6.4	8.5	14.8	7.3	15.5	6.9	6.2	12.1	21.4	16.3	14.8	8.4	8.3	8.4	10.8	6.6	9.8	8.1	25.4	10.5	6.8	11.7	6.2	8.5	9.3	14.9	6.9	15.2	11.1	9.5	15.2	10.2	9.1	8.7	11.9	0.5	6.6	7.9	12.4	6.3	15.2	9.7	9.7	14.8	10.6	8.7	11.2	10.7	7.0	12.5	11.0	10.2	5.1	18.1	14.7	7.9	8.0	10.3	24.1	12.3	19.9	14.9	12.5	17.0	10.4	8.2	8.7	31.8	9.0	8.5	8.9	15.8	24.0	7.4	11.9	12.8	20.7	8.9	10.9	8.8	15.1	7.3	35.0	13.4	15.6	14.5	33.7	13.8	6.2	10.2	15.0	13.7	12.2	15.1	17.3	14.1	6.0	13.3	10.5	9.4	15.0	17.1	23.9	13.1	15.3	28.4	13.8	20.6	24.2	0.1	6.0	0.5	8.8	6.1	11.4	8.7	8.0	10.3	11.9	7.9	12.4	11.3	0.5	7.9	6.6	6.6	10.7	6.3	7.7	10.7	8.4	9.7	7.1	6.4	6.9	6.2	8.3	6.9	8.9	11.0	9.2	10.8	18.5	9.6	14.0	5.1	25.4	33.0	7.0	5.9	9.2	8.3	8.4	28.6	11.7	2.7	0.0	11.8	7.5	9.5	8.9	15.1	25.5	7.2	14.3	3.5	11.6	6.3	34.2	11.5	7.4	10.1	2.8	5.1	6.5	10.6	3.5	11.0	6.0	6.4	12.9	14.6	25.9	60.1	19.6	4.2	5.7	9.4	7.7
ZBED2	MGC10796	ENSG00000177494	"Zinc finger BED-type containing 2"	Q9BTP6	3	111592900-111595443	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 21.0;thyroid gland: 74.5"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 41.7"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 64.0"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.4"	"Cell type enhanced"	"Detected in many"		"naive B-cell: 4.0"	"Group enriched"	"Detected in many"	6	"B-cells: 4.0;T-cells: 2.5"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 20.1;EFO-21: 14.0;HaCaT: 19.4;HBEC3-KT: 43.6;RPTEC TERT1: 29.0"					"Not detected"	"Not detected"			HPA029786			Approved	"Nuclear bodies,Mitochondria,Cytosol"		No	No			"Mitochondria, Cytosol"	"Nuclear bodies"	"HPA029786: AB_10601028"	"unprognostic (7.31e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.66e-1)"		"unprognostic (2.39e-3)"	"unprognostic (3.49e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (8.83e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.47e-6)"	"unprognostic (3.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.29e-2)"	0.1	0.0	0.1	0.9	1.4	0.0	0.1	0.1	0.1	3.7	0.1	0.1	0.1	0.0	0.2	0.2	8.1	11.1	0.2	0.1	0.1	0.0	0.3	0.1	5.6	3.4	0.1	0.1	1.2	0.1	0.0	0.4	4.0	0.1	0.1	0.0	0.1	1.7	0.1	0.1	1.3	0.3	0.1	0.1	0.1	0.1	0.2	0.2	21.0	74.5	7.5	7.4	0.2	6.2	4.0	0.0	0.1	0.0	0.5	2.5	0.3	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.1	14.0	0.0	0.0	19.4	0.0	43.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.0	3.6	0.6	0.3	0.0	4.0	1.9	2.5	0.1	0.5	0.0	0.0	1.1	0.3	0.1	1.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	41.7	1.4	0.0	0.2	3.9	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.7	0.0	0.1
ENDOD1	KIAA0830	ENSG00000149218	"Endonuclease domain containing 1"	O94919	11	95089810-95132645	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 62.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008932, HPA010517"	Enhanced		Approved	"Nuclear membrane"	"Secreted - unknown location"	NA	NA		19000000	"Nuclear membrane"		"HPA008932: AB_2262252, HPA010517: AB_1852351"	"unprognostic (8.81e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.65e-1)"	"prognostic unfavorable (8.86e-4)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.64e-7)"	"unprognostic (5.92e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (3.27e-4)"	14.9	13.8	20.3	7.9	27.9	4.1	15.0	14.3	31.0	17.6	25.4	52.6	9.7	8.4	13.7	12.2	19.0	13.1	12.2	14.4	24.0	22.3	18.9	4.9	10.6	7.3	33.5	20.1	12.0	4.7	48.8	11.8	12.1	40.6	36.5	29.4	15.5	12.5	22.9	34.4	20.6	14.5	16.2	40.4	22.9	8.3	9.3	25.5	0.5	12.6	12.3	6.7	9.0	16.5	7.3	2.9	1.3	5.4	3.1	5.9	6.1	1.1	1.7	2.2	1.3	62.5	20.0	9.2	8.3	1.8	2.2	2.3	8.6	15.1	8.0	10.3	6.6	5.0	11.1	2.1	11.4	0.8	6.3	1.6	17.3	0.8	3.6	6.8	3.1	22.4	18.1	14.9	1.3	4.2	15.3	7.7	7.7	3.5	5.2	8.3	2.9	1.3	0.1	0.5	12.4	5.6	5.8	0.0	3.3	6.6	9.3	1.1	0.9	3.5	3.5	6.2	3.1	3.6	0.9	5.5	12.2	3.6	8.1	3.5	4.3	3.2	0.6	3.7	1.7	27.2	1.3	1.3	0.9	5.9	3.2	5.5	7.2	3.9	5.0	2.9	7.3	3.2	3.8	0.6	3.1	5.4	1.3	2.2	6.1	20.3	27.9	14.3	31.0	24.0	22.3	33.5	20.1	40.6	25.5	8.9	14.2	11.5	14.8	7.1	2.1	4.4	17.8	1.4	11.4	10.4	0.0	4.6	1.7	4.5	2.5	22.4	35.5	23.3	7.7	6.5	8.6	20.7	13.9	2.9	2.9	0.0	15.5	38.1	4.3	2.6	9.5	5.5	27.0	1.0	22.5	1.9	6.1	40.2	14.2	9.3	0.6	38.8	19.1	0.3	3.6	10.9	10.4	5.1	18.4	8.6
SF3B6	"CGI-110, Ht006, P14, SAP14a, SF3B14a"	ENSG00000115128	"Splicing factor 3b subunit 6"	Q9Y3B4	2	24067584-24076443	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034829, HPA034830"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034829: AB_10673104, HPA034830: AB_10669680"	"unprognostic (6.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.35e-3)"	"prognostic unfavorable (5.57e-5)"	"unprognostic (1.74e-2)"	"unprognostic (8.75e-2)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.91e-1)"	39.4	43.5	39.5	31.0	35.9	72.5	57.1	24.2	35.5	43.7	49.7	30.8	34.6	39.5	41.3	58.6	62.9	36.5	35.4	38.8	35.5	31.5	60.3	64.5	33.1	37.1	35.3	29.2	41.5	43.1	26.4	41.4	49.3	30.8	41.8	45.5	27.1	46.4	36.3	40.8	33.4	62.1	46.0	40.4	42.5	35.8	42.2	34.7	56.9	57.1	63.3	47.3	49.6	42.2	54.1	49.9	71.1	45.6	44.0	62.4	47.4	49.8	24.2	38.9	32.3	30.9	48.2	23.9	38.0	40.6	45.9	47.4	51.6	31.6	37.4	21.5	34.9	47.3	29.8	39.8	47.8	55.8	36.6	47.9	39.5	31.1	44.8	55.6	48.7	24.7	44.6	57.3	46.6	53.6	48.4	45.9	35.2	44.7	28.4	47.8	37.7	36.6	73.7	31.2	62.2	47.8	27.0	53.4	37.1	54.4	28.1	34.8	52.3	21.2	42.1	83.5	34.7	20.5	50.5	27.4	25.3	35.1	26.5	62.1	28.5	36.6	101.1	34.6	81.5	34.9	56.6	43.9	64.9	36.8	45.6	40.5	54.1	46.9	43.9	49.9	40.7	46.4	49.1	71.1	44.0	40.2	45.6	62.4	47.4	39.5	35.9	24.2	35.5	35.5	31.5	35.3	29.2	30.8	34.7	65.5	65.5	119.9	229.6	0.0	50.2	109.1	163.1	143.2	101.2	130.9	15.7	250.0	330.0	180.8	127.3	117.2	210.5	140.2	145.5	328.8	128.0	207.7	98.1	161.7	204.5	17.5	173.1	131.3	129.1	26.7	194.8	118.8	0.0	227.2	200.2	113.5	180.1	263.1	169.7	338.6	53.4	116.4	169.3	210.5	163.8	0.0	227.2	122.2	209.2	366.6
U2SURP	"fSAPa, SR140"	ENSG00000163714	"U2 snRNP associated SURP domain containing"	O15042	3	142964497-143060546	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037545, HPA037546, HPA061407"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037545: AB_10672598, HPA037546: AB_2675535, HPA061407: AB_2684506"	"unprognostic (2.01e-1)"	"unprognostic (9.78e-2)"	"unprognostic (8.09e-2)"	"prognostic unfavorable (8.44e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (3.72e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.61e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (2.85e-3)"	"prognostic unfavorable (8.86e-7)"	"unprognostic (6.71e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.12e-1)"	"prognostic favorable (6.78e-4)"	21.2	17.7	21.3	17.6	30.8	48.2	24.0	29.7	27.9	26.3	20.3	18.8	18.0	12.9	24.3	22.2	22.3	19.2	12.7	16.6	18.4	16.4	17.8	22.1	17.9	26.8	24.5	24.8	28.4	22.8	22.3	39.6	21.7	25.8	21.2	20.7	19.2	18.6	15.8	26.4	21.9	22.1	26.0	26.6	23.5	18.3	19.2	27.3	32.3	21.2	16.5	24.5	23.2	19.0	33.8	31.2	19.9	25.7	18.4	26.6	11.3	38.0	12.8	14.3	9.6	7.6	7.1	24.9	17.2	11.1	19.9	14.9	17.0	11.7	44.0	18.5	11.1	38.2	13.8	29.4	15.3	22.8	11.9	20.6	47.7	11.8	13.5	7.9	46.2	18.0	8.6	7.7	15.4	19.7	8.9	10.7	28.2	29.3	14.1	9.2	10.7	22.9	20.2	23.1	12.2	12.0	23.4	28.1	18.4	10.0	24.1	18.5	10.8	34.6	11.4	20.2	15.5	20.3	20.0	11.7	10.8	12.7	8.4	27.6	16.9	21.6	75.4	8.6	16.8	14.8	18.9	19.7	18.3	25.2	18.6	22.0	31.7	23.1	22.3	15.4	33.8	26.6	22.8	19.9	18.4	25.7	31.2	22.1	11.3	21.3	30.8	29.7	27.9	18.4	16.4	24.5	24.8	25.8	27.3	110.2	113.9	58.8	76.8	54.0	118.7	107.4	50.9	109.7	113.7	59.3	62.8	66.9	44.7	59.1	24.0	69.2	40.4	23.3	69.1	74.2	66.7	59.6	93.8	51.4	53.1	87.4	53.0	59.5	57.8	14.6	100.7	82.2	49.0	103.6	66.5	100.5	72.4	56.1	75.0	46.0	116.0	77.6	76.2	174.5	202.9	56.7	66.1	72.6	70.6	61.5
CDC45	"CDC45L, CDC45L2"	ENSG00000093009	"Cell division cycle 45"	O75419	22	19479459-19520612	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.7;lymphoid tissue: 25.4;testis: 43.5"	"Cell type enhanced"	"Detected in some"	16	"Early spermatids: 88.0;Erythroid cells: 46.7;Spermatocytes: 23.9;Spermatogonia: 49.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 87.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000614, CAB009459"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	Yes			Nucleoplasm	"Centrosome, Cytosol"	"CAB009459: AB_2078507, HPA000614: AB_1078487"	"unprognostic (5.56e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.42e-3)"	"unprognostic (3.57e-1)"	"unprognostic (7.42e-2)"	"prognostic unfavorable (6.95e-6)"	"unprognostic (6.01e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (7.28e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.62e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.10e-1)"	0.9	0.9	0.3	8.4	0.5	15.7	0.9	0.3	0.6	1.3	3.4	0.3	0.2	2.2	0.6	1.4	6.2	0.4	0.8	1.6	0.7	0.3	0.8	1.4	1.3	7.5	0.4	0.2	0.7	0.5	0.1	0.4	3.5	0.4	0.7	4.3	0.2	1.3	0.2	0.4	2.1	3.1	1.1	0.4	4.2	1.8	43.5	0.2	25.4	0.5	7.2	10.2	1.3	1.9	0.7	0.9	1.6	0.5	1.8	3.2	1.9	13.2	11.1	13.9	10.9	0.6	1.3	5.9	16.4	7.7	18.9	18.8	8.5	7.4	14.8	5.8	4.9	7.5	12.8	14.8	10.8	17.0	18.0	25.0	19.8	12.6	9.3	0.7	28.7	10.9	0.4	0.5	14.5	6.5	1.8	9.5	15.3	87.8	18.7	11.0	17.7	23.3	13.6	4.2	25.7	8.4	19.4	23.1	6.5	4.4	12.7	18.0	9.5	8.9	9.8	2.8	6.5	6.4	12.8	3.6	14.8	23.7	11.2	14.9	6.4	11.8	17.2	7.8	14.4	19.7	0.0	0.2	0.0	2.2	0.0	0.0	0.7	1.4	2.3	0.6	0.0	1.0	0.7	1.6	1.8	0.5	0.9	3.2	1.9	0.3	0.5	0.3	0.6	0.7	0.3	0.4	0.2	0.4	0.2	0.0	0.0	0.8	0.4	2.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.9	88.0	0.3	0.4	46.7	0.0	16.8	1.0	0.2	0.0	0.0	6.2	0.0	0.0	3.7	0.6	6.1	0.6	0.9	0.0	0.0	0.8	0.0	0.1	0.0	0.7	0.0	0.0	6.5	0.9	23.9	49.8	1.6	4.1	1.3	2.5	0.4
DTX3L	"BBAP, RNF143"	ENSG00000163840	"Deltex E3 ubiquitin ligase 3L"	Q8TDB6	3	122564238-122575203	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Protein transport, Transport, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 34.2;BJ hTERT+ SV40 Large T+ RasG12V: 42.4;GAMG: 32.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010570	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA010570: AB_1847877"	"unprognostic (8.15e-2)"	"unprognostic (7.36e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.51e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.77e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.61e-2)"	32.3	13.0	5.9	22.7	8.4	8.1	11.2	2.0	6.8	14.2	18.5	5.9	6.0	14.8	14.0	12.8	17.9	12.0	15.1	21.5	5.0	5.1	17.3	39.2	21.3	18.3	6.4	3.3	21.7	18.5	10.3	13.9	22.2	6.5	20.9	12.1	7.6	13.9	9.8	14.6	6.2	31.8	10.8	9.7	35.2	12.4	4.9	6.9	24.8	23.9	8.0	18.3	17.0	22.1	6.4	6.5	21.9	13.6	7.8	10.2	6.7	11.1	3.4	1.0	2.9	4.6	10.6	3.8	2.9	10.7	34.2	42.4	3.3	11.4	1.2	5.7	4.7	32.9	11.2	3.4	4.6	7.5	9.4	1.3	9.7	2.6	3.5	9.0	4.9	7.6	9.1	5.5	5.1	2.9	6.5	6.4	6.2	1.2	6.9	2.5	3.4	12.0	3.5	0.6	3.4	6.3	13.4	7.8	2.1	8.7	7.2	1.4	1.5	6.0	2.7	21.6	0.7	3.1	6.3	7.9	3.9	5.5	0.3	3.7	2.5	1.4	5.9	6.8	6.5	4.0	12.5	8.5	8.7	9.3	13.6	10.2	5.9	7.8	10.0	6.5	6.4	7.1	7.6	21.9	7.8	13.5	0.7	7.4	6.7	5.9	8.4	2.0	6.8	5.0	5.1	6.4	3.3	6.5	6.9	29.8	25.5	10.7	7.5	7.9	0.2	4.4	20.4	16.0	15.9	7.0	0.0	3.1	0.0	21.6	1.5	16.6	25.5	0.0	27.9	13.8	9.6	16.0	15.1	50.5	24.2	0.0	17.7	24.5	34.9	0.6	7.8	19.5	5.0	20.8	21.5	5.0	28.4	11.5	8.5	11.1	0.2	32.3	6.6	0.9	0.7	5.3	1.5	13.4	16.9	18.6
HIST1H2BC	"H2B.1, H2B/l, H2BFL"	ENSG00000180596	"Histone cluster 1 H2B family member c"	P62807	6	26114873-26123926	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in all"	4	"blood: 115.7;lymphoid tissue: 143.2"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 42.1;Glandular cells: 78.6;Urothelial cells: 103.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	20	"neutrophil: 115.7"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 115.7"	"Cell line enhanced"	"Detected in many"		"K-562: 17.0;SiHa: 33.6;U-2 OS: 23.5;U-266/70: 19.4;U-266/84: 23.8"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (8.30e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.72e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (5.41e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.60e-3)"	7.8	5.8	5.5	21.3	7.1	31.3	10.7	2.1	5.9	12.9	11.5	5.9	12.8	5.2	4.1	13.1	20.9	10.8	8.1	5.8	6.5	4.6	8.4	20.2	15.3	11.4	5.4	4.1	5.6	9.6	1.7	9.9	17.5	3.8	31.7	4.1	5.9	12.4	18.6	20.0	10.0	6.0	4.3	10.4	11.7	10.6	9.4	4.5	143.2	6.4	8.7	23.4	12.9	14.3	4.3	2.8	115.7	1.3	1.2	1.8	2.7	3.0	1.8	0.9	0.9	0.9	0.5	1.1	3.0	1.1	2.0	1.7	2.4	1.8	1.1	5.7	1.0	1.5	2.3	1.2	1.2	1.0	2.7	1.0	0.9	2.7	4.1	1.2	1.4	3.8	12.6	0.7	0.8	0.5	1.0	0.8	0.9	17.0	9.5	3.8	3.4	3.2	3.1	1.0	3.2	5.5	1.4	1.3	7.0	3.5	0.7	4.3	1.4	33.6	2.6	1.2	2.6	14.3	1.3	2.4	2.5	23.5	1.5	1.2	19.4	23.8	5.7	1.1	3.7	1.7	4.5	1.1	5.8	1.2	1.3	1.6	2.3	1.8	1.7	0.8	4.3	1.4	1.0	115.7	1.2	1.2	2.8	1.1	2.7	5.5	7.1	2.1	5.9	6.5	4.6	5.4	4.1	3.8	4.5	6.0	2.7	3.0	40.5	0.8	3.0	1.8	5.1	21.4	7.9	3.5	0.0	3.9	1.7	6.8	42.1	2.9	9.5	0.0	8.0	5.4	4.1	78.6	4.6	13.0	5.8	0.0	1.7	1.8	3.7	4.5	1.4	4.6	0.0	1.8	7.4	2.9	25.5	9.9	1.1	3.5	3.9	0.0	1.8	1.8	3.2	1.0	35.8	10.1	4.9	103.5
SRI		ENSG00000075142	Sorcin	P30626	7	88205118-88226993	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 140.7"	"Cell type enhanced"	"Detected in all"	7	"Enterocytes: 1052.9;Paneth cells: 1613.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019004, HPA073666"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		1400000	"Nucleoplasm, Cytosol"		"HPA019004: AB_2670006, HPA073666: AB_2686623"	"unprognostic (1.86e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.24e-3)"	"prognostic favorable (3.08e-4)"	"unprognostic (9.87e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.87e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.14e-3)"	20.6	22.0	47.7	24.6	53.5	18.7	22.4	18.9	43.6	24.1	140.7	32.5	7.0	45.3	18.1	33.1	15.6	39.4	14.2	19.4	35.9	40.2	21.7	14.6	21.9	16.6	45.0	44.8	23.3	18.4	12.1	18.3	21.2	36.9	19.5	115.0	11.1	17.7	18.4	8.7	11.1	62.8	25.2	41.9	14.6	16.2	10.0	28.0	9.2	19.7	9.4	19.4	27.0	18.7	29.7	34.5	95.4	42.1	36.3	36.4	32.7	34.4	13.2	35.8	36.8	58.0	49.0	18.0	20.7	33.5	23.4	27.8	12.3	78.2	38.3	21.9	31.4	57.4	34.9	44.9	46.8	30.6	30.8	20.2	19.8	36.4	0.0	35.1	26.4	21.3	50.1	42.9	24.7	36.0	42.0	70.0	24.5	17.5	33.2	32.0	21.7	38.5	18.2	31.4	48.9	26.7	16.0	50.7	21.2	43.5	34.5	25.9	30.7	63.1	36.3	28.8	35.7	17.1	11.8	43.7	43.9	36.8	40.2	36.8	31.1	14.4	41.0	43.1	25.3	74.2	86.5	26.1	95.4	31.0	36.5	36.4	29.7	34.5	35.2	34.5	24.9	25.8	29.8	16.3	36.3	42.1	27.5	34.7	32.7	47.7	53.5	18.9	43.6	35.9	40.2	45.0	44.8	36.9	28.0	80.4	103.8	93.1	338.4	84.4	36.4	95.1	30.6	495.2	193.3	148.3	11.8	123.5	374.7	201.2	45.8	112.5	1052.9	210.2	371.4	826.3	181.0	282.1	132.7	33.9	132.6	44.5	90.6	92.1	77.3	23.0	159.3	104.1	99.5	215.6	393.6	112.7	336.5	1613.2	133.0	124.1	19.7	109.9	144.4	65.6	106.7	94.6	165.0	117.6	448.6	382.7
LOXL2	"LOR, WS9-14"	ENSG00000134013	"Lysyl oxidase like 2"	Q9Y4K0	8	23297189-23425328	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 15.5;Extravillous trophoblasts: 20.1;Fibroblasts: 16.6;Ito cells: 23.4;Sertoli cells: 25.8;Smooth muscle cells: 22.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	8	"pons and medulla: 22.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 109.9;BJ hTERT+ SV40 Large T+ RasG12V: 63.6;fHDF/TERT166: 71.2;TIME: 59.3;U-87 MG: 110.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025848, HPA036257, HPA056542"	Approved		Enhanced	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA			Nucleoplasm		"CAB025848: , HPA036257: AB_2675025, HPA056542: AB_2683168"	"unprognostic (9.48e-2)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (2.91e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (9.05e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.91e-7)"	"unprognostic (1.51e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.68e-3)"	37.8	2.7	1.2	14.5	1.6	0.6	22.4	2.9	1.6	16.9	18.4	1.0	12.2	5.8	11.8	9.1	11.5	4.1	5.4	7.2	1.2	1.3	4.3	4.1	6.2	7.5	1.9	0.7	15.6	4.4	1.3	2.2	38.0	22.7	8.4	3.8	1.6	5.6	9.7	6.2	4.3	10.7	27.3	10.9	8.3	7.7	4.1	0.7	1.6	4.3	8.0	8.6	19.1	6.4	1.9	1.3	3.0	0.7	2.1	2.8	0.7	6.3	17.0	5.1	4.1	14.0	23.1	2.2	109.9	35.6	50.4	63.6	0.1	0.4	1.2	0.8	71.2	23.4	5.3	0.2	9.4	26.7	0.2	0.9	0.0	2.3	0.1	28.3	0.0	0.4	20.4	0.4	18.8	2.5	33.6	42.1	0.2	0.0	0.2	16.6	3.4	0.0	0.1	3.3	0.0	2.6	0.2	4.2	0.0	14.6	0.0	0.1	1.4	13.7	0.7	1.0	16.8	0.1	0.1	59.3	46.9	12.4	19.1	14.4	0.4	0.0	3.3	110.2	0.1	48.8	1.9	0.7	3.0	1.6	0.3	0.8	1.9	0.6	1.3	0.5	0.9	0.8	2.8	1.6	2.1	0.6	1.3	0.2	0.7	1.2	1.6	2.9	1.0	1.2	1.3	1.9	0.7	22.7	0.7	0.0	4.0	0.5	0.4	2.3	1.7	1.7	0.0	1.4	0.0	0.0	0.0	2.0	0.0	1.5	0.5	15.5	0.0	0.0	1.3	20.1	16.6	0.5	0.0	0.0	1.1	1.6	0.0	23.4	0.3	0.0	0.9	0.5	3.3	0.0	0.0	0.8	3.4	0.0	0.4	0.0	3.1	25.8	22.6	0.9	0.9	2.8	0.8	0.0	0.0	0.1
MED15	"Arc105, CAG7A, PCQAP, TIG-1, TNRC7"	ENSG00000099917	"Mediator complex subunit 15"	Q96RN5	22	20495913-20587632	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 71.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003179	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003179: AB_1079581"	"unprognostic (7.98e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (7.30e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (3.73e-2)"	"unprognostic (1.12e-3)"	"unprognostic (3.46e-1)"	"prognostic unfavorable (9.09e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (1.32e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.60e-2)"	"unprognostic (5.57e-2)"	26.2	28.3	26.4	29.5	32.0	41.6	23.4	28.5	31.4	23.9	25.3	27.4	17.6	34.8	35.6	15.0	25.8	23.4	25.9	21.9	23.4	15.4	20.6	12.2	28.6	31.4	22.8	22.4	23.6	24.9	17.9	24.1	32.2	22.0	22.0	13.8	29.5	22.7	23.2	40.7	27.9	30.1	20.8	19.3	32.9	24.5	19.9	23.9	19.2	20.3	16.4	29.2	29.7	24.3	4.9	6.8	9.1	13.9	13.6	19.8	8.8	22.1	11.9	7.6	9.2	8.0	7.9	14.0	22.6	16.6	17.9	16.6	18.1	10.1	9.0	10.4	15.9	8.1	22.9	6.9	16.8	7.2	12.8	12.3	17.1	12.8	13.1	13.4	15.5	15.8	9.6	13.2	14.1	14.4	10.2	13.8	6.9	71.5	8.5	11.3	14.9	6.5	8.8	8.2	9.8	8.1	11.4	17.3	3.6	10.8	16.2	7.2	12.4	17.0	17.3	24.0	5.2	9.7	8.7	24.8	28.9	21.8	15.4	18.1	11.2	9.9	6.9	20.9	9.6	25.7	4.1	7.6	6.5	17.8	8.4	8.4	4.2	12.2	19.8	6.8	4.9	7.2	12.0	9.1	13.6	13.9	6.1	19.0	8.8	26.4	32.0	28.5	31.4	23.4	15.4	22.8	22.4	22.0	23.9	47.6	28.6	11.2	22.3	26.6	19.3	3.9	7.6	26.8	25.0	24.4	17.7	42.4	13.3	28.7	32.9	22.4	35.0	0.0	24.9	35.8	18.8	29.4	19.7	7.4	27.6	14.3	17.2	23.9	25.0	18.1	13.3	27.1	23.6	31.5	22.7	12.8	47.2	23.2	13.8	10.1	14.7	45.3	24.7	20.4	15.4	24.1	51.7	31.2	19.6	31.9
DR1	"NC2-BETA, NC2B, NCB2"	ENSG00000117505	"Down-regulator of transcription 1"	Q01658	1	93345888-93369498	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050785, HPA055308"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA050785: AB_2681237, HPA055308: AB_2682779"	"unprognostic (1.46e-1)"	"unprognostic (9.62e-2)"	"prognostic favorable (4.79e-4)"	"unprognostic (1.03e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.95e-7)"	"unprognostic (8.70e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.97e-1)"	"unprognostic (1.60e-1)"	18.5	15.2	14.6	19.4	17.9	37.2	16.9	20.1	18.7	19.2	19.0	17.5	12.6	19.4	20.7	9.7	26.7	13.6	17.0	19.0	14.5	13.9	17.0	17.8	19.0	28.2	15.0	10.1	17.1	14.3	14.4	17.6	25.9	14.2	17.6	12.2	16.7	18.2	10.9	32.2	27.0	21.4	15.4	15.9	21.8	21.8	44.4	14.9	63.4	17.8	17.8	25.4	20.5	22.1	19.0	28.0	39.8	26.0	16.5	27.9	18.7	33.0	10.4	16.7	21.5	15.5	17.7	20.6	26.8	16.5	18.3	19.6	12.0	12.0	35.1	31.1	19.7	24.9	17.6	20.0	18.5	27.0	29.5	18.8	29.5	21.9	13.1	24.7	34.6	21.8	12.3	22.4	25.4	37.0	19.1	16.2	21.1	30.3	34.0	21.6	10.2	32.8	10.9	27.8	11.5	25.5	28.6	36.9	35.8	12.9	20.2	16.2	20.7	22.8	21.2	28.1	15.8	15.0	27.4	25.1	33.1	26.4	32.3	40.0	19.7	21.8	36.3	9.5	27.7	13.4	36.8	22.8	39.8	19.0	26.0	21.1	19.0	21.0	21.6	28.0	16.1	21.2	20.6	31.9	16.5	22.1	22.9	27.9	18.7	14.6	17.9	20.1	18.7	14.5	13.9	15.0	10.1	14.2	14.9	26.8	23.2	41.0	28.2	152.1	30.2	28.2	22.9	12.0	25.0	34.9	23.6	62.2	38.1	30.0	119.9	35.9	27.5	46.7	24.1	58.0	36.2	39.6	48.4	24.3	46.8	47.7	20.0	32.5	46.7	83.6	26.2	41.6	42.2	63.1	37.3	14.2	36.5	23.0	24.8	31.0	24.1	32.3	43.2	95.6	40.9	140.4	91.9	44.7	23.4	63.0
MBOAT1	"dJ434O11.1, LPEAT1, MGC44669, OACT1"	ENSG00000172197	"Membrane bound O-acyltransferase domain containing 1"	Q6ZNC8	6	20102145-20212399	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 9.7;Melanocytes: 8.5;Paneth cells: 8.6;Suprabasal keratinocytes: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 30.3;HEL: 24.9;T-47d: 22.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.26e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.85e-3)"	"unprognostic (3.88e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.57e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.62e-3)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (2.90e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.24e-2)"	9.9	3.3	1.4	16.5	2.1	6.2	16.5	1.5	1.8	22.5	17.3	6.4	7.1	9.7	18.8	9.9	9.6	18.1	18.8	8.4	1.7	1.7	4.4	4.0	14.0	7.6	6.5	0.7	10.5	4.4	4.7	2.7	3.2	6.2	9.3	15.4	7.2	6.5	9.4	2.2	4.3	21.1	17.2	10.0	4.6	10.6	2.6	3.2	3.9	6.6	6.5	11.1	10.4	12.8	0.3	2.8	6.4	6.8	0.5	4.1	0.9	3.3	3.5	6.6	4.5	0.7	2.2	0.3	5.3	1.5	3.7	4.1	1.9	12.9	0.0	11.1	5.1	2.7	30.3	6.4	2.7	5.2	8.3	3.1	24.9	5.7	0.0	4.1	7.9	8.7	0.9	2.4	1.6	6.7	1.8	2.0	5.2	4.0	4.7	0.8	3.0	4.4	4.7	1.4	2.8	1.8	1.6	7.6	17.5	3.7	6.6	0.2	4.1	1.1	5.3	5.7	12.2	22.9	2.7	1.9	4.4	3.0	2.5	2.2	6.9	15.4	0.0	0.3	5.5	5.3	6.4	4.4	6.0	0.7	4.7	4.1	0.2	1.2	1.7	2.6	0.3	0.3	0.3	5.7	0.5	6.8	2.8	1.3	0.9	1.4	2.1	1.5	1.8	1.7	1.7	6.5	0.7	6.2	3.2	3.0	0.3	0.0	0.6	9.7	0.0	0.3	0.0	4.0	0.0	0.0	0.0	0.1	1.7	1.9	0.0	0.2	3.6	0.0	1.0	0.1	0.8	0.6	0.0	0.0	1.2	0.0	0.0	0.0	1.5	0.0	0.3	2.1	8.5	0.0	0.9	2.0	1.3	8.6	0.0	0.0	0.0	0.0	0.8	0.0	0.1	13.6	0.2	0.0	2.0	1.3
ARMC1	"Arcp, FLJ10511"	ENSG00000104442	"Armadillo repeat containing 1"	Q9NVT9	8	65602456-65634217	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026085	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA026085: AB_1845031"	"prognostic unfavorable (4.81e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (8.18e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (4.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.66e-1)"	16.2	16.5	25.5	13.1	25.6	11.5	19.2	30.4	32.3	17.1	19.0	22.6	10.2	15.8	19.7	17.8	17.7	14.1	12.3	21.6	26.9	24.0	22.9	23.5	12.6	18.1	24.5	18.7	20.4	15.2	18.4	18.9	16.7	27.1	19.2	17.6	13.1	15.1	18.8	22.2	11.6	15.3	22.5	27.5	15.0	14.5	10.0	18.9	20.7	15.4	10.4	20.0	20.4	14.0	8.8	6.1	20.7	7.9	9.6	10.5	5.8	22.7	16.3	15.9	14.8	15.8	14.5	11.6	20.5	15.3	21.8	16.1	11.9	18.5	35.5	5.2	18.5	23.7	15.3	28.4	16.5	29.7	20.1	14.8	27.5	10.4	17.3	21.1	10.3	15.0	13.2	19.1	17.9	24.7	17.2	22.3	25.3	28.3	25.3	23.3	14.6	38.1	13.6	16.5	28.5	18.1	22.2	19.9	12.5	17.2	10.8	11.8	12.8	12.9	16.4	19.3	16.9	26.3	12.2	13.2	20.7	15.2	15.6	19.1	18.8	19.8	24.0	19.6	19.3	20.0	20.7	4.8	6.1	7.6	7.9	10.5	8.8	9.1	9.1	6.1	6.8	9.4	9.3	0.6	9.6	7.2	5.3	9.5	5.8	25.5	25.6	30.4	32.3	26.9	24.0	24.5	18.7	27.1	18.9	38.7	20.1	24.4	9.6	14.1	23.1	28.3	12.7	16.0	27.3	15.7	21.6	29.7	46.4	22.5	6.2	16.3	15.7	23.3	24.4	37.1	21.1	14.3	10.4	21.3	22.4	19.1	22.4	26.4	15.1	4.3	24.2	16.9	20.3	28.9	18.5	44.1	23.2	10.5	31.5	32.1	20.5	6.5	25.5	31.8	21.7	16.2	31.5	20.1	21.7	7.6
ERBB2	"CD340, HER-2, HER2, NEU, NGL"	ENSG00000141736	"Erb-b2 receptor tyrosine kinase 2"	P04626	17	39687914-39730426	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 129.1;Enterocytes: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 8.8"	"Lineage enriched"	"Detected in many"	4	"T-cells: 8.8"	"Group enriched"	"Detected in many"	41	"OE19: 366.2;SK-BR-3: 179.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		430000	"Plasma membrane"	Cytosol	"CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: AB_2665610, HPA001060: AB_2666185, HPA001338: AB_2666279, HPA001383: AB_1078500"	"unprognostic (1.97e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.21e-2)"	"prognostic unfavorable (8.99e-8)"	"unprognostic (2.96e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (3.92e-1)"	"prognostic favorable (2.41e-14)"	"unprognostic (9.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.96e-1)"	5.8	2.4	5.2	10.4	7.0	0.1	20.1	4.2	7.0	19.1	46.5	9.1	55.2	21.6	14.9	18.7	40.9	22.7	26.6	24.8	6.3	3.1	37.5	21.5	17.6	3.7	5.1	5.6	19.3	16.2	27.7	8.1	60.8	7.5	23.6	16.6	15.9	28.7	58.1	8.9	35.3	47.2	10.9	4.5	4.0	17.1	6.5	3.7	2.8	35.7	20.8	22.9	19.7	20.3	1.3	0.3	2.1	0.4	0.9	8.8	2.2	2.1	2.5	2.9	1.8	3.5	2.4	3.9	1.5	2.5	3.3	2.8	1.9	5.8	0.1	3.1	3.5	1.8	6.7	0.1	3.4	1.5	0.2	2.2	0.1	2.0	3.1	2.0	0.0	0.0	2.4	3.2	2.0	1.2	3.2	1.3	0.1	0.3	0.1	2.4	3.3	0.3	0.1	5.2	366.2	0.6	0.2	1.1	0.3	3.4	6.7	0.5	0.1	2.9	179.8	0.9	3.7	5.0	0.1	0.1	1.7	2.2	2.1	0.9	0.3	0.1	0.1	0.1	0.0	5.6	1.6	0.4	0.8	8.8	0.3	0.7	0.9	0.5	2.5	0.3	1.3	1.0	2.5	2.1	0.9	0.2	0.2	0.4	2.2	5.2	7.0	4.2	7.0	6.3	3.1	5.1	5.6	7.5	3.7	38.7	34.4	1.3	21.0	12.5	4.3	13.5	30.6	10.7	15.9	129.1	11.8	9.7	6.6	27.1	0.3	4.6	93.2	0.0	22.3	75.4	11.0	33.4	0.0	10.4	3.5	6.4	15.0	12.3	2.4	0.7	17.0	1.8	10.1	1.0	56.6	30.9	26.2	42.1	21.5	20.7	5.9	0.0	10.3	7.1	5.3	16.6	19.0	2.2	63.0	28.1
CIP2A	KIAA1524	ENSG00000163507	"Cell proliferation regulating inhibitor of protein phosphatase 2A"	Q8TCG1	3	108549869-108589644	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.5"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 8.9;Exocrine glandular cells: 6.4;Extravillous trophoblasts: 10.7;Hofbauer cells: 6.7;monocytes: 5.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039570	Approved		Supported	"Plasma membrane,Cytosol"		NA	Yes			Cytosol	"Plasma membrane"	"HPA039570: AB_10796329"	"unprognostic (2.02e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.31e-3)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.91e-7)"	"unprognostic (2.80e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.18e-4)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (9.11e-3)"	"unprognostic (3.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.25e-1)"	2.1	2.3	2.5	8.5	6.3	10.4	3.6	6.3	6.2	3.2	3.1	2.6	0.8	2.0	3.2	1.8	4.0	1.8	2.0	2.7	2.9	2.1	2.2	1.6	2.2	10.2	2.0	3.2	3.8	1.8	1.8	3.0	3.3	2.4	3.0	4.4	2.2	2.3	1.4	2.0	1.9	2.7	2.5	2.4	5.5	2.0	8.5	1.5	21.5	1.9	1.5	8.0	4.0	2.7	1.9	0.3	0.7	1.1	0.0	1.6	0.6	18.9	5.6	15.9	10.2	0.7	1.5	6.5	14.4	6.8	17.1	20.1	6.8	8.5	12.8	5.0	5.2	13.0	9.7	5.4	5.1	31.2	4.0	5.3	15.3	7.8	5.1	0.2	9.8	11.0	0.6	1.0	13.3	5.5	2.8	7.6	5.9	9.4	20.7	16.7	3.9	11.8	8.8	16.4	7.1	9.8	13.6	14.8	7.0	5.2	5.3	7.7	10.2	10.6	4.2	5.9	9.7	7.1	7.0	5.5	17.6	19.9	5.3	17.3	4.8	5.3	21.2	7.8	10.7	17.9	0.6	0.3	0.7	0.0	0.5	1.3	1.2	0.7	0.3	0.0	1.9	0.7	1.6	0.0	0.0	1.1	0.3	0.8	0.6	2.5	6.3	6.3	6.2	2.9	2.1	2.0	3.2	2.4	1.5	8.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.7	4.5	3.5	0.0	2.5	1.7	2.4	0.0	0.0	0.0	0.0	6.4	10.7	0.0	0.0	3.5	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.4	0.0	0.0	3.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0
OASL	"OASL1, p59OASL, TRIP14"	ENSG00000135114	"2'-5'-oligoadenylate synthetase like"	Q15646	12	121019111-121039242	"Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.5;bone marrow: 33.1"	"Cell type enriched"	"Detected in many"	4	"Urothelial cells: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 52.2;BJ hTERT+ SV40 Large T+ RasG12V: 26.9;GAMG: 14.8;hTEC/SVTERT24-B: 20.9"	"Not detected"	"Not detected"							HPA001474	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA001474: AB_1079518"	"unprognostic (2.39e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.93e-3)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (4.61e-1)"	"prognostic unfavorable (3.70e-9)"	"unprognostic (2.52e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.17e-2)"	20.5	0.5	1.0	8.3	1.4	33.1	2.7	0.4	1.9	3.6	5.9	1.7	0.1	1.6	1.7	1.3	4.7	0.6	3.1	2.2	0.7	0.9	4.0	22.6	16.5	1.9	1.3	1.2	1.4	0.4	0.2	0.8	3.6	2.3	2.5	3.0	2.3	3.4	0.3	1.1	0.8	2.0	1.1	1.9	5.2	15.7	2.1	0.6	6.0	3.2	3.7	7.6	2.9	1.5	0.8	3.2	44.5	10.8	6.9	23.6	10.8	1.0	0.2	0.0	0.3	0.4	0.9	0.0	0.1	0.5	52.2	26.9	0.0	5.0	0.3	1.5	0.0	14.8	2.7	0.0	0.3	3.8	9.2	0.0	0.0	5.2	0.0	0.3	0.0	0.7	0.3	0.2	20.9	0.0	0.1	0.1	0.3	0.0	1.8	0.2	0.5	0.0	2.7	0.0	1.8	1.1	0.0	0.1	0.6	0.2	4.9	0.0	0.0	0.4	0.2	8.2	0.0	0.1	0.8	0.0	0.2	0.4	0.6	0.1	2.0	3.7	0.0	7.8	0.4	0.1	4.2	10.3	22.4	20.4	10.8	5.3	0.8	14.1	23.6	3.2	0.3	4.0	15.7	44.5	6.9	7.4	0.1	9.9	10.8	1.0	1.4	0.4	1.9	0.7	0.9	1.3	1.2	2.3	0.6	0.0	6.2	0.0	3.8	1.9	0.0	0.3	0.0	4.0	3.4	0.0	0.0	0.2	0.0	2.7	3.1	2.1	4.2	0.0	3.4	0.6	0.5	1.1	11.5	3.9	12.3	0.0	1.7	0.0	4.0	2.5	0.3	6.8	0.0	4.6	15.9	0.0	7.4	3.5	0.0	0.3	0.0	0.0	2.2	1.9	0.1	0.9	0.1	17.3	1.2	72.1
GFM1	"EFGM, EGF1, GFM"	ENSG00000168827	"G elongation factor mitochondrial 1"	Q96RP9	3	158644278-158692575	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034764, HPA034765, HPA061405"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA034764: AB_2674320, HPA034765: AB_10669849, HPA061405: AB_2684505"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.48e-3)"	"unprognostic (4.48e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.75e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.79e-1)"	"prognostic favorable (1.16e-7)"	"unprognostic (1.62e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.32e-2)"	"unprognostic (8.78e-2)"	20.1	23.3	17.6	14.1	18.6	14.7	19.8	32.8	23.4	11.4	20.7	17.8	19.1	18.8	15.4	17.9	16.2	14.3	12.6	27.9	18.0	17.9	34.1	42.2	13.5	13.2	18.9	19.5	13.2	17.0	30.9	16.4	17.4	22.6	15.3	23.3	13.8	16.3	15.4	46.5	15.4	16.0	16.0	18.5	14.2	17.1	19.8	17.8	14.5	21.4	17.6	13.6	15.0	13.2	13.2	16.5	10.8	19.8	16.0	21.1	11.5	30.1	17.3	8.4	10.2	13.5	8.8	11.3	15.6	13.6	21.8	17.1	23.1	18.6	25.9	19.8	11.6	10.4	18.4	18.8	14.5	24.4	14.3	12.7	21.5	11.9	12.8	15.4	27.6	11.7	12.2	17.2	14.1	13.1	6.2	14.6	14.4	22.3	15.9	19.8	16.7	16.2	11.0	19.1	32.4	11.7	15.7	10.1	41.7	17.4	12.7	15.3	14.8	24.6	33.4	26.5	7.0	41.1	22.5	10.7	14.6	7.2	22.8	24.6	30.6	19.3	47.1	13.8	23.2	16.3	10.8	13.2	9.1	16.1	19.8	21.1	13.2	15.0	16.9	16.5	11.9	17.6	18.5	1.9	16.0	14.0	8.6	11.9	11.5	17.6	18.6	32.8	23.4	18.0	17.9	18.9	19.5	22.6	17.8	17.9	14.7	27.9	22.5	19.2	53.1	51.8	17.8	28.1	12.5	12.2	29.5	26.9	10.0	16.6	12.5	28.9	18.2	23.3	21.6	15.7	18.2	17.8	18.5	53.5	25.1	14.3	18.6	25.8	22.5	5.7	21.0	23.4	16.9	31.5	21.4	25.3	16.3	5.8	15.9	31.0	49.5	12.9	21.9	25.1	32.1	18.3	25.7	20.0	24.7	18.2
WDHD1	"AND-1, CHTF4, CTF4"	ENSG00000198554	"WD repeat and HMG-box DNA binding protein 1"	O75717	14	54938950-55027105	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.1"	"Cell type enhanced"	"Detected in many"	9	"Spermatocytes: 10.6;Spermatogonia: 20.5"	"Cancer enhanced"	"Detected in all"		"testis cancer: 23.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000632, HPA001122"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000632: , HPA001122: AB_1080589"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.85e-3)"	"unprognostic (2.33e-4)"	"unprognostic (5.52e-3)"	"unprognostic (7.28e-3)"	"unprognostic (8.05e-3)"	"prognostic unfavorable (9.24e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.67e-4)"	"unprognostic (8.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.36e-2)"	5.0	2.8	6.3	6.6	7.5	10.8	3.8	7.2	4.6	3.7	4.9	2.7	0.6	3.2	4.2	2.9	7.0	4.0	2.3	2.3	3.2	2.3	2.8	2.1	2.9	8.9	3.3	2.5	4.1	2.0	3.0	1.9	6.0	4.4	2.1	7.3	2.6	3.0	2.2	2.0	4.5	3.6	4.6	2.8	4.6	2.8	8.8	3.5	21.1	2.1	6.4	11.2	3.6	4.3	4.8	1.8	4.3	0.9	4.3	4.6	1.6	16.0	10.4	20.6	9.0	2.0	4.9	12.0	15.6	6.7	12.6	15.5	6.9	10.8	18.4	8.0	4.4	9.1	13.7	30.6	9.0	26.6	12.3	5.3	12.1	10.1	6.6	0.8	22.8	9.3	2.5	1.6	15.6	6.1	3.0	8.2	12.0	15.1	9.3	12.1	8.9	21.4	4.5	16.3	8.6	10.8	20.1	29.6	7.1	3.6	10.8	12.0	8.4	16.6	4.2	5.4	15.7	11.3	4.6	5.3	16.1	19.1	11.7	13.2	2.8	5.7	24.6	7.3	11.3	12.6	4.3	0.8	1.4	2.3	0.6	3.2	3.0	2.7	3.3	1.4	4.8	3.3	4.6	1.2	4.3	0.9	1.8	3.9	1.6	6.3	7.5	7.2	4.6	3.2	2.3	3.3	2.5	4.4	3.5	0.0	1.3	2.9	1.5	3.4	2.1	1.5	0.0	4.0	5.7	3.5	0.0	5.8	0.0	1.8	0.5	1.0	0.5	0.0	0.9	8.0	3.1	0.5	0.0	0.8	3.4	3.2	0.0	1.3	1.6	0.8	0.0	2.0	1.7	1.8	2.5	1.5	1.0	0.0	2.8	1.9	3.3	0.0	3.3	10.6	20.5	2.0	2.2	0.0	3.1	0.9
CYP4F11		ENSG00000171903	"Cytochrome P450 family 4 subfamily F member 11"	Q9HBI6	19	15912367-15934867	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 88.6"	"Cell type enhanced"	"Detected in many"	17	"Ductal cells: 13.3;Hepatocytes: 48.8;Urothelial cells: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 7.6;CAPAN-2: 30.3;EFO-21: 11.4;Hep G2: 14.7;RPMI-8226: 7.9;RT4: 9.1"									"HPA017265, CAB033648, HPA058960"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB033648: AB_2088410, HPA017265: AB_1847451, HPA058960: AB_2683862"	"prognostic favorable (4.05e-4)"	"unprognostic (4.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.99e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (4.44e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.78e-2)"	"unprognostic (4.64e-2)"	0.4	2.2	3.6	0.5	4.4	0.5	1.7	1.8	5.4	1.1	2.5	4.4	0.0	7.5	0.5	11.8	7.9	2.2	12.9	0.4	3.9	1.4	4.9	88.6	2.4	0.4	2.1	3.8	0.3	3.5	0.2	0.6	0.2	8.3	2.4	1.9	0.6	2.6	3.4	0.5	0.8	15.7	0.2	9.7	0.9	2.7	1.0	3.0	0.0	2.2	2.8	1.8	4.8	2.0	0.1	0.1	0.8	1.2	0.0	0.2	0.1	7.6	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.1	11.4	0.0	6.5	0.9	0.0	3.9	0.0	0.0	0.0	0.0	2.3	14.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	6.1	0.0	1.1	0.0	0.1	0.0	6.7	0.0	0.0	0.1	7.9	2.1	9.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.1	0.1	0.1	0.1	0.3	0.1	0.2	0.9	0.0	0.8	0.5	0.0	0.1	1.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.7	0.1	0.0	0.1	3.6	4.4	1.8	5.4	3.9	1.4	2.1	3.8	8.3	3.0	0.0	0.0	0.0	7.8	0.1	0.0	0.3	0.0	4.0	1.2	8.7	0.0	0.0	1.7	13.3	0.0	0.0	5.3	0.0	9.9	0.0	0.0	7.8	0.0	48.8	0.0	0.0	1.2	0.0	1.6	0.0	0.3	0.0	0.0	0.0	3.0	2.5	7.5	2.9	0.0	5.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.7	13.3
EI24	"EPG4, PIG8, TP53I8"	ENSG00000149547	"EI24, autophagy associated transmembrane protein"	O14681	11	125569216-125584687	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 164.6"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 494.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 117.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047165, HPA051029"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	"Golgi apparatus"	"HPA047165: AB_2679965, HPA051029: AB_2681317"	"unprognostic (2.04e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.38e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.01e-1)"	13.4	10.2	13.3	8.9	16.2	4.6	16.7	11.2	22.1	12.7	17.0	14.4	13.8	11.3	13.6	12.9	22.7	12.1	15.8	16.4	10.6	10.7	14.6	55.5	12.1	11.2	12.0	11.1	13.1	34.2	164.6	9.2	11.9	11.0	13.7	18.9	13.2	20.9	14.3	26.5	17.2	16.1	15.9	9.2	10.5	17.7	10.4	10.5	9.9	12.0	14.2	13.0	16.2	12.9	8.5	15.5	5.4	7.3	6.5	10.0	4.9	24.5	18.7	21.4	25.8	35.2	26.8	26.8	25.2	19.1	17.4	15.7	28.4	49.7	24.7	42.9	23.7	18.5	28.4	32.5	53.0	22.6	6.5	20.6	117.9	13.4	26.6	26.2	26.6	12.8	25.0	48.6	26.1	38.7	17.2	36.7	13.5	53.5	10.1	24.4	17.3	12.1	13.6	28.2	63.6	20.5	17.8	25.3	21.0	29.0	44.0	20.0	19.2	29.5	35.2	9.5	37.0	71.9	26.5	30.5	22.4	15.2	15.7	20.4	6.3	12.7	32.2	9.8	40.8	29.8	4.1	7.3	5.4	8.2	7.0	8.1	8.5	6.5	10.0	11.6	7.3	9.4	7.6	0.9	6.5	5.1	15.5	9.0	4.9	13.3	16.2	11.2	22.1	10.6	10.7	12.0	11.1	11.0	10.5	29.8	34.7	29.8	114.2	107.2	57.4	55.7	129.9	9.4	27.3	104.7	35.3	140.6	122.7	154.4	19.7	84.2	53.8	0.0	158.4	174.0	83.1	141.9	27.6	494.9	92.4	77.9	94.5	65.1	44.4	33.9	66.2	50.8	86.0	34.3	100.9	68.5	153.1	52.6	67.8	102.8	30.5	45.3	89.6	92.8	109.0	158.6	117.2	35.1	116.3	136.4
ARHGAP42	"AD031, FLJ32810, GRAF3, TMEM133"	ENSG00000165895	"Rho GTPase activating protein 42"	"A6NI28, Q9H2Q1"	11	100687653-100993941	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 38.0"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 44.7;Early spermatids: 72.6;Rod photoreceptor cells: 60.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 23.1;RH-30: 16.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039924, HPA060528"	Uncertain		Approved	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA039924: AB_10674428, HPA060528: AB_2684308"	"unprognostic (1.04e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.03e-1)"	11.1	4.9	6.8	8.9	5.8	0.9	10.4	3.0	7.0	9.8	8.3	4.1	2.3	9.9	11.4	7.7	4.3	5.6	9.5	6.5	8.8	3.8	11.9	12.7	13.7	5.1	6.3	5.3	4.8	2.6	9.1	6.0	38.0	5.9	4.8	8.4	25.5	5.1	3.8	9.0	7.2	12.1	5.8	8.7	8.2	11.7	4.1	6.7	12.7	10.9	7.4	3.8	5.5	7.9	1.5	2.5	0.0	0.0	0.7	0.4	0.3	0.5	3.6	4.6	0.1	2.6	3.5	3.2	0.6	0.9	1.1	2.1	4.4	23.1	0.7	6.5	1.7	4.1	7.8	2.3	1.7	1.1	0.0	2.0	11.2	9.1	1.5	4.6	0.1	0.0	3.3	2.2	4.3	0.7	2.6	1.7	2.8	0.4	0.0	3.5	0.6	1.2	0.0	5.6	6.4	5.7	3.4	16.0	0.4	5.4	15.0	2.5	1.6	7.7	0.3	6.1	10.0	0.8	1.4	3.0	3.0	3.7	3.6	1.7	3.3	0.0	4.5	3.5	2.7	13.1	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.7	0.0	2.5	0.0	0.3	6.8	5.8	3.0	7.0	8.8	3.8	6.3	5.3	5.9	6.7	44.7	4.0	5.1	4.8	2.2	2.6	4.2	10.2	16.0	21.6	3.5	23.6	0.6	1.7	4.1	72.6	2.9	10.0	23.3	3.3	1.8	4.5	10.0	0.0	5.9	1.3	1.6	1.7	9.2	0.3	27.0	1.1	2.2	10.1	0.0	2.8	31.8	6.5	5.7	2.5	15.8	60.0	38.8	12.3	1.9	1.6	3.0	5.4	0.0	2.4	17.3
EPB41L1	"4.1N, KIAA0338"	ENSG00000088367	"Erythrocyte membrane protein band 4.1 like 1"	Q9H4G0	20	36091504-36232799	"Disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 147.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 3.9"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 3.9"	"Cell line enhanced"	"Detected in many"		"A549: 39.5;HaCaT: 58.2;OE19: 45.7;SK-BR-3: 45.6"	"Low region specificity"	"Detected in all"							"HPA054104, HPA056817"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA054104: AB_2682380, HPA056817: AB_2683244"	"unprognostic (2.01e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.76e-2)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (9.30e-4)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.39e-10)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.26e-2)"	23.1	57.8	36.0	3.5	39.5	0.3	10.9	21.5	56.8	18.4	14.0	28.8	7.3	6.2	13.1	14.7	21.5	21.4	18.3	9.4	31.2	34.6	30.5	3.9	13.5	1.9	35.2	39.4	20.2	13.2	16.8	8.7	9.8	45.2	12.9	9.8	9.4	23.9	20.8	4.8	6.5	7.4	12.7	22.3	3.6	27.9	8.2	23.7	0.0	11.4	4.6	6.1	14.9	11.1	0.2	3.9	0.0	0.0	0.0	0.2	0.0	12.6	39.5	14.2	5.2	9.2	5.8	13.3	4.1	9.1	8.6	6.9	26.1	22.8	0.7	6.8	12.6	17.7	58.2	6.5	4.7	6.5	0.1	3.7	0.1	13.2	25.4	2.8	0.0	4.8	5.0	2.3	8.0	0.6	11.1	2.1	3.1	0.6	10.1	7.4	8.1	0.4	0.2	5.4	45.7	12.3	0.6	3.9	15.6	7.4	20.4	5.0	6.1	18.2	45.6	1.6	11.3	11.2	0.5	1.7	10.3	11.2	5.2	0.9	13.3	4.5	0.1	17.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	36.0	39.5	21.5	56.8	31.2	34.6	35.2	39.4	45.2	23.7	14.9	16.6	0.0	5.2	2.6	31.6	7.9	28.1	26.8	17.0	45.4	147.3	1.3	16.6	19.2	2.3	6.8	8.8	0.0	9.5	0.4	6.4	3.9	49.8	0.4	5.7	30.2	14.9	9.2	1.6	2.0	14.7	1.8	3.3	0.0	5.5	22.2	22.2	16.5	39.6	24.9	8.0	32.3	7.5	4.1	3.6	1.5	0.9	0.0	10.6	14.4
XRN1	SEP1	ENSG00000114127	"5'-3' exoribonuclease 1"	Q8IZH2	3	142306607-142448062	"Predicted intracellular proteins"		"DNA-binding, Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"RH-30: 58.4"	"Low region specificity"	"Detected in all"							"HPA035005, HPA035006"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA035005: AB_10670695, HPA035006: AB_10672750"	"unprognostic (3.52e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.43e-2)"	"unprognostic (6.32e-2)"	16.5	12.4	9.9	16.2	15.5	24.4	15.9	23.8	15.7	15.7	17.5	7.5	12.4	14.7	15.2	14.2	13.4	11.5	11.0	10.1	8.4	6.8	9.6	21.7	15.9	16.1	11.7	9.0	17.4	13.2	17.4	26.5	23.6	10.7	12.5	13.0	8.2	14.4	13.3	21.2	17.2	25.0	14.4	15.2	16.2	11.7	11.8	10.9	30.8	12.9	10.8	15.3	15.0	15.2	7.4	6.1	18.3	4.7	4.3	8.4	2.5	10.0	1.9	4.6	3.9	5.2	8.6	2.8	4.7	6.3	6.1	7.6	1.7	3.0	4.0	4.9	6.2	4.9	3.9	4.1	2.4	9.4	10.2	3.1	5.9	3.3	1.6	4.5	5.9	6.0	6.7	2.7	4.4	5.8	5.7	5.5	4.5	3.9	9.6	5.5	1.9	5.1	3.1	1.4	1.4	2.1	4.2	58.4	5.0	2.9	5.1	2.7	3.4	8.4	4.6	3.6	2.9	5.6	4.6	7.4	4.3	2.4	4.9	4.0	13.8	7.0	6.4	4.0	3.1	3.7	18.3	4.7	12.2	8.3	4.2	5.8	7.4	6.4	7.4	2.3	6.0	8.4	5.8	17.2	4.3	4.0	6.1	4.6	2.5	9.9	15.5	23.8	15.7	8.4	6.8	11.7	9.0	10.7	10.9	50.6	26.6	34.1	28.0	22.8	31.5	23.0	17.8	26.8	33.0	43.6	47.1	17.6	10.0	12.9	37.7	26.6	30.0	23.3	11.0	6.0	21.8	33.7	19.8	42.4	14.1	25.4	27.1	36.8	30.0	15.1	23.0	23.1	13.5	26.2	18.5	23.2	15.6	24.6	27.3	12.0	57.0	6.5	17.9	55.7	14.9	24.7	44.7	35.5	13.6	42.3
TNFSF10	"Apo-2L, CD253, TL2, TRAIL"	ENSG00000121858	"TNF superfamily member 10"	P50591	3	172505508-172523507	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 115.1"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 542.5;Exocrine glandular cells: 368.6;Proximal tubular cells: 449.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 42.4;classical monocyte: 25.6;intermediate monocyte: 39.5;neutrophil: 50.3;non-classical monocyte: 38.3"	"Group enriched"	"Detected in all"	5	"granulocytes: 50.3;monocytes: 39.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 21.0;CAPAN-2: 14.9;HaCaT: 14.7;HMC-1: 69.1;RPTEC TERT1: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054938	Uncertain				"Secreted to blood"	NA	NA	67400				"HPA054938: AB_2682643"	"unprognostic (9.16e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.27e-2)"	30.9	22.1	3.4	14.6	4.7	2.0	23.3	3.0	5.4	31.4	25.8	4.4	17.1	20.6	13.0	10.3	33.3	9.6	10.7	9.9	3.8	3.2	115.1	44.4	91.5	23.5	5.5	3.4	13.5	11.6	10.9	6.7	100.8	6.7	37.6	19.5	12.0	50.6	12.9	13.9	13.0	54.0	7.9	5.6	35.8	9.5	6.0	4.6	8.3	28.2	17.7	16.1	22.4	24.0	3.4	9.5	50.3	39.5	9.3	7.0	11.9	3.4	0.1	0.0	0.0	2.4	1.8	21.0	0.0	0.1	1.0	1.6	0.0	14.9	2.1	10.1	0.0	0.9	14.7	0.0	1.8	0.2	5.3	0.0	0.0	0.4	0.3	0.1	3.9	69.1	2.4	2.4	0.4	0.0	0.0	7.6	0.4	0.0	2.5	0.0	0.0	0.5	5.2	0.0	0.1	0.1	0.8	0.0	0.9	34.8	1.3	0.1	0.1	7.7	0.3	0.1	0.1	4.2	2.2	0.3	0.0	0.0	0.0	0.2	2.6	0.3	2.6	0.2	2.2	0.0	42.4	25.6	2.7	2.3	39.5	3.1	3.2	6.4	3.5	9.5	3.4	4.7	1.8	50.3	9.3	38.3	0.6	7.0	11.9	3.4	4.7	3.0	5.4	3.8	3.2	5.5	3.4	6.7	4.6	65.5	119.9	15.2	153.0	19.6	0.1	4.5	63.7	99.0	113.7	62.8	0.0	1.1	38.1	542.5	3.9	163.8	223.5	23.3	368.6	166.3	27.9	96.6	248.5	58.7	22.3	1.6	46.3	140.0	77.7	2.8	17.0	51.4	6.8	16.2	96.5	21.7	249.5	190.0	4.6	449.0	0.8	0.0	10.3	0.0	0.2	22.3	9.2	43.6	68.5	109.1
NOTCH2		ENSG00000134250	"Notch 2"	Q04721	1	119911553-120069626	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Paneth cells: 129.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048743	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		67000000	"Nucleoplasm, Plasma membrane"		"HPA048743: AB_2680508"	"unprognostic (1.33e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.40e-3)"	"unprognostic (7.98e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.24e-4)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.86e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.35e-3)"	12.0	7.3	6.0	9.4	6.8	4.4	10.6	3.0	5.6	14.5	7.6	4.4	11.3	1.6	12.3	11.8	13.4	11.4	12.8	7.9	6.8	2.3	5.5	11.4	10.6	5.7	5.3	7.6	15.5	27.6	6.1	3.3	10.3	6.5	9.9	5.2	9.4	17.7	10.0	9.3	17.2	6.1	12.4	6.2	11.5	5.8	15.7	4.4	8.0	11.4	8.6	6.6	9.6	13.0	4.2	5.2	7.7	9.6	1.5	1.7	2.0	15.0	5.1	7.9	6.1	33.0	28.3	7.9	11.5	15.9	15.4	16.7	4.7	4.1	0.3	9.7	21.8	13.7	5.7	12.5	10.2	24.6	18.1	8.0	8.7	13.7	0.4	12.3	9.1	2.3	22.7	6.6	46.1	30.7	23.3	7.8	4.1	0.1	19.2	18.5	16.9	3.8	2.6	10.2	1.4	5.7	2.5	27.9	9.7	8.1	9.6	0.3	4.0	15.6	14.7	8.3	16.7	8.1	3.1	27.4	20.1	13.9	30.1	18.0	8.0	3.9	4.4	29.5	8.4	19.1	5.6	6.4	6.4	1.5	6.6	1.7	4.2	1.3	1.1	5.2	3.9	1.0	1.7	7.7	1.5	9.6	4.2	0.8	2.0	6.0	6.8	3.0	5.6	6.8	2.3	5.3	7.6	6.5	4.4	32.8	21.6	24.1	40.5	41.1	3.5	11.2	25.5	2.7	13.6	17.4	5.9	1.2	0.0	37.1	15.7	3.7	3.0	0.0	11.3	6.7	53.5	36.6	15.1	35.0	29.9	3.2	5.8	5.5	68.6	9.3	50.9	36.3	37.1	13.6	7.5	46.7	22.9	129.8	80.2	4.3	10.2	19.4	32.3	4.8	3.6	77.8	1.4	13.6	13.8	52.7
NTN4		ENSG00000074527	"Netrin 4"	Q9HB63	12	95657807-95791152	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 76.9"	"Cell type enhanced"	"Detected in many"	15	"Collecting duct cells: 188.5;Ito cells: 457.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"MAIT T-cell: 4.9"	"Lineage enriched"	"Detected in single"	49	"T-cells: 4.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 94.4;hTERT-HME1: 39.1;PC-3: 35.7;TIME: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA049832	Approved				"Secreted to extracellular matrix"	NA	NA					"HPA049832: AB_2680905"	"unprognostic (3.08e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.03e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (2.85e-1)"	"prognostic favorable (8.12e-9)"	"unprognostic (3.52e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.93e-1)"	"prognostic favorable (6.67e-5)"	11.1	8.5	4.0	4.4	6.3	0.0	22.8	1.2	9.0	9.9	8.9	2.5	7.3	3.4	8.2	11.9	10.7	10.7	13.0	27.2	3.9	2.4	35.8	13.6	21.7	0.7	4.1	6.1	28.5	18.2	6.6	4.5	7.7	2.8	24.1	5.4	8.4	14.7	19.6	7.2	3.8	8.7	7.2	2.2	76.9	14.5	6.5	2.2	1.5	6.7	9.7	4.2	14.1	11.9	0.0	0.0	0.0	0.0	0.0	4.9	0.0	4.8	13.3	0.3	0.0	5.4	8.7	0.5	9.2	94.4	12.6	15.1	10.4	9.2	0.0	0.6	19.5	17.2	7.7	0.1	2.7	6.4	0.0	0.8	0.4	2.4	2.0	0.3	0.0	0.0	0.2	8.1	14.5	39.1	13.9	24.7	0.0	0.0	0.0	4.7	3.6	0.0	0.0	0.2	1.4	35.7	0.0	0.1	0.0	12.2	24.8	0.0	0.1	11.2	14.4	0.2	0.4	4.2	0.0	53.7	4.9	1.8	19.1	0.9	0.0	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.0	6.3	1.2	9.0	3.9	2.4	4.1	6.1	2.8	2.2	38.7	99.7	15.7	94.2	4.1	1.9	36.7	40.8	14.7	17.0	188.5	0.0	3.8	5.0	34.9	7.2	20.0	1.7	0.0	24.2	2.0	15.0	61.0	1.1	6.8	0.3	0.0	0.0	457.9	41.5	3.1	2.0	2.5	6.8	1.0	41.2	0.2	37.2	2.9	3.2	38.3	0.0	25.8	33.3	1.9	0.5	1.9	1.4	4.9	5.3	78.5
MT2A	MT2	ENSG00000125148	"Metallothionein 2A"	P02795	16	56608199-56609497	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 626.9"	"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 13602.7;Proximal tubular cells: 7840.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 119.8;HBEC3-KT: 433.2;LHCN-M2: 174.3;U-138 MG: 121.8;U-87 MG: 143.4"															NA	NA						"unprognostic (1.14e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.89e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (5.74e-5)"	"unprognostic (5.69e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (8.59e-2)"	"prognostic unfavorable (2.92e-9)"	"unprognostic (4.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.03e-2)"	177.1	215.4	27.7	49.6	66.6	16.3	58.2	10.3	41.7	23.1	48.1	20.8	12.4	26.0	10.7	37.5	35.8	33.6	48.0	30.8	31.6	23.4	74.6	626.9	53.0	38.7	51.0	13.9	23.3	129.1	2.9	11.4	21.8	95.2	30.4	20.2	15.9	19.5	10.8	184.6	29.6	62.8	21.2	63.4	29.7	30.6	7.6	26.5	0.6	69.6	29.8	15.6	24.6	20.5	3.8	13.1	25.3	26.3	10.5	33.6	18.0	14.2	6.0	0.1	5.0	41.2	60.4	0.8	119.8	62.1	23.5	21.5	0.0	25.2	2.2	16.7	9.6	7.8	15.4	5.3	433.2	9.7	23.0	3.6	2.7	6.1	2.2	19.6	17.3	1.8	37.6	20.2	54.4	21.2	25.0	29.5	0.9	0.1	0.2	174.3	10.2	1.9	23.0	11.5	0.0	56.4	2.0	7.1	0.1	111.2	0.1	2.7	0.6	29.4	10.5	7.9	0.4	1.6	2.2	37.7	121.8	47.3	19.9	34.2	0.1	0.2	0.1	143.4	21.3	7.4	25.3	16.3	21.3	31.9	24.8	21.2	3.8	18.7	33.6	13.1	2.2	13.0	25.8	9.6	10.5	26.3	2.1	30.4	18.0	27.7	66.6	10.3	41.7	31.6	23.4	51.0	13.9	95.2	26.5	276.9	184.4	357.1	1299.4	1628.5	0.0	101.0	481.6	536.7	844.0	1059.0	0.0	515.1	2379.1	658.7	59.6	1015.9	5012.0	654.1	300.4	669.8	642.1	4438.7	248.5	13602.7	257.7	0.0	233.1	1138.6	1133.4	9.2	315.5	831.1	593.9	428.4	2564.2	0.0	802.3	3748.0	69.6	7840.0	0.0	1073.6	3753.4	1.4	12.1	637.9	375.9	600.6	1750.7	336.8
ABCC3	"cMOAT2, EST90757, MLP2, MOAT-D, MRP3"	ENSG00000108846	"ATP binding cassette subfamily C member 3"	O15438	17	50634777-50692252	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 53.5;liver: 66.2"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 262.4;Enterocytes: 161.4;Hepatocytes: 155.5;Paneth cells: 153.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 6.2;non-classical monocyte: 7.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.6"	"Cell line enhanced"	"Detected in many"		"A549: 31.4;CAPAN-2: 24.0;OE19: 34.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB037136, HPA048483"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB037136: AB_477165, HPA048483: AB_2680414"	"unprognostic (1.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.67e-3)"	"unprognostic (6.19e-3)"	"unprognostic (7.44e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (1.60e-3)"	"prognostic unfavorable (4.68e-6)"	"unprognostic (3.42e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.57e-3)"	3.5	36.0	0.4	17.0	0.4	0.5	7.7	0.3	0.4	1.9	23.9	0.8	14.1	10.3	1.6	4.6	5.3	1.0	53.5	0.8	0.4	0.4	13.5	66.2	9.0	10.3	0.6	0.0	1.0	22.2	1.7	0.8	3.5	1.5	5.4	7.7	0.8	4.7	23.6	0.4	4.8	37.0	2.5	4.6	4.9	12.8	1.0	0.0	0.8	4.5	7.0	7.9	7.1	3.5	0.0	1.6	1.3	7.6	0.3	0.5	7.4	2.2	31.4	0.0	0.1	1.8	2.8	0.0	4.2	5.2	0.3	0.3	1.7	24.0	0.0	3.3	8.2	5.9	5.7	0.0	0.4	0.4	0.0	0.0	0.6	13.2	9.5	7.1	0.0	0.0	3.1	2.3	1.2	2.5	3.5	0.5	0.0	0.0	0.0	3.3	7.3	0.0	0.0	0.0	34.9	4.1	0.0	0.0	0.1	13.7	13.6	0.0	0.2	7.6	1.3	0.0	0.0	1.0	0.0	6.9	0.2	1.4	0.1	3.3	0.0	0.0	0.0	3.4	0.0	0.3	0.3	2.8	0.0	0.0	6.2	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	1.3	0.3	7.6	0.2	0.5	7.4	0.4	0.4	0.3	0.4	0.4	0.4	0.6	0.0	1.5	0.0	17.9	5.6	2.4	103.4	8.4	1.2	2.5	262.4	0.0	23.9	14.0	0.0	0.3	5.0	84.3	55.0	1.4	161.4	0.0	92.3	3.0	3.5	62.4	0.0	155.5	27.5	1.6	22.7	4.9	18.2	59.8	8.3	13.8	3.3	4.6	85.5	3.7	82.4	153.0	2.8	7.9	0.1	0.0	5.2	0.7	0.6	9.3	0.8	2.5	66.2	81.6
ARHGAP29	PARG1	ENSG00000137962	"Rho GTPase activating protein 29"	Q52LW3	1	94148988-94275068	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Endothelial cells: 271.0;Glandular cells: 419.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"classical monocyte: 1.6;intermediate monocyte: 2.6;non-classical monocyte: 3.7"	"Lineage enriched"	"Detected in single"	38	"monocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"A-431: 48.5;hTERT-HME1: 43.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026534	Approved		Approved	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Nucleoplasm, Centrosome"	"Plasma membrane, Cytosol"	"HPA026534: AB_1844998"	"unprognostic (2.49e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (6.26e-5)"	"unprognostic (8.53e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (4.42e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.61e-3)"	28.1	3.2	7.2	6.8	10.6	0.3	24.4	34.9	11.5	11.9	7.4	2.3	9.0	2.8	10.3	8.1	6.9	8.2	9.1	15.9	7.8	5.2	27.7	21.1	23.0	8.2	6.7	3.6	11.5	6.5	12.8	7.4	22.9	10.0	12.2	4.7	11.7	20.7	10.4	10.3	13.5	5.4	8.0	6.4	26.0	8.8	7.7	7.0	2.2	22.7	8.9	3.8	10.6	14.8	0.0	0.0	0.0	3.7	0.0	0.0	0.3	48.5	2.0	3.0	0.0	10.6	25.2	10.8	16.3	26.5	13.8	20.2	5.8	2.4	0.0	36.7	32.6	15.8	10.4	0.1	11.1	28.5	0.0	1.6	0.2	2.8	2.6	1.0	0.0	0.0	4.9	2.0	10.5	43.7	16.3	37.2	0.0	0.0	0.0	13.7	1.6	0.9	0.0	3.9	0.2	33.4	0.6	2.5	0.0	29.1	4.3	0.0	0.6	10.0	7.8	0.7	12.2	2.3	0.1	33.3	8.4	11.5	12.9	12.5	0.0	0.0	0.0	1.6	0.0	0.4	0.0	1.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.3	7.2	10.6	34.9	11.5	7.8	5.2	6.7	3.6	10.0	7.0	47.6	17.3	2.9	135.8	20.8	9.7	19.9	25.5	9.4	33.0	123.9	17.7	21.9	46.4	71.3	49.8	271.0	0.0	0.0	14.7	90.4	34.4	419.1	3.5	51.3	2.6	87.4	0.0	176.8	18.6	16.2	22.7	5.6	25.3	0.0	0.9	95.2	37.1	0.0	20.5	47.5	80.7	187.5	197.8	66.2	123.5	15.1	11.8	4.3	0.4	45.2
MYL12B	MRLC2	ENSG00000118680	"Myosin light chain 12B"	O14950	18	3261909-3278284	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039262, HPA045244, HPA059197"	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944"	"unprognostic (2.55e-2)"	"unprognostic (7.31e-2)"	"unprognostic (5.69e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.38e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.18e-1)"	"prognostic favorable (8.17e-5)"	"unprognostic (3.38e-1)"	"unprognostic (3.77e-1)"	"prognostic favorable (6.62e-6)"	"unprognostic (1.27e-2)"	64.1	82.2	38.7	46.1	38.2	41.9	66.1	27.0	48.9	63.9	84.8	21.4	58.7	67.6	52.9	86.8	106.9	49.6	65.2	53.0	37.8	34.0	150.0	105.3	85.9	68.7	36.0	31.9	53.4	48.9	48.4	37.5	139.8	46.8	56.8	75.0	37.1	69.8	52.8	71.8	59.6	129.4	54.7	30.9	62.2	52.8	42.8	26.0	65.1	107.2	89.8	61.1	58.6	61.5	46.7	83.6	151.5	78.1	47.6	77.7	109.0	49.0	26.0	23.1	22.2	67.3	57.4	39.8	74.9	65.9	70.1	72.2	54.5	39.4	24.6	33.0	101.7	52.8	24.9	38.1	86.1	72.0	14.3	16.1	24.8	29.5	43.7	69.4	55.5	39.1	49.4	82.7	46.6	29.8	61.2	104.8	25.3	21.2	24.2	90.8	99.6	31.7	40.1	15.4	58.9	22.3	15.8	29.1	19.7	147.6	91.0	19.0	19.8	74.4	45.3	45.1	39.9	38.7	33.3	126.2	68.1	101.7	59.4	90.6	13.5	12.9	30.0	41.4	22.6	52.9	123.3	51.4	151.5	72.2	68.0	61.4	46.7	70.7	77.7	60.9	37.8	58.0	66.8	120.5	47.6	78.1	83.6	75.2	109.0	38.7	38.2	27.0	48.9	37.8	34.0	36.0	31.9	46.8	26.0	750.4	480.3	216.3	748.4	563.6	73.7	716.9	471.3	642.4	558.4	514.7	23.6	919.9	888.6	1342.8	114.5	450.9	1252.4	93.5	1292.5	904.2	420.1	592.5	429.2	253.2	547.6	62.0	234.2	683.2	403.1	161.2	413.3	509.2	327.3	1202.0	540.9	131.6	1740.8	831.1	407.3	1106.8	72.8	349.3	305.9	216.8	195.5	496.8	1173.0	496.0	458.6	860.6
HNRNPL	HNRPL	ENSG00000104824	"Heterogeneous nuclear ribonucleoprotein L"	P14866	19	38836388-38852347	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB016326, HPA051748, HPA052661"	Supported		Enhanced	Nucleoplasm		NA	NA		130000	Nucleoplasm		"CAB016326: AB_627736, HPA051748: AB_2681588, HPA052661: AB_2681905"	"unprognostic (5.33e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.67e-3)"	"unprognostic (8.99e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (1.45e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (1.96e-11)"	"unprognostic (2.17e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.39e-2)"	44.1	43.3	32.8	47.1	37.1	102.7	40.6	48.9	47.6	38.9	46.2	42.5	35.9	43.7	47.8	34.8	50.1	36.2	42.0	39.7	31.8	31.9	39.9	52.9	43.2	48.0	36.2	32.5	41.6	41.6	36.1	28.1	47.9	34.7	34.6	49.1	35.6	37.5	39.8	44.7	50.7	48.1	49.4	34.3	44.8	38.2	34.9	39.4	102.8	53.0	36.8	67.6	37.9	40.5	3.1	6.2	3.5	3.8	2.2	3.6	1.9	46.2	36.6	46.5	29.9	18.5	21.8	43.9	38.5	26.6	35.8	34.1	39.2	35.6	73.5	31.5	24.7	27.2	28.4	57.3	43.2	53.3	56.6	31.1	60.7	23.3	34.9	19.7	56.0	41.1	23.7	20.5	36.1	35.7	20.5	39.5	32.5	58.8	38.1	37.3	36.6	57.9	34.6	54.7	32.5	25.4	75.3	53.2	46.2	40.1	34.8	39.0	36.2	38.7	30.4	15.5	33.8	39.8	31.2	35.3	35.9	40.9	31.5	55.3	36.6	49.1	82.7	23.1	49.6	39.2	1.1	2.6	1.7	3.5	3.8	2.7	2.2	2.5	2.1	3.5	3.1	2.7	2.2	3.5	2.2	2.8	6.2	3.6	1.9	32.8	37.1	48.9	47.6	31.8	31.9	36.2	32.5	34.7	39.4	20.8	57.5	59.4	53.2	31.5	76.3	16.1	20.4	25.4	36.4	21.0	60.9	36.1	6.6	30.0	12.1	37.0	50.9	0.0	38.1	29.7	32.6	50.4	38.1	62.1	23.8	31.8	60.4	42.4	60.8	8.9	26.2	37.5	25.3	31.5	62.4	41.8	34.9	35.1	21.2	17.8	69.2	19.4	36.3	19.1	19.6	41.5	43.7	49.8	62.6	36.9
SLC6A14		ENSG00000268104	"Solute carrier family 6 member 14"	Q9UN76	X	116436622-116461458	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		Obesity	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 17.8;pituitary gland: 14.4;salivary gland: 26.3;tongue: 23.5"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 2: 100.3;Club cells: 33.0;Exocrine glandular cells: 28.5;Pancreatic endocrine cells: 101.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.8;Hep G2: 8.2;OE19: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003193	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA003193: AB_2190122"	"unprognostic (3.06e-2)"	"unprognostic (3.55e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (1.34e-2)"		"unprognostic (3.89e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	5.9	0.0	0.0	6.3	0.8	0.0	11.8	0.4	0.1	0.0	1.8	0.0	1.0	0.0	0.0		0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.2	0.5	0.3	0.0	26.3	5.8	0.0	1.1	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	23.5	1.2	1.0	1.0	0.4	0.2	1.1	0.4	0.3	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	3.8	8.2	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	3.0	0.0	0.2	0.0	0.5	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.2	0.0	1.4	0.5	0.0	0.0	0.1	0.0	1.1	0.4	0.5	0.4	0.1	0.3	0.4	0.2	0.2	0.1	0.4	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.0											20.8	100.3	0.0	0.1	0.1	0.0	0.2	0.0	10.7	33.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.2	0.0	28.5	0.0	0.0	5.2	3.5	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.1	0.0	101.5	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1.0	3.2
ZC3H15	LEREPO4	ENSG00000065548	"Zinc finger CCCH-type containing 15"	Q8WU90	2	186486156-186509363	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031099, HPA031100, HPA031101"	Enhanced		Enhanced	Cytosol		NA	Yes			Cytosol		"HPA031099: AB_10599418, HPA031100: AB_2257403, HPA031101: AB_10611669"	"unprognostic (1.51e-1)"	"prognostic unfavorable (6.45e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.11e-3)"	"unprognostic (5.92e-2)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (1.48e-7)"	"unprognostic (9.08e-3)"	"unprognostic (4.95e-2)"	"prognostic favorable (3.98e-4)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (5.72e-3)"	"unprognostic (5.69e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.89e-2)"	"unprognostic (3.45e-2)"	25.2	31.1	35.7	25.2	40.1	67.3	38.0	32.9	52.6	24.7	24.7	10.5	30.2	29.0	25.1	30.7	28.2	19.8	22.6	25.2	60.0	35.4	32.8	40.3	20.3	29.5	32.3	33.5	24.5	32.7	26.9	35.3	29.4	51.6	24.3	28.9	10.7	25.8	26.2	58.0	27.0	29.9	27.4	43.4	28.5	23.3	23.7	21.7	28.3	30.5	19.0	30.1	30.0	38.8	32.8	31.1	28.3	39.1	32.5	36.9	22.4	27.2	18.5	22.9	29.4	26.1	26.5	34.4	30.4	20.8	28.2	25.5	53.9	22.1	37.2	27.9	21.5	36.2	19.9	42.1	37.1	40.0	33.8	32.2	53.4	28.6	59.6	35.3	54.3	32.8	21.6	41.2	30.6	43.6	24.9	30.2	23.2	51.0	29.2	29.4	24.5	34.6	38.8	43.2	36.0	46.9	27.7	31.0	34.6	35.7	33.3	27.7	20.4	19.2	26.3	43.9	36.0	18.5	39.6	25.9	31.9	27.6	19.5	36.2	25.5	42.7	53.2	28.3	38.6	27.8	28.3	27.5	26.9	27.2	34.0	33.7	32.8	33.8	34.5	31.1	24.7	31.5	33.2	16.8	32.5	39.1	27.5	36.9	22.4	35.7	40.1	32.9	52.6	60.0	35.4	32.3	33.5	51.6	21.7	68.5	78.9	141.2	127.1	188.5	73.2	87.6	66.2	78.9	102.4	109.9	56.9	114.7	217.2	91.2	123.7	87.8	121.8	46.7	90.4	141.8	94.0	129.7	109.7	114.6	109.7	54.0	97.5	65.7	86.1	224.0	72.8	100.6	60.8	118.2	99.1	80.5	96.4	97.7	82.0	189.8	120.6	32.3	103.2	184.4	186.8	182.8	148.5	83.7	117.5	153.1
NUF2	"CDCA1, CT106, NUF2R"	ENSG00000143228	"NUF2, NDC80 kinetochore complex component"	Q9BZD4	1	163266576-163355764	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 38.6;testis: 29.0"	"Cell type enriched"	"Detected in many"	5	"Spermatocytes: 232.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA059692, HPA076604"			Supported	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			Nucleoplasm	"Kinetochore, Cytosol"	"HPA059692: AB_2684103, HPA076604: "	"unprognostic (9.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.04e-5)"	"prognostic unfavorable (9.16e-4)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (3.70e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.96e-2)"	1.3	0.9	0.8	9.8	0.9	14.1	0.6	0.5	0.9	1.4	2.5	0.6	0.9	2.3	0.6	2.1	6.1	0.5	0.7	1.5	0.8	0.6	0.7	0.6	1.9	9.9	0.8	0.6	0.7	0.4	0.3	0.4	3.6	0.7	0.6	2.9	0.8	1.3	0.0	0.5	2.2	3.2	1.0	1.4	4.4	1.6	29.0	0.3	38.6	0.5	5.1	9.2	1.5	1.8	1.4	0.6	2.6	0.2	3.0	7.7	1.0	26.3	9.2	24.5	10.2	0.7	2.5	13.3	16.7	11.8	27.2	23.9	7.0	23.3	22.7	14.0	6.7	11.3	15.5	14.9	6.3	34.5	23.7	10.7	8.9	10.6	10.0	0.0	15.3	18.4	0.3	0.6	13.7	9.7	5.1	12.3	22.3	16.7	31.5	25.7	5.1	27.9	20.6	13.3	19.4	14.2	19.0	21.4	20.1	7.7	3.6	18.3	21.1	8.9	9.7	9.2	15.9	14.9	32.1	8.7	20.3	22.8	15.2	33.6	22.6	31.8	43.3	6.7	12.6	22.4	2.6	0.2	2.5	2.4	0.1	1.0	1.2	3.6	2.4	0.5	1.4	2.5	2.1	0.9	3.0	0.2	0.6	7.7	1.0	0.8	0.9	0.5	0.9	0.8	0.6	0.8	0.6	0.7	0.3	0.0	0.3	3.7	1.8	5.3	1.0	0.8	0.0	0.0	4.5	0.0	0.0	2.7	0.0	0.7	15.8	0.1	0.8	46.7	0.2	23.9	1.8	0.4	4.6	0.2	11.3	0.0	0.0	1.8	3.7	10.7	2.3	2.5	0.0	1.0	0.9	2.5	0.2	0.0	2.1	0.0	2.0	6.5	0.5	232.2	40.5	2.0	3.3	3.8	2.2	1.4
GMNN	Gem	ENSG00000112312	"Geminin, DNA replication inhibitor"	O75496	6	24774931-24786099	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle"	"DNA replication inhibitor"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 95.0"	"Cell type enhanced"	"Detected in many"	8	"Paneth cells: 272.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011458, CAB047327, CAB047328, HPA049977, HPA054597"	Enhanced		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"CAB011458: AB_2110946, CAB047327: , CAB047328: , HPA049977: AB_2680978, HPA054597: AB_2682538"	"unprognostic (1.37e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.91e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.90e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.23e-3)"	"prognostic favorable (4.13e-4)"	"prognostic unfavorable (9.77e-4)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (7.82e-5)"	"unprognostic (2.25e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.90e-3)"	4.5	3.9	10.7	11.2	19.0	24.1	10.7	15.6	9.4	4.9	17.1	3.2	9.7	7.6	5.3	6.3	8.0	7.3	4.7	3.7	11.0	10.2	10.8	8.4	4.4	12.0	13.6	9.8	7.2	95.0	2.6	7.5	7.9	10.7	18.4	18.9	3.4	4.2	11.6	3.7	17.3	7.4	5.7	7.9	12.6	9.7	19.6	11.9	26.1	13.2	11.0	9.7	15.2	7.4	8.5	9.2	15.8	6.7	5.3	15.2	5.6	24.9	14.8	37.6	15.5	5.3	5.7	25.1	24.5	13.0	29.5	32.4	28.7	9.0	25.1	31.3	7.9	21.7	14.7	32.5	18.1	31.8	9.3	34.0	34.4	26.4	47.0	5.0	26.7	12.6	4.6	5.9	17.9	7.0	6.1	14.5	19.6	43.2	13.4	20.8	19.5	50.1	28.9	20.5	20.4	11.7	29.2	29.4	32.2	12.4	21.8	30.2	18.6	11.0	18.2	21.6	22.1	19.1	16.4	7.1	18.1	18.3	20.8	41.5	14.9	45.7	47.1	5.5	50.4	25.9	5.3	5.3	15.8	4.6	6.7	5.8	8.5	8.9	7.1	7.4	4.5	6.6	7.3	3.0	5.3	4.7	9.2	15.2	5.6	10.7	19.0	15.6	9.4	11.0	10.2	13.6	9.8	10.7	11.9	6.0	14.1	15.7	25.3	29.3	8.9	9.4	15.3	33.5	52.4	41.8	2.0	52.0	8.3	78.3	58.9	14.3	21.2	0.0	100.1	110.5	15.8	27.7	12.7	15.3	45.0	11.1	24.9	9.8	9.2	17.5	8.9	12.4	21.9	19.8	24.9	29.4	43.9	272.7	10.3	14.6	12.1	19.4	12.3	132.2	59.4	55.6	40.7	17.5	87.0	19.7
OSBPL8	"MST120, MSTP120, ORP8, OSBP10"	ENSG00000091039	"Oxysterol binding protein like 8"	Q9BZF1	12	76351797-76559809	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"granulocytes: 242.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001309	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA001309: AB_1079530"	"unprognostic (2.55e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.84e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.19e-3)"	29.3	11.4	13.9	18.4	41.9	23.1	17.2	13.7	20.2	20.0	11.5	6.8	8.4	7.5	18.5	10.7	20.1	10.4	15.0	19.3	13.4	12.9	30.2	15.2	20.5	22.7	12.1	13.2	14.9	11.2	12.4	16.5	14.4	13.9	16.2	9.7	9.2	15.8	11.1	21.5	22.9	12.6	15.5	14.8	24.9	12.4	12.8	14.7	41.0	11.7	10.6	24.8	18.0	24.5	11.7	15.8	57.2	15.0	9.9	10.9	8.1	12.4	8.0	17.8	12.6	24.8	35.1	11.3	19.2	27.0	12.4	11.3	11.5	5.2	17.5	11.0	22.8	7.7	5.2	13.2	11.1	18.7	14.9	11.7	46.9	7.9	6.8	15.3	29.7	19.1	18.5	21.2	18.4	23.0	22.3	10.6	10.2	32.1	8.1	20.3	8.6	19.8	14.1	8.7	4.5	7.9	10.4	24.3	10.0	9.5	10.6	9.7	10.2	16.4	6.0	11.9	14.6	4.6	18.1	24.8	20.0	10.0	20.6	10.3	8.1	12.7	19.3	7.6	16.7	11.6	27.5	15.0	20.1	9.0	10.8	8.5	11.7	9.6	7.3	13.2	11.6	8.7	7.1	57.2	9.9	11.7	15.8	10.9	8.1	13.9	41.9	13.7	19.9	13.4	12.9	12.1	13.2	13.9	14.7	53.6	69.1	48.0	37.5	103.3	37.1	37.6	20.4	40.2	34.2	48.8	84.4	28.5	51.4	49.5	35.1	65.2	13.0	23.3	47.9	23.5	68.6	48.2	242.1	32.5	69.5	39.7	9.1	50.3	88.2	15.3	60.9	125.5	33.7	85.6	23.5	51.8	73.4	24.6	77.8	126.3	27.5	45.3	89.0	45.6	131.8	108.8	40.3	78.4	14.9	59.7
FGF2	FGFB	ENSG00000138685	"Fibroblast growth factor 2"	P09038	4	122826708-122898236	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Fibroblasts: 12.4;Smooth muscle cells: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 57.4;BJ hTERT+: 33.7;fHDF/TERT166: 62.3;hTERT-HME1: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000125, HPA065502"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Secreted in other tissues"	NA	NA	92500		"Nucleoplasm, Nuclear bodies"		"CAB000125: , HPA065502: "	"unprognostic (1.53e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.33e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (3.37e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.45e-3)"	28.1	3.8	19.4	6.9	21.3	0.7	12.1	6.5	15.3	10.2	14.2	10.3	1.9	2.6	17.9	6.3	6.4	10.1	9.4	5.6	17.1	11.0	5.5	2.9	8.3	2.5	9.9	10.7	16.8	2.4	10.1	4.0	8.1	18.6	10.3	5.6	7.5	4.6	11.9	2.0	2.3	4.1	16.2	17.3	1.9	7.6	3.0	12.3	0.0	3.1	3.8	2.7	7.5	14.5	0.8	0.8	0.5	0.5	0.3	1.0	0.0	1.2	3.1	1.8	6.9	4.4	7.4	0.0	57.4	33.7	24.1	14.0	0.0	0.1	0.0	6.7	62.3	19.0	0.2	1.8	0.1	24.3	4.5	0.8	0.0	6.5	0.0	13.0	0.3	0.0	3.9	0.4	23.8	34.4	12.1	2.6	0.0	1.7	1.9	6.2	0.0	0.0	0.0	5.2	0.0	1.4	0.0	0.9	0.0	7.6	0.0	1.0	0.9	11.1	0.0	0.4	10.8	0.0	0.1	2.4	20.0	3.9	7.4	4.9	3.4	3.6	0.0	5.7	0.0	2.1	0.5	0.5	0.4	0.3	0.4	0.2	0.4	0.5	0.4	0.2	0.8	0.7	1.0	0.4	0.3	0.4	0.8	0.7	0.0	19.4	21.3	6.5	15.3	17.1	11.0	9.9	10.7	18.6	12.3	6.0	0.0	0.0	1.5	1.4	3.5	3.9	0.0	0.0	2.3	7.0	0.0	1.8	3.3	6.9	8.7	5.8	0.0	0.0	0.8	0.0	12.4	5.2	0.0	0.4	0.4	0.0	1.7	7.4	0.0	2.5	9.2	0.9	5.0	1.0	0.0	8.4	6.7	0.0	7.8	0.4	1.8	0.0	15.5	3.1	0.2	1.1	4.0	0.0	0.0	0.3
TC2N	"C14orf47, C2CD1, FLJ36557, MTAC2D1, Tac2-N"	ENSG00000165929	"Tandem C2 domains, nuclear"	Q8N9U0	14	91779751-91867536	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 100.1"	"Cell type enhanced"	"Detected in many"	7	"Exocrine glandular cells: 183.3;Pancreatic endocrine cells: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 32.2"	"Group enriched"	"Detected in many"	46	"NK-cells: 12.9;T-cells: 32.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.8;OE19: 31.5;RT4: 18.5;SK-BR-3: 22.5;T-47d: 11.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA027549	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA027549: AB_10603346"	"unprognostic (5.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.17e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.44e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (9.86e-4)"	"unprognostic (3.00e-1)"	"prognostic favorable (4.13e-5)"	"unprognostic (6.82e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.09e-2)"	6.6	1.5	0.9	15.8	0.9	1.9	12.3	0.4	1.9	8.9	10.2	0.6	16.7	5.4	7.6	7.0	11.6	5.4	24.9	4.7	0.9	1.0	3.7	6.8	13.5	11.3	0.8	0.5	5.5	100.1	12.4	8.4	13.1	1.6	9.3	7.0	6.6	29.8	20.1	2.1	6.9	11.7	3.2	1.1	12.3	10.8	4.9	0.1	8.7	10.3	5.8	27.9	8.3	9.5	0.2	0.0	0.4	0.0	12.9	32.2	7.7	4.5	0.7	0.0	0.0	0.8	0.0	6.3	0.0	0.1	0.0	0.0	3.2	9.8	3.0	0.2	0.0	0.1	0.5	4.5	4.6	0.0	0.0	2.4	0.0	1.2	0.0	0.0	0.0	0.0	0.1	4.7	0.0	0.2	0.0	0.0	0.2	0.0	2.4	0.0	8.1	0.0	0.0	0.6	31.5	0.0	0.0	0.0	0.0	2.2	18.5	3.4	0.0	0.4	22.5	0.0	1.3	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.7	0.0	32.2	0.2	16.2	18.6	0.0	0.1	13.3	11.0	0.4	12.9	0.0	0.0	5.2	7.7	0.9	0.9	0.4	1.9	0.9	1.0	0.8	0.5	1.6	0.1	38.7	70.6	6.7	26.4	47.5	0.0	0.7	30.6	68.3	59.1	24.4	0.0	0.9	1.7	55.7	12.8	4.0	23.4	0.0	183.3	3.0	10.8	49.3	6.9	0.8	0.2	0.0	30.5	5.5	1.0	21.7	52.6	2.2	57.3	1.0	54.7	3.7	110.5	40.8	12.0	7.7	0.0	0.0	4.3	35.2	8.1	72.1	4.6	54.6	33.0	58.8
ROCK1	p160ROCK	ENSG00000067900	"Rho associated coiled-coil containing protein kinase 1"	Q13464	18	20946906-21111851	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 335.7;Late spermatids: 390.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004562, HPA007567, HPA045639"	Approved					NA	NA		240000			"CAB004562: AB_628223, HPA007567: AB_1856393, HPA045639: AB_2679401"	"unprognostic (7.86e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.89e-3)"	"prognostic unfavorable (9.93e-4)"	"unprognostic (3.85e-2)"	"unprognostic (8.93e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.28e-1)"	19.3	9.7	9.7	16.3	9.7	40.0	15.1	18.3	11.0	13.9	12.6	7.1	14.4	10.1	16.0	14.9	13.3	14.4	11.7	11.9	10.3	5.6	10.5	9.2	17.0	20.5	10.1	6.0	13.7	9.5	11.2	12.2	11.5	10.3	14.2	9.4	9.5	9.4	9.8	7.9	8.5	11.6	27.7	10.7	17.3	12.0	6.6	12.4	24.8	10.9	9.6	11.2	17.9	21.0	5.4	5.3	17.9	5.0	2.6	5.1	2.0	6.4	4.0	4.0	3.9	7.6	8.2	6.6	9.0	4.4	4.0	4.4	6.7	2.8	8.0	6.5	10.6	2.2	5.3	3.6	5.2	8.2	11.3	4.2	6.4	7.4	2.9	3.9	17.6	10.0	5.9	4.8	6.0	4.9	3.3	6.1	3.2	3.6	8.3	4.7	4.1	8.3	3.8	3.4	4.3	6.8	11.8	4.7	3.1	3.9	6.0	4.7	3.7	7.2	4.9	3.6	3.8	4.8	6.7	10.1	8.2	6.8	7.3	7.3	11.4	5.1	9.2	6.1	7.6	5.0	2.8	5.0	6.3	5.1	3.1	4.1	3.7	3.8	3.9	4.0	5.4	3.7	3.6	17.9	2.6	3.6	5.3	3.2	2.0	9.7	9.7	18.3	11.0	10.3	5.6	10.1	6.0	10.3	12.4	89.3	78.4	61.5	52.6	41.1	96.1	123.9	25.5	57.6	86.4	31.4	123.7	47.6	13.3	52.8	335.7	72.9	30.7	0.0	33.3	52.8	65.1	50.5	69.5	41.2	54.5	57.2	95.0	46.1	128.2	390.9	90.3	132.9	62.4	85.6	37.7	47.5	51.9	60.4	130.4	14.9	135.4	168.1	157.5	68.9	76.9	32.0	35.9	96.4	35.1	57.6
PHF6	"BFLS, BORJ, CENP-31, KIAA1823, MGC14797"	ENSG00000156531	"PHD finger protein 6"	Q8IWS0	X	134373253-134428791	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation, Epilepsy, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001023	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA001023: AB_1079606"	"unprognostic (2.38e-3)"	"unprognostic (8.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-3)"	"unprognostic (5.20e-3)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (9.96e-4)"	"unprognostic (1.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.84e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	7.4	19.3	10.2	14.1	12.2	6.5	9.7	18.2	13.5	8.7	8.0	11.6	20.3	7.8	9.0	30.1	11.5	7.3	6.1	7.2	11.0	11.1	9.9	7.5	8.4	20.4	12.5	9.3	30.7	10.4	24.1	18.1	8.2	13.3	8.6	9.5	5.4	11.3	16.8	6.2	7.4	10.2	8.1	17.1	17.8	8.1	8.3	14.4	30.2	11.8	6.0	25.0	8.9	9.8	18.4	11.0	5.3	7.4	9.6	9.9	5.0	11.5	9.6	42.3	17.3	7.9	10.1	8.0	11.6	9.3	12.5	15.5	5.7	12.0	18.6	26.7	7.0	12.2	10.4	29.5	13.1	21.1	15.1	13.7	18.0	16.5	6.6	8.4	17.9	10.0	6.7	10.0	13.6	17.0	12.6	17.4	18.2	13.2	9.2	15.3	7.6	28.9	8.9	12.9	15.8	13.0	28.5	15.4	14.1	13.3	14.0	14.7	17.2	8.9	8.2	12.2	13.1	7.7	9.9	13.2	11.7	8.4	14.6	17.8	4.7	10.9	25.1	7.6	21.4	14.5	5.3	6.1	3.7	7.9	6.0	8.5	18.4	8.2	7.1	8.8	12.8	9.9	8.2	2.5	9.6	7.4	11.0	8.3	5.0	10.2	12.2	18.2	13.5	11.0	11.1	12.5	9.3	13.3	14.4	20.8	17.3	24.1	12.5	11.6	21.9	13.7	7.6	16.0	13.6	15.7	17.7	9.9	19.9	12.5	2.6	14.3	7.9	0.0	11.8	6.8	11.3	10.2	23.2	12.7	13.2	17.5	10.9	19.6	12.6	2.1	19.2	15.3	6.8	19.0	13.4	25.6	12.4	15.0	14.5	16.5	18.2	25.8	9.2	4.6	17.9	10.0	3.9	22.0	16.6	11.0
